@prefix ns1: <https://1145.am/db/> .
@prefix org: <http://www.w3.org/ns/org#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://1145.am/db/2211610/Matt_Cutts> a org:Organization ;
    ns1:basedInHighGeoName "Mountain View" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5375480/about.rdf> ;
    ns1:basedInHighRaw "MOUNTAIN VIEW, Calif." ;
    ns1:description "search quality group at Google" ;
    ns1:documentDate "2012-01-26T14:30:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "drchrono Closes New Funding Round Led by Yuri Milner; Google's Matt Cutts Joins as New Investor" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/drchrono-closes-new-funding-round-led-by-yuri-milner-google-s-matt-cutts-joins-as-new-investor-0> ;
    ns1:foundName "Matt Cutts" ;
    ns1:investor <https://1145.am/db/2211610/Investment_Matt_Cutts_Yuri_Milner_Drchrono_Completed> ;
    ns1:name "Matt Cutts" ;
    ns1:sameAsMedium <https://1145.am/db/1876308/Matt_Cutts>,
        <https://1145.am/db/2211653/Matt_Cutts> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2211610/Yuri_Milner> a org:Organization ;
    ns1:basedInHighGeoName "Mountain View" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5375480/about.rdf> ;
    ns1:basedInHighRaw "MOUNTAIN VIEW, Calif." ;
    ns1:description "Internet investor" ;
    ns1:documentDate "2012-01-26T14:30:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "drchrono Closes New Funding Round Led by Yuri Milner; Google's Matt Cutts Joins as New Investor" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/drchrono-closes-new-funding-round-led-by-yuri-milner-google-s-matt-cutts-joins-as-new-investor-0> ;
    ns1:foundName "Yuri Milner" ;
    ns1:industry "Internet" ;
    ns1:investor <https://1145.am/db/2211610/Investment_Matt_Cutts_Yuri_Milner_Drchrono_Completed> ;
    ns1:name "Yuri Milner" ;
    ns1:sameAsHigh <https://1145.am/db/1795658/Yuri_Milner>,
        <https://1145.am/db/1865235/Yuri_Milner>,
        <https://1145.am/db/2211653/Yuri_Milner> ;
    ns1:sameAsMedium <https://1145.am/db/1792284/Yuri_Milner>,
        <https://1145.am/db/1818901/Yuri_Milner>,
        <https://1145.am/db/1834604/Yuri_Milner>,
        <https://1145.am/db/1861010/Yuri_Milner>,
        <https://1145.am/db/1872766/Yuri_Milner>,
        <https://1145.am/db/1873680/Yuri_Milner>,
        <https://1145.am/db/1881980/Yuri_Milner>,
        <https://1145.am/db/1891907/Yuri_Milner>,
        <https://1145.am/db/2333119/Yuri_Milner>,
        <https://1145.am/db/2356396/Yuri_Milner>,
        <https://1145.am/db/2359655/Yuri_Milner> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2248746/Debt_Investment_Digital_Assent_Silicon_Valley_Bank_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-10-14T12:21:09+00:00"^^xsd:dateTime ;
    ns1:documentExtract "ATLANTA, Oct. 14, 2011 /PRNewswire/ - Digital Assent, provider of the award-winning PatientPad® self-service patient check-in and patient education solution, has secured $ 2.5 million in debt financing from Silicon Valley Bank." ;
    ns1:documentTitle "Digital Assent Secures $2.5 Million Debt Financing from Silicon Valley Bank" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/digital-assent-secures-2-5-million-debt-financing-from-silicon-valley-bank> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2248746/Digital_Assent>,
        <https://1145.am/db/2248746/Silicon_Valley_Bank> ;
    ns1:targetDetails "debt" ;
    ns1:valueRaw "$ 2.5 million" ;
    ns1:when "2011-10-14T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Oct. 14, 2011" ;
    ns1:whereGeoName "Atlanta" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4180439/about.rdf> ;
    ns1:whereRaw "ATLANTA" .

<https://1145.am/db/2263286/Anthem_Blue_Cross_Foundation> a org:Organization ;
    ns1:basedInLowRaw "LOS ANGELES" ;
    ns1:documentDate "2011-10-13T18:10:24+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Arthritis Foundation and Anthem Blue Cross Foundation Join Forces to Improve Lives of Those with Arthritis" ;
    ns1:documentURL <https://www.fiercehealthcare.com/payer/arthritis-foundation-and-anthem-blue-cross-foundation-join-forces-to-improve-lives-those> ;
    ns1:foundName "Anthem Blue Cross Foundation" ;
    ns1:investor <https://1145.am/db/2263286/Investment_Anthem_Blue_Cross_Foundation_The_Arthritis_Foundation_Has_Not_Happened> ;
    ns1:name "Anthem Blue Cross Foundation" ;
    ns1:sameAsMedium <https://1145.am/db/2001118/Anthem_Blue_Cross_Foundation> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2294263/Bain_Capital> a org:Organization ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:buyer <https://1145.am/db/2294263/Nobel_Biocare_Acquisition> ;
    ns1:documentDate "2011-10-24T14:06:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Nobel Biocare rises on buyout talks" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nobel-biocare-rises-buyout-talks> ;
    ns1:foundName "Bain",
        "Bain Capital" ;
    ns1:industry "private equity" ;
    ns1:name "Bain",
        "Bain Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1061433/Carlyle_Group>,
        <https://1145.am/db/107233/Bain_Capital>,
        <https://1145.am/db/107823/Bain_Capital>,
        <https://1145.am/db/108315/Bain_Capital>,
        <https://1145.am/db/1231520/Bain_Capital>,
        <https://1145.am/db/1233857/Bain_Capital_Private_Equity>,
        <https://1145.am/db/1262038/The_Carlyle_Group_Inc>,
        <https://1145.am/db/1296521/Bain_Capital>,
        <https://1145.am/db/1304663/Bain_Capital>,
        <https://1145.am/db/1347902/Bain_Capital>,
        <https://1145.am/db/1407766/Carlyle>,
        <https://1145.am/db/1488199/Carlyle_Group_Inc>,
        <https://1145.am/db/149696/Bain_Cd___R_Capvest>,
        <https://1145.am/db/1504328/Bain_Capital>,
        <https://1145.am/db/1666853/Carlyle_Group_Inc>,
        <https://1145.am/db/174026/Bain_Capital_Credit_Lp>,
        <https://1145.am/db/1947365/Bain_Capital>,
        <https://1145.am/db/1953912/Bain_Capital>,
        <https://1145.am/db/1977165/Carlyle_Group_Inc>,
        <https://1145.am/db/2029466/Bain_Capital>,
        <https://1145.am/db/2037629/Bain_Capital>,
        <https://1145.am/db/2044139/Carlyle_Group_Inc>,
        <https://1145.am/db/2045937/Bain_Capital>,
        <https://1145.am/db/2058459/Bain_Capital>,
        <https://1145.am/db/2065337/Bain_Capital>,
        <https://1145.am/db/2078008/Bain_Capital>,
        <https://1145.am/db/2087549/Bain_Capital>,
        <https://1145.am/db/2131372/Bain_Capital>,
        <https://1145.am/db/2182571/Bain_Capital>,
        <https://1145.am/db/2183330/Bain_Capital>,
        <https://1145.am/db/2201813/The_Carlyle_Group>,
        <https://1145.am/db/2220962/The_Carlyle_Group>,
        <https://1145.am/db/2290211/Bain_Capital>,
        <https://1145.am/db/241206/Carlyle_Investment_Management>,
        <https://1145.am/db/2454447/Bain_Capital>,
        <https://1145.am/db/2454954/Bain_Capital>,
        <https://1145.am/db/2558602/The_Carlyle_Group>,
        <https://1145.am/db/2650891/Bain>,
        <https://1145.am/db/2669868/Bain_Capital_Partners>,
        <https://1145.am/db/2670932/Bain_Capital_Partners>,
        <https://1145.am/db/2677923/Bain_Capital>,
        <https://1145.am/db/2786448/Carlyle>,
        <https://1145.am/db/2795655/Carlyle_Group>,
        <https://1145.am/db/2796885/Bain_Capital>,
        <https://1145.am/db/282976/Bain_Capital>,
        <https://1145.am/db/314073/Bain_Capital>,
        <https://1145.am/db/318189/Bain_Capital>,
        <https://1145.am/db/332624/Bain_Capital>,
        <https://1145.am/db/366024/Bain_Capital_Ventures>,
        <https://1145.am/db/4846/Bain_Capital>,
        <https://1145.am/db/575267/Bain_Capital>,
        <https://1145.am/db/584785/Bain_Capital>,
        <https://1145.am/db/597186/Bain_Capital>,
        <https://1145.am/db/636735/Bain_Capital>,
        <https://1145.am/db/638301/Bain_Capital>,
        <https://1145.am/db/644370/Bain_Capital>,
        <https://1145.am/db/685346/Bain_Capital>,
        <https://1145.am/db/688790/Bain_Capital>,
        <https://1145.am/db/770904/Bain_Capital>,
        <https://1145.am/db/834407/Carlyle>,
        <https://1145.am/db/945087/Bain_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1050813/Bain_Capital_Ventures>,
        <https://1145.am/db/1051836/Bain_Capital_Ventures>,
        <https://1145.am/db/1052283/Bain_Capital_Ventures>,
        <https://1145.am/db/1068867/Bain_Capital_Ventures>,
        <https://1145.am/db/107857/Bain_Capital>,
        <https://1145.am/db/1113091/Bain_Capital>,
        <https://1145.am/db/112816/Bain_Capital>,
        <https://1145.am/db/112896/Bain_Capital>,
        <https://1145.am/db/113387/Bain_Capital>,
        <https://1145.am/db/1138640/Bain_Capital_Ventures>,
        <https://1145.am/db/1138679/Bain_Capital_Ventures>,
        <https://1145.am/db/1140692/Bain_Capital_Ventures>,
        <https://1145.am/db/1223138/Bain_Capital>,
        <https://1145.am/db/1233321/Bain_Capital_Ventures>,
        <https://1145.am/db/1250558/Bain_Capital>,
        <https://1145.am/db/1263825/Bain_Capital_Ventures>,
        <https://1145.am/db/1423487/Bain_Capital_Ventures>,
        <https://1145.am/db/1462982/Bain_Capital>,
        <https://1145.am/db/147714/Bain_Capital_Ventures>,
        <https://1145.am/db/1499630/Bain_Capital_Ventures>,
        <https://1145.am/db/1709908/Bain_Capital_Ventures>,
        <https://1145.am/db/1718689/Bain_Capital_Ventures>,
        <https://1145.am/db/1719688/Bain_Capital_Ventures>,
        <https://1145.am/db/1727833/Bain_Capital_Ventures>,
        <https://1145.am/db/1728375/Bain_Ventures>,
        <https://1145.am/db/1732148/Bain_Capital>,
        <https://1145.am/db/1732599/Bain_Capital_Ventures>,
        <https://1145.am/db/1737493/Bain_Capital_Ventures>,
        <https://1145.am/db/1741056/Bain_Capital_Ventures>,
        <https://1145.am/db/1744862/Bain_Capital_Ventures>,
        <https://1145.am/db/1750828/Bain_Capital_Ventures>,
        <https://1145.am/db/1752961/Bain_Capital_Ventures>,
        <https://1145.am/db/1755937/Bain_Capital_Ventures>,
        <https://1145.am/db/1756420/Bain_Capital_Ventures>,
        <https://1145.am/db/1762788/Bain_Capital_Ventures>,
        <https://1145.am/db/1763269/Bain_Capital_Ventures>,
        <https://1145.am/db/1764318/Bain_Capital_Ventures>,
        <https://1145.am/db/1764779/Bain_Capital>,
        <https://1145.am/db/1765068/Bain_Capital>,
        <https://1145.am/db/1765653/Bain_Capital_Ventures>,
        <https://1145.am/db/1767814/Bain_Capital_Ventures>,
        <https://1145.am/db/1772323/Bain_Capital_Ventures>,
        <https://1145.am/db/1772737/Bain_Capital_Ventures>,
        <https://1145.am/db/1776621/Bain_Capital_Ventures>,
        <https://1145.am/db/1780621/Bain_Capital_Ventures>,
        <https://1145.am/db/178206/Bain_Capital_Ventures>,
        <https://1145.am/db/1784577/Bain_Capital_Ventures>,
        <https://1145.am/db/1786705/Bain_Capital_Ventures>,
        <https://1145.am/db/1790917/Bain_Capital_Ventures>,
        <https://1145.am/db/1804101/Bain_Capital_Ventures>,
        <https://1145.am/db/1805339/Bain_Capital_Ventures>,
        <https://1145.am/db/1806906/Bain_Capital_Ventures>,
        <https://1145.am/db/1810263/Bain_Capital_Ventures>,
        <https://1145.am/db/1815709/Bain_Capital_Ventures>,
        <https://1145.am/db/1816350/Bain_Capital_Ventures>,
        <https://1145.am/db/1817571/Bain_Capital_Ventures>,
        <https://1145.am/db/1823179/Bain_Capital_Ventures>,
        <https://1145.am/db/1825684/Bain_Capital_Ventures>,
        <https://1145.am/db/1827971/Bain_Capital_Ventures>,
        <https://1145.am/db/1828974/Bain_Capital_Ventures>,
        <https://1145.am/db/1831952/Bain_Capital>,
        <https://1145.am/db/1846476/Bain_Capital_Ventures>,
        <https://1145.am/db/1852207/Bain_Capital_Ventures>,
        <https://1145.am/db/1856827/Bain_Capital_Ventures>,
        <https://1145.am/db/1860145/Bain_Capital_Ventures>,
        <https://1145.am/db/1861880/Bain_Capital_Ventures>,
        <https://1145.am/db/1911416/Bain_Capital_Ventures>,
        <https://1145.am/db/1994269/Bain_Capital>,
        <https://1145.am/db/1995400/Bain_Capital>,
        <https://1145.am/db/2002834/Bain_Capital>,
        <https://1145.am/db/2005008/Bain_Capital_Lp>,
        <https://1145.am/db/2018566/Bain_Capital>,
        <https://1145.am/db/2029716/Bain_Capital>,
        <https://1145.am/db/2031790/Bain_Capital_Ventures>,
        <https://1145.am/db/2044937/Bain_Capital>,
        <https://1145.am/db/2065074/Bain_Capital>,
        <https://1145.am/db/2066531/Bain_Capital>,
        <https://1145.am/db/2074937/Bain_Capital_Ventures>,
        <https://1145.am/db/219707/Bain_Capital_Ventures>,
        <https://1145.am/db/227693/Bain_Capital>,
        <https://1145.am/db/2292812/Bain_Capital>,
        <https://1145.am/db/2300337/Bain_Capital>,
        <https://1145.am/db/2310123/Bain_Capital>,
        <https://1145.am/db/2334963/Bain_Capital>,
        <https://1145.am/db/243476/Bain_Capital_Ventures>,
        <https://1145.am/db/2454507/Bain_Capital>,
        <https://1145.am/db/2565273/Bain_Capital>,
        <https://1145.am/db/2608993/Bain_Capital>,
        <https://1145.am/db/2612761/Bain_Capital_Ventures>,
        <https://1145.am/db/2615691/Bain_Capital_Ventures>,
        <https://1145.am/db/2643383/Bain_Capital>,
        <https://1145.am/db/2679279/Bain_Capital_Partners>,
        <https://1145.am/db/2687157/Bain_Capital>,
        <https://1145.am/db/2707145/Bain_Capital>,
        <https://1145.am/db/2795559/Bain_Capital>,
        <https://1145.am/db/301841/Bain_Capital_Ventures>,
        <https://1145.am/db/312126/Bain_Capital>,
        <https://1145.am/db/329048/Bain_Capital>,
        <https://1145.am/db/367652/Bain_Capital>,
        <https://1145.am/db/370785/Bain_Capital_Ventures>,
        <https://1145.am/db/541011/Bain_Capital_Ventures>,
        <https://1145.am/db/545039/Bain_Capital_Ventures>,
        <https://1145.am/db/595717/Bain_Capital>,
        <https://1145.am/db/640018/Bain_Capital_Ventures>,
        <https://1145.am/db/641328/Bain_Capital>,
        <https://1145.am/db/641688/Bain_Capital>,
        <https://1145.am/db/668537/Bain_Capital>,
        <https://1145.am/db/677845/Bain_Capital>,
        <https://1145.am/db/679176/Bain_Capital_Ventures>,
        <https://1145.am/db/763818/Bain_Capital>,
        <https://1145.am/db/778445/Bain_Capital_Ventures>,
        <https://1145.am/db/786642/Bain_Capital_Ventures>,
        <https://1145.am/db/818625/Bain_Capital>,
        <https://1145.am/db/885557/Bain_Capital_Ventures>,
        <https://1145.am/db/890147/Bain_Capital_Ventures>,
        <https://1145.am/db/906511/Bain_Capital>,
        <https://1145.am/db/946710/Bain_Capital_Ventures>,
        <https://1145.am/db/958888/Bain_Capital_Ventures>,
        <https://1145.am/db/988084/Bain_Capital_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2294263/Dentsply> a org:Organization ;
    ns1:buyer <https://1145.am/db/2294263/Astrazeneca_Unit_Acquisition> ;
    ns1:documentDate "2011-10-24T14:06:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Nobel Biocare rises on buyout talks" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nobel-biocare-rises-buyout-talks> ;
    ns1:foundName "Dentsply" ;
    ns1:name "Dentsply" ;
    ns1:sameAsMedium <https://1145.am/db/2282064/Dentsply>,
        <https://1145.am/db/2291391/Dentsply>,
        <https://1145.am/db/2291860/Dentsply> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2294263/Eqt_Partners_Ab> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Sweden",
        "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf>,
        <https://sws.geonames.org/2661886/about.rdf> ;
    ns1:basedInHighRaw "Sweden",
        "Switzerland" ;
    ns1:buyer <https://1145.am/db/2294263/Nobel_Biocare_Acquisition> ;
    ns1:description "private equity" ;
    ns1:documentDate "2011-10-24T14:06:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Nobel Biocare rises on buyout talks" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nobel-biocare-rises-buyout-talks> ;
    ns1:foundName "EQT",
        "EQT Partners AB" ;
    ns1:industry "private equity" ;
    ns1:name "EQT",
        "EQT Partners AB" ;
    ns1:sameAsHigh <https://1145.am/db/112816/Eqt_Ab>,
        <https://1145.am/db/113536/Eqt>,
        <https://1145.am/db/1151566/Eqt_Private_Equity>,
        <https://1145.am/db/1153944/Eqt_Private_Equity>,
        <https://1145.am/db/1373946/Eqt_Private_Equity>,
        <https://1145.am/db/1381249/Eqt>,
        <https://1145.am/db/1423283/Eqt_Private_Equity>,
        <https://1145.am/db/1444357/Eqt_Private_Equity>,
        <https://1145.am/db/1457758/Eqt_X_Fund>,
        <https://1145.am/db/1560437/Eqt>,
        <https://1145.am/db/1717394/Eqt>,
        <https://1145.am/db/1781159/Eqt>,
        <https://1145.am/db/1937218/Eqt>,
        <https://1145.am/db/1941085/Eqt>,
        <https://1145.am/db/1948480/Eqt>,
        <https://1145.am/db/1968574/Eqt>,
        <https://1145.am/db/1982378/Eqt>,
        <https://1145.am/db/1993538/Eqt>,
        <https://1145.am/db/2000699/Eqt>,
        <https://1145.am/db/2049851/Eqt>,
        <https://1145.am/db/2056992/Eqt>,
        <https://1145.am/db/2072946/Eqt_Partners>,
        <https://1145.am/db/2090550/Eqt>,
        <https://1145.am/db/2134045/Eqt_Ab>,
        <https://1145.am/db/2195823/Eqt_Partners>,
        <https://1145.am/db/2293973/Eqt_Partners_Ab>,
        <https://1145.am/db/2294479/Eqt_Partners_And_Santo_Holding>,
        <https://1145.am/db/2297022/Eqt>,
        <https://1145.am/db/2298756/Eqt_Partners_And_Santo_Holding>,
        <https://1145.am/db/2306358/Eqt_Holdings>,
        <https://1145.am/db/2317206/Eqt>,
        <https://1145.am/db/2333598/Eqt_Ii>,
        <https://1145.am/db/2333932/Eqt_Partners>,
        <https://1145.am/db/2558316/Eqt_Partners>,
        <https://1145.am/db/2560477/Eqt_Partners>,
        <https://1145.am/db/2601873/Eqt>,
        <https://1145.am/db/2607951/Eqt_Infrastructure>,
        <https://1145.am/db/2620164/Eqt_Infrastructure>,
        <https://1145.am/db/2657844/Eqt_Vi>,
        <https://1145.am/db/2680827/Eqt_Partners>,
        <https://1145.am/db/296753/Eqt>,
        <https://1145.am/db/314169/Eqt_Infrastructure>,
        <https://1145.am/db/314330/Eqt_Infrastructure>,
        <https://1145.am/db/314956/Eqt_Infrastructure>,
        <https://1145.am/db/322674/Eqt>,
        <https://1145.am/db/323184/Eqt>,
        <https://1145.am/db/336406/Eqt_Infrastructure>,
        <https://1145.am/db/338339/Eqt>,
        <https://1145.am/db/339934/Eqt_Infrastructure>,
        <https://1145.am/db/342533/Eqt_Infrastructure>,
        <https://1145.am/db/343544/Eqt_Infrastructure>,
        <https://1145.am/db/344060/Eqt_Infrastructure>,
        <https://1145.am/db/344474/Eqt_Infrastructure>,
        <https://1145.am/db/346196/Eqt>,
        <https://1145.am/db/346206/Eqt>,
        <https://1145.am/db/367787/Eqt>,
        <https://1145.am/db/367795/Eqt>,
        <https://1145.am/db/368319/Eqt>,
        <https://1145.am/db/369278/Eqt_Ab>,
        <https://1145.am/db/385114/Eqt_Infrastructure>,
        <https://1145.am/db/388067/Eqt>,
        <https://1145.am/db/395549/Eqt>,
        <https://1145.am/db/446156/Eqt_Private_Equity>,
        <https://1145.am/db/446513/Eqt_Private_Equity>,
        <https://1145.am/db/538065/Eqt>,
        <https://1145.am/db/559133/Eqt_Future>,
        <https://1145.am/db/563278/Eqt>,
        <https://1145.am/db/570922/Eig_Partners>,
        <https://1145.am/db/682519/Eig_Partners>,
        <https://1145.am/db/854199/Eqt_Infrastructure> ;
    ns1:sameAsMedium <https://1145.am/db/2510186/Eqt_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2295691/Aphelion_Capital> a org:Organization ;
    ns1:basedInLowRaw "U.S." ;
    ns1:documentDate "2012-01-04T12:39:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Clear Catheter nabs $4M in first round of financing; Uptake raises $35M to develop emphysema tech;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/clear-catheter-nabs-4m-first-round-financing-uptake-raises-35m-to-develop-emphysema> ;
    ns1:foundName "Aphelion Capital" ;
    ns1:investor <https://1145.am/db/2295691/Investment_Aphelion_Capital_California_Technology_Ventures_Clear_Catheter_Systems_Research_Corporation_Technologies_Completed> ;
    ns1:name "Aphelion Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1202770/Aphelion_Capital>,
        <https://1145.am/db/1203467/Aphelion_Capital>,
        <https://1145.am/db/2287801/Aphelion_Capital>,
        <https://1145.am/db/2322726/Aphelion_Capital>,
        <https://1145.am/db/309011/Aphelion_Capital>,
        <https://1145.am/db/735512/Aphelion_Capital_Corp> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2295691/California_Technology_Ventures> a org:Organization ;
    ns1:basedInLowRaw "U.S." ;
    ns1:documentDate "2012-01-04T12:39:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Clear Catheter nabs $4M in first round of financing; Uptake raises $35M to develop emphysema tech;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/clear-catheter-nabs-4m-first-round-financing-uptake-raises-35m-to-develop-emphysema> ;
    ns1:foundName "California Technology Ventures" ;
    ns1:investor <https://1145.am/db/2295691/Investment_Aphelion_Capital_California_Technology_Ventures_Clear_Catheter_Systems_Research_Corporation_Technologies_Completed> ;
    ns1:name "California Technology Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1780999/California_Technology_Ventures>,
        <https://1145.am/db/1801164/California_Technology_Ventures>,
        <https://1145.am/db/1839630/California_Technology_Ventures>,
        <https://1145.am/db/2292313/California_Technology_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2295691/Research_Corporation_Technologies> a org:Organization ;
    ns1:basedInLowRaw "U.S." ;
    ns1:documentDate "2012-01-04T12:39:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Clear Catheter nabs $4M in first round of financing; Uptake raises $35M to develop emphysema tech;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/clear-catheter-nabs-4m-first-round-financing-uptake-raises-35m-to-develop-emphysema> ;
    ns1:foundName "Research Corporation Technologies" ;
    ns1:investor <https://1145.am/db/2295691/Investment_Aphelion_Capital_California_Technology_Ventures_Clear_Catheter_Systems_Research_Corporation_Technologies_Completed> ;
    ns1:name "Research Corporation Technologies" ;
    ns1:sameAsMedium <https://1145.am/db/1196322/Research_Corporation_Technologies>,
        <https://1145.am/db/1309309/Research_Corporation_Technologies>,
        <https://1145.am/db/509618/Research_Corporation_Technologies> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2295691/Venture_Capital_Investment_Uptake_Medical_Icad_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-01-04T12:39:29+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Uptake Medical has raised $ 35 million of a $ 41 million venture capital round, according to an SEC filing.",
        "> iCAD ($ ICAD) , which provides advanced image analysis, work flow solutions and radiation therapy for the early identification and treatment of cancer, has entered into a 5-year, $ 15 million debt facility agreement with Deerfield Management Company." ;
    ns1:documentTitle "Clear Catheter nabs $4M in first round of financing; Uptake raises $35M to develop emphysema tech;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/clear-catheter-nabs-4m-first-round-financing-uptake-raises-35m-to-develop-emphysema> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2295691/Icad>,
        <https://1145.am/db/2295691/Uptake_Medical> ;
    ns1:targetDetails "venture capital" ;
    ns1:valueRaw "$ 15 million",
        "$ 35 million",
        "$ 41 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "U.S." .

<https://1145.am/db/2296631/Hill-Rom_Holdings> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:buyer <https://1145.am/db/2296631/Volker_Group_Acquisition> ;
    ns1:documentDate "2012-02-14T20:59:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Hill-Rom completes $85M Volker buy; Neuros picks up RiverVest Venture Partners as investor;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/hill-rom-completes-85m-volker-buy-neuros-picks-up-rivervest-venture-partners-as> ;
    ns1:foundName "Hill-Rom Holdings" ;
    ns1:name "Hill-Rom Holdings" ;
    ns1:sameAsMedium <https://1145.am/db/2187133/Hill-Rom_Holdings>,
        <https://1145.am/db/2243983/Hill-Rom_Holdings_Inc>,
        <https://1145.am/db/2288977/Hill-Rom_Holdings>,
        <https://1145.am/db/438971/Hill-Rom_Holdings_Inc>,
        <https://1145.am/db/446169/Hill-Rom_Holdings_Inc>,
        <https://1145.am/db/446720/Hill-Rom_Holdings_Inc>,
        <https://1145.am/db/447058/Hill-Rom_Holdings_Inc>,
        <https://1145.am/db/448129/Hill-Rom_Holdings_Inc>,
        <https://1145.am/db/450035/Hill-Rom_Holdings>,
        <https://1145.am/db/450185/Hill-Rom_Holdings_Inc>,
        <https://1145.am/db/451392/Hill-Rom_Holdings>,
        <https://1145.am/db/454668/Hill-Rom_Holdings_Inc>,
        <https://1145.am/db/460896/Hill-Rom_Holdings_Inc>,
        <https://1145.am/db/461561/Hill-Rom_Holdings_Inc>,
        <https://1145.am/db/519147/Hill-Rom_Holdings_Inc>,
        <https://1145.am/db/590996/Hill-Rom_Holdings_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2296631/Investment_Neuros_Medical_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-14T20:59:32+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Neuros Medical, which is developing a device to block the chronic pain of amputees, has secured a new investor in RiverVest Venture Partners, which will participate in the startup's next funding round." ;
    ns1:documentTitle "Hill-Rom completes $85M Volker buy; Neuros picks up RiverVest Venture Partners as investor;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/hill-rom-completes-85m-volker-buy-neuros-picks-up-rivervest-venture-partners-as> ;
    ns1:foundName "funding",
        "investor" ;
    ns1:name "funding",
        "investor" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2296631/Neuros_Medical>,
        <https://1145.am/db/2296631/Rivervest_Venture_Partners> ;
    ns1:targetName "RiverVest Venture Partners" ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "U.K." .

<https://1145.am/db/2296631/Organovo> a org:Organization ;
    ns1:description "research and medical applications" ;
    ns1:documentDate "2012-02-14T20:59:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Hill-Rom completes $85M Volker buy; Neuros picks up RiverVest Venture Partners as investor;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/hill-rom-completes-85m-volker-buy-neuros-picks-up-rivervest-venture-partners-as> ;
    ns1:foundName "Organovo",
        "Organovo Holdings" ;
    ns1:name "Organovo" ;
    ns1:protagonist <https://1145.am/db/2296631/Investment_Organovo_Organovo_Has_Not_Happened>,
        <https://1145.am/db/2296631/Merger_Organovo_Organovo_Completed> ;
    ns1:sameAsMedium <https://1145.am/db/2324618/Organovo> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2296631/Oxford_Immunotec> a org:Organization ;
    ns1:basedInHighGeoName "Massachusetts" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6254926/about.rdf> ;
    ns1:basedInHighRaw "Massachusetts" ;
    ns1:description "diagnostics" ;
    ns1:documentDate "2012-02-14T20:59:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Hill-Rom completes $85M Volker buy; Neuros picks up RiverVest Venture Partners as investor;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/hill-rom-completes-85m-volker-buy-neuros-picks-up-rivervest-venture-partners-as> ;
    ns1:foundName "Oxford Immunotec" ;
    ns1:industry "diagnostics" ;
    ns1:investor <https://1145.am/db/2296631/Investment_Oxford_Immunotec_Has_Not_Happened> ;
    ns1:name "Oxford Immunotec" ;
    ns1:sameAsHigh <https://1145.am/db/2347878/Oxford_Immunotec>,
        <https://1145.am/db/2350851/Oxford_Immunotec_Global_Plc>,
        <https://1145.am/db/2366469/Oxford_Immunotec_Ltd> ;
    ns1:sameAsMedium <https://1145.am/db/192821/Oxford_Immunotec>,
        <https://1145.am/db/2300288/Oxford_Immunotec>,
        <https://1145.am/db/2300836/Oxford_Immunotec>,
        <https://1145.am/db/2347876/Oxford_Immunotec_Ltd> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2296631/Zonare_Medical_Systems> a org:Organization ;
    ns1:documentDate "2012-02-14T20:59:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Hill-Rom completes $85M Volker buy; Neuros picks up RiverVest Venture Partners as investor;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/hill-rom-completes-85m-volker-buy-neuros-picks-up-rivervest-venture-partners-as> ;
    ns1:foundName "ZONARE Medical Systems" ;
    ns1:investor <https://1145.am/db/2296631/Investment_Zonare_Medical_Systems_Has_Not_Happened> ;
    ns1:name "ZONARE Medical Systems" ;
    ns1:sameAsMedium <https://1145.am/db/2251217/Zonare_Medical_Systems>,
        <https://1145.am/db/2288083/Zonare_Medical_Systems>,
        <https://1145.am/db/2289107/Zonare_Medical_Systems> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337767/Capdecisif_2> a org:Organization ;
    ns1:basedInHighGeoName "Republic of France" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:basedInHighRaw "France" ;
    ns1:documentDate "2012-02-14T16:47:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "InnaVirVax lands $4.9 Million in Series B funding Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/innavirvax-lands-4-9-million-series-b-funding-round> ;
    ns1:foundName "CapDecisif 2" ;
    ns1:investor <https://1145.am/db/2337767/Series_B_Investment_Capdecisif_2_Frci_(fonds_Régional_De_Co-Investissement_Dile-De-France)_Fa_Dièse_G1j_Ile-De-France_Innavirvax_Pradeyrol_Développement_Completed> ;
    ns1:name "CapDecisif 2" ;
    ns1:sameAsMedium <https://1145.am/db/2337768/Capdecisif_2> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337767/Fa_Dièse> a org:Organization ;
    ns1:basedInHighGeoName "Republic of France" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:basedInHighRaw "France" ;
    ns1:documentDate "2012-02-14T16:47:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "InnaVirVax lands $4.9 Million in Series B funding Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/innavirvax-lands-4-9-million-series-b-funding-round> ;
    ns1:foundName "Fa Dièse" ;
    ns1:investor <https://1145.am/db/2337767/Series_B_Investment_Capdecisif_2_Frci_(fonds_Régional_De_Co-Investissement_Dile-De-France)_Fa_Dièse_G1j_Ile-De-France_Innavirvax_Pradeyrol_Développement_Completed> ;
    ns1:name "Fa Dièse" ;
    ns1:sameAsMedium <https://1145.am/db/2301320/Fa_Dièse>,
        <https://1145.am/db/2337768/Fa_Dièse> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337767/Frci_(fonds_Régional_De_Co-Investissement_Dile-De-France)> a org:Organization ;
    ns1:basedInHighGeoName "Republic of France" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:basedInHighRaw "France" ;
    ns1:description "private equity funds" ;
    ns1:documentDate "2012-02-14T16:47:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "InnaVirVax lands $4.9 Million in Series B funding Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/innavirvax-lands-4-9-million-series-b-funding-round> ;
    ns1:foundName "FRCI (Fonds Régional de Co-Investissement d'Ile-de-France)" ;
    ns1:industry "private equity funds" ;
    ns1:investor <https://1145.am/db/2337767/Series_B_Investment_Capdecisif_2_Frci_(fonds_Régional_De_Co-Investissement_Dile-De-France)_Fa_Dièse_G1j_Ile-De-France_Innavirvax_Pradeyrol_Développement_Completed> ;
    ns1:name "FRCI (Fonds Régional de Co-Investissement d'Ile-de-France)" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337767/G1j_Ile-De-France> a org:Organization ;
    ns1:basedInHighGeoName "Republic of France" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:basedInHighRaw "France" ;
    ns1:description "Business" ;
    ns1:documentDate "2012-02-14T16:47:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "InnaVirVax lands $4.9 Million in Series B funding Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/innavirvax-lands-4-9-million-series-b-funding-round> ;
    ns1:foundName "G1J Ile-de-France" ;
    ns1:investor <https://1145.am/db/2337767/Series_B_Investment_Capdecisif_2_Frci_(fonds_Régional_De_Co-Investissement_Dile-De-France)_Fa_Dièse_G1j_Ile-De-France_Innavirvax_Pradeyrol_Développement_Completed> ;
    ns1:name "G1J Ile-de-France" ;
    ns1:sameAsMedium <https://1145.am/db/2325232/G1j-Ile_De_France>,
        <https://1145.am/db/2337768/G1j_Ile-De-France> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337767/Pradeyrol_Développement> a org:Organization ;
    ns1:basedInHighGeoName "Republic of France" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:basedInHighRaw "France" ;
    ns1:documentDate "2012-02-14T16:47:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "InnaVirVax lands $4.9 Million in Series B funding Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/innavirvax-lands-4-9-million-series-b-funding-round> ;
    ns1:foundName "Pradeyrol Développement" ;
    ns1:investor <https://1145.am/db/2337767/Series_B_Investment_Capdecisif_2_Frci_(fonds_Régional_De_Co-Investissement_Dile-De-France)_Fa_Dièse_G1j_Ile-De-France_Innavirvax_Pradeyrol_Développement_Completed> ;
    ns1:name "Pradeyrol Développement" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337808/Boston_Harbor_Angels> a org:Organization ;
    ns1:basedInLowRaw "Massachusetts" ;
    ns1:documentDate "2011-11-10T16:49:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bo" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/avaxia-biologics-inc-raises-2-2-million-first-closing-of-series-a-financing-to-advance-oral> ;
    ns1:foundName "Boston Harbor Angels" ;
    ns1:investor <https://1145.am/db/2337808/Series_A_Investment_Avaxia_Biologics_Boston_Harbor_Angels_Cherrystone_Angels_Completed> ;
    ns1:name "Boston Harbor Angels" ;
    ns1:sameAsMedium <https://1145.am/db/1870128/Boston_Harbor_Angels>,
        <https://1145.am/db/2337765/Boston_Harbor_Angels>,
        <https://1145.am/db/2337805/Boston_Harbor_Angels>,
        <https://1145.am/db/2362638/Boston_Harbor_Angels>,
        <https://1145.am/db/2596451/Boston_Harbor_Angels> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337808/Cherrystone_Angels> a org:Organization ;
    ns1:basedInHighGeoName "Providence" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5224151/about.rdf> ;
    ns1:basedInHighRaw "Providence, Rhode Island" ;
    ns1:documentDate "2011-11-10T16:49:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bo" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/avaxia-biologics-inc-raises-2-2-million-first-closing-of-series-a-financing-to-advance-oral> ;
    ns1:foundName "Cherrystone Angels of Providence, Rhode Island" ;
    ns1:investor <https://1145.am/db/2337808/Series_A_Investment_Avaxia_Biologics_Boston_Harbor_Angels_Cherrystone_Angels_Completed> ;
    ns1:name "Cherrystone Angels" ;
    ns1:sameAsMedium <https://1145.am/db/2337765/Cherrystone_Angels>,
        <https://1145.am/db/2337805/Cherrystone_Angels>,
        <https://1145.am/db/2362638/Cherrystone_Angels>,
        <https://1145.am/db/2596451/Cherrystone_Angels> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338527/Enterprise_Partners_Venture_Capital> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:documentDate "2012-02-15T15:32:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/celladon-corporation-completes-43-million-financing-to-advance-mydicar%C2%AE-for-treatment-of> ;
    ns1:foundName "Enterprise Partners Venture Capital" ;
    ns1:investor <https://1145.am/db/2338527/Investment_Celladon_Corporation_Enterprise_Partners_Venture_Capital_Gbs_Venture_Partners_H___Q_Healthcare_Life_Sciences_Investors_Johnson___Johnson_Development_Corporation_Lundbeckfond_Ventures_Novartis_Venture_Funds_Pfizer_Venture_Investments_Venrock_Associates_Completed> ;
    ns1:name "Enterprise Partners Venture Capital" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338527/Gbs_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:documentDate "2012-02-15T15:32:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/celladon-corporation-completes-43-million-financing-to-advance-mydicar%C2%AE-for-treatment-of> ;
    ns1:foundName "GBS Venture Partners" ;
    ns1:investor <https://1145.am/db/2338527/Investment_Celladon_Corporation_Enterprise_Partners_Venture_Capital_Gbs_Venture_Partners_H___Q_Healthcare_Life_Sciences_Investors_Johnson___Johnson_Development_Corporation_Lundbeckfond_Ventures_Novartis_Venture_Funds_Pfizer_Venture_Investments_Venrock_Associates_Completed> ;
    ns1:name "GBS Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1281079/Gbs_Venture_Partners>,
        <https://1145.am/db/1281647/Gbs_Venture_Partners>,
        <https://1145.am/db/2306568/Gbs_Venture_Partners>,
        <https://1145.am/db/2343486/Gbs_Venture_Partners>,
        <https://1145.am/db/2363535/Gbs_Venture_Partners>,
        <https://1145.am/db/2366133/Gbs_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338527/H___Q_Healthcare_Life_Sciences_Investors> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:documentDate "2012-02-15T15:32:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/celladon-corporation-completes-43-million-financing-to-advance-mydicar%C2%AE-for-treatment-of> ;
    ns1:foundName "H & Q Healthcare/Life Sciences Investors" ;
    ns1:investor <https://1145.am/db/2338527/Investment_Celladon_Corporation_Enterprise_Partners_Venture_Capital_Gbs_Venture_Partners_H___Q_Healthcare_Life_Sciences_Investors_Johnson___Johnson_Development_Corporation_Lundbeckfond_Ventures_Novartis_Venture_Funds_Pfizer_Venture_Investments_Venrock_Associates_Completed> ;
    ns1:name "H & Q Healthcare/Life Sciences Investors" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338527/Johnson___Johnson_Development_Corporation> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:documentDate "2012-02-15T15:32:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/celladon-corporation-completes-43-million-financing-to-advance-mydicar%C2%AE-for-treatment-of> ;
    ns1:foundName "Johnson & Johnson Development Corporation" ;
    ns1:investor <https://1145.am/db/2338527/Investment_Celladon_Corporation_Enterprise_Partners_Venture_Capital_Gbs_Venture_Partners_H___Q_Healthcare_Life_Sciences_Investors_Johnson___Johnson_Development_Corporation_Lundbeckfond_Ventures_Novartis_Venture_Funds_Pfizer_Venture_Investments_Venrock_Associates_Completed> ;
    ns1:name "Johnson & Johnson Development Corporation" ;
    ns1:sameAsMedium <https://1145.am/db/1883008/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2291836/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292334/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292345/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292353/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292975/Johnson___Johnson_Development_Corp>,
        <https://1145.am/db/2299864/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2300306/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2300455/Johnson___Johnson_Development_Corp>,
        <https://1145.am/db/2303009/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2306163/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2308781/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2308791/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2311069/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2311075/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2316619/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2316624/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2317934/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2321856/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2327212/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2327227/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2336890/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2336943/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2337571/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2337577/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2338236/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2338237/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2341478/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2344597/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2344605/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2346978/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2350327/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2352357/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2352361/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2356290/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358640/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358657/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358658/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358812/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2361581/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2363907/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2364457/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2364458/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2365296/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2546216/Johnson___Johnson_Development_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338527/Lundbeckfond_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Denmark" ;
    ns1:documentDate "2012-02-15T15:32:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/celladon-corporation-completes-43-million-financing-to-advance-mydicar%C2%AE-for-treatment-of> ;
    ns1:foundName "Lundbeckfond Ventures" ;
    ns1:investor <https://1145.am/db/2338527/Investment_Celladon_Corporation_Enterprise_Partners_Venture_Capital_Gbs_Venture_Partners_H___Q_Healthcare_Life_Sciences_Investors_Johnson___Johnson_Development_Corporation_Lundbeckfond_Ventures_Novartis_Venture_Funds_Pfizer_Venture_Investments_Venrock_Associates_Completed> ;
    ns1:name "Lundbeckfond Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2296062/Lundbeckfonden_Ventures>,
        <https://1145.am/db/2300680/Lundbeckfond_Ventures>,
        <https://1145.am/db/2301536/Lundbeckfonden_Ventures>,
        <https://1145.am/db/2326981/Lundbeckfond_Ventures>,
        <https://1145.am/db/2336716/Lundbeckfond_Ventures>,
        <https://1145.am/db/2349048/Lundbeckfond_Ventures>,
        <https://1145.am/db/2349050/Lundbeckfond_Ventures>,
        <https://1145.am/db/2349405/Lundbeckfond_Ventures>,
        <https://1145.am/db/2349406/Lundbeckfond_Ventures>,
        <https://1145.am/db/2352357/Lundbeckfond_Ventures>,
        <https://1145.am/db/2352361/Lundbeckfond_Ventures>,
        <https://1145.am/db/2353098/Lundbeckfond_Ventures>,
        <https://1145.am/db/2353917/Lundbeckfond_Ventures>,
        <https://1145.am/db/2354401/Lundbeckfond_Ventures>,
        <https://1145.am/db/2356402/Lundbeckfond_Ventures>,
        <https://1145.am/db/2356411/Lundbeckfond_Ventures>,
        <https://1145.am/db/2359401/Lundbeckfond_Ventures>,
        <https://1145.am/db/2362148/Lundbeckfond_Ventures>,
        <https://1145.am/db/2362156/Lundbeckfond_Ventures>,
        <https://1145.am/db/2363947/Lundbeckfond_Ventures>,
        <https://1145.am/db/2363950/Lundbeckfond_Ventures>,
        <https://1145.am/db/2364492/Lundbeckfond_Ventures>,
        <https://1145.am/db/2365826/Lundbeckfond_Ventures>,
        <https://1145.am/db/2366303/Lundbeckfond_Ventures>,
        <https://1145.am/db/2369169/Lundbeckfond_Ventures>,
        <https://1145.am/db/2369953/Lundbeckfond_Ventures>,
        <https://1145.am/db/2544138/Lundbeckfond_Ventures>,
        <https://1145.am/db/2544140/Lundbeckfond_Ventures>,
        <https://1145.am/db/2573068/Lundbeckfond_Ventures>,
        <https://1145.am/db/281538/Lundbeckfonden_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338527/Novartis_Venture_Funds> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:documentDate "2012-02-15T15:32:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/celladon-corporation-completes-43-million-financing-to-advance-mydicar%C2%AE-for-treatment-of> ;
    ns1:foundName "Novartis Venture Funds" ;
    ns1:investor <https://1145.am/db/2338527/Investment_Celladon_Corporation_Enterprise_Partners_Venture_Capital_Gbs_Venture_Partners_H___Q_Healthcare_Life_Sciences_Investors_Johnson___Johnson_Development_Corporation_Lundbeckfond_Ventures_Novartis_Venture_Funds_Pfizer_Venture_Investments_Venrock_Associates_Completed> ;
    ns1:name "Novartis Venture Funds" ;
    ns1:sameAsMedium <https://1145.am/db/1340338/Novartis_Venture_Fund>,
        <https://1145.am/db/1523031/Novartis_Venture_Fund>,
        <https://1145.am/db/207823/Novartis_Venture_Fund>,
        <https://1145.am/db/2152422/Novartis_Venture_Fund>,
        <https://1145.am/db/2247240/Novartis_Venture_Funds>,
        <https://1145.am/db/2289983/Novartis_Venture_Funds>,
        <https://1145.am/db/2292300/Novartis_Venture_Funds>,
        <https://1145.am/db/2292345/Novartis_Venture_Funds>,
        <https://1145.am/db/2297795/Novartis_Venture_Funds>,
        <https://1145.am/db/2298176/Novartis_Venture_Fund>,
        <https://1145.am/db/2307682/Novartis_Venture_Fund>,
        <https://1145.am/db/2310905/Novartis_Venture_Fund>,
        <https://1145.am/db/2310907/Novartis_Venture_Fund>,
        <https://1145.am/db/2313438/Novartis_Venture_Fund>,
        <https://1145.am/db/2315943/Novartis_Venture_Fund>,
        <https://1145.am/db/2315957/Novartis_Venture_Fund>,
        <https://1145.am/db/2317737/Novartis_Venture_Fund>,
        <https://1145.am/db/2323210/Novartis_Venture_Funds>,
        <https://1145.am/db/2323228/Novartis_Venture_Fund>,
        <https://1145.am/db/2323682/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2323683/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2326222/Novartis_Venture_Fund>,
        <https://1145.am/db/2327256/Novartis_Venture_Fund>,
        <https://1145.am/db/2327441/Novartis_Venture_Fund>,
        <https://1145.am/db/2327442/Novartis_Venture_Fund>,
        <https://1145.am/db/2330711/Novartis_Venture_Fund>,
        <https://1145.am/db/2331343/Novartis_Venture_Funds>,
        <https://1145.am/db/2331750/Novartis_Venture_Fund>,
        <https://1145.am/db/2331751/Novartis_Venture_Fund>,
        <https://1145.am/db/2332658/Novartis_Venture_Fund>,
        <https://1145.am/db/2332659/Novartis_Venture_Fund>,
        <https://1145.am/db/2335764/Novartis_Venture_Funds>,
        <https://1145.am/db/2336032/Novartis_Venture_Fund>,
        <https://1145.am/db/2336328/Novartis_Venture_Funds>,
        <https://1145.am/db/2337294/Novartis_Venture_Funds>,
        <https://1145.am/db/2337645/Novartis_Venture_Fund>,
        <https://1145.am/db/2339193/Novartis_Venture_Fund>,
        <https://1145.am/db/2339196/Novartis_Venture_Fund>,
        <https://1145.am/db/2340344/Novartis_Venture_Fund>,
        <https://1145.am/db/2340345/Novartis_Venture_Fund>,
        <https://1145.am/db/2340612/Novartis_Venture_Fund>,
        <https://1145.am/db/2340942/Novartis_Venture_Fund>,
        <https://1145.am/db/2343486/Novartis_Venture_Funds>,
        <https://1145.am/db/2343493/Novartis_Venture_Funds>,
        <https://1145.am/db/2343966/Novartis_Venture_Funds>,
        <https://1145.am/db/2344045/Novartis_Venture_Fund>,
        <https://1145.am/db/2348012/Novartis_Venture_Fund>,
        <https://1145.am/db/2348348/Novartis_Venture_Funds>,
        <https://1145.am/db/2348350/Novartis_Venture_Funds>,
        <https://1145.am/db/2351958/Novartis_Venture_Funds>,
        <https://1145.am/db/2351959/Novartis_Venture_Fund>,
        <https://1145.am/db/2352203/Novartis_Venture_Fund>,
        <https://1145.am/db/2352204/Novartis_Venture_Fund>,
        <https://1145.am/db/2352216/Novartis_Venture_Fund>,
        <https://1145.am/db/2353098/Novartis_Venture_Fund>,
        <https://1145.am/db/2356287/Novartis_Venture_Fund>,
        <https://1145.am/db/2356290/Novartis_Venture_Fund>,
        <https://1145.am/db/2356391/Novartis_Venture_Fund>,
        <https://1145.am/db/2356393/Novartis_Venture_Fund>,
        <https://1145.am/db/2356395/Novartis_Venture_Fund>,
        <https://1145.am/db/2356567/Novartis_Venture_Fund>,
        <https://1145.am/db/2358430/Novartis_Venture_Funds>,
        <https://1145.am/db/2358725/Novartis_Venture_Funds>,
        <https://1145.am/db/2358733/Novartis_Venture_Fund>,
        <https://1145.am/db/2361588/Novartis_Venture_Funds>,
        <https://1145.am/db/2362715/Novartis_Venture_Funds>,
        <https://1145.am/db/2363510/Novartis_Venture_Funds>,
        <https://1145.am/db/2363907/Novartis_Venture_Funds>,
        <https://1145.am/db/2367046/Novartis_Venture_Fund>,
        <https://1145.am/db/2369548/Novartis_Venture_Fund>,
        <https://1145.am/db/2551315/Novartis_Venture_Fund>,
        <https://1145.am/db/2570481/Novartis_Venture_Fund>,
        <https://1145.am/db/2570483/Novartis_Venture_Fund>,
        <https://1145.am/db/2578837/Novartis_Venture_Funds>,
        <https://1145.am/db/2592611/Novartis_Venture_Funds>,
        <https://1145.am/db/509733/Novartis_Venture_Fund>,
        <https://1145.am/db/866508/Novartis_Venture_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338527/Pfizer_Venture_Investments> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:documentDate "2012-02-15T15:32:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/celladon-corporation-completes-43-million-financing-to-advance-mydicar%C2%AE-for-treatment-of> ;
    ns1:foundName "Pfizer Venture Investments" ;
    ns1:investor <https://1145.am/db/2338527/Investment_Celladon_Corporation_Enterprise_Partners_Venture_Capital_Gbs_Venture_Partners_H___Q_Healthcare_Life_Sciences_Investors_Johnson___Johnson_Development_Corporation_Lundbeckfond_Ventures_Novartis_Venture_Funds_Pfizer_Venture_Investments_Venrock_Associates_Completed> ;
    ns1:name "Pfizer Venture Investments" ;
    ns1:sameAsMedium <https://1145.am/db/2299758/Pfizer_Venture_Investments>,
        <https://1145.am/db/2306549/Pfizer_Venture_Investments>,
        <https://1145.am/db/2318310/Pfizer_Venture_Investments>,
        <https://1145.am/db/2319442/Pfizer_Venture_Investments>,
        <https://1145.am/db/2322984/Pfizer_Venture_Investments>,
        <https://1145.am/db/2323003/Pfizer_Venture_Investments>,
        <https://1145.am/db/2336335/Pfizer_Venture_Investments>,
        <https://1145.am/db/2337971/Pfizer_Venture_Investments>,
        <https://1145.am/db/2338528/Pfizer_Venture_Investments>,
        <https://1145.am/db/2340096/Pfizer_Venture_Investments>,
        <https://1145.am/db/2346978/Pfizer_Venture_Investments>,
        <https://1145.am/db/2348066/Pfizer_Venture_Investments>,
        <https://1145.am/db/2349143/Pfizer_Venture_Investments>,
        <https://1145.am/db/2352226/Pfizer_Venture_Investments>,
        <https://1145.am/db/2354296/Pfizer_Venture_Investments>,
        <https://1145.am/db/2355043/Pfizer_Venture_Investments>,
        <https://1145.am/db/2356287/Pfizer_Venture_Investments>,
        <https://1145.am/db/2356290/Pfizer_Venture_Investments>,
        <https://1145.am/db/2359321/Pfizer_Venture_Investments>,
        <https://1145.am/db/2362862/Pfizer_Venture_Investments>,
        <https://1145.am/db/2364457/Pfizer_Venture_Investments>,
        <https://1145.am/db/2364458/Pfizer_Venture_Investments>,
        <https://1145.am/db/2367549/Pfizer_Venture_Investments>,
        <https://1145.am/db/2369000/Pfizer_Venture_Investments>,
        <https://1145.am/db/2587938/Pfizer_Venture_Investments> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338527/Venrock_Associates> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:documentDate "2012-02-15T15:32:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/celladon-corporation-completes-43-million-financing-to-advance-mydicar%C2%AE-for-treatment-of> ;
    ns1:foundName "Venrock Associates" ;
    ns1:investor <https://1145.am/db/2338527/Investment_Celladon_Corporation_Enterprise_Partners_Venture_Capital_Gbs_Venture_Partners_H___Q_Healthcare_Life_Sciences_Investors_Johnson___Johnson_Development_Corporation_Lundbeckfond_Ventures_Novartis_Venture_Funds_Pfizer_Venture_Investments_Venrock_Associates_Completed> ;
    ns1:name "Venrock Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1694102/Venrock_Associates>,
        <https://1145.am/db/1703460/Venrock_Associates>,
        <https://1145.am/db/2307682/Venrock_Associates>,
        <https://1145.am/db/2307691/Venrock_Associates>,
        <https://1145.am/db/2318708/Venrock_Associates>,
        <https://1145.am/db/2330075/Venrock_Associates>,
        <https://1145.am/db/2332982/Venrock_Associates>,
        <https://1145.am/db/2338528/Venrock_Associates>,
        <https://1145.am/db/2350364/Venrock_Associates>,
        <https://1145.am/db/2630808/Venrock_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338566/Access_Bridgegap_Ventures> a org:Organization ;
    ns1:basedInLowRaw "PROVIDENCE, RI" ;
    ns1:documentDate "2012-02-16T13:45:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Mnemosyne Pharmaceuticals, Inc. Completes $5.4 Million Series A Round to Support Drug Discovery Programs" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mnemosyne-pharmaceuticals-inc-completes-5-4-million-series-a-round-to-support-drug> ;
    ns1:foundName "Access BridgeGap Ventures" ;
    ns1:investor <https://1145.am/db/2338566/Series_A_Investment_Access_Bridgegap_Ventures_Mnemosyne_Pharmaceuticals_Slater_Technology_Fund_Completed> ;
    ns1:name "Access BridgeGap Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2349496/Access_Bridgegap_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338566/Slater_Technology_Fund> a org:Organization ;
    ns1:basedInLowRaw "PROVIDENCE, RI" ;
    ns1:documentDate "2012-02-16T13:45:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Mnemosyne Pharmaceuticals, Inc. Completes $5.4 Million Series A Round to Support Drug Discovery Programs" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mnemosyne-pharmaceuticals-inc-completes-5-4-million-series-a-round-to-support-drug> ;
    ns1:foundName "Slater Technology Fund" ;
    ns1:investor <https://1145.am/db/2338566/Series_A_Investment_Access_Bridgegap_Ventures_Mnemosyne_Pharmaceuticals_Slater_Technology_Fund_Completed> ;
    ns1:name "Slater Technology Fund" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339435/Equity_Investment_Ampliphi_Biosciences_Corporation_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-11-17T17:40:45+00:00"^^xsd:dateTime ;
    ns1:documentExtract "& COLWORTH, UK, Nov 17, 2011 (BUSINESS WIRE) - AmpliPhi Biosciences Corporation (APHB.PK) , the leader in the development of bacteriophage - based anti-bacterial therapies to treat drug resistant infections, has announced that is has closed on an initial amount of $ 2.7M in equity investment and convertible loan notes to support the further progress of the Company.",
        "AMPLIPHI BIOSCIENCES Announces First Closing of $ 2.7m." ;
    ns1:documentTitle "AMPLIPHI BIOSCIENCES Announces First Closing of $2.7m" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ampliphi-biosciences-announces-first-closing-of-2-7m> ;
    ns1:foundName "investment" ;
    ns1:name "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2339435/Ampliphi_Biosciences_Corporation> ;
    ns1:targetDetails "equity" ;
    ns1:valueRaw "$ 2.7M",
        "$ 2.7m",
        "up to $ 5m" ;
    ns1:whenRaw "2011" ;
    ns1:whereGeoName "Richmond",
        "Seattle" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4781708/about.rdf>,
        <https://sws.geonames.org/5809844/about.rdf> ;
    ns1:whereRaw "RICHMOND, Va. & SEATTLE, Wa" .

<https://1145.am/db/2340207/Boston_Millennia_Partners> a org:Organization ;
    ns1:basedInLowRaw "R.I." ;
    ns1:documentDate "2012-02-22T16:24:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Collegium Pharmaceutical Announces Series B Financing and Advancement of Development Program for its DETERx® Tamper-Resistant, Extended-Release Opioid" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/collegium-pharmaceutical-announces-series-b-financing-and-advancement-of-development> ;
    ns1:foundName "Boston Millennia Partners" ;
    ns1:investor <https://1145.am/db/2340207/Series_B_Investment_Boston_Millennia_Partners_Collegium_Pharmaceutical_Frazier_Healthcare_Ventures_Longitude_Capital_Skyline_Ventures_Completed> ;
    ns1:name "Boston Millennia Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2102258/Boston_Millennia_Partners>,
        <https://1145.am/db/2189544/Boston_Millennia_Partners>,
        <https://1145.am/db/2300861/Boston_Millennia_Partners>,
        <https://1145.am/db/2318779/Boston_Millennia_Partners>,
        <https://1145.am/db/2318807/Boston_Millennia_Partners>,
        <https://1145.am/db/2336102/Boston_Millennia_Partners>,
        <https://1145.am/db/2336109/Boston_Millennia_Partners>,
        <https://1145.am/db/2338428/Boston_Millennia_Partners>,
        <https://1145.am/db/2340204/Boston_Millennia_Partners>,
        <https://1145.am/db/676953/Boston_Millennia_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340207/Longitude_Capital> a org:Organization ;
    ns1:basedInLowRaw "R.I." ;
    ns1:documentDate "2012-02-22T16:24:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Collegium Pharmaceutical Announces Series B Financing and Advancement of Development Program for its DETERx® Tamper-Resistant, Extended-Release Opioid" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/collegium-pharmaceutical-announces-series-b-financing-and-advancement-of-development> ;
    ns1:foundName "Longitude Capital" ;
    ns1:investor <https://1145.am/db/2340207/Series_B_Investment_Boston_Millennia_Partners_Collegium_Pharmaceutical_Frazier_Healthcare_Ventures_Longitude_Capital_Skyline_Ventures_Completed> ;
    ns1:name "Longitude Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1467975/Longitude_Capital>,
        <https://1145.am/db/1482048/Longitude_Capital>,
        <https://1145.am/db/1503165/Longitude_Capital>,
        <https://1145.am/db/1519688/Longitude_Capital>,
        <https://1145.am/db/1520070/Longitude_Capital>,
        <https://1145.am/db/2075754/Longitude_Capital>,
        <https://1145.am/db/2152399/Longitude_Capital>,
        <https://1145.am/db/2155668/Longitude_Capital>,
        <https://1145.am/db/2182698/Longitude_Capital>,
        <https://1145.am/db/2198647/Longitude_Capital>,
        <https://1145.am/db/2288251/Longitude_Capital>,
        <https://1145.am/db/2290453/Longitude_Capital>,
        <https://1145.am/db/2297930/Longitude_Capital>,
        <https://1145.am/db/2298634/Longitude_Capital>,
        <https://1145.am/db/2300708/Longitude_Capital>,
        <https://1145.am/db/2330799/Longitude_Capital>,
        <https://1145.am/db/2337591/Longitude_Capital>,
        <https://1145.am/db/2338428/Longitude_Capital>,
        <https://1145.am/db/2339214/Longitude_Capital>,
        <https://1145.am/db/2339223/Longitude_Capital>,
        <https://1145.am/db/2340204/Longitude_Capital>,
        <https://1145.am/db/2351129/Longitude_Capital>,
        <https://1145.am/db/2352167/Longitude_Capital>,
        <https://1145.am/db/2352170/Longitude_Capital>,
        <https://1145.am/db/2365501/Longitude_Capital>,
        <https://1145.am/db/2366753/Longitude_Capital>,
        <https://1145.am/db/2368232/Longitude_Capital>,
        <https://1145.am/db/2369359/Longitude_Capital>,
        <https://1145.am/db/2564563/Longitude_Capital>,
        <https://1145.am/db/2583466/Longitude_Capital>,
        <https://1145.am/db/955355/Longitude_Capital>,
        <https://1145.am/db/958767/Longitude_Capital>,
        <https://1145.am/db/959519/Longitude_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340207/Skyline_Ventures> a org:Organization ;
    ns1:basedInLowRaw "R.I." ;
    ns1:documentDate "2012-02-22T16:24:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Collegium Pharmaceutical Announces Series B Financing and Advancement of Development Program for its DETERx® Tamper-Resistant, Extended-Release Opioid" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/collegium-pharmaceutical-announces-series-b-financing-and-advancement-of-development> ;
    ns1:foundName "Skyline Ventures" ;
    ns1:investor <https://1145.am/db/2340207/Series_B_Investment_Boston_Millennia_Partners_Collegium_Pharmaceutical_Frazier_Healthcare_Ventures_Longitude_Capital_Skyline_Ventures_Completed> ;
    ns1:name "Skyline Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2300653/Skyline_Ventures>,
        <https://1145.am/db/2303098/Skyline_Ventures>,
        <https://1145.am/db/2303598/Skyline_Ventures>,
        <https://1145.am/db/2305791/Skyline_Ventures>,
        <https://1145.am/db/2308925/Skyline_Ventures>,
        <https://1145.am/db/2308931/Skyline_Ventures>,
        <https://1145.am/db/2313305/Skyline_Ventures>,
        <https://1145.am/db/2313306/Skyline_Ventures>,
        <https://1145.am/db/2337571/Skyline_Ventures>,
        <https://1145.am/db/2337577/Skyline_Ventures>,
        <https://1145.am/db/2340204/Skyline_Ventures>,
        <https://1145.am/db/2349753/Skyline_Ventures>,
        <https://1145.am/db/2353439/Skyline_Ventures>,
        <https://1145.am/db/2355586/Skyline_Ventures>,
        <https://1145.am/db/2359287/Skyline_Ventures>,
        <https://1145.am/db/2365296/Skyline_Ventures>,
        <https://1145.am/db/2546216/Skyline_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340284/Catalyst_Health_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SALT LAKE CITY" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-11-21T12:07:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor; Appoints Gregory C. Critchfiel" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sera-prognostics-secures-19-3-million-series-a-funding-to-commercialize-preterm-birth> ;
    ns1:foundName "Catalyst Health Ventures" ;
    ns1:investor <https://1145.am/db/2340284/Series_A_Investment_Catalyst_Health_Ventures_Domain_Associates_Interwest_Partners_Osage_University_Partners_Sera_Prognostics_Upstart_Life_Sciences_Capital_Completed> ;
    ns1:name "Catalyst Health Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1335924/Blue_Venture_Fund>,
        <https://1145.am/db/1336552/Blue_Venture_Fund>,
        <https://1145.am/db/1374213/Apollo_Health_Ventures>,
        <https://1145.am/db/1628978/Cvs_Health_Ventures>,
        <https://1145.am/db/2180772/7wireventures>,
        <https://1145.am/db/2281648/Medical_Excellence_Capital_Partners>,
        <https://1145.am/db/2282392/Pioneer_Healthcare_Partners>,
        <https://1145.am/db/2294753/Catalyst_Health_Ventures>,
        <https://1145.am/db/2298897/Healthlink_Capital>,
        <https://1145.am/db/2303251/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2303257/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2305524/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/230667/Red_Tree_Venture_Capital>,
        <https://1145.am/db/2309845/Healthcare_Ventures>,
        <https://1145.am/db/2311069/Healthcare_Ventures>,
        <https://1145.am/db/2311075/Healthcare_Ventures>,
        <https://1145.am/db/2321713/Healthcor_Partners_Management>,
        <https://1145.am/db/2323586/Healthcare_Ventures>,
        <https://1145.am/db/2329533/Essex_Woodlands_Healthcare_Ventures>,
        <https://1145.am/db/2329533/Gilde_Healthcare>,
        <https://1145.am/db/2330876/Healthcare_Venture>,
        <https://1145.am/db/2337166/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2342611/Healthcap>,
        <https://1145.am/db/2346204/Healthcare_Ventures>,
        <https://1145.am/db/2347469/Healthcare_Ventures>,
        <https://1145.am/db/2347822/Healthcap>,
        <https://1145.am/db/2349717/Healthcare_Ventures>,
        <https://1145.am/db/2352820/Healthcare_Ventures>,
        <https://1145.am/db/2356567/Mp_Healthcare_Venture_Management_Inc>,
        <https://1145.am/db/2365279/Founders_Fund>,
        <https://1145.am/db/2365296/Mp_Healthcare_Venture_Management>,
        <https://1145.am/db/2367497/Healthcare_Ventures>,
        <https://1145.am/db/2369086/Whitesun_Healthcare_Ventures>,
        <https://1145.am/db/348452/Inflect_Health>,
        <https://1145.am/db/662177/Apollo_Health_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2155189/Catalyst_Health_Ventures>,
        <https://1145.am/db/2296841/Catalyst_Health_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340284/Interwest_Partners> a org:Organization ;
    ns1:basedInLowRaw "SALT LAKE CITY" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-11-21T12:07:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor; Appoints Gregory C. Critchfiel" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sera-prognostics-secures-19-3-million-series-a-funding-to-commercialize-preterm-birth> ;
    ns1:foundName "InterWest Partners" ;
    ns1:investor <https://1145.am/db/2340284/Series_A_Investment_Catalyst_Health_Ventures_Domain_Associates_Interwest_Partners_Osage_University_Partners_Sera_Prognostics_Upstart_Life_Sciences_Capital_Completed> ;
    ns1:name "InterWest Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1091554/Riverfront_Ventures>,
        <https://1145.am/db/1091576/Riverfront_Ventures>,
        <https://1145.am/db/1150154/Norwind_Capital>,
        <https://1145.am/db/1263825/Westbridge_Capital>,
        <https://1145.am/db/1334273/West_Hill_Capital>,
        <https://1145.am/db/1335021/West_Hill_Capital>,
        <https://1145.am/db/1339788/Northzone>,
        <https://1145.am/db/1343467/Stormbreaker_Ventures>,
        <https://1145.am/db/1355824/Shorewind_Capital>,
        <https://1145.am/db/1398917/Red_River_West>,
        <https://1145.am/db/1407496/Storm_Ventures>,
        <https://1145.am/db/1433429/North_Island_Ventures>,
        <https://1145.am/db/1508460/North_Island_Ventures>,
        <https://1145.am/db/168364/Riverfront_Ventures>,
        <https://1145.am/db/1695419/Northgate_Capital>,
        <https://1145.am/db/1696310/Northzone>,
        <https://1145.am/db/1706170/Storm_Ventures>,
        <https://1145.am/db/1708291/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1717023/North_Island_Ventures>,
        <https://1145.am/db/1722944/Wind_Ventures>,
        <https://1145.am/db/1735168/Northgate_Capital>,
        <https://1145.am/db/1738465/Northzone>,
        <https://1145.am/db/1749607/Northzone>,
        <https://1145.am/db/1751200/Storm_Ventures>,
        <https://1145.am/db/1751800/Northgate_Capital>,
        <https://1145.am/db/1753643/Westbridge_Capital>,
        <https://1145.am/db/1754080/Northzone>,
        <https://1145.am/db/1760985/Westbridge_Capital>,
        <https://1145.am/db/1762493/Westbridge>,
        <https://1145.am/db/1765673/Norwest>,
        <https://1145.am/db/1791628/Interwest_Partners>,
        <https://1145.am/db/1793458/Storm_Ventures>,
        <https://1145.am/db/1808484/Northgate_Capital>,
        <https://1145.am/db/1808735/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1818901/Northgate_Capital>,
        <https://1145.am/db/1824252/Northgate_Capital>,
        <https://1145.am/db/1830655/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1832969/Interwest_Partners>,
        <https://1145.am/db/1841022/Northgate_Capital>,
        <https://1145.am/db/1846718/Northwest_Venture_Partners>,
        <https://1145.am/db/1848921/Interwest_Partners>,
        <https://1145.am/db/1849310/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1854203/Storm_Ventures>,
        <https://1145.am/db/1854846/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1857632/Northgate_Capital>,
        <https://1145.am/db/1860345/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1862872/Interwest_Partners>,
        <https://1145.am/db/1863401/Interwest_Partners>,
        <https://1145.am/db/1870838/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1872490/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1881065/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1890261/Storm_Ventures>,
        <https://1145.am/db/1890619/Northgate_Capital>,
        <https://1145.am/db/1894848/Storm_Ventures>,
        <https://1145.am/db/1906336/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1911080/Northbridge_Venture_Partners>,
        <https://1145.am/db/1991347/Loop_Ventures>,
        <https://1145.am/db/2294753/Interwest_Partners>,
        <https://1145.am/db/2304606/Interwest_Partners>,
        <https://1145.am/db/2305507/Interwest_Partners>,
        <https://1145.am/db/2309051/Warburg_Pincus>,
        <https://1145.am/db/2314380/Interwest_Partners>,
        <https://1145.am/db/2355531/Interwest_Partners>,
        <https://1145.am/db/2355543/Interwest_Partners>,
        <https://1145.am/db/2360647/Interwest_Partners>,
        <https://1145.am/db/2362453/Warburg_Pincus>,
        <https://1145.am/db/2370582/Interwest_Partners>,
        <https://1145.am/db/2606743/Pacificap>,
        <https://1145.am/db/2614160/North_Bridge_Venture_Partners>,
        <https://1145.am/db/474123/Northzone> ;
    ns1:sameAsMedium <https://1145.am/db/1697098/Interwest_Partners>,
        <https://1145.am/db/1711300/Interwest_Partners>,
        <https://1145.am/db/1717613/Interwest_Partners>,
        <https://1145.am/db/1792426/Interwest_Partners>,
        <https://1145.am/db/1831689/Interwest_Partners>,
        <https://1145.am/db/1840379/Interwest_Partners>,
        <https://1145.am/db/1842466/Interwest_Partners>,
        <https://1145.am/db/1842817/Interwest_Partners>,
        <https://1145.am/db/1847994/Interwest_Partners>,
        <https://1145.am/db/1853156/Interwest_Partners>,
        <https://1145.am/db/1853882/Interwest_Partners>,
        <https://1145.am/db/1860832/Interwest_Partners>,
        <https://1145.am/db/1864172/Interwest_Partners>,
        <https://1145.am/db/1866990/Interwest_Partners>,
        <https://1145.am/db/1881935/Interwest_Partners>,
        <https://1145.am/db/1882810/Interwest_Partners>,
        <https://1145.am/db/1883990/Interwest_Partners>,
        <https://1145.am/db/1886261/Interwest_Partners>,
        <https://1145.am/db/1891834/Interwest_Partners>,
        <https://1145.am/db/1906428/Interwest_Partners>,
        <https://1145.am/db/1911578/Interwest_Partners>,
        <https://1145.am/db/2155189/Interwest_Partners>,
        <https://1145.am/db/2218486/Interwest_Partners>,
        <https://1145.am/db/2242262/Interwest_Partners>,
        <https://1145.am/db/2242266/Interwest_Partners>,
        <https://1145.am/db/2296841/Interwest_Partners>,
        <https://1145.am/db/2301464/Interwest_Partners>,
        <https://1145.am/db/2301901/Interwest_Partners>,
        <https://1145.am/db/2302076/Interwest_Partners>,
        <https://1145.am/db/2302091/Interwest_Partners>,
        <https://1145.am/db/2302108/Interwest_Partners>,
        <https://1145.am/db/2302289/Interwest_Partners>,
        <https://1145.am/db/2304598/Interwest_Partners>,
        <https://1145.am/db/2305514/Interwest_Partners>,
        <https://1145.am/db/2310073/Interwest_Partners>,
        <https://1145.am/db/2313357/Interwest_Partners>,
        <https://1145.am/db/2314964/Interwest_Partners>,
        <https://1145.am/db/2315289/Interwest_Partners>,
        <https://1145.am/db/2317561/Interwest_Partners>,
        <https://1145.am/db/2317564/Interwest_Partners>,
        <https://1145.am/db/2317750/Interwest_Partners>,
        <https://1145.am/db/2317753/Interwest_Partners>,
        <https://1145.am/db/2319809/Interwest_Partners>,
        <https://1145.am/db/2325257/Interwest_Partners>,
        <https://1145.am/db/2326361/Interwest_Partners>,
        <https://1145.am/db/2326373/Interwest_Partners>,
        <https://1145.am/db/2332991/Interwest_Partners>,
        <https://1145.am/db/2339393/Interwest_Partners>,
        <https://1145.am/db/2340224/Interwest_Partners>,
        <https://1145.am/db/2348754/Interwest_Partners>,
        <https://1145.am/db/2349838/Interwest_Partners>,
        <https://1145.am/db/2358234/Interwest_Partners>,
        <https://1145.am/db/2447807/Interwest_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340284/Osage_University_Partners> a org:Organization ;
    ns1:basedInLowRaw "SALT LAKE CITY" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-11-21T12:07:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor; Appoints Gregory C. Critchfiel" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sera-prognostics-secures-19-3-million-series-a-funding-to-commercialize-preterm-birth> ;
    ns1:foundName "Osage University Partners" ;
    ns1:investor <https://1145.am/db/2340284/Series_A_Investment_Catalyst_Health_Ventures_Domain_Associates_Interwest_Partners_Osage_University_Partners_Sera_Prognostics_Upstart_Life_Sciences_Capital_Completed> ;
    ns1:name "Osage University Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1619110/Osage_University_Partners>,
        <https://1145.am/db/1810714/Osage_University_Partners>,
        <https://1145.am/db/2294753/Osage_University_Partners>,
        <https://1145.am/db/2341896/Osage_University_Partners>,
        <https://1145.am/db/2349691/Osage_University_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1441781/Osage_University_Partners>,
        <https://1145.am/db/1533327/Osage_University_Partners>,
        <https://1145.am/db/1533685/Osage_University_Partners>,
        <https://1145.am/db/1696377/Osage_University_Partners>,
        <https://1145.am/db/1759759/Osage_University_Partners>,
        <https://1145.am/db/1774684/Osage_University_Partners>,
        <https://1145.am/db/1782234/Osage_University_Partners>,
        <https://1145.am/db/1802088/Osage_University_Partners>,
        <https://1145.am/db/1823287/Osage_University_Partners>,
        <https://1145.am/db/1858399/Osage_University_Partners>,
        <https://1145.am/db/2153910/Osage_University_Partners>,
        <https://1145.am/db/2278799/Osage_University_Partners>,
        <https://1145.am/db/2292287/Osage_University_Partners>,
        <https://1145.am/db/2301464/Osage_University_Partners>,
        <https://1145.am/db/2319360/Osage_University_Partners>,
        <https://1145.am/db/2336032/Osage_University_Partners>,
        <https://1145.am/db/2336221/Osage_University_Partners>,
        <https://1145.am/db/2340888/Osage_University_Partners>,
        <https://1145.am/db/2349838/Osage_University_Partners>,
        <https://1145.am/db/2350044/Osage_University_Partners>,
        <https://1145.am/db/2350199/Osage_University_Partners>,
        <https://1145.am/db/2352349/Osage_University_Partners>,
        <https://1145.am/db/2352350/Osage_University_Partners>,
        <https://1145.am/db/2353771/Osage_University_Partners>,
        <https://1145.am/db/2353789/Osage_University_Partners>,
        <https://1145.am/db/2358430/Osage_University_Partners>,
        <https://1145.am/db/2359404/Osage_University_Partners>,
        <https://1145.am/db/2360521/Osage_University_Partners>,
        <https://1145.am/db/2360526/Osage_University_Partners>,
        <https://1145.am/db/2368351/Osage_University_Partners>,
        <https://1145.am/db/2369165/Osage_University_Partners>,
        <https://1145.am/db/2369169/Osage_University_Partners>,
        <https://1145.am/db/2370626/Osage_University_Partners>,
        <https://1145.am/db/2569831/Osage_University_Partners>,
        <https://1145.am/db/425953/Osage_University_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340284/Upstart_Life_Sciences_Capital> a org:Organization ;
    ns1:basedInLowRaw "SALT LAKE CITY" ;
    ns1:documentDate "2011-11-21T12:07:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor; Appoints Gregory C. Critchfiel" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sera-prognostics-secures-19-3-million-series-a-funding-to-commercialize-preterm-birth> ;
    ns1:foundName "UpStart Life Sciences Capital" ;
    ns1:investor <https://1145.am/db/2340284/Series_A_Investment_Catalyst_Health_Ventures_Domain_Associates_Interwest_Partners_Osage_University_Partners_Sera_Prognostics_Upstart_Life_Sciences_Capital_Completed> ;
    ns1:name "UpStart Life Sciences Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2294753/Upstart_Life_Sciences_Capital>,
        <https://1145.am/db/2296841/Upstart_Life_Sciences_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340305/Eastern_Capital_Limited> a org:Organization ;
    ns1:basedInLowRaw "Asia" ;
    ns1:documentDate "2011-11-21T16:01:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Portola Pharmaceuticals Announces Completion of $89 Million Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/portola-pharmaceuticals-announces-completion-of-89-million-financing> ;
    ns1:foundName "Eastern Capital Limited" ;
    ns1:investor <https://1145.am/db/2340305/Preferred_Stock_Investment_Eastern_Capital_Limited_Portola_Pharmaceuticals_Inc_Temasek_Completed> ;
    ns1:name "Eastern Capital Limited" ;
    ns1:sameAsMedium <https://1145.am/db/2299271/Eastern_Capital>,
        <https://1145.am/db/2344219/Eastern_Capital_Limited>,
        <https://1145.am/db/2349221/Eastern_Capital>,
        <https://1145.am/db/2537321/Eastern_Capital_Limited>,
        <https://1145.am/db/592382/Eastern_Capital_Limited> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340305/Temasek> a org:Organization ;
    ns1:basedInHighGeoName "Asia" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6255147/about.rdf> ;
    ns1:basedInHighRaw "Asia" ;
    ns1:description "Asia investment company" ;
    ns1:documentDate "2011-11-21T16:01:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Portola Pharmaceuticals Announces Completion of $89 Million Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/portola-pharmaceuticals-announces-completion-of-89-million-financing> ;
    ns1:foundName "Temasek" ;
    ns1:investor <https://1145.am/db/2340305/Preferred_Stock_Investment_Eastern_Capital_Limited_Portola_Pharmaceuticals_Inc_Temasek_Completed> ;
    ns1:name "Temasek" ;
    ns1:sameAsHigh <https://1145.am/db/1042545/Temasek>,
        <https://1145.am/db/1066315/Temasek>,
        <https://1145.am/db/1066322/Temasek>,
        <https://1145.am/db/1066323/Temasek>,
        <https://1145.am/db/1066333/Temasek>,
        <https://1145.am/db/1067524/Temasek>,
        <https://1145.am/db/1067526/Temasek>,
        <https://1145.am/db/1067529/Temasek>,
        <https://1145.am/db/1067530/Temasek>,
        <https://1145.am/db/1185911/Temasek>,
        <https://1145.am/db/1187636/Temasek>,
        <https://1145.am/db/1355546/Temasek>,
        <https://1145.am/db/1356171/Temasek>,
        <https://1145.am/db/1371212/Temasek>,
        <https://1145.am/db/1447378/Temasek_Holdings>,
        <https://1145.am/db/1448485/Temasek>,
        <https://1145.am/db/1451743/Singapores_Temasek_Holdings>,
        <https://1145.am/db/1502825/Temasek_Holdings>,
        <https://1145.am/db/1648491/Temasek>,
        <https://1145.am/db/1668144/Temasek>,
        <https://1145.am/db/1734427/Temasek>,
        <https://1145.am/db/1734560/Temasek>,
        <https://1145.am/db/1734901/Temasek>,
        <https://1145.am/db/1742532/Temasek>,
        <https://1145.am/db/1744957/Temasek>,
        <https://1145.am/db/1755004/Temasek>,
        <https://1145.am/db/1755209/Temasek>,
        <https://1145.am/db/1766628/Temasek>,
        <https://1145.am/db/1777816/Temasek_Holdings>,
        <https://1145.am/db/1785263/Temasek>,
        <https://1145.am/db/1821833/Temasek>,
        <https://1145.am/db/1847010/Temasek>,
        <https://1145.am/db/1965165/Temasek>,
        <https://1145.am/db/2067811/Temasek>,
        <https://1145.am/db/2074897/Temasek>,
        <https://1145.am/db/2110114/Temasek>,
        <https://1145.am/db/2110248/Temasek>,
        <https://1145.am/db/2111428/Temasek>,
        <https://1145.am/db/2299918/Temasek>,
        <https://1145.am/db/2599246/Temasek_Holdings>,
        <https://1145.am/db/2662465/Temasek_Holdings>,
        <https://1145.am/db/274611/Temasek_Holdings>,
        <https://1145.am/db/323290/Temasek>,
        <https://1145.am/db/342626/Temasek_Holdings>,
        <https://1145.am/db/372639/Temasek>,
        <https://1145.am/db/406679/Temasek>,
        <https://1145.am/db/406744/Temasek>,
        <https://1145.am/db/466426/Temasek>,
        <https://1145.am/db/588995/Temasek>,
        <https://1145.am/db/620653/Temasek>,
        <https://1145.am/db/684583/Temasek>,
        <https://1145.am/db/755411/Temasek>,
        <https://1145.am/db/782551/Temasek>,
        <https://1145.am/db/786455/Temasek>,
        <https://1145.am/db/817162/Temasek>,
        <https://1145.am/db/852005/Temasek>,
        <https://1145.am/db/882636/Temasek>,
        <https://1145.am/db/968382/Temasek>,
        <https://1145.am/db/973671/Temasek>,
        <https://1145.am/db/976348/Temasek> ;
    ns1:sameAsMedium <https://1145.am/db/1068016/Temasek>,
        <https://1145.am/db/1155304/Temasek>,
        <https://1145.am/db/1208698/Temasek>,
        <https://1145.am/db/1260744/Temasek>,
        <https://1145.am/db/1264889/Temasek>,
        <https://1145.am/db/1279018/Temasek>,
        <https://1145.am/db/1280577/Temasek>,
        <https://1145.am/db/1327131/Temasek>,
        <https://1145.am/db/1329147/Temasek>,
        <https://1145.am/db/1331421/Temasek>,
        <https://1145.am/db/1403851/Temasek>,
        <https://1145.am/db/1403897/Temasek>,
        <https://1145.am/db/1451672/Temasek>,
        <https://1145.am/db/165056/Temasek>,
        <https://1145.am/db/1694304/Temasek>,
        <https://1145.am/db/1695864/Temasek>,
        <https://1145.am/db/1696327/Temasek>,
        <https://1145.am/db/1696600/Temasek>,
        <https://1145.am/db/1714212/Temasek>,
        <https://1145.am/db/1715669/Temasek>,
        <https://1145.am/db/1722609/Temasek>,
        <https://1145.am/db/1729336/Temasek>,
        <https://1145.am/db/1734422/Temasek>,
        <https://1145.am/db/1739120/Temasek>,
        <https://1145.am/db/1739125/Temasek>,
        <https://1145.am/db/1739282/Temasek>,
        <https://1145.am/db/1739488/Temasek>,
        <https://1145.am/db/1742981/Temasek>,
        <https://1145.am/db/1746577/Temasek>,
        <https://1145.am/db/1746725/Temasek>,
        <https://1145.am/db/1747400/Temasek>,
        <https://1145.am/db/1749304/Temasek>,
        <https://1145.am/db/1750488/Temasek>,
        <https://1145.am/db/1753962/Temasek>,
        <https://1145.am/db/1754241/Temasek>,
        <https://1145.am/db/1755370/Temasek>,
        <https://1145.am/db/1756768/Temasek>,
        <https://1145.am/db/1757382/Temasek>,
        <https://1145.am/db/1757977/Temasek>,
        <https://1145.am/db/1758916/Temasek>,
        <https://1145.am/db/1761247/Temasek>,
        <https://1145.am/db/1762240/Temasek>,
        <https://1145.am/db/1763411/Temasek>,
        <https://1145.am/db/1765718/Temasek>,
        <https://1145.am/db/1766255/Temasek>,
        <https://1145.am/db/1770353/Temasek>,
        <https://1145.am/db/1774306/Temasek>,
        <https://1145.am/db/1778032/Temasek>,
        <https://1145.am/db/1784230/Temasek>,
        <https://1145.am/db/1787892/Temasek>,
        <https://1145.am/db/1788297/Temasek>,
        <https://1145.am/db/1790374/Temasek>,
        <https://1145.am/db/1790917/Temasek>,
        <https://1145.am/db/1791158/Temasek>,
        <https://1145.am/db/1799293/Temasek>,
        <https://1145.am/db/1806810/Temasek>,
        <https://1145.am/db/1809072/Temasek>,
        <https://1145.am/db/1809885/Temasek>,
        <https://1145.am/db/1814854/Temasek>,
        <https://1145.am/db/1814941/Temasek>,
        <https://1145.am/db/1815556/Temasek>,
        <https://1145.am/db/1816262/Temasek>,
        <https://1145.am/db/1820911/Temasek>,
        <https://1145.am/db/1896735/Temasek>,
        <https://1145.am/db/1964151/Temasek>,
        <https://1145.am/db/2052170/Temasek>,
        <https://1145.am/db/2083550/Temasek>,
        <https://1145.am/db/2109233/Temasek>,
        <https://1145.am/db/2111111/Temasek>,
        <https://1145.am/db/2133719/Temasek>,
        <https://1145.am/db/2151983/Temasek>,
        <https://1145.am/db/2152526/Temasek>,
        <https://1145.am/db/2196875/Temasek>,
        <https://1145.am/db/2279864/Temasek>,
        <https://1145.am/db/2286245/Temasek>,
        <https://1145.am/db/2294195/Temasek>,
        <https://1145.am/db/2540991/Temasek>,
        <https://1145.am/db/2625686/Temasek>,
        <https://1145.am/db/278394/Temasek>,
        <https://1145.am/db/2785350/Temasek>,
        <https://1145.am/db/283135/Temasek>,
        <https://1145.am/db/328689/Temasek>,
        <https://1145.am/db/341818/Temasek>,
        <https://1145.am/db/359190/Temasek>,
        <https://1145.am/db/371811/Temasek>,
        <https://1145.am/db/386669/Temasek>,
        <https://1145.am/db/474783/Temasek>,
        <https://1145.am/db/525170/Temasek>,
        <https://1145.am/db/579051/Temasek>,
        <https://1145.am/db/676716/Temasek>,
        <https://1145.am/db/711928/Temasek>,
        <https://1145.am/db/716886/Temasek>,
        <https://1145.am/db/717634/Temasek>,
        <https://1145.am/db/817705/Temasek>,
        <https://1145.am/db/834864/Temasek>,
        <https://1145.am/db/848318/Temasek>,
        <https://1145.am/db/882299/Temasek>,
        <https://1145.am/db/999577/Temasek> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340331/Pfizer_Inc> a org:Organization ;
    ns1:basedInLowRaw "CARLSBAD" ;
    ns1:description "Pharmaceuticals",
        "pharmaceuticals" ;
    ns1:documentDate "2011-11-22T14:17:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Isis to Receive Up to $14 Million from Pfizer for Its Acquisition of Excaliard Pharmaceuticals" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/isis-to-receive-up-to-14-million-from-pfizer-for-its-acquisition-of-excaliard> ;
    ns1:foundName "Pfizer",
        "Pfizer Inc",
        "Pfizer Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2340331/Excaliard_Pharmaceuticals_Equity_Ownership_Investment> ;
    ns1:name "Pfizer Inc",
        "Pfizer Inc." ;
    ns1:sameAsHigh <https://1145.am/db/1018723/Pfizer_Inc>,
        <https://1145.am/db/1042002/Pfizer_Inc>,
        <https://1145.am/db/1045477/Pfizer_Inc>,
        <https://1145.am/db/1046923/Pfizer>,
        <https://1145.am/db/1053698/Pfizer>,
        <https://1145.am/db/1054558/Pfizer_Inc>,
        <https://1145.am/db/1065617/Pfizer_Inc>,
        <https://1145.am/db/1066444/Pfizer_Inc>,
        <https://1145.am/db/1097779/GSK>,
        <https://1145.am/db/1097915/GSK>,
        <https://1145.am/db/1097915/Pfizer>,
        <https://1145.am/db/1098950/GSK>,
        <https://1145.am/db/1123210/Pfizer_Inc>,
        <https://1145.am/db/1124362/Pfizer_Inc>,
        <https://1145.am/db/1138594/Pfizer_Inc>,
        <https://1145.am/db/1146707/Pfizer>,
        <https://1145.am/db/118625/GSK>,
        <https://1145.am/db/1209318/Glaxosmithkline>,
        <https://1145.am/db/1258904/Pfizer_Inc>,
        <https://1145.am/db/1260932/Pfizer_Inc>,
        <https://1145.am/db/1261278/Pfizer_Inc>,
        <https://1145.am/db/1262347/Pfizer_Inc>,
        <https://1145.am/db/1262354/Pfizer_Inc>,
        <https://1145.am/db/1262545/Pfizer_Inc>,
        <https://1145.am/db/1264461/Pfizer_Inc>,
        <https://1145.am/db/1264475/Pfizer_Inc>,
        <https://1145.am/db/1270781/Pfizer_Inc>,
        <https://1145.am/db/1271008/Pfizer>,
        <https://1145.am/db/1308148/Pfizer_Inc>,
        <https://1145.am/db/1308675/Pfizer_Inc>,
        <https://1145.am/db/1361734/GSK>,
        <https://1145.am/db/1369714/GSK>,
        <https://1145.am/db/1385939/Pfizer_Inc>,
        <https://1145.am/db/1390822/Pfizer_Inc>,
        <https://1145.am/db/1394279/Pfizer_Inc>,
        <https://1145.am/db/1395353/Pfizer_Inc>,
        <https://1145.am/db/1549114/Pfizer_Inc>,
        <https://1145.am/db/1550950/Pfizer_Inc>,
        <https://1145.am/db/1684001/Pfizer_Inc>,
        <https://1145.am/db/1936001/Pfizer_Inc>,
        <https://1145.am/db/1936167/Pfizer_Inc>,
        <https://1145.am/db/1952785/Pfizer_Inc>,
        <https://1145.am/db/1972441/GSK>,
        <https://1145.am/db/2007025/Pfizer_Inc>,
        <https://1145.am/db/2009165/Pfizer_Inc>,
        <https://1145.am/db/2009856/Pfizer>,
        <https://1145.am/db/2013022/Pfizer_Inc>,
        <https://1145.am/db/2057315/Pfizer>,
        <https://1145.am/db/2070468/Pfizer>,
        <https://1145.am/db/2088776/Pfizer>,
        <https://1145.am/db/2119099/Pfizer>,
        <https://1145.am/db/2137303/GSK>,
        <https://1145.am/db/2138577/GSK>,
        <https://1145.am/db/2152849/Pfizer>,
        <https://1145.am/db/2152862/Pfizer>,
        <https://1145.am/db/2207119/Pfizer_Inc>,
        <https://1145.am/db/2221589/Pfizer>,
        <https://1145.am/db/2278803/GSK>,
        <https://1145.am/db/2279140/Pfizer>,
        <https://1145.am/db/2280707/Pfizer>,
        <https://1145.am/db/2280718/Pfizer>,
        <https://1145.am/db/2280933/Pfizer>,
        <https://1145.am/db/2281080/GSK>,
        <https://1145.am/db/2281622/Pfizer>,
        <https://1145.am/db/2281629/Pfizer>,
        <https://1145.am/db/2281879/Pfizer>,
        <https://1145.am/db/2283867/GSK>,
        <https://1145.am/db/2284235/Pfizer>,
        <https://1145.am/db/2285463/Pfizer>,
        <https://1145.am/db/2285764/Pfizer>,
        <https://1145.am/db/2289503/Pfizer>,
        <https://1145.am/db/2290507/Glaxosmithkline>,
        <https://1145.am/db/2291302/Glaxosmithkline>,
        <https://1145.am/db/2293631/Glaxosmithkline>,
        <https://1145.am/db/2293980/Pfizer>,
        <https://1145.am/db/2294613/Pfizer>,
        <https://1145.am/db/2295427/Pfizer>,
        <https://1145.am/db/2295635/Glaxosmithkline>,
        <https://1145.am/db/2296000/Pfizer>,
        <https://1145.am/db/2297455/Pfizer>,
        <https://1145.am/db/2297477/Pfizer>,
        <https://1145.am/db/2298256/Pfizer>,
        <https://1145.am/db/2301922/Pfizer>,
        <https://1145.am/db/230344/GSK>,
        <https://1145.am/db/230344/Glaxosmithkline>,
        <https://1145.am/db/2303447/Pfizer>,
        <https://1145.am/db/2304647/Pfizer>,
        <https://1145.am/db/2306213/Glaxosmithkline>,
        <https://1145.am/db/2306799/Glaxosmithkline>,
        <https://1145.am/db/2308656/Pfizer>,
        <https://1145.am/db/2308807/Pfizer>,
        <https://1145.am/db/2309065/Pfizer>,
        <https://1145.am/db/2309488/P_g>,
        <https://1145.am/db/2310071/Pfizer_Inc>,
        <https://1145.am/db/2310072/Pfizer>,
        <https://1145.am/db/2310168/Pfizer>,
        <https://1145.am/db/2310241/Pfizer>,
        <https://1145.am/db/2311347/Pfizer>,
        <https://1145.am/db/2311570/Pfizer_Inc>,
        <https://1145.am/db/2312314/Pfizer>,
        <https://1145.am/db/2312321/Pfizer_Inc>,
        <https://1145.am/db/2312865/Pfizer>,
        <https://1145.am/db/2312994/Pfizer>,
        <https://1145.am/db/2312995/Pfizer_Inc>,
        <https://1145.am/db/2313383/Pfizer_Inc>,
        <https://1145.am/db/2314928/Pfizer>,
        <https://1145.am/db/2315552/Pfizer>,
        <https://1145.am/db/2316517/Pfizer>,
        <https://1145.am/db/2316538/Pfizer_Inc>,
        <https://1145.am/db/2316843/Pfizer>,
        <https://1145.am/db/2317128/Pfizer-Wyeth>,
        <https://1145.am/db/2317915/Pfizer>,
        <https://1145.am/db/2318333/Pfizer>,
        <https://1145.am/db/2318922/Pfizer>,
        <https://1145.am/db/2320509/Pfizer>,
        <https://1145.am/db/2322306/Pfizer>,
        <https://1145.am/db/2322307/Pfizer>,
        <https://1145.am/db/2322620/Pfizer>,
        <https://1145.am/db/2322633/Pfizer_Inc>,
        <https://1145.am/db/2322733/Pfizer>,
        <https://1145.am/db/2322786/Pfizer>,
        <https://1145.am/db/2324128/Pfizer>,
        <https://1145.am/db/2324155/Pfizer>,
        <https://1145.am/db/2325165/Pfizer_Inc>,
        <https://1145.am/db/2326266/Glaxosmithkline_(gsk)>,
        <https://1145.am/db/2327511/Pfizer_Inc>,
        <https://1145.am/db/2328681/GSK>,
        <https://1145.am/db/2328712/Pfizer>,
        <https://1145.am/db/2329902/Pfizer>,
        <https://1145.am/db/2329920/Pfizer_Inc>,
        <https://1145.am/db/2330817/Pfizer_Inc>,
        <https://1145.am/db/2330955/Pfizer>,
        <https://1145.am/db/2332552/Pfizer>,
        <https://1145.am/db/2332767/Pfizer_Ltd>,
        <https://1145.am/db/2334133/Pfizer_Inc>,
        <https://1145.am/db/2334165/Pfizer_Inc>,
        <https://1145.am/db/2335568/Glaxosmithkline>,
        <https://1145.am/db/2335573/GSK>,
        <https://1145.am/db/2335634/Pfizer>,
        <https://1145.am/db/2335717/Pfizer>,
        <https://1145.am/db/2336060/Glaxosmithkline>,
        <https://1145.am/db/2336333/Pfizer>,
        <https://1145.am/db/2336704/GSK>,
        <https://1145.am/db/2337788/Pfizer>,
        <https://1145.am/db/2339633/Pfizer_Inc>,
        <https://1145.am/db/2340055/Pfizer>,
        <https://1145.am/db/2340072/GSK>,
        <https://1145.am/db/2340260/Glaxosmithkline>,
        <https://1145.am/db/2340321/Pfizer_Inc>,
        <https://1145.am/db/2340324/Pfizer_Inc>,
        <https://1145.am/db/2340325/Pfizer_Inc>,
        <https://1145.am/db/2340890/Pfizer>,
        <https://1145.am/db/2341325/Pfizer>,
        <https://1145.am/db/2341516/Pfizer>,
        <https://1145.am/db/2342559/Pfizer_Inc>,
        <https://1145.am/db/2343237/Pfizer_Inc>,
        <https://1145.am/db/2343273/Pfizer_Inc>,
        <https://1145.am/db/2343298/Pfizer_Inc>,
        <https://1145.am/db/2343344/Pfizer>,
        <https://1145.am/db/2343454/Pfizer_Inc>,
        <https://1145.am/db/2343861/Glaxosmithkline>,
        <https://1145.am/db/2344023/Glaxosmithkline>,
        <https://1145.am/db/2345065/Pfizer>,
        <https://1145.am/db/2345251/GSK>,
        <https://1145.am/db/2346602/Pfizer_Inc>,
        <https://1145.am/db/2347383/Pfizer_Inc>,
        <https://1145.am/db/2348510/Pfizer_Inc>,
        <https://1145.am/db/2351730/Pfizer_Inc>,
        <https://1145.am/db/2353039/Pfizer_Inc>,
        <https://1145.am/db/2353325/Pfizer>,
        <https://1145.am/db/2353326/Pfizer>,
        <https://1145.am/db/2353337/Pfizer>,
        <https://1145.am/db/2353364/Pfizer>,
        <https://1145.am/db/2353376/Pfizer>,
        <https://1145.am/db/2354567/Pfizer>,
        <https://1145.am/db/2355021/Pfizer>,
        <https://1145.am/db/2355025/Pfizer_Inc>,
        <https://1145.am/db/2355472/Pfizer_Inc>,
        <https://1145.am/db/2355641/GSK>,
        <https://1145.am/db/2355916/Pfizer_Inc>,
        <https://1145.am/db/2356124/Pfizer_Inc>,
        <https://1145.am/db/2356559/Glaxosmithkline>,
        <https://1145.am/db/2356597/Pfizer>,
        <https://1145.am/db/2356599/Pfizer>,
        <https://1145.am/db/2356811/GSK>,
        <https://1145.am/db/2357232/Pfizer>,
        <https://1145.am/db/2357308/Pfizer_Inc>,
        <https://1145.am/db/2358128/Pfizer>,
        <https://1145.am/db/2359697/Pfizer>,
        <https://1145.am/db/2359727/GSK>,
        <https://1145.am/db/2359727/Glaxosmithkline>,
        <https://1145.am/db/2359858/GSK>,
        <https://1145.am/db/2359858/Glaxosmithkline>,
        <https://1145.am/db/2360562/GSK>,
        <https://1145.am/db/2360633/Pfizer>,
        <https://1145.am/db/2360647/Pfizer_Inc>,
        <https://1145.am/db/2361700/GSK>,
        <https://1145.am/db/2361705/GSK>,
        <https://1145.am/db/2362439/Pfizer_Inc>,
        <https://1145.am/db/2362851/Pfizer_Inc>,
        <https://1145.am/db/2363435/Gsk_Pfizer>,
        <https://1145.am/db/2363446/Pfizer_Inc>,
        <https://1145.am/db/2363896/Pfizer>,
        <https://1145.am/db/2364087/Pfizer_Inc>,
        <https://1145.am/db/2364813/Glaxosmithkline>,
        <https://1145.am/db/2365103/Glaxosmithkline>,
        <https://1145.am/db/2365171/Pfizer_Ventures>,
        <https://1145.am/db/2366395/Pfizer_Inc>,
        <https://1145.am/db/2367283/Pfizer_Inc>,
        <https://1145.am/db/2367982/Pfizer>,
        <https://1145.am/db/2368146/Pfizer>,
        <https://1145.am/db/2369451/Glaxosmithkline>,
        <https://1145.am/db/2369755/GSK>,
        <https://1145.am/db/2369761/Glaxosmithkline>,
        <https://1145.am/db/2369876/Pfizer>,
        <https://1145.am/db/2369909/Pfizer_Inc>,
        <https://1145.am/db/2370016/Pfizer>,
        <https://1145.am/db/2370635/GSK>,
        <https://1145.am/db/2370843/Glaxosmithkline>,
        <https://1145.am/db/2371512/Pfizer>,
        <https://1145.am/db/238329/GSK>,
        <https://1145.am/db/2507041/Pfizer>,
        <https://1145.am/db/2536358/Pfizer_Inc>,
        <https://1145.am/db/2536361/Pfizer_Inc>,
        <https://1145.am/db/2536362/Pfizer_Inc>,
        <https://1145.am/db/2536365/Pfizer_Inc>,
        <https://1145.am/db/2536475/Pfizer>,
        <https://1145.am/db/2536493/Glaxosmithkline>,
        <https://1145.am/db/2536856/Pfizer>,
        <https://1145.am/db/2537054/Pfizer_Inc>,
        <https://1145.am/db/2537057/Pfizer_Inc>,
        <https://1145.am/db/2537171/Pfizer>,
        <https://1145.am/db/2537597/Pfizer>,
        <https://1145.am/db/2537699/Glaxosmithkline>,
        <https://1145.am/db/2538568/Pfizer_Inc>,
        <https://1145.am/db/2538861/Pfizer>,
        <https://1145.am/db/2538915/Pfizer_Inc>,
        <https://1145.am/db/2538924/Pfizer>,
        <https://1145.am/db/2539516/Pfizer>,
        <https://1145.am/db/2539695/GSK>,
        <https://1145.am/db/2540020/Glaxosmithkline>,
        <https://1145.am/db/2540170/Glaxosmithkline>,
        <https://1145.am/db/2540356/Pfizer>,
        <https://1145.am/db/2541091/GSK>,
        <https://1145.am/db/2541139/Pfizer_Inc>,
        <https://1145.am/db/2541146/Pfizer>,
        <https://1145.am/db/2541721/Pfizer>,
        <https://1145.am/db/2542064/GSK>,
        <https://1145.am/db/2542067/Pfizer_Inc>,
        <https://1145.am/db/2542072/Pfizer>,
        <https://1145.am/db/2542499/Pfizer>,
        <https://1145.am/db/2543278/Pfizer>,
        <https://1145.am/db/2543533/Pfizer>,
        <https://1145.am/db/2543826/Pfizer>,
        <https://1145.am/db/2543957/Pfizer>,
        <https://1145.am/db/2544062/Glaxosmithkline>,
        <https://1145.am/db/2544074/Pfizer>,
        <https://1145.am/db/2545058/Pfizer>,
        <https://1145.am/db/2545122/Pfizer>,
        <https://1145.am/db/2545537/Glaxosmithkline>,
        <https://1145.am/db/2545618/Pfizer>,
        <https://1145.am/db/2545634/Pfizer>,
        <https://1145.am/db/2545818/Pfizer>,
        <https://1145.am/db/2545847/GSK>,
        <https://1145.am/db/2546136/Glaxosmithkline>,
        <https://1145.am/db/2546260/Glaxosmithkline>,
        <https://1145.am/db/2546577/Glaxosmithkline>,
        <https://1145.am/db/2546583/Pfizer>,
        <https://1145.am/db/2546596/Pfizer>,
        <https://1145.am/db/2547000/Pfizer>,
        <https://1145.am/db/2547653/Pfizer>,
        <https://1145.am/db/2547954/Glaxosmithkline>,
        <https://1145.am/db/2548244/Pfizer_Inc>,
        <https://1145.am/db/2548674/Pfizer>,
        <https://1145.am/db/2548752/GSK>,
        <https://1145.am/db/2548752/Pfizer>,
        <https://1145.am/db/2548986/Pfizer>,
        <https://1145.am/db/2549151/Pfizer>,
        <https://1145.am/db/2549598/Glaxosmithkline>,
        <https://1145.am/db/2549673/Pfizer>,
        <https://1145.am/db/2549694/Glaxosmithkline>,
        <https://1145.am/db/2549719/Pfizer>,
        <https://1145.am/db/2549876/Glaxosmithkline>,
        <https://1145.am/db/2550054/Glaxosmithkline>,
        <https://1145.am/db/2550445/Pfizer>,
        <https://1145.am/db/2550460/GSK>,
        <https://1145.am/db/2550662/Glaxosmithkline>,
        <https://1145.am/db/2550685/Pfizer>,
        <https://1145.am/db/2551402/Glaxosmithkline>,
        <https://1145.am/db/2552165/Glaxosmithkline>,
        <https://1145.am/db/2552684/Pfizer>,
        <https://1145.am/db/2552794/Glaxosmithkline>,
        <https://1145.am/db/2553974/Pfizer>,
        <https://1145.am/db/2554044/Glaxosmithkline>,
        <https://1145.am/db/2554937/Pfizer>,
        <https://1145.am/db/2554938/Pfizer>,
        <https://1145.am/db/2555012/Glaxosmithkline>,
        <https://1145.am/db/2555896/Pfizer>,
        <https://1145.am/db/2555992/Pfizer>,
        <https://1145.am/db/2556407/Glaxosmithkline>,
        <https://1145.am/db/2557064/Pfizer>,
        <https://1145.am/db/2557083/Pfizer>,
        <https://1145.am/db/2557221/Glaxosmithkline>,
        <https://1145.am/db/2557221/Pfizer>,
        <https://1145.am/db/2558268/Pfizer>,
        <https://1145.am/db/2558417/Pfizer>,
        <https://1145.am/db/2558464/Pfizer>,
        <https://1145.am/db/2558862/GSK>,
        <https://1145.am/db/2558970/Pfizer>,
        <https://1145.am/db/2558971/Pfizer>,
        <https://1145.am/db/2559649/Pfizer>,
        <https://1145.am/db/2560282/Pfizer>,
        <https://1145.am/db/2560633/Glaxosmithkline>,
        <https://1145.am/db/2560720/Pfizer>,
        <https://1145.am/db/2561231/Pfizer>,
        <https://1145.am/db/2561650/GSK>,
        <https://1145.am/db/2561650/Pfizer>,
        <https://1145.am/db/2562102/Pfizer_Inc>,
        <https://1145.am/db/2562701/Pfizer>,
        <https://1145.am/db/2562773/GSK>,
        <https://1145.am/db/2562951/Glaxosmithkline>,
        <https://1145.am/db/2563857/Pfizer>,
        <https://1145.am/db/2563889/Pfizer>,
        <https://1145.am/db/2564032/Pfizer>,
        <https://1145.am/db/2564695/Glaxosmithkline>,
        <https://1145.am/db/2564884/GSK>,
        <https://1145.am/db/2566186/GSK>,
        <https://1145.am/db/2568121/Pfizer>,
        <https://1145.am/db/2568519/Pfizer>,
        <https://1145.am/db/2568899/Pfizer>,
        <https://1145.am/db/2568973/Glaxosmithkline>,
        <https://1145.am/db/2569378/Pfizer>,
        <https://1145.am/db/2570369/Pfizer_Inc>,
        <https://1145.am/db/2570791/Glaxosmithkline>,
        <https://1145.am/db/2571798/Pfizer_Inc>,
        <https://1145.am/db/2572036/Pfizer>,
        <https://1145.am/db/2572429/Glaxosmithkline>,
        <https://1145.am/db/2572927/Pfizer>,
        <https://1145.am/db/2573173/Pfizer>,
        <https://1145.am/db/2573245/Pfizer_Inc>,
        <https://1145.am/db/2573463/Pfizer>,
        <https://1145.am/db/2573465/Pfizer_Inc>,
        <https://1145.am/db/2573466/Pfizer>,
        <https://1145.am/db/2573551/Pfizer_Inc>,
        <https://1145.am/db/2573558/Pfizer_Inc>,
        <https://1145.am/db/2573562/Pfizer>,
        <https://1145.am/db/2573707/Pfizer>,
        <https://1145.am/db/2574332/Pfizer>,
        <https://1145.am/db/2574459/Pfizer_Inc>,
        <https://1145.am/db/2574461/Pfizer_Inc>,
        <https://1145.am/db/2574687/Pfizer>,
        <https://1145.am/db/2574691/Pfizer_Inc>,
        <https://1145.am/db/2575139/Pfizer_Inc>,
        <https://1145.am/db/2575145/Pfizer_Inc>,
        <https://1145.am/db/2575320/Pfizer>,
        <https://1145.am/db/2575471/Pfizer>,
        <https://1145.am/db/2575505/Pfizer_Inc>,
        <https://1145.am/db/2575575/Pfizer>,
        <https://1145.am/db/2575712/GSK>,
        <https://1145.am/db/2575723/Pfizer>,
        <https://1145.am/db/2576330/Pfizer_Inc>,
        <https://1145.am/db/2576526/Pfizer>,
        <https://1145.am/db/2576759/Pfizer>,
        <https://1145.am/db/2576762/Pfizer>,
        <https://1145.am/db/2577077/Pfizer>,
        <https://1145.am/db/2577226/Glaxosmithkline>,
        <https://1145.am/db/2577258/Pfizer_Inc>,
        <https://1145.am/db/2577655/Pfizer>,
        <https://1145.am/db/2577778/Glaxosmithkline>,
        <https://1145.am/db/2578528/GSK>,
        <https://1145.am/db/2579205/Glaxosmithkline>,
        <https://1145.am/db/2579252/Pfizer>,
        <https://1145.am/db/2579709/Pfizer_Inc>,
        <https://1145.am/db/2579716/Pfizer>,
        <https://1145.am/db/2580940/Pfizer>,
        <https://1145.am/db/2581331/Pfizer_Inc>,
        <https://1145.am/db/2581334/Pfizer_Inc>,
        <https://1145.am/db/2581339/Pfizer>,
        <https://1145.am/db/2581394/Pfizer>,
        <https://1145.am/db/2581659/GSK>,
        <https://1145.am/db/2581659/Pfizer>,
        <https://1145.am/db/2581661/Pfizer_Inc>,
        <https://1145.am/db/2582158/Pfizer_Inc>,
        <https://1145.am/db/2582160/Pfizer_Inc>,
        <https://1145.am/db/2582233/Glaxosmithkline>,
        <https://1145.am/db/2582343/Pfizer_Inc>,
        <https://1145.am/db/2582879/Pfizer_Inc>,
        <https://1145.am/db/2583155/Pfizer_Inc>,
        <https://1145.am/db/2583163/Pfizer>,
        <https://1145.am/db/2583165/Pfizer_Inc>,
        <https://1145.am/db/2583172/Pfizer>,
        <https://1145.am/db/2583242/Pfizer_Inc>,
        <https://1145.am/db/2583245/Pfizer_Inc>,
        <https://1145.am/db/2583337/Pfizer_Inc>,
        <https://1145.am/db/2583783/Pfizer>,
        <https://1145.am/db/2584085/Pfizer_Inc>,
        <https://1145.am/db/2584258/Pfizer_Inc>,
        <https://1145.am/db/2584601/Pfizer_Inc>,
        <https://1145.am/db/2584968/Pfizer>,
        <https://1145.am/db/2585700/Pfizer>,
        <https://1145.am/db/2585908/New_York-Pfizer_Inc>,
        <https://1145.am/db/2585908/Pfizer>,
        <https://1145.am/db/2585912/Pfizer>,
        <https://1145.am/db/2586034/Pfizer_Inc>,
        <https://1145.am/db/2586047/Pfizer_Inc>,
        <https://1145.am/db/2586804/GSK>,
        <https://1145.am/db/2587282/Glaxosmithkline>,
        <https://1145.am/db/2587387/Pfizer>,
        <https://1145.am/db/2587673/Pfizer>,
        <https://1145.am/db/2587770/Glaxosmithkline>,
        <https://1145.am/db/2588134/Pfizer_Inc>,
        <https://1145.am/db/2589365/Pfizer>,
        <https://1145.am/db/2589701/GSK>,
        <https://1145.am/db/2590549/Pfizer_Inc>,
        <https://1145.am/db/2590887/Pfizer>,
        <https://1145.am/db/2590988/Pfizer>,
        <https://1145.am/db/2590989/Pfizer>,
        <https://1145.am/db/2591081/Pfizer_Inc>,
        <https://1145.am/db/2591091/Pfizer>,
        <https://1145.am/db/2591092/Pfizer_Inc>,
        <https://1145.am/db/2591281/Pfizer>,
        <https://1145.am/db/2591652/Pfizer>,
        <https://1145.am/db/2591691/Pfizer>,
        <https://1145.am/db/2591733/Pfizer>,
        <https://1145.am/db/2592975/Pfizer_Inc>,
        <https://1145.am/db/2592977/Pfizer_Inc>,
        <https://1145.am/db/2592980/Pfizer>,
        <https://1145.am/db/2592987/Glaxosmithkline>,
        <https://1145.am/db/2592990/Pfizer_Inc>,
        <https://1145.am/db/2592992/Pfizer_Inc>,
        <https://1145.am/db/2593150/Pfizer>,
        <https://1145.am/db/2593886/Pfizer>,
        <https://1145.am/db/2593961/Pfizer_Inc>,
        <https://1145.am/db/2594141/Pfizer_Inc>,
        <https://1145.am/db/2594268/Pfizer_Inc>,
        <https://1145.am/db/2594422/Pfizer>,
        <https://1145.am/db/2594489/Pfizer_Inc>,
        <https://1145.am/db/2594574/Pfizer>,
        <https://1145.am/db/2594581/Pfizer>,
        <https://1145.am/db/2594992/Pfizer>,
        <https://1145.am/db/2595320/Pfizer_Inc>,
        <https://1145.am/db/2595472/Pfizer>,
        <https://1145.am/db/2595499/Pfizer>,
        <https://1145.am/db/2596344/Pfizer>,
        <https://1145.am/db/2596754/Pfizer_Inc>,
        <https://1145.am/db/2596778/Pfizer>,
        <https://1145.am/db/2596874/Pfizer>,
        <https://1145.am/db/2596947/Pfizer>,
        <https://1145.am/db/2597173/Pfizer>,
        <https://1145.am/db/2597183/Pfizer_Inc>,
        <https://1145.am/db/2597220/Glaxosmithkline>,
        <https://1145.am/db/2597643/Pfizer_Inc>,
        <https://1145.am/db/2597650/Pfizer>,
        <https://1145.am/db/2597651/Pfizer_Inc>,
        <https://1145.am/db/2597712/Pfizer>,
        <https://1145.am/db/2598461/Glaxosmithkline>,
        <https://1145.am/db/274660/Pfizer_Inc>,
        <https://1145.am/db/274739/Pfizer_Inc>,
        <https://1145.am/db/2792911/Pfizer>,
        <https://1145.am/db/2797157/GSK>,
        <https://1145.am/db/286227/Glaxosmithkline>,
        <https://1145.am/db/318295/Pfizer_Inc>,
        <https://1145.am/db/338190/GSK>,
        <https://1145.am/db/338242/Glaxosmithkline>,
        <https://1145.am/db/377761/Glaxosmithkline>,
        <https://1145.am/db/377769/Glaxosmithkline>,
        <https://1145.am/db/385094/GSK>,
        <https://1145.am/db/385100/GSK>,
        <https://1145.am/db/422377/Pfizer_Inc>,
        <https://1145.am/db/422378/Pfizer_Inc>,
        <https://1145.am/db/423571/Pfizer_Inc>,
        <https://1145.am/db/424190/Pfizer_Inc>,
        <https://1145.am/db/424896/Pfizer_Inc>,
        <https://1145.am/db/425689/Pfizer_Inc>,
        <https://1145.am/db/426841/Pfizer_Inc>,
        <https://1145.am/db/428975/Pfizer_Inc>,
        <https://1145.am/db/494811/GSK>,
        <https://1145.am/db/582690/GSK>,
        <https://1145.am/db/582690/Glaxosmithkline>,
        <https://1145.am/db/626832/Pfizer_Inc>,
        <https://1145.am/db/627349/Pfizer_Inc>,
        <https://1145.am/db/631317/Pfizer_Inc>,
        <https://1145.am/db/635031/Pfizer>,
        <https://1145.am/db/661291/GSK>,
        <https://1145.am/db/692994/Pfizer_Inc>,
        <https://1145.am/db/694218/Pfizer_Inc>,
        <https://1145.am/db/694224/Pfizer_Inc>,
        <https://1145.am/db/696927/Pfizer_Inc>,
        <https://1145.am/db/699199/Pfizer>,
        <https://1145.am/db/704642/Glaxosmithkline_Plc>,
        <https://1145.am/db/76007/Pfizer>,
        <https://1145.am/db/761748/Pfizer>,
        <https://1145.am/db/764460/Pfizer>,
        <https://1145.am/db/797138/Pfizer_Inc>,
        <https://1145.am/db/800318/Pfizer_Inc>,
        <https://1145.am/db/87287/Glaxosmithkline>,
        <https://1145.am/db/896566/Pfizer_Inc>,
        <https://1145.am/db/897457/Pfizer_Inc>,
        <https://1145.am/db/962850/Pfizer_Inc>,
        <https://1145.am/db/962851/Pfizer_Inc>,
        <https://1145.am/db/962899/Pfizer_Inc>,
        <https://1145.am/db/965490/Pfizer_Inc>,
        <https://1145.am/db/968220/Pfizer_Inc>,
        <https://1145.am/db/971984/Pfizer_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/1936264/Pfizer_Inc>,
        <https://1145.am/db/1983382/Pfizer_Inc>,
        <https://1145.am/db/2313175/Pfizer_Limited>,
        <https://1145.am/db/2327506/Pfizer>,
        <https://1145.am/db/2332830/Pfizer>,
        <https://1145.am/db/2350231/Pfizer>,
        <https://1145.am/db/2354370/Pfizer_Inc>,
        <https://1145.am/db/2539787/Pfizer>,
        <https://1145.am/db/2548137/Pfizer>,
        <https://1145.am/db/2550761/Pfizer>,
        <https://1145.am/db/2576064/Pfizer>,
        <https://1145.am/db/2595930/Pfizer>,
        <https://1145.am/db/2597185/Pfizer_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341136/Investment_Horizon_Pharma_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-29T16:48:39+00:00"^^xsd:dateTime ;
    ns1:documentExtract "DEERFIELD, IL- (Marketwire -02/29/12) - Horizon Pharma, Inc. (NASDAQ: HZNP - News) announced today the execution of a securities purchase agreement with a select group of institutional and accredited investors providing for a private placement financing.",
        "Horizon Pharma Announces $ 50.8 Million Private Placement." ;
    ns1:documentTitle "Horizon Pharma Announces $50.8 Million Private Placement" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/horizon-pharma-announces-50-8-million-private-placement> ;
    ns1:foundName "private placement" ;
    ns1:name "private placement" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2341136/Horizon_Pharma> ;
    ns1:valueRaw "$ 50.8 Million",
        "approximately $ 50.8 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2343244/Biogeneration_Ventures> a org:Organization ;
    ns1:basedInLowRaw "USA" ;
    ns1:description "fundraising" ;
    ns1:documentDate "2011-12-01T13:13:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argen-x-raises-eur-27-5-million-usd-37-million-oversubscribed-series-b-round> ;
    ns1:foundName "BioGeneration Ventures" ;
    ns1:investor <https://1145.am/db/2343244/Series_B_Investment_Biogeneration_Ventures_Credit_Agricole_Private_Equity_Erasmus_Biomedical_Fund_Forbion_Capital_Partners_Orbimed_Advisors_Seventure_Partners_Thuja_Capital_Vib_Argen-X_Completed> ;
    ns1:name "BioGeneration Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1523031/Biogeneration_Ventures>,
        <https://1145.am/db/2019705/Biogeneration_Ventures>,
        <https://1145.am/db/2154018/Biogeneration_Ventures>,
        <https://1145.am/db/2154415/Biogeneration_Ventures>,
        <https://1145.am/db/2285342/Biogeneration_Ventures>,
        <https://1145.am/db/2295805/Biogeneration_Ventures>,
        <https://1145.am/db/2301966/Biogeneration_Ventures>,
        <https://1145.am/db/2339932/Biogeneration_Ventures>,
        <https://1145.am/db/2339933/Biogeneration_Ventures>,
        <https://1145.am/db/2343250/Biogeneration_Ventures>,
        <https://1145.am/db/2353355/Biogeneration_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343244/Credit_Agricole_Private_Equity> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:description "Investing in companies",
        "Private Equity" ;
    ns1:documentDate "2011-12-01T13:13:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argen-x-raises-eur-27-5-million-usd-37-million-oversubscribed-series-b-round> ;
    ns1:foundName "Agricole Private Equity, LSP",
        "Credit Agricole Private Equity, LSP" ;
    ns1:investor <https://1145.am/db/2343244/Series_B_Investment_Biogeneration_Ventures_Credit_Agricole_Private_Equity_Erasmus_Biomedical_Fund_Forbion_Capital_Partners_Orbimed_Advisors_Seventure_Partners_Thuja_Capital_Vib_Argen-X_Completed> ;
    ns1:name "Agricole Private Equity",
        "Credit Agricole Private Equity" ;
    ns1:sameAsHigh <https://1145.am/db/1724650/Crédit_Agricole_Private_Equity>,
        <https://1145.am/db/1921869/Crédit_Agricole_Private_Equity>,
        <https://1145.am/db/2295207/Crédit_Agricole_Private_Equity>,
        <https://1145.am/db/2309865/Credit_Agricole_Private_Equity>,
        <https://1145.am/db/2313401/Credit_Agricole_Private_Equity>,
        <https://1145.am/db/2326139/Credit_Agricole_Private_Equity>,
        <https://1145.am/db/2355511/Crédit_Agricole_Private_Equity>,
        <https://1145.am/db/2355512/Crédit_Agricole_Private_Equity>,
        <https://1145.am/db/2361390/Crédit_Agricole_Private_Equity> ;
    ns1:sameAsMedium <https://1145.am/db/2291361/Crédit_Agricole_Private_Equity>,
        <https://1145.am/db/2293779/Credit_Agricole_Private_Equity>,
        <https://1145.am/db/2301966/Credit_Agricole_Private_Equity>,
        <https://1145.am/db/2309872/Credit_Agricole_Private_Equity>,
        <https://1145.am/db/2313410/Credit_Agricole_Private_Equity>,
        <https://1145.am/db/2326130/Credit_Agricole_Private_Equity>,
        <https://1145.am/db/2343250/Credit_Agricole_Private_Equity>,
        <https://1145.am/db/2346397/Crédit_Agricole_Private_Equity> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343244/Erasmus_Biomedical_Fund> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:description "The discovery and development of human monoclonal antibodies" ;
    ns1:documentDate "2011-12-01T13:13:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argen-x-raises-eur-27-5-million-usd-37-million-oversubscribed-series-b-round> ;
    ns1:foundName "Erasmus Biomedical Fund" ;
    ns1:investor <https://1145.am/db/2343244/Series_B_Investment_Biogeneration_Ventures_Credit_Agricole_Private_Equity_Erasmus_Biomedical_Fund_Forbion_Capital_Partners_Orbimed_Advisors_Seventure_Partners_Thuja_Capital_Vib_Argen-X_Completed> ;
    ns1:name "Erasmus Biomedical Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2343250/Erasmus_Biomedical_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343244/Seventure_Partners> a org:Organization ;
    ns1:basedInHighGeoName "Republic of France" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:basedInHighRaw "France" ;
    ns1:description "fundraising" ;
    ns1:documentDate "2011-12-01T13:13:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argen-x-raises-eur-27-5-million-usd-37-million-oversubscribed-series-b-round> ;
    ns1:foundName "Seventure Partners (France)" ;
    ns1:investor <https://1145.am/db/2343244/Series_B_Investment_Biogeneration_Ventures_Credit_Agricole_Private_Equity_Erasmus_Biomedical_Fund_Forbion_Capital_Partners_Orbimed_Advisors_Seventure_Partners_Thuja_Capital_Vib_Argen-X_Completed> ;
    ns1:name "Seventure Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1023024/Seventure_Partners>,
        <https://1145.am/db/1023822/Seventure_Partners>,
        <https://1145.am/db/1340145/Seventure_Partners>,
        <https://1145.am/db/1746321/Seventure_Partners>,
        <https://1145.am/db/1750172/Seventure_Partners>,
        <https://1145.am/db/1792086/Seventure_Partners>,
        <https://1145.am/db/1798194/Seventure_Partners>,
        <https://1145.am/db/1854186/Seventure_Partners>,
        <https://1145.am/db/1854191/Seventure_Partners>,
        <https://1145.am/db/1855692/Seventure_Partners>,
        <https://1145.am/db/1857633/Seventure_Partners>,
        <https://1145.am/db/1895222/Seventure_Partners>,
        <https://1145.am/db/2153759/Seventure_Partners>,
        <https://1145.am/db/2288440/Seventure_Partners>,
        <https://1145.am/db/2296842/Seventure_Partners>,
        <https://1145.am/db/2340937/Seventure_Partners>,
        <https://1145.am/db/2358268/Seventure_Partners>,
        <https://1145.am/db/2358269/Seventure_Partners>,
        <https://1145.am/db/2365032/Seventure_Partners>,
        <https://1145.am/db/2368646/Seventure_Partners>,
        <https://1145.am/db/2368659/Seventure_Partners>,
        <https://1145.am/db/545842/Seventure_Partners>,
        <https://1145.am/db/881549/Seventure_Partners>,
        <https://1145.am/db/978075/Seventure_Partners>,
        <https://1145.am/db/978699/Seventure_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343244/Thuja_Capital> a org:Organization ;
    ns1:basedInLowRaw "Belgium" ;
    ns1:description "Series B fundraising round" ;
    ns1:documentDate "2011-12-01T13:13:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argen-x-raises-eur-27-5-million-usd-37-million-oversubscribed-series-b-round> ;
    ns1:foundName "Thuja Capital" ;
    ns1:investor <https://1145.am/db/2343244/Series_B_Investment_Biogeneration_Ventures_Credit_Agricole_Private_Equity_Erasmus_Biomedical_Fund_Forbion_Capital_Partners_Orbimed_Advisors_Seventure_Partners_Thuja_Capital_Vib_Argen-X_Completed> ;
    ns1:name "Thuja Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2109799/Thuja_Capital>,
        <https://1145.am/db/2293248/Thuja_Capital>,
        <https://1145.am/db/2299386/Thuja_Capital>,
        <https://1145.am/db/2343250/Thuja_Capital>,
        <https://1145.am/db/700969/Thuja_Capital>,
        <https://1145.am/db/922439/Thuja_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343244/Vib> a org:Organization ;
    ns1:basedInLowRaw "Belgium" ;
    ns1:description "The fundraising was co - led by OrbiMed Advisors (USA) and Seven" ;
    ns1:documentDate "2011-12-01T13:13:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argen-x-raises-eur-27-5-million-usd-37-million-oversubscribed-series-b-round> ;
    ns1:foundName "VIB" ;
    ns1:investor <https://1145.am/db/2343244/Series_B_Investment_Biogeneration_Ventures_Credit_Agricole_Private_Equity_Erasmus_Biomedical_Fund_Forbion_Capital_Partners_Orbimed_Advisors_Seventure_Partners_Thuja_Capital_Vib_Argen-X_Completed> ;
    ns1:name "VIB" ;
    ns1:sameAsMedium <https://1145.am/db/2301966/Vib>,
        <https://1145.am/db/2343250/Vib> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343300/Investment_Mission_Therapeutics_Ltd_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-08-25T13:28:15+00:00"^^xsd:dateTime ;
    ns1:documentExtract "A TEAM led by Professor Stephen Jackson together with Cancer Research Technology (Cancer Research UK's commercial arm) and the University of Cambridge has today (Thursday) announced the launch of MISSION Therapeutics Ltd, with Series A funding from a top venture capital syndicate.",
        "MISSION THERAPEUTICS, A NEW CAMBRIDGE - BASED SPIN-OUT COMPANY, SECURES £6M IN SERIES-A FUNDING LED BY SOFINNOVA PARTNERS." ;
    ns1:documentTitle "MISSION THERAPEUTICS, A NEW CAMBRIDGE-BASED SPIN-OUT COMPANY, SECURES £6M IN SERIES-A FUNDING LED BY SOFINNOVA PARTNERS" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mission-therapeutics-a-new-cambridge-based-spin-out-company-secures-%C2%A36m-series-a-funding> ;
    ns1:foundName "launch" ;
    ns1:name "launch" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2343300/Mission_Therapeutics_Ltd> ;
    ns1:targetDetails "Series A" ;
    ns1:targetName "MISSION Therapeutics Ltd" ;
    ns1:valueRaw "£6M" ;
    ns1:whenRaw "Thursday" ;
    ns1:whereGeoName "Cambridgeshire",
        "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf>,
        <https://sws.geonames.org/2653940/about.rdf> ;
    ns1:whereRaw "Cambridge",
        "UK" .

<https://1145.am/db/2344357/Aurora_Funds_Harris___Harris_Group> a org:Organization ;
    ns1:basedInLowRaw "N.C." ;
    ns1:description "making pre-IPO investments in innovative, high-growth companies that are committed to and capable of" ;
    ns1:documentDate "2011-08-31T12:06:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Metabolon Secures $13 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/metabolon-secures-13-million-series-d-financing> ;
    ns1:foundName "Aurora Funds, Harris & Harris Group" ;
    ns1:investor <https://1145.am/db/2344357/Series_D_Investment_Aurora_Funds_Harris___Harris_Group_Fletcher_Spaght_Fulcrum_Financial_Partners_Keating_Capital_Metabolon_Sevin_Rosen_Funds_Syngenta_Ventures_Completed> ;
    ns1:name "Aurora Funds, Harris & Harris Group" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344357/Fletcher_Spaght> a org:Organization ;
    ns1:basedInLowRaw "N.C." ;
    ns1:documentDate "2011-08-31T12:06:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Metabolon Secures $13 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/metabolon-secures-13-million-series-d-financing> ;
    ns1:foundName "Fletcher Spaght" ;
    ns1:investor <https://1145.am/db/2344357/Series_D_Investment_Aurora_Funds_Harris___Harris_Group_Fletcher_Spaght_Fulcrum_Financial_Partners_Keating_Capital_Metabolon_Sevin_Rosen_Funds_Syngenta_Ventures_Completed> ;
    ns1:name "Fletcher Spaght" ;
    ns1:sameAsMedium <https://1145.am/db/2344356/Fletcher_Spaght> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344357/Fulcrum_Financial_Partners> a org:Organization ;
    ns1:basedInLowRaw "N.C." ;
    ns1:description "making pre-IPO investments in innovative, high-growth companies that are committed to and capable of" ;
    ns1:documentDate "2011-08-31T12:06:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Metabolon Secures $13 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/metabolon-secures-13-million-series-d-financing> ;
    ns1:foundName "Fulcrum Financial Partners" ;
    ns1:investor <https://1145.am/db/2344357/Series_D_Investment_Aurora_Funds_Harris___Harris_Group_Fletcher_Spaght_Fulcrum_Financial_Partners_Keating_Capital_Metabolon_Sevin_Rosen_Funds_Syngenta_Ventures_Completed> ;
    ns1:name "Fulcrum Financial Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2344356/Fulcrum_Financial_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344357/Keating_Capital> a org:Organization ;
    ns1:basedInLowRaw "N.C." ;
    ns1:description "making pre-IPO investments in innovative, high-growth companies that are committed to and capable of" ;
    ns1:documentDate "2011-08-31T12:06:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Metabolon Secures $13 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/metabolon-secures-13-million-series-d-financing> ;
    ns1:foundName "Keating Capital, Inc." ;
    ns1:industry "business development company" ;
    ns1:investor <https://1145.am/db/2344357/Series_D_Investment_Aurora_Funds_Harris___Harris_Group_Fletcher_Spaght_Fulcrum_Financial_Partners_Keating_Capital_Metabolon_Sevin_Rosen_Funds_Syngenta_Ventures_Completed> ;
    ns1:name "Keating Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1892105/Keating_Capital>,
        <https://1145.am/db/1892902/Keating_Capital>,
        <https://1145.am/db/2344356/Keating_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344357/Sevin_Rosen_Funds> a org:Organization ;
    ns1:basedInLowRaw "N.C." ;
    ns1:documentDate "2011-08-31T12:06:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Metabolon Secures $13 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/metabolon-secures-13-million-series-d-financing> ;
    ns1:foundName "Sevin Rosen Funds" ;
    ns1:investor <https://1145.am/db/2344357/Series_D_Investment_Aurora_Funds_Harris___Harris_Group_Fletcher_Spaght_Fulcrum_Financial_Partners_Keating_Capital_Metabolon_Sevin_Rosen_Funds_Syngenta_Ventures_Completed> ;
    ns1:name "Sevin Rosen Funds" ;
    ns1:sameAsMedium <https://1145.am/db/1701285/Sevin_Rosen_Funds>,
        <https://1145.am/db/1706416/Sevin_Rosen_Funds>,
        <https://1145.am/db/1898419/Sevin_Rosen_Funds>,
        <https://1145.am/db/2302047/Sevin_Rosen_Funds>,
        <https://1145.am/db/2302333/Sevin_Rosen_Funds>,
        <https://1145.am/db/2324756/Sevin_Rosen_Funds>,
        <https://1145.am/db/2344356/Sevin_Rosen_Funds> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344357/Syngenta_Ventures> a org:Organization ;
    ns1:basedInLowRaw "N.C." ;
    ns1:documentDate "2011-08-31T12:06:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Metabolon Secures $13 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/metabolon-secures-13-million-series-d-financing> ;
    ns1:foundName "Syngenta Ventures" ;
    ns1:investor <https://1145.am/db/2344357/Series_D_Investment_Aurora_Funds_Harris___Harris_Group_Fletcher_Spaght_Fulcrum_Financial_Partners_Keating_Capital_Metabolon_Sevin_Rosen_Funds_Syngenta_Ventures_Completed> ;
    ns1:name "Syngenta Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2324756/Syngenta_Ventures>,
        <https://1145.am/db/2344356/Syngenta_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2345318/Avalon_Ventures> a org:Organization ;
    ns1:basedInLowRaw "KANSAS CITY, Kan" ;
    ns1:documentDate "2011-12-07T15:38:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aratana Therapeutics Completes $15 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aratana-therapeutics-completes-15-million-series-b-financing> ;
    ns1:foundName "Avalon Ventures" ;
    ns1:investor <https://1145.am/db/2345318/Series_B_Investment_Aratana_Therapeutics_Avalon_Ventures_Cultivian_Ventures_Ewing_Marion_Kauffman_Foundation_Mpm_Capital_Completed> ;
    ns1:name "Avalon Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1582024/Avalon_Ventures>,
        <https://1145.am/db/1731233/Avalon_Ventures>,
        <https://1145.am/db/1770372/Avalon_Ventures>,
        <https://1145.am/db/1783415/Avalon_Ventures>,
        <https://1145.am/db/1788701/Avalon_Ventures>,
        <https://1145.am/db/1830629/Avalon_Ventures>,
        <https://1145.am/db/1833567/Avalon_Ventures>,
        <https://1145.am/db/1834224/Avalon_Ventures>,
        <https://1145.am/db/1834541/Avalon_Ventures>,
        <https://1145.am/db/1835195/Avalon_Ventures>,
        <https://1145.am/db/1837950/Avalon_Ventures>,
        <https://1145.am/db/1841070/Avalon_Ventures>,
        <https://1145.am/db/1853099/Avalon_Ventures>,
        <https://1145.am/db/1858323/Avalon_Ventures>,
        <https://1145.am/db/1872954/Avalon_Ventures>,
        <https://1145.am/db/1875916/Avalon_Ventures>,
        <https://1145.am/db/1889400/Avalon_Ventures>,
        <https://1145.am/db/1919661/Avalon_Ventures>,
        <https://1145.am/db/2156284/Avalon_Ventures>,
        <https://1145.am/db/2178960/Avalon_Ventures>,
        <https://1145.am/db/2293612/Avalon_Ventures>,
        <https://1145.am/db/2295967/Avalon_Ventures>,
        <https://1145.am/db/2298395/Avalon_Ventures>,
        <https://1145.am/db/2308758/Avalon_Ventures>,
        <https://1145.am/db/2321216/Avalon_Ventures>,
        <https://1145.am/db/2326130/Avalon_Ventures>,
        <https://1145.am/db/2326139/Avalon_Ventures>,
        <https://1145.am/db/2335943/Avalon_Ventures>,
        <https://1145.am/db/2336221/Avalon_Ventures>,
        <https://1145.am/db/2343765/Avalon_Ventures>,
        <https://1145.am/db/2345299/Avalon_Ventures>,
        <https://1145.am/db/2350044/Avalon_Ventures>,
        <https://1145.am/db/2359510/Avalon_Ventures>,
        <https://1145.am/db/2362475/Avalon_Ventures>,
        <https://1145.am/db/2366744/Avalon_Ventures>,
        <https://1145.am/db/2367673/Avalon_Ventures>,
        <https://1145.am/db/2367675/Avalon_Ventures>,
        <https://1145.am/db/2367676/Avalon_Ventures>,
        <https://1145.am/db/2368351/Avalon_Ventures>,
        <https://1145.am/db/935242/Avalon_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2345318/Cultivian_Ventures> a org:Organization ;
    ns1:basedInLowRaw "KANSAS CITY, Kan" ;
    ns1:documentDate "2011-12-07T15:38:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aratana Therapeutics Completes $15 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aratana-therapeutics-completes-15-million-series-b-financing> ;
    ns1:foundName "Cultivian Ventures" ;
    ns1:investor <https://1145.am/db/2345318/Series_B_Investment_Aratana_Therapeutics_Avalon_Ventures_Cultivian_Ventures_Ewing_Marion_Kauffman_Foundation_Mpm_Capital_Completed> ;
    ns1:name "Cultivian Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2345299/Cultivian_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2345318/Ewing_Marion_Kauffman_Foundation> a org:Organization ;
    ns1:basedInLowRaw "Kan" ;
    ns1:documentDate "2011-12-07T15:38:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aratana Therapeutics Completes $15 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aratana-therapeutics-completes-15-million-series-b-financing> ;
    ns1:foundName "the Ewing Marion Kauffman Foundation" ;
    ns1:investor <https://1145.am/db/2345318/Series_B_Investment_Aratana_Therapeutics_Avalon_Ventures_Cultivian_Ventures_Ewing_Marion_Kauffman_Foundation_Mpm_Capital_Completed> ;
    ns1:name "Ewing Marion Kauffman Foundation" ;
    ns1:sameAsMedium <https://1145.am/db/1121894/Ewing_Marion_Kauffman_Foundation>,
        <https://1145.am/db/1493332/Ewing_Marion_Kauffman_Foundation>,
        <https://1145.am/db/1540572/Ewing_Marion_Kauffman_Foundation>,
        <https://1145.am/db/2345299/Ewing_Marion_Kauffman_Foundation>,
        <https://1145.am/db/2345317/Ewing_Marion_Kauffman_Foundation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2345318/Mpm_Capital> a org:Organization ;
    ns1:basedInLowRaw "KANSAS CITY, Kan" ;
    ns1:documentDate "2011-12-07T15:38:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aratana Therapeutics Completes $15 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aratana-therapeutics-completes-15-million-series-b-financing> ;
    ns1:foundName "MPM Capital" ;
    ns1:investor <https://1145.am/db/2345318/Series_B_Investment_Aratana_Therapeutics_Avalon_Ventures_Cultivian_Ventures_Ewing_Marion_Kauffman_Foundation_Mpm_Capital_Completed> ;
    ns1:name "MPM Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1325968/Mpm_Capital>,
        <https://1145.am/db/1752458/Mpm_Capital>,
        <https://1145.am/db/2285876/Mpm_Capital>,
        <https://1145.am/db/2287191/Mpm_Capital>,
        <https://1145.am/db/2292334/Mpm_Capital>,
        <https://1145.am/db/2292353/Mpm_Capital>,
        <https://1145.am/db/2300455/Mpm_Capital>,
        <https://1145.am/db/2301901/Mpm_Capital>,
        <https://1145.am/db/2303391/Mpm_Capital>,
        <https://1145.am/db/2303833/Mpm_Capital>,
        <https://1145.am/db/2303855/Mpm_Capital>,
        <https://1145.am/db/2304634/Mpm_Capital>,
        <https://1145.am/db/2305503/Mpm_Capital>,
        <https://1145.am/db/2305656/Mpm_Capital>,
        <https://1145.am/db/2306705/Mpm_Capital>,
        <https://1145.am/db/2308887/Mpm_Capital>,
        <https://1145.am/db/2309845/Mpm_Capital>,
        <https://1145.am/db/2311551/Mpm_Capital>,
        <https://1145.am/db/2312285/Mpm_Capital>,
        <https://1145.am/db/2312309/Mpm_Capital>,
        <https://1145.am/db/2316391/Mpm_Capital>,
        <https://1145.am/db/2323055/Mpm_Capital>,
        <https://1145.am/db/2323066/Mpm_Capital>,
        <https://1145.am/db/2323094/Mpm_Capital>,
        <https://1145.am/db/2323563/Mpm_Capital>,
        <https://1145.am/db/2323568/Mpm_Capital>,
        <https://1145.am/db/2324195/Mpm_Capital>,
        <https://1145.am/db/2324226/Mpm_Capital>,
        <https://1145.am/db/2328338/Mpm_Capital>,
        <https://1145.am/db/2333119/Mpm_Capital>,
        <https://1145.am/db/2333525/Mpm_Capital>,
        <https://1145.am/db/2335701/Mpm_Capital>,
        <https://1145.am/db/2335714/Mpm_Capital>,
        <https://1145.am/db/2337140/Mpm_Capital>,
        <https://1145.am/db/2340957/Mpm_Capital>,
        <https://1145.am/db/2345299/Mpm_Capital>,
        <https://1145.am/db/2346204/Mpm_Capital>,
        <https://1145.am/db/2347140/Mpm_Capital>,
        <https://1145.am/db/2347469/Mpm_Capital>,
        <https://1145.am/db/2347984/Mpm_Capital>,
        <https://1145.am/db/2348484/Mpm_Capital>,
        <https://1145.am/db/2350030/Mpm_Capital>,
        <https://1145.am/db/2352172/Mpm_Capital>,
        <https://1145.am/db/2352362/Mpm_Capital>,
        <https://1145.am/db/2352899/Mpm_Capital>,
        <https://1145.am/db/2353365/Mpm_Capital>,
        <https://1145.am/db/2353404/Mpm_Capital>,
        <https://1145.am/db/2353413/Mpm_Capital>,
        <https://1145.am/db/2353415/Mpm_Capital>,
        <https://1145.am/db/2356396/Mpm_Capital>,
        <https://1145.am/db/2358979/Mpm_Capital>,
        <https://1145.am/db/2359001/Mpm_Capital>,
        <https://1145.am/db/2359873/Mpm_Capital>,
        <https://1145.am/db/2359875/Mpm_Capital>,
        <https://1145.am/db/2360526/Mpm_Capital>,
        <https://1145.am/db/2362871/Mpm_Capital>,
        <https://1145.am/db/2364492/Mpm_Capital>,
        <https://1145.am/db/2365098/Mpm_Capital>,
        <https://1145.am/db/2366744/Mpm_Capital>,
        <https://1145.am/db/2367199/Mpm_Capital>,
        <https://1145.am/db/2369202/Mpm_Capital>,
        <https://1145.am/db/2370582/Mpm_Capital>,
        <https://1145.am/db/2541350/Mpm_Capital>,
        <https://1145.am/db/677075/Mpm_Capital>,
        <https://1145.am/db/678997/Mpm_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347389/Advanced_Technology_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2011-12-13T13:29:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/catabasis-pharmaceuticals-announces-8-million-series-a-extension-financing> ;
    ns1:foundName "Advanced Technology Ventures" ;
    ns1:investor <https://1145.am/db/2347389/Series_A_Investment_Advanced_Technology_Ventures_Catabasis_Pharmaceuticals_Clarus_Ventures_Medimmune_Ventures_Sv_Life_Sciences_Completed> ;
    ns1:name "Advanced Technology Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1800080/Advanced_Technology_Ventures>,
        <https://1145.am/db/1830593/Advanced_Technology_Ventures>,
        <https://1145.am/db/1850376/Advanced_Technology_Ventures>,
        <https://1145.am/db/1854846/Advanced_Technology_Ventures>,
        <https://1145.am/db/1861352/Advanced_Technology_Ventures>,
        <https://1145.am/db/1872490/Advanced_Technology_Ventures>,
        <https://1145.am/db/2287777/Advanced_Technology_Ventures>,
        <https://1145.am/db/2291818/Advanced_Technology_Ventures>,
        <https://1145.am/db/2300322/Advanced_Technology_Ventures>,
        <https://1145.am/db/2316391/Advanced_Technology_Ventures>,
        <https://1145.am/db/2317467/Advanced_Technology_Ventures>,
        <https://1145.am/db/2317918/Advanced_Technology_Ventures>,
        <https://1145.am/db/2319874/Advanced_Technology_Ventures>,
        <https://1145.am/db/2322012/Advanced_Technology_Ventures>,
        <https://1145.am/db/2322022/Advanced_Technology_Ventures>,
        <https://1145.am/db/2328599/Advanced_Technology_Ventures>,
        <https://1145.am/db/2336313/Advanced_Technology_Ventures>,
        <https://1145.am/db/2338703/Advanced_Technology_Ventures>,
        <https://1145.am/db/2338704/Advanced_Technology_Ventures>,
        <https://1145.am/db/2341904/Advanced_Technology_Ventures>,
        <https://1145.am/db/2343722/Advanced_Technology_Ventures>,
        <https://1145.am/db/2343737/Advanced_Technology_Ventures>,
        <https://1145.am/db/2360756/Advanced_Technology_Ventures>,
        <https://1145.am/db/2360758/Advanced_Technology_Ventures>,
        <https://1145.am/db/2362553/Advanced_Technology_Ventures>,
        <https://1145.am/db/2362871/Advanced_Technology_Ventures>,
        <https://1145.am/db/2364939/Advanced_Technology_Ventures>,
        <https://1145.am/db/2367204/Advanced_Technology_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347389/Medimmune_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2011-12-13T13:29:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/catabasis-pharmaceuticals-announces-8-million-series-a-extension-financing> ;
    ns1:foundName "MedImmune Ventures" ;
    ns1:investor <https://1145.am/db/2347389/Series_A_Investment_Advanced_Technology_Ventures_Catabasis_Pharmaceuticals_Clarus_Ventures_Medimmune_Ventures_Sv_Life_Sciences_Completed> ;
    ns1:name "MedImmune Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2302192/Medimmune_Ventures>,
        <https://1145.am/db/2302351/Medimmune_Ventures>,
        <https://1145.am/db/2305587/Medimmune_Ventures>,
        <https://1145.am/db/2314492/Medimmune_Ventures>,
        <https://1145.am/db/2316823/Medimmune_Ventures>,
        <https://1145.am/db/2317561/Medimmune_Ventures>,
        <https://1145.am/db/2317564/Medimmune_Ventures>,
        <https://1145.am/db/2317737/Medimmune_Ventures>,
        <https://1145.am/db/2318656/Medimmune_Ventures>,
        <https://1145.am/db/2318657/Medimmune_Ventures>,
        <https://1145.am/db/2319360/Medimmune_Ventures>,
        <https://1145.am/db/2322012/Medimmune_Ventures>,
        <https://1145.am/db/2322022/Medimmune_Ventures>,
        <https://1145.am/db/2322939/Medimmune_Ventures>,
        <https://1145.am/db/2323785/Medimmune_Ventures>,
        <https://1145.am/db/2324159/Medimmune_Ventures>,
        <https://1145.am/db/2324289/Medimmune_Ventures>,
        <https://1145.am/db/2327379/Medimmune_Ventures>,
        <https://1145.am/db/2330867/Medimmune_Ventures>,
        <https://1145.am/db/2336313/Medimmune_Ventures>,
        <https://1145.am/db/2342213/Medimmune_Ventures>,
        <https://1145.am/db/2343722/Medimmune_Ventures>,
        <https://1145.am/db/2343725/Medimmune_Ventures>,
        <https://1145.am/db/2343737/Medimmune_Ventures>,
        <https://1145.am/db/2346030/Medimmune_Ventures>,
        <https://1145.am/db/2350199/Medimmune_Ventures>,
        <https://1145.am/db/2352436/Medimmune_Ventures>,
        <https://1145.am/db/2352442/Medimmune_Ventures>,
        <https://1145.am/db/2356420/Medimmune_Ventures>,
        <https://1145.am/db/2360756/Medimmune_Ventures>,
        <https://1145.am/db/2360758/Medimmune_Ventures>,
        <https://1145.am/db/2362472/Medimmune_Ventures>,
        <https://1145.am/db/2363442/Medimmune_Ventures>,
        <https://1145.am/db/2363459/Medimmune_Ventures>,
        <https://1145.am/db/2363460/Medimmune_Ventures>,
        <https://1145.am/db/2364853/Medimmune_Ventures>,
        <https://1145.am/db/2551315/Medimmune_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347389/Sv_Life_Sciences> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE, Mass." ;
    ns1:documentDate "2011-12-13T13:29:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/catabasis-pharmaceuticals-announces-8-million-series-a-extension-financing> ;
    ns1:foundName "SV Life Sciences" ;
    ns1:investor <https://1145.am/db/2347389/Series_A_Investment_Advanced_Technology_Ventures_Catabasis_Pharmaceuticals_Clarus_Ventures_Medimmune_Ventures_Sv_Life_Sciences_Completed> ;
    ns1:name "SV Life Sciences" ;
    ns1:sameAsMedium <https://1145.am/db/2236188/Sv_Life_Sciences>,
        <https://1145.am/db/2246177/Sv_Life_Sciences>,
        <https://1145.am/db/2293662/Sv_Life_Sciences>,
        <https://1145.am/db/2293765/Sv_Life_Sciences>,
        <https://1145.am/db/2297439/Sv_Life_Sciences>,
        <https://1145.am/db/2297604/Sv_Life_Sciences>,
        <https://1145.am/db/2298869/Sv_Life_Sciences>,
        <https://1145.am/db/2300322/Sv_Life_Sciences>,
        <https://1145.am/db/2302994/Sv_Life_Sciences>,
        <https://1145.am/db/2302995/Sv_Life_Sciences>,
        <https://1145.am/db/2305587/Sv_Life_Sciences>,
        <https://1145.am/db/2310485/Sv_Life_Sciences>,
        <https://1145.am/db/2311540/Sv_Life_Sciences>,
        <https://1145.am/db/2312831/Sv_Life_Sciences>,
        <https://1145.am/db/2312833/Sv_Life_Sciences>,
        <https://1145.am/db/2313287/Sv_Life_Sciences>,
        <https://1145.am/db/2313322/Sv_Life_Sciences>,
        <https://1145.am/db/2313438/Sv_Life_Sciences>,
        <https://1145.am/db/2314515/Sv_Life_Sciences>,
        <https://1145.am/db/2314625/Sv_Life_Sciences>,
        <https://1145.am/db/2316038/Sv_Life_Sciences>,
        <https://1145.am/db/2317635/Sv_Life_Sciences>,
        <https://1145.am/db/2319338/Sv_Life_Sciences>,
        <https://1145.am/db/2321713/Sv_Life_Sciences>,
        <https://1145.am/db/2321861/Sv_Life_Sciences>,
        <https://1145.am/db/2321870/Sv_Life_Sciences>,
        <https://1145.am/db/2327405/Sv_Life_Sciences>,
        <https://1145.am/db/2327677/Sv_Life_Sciences>,
        <https://1145.am/db/2328815/Sv_Life_Sciences>,
        <https://1145.am/db/2329550/Sv_Life_Sciences>,
        <https://1145.am/db/2336313/Sv_Life_Sciences>,
        <https://1145.am/db/2336890/Sv_Life_Sciences>,
        <https://1145.am/db/2337166/Sv_Life_Sciences>,
        <https://1145.am/db/2338193/Sv_Life_Sciences>,
        <https://1145.am/db/2338196/Sv_Life_Sciences>,
        <https://1145.am/db/2339295/Sv_Life_Sciences>,
        <https://1145.am/db/2342260/Sv_Life_Sciences>,
        <https://1145.am/db/2342261/Sv_Life_Sciences>,
        <https://1145.am/db/2342266/Sv_Life_Sciences>,
        <https://1145.am/db/2342284/Sv_Life_Sciences>,
        <https://1145.am/db/2342445/Sv_Life_Sciences>,
        <https://1145.am/db/2342862/Sv_Life_Sciences>,
        <https://1145.am/db/2343467/Sv_Life_Sciences>,
        <https://1145.am/db/2343722/Sv_Life_Sciences>,
        <https://1145.am/db/2343725/Sv_Life_Sciences>,
        <https://1145.am/db/2343737/Sv_Life_Sciences>,
        <https://1145.am/db/2346832/Sv_Life_Sciences>,
        <https://1145.am/db/2349406/Sv_Life_Sciences>,
        <https://1145.am/db/2349426/Sv_Life_Sciences>,
        <https://1145.am/db/2350034/Sv_Life_Sciences>,
        <https://1145.am/db/2350720/Sv_Life_Sciences>,
        <https://1145.am/db/2351394/Sv_Life_Sciences>,
        <https://1145.am/db/2351397/Sv_Life_Sciences>,
        <https://1145.am/db/2352382/Sv_Life_Sciences>,
        <https://1145.am/db/2352383/Sv_Life_Sciences>,
        <https://1145.am/db/2353098/Sv_Life_Sciences>,
        <https://1145.am/db/2353439/Sv_Life_Sciences>,
        <https://1145.am/db/2355586/Sv_Life_Sciences>,
        <https://1145.am/db/2356861/Sv_Life_Sciences>,
        <https://1145.am/db/2356876/Sv_Life_Sciences>,
        <https://1145.am/db/2358271/Sv_Life_Sciences>,
        <https://1145.am/db/2358272/Sv_Life_Sciences>,
        <https://1145.am/db/2359125/Sv_Life_Sciences>,
        <https://1145.am/db/2360756/Sv_Life_Sciences>,
        <https://1145.am/db/2360758/Sv_Life_Sciences>,
        <https://1145.am/db/2361065/Sv_Life_Sciences>,
        <https://1145.am/db/2365315/Sv_Life_Sciences>,
        <https://1145.am/db/2366519/Sv_Life_Sciences>,
        <https://1145.am/db/2366860/Sv_Life_Sciences>,
        <https://1145.am/db/2368251/Sv_Life_Sciences>,
        <https://1145.am/db/2368572/Sv_Life_Sciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347397/Vatera_Healthcare_Partners_Llc> a org:Organization ;
    ns1:basedInLowRaw "Mass" ;
    ns1:documentDate "2011-12-13T14:26:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "ImmusanT Raises $20 Million in Series A Financing to Advance Immunotherapeutic and Diagnostic for Celiac Disease Read more: htt" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/immusant-raises-20-million-series-a-financing-to-advance-immunotherapeutic-and-diagnostic> ;
    ns1:foundName "Vatera Healthcare Partners LLC" ;
    ns1:investor <https://1145.am/db/2347397/Series_A_Investment_Immusant_Vatera_Healthcare_Partners_Llc_Completed> ;
    ns1:name "Vatera Healthcare Partners LLC" ;
    ns1:sameAsMedium <https://1145.am/db/2341003/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2341005/Vatera_Healthcare>,
        <https://1145.am/db/2349120/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2350011/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2352277/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2353256/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2353260/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2354004/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2354009/Vatera_Healthcare_Partners_Llc>,
        <https://1145.am/db/2359662/Vatera_Healthcare_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348448/Cvf_Llc> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-12-15T14:20:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cerulean Pharma Closes $15 Million Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cerulean-pharma-closes-15-million-series-d-financing> ;
    ns1:foundName "CVF, LLC" ;
    ns1:investor <https://1145.am/db/2348448/Series_D_Investment_Bessemer_Venture_Partners_Cvf_Llc_Cerulean_Pharma_Inc_Henry_Crown_And_Company_Lilly_Ventures_Lux_Capital_Polaris_Venture_Partners_Venrock_Completed> ;
    ns1:name "CVF, LLC" ;
    ns1:sameAsHigh <https://1145.am/db/1011043/Goodwater_Capital>,
        <https://1145.am/db/1011921/Goodwater_Capital>,
        <https://1145.am/db/1038108/Great_Oaks_Vc>,
        <https://1145.am/db/1087544/Keen_Venture_Partners>,
        <https://1145.am/db/1226523/Vsquared>,
        <https://1145.am/db/1287476/Amplo_Vc>,
        <https://1145.am/db/1495833/Goodwater_Capital>,
        <https://1145.am/db/1640034/Pko_Vc>,
        <https://1145.am/db/1697373/Great_Oaks_Vc>,
        <https://1145.am/db/1709657/Greycroft_Partners>,
        <https://1145.am/db/1715487/Oreilly_Alphatech_Ventures>,
        <https://1145.am/db/1721392/Greycroft_Partners>,
        <https://1145.am/db/1722227/Greycroft_Partners>,
        <https://1145.am/db/1734104/Keen_Venture_Partners>,
        <https://1145.am/db/1740071/Eventures>,
        <https://1145.am/db/1747758/Goodwater_Capital>,
        <https://1145.am/db/1748362/Keen_Venture_Partners>,
        <https://1145.am/db/1751003/Goodwater_Capital>,
        <https://1145.am/db/1751553/Goodwater_Capital>,
        <https://1145.am/db/1753730/Goodwater_Capital>,
        <https://1145.am/db/1762040/Thorntree_Capital>,
        <https://1145.am/db/1762810/Grayhawk_Capital>,
        <https://1145.am/db/1768510/Goodwater_Capital>,
        <https://1145.am/db/1772381/Goodwater_Capital>,
        <https://1145.am/db/1785240/Greycroft_Partners>,
        <https://1145.am/db/1791628/Greycroft_Partners>,
        <https://1145.am/db/1794297/Goodwater_Capital>,
        <https://1145.am/db/1799113/Greycroft_Partners>,
        <https://1145.am/db/1800393/Arkley_Vc>,
        <https://1145.am/db/1802525/Greycroft_Partners>,
        <https://1145.am/db/1804054/Greycroft_Partners>,
        <https://1145.am/db/1806644/Greycroft_Partners>,
        <https://1145.am/db/1810710/Great_Oaks_Vc>,
        <https://1145.am/db/1810769/Greycroft_Partners>,
        <https://1145.am/db/1812656/Ventech>,
        <https://1145.am/db/1815962/Greycroft_Partners>,
        <https://1145.am/db/1818174/Greycroft_Partners>,
        <https://1145.am/db/1828663/Greycroft_Partners>,
        <https://1145.am/db/1845924/Greycroft_Partners>,
        <https://1145.am/db/1855363/Oreilly_Alphatech_Ventures>,
        <https://1145.am/db/1856616/Greycroft_Partners>,
        <https://1145.am/db/1859314/Goodwater_Capital>,
        <https://1145.am/db/1860188/Greycroft_Partners>,
        <https://1145.am/db/1863147/Greycroft_Partners>,
        <https://1145.am/db/1891161/Greycroft_Partners>,
        <https://1145.am/db/2007150/Venturetech_Alliance>,
        <https://1145.am/db/2120169/GGV>,
        <https://1145.am/db/2143438/Davidovs_Venture_Capital>,
        <https://1145.am/db/2291277/Droia>,
        <https://1145.am/db/2302333/Ventures_West_Hig>,
        <https://1145.am/db/232969/GGV>,
        <https://1145.am/db/2334165/Btf_Bv>,
        <https://1145.am/db/2347872/WFT>,
        <https://1145.am/db/2798718/Fortytwo_Vc>,
        <https://1145.am/db/587038/Keen_Venture_Partners>,
        <https://1145.am/db/591625/Resolute_Vc>,
        <https://1145.am/db/695183/Gaingles>,
        <https://1145.am/db/784869/Visary_Capital>,
        <https://1145.am/db/800060/Goodwater_Capital>,
        <https://1145.am/db/830571/Great_Oaks_Vc>,
        <https://1145.am/db/847862/Grayhawk_Capital>,
        <https://1145.am/db/881256/Ask_Capital>,
        <https://1145.am/db/918733/V_Square_Capital>,
        <https://1145.am/db/972082/Virtus_Inspire_Venture_Partners>,
        <https://1145.am/db/989658/Goodwater_Capital>,
        <https://1145.am/db/991360/Goodwater_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/2337571/Cvf_Llc>,
        <https://1145.am/db/2337577/Cvf_Llc>,
        <https://1145.am/db/2348440/CVF>,
        <https://1145.am/db/2356420/Cvf_Llc>,
        <https://1145.am/db/2546216/Cvf_Llc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348448/Henry_Crown_And_Company> a org:Organization ;
    ns1:basedInHighGeoName "Chicago" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4887398/about.rdf> ;
    ns1:basedInHighRaw "Chicago, Illinois" ;
    ns1:documentDate "2011-12-15T14:20:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cerulean Pharma Closes $15 Million Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cerulean-pharma-closes-15-million-series-d-financing> ;
    ns1:foundName "Henry Crown and Company of Chicago, Illinois" ;
    ns1:investor <https://1145.am/db/2348448/Series_D_Investment_Bessemer_Venture_Partners_Cvf_Llc_Cerulean_Pharma_Inc_Henry_Crown_And_Company_Lilly_Ventures_Lux_Capital_Polaris_Venture_Partners_Venrock_Completed> ;
    ns1:name "Henry Crown and Company" ;
    ns1:sameAsMedium <https://1145.am/db/1238569/Henry_Crown_And_Company>,
        <https://1145.am/db/1238666/Henry_Crown_And_Company>,
        <https://1145.am/db/129908/Henry_Crown_And_Company>,
        <https://1145.am/db/1741884/Henry_Crown_And_Company>,
        <https://1145.am/db/1763414/Henry_Crown_And_Company>,
        <https://1145.am/db/2356420/Henry_Crown_And_Company>,
        <https://1145.am/db/683167/Henry_Crown_And_Company> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348448/Illinois> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:documentDate "2011-12-15T14:20:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cerulean Pharma Closes $15 Million Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cerulean-pharma-closes-15-million-series-d-financing> ;
    ns1:foundName "Illinois" ;
    ns1:investor <https://1145.am/db/2348448/Series_D_Investment_Bessemer_Venture_Partners_Cvf_Llc_Cerulean_Pharma_Inc_Henry_Crown_And_Company_Lilly_Ventures_Lux_Capital_Polaris_Venture_Partners_Venrock_Completed> ;
    ns1:name "Illinois" ;
    ns1:sameAsMedium <https://1145.am/db/2181415/Illinois>,
        <https://1145.am/db/919601/Illinois> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348448/Lilly_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:documentDate "2011-12-15T14:20:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cerulean Pharma Closes $15 Million Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cerulean-pharma-closes-15-million-series-d-financing> ;
    ns1:foundName "Lilly Ventures" ;
    ns1:investor <https://1145.am/db/2348448/Series_D_Investment_Bessemer_Venture_Partners_Cvf_Llc_Cerulean_Pharma_Inc_Henry_Crown_And_Company_Lilly_Ventures_Lux_Capital_Polaris_Venture_Partners_Venrock_Completed> ;
    ns1:name "Lilly Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2301739/Lilly_Ventures>,
        <https://1145.am/db/2317455/Lilly_Ventures>,
        <https://1145.am/db/2318733/Lilly_Ventures>,
        <https://1145.am/db/2319777/Lilly_Ventures>,
        <https://1145.am/db/2320082/Lilly_Ventures>,
        <https://1145.am/db/2322022/Lilly_Ventures>,
        <https://1145.am/db/2322984/Lilly_Ventures>,
        <https://1145.am/db/2323003/Lilly_Ventures>,
        <https://1145.am/db/2324042/Lilly_Ventures>,
        <https://1145.am/db/2326222/Lilly_Ventures>,
        <https://1145.am/db/2327441/Lilly_Ventures>,
        <https://1145.am/db/2327442/Lilly_Ventures>,
        <https://1145.am/db/2332864/Lilly_Ventures>,
        <https://1145.am/db/2332868/Lilly_Ventures>,
        <https://1145.am/db/2336328/Lilly_Ventures>,
        <https://1145.am/db/2339666/Lilly_Ventures>,
        <https://1145.am/db/2340096/Lilly_Ventures>,
        <https://1145.am/db/2340942/Lilly_Ventures>,
        <https://1145.am/db/2343723/Lilly_Ventures>,
        <https://1145.am/db/2343724/Lilly_Ventures>,
        <https://1145.am/db/2347682/Lilly_Ventures>,
        <https://1145.am/db/2352414/Lilly_Ventures>,
        <https://1145.am/db/2353439/Lilly_Ventures>,
        <https://1145.am/db/2355586/Lilly_Ventures>,
        <https://1145.am/db/2356048/Lilly_Ventures>,
        <https://1145.am/db/2357676/Lilly_Ventures>,
        <https://1145.am/db/2357679/Lilly_Ventures>,
        <https://1145.am/db/2357682/Lilly_Ventures>,
        <https://1145.am/db/2361581/Lilly_Ventures>,
        <https://1145.am/db/2362715/Lilly_Ventures>,
        <https://1145.am/db/2363396/Lilly_Ventures>,
        <https://1145.am/db/2368240/Lilly_Ventures>,
        <https://1145.am/db/2368322/Lilly_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348448/Lux_Capital> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:description "a co-founder and managing partner at Lux Capital" ;
    ns1:documentDate "2011-12-15T14:20:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cerulean Pharma Closes $15 Million Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cerulean-pharma-closes-15-million-series-d-financing> ;
    ns1:foundName "Lux Capital" ;
    ns1:investor <https://1145.am/db/2348448/Series_D_Investment_Bessemer_Venture_Partners_Cvf_Llc_Cerulean_Pharma_Inc_Henry_Crown_And_Company_Lilly_Ventures_Lux_Capital_Polaris_Venture_Partners_Venrock_Completed> ;
    ns1:name "Lux Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1105217/Lux_Capital>,
        <https://1145.am/db/1106865/Lux_Capital>,
        <https://1145.am/db/1119433/Lux_Capital>,
        <https://1145.am/db/1119661/Lux_Capital>,
        <https://1145.am/db/1122753/Lux_Capital>,
        <https://1145.am/db/1139654/Lux_Capital>,
        <https://1145.am/db/1143903/Lux_Capital>,
        <https://1145.am/db/1238486/Lux_Capital>,
        <https://1145.am/db/1285901/Lux_Capital>,
        <https://1145.am/db/1374025/Lux_Capital>,
        <https://1145.am/db/1375318/Lux_Capital>,
        <https://1145.am/db/1376203/Lux_Capital>,
        <https://1145.am/db/1407553/Lux_Capital>,
        <https://1145.am/db/1536915/Lux_Capital>,
        <https://1145.am/db/1553919/Lux_Capital>,
        <https://1145.am/db/1555013/Lux_Capital>,
        <https://1145.am/db/1632690/Lux_Capital>,
        <https://1145.am/db/1669908/Lux_Capital>,
        <https://1145.am/db/1697296/Lux_Capital>,
        <https://1145.am/db/1734597/Lux_Capital>,
        <https://1145.am/db/1737151/Lux_Capital>,
        <https://1145.am/db/1737409/Lux_Capital>,
        <https://1145.am/db/174200/Lux_Capital>,
        <https://1145.am/db/1743303/Lux_Capital>,
        <https://1145.am/db/1758194/Lux_Capital>,
        <https://1145.am/db/1761607/Lux_Capital>,
        <https://1145.am/db/1762041/Lux_Capital>,
        <https://1145.am/db/1763354/Lux_Capital>,
        <https://1145.am/db/1766887/Lux_Capital>,
        <https://1145.am/db/1777184/Lux_Capital>,
        <https://1145.am/db/1782221/Lux_Capital>,
        <https://1145.am/db/1792186/Lux_Capital>,
        <https://1145.am/db/1796593/Lux_Capital>,
        <https://1145.am/db/1803458/Lux_Capital>,
        <https://1145.am/db/1808133/Lux_Capital>,
        <https://1145.am/db/1809178/Lux_Capital>,
        <https://1145.am/db/1811725/Lux_Capital>,
        <https://1145.am/db/1815044/Lux_Capital>,
        <https://1145.am/db/1817051/Lux_Capital>,
        <https://1145.am/db/1818204/Lux_Capital>,
        <https://1145.am/db/1819710/Lux_Capital>,
        <https://1145.am/db/1827904/Lux_Capital>,
        <https://1145.am/db/1829422/Lux_Capital>,
        <https://1145.am/db/1838965/Lux_Capital>,
        <https://1145.am/db/1845217/Lux_Capital>,
        <https://1145.am/db/1846254/Lux_Capital>,
        <https://1145.am/db/1930816/Lux_Capital>,
        <https://1145.am/db/1932856/Lux_Capital>,
        <https://1145.am/db/2006781/Lux_Capital>,
        <https://1145.am/db/2138013/Lux_Capital>,
        <https://1145.am/db/2141058/Lux_Capital>,
        <https://1145.am/db/2178040/Lux_Capital>,
        <https://1145.am/db/2284256/Lux_Capital>,
        <https://1145.am/db/2291716/Lux_Capital>,
        <https://1145.am/db/2291901/Lux_Capital>,
        <https://1145.am/db/2303675/Lux_Capital>,
        <https://1145.am/db/2304963/Lux_Capital>,
        <https://1145.am/db/2305327/Lux_Capital>,
        <https://1145.am/db/2328280/Lux_Capital>,
        <https://1145.am/db/2331549/Lux_Capital>,
        <https://1145.am/db/2335750/Lux_Capital>,
        <https://1145.am/db/2335755/Lux_Capital>,
        <https://1145.am/db/2337522/Lux_Capital>,
        <https://1145.am/db/2337571/Lux_Capital>,
        <https://1145.am/db/2337577/Lux_Capital>,
        <https://1145.am/db/2344256/Lux_Capital>,
        <https://1145.am/db/2345224/Lux_Capital>,
        <https://1145.am/db/2345439/Lux_Capital>,
        <https://1145.am/db/2347102/Lux_Capital>,
        <https://1145.am/db/2352414/Lux_Capital>,
        <https://1145.am/db/2546216/Lux_Capital>,
        <https://1145.am/db/2633440/Lux_Capital>,
        <https://1145.am/db/2801014/Lux_Capital>,
        <https://1145.am/db/412847/Lux_Capital>,
        <https://1145.am/db/424834/Lux_Capital>,
        <https://1145.am/db/425188/Lux_Capital>,
        <https://1145.am/db/425281/Lux_Capital>,
        <https://1145.am/db/426160/Lux_Capital>,
        <https://1145.am/db/516176/Lux_Capital>,
        <https://1145.am/db/516613/Lux_Capital>,
        <https://1145.am/db/540507/Lux_Capital>,
        <https://1145.am/db/684792/Lux_Capital>,
        <https://1145.am/db/747771/Lux_Capital>,
        <https://1145.am/db/765641/Lux_Capital>,
        <https://1145.am/db/823763/Lux_Capital>,
        <https://1145.am/db/863878/Lux_Capital>,
        <https://1145.am/db/918904/Lux_Capital>,
        <https://1145.am/db/935910/Lux_Capital>,
        <https://1145.am/db/936989/Lux_Capital>,
        <https://1145.am/db/940684/Lux_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348448/Polaris_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:documentDate "2011-12-15T14:20:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cerulean Pharma Closes $15 Million Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cerulean-pharma-closes-15-million-series-d-financing> ;
    ns1:foundName "Polaris Venture Partners" ;
    ns1:investor <https://1145.am/db/2348448/Series_D_Investment_Bessemer_Venture_Partners_Cvf_Llc_Cerulean_Pharma_Inc_Henry_Crown_And_Company_Lilly_Ventures_Lux_Capital_Polaris_Venture_Partners_Venrock_Completed> ;
    ns1:name "Polaris Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1701903/Polaris_Venture_Partners>,
        <https://1145.am/db/1708291/Polaris_Venture_Partners>,
        <https://1145.am/db/1830502/Polaris_Venture_Partners>,
        <https://1145.am/db/1870436/Polaris_Venture_Partners>,
        <https://1145.am/db/1877606/Polaris_Venture_Partners>,
        <https://1145.am/db/1897450/Polaris_Venture_Partners>,
        <https://1145.am/db/1909651/Polaris_Venture_Partners>,
        <https://1145.am/db/2174824/Polaris_Venture_Partners>,
        <https://1145.am/db/2292800/Polaris_Venture_Partners>,
        <https://1145.am/db/2302116/Polaris_Venture_Partners>,
        <https://1145.am/db/2303656/Polaris_Venture_Partners>,
        <https://1145.am/db/2303675/Polaris_Venture_Partners>,
        <https://1145.am/db/2313401/Polaris_Venture_Partners>,
        <https://1145.am/db/2313405/Polaris_Venture_Partners>,
        <https://1145.am/db/2314380/Polaris_Venture_Partners>,
        <https://1145.am/db/2315289/Polaris_Venture_Partners>,
        <https://1145.am/db/2323586/Polaris_Venture_Partners>,
        <https://1145.am/db/2324431/Polaris_Venture_Partners>,
        <https://1145.am/db/2331763/Polaris_Venture_Partners>,
        <https://1145.am/db/2337571/Polaris_Venture_Partners>,
        <https://1145.am/db/2337577/Polaris_Venture_Partners>,
        <https://1145.am/db/2338373/Polaris_Venture_Partners>,
        <https://1145.am/db/2339127/Polaris_Venture_Partners>,
        <https://1145.am/db/2339128/Polaris_Venture_Partners>,
        <https://1145.am/db/2342445/Polaris_Venture_Partners>,
        <https://1145.am/db/2342862/Polaris_Venture_Partners>,
        <https://1145.am/db/2343210/Polaris_Venture_Partners>,
        <https://1145.am/db/2344256/Polaris_Venture_Partners>,
        <https://1145.am/db/2345224/Polaris_Venture_Partners>,
        <https://1145.am/db/2347102/Polaris_Venture_Partners>,
        <https://1145.am/db/2350034/Polaris_Venture_Partners>,
        <https://1145.am/db/2352414/Polaris_Venture_Partners>,
        <https://1145.am/db/2354806/Polaris_Venture_Partners>,
        <https://1145.am/db/2365296/Polaris_Venture_Partners>,
        <https://1145.am/db/2365300/Polaris_Venture_Partners>,
        <https://1145.am/db/2366654/Polaris_Venture_Partners>,
        <https://1145.am/db/2367497/Polaris_Venture_Partners>,
        <https://1145.am/db/2440024/Polaris_Venture_Partners>,
        <https://1145.am/db/2450515/Polaris_Venture_Partners>,
        <https://1145.am/db/2546216/Polaris_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348448/Venrock> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:documentDate "2011-12-15T14:20:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cerulean Pharma Closes $15 Million Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cerulean-pharma-closes-15-million-series-d-financing> ;
    ns1:foundName "Venrock" ;
    ns1:investor <https://1145.am/db/2348448/Series_D_Investment_Bessemer_Venture_Partners_Cvf_Llc_Cerulean_Pharma_Inc_Henry_Crown_And_Company_Lilly_Ventures_Lux_Capital_Polaris_Venture_Partners_Venrock_Completed> ;
    ns1:name "Venrock" ;
    ns1:sameAsMedium <https://1145.am/db/1263825/Venrock>,
        <https://1145.am/db/1700286/Venrock>,
        <https://1145.am/db/1718033/Venrock>,
        <https://1145.am/db/1719688/Venrock>,
        <https://1145.am/db/1735836/Venrock>,
        <https://1145.am/db/1736582/Venrock>,
        <https://1145.am/db/1746940/Venrock>,
        <https://1145.am/db/1750203/Venrock>,
        <https://1145.am/db/1757897/Venrock>,
        <https://1145.am/db/1758165/Venrock>,
        <https://1145.am/db/1793754/Venrock>,
        <https://1145.am/db/1796590/Venrock>,
        <https://1145.am/db/1801792/Venrock>,
        <https://1145.am/db/1821534/Venrock>,
        <https://1145.am/db/1828008/Venrock>,
        <https://1145.am/db/1829024/Venrock>,
        <https://1145.am/db/1830635/Venrock>,
        <https://1145.am/db/1834607/Venrock>,
        <https://1145.am/db/1835080/Venrock>,
        <https://1145.am/db/1846413/Venrock>,
        <https://1145.am/db/1848371/Venrock>,
        <https://1145.am/db/1856457/Venrock>,
        <https://1145.am/db/1870276/Venrock>,
        <https://1145.am/db/1870808/Venrock>,
        <https://1145.am/db/1877870/Venrock>,
        <https://1145.am/db/1881935/Venrock>,
        <https://1145.am/db/1889137/Venrock>,
        <https://1145.am/db/1891984/Venrock>,
        <https://1145.am/db/1895986/Venrock>,
        <https://1145.am/db/1903951/Venrock>,
        <https://1145.am/db/1911226/Venrock>,
        <https://1145.am/db/2242614/Venrock>,
        <https://1145.am/db/2282806/Venrock>,
        <https://1145.am/db/2290283/Venrock>,
        <https://1145.am/db/2291211/Venrock>,
        <https://1145.am/db/2291384/Venrock>,
        <https://1145.am/db/2296169/Venrock>,
        <https://1145.am/db/2296869/Venrock>,
        <https://1145.am/db/2298631/Venrock>,
        <https://1145.am/db/2299758/Venrock>,
        <https://1145.am/db/2303675/Venrock>,
        <https://1145.am/db/2307476/Venrock>,
        <https://1145.am/db/2317918/Venrock>,
        <https://1145.am/db/2326903/Venrock>,
        <https://1145.am/db/2327474/Venrock>,
        <https://1145.am/db/2328599/Venrock>,
        <https://1145.am/db/2331784/Venrock>,
        <https://1145.am/db/2335748/Venrock>,
        <https://1145.am/db/2338126/Venrock>,
        <https://1145.am/db/2338127/Venrock>,
        <https://1145.am/db/2339666/Venrock>,
        <https://1145.am/db/2340942/Venrock>,
        <https://1145.am/db/2345037/Venrock>,
        <https://1145.am/db/2345047/Venrock>,
        <https://1145.am/db/2348857/Venrock>,
        <https://1145.am/db/2349834/Venrock>,
        <https://1145.am/db/2350164/Venrock>,
        <https://1145.am/db/2350167/Venrock>,
        <https://1145.am/db/2352414/Venrock>,
        <https://1145.am/db/2356064/Venrock>,
        <https://1145.am/db/2358173/Venrock>,
        <https://1145.am/db/2359334/Venrock>,
        <https://1145.am/db/2360682/Venrock>,
        <https://1145.am/db/2366775/Venrock>,
        <https://1145.am/db/2366984/Venrock>,
        <https://1145.am/db/2368501/Venrock>,
        <https://1145.am/db/2370436/Venrock>,
        <https://1145.am/db/2371160/Venrock>,
        <https://1145.am/db/2371163/Venrock>,
        <https://1145.am/db/2538407/Venrock>,
        <https://1145.am/db/2569515/Venrock>,
        <https://1145.am/db/2569522/Venrock>,
        <https://1145.am/db/437679/Venrock>,
        <https://1145.am/db/676854/Venrock>,
        <https://1145.am/db/678071/Venrock>,
        <https://1145.am/db/773235/Venrock>,
        <https://1145.am/db/893359/Venrock>,
        <https://1145.am/db/894233/Venrock>,
        <https://1145.am/db/922552/Venrock>,
        <https://1145.am/db/923335/Venrock> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348453/Glenmark> a org:Organization ;
    ns1:basedInLowRaw "Sweden" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2011-12-15T14:52:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ariad plans $224M stock offering; Dicerna earns $5M milestone from KHK; Salk team touts potential of new Alzheimer's drug;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ariad-plans-224m-stock-offering-dicerna-earns-5m-milestone-from-khk-salk-team-touts> ;
    ns1:foundName "Glenmark" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Glenmark" ;
    ns1:protagonist <https://1145.am/db/2348453/Investment_Glenmark_Napo_Pharmaceuticals_Has_Not_Happened> ;
    ns1:sameAsHigh <https://1145.am/db/1165995/Glenmark_Pharmaceuticals_Inc_Usa>,
        <https://1145.am/db/1165995/Glenmark_Pharmaceuticals_Ltd>,
        <https://1145.am/db/1651523/Glenmark_Pharmaceuticals_Ltd>,
        <https://1145.am/db/1938667/Glenmark_Pharmaceuticals_Ltd>,
        <https://1145.am/db/1965949/Glenmark_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2120286/Glenmark_Pharma>,
        <https://1145.am/db/2308761/Glenmark>,
        <https://1145.am/db/2338154/Glenmark_Pharmaceuticals>,
        <https://1145.am/db/2540629/Glenmark_Pharmaceuticals>,
        <https://1145.am/db/2542040/Glenmark_Pharmaceuticals>,
        <https://1145.am/db/2550541/Glenmark_Pharmaceuticals>,
        <https://1145.am/db/2553685/Glenmark_Pharmaceuticals>,
        <https://1145.am/db/2553773/Glenmark>,
        <https://1145.am/db/2555945/Glenmark_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2559769/Glenmark_Pharmaceuticals>,
        <https://1145.am/db/2560225/Glenmark_Pharmaceuticals>,
        <https://1145.am/db/2561312/Glenmark_Pharmaceuticals>,
        <https://1145.am/db/2561694/Glenmark_Life_Sciences>,
        <https://1145.am/db/2562524/Glenmark_Pharmaceuticals>,
        <https://1145.am/db/2563407/Glenmark_Pharmaceuticals>,
        <https://1145.am/db/2565209/Glenmark_Pharma>,
        <https://1145.am/db/2567692/Glenmark_Pharmaceuticals>,
        <https://1145.am/db/2573935/Glenmark_Pharmaceuticals>,
        <https://1145.am/db/2580381/Glenmark_Pharmaceuticals>,
        <https://1145.am/db/2587281/Glenmark_Pharmaceuticals>,
        <https://1145.am/db/2596844/Glenmark_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348453/Ipo_Ariad_Pharmaceuticals_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "ipo" ;
    ns1:documentDate "2011-12-15T14:52:57+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Ariad Pharmaceuticals ($ ARIA) is planning to raise $ 224 million through a stock offering to fund its final development work on the closely watched ponatinib." ;
    ns1:documentTitle "Ariad plans $224M stock offering; Dicerna earns $5M milestone from KHK; Salk team touts potential of new Alzheimer's drug;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ariad-plans-224m-stock-offering-dicerna-earns-5m-milestone-from-khk-salk-team-touts> ;
    ns1:foundName "raise",
        "stock offering" ;
    ns1:name "raise",
        "stock offering" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:valueRaw "$ 224 million" ;
    ns1:vendor <https://1145.am/db/2348453/Ariad_Pharmaceuticals> ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2348453/Kyowa_Hakko_Kirin> a org:Organization ;
    ns1:basedInLowRaw "Japan" ;
    ns1:documentDate "2011-12-15T14:52:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ariad plans $224M stock offering; Dicerna earns $5M milestone from KHK; Salk team touts potential of new Alzheimer's drug;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ariad-plans-224m-stock-offering-dicerna-earns-5m-milestone-from-khk-salk-team-touts> ;
    ns1:foundName "Kyowa Hakko Kirin" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2348453/Investment_Dicerna_Pharmaceuticals_Kyowa_Hakko_Kirin_Has_Not_Happened> ;
    ns1:name "Kyowa Hakko Kirin" ;
    ns1:sameAsHigh <https://1145.am/db/1206173/Kyowa_Kirin_Co_Ltd>,
        <https://1145.am/db/2137293/Kyowa_Kirin>,
        <https://1145.am/db/2283321/Kyowa_Kirin>,
        <https://1145.am/db/2312495/Kyowa_Pharmaceutical_Industry_Co_Ltd>,
        <https://1145.am/db/2326764/Kyowa_Hakko_Usa>,
        <https://1145.am/db/2541058/Kyowa_Hakko>,
        <https://1145.am/db/2544679/Kyowa_Pharmaceutical_Industry_Co>,
        <https://1145.am/db/2550695/Kyowa_Hakko_Kirin>,
        <https://1145.am/db/2558689/Kyowa_Hakko_Kogyo>,
        <https://1145.am/db/2567473/Kyowa_Kirin>,
        <https://1145.am/db/2587155/Kyowa_Hakko_Kirin>,
        <https://1145.am/db/505776/Kyowa_Kirin_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348453/Napo_Pharmaceuticals> a org:Organization ;
    ns1:documentDate "2011-12-15T14:52:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ariad plans $224M stock offering; Dicerna earns $5M milestone from KHK; Salk team touts potential of new Alzheimer's drug;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ariad-plans-224m-stock-offering-dicerna-earns-5m-milestone-from-khk-salk-team-touts> ;
    ns1:foundName "Napo Pharmaceuticals" ;
    ns1:industry "pharmaceuticals" ;
    ns1:name "Napo Pharmaceuticals" ;
    ns1:protagonist <https://1145.am/db/2348453/Investment_Glenmark_Napo_Pharmaceuticals_Has_Not_Happened> ;
    ns1:sameAsHigh <https://1145.am/db/2314325/Napo_Pharmaceuticals>,
        <https://1145.am/db/781216/Napo_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350491/Aberdare_Ventures> a org:Organization ;
    ns1:basedInLowRaw "IRVINE, Calif" ;
    ns1:documentDate "2011-12-20T01:20:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aviir Announces Agreement to Raise up to $30 Million in Latest Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aviir-announces-agreement-to-raise-up-to-30-million-latest-financing-round> ;
    ns1:foundName "Aberdare Ventures" ;
    ns1:investor <https://1145.am/db/2350491/Investment_Aberdare_Ventures_Aviir_Inc_Bay_City_Capital_New_Leaf_Venture_Partners_Has_Not_Happened> ;
    ns1:name "Aberdare Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1856457/Aberdare_Ventures>,
        <https://1145.am/db/1857326/Aberdare_Ventures>,
        <https://1145.am/db/2292334/Aberdare_Ventures>,
        <https://1145.am/db/2292353/Aberdare_Ventures>,
        <https://1145.am/db/2307565/Aberdare_Ventures>,
        <https://1145.am/db/2318708/Aberdare_Ventures>,
        <https://1145.am/db/2323531/Aberdare_Ventures>,
        <https://1145.am/db/2329550/Aberdare_Ventures>,
        <https://1145.am/db/2330876/Aberdare_Ventures>,
        <https://1145.am/db/2343723/Aberdare_Ventures>,
        <https://1145.am/db/2343724/Aberdare_Ventures>,
        <https://1145.am/db/2343744/Aberdare_Ventures>,
        <https://1145.am/db/2346534/Aberdare_Ventures>,
        <https://1145.am/db/2362035/Aberdare_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350491/Bay_City_Capital> a org:Organization ;
    ns1:basedInLowRaw "IRVINE, Calif" ;
    ns1:documentDate "2011-12-20T01:20:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aviir Announces Agreement to Raise up to $30 Million in Latest Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aviir-announces-agreement-to-raise-up-to-30-million-latest-financing-round> ;
    ns1:foundName "Bay City Capital" ;
    ns1:investor <https://1145.am/db/2350491/Investment_Aberdare_Ventures_Aviir_Inc_Bay_City_Capital_New_Leaf_Venture_Partners_Has_Not_Happened> ;
    ns1:name "Bay City Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2292334/Bay_City_Capital>,
        <https://1145.am/db/2292353/Bay_City_Capital>,
        <https://1145.am/db/2296810/Bay_City_Capital>,
        <https://1145.am/db/2301824/Bay_City_Capital>,
        <https://1145.am/db/2302897/Bay_City_Capital>,
        <https://1145.am/db/2306568/Bay_City_Capital>,
        <https://1145.am/db/2308713/Bay_City_Capital>,
        <https://1145.am/db/2311570/Bay_City_Capital>,
        <https://1145.am/db/2312435/Bay_City_Capital>,
        <https://1145.am/db/2314492/Bay_City_Capital>,
        <https://1145.am/db/2319822/Bay_City_Capital_Llc>,
        <https://1145.am/db/2319965/Bay_City_Capital>,
        <https://1145.am/db/2320476/Bay_City_Capital>,
        <https://1145.am/db/2324289/Bay_City_Capital>,
        <https://1145.am/db/2326903/Bay_City_Capital>,
        <https://1145.am/db/2329010/Bay_City_Capital>,
        <https://1145.am/db/2329011/Bay_City_Capital>,
        <https://1145.am/db/2331700/Bay_City_Capital>,
        <https://1145.am/db/2331784/Bay_City_Capital>,
        <https://1145.am/db/2336510/Bay_City_Capital>,
        <https://1145.am/db/2336511/Bay_City_Capital>,
        <https://1145.am/db/2337599/Bay_City_Capital>,
        <https://1145.am/db/2342864/Bay_City_Capital>,
        <https://1145.am/db/2346534/Bay_City_Capital>,
        <https://1145.am/db/2351129/Bay_City_Capital>,
        <https://1145.am/db/2356290/Bay_City_Capital>,
        <https://1145.am/db/2357418/Bay_City_Capital>,
        <https://1145.am/db/2358409/Bay_City_Capital>,
        <https://1145.am/db/2359185/Bay_City_Capital>,
        <https://1145.am/db/2360266/Bay_City_Capital>,
        <https://1145.am/db/2367022/Bay_City_Capital>,
        <https://1145.am/db/2367023/Bay_City_Capital>,
        <https://1145.am/db/2367026/Bay_City_Capital>,
        <https://1145.am/db/2583466/Bay_City_Capital>,
        <https://1145.am/db/2588372/Bay_City_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350491/New_Leaf_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "IRVINE, Calif" ;
    ns1:documentDate "2011-12-20T01:20:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aviir Announces Agreement to Raise up to $30 Million in Latest Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aviir-announces-agreement-to-raise-up-to-30-million-latest-financing-round> ;
    ns1:foundName "New Leaf Venture Partners" ;
    ns1:investor <https://1145.am/db/2350491/Investment_Aberdare_Ventures_Aviir_Inc_Bay_City_Capital_New_Leaf_Venture_Partners_Has_Not_Happened> ;
    ns1:name "New Leaf Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1287338/New_Leaf_Venture_Partners>,
        <https://1145.am/db/1749104/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2151983/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2155668/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2208603/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2289585/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2293765/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2298642/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2300322/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2301824/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2301828/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305507/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305514/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2307682/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2311595/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2312792/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315071/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315932/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315934/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2316674/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2317919/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318656/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318657/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325326/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325398/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334479/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334797/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2341003/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342925/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342937/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2343298/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345037/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345047/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346532/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346542/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347043/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347571/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347876/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347878/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348149/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348618/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2349120/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350164/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350167/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2352059/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2357356/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2359683/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2360174/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2361416/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362736/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362737/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2366860/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2569522/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2594141/New_Leaf_Venture_Partners>,
        <https://1145.am/db/425953/New_Leaf_Venture_Partners>,
        <https://1145.am/db/583528/New_Leaf_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350553/Preferred_Stock_Investment_Nabsys_Inc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-09-15T16:30:25+00:00"^^xsd:dateTime ;
    ns1:documentExtract "PROVIDENCE, R.I., Sep 14, 2011 (BUSINESS WIRE) - NABsys, Inc., developers of solid-state electronic systems for single-molecule DNA sequencing and analysis, has closed a $ 10 million venture capital round." ;
    ns1:documentTitle "NABsys Raises $10M for Continued Development and Commercialization of Solid-State Systems for Single-Molecule DNA Analysis" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nabsys-raises-10m-for-continued-development-and-commercialization-of-solid-state-systems> ;
    ns1:foundName "capital",
        "financing" ;
    ns1:name "capital",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2350553/Nabsys_Inc> ;
    ns1:targetDetails "Preferred Stock",
        "venture" ;
    ns1:valueRaw "$ 10 million" ;
    ns1:when "2011-09-14T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Sep 14, 2011" ;
    ns1:whereGeoName "Providence" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5224151/about.rdf> ;
    ns1:whereRaw "PROVIDENCE, R.I." .

<https://1145.am/db/2352586/Amorcyte_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-01-03T13:20:24+00:00"^^xsd:dateTime ;
    ns1:documentExtract "We have closed two acquisitions - Progenitor Cell Therapy, LLC (\"PCT\") and Amorcyte, LLC (\"Amorcyte\") ." ;
    ns1:documentTitle "NeoStem's CEO Letter to Shareholders" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/neostem-s-ceo-letter-to-shareholders> ;
    ns1:foundName "acquisitions" ;
    ns1:name "acquisitions" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2352586/Amorcyte> ;
    ns1:targetName "Amorcyte" .

<https://1145.am/db/2352586/Progenitor_Cell_Therapy_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2012-01-03T13:20:24+00:00"^^xsd:dateTime ;
    ns1:documentExtract "We have closed two acquisitions - Progenitor Cell Therapy, LLC (\"PCT\") and Amorcyte, LLC (\"Amorcyte\") ." ;
    ns1:documentTitle "NeoStem's CEO Letter to Shareholders" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/neostem-s-ceo-letter-to-shareholders> ;
    ns1:foundName "acquisitions",
        "closed" ;
    ns1:name "acquisitions",
        "closed" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2352586/Progenitor_Cell_Therapy> ;
    ns1:targetName "Progenitor Cell Therapy" .

<https://1145.am/db/2352633/Cti_Life_Sciences_Fund> a org:Organization ;
    ns1:basedInLowRaw "British Columbia" ;
    ns1:description "Investing in life sciences" ;
    ns1:documentDate "2011-09-22T16:00:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zymeworks Completes $8.1 Million Round of Financing to Advance Platform Technology and Therapeutics Pipeline Programs" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zymeworks-completes-8-1-million-round-of-financing-to-advance-platform-technology-and> ;
    ns1:foundName "CTI Life Sciences Fund, L.P." ;
    ns1:investor <https://1145.am/db/2352633/Investment_Advanced_Biotechnologies_Venture_Fund_Zymeworks_Inc_Completed> ;
    ns1:name "CTI Life Sciences Fund" ;
    ns1:sameAsHigh <https://1145.am/db/2311133/Vengrowth_Advanced_Life_Sciences_Fund_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2314850/Cti_Life_Sciences_Fund>,
        <https://1145.am/db/2365679/Cti_Life_Sciences_Fund>,
        <https://1145.am/db/2369027/Cti_Life_Sciences_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353610/Bb_Biotech> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:documentDate "2012-01-04T16:04:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Probiodrug AG Raises Additional EUR 15 Million to Advance Its Clinical Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/probiodrug-ag-raises-additional-eur-15-million-to-advance-its-clinical-program> ;
    ns1:foundName "BB Biotech" ;
    ns1:investor <https://1145.am/db/2353610/Investment_Bb_Biotech_Biogen_Idec_New_Ventures_Edmond_De_Rothschild_Investment_Partners_Goodvent__Ibg_Hbm_Bioventures_Life_Sciences_Partners_Probiodrug_Ag_Tvm_Capital_Has_Not_Happened> ;
    ns1:name "BB Biotech" ;
    ns1:sameAsMedium <https://1145.am/db/2325831/Bb_Biotech>,
        <https://1145.am/db/2353607/Bb_Biotech>,
        <https://1145.am/db/2355590/Bb_Biotech>,
        <https://1145.am/db/2366137/Bb_Biotech> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353610/Biogen_Idec_New_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:documentDate "2012-01-04T16:04:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Probiodrug AG Raises Additional EUR 15 Million to Advance Its Clinical Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/probiodrug-ag-raises-additional-eur-15-million-to-advance-its-clinical-program> ;
    ns1:foundName "Biogen Idec New Ventures",
        "Idec New Ventures" ;
    ns1:investor <https://1145.am/db/2353610/Investment_Bb_Biotech_Biogen_Idec_New_Ventures_Edmond_De_Rothschild_Investment_Partners_Goodvent__Ibg_Hbm_Bioventures_Life_Sciences_Partners_Probiodrug_Ag_Tvm_Capital_Has_Not_Happened> ;
    ns1:name "Biogen Idec New Ventures",
        "Idec New Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2313401/Biogen_Idec_New_Ventures>,
        <https://1145.am/db/2313410/Biogen_Idec_New_Ventures>,
        <https://1145.am/db/2325348/Biogen_Idec_New_Ventures>,
        <https://1145.am/db/2325831/Biogen_Idec_New_Ventures>,
        <https://1145.am/db/2325846/Biogen_Idec_New_Ventures>,
        <https://1145.am/db/2347594/Biogen_Idec_New_Ventures>,
        <https://1145.am/db/2353607/Biogen_Idec_New_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353610/Edmond_De_Rothschild_Investment_Partners> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:documentDate "2012-01-04T16:04:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Probiodrug AG Raises Additional EUR 15 Million to Advance Its Clinical Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/probiodrug-ag-raises-additional-eur-15-million-to-advance-its-clinical-program> ;
    ns1:foundName "Edmond de Rothschild Investment Partners" ;
    ns1:investor <https://1145.am/db/2353610/Investment_Bb_Biotech_Biogen_Idec_New_Ventures_Edmond_De_Rothschild_Investment_Partners_Goodvent__Ibg_Hbm_Bioventures_Life_Sciences_Partners_Probiodrug_Ag_Tvm_Capital_Has_Not_Happened> ;
    ns1:name "Edmond de Rothschild Investment Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2289591/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2297507/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2299423/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2301041/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2301096/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2303210/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2303641/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2303642/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2303849/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2313401/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2313410/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2320503/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2325831/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2336923/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2338023/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2338193/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2338196/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2348331/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2350101/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2351191/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2351192/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2353607/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2356567/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2358268/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2358269/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2358541/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2363938/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2363941/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2367201/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2368740/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2369953/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2369982/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2369999/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2555540/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2701527/Edmond_De_Rothschild_Investment_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353610/Goodvent__Ibg> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:documentDate "2012-01-04T16:04:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Probiodrug AG Raises Additional EUR 15 Million to Advance Its Clinical Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/probiodrug-ag-raises-additional-eur-15-million-to-advance-its-clinical-program> ;
    ns1:foundName "Goodvent/ IBG" ;
    ns1:investor <https://1145.am/db/2353610/Investment_Bb_Biotech_Biogen_Idec_New_Ventures_Edmond_De_Rothschild_Investment_Partners_Goodvent__Ibg_Hbm_Bioventures_Life_Sciences_Partners_Probiodrug_Ag_Tvm_Capital_Has_Not_Happened> ;
    ns1:name "Goodvent/ IBG" ;
    ns1:sameAsMedium <https://1145.am/db/2353607/Goodvent_Ibg>,
        <https://1145.am/db/2440017/Ibg___Goodvent> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353610/Hbm_Bioventures> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:documentDate "2012-01-04T16:04:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Probiodrug AG Raises Additional EUR 15 Million to Advance Its Clinical Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/probiodrug-ag-raises-additional-eur-15-million-to-advance-its-clinical-program> ;
    ns1:foundName "HBM BioVentures" ;
    ns1:investor <https://1145.am/db/2353610/Investment_Bb_Biotech_Biogen_Idec_New_Ventures_Edmond_De_Rothschild_Investment_Partners_Goodvent__Ibg_Hbm_Bioventures_Life_Sciences_Partners_Probiodrug_Ag_Tvm_Capital_Has_Not_Happened> ;
    ns1:name "HBM BioVentures" ;
    ns1:sameAsMedium <https://1145.am/db/2292772/Hbm_Bioventures>,
        <https://1145.am/db/2301790/Hbm_Bioventures>,
        <https://1145.am/db/2302994/Hbm_Bioventures>,
        <https://1145.am/db/2302995/Hbm_Bioventures>,
        <https://1145.am/db/2303121/Hbm_Bioventures>,
        <https://1145.am/db/2304335/Hbm_Bioventures>,
        <https://1145.am/db/2304340/Hbm_Bioventures>,
        <https://1145.am/db/2313322/Hbm_Bioventures>,
        <https://1145.am/db/2313438/Hbm_Bioventures>,
        <https://1145.am/db/2324255/Hbm_Bioventures>,
        <https://1145.am/db/2325831/Hbm_Bioventures>,
        <https://1145.am/db/2326176/Hbm_Bioventures>,
        <https://1145.am/db/2329550/Hbm_Bioventures>,
        <https://1145.am/db/2332864/Hbm_Bioventures>,
        <https://1145.am/db/2335700/Hbm_Bioventures>,
        <https://1145.am/db/2339295/Hbm_Bioventures>,
        <https://1145.am/db/2349301/Hbm_Bioventures_Ltd>,
        <https://1145.am/db/2352382/Hbm_Bioventures>,
        <https://1145.am/db/2353607/Hbm_Bioventures>,
        <https://1145.am/db/2365748/Hbm_Bioventures>,
        <https://1145.am/db/2584056/Hbm_Bioventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353610/Life_Sciences_Partners> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:documentDate "2012-01-04T16:04:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Probiodrug AG Raises Additional EUR 15 Million to Advance Its Clinical Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/probiodrug-ag-raises-additional-eur-15-million-to-advance-its-clinical-program> ;
    ns1:foundName "Life Sciences Partners" ;
    ns1:investor <https://1145.am/db/2353610/Investment_Bb_Biotech_Biogen_Idec_New_Ventures_Edmond_De_Rothschild_Investment_Partners_Goodvent__Ibg_Hbm_Bioventures_Life_Sciences_Partners_Probiodrug_Ag_Tvm_Capital_Has_Not_Happened> ;
    ns1:name "Life Sciences Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1857633/Life_Sciences_Partners>,
        <https://1145.am/db/2289408/Life_Science_Partners>,
        <https://1145.am/db/2291851/Life_Sciences_Partners>,
        <https://1145.am/db/2292345/Life_Sciences_Partners>,
        <https://1145.am/db/2301093/Life_Sciences_Partners>,
        <https://1145.am/db/2301966/Life_Sciences_Partners>,
        <https://1145.am/db/2302541/Life_Sciences_Partners>,
        <https://1145.am/db/2302549/Life_Sciences_Partners>,
        <https://1145.am/db/2306885/Life_Sciences_Partners>,
        <https://1145.am/db/2310922/Life_Sciences_Partners>,
        <https://1145.am/db/2313915/Life_Sciences_Partners>,
        <https://1145.am/db/2324015/Life_Sciences_Partners>,
        <https://1145.am/db/2331946/Life_Science_Partners>,
        <https://1145.am/db/2331946/Life_Sciences_Partners>,
        <https://1145.am/db/2348331/Life_Sciences_Partners>,
        <https://1145.am/db/2353607/Life_Sciences_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353610/Tvm_Capital> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:documentDate "2012-01-04T16:04:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Probiodrug AG Raises Additional EUR 15 Million to Advance Its Clinical Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/probiodrug-ag-raises-additional-eur-15-million-to-advance-its-clinical-program> ;
    ns1:foundName "TVM Capital" ;
    ns1:investor <https://1145.am/db/2353610/Investment_Bb_Biotech_Biogen_Idec_New_Ventures_Edmond_De_Rothschild_Investment_Partners_Goodvent__Ibg_Hbm_Bioventures_Life_Sciences_Partners_Probiodrug_Ag_Tvm_Capital_Has_Not_Happened> ;
    ns1:name "TVM Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1919300/Tvm_Capital>,
        <https://1145.am/db/2289349/Tvm_Capital>,
        <https://1145.am/db/2298846/Tvm_Capital>,
        <https://1145.am/db/2303598/Tvm_Capital>,
        <https://1145.am/db/2314674/Tvm_Capital>,
        <https://1145.am/db/2317779/Tvm_Capital>,
        <https://1145.am/db/2322531/Tvm_Capital>,
        <https://1145.am/db/2323243/Tvm_Capital>,
        <https://1145.am/db/2325366/Tvm_Capital>,
        <https://1145.am/db/2326376/Tvm_Capital>,
        <https://1145.am/db/2327406/Tvm_Capital>,
        <https://1145.am/db/2336126/Tvm_Capital>,
        <https://1145.am/db/2347977/Tvm_Capital>,
        <https://1145.am/db/2347983/Tvm_Capital>,
        <https://1145.am/db/2352814/Tvm_Capital>,
        <https://1145.am/db/2352819/Tvm_Capital>,
        <https://1145.am/db/2352820/Tvm_Capital>,
        <https://1145.am/db/2353522/Tvm_Capital>,
        <https://1145.am/db/2353525/Tvm_Capital>,
        <https://1145.am/db/2353607/Tvm_Capital>,
        <https://1145.am/db/2358268/Tvm_Capital>,
        <https://1145.am/db/2358269/Tvm_Capital>,
        <https://1145.am/db/2365103/Tvm_Capital>,
        <https://1145.am/db/2366539/Tvm_Capital>,
        <https://1145.am/db/2564563/Tvm_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353646/Cleveland_Biolabs> a org:Organization ;
    ns1:basedInLowRaw "Russia" ;
    ns1:documentDate "2011-09-26T16:11:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Valeant hikes bid for Afexa; Cleveland BioLabs launches preclin cancer drug subsidiary; Mela diagnostic on path to an approval;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/valeant-hikes-bid-for-afexa-cleveland-biolabs-launches-preclin-cancer-drug-subsidiary-mela> ;
    ns1:foundName "Cleveland BioLabs" ;
    ns1:name "Cleveland BioLabs" ;
    ns1:protagonist <https://1145.am/db/2353646/Investment_Cleveland_Biolabs_Has_Not_Happened> ;
    ns1:sameAsMedium <https://1145.am/db/2311085/Cleveland_Biolabs>,
        <https://1145.am/db/2340690/Cleveland_Biolabs>,
        <https://1145.am/db/2350443/Cleveland_Biolabs_Inc>,
        <https://1145.am/db/2360974/Cleveland_Biolabs_Inc>,
        <https://1145.am/db/2362389/Cleveland_Biolabs>,
        <https://1145.am/db/2366687/Cleveland_Biolabs_Inc>,
        <https://1145.am/db/2366692/Cleveland_Biolabs>,
        <https://1145.am/db/2581670/Cleveland_Biolabs> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353646/Paladin_Labs> a org:Organization ;
    ns1:buyer <https://1145.am/db/2353646/Afexa_Acquisition> ;
    ns1:documentDate "2011-09-26T16:11:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Valeant hikes bid for Afexa; Cleveland BioLabs launches preclin cancer drug subsidiary; Mela diagnostic on path to an approval;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/valeant-hikes-bid-for-afexa-cleveland-biolabs-launches-preclin-cancer-drug-subsidiary-mela> ;
    ns1:foundName "Paladin Labs" ;
    ns1:name "Paladin Labs" ;
    ns1:sameAsMedium <https://1145.am/db/2291572/Paladin_Labs>,
        <https://1145.am/db/2295973/Paladin_Labs>,
        <https://1145.am/db/2313367/Paladin_Labs_Inc>,
        <https://1145.am/db/2314217/Paladin_Labs>,
        <https://1145.am/db/2315308/Paladin_Labs>,
        <https://1145.am/db/2315664/Paladin_Labs>,
        <https://1145.am/db/2317622/Paladin_Labs_Inc>,
        <https://1145.am/db/2319656/Paladin_Labs_Inc>,
        <https://1145.am/db/2335600/Paladin_Labs>,
        <https://1145.am/db/2338090/Paladin_Labs>,
        <https://1145.am/db/2339487/Paladin_Labs>,
        <https://1145.am/db/2339856/Paladin_Labs>,
        <https://1145.am/db/2555487/Paladin_Labs>,
        <https://1145.am/db/2557083/Paladin_Labs>,
        <https://1145.am/db/2571068/Paladin_Labs>,
        <https://1145.am/db/2575133/Paladin_Labs>,
        <https://1145.am/db/2582969/Paladin_Labs>,
        <https://1145.am/db/2594087/Paladin_Labs>,
        <https://1145.am/db/2594116/Paladin_Labs>,
        <https://1145.am/db/2597086/Paladin_Labs>,
        <https://1145.am/db/2598012/Paladin_Labs> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354625/Dievini_Hopp_Biotech_Holding_Gmbh___Co_Kg> a org:Organization ;
    ns1:basedInLowRaw "Heidelberg" ;
    ns1:description "Business" ;
    ns1:documentDate "2012-01-05T14:53:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Apogenix Raises EUR 7.5 Million to Further Advance APG101 to Treat Glioblastoma and other Tumors" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/apogenix-raises-eur-7-5-million-to-further-advance-apg101-to-treat-glioblastoma-and-other> ;
    ns1:foundName "dievini Hopp BioTech holding GmbH & Co. KG (dievini)" ;
    ns1:industry "biopharmaceutical" ;
    ns1:investor <https://1145.am/db/2354625/Investment_Apogenix_Gmbh_German_Cancer_Research_Center_Dievini_Hopp_Biotech_Holding_Gmbh___Co_Kg_Completed> ;
    ns1:name "dievini Hopp BioTech holding GmbH & Co. KG" ;
    ns1:sameAsHigh <https://1145.am/db/2351883/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2359443/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2562086/Dievini_Hopp_Biotech_Holding> ;
    ns1:sameAsMedium <https://1145.am/db/2331155/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2351879/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2361079/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2361082/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2361094/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2363262/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2363274/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2363275/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2368133/Dievini_Hopp_Biotech_Holding_Gmbh___Co_Kg>,
        <https://1145.am/db/2579135/Dievini_Hopp_Biotech_Holding> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354625/German_Cancer_Research_Center> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:documentDate "2012-01-05T14:53:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Apogenix Raises EUR 7.5 Million to Further Advance APG101 to Treat Glioblastoma and other Tumors" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/apogenix-raises-eur-7-5-million-to-further-advance-apg101-to-treat-glioblastoma-and-other> ;
    ns1:foundName "the German Cancer Research Center (DKFZ)" ;
    ns1:investor <https://1145.am/db/2354625/Investment_Apogenix_Gmbh_German_Cancer_Research_Center_Dievini_Hopp_Biotech_Holding_Gmbh___Co_Kg_Completed> ;
    ns1:name "German Cancer Research Center" ;
    ns1:sameAsMedium <https://1145.am/db/2327489/German_Cancer_Research_Center> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354706/Newspring_Health_Capital> a org:Organization ;
    ns1:basedInLowRaw "ME" ;
    ns1:description "financing" ;
    ns1:documentDate "2011-09-29T16:18:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Safeguard Scientifics Leads $21M Round for Putney" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/safeguard-scientifics-leads-21m-round-for-putney> ;
    ns1:foundName "NewSpring Health Capital" ;
    ns1:investor <https://1145.am/db/2354706/Investment_Putney_Completed> ;
    ns1:name "NewSpring Health Capital" ;
    ns1:sameAsHigh <https://1145.am/db/564787/Health_Catalyst_Capital>,
        <https://1145.am/db/567134/Health_Catalyst_Capital>,
        <https://1145.am/db/838323/Evidity_Health_Capital>,
        <https://1145.am/db/838323/Healthquest_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/2290410/Newspring_Health_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354706/Safeguard_Scientifics> a org:Organization ;
    ns1:basedInLowRaw "ME" ;
    ns1:description "life sciences and technology" ;
    ns1:documentDate "2011-09-29T16:18:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Safeguard Scientifics Leads $21M Round for Putney" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/safeguard-scientifics-leads-21m-round-for-putney> ;
    ns1:foundName "Safeguard",
        "Safeguard Scientifics, Inc",
        "Safeguard Scientifics, Inc." ;
    ns1:industry "life sciences and technology" ;
    ns1:investor <https://1145.am/db/2354706/Investment_Putney_Completed> ;
    ns1:name "Safeguard Scientifics" ;
    ns1:sameAsHigh <https://1145.am/db/2290453/Safeguard_Scientifics>,
        <https://1145.am/db/2295945/Safeguard_Scientifics>,
        <https://1145.am/db/2305609/Safeguard_Scientifics>,
        <https://1145.am/db/2307837/Safeguard_Scientifics>,
        <https://1145.am/db/2322984/Safeguard_Scientifics>,
        <https://1145.am/db/2323003/Safeguard_Scientifics>,
        <https://1145.am/db/2576460/Safeguard_Scientifics> ;
    ns1:sameAsMedium <https://1145.am/db/1232627/Safeguard_Scientifics>,
        <https://1145.am/db/1383287/Safeguard_Scientifics>,
        <https://1145.am/db/1801934/Safeguard_Scientifics>,
        <https://1145.am/db/1843216/Safeguard_Scientifics>,
        <https://1145.am/db/1855887/Safeguard_Scientifics>,
        <https://1145.am/db/1873156/Safeguard_Scientifics>,
        <https://1145.am/db/1914893/Safeguard_Scientifics>,
        <https://1145.am/db/2147446/Safeguard_Scientifics>,
        <https://1145.am/db/2182583/Safeguard_Scientifics>,
        <https://1145.am/db/2291872/Safeguard_Scientifics>,
        <https://1145.am/db/2292039/Safeguard_Scientifics>,
        <https://1145.am/db/2297604/Safeguard_Scientifics>,
        <https://1145.am/db/2298535/Safeguard_Scientifics>,
        <https://1145.am/db/2304598/Safeguard_Scientifics>,
        <https://1145.am/db/2304605/Safeguard_Scientifics_Inc>,
        <https://1145.am/db/2305443/Safeguard_Scientifics>,
        <https://1145.am/db/2316302/Safeguard_Scientifics>,
        <https://1145.am/db/2317455/Safeguard_Scientifics_Inc>,
        <https://1145.am/db/2319506/Safeguard_Scientifics>,
        <https://1145.am/db/2323336/Safeguard_Scientifics>,
        <https://1145.am/db/2325237/Safeguard_Scientifics>,
        <https://1145.am/db/2359125/Safeguard_Scientifics>,
        <https://1145.am/db/2436408/Safeguard_Scientifics_Inc>,
        <https://1145.am/db/2447203/Safeguard_Scientifics_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355712/European_Commission> a org:Organization ;
    ns1:basedInLowRaw "European" ;
    ns1:description "a number of projects" ;
    ns1:documentDate "2012-01-10T11:20:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cardio3 BioSciences Secures Additional €3.1 Million in Non-dilutive Funding From the Walloon Region and the European Commission" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cardio3-biosciences-secures-additional-%E2%82%AC3-1-million-non-dilutive-funding-from-walloon> ;
    ns1:foundName "European" ;
    ns1:name "European Commission" ;
    ns1:participant <https://1145.am/db/2355712/Investment_Cardio3biosciences_European_Commission_Seventh_Framework_Programme_Walloon_Region_Has_Not_Happened> ;
    ns1:sameAsMedium <https://1145.am/db/108315/European_Commission>,
        <https://1145.am/db/1148797/European_Commission>,
        <https://1145.am/db/1426302/European_Commission>,
        <https://1145.am/db/1428641/European_Commission>,
        <https://1145.am/db/1502437/European_Commission>,
        <https://1145.am/db/1510562/European_Commission>,
        <https://1145.am/db/1543097/European_Commission>,
        <https://1145.am/db/1578497/Eu_Commission>,
        <https://1145.am/db/1580472/Eu_Commission>,
        <https://1145.am/db/158688/European_Commission>,
        <https://1145.am/db/1667520/European_Commission>,
        <https://1145.am/db/1771276/European_Commission>,
        <https://1145.am/db/1872318/European_Commission>,
        <https://1145.am/db/2006775/European_Commission>,
        <https://1145.am/db/2059366/European_Commission>,
        <https://1145.am/db/2064907/European_Commission>,
        <https://1145.am/db/2065036/European_Commission>,
        <https://1145.am/db/2325783/European_Commission>,
        <https://1145.am/db/2333299/European_Commission>,
        <https://1145.am/db/2454300/Eu_Commission>,
        <https://1145.am/db/2669657/European_Commission>,
        <https://1145.am/db/2676711/European_Commission>,
        <https://1145.am/db/2689831/European_Commission>,
        <https://1145.am/db/270370/European_Commission>,
        <https://1145.am/db/315007/European_Commission>,
        <https://1145.am/db/559204/European_Commission>,
        <https://1145.am/db/580608/European_Commission>,
        <https://1145.am/db/76007/European_Commission> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355712/Seventh_Framework_Programme> a org:Organization ;
    ns1:basedInLowRaw "European" ;
    ns1:description "Research" ;
    ns1:documentDate "2012-01-10T11:20:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cardio3 BioSciences Secures Additional €3.1 Million in Non-dilutive Funding From the Walloon Region and the European Commission" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cardio3-biosciences-secures-additional-%E2%82%AC3-1-million-non-dilutive-funding-from-walloon> ;
    ns1:foundName "Seventh Framework Programme" ;
    ns1:investor <https://1145.am/db/2355712/Investment_Cardio3biosciences_European_Commission_Seventh_Framework_Programme_Walloon_Region_Has_Not_Happened> ;
    ns1:name "Seventh Framework Programme" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355712/Walloon_Region> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Belgium" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2802361/about.rdf> ;
    ns1:basedInHighRaw "Belgium" ;
    ns1:description "a region" ;
    ns1:documentDate "2012-01-10T11:20:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cardio3 BioSciences Secures Additional €3.1 Million in Non-dilutive Funding From the Walloon Region and the European Commission" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cardio3-biosciences-secures-additional-%E2%82%AC3-1-million-non-dilutive-funding-from-walloon> ;
    ns1:foundName "Walloon Region" ;
    ns1:investor <https://1145.am/db/2355712/Investment_Cardio3biosciences_European_Commission_Seventh_Framework_Programme_Walloon_Region_Has_Not_Happened> ;
    ns1:name "Walloon Region" ;
    ns1:sameAsMedium <https://1145.am/db/2348352/Walloon_Region>,
        <https://1145.am/db/2586342/Walloon_Region> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355715/Investment_Canaan_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-01-10T12:30:39+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Canaan Partners Closes $ 600 Million Fund, Canaan IX.",
        "Canaan Partners, a multi-billion dollar, global venture capital firm, announced today the closing of a $ 600 million fund, Canaan IX." ;
    ns1:documentTitle "Canaan Partners Closes $600 Million Fund, Canaan IX" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/canaan-partners-closes-600-million-fund-canaan-ix> ;
    ns1:foundName "closing" ;
    ns1:name "closing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2355715/Canaan_Ix>,
        <https://1145.am/db/2355715/Canaan_Partners> ;
    ns1:targetName "Canaan IX" ;
    ns1:valueRaw "$ 600 Million",
        "$ 600 million" ;
    ns1:whereRaw "global" .

<https://1145.am/db/2357799/Kdb_Capital> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Korea" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1835841/about.rdf> ;
    ns1:basedInHighRaw "Korea" ;
    ns1:description "major financial institution in Korea" ;
    ns1:documentDate "2012-01-13T16:09:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CrystalGenomics Scores KRW 3 Billion in Strategic Equity Investment from KSLSF, a Life Science Fund Backed by the City of Seoul" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crystalgenomics-scores-krw-3-billion-strategic-equity-investment-from-kslsf-a-life-science> ;
    ns1:foundName "KDB Capital" ;
    ns1:industry "financial" ;
    ns1:investor <https://1145.am/db/2357799/Investment_Crystalgenomics_Inc_Korea_Seoul_Life_Science_Fund_Completed> ;
    ns1:name "KDB Capital" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357799/Korea_Seoul_Life_Science_Fund> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Korea" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1835841/about.rdf> ;
    ns1:basedInHighRaw "Korea" ;
    ns1:documentDate "2012-01-13T16:09:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CrystalGenomics Scores KRW 3 Billion in Strategic Equity Investment from KSLSF, a Life Science Fund Backed by the City of Seoul" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crystalgenomics-scores-krw-3-billion-strategic-equity-investment-from-kslsf-a-life-science> ;
    ns1:foundName "Korea Seoul Life Science Fund" ;
    ns1:investor <https://1145.am/db/2357799/Investment_Crystalgenomics_Inc_Korea_Seoul_Life_Science_Fund_Completed> ;
    ns1:name "Korea Seoul Life Science Fund" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357799/Tube_Investment> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Korea" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1835841/about.rdf> ;
    ns1:basedInHighRaw "Korea" ;
    ns1:description "investment" ;
    ns1:documentDate "2012-01-13T16:09:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CrystalGenomics Scores KRW 3 Billion in Strategic Equity Investment from KSLSF, a Life Science Fund Backed by the City of Seoul" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crystalgenomics-scores-krw-3-billion-strategic-equity-investment-from-kslsf-a-life-science> ;
    ns1:foundName "Tube Investment" ;
    ns1:industry "investment firm" ;
    ns1:investor <https://1145.am/db/2357799/Investment_Crystalgenomics_Inc_Korea_Seoul_Life_Science_Fund_Completed> ;
    ns1:name "Tube Investment" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357809/Johnson___Johnson_Corporate_Office_Of_Science_And_Technology> a org:Organization ;
    ns1:basedInLowRaw "Colo" ;
    ns1:description "Investing in new technologies" ;
    ns1:documentDate "2012-01-15T18:53:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Clarimedix, Inc. Secures Investment for Proof-of-Concept Study in Cerebral Vasospasm" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/clarimedix-inc-secures-investment-for-proof-of-concept-study-cerebral-vasospasm> ;
    ns1:foundName "Johnson & Johnson Corporate Office of Science and Technology" ;
    ns1:investor <https://1145.am/db/2357809/Investment_Clarimedix_Inc_Johnson___Johnson_Corporate_Office_Of_Science_And_Technology_Has_Not_Happened> ;
    ns1:name "Johnson & Johnson Corporate Office of Science and Technology" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357829/Clearlake_Capital_Group> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:description "Investing" ;
    ns1:documentDate "2012-01-17T14:04:24+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Entelos Announces Recapitalization and Significant Capital Infusion to Drive Future Growth" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/entelos-announces-recapitalization-and-significant-capital-infusion-to-drive-future-growth> ;
    ns1:foundName "Clearlake Capital Group, L.P." ;
    ns1:investor <https://1145.am/db/2357829/Investment_Clearlake_Capital_Group_Imperium_Partners_Group_Llc_San_Mateo_Calif-Entelos_Holding_Corporation_Completed> ;
    ns1:name "Clearlake Capital Group" ;
    ns1:sameAsHigh <https://1145.am/db/1007509/Clearlake_Capital_Group_Lp>,
        <https://1145.am/db/1046145/Clearlake_Capital>,
        <https://1145.am/db/1558864/Clearlake_Capital>,
        <https://1145.am/db/1636073/Clearlake_Capital>,
        <https://1145.am/db/1636291/Clearlake_Capital>,
        <https://1145.am/db/1652773/Clearlake_Capital>,
        <https://1145.am/db/1844919/Clearlake_Capital_Group>,
        <https://1145.am/db/2190137/Clearlake_Capital_Group>,
        <https://1145.am/db/255602/Clearlake_Capital_Group>,
        <https://1145.am/db/377079/Clearlake_Capital_Group_Lp>,
        <https://1145.am/db/511793/Lydall_Inc>,
        <https://1145.am/db/661455/Clearlake_Capital_Group>,
        <https://1145.am/db/671677/Clearlake_Capital_Group>,
        <https://1145.am/db/704572/Clearlake_Capital_Group>,
        <https://1145.am/db/722965/Clearlake_Capital_Group>,
        <https://1145.am/db/768105/Clearlake_Capital_Group>,
        <https://1145.am/db/920446/Clearlake_Capital_Group>,
        <https://1145.am/db/945853/Clearlake_Capital_Group>,
        <https://1145.am/db/947758/Clearlake_Capital_Group> ;
    ns1:sameAsMedium <https://1145.am/db/1007601/Clearlake_Capital_Group>,
        <https://1145.am/db/1049478/Clearlake_Capital_Group>,
        <https://1145.am/db/1053357/Clearlake_Capital_Group_Lp>,
        <https://1145.am/db/1073728/Clearlake_Capital_Group>,
        <https://1145.am/db/1160717/Clearlake_Capital_Group_Lp>,
        <https://1145.am/db/1169634/Clearlake_Capital_Group>,
        <https://1145.am/db/1173697/Clearlake_Capital_Group>,
        <https://1145.am/db/1177517/Clearlake_Capital_Group>,
        <https://1145.am/db/1178170/Clearlake_Capital_Group>,
        <https://1145.am/db/1208227/Clearlake_Capital_Group>,
        <https://1145.am/db/1229514/Clearlake_Capital_Group>,
        <https://1145.am/db/1248379/Clearlake_Capital_Group>,
        <https://1145.am/db/1249014/Clearlake_Capital_Group>,
        <https://1145.am/db/1472542/Clearlake_Capital_Group>,
        <https://1145.am/db/2097793/Clearlake_Capital_Group>,
        <https://1145.am/db/328274/Clearlake_Capital_Group>,
        <https://1145.am/db/367850/Clearlake_Capital_Group>,
        <https://1145.am/db/391839/Clearlake_Capital_Group>,
        <https://1145.am/db/397218/Clearlake_Capital_Group>,
        <https://1145.am/db/397343/Clearlake_Capital_Group>,
        <https://1145.am/db/398203/Clearlake_Capital_Group>,
        <https://1145.am/db/438466/Clearlake_Capital_Group>,
        <https://1145.am/db/472167/Clearlake_Capital_Group>,
        <https://1145.am/db/473085/Clearlake_Capital_Group>,
        <https://1145.am/db/478211/Clearlake_Capital_Group>,
        <https://1145.am/db/511793/Clearlake_Capital_Group>,
        <https://1145.am/db/550797/Clearlake_Capital_Group>,
        <https://1145.am/db/551238/Clearlake_Capital_Group>,
        <https://1145.am/db/551325/Clearlake_Capital_Group>,
        <https://1145.am/db/671504/Clearlake_Capital_Group>,
        <https://1145.am/db/672516/Clearlake_Capital_Group>,
        <https://1145.am/db/918671/Clearlake_Capital_Group>,
        <https://1145.am/db/992577/Clearlake_Capital_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357829/Imperium_Partners_Group_Llc> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:description "Investing" ;
    ns1:documentDate "2012-01-17T14:04:24+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Entelos Announces Recapitalization and Significant Capital Infusion to Drive Future Growth" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/entelos-announces-recapitalization-and-significant-capital-infusion-to-drive-future-growth> ;
    ns1:foundName "Imperium Partners Group, LLC" ;
    ns1:investor <https://1145.am/db/2357829/Investment_Clearlake_Capital_Group_Imperium_Partners_Group_Llc_San_Mateo_Calif-Entelos_Holding_Corporation_Completed> ;
    ns1:name "Imperium Partners Group, LLC" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357858/5am_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:documentDate "2011-10-11T13:15:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cleave-biosciences-raises-42-million-series-a-financing-for-novel-cancer-therapies> ;
    ns1:foundName "5AM Ventures" ;
    ns1:investor <https://1145.am/db/2357858/Series_A_Investment_5am_Ventures_Astellas_Venture_Management_Clarus_Ventures_Cleave_Biosciences_Orbimed_Advisors_Us_Venture_Partners_Completed> ;
    ns1:name "5AM Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1157541/5am_Ventures>,
        <https://1145.am/db/1533327/5am_Ventures>,
        <https://1145.am/db/1533685/5am_Ventures>,
        <https://1145.am/db/1608803/5am_Ventures>,
        <https://1145.am/db/1669813/5am_Ventures>,
        <https://1145.am/db/2152422/5am_Ventures>,
        <https://1145.am/db/2153726/5am_Ventures>,
        <https://1145.am/db/2153910/5am_Ventures>,
        <https://1145.am/db/2283394/5am_Ventures>,
        <https://1145.am/db/2286204/5am_Ventures>,
        <https://1145.am/db/2286665/5am_Ventures>,
        <https://1145.am/db/2288016/5am_Ventures>,
        <https://1145.am/db/2298404/5am_Ventures>,
        <https://1145.am/db/2298642/5am_Ventures>,
        <https://1145.am/db/2306549/5am_Ventures>,
        <https://1145.am/db/2306551/5am_Ventures>,
        <https://1145.am/db/2306754/5am_Ventures>,
        <https://1145.am/db/2311595/5am_Ventures>,
        <https://1145.am/db/2313985/5am_Ventures>,
        <https://1145.am/db/2317919/5am_Ventures>,
        <https://1145.am/db/2318733/5am_Ventures>,
        <https://1145.am/db/2319784/5am_Ventures>,
        <https://1145.am/db/2322646/5am_Ventures>,
        <https://1145.am/db/2323210/5am_Ventures>,
        <https://1145.am/db/2323226/5am_Ventures>,
        <https://1145.am/db/2324195/5am_Ventures>,
        <https://1145.am/db/2328146/5am_Ventures>,
        <https://1145.am/db/2328338/5am_Ventures>,
        <https://1145.am/db/2329778/5am_Ventures>,
        <https://1145.am/db/2332322/5am_Ventures>,
        <https://1145.am/db/2339885/5am_Ventures>,
        <https://1145.am/db/2339886/5am_Ventures>,
        <https://1145.am/db/2340344/5am_Ventures>,
        <https://1145.am/db/2340345/5am_Ventures>,
        <https://1145.am/db/2340348/5am_Ventures>,
        <https://1145.am/db/2341003/5am_Ventures>,
        <https://1145.am/db/2342352/5am_Ventures>,
        <https://1145.am/db/2347885/5am_Ventures>,
        <https://1145.am/db/2348754/5am_Ventures>,
        <https://1145.am/db/2348857/5am_Ventures>,
        <https://1145.am/db/2349120/5am_Ventures>,
        <https://1145.am/db/2349834/5am_Ventures>,
        <https://1145.am/db/2351316/5am_Ventures>,
        <https://1145.am/db/2351683/5am_Ventures>,
        <https://1145.am/db/2351684/5am_Ventures>,
        <https://1145.am/db/2354296/5am_Ventures>,
        <https://1145.am/db/2355238/5am_Ventures>,
        <https://1145.am/db/2359401/5am_Ventures>,
        <https://1145.am/db/2359864/5am_Ventures>,
        <https://1145.am/db/2360174/5am_Ventures>,
        <https://1145.am/db/2360415/5am_Ventures>,
        <https://1145.am/db/2362475/5am_Ventures>,
        <https://1145.am/db/2362481/5am_Ventures>,
        <https://1145.am/db/2364492/5am_Ventures>,
        <https://1145.am/db/2367275/5am_Ventures>,
        <https://1145.am/db/2370609/5am_Ventures>,
        <https://1145.am/db/2371160/5am_Ventures>,
        <https://1145.am/db/2371163/5am_Ventures>,
        <https://1145.am/db/2538476/5am_Ventures>,
        <https://1145.am/db/2569220/5am_Ventures>,
        <https://1145.am/db/2572398/5am_Ventures>,
        <https://1145.am/db/2587596/5am_Ventures>,
        <https://1145.am/db/2592685/5am_Ventures>,
        <https://1145.am/db/359190/5am_Ventures>,
        <https://1145.am/db/428737/5am_Ventures>,
        <https://1145.am/db/509733/5am_Ventures>,
        <https://1145.am/db/558016/5am_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357858/Astellas_Venture_Management> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:documentDate "2011-10-11T13:15:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cleave-biosciences-raises-42-million-series-a-financing-for-novel-cancer-therapies> ;
    ns1:foundName "Astellas Venture Management" ;
    ns1:investor <https://1145.am/db/2357858/Series_A_Investment_5am_Ventures_Astellas_Venture_Management_Clarus_Ventures_Cleave_Biosciences_Orbimed_Advisors_Us_Venture_Partners_Completed> ;
    ns1:name "Astellas Venture Management" ;
    ns1:sameAsMedium <https://1145.am/db/1150529/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/1156304/Astellas_Venture_Management>,
        <https://1145.am/db/1503058/Astellas_Venture_Management>,
        <https://1145.am/db/2073480/Astellas_Venture_Management>,
        <https://1145.am/db/2302731/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/2318733/Astellas_Venture_Management>,
        <https://1145.am/db/2319777/Astellas_Venture_Management>,
        <https://1145.am/db/2320476/Astellas_Venture_Management>,
        <https://1145.am/db/2329125/Astellas_Venture_Management>,
        <https://1145.am/db/2329131/Astellas_Venture_Management>,
        <https://1145.am/db/2358430/Astellas_Venture_Management>,
        <https://1145.am/db/2358657/Astellas_Venture_Management>,
        <https://1145.am/db/2362871/Astellas_Venture_Management>,
        <https://1145.am/db/2365138/Astellas_Venture_Management>,
        <https://1145.am/db/2365748/Astellas_Venture_Management>,
        <https://1145.am/db/2370582/Astellas_Venture_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357858/Us_Venture_Partners> a org:Organization ;
    ns1:basedInHighGeoName "San Francisco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391959/about.rdf> ;
    ns1:basedInHighRaw "SAN FRANCISCO" ;
    ns1:documentDate "2011-10-11T13:15:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cleave-biosciences-raises-42-million-series-a-financing-for-novel-cancer-therapies> ;
    ns1:foundName ".S." ;
    ns1:investor <https://1145.am/db/2357858/Series_A_Investment_5am_Ventures_Astellas_Venture_Management_Clarus_Ventures_Cleave_Biosciences_Orbimed_Advisors_Us_Venture_Partners_Completed> ;
    ns1:name "U.S. Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1147854/Us_Venture_Partners>,
        <https://1145.am/db/1418766/Us_Venture_Partners>,
        <https://1145.am/db/1454909/Us_Venture_Partners>,
        <https://1145.am/db/1681426/Us_Venture_Partners>,
        <https://1145.am/db/1697656/Us_Venture_Partners>,
        <https://1145.am/db/1701580/Us_Venture_Partners>,
        <https://1145.am/db/1710567/Us_Venture_Partners>,
        <https://1145.am/db/1712506/Us_Venture_Partners>,
        <https://1145.am/db/1718048/Us_Venture_Partners>,
        <https://1145.am/db/1725165/Us_Venture_Partners>,
        <https://1145.am/db/1737882/Us_Venture_Partners>,
        <https://1145.am/db/1748970/Us_Venture_Partners>,
        <https://1145.am/db/1758985/Us_Venture_Partners>,
        <https://1145.am/db/1763964/Us_Venture_Partners>,
        <https://1145.am/db/1771750/Us_Venture_Partners>,
        <https://1145.am/db/1787502/Us_Venture_Partners>,
        <https://1145.am/db/1796259/Us_Venture_Partners>,
        <https://1145.am/db/1797905/Us_Venture_Partners>,
        <https://1145.am/db/1812267/Us_Venture_Partners>,
        <https://1145.am/db/1831222/Us_Venture_Partners>,
        <https://1145.am/db/1834392/Us_Venture_Partners>,
        <https://1145.am/db/1842350/Us_Venture_Partners>,
        <https://1145.am/db/1842466/Us_Venture_Partners>,
        <https://1145.am/db/1844571/Us_Venture_Partners>,
        <https://1145.am/db/1845308/Us_Venture_Partners>,
        <https://1145.am/db/1845321/Us_Venture_Partners>,
        <https://1145.am/db/1845924/Us_Venture_Partners>,
        <https://1145.am/db/1846470/Us_Venture_Partners>,
        <https://1145.am/db/1847323/Us_Venture_Partners>,
        <https://1145.am/db/1851689/Us_Venture_Partners>,
        <https://1145.am/db/1852806/Us_Venture_Partners>,
        <https://1145.am/db/1863147/Us_Venture_Partners>,
        <https://1145.am/db/1864900/Us_Venture_Partners>,
        <https://1145.am/db/1867951/Us_Venture_Partners>,
        <https://1145.am/db/1870790/Us_Venture_Partners>,
        <https://1145.am/db/1871784/Us_Venture_Partners>,
        <https://1145.am/db/1877830/Us_Venture_Partners>,
        <https://1145.am/db/1879026/Us_Venture_Partners>,
        <https://1145.am/db/1884155/Us_Venture_Partners>,
        <https://1145.am/db/1895986/Us_Venture_Partners>,
        <https://1145.am/db/1915640/Us_Venture_Partners>,
        <https://1145.am/db/2050254/Us_Venture_Partners>,
        <https://1145.am/db/2150562/Us_Venture_Partners>,
        <https://1145.am/db/2192716/Us_Venture_Partners>,
        <https://1145.am/db/2257512/Us_Venture_Partners>,
        <https://1145.am/db/2278799/Us_Venture_Partners>,
        <https://1145.am/db/2279124/Us_Venture_Partners>,
        <https://1145.am/db/2288251/Us_Venture_Partners>,
        <https://1145.am/db/2288899/Us_Venture_Partners>,
        <https://1145.am/db/2293765/Us_Venture_Partners>,
        <https://1145.am/db/2299776/Us_Venture_Partners>,
        <https://1145.am/db/2301809/Us_Venture_Partners>,
        <https://1145.am/db/2319658/Us_Venture_Partners>,
        <https://1145.am/db/2343206/Us_Venture_Partners>,
        <https://1145.am/db/2358430/Us_Venture_Partners>,
        <https://1145.am/db/2367204/Us_Venture_Partners>,
        <https://1145.am/db/2645160/Us_Venture_Partners>,
        <https://1145.am/db/425262/Us_Venture_Partners>,
        <https://1145.am/db/838691/Us_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358883/Sonosite_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Alpharetta" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4179574/about.rdf> ;
    ns1:basedInHighRaw "ALPHARETTA, Ga." ;
    ns1:documentDate "2012-01-19T16:26:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Carticept Medical Closes $10 Million Series C Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/carticept-medical-closes-10-million-series-c-financing-round> ;
    ns1:foundName "SonoSite, Inc" ;
    ns1:investor <https://1145.am/db/2358883/Investment_Carticept_Medical_Domain_Associates_New_Enterprise_Associates_Sonosite_Inc_Completed> ;
    ns1:name "SonoSite, Inc" ;
    ns1:sameAsMedium <https://1145.am/db/2297596/Sonosite> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358888/First_Round_Capital> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:description "Investing" ;
    ns1:documentDate "2011-10-12T14:14:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DNAnexus Secures $15 Million Funding Led by Google Ventures and TPG Biotech" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dnanexus-secures-15-million-funding-led-by-google-ventures-and-tpg-biotech> ;
    ns1:foundName "First Round Capital" ;
    ns1:investor <https://1145.am/db/2358888/Investment_Dnanexus_Felicis_Ventures_First_Round_Capital_Google_Ventures_K9_Ventures_Softtech_Vc_Tpg_Biotech_Completed> ;
    ns1:name "First Round Capital" ;
    ns1:sameAsHigh <https://1145.am/db/509651/First_Round_Capital>,
        <https://1145.am/db/854351/Initialized_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1022148/First_Round_Capital>,
        <https://1145.am/db/1127018/First_Round_Capital>,
        <https://1145.am/db/1183387/First_Round_Capital>,
        <https://1145.am/db/1342399/First_Round_Capital>,
        <https://1145.am/db/1694241/First_Round_Capital>,
        <https://1145.am/db/1697005/First_Round_Capital>,
        <https://1145.am/db/1699228/First_Round_Capital>,
        <https://1145.am/db/1707512/First_Round_Capital>,
        <https://1145.am/db/1718033/First_Round_Capital>,
        <https://1145.am/db/1720463/First_Round_Capital>,
        <https://1145.am/db/1726149/First_Round_Capital>,
        <https://1145.am/db/1731233/First_Round_Capital>,
        <https://1145.am/db/1732340/First_Round_Capital>,
        <https://1145.am/db/1732969/First_Round_Capital>,
        <https://1145.am/db/1738342/First_Round_Capital>,
        <https://1145.am/db/1738685/First_Round_Capital>,
        <https://1145.am/db/1747873/First_Round_Capital>,
        <https://1145.am/db/1748573/First_Round_Capital>,
        <https://1145.am/db/1753299/First_Round_Capital>,
        <https://1145.am/db/1753949/First_Round_Capital>,
        <https://1145.am/db/1756444/First_Round_Capital>,
        <https://1145.am/db/1756775/First_Round_Capital>,
        <https://1145.am/db/1773402/First_Round_Capital>,
        <https://1145.am/db/1788532/First_Round_Capital>,
        <https://1145.am/db/1791642/First_Round_Capital>,
        <https://1145.am/db/1799250/First_Round_Capital>,
        <https://1145.am/db/1802086/First_Round_Capital>,
        <https://1145.am/db/1802794/First_Round_Capital>,
        <https://1145.am/db/1803056/First_Round_Capital>,
        <https://1145.am/db/1810077/First_Round_Capital>,
        <https://1145.am/db/1813348/First_Round_Capital>,
        <https://1145.am/db/1824282/First_Round_Capital>,
        <https://1145.am/db/1825516/First_Round_Capital>,
        <https://1145.am/db/1825744/First_Round_Capital>,
        <https://1145.am/db/1826012/First_Round_Capital>,
        <https://1145.am/db/1827884/First_Round_Capital>,
        <https://1145.am/db/1828658/First_Round_Capital>,
        <https://1145.am/db/1828663/First_Round_Capital>,
        <https://1145.am/db/1830647/First_Round_Capital>,
        <https://1145.am/db/1836676/First_Round_Capital>,
        <https://1145.am/db/1836984/First_Round_Capital>,
        <https://1145.am/db/1839441/First_Round_Capital>,
        <https://1145.am/db/1839574/First_Round_Capital>,
        <https://1145.am/db/1840250/First_Round_Capital>,
        <https://1145.am/db/1841111/First_Round_Capital>,
        <https://1145.am/db/1844180/First_Round_Capital>,
        <https://1145.am/db/1846785/First_Round_Capital>,
        <https://1145.am/db/1848109/First_Round_Capital>,
        <https://1145.am/db/1848365/First_Round_Capital>,
        <https://1145.am/db/1851475/First_Round_Capital>,
        <https://1145.am/db/1852278/First_Round_Capital>,
        <https://1145.am/db/1854668/First_Round_Capital>,
        <https://1145.am/db/1854797/First_Round_Capital>,
        <https://1145.am/db/1855458/First_Round_Capital>,
        <https://1145.am/db/1855475/First_Round_Capital>,
        <https://1145.am/db/1856424/First_Round_Capital>,
        <https://1145.am/db/1857105/First_Round_Capital>,
        <https://1145.am/db/1857306/First_Round_Capital>,
        <https://1145.am/db/1858995/First_Round_Capital>,
        <https://1145.am/db/1860868/First_Round_Capital>,
        <https://1145.am/db/1861858/First_Round_Capital>,
        <https://1145.am/db/1864594/First_Round_Capital>,
        <https://1145.am/db/1866404/First_Round_Capital>,
        <https://1145.am/db/1870118/First_Round_Capital>,
        <https://1145.am/db/1871047/First_Round_Capital>,
        <https://1145.am/db/1871814/First_Round_Capital>,
        <https://1145.am/db/1876483/First_Round_Capital>,
        <https://1145.am/db/1877243/First_Round_Capital>,
        <https://1145.am/db/1879113/First_Round_Capital>,
        <https://1145.am/db/1882330/First_Round_Capital>,
        <https://1145.am/db/1882598/First_Round_Capital>,
        <https://1145.am/db/1884349/First_Round_Capital>,
        <https://1145.am/db/1884908/First_Round_Capital>,
        <https://1145.am/db/1891814/First_Round_Capital>,
        <https://1145.am/db/1893956/First_Round_Capital>,
        <https://1145.am/db/1896364/First_Round_Capital>,
        <https://1145.am/db/1898789/First_Round_Capital>,
        <https://1145.am/db/1906922/First_Round_Capital>,
        <https://1145.am/db/1911840/First_Round_Capital>,
        <https://1145.am/db/1915640/First_Round_Capital>,
        <https://1145.am/db/1916584/First_Round_Capital>,
        <https://1145.am/db/1917567/First_Round_Capital>,
        <https://1145.am/db/1919724/First_Round_Capital>,
        <https://1145.am/db/1921374/First_Round_Capital>,
        <https://1145.am/db/1922138/First_Round_Capital>,
        <https://1145.am/db/1926024/First_Round_Capital>,
        <https://1145.am/db/2006781/First_Round_Capital>,
        <https://1145.am/db/2017304/First_Round_Capital>,
        <https://1145.am/db/2060462/First_Round_Capital>,
        <https://1145.am/db/2068430/First_Round_Capital>,
        <https://1145.am/db/2153004/First_Round_Capital>,
        <https://1145.am/db/2184802/First_Round_Capital>,
        <https://1145.am/db/2308700/First_Round_Capital>,
        <https://1145.am/db/2342724/First_Round_Capital>,
        <https://1145.am/db/2430630/First_Round_Capital>,
        <https://1145.am/db/2649404/First_Round_Capital>,
        <https://1145.am/db/348633/First_Round_Capital>,
        <https://1145.am/db/460548/First_Round_Capital>,
        <https://1145.am/db/474928/First_Round_Capital>,
        <https://1145.am/db/694272/First_Round_Capital>,
        <https://1145.am/db/768089/First_Round_Capital>,
        <https://1145.am/db/840680/First_Round_Capital>,
        <https://1145.am/db/854795/First_Round_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358888/Softtech_Vc> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:description "financing" ;
    ns1:documentDate "2011-10-12T14:14:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DNAnexus Secures $15 Million Funding Led by Google Ventures and TPG Biotech" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dnanexus-secures-15-million-funding-led-by-google-ventures-and-tpg-biotech> ;
    ns1:foundName "SoftTech VC" ;
    ns1:investor <https://1145.am/db/2358888/Investment_Dnanexus_Felicis_Ventures_First_Round_Capital_Google_Ventures_K9_Ventures_Softtech_Vc_Tpg_Biotech_Completed> ;
    ns1:name "SoftTech VC" ;
    ns1:sameAsHigh <https://1145.am/db/1748731/Softbank>,
        <https://1145.am/db/1766871/Softbank>,
        <https://1145.am/db/1769550/Softbank>,
        <https://1145.am/db/1776414/Softbank_Group>,
        <https://1145.am/db/1824805/Softtech_Vc>,
        <https://1145.am/db/1830762/Softbank_Capital>,
        <https://1145.am/db/1837950/Softbank_Capital>,
        <https://1145.am/db/1850306/Softbank_Capital>,
        <https://1145.am/db/1860137/Softbank_Capital>,
        <https://1145.am/db/2264763/Softbank_Capital>,
        <https://1145.am/db/2337135/Puretech_Ventures>,
        <https://1145.am/db/2634818/Softbank_Capital>,
        <https://1145.am/db/366024/Softbank_Group_Corp>,
        <https://1145.am/db/368673/Softbank>,
        <https://1145.am/db/368676/Softbank>,
        <https://1145.am/db/369042/Softbank>,
        <https://1145.am/db/513473/Softbank_Group>,
        <https://1145.am/db/544649/Softbank_Group_Corp>,
        <https://1145.am/db/559220/Softbank>,
        <https://1145.am/db/799047/Softbank>,
        <https://1145.am/db/799292/Softbank>,
        <https://1145.am/db/813667/Softbank>,
        <https://1145.am/db/905614/Softbank_Group_Corp> ;
    ns1:sameAsMedium <https://1145.am/db/1780131/Softtech_Vc>,
        <https://1145.am/db/1793825/Softtech_Vc>,
        <https://1145.am/db/1799099/Softtech_Vc>,
        <https://1145.am/db/1799102/Softtech_Vc>,
        <https://1145.am/db/1806080/Softtech_Vc>,
        <https://1145.am/db/1826683/Softtech_Vc>,
        <https://1145.am/db/1846129/Softtech_Vc>,
        <https://1145.am/db/1846483/Softtech_Vc>,
        <https://1145.am/db/1849669/Softtech_Vc>,
        <https://1145.am/db/1850530/Softtech_Vc>,
        <https://1145.am/db/1851705/Softtech_Vc>,
        <https://1145.am/db/1857930/Softtech_Vc>,
        <https://1145.am/db/1898265/Softtech_Vc>,
        <https://1145.am/db/1901653/Softtech_Vc>,
        <https://1145.am/db/1915118/Softtech_Vc>,
        <https://1145.am/db/1917676/Softtech_Vc>,
        <https://1145.am/db/1922138/Softtech_Vc>,
        <https://1145.am/db/2210557/Softtech_Vc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359960/Sofinnova_Partners> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-10-17T11:54:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Hookipa Biotech Closes €7 million Series A Financing led by Sofinnova Partners" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/hookipa-biotech-closes-%E2%82%AC7-million-series-a-financing-led-by-sofinnova-partners> ;
    ns1:foundName "Sofinnova Partners" ;
    ns1:investor <https://1145.am/db/2359960/Series_A_Investment_Forbion_Capital_Partners_Hookipa_Biotech_Sofinnova_Partners_Completed> ;
    ns1:name "Sofinnova Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1006252/Menlo_Ventures>,
        <https://1145.am/db/1006262/Com_Prelude_Ventures>,
        <https://1145.am/db/1006574/Integr8d_Capital>,
        <https://1145.am/db/1006880/Root_Ventures>,
        <https://1145.am/db/1007193/Capital_One_Ventures>,
        <https://1145.am/db/1007527/Integr8d_Capital>,
        <https://1145.am/db/1008085/Root_Ventures>,
        <https://1145.am/db/1008260/Servicenow_Ventures>,
        <https://1145.am/db/1010064/Greatpoint_Ventures>,
        <https://1145.am/db/1010064/Maverick_Ventures>,
        <https://1145.am/db/1010199/One9_Ventures>,
        <https://1145.am/db/102038/Allegion_Ventures>,
        <https://1145.am/db/102038/Pathbreaker_Ventures>,
        <https://1145.am/db/102038/West_Ventures>,
        <https://1145.am/db/1023252/Digitalbridge_Ventures>,
        <https://1145.am/db/1024247/Digitalbridge_Ventures>,
        <https://1145.am/db/1024483/Investbridge_Capital>,
        <https://1145.am/db/1026319/Able_Partners>,
        <https://1145.am/db/1034591/Valia_Ventures>,
        <https://1145.am/db/1041601/Kineo_Finance>,
        <https://1145.am/db/1042250/Kineo_Finance>,
        <https://1145.am/db/1043051/Sequoia_Capital>,
        <https://1145.am/db/1043259/Sequoia_Capital>,
        <https://1145.am/db/1043342/Root_Ventures>,
        <https://1145.am/db/1043516/Kineo_Finance>,
        <https://1145.am/db/1045242/Dipalo_Ventures>,
        <https://1145.am/db/1045384/Sequoia_Capital>,
        <https://1145.am/db/1051115/Dn_Capital>,
        <https://1145.am/db/1051644/Vestigo_Ventures>,
        <https://1145.am/db/1052155/Gate_Ventures>,
        <https://1145.am/db/1059993/Tera_Ventures>,
        <https://1145.am/db/1060146/Ulu_Ventures>,
        <https://1145.am/db/1061824/Bluebird_Ventures>,
        <https://1145.am/db/1061911/Ulu_Ventures>,
        <https://1145.am/db/1065366/Applied_Ventures_Llc>,
        <https://1145.am/db/1065544/Menlo_Ventures>,
        <https://1145.am/db/1066120/Crosslink_Capital>,
        <https://1145.am/db/1081175/Rse_Ventures>,
        <https://1145.am/db/1081490/Vinco_Ventures>,
        <https://1145.am/db/1081888/Ggv_Capital>,
        <https://1145.am/db/1082613/Rse_Ventures>,
        <https://1145.am/db/1082719/Dorilton_Ventures>,
        <https://1145.am/db/1082814/Cathexis_Ventures>,
        <https://1145.am/db/1082814/Promus_Ventures>,
        <https://1145.am/db/1082814/Type_One_Ventures>,
        <https://1145.am/db/1084014/Ret_Ventures>,
        <https://1145.am/db/1085867/Ret_Ventures>,
        <https://1145.am/db/1086604/Alerion_Ventures>,
        <https://1145.am/db/1086673/Wintrust_Ventures>,
        <https://1145.am/db/1089416/Nexo_Ventures>,
        <https://1145.am/db/1090643/Argon_Ventures>,
        <https://1145.am/db/1090643/Glasswing_Ventures>,
        <https://1145.am/db/1101244/Acequia_Capital>,
        <https://1145.am/db/1103270/Acequia_Capital>,
        <https://1145.am/db/1106082/Northpond_Ventures>,
        <https://1145.am/db/1106670/Sequoia_Capital>,
        <https://1145.am/db/1111505/Nissay_Capital>,
        <https://1145.am/db/1111505/Remiges_Ventures>,
        <https://1145.am/db/1112074/Nissay_Capital>,
        <https://1145.am/db/1112074/Remiges_Ventures>,
        <https://1145.am/db/1114979/Catapult_Ventures>,
        <https://1145.am/db/1115103/Northpond_Ventures>,
        <https://1145.am/db/1119456/Truist_Ventures>,
        <https://1145.am/db/1119699/Prelude_Ventures>,
        <https://1145.am/db/1120030/Morpheus_Ventures>,
        <https://1145.am/db/1120030/Point72_Ventures>,
        <https://1145.am/db/1120071/Morpheus_Ventures>,
        <https://1145.am/db/1120071/Point72_Ventures>,
        <https://1145.am/db/1122750/Prelude_Ventures>,
        <https://1145.am/db/1129561/Redbeard_Ventures>,
        <https://1145.am/db/1130744/Redbeard_Ventures>,
        <https://1145.am/db/1133003/Sequoia_Capital>,
        <https://1145.am/db/1134165/Boldstart_Ventures>,
        <https://1145.am/db/1136173/Boldstart_Ventures>,
        <https://1145.am/db/1137178/CRV>,
        <https://1145.am/db/1138154/Ggv_Capital>,
        <https://1145.am/db/1139703/Industry_Ventures>,
        <https://1145.am/db/1140286/Origin_Ventures>,
        <https://1145.am/db/1141736/Redpoint_Ventures>,
        <https://1145.am/db/1150154/Riv_Capital>,
        <https://1145.am/db/1150529/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/1150529/Solasta_Ventures>,
        <https://1145.am/db/1151328/Index_Ventures>,
        <https://1145.am/db/1151736/True_Ventures>,
        <https://1145.am/db/1152929/Aperiamventures>,
        <https://1145.am/db/1153706/Index_Ventures>,
        <https://1145.am/db/1154242/True_Ventures>,
        <https://1145.am/db/1163139/Sentiero_Ventures>,
        <https://1145.am/db/1163139/Skyriver_Ventures>,
        <https://1145.am/db/1164299/Lavrock_Ventures>,
        <https://1145.am/db/1164299/Progress_Ventures>,
        <https://1145.am/db/1164688/Abstract_Ventures>,
        <https://1145.am/db/1164688/Spacecadet_Ventures>,
        <https://1145.am/db/1164845/Lavrock_Ventures>,
        <https://1145.am/db/1164845/Progress_Ventures>,
        <https://1145.am/db/1165515/G2_Group_Ventures>,
        <https://1145.am/db/1166154/Allos_Ventures>,
        <https://1145.am/db/1166957/Seedil_Ventures>,
        <https://1145.am/db/1168757/Accomplice_Ventures>,
        <https://1145.am/db/1169687/Artiman_Ventures>,
        <https://1145.am/db/1169687/J_Ventures>,
        <https://1145.am/db/1169687/Nd_Capital>,
        <https://1145.am/db/1169815/Accomplice_Ventures>,
        <https://1145.am/db/1170971/Equinor_Ventures>,
        <https://1145.am/db/1173428/Equinor_Ventures>,
        <https://1145.am/db/1175576/Divcowest_Ventures>,
        <https://1145.am/db/1175576/Point72_Ventures>,
        <https://1145.am/db/1175576/Signia_Ventures>,
        <https://1145.am/db/1176018/First_Star_Ventures>,
        <https://1145.am/db/1187600/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/11887/Adv>,
        <https://1145.am/db/1190097/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/1190127/Animo_Ventures>,
        <https://1145.am/db/1190127/Chaac_Ventures>,
        <https://1145.am/db/1190127/Ulu_Ventures>,
        <https://1145.am/db/1196068/Arthur_Ventures>,
        <https://1145.am/db/1196728/Greatpoint_Ventures>,
        <https://1145.am/db/1199177/Greatpoint_Ventures>,
        <https://1145.am/db/1199182/Boxone_Ventures>,
        <https://1145.am/db/1202673/Basecamp_Ventures>,
        <https://1145.am/db/1203180/Basecamp_Ventures>,
        <https://1145.am/db/1206820/Tenoneten_Ventures>,
        <https://1145.am/db/1208519/Tappanhill_Ventures>,
        <https://1145.am/db/1208749/Industry_Ventures>,
        <https://1145.am/db/1208749/Keshif_Ventures>,
        <https://1145.am/db/1208749/Tenoneten_Ventures>,
        <https://1145.am/db/1213076/Equinor_Ventures>,
        <https://1145.am/db/1213076/Scf_Ventures>,
        <https://1145.am/db/1213119/Nevcaut_Ventures>,
        <https://1145.am/db/1215930/Northpond_Ventures>,
        <https://1145.am/db/1219982/Soma_Ventures>,
        <https://1145.am/db/1221237/C2_Ventures>,
        <https://1145.am/db/1222789/Glasswing_Ventures>,
        <https://1145.am/db/1232497/Droia_Ventures>,
        <https://1145.am/db/1232497/Gv>,
        <https://1145.am/db/1233314/Citta_Capital>,
        <https://1145.am/db/1236549/Adit_Ventures>,
        <https://1145.am/db/1247755/Sinewave_Ventures>,
        <https://1145.am/db/1247761/Clear_Ventures>,
        <https://1145.am/db/1248631/Sinewave_Ventures>,
        <https://1145.am/db/1252447/Gaingels>,
        <https://1145.am/db/1256269/Ampd_Ventures_Inc>,
        <https://1145.am/db/1264028/K3_Ventures>,
        <https://1145.am/db/1264587/Index_Ventures>,
        <https://1145.am/db/1268150/Pender_Ventures>,
        <https://1145.am/db/1269968/Abstract_Ventures>,
        <https://1145.am/db/1272468/Launchpad_Capital>,
        <https://1145.am/db/1279264/Roosh_Ventures>,
        <https://1145.am/db/1281079/Morgenthaler_Ventures>,
        <https://1145.am/db/1281647/Morgenthaler_Ventures>,
        <https://1145.am/db/1282820/Agya_Ventures>,
        <https://1145.am/db/1286872/Morevc>,
        <https://1145.am/db/1287476/Felicis_Ventures>,
        <https://1145.am/db/1297417/Bitkraft_Ventures>,
        <https://1145.am/db/1299578/Seedtob_Capital>,
        <https://1145.am/db/1307620/Inventus_Capital_Partners>,
        <https://1145.am/db/1311917/Avid_Ventures>,
        <https://1145.am/db/1311917/Canapi_Ventures>,
        <https://1145.am/db/1322441/Solana_Ventures>,
        <https://1145.am/db/1326376/Dexcom_Ventures>,
        <https://1145.am/db/1329887/Peter_Nagar>,
        <https://1145.am/db/1331691/Pelion_Ventures>,
        <https://1145.am/db/1332798/Acrobator_Ventures>,
        <https://1145.am/db/1334186/First_Ascent_Ventures>,
        <https://1145.am/db/1334193/Version_One_Ventures>,
        <https://1145.am/db/1334395/Gv>,
        <https://1145.am/db/1334895/Soleus_Capital>,
        <https://1145.am/db/1335073/Yl_Ventures>,
        <https://1145.am/db/1335080/Dorilton_Ventures>,
        <https://1145.am/db/1344240/Neotribe_Ventures>,
        <https://1145.am/db/1352420/Vamos_Ventures>,
        <https://1145.am/db/1353145/Infinity_Ventures>,
        <https://1145.am/db/1362743/Cobalt_Ventures>,
        <https://1145.am/db/1373683/BGV>,
        <https://1145.am/db/1375916/J2_Ventures>,
        <https://1145.am/db/1376353/J2_Ventures>,
        <https://1145.am/db/1378599/Menlo_Ventures>,
        <https://1145.am/db/1381832/Northpond_Ventures>,
        <https://1145.am/db/1382787/Northpond_Ventures>,
        <https://1145.am/db/1383818/Newlin_Ventures>,
        <https://1145.am/db/1387557/Naventures>,
        <https://1145.am/db/138878/Metacartel_Ventures>,
        <https://1145.am/db/1398057/Owen_Van_Natta_Temaris___Associates>,
        <https://1145.am/db/1398917/Trousdale_Ventures>,
        <https://1145.am/db/1407553/Sequoia_Capital>,
        <https://1145.am/db/1407614/C2_Ventures>,
        <https://1145.am/db/1411289/Sequoia_Capital>,
        <https://1145.am/db/1411934/Riptide_Ventures>,
        <https://1145.am/db/1425749/Menlo_Ventures>,
        <https://1145.am/db/1425749/Se_Ventures>,
        <https://1145.am/db/1433429/Crosslink_Capital>,
        <https://1145.am/db/1445378/Mvp_Ventures>,
        <https://1145.am/db/1445935/Verissimo_Ventures>,
        <https://1145.am/db/1449316/+Nd_Capital>,
        <https://1145.am/db/1449740/Mistral_Ventures>,
        <https://1145.am/db/1452107/Abstract_Ventures>,
        <https://1145.am/db/1455216/Engage_Ventures>,
        <https://1145.am/db/1455616/Abstract_Ventures>,
        <https://1145.am/db/1463829/1sharpe_Ventures>,
        <https://1145.am/db/1467693/Preseed_Ventures>,
        <https://1145.am/db/1467892/M_Ventures>,
        <https://1145.am/db/1467932/Sequoia_Capital_Gv>,
        <https://1145.am/db/1468981/Preseed_Ventures>,
        <https://1145.am/db/1476448/Origin_Ventures>,
        <https://1145.am/db/1480152/True_Ventures>,
        <https://1145.am/db/1480651/Glasswing_Ventures>,
        <https://1145.am/db/1480989/Infinity_Ventures>,
        <https://1145.am/db/1481875/Infinity_Ventures>,
        <https://1145.am/db/1482705/Oif_Ventures>,
        <https://1145.am/db/1484103/Boxone_Ventures>,
        <https://1145.am/db/1484857/Iu_Ventures>,
        <https://1145.am/db/1488858/Alkeon_Capital>,
        <https://1145.am/db/1490126/Seedtob_Capital>,
        <https://1145.am/db/1490183/Sofinnova_Partners>,
        <https://1145.am/db/1490978/Seedtob_Capital>,
        <https://1145.am/db/1492889/Future_Ventures>,
        <https://1145.am/db/1492889/Radical_Ventures>,
        <https://1145.am/db/1494028/Alkeon_Capital>,
        <https://1145.am/db/1496360/Realist_Ventures>,
        <https://1145.am/db/1503768/Nevateam_Partners>,
        <https://1145.am/db/1508325/Aramco_Ventures>,
        <https://1145.am/db/1509462/F7_Ventures>,
        <https://1145.am/db/1512891/Acme_Capital>,
        <https://1145.am/db/1515109/Cmfg_Ventures>,
        <https://1145.am/db/1515916/Sequoia_Capital>,
        <https://1145.am/db/1520070/Menlo_Ventures>,
        <https://1145.am/db/1520070/Northpond_Ventures>,
        <https://1145.am/db/1520772/January_Ventures>,
        <https://1145.am/db/1537166/Catalio_Capital_Management>,
        <https://1145.am/db/1537970/Catalio_Capital_Management>,
        <https://1145.am/db/1541308/Panoramic_Ventures>,
        <https://1145.am/db/1541797/G1_Ventures>,
        <https://1145.am/db/1545833/Alerion_Ventures>,
        <https://1145.am/db/1545994/Noemis_Ventures>,
        <https://1145.am/db/1546945/Alerion_Ventures>,
        <https://1145.am/db/1546965/Citi_Ventures>,
        <https://1145.am/db/1546965/Truist_Ventures>,
        <https://1145.am/db/1547281/Noemis_Ventures>,
        <https://1145.am/db/1548592/Gopoint_Ventures>,
        <https://1145.am/db/1556397/Dnx_Ventures>,
        <https://1145.am/db/1556442/C16_Ventures>,
        <https://1145.am/db/1557877/Embark_Ventures>,
        <https://1145.am/db/1559824/Embark_Ventures>,
        <https://1145.am/db/1560704/Breaktrail_Ventures>,
        <https://1145.am/db/1563623/Amex_Ventures>,
        <https://1145.am/db/1564049/Amex_Ventures>,
        <https://1145.am/db/1571330/Seae_Ventures>,
        <https://1145.am/db/1571330/Venturesouth>,
        <https://1145.am/db/1572216/Seae_Ventures>,
        <https://1145.am/db/1572216/Venturesouth>,
        <https://1145.am/db/1574557/True_Ventures>,
        <https://1145.am/db/1574647/Vanterra_Ventures>,
        <https://1145.am/db/1575612/Interlace_Ventures>,
        <https://1145.am/db/1575612/Valia_Ventures>,
        <https://1145.am/db/1578178/N49p>,
        <https://1145.am/db/1578178/Naventures>,
        <https://1145.am/db/1578327/Crit_Ventures>,
        <https://1145.am/db/1578327/Nextview_Ventures>,
        <https://1145.am/db/1579770/Schams_Ventures>,
        <https://1145.am/db/1579792/Crit_Ventures>,
        <https://1145.am/db/1579792/Nextview_Ventures>,
        <https://1145.am/db/1580468/Cohort_Ventures>,
        <https://1145.am/db/1582024/Avalon_Ventures>,
        <https://1145.am/db/1582111/Forepont_Capital_Partners>,
        <https://1145.am/db/1583413/Navigare_Ventures>,
        <https://1145.am/db/1615195/Digitalis_Ventures>,
        <https://1145.am/db/1616990/Digitalis_Ventures>,
        <https://1145.am/db/1632002/Catalio_Capital_Management>,
        <https://1145.am/db/1632028/Catalio_Capital_Management>,
        <https://1145.am/db/1632131/Catalio_Capital_Management>,
        <https://1145.am/db/1632156/Catalio_Capital_Management>,
        <https://1145.am/db/1638640/1digi_Ventures>,
        <https://1145.am/db/1649691/Sequoia_Capital>,
        <https://1145.am/db/1653506/Ascendum_Capital>,
        <https://1145.am/db/1653506/Citta_Capital>,
        <https://1145.am/db/1653506/Morgenthaler_Ventures>,
        <https://1145.am/db/1664837/Civilization_Ventures>,
        <https://1145.am/db/1664948/Dreamit_Ventures>,
        <https://1145.am/db/1669908/Aviso_Ventures>,
        <https://1145.am/db/1670128/Primary_Ventures>,
        <https://1145.am/db/1676513/Connect_Ventures>,
        <https://1145.am/db/1685482/Lavrock_Ventures>,
        <https://1145.am/db/1690703/Arkam_Ventures>,
        <https://1145.am/db/1690703/Prosus_Ventures>,
        <https://1145.am/db/1691060/Veblen_Ventures>,
        <https://1145.am/db/1691364/Ts_Ventures>,
        <https://1145.am/db/1693592/Cventures>,
        <https://1145.am/db/1693668/Sunny_Side_Ventures>,
        <https://1145.am/db/1693981/Boldstart_Ventures>,
        <https://1145.am/db/1694241/True_Ventures>,
        <https://1145.am/db/1694301/Dn_Capital>,
        <https://1145.am/db/1694417/Sequoia_Capital>,
        <https://1145.am/db/1694448/Presidio_Ventures>,
        <https://1145.am/db/1694592/Credo_Ventures>,
        <https://1145.am/db/1694592/Susa_Ventures>,
        <https://1145.am/db/1694798/Udc_Ventures>,
        <https://1145.am/db/1694947/Intersouth_Partners>,
        <https://1145.am/db/1695849/Salesforce_Ventures>,
        <https://1145.am/db/1695885/True_Ventures>,
        <https://1145.am/db/1697044/Palomar_Ventures>,
        <https://1145.am/db/1697044/Sequoia_Capital>,
        <https://1145.am/db/1697373/Lerer_Ventures>,
        <https://1145.am/db/1697910/Entrepia_Ventures>,
        <https://1145.am/db/1697910/Innovacom>,
        <https://1145.am/db/1698516/Engage_Ventures>,
        <https://1145.am/db/1698516/Tyh_Ventures>,
        <https://1145.am/db/1698644/Inovia_Capital>,
        <https://1145.am/db/1699263/Contour_Venture_Partners>,
        <https://1145.am/db/1700565/Sequoia_Capital>,
        <https://1145.am/db/1700572/Contour_Venture_Partners>,
        <https://1145.am/db/1701414/Sequoia_Capital>,
        <https://1145.am/db/1702003/Ventures_West>,
        <https://1145.am/db/1702065/Kreos_Capital>,
        <https://1145.am/db/1702472/Chiratae_Ventures>,
        <https://1145.am/db/1702483/Sure_Ventures_Usvp>,
        <https://1145.am/db/1702517/Prime_Ventures>,
        <https://1145.am/db/1702871/Charles_River_Ventures>,
        <https://1145.am/db/1703120/Point72_Ventures>,
        <https://1145.am/db/1703551/People_Ventures>,
        <https://1145.am/db/1703907/T-Venture>,
        <https://1145.am/db/1704404/True_Ventures>,
        <https://1145.am/db/1704740/T-Venture>,
        <https://1145.am/db/1704842/Se_Ventures>,
        <https://1145.am/db/1704871/Yl_Ventures>,
        <https://1145.am/db/1705825/Ventures_Platform>,
        <https://1145.am/db/1707227/Schams_Ventures>,
        <https://1145.am/db/1707540/Prosus_Ventures>,
        <https://1145.am/db/1707567/Contour_Venture_Partners>,
        <https://1145.am/db/1707567/Reign_Ventures>,
        <https://1145.am/db/1707637/Resolute_Ventures>,
        <https://1145.am/db/1707736/Artiman_Ventures>,
        <https://1145.am/db/1708555/20vc>,
        <https://1145.am/db/1708903/Kaedan_Capital>,
        <https://1145.am/db/1709168/Morgenthaler_Ventures>,
        <https://1145.am/db/1710027/Contour_Venture_Partners>,
        <https://1145.am/db/1711208/Sequoia_Capital>,
        <https://1145.am/db/1711383/Aviso_Ventures>,
        <https://1145.am/db/1711383/Pelion_Ventures>,
        <https://1145.am/db/1711750/Index_Ventures>,
        <https://1145.am/db/1711790/CRV>,
        <https://1145.am/db/1711849/K20_Ventures>,
        <https://1145.am/db/1712471/Cervin_Ventures>,
        <https://1145.am/db/1713712/Grotech_Ventures>,
        <https://1145.am/db/1714098/Charles_River_Ventures>,
        <https://1145.am/db/1714148/Ulu_Ventures>,
        <https://1145.am/db/1714624/Abstract_Ventures>,
        <https://1145.am/db/1714630/January_Ventures>,
        <https://1145.am/db/1716124/Appian_Ventures>,
        <https://1145.am/db/1716168/Onset_Ventures>,
        <https://1145.am/db/1716667/Dag_Ventures>,
        <https://1145.am/db/1717317/Index_Ventures>,
        <https://1145.am/db/1718012/Dag_Ventures>,
        <https://1145.am/db/1718012/Presidio_Ventures>,
        <https://1145.am/db/1718018/Ggv_Capital>,
        <https://1145.am/db/1718081/Jafco_Ventures>,
        <https://1145.am/db/1718748/Truist_Ventures>,
        <https://1145.am/db/1718787/J_Ventures>,
        <https://1145.am/db/1719362/True_Ventures>,
        <https://1145.am/db/1719370/Bv_Capital>,
        <https://1145.am/db/1720145/Bessemer_Ventures>,
        <https://1145.am/db/1720182/Convivialité_Ventures>,
        <https://1145.am/db/1720441/Origin_Ventures>,
        <https://1145.am/db/1721171/Citi_Ventures>,
        <https://1145.am/db/1721392/Redpoint_Ventures>,
        <https://1145.am/db/1721393/Trinity_Ventures>,
        <https://1145.am/db/1721548/Ggv_Capital>,
        <https://1145.am/db/1721548/Menlo_Ventures>,
        <https://1145.am/db/1722252/Onset_Ventures>,
        <https://1145.am/db/1723165/Menlo_Ventures>,
        <https://1145.am/db/1723664/T-Venture>,
        <https://1145.am/db/1723932/Citi_Ventures>,
        <https://1145.am/db/1724979/Jafco_Ventures>,
        <https://1145.am/db/1724979/Sequoia_Capital>,
        <https://1145.am/db/1725680/Index_Ventures>,
        <https://1145.am/db/1726088/Zeev_Ventures>,
        <https://1145.am/db/1726121/Index_Ventures>,
        <https://1145.am/db/1726149/Index_Ventures>,
        <https://1145.am/db/1726544/Ei_Ventures>,
        <https://1145.am/db/1727288/Sozo_Ventures>,
        <https://1145.am/db/1728569/Redpoint_Ventures>,
        <https://1145.am/db/1729186/Catamount_Ventures>,
        <https://1145.am/db/1731187/Rho_Ventures>,
        <https://1145.am/db/1731419/Redpoint_Ventures>,
        <https://1145.am/db/1734104/Alpana_Ventures>,
        <https://1145.am/db/1734104/Highsage_Ventures>,
        <https://1145.am/db/1734728/Talis_Capital>,
        <https://1145.am/db/1735194/Eqt_Ventures>,
        <https://1145.am/db/1735248/Corigin_Ventures>,
        <https://1145.am/db/1735726/Nextview_Ventures>,
        <https://1145.am/db/1735755/Firebolt_Ventures>,
        <https://1145.am/db/1735774/Alpha4_Ventures>,
        <https://1145.am/db/1736136/Ggv_Capital>,
        <https://1145.am/db/1737278/Crosslink_Capital>,
        <https://1145.am/db/1737392/Moxxie_Ventures>,
        <https://1145.am/db/1737979/CRV>,
        <https://1145.am/db/1738162/3one4_Capital>,
        <https://1145.am/db/1738300/Chryscapital>,
        <https://1145.am/db/1738415/Capnamic_Ventures>,
        <https://1145.am/db/1738444/Prosus_Ventures>,
        <https://1145.am/db/1738776/Illuminate_Ventures>,
        <https://1145.am/db/1739022/Eventures>,
        <https://1145.am/db/1739042/Experior_Venture_Fund>,
        <https://1145.am/db/1739064/Jsw_Ventures>,
        <https://1145.am/db/1739106/Sequoia_Capital>,
        <https://1145.am/db/1739120/Sequoia_Capital>,
        <https://1145.am/db/1739285/Sequoia_Capital>,
        <https://1145.am/db/1739630/Redsea_Ventures>,
        <https://1145.am/db/1739719/Seedplus>,
        <https://1145.am/db/1739851/Signum_Capital>,
        <https://1145.am/db/1739909/Root_Ventures>,
        <https://1145.am/db/1739946/Dn_Capital>,
        <https://1145.am/db/1740077/3one4_Capital>,
        <https://1145.am/db/1740665/First_Bridge_Ventures>,
        <https://1145.am/db/1740832/J_Ventures>,
        <https://1145.am/db/1740832/Susa_Ventures>,
        <https://1145.am/db/1740859/Ggv_Capital>,
        <https://1145.am/db/1741357/Dn_Capital>,
        <https://1145.am/db/1741575/Addventure>,
        <https://1145.am/db/1741635/Zeev_Ventures>,
        <https://1145.am/db/1742267/Firebolt_Ventures>,
        <https://1145.am/db/1742267/Point72_Ventures>,
        <https://1145.am/db/1743271/Liil_Ventures>,
        <https://1145.am/db/1743348/Felicis_Ventures>,
        <https://1145.am/db/1743409/Dreamit_Ventures>,
        <https://1145.am/db/1743737/Regah_Ventures>,
        <https://1145.am/db/1744229/R7>,
        <https://1145.am/db/1744775/Point72_Ventures>,
        <https://1145.am/db/1744864/Sequoia_Capital>,
        <https://1145.am/db/1744922/Aglaé_Ventures>,
        <https://1145.am/db/1745326/Eqt_Ventures>,
        <https://1145.am/db/1745326/Lios_Ventures>,
        <https://1145.am/db/1745326/Prime_Ventures>,
        <https://1145.am/db/1745746/Garuda_Ventures>,
        <https://1145.am/db/1745746/Starling_Ventures>,
        <https://1145.am/db/1745920/Sequoia_Capital>,
        <https://1145.am/db/1747252/Citi_Ventures>,
        <https://1145.am/db/1747391/Sequoia_Capital>,
        <https://1145.am/db/1747400/Eqt_Ventures>,
        <https://1145.am/db/1747503/Brighteye_Ventures>,
        <https://1145.am/db/1747722/Shinhan_Capital>,
        <https://1145.am/db/1747943/Altai_Ventures>,
        <https://1145.am/db/1748417/Zeev_Ventures>,
        <https://1145.am/db/1749226/Dn_Capital>,
        <https://1145.am/db/1749425/Ac_Ventures>,
        <https://1145.am/db/1749651/Colle_Capital>,
        <https://1145.am/db/1749911/Khwarizmi_Ventures>,
        <https://1145.am/db/1750942/Celesta_Capital>,
        <https://1145.am/db/1750942/Chiratae_Ventures>,
        <https://1145.am/db/1751135/Inovia_Capital>,
        <https://1145.am/db/1751312/Abstract_Ventures>,
        <https://1145.am/db/1751361/Kreos_Capital>,
        <https://1145.am/db/1751506/Ggv_Capital>,
        <https://1145.am/db/1751551/Gaingels>,
        <https://1145.am/db/1751553/Canapi_Ventures>,
        <https://1145.am/db/1751743/Intudo_Ventures>,
        <https://1145.am/db/1751800/Morpheus_Ventures>,
        <https://1145.am/db/1751954/Novastar_Ventures>,
        <https://1145.am/db/1752102/Origin_Ventures>,
        <https://1145.am/db/1752403/Yl_Ventures>,
        <https://1145.am/db/1752998/Aglaé_Ventures>,
        <https://1145.am/db/1753704/Apex_Ventures>,
        <https://1145.am/db/1753721/Financial_Venture_Studio>,
        <https://1145.am/db/1753721/Resolute_Ventures>,
        <https://1145.am/db/1753745/2i_Ventures>,
        <https://1145.am/db/1754211/Citi_Ventures>,
        <https://1145.am/db/1754211/Menlo_Ventures>,
        <https://1145.am/db/1754242/Gsv_Ventures>,
        <https://1145.am/db/1754595/Global_Ventures>,
        <https://1145.am/db/1754595/Otg_Ventures>,
        <https://1145.am/db/1754751/Menlo_Ventures>,
        <https://1145.am/db/1754787/Letsventure>,
        <https://1145.am/db/1754997/Alkeon_Capital>,
        <https://1145.am/db/1755086/Kollective_Ventures>,
        <https://1145.am/db/1755278/Zeev_Ventures>,
        <https://1145.am/db/1755704/Promus_Ventures>,
        <https://1145.am/db/1755828/Future_Ventures>,
        <https://1145.am/db/1755860/Dg_Ventures>,
        <https://1145.am/db/1755860/Intudo_Ventures>,
        <https://1145.am/db/1756040/Altos_Ventures>,
        <https://1145.am/db/1756094/CRV>,
        <https://1145.am/db/1756141/Index_Ventures>,
        <https://1145.am/db/1756231/Kreos_Capital>,
        <https://1145.am/db/1756326/Neotribe_Ventures>,
        <https://1145.am/db/1756384/Abstract_Ventures>,
        <https://1145.am/db/1756384/Lightspeed_Ventures>,
        <https://1145.am/db/1756599/True_Ventures>,
        <https://1145.am/db/1757035/Vectr_Ventures>,
        <https://1145.am/db/1757365/Will_Ventures>,
        <https://1145.am/db/1757382/Gl_Ventures>,
        <https://1145.am/db/1757590/Kreos_Capital>,
        <https://1145.am/db/1757772/Lorimer_Ventures>,
        <https://1145.am/db/1758193/Tenoneten_Ventures>,
        <https://1145.am/db/1758193/Valia_Ventures>,
        <https://1145.am/db/1758313/Venture_Field>,
        <https://1145.am/db/1758622/Oca_Ventures>,
        <https://1145.am/db/1759048/Avid_Ventures>,
        <https://1145.am/db/1759048/Lightspeed_Ventures>,
        <https://1145.am/db/1759567/J_Ventures>,
        <https://1145.am/db/1759922/Verance_Capital>,
        <https://1145.am/db/1760383/True_Ventures>,
        <https://1145.am/db/1760520/Prologis_Ventures>,
        <https://1145.am/db/1760816/Index_Ventures>,
        <https://1145.am/db/1760984/Index_Ventures>,
        <https://1145.am/db/1760984/Sequoia_Capital>,
        <https://1145.am/db/1760985/Frontier_Ventures>,
        <https://1145.am/db/1761126/Redpoint_Ventures>,
        <https://1145.am/db/1761566/Index_Ventures>,
        <https://1145.am/db/1761607/Menlo_Ventures>,
        <https://1145.am/db/1761607/Sinewave_Ventures>,
        <https://1145.am/db/1761957/Alkeon_Capital>,
        <https://1145.am/db/1761999/Ggv_Capital>,
        <https://1145.am/db/1762031/Menlo_Ventures>,
        <https://1145.am/db/1762055/Altos_Ventures>,
        <https://1145.am/db/1762277/Ac_Ventures>,
        <https://1145.am/db/1762453/Line_Ventures>,
        <https://1145.am/db/1762561/Grotech_Ventures>,
        <https://1145.am/db/1762669/Creandum>,
        <https://1145.am/db/1762844/Signum_Capital>,
        <https://1145.am/db/1763356/Aglaé_Ventures>,
        <https://1145.am/db/1763371/Spacecadet_Ventures>,
        <https://1145.am/db/1763395/Idc_Ventures>,
        <https://1145.am/db/1763565/Felicis_Ventures>,
        <https://1145.am/db/1763774/Ggv_Capital>,
        <https://1145.am/db/1763795/Ventures_Platform>,
        <https://1145.am/db/1763795/Xyz_Ventures>,
        <https://1145.am/db/1763875/Golden_Gate_Ventures>,
        <https://1145.am/db/1764027/Menlo_Ventures>,
        <https://1145.am/db/1764255/Pathbreaker_Ventures>,
        <https://1145.am/db/1764255/Stageone_Ventures>,
        <https://1145.am/db/1764345/Talis_Capital>,
        <https://1145.am/db/1764527/Presidio_Ventures>,
        <https://1145.am/db/1764527/Yl_Ventures>,
        <https://1145.am/db/1765273/Adevinta_Ventures>,
        <https://1145.am/db/1765273/Venturefriends>,
        <https://1145.am/db/1765372/Irobot_Ventures>,
        <https://1145.am/db/1765377/Redpoint_Ventures>,
        <https://1145.am/db/1765550/Sequoia_Capital>,
        <https://1145.am/db/1765646/Amiti_Ventures>,
        <https://1145.am/db/1765673/Salesforce_Ventures>,
        <https://1145.am/db/1766091/Inreach_Ventures>,
        <https://1145.am/db/1766096/Borealis_Ventures>,
        <https://1145.am/db/1766096/Northpond_Ventures>,
        <https://1145.am/db/1766253/Redpoint_Ventures>,
        <https://1145.am/db/1766253/True_Ventures>,
        <https://1145.am/db/1766540/Industry_Ventures>,
        <https://1145.am/db/1766978/Rga_Ventures>,
        <https://1145.am/db/1768099/Eventures>,
        <https://1145.am/db/1768363/Golden_Gate_Ventures>,
        <https://1145.am/db/1768841/Sequoia_Capital>,
        <https://1145.am/db/1769188/Felicis_Ventures>,
        <https://1145.am/db/1770095/Crosslink_Capital>,
        <https://1145.am/db/1770139/Victress_Capital>,
        <https://1145.am/db/1770265/Techstars_Ventures>,
        <https://1145.am/db/1770372/Avalon_Ventures>,
        <https://1145.am/db/1770372/Korelya_Capital>,
        <https://1145.am/db/1770802/Sequoia_Capital>,
        <https://1145.am/db/1770982/Gv>,
        <https://1145.am/db/1770982/Index_Ventures>,
        <https://1145.am/db/1771011/Ggv_Capital>,
        <https://1145.am/db/1771548/Seekdource_Capital>,
        <https://1145.am/db/1771613/Creandum>,
        <https://1145.am/db/1771642/Felicis_Ventures>,
        <https://1145.am/db/1772004/Raed_Ventures>,
        <https://1145.am/db/1772004/Seed_Equity_Venture_Partners>,
        <https://1145.am/db/1772381/Altos_Ventures>,
        <https://1145.am/db/1772452/Connect_Ventures>,
        <https://1145.am/db/1773130/Capnamic_Ventures>,
        <https://1145.am/db/1773143/Venturefriends>,
        <https://1145.am/db/1773323/Crosslink_Capital>,
        <https://1145.am/db/1774348/True_Ventures>,
        <https://1145.am/db/1774535/Felicis_Ventures>,
        <https://1145.am/db/1774535/Susa_Ventures>,
        <https://1145.am/db/1774658/Gv>,
        <https://1145.am/db/1775965/Felicis_Ventures>,
        <https://1145.am/db/1776340/Ggv_Capital>,
        <https://1145.am/db/1776340/Menlo_Ventures>,
        <https://1145.am/db/1776537/Origin_Ventures>,
        <https://1145.am/db/1776537/Tekton_Ventures>,
        <https://1145.am/db/1776621/Redpoint_Ventures>,
        <https://1145.am/db/1777289/Dn_Capital>,
        <https://1145.am/db/1777563/Evolv_Ventures>,
        <https://1145.am/db/1777563/Ggv_Capital>,
        <https://1145.am/db/1777848/Industry_Ventures>,
        <https://1145.am/db/1778935/Oryzn_Capital>,
        <https://1145.am/db/1780024/Partech_Ventures>,
        <https://1145.am/db/1782098/Addventure>,
        <https://1145.am/db/1782221/Point72_Ventures>,
        <https://1145.am/db/1783189/Citi_Ventures>,
        <https://1145.am/db/1784644/Creathor_Ventures>,
        <https://1145.am/db/1784964/Clear_Ventures>,
        <https://1145.am/db/1785361/M_Ventures>,
        <https://1145.am/db/1786249/Redpoint_Ventures>,
        <https://1145.am/db/1786249/Resolute_Ventures>,
        <https://1145.am/db/1786663/Edenred_Capital_Partners>,
        <https://1145.am/db/1786663/Eqt_Ventures>,
        <https://1145.am/db/1787249/Kpn_Ventures>,
        <https://1145.am/db/1787342/Korelya_Capital>,
        <https://1145.am/db/1787536/Point72_Ventures>,
        <https://1145.am/db/1787791/True_Ventures>,
        <https://1145.am/db/1787886/True_Ventures>,
        <https://1145.am/db/1788328/Index_Ventures>,
        <https://1145.am/db/1788570/Sequoia_Capital>,
        <https://1145.am/db/1788726/Redbeat_Capital>,
        <https://1145.am/db/1789460/Eventures>,
        <https://1145.am/db/1789754/Advancit_Capital>,
        <https://1145.am/db/1790280/Arthur_Ventures>,
        <https://1145.am/db/1790399/Capnamic_Ventures>,
        <https://1145.am/db/1790574/Crosslink_Capital>,
        <https://1145.am/db/1790574/Red_Swan_Ventures>,
        <https://1145.am/db/1790574/Sherpa_Ventures>,
        <https://1145.am/db/1790641/Dn_Capital>,
        <https://1145.am/db/1790771/Redpoint_Ventures>,
        <https://1145.am/db/1790777/Connect_Ventures>,
        <https://1145.am/db/1791216/True_Ventures>,
        <https://1145.am/db/1791303/Index_Ventures>,
        <https://1145.am/db/1791628/Industry_Ventures>,
        <https://1145.am/db/1791838/Advancit_Capital>,
        <https://1145.am/db/1792186/Sequoia_Capital>,
        <https://1145.am/db/1792771/Softtechvc>,
        <https://1145.am/db/1792887/Kaedan_Capital>,
        <https://1145.am/db/1792887/Stageone_Ventures>,
        <https://1145.am/db/1794699/Ws_Ventures>,
        <https://1145.am/db/1794935/Intervest_Co_Ltd>,
        <https://1145.am/db/1795020/Redpoint_Ventures>,
        <https://1145.am/db/1795210/Sequoia_Capital>,
        <https://1145.am/db/1795469/Index_Ventures>,
        <https://1145.am/db/1795538/Skystar_Capital>,
        <https://1145.am/db/1796109/Contour_Venture_Partners>,
        <https://1145.am/db/1796593/Tenoneten_Ventures>,
        <https://1145.am/db/1796901/Red_Swan_Ventures>,
        <https://1145.am/db/1796922/Cagni_Ventures>,
        <https://1145.am/db/1797209/Kdwc_Ventures>,
        <https://1145.am/db/1797518/Sequoia_Capital>,
        <https://1145.am/db/1797899/Brave_Ventures>,
        <https://1145.am/db/1797999/Redpoint_Ventures>,
        <https://1145.am/db/1798568/Index_Ventures>,
        <https://1145.am/db/1799099/Inovia_Capital>,
        <https://1145.am/db/1799184/Ggv_Capital>,
        <https://1145.am/db/1800232/Index_Ventures>,
        <https://1145.am/db/1800929/Ventureast>,
        <https://1145.am/db/1802086/High_Line_Ventures>,
        <https://1145.am/db/1802227/Advancit_Capital>,
        <https://1145.am/db/1802288/Sequoia_Capital>,
        <https://1145.am/db/1802336/Capnamic_Ventures>,
        <https://1145.am/db/1804102/True_Ventures>,
        <https://1145.am/db/1804247/Holtzbrinck_Ventures>,
        <https://1145.am/db/1804476/Felicis_Ventures>,
        <https://1145.am/db/1804476/True_Ventures>,
        <https://1145.am/db/1804992/Talis_Capital>,
        <https://1145.am/db/1805389/Industry_Ventures>,
        <https://1145.am/db/1805604/Connect_Ventures>,
        <https://1145.am/db/1805604/Inreach_Ventures>,
        <https://1145.am/db/1806644/Sequoia_Capital>,
        <https://1145.am/db/1806739/Golden_Gate_Ventures>,
        <https://1145.am/db/1808047/Salesforce_Ventures>,
        <https://1145.am/db/1808505/Helion_Ventures>,
        <https://1145.am/db/1808723/Mindworks_Ventures>,
        <https://1145.am/db/1808735/Commonangels_Ventures>,
        <https://1145.am/db/1809007/Sequoia_Capital>,
        <https://1145.am/db/1809844/Real_Ventures>,
        <https://1145.am/db/1809862/Acequia_Capital>,
        <https://1145.am/db/1810384/Starstrike_Ventures>,
        <https://1145.am/db/1810710/Ia_Ventures>,
        <https://1145.am/db/1810714/Catalus_Capital>,
        <https://1145.am/db/1810769/Eventures>,
        <https://1145.am/db/1810769/Sequoia_Capital>,
        <https://1145.am/db/1811357/Index_Ventures>,
        <https://1145.am/db/1812233/Sequoia_Capital>,
        <https://1145.am/db/1812856/Exfinity_Ventures>,
        <https://1145.am/db/1813375/Creandum>,
        <https://1145.am/db/1813575/Ggv_Capital>,
        <https://1145.am/db/1813944/Menlo_Ventures>,
        <https://1145.am/db/1814064/Index_Ventures>,
        <https://1145.am/db/1814643/Corigin_Ventures>,
        <https://1145.am/db/1814643/Launchcapital>,
        <https://1145.am/db/1815038/Plus_Ventures>,
        <https://1145.am/db/1815507/Globis_Capital_Partners>,
        <https://1145.am/db/1815697/Cherubic_Ventures>,
        <https://1145.am/db/1815701/True_Ventures>,
        <https://1145.am/db/1815886/Teneleven_Ventures>,
        <https://1145.am/db/1816491/Grotech_Ventures>,
        <https://1145.am/db/1818174/Advancit_Capital>,
        <https://1145.am/db/1818876/Kreos_Capital>,
        <https://1145.am/db/1818901/Sequoia_Capital>,
        <https://1145.am/db/1819374/Rothenberg_Ventures>,
        <https://1145.am/db/1819387/Index_Ventures>,
        <https://1145.am/db/1820882/Inven_Capital>,
        <https://1145.am/db/1821174/Index_Ventures>,
        <https://1145.am/db/1821711/Winton_Ventures>,
        <https://1145.am/db/1821752/Sequoia_Capital>,
        <https://1145.am/db/1823162/True_Ventures>,
        <https://1145.am/db/1823217/Kdc_Ventures>,
        <https://1145.am/db/1823217/Nbm_Ventures>,
        <https://1145.am/db/1823684/Dcm_Ventures>,
        <https://1145.am/db/1823684/Idg_Ventures>,
        <https://1145.am/db/1824252/Allos_Ventures>,
        <https://1145.am/db/1824253/Trinity_Ventures>,
        <https://1145.am/db/1824944/True_Ventures>,
        <https://1145.am/db/1825465/Ben_Narasin>,
        <https://1145.am/db/1825713/Menlo_Ventures>,
        <https://1145.am/db/1825946/Lerer_Ventures>,
        <https://1145.am/db/1826265/Idg_Ventures>,
        <https://1145.am/db/1826648/True_Ventures>,
        <https://1145.am/db/1826922/Ggv_Capital>,
        <https://1145.am/db/1827021/Dag_Ventures>,
        <https://1145.am/db/1828036/Redpoint_Ventures>,
        <https://1145.am/db/1828092/Eden_Ventures>,
        <https://1145.am/db/1828251/Golden_Gate_Ventures>,
        <https://1145.am/db/1828455/Quotidien_Ventures>,
        <https://1145.am/db/1828658/Focus_Ventures>,
        <https://1145.am/db/1828663/Great_Oaks_Ventures>,
        <https://1145.am/db/1828663/Inovia_Capital>,
        <https://1145.am/db/1829257/Sequoia_Capital>,
        <https://1145.am/db/1829422/Felicis_Ventures>,
        <https://1145.am/db/1829422/Rothenberg_Ventures>,
        <https://1145.am/db/1829612/Lerer_Ventures>,
        <https://1145.am/db/1830502/Frontline_Ventures>,
        <https://1145.am/db/1830613/True_Ventures>,
        <https://1145.am/db/1830809/Numecent>,
        <https://1145.am/db/1830809/T-Ventures>,
        <https://1145.am/db/1830817/Charles_River_Ventures>,
        <https://1145.am/db/1831577/Artiman_Ventures>,
        <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1831764/Sequoia_Capital>,
        <https://1145.am/db/1832038/True_Ventures>,
        <https://1145.am/db/1832316/Partech_Ventures>,
        <https://1145.am/db/1832316/Scentan_Ventures>,
        <https://1145.am/db/1832316/Startcaps_Ventures>,
        <https://1145.am/db/1832856/Grotech_Ventures>,
        <https://1145.am/db/1834224/Avalon_Ventures>,
        <https://1145.am/db/1834224/Orix_Ventures>,
        <https://1145.am/db/1834305/Charles_River_Ventures>,
        <https://1145.am/db/1834334/Altos_Ventures>,
        <https://1145.am/db/1834334/Baseline_Ventures>,
        <https://1145.am/db/1834334/Firebolt_Ventures>,
        <https://1145.am/db/1834334/Lazerow_Ventures>,
        <https://1145.am/db/1834520/Ben_Horowitz>,
        <https://1145.am/db/1834541/Avalon_Ventures>,
        <https://1145.am/db/1834708/Sherpa_Ventures>,
        <https://1145.am/db/1834965/Lerer_Ventures>,
        <https://1145.am/db/1835229/Lerer_Ventures>,
        <https://1145.am/db/1835229/Trinity_Ventures>,
        <https://1145.am/db/1835229/Xg_Ventures>,
        <https://1145.am/db/1835740/Lerer_Ventures>,
        <https://1145.am/db/1835749/Gree_Ventures>,
        <https://1145.am/db/1835825/Focus_Ventures>,
        <https://1145.am/db/1836984/Siemer_Ventures>,
        <https://1145.am/db/1836984/Tekton_Ventures>,
        <https://1145.am/db/1837741/Menlo_Ventures>,
        <https://1145.am/db/1838026/Plus_Ventures>,
        <https://1145.am/db/1840775/Ggv_Capital>,
        <https://1145.am/db/1840881/Felicis_Ventures>,
        <https://1145.am/db/1840881/Trinity_Ventures>,
        <https://1145.am/db/1841176/Lerer_Ventures>,
        <https://1145.am/db/1841176/True_Ventures>,
        <https://1145.am/db/1842402/Index_Ventures>,
        <https://1145.am/db/1842402/Redpoint_Ventures>,
        <https://1145.am/db/1842898/Grotech_Ventures>,
        <https://1145.am/db/1843003/Eventures>,
        <https://1145.am/db/1843003/Index_Ventures>,
        <https://1145.am/db/1843031/Index_Ventures>,
        <https://1145.am/db/1843449/Redpoint_Ventures>,
        <https://1145.am/db/1843602/Nextview_Ventures>,
        <https://1145.am/db/1843659/Sequoia_Capital>,
        <https://1145.am/db/1844143/Inovia_Capital>,
        <https://1145.am/db/1844472/Sequoia_Capital>,
        <https://1145.am/db/1844737/True_Ventures>,
        <https://1145.am/db/1844931/Charles_River_Ventures>,
        <https://1145.am/db/1845308/Ia_Ventures>,
        <https://1145.am/db/1845960/Lerer_Ventures>,
        <https://1145.am/db/1846254/Index_Ventures>,
        <https://1145.am/db/1846483/Inovia_Capital>,
        <https://1145.am/db/1847463/Prism_Ventureworks>,
        <https://1145.am/db/1847752/T-Venture>,
        <https://1145.am/db/1848523/Trinity_Ventures>,
        <https://1145.am/db/1849673/Inventure_Partners>,
        <https://1145.am/db/1849884/Index_Ventures>,
        <https://1145.am/db/1849949/Holtzbrinck_Ventures>,
        <https://1145.am/db/1850020/Sequoia_Capital>,
        <https://1145.am/db/1850668/True_Ventures>,
        <https://1145.am/db/1850989/Artiman_Ventures>,
        <https://1145.am/db/1850989/Sequoia_Capital>,
        <https://1145.am/db/1851035/Acequia_Capital>,
        <https://1145.am/db/1851035/Index_Ventures>,
        <https://1145.am/db/1851035/Redpoint_Ventures>,
        <https://1145.am/db/1851705/Promus_Ventures>,
        <https://1145.am/db/1851854/Partech_Ventures>,
        <https://1145.am/db/1851923/Dag_Ventures>,
        <https://1145.am/db/1852308/Plus_Ventures>,
        <https://1145.am/db/1852513/Quotidian_Ventures>,
        <https://1145.am/db/1852513/Trestle_Ventures>,
        <https://1145.am/db/1852556/Dave_Morin>,
        <https://1145.am/db/1852806/Redpoint_Ventures>,
        <https://1145.am/db/1852870/Golden_Gate_Ventures>,
        <https://1145.am/db/1852870/Siemer_Ventures>,
        <https://1145.am/db/1853417/Catamount_Ventures>,
        <https://1145.am/db/1853496/T-Ventures>,
        <https://1145.am/db/1854200/Ggv_Capital>,
        <https://1145.am/db/1854201/Charles_River_Ventures>,
        <https://1145.am/db/1854786/Eden_Ventures>,
        <https://1145.am/db/1854874/Crosslink_Capital>,
        <https://1145.am/db/1854874/Sherpa_Ventures>,
        <https://1145.am/db/1854874/Softtech>,
        <https://1145.am/db/1855353/Sequoia_Capital>,
        <https://1145.am/db/1855363/True_Ventures>,
        <https://1145.am/db/1855403/Rho_Ventures>,
        <https://1145.am/db/1855780/Bds_Ventures>,
        <https://1145.am/db/1855780/Ggv_Capital>,
        <https://1145.am/db/1856191/Creandum>,
        <https://1145.am/db/1856380/Softtech>,
        <https://1145.am/db/1856402/Sequoia_Capital>,
        <https://1145.am/db/1856457/Aeris_Capital>,
        <https://1145.am/db/1856616/Redpoint_Ventures>,
        <https://1145.am/db/1856834/Sequoia_Capital>,
        <https://1145.am/db/1857635/Rikard_Steiber>,
        <https://1145.am/db/1857659/Revolution_Ventures>,
        <https://1145.am/db/1857930/Inovia_Capital>,
        <https://1145.am/db/1857930/Version_One_Ventures>,
        <https://1145.am/db/1858323/Avalon_Ventures>,
        <https://1145.am/db/1858545/Sequoia_Capital>,
        <https://1145.am/db/1858592/Apex_Venture_Partners>,
        <https://1145.am/db/1858592/Origin_Ventures>,
        <https://1145.am/db/1858991/Capnamic_Ventures>,
        <https://1145.am/db/1859199/True_Ventures>,
        <https://1145.am/db/1859314/Version_One_Ventures>,
        <https://1145.am/db/1860163/Inovia_Capital>,
        <https://1145.am/db/1860345/Commonangels>,
        <https://1145.am/db/1860345/Launchcapital>,
        <https://1145.am/db/1861054/Sequoia_Capital>,
        <https://1145.am/db/1861355/Rho_Ventures>,
        <https://1145.am/db/1862590/Felicis_Ventures>,
        <https://1145.am/db/1862878/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1863147/Apex_Venture_Partners>,
        <https://1145.am/db/1864601/Trinity_Ventures>,
        <https://1145.am/db/1864646/Inventus_Capital>,
        <https://1145.am/db/1865436/Sequoia_Capital>,
        <https://1145.am/db/1865480/Felicis_Ventures>,
        <https://1145.am/db/1865480/Sequoia_Capital>,
        <https://1145.am/db/1865480/Sherpalo_Ventures>,
        <https://1145.am/db/1866032/Launchcapital>,
        <https://1145.am/db/1866134/Embarcadero_Ventures>,
        <https://1145.am/db/1866134/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1866155/Presidio_Ventures>,
        <https://1145.am/db/1867543/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1867599/Cava_Capital>,
        <https://1145.am/db/1868107/Redpoint_Ventures>,
        <https://1145.am/db/1868109/Charles_River_Ventures>,
        <https://1145.am/db/1868178/True_Ventures>,
        <https://1145.am/db/1870015/Redpoint_Ventures>,
        <https://1145.am/db/1870465/Nextview_Ventures>,
        <https://1145.am/db/1871221/True_Ventures>,
        <https://1145.am/db/1871574/Redpoint_Ventures>,
        <https://1145.am/db/1871777/Charles_River_Ventures>,
        <https://1145.am/db/1871784/Charles_River_Ventures>,
        <https://1145.am/db/1871888/Charles_River_Ventures>,
        <https://1145.am/db/1873191/El_Dorado_Ventures>,
        <https://1145.am/db/1873680/Crosslink_Capital>,
        <https://1145.am/db/1873680/Lerer_Ventures>,
        <https://1145.am/db/1873680/Xg_Ventures>,
        <https://1145.am/db/1874749/True_Ventures>,
        <https://1145.am/db/1874937/Quotidian_Ventures>,
        <https://1145.am/db/1877243/Felicis_Ventures>,
        <https://1145.am/db/1877283/Northzone_Ventures>,
        <https://1145.am/db/1877473/True_Ventures>,
        <https://1145.am/db/1877642/Dag_Ventures>,
        <https://1145.am/db/1878620/Ggv_Capital>,
        <https://1145.am/db/1879279/High_Line_Ventures>,
        <https://1145.am/db/1879759/T-Venture>,
        <https://1145.am/db/1880679/Northzone_Ventures>,
        <https://1145.am/db/1881464/Ggv_Capital>,
        <https://1145.am/db/1881748/Morgenthaler_Ventures>,
        <https://1145.am/db/1882330/New_World_Ventures>,
        <https://1145.am/db/1882727/Charles_River_Ventures>,
        <https://1145.am/db/1882907/Starfish_Ventures>,
        <https://1145.am/db/1883568/Eden_Ventures>,
        <https://1145.am/db/1883572/Astutia_Ventures>,
        <https://1145.am/db/1886402/New_Atlantic_Ventures>,
        <https://1145.am/db/1886566/Sequoia_Capital>,
        <https://1145.am/db/1889394/Focus_Ventures>,
        <https://1145.am/db/1889629/Sequoia_Capital>,
        <https://1145.am/db/1890000/Lerer_Ventures>,
        <https://1145.am/db/1890122/East_Ventures>,
        <https://1145.am/db/1890133/Crosslink_Capital>,
        <https://1145.am/db/1890133/Dag_Ventures>,
        <https://1145.am/db/1890133/Focus_Ventures>,
        <https://1145.am/db/1890157/Morgenthaler_Ventures>,
        <https://1145.am/db/1890208/Menlo_Ventures>,
        <https://1145.am/db/1890619/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1890839/Inovia_Capital>,
        <https://1145.am/db/1890903/Miven_Ventures>,
        <https://1145.am/db/1891615/Holtzbrinck_Ventures>,
        <https://1145.am/db/1891777/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1891913/New_World_Ventures>,
        <https://1145.am/db/1891913/Oca_Ventures>,
        <https://1145.am/db/1891926/New_World_Ventures>,
        <https://1145.am/db/1892050/Charles_River_Ventures>,
        <https://1145.am/db/1892105/Crosscreek_Capital>,
        <https://1145.am/db/1892105/Industry_Ventures>,
        <https://1145.am/db/1892106/Altos_Ventures>,
        <https://1145.am/db/1892106/Illuminate_Ventures>,
        <https://1145.am/db/1892620/True_Ventures>,
        <https://1145.am/db/1892674/Appian_Ventures>,
        <https://1145.am/db/1892902/Crosslink_Capital>,
        <https://1145.am/db/1892955/Guy_Gamzu>,
        <https://1145.am/db/1895072/Nextview_Ventures>,
        <https://1145.am/db/1895951/Windward_Ventures>,
        <https://1145.am/db/1896159/Ia_Ventures>,
        <https://1145.am/db/1896185/Index_Ventures>,
        <https://1145.am/db/1896379/Index_Ventures>,
        <https://1145.am/db/1896379/Redpoint_Ventures>,
        <https://1145.am/db/1896419/True_Ventures>,
        <https://1145.am/db/1902330/Baseline_Ventures>,
        <https://1145.am/db/1905483/Industry_Ventures>,
        <https://1145.am/db/1905858/Index_Ventures>,
        <https://1145.am/db/1907771/Dag_Ventures>,
        <https://1145.am/db/1909430/Menlo_Ventures>,
        <https://1145.am/db/1909651/Revolution_Ventures>,
        <https://1145.am/db/1910694/True_Ventures>,
        <https://1145.am/db/1910922/Charles_River_Ventures>,
        <https://1145.am/db/1912684/Charles_River_Ventures>,
        <https://1145.am/db/1913863/Tl_Ventures>,
        <https://1145.am/db/1913874/Redpoint_Ventures>,
        <https://1145.am/db/1914220/Index_Ventures>,
        <https://1145.am/db/1915393/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1915862/Dag_Ventures>,
        <https://1145.am/db/1915862/Focus_Ventures>,
        <https://1145.am/db/1919724/Dag_Ventures>,
        <https://1145.am/db/1920478/Dawntreader_Ventures>,
        <https://1145.am/db/1920837/Onset_Ventures>,
        <https://1145.am/db/1927817/Trm_Ventures>,
        <https://1145.am/db/1939926/Cobalt_Ventures>,
        <https://1145.am/db/1945479/Crosslink_Capital>,
        <https://1145.am/db/1947303/Cavallo_Ventures>,
        <https://1145.am/db/1947312/Boldstart_Ventures>,
        <https://1145.am/db/1952989/Singularity_Ventures>,
        <https://1145.am/db/1954147/Accomplice_Ventures>,
        <https://1145.am/db/1957179/Sozo_Ventures>,
        <https://1145.am/db/1958963/Prosus_Ventures>,
        <https://1145.am/db/1959001/Capital_Technology_Ventures>,
        <https://1145.am/db/1959001/Glasswing_Ventures>,
        <https://1145.am/db/1962819/Connetic_Ventures>,
        <https://1145.am/db/1967592/Firebolt_Ventures>,
        <https://1145.am/db/1967683/Dig_Ventures_Vine_Ventures>,
        <https://1145.am/db/1975490/Northview_Ventures>,
        <https://1145.am/db/1975547/Nanban_Ventures>,
        <https://1145.am/db/1975547/Sinewave_Ventures>,
        <https://1145.am/db/1986122/Menlo_Ventures>,
        <https://1145.am/db/1995926/Neotribe_Ventures>,
        <https://1145.am/db/1998196/Gni_Group_Ltd>,
        <https://1145.am/db/1999771/Servicenow_Ventures>,
        <https://1145.am/db/2004427/Convivialité_Ventures>,
        <https://1145.am/db/2005131/Wwventures>,
        <https://1145.am/db/2007132/Nventures>,
        <https://1145.am/db/2020041/Inovia_Capital>,
        <https://1145.am/db/2020041/TCV>,
        <https://1145.am/db/2023596/Salesforce_Ventures>,
        <https://1145.am/db/2025081/True_Ventures>,
        <https://1145.am/db/2029648/Sequoia_Capital>,
        <https://1145.am/db/2035454/Gv>,
        <https://1145.am/db/2036021/Clear_Ventures>,
        <https://1145.am/db/2038783/Sequoia_Capital>,
        <https://1145.am/db/2039177/Stellantis_Ventures>,
        <https://1145.am/db/2041480/Brunnur_Ventures>,
        <https://1145.am/db/2042858/Gv>,
        <https://1145.am/db/2044380/20sales>,
        <https://1145.am/db/2045587/Veritec_Ventures>,
        <https://1145.am/db/2050229/Nventures>,
        <https://1145.am/db/2050359/At_One_Ventures>,
        <https://1145.am/db/2051164/Aviso_Ventures>,
        <https://1145.am/db/2053027/Glasswing_Ventures>,
        <https://1145.am/db/2055707/Globis_Capital_Partners>,
        <https://1145.am/db/2056931/We_Ventures>,
        <https://1145.am/db/2060003/Crit_Ventures_100___100_Ventures>,
        <https://1145.am/db/2061278/Incisive_Ventures>,
        <https://1145.am/db/2061278/Volo_Ventures>,
        <https://1145.am/db/2063642/Clear_Bridge_Ventures>,
        <https://1145.am/db/2063967/Vsquared_Ventures>,
        <https://1145.am/db/2069147/Boldstart_Ventures>,
        <https://1145.am/db/2069147/Pelion_Ventures>,
        <https://1145.am/db/2069147/Salesforce_Ventures>,
        <https://1145.am/db/2069495/Intermountain_Ventures>,
        <https://1145.am/db/2069495/Northpond_Ventures>,
        <https://1145.am/db/2073129/Abstract_Ventures>,
        <https://1145.am/db/2073132/Idc_Ventures>,
        <https://1145.am/db/2073480/Astellas_Venture_Management>,
        <https://1145.am/db/2075625/Rocketship_Ventures>,
        <https://1145.am/db/2081180/S4s_Ventures>,
        <https://1145.am/db/2081674/Capital_One_Ventures>,
        <https://1145.am/db/2082068/Arctern_Ventures>,
        <https://1145.am/db/2082068/Prelude_Ventures>,
        <https://1145.am/db/2083987/Vanterra_Ventures>,
        <https://1145.am/db/2087289/Jven_Capital>,
        <https://1145.am/db/2087289/Northpond_Ventures>,
        <https://1145.am/db/2089206/Crescendo_Venture_Partners>,
        <https://1145.am/db/2093427/Yl_Ventures>,
        <https://1145.am/db/2093713/Yl_Ventures>,
        <https://1145.am/db/209861/Crosslink_Capital>,
        <https://1145.am/db/2100116/Epic_Ventures>,
        <https://1145.am/db/2107533/Globis_Capital_Partners>,
        <https://1145.am/db/2109529/Point72_Ventures>,
        <https://1145.am/db/2109799/Sofinnova_Partners>,
        <https://1145.am/db/2109932/Catalio_Capital_Management>,
        <https://1145.am/db/2109932/Epic_Ventures>,
        <https://1145.am/db/2109932/Intermountain_Ventures>,
        <https://1145.am/db/2109932/North_South_Ventures>,
        <https://1145.am/db/2116769/Celesta_Capital>,
        <https://1145.am/db/2116769/Chiratae_Ventures>,
        <https://1145.am/db/2123953/Amex_Ventures>,
        <https://1145.am/db/2123953/Industry_Ventures>,
        <https://1145.am/db/2123953/Infinity_Ventures>,
        <https://1145.am/db/2124766/P1_Ventures>,
        <https://1145.am/db/2125182/Nevcaut_Ventures>,
        <https://1145.am/db/2125182/Ulu_Ventures>,
        <https://1145.am/db/2125927/1984_Ventures>,
        <https://1145.am/db/2127882/Akkadian_Ventures>,
        <https://1145.am/db/2134989/Clear_Ventures>,
        <https://1145.am/db/2134989/Felicis_Ventures>,
        <https://1145.am/db/2141183/S_Ventures>,
        <https://1145.am/db/2141328/Connetic_Ventures>,
        <https://1145.am/db/2143438/Scorpio_Capital>,
        <https://1145.am/db/2147767/Catapult_Ventures>,
        <https://1145.am/db/2147767/Tenoneten_Ventures>,
        <https://1145.am/db/2151983/CRV>,
        <https://1145.am/db/2151983/Greatpoint_Ventures>,
        <https://1145.am/db/2155426/Brighteyes_Ventures>,
        <https://1145.am/db/2155625/Sofinnova_Partners>,
        <https://1145.am/db/2164121/Menlo_Ventures>,
        <https://1145.am/db/2169799/Nwise_Ventures>,
        <https://1145.am/db/217906/Sequoia_Capital>,
        <https://1145.am/db/2181016/Foresite_Capital>,
        <https://1145.am/db/2182443/Global_Ventures>,
        <https://1145.am/db/2183352/Optum_Ventures>,
        <https://1145.am/db/2186568/Frist_Cressey_Ventures>,
        <https://1145.am/db/2186568/Springrock_Ventures>,
        <https://1145.am/db/2186949/Greatpoint_Ventures_And_Cross_Creek>,
        <https://1145.am/db/2186949/Springrock_Ventures>,
        <https://1145.am/db/2190141/Link_Ventures>,
        <https://1145.am/db/2192636/TCV>,
        <https://1145.am/db/219311/Origin_Ventures>,
        <https://1145.am/db/2196875/Sequoia_Capital>,
        <https://1145.am/db/2208603/McKesson_Ventures>,
        <https://1145.am/db/2210557/True_Ventures>,
        <https://1145.am/db/221321/Ggv_Capital>,
        <https://1145.am/db/2214690/Idg_Ventures>,
        <https://1145.am/db/2254568/Felicis_Ventures>,
        <https://1145.am/db/2264763/True_Ventures>,
        <https://1145.am/db/2283006/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Northpond_Ventures>,
        <https://1145.am/db/2284412/Soleus_Capital>,
        <https://1145.am/db/2286665/Shanda_Group>,
        <https://1145.am/db/2288209/Echelon_Ventures>,
        <https://1145.am/db/2288596/Sanderling_Ventures>,
        <https://1145.am/db/2291277/Foresite_Capital>,
        <https://1145.am/db/2293172/Prospect_Ventures>,
        <https://1145.am/db/2294202/Trinitas_Capital>,
        <https://1145.am/db/2294815/Foresite_Capital>,
        <https://1145.am/db/2295253/Arkitekt_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2296249/Proxima_Ventures>,
        <https://1145.am/db/2296869/Dcm_Ventures>,
        <https://1145.am/db/2297406/Sequoia_Capital>,
        <https://1145.am/db/2298897/Eshelman_Ventures>,
        <https://1145.am/db/2300254/Sequoia_Capital>,
        <https://1145.am/db/2302351/Rho_Ventures>,
        <https://1145.am/db/2302731/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/2302750/Sofinnova_Partners>,
        <https://1145.am/db/2302897/Ventures_West_Capital>,
        <https://1145.am/db/2303098/Seaflower_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304606/Prism_Ventureworks>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2305745/Sanderling_Ventures>,
        <https://1145.am/db/2306281/Sanderling_Ventures>,
        <https://1145.am/db/2306568/Cmea_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2309507/Rho_Ventures>,
        <https://1145.am/db/2309840/Index_Ventures>,
        <https://1145.am/db/2311069/Morgenthaler_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2312288/Pappas_Ventures>,
        <https://1145.am/db/2312792/Onset_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2314380/Puretech_Ventures>,
        <https://1145.am/db/2314397/Pappas_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Pappas_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314515/Apjohnventures>,
        <https://1145.am/db/2315754/Arcturus_Capital>,
        <https://1145.am/db/2317779/Index_Ventures>,
        <https://1145.am/db/2317779/Sofinnova_Partners>,
        <https://1145.am/db/2319777/Astellas_Venture_Management>,
        <https://1145.am/db/2321856/Ventures_West_Capital_Ltd>,
        <https://1145.am/db/2323785/Eshelman_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2325015/True_Ventures>,
        <https://1145.am/db/2325140/Index_Ventures>,
        <https://1145.am/db/2325257/Ventures_West>,
        <https://1145.am/db/2325337/Resolvyx>,
        <https://1145.am/db/2326080/Felicis_Ventures>,
        <https://1145.am/db/2326362/Nextech_Venture>,
        <https://1145.am/db/2326404/Intersouth_Partners>,
        <https://1145.am/db/2328585/Cmea_Ventures>,
        <https://1145.am/db/2329870/Sofinnova_Partners>,
        <https://1145.am/db/2330775/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335587/Sofinnova_Partners>,
        <https://1145.am/db/2338023/Cipla_Ventures>,
        <https://1145.am/db/2338196/Index_Ventures>,
        <https://1145.am/db/2338236/Sanderling_Ventures>,
        <https://1145.am/db/2338703/Wavepoint_Ventures>,
        <https://1145.am/db/2339206/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2340429/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341942/High-Tech_Gründerfonds>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2343184/Jven_Capital>,
        <https://1145.am/db/2345017/Venture_Investments>,
        <https://1145.am/db/2345268/Foresite_Capital>,
        <https://1145.am/db/2346300/High-Tech_Gründerfonds>,
        <https://1145.am/db/2346452/Aescap_Venture>,
        <https://1145.am/db/2346532/Pappas_Ventures>,
        <https://1145.am/db/2346978/Ventures_West_Capital>,
        <https://1145.am/db/2347571/Index_Ventures>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2348618/Index_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Partners>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2350044/Avalon_Ventures>,
        <https://1145.am/db/2352436/Forward_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2356384/Sofinnova_Partners>,
        <https://1145.am/db/2357487/Savitr_Capital>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358657/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2358747/Solon_Ventures>,
        <https://1145.am/db/2358812/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2359562/Pappas_Ventures>,
        <https://1145.am/db/2362638/Launchpad_Venture_Group>,
        <https://1145.am/db/2363460/Rho_Ventures>,
        <https://1145.am/db/2363854/Chrysalis_Ventures>,
        <https://1145.am/db/2364820/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2365103/Aescap_Venture>,
        <https://1145.am/db/2367675/Avalon_Ventures>,
        <https://1145.am/db/2369967/Foresite_Capital>,
        <https://1145.am/db/2370240/Clarus_Ventures>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/238282/Carnrite_Ventures>,
        <https://1145.am/db/2400536/Capital_One_Ventures>,
        <https://1145.am/db/2423653/Venturewell>,
        <https://1145.am/db/253438/Esplanade_Ventures>,
        <https://1145.am/db/254357/Ulu_Ventures>,
        <https://1145.am/db/2549491/Ktb_Ventures>,
        <https://1145.am/db/2552636/Morningside_Ventures>,
        <https://1145.am/db/2569491/High-Tech_Gründerfonds>,
        <https://1145.am/db/2570138/Sherpa_Ventures>,
        <https://1145.am/db/2570481/Morgenthaler_Ventures>,
        <https://1145.am/db/2570483/Morgenthaler_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Partners>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2603254/Salesforce_Ventures>,
        <https://1145.am/db/2628424/Verana_Networks>,
        <https://1145.am/db/2628848/Neocarta_Ventures>,
        <https://1145.am/db/2635849/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2638432/Nissay_Capital>,
        <https://1145.am/db/2641337/Promus_Ventures>,
        <https://1145.am/db/2641337/True_Ventures>,
        <https://1145.am/db/2654391/Biggell_Finance>,
        <https://1145.am/db/265532/Ulu_Ventures>,
        <https://1145.am/db/2702871/Inovia_Capital>,
        <https://1145.am/db/274170/G1_Ventures>,
        <https://1145.am/db/2754677/Golden_Gate_Ventures>,
        <https://1145.am/db/2765022/Garuda_Ventures>,
        <https://1145.am/db/2765030/Daniel_Ventures>,
        <https://1145.am/db/2765418/Rw3_Ventures>,
        <https://1145.am/db/2786411/Allegion_Ventures>,
        <https://1145.am/db/2788052/Rx_Ventures>,
        <https://1145.am/db/2790064/Novastar_Ventures>,
        <https://1145.am/db/2794396/Snowpoint_Ventures>,
        <https://1145.am/db/2797562/Menlo_Ventures>,
        <https://1145.am/db/283272/Salesforce_Ventures>,
        <https://1145.am/db/283607/Salesforce_Ventures>,
        <https://1145.am/db/293715/Signum_Capital>,
        <https://1145.am/db/293849/Felicis_Ventures>,
        <https://1145.am/db/293891/Ggv_Capital>,
        <https://1145.am/db/299738/Steadfast_Capital_Ventures>,
        <https://1145.am/db/306236/Index_Ventures>,
        <https://1145.am/db/319155/Bgv_Ventures>,
        <https://1145.am/db/323273/Index_Ventures>,
        <https://1145.am/db/341984/Salesforce_Ventures>,
        <https://1145.am/db/341984/Sequoia_Capital>,
        <https://1145.am/db/341990/Salesforce_Ventures>,
        <https://1145.am/db/341990/Sequoia_Capital>,
        <https://1145.am/db/343459/F7_Ventures>,
        <https://1145.am/db/346598/Salesforce_Ventures>,
        <https://1145.am/db/348442/Triventures>,
        <https://1145.am/db/348659/Launchpad_Capital>,
        <https://1145.am/db/361303/Sequoia_Capital>,
        <https://1145.am/db/364168/Alerion_Ventures>,
        <https://1145.am/db/367592/Gv>,
        <https://1145.am/db/367592/Sequoia_Capital>,
        <https://1145.am/db/388551/Vestigo_Ventures>,
        <https://1145.am/db/396305/Real_Ventures>,
        <https://1145.am/db/402103/1776_Ventures>,
        <https://1145.am/db/402701/January_Ventures>,
        <https://1145.am/db/403810/Riverstone_Ventures>,
        <https://1145.am/db/410322/Gv>,
        <https://1145.am/db/410473/Celesta_Capital>,
        <https://1145.am/db/410473/Lytical_Ventures_And_Nepenthe_Capital>,
        <https://1145.am/db/410529/Goodyear_Ventures>,
        <https://1145.am/db/411539/Zeev_Ventures>,
        <https://1145.am/db/412020/Defi_Ventures_Inc>,
        <https://1145.am/db/415322/CRV>,
        <https://1145.am/db/416041/Akkadian_Ventures>,
        <https://1145.am/db/416041/Signia_Ventures>,
        <https://1145.am/db/416041/Zeev_Ventures>,
        <https://1145.am/db/419489/Point72_Ventures>,
        <https://1145.am/db/424877/North_First_Ventures>,
        <https://1145.am/db/425262/Yl_Ventures>,
        <https://1145.am/db/425423/True_Ventures>,
        <https://1145.am/db/425973/Will_Ventures>,
        <https://1145.am/db/426615/Sequoia_Capital>,
        <https://1145.am/db/429179/C5_Capital>,
        <https://1145.am/db/430986/Cortado_Ventures>,
        <https://1145.am/db/434334/1up_Ventures>,
        <https://1145.am/db/435691/Klick_Ventures>,
        <https://1145.am/db/439819/Cavu_Ventures>,
        <https://1145.am/db/441319/Celesta_Capital>,
        <https://1145.am/db/444105/Exfinity_Ventures>,
        <https://1145.am/db/445365/Revolution_Ventures>,
        <https://1145.am/db/446341/Sinewave_Ventures>,
        <https://1145.am/db/455558/Intudo_Ventures>,
        <https://1145.am/db/457435/Alerce>,
        <https://1145.am/db/457435/Clin>,
        <https://1145.am/db/460454/Index_Ventures>,
        <https://1145.am/db/471253/Gv>,
        <https://1145.am/db/471436/Citi_Ventures>,
        <https://1145.am/db/471504/Canapi_Ventures>,
        <https://1145.am/db/473030/Highsage_Ventures>,
        <https://1145.am/db/474928/Susa_Ventures>,
        <https://1145.am/db/478049/Worldquant_Ventures>,
        <https://1145.am/db/479113/Index_Ventures>,
        <https://1145.am/db/479113/Menlo_Ventures>,
        <https://1145.am/db/485616/K3_Ventures>,
        <https://1145.am/db/486858/Gaingels>,
        <https://1145.am/db/486901/Gaingels>,
        <https://1145.am/db/488743/Salesforce_Ventures>,
        <https://1145.am/db/491130/Raiven_Capital>,
        <https://1145.am/db/491338/Raiven_Capital>,
        <https://1145.am/db/493560/Tyh_Ventures>,
        <https://1145.am/db/495912/Regah_Ventures>,
        <https://1145.am/db/506588/Trinity_Ventures>,
        <https://1145.am/db/508145/Sora_Finance>,
        <https://1145.am/db/508161/Sora_Finance>,
        <https://1145.am/db/510565/Epic_Ventures>,
        <https://1145.am/db/513305/Avid_Ventures>,
        <https://1145.am/db/513305/Canapi_Ventures>,
        <https://1145.am/db/513897/Rlc_Ventures>,
        <https://1145.am/db/514151/Rlc_Ventures>,
        <https://1145.am/db/516396/Acequia_Capital>,
        <https://1145.am/db/517213/Acequia_Capital>,
        <https://1145.am/db/523349/Osf_Ventures>,
        <https://1145.am/db/523776/Root_Ventures>,
        <https://1145.am/db/525285/Inventum_Ventures>,
        <https://1145.am/db/525285/Optima_Ventures>,
        <https://1145.am/db/526109/Ggv_Capital>,
        <https://1145.am/db/526175/Ridgeline_Ventures>,
        <https://1145.am/db/529812/Inventum_Ventures>,
        <https://1145.am/db/529812/Optima_Ventures>,
        <https://1145.am/db/532016/Id_Ventures>,
        <https://1145.am/db/539571/Origin_Ventures>,
        <https://1145.am/db/545843/Capital_One_Ventures>,
        <https://1145.am/db/545852/Boxone_Ventures>,
        <https://1145.am/db/545852/Panache_Ventures>,
        <https://1145.am/db/547770/BGV>,
        <https://1145.am/db/547944/BGV>,
        <https://1145.am/db/554552/Konvoy_Ventures>,
        <https://1145.am/db/555193/Illumina_Ventures>,
        <https://1145.am/db/555193/Technology_Venture_Partners>,
        <https://1145.am/db/556705/Congress_Ave_Ventures>,
        <https://1145.am/db/558005/Illumina_Ventures>,
        <https://1145.am/db/558005/Technology_Venture_Partners>,
        <https://1145.am/db/558877/Falabella_Ventures>,
        <https://1145.am/db/559220/Ulu_Ventures>,
        <https://1145.am/db/561662/Redpoint_Ventures>,
        <https://1145.am/db/561662/Vandelay_Ventures>,
        <https://1145.am/db/562745/Vinmar_Ventures>,
        <https://1145.am/db/563575/Celesta_Capital>,
        <https://1145.am/db/564008/D1_Ventures>,
        <https://1145.am/db/571769/Illumina_Ventures>,
        <https://1145.am/db/571769/M_Ventures>,
        <https://1145.am/db/572097/Menlo_Ventures>,
        <https://1145.am/db/572097/Teneleven_Ventures>,
        <https://1145.am/db/575249/TCV>,
        <https://1145.am/db/576186/Konvoy_Ventures>,
        <https://1145.am/db/577120/Index_Ventures>,
        <https://1145.am/db/586525/Tenoneten_Ventures>,
        <https://1145.am/db/587038/Coparion>,
        <https://1145.am/db/591566/Morningside_Ventures>,
        <https://1145.am/db/596145/Anorak_Ventures>,
        <https://1145.am/db/596564/Anorak_Ventures>,
        <https://1145.am/db/601455/Morningside_Ventures>,
        <https://1145.am/db/603725/Ignitexl_Ventures>,
        <https://1145.am/db/606074/Fiscus_Ventures>,
        <https://1145.am/db/606144/Ggv_Capital>,
        <https://1145.am/db/615337/Companyon_Ventures>,
        <https://1145.am/db/619284/Scf_Ventures>,
        <https://1145.am/db/619366/Capital_One_Ventures>,
        <https://1145.am/db/619736/Lightspeed_Ventures>,
        <https://1145.am/db/623178/Array_Ventures>,
        <https://1145.am/db/625791/Sofinnova_Partners>,
        <https://1145.am/db/626781/Dnx_Ventures>,
        <https://1145.am/db/627030/Launchpad_Capital>,
        <https://1145.am/db/628654/Prologis_Ventures>,
        <https://1145.am/db/633238/True_Ventures>,
        <https://1145.am/db/633869/Skywell_Capital_Partners>,
        <https://1145.am/db/633869/Stageone_Ventures>,
        <https://1145.am/db/640939/Ggv_Capital>,
        <https://1145.am/db/642123/Charles_River_Ventures>,
        <https://1145.am/db/642518/Network_Ventures>,
        <https://1145.am/db/643600/Vinco_Ventures>,
        <https://1145.am/db/648552/True_Ventures>,
        <https://1145.am/db/659010/Index_Ventures>,
        <https://1145.am/db/659675/Gv>,
        <https://1145.am/db/661747/Adit_Ventures>,
        <https://1145.am/db/661818/Index_Ventures>,
        <https://1145.am/db/665129/Ac_Ventures>,
        <https://1145.am/db/665776/Firstime_Ventures>,
        <https://1145.am/db/676217/Steelsky_Ventures>,
        <https://1145.am/db/676869/Ggv_Capital>,
        <https://1145.am/db/678140/Ggv_Capital>,
        <https://1145.am/db/678587/Lightshed_Ventures>,
        <https://1145.am/db/678593/Solana_Ventures>,
        <https://1145.am/db/687538/Kayyak_Ventures>,
        <https://1145.am/db/689460/True_Ventures>,
        <https://1145.am/db/694513/Authentic_Ventures>,
        <https://1145.am/db/694924/Avid_Ventures>,
        <https://1145.am/db/700171/Sequoia_Capital>,
        <https://1145.am/db/700327/Menlo_Ventures>,
        <https://1145.am/db/700877/Gaingels>,
        <https://1145.am/db/703983/Eqventure>,
        <https://1145.am/db/704489/Eqventure>,
        <https://1145.am/db/704753/Felicis_Ventures>,
        <https://1145.am/db/704753/Menlo_Ventures>,
        <https://1145.am/db/704793/Quidnet_Ventures>,
        <https://1145.am/db/704991/Gaingels>,
        <https://1145.am/db/709633/Connetic_Ventures>,
        <https://1145.am/db/726461/Contour_Ventures>,
        <https://1145.am/db/729628/Kyber_Ventures>,
        <https://1145.am/db/729628/Signum_Capital>,
        <https://1145.am/db/738920/Oca_Ventures>,
        <https://1145.am/db/738920/Susa_Ventures>,
        <https://1145.am/db/739538/Morpheus_Ventures>,
        <https://1145.am/db/739538/Oca_Ventures>,
        <https://1145.am/db/739538/Susa_Ventures>,
        <https://1145.am/db/747051/Tenoneten_Ventures>,
        <https://1145.am/db/747771/Ta_Ventures>,
        <https://1145.am/db/749147/1984_Ventures>,
        <https://1145.am/db/749147/Index_Ventures>,
        <https://1145.am/db/749209/1984_Ventures>,
        <https://1145.am/db/749209/Index_Ventures>,
        <https://1145.am/db/750305/Yl_Ventures>,
        <https://1145.am/db/750725/Vestigo_Ventures>,
        <https://1145.am/db/751176/Maverick_Ventures>,
        <https://1145.am/db/751176/Susa_Ventures>,
        <https://1145.am/db/751387/Menlo_Ventures>,
        <https://1145.am/db/753120/Sequoia_Capital>,
        <https://1145.am/db/753251/Savantus_Ventures>,
        <https://1145.am/db/753913/Brunnur_Ventures>,
        <https://1145.am/db/755844/Sequoia_Capital>,
        <https://1145.am/db/758206/Great_North_Ventures>,
        <https://1145.am/db/758206/Grotech_Ventures>,
        <https://1145.am/db/759749/Cava_Capital>,
        <https://1145.am/db/763083/Gaingels>,
        <https://1145.am/db/764875/Rev1_Ventures>,
        <https://1145.am/db/764896/Rev1_Ventures>,
        <https://1145.am/db/765216/True_Ventures>,
        <https://1145.am/db/768172/Gaingels>,
        <https://1145.am/db/768172/Type_One_Ventures>,
        <https://1145.am/db/768349/Salesforce_Ventures>,
        <https://1145.am/db/768852/Felicis_Ventures>,
        <https://1145.am/db/769568/Axon_Ventures>,
        <https://1145.am/db/772099/Array_Ventures>,
        <https://1145.am/db/773235/Prelude_Ventures>,
        <https://1145.am/db/773684/Fulgur_Ventures>,
        <https://1145.am/db/773794/Array_Ventures>,
        <https://1145.am/db/778025/Felicis_Ventures>,
        <https://1145.am/db/778423/Sentiero_Ventures>,
        <https://1145.am/db/779637/Felicis_Ventures>,
        <https://1145.am/db/779867/Genesis_Block_Ventures>,
        <https://1145.am/db/780272/East_Ventures>,
        <https://1145.am/db/780289/East_Ventures>,
        <https://1145.am/db/783431/Cathay_Venture_Inc>,
        <https://1145.am/db/784093/Boldstart_Ventures>,
        <https://1145.am/db/787806/Boldstart_Ventures>,
        <https://1145.am/db/788016/Boldstart_Ventures>,
        <https://1145.am/db/791505/Index_Ventures>,
        <https://1145.am/db/796250/Sp_Ventures>,
        <https://1145.am/db/796629/Index_Ventures>,
        <https://1145.am/db/797597/Lansdowne_Partners>,
        <https://1145.am/db/798095/Index_Ventures>,
        <https://1145.am/db/798753/Sofinnova_Partners>,
        <https://1145.am/db/800093/Sequoia_Capital>,
        <https://1145.am/db/800101/Gaingels>,
        <https://1145.am/db/803541/Credo_Ventures>,
        <https://1145.am/db/803541/Index_Ventures>,
        <https://1145.am/db/803541/Sequoia_Capital>,
        <https://1145.am/db/8045/Greatpoint_Ventures>,
        <https://1145.am/db/806828/Promus_Ventures>,
        <https://1145.am/db/806994/Companyon_Ventures>,
        <https://1145.am/db/807080/K3_Ventures>,
        <https://1145.am/db/808020/Starlight_Ventures>,
        <https://1145.am/db/808020/Valo_Ventures>,
        <https://1145.am/db/8146/Rev1_Ventures>,
        <https://1145.am/db/817162/Orbia_Ventures>,
        <https://1145.am/db/818444/1984_Ventures>,
        <https://1145.am/db/821135/Se_Ventures>,
        <https://1145.am/db/823763/Infinity_Ventures>,
        <https://1145.am/db/828716/Idc_Ventures>,
        <https://1145.am/db/829118/Salesforce_Ventures>,
        <https://1145.am/db/830571/Company_Ventures>,
        <https://1145.am/db/830689/Soleus_Capital>,
        <https://1145.am/db/832264/Salesforce_Ventures>,
        <https://1145.am/db/832573/Solasta_Ventures>,
        <https://1145.am/db/834864/Ggv_Capital>,
        <https://1145.am/db/834864/K3_Ventures>,
        <https://1145.am/db/836848/Technexus_Venture_Collaborative>,
        <https://1145.am/db/836908/Frontier_Ventures>,
        <https://1145.am/db/837034/Redpoint_Ventures>,
        <https://1145.am/db/838138/Root_Ventures>,
        <https://1145.am/db/838181/Sequoia_Capital>,
        <https://1145.am/db/838691/Crosslink_Capital>,
        <https://1145.am/db/847157/Signum_Capital>,
        <https://1145.am/db/847862/Wise_Ventures>,
        <https://1145.am/db/854001/Gv>,
        <https://1145.am/db/854589/Verance_Capital>,
        <https://1145.am/db/854654/Mrtnz_Ventures>,
        <https://1145.am/db/854795/Menlo_Ventures>,
        <https://1145.am/db/867865/Applied_Ventures>,
        <https://1145.am/db/868093/Cobro_Ventures>,
        <https://1145.am/db/869652/Forever_Ventures>,
        <https://1145.am/db/874394/Nextview_Ventures>,
        <https://1145.am/db/874394/True_Ventures>,
        <https://1145.am/db/880050/Crosslink_Capital>,
        <https://1145.am/db/881298/At_One_Ventures>,
        <https://1145.am/db/882723/At_One_Ventures>,
        <https://1145.am/db/884787/Foresite_Capital>,
        <https://1145.am/db/884787/Gv>,
        <https://1145.am/db/884787/Northpond_Ventures>,
        <https://1145.am/db/886445/Gv>,
        <https://1145.am/db/887062/Panoramic_Ventures>,
        <https://1145.am/db/889246/At_One_Ventures>,
        <https://1145.am/db/890271/Panoramic_Ventures>,
        <https://1145.am/db/891162/Emergingvc>,
        <https://1145.am/db/891162/Launchpad_Venture_Group>,
        <https://1145.am/db/903689/Vectr_Ventures>,
        <https://1145.am/db/904276/Nextview_Ventures>,
        <https://1145.am/db/906393/East_Ventures>,
        <https://1145.am/db/907844/Argon_Ventures>,
        <https://1145.am/db/907844/Glasswing_Ventures>,
        <https://1145.am/db/913422/Sequoia_Capital>,
        <https://1145.am/db/913678/Sandbridge_Capital>,
        <https://1145.am/db/919636/Menlo_Ventures>,
        <https://1145.am/db/921704/Scop_Ventures>,
        <https://1145.am/db/92200/Knoll_Ventures>,
        <https://1145.am/db/922066/Irrvrnt_Vc>,
        <https://1145.am/db/922192/Gv>,
        <https://1145.am/db/922498/Sozo_Ventures>,
        <https://1145.am/db/923723/Scop_Ventures>,
        <https://1145.am/db/928711/Frontline_Ventures>,
        <https://1145.am/db/934946/Ggv_Capital>,
        <https://1145.am/db/935046/Origin_Ventures>,
        <https://1145.am/db/935249/Victress_Capital>,
        <https://1145.am/db/935322/Alpana_Ventures>,
        <https://1145.am/db/935322/M_Ventures>,
        <https://1145.am/db/935796/Salesforce_Ventures>,
        <https://1145.am/db/935962/Digitalbridge_Ventures>,
        <https://1145.am/db/936045/Lpc_Ventures>,
        <https://1145.am/db/936057/Noemis_Ventures>,
        <https://1145.am/db/936154/Salesforce_Ventures>,
        <https://1145.am/db/936448/Ggv_Capital>,
        <https://1145.am/db/936862/Lool_Ventures>,
        <https://1145.am/db/936906/Neotribe_Ventures>,
        <https://1145.am/db/937210/Citi_Ventures>,
        <https://1145.am/db/937210/Firebolt_Ventures>,
        <https://1145.am/db/937460/Sequoia_Capital>,
        <https://1145.am/db/938108/Conti_Ventures>,
        <https://1145.am/db/938555/Digitalbridge_Ventures>,
        <https://1145.am/db/938586/Venturesouth>,
        <https://1145.am/db/938921/Redpoint_Ventures>,
        <https://1145.am/db/938975/Ggv_Capital>,
        <https://1145.am/db/939163/Goodyear_Ventures>,
        <https://1145.am/db/940740/Agnc_Ventures>,
        <https://1145.am/db/940913/True_Ventures>,
        <https://1145.am/db/941816/Radical_Ventures>,
        <https://1145.am/db/942825/Argon_Ventures>,
        <https://1145.am/db/946710/Citi_Ventures>,
        <https://1145.am/db/947238/Kyros_Ventures>,
        <https://1145.am/db/952434/Verissimo_Ventures>,
        <https://1145.am/db/955201/Gv>,
        <https://1145.am/db/960022/Verance_Capital>,
        <https://1145.am/db/961837/Sequoia_Capital>,
        <https://1145.am/db/962622/Sequoia_Capital>,
        <https://1145.am/db/970950/Ulu_Ventures>,
        <https://1145.am/db/971415/Altai_Ventures>,
        <https://1145.am/db/971450/Allon_Ventures>,
        <https://1145.am/db/971939/Formic_Ventures>,
        <https://1145.am/db/975114/Formic_Ventures>,
        <https://1145.am/db/979753/Menlo_Ventures>,
        <https://1145.am/db/980678/Menlo_Ventures>,
        <https://1145.am/db/984645/Vinco_Ventures>,
        <https://1145.am/db/987688/Brightspark_Ventures>,
        <https://1145.am/db/987700/Infinityvc>,
        <https://1145.am/db/988084/Abstract_Ventures>,
        <https://1145.am/db/988084/Blank_Ventures>,
        <https://1145.am/db/988318/Arthur_Ventures>,
        <https://1145.am/db/988482/Brightspark_Ventures>,
        <https://1145.am/db/988979/Infinityvc>,
        <https://1145.am/db/989392/Arthur_Ventures>,
        <https://1145.am/db/990085/Radical_Ventures>,
        <https://1145.am/db/995593/Raiven_Capital>,
        <https://1145.am/db/995737/Nuoyan_Capital>,
        <https://1145.am/db/996563/Raiven_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1039135/Sofinnova_Partners>,
        <https://1145.am/db/1054859/Sofinnova_Partners>,
        <https://1145.am/db/1112260/Sofinnova_Partners>,
        <https://1145.am/db/1113007/Sofinnova_Partners>,
        <https://1145.am/db/1118732/Sofinnova_Partners>,
        <https://1145.am/db/1196006/Sofinnova_Partners>,
        <https://1145.am/db/1196618/Sofinnova_Partners>,
        <https://1145.am/db/1199155/Sofinnova_Partners>,
        <https://1145.am/db/1419128/Sofinnova_Partners>,
        <https://1145.am/db/1490997/Sofinnova_Partners>,
        <https://1145.am/db/1583413/Sofinnova_Partners>,
        <https://1145.am/db/1584328/Sofinnova_Partners>,
        <https://1145.am/db/1618717/Sofinnova_Partners>,
        <https://1145.am/db/1619418/Sofinnova_Partners>,
        <https://1145.am/db/1707724/Sofinnova_Partners>,
        <https://1145.am/db/1722774/Sofinnova_Partners>,
        <https://1145.am/db/1735325/Sofinnova_Partners>,
        <https://1145.am/db/1773491/Sofinnova_Partners>,
        <https://1145.am/db/1802402/Sofinnova_Partners>,
        <https://1145.am/db/1876390/Sofinnova_Partners>,
        <https://1145.am/db/1892777/Sofinnova_Partners>,
        <https://1145.am/db/1919228/Sofinnova_Partners>,
        <https://1145.am/db/1928060/Sofinnova_Partners>,
        <https://1145.am/db/1975388/Sofinnova_Partners>,
        <https://1145.am/db/2066938/Sofinnova_Partners>,
        <https://1145.am/db/2075963/Sofinnova_Partners>,
        <https://1145.am/db/2152180/Sofinnova_Partners>,
        <https://1145.am/db/2153042/Sofinnova_Partners>,
        <https://1145.am/db/2153373/Sofinnova_Partners>,
        <https://1145.am/db/2280230/Sofinnova_Partners>,
        <https://1145.am/db/2282400/Sofinnova_Partners>,
        <https://1145.am/db/2282747/Sofinnova_Partners>,
        <https://1145.am/db/2286182/Sofinnova_Partners>,
        <https://1145.am/db/2286404/Sofinnova_Partners>,
        <https://1145.am/db/2288699/Sofinnova_Partners>,
        <https://1145.am/db/2291023/Sofinnova_Partners>,
        <https://1145.am/db/2291790/Sofinnova_Partners>,
        <https://1145.am/db/2294367/Sofinnova_Partners>,
        <https://1145.am/db/2294502/Sofinnova_Partners>,
        <https://1145.am/db/2297649/Sofinnova_Partners>,
        <https://1145.am/db/2298624/Sofinnova_Partners>,
        <https://1145.am/db/2298631/Sofinnova_Partners>,
        <https://1145.am/db/2298641/Sofinnova_Partners>,
        <https://1145.am/db/2299758/Sofinnova_Partners>,
        <https://1145.am/db/2302741/Sofinnova_Partners>,
        <https://1145.am/db/2303849/Sofinnova_Partners>,
        <https://1145.am/db/2306395/Sofinnova_Partners>,
        <https://1145.am/db/2321542/Sofinnova_Partners>,
        <https://1145.am/db/2322646/Sofinnova_Partners>,
        <https://1145.am/db/2323100/Sofinnova_Partners>,
        <https://1145.am/db/2323102/Sofinnova_Partners>,
        <https://1145.am/db/2323243/Sofinnova_Partners>,
        <https://1145.am/db/2324027/Sofinnova_Partners>,
        <https://1145.am/db/2324034/Sofinnova_Partners>,
        <https://1145.am/db/2325549/Sofinnova_Partners>,
        <https://1145.am/db/2327222/Sofinnova_Partners>,
        <https://1145.am/db/2328763/Sofinnova_Partners>,
        <https://1145.am/db/2328769/Sofinnova_Partners>,
        <https://1145.am/db/2328825/Sofinnova_Partners>,
        <https://1145.am/db/2330876/Sofinnova_Partners>,
        <https://1145.am/db/2335582/Sofinnova_Partners>,
        <https://1145.am/db/2336333/Sofinnova_Partners>,
        <https://1145.am/db/2336335/Sofinnova_Partners>,
        <https://1145.am/db/2339692/Sofinnova_Partners>,
        <https://1145.am/db/2343301/Sofinnova_Partners>,
        <https://1145.am/db/2343545/Sofinnova_Partners>,
        <https://1145.am/db/2349013/Sofinnova_Partners>,
        <https://1145.am/db/2354296/Sofinnova_Partners>,
        <https://1145.am/db/2355740/Sofinnova_Partners>,
        <https://1145.am/db/2355741/Sofinnova_Partners>,
        <https://1145.am/db/2355885/Sofinnova_Partners>,
        <https://1145.am/db/2358268/Sofinnova_Partners>,
        <https://1145.am/db/2358269/Sofinnova_Partners>,
        <https://1145.am/db/236357/Sofinnova_Partners>,
        <https://1145.am/db/2363593/Sofinnova_Partners>,
        <https://1145.am/db/2363597/Sofinnova_Partners>,
        <https://1145.am/db/2365826/Sofinnova_Partners>,
        <https://1145.am/db/2366303/Sofinnova_Partners>,
        <https://1145.am/db/2367549/Sofinnova_Partners>,
        <https://1145.am/db/2370118/Sofinnova_Partners>,
        <https://1145.am/db/2538923/Sofinnova_Partners>,
        <https://1145.am/db/2555540/Sofinnova_Partners>,
        <https://1145.am/db/2571050/Sofinnova_Partners>,
        <https://1145.am/db/2578627/Sofinnova_Partners>,
        <https://1145.am/db/2765863/Sofinnova_Partners>,
        <https://1145.am/db/2765866/Sofinnova_Partners>,
        <https://1145.am/db/2765873/Sofinnova_Partners>,
        <https://1145.am/db/530060/Sofinnova_Partners>,
        <https://1145.am/db/555385/Sofinnova_Partners>,
        <https://1145.am/db/577785/Sofinnova_Partners>,
        <https://1145.am/db/595282/Sofinnova_Partners>,
        <https://1145.am/db/602316/Sofinnova_Partners>,
        <https://1145.am/db/695229/Sofinnova_Partners>,
        <https://1145.am/db/695704/Sofinnova_Partners>,
        <https://1145.am/db/810584/Sofinnova_Partners>,
        <https://1145.am/db/955355/Sofinnova_Partners>,
        <https://1145.am/db/992046/Sofinnova_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360006/Prospect_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "CA" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-10-18T15:40:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TOPICA Announces Completion of $27 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/topica-announces-completion-of-27-million-series-b-financing> ;
    ns1:foundName "Prospect Venture Partners" ;
    ns1:investor <https://1145.am/db/2360006/Series_B_Investment_Prospect_Venture_Partners_Topica_Pharmaceuticals_Third_Rock_Ventures_Yasuda_Enterprise_Development_Corporation_Completed> ;
    ns1:name "Prospect Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1754484/Top_Tier_Capital_Partners>,
        <https://1145.am/db/1755860/Vs_Partners>,
        <https://1145.am/db/1767026/Target_Partners>,
        <https://1145.am/db/1789767/Group_11>,
        <https://1145.am/db/1853417/New_Markets_Venture_Partners>,
        <https://1145.am/db/1855529/Target_Partners>,
        <https://1145.am/db/1856228/Venture_Partners>,
        <https://1145.am/db/1858991/Target_Partners>,
        <https://1145.am/db/1859494/Partners_Investment>,
        <https://1145.am/db/1928828/Top_Tier_Capital_Partners>,
        <https://1145.am/db/2222905/Venture_Capitalists>,
        <https://1145.am/db/2299743/Venture_Investors>,
        <https://1145.am/db/2309506/Prospect_Venture_Partners>,
        <https://1145.am/db/2330852/Prospect_Venture_Partners>,
        <https://1145.am/db/2331868/Prospect_Venture_Partners>,
        <https://1145.am/db/2337972/Venture_Investments>,
        <https://1145.am/db/2352804/Prospect_Venture_Partners>,
        <https://1145.am/db/2357333/Investinor>,
        <https://1145.am/db/2370798/Investinor>,
        <https://1145.am/db/396235/Top_Tier_Capital_Partners>,
        <https://1145.am/db/588551/Citi_Ventures>,
        <https://1145.am/db/704753/Target_Partners>,
        <https://1145.am/db/734448/Venture_Investments>,
        <https://1145.am/db/838181/Index_Venture_Capital>,
        <https://1145.am/db/893076/Top_Tier_Capital_Partners>,
        <https://1145.am/db/893316/Top_Tier_Capital_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/2300697/Prospect_Venture_Partners>,
        <https://1145.am/db/2303219/Prospect_Venture_Partners>,
        <https://1145.am/db/2308758/Prospect_Venture_Partners>,
        <https://1145.am/db/2309507/Prospect_Venture_Partners>,
        <https://1145.am/db/2314964/Prospect_Venture_Partners>,
        <https://1145.am/db/2319809/Prospect_Venture_Partners>,
        <https://1145.am/db/2323578/Prospect_Venture_Partners>,
        <https://1145.am/db/2330712/Prospect_Venture_Partners>,
        <https://1145.am/db/2331754/Prospect_Venture_Partners>,
        <https://1145.am/db/2339883/Prospect_Venture_Partners>,
        <https://1145.am/db/2340224/Prospect_Venture_Partners>,
        <https://1145.am/db/2352807/Prospect_Venture_Partners>,
        <https://1145.am/db/2358234/Prospect_Venture_Partners>,
        <https://1145.am/db/2360004/Prospect_Venture_Partners>,
        <https://1145.am/db/2364505/Prospect_Venture_Partners>,
        <https://1145.am/db/2367442/Prospect_Venture_Partners>,
        <https://1145.am/db/2367448/Prospect_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360006/Yasuda_Enterprise_Development_Corporation> a org:Organization ;
    ns1:basedInLowRaw "Japan" ;
    ns1:documentDate "2011-10-18T15:40:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TOPICA Announces Completion of $27 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/topica-announces-completion-of-27-million-series-b-financing> ;
    ns1:foundName "Yasuda Enterprise Development Corporation, Ltd" ;
    ns1:investor <https://1145.am/db/2360006/Series_B_Investment_Prospect_Venture_Partners_Topica_Pharmaceuticals_Third_Rock_Ventures_Yasuda_Enterprise_Development_Corporation_Completed> ;
    ns1:name "Yasuda Enterprise Development Corporation" ;
    ns1:sameAsMedium <https://1145.am/db/2308148/Yasuda_Enterprise_Development>,
        <https://1145.am/db/2318781/Yasuda_Enterprise_Development>,
        <https://1145.am/db/2318796/Yasuda_Enterprise_Development>,
        <https://1145.am/db/2360004/Yasuda_Enterprise_Development_Corporation>,
        <https://1145.am/db/2367497/Yasuda_Enterprise_Development_Company> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360945/Emerging_Technology_Partners_Llc> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:description "Investing in technology" ;
    ns1:documentDate "2012-01-23T17:42:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "EntreMed Secures $10 Million Strategic Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/entremed-secures-10-million-strategic-financing> ;
    ns1:foundName "Emerging Technology Partners, LLC" ;
    ns1:investor <https://1145.am/db/2360945/Investment_Emerging_Technology_Partners_Llc_Entremed_Idg-Accel_China_Growth_Fund_Ii_Lp_Tak_W_Mak_Completed> ;
    ns1:name "Emerging Technology Partners, LLC" ;
    ns1:sameAsHigh <https://1145.am/db/2359926/Emerging_Technology_Partners_Llc> ;
    ns1:sameAsMedium <https://1145.am/db/2359951/Emerging_Technology_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360945/Idg-Accel_China_Growth_Fund_Ii_Lp> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:description "Investing in technology" ;
    ns1:documentDate "2012-01-23T17:42:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "EntreMed Secures $10 Million Strategic Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/entremed-secures-10-million-strategic-financing> ;
    ns1:foundName "IDG-Accel China Growth Fund II L.P." ;
    ns1:investor <https://1145.am/db/2360945/Investment_Emerging_Technology_Partners_Llc_Entremed_Idg-Accel_China_Growth_Fund_Ii_Lp_Tak_W_Mak_Completed> ;
    ns1:name "IDG-Accel China Growth Fund II L.P." ;
    ns1:sameAsHigh <https://1145.am/db/2359926/Idg-Accel_China_Growth_Fund_Ii_Lp> ;
    ns1:sameAsMedium <https://1145.am/db/2359951/Idg-Accel_China_Growth_Fund_Ii>,
        <https://1145.am/db/2370424/Idg-Accel_China_Growth_Fund_Iii_Lp>,
        <https://1145.am/db/2540395/Idg-Accel_China_Growth_Fund_Iii_Lp> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360945/Tak_W_Mak> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:description "cancer research" ;
    ns1:documentDate "2012-01-23T17:42:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "EntreMed Secures $10 Million Strategic Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/entremed-secures-10-million-strategic-financing> ;
    ns1:foundName "Dr. Tak W. Mak",
        "Tak W. Mak" ;
    ns1:industry "pharmaceutical" ;
    ns1:investor <https://1145.am/db/2360945/Investment_Emerging_Technology_Partners_Llc_Entremed_Idg-Accel_China_Growth_Fund_Ii_Lp_Tak_W_Mak_Completed> ;
    ns1:name "Tak W. Mak" ;
    ns1:sameAsHigh <https://1145.am/db/1685745/Dmk_Pharmaceuticals_Corp>,
        <https://1145.am/db/2282222/Igm_Biosciences>,
        <https://1145.am/db/2313216/Bipar_Sciences>,
        <https://1145.am/db/2359926/Tak_W_Mak>,
        <https://1145.am/db/2359951/Tak_W_Mak> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2361022/Atlas_Venture> a org:Organization ;
    ns1:basedInHighGeoName "Cambridgeshire" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2653940/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE" ;
    ns1:documentDate "2011-10-19T13:49:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Arteaus Therapeutics, LLC Raises $18M to Prevent Migraines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/arteaus-therapeutics-llc-raises-18m-to-prevent-migraines> ;
    ns1:foundName "Atlas Venture" ;
    ns1:investor <https://1145.am/db/2361022/Investment_Arteaus_Therapeutics_Atlas_Venture_Orbimed_Advisors_Completed> ;
    ns1:name "Atlas Venture" ;
    ns1:sameAsMedium <https://1145.am/db/1334624/Atlas_Venture>,
        <https://1145.am/db/1608803/Atlas_Venture>,
        <https://1145.am/db/1698345/Atlas_Venture>,
        <https://1145.am/db/1788233/Atlas_Venture>,
        <https://1145.am/db/1814782/Atlas_Venture>,
        <https://1145.am/db/1824026/Atlas_Venture>,
        <https://1145.am/db/1824878/Atlas_Venture>,
        <https://1145.am/db/1827753/Atlas_Venture>,
        <https://1145.am/db/1828416/Atlas_Venture>,
        <https://1145.am/db/1830149/Atlas_Venture>,
        <https://1145.am/db/1833567/Atlas_Venture>,
        <https://1145.am/db/1834305/Atlas_Venture>,
        <https://1145.am/db/1838696/Atlas_Venture>,
        <https://1145.am/db/1838850/Atlas_Venture>,
        <https://1145.am/db/1838944/Atlas_Venture>,
        <https://1145.am/db/1838979/Atlas_Venture>,
        <https://1145.am/db/1840388/Atlas_Venture>,
        <https://1145.am/db/1840776/Atlas_Venture>,
        <https://1145.am/db/1841385/Atlas_Venture>,
        <https://1145.am/db/1843823/Atlas_Venture>,
        <https://1145.am/db/1847483/Atlas_Venture>,
        <https://1145.am/db/1855553/Atlas_Venture>,
        <https://1145.am/db/1855780/Atlas_Venture>,
        <https://1145.am/db/1857243/Atlas_Venture>,
        <https://1145.am/db/1857978/Atlas_Venture>,
        <https://1145.am/db/1858399/Atlas_Venture>,
        <https://1145.am/db/1863373/Atlas_Venture>,
        <https://1145.am/db/1868932/Atlas_Venture>,
        <https://1145.am/db/1877727/Atlas_Venture>,
        <https://1145.am/db/1878546/Atlas_Venture>,
        <https://1145.am/db/1880181/Atlas_Venture>,
        <https://1145.am/db/1880537/Atlas_Venture>,
        <https://1145.am/db/1891067/Atlas_Venture>,
        <https://1145.am/db/1893502/Atlas_Venture>,
        <https://1145.am/db/1895072/Atlas_Venture>,
        <https://1145.am/db/1901641/Atlas_Venture>,
        <https://1145.am/db/1913598/Atlas_Venture>,
        <https://1145.am/db/1917671/Atlas_Venture>,
        <https://1145.am/db/2062003/Atlas_Venture>,
        <https://1145.am/db/2109798/Atlas_Venture>,
        <https://1145.am/db/2110113/Atlas_Venture>,
        <https://1145.am/db/2178988/Atlas_Venture>,
        <https://1145.am/db/2286541/Atlas_Venture>,
        <https://1145.am/db/2287244/Atlas_Venture>,
        <https://1145.am/db/2290028/Atlas_Venture>,
        <https://1145.am/db/2292284/Atlas_Venture>,
        <https://1145.am/db/2297439/Atlas_Venture>,
        <https://1145.am/db/2298485/Atlas_Venture>,
        <https://1145.am/db/2299411/Atlas_Venture>,
        <https://1145.am/db/2299772/Atlas_Venture>,
        <https://1145.am/db/2303656/Atlas_Venture>,
        <https://1145.am/db/2304044/Atlas_Venture>,
        <https://1145.am/db/2304237/Atlas_Venture>,
        <https://1145.am/db/2309821/Atlas_Venture>,
        <https://1145.am/db/2309840/Atlas_Venture>,
        <https://1145.am/db/2309847/Atlas_Venture>,
        <https://1145.am/db/2310940/Atlas_Venture>,
        <https://1145.am/db/2318778/Atlas_Venture>,
        <https://1145.am/db/2319412/Atlas_Venture>,
        <https://1145.am/db/2325326/Atlas_Venture>,
        <https://1145.am/db/2327406/Atlas_Venture>,
        <https://1145.am/db/2330852/Atlas_Venture>,
        <https://1145.am/db/2330882/Atlas_Venture>,
        <https://1145.am/db/2331870/Atlas_Venture>,
        <https://1145.am/db/2333601/Atlas_Venture>,
        <https://1145.am/db/2336782/Atlas_Venture>,
        <https://1145.am/db/2337455/Atlas_Venture>,
        <https://1145.am/db/2340096/Atlas_Venture>,
        <https://1145.am/db/2340581/Atlas_Venture>,
        <https://1145.am/db/2341478/Atlas_Venture>,
        <https://1145.am/db/2347106/Atlas_Venture>,
        <https://1145.am/db/2347682/Atlas_Venture>,
        <https://1145.am/db/2352967/Atlas_Venture>,
        <https://1145.am/db/2353524/Atlas_Venture>,
        <https://1145.am/db/2353525/Atlas_Venture>,
        <https://1145.am/db/2354307/Atlas_Venture>,
        <https://1145.am/db/2354314/Atlas_Venture>,
        <https://1145.am/db/2354856/Atlas_Venture>,
        <https://1145.am/db/2355609/Atlas_Venture>,
        <https://1145.am/db/2356048/Atlas_Venture>,
        <https://1145.am/db/2357676/Atlas_Venture>,
        <https://1145.am/db/2357679/Atlas_Venture>,
        <https://1145.am/db/2357682/Atlas_Venture>,
        <https://1145.am/db/2357905/Atlas_Venture>,
        <https://1145.am/db/2358301/Atlas_Venture>,
        <https://1145.am/db/2358860/Atlas_Venture>,
        <https://1145.am/db/2359683/Atlas_Venture>,
        <https://1145.am/db/2359818/Atlas_Venture>,
        <https://1145.am/db/2360814/Atlas_Venture>,
        <https://1145.am/db/2361018/Atlas_Venture>,
        <https://1145.am/db/2361027/Atlas_Venture>,
        <https://1145.am/db/2363396/Atlas_Venture>,
        <https://1145.am/db/2365103/Atlas_Venture>,
        <https://1145.am/db/2367740/Atlas_Venture>,
        <https://1145.am/db/2369004/Atlas_Venture>,
        <https://1145.am/db/2369718/Atlas_Venture>,
        <https://1145.am/db/2370094/Atlas_Venture>,
        <https://1145.am/db/2370540/Atlas_Venture>,
        <https://1145.am/db/2570138/Atlas_Venture>,
        <https://1145.am/db/2573068/Atlas_Venture>,
        <https://1145.am/db/2638432/Atlas_Venture>,
        <https://1145.am/db/2787561/Atlas_Venture>,
        <https://1145.am/db/545988/Atlas_Venture>,
        <https://1145.am/db/75445/Atlas_Venture>,
        <https://1145.am/db/979509/Atlas_Venture> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362024/Series_A_Investment_Dermira_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-10-21T12:34:34+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Dermira Announces a $ 42m Series A Financing to Fund Therapeutic Advances in Dermatology.",
        "REDWOOD CITY, Calif., Oct 20, 2011 (BUSINESS WIRE) - Dermira today announced a $ 42 million Series A financing to support the acquisition, development and commercialization of novel therapeutics in dermatology." ;
    ns1:documentTitle "Dermira Announces a $42m Series A Financing to Fund Therapeutic Advances in Dermatology" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dermira-announces-a-42m-series-a-financing-to-fund-therapeutic-advances-dermatology> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2362024/Dermira> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 42 million",
        "$ 42m" ;
    ns1:whenRaw "2011" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2364014/Birk_Venture> a org:Organization ;
    ns1:basedInLowRaw "Norway" ;
    ns1:documentDate "2012-02-02T11:42:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Targovax Secures NOK 13 Million Series A Funding for TGO1 Pancreatic Cancer Vaccine Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/targovax-secures-nok-13-million-series-a-funding-for-tgo1-pancreatic-cancer-vaccine> ;
    ns1:foundName "Birk Venture" ;
    ns1:investor <https://1145.am/db/2364014/Investment_Birk_Venture_Ro_Invest_Radium_Hospital_Research_Foundation_Targovax_Has_Not_Happened> ;
    ns1:name "Birk Venture" ;
    ns1:sameAsMedium <https://1145.am/db/2363043/Birk_Venture>,
        <https://1145.am/db/2594440/Birk_Venture> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364014/Innovation_Norway> a org:Organization ;
    ns1:basedInLowRaw "Norway" ;
    ns1:documentDate "2012-02-02T11:42:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Targovax Secures NOK 13 Million Series A Funding for TGO1 Pancreatic Cancer Vaccine Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/targovax-secures-nok-13-million-series-a-funding-for-tgo1-pancreatic-cancer-vaccine> ;
    ns1:foundName "Innovation Norway" ;
    ns1:investor <https://1145.am/db/2364014/Investment_Innovation_Norway_Has_Not_Happened> ;
    ns1:name "Innovation Norway" ;
    ns1:sameAsMedium <https://1145.am/db/2363043/Innovation_Norway>,
        <https://1145.am/db/2594440/Innovation_Norway> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364014/Radium_Hospital_Research_Foundation> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Norway" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3144096/about.rdf> ;
    ns1:basedInHighRaw "Norway" ;
    ns1:documentDate "2012-02-02T11:42:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Targovax Secures NOK 13 Million Series A Funding for TGO1 Pancreatic Cancer Vaccine Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/targovax-secures-nok-13-million-series-a-funding-for-tgo1-pancreatic-cancer-vaccine> ;
    ns1:foundName "the Radium Hospital Research Foundation" ;
    ns1:investor <https://1145.am/db/2364014/Investment_Birk_Venture_Ro_Invest_Radium_Hospital_Research_Foundation_Targovax_Has_Not_Happened> ;
    ns1:name "Radium Hospital Research Foundation" ;
    ns1:sameAsMedium <https://1145.am/db/2362635/Radium_Hospital_Research_Foundation>,
        <https://1145.am/db/2363043/Radium_Hospital_Research_Foundation>,
        <https://1145.am/db/2594440/Radium_Hospital_Research_Foundation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364014/Ro_Invest> a org:Organization ;
    ns1:basedInLowRaw "Norway" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-02-02T11:42:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Targovax Secures NOK 13 Million Series A Funding for TGO1 Pancreatic Cancer Vaccine Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/targovax-secures-nok-13-million-series-a-funding-for-tgo1-pancreatic-cancer-vaccine> ;
    ns1:foundName "RO Invest" ;
    ns1:investor <https://1145.am/db/2364014/Investment_Birk_Venture_Ro_Invest_Radium_Hospital_Research_Foundation_Targovax_Has_Not_Happened> ;
    ns1:name "RO Invest" ;
    ns1:sameAsHigh <https://1145.am/db/1006950/Shell_Ventures>,
        <https://1145.am/db/1014186/Soma_Capital>,
        <https://1145.am/db/1014305/Sp_Ventures>,
        <https://1145.am/db/1049509/021_Capital>,
        <https://1145.am/db/1083572/Spero_Ventures>,
        <https://1145.am/db/1085737/Spero_Ventures>,
        <https://1145.am/db/1106541/Jumpstart_Ventures>,
        <https://1145.am/db/1119699/Xplorer_Capital>,
        <https://1145.am/db/1122750/Xplorer_Capital>,
        <https://1145.am/db/1133402/Silicon_Road_Ventures>,
        <https://1145.am/db/1134486/Silicon_Road_Ventures>,
        <https://1145.am/db/1140286/B_Capital_Group>,
        <https://1145.am/db/1140286/Commerce_Ventures>,
        <https://1145.am/db/1151339/Big_Idea_Ventures>,
        <https://1145.am/db/1165515/Jumpstart_Ventures>,
        <https://1145.am/db/1174129/Stage_1_Ventures>,
        <https://1145.am/db/1175198/Sure_Ventures>,
        <https://1145.am/db/1175459/Khosla_Ventures>,
        <https://1145.am/db/1196728/Gsr_Ventures>,
        <https://1145.am/db/1199177/Gsr_Ventures>,
        <https://1145.am/db/1200402/Xseed_Capital>,
        <https://1145.am/db/1232192/Lfg_Ventures>,
        <https://1145.am/db/1238845/Union_Square_Ventures>,
        <https://1145.am/db/1247755/Syn_Ventures>,
        <https://1145.am/db/1248631/Syn_Ventures>,
        <https://1145.am/db/1269968/Usvp>,
        <https://1145.am/db/1282835/Khosla_Ventures>,
        <https://1145.am/db/1285848/Syn_Ventures>,
        <https://1145.am/db/1287496/D1_Capital>,
        <https://1145.am/db/1288309/Psl_Ventures>,
        <https://1145.am/db/1322711/Venture_Stars>,
        <https://1145.am/db/1329887/Shell_Ventures>,
        <https://1145.am/db/1329887/Sosv>,
        <https://1145.am/db/1340587/Xseed_Capital>,
        <https://1145.am/db/1341445/Xseed_Capital>,
        <https://1145.am/db/1354722/Psl_Ventures>,
        <https://1145.am/db/1354749/Psl_Ventures>,
        <https://1145.am/db/1375916/Sv_Pacific_Ventures>,
        <https://1145.am/db/1376353/Sv_Pacific_Ventures>,
        <https://1145.am/db/1394919/Exsight_Ventures>,
        <https://1145.am/db/1408996/Khosla_Ventures>,
        <https://1145.am/db/1419583/Strongher_Vc>,
        <https://1145.am/db/1419583/Venture_Catalyst>,
        <https://1145.am/db/1445935/97212_Ventures>,
        <https://1145.am/db/1452107/Soma_Capital>,
        <https://1145.am/db/1454909/Us_Venture_Partners>,
        <https://1145.am/db/1455119/Jumpstart_Ventures>,
        <https://1145.am/db/1455616/Soma_Capital>,
        <https://1145.am/db/1468368/Sanabil_Investments>,
        <https://1145.am/db/1470303/Union_Square_Ventures>,
        <https://1145.am/db/1475091/Soma_Capital>,
        <https://1145.am/db/1489698/Stage_1_Ventures>,
        <https://1145.am/db/1582111/Khosla_Ventures>,
        <https://1145.am/db/1584937/Sharad_Sanghi>,
        <https://1145.am/db/1584937/Yournest_Venture_Capital>,
        <https://1145.am/db/1653506/Sve_Capital>,
        <https://1145.am/db/166138/Royal_Street_Ventures>,
        <https://1145.am/db/1663572/Khosla_Ventures>,
        <https://1145.am/db/1679431/Booz_Allen_Ventures_Llc>,
        <https://1145.am/db/1690703/021_Capital>,
        <https://1145.am/db/1691364/Hv_Capital>,
        <https://1145.am/db/1693658/Shima_Capital>,
        <https://1145.am/db/1694448/B37_Ventures>,
        <https://1145.am/db/1696614/Z_Venture_Capital>,
        <https://1145.am/db/1698130/Union_Square_Ventures>,
        <https://1145.am/db/1698180/Shasta_Ventures>,
        <https://1145.am/db/1698192/Saison_Capital>,
        <https://1145.am/db/1699877/Sutter_Hill_Ventures>,
        <https://1145.am/db/1702019/Sutter_Hill_Ventures>,
        <https://1145.am/db/1704402/Sosv>,
        <https://1145.am/db/1710011/Z_Venture_Capital>,
        <https://1145.am/db/1711384/Union_Square_Ventures>,
        <https://1145.am/db/1713248/Xplorer_Capital>,
        <https://1145.am/db/1714154/Psl_Ventures>,
        <https://1145.am/db/1714544/Hv_Capital>,
        <https://1145.am/db/1722058/Union_Square_Ventures>,
        <https://1145.am/db/1722914/B_Capital>,
        <https://1145.am/db/1722944/Soma_Capital>,
        <https://1145.am/db/1723099/Union_Square_Ventures>,
        <https://1145.am/db/1724641/Union_Square_Ventures>,
        <https://1145.am/db/1726121/Khosla_Ventures>,
        <https://1145.am/db/1730882/Union_Square_Ventures>,
        <https://1145.am/db/1732364/Sutter_Hill_Ventures>,
        <https://1145.am/db/1734681/Union_Square_Ventures>,
        <https://1145.am/db/1736478/Z_Venture_Capital>,
        <https://1145.am/db/1736668/Amit_Kapur>,
        <https://1145.am/db/1738378/S_Capital_Vc>,
        <https://1145.am/db/1739022/Khosla_Ventures>,
        <https://1145.am/db/1741014/Khosla_Ventures>,
        <https://1145.am/db/1742276/Shasta_Ventures>,
        <https://1145.am/db/1743316/Khosla_Ventures>,
        <https://1145.am/db/1745326/Venture_Stars>,
        <https://1145.am/db/1747732/Khosla_Ventures>,
        <https://1145.am/db/1747805/Khosla_Ventures>,
        <https://1145.am/db/1749148/Khosla_Ventures>,
        <https://1145.am/db/1749226/Khosla_Ventures>,
        <https://1145.am/db/1750460/Francisco_Partners>,
        <https://1145.am/db/1750483/Hv_Capital>,
        <https://1145.am/db/1750867/Fin_Vc>,
        <https://1145.am/db/1751312/Khosla_Ventures>,
        <https://1145.am/db/1753725/Z_Venture_Capital>,
        <https://1145.am/db/1754057/Spero_Ventures>,
        <https://1145.am/db/1754996/B_Capital>,
        <https://1145.am/db/1755846/Khosla_Ventures>,
        <https://1145.am/db/1756103/Union_Square_Ventures>,
        <https://1145.am/db/1756775/Khosla_Ventures>,
        <https://1145.am/db/1757376/1982_Ventures>,
        <https://1145.am/db/1757432/B37_Ventures>,
        <https://1145.am/db/1757987/R2>,
        <https://1145.am/db/1759567/Spero_Ventures>,
        <https://1145.am/db/1760730/Esun_Venture_Capital>,
        <https://1145.am/db/1762512/Khosla_Ventures>,
        <https://1145.am/db/1767643/Shasta_Ventures>,
        <https://1145.am/db/1768138/Vas_Ventures>,
        <https://1145.am/db/1771112/Khosla_Ventures>,
        <https://1145.am/db/1773491/Sosv>,
        <https://1145.am/db/1775532/Resolute_Venture_Partners>,
        <https://1145.am/db/1776687/Khosla_Ventures>,
        <https://1145.am/db/1777067/Scott>,
        <https://1145.am/db/1778179/Union_Square_Ventures>,
        <https://1145.am/db/1779627/Fosun>,
        <https://1145.am/db/1784405/Venture_51>,
        <https://1145.am/db/1784577/Khosla_Ventures>,
        <https://1145.am/db/1785920/Khosla_Ventures>,
        <https://1145.am/db/1786720/Union_Square_Ventures>,
        <https://1145.am/db/1786861/Ms___Ad_Ventures>,
        <https://1145.am/db/1787190/Gsr_Ventures>,
        <https://1145.am/db/1789140/Sosv>,
        <https://1145.am/db/1790631/Union_Square_Ventures>,
        <https://1145.am/db/1793825/Softtech_Vc>,
        <https://1145.am/db/1795210/Khosla_Ventures>,
        <https://1145.am/db/1795934/Shasta_Ventures>,
        <https://1145.am/db/1797561/Khosla_Ventures>,
        <https://1145.am/db/1799099/Softtech_Vc>,
        <https://1145.am/db/1799102/Softtech_Vc>,
        <https://1145.am/db/1802288/Khosla_Ventures>,
        <https://1145.am/db/1802352/Smedvig_Capital>,
        <https://1145.am/db/1803458/Union_Square_Ventures>,
        <https://1145.am/db/1804091/Active_Venture_Partners>,
        <https://1145.am/db/1804960/Khosla_Ventures>,
        <https://1145.am/db/1807542/Earlybird_Ventures>,
        <https://1145.am/db/1809007/Khosla_Ventures>,
        <https://1145.am/db/1812267/Us_Venture_Partners>,
        <https://1145.am/db/1815701/Khosla_Ventures>,
        <https://1145.am/db/1815910/E-Ventures>,
        <https://1145.am/db/1816423/Usvp>,
        <https://1145.am/db/1818161/Shasta_Ventures>,
        <https://1145.am/db/1818174/Eventures>,
        <https://1145.am/db/1821929/Khosla_Ventures>,
        <https://1145.am/db/1823663/Ifc>,
        <https://1145.am/db/1825387/Shasta_Ventures>,
        <https://1145.am/db/1826265/Mkii_Ventures>,
        <https://1145.am/db/1827021/Shasta_Ventures>,
        <https://1145.am/db/1828336/Khosla_Ventures>,
        <https://1145.am/db/1829581/Union_Square_Ventures>,
        <https://1145.am/db/1829612/Khosla_Ventures>,
        <https://1145.am/db/1829878/Active_Venture_Partners>,
        <https://1145.am/db/1830613/Sutter_Hill_Ventures>,
        <https://1145.am/db/1834279/Xseed_Capital>,
        <https://1145.am/db/1835126/Khosla_Ventures>,
        <https://1145.am/db/1835229/Sparklabs_Global_Ventures>,
        <https://1145.am/db/1835825/Shasta_Ventures>,
        <https://1145.am/db/1837155/Xseed_Capital>,
        <https://1145.am/db/1840793/Khosla_Ventures>,
        <https://1145.am/db/1842301/Khosla_Ventures>,
        <https://1145.am/db/1842466/Us_Venture_Partners>,
        <https://1145.am/db/1843362/Khosla_Ventures>,
        <https://1145.am/db/1846483/Softtech_Vc>,
        <https://1145.am/db/1846721/Union_Square_Ventures>,
        <https://1145.am/db/1852806/Us_Venture_Partners>,
        <https://1145.am/db/1853548/Khosla_Ventures>,
        <https://1145.am/db/1854200/Khosla_Ventures>,
        <https://1145.am/db/1855363/Sk_Ventures>,
        <https://1145.am/db/1856376/Khosla_Ventures>,
        <https://1145.am/db/1857635/Active_Venture_Partners>,
        <https://1145.am/db/1857930/Softtech_Vc>,
        <https://1145.am/db/1858323/Union_Square_Ventures>,
        <https://1145.am/db/1858991/Active_Venture_Partners>,
        <https://1145.am/db/1859199/Khosla_Ventures>,
        <https://1145.am/db/1860091/Union_Square_Ventures>,
        <https://1145.am/db/1860196/Union_Square_Ventures>,
        <https://1145.am/db/1861355/Khosla_Ventures>,
        <https://1145.am/db/1862590/Sutter_Hill_Ventures>,
        <https://1145.am/db/1863500/Khosla_Ventures>,
        <https://1145.am/db/1868107/Shasta_Ventures>,
        <https://1145.am/db/1868572/Union_Square_Ventures>,
        <https://1145.am/db/1871784/Us_Venture_Partners>,
        <https://1145.am/db/1872654/Sutter_Hill_Ventures>,
        <https://1145.am/db/1874278/Khosla_Ventures>,
        <https://1145.am/db/1875709/Sutter_Hill_Ventures>,
        <https://1145.am/db/1876758/Union_Square_Ventures>,
        <https://1145.am/db/1879026/Us_Venture_Partners>,
        <https://1145.am/db/1881464/Khosla_Ventures>,
        <https://1145.am/db/1884155/Us_Venture_Partners>,
        <https://1145.am/db/1892472/Union_Square_Ventures>,
        <https://1145.am/db/1895951/Khosla_Ventures>,
        <https://1145.am/db/1896368/New_Wave_Ventures>,
        <https://1145.am/db/1896530/Khosla_Ventures>,
        <https://1145.am/db/1899282/Mk_Capital>,
        <https://1145.am/db/1899737/Union_Square_Ventures>,
        <https://1145.am/db/1900812/Khosla_Ventures>,
        <https://1145.am/db/1904202/Shasta_Ventures>,
        <https://1145.am/db/1911584/Stage_1_Ventures>,
        <https://1145.am/db/1911840/Shasta_Ventures>,
        <https://1145.am/db/1915640/Us_Venture_Partners>,
        <https://1145.am/db/1917671/Fidelity_Ventures>,
        <https://1145.am/db/1922138/Softtech_Vc>,
        <https://1145.am/db/1931918/Svb_Financial_Group>,
        <https://1145.am/db/1939990/Gsr_Ventures>,
        <https://1145.am/db/1947193/Starbloom_Capital>,
        <https://1145.am/db/1947303/B37_Ventures>,
        <https://1145.am/db/1960888/Khosla_Ventures>,
        <https://1145.am/db/1962819/Jumpstart_Ventures>,
        <https://1145.am/db/2009653/Nationwide_Ventures>,
        <https://1145.am/db/2032146/Booz_Allen_Ventures>,
        <https://1145.am/db/2056931/L___S_Venture_Capital>,
        <https://1145.am/db/2071531/A_o>,
        <https://1145.am/db/2082923/Psl_Ventures>,
        <https://1145.am/db/2090647/Khosla_Ventures>,
        <https://1145.am/db/2092604/Srmg_Ventures>,
        <https://1145.am/db/2099365/Do_Ventures>,
        <https://1145.am/db/2114292/Khosla_Ventures>,
        <https://1145.am/db/2114498/Khosla_Ventures>,
        <https://1145.am/db/2134994/Union_Square_Ventures>,
        <https://1145.am/db/2135622/Khosla_Ventures>,
        <https://1145.am/db/2135690/Better_Ventures>,
        <https://1145.am/db/2142825/Commerce_Ventures>,
        <https://1145.am/db/2151946/Khosla_Ventures>,
        <https://1145.am/db/2153616/South>,
        <https://1145.am/db/2154009/Andera_Partners>,
        <https://1145.am/db/2155474/Sig>,
        <https://1145.am/db/2194249/Union_Square_Ventures>,
        <https://1145.am/db/2210557/Softtech_Vc>,
        <https://1145.am/db/2285566/Sabadell_Venture_Capital>,
        <https://1145.am/db/2288251/Us_Venture_Partners>,
        <https://1145.am/db/2300288/Spark_Ventures>,
        <https://1145.am/db/2300466/Khosla_Ventures>,
        <https://1145.am/db/2305964/Sls_Venture>,
        <https://1145.am/db/2310285/Valley_Ventures>,
        <https://1145.am/db/2311076/Venture_Investors>,
        <https://1145.am/db/2315754/Valley_Ventures>,
        <https://1145.am/db/2319675/Sac>,
        <https://1145.am/db/2343206/Us_Venture_Partners>,
        <https://1145.am/db/2348356/Sambrinvest>,
        <https://1145.am/db/2352804/Enterprise_Partners>,
        <https://1145.am/db/2354752/Venture_Investors_Llc>,
        <https://1145.am/db/2354770/Venture_Investors_Llc>,
        <https://1145.am/db/2567406/Exsight_Ventures>,
        <https://1145.am/db/2575232/Venture_Investors_Llc>,
        <https://1145.am/db/2616685/Silver_Creek_Ventures>,
        <https://1145.am/db/2641337/Valuestream_Ventures>,
        <https://1145.am/db/2790795/Shima_Capital>,
        <https://1145.am/db/365631/Khosla_Ventures>,
        <https://1145.am/db/376872/K50_Ventures>,
        <https://1145.am/db/396307/B_Capital_Group>,
        <https://1145.am/db/407681/Khosla_Ventures>,
        <https://1145.am/db/425922/Royal_Street_Ventures>,
        <https://1145.am/db/426637/Khosla_Ventures>,
        <https://1145.am/db/428324/Khosla_Ventures>,
        <https://1145.am/db/429179/Shasta_Ventures>,
        <https://1145.am/db/430553/Shasta_Ventures>,
        <https://1145.am/db/430986/Olsf_Ventures>,
        <https://1145.am/db/432552/Valuestream_Ventures>,
        <https://1145.am/db/437556/Khosla_Ventures>,
        <https://1145.am/db/438632/Khosla_Ventures>,
        <https://1145.am/db/447456/Starta_Vc>,
        <https://1145.am/db/486858/Khosla_Ventures>,
        <https://1145.am/db/486901/Khosla_Ventures>,
        <https://1145.am/db/502886/Sutter_Hill_Ventures>,
        <https://1145.am/db/506085/Sutter_Hill_Ventures>,
        <https://1145.am/db/523013/Hscm_Ventures>,
        <https://1145.am/db/523013/Sure_Ventures>,
        <https://1145.am/db/527960/Hscm_Ventures>,
        <https://1145.am/db/527960/Sure_Ventures>,
        <https://1145.am/db/562996/Shasta_Ventures>,
        <https://1145.am/db/564008/Secure_Ventures>,
        <https://1145.am/db/572414/A-Street_Ventures>,
        <https://1145.am/db/577305/A-Street_Ventures>,
        <https://1145.am/db/587038/Hv_Capital>,
        <https://1145.am/db/606074/Elementum_Ventures>,
        <https://1145.am/db/661747/Sosv>,
        <https://1145.am/db/663618/Sosv>,
        <https://1145.am/db/676938/Khosla_Ventures>,
        <https://1145.am/db/678262/Khosla_Ventures>,
        <https://1145.am/db/678416/St_Engineering_Ventures_Pte_Ltd>,
        <https://1145.am/db/679989/Khosla_Ventures>,
        <https://1145.am/db/696617/Suro_Capital>,
        <https://1145.am/db/753251/Sosv>,
        <https://1145.am/db/753759/Ms___Ad_Ventures>,
        <https://1145.am/db/75860/Sws_Venture_Capital>,
        <https://1145.am/db/778025/Soma_Capital>,
        <https://1145.am/db/784869/Hbse_Ventures>,
        <https://1145.am/db/791643/Cssd_Capital>,
        <https://1145.am/db/800101/Khosla_Ventures>,
        <https://1145.am/db/807080/Adb_Ventures>,
        <https://1145.am/db/817162/Khosla_Ventures>,
        <https://1145.am/db/817162/Shell_Ventures>,
        <https://1145.am/db/883036/Big_Idea_Ventures>,
        <https://1145.am/db/890955/S2g_Ventures>,
        <https://1145.am/db/906393/1982_Ventures>,
        <https://1145.am/db/912943/Khosla_Ventures>,
        <https://1145.am/db/928782/Psl_Ventures>,
        <https://1145.am/db/930464/Psl_Ventures>,
        <https://1145.am/db/935046/Gsr_Ventures>,
        <https://1145.am/db/940913/Xplorer_Capital>,
        <https://1145.am/db/952434/K50_Ventures>,
        <https://1145.am/db/979911/Khosla_Ventures>,
        <https://1145.am/db/980951/Khosla_Ventures>,
        <https://1145.am/db/996940/Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2363043/Ro_Invest>,
        <https://1145.am/db/2594440/Ro_Invest> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364035/Merck_Serono_Ventures> a org:Organization ;
    ns1:basedInLowRaw "MENLO PARK, Calif" ;
    ns1:documentDate "2012-02-02T17:11:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Auxogyn Completes $20 Million In Series A Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/auxogyn-completes-20-million-series-a-funding> ;
    ns1:foundName "Merck Serono Ventures" ;
    ns1:investor <https://1145.am/db/2364035/Series_A_Investment_Auxogyn_Inc_Kleiner_Perkins_Caufield_And_Byers_Merck_Serono_Ventures_Tpg_Biotech_Completed> ;
    ns1:name "Merck Serono Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2307739/Merck_Serono_Ventures>,
        <https://1145.am/db/2365103/Merck_Serono_Ventures>,
        <https://1145.am/db/2367218/Merck_Serono_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365515/Chione_Ltd> a org:Organization ;
    ns1:basedInLowRaw "NATICK, Mass" ;
    ns1:documentDate "2011-11-02T15:27:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Karyopharm Therapeutics Closes $10 Million Series A2 Financing to Expand Planned Phase 1 Program of Oral Selective Inhibitors" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/karyopharm-therapeutics-closes-10-million-series-a2-financing-to-expand-planned-phase-1> ;
    ns1:foundName "Chione Ltd" ;
    ns1:investor <https://1145.am/db/2365515/Series_A2_Investment_Chione_Ltd_Karyopharm_Therapeutics_Inc_Completed> ;
    ns1:name "Chione Ltd" ;
    ns1:sameAsMedium <https://1145.am/db/2155189/Chione>,
        <https://1145.am/db/2296841/Chione> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365999/Investment_Altheos_Inc_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-09T15:43:16+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Altheos Announces Initiation of Phase 2a Clinical Trial for its Lead Glaucoma Drug Candidate, ATS907.",
        "Altheos also announced the company raised an additional $ 12.5M in its Series A financing, bringing the total to $ 32.5M.",
        "SOUTH SAN FRANCISCO, Calif., Feb 09, 2012 (BUSINESS WIRE) - Altheos, Inc., announced today the dosing of the first patient in a Phase 2a clinical trial of its lead investigational candidate, ATS907, a Rho kinase (ROCK) -selective inhibitor in development as a next-generation eye drop for the reduction of elevated intraocular pressure (IOP) in primary open angle glaucoma and ocular hypertension." ;
    ns1:documentTitle "Altheos Announces Initiation of Phase 2a Clinical Trial for its Lead Glaucoma Drug Candidate, ATS907" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/altheos-announces-initiation-of-phase-2a-clinical-trial-for-its-lead-glaucoma-drug> ;
    ns1:foundName "financing",
        "raises" ;
    ns1:name "financing",
        "raises" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2365999/Altheos_Inc> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 12.5M",
        "$ 32.5M" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2366003/Investment_Zealand_Pharma_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-09T16:50:11+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Copenhagen, 2012-02-09 12:02 CET (GLOBE NEWSWIRE) - Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL) , a Danish biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs, announces a milestone payment of USD 20 million to be received from Sanofi following the successful completion of the global GetGoal Phase III clinical trial program for lixisenatide (Lyxumia®1) ).",
        "Zealand Pharma to receive USD 20 million milestone payment following Sanofi's completion of the global GetGoal Phase III program for lixisenatide (Lyxumia®1) ) in Type 2 diabetes." ;
    ns1:documentTitle "Zealand Pharma to receive USD 20 million milestone payment following Sanofi's completion of the global GetGoal Phase III program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zealand-pharma-to-receive-usd-20-million-milestone-payment-following-sanofi-s-completion-of> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2366003/Zealand_Pharma> ;
    ns1:targetName "Zealand Pharma" ;
    ns1:valueRaw "USD 20 million" ;
    ns1:whereGeoName "Pharma",
        "Region Sjælland",
        "Å i Åfjord" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/10678659/about.rdf>,
        <https://sws.geonames.org/3163608/about.rdf>,
        <https://sws.geonames.org/6418541/about.rdf> ;
    ns1:whereRaw "Zealand",
        "Zealand Pharma A/S" .

<https://1145.am/db/2366049/Ge> a org:Organization ;
    ns1:basedInLowRaw "SEATTLE" ;
    ns1:description "GE, BioMed Ventures and Henri Termeer, former Chairman" ;
    ns1:documentDate "2011-11-07T13:21:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Secures $20M in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-secures-20m-series-d-financing-0> ;
    ns1:foundName "GE" ;
    ns1:investor <https://1145.am/db/2366049/Equity_Investment_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Henri_Termeer_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "GE" ;
    ns1:sameAsMedium <https://1145.am/db/1715197/Ge>,
        <https://1145.am/db/1770173/Ge>,
        <https://1145.am/db/1854301/Ge>,
        <https://1145.am/db/1862378/Ge>,
        <https://1145.am/db/1870685/Ge>,
        <https://1145.am/db/1874655/Ge>,
        <https://1145.am/db/1884994/Ge>,
        <https://1145.am/db/2013430/Ge>,
        <https://1145.am/db/2167707/Ge>,
        <https://1145.am/db/2172059/Ge>,
        <https://1145.am/db/2204344/Ge>,
        <https://1145.am/db/2221158/Ge>,
        <https://1145.am/db/2264087/Ge>,
        <https://1145.am/db/2288633/Ge>,
        <https://1145.am/db/2289588/Ge>,
        <https://1145.am/db/2295938/Ge>,
        <https://1145.am/db/2296600/Ge>,
        <https://1145.am/db/2306391/Ge>,
        <https://1145.am/db/2356683/Ge>,
        <https://1145.am/db/2438781/Ge>,
        <https://1145.am/db/2438801/Ge>,
        <https://1145.am/db/495687/Ge>,
        <https://1145.am/db/572109/Ge>,
        <https://1145.am/db/581496/Ge>,
        <https://1145.am/db/708834/Ge>,
        <https://1145.am/db/710146/Ge> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366055/Ge_Healthymagination_Fund> a org:Organization ;
    ns1:basedInLowRaw "SEATTLE" ;
    ns1:description "investing",
        "life science tools" ;
    ns1:documentDate "2011-11-07T13:25:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Secures $20M in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-secures-20m-series-d-financing> ;
    ns1:foundName "GE",
        "GE healthymagination Fund" ;
    ns1:investor <https://1145.am/db/2366055/Equity_Investment_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Healthymagination_Fund_Henri_Termeer_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "GE",
        "GE healthymagination Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2349628/Ge_Healthymagination_Fund>,
        <https://1145.am/db/2354295/Ge_Healthymagination_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366079/Paul_Buchheit> a org:Organization ;
    ns1:basedInHighGeoName "Palo Alto" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5380748/about.rdf> ;
    ns1:basedInHighRaw "PALO ALTO, CALIF." ;
    ns1:basedInLowRaw "CALIF" ;
    ns1:documentDate "2011-11-08T12:17:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "COMPREHEND SYSTEMS SECURES $1.2MM IN SEED FUNDING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/comprehend-systems-secures-1-2mm-seed-funding> ;
    ns1:foundName "Buchheit",
        "Paul Buchheit" ;
    ns1:investor <https://1145.am/db/2366079/Seed_Round_Investment_Comprehend_Systems_Crosslink_Capital_Garry_Tan_Quotidian_Ventures_Completed> ;
    ns1:name "Buchheit",
        "Paul Buchheit" ;
    ns1:sameAsMedium <https://1145.am/db/1761511/Paul_Buchheit>,
        <https://1145.am/db/1767853/Paul_Buchheit>,
        <https://1145.am/db/1769492/Paul_Buchheit>,
        <https://1145.am/db/1776687/Paul_Buchheit>,
        <https://1145.am/db/1786660/Paul_Buchheit>,
        <https://1145.am/db/1790953/Paul_Buchheit>,
        <https://1145.am/db/1792353/Paul_Buchheit>,
        <https://1145.am/db/1872766/Paul_Buchheit> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366079/Talent_Fund> a org:Organization ;
    ns1:basedInLowRaw "CALIF" ;
    ns1:documentDate "2011-11-08T12:17:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "COMPREHEND SYSTEMS SECURES $1.2MM IN SEED FUNDING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/comprehend-systems-secures-1-2mm-seed-funding> ;
    ns1:foundName "Talent Fund" ;
    ns1:investor <https://1145.am/db/2366079/Seed_Round_Investment_Comprehend_Systems_Crosslink_Capital_Garry_Tan_Quotidian_Ventures_Completed> ;
    ns1:name "Talent Fund" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2443170/Anthem_Capital> a org:Organization ;
    ns1:basedInLowRaw "GERMANTOWN" ;
    ns1:documentDate "2011-11-02T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "SMSI Raises $54.1 Million Series D Financing" ;
    ns1:documentURL <https://www.fierceelectronics.com/embedded/smsi-raises-54-1-million-series-d-financing> ;
    ns1:foundName "Anthem Capital" ;
    ns1:investor <https://1145.am/db/2443170/Equity_Investment_Anthem_Capital_Delphi_Ventures_Greenspring_Associates_Healthcare_Ventures_New_Enterprise_Associates_Sensors_For_Medicine_And_Science_Inc_Completed> ;
    ns1:name "Anthem Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2323682/Anthem_Capital>,
        <https://1145.am/db/2323683/Anthem_Capital> ;
    ns1:sourceName "Fierce Electronics" .

<https://1145.am/db/2443170/Delphi_Ventures> a org:Organization ;
    ns1:basedInLowRaw "GERMANTOWN" ;
    ns1:documentDate "2011-11-02T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "SMSI Raises $54.1 Million Series D Financing" ;
    ns1:documentURL <https://www.fierceelectronics.com/embedded/smsi-raises-54-1-million-series-d-financing> ;
    ns1:foundName "Delphi Ventures" ;
    ns1:investor <https://1145.am/db/2443170/Equity_Investment_Anthem_Capital_Delphi_Ventures_Greenspring_Associates_Healthcare_Ventures_New_Enterprise_Associates_Sensors_For_Medicine_And_Science_Inc_Completed> ;
    ns1:name "Delphi Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1124122/Delphi_Ventures>,
        <https://1145.am/db/1718690/Delphi_Ventures>,
        <https://1145.am/db/2290453/Delphi_Ventures>,
        <https://1145.am/db/2291818/Delphi_Ventures>,
        <https://1145.am/db/2292554/Delphi_Ventures>,
        <https://1145.am/db/2294721/Delphi_Ventures>,
        <https://1145.am/db/2299776/Delphi_Ventures>,
        <https://1145.am/db/2300293/Delphi_Ventures>,
        <https://1145.am/db/2300306/Delphi_Ventures>,
        <https://1145.am/db/2300455/Delphi_Ventures>,
        <https://1145.am/db/2302333/Delphi_Ventures>,
        <https://1145.am/db/2304340/Delphi_Ventures>,
        <https://1145.am/db/2306568/Delphi_Ventures>,
        <https://1145.am/db/2308063/Delphi_Ventures>,
        <https://1145.am/db/2310285/Delphi_Ventures>,
        <https://1145.am/db/2317467/Delphi_Ventures>,
        <https://1145.am/db/2317919/Delphi_Ventures>,
        <https://1145.am/db/2319874/Delphi_Ventures>,
        <https://1145.am/db/2326571/Delphi_Ventures>,
        <https://1145.am/db/2333495/Delphi_Ventures>,
        <https://1145.am/db/2333504/Delphi_Ventures>,
        <https://1145.am/db/2335700/Delphi_Ventures>,
        <https://1145.am/db/2343206/Delphi_Ventures>,
        <https://1145.am/db/2352508/Delphi_Ventures>,
        <https://1145.am/db/2359510/Delphi_Ventures>,
        <https://1145.am/db/2360174/Delphi_Ventures>,
        <https://1145.am/db/2362553/Delphi_Ventures>,
        <https://1145.am/db/2365679/Delphi_Ventures>,
        <https://1145.am/db/2367204/Delphi_Ventures>,
        <https://1145.am/db/2575044/Delphi_Ventures>,
        <https://1145.am/db/2584056/Delphi_Ventures> ;
    ns1:sourceName "Fierce Electronics" .

<https://1145.am/db/2443170/Greenspring_Associates> a org:Organization ;
    ns1:basedInLowRaw "GERMANTOWN" ;
    ns1:documentDate "2011-11-02T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "SMSI Raises $54.1 Million Series D Financing" ;
    ns1:documentURL <https://www.fierceelectronics.com/embedded/smsi-raises-54-1-million-series-d-financing> ;
    ns1:foundName "Greenspring Associates" ;
    ns1:investor <https://1145.am/db/2443170/Equity_Investment_Anthem_Capital_Delphi_Ventures_Greenspring_Associates_Healthcare_Ventures_New_Enterprise_Associates_Sensors_For_Medicine_And_Science_Inc_Completed> ;
    ns1:name "Greenspring Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1737723/Greenspring_Associates>,
        <https://1145.am/db/1744228/Greenspring_Associates>,
        <https://1145.am/db/1751506/Greenspring_Associates>,
        <https://1145.am/db/1760148/Greenspring_Associates>,
        <https://1145.am/db/1760399/Greenspring_Associates>,
        <https://1145.am/db/1762479/Greenspring_Associates>,
        <https://1145.am/db/1784596/Greenspring_Associates>,
        <https://1145.am/db/1788142/Greenspring_Associates>,
        <https://1145.am/db/1798788/Greenspring_Associates>,
        <https://1145.am/db/1806644/Greenspring_Associates>,
        <https://1145.am/db/1810769/Greenspring_Associates>,
        <https://1145.am/db/1818011/Greenspring_Associates>,
        <https://1145.am/db/1823460/Greenspring_Associates>,
        <https://1145.am/db/1828087/Greenspring_Associates>,
        <https://1145.am/db/1854807/Greenspring_Associates>,
        <https://1145.am/db/1881490/Greenspring_Associates>,
        <https://1145.am/db/2170734/Greenspring_Associates>,
        <https://1145.am/db/2188661/Greenspring_Associates>,
        <https://1145.am/db/2246652/Greenspring_Associates>,
        <https://1145.am/db/2310796/Greenspring_Associates>,
        <https://1145.am/db/2344565/Greenspring_Associates_Inc>,
        <https://1145.am/db/2345549/Greenspring_Associates_Inc>,
        <https://1145.am/db/2537417/Greenspring_Associates>,
        <https://1145.am/db/2648036/Greenspring_Associates>,
        <https://1145.am/db/336270/Greenspring_Associates>,
        <https://1145.am/db/410473/Greenspring_Associates>,
        <https://1145.am/db/487425/Greenspring_Associates>,
        <https://1145.am/db/559318/Greenspring_Associates>,
        <https://1145.am/db/583208/Greenspring_Associates> ;
    ns1:sourceName "Fierce Electronics" .

<https://1145.am/db/2443170/Healthcare_Ventures> a org:Organization ;
    ns1:basedInLowRaw "GERMANTOWN" ;
    ns1:documentDate "2011-11-02T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "SMSI Raises $54.1 Million Series D Financing" ;
    ns1:documentURL <https://www.fierceelectronics.com/embedded/smsi-raises-54-1-million-series-d-financing> ;
    ns1:foundName "HealthCare Ventures" ;
    ns1:investor <https://1145.am/db/2443170/Equity_Investment_Anthem_Capital_Delphi_Ventures_Greenspring_Associates_Healthcare_Ventures_New_Enterprise_Associates_Sensors_For_Medicine_And_Science_Inc_Completed> ;
    ns1:name "HealthCare Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2235852/Healthcare_Ventures>,
        <https://1145.am/db/2304650/Healthcare_Ventures>,
        <https://1145.am/db/2308148/Healthcare_Ventures>,
        <https://1145.am/db/2308887/Healthcare_Ventures>,
        <https://1145.am/db/2309845/Healthcare_Ventures>,
        <https://1145.am/db/2311069/Healthcare_Ventures>,
        <https://1145.am/db/2311075/Healthcare_Ventures>,
        <https://1145.am/db/2312192/Healthcare_Ventures>,
        <https://1145.am/db/2313405/Healthcare_Ventures>,
        <https://1145.am/db/2316601/Healthcare_Ventures>,
        <https://1145.am/db/2316605/Healthcare_Ventures>,
        <https://1145.am/db/2316823/Healthcare_Ventures>,
        <https://1145.am/db/2318657/Healthcare_Ventures>,
        <https://1145.am/db/2321097/Healthcare_Ventures>,
        <https://1145.am/db/2323586/Healthcare_Ventures>,
        <https://1145.am/db/2331639/Healthcare_Ventures>,
        <https://1145.am/db/2338373/Healthcare_Ventures>,
        <https://1145.am/db/2342269/Healthcare_Ventures>,
        <https://1145.am/db/2343202/Healthcare_Ventures>,
        <https://1145.am/db/2343210/Healthcare_Ventures>,
        <https://1145.am/db/2346204/Healthcare_Ventures>,
        <https://1145.am/db/2347469/Healthcare_Ventures>,
        <https://1145.am/db/2348486/Healthcare_Ventures>,
        <https://1145.am/db/2349717/Healthcare_Ventures>,
        <https://1145.am/db/2349722/Healthcare_Ventures>,
        <https://1145.am/db/2352814/Healthcare_Ventures>,
        <https://1145.am/db/2352820/Healthcare_Ventures>,
        <https://1145.am/db/2363510/Healthcare_Ventures>,
        <https://1145.am/db/2365138/Healthcare_Ventures>,
        <https://1145.am/db/2365171/Healthcare_Ventures>,
        <https://1145.am/db/2367497/Healthcare_Ventures> ;
    ns1:sourceName "Fierce Electronics" .

<https://1145.am/db/2525964/Vail_Resorts> a org:Organization ;
    ns1:buyer <https://1145.am/db/2525964/Northstar-at-Tahoe_Resort_Acquisition> ;
    ns1:description "skiing and riding" ;
    ns1:documentDate "2011-10-20T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "North Lake Tahoe Rolls Out Improvements for 2011-2012 Ski Season" ;
    ns1:documentURL <https://www.travelagentcentral.com/destinations/north-lake-tahoe-rolls-out-improvements-for-2011-2012-ski-season> ;
    ns1:foundName "Vail Resorts" ;
    ns1:investor <https://1145.am/db/2525964/Northstar-at-Tahoe_Resort_Acquisition> ;
    ns1:name "Vail Resorts" ;
    ns1:sameAsHigh <https://1145.am/db/1252608/Vail_Resorts>,
        <https://1145.am/db/1472478/Vail_Resorts>,
        <https://1145.am/db/1538439/Vail_Resorts_Inc>,
        <https://1145.am/db/2475707/Vail_Resorts>,
        <https://1145.am/db/2476953/Vail_Resorts_Inc>,
        <https://1145.am/db/2490748/Vail_Resorts>,
        <https://1145.am/db/2494114/Vail_Resorts>,
        <https://1145.am/db/2505372/Vail_Resorts_Inc>,
        <https://1145.am/db/2523399/Vail_Resorts>,
        <https://1145.am/db/2526054/Vail_Resorts>,
        <https://1145.am/db/2526850/Vail_Resorts>,
        <https://1145.am/db/2535174/Vail_Resorts>,
        <https://1145.am/db/2692176/Vail_Resorts>,
        <https://1145.am/db/684228/Vail_Resorts> ;
    ns1:sameAsMedium <https://1145.am/db/1196443/Vail_Resorts>,
        <https://1145.am/db/2514904/Vail_Resorts>,
        <https://1145.am/db/2524680/Vail_Resorts>,
        <https://1145.am/db/2533488/Vail_Resorts>,
        <https://1145.am/db/397833/Vail_Resorts> ;
    ns1:sourceName "Travel Agent Central" .

<https://1145.am/db/2546371/Genmab> a org:Organization ;
    ns1:documentDate "2011-11-08T12:41:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Endo wooed by $1.2M incentives from PA; Wellspring acquired by Sentinel, Ancor;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/endo-wooed-by-1-2m-incentives-from-pa-wellspring-acquired-by-sentinel-ancor> ;
    ns1:foundName "Genmab" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Genmab" ;
    ns1:protagonist <https://1145.am/db/2546371/Investment_Genmab_Lonza_Has_Not_Happened>,
        <https://1145.am/db/2546371/Investment_Genmab_Lonza_Universal_Corp_Has_Not_Happened> ;
    ns1:sameAsHigh <https://1145.am/db/2152401/Genmab>,
        <https://1145.am/db/2310095/Genmab>,
        <https://1145.am/db/2328681/Genmab>,
        <https://1145.am/db/2370615/Genmab> ;
    ns1:sameAsMedium <https://1145.am/db/2302275/Genmab_As>,
        <https://1145.am/db/2304849/Genmab>,
        <https://1145.am/db/2310091/Genmab>,
        <https://1145.am/db/2312501/Genmab>,
        <https://1145.am/db/2320072/Genmab>,
        <https://1145.am/db/2326901/Genmab_A_S>,
        <https://1145.am/db/2327610/Genmab>,
        <https://1145.am/db/2355423/Genmab>,
        <https://1145.am/db/2363509/Genmab_A_S>,
        <https://1145.am/db/2368317/Genmab>,
        <https://1145.am/db/2547136/Genmab>,
        <https://1145.am/db/2554905/Genmab> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546371/Investment_Hebei_Aoxing_Pharmaceutical_Group_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-11-08T12:41:08+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Hebei Aoxing Pharmaceutical Group, unit of China's Aoxing Pharmaceuticals ($ AXN) , has received government funding of $ 315,000 for manufacturing plant improvements.",
        "> Lonza has announced a development and manufacturing agreement with Genmab to produce HuMax-TF, a tumor-fighting antibody-drug conjugate." ;
    ns1:documentTitle "Endo wooed by $1.2M incentives from PA; Wellspring acquired by Sentinel, Ancor;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/endo-wooed-by-1-2m-incentives-from-pa-wellspring-acquired-by-sentinel-ancor> ;
    ns1:foundName "funding" ;
    ns1:name "funding" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2546371/Hebei_Aoxing_Pharmaceutical_Group> ;
    ns1:valueRaw "$ 315,000" ;
    ns1:whereGeoName "Canada" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:whereRaw "Canada" .

<https://1145.am/db/2546371/Lonza> a org:Organization ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2011-11-08T12:41:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Endo wooed by $1.2M incentives from PA; Wellspring acquired by Sentinel, Ancor;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/endo-wooed-by-1-2m-incentives-from-pa-wellspring-acquired-by-sentinel-ancor> ;
    ns1:foundName "Lonza" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Lonza" ;
    ns1:protagonist <https://1145.am/db/2546371/Investment_Genmab_Lonza_Has_Not_Happened>,
        <https://1145.am/db/2546371/Investment_Genmab_Lonza_Universal_Corp_Has_Not_Happened> ;
    ns1:sameAsHigh <https://1145.am/db/227693/Lonza>,
        <https://1145.am/db/2308469/Lonza>,
        <https://1145.am/db/2318223/Lonza_Group>,
        <https://1145.am/db/2322189/Lonza>,
        <https://1145.am/db/2322201/Lonza>,
        <https://1145.am/db/2326780/Lonza>,
        <https://1145.am/db/2326916/Lonza_Group_Ag>,
        <https://1145.am/db/2544857/Lonza>,
        <https://1145.am/db/2545296/Lonza_Group>,
        <https://1145.am/db/2558602/Cdmo_Lonza>,
        <https://1145.am/db/2559372/Lonza>,
        <https://1145.am/db/2560766/Lonza>,
        <https://1145.am/db/2561187/Lonza>,
        <https://1145.am/db/2564708/Lonza>,
        <https://1145.am/db/2565273/Lonza>,
        <https://1145.am/db/2566265/Lonza>,
        <https://1145.am/db/2567736/Lonza>,
        <https://1145.am/db/2575028/Lonza>,
        <https://1145.am/db/368416/Lonza> ;
    ns1:sameAsMedium <https://1145.am/db/2155066/Lonza>,
        <https://1145.am/db/2285718/Lonza>,
        <https://1145.am/db/2311682/Lonza>,
        <https://1145.am/db/2323007/Lonza>,
        <https://1145.am/db/2326915/Lonza>,
        <https://1145.am/db/2328713/Lonza>,
        <https://1145.am/db/2551165/Lonza>,
        <https://1145.am/db/2557028/Lonza>,
        <https://1145.am/db/2562263/Lonza>,
        <https://1145.am/db/2563227/Lonza>,
        <https://1145.am/db/2566932/Lonza>,
        <https://1145.am/db/2574558/Lonza>,
        <https://1145.am/db/2575604/Lonza>,
        <https://1145.am/db/430563/Lonza>,
        <https://1145.am/db/595717/Lonza>,
        <https://1145.am/db/820519/Lonza>,
        <https://1145.am/db/956691/Lonza> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546371/Universal_Corp> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Kenya" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/192950/about.rdf> ;
    ns1:basedInHighRaw "Kenya" ;
    ns1:documentDate "2011-11-08T12:41:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Endo wooed by $1.2M incentives from PA; Wellspring acquired by Sentinel, Ancor;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/endo-wooed-by-1-2m-incentives-from-pa-wellspring-acquired-by-sentinel-ancor> ;
    ns1:foundName "Universal Corp." ;
    ns1:investor <https://1145.am/db/2546371/Investment_Genmab_Lonza_Universal_Corp_Has_Not_Happened>,
        <https://1145.am/db/2546371/Investment_Universal_Corp_Has_Not_Happened> ;
    ns1:name "Universal Corp" ;
    ns1:sameAsMedium <https://1145.am/db/2548179/Universal_Corp>,
        <https://1145.am/db/457955/Universal_Corporation>,
        <https://1145.am/db/524447/Universal_Corporation> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2587996/Acino> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:buyer <https://1145.am/db/2587996/Businesses_Acquisition_Acino_Mepha_Has_Not_Happened> ;
    ns1:documentDate "2011-12-22T13:23:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Acino to buy Mepha businesses in Latin America, Asia; Ranbaxy's $500M reserve wipes out Lipitor gains;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/acino-to-buy-mepha-businesses-latin-america-asia-ranbaxy-s-500m-reserve-wipes-out-lipitor> ;
    ns1:foundName "Acino" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Acino" ;
    ns1:sameAsHigh <https://1145.am/db/566598/Acino> ;
    ns1:sameAsMedium <https://1145.am/db/2555731/Acino>,
        <https://1145.am/db/2573398/Acino>,
        <https://1145.am/db/2588775/Acino>,
        <https://1145.am/db/2596830/Acino> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2587996/Novocol_Pharmaceutical> a org:Organization ;
    ns1:basedInHighGeoName "Canada" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:basedInHighRaw "Canada" ;
    ns1:description "Dental anesthetic" ;
    ns1:documentDate "2011-12-22T13:23:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Acino to buy Mepha businesses in Latin America, Asia; Ranbaxy's $500M reserve wipes out Lipitor gains;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/acino-to-buy-mepha-businesses-latin-america-asia-ranbaxy-s-500m-reserve-wipes-out-lipitor> ;
    ns1:foundName "Novocol Pharmaceutical" ;
    ns1:industry "Pharmaceutical" ;
    ns1:investor <https://1145.am/db/2587996/Investment_Novocol_Pharmaceutical_Has_Not_Happened> ;
    ns1:name "Novocol Pharmaceutical" ;
    ns1:sameAsHigh <https://1145.am/db/2117423/Novo_Holdings>,
        <https://1145.am/db/2121791/Novo_Holdings>,
        <https://1145.am/db/2296065/Novo_Holdings_A_S>,
        <https://1145.am/db/2319236/Novo_A_S>,
        <https://1145.am/db/2338817/Novo_A_S>,
        <https://1145.am/db/2341934/Novo>,
        <https://1145.am/db/2343966/Novo_Ventures>,
        <https://1145.am/db/2349050/Novo_A_S>,
        <https://1145.am/db/2353241/Novo_A_S>,
        <https://1145.am/db/2355183/Novo_A_S>,
        <https://1145.am/db/2358271/Novo_A_S>,
        <https://1145.am/db/2358459/Novo>,
        <https://1145.am/db/2358601/Novogen_Limited>,
        <https://1145.am/db/2360562/Novo>,
        <https://1145.am/db/2366333/Novo_A_S>,
        <https://1145.am/db/2368537/Novogen_Limited>,
        <https://1145.am/db/2368599/Novogen_Limited>,
        <https://1145.am/db/2543793/Novo>,
        <https://1145.am/db/2544115/Novo>,
        <https://1145.am/db/2546388/Novogen_Limited>,
        <https://1145.am/db/2552947/Novo>,
        <https://1145.am/db/2557027/Novo>,
        <https://1145.am/db/2570463/Novo_Nordisk>,
        <https://1145.am/db/842953/Novo_Nordisk> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2595150/Glaxosmithkline> a org:Organization ;
    ns1:basedInLowRaw "Australia" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2012-02-06T15:29:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DEA suspends Class 1 Cardinal Health facility; GSK earmarks $64M for Australian expansion;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dea-suspends-class-1-cardinal-health-facility-gsk-earmarks-64m-for-australian-expansion> ;
    ns1:foundName "GlaxoSmithKline" ;
    ns1:industry "Pharmaceutical" ;
    ns1:investor <https://1145.am/db/2595150/Investment_Glaxosmithkline_Has_Not_Happened> ;
    ns1:name "GlaxoSmithKline" ;
    ns1:sameAsHigh <https://1145.am/db/1002406/Glaxosmithkline_Plc>,
        <https://1145.am/db/1003861/Glaxosmithkline_Plc>,
        <https://1145.am/db/1034874/Glaxosmithkline_Plc>,
        <https://1145.am/db/1035942/GSK>,
        <https://1145.am/db/1036772/Glaxosmithkline_Plc>,
        <https://1145.am/db/1037557/GSK>,
        <https://1145.am/db/118625/GSK>,
        <https://1145.am/db/1368193/GSK>,
        <https://1145.am/db/1369714/GSK>,
        <https://1145.am/db/1972441/GSK>,
        <https://1145.am/db/1983958/Gsk_Plc>,
        <https://1145.am/db/2153110/Glaxosmithkline>,
        <https://1145.am/db/2156284/Glaxosmithkline>,
        <https://1145.am/db/2190363/Glaxosmithkline>,
        <https://1145.am/db/2192331/Glaxosmithkline>,
        <https://1145.am/db/2200884/Glaxosmithkline>,
        <https://1145.am/db/2204941/Glaxosmithkline>,
        <https://1145.am/db/2224597/Glaxosmithkline>,
        <https://1145.am/db/2278803/GSK>,
        <https://1145.am/db/2279371/Glaxosmithkline>,
        <https://1145.am/db/2282253/Glaxosmithkline>,
        <https://1145.am/db/2282592/Glaxosmithkline>,
        <https://1145.am/db/2283644/Glaxosmithkline>,
        <https://1145.am/db/2286031/Glaxosmithkline>,
        <https://1145.am/db/2287351/Glaxosmithkline>,
        <https://1145.am/db/2289482/Glaxosmithkline>,
        <https://1145.am/db/2290507/Glaxosmithkline>,
        <https://1145.am/db/2290596/Glaxosmithkline>,
        <https://1145.am/db/2291302/Glaxosmithkline>,
        <https://1145.am/db/2291743/Glaxosmithkline>,
        <https://1145.am/db/2292884/Glaxosmithkline>,
        <https://1145.am/db/2293175/Glaxosmithkline>,
        <https://1145.am/db/2297702/Glaxosmithkline>,
        <https://1145.am/db/2302462/Glaxosmithkline>,
        <https://1145.am/db/2303242/Glaxosmithkline>,
        <https://1145.am/db/2303245/Glaxosmithkline>,
        <https://1145.am/db/230344/Glaxosmithkline>,
        <https://1145.am/db/2305277/Glaxosmithkline>,
        <https://1145.am/db/2305279/Glaxosmithkline>,
        <https://1145.am/db/2306213/Glaxosmithkline>,
        <https://1145.am/db/2306799/Glaxosmithkline>,
        <https://1145.am/db/2307723/Glaxosmithkline>,
        <https://1145.am/db/2308007/Glaxosmithkline>,
        <https://1145.am/db/2309511/Glaxo>,
        <https://1145.am/db/2310192/Glaxosmithkline>,
        <https://1145.am/db/2311402/Glaxosmithkline_Plc>,
        <https://1145.am/db/2312131/Glaxosmithkline>,
        <https://1145.am/db/2312187/Glaxosmithkline>,
        <https://1145.am/db/2312416/Glaxosmithkline>,
        <https://1145.am/db/2312656/Glaxosmithkline>,
        <https://1145.am/db/2313289/Glaxosmithkline>,
        <https://1145.am/db/2314290/Glaxosmithkline>,
        <https://1145.am/db/2314853/Glaxosmithkline>,
        <https://1145.am/db/2315422/Glaxosmithkline>,
        <https://1145.am/db/2316364/Glaxosmithkline>,
        <https://1145.am/db/2316660/Glaxosmithkline>,
        <https://1145.am/db/2316797/Glaxosmithkline>,
        <https://1145.am/db/2317846/Glaxosmithkline>,
        <https://1145.am/db/2318310/Glaxosmithkline>,
        <https://1145.am/db/2318589/Glaxosmithkline>,
        <https://1145.am/db/2318644/Glaxosmithkline>,
        <https://1145.am/db/2318658/Glaxosmithkline_Plc>,
        <https://1145.am/db/2318681/Glaxosmithkline>,
        <https://1145.am/db/2318708/Glaxosmithkline>,
        <https://1145.am/db/2318919/Glaxosmithkline>,
        <https://1145.am/db/2319445/Glaxosmithkline>,
        <https://1145.am/db/2319763/Glaxosmithkline>,
        <https://1145.am/db/2319782/Glaxosmithkline>,
        <https://1145.am/db/2319892/Glaxosmithkline>,
        <https://1145.am/db/2320824/Glaxosmithkline>,
        <https://1145.am/db/2320992/Glaxosmithkline>,
        <https://1145.am/db/2321971/Glaxosmithkline>,
        <https://1145.am/db/2324095/Glaxosmithkline>,
        <https://1145.am/db/2324141/Glaxosmithkline>,
        <https://1145.am/db/2325359/Glaxosmithkline>,
        <https://1145.am/db/2325364/Glaxosmithkline>,
        <https://1145.am/db/2325490/Glaxosmithkline>,
        <https://1145.am/db/2325729/Glaxosmithkline_Plc>,
        <https://1145.am/db/2326266/Glaxosmithkline_(gsk)>,
        <https://1145.am/db/2326590/Glaxosmithkline>,
        <https://1145.am/db/2327305/Glaxosmithkline>,
        <https://1145.am/db/2327507/Glaxosmithkline>,
        <https://1145.am/db/2327529/Glaxosmithkline>,
        <https://1145.am/db/2327656/Glaxosmithkline>,
        <https://1145.am/db/2328471/Glaxosmithkline>,
        <https://1145.am/db/2328637/Glaxosmithkline>,
        <https://1145.am/db/2328666/Glaxosmithkline>,
        <https://1145.am/db/2328681/Glaxosmithkline>,
        <https://1145.am/db/2328981/Glaxosmithkline>,
        <https://1145.am/db/2330949/Glaxosmithkline>,
        <https://1145.am/db/2330955/Glaxosmithkline>,
        <https://1145.am/db/2330986/Glaxosmithkline>,
        <https://1145.am/db/2331010/Glaxosmithkline>,
        <https://1145.am/db/2331763/Glaxosmithkline>,
        <https://1145.am/db/2331819/Glaxosmithkline>,
        <https://1145.am/db/2331823/Glaxosmithkline>,
        <https://1145.am/db/2332005/Glaxosmithkline_Pliva>,
        <https://1145.am/db/2332660/Glaxosmithkline>,
        <https://1145.am/db/2332695/Glaxosmithkline>,
        <https://1145.am/db/2333658/Glaxosmithkline>,
        <https://1145.am/db/2335573/GSK>,
        <https://1145.am/db/2335582/Glaxosmithkline>,
        <https://1145.am/db/2335587/Glaxosmithkline>,
        <https://1145.am/db/2336060/Glaxosmithkline>,
        <https://1145.am/db/2336704/GSK>,
        <https://1145.am/db/2336990/Glaxosmithkline>,
        <https://1145.am/db/2337186/Glaxosmithkline>,
        <https://1145.am/db/2338296/Glaxosmithkline>,
        <https://1145.am/db/2339979/Glaxosmithkline>,
        <https://1145.am/db/2340071/Glaxosmithkline>,
        <https://1145.am/db/2340591/Glaxosmithkline>,
        <https://1145.am/db/2342074/Glaxosmithkline>,
        <https://1145.am/db/2342876/Glaxosmithkline>,
        <https://1145.am/db/2343855/Glaxosmithkline>,
        <https://1145.am/db/2343861/Glaxosmithkline>,
        <https://1145.am/db/2344023/Glaxosmithkline>,
        <https://1145.am/db/2344939/Glaxosmithkline>,
        <https://1145.am/db/2345251/GSK>,
        <https://1145.am/db/2345410/Glaxosmithkline>,
        <https://1145.am/db/2345604/Glaxosmithkline>,
        <https://1145.am/db/2348686/Glaxosmithkline>,
        <https://1145.am/db/2348693/Glaxosmithkline>,
        <https://1145.am/db/2349724/GSK>,
        <https://1145.am/db/2349724/Glaxosmithkline_Biologicals>,
        <https://1145.am/db/2352499/Glaxosmithkline>,
        <https://1145.am/db/2352506/Glaxosmithkline_Plc>,
        <https://1145.am/db/2353506/Glaxosmithkline>,
        <https://1145.am/db/2353547/Glaxosmithkline>,
        <https://1145.am/db/2354253/Glaxosmithkline>,
        <https://1145.am/db/2354577/Glaxosmithkline>,
        <https://1145.am/db/2355587/Glaxosmithkline>,
        <https://1145.am/db/2355595/Glaxosmithkline>,
        <https://1145.am/db/2355640/Cellzome>,
        <https://1145.am/db/2356391/Glaxosmithkline>,
        <https://1145.am/db/2356559/Glaxosmithkline>,
        <https://1145.am/db/2356560/Glaxosmithkline>,
        <https://1145.am/db/2356639/Glaxosmithkline>,
        <https://1145.am/db/2356654/Glaxosmithkline>,
        <https://1145.am/db/2357361/Glaxosmithkline_Plc>,
        <https://1145.am/db/2359072/Glaxosmithkline>,
        <https://1145.am/db/2359553/Glaxosmithkline>,
        <https://1145.am/db/2359727/GSK>,
        <https://1145.am/db/2359727/Glaxosmithkline>,
        <https://1145.am/db/2359836/Glaxosmithkline>,
        <https://1145.am/db/2359838/Glaxosmithkline>,
        <https://1145.am/db/2359858/Glaxosmithkline>,
        <https://1145.am/db/2360093/Glaxosmithkline>,
        <https://1145.am/db/2360094/Glaxosmithkline>,
        <https://1145.am/db/2360371/Glaxosmithkline>,
        <https://1145.am/db/2360552/Glaxosmithkline>,
        <https://1145.am/db/2360562/GSK>,
        <https://1145.am/db/2361700/GSK>,
        <https://1145.am/db/2364819/Glaxosmithkline>,
        <https://1145.am/db/2364846/Glaxosmithkline>,
        <https://1145.am/db/2367620/Glaxosmithkline>,
        <https://1145.am/db/2367621/Glaxosmithkline>,
        <https://1145.am/db/2368765/Glaxosmithkline>,
        <https://1145.am/db/2368770/Glaxosmithkline_Plc>,
        <https://1145.am/db/2369276/Glaxosmithkline>,
        <https://1145.am/db/2369449/Glaxosmithkline>,
        <https://1145.am/db/2369451/Glaxosmithkline>,
        <https://1145.am/db/2369755/GSK>,
        <https://1145.am/db/2369761/Glaxosmithkline>,
        <https://1145.am/db/2370635/GSK>,
        <https://1145.am/db/238329/Glaxosmithkline>,
        <https://1145.am/db/2536540/Glaxosmithkline>,
        <https://1145.am/db/2536585/Glaxosmithkline>,
        <https://1145.am/db/2536945/Glaxosmithkline>,
        <https://1145.am/db/2537064/Glaxosmithkline>,
        <https://1145.am/db/2537699/Glaxosmithkline>,
        <https://1145.am/db/2539219/Glaxosmithkline>,
        <https://1145.am/db/2539221/Glaxosmithkline>,
        <https://1145.am/db/2539308/Glaxosmithkline>,
        <https://1145.am/db/2539972/Glaxosmithkline>,
        <https://1145.am/db/2540020/Glaxosmithkline>,
        <https://1145.am/db/2540027/Glaxosmithkline>,
        <https://1145.am/db/2540091/Glaxosmithkline>,
        <https://1145.am/db/2540172/Glaxosmithkline>,
        <https://1145.am/db/2540527/Glaxosmithkline>,
        <https://1145.am/db/2541499/Glaxosmithkline>,
        <https://1145.am/db/2542064/GSK>,
        <https://1145.am/db/2542065/Glaxosmithkline>,
        <https://1145.am/db/2542090/Glaxosmithkline>,
        <https://1145.am/db/2542192/GSK>,
        <https://1145.am/db/2542499/Glaxosmithkline>,
        <https://1145.am/db/2542503/Glaxosmithkline>,
        <https://1145.am/db/2542506/Glaxosmithkline>,
        <https://1145.am/db/2543552/Glaxosmithkline>,
        <https://1145.am/db/2544274/Glaxosmithkline>,
        <https://1145.am/db/2544350/Glaxosmithkline>,
        <https://1145.am/db/2545023/Glaxosmithkline>,
        <https://1145.am/db/2545242/Glaxosmithkline>,
        <https://1145.am/db/2545284/Glaxosmithkline>,
        <https://1145.am/db/2545518/Glaxosmithkline>,
        <https://1145.am/db/2545537/Glaxosmithkline>,
        <https://1145.am/db/2546260/Glaxosmithkline>,
        <https://1145.am/db/2546574/Glaxosmithkline>,
        <https://1145.am/db/2546577/Glaxosmithkline>,
        <https://1145.am/db/2546616/Glaxosmithkline>,
        <https://1145.am/db/2546929/Glaxosmithkline>,
        <https://1145.am/db/2547142/Glaxosmithkline>,
        <https://1145.am/db/2547143/Glaxosmithkline>,
        <https://1145.am/db/2547835/Glaxosmithkline>,
        <https://1145.am/db/2547954/Glaxosmithkline>,
        <https://1145.am/db/2547976/Glaxosmithkline>,
        <https://1145.am/db/2548034/Glaxosmithkline>,
        <https://1145.am/db/2548208/Glaxosmithkline>,
        <https://1145.am/db/2548518/Glaxosmithkline>,
        <https://1145.am/db/2548523/Glaxosmithkline>,
        <https://1145.am/db/2549082/Glaxosmithkline>,
        <https://1145.am/db/2549876/Glaxosmithkline>,
        <https://1145.am/db/2550054/Glaxosmithkline>,
        <https://1145.am/db/2550318/Glaxosmithkline>,
        <https://1145.am/db/2550460/GSK>,
        <https://1145.am/db/2550460/Glaxosmithkline>,
        <https://1145.am/db/2550543/Glaxosmithkline>,
        <https://1145.am/db/2550662/Glaxosmithkline>,
        <https://1145.am/db/2551402/Glaxosmithkline>,
        <https://1145.am/db/2551695/Glaxosmithkline>,
        <https://1145.am/db/2552794/Glaxosmithkline>,
        <https://1145.am/db/2553168/GSK>,
        <https://1145.am/db/2553206/Glaxosmithkline>,
        <https://1145.am/db/2553462/Glaxosmithkline>,
        <https://1145.am/db/2554044/Glaxosmithkline>,
        <https://1145.am/db/2554324/Glaxosmithkline>,
        <https://1145.am/db/2554578/Glaxosmithkline>,
        <https://1145.am/db/2554641/Glaxosmithkline>,
        <https://1145.am/db/2554937/Glaxosmithkline>,
        <https://1145.am/db/2555012/Glaxosmithkline>,
        <https://1145.am/db/2556628/Glaxosmithkline>,
        <https://1145.am/db/2556820/Glaxosmithkline>,
        <https://1145.am/db/2556995/Glaxosmithkline>,
        <https://1145.am/db/2557515/Glaxosmithkline>,
        <https://1145.am/db/2558165/Glaxosmithkline>,
        <https://1145.am/db/2558862/GSK>,
        <https://1145.am/db/2558862/Glaxosmithkline>,
        <https://1145.am/db/2558927/Glaxosmithkline>,
        <https://1145.am/db/2558940/Glaxosmithkline>,
        <https://1145.am/db/2560234/Glaxosmithkline>,
        <https://1145.am/db/2560260/Glaxosmithkline>,
        <https://1145.am/db/2560633/Glaxosmithkline>,
        <https://1145.am/db/2560853/Glaxosmithkline>,
        <https://1145.am/db/2560873/Glaxosmithkline>,
        <https://1145.am/db/2561334/Glaxo>,
        <https://1145.am/db/2561353/Glaxosmithkline>,
        <https://1145.am/db/2561599/Glaxosmithkline>,
        <https://1145.am/db/2561650/GSK>,
        <https://1145.am/db/2561960/Glaxosmithkline>,
        <https://1145.am/db/2562951/Glaxosmithkline>,
        <https://1145.am/db/2563194/Glaxosmithkline>,
        <https://1145.am/db/2563381/Glaxosmithkline>,
        <https://1145.am/db/2564238/Glaxosmithkline>,
        <https://1145.am/db/2564695/Glaxosmithkline>,
        <https://1145.am/db/2564786/Glaxosmithkline>,
        <https://1145.am/db/2566186/GSK>,
        <https://1145.am/db/2566825/Glaxosmithkline>,
        <https://1145.am/db/2567009/Glaxosmithkline>,
        <https://1145.am/db/2567104/GSK>,
        <https://1145.am/db/2568932/Glaxosmithkline>,
        <https://1145.am/db/2568968/Glaxosmithkline>,
        <https://1145.am/db/2569734/Glaxosmithkline_Plc>,
        <https://1145.am/db/2569735/Glaxosmithkline_Plc>,
        <https://1145.am/db/2572429/Glaxosmithkline>,
        <https://1145.am/db/2572963/Glaxosmithkline>,
        <https://1145.am/db/2573002/Glaxosmithkline>,
        <https://1145.am/db/2573201/Glaxosmithkline>,
        <https://1145.am/db/2573585/Glaxosmithkline>,
        <https://1145.am/db/2574333/Glaxosmithkline>,
        <https://1145.am/db/2575289/Glaxosmithkline>,
        <https://1145.am/db/2575462/First_Glaxosmithkline>,
        <https://1145.am/db/2576042/Glaxosmithkline>,
        <https://1145.am/db/2576046/Glaxosmithkline>,
        <https://1145.am/db/2576156/Glaxosmithkline>,
        <https://1145.am/db/2576230/Glaxosmithkline_Plc>,
        <https://1145.am/db/2576242/Glaxosmithkline>,
        <https://1145.am/db/2576256/Glaxo>,
        <https://1145.am/db/2576263/Glaxosmithkline>,
        <https://1145.am/db/2576267/GSK>,
        <https://1145.am/db/2576267/Glaxosmithkline>,
        <https://1145.am/db/2576516/Glaxosmithkline>,
        <https://1145.am/db/2577566/First_Glaxosmithkline>,
        <https://1145.am/db/2577566/Glaxo>,
        <https://1145.am/db/2577747/Glaxosmithkline>,
        <https://1145.am/db/2577778/Glaxosmithkline>,
        <https://1145.am/db/2578161/Glaxosmithkline>,
        <https://1145.am/db/2578420/Glaxosmithkline>,
        <https://1145.am/db/2578528/GSK>,
        <https://1145.am/db/2578536/Glaxosmithkline>,
        <https://1145.am/db/2579172/Glaxosmithkline>,
        <https://1145.am/db/2579177/Glaxosmithkline>,
        <https://1145.am/db/2579180/GSK>,
        <https://1145.am/db/2579205/Glaxosmithkline>,
        <https://1145.am/db/2580047/Glaxosmithkline>,
        <https://1145.am/db/2580053/Glaxosmithkline>,
        <https://1145.am/db/2580140/Glaxosmithkline>,
        <https://1145.am/db/2580509/Glaxosmithkline>,
        <https://1145.am/db/2580916/Glaxosmithkline>,
        <https://1145.am/db/2581141/Glaxosmithkline_Plc>,
        <https://1145.am/db/2581145/Glaxosmithkline>,
        <https://1145.am/db/2581176/Glaxosmithkline>,
        <https://1145.am/db/2581659/GSK>,
        <https://1145.am/db/2581661/Glaxosmithkline>,
        <https://1145.am/db/2582227/Glaxosmithkline>,
        <https://1145.am/db/2582344/Glaxosmithkline>,
        <https://1145.am/db/2582416/Glaxosmithkline>,
        <https://1145.am/db/2583228/Glaxosmithkline_Plc>,
        <https://1145.am/db/2583281/Glaxosmithkline>,
        <https://1145.am/db/2583584/Glaxosmithkline>,
        <https://1145.am/db/2584216/Glaxosmithkline>,
        <https://1145.am/db/2584538/Glaxosmithkline>,
        <https://1145.am/db/2585246/Glaxosmithkline_Plc>,
        <https://1145.am/db/2585251/Glaxosmithkline>,
        <https://1145.am/db/2586067/Glaxosmithkline>,
        <https://1145.am/db/2586099/Glaxosmithkline>,
        <https://1145.am/db/2586139/Glaxosmithkline>,
        <https://1145.am/db/2586802/GSK>,
        <https://1145.am/db/2586802/Glaxosmithkline>,
        <https://1145.am/db/2587282/Glaxosmithkline>,
        <https://1145.am/db/2587657/Glaxosmithkline>,
        <https://1145.am/db/2587770/Glaxosmithkline>,
        <https://1145.am/db/2587966/Glaxosmithkline>,
        <https://1145.am/db/2587967/GSK>,
        <https://1145.am/db/2587968/GSK>,
        <https://1145.am/db/2588258/Glaxosmithkline>,
        <https://1145.am/db/2588918/Glaxosmithkline>,
        <https://1145.am/db/2589035/Glaxosmithkline>,
        <https://1145.am/db/2589642/Glaxosmithkline>,
        <https://1145.am/db/2589701/GSK>,
        <https://1145.am/db/2589701/Glaxosmithkline>,
        <https://1145.am/db/2590051/Glaxosmithkline>,
        <https://1145.am/db/2590712/Glaxosmithkline>,
        <https://1145.am/db/2592987/Glaxosmithkline>,
        <https://1145.am/db/2593710/Glaxosmithkline>,
        <https://1145.am/db/2594208/Glaxosmithkline>,
        <https://1145.am/db/2594422/Glaxosmithkline>,
        <https://1145.am/db/2595001/Glaxosmithkline>,
        <https://1145.am/db/2596213/Glaxosmithkline>,
        <https://1145.am/db/2596402/Glaxosmithkline_Plc>,
        <https://1145.am/db/2596577/Glaxosmithkline>,
        <https://1145.am/db/2596835/Glaxosmithkline>,
        <https://1145.am/db/2597004/GSK>,
        <https://1145.am/db/2597220/Glaxosmithkline>,
        <https://1145.am/db/2597554/Glaxosmithkline>,
        <https://1145.am/db/2597558/Glaxosmithkline_Pte>,
        <https://1145.am/db/2597960/Glaxosmithkline>,
        <https://1145.am/db/286227/Glaxosmithkline>,
        <https://1145.am/db/338242/Glaxosmithkline>,
        <https://1145.am/db/377761/Glaxosmithkline>,
        <https://1145.am/db/377769/Glaxosmithkline>,
        <https://1145.am/db/446194/Glaxosmithkline>,
        <https://1145.am/db/494811/Glaxosmithkline>,
        <https://1145.am/db/538122/Glaxosmithkline>,
        <https://1145.am/db/576236/Glaxosmithkline>,
        <https://1145.am/db/582690/GSK>,
        <https://1145.am/db/702938/Glaxosmithkline>,
        <https://1145.am/db/761748/Glaxosmithkline>,
        <https://1145.am/db/761841/Glaxosmithkline_Plc>,
        <https://1145.am/db/763207/Glaxosmithkline>,
        <https://1145.am/db/771701/Glaxosmithkline>,
        <https://1145.am/db/85758/Glaxosmithkline>,
        <https://1145.am/db/922192/Glaxosmithkline>,
        <https://1145.am/db/970746/Glaxosmithkline>,
        <https://1145.am/db/973116/Glaxosmithkline>,
        <https://1145.am/db/975768/Glaxosmithkline>,
        <https://1145.am/db/977067/Glaxosmithkline> ;
    ns1:sameAsMedium <https://1145.am/db/1022812/Glaxosmithkline_Plc>,
        <https://1145.am/db/1026879/Glaxosmithkline>,
        <https://1145.am/db/1209318/Glaxosmithkline>,
        <https://1145.am/db/2293631/Glaxosmithkline>,
        <https://1145.am/db/2295635/Glaxosmithkline>,
        <https://1145.am/db/2329533/Glaxosmithkline>,
        <https://1145.am/db/2335568/Glaxosmithkline>,
        <https://1145.am/db/2340260/Glaxosmithkline>,
        <https://1145.am/db/2364813/Glaxosmithkline>,
        <https://1145.am/db/2365103/Glaxosmithkline>,
        <https://1145.am/db/2370843/Glaxosmithkline>,
        <https://1145.am/db/2536493/Glaxosmithkline>,
        <https://1145.am/db/2540170/Glaxosmithkline>,
        <https://1145.am/db/2541733/Glaxosmithkline>,
        <https://1145.am/db/2544062/Glaxosmithkline>,
        <https://1145.am/db/2546136/Glaxosmithkline>,
        <https://1145.am/db/2549598/Glaxosmithkline>,
        <https://1145.am/db/2549694/Glaxosmithkline>,
        <https://1145.am/db/2552165/Glaxosmithkline>,
        <https://1145.am/db/2554902/Glaxosmithkline>,
        <https://1145.am/db/2556407/Glaxosmithkline>,
        <https://1145.am/db/2557221/Glaxosmithkline>,
        <https://1145.am/db/2560668/Glaxosmithkline>,
        <https://1145.am/db/2568973/Glaxosmithkline>,
        <https://1145.am/db/2570721/Glaxosmithkline>,
        <https://1145.am/db/2570791/Glaxosmithkline>,
        <https://1145.am/db/2577226/Glaxosmithkline>,
        <https://1145.am/db/2582233/Glaxosmithkline>,
        <https://1145.am/db/2594187/Glaxosmithkline>,
        <https://1145.am/db/2598461/Glaxosmithkline>,
        <https://1145.am/db/582690/Glaxosmithkline>,
        <https://1145.am/db/704642/Glaxosmithkline_Plc>,
        <https://1145.am/db/87287/Glaxosmithkline> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2595150/Investment_Questcor_Pharmaceuticals_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-06T15:29:28+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Questcor Pharmaceuticals reported street-beating fourth-quarter sales of $ 75 million, thanks to strong sales of its drug Acthar." ;
    ns1:documentTitle "DEA suspends Class 1 Cardinal Health facility; GSK earmarks $64M for Australian expansion;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dea-suspends-class-1-cardinal-health-facility-gsk-earmarks-64m-for-australian-expansion> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2595150/Questcor_Pharmaceuticals> ;
    ns1:whereGeoName "Commonwealth of Australia" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2077456/about.rdf> ;
    ns1:whereRaw "Australia" .

<https://1145.am/db/2595150/Mylan> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2595150/Dermik_Acquisition> ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2012-02-06T15:29:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DEA suspends Class 1 Cardinal Health facility; GSK earmarks $64M for Australian expansion;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dea-suspends-class-1-cardinal-health-facility-gsk-earmarks-64m-for-australian-expansion> ;
    ns1:foundName "Mylan" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Mylan" ;
    ns1:sameAsHigh <https://1145.am/db/2153071/Mylan>,
        <https://1145.am/db/2199405/Mylan_Inc>,
        <https://1145.am/db/2304609/Mylan_Laboratories>,
        <https://1145.am/db/2305922/Mylan>,
        <https://1145.am/db/2308068/Mylan_Pharmaceuticals>,
        <https://1145.am/db/2309862/Mylan_Inc>,
        <https://1145.am/db/2310002/Mylan>,
        <https://1145.am/db/2311091/Mylan_Inc>,
        <https://1145.am/db/2313885/Mylan_Inc>,
        <https://1145.am/db/2315603/Mylan_Laboratories>,
        <https://1145.am/db/2317494/Mylan>,
        <https://1145.am/db/2321261/Mylan>,
        <https://1145.am/db/2323302/Mylan>,
        <https://1145.am/db/2326453/Mylan_Laboratories>,
        <https://1145.am/db/2331788/Mylan_Inc>,
        <https://1145.am/db/2332709/Mylan_Inc>,
        <https://1145.am/db/2336933/Mylan_Specialty>,
        <https://1145.am/db/2337788/Mylan>,
        <https://1145.am/db/2343774/Mylan_Inc>,
        <https://1145.am/db/2354247/Mylan_Inc>,
        <https://1145.am/db/2360743/Mylan>,
        <https://1145.am/db/2363358/Mylan_Inc>,
        <https://1145.am/db/2370340/Mylan_Nv>,
        <https://1145.am/db/2536206/Mylan>,
        <https://1145.am/db/2536469/Mylan>,
        <https://1145.am/db/2536917/Mylan>,
        <https://1145.am/db/2537465/Mylan>,
        <https://1145.am/db/2537654/Mylan>,
        <https://1145.am/db/2538861/Mylan>,
        <https://1145.am/db/2538918/Mylan>,
        <https://1145.am/db/2540502/Mylan>,
        <https://1145.am/db/2540516/Mylan>,
        <https://1145.am/db/2541469/Mylan>,
        <https://1145.am/db/2541485/Mylan>,
        <https://1145.am/db/2543472/Mylan>,
        <https://1145.am/db/2543940/Mylan>,
        <https://1145.am/db/2544505/Mylan>,
        <https://1145.am/db/2545435/Mylan>,
        <https://1145.am/db/2545545/Mylan>,
        <https://1145.am/db/2546440/Mylan>,
        <https://1145.am/db/2547596/Mylan>,
        <https://1145.am/db/2548696/Mylan>,
        <https://1145.am/db/2549613/Mylan>,
        <https://1145.am/db/2550074/Mylan>,
        <https://1145.am/db/2551713/Mylan>,
        <https://1145.am/db/2553677/Mylan>,
        <https://1145.am/db/2553974/Mylan>,
        <https://1145.am/db/2554769/Mylan_Nv>,
        <https://1145.am/db/2555326/Mylan>,
        <https://1145.am/db/2556903/Mylan_Nv>,
        <https://1145.am/db/2558063/Mylan>,
        <https://1145.am/db/2558931/Mylan>,
        <https://1145.am/db/2558967/Mylan>,
        <https://1145.am/db/2561438/Mylan>,
        <https://1145.am/db/2562354/Mylan>,
        <https://1145.am/db/2562362/Mylan>,
        <https://1145.am/db/2563325/Mylan>,
        <https://1145.am/db/2563341/Mylan>,
        <https://1145.am/db/2563858/Mylan>,
        <https://1145.am/db/2564030/Mylan_Pharmaceuticals>,
        <https://1145.am/db/2568832/Mylan_Inc>,
        <https://1145.am/db/2568859/Mylan>,
        <https://1145.am/db/2568971/Mylan>,
        <https://1145.am/db/2569132/Mylan_Nv_And_Mylan_Inc>,
        <https://1145.am/db/2569442/Mylan>,
        <https://1145.am/db/2570106/Mylan_Nv>,
        <https://1145.am/db/2570113/Mylan_Nv>,
        <https://1145.am/db/2570437/Mylan>,
        <https://1145.am/db/2570841/Mylan>,
        <https://1145.am/db/2571028/Mylan_Inc>,
        <https://1145.am/db/2571324/Mylan>,
        <https://1145.am/db/2571326/Mylan_Nv>,
        <https://1145.am/db/2571355/Mylan>,
        <https://1145.am/db/2571370/Mylan_Nv>,
        <https://1145.am/db/2571373/Mylan_Nv>,
        <https://1145.am/db/2572093/Mylan>,
        <https://1145.am/db/2572137/Mylan_Nv>,
        <https://1145.am/db/2572236/Mylan>,
        <https://1145.am/db/2572237/Mylan_Inc>,
        <https://1145.am/db/2572592/Mylan>,
        <https://1145.am/db/2572600/Mylan>,
        <https://1145.am/db/2572601/Mylan>,
        <https://1145.am/db/2572952/Mylan>,
        <https://1145.am/db/2572985/Mylan>,
        <https://1145.am/db/2573173/Mylan>,
        <https://1145.am/db/2573259/Mylan>,
        <https://1145.am/db/2573261/Mylan_Inc>,
        <https://1145.am/db/2573263/Mylan>,
        <https://1145.am/db/2574584/Mylan>,
        <https://1145.am/db/2574863/Mylan>,
        <https://1145.am/db/2575119/Mylan>,
        <https://1145.am/db/2575376/Mylan_Inc>,
        <https://1145.am/db/2576137/Mylan>,
        <https://1145.am/db/2576143/Mylan_Inc>,
        <https://1145.am/db/2577053/Mylan>,
        <https://1145.am/db/2577077/Mylan>,
        <https://1145.am/db/2577804/Mylan>,
        <https://1145.am/db/2577809/Mylan>,
        <https://1145.am/db/2577810/Mylan>,
        <https://1145.am/db/2577833/Mylan_Nv>,
        <https://1145.am/db/2577839/Mylan>,
        <https://1145.am/db/2578466/Mylan>,
        <https://1145.am/db/2578808/Mylan>,
        <https://1145.am/db/2579095/Mylan>,
        <https://1145.am/db/2579252/Mylan>,
        <https://1145.am/db/2581804/Mylan>,
        <https://1145.am/db/2582594/Mylan_Nv>,
        <https://1145.am/db/2583676/Mylan>,
        <https://1145.am/db/2584589/Mylan>,
        <https://1145.am/db/2584598/Mylan_Nv>,
        <https://1145.am/db/2584603/Mylan>,
        <https://1145.am/db/2584968/Mylan>,
        <https://1145.am/db/2585604/Mylan>,
        <https://1145.am/db/2585605/Mylan>,
        <https://1145.am/db/2585619/Mylan>,
        <https://1145.am/db/2585804/Mylan>,
        <https://1145.am/db/2587506/Mylan>,
        <https://1145.am/db/2587696/Mylan>,
        <https://1145.am/db/2591596/Mylan>,
        <https://1145.am/db/2591884/Mylan>,
        <https://1145.am/db/2591947/Mylan>,
        <https://1145.am/db/2592531/Mylan>,
        <https://1145.am/db/2593150/Mylan>,
        <https://1145.am/db/2593465/Mylan>,
        <https://1145.am/db/2594186/Mylan>,
        <https://1145.am/db/2594867/Mylan>,
        <https://1145.am/db/2596344/Mylan>,
        <https://1145.am/db/2596531/Mylan>,
        <https://1145.am/db/2597127/Mylan_Inc>,
        <https://1145.am/db/685681/Mylan>,
        <https://1145.am/db/76007/Mylan_Nv> ;
    ns1:sameAsMedium <https://1145.am/db/2303705/Mylan_Inc>,
        <https://1145.am/db/2310282/Mylan_Inc>,
        <https://1145.am/db/2320300/Mylan_Inc>,
        <https://1145.am/db/2324062/Mylan_Inc>,
        <https://1145.am/db/2325168/Mylan>,
        <https://1145.am/db/2326614/Mylan_Inc>,
        <https://1145.am/db/2337553/Mylan_Inc>,
        <https://1145.am/db/2540572/Mylan>,
        <https://1145.am/db/2543826/Mylan>,
        <https://1145.am/db/2553750/Mylan>,
        <https://1145.am/db/2558970/Mylan>,
        <https://1145.am/db/2568858/Mylan_Nv>,
        <https://1145.am/db/2570827/Mylan>,
        <https://1145.am/db/2572085/Mylan_Nv>,
        <https://1145.am/db/2572248/Mylan>,
        <https://1145.am/db/2583849/Mylan>,
        <https://1145.am/db/2585584/Mylan_Nv>,
        <https://1145.am/db/2585606/Mylan_Nv>,
        <https://1145.am/db/2586571/Mylan_Nv>,
        <https://1145.am/db/2586572/Mylan>,
        <https://1145.am/db/2587513/Mylan_Nv>,
        <https://1145.am/db/2587539/Mylan>,
        <https://1145.am/db/2592352/Mylan_Nv>,
        <https://1145.am/db/2597130/Mylan> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2595150/Novartis> a org:Organization ;
    ns1:basedInLowRaw "U.K." ;
    ns1:description "medical education, training and support" ;
    ns1:documentDate "2012-02-06T15:29:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DEA suspends Class 1 Cardinal Health facility; GSK earmarks $64M for Australian expansion;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dea-suspends-class-1-cardinal-health-facility-gsk-earmarks-64m-for-australian-expansion> ;
    ns1:foundName "Novartis" ;
    ns1:industry "pharmaceutical" ;
    ns1:investor <https://1145.am/db/2595150/Investment_Novartis_Has_Not_Happened> ;
    ns1:name "Novartis" ;
    ns1:sameAsHigh <https://1145.am/db/1176158/Novartis>,
        <https://1145.am/db/1177562/Novartis>,
        <https://1145.am/db/131136/Novartis>,
        <https://1145.am/db/132002/Novartis>,
        <https://1145.am/db/1328753/Novartis>,
        <https://1145.am/db/1507918/Novartis_Ag>,
        <https://1145.am/db/156403/Novartis>,
        <https://1145.am/db/1567521/Novartis>,
        <https://1145.am/db/1578114/Novartis>,
        <https://1145.am/db/1628428/Novalgen_Ltd>,
        <https://1145.am/db/1629605/Novartis>,
        <https://1145.am/db/1629663/Novartis>,
        <https://1145.am/db/165056/Novartis>,
        <https://1145.am/db/176334/Novartis>,
        <https://1145.am/db/177096/Novartis>,
        <https://1145.am/db/1986468/Novabay®_Pharmaceuticals_Inc>,
        <https://1145.am/db/2033677/Novartis>,
        <https://1145.am/db/2062728/Novan>,
        <https://1145.am/db/2107835/Novartis>,
        <https://1145.am/db/2129754/Novartis>,
        <https://1145.am/db/2152605/Novartis>,
        <https://1145.am/db/2152618/Novartis>,
        <https://1145.am/db/2153059/Novartis>,
        <https://1145.am/db/2154527/Novartis>,
        <https://1145.am/db/2155069/Novartis>,
        <https://1145.am/db/2155665/Novartis>,
        <https://1145.am/db/2190363/Novartis_Ag>,
        <https://1145.am/db/2194161/Novartis>,
        <https://1145.am/db/2279108/Novartis>,
        <https://1145.am/db/2279232/Novartis>,
        <https://1145.am/db/2279829/Novartis>,
        <https://1145.am/db/2280153/Novartis>,
        <https://1145.am/db/2280350/Novartis>,
        <https://1145.am/db/2283590/Novartis>,
        <https://1145.am/db/2283645/Novartis>,
        <https://1145.am/db/2285311/Novartis>,
        <https://1145.am/db/2286604/Novartis>,
        <https://1145.am/db/2288851/Novartis>,
        <https://1145.am/db/2289846/Novartis>,
        <https://1145.am/db/2290022/Novartis>,
        <https://1145.am/db/2293323/Novartis>,
        <https://1145.am/db/2293342/Novartis>,
        <https://1145.am/db/2293591/Novartis>,
        <https://1145.am/db/2294026/Novartis>,
        <https://1145.am/db/2294585/Novartis>,
        <https://1145.am/db/2296504/Novartis>,
        <https://1145.am/db/2296552/Novartis>,
        <https://1145.am/db/2298606/Novartis>,
        <https://1145.am/db/2301066/Novartis>,
        <https://1145.am/db/2301089/Novartis>,
        <https://1145.am/db/2301705/Novasep>,
        <https://1145.am/db/2301735/Novartis>,
        <https://1145.am/db/2301857/Novartis>,
        <https://1145.am/db/2302724/Novartis>,
        <https://1145.am/db/2302727/Novartis>,
        <https://1145.am/db/2303121/Novartis_Bioventures>,
        <https://1145.am/db/230344/Swiss_Drugmaker_Novartis>,
        <https://1145.am/db/2304113/Novartis>,
        <https://1145.am/db/2304373/Novartis>,
        <https://1145.am/db/2304374/Novartis>,
        <https://1145.am/db/2305192/Novartis>,
        <https://1145.am/db/2305244/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2307228/Novadel_Pharma_Inc>,
        <https://1145.am/db/2307347/Novartis>,
        <https://1145.am/db/2307847/Novartis>,
        <https://1145.am/db/2307863/Novartis>,
        <https://1145.am/db/2307998/Novartis>,
        <https://1145.am/db/2308010/Novartis>,
        <https://1145.am/db/2308298/Novartis>,
        <https://1145.am/db/2308765/Novartis>,
        <https://1145.am/db/2308812/Novartis>,
        <https://1145.am/db/2308946/Novartis_Ag>,
        <https://1145.am/db/2309065/Novartis_Intercell>,
        <https://1145.am/db/2310150/Novartis>,
        <https://1145.am/db/2312008/Novartis>,
        <https://1145.am/db/2312018/Novartis_International_Ag>,
        <https://1145.am/db/2312088/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2312436/Novartis>,
        <https://1145.am/db/2317845/Novadel>,
        <https://1145.am/db/2317949/Novalar_Pharmaceuticals>,
        <https://1145.am/db/2317951/Novalar_Pharmaceuticals>,
        <https://1145.am/db/2318994/Novadel>,
        <https://1145.am/db/2319412/Novartis>,
        <https://1145.am/db/2320828/Novartis>,
        <https://1145.am/db/2321067/Novartis>,
        <https://1145.am/db/2322266/Novartis>,
        <https://1145.am/db/2323188/Novartis>,
        <https://1145.am/db/2323692/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2324255/Novartis_Bioventures>,
        <https://1145.am/db/2325073/Novartis>,
        <https://1145.am/db/2325869/Novartis>,
        <https://1145.am/db/2326949/Novartis>,
        <https://1145.am/db/2327560/Novartis>,
        <https://1145.am/db/2329413/Novadel_Pharma_Inc>,
        <https://1145.am/db/2329475/Novadel_Pharma>,
        <https://1145.am/db/2329597/Novartis>,
        <https://1145.am/db/2330648/Novartis>,
        <https://1145.am/db/2331875/Novadel>,
        <https://1145.am/db/2332005/Novartis>,
        <https://1145.am/db/2332788/Novartis_Ag>,
        <https://1145.am/db/2332796/Novadel_Pharma_Inc>,
        <https://1145.am/db/2332872/Novartis>,
        <https://1145.am/db/2334206/Novartis>,
        <https://1145.am/db/2334645/Novast>,
        <https://1145.am/db/2336028/Novartis>,
        <https://1145.am/db/2336704/Novartis>,
        <https://1145.am/db/2339656/Novartis>,
        <https://1145.am/db/2339669/Novartis>,
        <https://1145.am/db/2340615/Novartis>,
        <https://1145.am/db/2340948/Novartis>,
        <https://1145.am/db/2344017/Novartis>,
        <https://1145.am/db/2344434/Novartis>,
        <https://1145.am/db/2346576/Novadel_Pharma_Inc>,
        <https://1145.am/db/2346629/Novartis>,
        <https://1145.am/db/2348176/Novartis>,
        <https://1145.am/db/2349068/Novartis>,
        <https://1145.am/db/2352045/Novartis>,
        <https://1145.am/db/2352046/Novartis>,
        <https://1145.am/db/2354148/Novartis>,
        <https://1145.am/db/2358273/Novartis>,
        <https://1145.am/db/2358297/Novartis>,
        <https://1145.am/db/2359165/Novartis>,
        <https://1145.am/db/2359179/Novartis>,
        <https://1145.am/db/2359915/Novadel_Pharma_Inc>,
        <https://1145.am/db/2360526/Novartis>,
        <https://1145.am/db/2360633/Novartis>,
        <https://1145.am/db/2362448/Novadel_Pharma_Inc>,
        <https://1145.am/db/2363618/Novartis_Uk>,
        <https://1145.am/db/2367118/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2367207/Novartis>,
        <https://1145.am/db/2367829/Novartis_International_Ag>,
        <https://1145.am/db/2367836/Novartis_International_Ag>,
        <https://1145.am/db/2367993/Novabay>,
        <https://1145.am/db/2368571/Novartis>,
        <https://1145.am/db/2368646/Novartis>,
        <https://1145.am/db/2368659/Novartis>,
        <https://1145.am/db/2369183/Novartis>,
        <https://1145.am/db/2369450/Novartis>,
        <https://1145.am/db/2369451/Novartis>,
        <https://1145.am/db/2369555/Swiss_Pharma_Giant_Novartis>,
        <https://1145.am/db/2369718/Novartis>,
        <https://1145.am/db/2370010/Novartis>,
        <https://1145.am/db/2370013/Novartis>,
        <https://1145.am/db/2370615/Novartis>,
        <https://1145.am/db/2370635/Novartis>,
        <https://1145.am/db/2371070/Novartis>,
        <https://1145.am/db/2371077/Novartis>,
        <https://1145.am/db/2371323/Novartis>,
        <https://1145.am/db/2371326/Novartis>,
        <https://1145.am/db/2434670/Novartis>,
        <https://1145.am/db/2536325/Novartis>,
        <https://1145.am/db/2536882/Novartis>,
        <https://1145.am/db/2536914/Novartis>,
        <https://1145.am/db/2537064/Novartis>,
        <https://1145.am/db/2537477/Novartis>,
        <https://1145.am/db/2537482/Novacea>,
        <https://1145.am/db/2538344/Novartis>,
        <https://1145.am/db/2538791/Novartis>,
        <https://1145.am/db/2539541/Novasep>,
        <https://1145.am/db/2539787/Novartis>,
        <https://1145.am/db/2539925/Novartis>,
        <https://1145.am/db/2540187/Novartis>,
        <https://1145.am/db/2541511/Novartis>,
        <https://1145.am/db/2542938/Novartis>,
        <https://1145.am/db/2543689/Novartis>,
        <https://1145.am/db/2544236/Novartis>,
        <https://1145.am/db/2544326/Novartis>,
        <https://1145.am/db/2545284/Novartis>,
        <https://1145.am/db/2545651/Novartis>,
        <https://1145.am/db/2545966/Novartis>,
        <https://1145.am/db/2545986/Novartis>,
        <https://1145.am/db/2546157/Novartis>,
        <https://1145.am/db/2546170/Novartis>,
        <https://1145.am/db/2546603/Novartis>,
        <https://1145.am/db/2547397/Novartis>,
        <https://1145.am/db/2548223/Novartis>,
        <https://1145.am/db/2548224/Novartis_Group>,
        <https://1145.am/db/2549043/Novartis>,
        <https://1145.am/db/2549631/Novast>,
        <https://1145.am/db/2550855/Novartis>,
        <https://1145.am/db/2551143/Novartis>,
        <https://1145.am/db/2551693/Novartis>,
        <https://1145.am/db/2551694/Novartis>,
        <https://1145.am/db/2552165/Novartis>,
        <https://1145.am/db/2552258/Novartis>,
        <https://1145.am/db/2553024/Novartis>,
        <https://1145.am/db/2553276/Novartis>,
        <https://1145.am/db/2553480/Novartis>,
        <https://1145.am/db/2553740/Novasep>,
        <https://1145.am/db/2553810/Novartis>,
        <https://1145.am/db/2553846/Novartis>,
        <https://1145.am/db/2554060/Novartis>,
        <https://1145.am/db/2554669/Novasep>,
        <https://1145.am/db/2555555/Novartis>,
        <https://1145.am/db/2555561/Novartis>,
        <https://1145.am/db/2556030/Novartis>,
        <https://1145.am/db/2556543/Novartis>,
        <https://1145.am/db/2557588/Novartis>,
        <https://1145.am/db/2558316/Novartis>,
        <https://1145.am/db/2558415/Novartis>,
        <https://1145.am/db/2558779/Novartis>,
        <https://1145.am/db/2558927/Novartis>,
        <https://1145.am/db/2559306/Novartis>,
        <https://1145.am/db/2559655/Novartis>,
        <https://1145.am/db/2559797/Novartis>,
        <https://1145.am/db/2559802/Novartis>,
        <https://1145.am/db/2559810/Switzerlands_Novartis>,
        <https://1145.am/db/2560023/Novartis>,
        <https://1145.am/db/2560079/Novartis>,
        <https://1145.am/db/2561162/Novasep>,
        <https://1145.am/db/2561268/Novartis>,
        <https://1145.am/db/2561541/Novartis>,
        <https://1145.am/db/2561955/Novartis>,
        <https://1145.am/db/2562202/Novartis>,
        <https://1145.am/db/2562695/Novartis>,
        <https://1145.am/db/2562951/Novartis>,
        <https://1145.am/db/2563497/Novartis>,
        <https://1145.am/db/2563987/Novartis>,
        <https://1145.am/db/2564141/Novartis>,
        <https://1145.am/db/2564268/Novartis>,
        <https://1145.am/db/2564695/Novartis>,
        <https://1145.am/db/2565142/Novartis>,
        <https://1145.am/db/2565794/Novartis>,
        <https://1145.am/db/2565844/Novartis>,
        <https://1145.am/db/2567283/Novartis>,
        <https://1145.am/db/2567300/Novartis>,
        <https://1145.am/db/2567942/Novartis>,
        <https://1145.am/db/2568308/Novartis>,
        <https://1145.am/db/2568932/Novartis>,
        <https://1145.am/db/2568968/Novartis>,
        <https://1145.am/db/2568973/Novartis>,
        <https://1145.am/db/2570214/Novartis>,
        <https://1145.am/db/2570791/Novartis>,
        <https://1145.am/db/2570932/Novartis>,
        <https://1145.am/db/2570937/Novartis_Uk>,
        <https://1145.am/db/2571513/Novartis>,
        <https://1145.am/db/2571519/Novartis>,
        <https://1145.am/db/2571527/Novartis>,
        <https://1145.am/db/2572713/Novartis>,
        <https://1145.am/db/2572904/Novartis_Group>,
        <https://1145.am/db/2572985/Novartis>,
        <https://1145.am/db/2573002/Novartis>,
        <https://1145.am/db/2573473/Novartis>,
        <https://1145.am/db/2573517/Novartis>,
        <https://1145.am/db/2573611/Novartis>,
        <https://1145.am/db/2574958/Novartis>,
        <https://1145.am/db/2575047/Novartis>,
        <https://1145.am/db/2575310/Novartis>,
        <https://1145.am/db/2575313/Novartis>,
        <https://1145.am/db/2575488/Novartis>,
        <https://1145.am/db/2575545/Novartis>,
        <https://1145.am/db/2575625/Novartis>,
        <https://1145.am/db/2575702/Novartis>,
        <https://1145.am/db/2575712/Novartis>,
        <https://1145.am/db/2575810/Novartis_Ag>,
        <https://1145.am/db/2575813/Novartis>,
        <https://1145.am/db/2576242/Novartis>,
        <https://1145.am/db/2576254/Novartis>,
        <https://1145.am/db/2576547/Novartis>,
        <https://1145.am/db/2576933/Novartis>,
        <https://1145.am/db/2577129/Novartis>,
        <https://1145.am/db/2577419/Novartis>,
        <https://1145.am/db/2577998/Novartis>,
        <https://1145.am/db/2579507/Novartis>,
        <https://1145.am/db/2579519/Novartis>,
        <https://1145.am/db/2580047/Novartis>,
        <https://1145.am/db/2580401/Novartis>,
        <https://1145.am/db/2580963/Novartis>,
        <https://1145.am/db/2581378/Novartis>,
        <https://1145.am/db/2581394/Novartis>,
        <https://1145.am/db/2581397/Novartis>,
        <https://1145.am/db/2581493/Novartis>,
        <https://1145.am/db/2581716/Novartis>,
        <https://1145.am/db/2582355/Novartis>,
        <https://1145.am/db/2582395/Novartis>,
        <https://1145.am/db/2582400/Novartis>,
        <https://1145.am/db/2582402/Novartis>,
        <https://1145.am/db/2582623/Novartis>,
        <https://1145.am/db/2582643/Novartis>,
        <https://1145.am/db/2583067/Novartis>,
        <https://1145.am/db/2584538/Novartis>,
        <https://1145.am/db/2585039/Novartis>,
        <https://1145.am/db/2585121/Novartis>,
        <https://1145.am/db/2586661/Novatis>,
        <https://1145.am/db/2586670/Novartis>,
        <https://1145.am/db/2587047/Novartis>,
        <https://1145.am/db/2587857/Novartis>,
        <https://1145.am/db/2588196/Novartis>,
        <https://1145.am/db/2589178/Novartis>,
        <https://1145.am/db/2589535/Novartis>,
        <https://1145.am/db/2591905/Novartis>,
        <https://1145.am/db/2592351/Novartis>,
        <https://1145.am/db/2592505/Novartis>,
        <https://1145.am/db/2592895/Novartis>,
        <https://1145.am/db/2592987/Novartis>,
        <https://1145.am/db/2593443/Novartis>,
        <https://1145.am/db/2594494/Novartis>,
        <https://1145.am/db/2594935/Novartis>,
        <https://1145.am/db/2594940/Novartis>,
        <https://1145.am/db/2595048/Novartis>,
        <https://1145.am/db/2595688/Novartis>,
        <https://1145.am/db/2596344/Novartis>,
        <https://1145.am/db/2597197/Novamed_Pharmaceuticals>,
        <https://1145.am/db/2598636/Novartis>,
        <https://1145.am/db/2787530/Novartis>,
        <https://1145.am/db/282192/Novartis>,
        <https://1145.am/db/346162/Novartis>,
        <https://1145.am/db/488391/Novartis>,
        <https://1145.am/db/509708/Novabay®_Pharmaceuticals_Inc>,
        <https://1145.am/db/595011/Novartis>,
        <https://1145.am/db/601300/Novabay®_Pharmaceuticals_Inc>,
        <https://1145.am/db/637582/Novartis>,
        <https://1145.am/db/652831/Novartis>,
        <https://1145.am/db/661296/Novartis>,
        <https://1145.am/db/691279/Novartis>,
        <https://1145.am/db/712016/Novartis>,
        <https://1145.am/db/895235/Novan> ;
    ns1:sameAsMedium <https://1145.am/db/1151476/Novartis>,
        <https://1145.am/db/1629127/Novartis>,
        <https://1145.am/db/1630421/Novartis>,
        <https://1145.am/db/2033933/Novartis>,
        <https://1145.am/db/2036487/Novartis_Ag>,
        <https://1145.am/db/2065993/Novartis_Ag>,
        <https://1145.am/db/2076347/Novartis>,
        <https://1145.am/db/2155042/Novartis>,
        <https://1145.am/db/2186148/Novartis>,
        <https://1145.am/db/2290898/Novartis>,
        <https://1145.am/db/2291090/Novartis>,
        <https://1145.am/db/2291713/Novartis>,
        <https://1145.am/db/2293419/Novartis>,
        <https://1145.am/db/2294680/Novartis>,
        <https://1145.am/db/2299847/Novartis>,
        <https://1145.am/db/2307851/Novartis>,
        <https://1145.am/db/2309347/Novartis>,
        <https://1145.am/db/2321958/Novartis>,
        <https://1145.am/db/2325386/Novartis>,
        <https://1145.am/db/2332408/Novartis>,
        <https://1145.am/db/2333390/Novartis>,
        <https://1145.am/db/2336990/Novartis>,
        <https://1145.am/db/2337976/Novartis>,
        <https://1145.am/db/2342687/Novartis>,
        <https://1145.am/db/2343460/Novartis>,
        <https://1145.am/db/2352178/Novartis>,
        <https://1145.am/db/2358559/Novartis>,
        <https://1145.am/db/2358579/Novartis>,
        <https://1145.am/db/2361451/Novartis>,
        <https://1145.am/db/2369178/Novartis>,
        <https://1145.am/db/2371165/Novartis>,
        <https://1145.am/db/2371188/Novartis>,
        <https://1145.am/db/2371203/Novartis>,
        <https://1145.am/db/2536538/Novartis>,
        <https://1145.am/db/2537155/Novartis>,
        <https://1145.am/db/2544350/Novartis>,
        <https://1145.am/db/2544409/Novartis>,
        <https://1145.am/db/2550764/Novartis>,
        <https://1145.am/db/2551001/Novartis>,
        <https://1145.am/db/2551402/Novartis>,
        <https://1145.am/db/2552856/Novartis>,
        <https://1145.am/db/2553487/Novartis>,
        <https://1145.am/db/2557204/Novartis>,
        <https://1145.am/db/2560238/Novartis>,
        <https://1145.am/db/2562442/Novartis>,
        <https://1145.am/db/2565564/Novartis>,
        <https://1145.am/db/2566121/Novartis>,
        <https://1145.am/db/2568734/Novartis>,
        <https://1145.am/db/2569724/Novartis>,
        <https://1145.am/db/2570062/Novartis>,
        <https://1145.am/db/2570721/Novartis>,
        <https://1145.am/db/2571462/Novartis>,
        <https://1145.am/db/2573984/Novartis>,
        <https://1145.am/db/2574584/Novartis>,
        <https://1145.am/db/2574950/Novartis>,
        <https://1145.am/db/2575947/Novartis>,
        <https://1145.am/db/2576892/Novartis>,
        <https://1145.am/db/2578046/Novartis>,
        <https://1145.am/db/2579890/Novartis>,
        <https://1145.am/db/2581804/Novartis>,
        <https://1145.am/db/2582646/Novartis>,
        <https://1145.am/db/2583163/Novartis>,
        <https://1145.am/db/2584135/Novartis>,
        <https://1145.am/db/2584245/Novartis>,
        <https://1145.am/db/2587048/Novartis>,
        <https://1145.am/db/2587805/Novartis>,
        <https://1145.am/db/2588333/Novartis>,
        <https://1145.am/db/2588691/Novartis>,
        <https://1145.am/db/2589799/Novartis>,
        <https://1145.am/db/2590887/Novartis>,
        <https://1145.am/db/2593780/Novartis>,
        <https://1145.am/db/2595924/Novartis_Ag>,
        <https://1145.am/db/619955/Novartis>,
        <https://1145.am/db/623985/Novartis> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2595150/Shanghai_Pharmaceuticals> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:description "active pharmaceutical ingredients" ;
    ns1:documentDate "2012-02-06T15:29:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DEA suspends Class 1 Cardinal Health facility; GSK earmarks $64M for Australian expansion;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dea-suspends-class-1-cardinal-health-facility-gsk-earmarks-64m-for-australian-expansion> ;
    ns1:foundName "Shanghai Pharmaceuticals" ;
    ns1:industry "pharmaceutical ingredients" ;
    ns1:investor <https://1145.am/db/2595150/Changzhou_Kony_Pharm_Stake_Investment> ;
    ns1:name "Shanghai Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/1084077/Pharmaron_Beijing_Co_Limited>,
        <https://1145.am/db/1085897/Pharmaron_Beijing_Co_Limited>,
        <https://1145.am/db/1226394/Zhongrun>,
        <https://1145.am/db/1232326/Zhongrun>,
        <https://1145.am/db/137166/Yixintang_Pharmaceutical_Group_Co_Ltd>,
        <https://1145.am/db/137230/Yixintang_Pharmaceutical_Group_Co_Ltd>,
        <https://1145.am/db/1539584/Shanghai_Fosun_Pharmaceutical_Group_Co_Ltd>,
        <https://1145.am/db/1579432/Zhongrun>,
        <https://1145.am/db/1606076/Beijing_Continent>,
        <https://1145.am/db/1616035/Sihuan_Pharmaceutical_Holdings_Group_Co_Ltd>,
        <https://1145.am/db/1981788/Shanghai_Fosun_Pharmaceutical_Group_Co_Ltd>,
        <https://1145.am/db/2202794/Shengtai_Pharmaceutical>,
        <https://1145.am/db/2203882/Shengtai_Pharmaceutical>,
        <https://1145.am/db/2290845/Shanghai_Pharmaceuticals>,
        <https://1145.am/db/2296208/Shanghai_Pharma>,
        <https://1145.am/db/2297651/Tonghua_Dongbao_Pharmaceuticals>,
        <https://1145.am/db/2302222/China_Pharma_Holdings_Inc>,
        <https://1145.am/db/2303132/China_Health_Holding>,
        <https://1145.am/db/2303514/Shenzhen_Hepalink_Pharmaceutical>,
        <https://1145.am/db/2304097/Guangxi_Lingfeng_Pharmaceutical>,
        <https://1145.am/db/2305866/Wuxi_Pharmatech>,
        <https://1145.am/db/2306155/China_Medicine_Corporation>,
        <https://1145.am/db/2308945/Wuxi_Pharmatec>,
        <https://1145.am/db/2308964/Zhangjiakou_Shengda_Pharmaceutical>,
        <https://1145.am/db/2309365/China_Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2312709/Tongjitang_Chinese_Medicines_Company>,
        <https://1145.am/db/2312926/Wuxi_Pharmatech>,
        <https://1145.am/db/2314210/Shijiazhuang_Le_Ren_Tang_Pharmaceutical>,
        <https://1145.am/db/2314211/Shijiazhuang_Le_Ren_Tang_Pharmaceutical>,
        <https://1145.am/db/2314615/Beijing_Med-Pharm>,
        <https://1145.am/db/2315545/China_Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2315545/Shijiazhuang_Lerentang_Pharmaceutical_Company_Ltd>,
        <https://1145.am/db/2317680/Wuxi_Pharmatech>,
        <https://1145.am/db/2318272/Tianyin_Pharmaceutical>,
        <https://1145.am/db/2318280/Tianyin_Pharmaceutical_Co_Inc>,
        <https://1145.am/db/2320000/Beijing_Med-Pharm>,
        <https://1145.am/db/2321775/Wuxi_Pharmatech>,
        <https://1145.am/db/2321858/Changchun_Xinan_Pharmaceutical_Group>,
        <https://1145.am/db/2321867/Changchun_Xinan_Pharmaceutical_Group_Company_Limited>,
        <https://1145.am/db/2321868/Shandong_Simcere_Medgenn_Bio-Pharmaceutical>,
        <https://1145.am/db/2321885/Shandong_Simcere_Medgenn_Bio-Pharmaceutical_Co>,
        <https://1145.am/db/2322489/Shengtai_Pharmaceutical_Inc>,
        <https://1145.am/db/2322490/China_Yongxin_Pharmaceutical_Inc>,
        <https://1145.am/db/2322854/Wuxi_Pharmatech>,
        <https://1145.am/db/2324777/Jiangbo_Pharmaceuticals>,
        <https://1145.am/db/2325432/China_Health_Holdings>,
        <https://1145.am/db/2325432/Xian_Chunhui_Pharmaceuticals>,
        <https://1145.am/db/2327401/Wuxi_Pharmatech>,
        <https://1145.am/db/2327517/Shengtai_Pharmaceutical>,
        <https://1145.am/db/2328605/Shengtai_Pharmaceutical>,
        <https://1145.am/db/2328959/Tianyin_Pharmaceutical_Co_Inc>,
        <https://1145.am/db/2330121/Zhejiang_Hisun_Pharmaceutical>,
        <https://1145.am/db/2330122/Zhejiang_Hisun_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/2332322/Wuxi_Pharmatech>,
        <https://1145.am/db/2332622/Wuxi_Pharmatech>,
        <https://1145.am/db/2332973/Wuxi_Pharmatech>,
        <https://1145.am/db/2332977/Wuxi_Pharmatech>,
        <https://1145.am/db/2332992/Wuxi_Pharmatech>,
        <https://1145.am/db/2333380/Wuxi_Pharmatech>,
        <https://1145.am/db/2333547/Beijing_Med-Pharm>,
        <https://1145.am/db/2333559/Beijing_Med-Pharm>,
        <https://1145.am/db/2334018/Wuxi_Pharmatech>,
        <https://1145.am/db/2339255/Wuxi_Pharmatech>,
        <https://1145.am/db/2339514/Yantai_Tianzheng_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/2345570/China_Pharmahub_Corp>,
        <https://1145.am/db/2345740/Wuxi_Pharmatech>,
        <https://1145.am/db/2349221/Shenzhen_Hepalink_Pharmaceutical>,
        <https://1145.am/db/2351684/Wuxi_Pharmatech>,
        <https://1145.am/db/2351908/Guangxi_Wuzhou_Pharmaceutical_Group_Co_Ltd>,
        <https://1145.am/db/2354127/Wuxi_Pharmatech>,
        <https://1145.am/db/2355454/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/2356518/China_Medicine>,
        <https://1145.am/db/2358954/Wuxi_Pharmatech>,
        <https://1145.am/db/2361298/Beijing_Jialin_Pharma_Pharmaceutical>,
        <https://1145.am/db/2363450/Guangdong_Medi-World_Pharmaceutical>,
        <https://1145.am/db/2363450/Jiangyin_Tianjiang_Pharmaceutical>,
        <https://1145.am/db/2367156/Jiangbo_Pharmaceuticals_Inc>,
        <https://1145.am/db/2367164/Jiangbo_Pharmaceuticals>,
        <https://1145.am/db/2536549/Wuxi_Pharmatech>,
        <https://1145.am/db/2536754/Guangxi_Wuzhou_Pharmaceutical>,
        <https://1145.am/db/2536776/Guangxi_Wuzhou_Pharmaceutical>,
        <https://1145.am/db/2536790/Wuxi_Pharmatech>,
        <https://1145.am/db/2537079/Jiangxi_Dongbang_Pharmaceutical>,
        <https://1145.am/db/2537316/Shenzhen_Hepalink_Pharmaceutical>,
        <https://1145.am/db/2537340/Zhejiang_Wansheng_Pharma>,
        <https://1145.am/db/2537372/Shenzhen_Hepalink_Pharmaceutical>,
        <https://1145.am/db/2537821/Zhejiang_Wansheng_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/2538197/Wuxi_Pharmatech>,
        <https://1145.am/db/2539062/Shenzhen_Hepalink_Pharmaceutical>,
        <https://1145.am/db/2540165/Beijing_Med-Pharm>,
        <https://1145.am/db/2540242/Zhejiang_Wansheng_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/2540502/Shanghai_Fosun_Pharmaceuticals>,
        <https://1145.am/db/2540508/Shanghai_Fosun_Pharmaceutical>,
        <https://1145.am/db/2543972/Shanghai_Pharma>,
        <https://1145.am/db/2545296/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/2545361/Tianyi>,
        <https://1145.am/db/2545366/Shanghai_Cp_Guojian_Pharmaceutical>,
        <https://1145.am/db/2546406/Jiangsu_Hansoh_Pharmaceutical>,
        <https://1145.am/db/2546427/Yichang_Hec_Changjiang_Pharmaceutical>,
        <https://1145.am/db/2547546/Shenzhen_Hepalink_Pharmaceutical>,
        <https://1145.am/db/2549427/Tianyin_Pharmaceutical>,
        <https://1145.am/db/2549518/Wuxi_Pharmatech>,
        <https://1145.am/db/2550212/Shijiazhuang_Lerentang_Pharmaceutical>,
        <https://1145.am/db/2550511/China_Resources_Pharmaceutical_Group>,
        <https://1145.am/db/2553148/China_Resources_Pharmaceutical_Group>,
        <https://1145.am/db/2553655/Wuxi_Pharmatech>,
        <https://1145.am/db/2553755/Shenzhen_Hepalink_Pharmaceutical>,
        <https://1145.am/db/2555040/Jiangsu_Acebright_Pharmaceutical>,
        <https://1145.am/db/2555291/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/2555342/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/2555844/Wuxi_Pharmatech>,
        <https://1145.am/db/2556124/Shanghai_Fosun_Pharmaceutical>,
        <https://1145.am/db/2556124/Suzhou_Pharmaceutical_Factory>,
        <https://1145.am/db/2557866/Nanjing_Pharmaceutical_Company>,
        <https://1145.am/db/2559081/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/2559665/Shanghai_Pharmaceuticals>,
        <https://1145.am/db/2560179/Beijing_Jialin_Pharmaceutical>,
        <https://1145.am/db/2560187/Beijing_Jialin_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/2561248/Chongqing_Lummy_Pharmaceutical>,
        <https://1145.am/db/2561248/Tianjin_Zhongxin_Pharmaceutical>,
        <https://1145.am/db/2561426/China_Pharma>,
        <https://1145.am/db/2563016/Shanghai_Pharmaceutical_Industry>,
        <https://1145.am/db/2563847/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/2563850/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/2565596/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/2569364/Liaoning_Tianyi_Biological_Pharmaceutical>,
        <https://1145.am/db/2569370/Hong_Sun>,
        <https://1145.am/db/2569370/Tianyi>,
        <https://1145.am/db/2569370/Xiaojun_Zhao>,
        <https://1145.am/db/2570062/Jiangsu_Hansoh>,
        <https://1145.am/db/2572398/Wuxi_Pharmatech>,
        <https://1145.am/db/2572442/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/2572625/Shanghai_Pharmaceuticals>,
        <https://1145.am/db/2572679/Nanjing_Meirui_Pharma>,
        <https://1145.am/db/2572938/China_Medical>,
        <https://1145.am/db/2573585/Nanjing_Meirui_Pharma>,
        <https://1145.am/db/2575314/Shanghai_Modern_Pharmaceutical>,
        <https://1145.am/db/2577081/Chinas_Shenzhen_Hepalink_Pharmaceutical>,
        <https://1145.am/db/2580344/Shanghai_Pharmaceuticals>,
        <https://1145.am/db/2586048/Sihuan_Pharmaceutical_Holdings_Group_Ltd>,
        <https://1145.am/db/2587281/Jiangsu_Yanshen>,
        <https://1145.am/db/2587657/Shandong_Buchang_Pharmaceutical>,
        <https://1145.am/db/2588092/Shanghai_Pharmaceutical>,
        <https://1145.am/db/2594042/Guangxi_Wuzhou_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/2595154/Shanghai_Pharmaceuticals>,
        <https://1145.am/db/2598064/Jiangzhong_Pharmaceuticals>,
        <https://1145.am/db/2722105/China_Resources_Pharmaceutical_Group>,
        <https://1145.am/db/2722105/Jiangzhong_Group>,
        <https://1145.am/db/2748691/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/438036/China_Grand_Pharmaceutical_And_Healthcare_Holdings_Limited>,
        <https://1145.am/db/742121/Pharmaron_Beijing_Co_Limited>,
        <https://1145.am/db/742618/Pharmaron_Beijing_Co_Limited>,
        <https://1145.am/db/744958/Pharmaron_Beijing_Co_Limited>,
        <https://1145.am/db/746462/Pharmaron_Beijing_Co_Limited>,
        <https://1145.am/db/773492/China_Sxt_Pharmaceuticals_Inc>,
        <https://1145.am/db/902672/China_Sxt_Pharmaceuticals_Inc>,
        <https://1145.am/db/973707/Zhongrun> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2595511/Biogen_Idec> a org:Organization ;
    ns1:basedInHighGeoName "Massachusetts" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6254926/about.rdf> ;
    ns1:basedInHighRaw "Massachusetts" ;
    ns1:buyer <https://1145.am/db/2595511/Avonex_Joint_Venture> ;
    ns1:description "Business" ;
    ns1:documentDate "2011-09-06T15:58:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biogen takes European MS marketing in-house with JV buyouts" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/biogen-takes-european-ms-marketing-house-jv-buyouts> ;
    ns1:foundName "Biogen Idec" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Biogen Idec" ;
    ns1:sameAsHigh <https://1145.am/db/1004139/Entrechem_Sl>,
        <https://1145.am/db/101302/Biotec_Pharmacon_Asa>,
        <https://1145.am/db/1037440/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/1043614/Pharmajet>,
        <https://1145.am/db/1046013/Pharmajet>,
        <https://1145.am/db/108359/Biogen_Inc>,
        <https://1145.am/db/1182119/Pharnext_Sa>,
        <https://1145.am/db/1196435/Infinity_Biologix_Llc>,
        <https://1145.am/db/1198542/Infinity_Biologix_Llc>,
        <https://1145.am/db/1263299/Biolab>,
        <https://1145.am/db/1265716/Bioivt>,
        <https://1145.am/db/1270730/Bioasis_Technologies_Inc>,
        <https://1145.am/db/1319248/Think_Bioscience>,
        <https://1145.am/db/1321358/Ichor_Life_Sciences>,
        <https://1145.am/db/1325997/Biopharma_Global>,
        <https://1145.am/db/1337532/Bioivt>,
        <https://1145.am/db/1345925/Innovation1_Biotech_Inc>,
        <https://1145.am/db/1376181/Flagship_Biosciences>,
        <https://1145.am/db/1380463/Vicapsys_Life_Sciences_Inc>,
        <https://1145.am/db/1397594/Rectify_Pharmaceuticals_Inc>,
        <https://1145.am/db/1402913/Biogen>,
        <https://1145.am/db/1405080/Ochre_Bio>,
        <https://1145.am/db/1406734/Bioneex>,
        <https://1145.am/db/1408996/Ochre_Bio>,
        <https://1145.am/db/1418668/Simcere_Pharmaceuticals>,
        <https://1145.am/db/1490051/Biogen>,
        <https://1145.am/db/1494850/Biogen_Inc>,
        <https://1145.am/db/1507989/Bionomics>,
        <https://1145.am/db/1522097/Bionomics_Limited>,
        <https://1145.am/db/1523985/Biocorrx_Pharmaceuticals_Inc>,
        <https://1145.am/db/1531806/Lifecore_Biomedical>,
        <https://1145.am/db/1545261/Cardior_Pharmaceuticals>,
        <https://1145.am/db/1563797/Be_Biopharma>,
        <https://1145.am/db/1576268/Bioasis_Technologies_Inc>,
        <https://1145.am/db/1619442/Hightide>,
        <https://1145.am/db/1628791/Atai_Life_Sciences>,
        <https://1145.am/db/1630569/Lifecore_Biomedical_Inc>,
        <https://1145.am/db/1659339/Biocon>,
        <https://1145.am/db/1680653/149_Bio>,
        <https://1145.am/db/1935113/Provention_Bio_Inc>,
        <https://1145.am/db/1957460/Pardes_Biosciences_Inc>,
        <https://1145.am/db/1979877/Biocon_Ltd>,
        <https://1145.am/db/1981295/Rectify_Pharmaceuticals_Inc>,
        <https://1145.am/db/1988637/Iveric_Bio>,
        <https://1145.am/db/1988943/Iveric_Bio_Inc>,
        <https://1145.am/db/2003152/Pharmacyte>,
        <https://1145.am/db/2004568/Medincell>,
        <https://1145.am/db/2017278/Erytech_Pharma>,
        <https://1145.am/db/2021869/Abionyx_Pharma>,
        <https://1145.am/db/2036830/Biogen>,
        <https://1145.am/db/2037970/Erytech_Pharma>,
        <https://1145.am/db/2056049/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2067011/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2090091/Concord_Biotech>,
        <https://1145.am/db/2152658/Atea_Pharmaceuticals>,
        <https://1145.am/db/2153005/Genentech>,
        <https://1145.am/db/2154198/Attune_Pharmaceuticals>,
        <https://1145.am/db/2154706/Biotage>,
        <https://1145.am/db/2155042/The_Medicines_Company>,
        <https://1145.am/db/2156114/X4_Pharmaceuticals>,
        <https://1145.am/db/2223218/United_Biosource_Corporation>,
        <https://1145.am/db/2230917/Scifluor_Life_Sciences>,
        <https://1145.am/db/2242573/Pharmarc>,
        <https://1145.am/db/2243599/Biogen_Idec>,
        <https://1145.am/db/2254330/Pharmathene>,
        <https://1145.am/db/2280215/Atea_Pharmaceuticals>,
        <https://1145.am/db/2280231/D___D_Pharmatech>,
        <https://1145.am/db/2280769/Iveric_Bio>,
        <https://1145.am/db/2282241/Be_Biopharma>,
        <https://1145.am/db/2282756/Isa_Pharmaceuticals>,
        <https://1145.am/db/2283468/Biohaven>,
        <https://1145.am/db/2284603/Biotech>,
        <https://1145.am/db/2285239/Bio>,
        <https://1145.am/db/2286092/Be_Biopharma>,
        <https://1145.am/db/2286404/Enthera_Pharmaceuticals>,
        <https://1145.am/db/2288191/Pharmaron>,
        <https://1145.am/db/2290480/Entera_Bio>,
        <https://1145.am/db/2291446/Roivant_Sciences>,
        <https://1145.am/db/2293310/Biogen>,
        <https://1145.am/db/2293696/Provention_Bio>,
        <https://1145.am/db/2295048/Proclara_Biosciences>,
        <https://1145.am/db/2296016/Ds_Biopharma>,
        <https://1145.am/db/2298167/Aetion>,
        <https://1145.am/db/2300489/Roivant_Sciences>,
        <https://1145.am/db/2301083/Biolinerx>,
        <https://1145.am/db/2301537/Proclara_Biosciences>,
        <https://1145.am/db/2301767/Bioxell_Spa>,
        <https://1145.am/db/2301820/Sciele_Pharma>,
        <https://1145.am/db/2301844/Biogen_Idec>,
        <https://1145.am/db/2301979/Biogen_Idec_Inc>,
        <https://1145.am/db/2302715/Biomimetic_Therapeutics>,
        <https://1145.am/db/2302897/Sagamore_Bioventures>,
        <https://1145.am/db/2303025/Profectus_Biosciences>,
        <https://1145.am/db/2303208/Biomarin_Pharmaceutical>,
        <https://1145.am/db/2303357/Biocon>,
        <https://1145.am/db/2303415/Biogen_Idec>,
        <https://1145.am/db/2303502/Accutest_Research_Laboratories>,
        <https://1145.am/db/2303604/Facet_Biotech_Corporation>,
        <https://1145.am/db/2303937/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2304165/Bioclinica>,
        <https://1145.am/db/2304628/Bioreliance>,
        <https://1145.am/db/2304829/Pharming_Group_Nv>,
        <https://1145.am/db/2304919/Biovail>,
        <https://1145.am/db/2305020/Biodelivery>,
        <https://1145.am/db/2305559/Via_Pharmaceuticals>,
        <https://1145.am/db/2305822/D-Pharm>,
        <https://1145.am/db/2305956/Biotrove>,
        <https://1145.am/db/2306113/Pharming>,
        <https://1145.am/db/2306117/Biogen_Idec>,
        <https://1145.am/db/2306160/Pharminox_Limited>,
        <https://1145.am/db/2306464/Bioseek>,
        <https://1145.am/db/2306935/Biogen_Idec>,
        <https://1145.am/db/2307579/Biovectra>,
        <https://1145.am/db/2308761/Biolinerx>,
        <https://1145.am/db/2308916/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2309484/Biovail_Corporation>,
        <https://1145.am/db/230953/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2309736/Bioclinica>,
        <https://1145.am/db/2309970/Biomarin_Pharmaceutical>,
        <https://1145.am/db/2311264/Biogen_Idec>,
        <https://1145.am/db/2311476/Bioclinica>,
        <https://1145.am/db/2312358/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2313765/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2314230/Sciele_Pharma>,
        <https://1145.am/db/2314546/Combinature_Biopharm>,
        <https://1145.am/db/2314683/Pharming_Group_Nv>,
        <https://1145.am/db/2314688/Pharming_Group>,
        <https://1145.am/db/2315632/Synthetech>,
        <https://1145.am/db/2315688/Biovitrum>,
        <https://1145.am/db/2316066/Biogen_Idec>,
        <https://1145.am/db/2316356/Biogen_Idec>,
        <https://1145.am/db/2316481/Life_Technologies>,
        <https://1145.am/db/2316720/Biogen_Idec>,
        <https://1145.am/db/2316915/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2317508/Biovail>,
        <https://1145.am/db/2317680/Sciele_Pharma>,
        <https://1145.am/db/2318404/Almirall>,
        <https://1145.am/db/2318581/Sciele_Pharma>,
        <https://1145.am/db/2318644/Biovail_Corporation>,
        <https://1145.am/db/2318658/Biovail_Corporation>,
        <https://1145.am/db/2318658/Biovail_International_Laboratories_Srl>,
        <https://1145.am/db/2318766/Sciele>,
        <https://1145.am/db/2319577/Genentech>,
        <https://1145.am/db/2319587/Bioclinica>,
        <https://1145.am/db/2320110/Biovail>,
        <https://1145.am/db/2320163/Berna_Biotech>,
        <https://1145.am/db/2320648/Bioclinica>,
        <https://1145.am/db/2321134/Biomira>,
        <https://1145.am/db/2321911/Biovail_Corporation>,
        <https://1145.am/db/2322012/Biogen-Idec_Ventures>,
        <https://1145.am/db/2322089/Biovail_Corporation>,
        <https://1145.am/db/2322091/Biovail>,
        <https://1145.am/db/2322093/Biovail>,
        <https://1145.am/db/2322189/Genentech>,
        <https://1145.am/db/2322201/Genentech>,
        <https://1145.am/db/2322295/Topgen_Esv>,
        <https://1145.am/db/2322805/Clinipace>,
        <https://1145.am/db/2322850/Clinipace>,
        <https://1145.am/db/2323097/Biovitrum_Ab>,
        <https://1145.am/db/2324079/Biostorage_Technologies>,
        <https://1145.am/db/2324234/Biothorpe_Pharmaceuticals>,
        <https://1145.am/db/2324755/Biomarin>,
        <https://1145.am/db/2325714/Biogen_Idec>,
        <https://1145.am/db/2325717/Biogen_Idec>,
        <https://1145.am/db/2326031/Bioclinica>,
        <https://1145.am/db/2326186/Sciele_Pharma>,
        <https://1145.am/db/2326815/Biovail_Corporation>,
        <https://1145.am/db/2326817/Biovail>,
        <https://1145.am/db/2326895/Biovitrum>,
        <https://1145.am/db/2327243/Bioenvision>,
        <https://1145.am/db/2328437/Biogen_Idec>,
        <https://1145.am/db/2328960/Biodel_Inc>,
        <https://1145.am/db/2328998/Via_Pharmaceuticals>,
        <https://1145.am/db/2330549/Celator_Pharmaceuticals>,
        <https://1145.am/db/2330782/Pharminggroup_Nv>,
        <https://1145.am/db/2330990/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2331044/Genentech>,
        <https://1145.am/db/2331511/Bioclinica>,
        <https://1145.am/db/2331622/Bioprocessors_Corporation>,
        <https://1145.am/db/2331991/Atrium_Biotechnologies>,
        <https://1145.am/db/2332200/Life_Technologies>,
        <https://1145.am/db/233261/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2332847/Atrium_Biotechnologies_Inc>,
        <https://1145.am/db/2333447/Eresearch_Technology>,
        <https://1145.am/db/2334032/Biooutsource>,
        <https://1145.am/db/2334133/Biorexis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2334181/Pharming>,
        <https://1145.am/db/2334589/Bioclinica>,
        <https://1145.am/db/2335029/Bioclinica>,
        <https://1145.am/db/2336028/Biolinerx>,
        <https://1145.am/db/2336041/Bioset>,
        <https://1145.am/db/2336113/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2336259/Coherus_Biosciences>,
        <https://1145.am/db/2336983/Biogen_Idec>,
        <https://1145.am/db/2337080/Medistem_Inc>,
        <https://1145.am/db/2337420/Chs_Pharma_Inc>,
        <https://1145.am/db/2338836/Biogen_Idec>,
        <https://1145.am/db/2340015/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2340213/Satori_Pharmaceuticals>,
        <https://1145.am/db/2340286/Pharmasset>,
        <https://1145.am/db/2340402/Biolinerx>,
        <https://1145.am/db/2341010/Lfb_Biotechnologies>,
        <https://1145.am/db/2341165/Pharmasset>,
        <https://1145.am/db/2342188/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2342800/Theraclone_Sciences>,
        <https://1145.am/db/2342805/Theraclone_Sciences>,
        <https://1145.am/db/2343628/Galecto_Biotech_Ab>,
        <https://1145.am/db/2343817/Biomotiv>,
        <https://1145.am/db/2344078/Pharmathene>,
        <https://1145.am/db/2344192/Biologics>,
        <https://1145.am/db/2344318/Theraclone_Sciences>,
        <https://1145.am/db/2344560/Dmi_Biosciences_Inc>,
        <https://1145.am/db/2344940/Biodelivery_Sciences_International>,
        <https://1145.am/db/2345508/Pevion_Biotech_Ltd>,
        <https://1145.am/db/2346347/Biospecifics_Technologies_Corp>,
        <https://1145.am/db/2347256/Biocis_Pharma_Oy>,
        <https://1145.am/db/2347768/Biothera>,
        <https://1145.am/db/2347792/Biomarin>,
        <https://1145.am/db/2347799/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2348159/Biocon>,
        <https://1145.am/db/2348440/Cerulean_Pharma>,
        <https://1145.am/db/2348522/Am-Pharma>,
        <https://1145.am/db/2348776/Genentech>,
        <https://1145.am/db/2348923/Biothera>,
        <https://1145.am/db/2349891/Bioclinica>,
        <https://1145.am/db/2350127/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350245/Biodelivery_Sciences_International>,
        <https://1145.am/db/2351103/Genentech>,
        <https://1145.am/db/2351826/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2352246/Genentech>,
        <https://1145.am/db/2352261/Biodelivery_Sciences_International>,
        <https://1145.am/db/2353157/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2353325/Am-Pharma>,
        <https://1145.am/db/2353337/Am-Pharma>,
        <https://1145.am/db/2353644/Bionovo_Inc>,
        <https://1145.am/db/2353663/Biotie>,
        <https://1145.am/db/2353771/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2353789/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2353951/Biodelivery_Sciences_International_Inc>,
        <https://1145.am/db/2353974/Acesion_Pharma>,
        <https://1145.am/db/2354079/Pharming>,
        <https://1145.am/db/2354084/Pharming_Group>,
        <https://1145.am/db/2354589/Biogen>,
        <https://1145.am/db/2354987/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2355177/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2355667/Pharmasset>,
        <https://1145.am/db/2356073/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2356186/Biothera>,
        <https://1145.am/db/2356597/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2356599/Biomarin>,
        <https://1145.am/db/2356945/Biovail_Laboratories_International_Srl>,
        <https://1145.am/db/2357049/Theravance>,
        <https://1145.am/db/2357068/Theravance_Inc>,
        <https://1145.am/db/2357123/Biogen_Idec>,
        <https://1145.am/db/2357508/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2357932/Biogen_Idec>,
        <https://1145.am/db/2358167/Alexion_Pharmaceuticals>,
        <https://1145.am/db/2358612/Bioclinica>,
        <https://1145.am/db/2358763/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2359141/Bioclinica>,
        <https://1145.am/db/2359286/Axim_Biotechnologies>,
        <https://1145.am/db/2360257/Aldea_Pharmaceuticals>,
        <https://1145.am/db/2360710/Xbiotech>,
        <https://1145.am/db/2360719/Biodelivery_Sciences_International_Inc>,
        <https://1145.am/db/2360960/Pharmarc>,
        <https://1145.am/db/2361646/Biomarin>,
        <https://1145.am/db/2361667/Diamedica>,
        <https://1145.am/db/2361850/Provectus_Pharmaceuticals>,
        <https://1145.am/db/2362027/Biotie_Therapeutics>,
        <https://1145.am/db/2362341/Biontech_Ag>,
        <https://1145.am/db/2362901/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2363699/Prism_Pharma>,
        <https://1145.am/db/2364095/Biogen_Idec>,
        <https://1145.am/db/2364364/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2364671/Biogen_Idec>,
        <https://1145.am/db/2364672/Biogen_Idec>,
        <https://1145.am/db/2364678/Biogen_Idec>,
        <https://1145.am/db/2364813/Biomarin>,
        <https://1145.am/db/2365199/Biovail>,
        <https://1145.am/db/2365200/Biovail>,
        <https://1145.am/db/2366353/Biodelivery_Sciences_International>,
        <https://1145.am/db/2366651/Pharming_Group_Nv>,
        <https://1145.am/db/2366688/Pharmagap_Inc>,
        <https://1145.am/db/2366933/Lux_Biosciences>,
        <https://1145.am/db/2367158/Lux_Biosciences>,
        <https://1145.am/db/2367182/Biotica>,
        <https://1145.am/db/2367612/Biota_Pharmaceuticals>,
        <https://1145.am/db/2368283/Eligo_Bioscience>,
        <https://1145.am/db/2368369/Biodelivery_Sciences_International>,
        <https://1145.am/db/2368429/Biodelivery_Sciences_International>,
        <https://1145.am/db/2368439/Biodelivery_Sciences_International>,
        <https://1145.am/db/2368457/Axovant_Sciences>,
        <https://1145.am/db/2368754/Biodelivery_Sciences_International>,
        <https://1145.am/db/2369234/Biodelivery_Sciences_International_Inc>,
        <https://1145.am/db/2369490/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2369860/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2370706/Amo_Pharma>,
        <https://1145.am/db/2371179/Apellis_Pharmaceuticals>,
        <https://1145.am/db/2371314/Genentech>,
        <https://1145.am/db/239789/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2537484/Sciele>,
        <https://1145.am/db/2538019/Biovitrum>,
        <https://1145.am/db/2540240/Biogen>,
        <https://1145.am/db/2541239/Biogen_Idec>,
        <https://1145.am/db/2541294/Ark_Biosciences>,
        <https://1145.am/db/2541703/A___C_Bio>,
        <https://1145.am/db/2543106/Biocon>,
        <https://1145.am/db/2543334/Mabspace_Biosciences>,
        <https://1145.am/db/2543721/Biocon_Biologics>,
        <https://1145.am/db/2543962/Quotient_Sciences>,
        <https://1145.am/db/2545015/Biovail>,
        <https://1145.am/db/2546113/Biodelivery_Sciences_International>,
        <https://1145.am/db/2546153/Coherus_Biosciences>,
        <https://1145.am/db/2547550/Bio_Pure_Technology>,
        <https://1145.am/db/2548022/Jsc_Biosintez>,
        <https://1145.am/db/2548151/Biocon>,
        <https://1145.am/db/2549670/Genentech>,
        <https://1145.am/db/2550148/Organon_Biosciences>,
        <https://1145.am/db/2550232/Xcelience>,
        <https://1145.am/db/2550837/Biohaven>,
        <https://1145.am/db/2551030/Biological_E>,
        <https://1145.am/db/2551075/Biosims>,
        <https://1145.am/db/2553491/Biomarin>,
        <https://1145.am/db/2553835/Biovail>,
        <https://1145.am/db/2559286/Biocon_Biologics>,
        <https://1145.am/db/2559490/Iveric_Bio>,
        <https://1145.am/db/2560880/Biovail>,
        <https://1145.am/db/2563423/Anthera_Pharmaceuticals>,
        <https://1145.am/db/2566088/Stellar_Biotechnologies>,
        <https://1145.am/db/2567129/Biocon_Biologics>,
        <https://1145.am/db/2567727/Biocon>,
        <https://1145.am/db/2567935/Medsenic>,
        <https://1145.am/db/2568444/Biogen>,
        <https://1145.am/db/2573593/Biotica>,
        <https://1145.am/db/2575552/Biovail>,
        <https://1145.am/db/2575644/Biodelivery_Sciences_International>,
        <https://1145.am/db/2576156/Biogen_Idec>,
        <https://1145.am/db/2577183/Biogen_Idec>,
        <https://1145.am/db/2577184/Biogen_Idec>,
        <https://1145.am/db/2577419/Biovail>,
        <https://1145.am/db/2580337/Biodelivery_Sciences_International>,
        <https://1145.am/db/2581394/Biocon>,
        <https://1145.am/db/2581855/Biogen_Idec>,
        <https://1145.am/db/2583414/Bioton>,
        <https://1145.am/db/2583783/Biomarin>,
        <https://1145.am/db/2583839/Biogen_Idec>,
        <https://1145.am/db/2585066/Advanced_Bio-Technologies>,
        <https://1145.am/db/2586160/Biogen_Idec>,
        <https://1145.am/db/2587981/Biochem>,
        <https://1145.am/db/2588178/Biovail>,
        <https://1145.am/db/2588378/Enlight_Biosciences>,
        <https://1145.am/db/2591550/Genentech>,
        <https://1145.am/db/2593529/Pharmstandard>,
        <https://1145.am/db/2593831/Biovail>,
        <https://1145.am/db/2594877/Biogen_Idec>,
        <https://1145.am/db/2595561/Biomarin_Pharmaceutical>,
        <https://1145.am/db/2597220/Biological_E>,
        <https://1145.am/db/2598558/Biovail>,
        <https://1145.am/db/2798422/Biomarin_Pharmaceutical>,
        <https://1145.am/db/291851/Altasciences>,
        <https://1145.am/db/317345/Realta_Life_Sciences>,
        <https://1145.am/db/345698/Flagship_Biosciences>,
        <https://1145.am/db/426688/Cardior_Pharmaceuticals>,
        <https://1145.am/db/427181/Cellect_Biotechnology_Ltd>,
        <https://1145.am/db/453079/Infinity_Pharmaceuticals>,
        <https://1145.am/db/486464/Aadi_Bioscience>,
        <https://1145.am/db/488591/Be_Biopharma>,
        <https://1145.am/db/522502/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/545988/Rectify_Pharmaceuticals>,
        <https://1145.am/db/556149/D___D_Pharmatech_Inc>,
        <https://1145.am/db/583231/D___D_Pharmatech>,
        <https://1145.am/db/662958/Biocina>,
        <https://1145.am/db/665573/Abionyx_Pharma>,
        <https://1145.am/db/674262/Abionyx_Pharma>,
        <https://1145.am/db/678224/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/685681/Biocon_Ltd>,
        <https://1145.am/db/709723/Pardes_Biosciences>,
        <https://1145.am/db/712921/Replicel_Life_Sciences_Inc>,
        <https://1145.am/db/714643/Achieve_Life_Sciences>,
        <https://1145.am/db/722194/Biogen_Inc>,
        <https://1145.am/db/724168/Biogen_Inc>,
        <https://1145.am/db/726160/Biogen_Inc>,
        <https://1145.am/db/731137/Altasciences>,
        <https://1145.am/db/734635/Altasciences>,
        <https://1145.am/db/736861/Bionomics>,
        <https://1145.am/db/739339/Iveric_Bio>,
        <https://1145.am/db/832408/Biodelivery_Sciences_International>,
        <https://1145.am/db/833269/Biodelivery_Sciences_International>,
        <https://1145.am/db/840678/Gt_Biopharma>,
        <https://1145.am/db/862305/Biocon_Biologics>,
        <https://1145.am/db/862305/Biocon_Ltd>,
        <https://1145.am/db/866237/Cardior_Pharmaceuticals>,
        <https://1145.am/db/882284/Biofrontera_Inc>,
        <https://1145.am/db/901032/Achieve_Life_Sciences>,
        <https://1145.am/db/906534/Kither_Biotech>,
        <https://1145.am/db/926227/Biodelivery_Sciences_International_Inc>,
        <https://1145.am/db/966626/Biogen>,
        <https://1145.am/db/973736/Biocorrx_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2238762/Biogen_Idec>,
        <https://1145.am/db/2297083/Biogen_Idec>,
        <https://1145.am/db/2301684/Biogen_Idec_Inc>,
        <https://1145.am/db/2301691/Biogen_Idec>,
        <https://1145.am/db/2301809/Biogen_Idec>,
        <https://1145.am/db/2301977/Biogen_Idec_Inc>,
        <https://1145.am/db/2301983/Biogen_Idec>,
        <https://1145.am/db/2302002/Biogen_Idec>,
        <https://1145.am/db/2302112/Biogen_Idec>,
        <https://1145.am/db/2302275/Biogen_Idec>,
        <https://1145.am/db/2303604/Biogen_Idec>,
        <https://1145.am/db/2304017/Biogen_Idec_Inc>,
        <https://1145.am/db/2304845/Biogen_Idec>,
        <https://1145.am/db/2304924/Biogen_Idec>,
        <https://1145.am/db/2305209/Biogen_Idec>,
        <https://1145.am/db/2305210/Biogen_Idec>,
        <https://1145.am/db/2305215/Biogen_Idec>,
        <https://1145.am/db/2305804/Biogen_Idec>,
        <https://1145.am/db/2306662/Biogen_Idec>,
        <https://1145.am/db/2308142/Biogen_Idec>,
        <https://1145.am/db/2310216/Biogen_Idec>,
        <https://1145.am/db/2311233/Biogen_Idec>,
        <https://1145.am/db/2311545/Biogen_Idec>,
        <https://1145.am/db/2313448/Biogen_Idec>,
        <https://1145.am/db/2314822/Biogen_Idec>,
        <https://1145.am/db/2317000/Biogen_Idec>,
        <https://1145.am/db/2317136/Biogen_Idec_Inc>,
        <https://1145.am/db/2317505/Biogen_Idec>,
        <https://1145.am/db/2320138/Biogen_Idec>,
        <https://1145.am/db/2326219/Biogen_Idec>,
        <https://1145.am/db/2329776/Biogen_Idec>,
        <https://1145.am/db/2329848/Biogen_Idec>,
        <https://1145.am/db/2332651/Biogen_Idec>,
        <https://1145.am/db/2335838/Biogen_Idec>,
        <https://1145.am/db/2336274/Biogen_Idec>,
        <https://1145.am/db/2337745/Biogen_Idec>,
        <https://1145.am/db/2340610/Biogen_Idec>,
        <https://1145.am/db/2341549/Biogen_Idec>,
        <https://1145.am/db/2341558/Biogen_Idec>,
        <https://1145.am/db/2345027/Biogen_Idec>,
        <https://1145.am/db/2345999/Biogen_Idec>,
        <https://1145.am/db/2352069/Biogen_Idec>,
        <https://1145.am/db/2352070/Biogen_Idec>,
        <https://1145.am/db/2353066/Biogen_Idec>,
        <https://1145.am/db/2354694/Biogen_Idec>,
        <https://1145.am/db/2354701/Biogen_Idec>,
        <https://1145.am/db/2358296/Biogen_Idec>,
        <https://1145.am/db/2358301/Biogen_Idec>,
        <https://1145.am/db/2359499/Biogen_Idec>,
        <https://1145.am/db/2359505/Biogen_Idec>,
        <https://1145.am/db/2360274/Biogen_Idec>,
        <https://1145.am/db/2361297/Biogen_Idec>,
        <https://1145.am/db/2361405/Biogen_Idec>,
        <https://1145.am/db/2363538/Biogen_Idec>,
        <https://1145.am/db/2364681/Biogen_Idec>,
        <https://1145.am/db/2366338/Biogen_Idec>,
        <https://1145.am/db/2366915/Biogen_Idec>,
        <https://1145.am/db/2367043/Biogen_Idec>,
        <https://1145.am/db/2542993/Biogen_Idec>,
        <https://1145.am/db/2577382/Biogen_Idec>,
        <https://1145.am/db/2578528/Biogen_Idec>,
        <https://1145.am/db/2579483/Biogen_Idec>,
        <https://1145.am/db/2580963/Biogen_Idec>,
        <https://1145.am/db/2586117/Biogen_Idec>,
        <https://1145.am/db/2595513/Biogen_Idec>,
        <https://1145.am/db/2598449/Biogen_Idec> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2598439/Johnson___Johnson_Inc> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2598439/Partnership_Interest_Acquisition_Johnson___Johnson_Inc_Merck_Sharp___Dohme_Corp_Completed> ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2011-09-29T12:19:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "McNEIL-PPC, Inc. Acquires Full Ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Joint Venture" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/mcneil-ppc-inc-acquires-full-ownership-of-johnson-johnson-merck-consumer-pharmaceuticals-co> ;
    ns1:foundName "Johnson & Johnson Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2598439/Partnership_Interest_Investment_Johnson___Johnson_Inc_Merck_Canada_Inc_Completed> ;
    ns1:name "Johnson & Johnson Inc." ;
    ns1:sameAsHigh <https://1145.am/db/1048908/Johnson___Johnson>,
        <https://1145.am/db/1177562/Novartis>,
        <https://1145.am/db/1262552/Johnson___Johnson>,
        <https://1145.am/db/1270868/Johnson___Johnson>,
        <https://1145.am/db/131136/Novartis>,
        <https://1145.am/db/132002/Novartis>,
        <https://1145.am/db/1328753/Novartis>,
        <https://1145.am/db/1507918/Novartis_Ag>,
        <https://1145.am/db/1551329/Johnson___Johnson>,
        <https://1145.am/db/1629605/Novartis>,
        <https://1145.am/db/1629663/Novartis>,
        <https://1145.am/db/165056/Novartis>,
        <https://1145.am/db/1673527/Johnson___Johnson>,
        <https://1145.am/db/1673809/Johnson___Johnson>,
        <https://1145.am/db/176334/Novartis>,
        <https://1145.am/db/177096/Novartis>,
        <https://1145.am/db/1822601/Johnson___Johnson>,
        <https://1145.am/db/2033933/Novartis>,
        <https://1145.am/db/2036487/Novartis_Ag>,
        <https://1145.am/db/2057335/Johnson___Johnson>,
        <https://1145.am/db/2065993/Novartis_Ag>,
        <https://1145.am/db/2089281/Johnson___Johnson>,
        <https://1145.am/db/2096209/Johnson___Johnson>,
        <https://1145.am/db/2103283/Johnson___Johnson>,
        <https://1145.am/db/2107835/Novartis>,
        <https://1145.am/db/2153410/Johnson___Johnson>,
        <https://1145.am/db/2154194/Johnson___Johnson>,
        <https://1145.am/db/2154521/Johnson___Johnson>,
        <https://1145.am/db/2193661/Johnson___Johnson>,
        <https://1145.am/db/2279434/Johnson___Johnson>,
        <https://1145.am/db/2279829/Novartis>,
        <https://1145.am/db/2280153/Novartis>,
        <https://1145.am/db/2280422/Johnson___Johnson>,
        <https://1145.am/db/2282888/Johnson_And_Johnson>,
        <https://1145.am/db/2282888/Johnson___Johnson>,
        <https://1145.am/db/2283645/Novartis>,
        <https://1145.am/db/2284930/Johnson___Johnson>,
        <https://1145.am/db/2285587/Johnson___Johnson>,
        <https://1145.am/db/2286603/Johnson___Johnson>,
        <https://1145.am/db/2287377/Johnson___Johnson>,
        <https://1145.am/db/2290342/Johnson___Johnson>,
        <https://1145.am/db/2290894/Johnson___Johnson>,
        <https://1145.am/db/2291777/Johnson___Johnson>,
        <https://1145.am/db/2292345/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2293342/Novartis>,
        <https://1145.am/db/2294862/Johnson___Johnson>,
        <https://1145.am/db/2295495/Johnson___Johnson>,
        <https://1145.am/db/2296402/Johnson___Johnson>,
        <https://1145.am/db/2296598/Johnson___Johnson>,
        <https://1145.am/db/2297186/Johnson___Johnson>,
        <https://1145.am/db/2297962/Johnson___Johnson>,
        <https://1145.am/db/2298037/Johnson___Johnson>,
        <https://1145.am/db/2298501/Johnson___Johnson>,
        <https://1145.am/db/2301089/Novartis>,
        <https://1145.am/db/2301819/Johnson___Johnson>,
        <https://1145.am/db/2302021/Johnson___Johnson>,
        <https://1145.am/db/2302727/Novartis>,
        <https://1145.am/db/2304373/Novartis>,
        <https://1145.am/db/2306163/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2307347/Novartis>,
        <https://1145.am/db/2307847/Novartis>,
        <https://1145.am/db/2307851/Novartis>,
        <https://1145.am/db/2308010/Novartis>,
        <https://1145.am/db/2308812/Novartis>,
        <https://1145.am/db/2309930/Johnson___Johnson>,
        <https://1145.am/db/2309931/Johnson___Johnson>,
        <https://1145.am/db/2310118/Johnson___Johnson>,
        <https://1145.am/db/2314331/Johnson___Johnson>,
        <https://1145.am/db/2315481/Johnson___Johnson>,
        <https://1145.am/db/2317181/Johnson___Johnson>,
        <https://1145.am/db/2317639/Johnson___Johnson>,
        <https://1145.am/db/2318685/Johnson___Johnson>,
        <https://1145.am/db/2319656/Johnson___Johnson>,
        <https://1145.am/db/2322024/Johnson___Johnson>,
        <https://1145.am/db/2322266/Novartis>,
        <https://1145.am/db/2322998/Johnson___Johnson>,
        <https://1145.am/db/2323000/Johnson___Johnson>,
        <https://1145.am/db/2325073/Novartis>,
        <https://1145.am/db/2327024/Johnson___Johnson>,
        <https://1145.am/db/2329487/Johnson___Johnson>,
        <https://1145.am/db/2330734/Johnson___Johnson>,
        <https://1145.am/db/2331745/Johnson___Johnson>,
        <https://1145.am/db/2331746/Johnson___Johnson>,
        <https://1145.am/db/2332005/Novartis>,
        <https://1145.am/db/2332872/Novartis>,
        <https://1145.am/db/2334206/Novartis>,
        <https://1145.am/db/2336790/Johnson___Johnson>,
        <https://1145.am/db/2336797/Johnson___Johnson>,
        <https://1145.am/db/2336990/Novartis>,
        <https://1145.am/db/2339656/Novartis>,
        <https://1145.am/db/2339892/Johnson___Johnson>,
        <https://1145.am/db/2340071/Johnson___Johnson>,
        <https://1145.am/db/2341850/Johnson___Johnson>,
        <https://1145.am/db/2344017/Novartis>,
        <https://1145.am/db/2344683/Johnson___Johnson>,
        <https://1145.am/db/2346629/Novartis>,
        <https://1145.am/db/2346978/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2350115/Johnson___Johnson>,
        <https://1145.am/db/2350116/Johnson___Johnson>,
        <https://1145.am/db/2350440/Johnson___Johnson_Inc>,
        <https://1145.am/db/2352178/Novartis>,
        <https://1145.am/db/2354402/Johnson___Johnson>,
        <https://1145.am/db/2354835/Johnson___Johnson>,
        <https://1145.am/db/2355411/Johnson___Johnson>,
        <https://1145.am/db/2358273/Novartis>,
        <https://1145.am/db/2358579/Novartis>,
        <https://1145.am/db/2358657/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358981/Johnson___Johnson>,
        <https://1145.am/db/2359302/Johnson___Johnson>,
        <https://1145.am/db/2359467/Johnson___Johnson>,
        <https://1145.am/db/2360256/Johnson___Johnson>,
        <https://1145.am/db/2360309/Novartis_Pharma_Ag>,
        <https://1145.am/db/2360754/Johnson___Johnson>,
        <https://1145.am/db/2362893/Johnson___Johnson>,
        <https://1145.am/db/2364457/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2364593/Johnson___Johnson>,
        <https://1145.am/db/2364601/Johnson___Johnson>,
        <https://1145.am/db/2366653/Johnson___Johnson>,
        <https://1145.am/db/2367207/Novartis>,
        <https://1145.am/db/2367616/Johnson___Johnson>,
        <https://1145.am/db/2367617/Johnson___Johnson>,
        <https://1145.am/db/2368571/Novartis>,
        <https://1145.am/db/2369449/Novartis_Pharma_Ag>,
        <https://1145.am/db/2369450/Novartis>,
        <https://1145.am/db/2369451/Novartis>,
        <https://1145.am/db/2370010/Novartis>,
        <https://1145.am/db/2370259/Johnson___Johnson>,
        <https://1145.am/db/2371188/Novartis>,
        <https://1145.am/db/2536264/Johnson___Johnson>,
        <https://1145.am/db/2536882/Novartis>,
        <https://1145.am/db/2537064/Novartis>,
        <https://1145.am/db/2537477/Novartis>,
        <https://1145.am/db/2538791/Novartis>,
        <https://1145.am/db/2540187/Novartis>,
        <https://1145.am/db/2541548/Johnson___Johnson>,
        <https://1145.am/db/2543863/Johnson___Johnson>,
        <https://1145.am/db/2544755/Johnson___Johnson>,
        <https://1145.am/db/2545522/Johnson___Johnson>,
        <https://1145.am/db/2545966/Novartis>,
        <https://1145.am/db/2546157/Novartis>,
        <https://1145.am/db/2546172/Johnson___Johnson>,
        <https://1145.am/db/2547152/Johnson___Johnson>,
        <https://1145.am/db/2548042/Johnson___Johnson>,
        <https://1145.am/db/2548223/Novartis>,
        <https://1145.am/db/2549043/Novartis>,
        <https://1145.am/db/2553024/Johnson___Johnson>,
        <https://1145.am/db/2553276/Novartis>,
        <https://1145.am/db/2553846/Novartis>,
        <https://1145.am/db/2553852/Johnson___Johnson>,
        <https://1145.am/db/2554060/Novartis>,
        <https://1145.am/db/2555555/Novartis>,
        <https://1145.am/db/2555561/Novartis>,
        <https://1145.am/db/2556543/Novartis>,
        <https://1145.am/db/2557204/Novartis>,
        <https://1145.am/db/2557603/Johnson___Johnson>,
        <https://1145.am/db/2557900/Johnson___Johnson>,
        <https://1145.am/db/2558316/Novartis>,
        <https://1145.am/db/2559306/Novartis>,
        <https://1145.am/db/2560079/Novartis>,
        <https://1145.am/db/2560372/Johnson___Johnson>,
        <https://1145.am/db/2561268/Novartis>,
        <https://1145.am/db/2562202/Novartis>,
        <https://1145.am/db/2562951/Novartis>,
        <https://1145.am/db/2564032/Johnson___Johnson>,
        <https://1145.am/db/2564462/Johnson___Johnson_Novartis>,
        <https://1145.am/db/2565794/Novartis>,
        <https://1145.am/db/2566121/Novartis>,
        <https://1145.am/db/2566147/Johnson___Johnson>,
        <https://1145.am/db/2567300/Novartis>,
        <https://1145.am/db/2568308/Novartis>,
        <https://1145.am/db/2568734/Novartis>,
        <https://1145.am/db/2568932/Novartis>,
        <https://1145.am/db/2568973/Novartis>,
        <https://1145.am/db/2569724/Novartis>,
        <https://1145.am/db/2570214/Novartis>,
        <https://1145.am/db/2570721/Novartis>,
        <https://1145.am/db/2570791/Novartis>,
        <https://1145.am/db/2571513/Novartis>,
        <https://1145.am/db/2572466/Johnson___Johnson>,
        <https://1145.am/db/2572655/Johnson___Johnson>,
        <https://1145.am/db/2572985/Novartis>,
        <https://1145.am/db/2573373/Johnson___Johnson>,
        <https://1145.am/db/2573517/Novartis>,
        <https://1145.am/db/2573611/Novartis>,
        <https://1145.am/db/2574347/Johnson___Johnson>,
        <https://1145.am/db/2574584/Novartis>,
        <https://1145.am/db/2574907/Johnson___Johnson>,
        <https://1145.am/db/2575313/Novartis>,
        <https://1145.am/db/2575492/Johnson___Johnson>,
        <https://1145.am/db/2575496/Johnson___Johnson>,
        <https://1145.am/db/2575702/Novartis>,
        <https://1145.am/db/2575810/Novartis_Pharma_Ag>,
        <https://1145.am/db/2575813/Novartis>,
        <https://1145.am/db/2576439/Johnson___Johnson>,
        <https://1145.am/db/2576547/Novartis>,
        <https://1145.am/db/2576962/Johnson___Johnson>,
        <https://1145.am/db/2577059/Johnson___Johnson>,
        <https://1145.am/db/2580401/Novartis>,
        <https://1145.am/db/2581378/Novartis>,
        <https://1145.am/db/2581394/Novartis>,
        <https://1145.am/db/2581397/Novartis>,
        <https://1145.am/db/2581480/Johnson___Johnson>,
        <https://1145.am/db/2581493/Novartis>,
        <https://1145.am/db/2582355/Novartis>,
        <https://1145.am/db/2582400/Novartis>,
        <https://1145.am/db/2583067/Novartis>,
        <https://1145.am/db/2583189/Johnson___Johnson>,
        <https://1145.am/db/2584383/Johnson___Johnson>,
        <https://1145.am/db/2584814/Johnson___Johnson>,
        <https://1145.am/db/2585039/Novartis>,
        <https://1145.am/db/2585121/Novartis>,
        <https://1145.am/db/2585600/Johnson___Johnson>,
        <https://1145.am/db/2585710/Johnson___Johnson>,
        <https://1145.am/db/2587143/Johnson___Johnson>,
        <https://1145.am/db/2587177/Johnson___Johnson>,
        <https://1145.am/db/2587626/Johnson___Johnson>,
        <https://1145.am/db/2587805/Novartis>,
        <https://1145.am/db/2588074/Johnson___Johnson>,
        <https://1145.am/db/2588196/Novartis>,
        <https://1145.am/db/2588718/Johnson___Johnson>,
        <https://1145.am/db/2589402/Johnson___Johnson>,
        <https://1145.am/db/2589799/Novartis>,
        <https://1145.am/db/2591073/Johnson___Johnson>,
        <https://1145.am/db/2591074/Johnson___Johnson>,
        <https://1145.am/db/2591076/Johnson___Johnson>,
        <https://1145.am/db/2592505/Novartis>,
        <https://1145.am/db/2592534/Johnson___Johnson>,
        <https://1145.am/db/2592895/Novartis>,
        <https://1145.am/db/2593889/Johnson___Johnson>,
        <https://1145.am/db/2594106/Johnson___Johnson>,
        <https://1145.am/db/2594935/Novartis>,
        <https://1145.am/db/2595048/Novartis>,
        <https://1145.am/db/2595924/Novartis_Ag>,
        <https://1145.am/db/2596344/Novartis>,
        <https://1145.am/db/2597086/Johnson___Johnson>,
        <https://1145.am/db/2597135/Johnson___Johnson>,
        <https://1145.am/db/2598455/Johnson___Johnson_Merck_Consumer_Pharmaceuticals_Co>,
        <https://1145.am/db/2598458/Johnson___Johnson_Merck_Consumer_Pharmaceuticals_Co>,
        <https://1145.am/db/2598636/Novartis>,
        <https://1145.am/db/2787530/Novartis>,
        <https://1145.am/db/2787550/Johnson___Johnson>,
        <https://1145.am/db/282192/Novartis>,
        <https://1145.am/db/346162/Novartis>,
        <https://1145.am/db/543155/Johnson___Johnson>,
        <https://1145.am/db/637582/Novartis>,
        <https://1145.am/db/691279/Novartis>,
        <https://1145.am/db/699695/Johnson___Johnson>,
        <https://1145.am/db/712016/Novartis>,
        <https://1145.am/db/766907/Johnson___Johnson> ;
    ns1:sameAsMedium <https://1145.am/db/1148074/Johnson___Johnson>,
        <https://1145.am/db/1214189/Johnson___Johnson>,
        <https://1145.am/db/1217341/Johnson___Johnson>,
        <https://1145.am/db/1463456/Johnson___Johnson>,
        <https://1145.am/db/1464682/Johnson___Johnson>,
        <https://1145.am/db/1465999/Johnson___Johnson>,
        <https://1145.am/db/1466112/Johnson___Johnson>,
        <https://1145.am/db/1466861/Johnson___Johnson>,
        <https://1145.am/db/1506241/Johnson___Johnson>,
        <https://1145.am/db/1543996/Johnson___Johnson>,
        <https://1145.am/db/1544359/Johnson___Johnson>,
        <https://1145.am/db/1544540/Johnson___Johnson>,
        <https://1145.am/db/1578164/Johnson___Johnson>,
        <https://1145.am/db/1591324/Johnson___Johnson>,
        <https://1145.am/db/1597750/Johnson___Johnson>,
        <https://1145.am/db/1598566/Johnson___Johnson>,
        <https://1145.am/db/1979575/Johnson___Johnson>,
        <https://1145.am/db/1988558/Johnson___Johnson_Inc>,
        <https://1145.am/db/1990327/Johnson___Johnson_Inc>,
        <https://1145.am/db/1996518/Johnson___Johnson_Inc>,
        <https://1145.am/db/2095043/Johnson___Johnson>,
        <https://1145.am/db/2152816/Johnson___Johnson>,
        <https://1145.am/db/2153916/Johnson___Johnson>,
        <https://1145.am/db/2154524/Johnson___Johnson>,
        <https://1145.am/db/2188348/Johnson___Johnson>,
        <https://1145.am/db/2211680/Johnson___Johnson>,
        <https://1145.am/db/2226737/Johnson___Johnson>,
        <https://1145.am/db/2278910/Johnson___Johnson>,
        <https://1145.am/db/2281285/Johnson___Johnson>,
        <https://1145.am/db/2287841/Johnson___Johnson>,
        <https://1145.am/db/2288373/Johnson___Johnson>,
        <https://1145.am/db/2288800/Johnson___Johnson>,
        <https://1145.am/db/2289267/Johnson___Johnson>,
        <https://1145.am/db/2289275/Johnson___Johnson>,
        <https://1145.am/db/2289414/Johnson___Johnson>,
        <https://1145.am/db/2290858/Johnson___Johnson>,
        <https://1145.am/db/2290886/Johnson___Johnson>,
        <https://1145.am/db/2291600/Johnson___Johnson>,
        <https://1145.am/db/2291671/Johnson___Johnson>,
        <https://1145.am/db/2292262/Johnson___Johnson>,
        <https://1145.am/db/2293507/Johnson___Johnson>,
        <https://1145.am/db/2293778/Johnson___Johnson>,
        <https://1145.am/db/2294098/Johnson___Johnson>,
        <https://1145.am/db/2294498/Johnson___Johnson>,
        <https://1145.am/db/2294715/Johnson___Johnson>,
        <https://1145.am/db/2294972/Johnson___Johnson>,
        <https://1145.am/db/2295229/Johnson___Johnson>,
        <https://1145.am/db/2295273/Johnson___Johnson>,
        <https://1145.am/db/2295364/Johnson___Johnson>,
        <https://1145.am/db/2296413/Johnson___Johnson>,
        <https://1145.am/db/2297280/Johnson___Johnson>,
        <https://1145.am/db/2298405/Johnson___Johnson>,
        <https://1145.am/db/2298532/Johnson___Johnson>,
        <https://1145.am/db/2298782/Johnson___Johnson>,
        <https://1145.am/db/2299019/Johnson___Johnson>,
        <https://1145.am/db/2299243/Johnson___Johnson>,
        <https://1145.am/db/2299307/Johnson___Johnson>,
        <https://1145.am/db/2299311/Johnson___Johnson>,
        <https://1145.am/db/2299849/Johnson___Johnson>,
        <https://1145.am/db/2300238/Johnson___Johnson>,
        <https://1145.am/db/2300404/Johnson___Johnson>,
        <https://1145.am/db/2300475/Johnson___Johnson>,
        <https://1145.am/db/2300479/Johnson___Johnson>,
        <https://1145.am/db/2300726/Johnson___Johnson>,
        <https://1145.am/db/2300789/Johnson___Johnson>,
        <https://1145.am/db/2300886/Johnson___Johnson>,
        <https://1145.am/db/2301032/Johnson___Johnson>,
        <https://1145.am/db/2301300/Johnson___Johnson>,
        <https://1145.am/db/2301488/Johnson___Johnson>,
        <https://1145.am/db/2301497/Johnson___Johnson>,
        <https://1145.am/db/2303215/Johnson___Johnson>,
        <https://1145.am/db/2311031/Johnson___Johnson>,
        <https://1145.am/db/2311832/Johnson___Johnson>,
        <https://1145.am/db/2311842/Johnson___Johnson>,
        <https://1145.am/db/2314031/Johnson___Johnson>,
        <https://1145.am/db/2316541/Johnson___Johnson>,
        <https://1145.am/db/2319481/Johnson___Johnson>,
        <https://1145.am/db/2322035/Johnson___Johnson>,
        <https://1145.am/db/2324143/Johnson___Johnson>,
        <https://1145.am/db/2339375/Johnson___Johnson>,
        <https://1145.am/db/2341384/Johnson___Johnson>,
        <https://1145.am/db/2344487/Johnson___Johnson>,
        <https://1145.am/db/2347608/Johnson___Johnson>,
        <https://1145.am/db/2349121/Johnson___Johnson>,
        <https://1145.am/db/2359489/Johnson___Johnson>,
        <https://1145.am/db/2360241/Johnson___Johnson>,
        <https://1145.am/db/2360495/Johnson___Johnson>,
        <https://1145.am/db/2360755/Johnson___Johnson>,
        <https://1145.am/db/2361612/Johnson___Johnson>,
        <https://1145.am/db/2365300/Johnson___Johnson>,
        <https://1145.am/db/2370272/Johnson___Johnson>,
        <https://1145.am/db/2370771/Johnson___Johnson>,
        <https://1145.am/db/2370777/Johnson___Johnson>,
        <https://1145.am/db/2541966/Johnson___Johnson>,
        <https://1145.am/db/2545058/Johnson___Johnson>,
        <https://1145.am/db/2548361/Johnson___Johnson>,
        <https://1145.am/db/2548431/Johnson___Johnson>,
        <https://1145.am/db/2549346/Johnson___Johnson>,
        <https://1145.am/db/2549438/Johnson___Johnson>,
        <https://1145.am/db/2553161/Johnson___Johnson>,
        <https://1145.am/db/2558099/Johnson___Johnson>,
        <https://1145.am/db/2558689/Johnson___Johnson>,
        <https://1145.am/db/2561491/Johnson___Johnson>,
        <https://1145.am/db/2561691/Johnson___Johnson>,
        <https://1145.am/db/2569069/Johnson___Johnson>,
        <https://1145.am/db/2570365/Johnson___Johnson>,
        <https://1145.am/db/2572160/Johnson___Johnson>,
        <https://1145.am/db/2573372/Johnson___Johnson>,
        <https://1145.am/db/2573643/Johnson___Johnson>,
        <https://1145.am/db/2574495/Johnson___Johnson>,
        <https://1145.am/db/2579209/Johnson___Johnson>,
        <https://1145.am/db/2580381/Johnson___Johnson>,
        <https://1145.am/db/2582055/Johnson___Johnson>,
        <https://1145.am/db/2582468/Johnson___Johnson>,
        <https://1145.am/db/2583233/Johnson___Johnson>,
        <https://1145.am/db/2583920/Johnson___Johnson>,
        <https://1145.am/db/2585185/Johnson___Johnson>,
        <https://1145.am/db/2586824/Johnson___Johnson>,
        <https://1145.am/db/2587125/Johnson___Johnson>,
        <https://1145.am/db/2587212/Johnson___Johnson>,
        <https://1145.am/db/2589130/Johnson___Johnson>,
        <https://1145.am/db/2589813/Johnson___Johnson>,
        <https://1145.am/db/2590047/Johnson___Johnson>,
        <https://1145.am/db/2591001/Johnson___Johnson>,
        <https://1145.am/db/2595685/Johnson___Johnson>,
        <https://1145.am/db/2596818/Johnson___Johnson>,
        <https://1145.am/db/2597794/Johnson___Johnson>,
        <https://1145.am/db/2597802/Johnson___Johnson>,
        <https://1145.am/db/2597824/Johnson___Johnson>,
        <https://1145.am/db/2598257/Johnson___Johnson>,
        <https://1145.am/db/270375/Johnson___Johnson>,
        <https://1145.am/db/2718487/Johnson___Johnson>,
        <https://1145.am/db/309395/Johnson___Johnson>,
        <https://1145.am/db/418587/Johnson___Johnson>,
        <https://1145.am/db/543112/Johnson___Johnson> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2609817/Permira_Advisers> a org:Organization ;
    ns1:basedInHighGeoName "London" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2643743/about.rdf> ;
    ns1:basedInHighRaw "London" ;
    ns1:buyer <https://1145.am/db/2609817/Division_Acquisition_Alcatel-Lucent_Permira_Advisers_Stopped> ;
    ns1:description "buyout fund" ;
    ns1:documentDate "2011-09-06T13:54:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Alcatel-Lucent's enterprise sale to Permira Advisers falls through" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/alcatel-lucent-s-enterprise-sale-to-permira-advisers-falls-through> ;
    ns1:foundName "Permira",
        "Permira Advisers" ;
    ns1:industry "buyout fund" ;
    ns1:investor <https://1145.am/db/2609817/Division_Investment_Alcatel-Lucent_Permira_Advisers_Stopped> ;
    ns1:name "Permira Advisers" ;
    ns1:sameAsHigh <https://1145.am/db/1241259/Permira>,
        <https://1145.am/db/2746226/Permira> ;
    ns1:sameAsMedium <https://1145.am/db/1304986/Permira_Advisers_Llc>,
        <https://1145.am/db/601687/Permira_Advisers_Llc>,
        <https://1145.am/db/603547/Permira_Advisers_Llc> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2609875/Associated_Partners> a org:Organization ;
    ns1:basedInLowRaw "U.S" ;
    ns1:description "U.S. investors" ;
    ns1:documentDate "2011-09-15T15:04:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CURRENT gets $13M to target international smart grid prospects" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/current-gets-13m-to-target-international-smart-grid-prospects> ;
    ns1:foundName "Associated Partners" ;
    ns1:investor <https://1145.am/db/2609875/Investment_Associated_Partners_Business_Media_China_Current_Enertech_Capital_Goldman_Sachs_Completed> ;
    ns1:name "Associated Partners" ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2609875/Business_Media_China> a org:Organization ;
    ns1:basedInLowRaw "Chinese" ;
    ns1:documentDate "2011-09-15T15:04:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CURRENT gets $13M to target international smart grid prospects" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/current-gets-13m-to-target-international-smart-grid-prospects> ;
    ns1:foundName "Business Media China" ;
    ns1:investor <https://1145.am/db/2609875/Investment_Associated_Partners_Business_Media_China_Current_Enertech_Capital_Goldman_Sachs_Completed> ;
    ns1:name "Business Media China" ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2609875/Enertech_Capital> a org:Organization ;
    ns1:basedInLowRaw "U.S" ;
    ns1:description "U.S. investors" ;
    ns1:documentDate "2011-09-15T15:04:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CURRENT gets $13M to target international smart grid prospects" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/current-gets-13m-to-target-international-smart-grid-prospects> ;
    ns1:foundName "EnerTech Capital" ;
    ns1:investor <https://1145.am/db/2609875/Investment_Associated_Partners_Business_Media_China_Current_Enertech_Capital_Goldman_Sachs_Completed> ;
    ns1:name "EnerTech Capital" ;
    ns1:sameAsMedium <https://1145.am/db/976746/Enertech_Capital> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2609875/Espírito_Santo_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Portuguese Republic" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2264397/about.rdf> ;
    ns1:basedInHighRaw "Portugal" ;
    ns1:documentDate "2011-09-15T15:04:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CURRENT gets $13M to target international smart grid prospects" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/current-gets-13m-to-target-international-smart-grid-prospects> ;
    ns1:foundName "Espírito Santo Ventures" ;
    ns1:investor <https://1145.am/db/2609875/Investment_Associated_Partners_Business_Media_China_Current_Enertech_Capital_Goldman_Sachs_Completed> ;
    ns1:name "Espírito Santo Ventures" ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2609875/Goldman_Sachs> a org:Organization ;
    ns1:basedInLowRaw "U.S" ;
    ns1:description "U.S. investors" ;
    ns1:documentDate "2011-09-15T15:04:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CURRENT gets $13M to target international smart grid prospects" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/current-gets-13m-to-target-international-smart-grid-prospects> ;
    ns1:foundName "Goldman Sachs" ;
    ns1:investor <https://1145.am/db/2609875/Investment_Associated_Partners_Business_Media_China_Current_Enertech_Capital_Goldman_Sachs_Completed> ;
    ns1:name "Goldman Sachs" ;
    ns1:sameAsHigh <https://1145.am/db/1849797/Goldman_Sachs>,
        <https://1145.am/db/2719561/Goldman_Sachs_Group_Inc>,
        <https://1145.am/db/417305/Goldman_Sachs>,
        <https://1145.am/db/547965/Goldman_Sachs>,
        <https://1145.am/db/987786/Goldman_Sachs_Asset_Management> ;
    ns1:sameAsMedium <https://1145.am/db/1006297/Goldman_Sachs>,
        <https://1145.am/db/1047510/Goldman_Sachs>,
        <https://1145.am/db/1102089/Goldman_Sachs>,
        <https://1145.am/db/1142600/Goldman_Sachs>,
        <https://1145.am/db/1207590/Goldman_Sachs>,
        <https://1145.am/db/1208555/Goldman_Sachs>,
        <https://1145.am/db/1387975/Goldman_Sachs>,
        <https://1145.am/db/1390068/Goldman_Sachs>,
        <https://1145.am/db/1401543/Goldman_Sachs>,
        <https://1145.am/db/1462447/Goldman_Sachs>,
        <https://1145.am/db/1462820/Goldman_Sachs>,
        <https://1145.am/db/150562/Goldman_Sachs>,
        <https://1145.am/db/1540064/Goldman_Sachs>,
        <https://1145.am/db/158562/Goldman_Sachs>,
        <https://1145.am/db/1627942/Goldman_Sachs>,
        <https://1145.am/db/1631621/Goldman_Sachs>,
        <https://1145.am/db/1668001/Goldman_Sachs>,
        <https://1145.am/db/1694241/Goldman_Sachs>,
        <https://1145.am/db/1697693/Goldman_Sachs>,
        <https://1145.am/db/1703860/Goldman_Sachs>,
        <https://1145.am/db/1721158/Goldman_Sachs>,
        <https://1145.am/db/1725220/Goldman_Sachs>,
        <https://1145.am/db/1730048/Goldman_Sachs>,
        <https://1145.am/db/1732135/Goldman_Sachs>,
        <https://1145.am/db/1734775/Goldman_Sachs>,
        <https://1145.am/db/1735554/Goldman_Sachs>,
        <https://1145.am/db/1737385/Goldman_Sachs>,
        <https://1145.am/db/1744154/Goldman_Sachs>,
        <https://1145.am/db/1745516/Goldman_Sachs>,
        <https://1145.am/db/1746577/Goldman_Sachs>,
        <https://1145.am/db/1747060/Goldman_Sachs>,
        <https://1145.am/db/1747571/Goldman_Sachs>,
        <https://1145.am/db/1753279/Goldman_Sachs>,
        <https://1145.am/db/1753418/Goldman_Sachs>,
        <https://1145.am/db/1761940/Goldman_Sachs>,
        <https://1145.am/db/1764779/Goldman_Sachs>,
        <https://1145.am/db/1764853/Goldman_Sachs>,
        <https://1145.am/db/1770648/Goldman_Sachs>,
        <https://1145.am/db/1774767/Goldman_Sachs>,
        <https://1145.am/db/1775794/Goldman_Sachs>,
        <https://1145.am/db/1779303/Goldman_Sachs>,
        <https://1145.am/db/1782131/Goldman_Sachs>,
        <https://1145.am/db/1783737/Goldman_Sachs>,
        <https://1145.am/db/1783766/Goldman_Sachs>,
        <https://1145.am/db/1785371/Goldman_Sachs>,
        <https://1145.am/db/1787609/Goldman_Sachs>,
        <https://1145.am/db/1789188/Goldman_Sachs>,
        <https://1145.am/db/1790097/Goldman_Sachs>,
        <https://1145.am/db/1791222/Goldman_Sachs>,
        <https://1145.am/db/1792241/Goldman_Sachs>,
        <https://1145.am/db/1798631/Goldman_Sachs>,
        <https://1145.am/db/1805753/Goldman_Sachs>,
        <https://1145.am/db/1808604/Goldman_Sachs>,
        <https://1145.am/db/1808918/Goldman_Sachs>,
        <https://1145.am/db/1811126/Goldman_Sachs>,
        <https://1145.am/db/1816027/Goldman_Sachs>,
        <https://1145.am/db/1822403/Goldman_Sachs>,
        <https://1145.am/db/1834722/Goldman_Sachs>,
        <https://1145.am/db/1839749/Goldman_Sachs>,
        <https://1145.am/db/1841784/Goldman_Sachs>,
        <https://1145.am/db/1843449/Goldman_Sachs>,
        <https://1145.am/db/1849103/Goldman_Sachs>,
        <https://1145.am/db/1852207/Goldman_Sachs>,
        <https://1145.am/db/1856702/Goldman_Sachs>,
        <https://1145.am/db/1858690/Goldman_Sachs>,
        <https://1145.am/db/1876344/Goldman_Sachs>,
        <https://1145.am/db/1877642/Goldman_Sachs>,
        <https://1145.am/db/1892777/Goldman_Sachs>,
        <https://1145.am/db/1895233/Goldman_Sachs>,
        <https://1145.am/db/1918332/Goldman_Sachs>,
        <https://1145.am/db/2029866/Goldman_Sachs>,
        <https://1145.am/db/2053424/Goldman_Sachs>,
        <https://1145.am/db/2067772/Goldman_Sachs>,
        <https://1145.am/db/2087870/Goldman_Sachs>,
        <https://1145.am/db/2093383/Goldman_Sachs>,
        <https://1145.am/db/2099475/Goldman_Sachs>,
        <https://1145.am/db/2114078/Goldman_Sachs>,
        <https://1145.am/db/2116159/Goldman_Sachs>,
        <https://1145.am/db/2119173/Goldman_Sachs>,
        <https://1145.am/db/214285/Goldman_Sachs>,
        <https://1145.am/db/2143574/Goldman_Sachs>,
        <https://1145.am/db/2159060/Goldman_Sachs>,
        <https://1145.am/db/2189089/Goldman_Sachs>,
        <https://1145.am/db/2229181/Goldman_Sachs>,
        <https://1145.am/db/2243776/Goldman_Sachs>,
        <https://1145.am/db/2280482/Goldman_Sachs>,
        <https://1145.am/db/2296358/Goldman_Sachs>,
        <https://1145.am/db/2304832/Goldman_Sachs>,
        <https://1145.am/db/2304844/Goldman_Sachs>,
        <https://1145.am/db/2309558/Goldman_Sachs>,
        <https://1145.am/db/2316391/Goldman_Sachs>,
        <https://1145.am/db/2326028/Goldman_Sachs___Co>,
        <https://1145.am/db/2368258/Goldman_Sachs>,
        <https://1145.am/db/2485927/Goldman_Sachs>,
        <https://1145.am/db/2545376/Goldman_Sachs>,
        <https://1145.am/db/2545385/Goldman_Sachs>,
        <https://1145.am/db/2546405/Goldman_Sachs>,
        <https://1145.am/db/2554610/Goldman_Sachs>,
        <https://1145.am/db/2623208/Goldman_Sachs>,
        <https://1145.am/db/2636409/Goldman_Sachs>,
        <https://1145.am/db/2645972/Goldman_Sachs>,
        <https://1145.am/db/265373/Goldman_Sachs>,
        <https://1145.am/db/2688475/Goldman_Sachs>,
        <https://1145.am/db/2691118/Goldman_Sachs>,
        <https://1145.am/db/2703231/Goldman_Sachs>,
        <https://1145.am/db/2720436/Goldman_Sachs>,
        <https://1145.am/db/274611/Goldman_Sachs>,
        <https://1145.am/db/2800393/Goldman_Sachs>,
        <https://1145.am/db/307789/Goldman_Sachs>,
        <https://1145.am/db/308562/Goldman_Sachs>,
        <https://1145.am/db/331288/Goldman_Sachs>,
        <https://1145.am/db/360476/Goldman_Sachs>,
        <https://1145.am/db/363100/Goldman_Sachs>,
        <https://1145.am/db/367651/Goldman_Sachs>,
        <https://1145.am/db/367735/Goldman_Sachs>,
        <https://1145.am/db/373566/Goldman_Sachs>,
        <https://1145.am/db/427871/Goldman_Sachs>,
        <https://1145.am/db/472129/Goldman_Sachs>,
        <https://1145.am/db/473009/Goldman_Sachs>,
        <https://1145.am/db/476326/Goldman_Sachs>,
        <https://1145.am/db/512780/Goldman_Sachs>,
        <https://1145.am/db/534085/Goldman_Sachs>,
        <https://1145.am/db/536638/Goldman_Sachs>,
        <https://1145.am/db/610092/Goldman_Sachs>,
        <https://1145.am/db/675103/Goldman_Sachs>,
        <https://1145.am/db/699689/Goldman_Sachs>,
        <https://1145.am/db/702810/Goldman_Sachs>,
        <https://1145.am/db/711018/Goldman_Sachs>,
        <https://1145.am/db/746914/Goldman_Sachs>,
        <https://1145.am/db/751030/Goldman_Sachs>,
        <https://1145.am/db/788125/Goldman_Sachs>,
        <https://1145.am/db/863024/Goldman_Sachs>,
        <https://1145.am/db/863541/Goldman_Sachs>,
        <https://1145.am/db/867879/Goldman_Sachs>,
        <https://1145.am/db/886532/Goldman_Sachs>,
        <https://1145.am/db/894391/Goldman_Sachs>,
        <https://1145.am/db/930479/Goldman_Sachs>,
        <https://1145.am/db/968901/Goldman_Sachs> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2618832/Consolidated_Communications> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2618832/Surewest_Acquisition> ;
    ns1:description "ensuring the transition of accounting and financial reporting during the merger process" ;
    ns1:documentDate "2012-02-27T13:11:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "SureWest, Consolidated name leaders of merger transition team" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/surewest-consolidated-name-leaders-merger-transition-team> ;
    ns1:foundName "Consolidated Communications" ;
    ns1:name "Consolidated Communications" ;
    ns1:sameAsMedium <https://1145.am/db/1537154/Consolidated_Communications>,
        <https://1145.am/db/1537960/Consolidated_Communications>,
        <https://1145.am/db/1550112/Consolidated_Communications>,
        <https://1145.am/db/1632014/Consolidated_Communications>,
        <https://1145.am/db/1632121/Consolidated_Communications>,
        <https://1145.am/db/1660215/Consolidated_Communications>,
        <https://1145.am/db/2074216/Consolidated_Communications>,
        <https://1145.am/db/2157877/Consolidated_Communications>,
        <https://1145.am/db/2162752/Consolidated_Communications>,
        <https://1145.am/db/2600516/Consolidated_Communications>,
        <https://1145.am/db/2600528/Consolidated_Communications>,
        <https://1145.am/db/2600722/Consolidated_Communications>,
        <https://1145.am/db/2601424/Consolidated_Communications>,
        <https://1145.am/db/2602107/Consolidated_Communications>,
        <https://1145.am/db/2602394/Consolidated_Communications>,
        <https://1145.am/db/2602584/Consolidated_Communications>,
        <https://1145.am/db/2602900/Consolidated_Communications>,
        <https://1145.am/db/2603387/Consolidated_Communications>,
        <https://1145.am/db/2604893/Consolidated_Communications>,
        <https://1145.am/db/2606523/Consolidated_Communications>,
        <https://1145.am/db/2607707/Consolidated_Communications>,
        <https://1145.am/db/2609492/Consolidated_Communications>,
        <https://1145.am/db/2610225/Consolidated_Communications>,
        <https://1145.am/db/2610241/Consolidated_Communications>,
        <https://1145.am/db/2610652/Consolidated_Communications>,
        <https://1145.am/db/2614377/Consolidated_Communications>,
        <https://1145.am/db/2615306/Consolidated_Communications>,
        <https://1145.am/db/2615425/Consolidated_Communications>,
        <https://1145.am/db/2615762/Consolidated_Communications>,
        <https://1145.am/db/2617406/Consolidated_Communications>,
        <https://1145.am/db/2619674/Consolidated_Communications>,
        <https://1145.am/db/2620924/Consolidated_Communications>,
        <https://1145.am/db/2621242/Consolidated_Communications>,
        <https://1145.am/db/2621542/Consolidated_Communications>,
        <https://1145.am/db/2765235/Consolidated_Communications>,
        <https://1145.am/db/734513/Consolidated_Communications> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2628938/Dish_Network> a org:Organization ;
    ns1:basedInLowRaw "America" ;
    ns1:buyer <https://1145.am/db/2628938/Sprint_Nextel_Acquisition> ;
    ns1:description "satellite company" ;
    ns1:documentDate "2011-09-25T22:54:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Dish Network looking at partnering, acquiring wireless operator" ;
    ns1:documentURL <https://www.fiercewireless.com/tech/dish-network-looking-at-partnering-acquiring-wireless-operator> ;
    ns1:foundName "Dish Network" ;
    ns1:industry "satellite company" ;
    ns1:name "Dish Network" ;
    ns1:sameAsHigh <https://1145.am/db/1414969/Dish_Network_Corp>,
        <https://1145.am/db/1828852/Dish_Network>,
        <https://1145.am/db/1871585/Dish_Network>,
        <https://1145.am/db/2057379/Dish_Network>,
        <https://1145.am/db/2080036/Dish_Network>,
        <https://1145.am/db/2156911/Dish_Network>,
        <https://1145.am/db/2158102/Dish_Network>,
        <https://1145.am/db/2158505/Dish_Network>,
        <https://1145.am/db/2161463/Dish_Network>,
        <https://1145.am/db/2162239/Dish_Network>,
        <https://1145.am/db/2162920/Dish_Network>,
        <https://1145.am/db/2162989/Dish_Network>,
        <https://1145.am/db/2165021/Dish_Network>,
        <https://1145.am/db/2168509/Dish_Network>,
        <https://1145.am/db/2170437/Dish_Network>,
        <https://1145.am/db/2170857/Dish_Network>,
        <https://1145.am/db/2171982/Dish_Network>,
        <https://1145.am/db/2172101/Dish_Network>,
        <https://1145.am/db/2172901/Dish_Network>,
        <https://1145.am/db/2172911/Echostar_Dish>,
        <https://1145.am/db/2173675/Dish_Network>,
        <https://1145.am/db/2174986/Dish_Network>,
        <https://1145.am/db/2175716/Dish_Network>,
        <https://1145.am/db/2176115/Dish_Network>,
        <https://1145.am/db/2177634/Dish_Network>,
        <https://1145.am/db/2179082/Dish_Network>,
        <https://1145.am/db/2602950/Dish_Network>,
        <https://1145.am/db/2614911/Dish_Network>,
        <https://1145.am/db/2628816/Dish_Network>,
        <https://1145.am/db/2629786/Dish>,
        <https://1145.am/db/2631623/Dish_Network>,
        <https://1145.am/db/2638870/Dish_Network>,
        <https://1145.am/db/2640032/Dish_Network>,
        <https://1145.am/db/2640950/Dish_Network>,
        <https://1145.am/db/2648932/Dish_Network>,
        <https://1145.am/db/2668987/Dish_Network>,
        <https://1145.am/db/2671555/Dish_Networks>,
        <https://1145.am/db/2672784/Dish_Network>,
        <https://1145.am/db/2678734/Dish_Network>,
        <https://1145.am/db/2678781/Dish_Network>,
        <https://1145.am/db/2684574/Dish_Network>,
        <https://1145.am/db/2686210/Dish_Network>,
        <https://1145.am/db/2686325/Dish_Network>,
        <https://1145.am/db/611270/Dish_Network_Corporation> ;
    ns1:sameAsMedium <https://1145.am/db/1468719/Dish_Network_Corporation>,
        <https://1145.am/db/1889015/Dish_Network>,
        <https://1145.am/db/2158518/Dish_Network>,
        <https://1145.am/db/2159439/Dish_Network>,
        <https://1145.am/db/2162970/Dish_Network>,
        <https://1145.am/db/2167939/Dish_Network>,
        <https://1145.am/db/2175144/Dish_Network>,
        <https://1145.am/db/2598817/Dish_Network>,
        <https://1145.am/db/2614751/Dish_Network>,
        <https://1145.am/db/2626526/Dish_Network>,
        <https://1145.am/db/2627221/Dish_Network>,
        <https://1145.am/db/2629788/Dish_Network>,
        <https://1145.am/db/2634015/Dish_Network>,
        <https://1145.am/db/2638859/Dish_Network>,
        <https://1145.am/db/2644908/Dish_Network>,
        <https://1145.am/db/2645879/Dish_Network>,
        <https://1145.am/db/2646574/Dish_Network>,
        <https://1145.am/db/2646848/Dish_Network>,
        <https://1145.am/db/2646856/Dish_Network>,
        <https://1145.am/db/2654198/Dish_Network>,
        <https://1145.am/db/2655140/Dish_Network>,
        <https://1145.am/db/2656030/Dish_Network>,
        <https://1145.am/db/2656081/Dish_Network>,
        <https://1145.am/db/2661405/Dish_Network>,
        <https://1145.am/db/2661443/Dish_Network>,
        <https://1145.am/db/2662335/Dish_Network>,
        <https://1145.am/db/2662471/Dish_Network>,
        <https://1145.am/db/2666088/Dish_Network>,
        <https://1145.am/db/2667137/Dish_Network>,
        <https://1145.am/db/2669942/Dish_Network>,
        <https://1145.am/db/2672780/Dish_Network>,
        <https://1145.am/db/2672787/Dish_Network>,
        <https://1145.am/db/2672793/Dish_Network>,
        <https://1145.am/db/2674444/Dish_Network>,
        <https://1145.am/db/2675179/Dish_Network>,
        <https://1145.am/db/2676378/Dish_Network>,
        <https://1145.am/db/2677542/Dish_Network>,
        <https://1145.am/db/2678731/Dish_Network>,
        <https://1145.am/db/2681702/Dish_Network>,
        <https://1145.am/db/2685132/Dish_Network>,
        <https://1145.am/db/2686073/Dish_Network>,
        <https://1145.am/db/444153/Dish_Network_Corporation> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2651198/Afk_Sistema> a org:Organization ;
    ns1:basedInHighGeoName "Russian Federation" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2017370/about.rdf> ;
    ns1:basedInHighRaw "Russia" ;
    ns1:buyer <https://1145.am/db/2651198/Mobile_Telesystems_Stake_Acquisition> ;
    ns1:documentDate "2011-09-16T15:09:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: Russia's AFK Sistema in talks with FT for ownership swap" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/report-russia-s-afk-sistema-talks-ft-for-ownership-swap> ;
    ns1:foundName "AFK Sistema" ;
    ns1:industry "financial" ;
    ns1:name "AFK Sistema" ;
    ns1:sameAsMedium <https://1145.am/db/1688922/Afk_Sistema> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2651198/France_Telecom> a org:Organization ;
    ns1:basedInHighGeoName "Republic of France" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:basedInHighRaw "France" ;
    ns1:documentDate "2011-09-16T15:09:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: Russia's AFK Sistema in talks with FT for ownership swap" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/report-russia-s-afk-sistema-talks-ft-for-ownership-swap> ;
    ns1:foundName "France Telecom" ;
    ns1:name "France Telecom" ;
    ns1:protagonist <https://1145.am/db/2651198/Mobile_Telesystems_Stake_Acquisition> ;
    ns1:sameAsMedium <https://1145.am/db/1826027/France_Telecom>,
        <https://1145.am/db/1868085/France_Telecom>,
        <https://1145.am/db/2602057/France_Telecom>,
        <https://1145.am/db/2606207/France_Telecom>,
        <https://1145.am/db/2606784/France_Telecom>,
        <https://1145.am/db/2609688/France_Telecom>,
        <https://1145.am/db/2611323/France_Telecom>,
        <https://1145.am/db/2611525/France_Telecom>,
        <https://1145.am/db/2613016/France_Telecom>,
        <https://1145.am/db/2617941/France_Telecom>,
        <https://1145.am/db/2618127/France_Telecom>,
        <https://1145.am/db/2618408/France_Telecom>,
        <https://1145.am/db/2618673/France_Telecom>,
        <https://1145.am/db/2619137/France_Telecom>,
        <https://1145.am/db/2620761/France_Telecom>,
        <https://1145.am/db/2622457/France_Telecom>,
        <https://1145.am/db/2625919/France_Telecom>,
        <https://1145.am/db/2629260/France_Telecom>,
        <https://1145.am/db/2630790/France_Telecom>,
        <https://1145.am/db/2631682/France_Telecom>,
        <https://1145.am/db/2633551/France_Telecom>,
        <https://1145.am/db/2640565/France_Telecom>,
        <https://1145.am/db/2650969/France_Telecom>,
        <https://1145.am/db/2651218/France_Telecom>,
        <https://1145.am/db/2652154/France_Telecom>,
        <https://1145.am/db/2652907/France_Telecom>,
        <https://1145.am/db/2653606/France_Telecom>,
        <https://1145.am/db/2653713/France_Telecom>,
        <https://1145.am/db/2653724/France_Telecom>,
        <https://1145.am/db/2653778/France_Telecom>,
        <https://1145.am/db/2653910/France_Telecom>,
        <https://1145.am/db/2654367/France_Telecom>,
        <https://1145.am/db/2655736/France_Telecom>,
        <https://1145.am/db/2656168/France_Telecom>,
        <https://1145.am/db/2656676/France_Telecom>,
        <https://1145.am/db/2657450/France_Telecom>,
        <https://1145.am/db/2657740/France_Telecom>,
        <https://1145.am/db/2659172/France_Telecom>,
        <https://1145.am/db/2659382/France_Telecom>,
        <https://1145.am/db/2659739/France_Telecom>,
        <https://1145.am/db/2660508/France_Telecom>,
        <https://1145.am/db/2660515/France_Telecom>,
        <https://1145.am/db/2661611/France_Telecom>,
        <https://1145.am/db/2662050/France_Telecom>,
        <https://1145.am/db/2662264/France_Telecom>,
        <https://1145.am/db/2662411/France_Telecom>,
        <https://1145.am/db/2662424/France_Telecom>,
        <https://1145.am/db/2662582/France_Telecom>,
        <https://1145.am/db/2663403/France_Telecom>,
        <https://1145.am/db/2663765/France_Telecom>,
        <https://1145.am/db/2663987/France_Telecom>,
        <https://1145.am/db/2664165/France_Telecom>,
        <https://1145.am/db/2664799/France_Telecom>,
        <https://1145.am/db/2664862/France_Telecom>,
        <https://1145.am/db/2665863/France_Telecom>,
        <https://1145.am/db/2665887/France_Telecom>,
        <https://1145.am/db/2666650/France_Telecom>,
        <https://1145.am/db/2666759/France_Telecom>,
        <https://1145.am/db/2666767/France_Telecom>,
        <https://1145.am/db/2668148/France_Telecom>,
        <https://1145.am/db/2668525/France_Telecom>,
        <https://1145.am/db/2668930/France_Telecom>,
        <https://1145.am/db/2669362/France_Telecom>,
        <https://1145.am/db/2670930/France_Telecom>,
        <https://1145.am/db/2671068/France_Telecom>,
        <https://1145.am/db/2671738/France_Telecom>,
        <https://1145.am/db/2672620/France_Telecom>,
        <https://1145.am/db/2672628/France_Telecom>,
        <https://1145.am/db/2672886/France_Telecom>,
        <https://1145.am/db/2672903/France_Telecom>,
        <https://1145.am/db/2672940/France_Telecom>,
        <https://1145.am/db/2673616/France_Telecom>,
        <https://1145.am/db/2673628/France_Telecom>,
        <https://1145.am/db/2673904/France_Telecom>,
        <https://1145.am/db/2673917/France_Telecom>,
        <https://1145.am/db/2674070/France_Telecom>,
        <https://1145.am/db/2674092/France_Telecom>,
        <https://1145.am/db/2674236/France_Telecom>,
        <https://1145.am/db/2674846/France_Telecom>,
        <https://1145.am/db/2675258/France_Telecom>,
        <https://1145.am/db/2676038/France_Telecom>,
        <https://1145.am/db/2677517/France_Telecom>,
        <https://1145.am/db/2677616/France_Telecom>,
        <https://1145.am/db/2677617/France_Telecom>,
        <https://1145.am/db/2678426/France_Telecom>,
        <https://1145.am/db/2678974/France_Telecom>,
        <https://1145.am/db/2679833/France_Telecom>,
        <https://1145.am/db/2680430/France_Telecom>,
        <https://1145.am/db/2682070/France_Telecom>,
        <https://1145.am/db/2683565/France_Telecom> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2652948/Carlyle> a org:Organization ;
    ns1:basedInLowRaw "Spain" ;
    ns1:description "investment" ;
    ns1:documentDate "2011-10-19T10:53:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Carlyle Group takes control of Telecable" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/carlyle-group-takes-control-telecable> ;
    ns1:foundName "Carlyle" ;
    ns1:investor <https://1145.am/db/2652948/Telecable_De_Asturias_Stake_Investment> ;
    ns1:name "Carlyle" ;
    ns1:sameAsHigh <https://1145.am/db/1015212/KKR>,
        <https://1145.am/db/1016588/KKR>,
        <https://1145.am/db/1042233/Carlyle>,
        <https://1145.am/db/1051390/KKR>,
        <https://1145.am/db/1055774/KKR>,
        <https://1145.am/db/1060012/Carlyle>,
        <https://1145.am/db/1061433/Carlyle_Group>,
        <https://1145.am/db/1063827/KKR>,
        <https://1145.am/db/1064625/KKR>,
        <https://1145.am/db/1068387/KKR>,
        <https://1145.am/db/1113018/KKR>,
        <https://1145.am/db/1118091/KKR>,
        <https://1145.am/db/1160033/KKR>,
        <https://1145.am/db/1160920/KKR>,
        <https://1145.am/db/1190440/KKR>,
        <https://1145.am/db/1192098/KKR>,
        <https://1145.am/db/1192924/KKR>,
        <https://1145.am/db/1215547/KKR>,
        <https://1145.am/db/1215996/KKR>,
        <https://1145.am/db/1229887/KKR>,
        <https://1145.am/db/1230736/KKR>,
        <https://1145.am/db/1247887/KKR>,
        <https://1145.am/db/1248726/KKR>,
        <https://1145.am/db/1250422/KKR>,
        <https://1145.am/db/1262038/The_Carlyle_Group_Inc>,
        <https://1145.am/db/1263937/KKR>,
        <https://1145.am/db/1265687/Carlyle>,
        <https://1145.am/db/1270094/KKR>,
        <https://1145.am/db/1281471/KKR>,
        <https://1145.am/db/1294469/KKR>,
        <https://1145.am/db/1295782/KKR>,
        <https://1145.am/db/1310687/KKR>,
        <https://1145.am/db/1340026/Carlyle>,
        <https://1145.am/db/1344276/Carlyle>,
        <https://1145.am/db/1354162/Kkr___Co_Inc>,
        <https://1145.am/db/1364/Kkr___Co>,
        <https://1145.am/db/1394821/KKR>,
        <https://1145.am/db/1416023/KKR>,
        <https://1145.am/db/1420083/KKR>,
        <https://1145.am/db/1436822/KKR>,
        <https://1145.am/db/1438103/KKR>,
        <https://1145.am/db/1444994/Carlyle>,
        <https://1145.am/db/1449022/KKR>,
        <https://1145.am/db/1449914/KKR>,
        <https://1145.am/db/1452259/KKR>,
        <https://1145.am/db/1452519/KKR>,
        <https://1145.am/db/1455940/KKR>,
        <https://1145.am/db/1473068/KKR>,
        <https://1145.am/db/1475136/KKR>,
        <https://1145.am/db/1476460/KKR>,
        <https://1145.am/db/149545/KKR>,
        <https://1145.am/db/1495463/KKR>,
        <https://1145.am/db/1496959/KKR>,
        <https://1145.am/db/1506577/KKR>,
        <https://1145.am/db/1509288/KKR>,
        <https://1145.am/db/1512558/KKR>,
        <https://1145.am/db/152934/KKR>,
        <https://1145.am/db/1554054/KKR>,
        <https://1145.am/db/1555857/KKR>,
        <https://1145.am/db/1590538/KKR>,
        <https://1145.am/db/1591345/KKR>,
        <https://1145.am/db/1591763/KKR>,
        <https://1145.am/db/1648448/KKR>,
        <https://1145.am/db/1649860/KKR>,
        <https://1145.am/db/1649938/KKR>,
        <https://1145.am/db/1651830/KKR>,
        <https://1145.am/db/1658552/Kkr___Co_Inc>,
        <https://1145.am/db/1658979/KKR>,
        <https://1145.am/db/1661134/Kkr_Inc>,
        <https://1145.am/db/1666847/KKR>,
        <https://1145.am/db/1680588/KKR>,
        <https://1145.am/db/1688398/KKR>,
        <https://1145.am/db/171093/KKR>,
        <https://1145.am/db/1712/Kkr___Co>,
        <https://1145.am/db/173791/KKR>,
        <https://1145.am/db/1757984/KKR>,
        <https://1145.am/db/1760592/KKR>,
        <https://1145.am/db/1761520/KKR>,
        <https://1145.am/db/1822745/KKR>,
        <https://1145.am/db/1845096/KKR>,
        <https://1145.am/db/194974/KKR>,
        <https://1145.am/db/1950829/KKR>,
        <https://1145.am/db/195311/KKR>,
        <https://1145.am/db/195381/KKR>,
        <https://1145.am/db/195385/KKR>,
        <https://1145.am/db/1986543/KKR>,
        <https://1145.am/db/1996605/KKR>,
        <https://1145.am/db/2000656/Kkr___Co_Inc>,
        <https://1145.am/db/2002801/KKR>,
        <https://1145.am/db/2008433/Kkr___Co_Inc>,
        <https://1145.am/db/2023610/KKR>,
        <https://1145.am/db/2027104/KKR>,
        <https://1145.am/db/2028313/KKR>,
        <https://1145.am/db/2043935/KKR>,
        <https://1145.am/db/2044139/Carlyle_Group_Inc>,
        <https://1145.am/db/2050989/KKR>,
        <https://1145.am/db/2056647/KKR>,
        <https://1145.am/db/2066225/KKR>,
        <https://1145.am/db/2073937/KKR>,
        <https://1145.am/db/2075344/KKR>,
        <https://1145.am/db/2080109/KKR>,
        <https://1145.am/db/2085686/KKR>,
        <https://1145.am/db/2089461/KKR>,
        <https://1145.am/db/2097007/KKR>,
        <https://1145.am/db/210878/Carlyle_Group>,
        <https://1145.am/db/2109787/KKR>,
        <https://1145.am/db/2113323/KKR>,
        <https://1145.am/db/2114093/KKR>,
        <https://1145.am/db/2124274/Kkr___Co>,
        <https://1145.am/db/212685/KKR>,
        <https://1145.am/db/2131893/KKR>,
        <https://1145.am/db/2132959/KKR>,
        <https://1145.am/db/2135051/KKR>,
        <https://1145.am/db/2149115/KKR>,
        <https://1145.am/db/2194895/KKR>,
        <https://1145.am/db/2290211/KKR>,
        <https://1145.am/db/2290727/KKR>,
        <https://1145.am/db/2300371/KKR>,
        <https://1145.am/db/2314081/KKR>,
        <https://1145.am/db/2315159/New_York-KKR>,
        <https://1145.am/db/2317339/KKR>,
        <https://1145.am/db/2330390/KKR>,
        <https://1145.am/db/2336420/KKR>,
        <https://1145.am/db/240691/KKR>,
        <https://1145.am/db/2429989/KKR>,
        <https://1145.am/db/2477142/Kkr___Co>,
        <https://1145.am/db/255858/KKR>,
        <https://1145.am/db/2560676/KKR>,
        <https://1145.am/db/2573232/KKR>,
        <https://1145.am/db/2591917/KKR>,
        <https://1145.am/db/2594570/KKR>,
        <https://1145.am/db/2594867/KKR>,
        <https://1145.am/db/2637995/KKR>,
        <https://1145.am/db/2651063/KKR>,
        <https://1145.am/db/2695157/The_Carlyle_Group>,
        <https://1145.am/db/2719490/KKR>,
        <https://1145.am/db/2785212/KKR>,
        <https://1145.am/db/2786374/KKR>,
        <https://1145.am/db/2795258/KKR>,
        <https://1145.am/db/2795446/KKR>,
        <https://1145.am/db/2796864/KKR>,
        <https://1145.am/db/287966/KKR>,
        <https://1145.am/db/293364/Kkr___Co>,
        <https://1145.am/db/319737/KKR>,
        <https://1145.am/db/322468/KKR>,
        <https://1145.am/db/322933/KKR>,
        <https://1145.am/db/334317/KKR>,
        <https://1145.am/db/337257/KKR>,
        <https://1145.am/db/338225/KKR>,
        <https://1145.am/db/341447/The_Carlyle_Group>,
        <https://1145.am/db/341462/The_Carlyle_Group>,
        <https://1145.am/db/344076/KKR>,
        <https://1145.am/db/346265/KKR>,
        <https://1145.am/db/346358/Kkr___Co>,
        <https://1145.am/db/346368/Kkr___Co>,
        <https://1145.am/db/347280/KKR>,
        <https://1145.am/db/357173/KKR>,
        <https://1145.am/db/3573/KKR>,
        <https://1145.am/db/377208/Kkr___Co_Inc>,
        <https://1145.am/db/388746/KKR>,
        <https://1145.am/db/409008/KKR>,
        <https://1145.am/db/429762/KKR>,
        <https://1145.am/db/432705/KKR>,
        <https://1145.am/db/433673/KKR>,
        <https://1145.am/db/444316/KKR>,
        <https://1145.am/db/456088/KKR>,
        <https://1145.am/db/461148/KKR>,
        <https://1145.am/db/462950/The_Carlyle_Group>,
        <https://1145.am/db/463978/KKR>,
        <https://1145.am/db/464569/KKR>,
        <https://1145.am/db/473485/The_Carlyle_Group>,
        <https://1145.am/db/474753/KKR>,
        <https://1145.am/db/487377/Carlyle>,
        <https://1145.am/db/523447/Kkr_And_Carlyle>,
        <https://1145.am/db/531779/KKR>,
        <https://1145.am/db/537800/KKR>,
        <https://1145.am/db/538125/Kkr___Co_Inc>,
        <https://1145.am/db/539290/KKR>,
        <https://1145.am/db/544684/KKR>,
        <https://1145.am/db/585991/KKR>,
        <https://1145.am/db/595003/KKR>,
        <https://1145.am/db/595062/KKR>,
        <https://1145.am/db/596244/KKR>,
        <https://1145.am/db/600948/KKR>,
        <https://1145.am/db/602304/KKR>,
        <https://1145.am/db/606208/KKR>,
        <https://1145.am/db/613508/The_Carlyle_Group>,
        <https://1145.am/db/613807/KKR>,
        <https://1145.am/db/615304/The_Carlyle_Group>,
        <https://1145.am/db/624410/KKR>,
        <https://1145.am/db/647441/KKR>,
        <https://1145.am/db/652863/KKR>,
        <https://1145.am/db/653953/KKR>,
        <https://1145.am/db/665505/KKR>,
        <https://1145.am/db/667263/KKR>,
        <https://1145.am/db/669082/Carlyle>,
        <https://1145.am/db/672092/Carlyle>,
        <https://1145.am/db/672144/Carlyle>,
        <https://1145.am/db/679542/Carlyle>,
        <https://1145.am/db/693816/KKR>,
        <https://1145.am/db/695839/KKR>,
        <https://1145.am/db/696425/KKR>,
        <https://1145.am/db/696885/KKR>,
        <https://1145.am/db/698056/KKR>,
        <https://1145.am/db/699689/Kkr___Co_Inc>,
        <https://1145.am/db/703846/KKR>,
        <https://1145.am/db/746000/KKR>,
        <https://1145.am/db/748180/KKR>,
        <https://1145.am/db/75900/KKR>,
        <https://1145.am/db/769166/KKR>,
        <https://1145.am/db/770078/KKR>,
        <https://1145.am/db/783138/KKR>,
        <https://1145.am/db/785008/KKR>,
        <https://1145.am/db/787319/KKR>,
        <https://1145.am/db/797358/KKR>,
        <https://1145.am/db/800916/KKR>,
        <https://1145.am/db/814184/KKR>,
        <https://1145.am/db/829829/Carlyle_Group>,
        <https://1145.am/db/835332/KKR>,
        <https://1145.am/db/849227/KKR>,
        <https://1145.am/db/865540/KKR>,
        <https://1145.am/db/893986/Carlyle_Group>,
        <https://1145.am/db/896222/Carlyle_Group>,
        <https://1145.am/db/907556/KKR>,
        <https://1145.am/db/908907/KKR>,
        <https://1145.am/db/910191/KKR>,
        <https://1145.am/db/912132/Kkr___Co>,
        <https://1145.am/db/913484/KKR>,
        <https://1145.am/db/91884/KKR>,
        <https://1145.am/db/923834/KKR>,
        <https://1145.am/db/924993/KKR>,
        <https://1145.am/db/926313/KKR>,
        <https://1145.am/db/930281/KKR>,
        <https://1145.am/db/934927/KKR>,
        <https://1145.am/db/964816/Kkr___Co_Inc>,
        <https://1145.am/db/968064/KKR>,
        <https://1145.am/db/968112/KKR>,
        <https://1145.am/db/970108/KKR>,
        <https://1145.am/db/971684/KKR>,
        <https://1145.am/db/972089/KKR>,
        <https://1145.am/db/972213/KKR>,
        <https://1145.am/db/976442/KKR>,
        <https://1145.am/db/978086/KKR>,
        <https://1145.am/db/984390/KKR>,
        <https://1145.am/db/986270/KKR>,
        <https://1145.am/db/989353/KKR>,
        <https://1145.am/db/992099/KKR> ;
    ns1:sameAsMedium <https://1145.am/db/1263372/Carlyle>,
        <https://1145.am/db/1324695/Carlyle>,
        <https://1145.am/db/1325517/Carlyle>,
        <https://1145.am/db/1407766/Carlyle>,
        <https://1145.am/db/1511707/Carlyle>,
        <https://1145.am/db/1664492/Carlyle>,
        <https://1145.am/db/1696377/Carlyle>,
        <https://1145.am/db/1739485/Carlyle>,
        <https://1145.am/db/1756298/Carlyle>,
        <https://1145.am/db/193707/Carlyle>,
        <https://1145.am/db/193708/Carlyle>,
        <https://1145.am/db/193712/Carlyle>,
        <https://1145.am/db/1990572/Carlyle>,
        <https://1145.am/db/2076171/Carlyle>,
        <https://1145.am/db/2111256/Carlyle>,
        <https://1145.am/db/2282263/Carlyle>,
        <https://1145.am/db/2299311/Carlyle>,
        <https://1145.am/db/235660/Carlyle>,
        <https://1145.am/db/245856/Carlyle>,
        <https://1145.am/db/2540527/Carlyle>,
        <https://1145.am/db/2555127/Carlyle>,
        <https://1145.am/db/2562557/Carlyle>,
        <https://1145.am/db/2612648/Carlyle>,
        <https://1145.am/db/2786448/Carlyle>,
        <https://1145.am/db/393962/Carlyle>,
        <https://1145.am/db/455528/Carlyle>,
        <https://1145.am/db/559940/Carlyle>,
        <https://1145.am/db/625913/Carlyle>,
        <https://1145.am/db/715313/Carlyle>,
        <https://1145.am/db/834407/Carlyle> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2652948/The_Carlyle_Group> a org:Organization ;
    ns1:basedInLowRaw "Spain" ;
    ns1:buyer <https://1145.am/db/2652948/Telecable_De_Asturias_Stake_Investment> ;
    ns1:description "Asset management" ;
    ns1:documentDate "2011-10-19T10:53:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Carlyle Group takes control of Telecable" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/carlyle-group-takes-control-telecable> ;
    ns1:foundName "The Carlyle Group" ;
    ns1:industry "Asset management" ;
    ns1:name "The Carlyle Group" ;
    ns1:sameAsHigh <https://1145.am/db/1842406/The_Carlyle_Group>,
        <https://1145.am/db/1919816/The_Carlyle_Group> ;
    ns1:sameAsMedium <https://1145.am/db/1059667/Carlyle_Group_Inc>,
        <https://1145.am/db/1061433/Carlyle_Group>,
        <https://1145.am/db/1081056/The_Carlyle_Group>,
        <https://1145.am/db/1106015/The_Carlyle_Group_Inc>,
        <https://1145.am/db/1108833/The_Carlyle_Group_Inc>,
        <https://1145.am/db/1146363/The_Carlyle_Group_Inc>,
        <https://1145.am/db/118613/Carlyle_Group_Inc>,
        <https://1145.am/db/1188247/Carlyle_Group_Inc>,
        <https://1145.am/db/1191566/Carlyle_Group>,
        <https://1145.am/db/123062/Carlyle_Group>,
        <https://1145.am/db/124264/Carlyle_Group>,
        <https://1145.am/db/1262038/The_Carlyle_Group_Inc>,
        <https://1145.am/db/128762/Carlyle_Group_Inc>,
        <https://1145.am/db/128784/Carlyle_Group_Inc>,
        <https://1145.am/db/1296521/Carlyle_Group>,
        <https://1145.am/db/1305007/Carlyle_Group_Inc>,
        <https://1145.am/db/1315553/Carlyle_Group_Inc>,
        <https://1145.am/db/1317266/Carlyle_Group>,
        <https://1145.am/db/132708/Carlyle_Group>,
        <https://1145.am/db/1338721/The_Carlyle_Group_Inc>,
        <https://1145.am/db/137128/Carlyle_Group>,
        <https://1145.am/db/1378133/Carlyle_Group>,
        <https://1145.am/db/1414853/Carlyle_Group>,
        <https://1145.am/db/1475609/Carlyle_Group_Inc>,
        <https://1145.am/db/1488199/Carlyle_Group_Inc>,
        <https://1145.am/db/1504465/Carlyle_Group_Inc>,
        <https://1145.am/db/1535587/Carlyle_Group>,
        <https://1145.am/db/1547742/Carlyle_Group_Inc>,
        <https://1145.am/db/1631508/Carlyle_Group>,
        <https://1145.am/db/1663046/Carlyle_Group>,
        <https://1145.am/db/1664716/Carlyle_Group_Inc>,
        <https://1145.am/db/1666853/Carlyle_Group_Inc>,
        <https://1145.am/db/1684816/Carlyle_Group>,
        <https://1145.am/db/1717980/The_Carlyle_Group>,
        <https://1145.am/db/1766563/Carlyle_Group>,
        <https://1145.am/db/1792492/The_Carlyle_Group>,
        <https://1145.am/db/1937022/Carlyle_Group>,
        <https://1145.am/db/194149/Carlyle_Group>,
        <https://1145.am/db/1969596/Carlyle_Group_Inc>,
        <https://1145.am/db/1977165/Carlyle_Group_Inc>,
        <https://1145.am/db/2044139/Carlyle_Group_Inc>,
        <https://1145.am/db/2060422/Carlyle_Group_Inc>,
        <https://1145.am/db/2079578/Carlyle_Group>,
        <https://1145.am/db/2087699/Carlyle_Group>,
        <https://1145.am/db/2107041/Carlyle_Group>,
        <https://1145.am/db/210878/Carlyle_Group>,
        <https://1145.am/db/2130564/Carlyle_Group_Inc>,
        <https://1145.am/db/2158772/Carlyle_Group>,
        <https://1145.am/db/2178636/Carlyle_Group>,
        <https://1145.am/db/2192624/The_Carlyle_Group>,
        <https://1145.am/db/2197351/Carlyle_Group>,
        <https://1145.am/db/2201813/The_Carlyle_Group>,
        <https://1145.am/db/2217035/Carlyle_Group>,
        <https://1145.am/db/2220962/The_Carlyle_Group>,
        <https://1145.am/db/222616/Carlyle_Group>,
        <https://1145.am/db/224045/Carlyle_Group>,
        <https://1145.am/db/2287161/The_Carlyle_Group>,
        <https://1145.am/db/2290453/The_Carlyle_Group>,
        <https://1145.am/db/2291600/The_Carlyle_Group>,
        <https://1145.am/db/2296402/Carlyle_Group>,
        <https://1145.am/db/2296413/Carlyle_Group>,
        <https://1145.am/db/2296425/Carlyle_Group>,
        <https://1145.am/db/2299307/Carlyle_Group>,
        <https://1145.am/db/229993/Carlyle_Group>,
        <https://1145.am/db/2300673/Carlyle_Group>,
        <https://1145.am/db/2331820/The_Carlyle_Group>,
        <https://1145.am/db/2334963/Carlyle_Group>,
        <https://1145.am/db/2343264/The_Carlyle_Group>,
        <https://1145.am/db/2355721/The_Carlyle_Group>,
        <https://1145.am/db/236024/Carlyle_Group_Inc>,
        <https://1145.am/db/250407/Carlyle_Group>,
        <https://1145.am/db/250618/Carlyle_Group>,
        <https://1145.am/db/2536473/Carlyle_Group>,
        <https://1145.am/db/2537654/Carlyle_Group>,
        <https://1145.am/db/2538577/The_Carlyle_Group>,
        <https://1145.am/db/2539860/The_Carlyle_Group>,
        <https://1145.am/db/2547835/The_Carlyle_Group>,
        <https://1145.am/db/2554800/The_Carlyle_Group>,
        <https://1145.am/db/2554801/Carlyle_Group>,
        <https://1145.am/db/2558602/The_Carlyle_Group>,
        <https://1145.am/db/2562207/The_Carlyle_Group>,
        <https://1145.am/db/2562208/The_Carlyle_Group>,
        <https://1145.am/db/2569234/Carlyle_Group>,
        <https://1145.am/db/2586824/The_Carlyle_Group>,
        <https://1145.am/db/2595675/The_Carlyle_Group>,
        <https://1145.am/db/2612663/Carlyle_Group>,
        <https://1145.am/db/2642638/Carlyle_Group>,
        <https://1145.am/db/2650239/The_Carlyle_Group>,
        <https://1145.am/db/2651661/The_Carlyle_Group>,
        <https://1145.am/db/2669433/The_Carlyle_Group>,
        <https://1145.am/db/2677493/Carlyle_Group>,
        <https://1145.am/db/2681611/The_Carlyle_Group>,
        <https://1145.am/db/2695157/The_Carlyle_Group>,
        <https://1145.am/db/2697498/Carlyle_Group>,
        <https://1145.am/db/2756502/Carlyle_Group>,
        <https://1145.am/db/2795655/Carlyle_Group>,
        <https://1145.am/db/316299/Carlyle_Group>,
        <https://1145.am/db/316648/Carlyle_Group_Inc>,
        <https://1145.am/db/317815/Carlyle_Group>,
        <https://1145.am/db/341447/The_Carlyle_Group>,
        <https://1145.am/db/341462/The_Carlyle_Group>,
        <https://1145.am/db/367652/Carlyle_Group_Inc>,
        <https://1145.am/db/385358/Carlyle_Group_Inc>,
        <https://1145.am/db/391980/Carlyle_Group>,
        <https://1145.am/db/400681/The_Carlyle_Group>,
        <https://1145.am/db/462950/The_Carlyle_Group>,
        <https://1145.am/db/473485/The_Carlyle_Group>,
        <https://1145.am/db/555674/The_Carlyle_Group>,
        <https://1145.am/db/594889/Carlyle_Group>,
        <https://1145.am/db/613126/The_Carlyle_Group>,
        <https://1145.am/db/613508/The_Carlyle_Group>,
        <https://1145.am/db/613921/The_Carlyle_Group>,
        <https://1145.am/db/613938/The_Carlyle_Group>,
        <https://1145.am/db/615304/The_Carlyle_Group>,
        <https://1145.am/db/637797/Carlyle_Group>,
        <https://1145.am/db/643748/Carlyle_Group_Inc>,
        <https://1145.am/db/644370/Carlyle_Group>,
        <https://1145.am/db/644596/Carlyle_Group>,
        <https://1145.am/db/668225/Carlyle_Group>,
        <https://1145.am/db/686863/Carlyle_Group_Inc>,
        <https://1145.am/db/733897/Carlyle_Group>,
        <https://1145.am/db/799126/Carlyle_Group_Inc>,
        <https://1145.am/db/802006/Carlyle_Group>,
        <https://1145.am/db/802741/Carlyle_Group>,
        <https://1145.am/db/810188/Carlyle_Group_Inc>,
        <https://1145.am/db/829829/Carlyle_Group>,
        <https://1145.am/db/890601/Carlyle_Group_Inc>,
        <https://1145.am/db/892628/Carlyle_Group_Inc>,
        <https://1145.am/db/893986/Carlyle_Group>,
        <https://1145.am/db/896222/Carlyle_Group>,
        <https://1145.am/db/912159/Carlyle_Group>,
        <https://1145.am/db/949279/The_Carlyle_Group>,
        <https://1145.am/db/961653/Carlyle_Group_Inc> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2659467/KHC> a org:Organization ;
    ns1:basedInHighGeoName "Saudi" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/7949880/about.rdf> ;
    ns1:basedInHighRaw "Saudi" ;
    ns1:documentDate "2011-12-20T04:28:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: Sprint abandons Carrier IQ; Huawei, ZTE eye $200m India revenue" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-sprint-abandons-carrier-iq-huawei-zte-eye-200m-india-revenue> ;
    ns1:foundName "KHC" ;
    ns1:investor <https://1145.am/db/2659467/Investment_Khc_Walid_Bin_Tatal_Completed>,
        <https://1145.am/db/2659467/Twitter_Acquisition> ;
    ns1:name "KHC" ;
    ns1:sameAsMedium <https://1145.am/db/1895559/KHC>,
        <https://1145.am/db/2670351/KHC> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2659467/Telekom_Srbija> a org:Organization ;
    ns1:basedInLowRaw "Serbia" ;
    ns1:description "Business" ;
    ns1:documentDate "2011-12-20T04:28:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: Sprint abandons Carrier IQ; Huawei, ZTE eye $200m India revenue" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-sprint-abandons-carrier-iq-huawei-zte-eye-200m-india-revenue> ;
    ns1:foundName "Telekom Srbija" ;
    ns1:industry "Telecom" ;
    ns1:investor <https://1145.am/db/2659467/Investment_Ote_Telekom_Srbija_Has_Not_Happened> ;
    ns1:name "Telekom Srbija" ;
    ns1:sameAsHigh <https://1145.am/db/2615058/Telekom_Srbija>,
        <https://1145.am/db/2615826/Telekom_Srbija>,
        <https://1145.am/db/2652759/Telekom_Srbija>,
        <https://1145.am/db/2657527/Telekom_Srbija>,
        <https://1145.am/db/2659815/Telekom_Srbija>,
        <https://1145.am/db/2661621/Telekom_Srbija>,
        <https://1145.am/db/2663829/Telekom_Srbija>,
        <https://1145.am/db/2664587/Telekom_Srbija>,
        <https://1145.am/db/2672912/Telekom_Srbija> ;
    ns1:sameAsMedium <https://1145.am/db/2614152/Telekom_Srbija>,
        <https://1145.am/db/2618623/Telekom_Srbija>,
        <https://1145.am/db/2657419/Telekom_Srbija>,
        <https://1145.am/db/2661700/Telekom_Srbija> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2659467/Walid_Bin_Tatal> a org:Organization ;
    ns1:basedInHighGeoName "Saudi" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/7949880/about.rdf> ;
    ns1:basedInHighRaw "Saudi" ;
    ns1:buyer <https://1145.am/db/2659467/Acquisition_Walid_Bin_Tatal_Completed>,
        <https://1145.am/db/2659467/Twitter_Acquisition> ;
    ns1:documentDate "2011-12-20T04:28:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: Sprint abandons Carrier IQ; Huawei, ZTE eye $200m India revenue" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-sprint-abandons-carrier-iq-huawei-zte-eye-200m-india-revenue> ;
    ns1:foundName "Walid bin Tatal" ;
    ns1:investor <https://1145.am/db/2659467/Investment_Khc_Walid_Bin_Tatal_Completed>,
        <https://1145.am/db/2659467/Twitter_Acquisition> ;
    ns1:name "Walid bin Tatal" ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2659492/Bouygues> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:buyer <https://1145.am/db/2659492/Kpn_France_Acquisition> ;
    ns1:documentDate "2011-12-23T02:40:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: KPN to sell French unit to Bouygues; TeliaSonera buys out Kcell" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-kpn-to-sell-french-unit-to-bouygues-teliasonera-buys-out-kcell> ;
    ns1:foundName "Bouygues" ;
    ns1:name "Bouygues" ;
    ns1:sameAsMedium <https://1145.am/db/1218615/Bouygues>,
        <https://1145.am/db/1717333/Bouygues>,
        <https://1145.am/db/196886/Bouygues>,
        <https://1145.am/db/196888/Bouygues>,
        <https://1145.am/db/2598834/Bouygues>,
        <https://1145.am/db/2664210/Bouygues_Sa>,
        <https://1145.am/db/2666408/Bouygues>,
        <https://1145.am/db/2666416/Bouygues>,
        <https://1145.am/db/2673142/Bouygues>,
        <https://1145.am/db/269889/Bouygues>,
        <https://1145.am/db/334871/Bouygues>,
        <https://1145.am/db/335016/Bouygues>,
        <https://1145.am/db/584773/Bouygues>,
        <https://1145.am/db/612121/Bouygues>,
        <https://1145.am/db/990689/Bouygues> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2659492/Corp> a org:Organization ;
    ns1:basedInLowRaw "Japan" ;
    ns1:documentDate "2011-12-23T02:40:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: KPN to sell French unit to Bouygues; TeliaSonera buys out Kcell" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-kpn-to-sell-french-unit-to-bouygues-teliasonera-buys-out-kcell> ;
    ns1:foundName "Corp" ;
    ns1:name "Corp" ;
    ns1:protagonist <https://1145.am/db/2659492/Joint_Venture_Acquisition_Corp_Softbank_Has_Not_Happened> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2659492/Joint_Venture_Acquisition_Softbank_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-12-23T02:40:30+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Japan's Softbank reportedly plans liquidate its 50/50 joint venture with News Corp which operates the Japanese-language version of MySpace, transferring management of the site to MySpace LLC." ;
    ns1:documentTitle "Webwire: KPN to sell French unit to Bouygues; TeliaSonera buys out Kcell" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-kpn-to-sell-french-unit-to-bouygues-teliasonera-buys-out-kcell> ;
    ns1:foundName "liquidate" ;
    ns1:name "liquidate" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:targetDetails "joint venture" ;
    ns1:vendor <https://1145.am/db/2659492/Softbank> ;
    ns1:whereGeoName "Japan" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1861060/about.rdf> ;
    ns1:whereRaw "Japan" .

<https://1145.am/db/2659492/Teliasonera> a org:Organization ;
    ns1:basedInLowRaw "Sweden" ;
    ns1:buyer <https://1145.am/db/2659492/Kcell_Acquisition> ;
    ns1:documentDate "2011-12-23T02:40:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: KPN to sell French unit to Bouygues; TeliaSonera buys out Kcell" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-kpn-to-sell-french-unit-to-bouygues-teliasonera-buys-out-kcell> ;
    ns1:foundName "TeliaSonera" ;
    ns1:name "TeliaSonera" ;
    ns1:sameAsMedium <https://1145.am/db/2173980/Teliasonera>,
        <https://1145.am/db/2608548/Teliasonera>,
        <https://1145.am/db/2610841/Teliasonera>,
        <https://1145.am/db/2611525/Teliasonera>,
        <https://1145.am/db/2612255/Teliasonera>,
        <https://1145.am/db/2613016/Teliasonera>,
        <https://1145.am/db/2613491/Teliasonera>,
        <https://1145.am/db/2625103/Teliasonera>,
        <https://1145.am/db/2632777/Teliasonera>,
        <https://1145.am/db/2640565/Teliasonera>,
        <https://1145.am/db/2651815/Teliasonera>,
        <https://1145.am/db/2651859/Teliasonera>,
        <https://1145.am/db/2652353/Teliasonera>,
        <https://1145.am/db/2652976/Teliasonera>,
        <https://1145.am/db/2653163/Teliasonera>,
        <https://1145.am/db/2653226/Teliasonera>,
        <https://1145.am/db/2653278/Teliasonera>,
        <https://1145.am/db/2653325/Teliasonera>,
        <https://1145.am/db/2654552/Teliasonera>,
        <https://1145.am/db/2655754/Teliasonera>,
        <https://1145.am/db/2656761/Teliasonera>,
        <https://1145.am/db/2656768/Teliasonera>,
        <https://1145.am/db/2656843/Teliasonera>,
        <https://1145.am/db/2658167/Teliasonera>,
        <https://1145.am/db/2659167/Teliasonera>,
        <https://1145.am/db/2659514/Teliasonera>,
        <https://1145.am/db/2659801/Teliasonera>,
        <https://1145.am/db/2660884/Teliasonera>,
        <https://1145.am/db/2660899/Teliasonera>,
        <https://1145.am/db/2661028/Teliasonera>,
        <https://1145.am/db/2661960/Teliasonera>,
        <https://1145.am/db/2661980/Teliasonera>,
        <https://1145.am/db/2663040/Teliasonera>,
        <https://1145.am/db/2663738/Teliasonera>,
        <https://1145.am/db/2663846/Teliasonera>,
        <https://1145.am/db/2664799/Teliasonera>,
        <https://1145.am/db/2665182/Teliasonera>,
        <https://1145.am/db/2665863/Teliasonera>,
        <https://1145.am/db/2666273/Teliasonera>,
        <https://1145.am/db/2666331/Teliasonera>,
        <https://1145.am/db/2666445/Teliasonera>,
        <https://1145.am/db/2667068/Teliasonera>,
        <https://1145.am/db/2667487/Teliasonera>,
        <https://1145.am/db/2669163/Teliasonera>,
        <https://1145.am/db/2669499/Teliasonera>,
        <https://1145.am/db/2670384/Teliasonera>,
        <https://1145.am/db/2671804/Teliasonera>,
        <https://1145.am/db/2671847/Teliasonera>,
        <https://1145.am/db/2672822/Teliasonera>,
        <https://1145.am/db/2673616/Teliasonera>,
        <https://1145.am/db/2674820/Teliasonera>,
        <https://1145.am/db/2674846/Teliasonera>,
        <https://1145.am/db/2675188/Teliasonera>,
        <https://1145.am/db/2675199/Teliasonera>,
        <https://1145.am/db/2675339/Teliasonera>,
        <https://1145.am/db/2675499/Teliasonera>,
        <https://1145.am/db/2675505/Teliasonera>,
        <https://1145.am/db/2676038/Teliasonera>,
        <https://1145.am/db/2676595/Teliasonera>,
        <https://1145.am/db/2676710/Teliasonera>,
        <https://1145.am/db/2678426/Teliasonera> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2664500/Leap_Wireless> a org:Organization ;
    ns1:basedInLowRaw "USA" ;
    ns1:documentDate "2011-09-19T14:18:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: AT&T reaches out to Sprint, MetroPCS, Leap on T-Mobile asset sales" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-at-t-reaches-out-to-sprint-metropcs-leap-t-mobile-asset-sales> ;
    ns1:foundName "Leap Wireless" ;
    ns1:name "Leap Wireless" ;
    ns1:participant <https://1145.am/db/2664500/T-Mobile_Usa_Acquisition> ;
    ns1:sameAsMedium <https://1145.am/db/1836084/Leap_Wireless>,
        <https://1145.am/db/2173415/Leap_Wireless>,
        <https://1145.am/db/2625775/Leap_Wireless>,
        <https://1145.am/db/2631033/Leap_Wireless>,
        <https://1145.am/db/2637762/Leap_Wireless>,
        <https://1145.am/db/2639625/Leap_Wireless>,
        <https://1145.am/db/2647888/Leap_Wireless>,
        <https://1145.am/db/2655150/Leap_Wireless>,
        <https://1145.am/db/2658466/Leap_Wireless>,
        <https://1145.am/db/2661159/Leap_Wireless>,
        <https://1145.am/db/2661168/Leap_Wireless>,
        <https://1145.am/db/2662193/Leap_Wireless>,
        <https://1145.am/db/2662378/Leap_Wireless>,
        <https://1145.am/db/2664378/Leap_Wireless>,
        <https://1145.am/db/2665469/Leap_Wireless>,
        <https://1145.am/db/2669926/Leap_Wireless>,
        <https://1145.am/db/2674567/Leap_Wireless>,
        <https://1145.am/db/2676099/Leap_Wireless>,
        <https://1145.am/db/2678516/Leap_Wireless>,
        <https://1145.am/db/2680894/Leap_Wireless>,
        <https://1145.am/db/2680897/Leap_Wireless>,
        <https://1145.am/db/2680900/Leap_Wireless>,
        <https://1145.am/db/2680905/Leap_Wireless>,
        <https://1145.am/db/2680906/Leap_Wireless>,
        <https://1145.am/db/2681282/Leap_Wireless>,
        <https://1145.am/db/2681584/Leap_Wireless>,
        <https://1145.am/db/2681695/Leap_Wireless>,
        <https://1145.am/db/2681734/Leap_Wireless>,
        <https://1145.am/db/2682715/Leap_Wireless>,
        <https://1145.am/db/2684439/Leap_Wireless>,
        <https://1145.am/db/2685183/Leap_Wireless>,
        <https://1145.am/db/2685314/Leap_Wireless>,
        <https://1145.am/db/2685799/Leap_Wireless>,
        <https://1145.am/db/2686174/Leap_Wireless>,
        <https://1145.am/db/2686488/Leap_Wireless> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2664500/Metropcs> a org:Organization ;
    ns1:basedInLowRaw "USA" ;
    ns1:documentDate "2011-09-19T14:18:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: AT&T reaches out to Sprint, MetroPCS, Leap on T-Mobile asset sales" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-at-t-reaches-out-to-sprint-metropcs-leap-t-mobile-asset-sales> ;
    ns1:foundName "MetroPCS" ;
    ns1:name "MetroPCS" ;
    ns1:participant <https://1145.am/db/2664500/T-Mobile_Usa_Acquisition> ;
    ns1:sameAsMedium <https://1145.am/db/2625808/Metropcs>,
        <https://1145.am/db/2626494/Metropcs>,
        <https://1145.am/db/2631033/Metropcs>,
        <https://1145.am/db/2640440/Metropcs>,
        <https://1145.am/db/2650228/Metropcs>,
        <https://1145.am/db/2656845/Metropcs>,
        <https://1145.am/db/2656851/Metropcs>,
        <https://1145.am/db/2658569/Metropcs>,
        <https://1145.am/db/2658575/Metropcs>,
        <https://1145.am/db/2658580/Metropcs>,
        <https://1145.am/db/2658589/Metropcs>,
        <https://1145.am/db/2659586/Metropcs>,
        <https://1145.am/db/2659591/Metropcs>,
        <https://1145.am/db/2659597/Metropcs>,
        <https://1145.am/db/2659631/Metropcs>,
        <https://1145.am/db/2662860/Metropcs>,
        <https://1145.am/db/2662872/Metropcs>,
        <https://1145.am/db/2663892/Metropcs>,
        <https://1145.am/db/2664986/Metropcs>,
        <https://1145.am/db/2666714/Metropcs>,
        <https://1145.am/db/2668208/Metropcs>,
        <https://1145.am/db/2668226/Metropcs>,
        <https://1145.am/db/2669319/Metropcs>,
        <https://1145.am/db/2669321/Metropcs>,
        <https://1145.am/db/2669338/Metropcs>,
        <https://1145.am/db/2670397/Metropcs>,
        <https://1145.am/db/2670454/Metropcs>,
        <https://1145.am/db/2671585/Metropcs>,
        <https://1145.am/db/2671623/Metropcs>,
        <https://1145.am/db/2671629/Metropcs>,
        <https://1145.am/db/2673938/Metropcs>,
        <https://1145.am/db/2676975/Metropcs>,
        <https://1145.am/db/2681282/Metropcs>,
        <https://1145.am/db/2681285/Metropcs>,
        <https://1145.am/db/2681584/Metropcs>,
        <https://1145.am/db/2682450/Metropcs>,
        <https://1145.am/db/2683705/Metropcs>,
        <https://1145.am/db/2685314/Metropcs>,
        <https://1145.am/db/2685799/Metropcs>,
        <https://1145.am/db/2686488/Metropcs> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2668825/Clearwire_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment",
        "ipo" ;
    ns1:documentDate "2011-11-07T15:46:45+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Sprint Nextel (NYSE: S) said it raised $ 4 billion in a debt offering on Friday and may use some of the proceeds to fund Clearwire (NASDAQ: CLWR) ." ;
    ns1:documentTitle "Sprint raises $4B in debt offering, hints at Clearwire funding" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/sprint-raises-4b-debt-offering-hints-at-clearwire-funding> ;
    ns1:foundName "debt offering",
        "raised" ;
    ns1:name "debt offering",
        "raised" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened",
        "unknown" ;
    ns1:target <https://1145.am/db/2668825/Clearwire>,
        <https://1145.am/db/2668825/Sprint_Nextel> ;
    ns1:targetName "Clearwire" ;
    ns1:valueRaw "$ 4 billion" ;
    ns1:vendor <https://1145.am/db/2668825/Sprint_Nextel> .

<https://1145.am/db/2174887/Admeld> a org:Organization ;
    ns1:description "AdMeld was founded in 2007, and interfaces with ad networks, exchanges and" ;
    ns1:documentDate "2011-11-29T00:10:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Google $400M deal for AdMeld likely to get DOJ nod" ;
    ns1:documentURL <https://www.streamtvinsider.com/online-video/google-400m-deal-for-admeld-likely-to-get-doj-nod> ;
    ns1:foundName "AdMeld",
        "Admeld" ;
    ns1:industry "ad technology platform" ;
    ns1:name "AdMeld" ;
    ns1:sameAsHigh <https://1145.am/db/1862556/Admeld>,
        <https://1145.am/db/2670335/Admeld> ;
    ns1:sameAsMedium <https://1145.am/db/1873704/Admeld> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2174887/Google> a org:Organization ;
    ns1:buyer <https://1145.am/db/2174887/Series_C_Investment_Admeld_Completed> ;
    ns1:description "Search" ;
    ns1:documentDate "2011-11-29T00:10:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Google $400M deal for AdMeld likely to get DOJ nod" ;
    ns1:documentURL <https://www.streamtvinsider.com/online-video/google-400m-deal-for-admeld-likely-to-get-doj-nod> ;
    ns1:foundName "Google'" ;
    ns1:industry "search" ;
    ns1:name "Google" ;
    ns1:sameAsHigh <https://1145.am/db/1697208/Google>,
        <https://1145.am/db/1697695/Google>,
        <https://1145.am/db/1702905/Google>,
        <https://1145.am/db/1707415/Google_Inc>,
        <https://1145.am/db/1718244/Google>,
        <https://1145.am/db/1720864/Google>,
        <https://1145.am/db/1721364/Google>,
        <https://1145.am/db/1737526/Google>,
        <https://1145.am/db/1745775/Google>,
        <https://1145.am/db/1746459/Google>,
        <https://1145.am/db/1757953/Google>,
        <https://1145.am/db/1758152/Google>,
        <https://1145.am/db/1758703/Google>,
        <https://1145.am/db/1760788/Google>,
        <https://1145.am/db/1767376/Google>,
        <https://1145.am/db/1769482/Google>,
        <https://1145.am/db/1774154/Google>,
        <https://1145.am/db/1775616/Google>,
        <https://1145.am/db/1793825/Google>,
        <https://1145.am/db/1798739/Google>,
        <https://1145.am/db/1819728/Google>,
        <https://1145.am/db/1824018/Google>,
        <https://1145.am/db/1824305/Google>,
        <https://1145.am/db/1841458/Google_Inc>,
        <https://1145.am/db/1846267/Google>,
        <https://1145.am/db/1849311/Google>,
        <https://1145.am/db/1852147/Google_Inc>,
        <https://1145.am/db/1853116/Google>,
        <https://1145.am/db/1863462/Google>,
        <https://1145.am/db/1868489/Google>,
        <https://1145.am/db/1869712/Google>,
        <https://1145.am/db/1873704/Google>,
        <https://1145.am/db/1886541/Google>,
        <https://1145.am/db/1887780/Google>,
        <https://1145.am/db/1888219/Google>,
        <https://1145.am/db/1894569/Google>,
        <https://1145.am/db/1896565/Google>,
        <https://1145.am/db/1906416/Google>,
        <https://1145.am/db/1925850/Google>,
        <https://1145.am/db/2164099/Google>,
        <https://1145.am/db/2168618/Google>,
        <https://1145.am/db/2170088/Google>,
        <https://1145.am/db/2170124/Google>,
        <https://1145.am/db/2172445/Google>,
        <https://1145.am/db/2174085/Google>,
        <https://1145.am/db/2175876/Google>,
        <https://1145.am/db/2177262/Google>,
        <https://1145.am/db/2187497/Google>,
        <https://1145.am/db/2189110/Google>,
        <https://1145.am/db/2190148/Google>,
        <https://1145.am/db/222159/Google>,
        <https://1145.am/db/2524835/Google>,
        <https://1145.am/db/2524836/Google>,
        <https://1145.am/db/2527805/Google>,
        <https://1145.am/db/2527814/Google>,
        <https://1145.am/db/2611906/Google>,
        <https://1145.am/db/2612470/Google>,
        <https://1145.am/db/2614160/Google>,
        <https://1145.am/db/2623391/Google>,
        <https://1145.am/db/2623692/Google>,
        <https://1145.am/db/2624673/Google>,
        <https://1145.am/db/2643391/Google>,
        <https://1145.am/db/2654442/Google>,
        <https://1145.am/db/2664460/Google>,
        <https://1145.am/db/2664505/Google>,
        <https://1145.am/db/2665583/Google>,
        <https://1145.am/db/2666652/Google>,
        <https://1145.am/db/2667803/Google>,
        <https://1145.am/db/2669172/Google>,
        <https://1145.am/db/2669647/Google>,
        <https://1145.am/db/2670741/Google>,
        <https://1145.am/db/2670872/Google>,
        <https://1145.am/db/2674324/Google>,
        <https://1145.am/db/2677662/Google>,
        <https://1145.am/db/2681250/Google>,
        <https://1145.am/db/2686449/Google>,
        <https://1145.am/db/2723493/Google>,
        <https://1145.am/db/306767/Google>,
        <https://1145.am/db/489758/Google> ;
    ns1:sameAsMedium <https://1145.am/db/1106670/Google>,
        <https://1145.am/db/112896/Google>,
        <https://1145.am/db/1218545/Google>,
        <https://1145.am/db/1323515/Google>,
        <https://1145.am/db/1336111/Google_Llc>,
        <https://1145.am/db/1462007/Google>,
        <https://1145.am/db/1677491/Google>,
        <https://1145.am/db/1695636/Google>,
        <https://1145.am/db/1697158/Google>,
        <https://1145.am/db/1697634/Google>,
        <https://1145.am/db/1700956/Google>,
        <https://1145.am/db/1703059/Google>,
        <https://1145.am/db/1703789/Google>,
        <https://1145.am/db/1704398/Google>,
        <https://1145.am/db/1704767/Google>,
        <https://1145.am/db/1705792/Google>,
        <https://1145.am/db/1706457/Google>,
        <https://1145.am/db/1708232/Google>,
        <https://1145.am/db/1710376/Google>,
        <https://1145.am/db/1717957/Google>,
        <https://1145.am/db/1719418/Google>,
        <https://1145.am/db/1720718/Google>,
        <https://1145.am/db/1724856/Google>,
        <https://1145.am/db/1728038/Google>,
        <https://1145.am/db/1729557/Google>,
        <https://1145.am/db/1730099/Google>,
        <https://1145.am/db/1731064/Google>,
        <https://1145.am/db/1734054/Google>,
        <https://1145.am/db/1736673/Google>,
        <https://1145.am/db/1737025/Google>,
        <https://1145.am/db/1737156/Google>,
        <https://1145.am/db/1738139/Google>,
        <https://1145.am/db/1738867/Google>,
        <https://1145.am/db/1739221/Google>,
        <https://1145.am/db/1739522/Google>,
        <https://1145.am/db/1742225/Google>,
        <https://1145.am/db/1743102/Google>,
        <https://1145.am/db/1744789/Google>,
        <https://1145.am/db/1746725/Google>,
        <https://1145.am/db/1748902/Google>,
        <https://1145.am/db/1748912/Google>,
        <https://1145.am/db/1748945/Google>,
        <https://1145.am/db/1749554/Google>,
        <https://1145.am/db/1751204/Google>,
        <https://1145.am/db/1751390/Google>,
        <https://1145.am/db/1752062/Google>,
        <https://1145.am/db/1755918/Google>,
        <https://1145.am/db/1758222/Google>,
        <https://1145.am/db/1758466/Google>,
        <https://1145.am/db/1758482/Google>,
        <https://1145.am/db/1758684/Google>,
        <https://1145.am/db/1762615/Google>,
        <https://1145.am/db/1767407/Google>,
        <https://1145.am/db/1767820/Google>,
        <https://1145.am/db/1769091/Google>,
        <https://1145.am/db/1769940/Google>,
        <https://1145.am/db/1770726/Google>,
        <https://1145.am/db/1770813/Google>,
        <https://1145.am/db/1772295/Google>,
        <https://1145.am/db/1772305/Google>,
        <https://1145.am/db/1772373/Google>,
        <https://1145.am/db/1772719/Google>,
        <https://1145.am/db/1773437/Google>,
        <https://1145.am/db/1776165/Google>,
        <https://1145.am/db/1776355/Google>,
        <https://1145.am/db/1778164/Google>,
        <https://1145.am/db/1778465/Google>,
        <https://1145.am/db/1779223/Google>,
        <https://1145.am/db/1779285/Google>,
        <https://1145.am/db/1779669/Google>,
        <https://1145.am/db/1780554/Google>,
        <https://1145.am/db/1780932/Google>,
        <https://1145.am/db/1783458/Google>,
        <https://1145.am/db/1786028/Google>,
        <https://1145.am/db/1791967/Google>,
        <https://1145.am/db/1792698/Google>,
        <https://1145.am/db/1792910/Google>,
        <https://1145.am/db/1795057/Google>,
        <https://1145.am/db/1795099/Google>,
        <https://1145.am/db/1795360/Google>,
        <https://1145.am/db/1798124/Google>,
        <https://1145.am/db/1798130/Google>,
        <https://1145.am/db/1799129/Google>,
        <https://1145.am/db/1800114/Google>,
        <https://1145.am/db/1801884/Google>,
        <https://1145.am/db/1802109/Google>,
        <https://1145.am/db/1802418/Google>,
        <https://1145.am/db/1805871/Google>,
        <https://1145.am/db/1808224/Google>,
        <https://1145.am/db/1808959/Google>,
        <https://1145.am/db/1809694/Google>,
        <https://1145.am/db/1811332/Google>,
        <https://1145.am/db/1813540/Google>,
        <https://1145.am/db/1815058/Google>,
        <https://1145.am/db/1815094/Google>,
        <https://1145.am/db/1815217/Google>,
        <https://1145.am/db/181730/Google>,
        <https://1145.am/db/1817588/Google>,
        <https://1145.am/db/1817652/Google>,
        <https://1145.am/db/1818255/Google>,
        <https://1145.am/db/1820065/Google>,
        <https://1145.am/db/1821549/Google>,
        <https://1145.am/db/1822360/Google>,
        <https://1145.am/db/1823609/Google>,
        <https://1145.am/db/1826478/Google>,
        <https://1145.am/db/1826800/Google>,
        <https://1145.am/db/1827824/Google>,
        <https://1145.am/db/1828337/Google>,
        <https://1145.am/db/1829772/Google>,
        <https://1145.am/db/1830114/Google>,
        <https://1145.am/db/1830201/Google>,
        <https://1145.am/db/1831926/Google>,
        <https://1145.am/db/1833042/Google>,
        <https://1145.am/db/1833091/Google>,
        <https://1145.am/db/1834517/Google>,
        <https://1145.am/db/1834744/Google>,
        <https://1145.am/db/1837426/Google>,
        <https://1145.am/db/1837821/Google>,
        <https://1145.am/db/1838256/Google>,
        <https://1145.am/db/1838888/Google>,
        <https://1145.am/db/1839678/Google>,
        <https://1145.am/db/1839704/Google>,
        <https://1145.am/db/1840331/Google>,
        <https://1145.am/db/1840731/Google>,
        <https://1145.am/db/1843250/Google>,
        <https://1145.am/db/1844820/Google>,
        <https://1145.am/db/1846050/Google>,
        <https://1145.am/db/1847479/Google>,
        <https://1145.am/db/1847630/Google>,
        <https://1145.am/db/1847774/Google>,
        <https://1145.am/db/1849179/Google>,
        <https://1145.am/db/1850562/Google>,
        <https://1145.am/db/1851706/Google>,
        <https://1145.am/db/1853307/Google>,
        <https://1145.am/db/1853649/Google>,
        <https://1145.am/db/1857130/Google>,
        <https://1145.am/db/1857572/Google>,
        <https://1145.am/db/1858212/Google>,
        <https://1145.am/db/1858297/Google>,
        <https://1145.am/db/1858590/Google>,
        <https://1145.am/db/1858692/Google>,
        <https://1145.am/db/1858956/Google>,
        <https://1145.am/db/1859504/Google>,
        <https://1145.am/db/1859740/Google>,
        <https://1145.am/db/1859841/Google>,
        <https://1145.am/db/1862377/Google>,
        <https://1145.am/db/1865114/Google>,
        <https://1145.am/db/1865788/Google>,
        <https://1145.am/db/1867553/Google>,
        <https://1145.am/db/1869561/Google>,
        <https://1145.am/db/1871344/Google+>,
        <https://1145.am/db/1871611/Google>,
        <https://1145.am/db/1871915/Google>,
        <https://1145.am/db/1877246/Google>,
        <https://1145.am/db/1877348/Google>,
        <https://1145.am/db/1877354/Google>,
        <https://1145.am/db/1877356/Google>,
        <https://1145.am/db/1877357/Google>,
        <https://1145.am/db/1879028/Google>,
        <https://1145.am/db/1881522/Google>,
        <https://1145.am/db/1881903/Google>,
        <https://1145.am/db/1882463/Google>,
        <https://1145.am/db/1884438/Google>,
        <https://1145.am/db/1884486/Google>,
        <https://1145.am/db/1885182/Google>,
        <https://1145.am/db/1885243/Google>,
        <https://1145.am/db/1886030/Google>,
        <https://1145.am/db/1887769/Google>,
        <https://1145.am/db/1887823/Google>,
        <https://1145.am/db/1887836/Google>,
        <https://1145.am/db/1888284/Google>,
        <https://1145.am/db/1889055/Google>,
        <https://1145.am/db/1889259/Google>,
        <https://1145.am/db/1889867/Google>,
        <https://1145.am/db/1890160/Google>,
        <https://1145.am/db/1890192/Google>,
        <https://1145.am/db/1890424/Google>,
        <https://1145.am/db/1891853/Google>,
        <https://1145.am/db/1892482/Google>,
        <https://1145.am/db/1896336/Google>,
        <https://1145.am/db/1898576/Google>,
        <https://1145.am/db/1899822/Google>,
        <https://1145.am/db/1900317/Google_Inc>,
        <https://1145.am/db/1902108/Google>,
        <https://1145.am/db/1902687/Google>,
        <https://1145.am/db/1907859/Google>,
        <https://1145.am/db/1908799/Google>,
        <https://1145.am/db/1908800/Google>,
        <https://1145.am/db/1909430/Google>,
        <https://1145.am/db/1910432/Google>,
        <https://1145.am/db/1911348/Google>,
        <https://1145.am/db/1915046/Google>,
        <https://1145.am/db/1915624/Google>,
        <https://1145.am/db/1916204/Google>,
        <https://1145.am/db/1917060/Google>,
        <https://1145.am/db/1917642/Google>,
        <https://1145.am/db/1918520/Google>,
        <https://1145.am/db/1923676/Google>,
        <https://1145.am/db/1925079/Google>,
        <https://1145.am/db/1951121/Google>,
        <https://1145.am/db/1953004/Google>,
        <https://1145.am/db/197394/Google>,
        <https://1145.am/db/199411/Google>,
        <https://1145.am/db/2017044/Google>,
        <https://1145.am/db/2052555/Google>,
        <https://1145.am/db/2052989/Google>,
        <https://1145.am/db/2101918/Google>,
        <https://1145.am/db/2157766/Google>,
        <https://1145.am/db/2159950/Google>,
        <https://1145.am/db/2160798/Google>,
        <https://1145.am/db/2162077/Google>,
        <https://1145.am/db/2162792/Google>,
        <https://1145.am/db/2164941/Google>,
        <https://1145.am/db/2168612/Google>,
        <https://1145.am/db/2168633/Google>,
        <https://1145.am/db/2169255/Google>,
        <https://1145.am/db/2169256/Google>,
        <https://1145.am/db/2170078/Google>,
        <https://1145.am/db/2170852/Google>,
        <https://1145.am/db/2172598/Google>,
        <https://1145.am/db/2173392/Google>,
        <https://1145.am/db/2175293/Google>,
        <https://1145.am/db/2175679/Google>,
        <https://1145.am/db/2175906/Google>,
        <https://1145.am/db/2176439/Google>,
        <https://1145.am/db/2177610/Google>,
        <https://1145.am/db/2178519/Google>,
        <https://1145.am/db/2179004/Google>,
        <https://1145.am/db/2182718/Google>,
        <https://1145.am/db/2185365/Google>,
        <https://1145.am/db/2189690/Google>,
        <https://1145.am/db/2191086/Google>,
        <https://1145.am/db/2193606/Google>,
        <https://1145.am/db/2200229/Google>,
        <https://1145.am/db/2272691/Google>,
        <https://1145.am/db/2291187/Google>,
        <https://1145.am/db/2370295/Google>,
        <https://1145.am/db/2422695/Google>,
        <https://1145.am/db/2526804/Google>,
        <https://1145.am/db/2526840/Google>,
        <https://1145.am/db/2529473/Google>,
        <https://1145.am/db/2573984/Google>,
        <https://1145.am/db/2604772/Google>,
        <https://1145.am/db/2604783/Google>,
        <https://1145.am/db/2608334/Google>,
        <https://1145.am/db/2609095/Google>,
        <https://1145.am/db/2625283/Google>,
        <https://1145.am/db/2625598/Google>,
        <https://1145.am/db/2626062/Google>,
        <https://1145.am/db/2627016/Google>,
        <https://1145.am/db/2627999/Google>,
        <https://1145.am/db/2632002/Google>,
        <https://1145.am/db/2632674/Google>,
        <https://1145.am/db/2633301/Google>,
        <https://1145.am/db/2639636/Google>,
        <https://1145.am/db/2641504/Google>,
        <https://1145.am/db/2642235/Google>,
        <https://1145.am/db/2643797/Google>,
        <https://1145.am/db/2643947/Google>,
        <https://1145.am/db/2646085/Google>,
        <https://1145.am/db/2650594/Google>,
        <https://1145.am/db/2650814/Google>,
        <https://1145.am/db/2652107/Google>,
        <https://1145.am/db/2652313/Google>,
        <https://1145.am/db/2652344/Google>,
        <https://1145.am/db/2653149/Google>,
        <https://1145.am/db/2653764/Google>,
        <https://1145.am/db/2654863/Google>,
        <https://1145.am/db/2655692/Google>,
        <https://1145.am/db/2655699/Google>,
        <https://1145.am/db/2657713/Google>,
        <https://1145.am/db/2658031/Google>,
        <https://1145.am/db/2658037/Google>,
        <https://1145.am/db/2658152/Google>,
        <https://1145.am/db/2658673/Google_Inc>,
        <https://1145.am/db/2658696/Google>,
        <https://1145.am/db/2659042/Google>,
        <https://1145.am/db/2659387/Google>,
        <https://1145.am/db/2661233/Google>,
        <https://1145.am/db/2661238/Google>,
        <https://1145.am/db/2661287/Google>,
        <https://1145.am/db/2661289/Google>,
        <https://1145.am/db/2661290/Google>,
        <https://1145.am/db/2661298/Google>,
        <https://1145.am/db/2661302/Google>,
        <https://1145.am/db/2661307/Google>,
        <https://1145.am/db/2661315/Google>,
        <https://1145.am/db/2662204/Google>,
        <https://1145.am/db/2663334/Google>,
        <https://1145.am/db/2663792/Google>,
        <https://1145.am/db/2664557/Google>,
        <https://1145.am/db/2664675/Google>,
        <https://1145.am/db/2664847/Google>,
        <https://1145.am/db/2664986/Google>,
        <https://1145.am/db/2665530/Google>,
        <https://1145.am/db/2665685/Google>,
        <https://1145.am/db/2666538/Google>,
        <https://1145.am/db/2667309/Google>,
        <https://1145.am/db/2667642/Google>,
        <https://1145.am/db/2667768/Google>,
        <https://1145.am/db/2667823/Google>,
        <https://1145.am/db/2670335/Google>,
        <https://1145.am/db/2670351/Google>,
        <https://1145.am/db/2671693/Google>,
        <https://1145.am/db/2672934/Google>,
        <https://1145.am/db/2673032/Google>,
        <https://1145.am/db/2675505/Google>,
        <https://1145.am/db/2675758/Google>,
        <https://1145.am/db/2676995/Google>,
        <https://1145.am/db/2677426/Google>,
        <https://1145.am/db/2677514/Google>,
        <https://1145.am/db/2677517/Google>,
        <https://1145.am/db/2678139/Google>,
        <https://1145.am/db/2678181/Google>,
        <https://1145.am/db/2679166/Google>,
        <https://1145.am/db/2679193/Google>,
        <https://1145.am/db/2682016/Google>,
        <https://1145.am/db/2683123/Google>,
        <https://1145.am/db/2683129/Google>,
        <https://1145.am/db/2683133/Google>,
        <https://1145.am/db/2684336/Google>,
        <https://1145.am/db/2684516/Google>,
        <https://1145.am/db/2684668/Google>,
        <https://1145.am/db/2685515/Google>,
        <https://1145.am/db/2686013/Google>,
        <https://1145.am/db/2686075/Google>,
        <https://1145.am/db/2686285/Google>,
        <https://1145.am/db/2686301/Google>,
        <https://1145.am/db/2686399/Google>,
        <https://1145.am/db/2745983/Google>,
        <https://1145.am/db/2784669/Google>,
        <https://1145.am/db/301432/Google>,
        <https://1145.am/db/303111/Google>,
        <https://1145.am/db/494237/Google>,
        <https://1145.am/db/531962/Google>,
        <https://1145.am/db/587644/Google>,
        <https://1145.am/db/594884/Google_Llc>,
        <https://1145.am/db/608499/Google>,
        <https://1145.am/db/781794/Google>,
        <https://1145.am/db/884422/Google>,
        <https://1145.am/db/884534/Google_Llc>,
        <https://1145.am/db/886026/Google>,
        <https://1145.am/db/886172/Google>,
        <https://1145.am/db/890581/Google>,
        <https://1145.am/db/908751/Google_Llc>,
        <https://1145.am/db/909802/Google_Llc>,
        <https://1145.am/db/94376/Google> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2174887/Series_C_Investment_Admeld_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-11-29T00:10:22+00:00"^^xsd:dateTime ;
    ns1:documentExtract "AdMeld closes $ 15 million Series C funding round.",
        "Google's (Nasdaq: GOOG) acquisition of Admeld, the ad technology platform the search giant ponied up $ 400 million for in June, appears to be on its way to being green lighted by the Department of Justice, which had been looking into possible antitrust violations associated with the deal." ;
    ns1:documentTitle "Google $400M deal for AdMeld likely to get DOJ nod" ;
    ns1:documentURL <https://www.streamtvinsider.com/online-video/google-400m-deal-for-admeld-likely-to-get-doj-nod> ;
    ns1:foundName "acquisition",
        "funding" ;
    ns1:name "acquisition",
        "funding" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2174887/Admeld> ;
    ns1:targetDetails "Series C" ;
    ns1:targetName "AdMeld" ;
    ns1:valueRaw "$ 15 million",
        "$ 400 million" ;
    ns1:whenRaw "June" .

<https://1145.am/db/2211610/Drchrono> a org:Organization ;
    ns1:basedInHighGeoName "Mountain View" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5375480/about.rdf> ;
    ns1:basedInHighRaw "MOUNTAIN VIEW, Calif." ;
    ns1:description "healthcare" ;
    ns1:documentDate "2012-01-26T14:30:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "drchrono Closes New Funding Round Led by Yuri Milner; Google's Matt Cutts Joins as New Investor" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/drchrono-closes-new-funding-round-led-by-yuri-milner-google-s-matt-cutts-joins-as-new-investor-0> ;
    ns1:foundName "drchrono" ;
    ns1:industry "healthcare" ;
    ns1:name "drchrono" ;
    ns1:sameAsHigh <https://1145.am/db/2211653/Drchrono>,
        <https://1145.am/db/2232255/Drchrono>,
        <https://1145.am/db/586689/Drchrono>,
        <https://1145.am/db/636764/Drchrono> ;
    ns1:sameAsMedium <https://1145.am/db/1699204/Drchrono>,
        <https://1145.am/db/1821250/Drchrono>,
        <https://1145.am/db/1876308/Drchrono>,
        <https://1145.am/db/2256897/Drchrono> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2248746/Digital_Assent> a org:Organization ;
    ns1:basedInHighGeoName "Atlanta" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4180439/about.rdf> ;
    ns1:basedInHighRaw "ATLANTA" ;
    ns1:description "Business" ;
    ns1:documentDate "2011-10-14T12:21:09+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Digital Assent Secures $2.5 Million Debt Financing from Silicon Valley Bank" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/digital-assent-secures-2-5-million-debt-financing-from-silicon-valley-bank> ;
    ns1:foundName "Digital Assent" ;
    ns1:industry "Healthcare" ;
    ns1:name "Digital Assent" ;
    ns1:sameAsMedium <https://1145.am/db/2245807/Digital_Assent> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2248746/Silicon_Valley_Bank> a org:Organization ;
    ns1:basedInLowRaw "ATLANTA" ;
    ns1:documentDate "2011-10-14T12:21:09+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Digital Assent Secures $2.5 Million Debt Financing from Silicon Valley Bank" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/digital-assent-secures-2-5-million-debt-financing-from-silicon-valley-bank> ;
    ns1:foundName "Silicon Valley Bank" ;
    ns1:name "Silicon Valley Bank" ;
    ns1:sameAsMedium <https://1145.am/db/1083805/Silicon_Valley_Bank>,
        <https://1145.am/db/1150348/Silicon_Valley_Bank>,
        <https://1145.am/db/1152132/Silicon_Valley_Bank>,
        <https://1145.am/db/1152410/Silicon_Valley_Bank>,
        <https://1145.am/db/1156520/Silicon_Valley_Bank>,
        <https://1145.am/db/1156858/Silicon_Valley_Bank>,
        <https://1145.am/db/1157082/Silicon_Valley_Bank>,
        <https://1145.am/db/1322428/Silicon_Valley_Bank>,
        <https://1145.am/db/1322978/Silicon_Valley_Bank>,
        <https://1145.am/db/1323008/Silicon_Valley_Bank>,
        <https://1145.am/db/1364929/Silicon_Valley_Bank>,
        <https://1145.am/db/1406733/Silicon_Valley_Bank>,
        <https://1145.am/db/1407485/Silicon_Valley_Bank>,
        <https://1145.am/db/1459745/Silicon_Valley_Bank>,
        <https://1145.am/db/1459827/Silicon_Valley_Bank>,
        <https://1145.am/db/1459870/Silicon_Valley_Bank>,
        <https://1145.am/db/1488514/Silicon_Valley_Bank>,
        <https://1145.am/db/1541570/Silicon_Valley_Bank>,
        <https://1145.am/db/1593099/Silicon_Valley_Bank>,
        <https://1145.am/db/1593638/Silicon_Valley_Bank>,
        <https://1145.am/db/1593923/Silicon_Valley_Bank>,
        <https://1145.am/db/1632797/Silicon_Valley_Bank>,
        <https://1145.am/db/1642059/Silicon_Valley_Bank>,
        <https://1145.am/db/1642619/Silicon_Valley_Bank>,
        <https://1145.am/db/1667921/Silicon_Valley_Bank>,
        <https://1145.am/db/1698574/Silicon_Valley_Bank>,
        <https://1145.am/db/1713202/Silicon_Valley_Bank>,
        <https://1145.am/db/1741357/Silicon_Valley_Bank>,
        <https://1145.am/db/1742374/Silicon_Valley_Bank>,
        <https://1145.am/db/1743415/Silicon_Valley_Bank>,
        <https://1145.am/db/1754583/Silicon_Valley_Bank>,
        <https://1145.am/db/1763293/Silicon_Valley_Bank>,
        <https://1145.am/db/1763925/Silicon_Valley_Bank>,
        <https://1145.am/db/1764096/Silicon_Valley_Bank>,
        <https://1145.am/db/1770095/Silicon_Valley_Bank>,
        <https://1145.am/db/1772737/Silicon_Valley_Bank>,
        <https://1145.am/db/1773924/Silicon_Valley_Bank>,
        <https://1145.am/db/1774323/Silicon_Valley_Bank>,
        <https://1145.am/db/1776688/Silicon_Valley_Bank>,
        <https://1145.am/db/1779266/Silicon_Valley_Bank>,
        <https://1145.am/db/1786720/Silicon_Valley_Bank>,
        <https://1145.am/db/1788937/Silicon_Valley_Bank>,
        <https://1145.am/db/1790917/Silicon_Valley_Bank>,
        <https://1145.am/db/1797945/Silicon_Valley_Bank>,
        <https://1145.am/db/1798154/Silicon_Valley_Bank>,
        <https://1145.am/db/1800466/Silicon_Valley_Bank>,
        <https://1145.am/db/1801332/Silicon_Valley_Bank>,
        <https://1145.am/db/1801801/Silicon_Valley_Bank>,
        <https://1145.am/db/1802212/Silicon_Valley_Bank>,
        <https://1145.am/db/1805339/Silicon_Valley_Bank>,
        <https://1145.am/db/1811789/Silicon_Valley_Bank>,
        <https://1145.am/db/1815709/Silicon_Valley_Bank>,
        <https://1145.am/db/1816776/Silicon_Valley_Bank>,
        <https://1145.am/db/1826128/Silicon_Valley_Bank>,
        <https://1145.am/db/1835585/Silicon_Valley_Bank>,
        <https://1145.am/db/1835823/Silicon_Valley_Bank>,
        <https://1145.am/db/1838850/Silicon_Valley_Bank>,
        <https://1145.am/db/1844083/Silicon_Valley_Bank>,
        <https://1145.am/db/1847903/Silicon_Valley_Bank>,
        <https://1145.am/db/1850081/Silicon_Valley_Bank>,
        <https://1145.am/db/1851311/Silicon_Valley_Bank>,
        <https://1145.am/db/1851910/Silicon_Valley_Bank>,
        <https://1145.am/db/1859520/Silicon_Valley_Bank>,
        <https://1145.am/db/1865990/Silicon_Valley_Bank>,
        <https://1145.am/db/1870276/Silicon_Valley_Bank>,
        <https://1145.am/db/1879085/Silicon_Valley_Bank>,
        <https://1145.am/db/1885748/Silicon_Valley_Bank>,
        <https://1145.am/db/1892674/Silicon_Valley_Bank>,
        <https://1145.am/db/1910560/Silicon_Valley_Bank>,
        <https://1145.am/db/1920478/Silicon_Valley_Bank>,
        <https://1145.am/db/1930908/Silicon_Valley_Bank>,
        <https://1145.am/db/1934634/Silicon_Valley_Bank_Uk_Limited>,
        <https://1145.am/db/1934658/Silicon_Valley_Bank>,
        <https://1145.am/db/1934735/Silicon_Valley_Bank>,
        <https://1145.am/db/1934736/Silicon_Valley_Bank>,
        <https://1145.am/db/1934742/Silicon_Valley_Bank_Uk>,
        <https://1145.am/db/1934843/Silicon_Valley_Bank>,
        <https://1145.am/db/1935125/Silicon_Valley_Bank>,
        <https://1145.am/db/1935154/Silicon_Valley_Bank>,
        <https://1145.am/db/1935871/Silicon_Valley_Bank>,
        <https://1145.am/db/1935994/Silicon_Valley_Bank>,
        <https://1145.am/db/1937022/Silicon_Valley_Bank>,
        <https://1145.am/db/1939035/Silicon_Valley_Bank>,
        <https://1145.am/db/1941577/Silicon_Valley_Bank>,
        <https://1145.am/db/1942037/Silicon_Valley_Bank>,
        <https://1145.am/db/1943030/Silicon_Valley_Bank>,
        <https://1145.am/db/1947358/Silicon_Valley_Bank>,
        <https://1145.am/db/1947401/Silicon_Valley_Bank>,
        <https://1145.am/db/1949094/Silicon_Valley_Bank>,
        <https://1145.am/db/1949839/Silicon_Valley_Bank>,
        <https://1145.am/db/1950157/Silicon_Valley_Bank>,
        <https://1145.am/db/1950194/Silicon_Valley_Bank>,
        <https://1145.am/db/1950239/Silicon_Valley_Bank>,
        <https://1145.am/db/1951636/Silicon_Valley_Bank>,
        <https://1145.am/db/1955045/Silicon_Valley_Bank>,
        <https://1145.am/db/2002123/Silicon_Valley_Bank>,
        <https://1145.am/db/2038928/Silicon_Valley_Bank>,
        <https://1145.am/db/2073939/Silicon_Valley_Bank>,
        <https://1145.am/db/2075411/Silicon_Valley_Bank>,
        <https://1145.am/db/2115567/Silicon_Valley_Bank>,
        <https://1145.am/db/2163392/Silicon_Valley_Bank>,
        <https://1145.am/db/2170076/Silicon_Valley_Bank>,
        <https://1145.am/db/2189022/Silicon_Valley_Bank>,
        <https://1145.am/db/2192716/Silicon_Valley_Bank>,
        <https://1145.am/db/2206103/Silicon_Valley_Bank>,
        <https://1145.am/db/2235296/Silicon_Valley_Bank>,
        <https://1145.am/db/2281936/Silicon_Valley_Bank>,
        <https://1145.am/db/2288016/Silicon_Valley_Bank>,
        <https://1145.am/db/2297263/Silicon_Valley_Bank>,
        <https://1145.am/db/2302085/Silicon_Valley_Bank>,
        <https://1145.am/db/2302707/Silicon_Valley_Bank>,
        <https://1145.am/db/2306687/Silicon_Valley_Bank>,
        <https://1145.am/db/2307820/Silicon_Valley_Bank>,
        <https://1145.am/db/2328616/Silicon_Valley_Bank>,
        <https://1145.am/db/2331928/Silicon_Valley_Bank>,
        <https://1145.am/db/2332435/Silicon_Valley_Bank>,
        <https://1145.am/db/2341774/Silicon_Valley_Bank>,
        <https://1145.am/db/2342734/Silicon_Valley_Bank>,
        <https://1145.am/db/2344593/Silicon_Valley_Bank>,
        <https://1145.am/db/2364404/Silicon_Valley_Bank>,
        <https://1145.am/db/2430644/Silicon_Valley_Bank>,
        <https://1145.am/db/2752043/Silicon_Valley_Bank>,
        <https://1145.am/db/2752829/Silicon_Valley_Bank>,
        <https://1145.am/db/366024/Silicon_Valley_Bank>,
        <https://1145.am/db/490152/Silicon_Valley_Bank>,
        <https://1145.am/db/490991/Silicon_Valley_Bank>,
        <https://1145.am/db/563676/Silicon_Valley_Bank>,
        <https://1145.am/db/596524/Silicon_Valley_Bank>,
        <https://1145.am/db/658338/Silicon_Valley_Bank>,
        <https://1145.am/db/714643/Silicon_Valley_Bank>,
        <https://1145.am/db/880050/Silicon_Valley_Bank>,
        <https://1145.am/db/941028/Silicon_Valley_Bank>,
        <https://1145.am/db/980498/Silicon_Valley_Bank>,
        <https://1145.am/db/996844/Silicon_Valley_Bank>,
        <https://1145.am/db/998845/Silicon_Valley_Bank> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2263286/Investment_Anthem_Blue_Cross_Foundation_The_Arthritis_Foundation_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-10-13T18:10:24+00:00"^^xsd:dateTime ;
    ns1:documentExtract "LOS ANGELES, Oct. 13, 2011 /PRNewswire-USNewswire/ - The Arthritis Foundation, Pacific Region, has received a grant from the Anthem Blue Cross Foundation to expand its patient education and evidence - based exercise classes that will reduce the pain and disability of arthritis for thousands of southern California residents." ;
    ns1:documentTitle "Arthritis Foundation and Anthem Blue Cross Foundation Join Forces to Improve Lives of Those with Arthritis" ;
    ns1:documentURL <https://www.fiercehealthcare.com/payer/arthritis-foundation-and-anthem-blue-cross-foundation-join-forces-to-improve-lives-those> ;
    ns1:foundName "grant",
        "received" ;
    ns1:name "grant",
        "received" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2263286/The_Arthritis_Foundation> ;
    ns1:when "2011-10-13T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Oct. 13, 2011" ;
    ns1:whereGeoName "California" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5332921/about.rdf> ;
    ns1:whereRaw "California" .

<https://1145.am/db/2263286/The_Arthritis_Foundation> a org:Organization ;
    ns1:basedInHighGeoName "Los Angeles County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5368381/about.rdf> ;
    ns1:basedInHighRaw "LOS ANGELES" ;
    ns1:description "educating people about arthritis" ;
    ns1:documentDate "2011-10-13T18:10:24+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Arthritis Foundation and Anthem Blue Cross Foundation Join Forces to Improve Lives of Those with Arthritis" ;
    ns1:documentURL <https://www.fiercehealthcare.com/payer/arthritis-foundation-and-anthem-blue-cross-foundation-join-forces-to-improve-lives-those> ;
    ns1:foundName "The Arthritis Foundation, Pacific Region," ;
    ns1:name "The Arthritis Foundation" ;
    ns1:sameAsMedium <https://1145.am/db/2355234/The_Arthritis_Foundation> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2293308/Aeris_Capital_Ag> a org:Organization ;
    ns1:basedInLowRaw "South San Francisco" ;
    ns1:documentDate "2011-09-12T13:49:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Crescendo raises $56M, enters pact with Myriad" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/crescendo-raises-56m-enters-pact-myriad> ;
    ns1:foundName "aeris CAPITAL AG" ;
    ns1:investor <https://1145.am/db/2293308/Crescendo_Series_C_Investment> ;
    ns1:name "aeris CAPITAL AG" ;
    ns1:sameAsMedium <https://1145.am/db/1697327/Aeris_Capital>,
        <https://1145.am/db/1730217/Aeris_Capital>,
        <https://1145.am/db/1856457/Aeris_Capital>,
        <https://1145.am/db/1860817/Aeris_Capital>,
        <https://1145.am/db/2308420/Aeris_Capital>,
        <https://1145.am/db/2308423/Aeris_Capital_Ag>,
        <https://1145.am/db/2308429/Aeris_Capital_Ag>,
        <https://1145.am/db/2326926/Aeris_Capital>,
        <https://1145.am/db/2326935/Aeris_Capital>,
        <https://1145.am/db/2337043/Aeris_Capital>,
        <https://1145.am/db/2349519/Aeris_Capital_Ag>,
        <https://1145.am/db/2360667/Aeris_Capital_Ag>,
        <https://1145.am/db/2575687/Aeris_Capital_Ag> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2293308/Crescendo> a org:Organization ;
    ns1:basedInHighGeoName "South San Francisco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5397765/about.rdf> ;
    ns1:basedInHighRaw "South San Francisco" ;
    ns1:description "autoimmune disorders" ;
    ns1:documentDate "2011-09-12T13:49:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Crescendo raises $56M, enters pact with Myriad" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/crescendo-raises-56m-enters-pact-myriad> ;
    ns1:foundName "Crescendo",
        "Crescendo Bioscience" ;
    ns1:industry "Bioscience" ;
    ns1:name "Crescendo" ;
    ns1:sameAsHigh <https://1145.am/db/2288035/Crescendo> ;
    ns1:sameAsMedium <https://1145.am/db/2297223/Crescendo> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2293308/Mohr_Davidow_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Americans" ;
    ns1:documentDate "2011-09-12T13:49:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Crescendo raises $56M, enters pact with Myriad" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/crescendo-raises-56m-enters-pact-myriad> ;
    ns1:foundName "Mohr Davidow Ventures" ;
    ns1:investor <https://1145.am/db/2293308/Crescendo_Series_C_Investment> ;
    ns1:name "Mohr Davidow Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1704643/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1713745/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1825596/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1846737/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1861044/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1862878/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1866134/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1866492/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1867543/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1872463/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1873191/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1876054/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1880666/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1884011/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1890172/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1890619/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1891777/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1894610/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1906154/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1911282/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1911316/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1915393/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2206261/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2206263/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2292797/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2312700/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2340423/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2340429/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2349519/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2362862/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2635849/Mohr_Davidow_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2293308/Myriad_Genetics> a org:Organization ;
    ns1:basedInLowRaw "Americans" ;
    ns1:buyer <https://1145.am/db/2293308/Crescendo_Series_C_Investment> ;
    ns1:description "oncology, preventative care, urology, dermatology and neuroscience" ;
    ns1:documentDate "2011-09-12T13:49:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Crescendo raises $56M, enters pact with Myriad" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/crescendo-raises-56m-enters-pact-myriad> ;
    ns1:foundName "Myriad",
        "Myriad Genetics" ;
    ns1:investor <https://1145.am/db/2293308/Crescendo_Series_C_Investment> ;
    ns1:name "Myriad",
        "Myriad Genetics" ;
    ns1:sameAsMedium <https://1145.am/db/1461868/Myriad_Genetics>,
        <https://1145.am/db/1463558/Myriad_Genetics>,
        <https://1145.am/db/1591123/Myriad_Genetics>,
        <https://1145.am/db/2288035/Myriad_Genetics>,
        <https://1145.am/db/2294544/Myriad_Genetics>,
        <https://1145.am/db/2296428/Myriad_Genetics>,
        <https://1145.am/db/2296937/Myriad_Genetics>,
        <https://1145.am/db/2296993/Myriad_Genetics>,
        <https://1145.am/db/2315046/Myriad_Genetics>,
        <https://1145.am/db/2320999/Myriad_Genetics>,
        <https://1145.am/db/2332792/Myriad_Genetics>,
        <https://1145.am/db/2332797/Myriad_Genetics>,
        <https://1145.am/db/2337718/Myriad_Genetics>,
        <https://1145.am/db/2340128/Myriad_Genetics>,
        <https://1145.am/db/2349519/Myriad_Genetics>,
        <https://1145.am/db/2360291/Myriad_Genetics>,
        <https://1145.am/db/2361752/Myriad_Genetics>,
        <https://1145.am/db/2370810/Myriad_Genetics_Gmbh>,
        <https://1145.am/db/2538017/Myriad_Genetics>,
        <https://1145.am/db/317075/Myriad_Genetics>,
        <https://1145.am/db/469186/Myriad_Genetics>,
        <https://1145.am/db/470126/Myriad_Genetics>,
        <https://1145.am/db/470228/Myriad_Genetics>,
        <https://1145.am/db/500061/Myriad_Genetics>,
        <https://1145.am/db/697868/Myriad_Genetics>,
        <https://1145.am/db/737295/Myriad_Genetics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2293793/Biostar_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Palo Alto, CA" ;
    ns1:documentDate "2011-10-04T16:34:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NEA leads $16M round for drug-eluting balloon firm" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nea-leads-16m-round-for-drug-eluting-balloon-firm> ;
    ns1:foundName "BioStar Ventures" ;
    ns1:industry "medical devices" ;
    ns1:investor <https://1145.am/db/2293793/Series_B_Investment_Biostar_Ventures_New_Enterprise_Associates_Synergy_Ventures_Western_Technology_Completed> ;
    ns1:name "BioStar Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2042773/Highpoint_Ventures>,
        <https://1145.am/db/2292554/Ascension_Ventures>,
        <https://1145.am/db/2292554/Delphi_Ventures>,
        <https://1145.am/db/634706/Femhealth_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2154438/Biostar_Ventures>,
        <https://1145.am/db/2292772/Biostar_Ventures>,
        <https://1145.am/db/2293913/Biostar_Ventures>,
        <https://1145.am/db/2297471/Biostar_Ventures>,
        <https://1145.am/db/2297644/Biostar_Ventures>,
        <https://1145.am/db/2299852/Biostar_Ventures>,
        <https://1145.am/db/2316203/Biostar_Ventures>,
        <https://1145.am/db/2334481/Biostar_Ventures>,
        <https://1145.am/db/2355754/Biostar_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2293793/Synergy_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Palo Alto, CA" ;
    ns1:documentDate "2011-10-04T16:34:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NEA leads $16M round for drug-eluting balloon firm" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nea-leads-16m-round-for-drug-eluting-balloon-firm> ;
    ns1:foundName "Synergy Ventures" ;
    ns1:industry "medical devices" ;
    ns1:investor <https://1145.am/db/2293793/Series_B_Investment_Biostar_Ventures_New_Enterprise_Associates_Synergy_Ventures_Western_Technology_Completed> ;
    ns1:name "Synergy Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2295253/Synergy_Ventures>,
        <https://1145.am/db/2355754/Synergy_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2293793/Western_Technology> a org:Organization ;
    ns1:basedInLowRaw "Palo Alto, CA" ;
    ns1:description "life sciences start-ups" ;
    ns1:documentDate "2011-10-04T16:34:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NEA leads $16M round for drug-eluting balloon firm" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nea-leads-16m-round-for-drug-eluting-balloon-firm> ;
    ns1:foundName "Western",
        "Western Technology" ;
    ns1:industry "medical devices" ;
    ns1:investor <https://1145.am/db/2293793/Series_B_Investment_Biostar_Ventures_New_Enterprise_Associates_Synergy_Ventures_Western_Technology_Completed>,
        <https://1145.am/db/2293793/Series_B_Investment_Cv_Ingenuity_New_Enterprise_Associates_Western_Technology_Completed> ;
    ns1:name "Western Technology" ;
    ns1:sameAsHigh <https://1145.am/db/1003515/Outset_Medical>,
        <https://1145.am/db/1004668/Outset_Medical>,
        <https://1145.am/db/1007780/Medcura>,
        <https://1145.am/db/1031632/Conmed_Corporation>,
        <https://1145.am/db/1032156/Conmed_Corporation>,
        <https://1145.am/db/1045011/Ir-Med>,
        <https://1145.am/db/1053242/Ir-Med>,
        <https://1145.am/db/1101839/Innovative_Medtech>,
        <https://1145.am/db/1130082/Conmed_Corporation>,
        <https://1145.am/db/1131920/Conmed_Corporation>,
        <https://1145.am/db/1155018/Medtronic_Plc>,
        <https://1145.am/db/1200158/The_Mediliant_Group>,
        <https://1145.am/db/1200432/Medtronic>,
        <https://1145.am/db/1232303/Medo>,
        <https://1145.am/db/1245151/Conmed_Corporation>,
        <https://1145.am/db/1246123/Conmed_Corporation>,
        <https://1145.am/db/1267851/Conmed_Corporation>,
        <https://1145.am/db/1269755/Conmed_Corporation>,
        <https://1145.am/db/1281079/Advent_Life_Sciences>,
        <https://1145.am/db/1281647/Advent_Life_Sciences>,
        <https://1145.am/db/1300497/Medtronic_Plc>,
        <https://1145.am/db/1329353/Medcura>,
        <https://1145.am/db/1346998/Medcura_Inc>,
        <https://1145.am/db/1468209/Confluent_Medical_Technologies>,
        <https://1145.am/db/1476020/Outset_Medical>,
        <https://1145.am/db/1476484/Outset_Medical>,
        <https://1145.am/db/1502825/Advanced_Medtech>,
        <https://1145.am/db/1508320/Ir-Med>,
        <https://1145.am/db/1524232/Corit_Medical>,
        <https://1145.am/db/1540248/Biodex>,
        <https://1145.am/db/1542935/Biodex>,
        <https://1145.am/db/1549714/Micromed>,
        <https://1145.am/db/1558876/Medtech>,
        <https://1145.am/db/1561915/Science_Corporation>,
        <https://1145.am/db/1598651/Man___Science>,
        <https://1145.am/db/159960/Viamed>,
        <https://1145.am/db/1628474/Memry_Corporation>,
        <https://1145.am/db/1650880/Micromed>,
        <https://1145.am/db/177462/Novelcath>,
        <https://1145.am/db/1818814/Resmed>,
        <https://1145.am/db/1831222/Company>,
        <https://1145.am/db/1831222/Medtronic>,
        <https://1145.am/db/1850347/Ihear_Medical>,
        <https://1145.am/db/1929261/Intraop_Medical>,
        <https://1145.am/db/1963100/Intraop_Medical>,
        <https://1145.am/db/1975195/Medshift>,
        <https://1145.am/db/2025992/Biocorp>,
        <https://1145.am/db/2028146/Biocorp>,
        <https://1145.am/db/2050177/Linear_Health_Sciences>,
        <https://1145.am/db/2068105/Vantive>,
        <https://1145.am/db/2082305/Ap_Technologies>,
        <https://1145.am/db/2125458/Intech>,
        <https://1145.am/db/2130564/Medtronic>,
        <https://1145.am/db/2134381/Insulet_Corp>,
        <https://1145.am/db/2153916/Ethicon>,
        <https://1145.am/db/2186148/Resmed>,
        <https://1145.am/db/2235188/Tangent_Medical_Technologies>,
        <https://1145.am/db/2237051/Medegen>,
        <https://1145.am/db/2237639/Atricure>,
        <https://1145.am/db/2245385/Atricure>,
        <https://1145.am/db/2249557/Theragenics_Corporation>,
        <https://1145.am/db/2280189/Mitech>,
        <https://1145.am/db/2280691/Mitech>,
        <https://1145.am/db/2280691/The_Medtech>,
        <https://1145.am/db/2283901/Mitech>,
        <https://1145.am/db/2288215/D_Medical_Industries>,
        <https://1145.am/db/2288237/Bioimagene>,
        <https://1145.am/db/2288665/Medtronic>,
        <https://1145.am/db/2288707/Medtronic>,
        <https://1145.am/db/2289043/Medtronic>,
        <https://1145.am/db/2289074/Medtronic>,
        <https://1145.am/db/2289766/Medtronic>,
        <https://1145.am/db/2289962/Medicel>,
        <https://1145.am/db/2290861/Medtronic>,
        <https://1145.am/db/2291044/Medtronic>,
        <https://1145.am/db/2291361/Novate_Medical>,
        <https://1145.am/db/2291384/Advance_Medical>,
        <https://1145.am/db/2291586/Medtronic>,
        <https://1145.am/db/2292310/Resmed>,
        <https://1145.am/db/2292788/R___d>,
        <https://1145.am/db/2294126/Medtech>,
        <https://1145.am/db/2294509/Medventure_Technology>,
        <https://1145.am/db/2294917/Medtronic>,
        <https://1145.am/db/2295850/Medtronic>,
        <https://1145.am/db/2296826/Medtronic>,
        <https://1145.am/db/2297382/Insulet>,
        <https://1145.am/db/2299022/Personal_Medical_Corp>,
        <https://1145.am/db/2299765/Medtronic>,
        <https://1145.am/db/2299822/Medihoney>,
        <https://1145.am/db/2300270/Smart_Medical>,
        <https://1145.am/db/2300312/Biocontrol_Medical>,
        <https://1145.am/db/2300312/Medtronic>,
        <https://1145.am/db/2300380/Biomet>,
        <https://1145.am/db/2300658/Biomet>,
        <https://1145.am/db/2306488/Medpace>,
        <https://1145.am/db/2310099/Accumetrics_Inc>,
        <https://1145.am/db/2310670/Medtronic>,
        <https://1145.am/db/2312880/Medtronic>,
        <https://1145.am/db/2312881/Medtronic>,
        <https://1145.am/db/2316165/Oculeve>,
        <https://1145.am/db/2316276/Stat-Tech_Services>,
        <https://1145.am/db/2316278/Stat-Tech>,
        <https://1145.am/db/2320652/Medvance>,
        <https://1145.am/db/2321690/Medtronic>,
        <https://1145.am/db/2325955/Medtronic>,
        <https://1145.am/db/2331034/Biopure_Corporation>,
        <https://1145.am/db/2331820/Medtronic>,
        <https://1145.am/db/2334498/Medtronic>,
        <https://1145.am/db/2334992/Medtronic>,
        <https://1145.am/db/2341458/Allied_Medical>,
        <https://1145.am/db/2341975/Biosig_Technologies>,
        <https://1145.am/db/2347721/Medtronic>,
        <https://1145.am/db/2353380/Biosig_Technologies>,
        <https://1145.am/db/2354369/Biosig_Technologies>,
        <https://1145.am/db/2357855/Medtronic_Inc>,
        <https://1145.am/db/2360229/Insulet_Corporation>,
        <https://1145.am/db/2367947/Insulet_Corporation>,
        <https://1145.am/db/2368049/Oculeve>,
        <https://1145.am/db/2369055/Enteromedics_Inc>,
        <https://1145.am/db/2369615/Enteromedics_Inc>,
        <https://1145.am/db/2449267/Remon_Medical_Technologies>,
        <https://1145.am/db/2537878/Curative_Medical>,
        <https://1145.am/db/2543285/Medisize>,
        <https://1145.am/db/2545058/Medtronic>,
        <https://1145.am/db/2547647/Medtronic>,
        <https://1145.am/db/2550471/Biomet>,
        <https://1145.am/db/2557857/Ethicon>,
        <https://1145.am/db/2561147/Clinical_Technologies>,
        <https://1145.am/db/2581261/Medtronic>,
        <https://1145.am/db/299821/Medshift>,
        <https://1145.am/db/373153/Mediliant>,
        <https://1145.am/db/391758/Medtronic>,
        <https://1145.am/db/396349/Medtronic_Plc>,
        <https://1145.am/db/448129/Medtronic>,
        <https://1145.am/db/479135/Bioadvance>,
        <https://1145.am/db/505327/Bioderm>,
        <https://1145.am/db/581849/Medshift>,
        <https://1145.am/db/665829/Mirion_Technologies>,
        <https://1145.am/db/734291/Confluent_Medical_Technologies>,
        <https://1145.am/db/753945/Iimed_Medical_Solutions>,
        <https://1145.am/db/765096/Augmedics>,
        <https://1145.am/db/765718/Augmedics>,
        <https://1145.am/db/783746/Medtronic>,
        <https://1145.am/db/786503/Medtronic>,
        <https://1145.am/db/835962/Outset_Medical>,
        <https://1145.am/db/838605/Outset_Medical>,
        <https://1145.am/db/866877/Rapid_Medical>,
        <https://1145.am/db/868928/Rapid_Medical>,
        <https://1145.am/db/890737/Memic>,
        <https://1145.am/db/904175/Augmedics>,
        <https://1145.am/db/905271/Augmedics>,
        <https://1145.am/db/938561/Channel_Medsystems>,
        <https://1145.am/db/941561/Channel_Medsystems>,
        <https://1145.am/db/944174/Medshift>,
        <https://1145.am/db/959747/Nonin_Medical>,
        <https://1145.am/db/960265/Bioventus>,
        <https://1145.am/db/994232/LTD> ;
    ns1:sameAsMedium <https://1145.am/db/2355754/Western_Technology> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2294263/Astrazeneca> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:documentDate "2011-10-24T14:06:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Nobel Biocare rises on buyout talks" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nobel-biocare-rises-buyout-talks> ;
    ns1:foundName "Astra Tech" ;
    ns1:name "AstraZeneca" ;
    ns1:sameAsMedium <https://1145.am/db/1180597/Astrazeneca>,
        <https://1145.am/db/1241325/Astrazeneca>,
        <https://1145.am/db/1392122/Astrazeneca>,
        <https://1145.am/db/1536697/Astrazeneca>,
        <https://1145.am/db/1539672/Astrazeneca>,
        <https://1145.am/db/1627652/Astrazeneca>,
        <https://1145.am/db/1633177/Astrazeneca>,
        <https://1145.am/db/171176/Astrazeneca>,
        <https://1145.am/db/172070/Astrazeneca>,
        <https://1145.am/db/173169/Astrazeneca>,
        <https://1145.am/db/2041475/Astrazeneca>,
        <https://1145.am/db/2071435/Astrazeneca>,
        <https://1145.am/db/2151794/Astrazeneca>,
        <https://1145.am/db/2154218/Astrazeneca>,
        <https://1145.am/db/2201236/Astrazeneca>,
        <https://1145.am/db/2278880/Astrazeneca>,
        <https://1145.am/db/2279647/Astrazeneca>,
        <https://1145.am/db/2280289/Astrazeneca>,
        <https://1145.am/db/2280668/Astrazeneca>,
        <https://1145.am/db/2282580/Astrazeneca>,
        <https://1145.am/db/2282916/Astrazeneca>,
        <https://1145.am/db/2282957/Astrazeneca>,
        <https://1145.am/db/2283156/Astrazeneca>,
        <https://1145.am/db/2283309/Astrazeneca>,
        <https://1145.am/db/2284338/Astrazeneca>,
        <https://1145.am/db/2285828/Astrazeneca>,
        <https://1145.am/db/2287488/Astrazeneca>,
        <https://1145.am/db/2290060/Astrazeneca>,
        <https://1145.am/db/2290860/Astrazeneca>,
        <https://1145.am/db/2291860/Astrazeneca>,
        <https://1145.am/db/2293132/Astrazeneca>,
        <https://1145.am/db/2296196/Astrazeneca>,
        <https://1145.am/db/2299349/Astrazeneca>,
        <https://1145.am/db/2303920/Astrazeneca>,
        <https://1145.am/db/2305152/Astrazeneca>,
        <https://1145.am/db/2305155/Astrazeneca>,
        <https://1145.am/db/2305826/Astrazeneca>,
        <https://1145.am/db/2305866/Astrazeneca>,
        <https://1145.am/db/2306905/Astrazeneca>,
        <https://1145.am/db/2307059/Astrazeneca>,
        <https://1145.am/db/2307068/Astrazeneca>,
        <https://1145.am/db/2307834/Astrazeneca>,
        <https://1145.am/db/2307913/Astrazeneca>,
        <https://1145.am/db/2309183/Astrazeneca>,
        <https://1145.am/db/2312476/Astrazeneca>,
        <https://1145.am/db/2315716/Astrazeneca>,
        <https://1145.am/db/2316364/Astrazeneca>,
        <https://1145.am/db/2318484/Astrazeneca>,
        <https://1145.am/db/2318485/Astrazeneca>,
        <https://1145.am/db/2318609/Astrazeneca>,
        <https://1145.am/db/2319675/Astrazeneca>,
        <https://1145.am/db/2329585/Astrazeneca>,
        <https://1145.am/db/2331622/Astrazeneca>,
        <https://1145.am/db/2334131/Astrazeneca>,
        <https://1145.am/db/2335286/Astrazeneca>,
        <https://1145.am/db/2335717/Astrazeneca>,
        <https://1145.am/db/2336050/Astrazeneca>,
        <https://1145.am/db/2339206/Astrazeneca>,
        <https://1145.am/db/2340097/Astrazeneca>,
        <https://1145.am/db/2342213/Astrazeneca>,
        <https://1145.am/db/2342722/Astrazeneca>,
        <https://1145.am/db/2343632/Astrazeneca>,
        <https://1145.am/db/2343892/Astrazeneca>,
        <https://1145.am/db/2343913/Astrazeneca>,
        <https://1145.am/db/2343920/Astrazeneca>,
        <https://1145.am/db/2344057/Astrazeneca>,
        <https://1145.am/db/2345187/Astrazeneca>,
        <https://1145.am/db/2345426/Astrazeneca>,
        <https://1145.am/db/2345983/Astrazeneca>,
        <https://1145.am/db/2345996/Astrazeneca>,
        <https://1145.am/db/2347800/Astrazeneca>,
        <https://1145.am/db/2347970/Astrazeneca>,
        <https://1145.am/db/2347971/Astrazeneca>,
        <https://1145.am/db/2352067/Astrazeneca>,
        <https://1145.am/db/2352525/Astrazeneca>,
        <https://1145.am/db/2352532/Astrazeneca>,
        <https://1145.am/db/2352716/Astrazeneca>,
        <https://1145.am/db/2353153/Astrazeneca>,
        <https://1145.am/db/2353550/Astrazeneca>,
        <https://1145.am/db/2353551/Astrazeneca>,
        <https://1145.am/db/2353753/Astrazeneca>,
        <https://1145.am/db/2354112/Astrazeneca>,
        <https://1145.am/db/2354774/Astrazeneca>,
        <https://1145.am/db/2354978/Astrazeneca>,
        <https://1145.am/db/2354998/Astrazeneca>,
        <https://1145.am/db/2355029/Astrazeneca>,
        <https://1145.am/db/2356098/Astrazeneca>,
        <https://1145.am/db/2356384/Astrazeneca>,
        <https://1145.am/db/2357230/Astrazeneca>,
        <https://1145.am/db/2358228/Astrazeneca>,
        <https://1145.am/db/2358768/Astrazeneca>,
        <https://1145.am/db/2359437/Astrazeneca>,
        <https://1145.am/db/2359439/Astrazeneca>,
        <https://1145.am/db/2359539/Astrazeneca>,
        <https://1145.am/db/2360237/Astrazeneca>,
        <https://1145.am/db/2360562/Astrazeneca>,
        <https://1145.am/db/2360683/Astrazeneca>,
        <https://1145.am/db/2362667/Astrazeneca>,
        <https://1145.am/db/2362670/Astrazeneca>,
        <https://1145.am/db/2362966/Astrazeneca>,
        <https://1145.am/db/2363405/Astrazeneca>,
        <https://1145.am/db/2364805/Astrazeneca>,
        <https://1145.am/db/2365403/Astrazeneca>,
        <https://1145.am/db/2367645/Astrazeneca>,
        <https://1145.am/db/2367646/Astrazeneca>,
        <https://1145.am/db/2368632/Astrazeneca>,
        <https://1145.am/db/2368742/Astrazeneca>,
        <https://1145.am/db/2368900/Astrazeneca>,
        <https://1145.am/db/2369491/Astrazeneca>,
        <https://1145.am/db/2369493/Astrazeneca>,
        <https://1145.am/db/2369607/Astrazeneca>,
        <https://1145.am/db/2370174/Astrazeneca>,
        <https://1145.am/db/2370175/Astrazeneca>,
        <https://1145.am/db/2371094/Astrazeneca>,
        <https://1145.am/db/252780/Astrazeneca>,
        <https://1145.am/db/2537410/Astrazeneca>,
        <https://1145.am/db/2538238/Astrazeneca>,
        <https://1145.am/db/2538239/Astrazeneca>,
        <https://1145.am/db/2538821/Astrazeneca>,
        <https://1145.am/db/2539508/Astrazeneca>,
        <https://1145.am/db/2539509/Astrazeneca>,
        <https://1145.am/db/2539517/Astrazeneca>,
        <https://1145.am/db/2539787/Astrazeneca>,
        <https://1145.am/db/2540845/Astrazeneca>,
        <https://1145.am/db/2544077/Astrazeneca>,
        <https://1145.am/db/2544536/Astrazeneca>,
        <https://1145.am/db/2544701/Astrazeneca>,
        <https://1145.am/db/2545023/Astrazeneca>,
        <https://1145.am/db/2545184/Astrazeneca>,
        <https://1145.am/db/2545426/Astrazeneca>,
        <https://1145.am/db/2545769/Astrazeneca>,
        <https://1145.am/db/2546143/Astrazeneca>,
        <https://1145.am/db/2546314/Astrazeneca>,
        <https://1145.am/db/2547386/Astrazeneca>,
        <https://1145.am/db/2547785/Astrazeneca>,
        <https://1145.am/db/2548384/Astrazeneca>,
        <https://1145.am/db/2549890/Astrazeneca>,
        <https://1145.am/db/2550962/Astrazeneca>,
        <https://1145.am/db/2553162/Astrazeneca>,
        <https://1145.am/db/2553168/Astrazeneca>,
        <https://1145.am/db/2554064/Astrazeneca>,
        <https://1145.am/db/2554571/Astrazeneca>,
        <https://1145.am/db/2554933/Astrazeneca>,
        <https://1145.am/db/2555141/Astrazeneca>,
        <https://1145.am/db/2555142/Astrazeneca>,
        <https://1145.am/db/2556522/Astrazeneca>,
        <https://1145.am/db/2556536/Astrazeneca>,
        <https://1145.am/db/2556928/Astrazeneca>,
        <https://1145.am/db/2557406/Astrazeneca>,
        <https://1145.am/db/2558118/Astrazeneca>,
        <https://1145.am/db/2559469/Astrazeneca>,
        <https://1145.am/db/2559649/Astrazeneca>,
        <https://1145.am/db/2561319/Astrazeneca>,
        <https://1145.am/db/2562249/Astrazeneca>,
        <https://1145.am/db/2562728/Astrazeneca>,
        <https://1145.am/db/2564897/Astrazeneca>,
        <https://1145.am/db/2565399/Astrazeneca>,
        <https://1145.am/db/2565682/Astrazeneca>,
        <https://1145.am/db/2565951/Astrazeneca>,
        <https://1145.am/db/2566037/Astrazeneca>,
        <https://1145.am/db/2566415/Astrazeneca>,
        <https://1145.am/db/2566926/Astrazeneca>,
        <https://1145.am/db/2566929/Astrazeneca>,
        <https://1145.am/db/2567518/Astrazeneca>,
        <https://1145.am/db/2568895/Astrazeneca>,
        <https://1145.am/db/2569075/Astrazeneca_Plc>,
        <https://1145.am/db/2569709/Astrazeneca>,
        <https://1145.am/db/2570586/Astrazeneca>,
        <https://1145.am/db/2570592/Astrazeneca>,
        <https://1145.am/db/257192/Astrazeneca_Plc>,
        <https://1145.am/db/2572938/Astrazeneca>,
        <https://1145.am/db/2573463/Astrazeneca>,
        <https://1145.am/db/2573978/Astrazeneca>,
        <https://1145.am/db/2573984/Astrazeneca>,
        <https://1145.am/db/2574096/Astrazeneca>,
        <https://1145.am/db/2575176/Astrazeneca>,
        <https://1145.am/db/2575183/Astrazeneca>,
        <https://1145.am/db/2575269/Astrazeneca>,
        <https://1145.am/db/2575270/Astrazeneca>,
        <https://1145.am/db/257625/Astrazeneca_Plc>,
        <https://1145.am/db/2577797/Astrazeneca>,
        <https://1145.am/db/2578213/Astrazeneca>,
        <https://1145.am/db/2578454/Astrazeneca>,
        <https://1145.am/db/2579507/Astrazeneca>,
        <https://1145.am/db/2579630/Astrazeneca>,
        <https://1145.am/db/2580038/Astrazeneca>,
        <https://1145.am/db/2580053/Astrazeneca>,
        <https://1145.am/db/2580491/Astrazeneca>,
        <https://1145.am/db/2580556/Astrazeneca>,
        <https://1145.am/db/2580632/Astrazeneca>,
        <https://1145.am/db/2580642/Astrazeneca>,
        <https://1145.am/db/2582242/Astrazeneca>,
        <https://1145.am/db/2582823/Astrazeneca>,
        <https://1145.am/db/2582826/Astrazeneca>,
        <https://1145.am/db/2583124/Astrazeneca>,
        <https://1145.am/db/2585819/Astrazeneca>,
        <https://1145.am/db/2586257/Astrazeneca>,
        <https://1145.am/db/2587500/Astrazeneca>,
        <https://1145.am/db/2588049/Astrazeneca>,
        <https://1145.am/db/2588089/Astrazeneca>,
        <https://1145.am/db/2588660/Astrazeneca>,
        <https://1145.am/db/2590009/Astrazeneca>,
        <https://1145.am/db/2591384/Astrazeneca>,
        <https://1145.am/db/2591652/Astrazeneca>,
        <https://1145.am/db/2591691/Astrazeneca>,
        <https://1145.am/db/2592696/Astrazeneca>,
        <https://1145.am/db/2593265/Astrazeneca>,
        <https://1145.am/db/2594107/Astrazeneca>,
        <https://1145.am/db/2594365/Astrazeneca>,
        <https://1145.am/db/2595981/Astrazeneca>,
        <https://1145.am/db/2596046/Astrazeneca>,
        <https://1145.am/db/2596053/Astrazeneca>,
        <https://1145.am/db/2597175/Astrazeneca>,
        <https://1145.am/db/2598202/Astrazeneca>,
        <https://1145.am/db/2789987/Astrazeneca>,
        <https://1145.am/db/340451/Astrazeneca>,
        <https://1145.am/db/340474/Astrazeneca>,
        <https://1145.am/db/347044/Astrazeneca>,
        <https://1145.am/db/376382/Astrazeneca>,
        <https://1145.am/db/381681/Astrazeneca_Plc>,
        <https://1145.am/db/488413/Astrazeneca>,
        <https://1145.am/db/510316/Astrazeneca>,
        <https://1145.am/db/624169/Astrazeneca> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2294263/Astrazeneca_Unit_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-10-24T14:06:06+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Over the summer, Dentsply emerged as the winner in the bid to buy AstraZeneca's ($ AZN) Astra Tech unit." ;
    ns1:documentTitle "Nobel Biocare rises on buyout talks" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nobel-biocare-rises-buyout-talks> ;
    ns1:foundName "buy" ;
    ns1:name "buy" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2294263/Astrazeneca> ;
    ns1:targetDetails "unit" ;
    ns1:targetName "AstraZeneca" .

<https://1145.am/db/2294263/Nobel_Biocare> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:documentDate "2011-10-24T14:06:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Nobel Biocare rises on buyout talks" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nobel-biocare-rises-buyout-talks> ;
    ns1:foundName "Nobel Biocare" ;
    ns1:industry "Dental-implant maker" ;
    ns1:name "Nobel Biocare" ;
    ns1:sameAsHigh <https://1145.am/db/1582951/Biotech_Dental_Sas>,
        <https://1145.am/db/1585720/Biotech_Dental_Sas>,
        <https://1145.am/db/1962754/Biotech_Dental_Sas>,
        <https://1145.am/db/2291073/Nobel_Biocare>,
        <https://1145.am/db/2291391/Nobel_Biocare>,
        <https://1145.am/db/2292497/Nobel_Biocare>,
        <https://1145.am/db/2311846/Biomet> ;
    ns1:sameAsMedium <https://1145.am/db/2290619/Nobel_Biocare>,
        <https://1145.am/db/2292295/Nobel_Biocare> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2295691/Clear_Catheter_Systems> a org:Organization ;
    ns1:basedInLowRaw "U.S." ;
    ns1:documentDate "2012-01-04T12:39:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Clear Catheter nabs $4M in first round of financing; Uptake raises $35M to develop emphysema tech;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/clear-catheter-nabs-4m-first-round-financing-uptake-raises-35m-to-develop-emphysema> ;
    ns1:foundName "Clear Catheter Systems" ;
    ns1:name "Clear Catheter Systems" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2295691/Icad> a org:Organization ;
    ns1:description "advanced image analysis, work flow solutions and radiation therapy for the early identification and treatment of cancer" ;
    ns1:documentDate "2012-01-04T12:39:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Clear Catheter nabs $4M in first round of financing; Uptake raises $35M to develop emphysema tech;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/clear-catheter-nabs-4m-first-round-financing-uptake-raises-35m-to-develop-emphysema> ;
    ns1:foundName "iCAD" ;
    ns1:industry "medical device technologies" ;
    ns1:name "iCAD" ;
    ns1:sameAsHigh <https://1145.am/db/1639822/Icad>,
        <https://1145.am/db/678002/Icad> ;
    ns1:sameAsMedium <https://1145.am/db/2239059/Icad> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2295691/Uptake_Medical> a org:Organization ;
    ns1:description "developing new medical device technologies" ;
    ns1:documentDate "2012-01-04T12:39:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Clear Catheter nabs $4M in first round of financing; Uptake raises $35M to develop emphysema tech;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/clear-catheter-nabs-4m-first-round-financing-uptake-raises-35m-to-develop-emphysema> ;
    ns1:foundName "Uptake Medical" ;
    ns1:industry "medical device" ;
    ns1:name "Uptake Medical" ;
    ns1:sameAsHigh <https://1145.am/db/2300724/Uptake_Medical> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2296631/Investment_Organovo_Organovo_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-14T20:59:32+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Organovo Holdings has completed a merger with Organovo, a company focused on the development of 3-D bioprinting technology for research and medical applications." ;
    ns1:documentTitle "Hill-Rom completes $85M Volker buy; Neuros picks up RiverVest Venture Partners as investor;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/hill-rom-completes-85m-volker-buy-neuros-picks-up-rivervest-venture-partners-as> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "U.K." .

<https://1145.am/db/2296631/Investment_Oxford_Immunotec_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-14T20:59:32+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> U.K. diagnostics company Oxford Immunotec wants to put its first U.S. location outside of its Massachusetts headquarters in Memphis." ;
    ns1:documentTitle "Hill-Rom completes $85M Volker buy; Neuros picks up RiverVest Venture Partners as investor;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/hill-rom-completes-85m-volker-buy-neuros-picks-up-rivervest-venture-partners-as> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "U.K." .

<https://1145.am/db/2296631/Investment_Zonare_Medical_Systems_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-14T20:59:32+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> ZONARE Medical Systems has promoted Timothy Marcotte, tapping him as its president and CEO." ;
    ns1:documentTitle "Hill-Rom completes $85M Volker buy; Neuros picks up RiverVest Venture Partners as investor;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/hill-rom-completes-85m-volker-buy-neuros-picks-up-rivervest-venture-partners-as> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "U.K." .

<https://1145.am/db/2296631/Merger_Organovo_Organovo_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "merger" ;
    ns1:documentDate "2012-02-14T20:59:32+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Organovo Holdings has completed a merger with Organovo, a company focused on the development of 3-D bioprinting technology for research and medical applications." ;
    ns1:documentTitle "Hill-Rom completes $85M Volker buy; Neuros picks up RiverVest Venture Partners as investor;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/hill-rom-completes-85m-volker-buy-neuros-picks-up-rivervest-venture-partners-as> ;
    ns1:foundName "merger" ;
    ns1:name "merger" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "U.K." .

<https://1145.am/db/2296631/Neuros_Medical> a org:Organization ;
    ns1:description "medical" ;
    ns1:documentDate "2012-02-14T20:59:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Hill-Rom completes $85M Volker buy; Neuros picks up RiverVest Venture Partners as investor;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/hill-rom-completes-85m-volker-buy-neuros-picks-up-rivervest-venture-partners-as> ;
    ns1:foundName "Neuros Medical" ;
    ns1:industry "medical" ;
    ns1:name "Neuros Medical" ;
    ns1:sameAsHigh <https://1145.am/db/2295615/Neuros_Medical>,
        <https://1145.am/db/2297118/Neurodyne_Medical> ;
    ns1:sameAsMedium <https://1145.am/db/2242430/Neuros_Medical> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2296631/Rivervest_Venture_Partners> a org:Organization ;
    ns1:documentDate "2012-02-14T20:59:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Hill-Rom completes $85M Volker buy; Neuros picks up RiverVest Venture Partners as investor;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/hill-rom-completes-85m-volker-buy-neuros-picks-up-rivervest-venture-partners-as> ;
    ns1:foundName "RiverVest Venture Partners" ;
    ns1:name "RiverVest Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1283038/Rivervest_Venture_Partners>,
        <https://1145.am/db/1669813/Rivervest_Venture_Partners>,
        <https://1145.am/db/2155730/Rivervest_Venture_Partners>,
        <https://1145.am/db/2286035/Rivervest_Venture_Partners>,
        <https://1145.am/db/2288553/Rivervest_Venture_Partners>,
        <https://1145.am/db/2294113/Rivervest_Venture_Partners>,
        <https://1145.am/db/2294893/Rivervest_Venture_Partners>,
        <https://1145.am/db/2299423/Rivervest_Venture_Partners>,
        <https://1145.am/db/2329550/Rivervest_Venture_Partners>,
        <https://1145.am/db/2336221/Rivervest_Venture_Partners>,
        <https://1145.am/db/2337106/Rivervest_Venture_Partners>,
        <https://1145.am/db/2340887/Rivervest_Venture_Partners>,
        <https://1145.am/db/2350044/Rivervest_Venture_Partners>,
        <https://1145.am/db/2354899/Rivervest_Venture_Partners>,
        <https://1145.am/db/2355274/Rivervest_Venture_Partners>,
        <https://1145.am/db/2356216/Rivervest_Venture_Partners>,
        <https://1145.am/db/2358496/Rivervest_Venture_Partners>,
        <https://1145.am/db/2358502/Rivervest_Venture_Partners>,
        <https://1145.am/db/2369916/Rivervest_Venture_Partners>,
        <https://1145.am/db/583798/Rivervest_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2296631/Volker_Group> a org:Organization ;
    ns1:basedInHighGeoName "Federal Republic of Germany" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:basedInHighRaw "Germany" ;
    ns1:description "Construction" ;
    ns1:documentDate "2012-02-14T20:59:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Hill-Rom completes $85M Volker buy; Neuros picks up RiverVest Venture Partners as investor;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/hill-rom-completes-85m-volker-buy-neuros-picks-up-rivervest-venture-partners-as> ;
    ns1:foundName "Volker group" ;
    ns1:name "Volker group" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2296631/Volker_Group_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2012-02-14T20:59:32+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Hill-Rom Holdings ($ HRC) has completed its $ 85 million purchase of Germany's Volker group." ;
    ns1:documentTitle "Hill-Rom completes $85M Volker buy; Neuros picks up RiverVest Venture Partners as investor;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/hill-rom-completes-85m-volker-buy-neuros-picks-up-rivervest-venture-partners-as> ;
    ns1:foundName "purchase" ;
    ns1:name "purchase" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2296631/Volker_Group> ;
    ns1:targetName "Volker group" ;
    ns1:valueRaw "$ 85 million" ;
    ns1:whereGeoName "Federal Republic of Germany" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:whereRaw "Germany" .

<https://1145.am/db/2337767/Innavirvax> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:description "pathologies associated with immune dysregulation" ;
    ns1:documentDate "2012-02-14T16:47:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "InnaVirVax lands $4.9 Million in Series B funding Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/innavirvax-lands-4-9-million-series-b-funding-round> ;
    ns1:foundName "InnaVirVax" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "InnaVirVax" ;
    ns1:sameAsHigh <https://1145.am/db/2281255/Innoviva> ;
    ns1:sameAsMedium <https://1145.am/db/2337768/Innavirvax> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337808/Avaxia_Biologics> a org:Organization ;
    ns1:description "advancing Oral Antibodies for Inflammatory Bowel Disease" ;
    ns1:documentDate "2011-11-10T16:49:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bo" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/avaxia-biologics-inc-raises-2-2-million-first-closing-of-series-a-financing-to-advance-oral> ;
    ns1:foundName "Avaxia Biologics, Inc." ;
    ns1:industry "biotech" ;
    ns1:name "Avaxia Biologics" ;
    ns1:sameAsHigh <https://1145.am/db/1422573/Avalyn_Pharma_Inc>,
        <https://1145.am/db/1423274/Avalyn_Pharma_Inc>,
        <https://1145.am/db/2337765/Avaxia_Biologics>,
        <https://1145.am/db/2344945/Avaxia_Biologics_Inc>,
        <https://1145.am/db/2357331/Avaxia_Biologics>,
        <https://1145.am/db/2362638/Avaxia_Biologics>,
        <https://1145.am/db/2362641/Avaxia_Biologics>,
        <https://1145.am/db/2596451/Avaxia_Biologics>,
        <https://1145.am/db/559645/Avalyn_Pharma_Inc>,
        <https://1145.am/db/902651/Avadel_Pharmaceuticals_Plc>,
        <https://1145.am/db/917598/Avacta_Group_Plc>,
        <https://1145.am/db/918545/Avacta_Group_Plc> ;
    ns1:sameAsMedium <https://1145.am/db/2337805/Avaxia_Biologics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337826/Crosslink_Capital> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:documentDate "2011-11-12T10:30:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Comprehend Systems Secures $1.2MM in Seed Funding Leading VC and Angel Investors Back Growing Clinical Data Visualization" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/comprehend-systems-secures-1-2mm-seed-funding-leading-vc-and-angel-investors-back-growing> ;
    ns1:foundName "Crosslink",
        "Crosslink Capital" ;
    ns1:investor <https://1145.am/db/2337826/Seed_Investment_Comprehend_Systems_Crosslink_Capital_Garry_Tan_Palo_Alto_Calif_Quotidian_Ventures_Completed> ;
    ns1:name "Crosslink Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1066120/Crosslink_Capital>,
        <https://1145.am/db/1091554/Crosslink_Capital>,
        <https://1145.am/db/1091576/Crosslink_Capital>,
        <https://1145.am/db/1134229/Crosslink_Capital>,
        <https://1145.am/db/1390640/Crosslink_Capital>,
        <https://1145.am/db/1408186/Crosslink_Capital>,
        <https://1145.am/db/1433429/Crosslink_Capital>,
        <https://1145.am/db/1506306/Crosslink_Capital>,
        <https://1145.am/db/1508975/Crosslink_Capital>,
        <https://1145.am/db/1559082/Crosslink_Capital>,
        <https://1145.am/db/160809/Crosslink_Capital>,
        <https://1145.am/db/1697327/Crosslink_Capital>,
        <https://1145.am/db/1698138/Crosslink_Capital>,
        <https://1145.am/db/1716622/Crosslink_Capital>,
        <https://1145.am/db/1724789/Crosslink_Capital>,
        <https://1145.am/db/1737008/Crosslink_Capital>,
        <https://1145.am/db/1737278/Crosslink_Capital>,
        <https://1145.am/db/1740732/Crosslink_Capital>,
        <https://1145.am/db/1753148/Crosslink_Capital>,
        <https://1145.am/db/1755757/Crosslink_Capital>,
        <https://1145.am/db/1763964/Crosslink_Capital>,
        <https://1145.am/db/1770095/Crosslink_Capital>,
        <https://1145.am/db/1772041/Crosslink_Capital>,
        <https://1145.am/db/1773323/Crosslink_Capital>,
        <https://1145.am/db/1778522/Crosslink_Capital>,
        <https://1145.am/db/1780710/Crosslink_Capital>,
        <https://1145.am/db/1786705/Crosslink_Capital>,
        <https://1145.am/db/1790574/Crosslink_Capital>,
        <https://1145.am/db/1792682/Crosslink_Capital>,
        <https://1145.am/db/1805753/Crosslink_Capital>,
        <https://1145.am/db/1813326/Crosslink_Capital>,
        <https://1145.am/db/1828008/Crosslink_Capital>,
        <https://1145.am/db/1828036/Crosslink_Capital>,
        <https://1145.am/db/1842583/Crosslink_Capital>,
        <https://1145.am/db/1852928/Crosslink_Capital>,
        <https://1145.am/db/1854874/Crosslink_Capital>,
        <https://1145.am/db/1856736/Crosslink_Capital>,
        <https://1145.am/db/1863426/Crosslink_Capital>,
        <https://1145.am/db/1864601/Crosslink_Capital>,
        <https://1145.am/db/1870014/Crosslink_Capital>,
        <https://1145.am/db/1873031/Crosslink_Capital>,
        <https://1145.am/db/1873680/Crosslink_Capital>,
        <https://1145.am/db/1876103/Crosslink_Capital>,
        <https://1145.am/db/1877469/Crosslink_Capital>,
        <https://1145.am/db/1888815/Crosslink_Capital>,
        <https://1145.am/db/1890133/Crosslink_Capital>,
        <https://1145.am/db/1890136/Crosslink_Capital>,
        <https://1145.am/db/1892128/Crosslink_Capital>,
        <https://1145.am/db/1892902/Crosslink_Capital>,
        <https://1145.am/db/1893919/Crosslink_Capital>,
        <https://1145.am/db/1894610/Crosslink_Capital>,
        <https://1145.am/db/1895406/Crosslink_Capital>,
        <https://1145.am/db/1896735/Crosslink_Capital>,
        <https://1145.am/db/1911316/Crosslink_Capital>,
        <https://1145.am/db/1945479/Crosslink_Capital>,
        <https://1145.am/db/203518/Crosslink_Capital>,
        <https://1145.am/db/2095175/Crosslink_Capital>,
        <https://1145.am/db/209861/Crosslink_Capital>,
        <https://1145.am/db/2125508/Crosslink_Capital>,
        <https://1145.am/db/2321813/Crosslink_Capital>,
        <https://1145.am/db/2366079/Crosslink_Capital>,
        <https://1145.am/db/2606711/Crosslink_Capital>,
        <https://1145.am/db/285189/Crosslink_Capital>,
        <https://1145.am/db/342304/Crosslink_Capital>,
        <https://1145.am/db/490875/Crosslink_Capital>,
        <https://1145.am/db/593826/Crosslink_Capital>,
        <https://1145.am/db/657632/Crosslink_Capital>,
        <https://1145.am/db/751135/Crosslink_Capital>,
        <https://1145.am/db/838691/Crosslink_Capital>,
        <https://1145.am/db/879937/Crosslink_Capital>,
        <https://1145.am/db/880050/Crosslink_Capital>,
        <https://1145.am/db/880570/Crosslink_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337826/Garry_Tan> a org:Organization ;
    ns1:basedInLowRaw "PALO ALTO, Calif" ;
    ns1:documentDate "2011-11-12T10:30:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Comprehend Systems Secures $1.2MM in Seed Funding Leading VC and Angel Investors Back Growing Clinical Data Visualization" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/comprehend-systems-secures-1-2mm-seed-funding-leading-vc-and-angel-investors-back-growing> ;
    ns1:foundName "Garry Tan" ;
    ns1:investor <https://1145.am/db/2337826/Seed_Investment_Comprehend_Systems_Crosslink_Capital_Garry_Tan_Palo_Alto_Calif_Quotidian_Ventures_Completed> ;
    ns1:name "Garry Tan" ;
    ns1:sameAsMedium <https://1145.am/db/1740345/Garry_Tan>,
        <https://1145.am/db/1764067/Garry_Tan>,
        <https://1145.am/db/2366079/Garry_Tan> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337826/Palo_Alto_Calif> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:documentDate "2011-11-12T10:30:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Comprehend Systems Secures $1.2MM in Seed Funding Leading VC and Angel Investors Back Growing Clinical Data Visualization" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/comprehend-systems-secures-1-2mm-seed-funding-leading-vc-and-angel-investors-back-growing> ;
    ns1:foundName "PALO ALTO, Calif.-" ;
    ns1:name "PALO ALTO, Calif." ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337826/Quotidian_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:documentDate "2011-11-12T10:30:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Comprehend Systems Secures $1.2MM in Seed Funding Leading VC and Angel Investors Back Growing Clinical Data Visualization" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/comprehend-systems-secures-1-2mm-seed-funding-leading-vc-and-angel-investors-back-growing> ;
    ns1:foundName "Quotidian Ventures" ;
    ns1:investor <https://1145.am/db/2337826/Seed_Investment_Comprehend_Systems_Crosslink_Capital_Garry_Tan_Palo_Alto_Calif_Quotidian_Ventures_Completed> ;
    ns1:name "Quotidian Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1838403/Quotidian_Ventures>,
        <https://1145.am/db/1847287/Quotidian_Ventures>,
        <https://1145.am/db/1850782/Quotidian_Ventures>,
        <https://1145.am/db/1852513/Quotidian_Ventures>,
        <https://1145.am/db/1874937/Quotidian_Ventures>,
        <https://1145.am/db/1887528/Quotidian_Ventures>,
        <https://1145.am/db/1892120/Quotidian_Ventures>,
        <https://1145.am/db/1892395/Quotidian_Ventures>,
        <https://1145.am/db/2366079/Quotidian_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338527/Celladon_Corporation> a org:Organization ;
    ns1:description "cardiovascular diseases" ;
    ns1:documentDate "2012-02-15T15:32:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/celladon-corporation-completes-43-million-financing-to-advance-mydicar%C2%AE-for-treatment-of> ;
    ns1:foundName "Celladon Corporation" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Celladon Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/2301768/Cellerix>,
        <https://1145.am/db/2327996/Cellerix>,
        <https://1145.am/db/2328011/Cellerix>,
        <https://1145.am/db/2594575/Cellestis> ;
    ns1:sameAsMedium <https://1145.am/db/2312417/Celladon>,
        <https://1145.am/db/2312551/Celladon_Corporation>,
        <https://1145.am/db/2336269/Celladon_Corporation>,
        <https://1145.am/db/2338528/Celladon>,
        <https://1145.am/db/2343563/Celladon_Corporation>,
        <https://1145.am/db/2344637/Celladon_Corporation>,
        <https://1145.am/db/2355590/Celladon>,
        <https://1145.am/db/2358615/Celladon_Corporation>,
        <https://1145.am/db/2358620/Celladon_Corporation>,
        <https://1145.am/db/2367782/Celladon_Corporation>,
        <https://1145.am/db/2367991/Celladon> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338527/Mydicar> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:description "heart failure" ;
    ns1:documentDate "2012-02-15T15:32:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/celladon-corporation-completes-43-million-financing-to-advance-mydicar%C2%AE-for-treatment-of> ;
    ns1:foundName "MYDICAR" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "MYDICAR" ;
    ns1:sameAsMedium <https://1145.am/db/2367782/Mydicar> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338566/Mnemosyne_Pharmaceuticals> a org:Organization ;
    ns1:description "Drug Discovery" ;
    ns1:documentDate "2012-02-16T13:45:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Mnemosyne Pharmaceuticals, Inc. Completes $5.4 Million Series A Round to Support Drug Discovery Programs" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mnemosyne-pharmaceuticals-inc-completes-5-4-million-series-a-round-to-support-drug> ;
    ns1:foundName "Mnemosyne Pharmaceuticals, Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Mnemosyne Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2337455/Mnemosyne_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338625/Allena_Pharmaceuticals> a org:Organization ;
    ns1:description "Life Sciences" ;
    ns1:documentDate "2011-11-16T11:51:24+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Allena Pharmaceuticals Launches with $15 Million Series A Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/allena-pharmaceuticals-launches-15-million-series-a-round> ;
    ns1:foundName "Allena Pharmaceuticals",
        "Allena Pharmaceuticals, Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Allena Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2303294/Amira_Pharmaceuticals>,
        <https://1145.am/db/2347122/Allena_Pharmaceuticals>,
        <https://1145.am/db/2347466/Amira_Pharmaceuticals>,
        <https://1145.am/db/2347486/Amira_Pharmaceuticals>,
        <https://1145.am/db/2364742/Amira_Pharmaceuticals>,
        <https://1145.am/db/2596128/Amira_Pharmaceuticals>,
        <https://1145.am/db/2596137/Amira_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2349856/Allena_Pharmaceuticals>,
        <https://1145.am/db/2351519/Allena_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338625/Bessemer_Venture_Partners> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-11-16T11:51:24+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Allena Pharmaceuticals Launches with $15 Million Series A Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/allena-pharmaceuticals-launches-15-million-series-a-round> ;
    ns1:foundName "Bessemer Venture Partners" ;
    ns1:investor <https://1145.am/db/2338625/Series_A_Investment_Allena_Pharmaceuticals_Bessemer_Venture_Partners_Frazier_Healthcare_Third_Rock_Ventures_Completed> ;
    ns1:name "Bessemer Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1006362/Bessemer_Ventures>,
        <https://1145.am/db/1007121/Bessemer_Ventures>,
        <https://1145.am/db/1140521/Bessemer_Venture_Partners>,
        <https://1145.am/db/1150887/Bessemer_Venture_Partners>,
        <https://1145.am/db/1153184/Bessemer_Venture_Partners>,
        <https://1145.am/db/1168925/Bessemer_Venture_Partners>,
        <https://1145.am/db/1171251/Bessemer_Venture_Partners>,
        <https://1145.am/db/1287496/Bessemer_Venture_Partners>,
        <https://1145.am/db/1297270/Bessemer_Venture_Partners>,
        <https://1145.am/db/1298072/Bessemer_Venture_Partners>,
        <https://1145.am/db/1311917/Bessemer_Venture_Partners>,
        <https://1145.am/db/1412727/Bessemer_Venture_Partners>,
        <https://1145.am/db/1445566/Bessemer_Venture_Partners>,
        <https://1145.am/db/1449740/Bessemer_Venture_Partners>,
        <https://1145.am/db/1490295/Bessemer_Venture_Partners>,
        <https://1145.am/db/1667738/Bessemer_Venture_Partners>,
        <https://1145.am/db/1703633/Bessemer_Venture_Partners>,
        <https://1145.am/db/1726088/Bessemer_Venture_Partners>,
        <https://1145.am/db/1731036/Bessemer_Venture_Partners>,
        <https://1145.am/db/1735755/Bessemer_Venture_Partners>,
        <https://1145.am/db/1736811/Bessemer_Venture_Partners>,
        <https://1145.am/db/1744676/Bessemer_Venture_Partners>,
        <https://1145.am/db/1748765/Bessemer_Venture_Partners>,
        <https://1145.am/db/1749643/Bessemer_Venture_Partners>,
        <https://1145.am/db/1750217/Bessemer_Venture_Partners>,
        <https://1145.am/db/1751506/Bessemer_Venture_Partners>,
        <https://1145.am/db/1751790/Bessemer_Venture_Partners>,
        <https://1145.am/db/1751800/Bessemer_Venture_Partners>,
        <https://1145.am/db/1756092/Bessemer_Venture_Partners>,
        <https://1145.am/db/1760614/Bessemer_Ventures>,
        <https://1145.am/db/1762343/Bessemer_Venture_Partners>,
        <https://1145.am/db/1763774/Bessemer_Venture_Partners>,
        <https://1145.am/db/1765092/Bessemer_Venture_Partners>,
        <https://1145.am/db/1765646/Bessemer_Venture_Partners>,
        <https://1145.am/db/1772381/Bessemer_Venture_Partners>,
        <https://1145.am/db/1774323/Bessemer_Venture_Partners>,
        <https://1145.am/db/1775794/Bessemer_Venture_Partners>,
        <https://1145.am/db/1778844/Bessemer_Venture_Partners>,
        <https://1145.am/db/1779320/Bessemer_Venture_Partners>,
        <https://1145.am/db/1780998/Bessemer_Venture_Partners>,
        <https://1145.am/db/1795531/Bessemer_Venture_Partners>,
        <https://1145.am/db/1797945/Bessemer_Venture_Partners>,
        <https://1145.am/db/1801088/Bessemer_Venture_Partners>,
        <https://1145.am/db/1802590/Bessemer_Venture_Partners>,
        <https://1145.am/db/1802834/Bessemer_Venture_Partners>,
        <https://1145.am/db/1808735/Bessemer_Venture_Partners>,
        <https://1145.am/db/1813337/Bessemer_Venture_Partners>,
        <https://1145.am/db/1819651/Bessemer_Venture_Partners>,
        <https://1145.am/db/1820660/Bessemer_Venture_Partners>,
        <https://1145.am/db/1823001/Bessemer_Venture_Partners>,
        <https://1145.am/db/1823041/Bessemer_Ventures>,
        <https://1145.am/db/1826794/Bessemer_Ventures_Partners>,
        <https://1145.am/db/1833296/Bessemer_Venture_Partners>,
        <https://1145.am/db/1839990/Bessemer_Venture_Partners>,
        <https://1145.am/db/1849606/Bessemer_Venture_Partners>,
        <https://1145.am/db/1851792/Bessemer_Venture_Partners>,
        <https://1145.am/db/1853292/Bessemer_Venture_Partners>,
        <https://1145.am/db/1860406/Bessemer_Venture_Partners>,
        <https://1145.am/db/1860637/Bessemer_Venture_Partners>,
        <https://1145.am/db/1866032/Bessemer_Venture_Partners>,
        <https://1145.am/db/1892105/Bessemer_Venture_Partners>,
        <https://1145.am/db/1893502/Bessemer_Venture_Partners>,
        <https://1145.am/db/1898837/Bessemer_Venture_Partners>,
        <https://1145.am/db/1904197/Bessemer_Venture_Partners>,
        <https://1145.am/db/1914189/Bessemer_Venture_Partners>,
        <https://1145.am/db/1917346/Bessemer_Venture_Partners>,
        <https://1145.am/db/1921374/Bessemer_Venture_Partners>,
        <https://1145.am/db/1947303/Bessemer_Venture_Partners>,
        <https://1145.am/db/1954147/Bessemer_Venture_Partners>,
        <https://1145.am/db/2013193/Bessemer_Venture_Partners>,
        <https://1145.am/db/2051110/Bessemer_Venture_Partners>,
        <https://1145.am/db/2059038/Bessemer_Venture_Partners>,
        <https://1145.am/db/2070098/Bessemer_Venture_Partners>,
        <https://1145.am/db/2125259/Bessemer_Venture_Partners>,
        <https://1145.am/db/2142825/Bessemer_Venture_Partners>,
        <https://1145.am/db/2181016/Bessemer_Venture_Partners>,
        <https://1145.am/db/221321/Bessemer_Venture_Partners>,
        <https://1145.am/db/2236188/Bessemer_Venture_Partners>,
        <https://1145.am/db/2303251/Bessemer_Venture_Partners>,
        <https://1145.am/db/2303257/Bessemer_Venture_Partners>,
        <https://1145.am/db/2303675/Bessemer_Venture_Partners>,
        <https://1145.am/db/2317918/Bessemer_Venture_Partners>,
        <https://1145.am/db/2325326/Bessemer_Venture_Partners>,
        <https://1145.am/db/2339925/Bessemer_Venture_Partners>,
        <https://1145.am/db/2349437/Bessemer_Venture_Partners>,
        <https://1145.am/db/2362871/Bessemer_Venture_Partners>,
        <https://1145.am/db/2621506/Bessemer_Venture_Partners>,
        <https://1145.am/db/2766437/Bessemer_Venture_Partners>,
        <https://1145.am/db/293891/Bessemer_Venture_Partners>,
        <https://1145.am/db/325080/Bessemer_Venture_Partners>,
        <https://1145.am/db/472389/Bessemer_Venture_Partners>,
        <https://1145.am/db/473354/Bessemer_Venture_Partners>,
        <https://1145.am/db/507249/Bessemer_Venture_Partners>,
        <https://1145.am/db/508115/Bessemer_Venture_Partners>,
        <https://1145.am/db/511072/Bessemer_Venture_Partners>,
        <https://1145.am/db/513305/Bessemer_Venture_Partners>,
        <https://1145.am/db/575249/Bessemer_Venture_Partners>,
        <https://1145.am/db/606291/Bessemer_Venture_Partners>,
        <https://1145.am/db/676869/Bessemer_Venture_Partners>,
        <https://1145.am/db/678140/Bessemer_Venture_Partners>,
        <https://1145.am/db/694924/Bessemer_Venture_Partners>,
        <https://1145.am/db/803541/Bessemer_Venture_Partners>,
        <https://1145.am/db/8314/Bessemer_Venture_Partners>,
        <https://1145.am/db/847157/Bessemer_Venture_Partners>,
        <https://1145.am/db/862760/Bessemer_Venture_Partners>,
        <https://1145.am/db/862851/Bessemer_Venture_Partners>,
        <https://1145.am/db/884806/Bessemer_Venture_Partners>,
        <https://1145.am/db/924505/Bessemer_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1060146/Bessemer_Venture_Partners>,
        <https://1145.am/db/1061468/Bessemer_Venture_Partners>,
        <https://1145.am/db/1061911/Bessemer_Venture_Partners>,
        <https://1145.am/db/1064710/Bessemer_Venture_Partners>,
        <https://1145.am/db/1090262/Bessemer_Venture_Partners>,
        <https://1145.am/db/1480187/Bessemer_Venture_Partners>,
        <https://1145.am/db/1669991/Bessemer_Venture_Partners>,
        <https://1145.am/db/1697155/Bessemer_Venture_Partners>,
        <https://1145.am/db/1698509/Bessemer_Venture_Partners>,
        <https://1145.am/db/1706697/Bessemer_Venture_Partners>,
        <https://1145.am/db/1707187/Bessemer_Venture_Partners>,
        <https://1145.am/db/1712471/Bessemer_Venture_Partners>,
        <https://1145.am/db/1717313/Bessemer_Venture_Partners>,
        <https://1145.am/db/1718800/Bessemer_Venture_Partners>,
        <https://1145.am/db/1723948/Bessemer_Venture_Partners>,
        <https://1145.am/db/1725530/Bessemer_Venture_Partners>,
        <https://1145.am/db/1742802/Bessemer_Venture_Partners>,
        <https://1145.am/db/1744158/Bessemer_Venture_Partners>,
        <https://1145.am/db/1744201/Bessemer_Venture_Partners>,
        <https://1145.am/db/1744656/Bessemer_Venture_Partners>,
        <https://1145.am/db/1752609/Bessemer_Venture_Partners>,
        <https://1145.am/db/1756150/Bessemer_Venture_Partners>,
        <https://1145.am/db/1756999/Bessemer_Venture_Partners>,
        <https://1145.am/db/1757845/Bessemer_Venture_Partners>,
        <https://1145.am/db/1758776/Bessemer_Venture_Partners>,
        <https://1145.am/db/1759851/Bessemer_Venture_Partners>,
        <https://1145.am/db/1759923/Bessemer_Venture_Partners>,
        <https://1145.am/db/1760213/Bessemer_Venture_Partners>,
        <https://1145.am/db/1763433/Bessemer_Venture_Partners>,
        <https://1145.am/db/1767075/Bessemer_Venture_Partners>,
        <https://1145.am/db/1771769/Bessemer_Venture_Partners>,
        <https://1145.am/db/1772047/Bessemer_Venture_Partners>,
        <https://1145.am/db/1776988/Bessemer_Venture_Partners>,
        <https://1145.am/db/1779634/Bessemer_Venture_Partners>,
        <https://1145.am/db/1800364/Bessemer_Venture_Partners>,
        <https://1145.am/db/1802034/Bessemer_Venture_Partners>,
        <https://1145.am/db/1806684/Bessemer_Venture_Partners>,
        <https://1145.am/db/1813349/Bessemer_Venture_Partners>,
        <https://1145.am/db/1814014/Bessemer_Venture_Partners>,
        <https://1145.am/db/1816701/Bessemer_Venture_Partners>,
        <https://1145.am/db/1818326/Bessemer_Venture_Partners>,
        <https://1145.am/db/1818535/Bessemer_Venture_Partners>,
        <https://1145.am/db/1821929/Bessemer_Venture_Partners>,
        <https://1145.am/db/1823415/Bessemer_Venture_Partners>,
        <https://1145.am/db/1825267/Bessemer_Venture_Partners>,
        <https://1145.am/db/1828092/Bessemer_Venture_Partners>,
        <https://1145.am/db/1836250/Bessemer_Venture_Partners>,
        <https://1145.am/db/1838678/Bessemer_Venture_Partners>,
        <https://1145.am/db/1843244/Bessemer_Venture_Partners>,
        <https://1145.am/db/1846957/Bessemer_Venture_Partners>,
        <https://1145.am/db/1847160/Bessemer_Venture_Partners>,
        <https://1145.am/db/1849046/Bessemer_Venture_Partners>,
        <https://1145.am/db/1849746/Bessemer_Venture_Partners>,
        <https://1145.am/db/1850076/Bessemer_Venture_Partners>,
        <https://1145.am/db/1850727/Bessemer_Venture_Partners>,
        <https://1145.am/db/1856085/Bessemer_Venture_Partners>,
        <https://1145.am/db/1857212/Bessemer_Venture_Partners>,
        <https://1145.am/db/1857278/Bessemer_Venture_Partners>,
        <https://1145.am/db/1859331/Bessemer_Venture_Partners>,
        <https://1145.am/db/1860367/Bessemer_Venture_Partners>,
        <https://1145.am/db/1861518/Bessemer_Venture_Partners>,
        <https://1145.am/db/1876003/Bessemer_Venture_Partners>,
        <https://1145.am/db/1883858/Bessemer_Venture_Partners>,
        <https://1145.am/db/1885320/Bessemer_Venture_Partners>,
        <https://1145.am/db/1885998/Bessemer_Venture_Partners>,
        <https://1145.am/db/1889732/Bessemer_Venture_Partners>,
        <https://1145.am/db/1910644/Bessemer_Venture_Partners>,
        <https://1145.am/db/1921599/Bessemer_Venture_Partners>,
        <https://1145.am/db/2011521/Bessemer_Venture_Partners>,
        <https://1145.am/db/2031790/Bessemer_Venture_Partners>,
        <https://1145.am/db/2043214/Bessemer_Venture_Partners>,
        <https://1145.am/db/207823/Bessemer_Venture_Partners>,
        <https://1145.am/db/2127786/Bessemer_Venture_Partners>,
        <https://1145.am/db/2141061/Bessemer_Venture_Partners>,
        <https://1145.am/db/2173983/Bessemer_Venture_Partners>,
        <https://1145.am/db/2194210/Bessemer_Venture_Partners>,
        <https://1145.am/db/2197248/Bessemer_Venture_Partners>,
        <https://1145.am/db/2303250/Bessemer_Venture_Partners>,
        <https://1145.am/db/2311551/Bessemer_Venture_Partners>,
        <https://1145.am/db/2316356/Bessemer_Venture_Partners>,
        <https://1145.am/db/2324076/Bessemer_Venture_Partners>,
        <https://1145.am/db/2338633/Bessemer_Venture_Partners>,
        <https://1145.am/db/2339926/Bessemer_Venture_Partners>,
        <https://1145.am/db/2348448/Bessemer_Venture_Partners>,
        <https://1145.am/db/2351520/Bessemer_Venture_Partners>,
        <https://1145.am/db/2352414/Bessemer_Venture_Partners>,
        <https://1145.am/db/2353404/Bessemer_Venture_Partners>,
        <https://1145.am/db/2353415/Bessemer_Venture_Partners>,
        <https://1145.am/db/2363330/Bessemer_Venture_Partners>,
        <https://1145.am/db/2677219/Bessemer_Venture_Partners>,
        <https://1145.am/db/341984/Bessemer_Venture_Partners>,
        <https://1145.am/db/341990/Bessemer_Venture_Partners>,
        <https://1145.am/db/425262/Bessemer_Venture_Partners>,
        <https://1145.am/db/478025/Bessemer_Venture_Partners>,
        <https://1145.am/db/506309/Bessemer_Venture_Partners>,
        <https://1145.am/db/559318/Bessemer_Venture_Partners>,
        <https://1145.am/db/668230/Bessemer_Venture_Partners>,
        <https://1145.am/db/668965/Bessemer_Venture_Partners>,
        <https://1145.am/db/699860/Bessemer_Venture_Partners>,
        <https://1145.am/db/700171/Bessemer_Venture_Partners>,
        <https://1145.am/db/829118/Bessemer_Venture_Partners>,
        <https://1145.am/db/832264/Bessemer_Venture_Partners>,
        <https://1145.am/db/877618/Bessemer_Venture_Partners>,
        <https://1145.am/db/902390/Bessemer_Venture_Partners>,
        <https://1145.am/db/907582/Bessemer_Venture_Partners>,
        <https://1145.am/db/907975/Bessemer_Venture_Partners>,
        <https://1145.am/db/955858/Bessemer_Venture_Partners>,
        <https://1145.am/db/960320/Bessemer_Venture_Partners>,
        <https://1145.am/db/971418/Bessemer_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338625/Frazier_Healthcare> a org:Organization ;
    ns1:description "venture investors" ;
    ns1:documentDate "2011-11-16T11:51:24+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Allena Pharmaceuticals Launches with $15 Million Series A Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/allena-pharmaceuticals-launches-15-million-series-a-round> ;
    ns1:foundName "Frazier Healthcare" ;
    ns1:investor <https://1145.am/db/2338625/Series_A_Investment_Allena_Pharmaceuticals_Bessemer_Venture_Partners_Frazier_Healthcare_Third_Rock_Ventures_Completed> ;
    ns1:name "Frazier Healthcare" ;
    ns1:sameAsHigh <https://1145.am/db/1244886/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1245863/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2152824/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2196903/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2278780/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2307829/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2318577/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2330075/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2331784/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2342352/Frazier_Healthcare>,
        <https://1145.am/db/2346532/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2346542/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2351519/Frazier_Healthcare>,
        <https://1145.am/db/2356269/Frazier_Healthcare>,
        <https://1145.am/db/2365700/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2366187/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2553555/Frazier_Healthcare>,
        <https://1145.am/db/2592685/Frazier_Healthcare>,
        <https://1145.am/db/505366/Frazier_Healthcare_Partners>,
        <https://1145.am/db/770024/Frazier_Healthcare_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1329605/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1374146/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1813040/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2154276/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2189855/Frazier_Healthcare>,
        <https://1145.am/db/2245812/Frazier_Healthcare>,
        <https://1145.am/db/2292109/Frazier_Healthcare>,
        <https://1145.am/db/2294202/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2303250/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2303251/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2303257/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2305524/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2307824/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2308855/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2310795/Frazier_Healthcare>,
        <https://1145.am/db/2310798/Frazier_Healthcare>,
        <https://1145.am/db/2311551/Frazier_Healthcare>,
        <https://1145.am/db/2316391/Frazier_Healthcare>,
        <https://1145.am/db/2318274/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2318276/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2318635/Frazier_Healthcare>,
        <https://1145.am/db/2321216/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2325326/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2326430/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2327441/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2327442/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2330079/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2334616/Frazier_Healthcare>,
        <https://1145.am/db/2334622/Frazier_Healthcare>,
        <https://1145.am/db/2334624/Frazier_Healthcare>,
        <https://1145.am/db/2335675/Frazier_Healthcare>,
        <https://1145.am/db/2335743/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2336032/Frazier_Healthcare>,
        <https://1145.am/db/2337166/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2338633/Frazier_Healthcare>,
        <https://1145.am/db/2339925/Frazier_Healthcare>,
        <https://1145.am/db/2339926/Frazier_Healthcare>,
        <https://1145.am/db/2340204/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2340207/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2342629/Frazier_Healthcare>,
        <https://1145.am/db/2348754/Frazier_Healthcare>,
        <https://1145.am/db/2351520/Frazier_Healthcare>,
        <https://1145.am/db/2356306/Frazier_Healthcare>,
        <https://1145.am/db/2361549/Frazier_Healthcare>,
        <https://1145.am/db/2361551/Frazier_Healthcare>,
        <https://1145.am/db/2366700/Frazier_Healthcare>,
        <https://1145.am/db/2368333/Frazier_Healthcare>,
        <https://1145.am/db/2370761/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2537423/Frazier_Healthcare>,
        <https://1145.am/db/2584561/Frazier_Healthcare_Partners>,
        <https://1145.am/db/490601/Frazier_Healthcare_Partners>,
        <https://1145.am/db/578056/Frazier_Healthcare_Partners>,
        <https://1145.am/db/578059/Frazier_Healthcare_Partners>,
        <https://1145.am/db/699981/Frazier_Healthcare_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339384/Series_A_Investment_Devon_Park_Bioventures_Vascular_Magnetics_Inc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-22T13:14:12+00:00"^^xsd:dateTime ;
    ns1:documentExtract "PHILADELPHIA- (BUSINESS WIRE) -Vascular Magnetics, Inc. announced today that it has raised $ 7 million in a Series A financing to advance the development of its proprietary, magnetically targeted drug delivery system for the treatment of peripheral artery disease (PAD) .",
        "Vascular Magnetics Raises $ 7 Million in Series A Financing to Advance Magnetically Targeted Drug Delivery System for Peripheral Artery Disease." ;
    ns1:documentTitle "Vascular Magnetics Raises $7 Million in Series A Financing to Advance Magnetically Targeted Drug Delivery System for Peripheral Artery Disease" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vascular-magnetics-raises-7-million-series-a-financing-to-advance-magnetically-targeted-1> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2339384/Vascular_Magnetics_Inc> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 7 Million",
        "$ 7 million" ;
    ns1:whereGeoName "Philadelphia" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4560349/about.rdf> ;
    ns1:whereRaw "PHILADELPHIA" .

<https://1145.am/db/2339395/Series_A_Investment_Devon_Park_Bioventures_Vascular_Magnetics_Inc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-22T13:49:24+00:00"^^xsd:dateTime ;
    ns1:documentExtract "PHILADELPHIA- (BUSINESS WIRE) -Vascular Magnetics, Inc. announced today that it has raised $ 7 million in a Series A financing to advance the development of its proprietary, magnetically targeted drug delivery system for the treatment of peripheral artery disease (PAD) .",
        "Vascular Magnetics Raises $ 7 Million in Series A Financing to Advance Magnetically Targeted Drug Delivery System for PAD." ;
    ns1:documentTitle "Vascular Magnetics Raises $7 Million in Series A Financing to Advance Magnetically Targeted Drug Delivery System for PAD" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vascular-magnetics-raises-7-million-series-a-financing-to-advance-magnetically-targeted-0> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2339395/Vascular_Magnetics_Inc> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 7 Million",
        "$ 7 million" ;
    ns1:whereGeoName "Philadelphia" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4560349/about.rdf> ;
    ns1:whereRaw "PHILADELPHIA" .

<https://1145.am/db/2339419/Biovest> a org:Organization ;
    ns1:basedInLowRaw "Benaruca" ;
    ns1:description "investment holding of the Colruyt family" ;
    ns1:documentDate "2011-11-17T14:21:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising-0> ;
    ns1:foundName "Biovest" ;
    ns1:investor <https://1145.am/db/2339419/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> ;
    ns1:name "Biovest" ;
    ns1:sameAsHigh <https://1145.am/db/2339425/Biovest> ;
    ns1:sameAsMedium <https://1145.am/db/2288454/Biovest>,
        <https://1145.am/db/2322622/Biovest>,
        <https://1145.am/db/2327838/Biovest> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339419/Debiopharm_Group> a org:Organization ;
    ns1:basedInLowRaw "Benaruca" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2011-11-17T14:21:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising-0> ;
    ns1:foundName "Debiopharm Group™" ;
    ns1:investor <https://1145.am/db/2339419/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> ;
    ns1:name "Debiopharm Group" ;
    ns1:sameAsHigh <https://1145.am/db/2295330/Debiopharm>,
        <https://1145.am/db/2323185/Debiopharm_Group>,
        <https://1145.am/db/2339425/Debiopharm_Group>,
        <https://1145.am/db/2356419/Valiance_Debiopharm_Group™> ;
    ns1:sameAsMedium <https://1145.am/db/1835975/Debiopharm_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339419/Ihl_Sa> a org:Organization ;
    ns1:basedInLowRaw "Belgium" ;
    ns1:description "Investing" ;
    ns1:documentDate "2011-11-17T14:21:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising-0> ;
    ns1:foundName "IHL SA",
        "IHL SA (Luc Verelst)" ;
    ns1:investor <https://1145.am/db/2339419/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> ;
    ns1:name "IHL SA" ;
    ns1:sameAsHigh <https://1145.am/db/2339425/Ihl_Sa> ;
    ns1:sameAsMedium <https://1145.am/db/2695840/Ihl> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339419/Korys> a org:Organization ;
    ns1:basedInLowRaw "Benaruca" ;
    ns1:description "investment holding" ;
    ns1:documentDate "2011-11-17T14:21:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising-0> ;
    ns1:foundName "Korys" ;
    ns1:investor <https://1145.am/db/2339419/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> ;
    ns1:name "Korys" ;
    ns1:sameAsHigh <https://1145.am/db/2339425/Korys>,
        <https://1145.am/db/2356419/Korys> ;
    ns1:sameAsMedium <https://1145.am/db/2332543/Korys> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339419/New_Rhein_Healthcare> a org:Organization ;
    ns1:basedInLowRaw "Benaruca" ;
    ns1:description "healthcare" ;
    ns1:documentDate "2011-11-17T14:21:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising-0> ;
    ns1:foundName "New Rhein Healthcare" ;
    ns1:investor <https://1145.am/db/2339419/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> ;
    ns1:name "New Rhein Healthcare" ;
    ns1:sameAsHigh <https://1145.am/db/2339425/New_Rhein_Healthcare>,
        <https://1145.am/db/2356419/New_Rhein_Healthcare> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339419/PMV> a org:Organization ;
    ns1:basedInLowRaw "Benaruca" ;
    ns1:description "life science" ;
    ns1:documentDate "2011-11-17T14:21:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising-0> ;
    ns1:foundName "PMV" ;
    ns1:investor <https://1145.am/db/2339419/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> ;
    ns1:name "PMV" ;
    ns1:sameAsHigh <https://1145.am/db/2339425/PMV>,
        <https://1145.am/db/2370680/PMV> ;
    ns1:sameAsMedium <https://1145.am/db/1297146/PMV>,
        <https://1145.am/db/1545620/PMV>,
        <https://1145.am/db/1546297/PMV>,
        <https://1145.am/db/1549508/PMV>,
        <https://1145.am/db/2301464/PMV>,
        <https://1145.am/db/2346397/PMV>,
        <https://1145.am/db/2356419/PMV>,
        <https://1145.am/db/2370764/PMV>,
        <https://1145.am/db/2370786/PMV>,
        <https://1145.am/db/938290/PMV> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339419/Philips_Johnson___Johnson_Development_Corporation> a org:Organization ;
    ns1:description "Investing" ;
    ns1:documentDate "2011-11-17T14:21:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising-0> ;
    ns1:foundName "Philips, Johnson & Johnson Development Corporation" ;
    ns1:investor <https://1145.am/db/2339419/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> ;
    ns1:name "Philips, Johnson & Johnson Development Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/2339425/Philips_Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2356419/Philips_Johnson___Johnson_Development_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339419/Valiance> a org:Organization ;
    ns1:basedInLowRaw "Benaruca" ;
    ns1:description "investment holding of the Colruyt family" ;
    ns1:documentDate "2011-11-17T14:21:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising-0> ;
    ns1:foundName "Valiance" ;
    ns1:investor <https://1145.am/db/2339419/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> ;
    ns1:name "Valiance" ;
    ns1:sameAsHigh <https://1145.am/db/2339425/Valiance> ;
    ns1:sameAsMedium <https://1145.am/db/2319516/Valiance> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339419/Wellcome_Trust> a org:Organization ;
    ns1:description "Investing" ;
    ns1:documentDate "2011-11-17T14:21:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising-0> ;
    ns1:foundName "Wellcome Trust" ;
    ns1:investor <https://1145.am/db/2339419/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> ;
    ns1:name "Wellcome Trust" ;
    ns1:sameAsHigh <https://1145.am/db/2318656/The_Wellcome_Trust>,
        <https://1145.am/db/2339425/Wellcome_Trust> ;
    ns1:sameAsMedium <https://1145.am/db/1803348/Wellcome_Trust>,
        <https://1145.am/db/1873138/Wellcome_Trust>,
        <https://1145.am/db/1877263/Wellcome_Trust>,
        <https://1145.am/db/2291581/Wellcome_Trust>,
        <https://1145.am/db/2297218/Wellcome_Trust>,
        <https://1145.am/db/2312120/Wellcome_Trust>,
        <https://1145.am/db/2330075/Wellcome_Trust>,
        <https://1145.am/db/2338829/Wellcome_Trust>,
        <https://1145.am/db/2338835/Wellcome_Trust>,
        <https://1145.am/db/2344045/Wellcome_Trust>,
        <https://1145.am/db/2354253/Wellcome_Trust>,
        <https://1145.am/db/2364481/Wellcome_Trust>,
        <https://1145.am/db/2369419/Wellcome_Trust>,
        <https://1145.am/db/2370680/Wellcome_Trust>,
        <https://1145.am/db/2370786/Wellcome_Trust>,
        <https://1145.am/db/240593/Wellcome_Trust>,
        <https://1145.am/db/2559928/Wellcome_Trust>,
        <https://1145.am/db/2573020/Wellcome_Trust> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339425/Biovest> a org:Organization ;
    ns1:basedInLowRaw "Benaruca" ;
    ns1:description "investment holding of the Colruyt family" ;
    ns1:documentDate "2011-11-17T14:39:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising> ;
    ns1:foundName "Biovest" ;
    ns1:investor <https://1145.am/db/2339425/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> ;
    ns1:name "Biovest" ;
    ns1:sameAsHigh <https://1145.am/db/2339419/Biovest> ;
    ns1:sameAsMedium <https://1145.am/db/2288454/Biovest>,
        <https://1145.am/db/2322622/Biovest>,
        <https://1145.am/db/2327838/Biovest> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339425/Debiopharm_Group> a org:Organization ;
    ns1:basedInLowRaw "Benaruca" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2011-11-17T14:39:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising> ;
    ns1:foundName "Debiopharm GroupTM" ;
    ns1:investor <https://1145.am/db/2339425/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> ;
    ns1:name "Debiopharm Group" ;
    ns1:sameAsHigh <https://1145.am/db/2295330/Debiopharm>,
        <https://1145.am/db/2323185/Debiopharm_Group>,
        <https://1145.am/db/2339419/Debiopharm_Group>,
        <https://1145.am/db/2356419/Valiance_Debiopharm_Group™> ;
    ns1:sameAsMedium <https://1145.am/db/1835975/Debiopharm_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339425/Ihl_Sa> a org:Organization ;
    ns1:basedInLowRaw "Belgium" ;
    ns1:description "Investing" ;
    ns1:documentDate "2011-11-17T14:39:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising> ;
    ns1:foundName "IHL SA",
        "IHL SA (Luc Verelst)" ;
    ns1:investor <https://1145.am/db/2339425/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> ;
    ns1:name "IHL SA" ;
    ns1:sameAsHigh <https://1145.am/db/2339419/Ihl_Sa> ;
    ns1:sameAsMedium <https://1145.am/db/2695840/Ihl> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339425/Korys> a org:Organization ;
    ns1:basedInLowRaw "Benaruca" ;
    ns1:description "investment holding" ;
    ns1:documentDate "2011-11-17T14:39:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising> ;
    ns1:foundName "Korys" ;
    ns1:investor <https://1145.am/db/2339425/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> ;
    ns1:name "Korys" ;
    ns1:sameAsHigh <https://1145.am/db/2339419/Korys>,
        <https://1145.am/db/2356419/Korys> ;
    ns1:sameAsMedium <https://1145.am/db/2332543/Korys> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339425/New_Rhein_Healthcare> a org:Organization ;
    ns1:basedInLowRaw "Benaruca" ;
    ns1:description "Healthcare",
        "healthcare" ;
    ns1:documentDate "2011-11-17T14:39:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising> ;
    ns1:foundName "New Rhein Healthcare",
        "Rhein Healthcare" ;
    ns1:investor <https://1145.am/db/2339425/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> ;
    ns1:name "New Rhein Healthcare",
        "Rhein Healthcare" ;
    ns1:sameAsHigh <https://1145.am/db/2339419/New_Rhein_Healthcare>,
        <https://1145.am/db/2356419/New_Rhein_Healthcare> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339425/PMV> a org:Organization ;
    ns1:basedInLowRaw "Benaruca" ;
    ns1:description "life science" ;
    ns1:documentDate "2011-11-17T14:39:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising> ;
    ns1:foundName "PMV" ;
    ns1:investor <https://1145.am/db/2339425/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> ;
    ns1:name "PMV" ;
    ns1:sameAsHigh <https://1145.am/db/2339419/PMV>,
        <https://1145.am/db/2370680/PMV> ;
    ns1:sameAsMedium <https://1145.am/db/1297146/PMV>,
        <https://1145.am/db/1545620/PMV>,
        <https://1145.am/db/1546297/PMV>,
        <https://1145.am/db/1549508/PMV>,
        <https://1145.am/db/2301464/PMV>,
        <https://1145.am/db/2346397/PMV>,
        <https://1145.am/db/2356419/PMV>,
        <https://1145.am/db/2370764/PMV>,
        <https://1145.am/db/2370786/PMV>,
        <https://1145.am/db/938290/PMV> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339425/Philips_Johnson___Johnson_Development_Corporation> a org:Organization ;
    ns1:description "Investing" ;
    ns1:documentDate "2011-11-17T14:39:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising> ;
    ns1:foundName "Philips, Johnson & Johnson Development Corporation" ;
    ns1:investor <https://1145.am/db/2339425/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> ;
    ns1:name "Philips, Johnson & Johnson Development Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/2339419/Philips_Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2356419/Philips_Johnson___Johnson_Development_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339425/Valiance> a org:Organization ;
    ns1:basedInLowRaw "Benaruca" ;
    ns1:description "investment holding of the Colruyt family" ;
    ns1:documentDate "2011-11-17T14:39:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising> ;
    ns1:foundName "Valiance" ;
    ns1:investor <https://1145.am/db/2339425/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> ;
    ns1:name "Valiance" ;
    ns1:sameAsHigh <https://1145.am/db/2339419/Valiance> ;
    ns1:sameAsMedium <https://1145.am/db/2319516/Valiance> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339425/Wellcome_Trust> a org:Organization ;
    ns1:description "Investing" ;
    ns1:documentDate "2011-11-17T14:39:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising> ;
    ns1:foundName "Wellcome Trust" ;
    ns1:investor <https://1145.am/db/2339425/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> ;
    ns1:name "Wellcome Trust" ;
    ns1:sameAsHigh <https://1145.am/db/2318656/The_Wellcome_Trust>,
        <https://1145.am/db/2339419/Wellcome_Trust> ;
    ns1:sameAsMedium <https://1145.am/db/1803348/Wellcome_Trust>,
        <https://1145.am/db/1873138/Wellcome_Trust>,
        <https://1145.am/db/1877263/Wellcome_Trust>,
        <https://1145.am/db/2291581/Wellcome_Trust>,
        <https://1145.am/db/2297218/Wellcome_Trust>,
        <https://1145.am/db/2312120/Wellcome_Trust>,
        <https://1145.am/db/2330075/Wellcome_Trust>,
        <https://1145.am/db/2338829/Wellcome_Trust>,
        <https://1145.am/db/2338835/Wellcome_Trust>,
        <https://1145.am/db/2344045/Wellcome_Trust>,
        <https://1145.am/db/2354253/Wellcome_Trust>,
        <https://1145.am/db/2364481/Wellcome_Trust>,
        <https://1145.am/db/2369419/Wellcome_Trust>,
        <https://1145.am/db/2370680/Wellcome_Trust>,
        <https://1145.am/db/2370786/Wellcome_Trust>,
        <https://1145.am/db/240593/Wellcome_Trust>,
        <https://1145.am/db/2559928/Wellcome_Trust>,
        <https://1145.am/db/2573020/Wellcome_Trust> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339435/Ampliphi_Biosciences_Corporation> a org:Organization ;
    ns1:basedInHighGeoName "Richmond" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4781708/about.rdf> ;
    ns1:basedInHighRaw "RICHMOND, Va." ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "developing bacteriophage - based anti-bacterial therapies to treat drug resistant infections" ;
    ns1:documentDate "2011-11-17T17:40:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AMPLIPHI BIOSCIENCES Announces First Closing of $2.7m" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ampliphi-biosciences-announces-first-closing-of-2-7m> ;
    ns1:foundName "AMPLIPHI BIOSCIENCES",
        "AmpliPhi Biosciences Corporation" ;
    ns1:name "AMPLIPHI BIOSCIENCES",
        "AmpliPhi Biosciences Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/2336292/Ampliphi_Biosciences_Corporation>,
        <https://1145.am/db/2336957/Ampliphi_Biosciences_Corp>,
        <https://1145.am/db/2338446/Ampliphi_Biosciences_Corporation>,
        <https://1145.am/db/2338446/Intrexon>,
        <https://1145.am/db/2339860/Ampliphi_Biosciences_Corporation>,
        <https://1145.am/db/2351279/Ampliphi_Biosciences_Corporation>,
        <https://1145.am/db/2369442/Ampliphi_Biosciences_Corporation>,
        <https://1145.am/db/2369867/Ampliphi_Biosciences_Corporation> ;
    ns1:sameAsMedium <https://1145.am/db/2336954/Ampliphi_Biosciences>,
        <https://1145.am/db/2338449/Ampliphi_Biosciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340207/Collegium_Pharmaceutical> a org:Organization ;
    ns1:description "Pharmaceutical" ;
    ns1:documentDate "2012-02-22T16:24:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Collegium Pharmaceutical Announces Series B Financing and Advancement of Development Program for its DETERx® Tamper-Resistant, Extended-Release Opioid" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/collegium-pharmaceutical-announces-series-b-financing-and-advancement-of-development> ;
    ns1:foundName "Collegium Pharmaceutical",
        "Collegium Pharmaceutical, Inc." ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Collegium Pharmaceutical" ;
    ns1:sameAsHigh <https://1145.am/db/1203801/TRC>,
        <https://1145.am/db/1205649/TRC>,
        <https://1145.am/db/1336076/Nlc_Pharma>,
        <https://1145.am/db/1979718/Ipca>,
        <https://1145.am/db/2152744/Essa_Pharma>,
        <https://1145.am/db/2152756/Eusa_Pharma>,
        <https://1145.am/db/2155863/Glypharma>,
        <https://1145.am/db/2189077/Enclara_Pharmacia>,
        <https://1145.am/db/2202776/Eusa_Pharma_Inc>,
        <https://1145.am/db/2281676/Apnimed>,
        <https://1145.am/db/2284072/Alliance_Pharma>,
        <https://1145.am/db/2299131/Nmd_Pharma>,
        <https://1145.am/db/2302052/Antares_Pharma>,
        <https://1145.am/db/2303588/Eusa_Pharma_Inc>,
        <https://1145.am/db/2305488/Eusa_Pharma_Inc>,
        <https://1145.am/db/2306649/Eusa_Pharma_Inc>,
        <https://1145.am/db/2306885/U3_Pharma>,
        <https://1145.am/db/2306929/Mgi_Pharma>,
        <https://1145.am/db/2309040/Ista_Pharma>,
        <https://1145.am/db/2310483/Antares_Pharma>,
        <https://1145.am/db/2310765/Collbio>,
        <https://1145.am/db/2312649/Topotarget_A_S>,
        <https://1145.am/db/2313509/Mgi_Pharma>,
        <https://1145.am/db/2315519/Eusa_Pharma>,
        <https://1145.am/db/2318600/Idm_Pharma>,
        <https://1145.am/db/2318606/Idm_Pharma>,
        <https://1145.am/db/2318984/Idm_Pharma>,
        <https://1145.am/db/2320110/Pharma_Pass_Ii>,
        <https://1145.am/db/2321910/Idm_Pharma>,
        <https://1145.am/db/2321912/Idm_Pharma>,
        <https://1145.am/db/2324112/Antares_Pharma>,
        <https://1145.am/db/2327512/Eusa_Pharma_Inc>,
        <https://1145.am/db/2329301/Penn_Pharma>,
        <https://1145.am/db/2331898/U3_Pharma_Ag>,
        <https://1145.am/db/2335807/Antares_Pharma>,
        <https://1145.am/db/2335971/Antares_Pharma>,
        <https://1145.am/db/2336879/Antares_Pharma>,
        <https://1145.am/db/2338428/Collegium_Pharmaceutical>,
        <https://1145.am/db/2338429/Collegium_Pharmaceutical>,
        <https://1145.am/db/2340204/Collegium_Pharmaceutical>,
        <https://1145.am/db/2342825/Antares_Pharma>,
        <https://1145.am/db/2346313/Ucb_Pharma>,
        <https://1145.am/db/2347775/Antares_Pharma_Inc>,
        <https://1145.am/db/2347983/Pharmstandard_International>,
        <https://1145.am/db/2348187/Eusa_Pharma>,
        <https://1145.am/db/2350273/Collegium_Pharmaceutical>,
        <https://1145.am/db/2352288/Collegium_Pharmaceutical>,
        <https://1145.am/db/2353565/Eusa_Pharma>,
        <https://1145.am/db/2355927/Eusa_Pharma>,
        <https://1145.am/db/2357116/Nps_Pharma>,
        <https://1145.am/db/2358635/Collegium_Pharmaceutical>,
        <https://1145.am/db/2358734/Prosidion>,
        <https://1145.am/db/2360875/Antares_Pharma>,
        <https://1145.am/db/2364528/Antares_Pharma>,
        <https://1145.am/db/2366405/Collegium_Pharmaceutical>,
        <https://1145.am/db/2367945/Collegium_Pharmaceutical_Inc>,
        <https://1145.am/db/2368257/Almirall>,
        <https://1145.am/db/2368951/Intec_Pharma>,
        <https://1145.am/db/2369052/Essa_Pharma_Inc>,
        <https://1145.am/db/2540931/Pharmtek>,
        <https://1145.am/db/2548187/Freund_Pharmatec>,
        <https://1145.am/db/2551477/Penn_Pharma>,
        <https://1145.am/db/2551505/Eusa_Pharma>,
        <https://1145.am/db/2551516/Penn_Pharma>,
        <https://1145.am/db/2553920/Antares_Pharma>,
        <https://1145.am/db/2555777/Steri-Pharma>,
        <https://1145.am/db/2557083/Collegium_Pharmaceutical>,
        <https://1145.am/db/2561955/Meda>,
        <https://1145.am/db/2564490/Pharmtek>,
        <https://1145.am/db/2569599/Collegium_Pharmaceutical>,
        <https://1145.am/db/2569778/Eusa_Pharma>,
        <https://1145.am/db/2570482/Ra_Pharma>,
        <https://1145.am/db/2570807/Pharmacyclics>,
        <https://1145.am/db/2574345/Immdal_Limited>,
        <https://1145.am/db/2580047/Fougera>,
        <https://1145.am/db/2586802/Pt_Pharma_Healthcare>,
        <https://1145.am/db/2592696/Alliance_Pharma>,
        <https://1145.am/db/2797067/Pharmeasy>,
        <https://1145.am/db/659107/Nlc_Pharma>,
        <https://1145.am/db/659216/Nlc_Pharma>,
        <https://1145.am/db/669589/Eusa_Pharma>,
        <https://1145.am/db/670217/Eusa_Pharma>,
        <https://1145.am/db/832408/Collegium_Pharmaceutical>,
        <https://1145.am/db/833269/Collegium_Pharmaceutical>,
        <https://1145.am/db/884665/Pharmaceutical_Institute>,
        <https://1145.am/db/889331/Théa_Pharma>,
        <https://1145.am/db/926227/Collegium_Pharmaceutical_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340207/Frazier_Healthcare_Ventures> a org:Organization ;
    ns1:basedInLowRaw "R.I." ;
    ns1:description "healthcare" ;
    ns1:documentDate "2012-02-22T16:24:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Collegium Pharmaceutical Announces Series B Financing and Advancement of Development Program for its DETERx® Tamper-Resistant, Extended-Release Opioid" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/collegium-pharmaceutical-announces-series-b-financing-and-advancement-of-development> ;
    ns1:foundName "Frazier Healthcare Ventures" ;
    ns1:investor <https://1145.am/db/2340207/Series_B_Investment_Boston_Millennia_Partners_Collegium_Pharmaceutical_Frazier_Healthcare_Ventures_Longitude_Capital_Skyline_Ventures_Completed> ;
    ns1:name "Frazier Healthcare Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2339925/Frazier_Healthcare>,
        <https://1145.am/db/2366693/Frazier_Healthcare_And_Three_Arch_Partners>,
        <https://1145.am/db/2366700/Frazier_Healthcare> ;
    ns1:sameAsMedium <https://1145.am/db/1244886/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1245863/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1329605/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1374146/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1813040/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2152824/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2154276/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2189855/Frazier_Healthcare>,
        <https://1145.am/db/2196903/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2245812/Frazier_Healthcare>,
        <https://1145.am/db/2278780/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2292109/Frazier_Healthcare>,
        <https://1145.am/db/2294202/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2303250/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2303251/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2303257/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2305524/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2307824/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2307829/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2308855/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2310795/Frazier_Healthcare>,
        <https://1145.am/db/2310798/Frazier_Healthcare>,
        <https://1145.am/db/2311551/Frazier_Healthcare>,
        <https://1145.am/db/2316391/Frazier_Healthcare>,
        <https://1145.am/db/2318274/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2318276/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2318577/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2318635/Frazier_Healthcare>,
        <https://1145.am/db/2321216/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2325326/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2326430/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2327441/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2327442/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2330075/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2330079/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2331784/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2334616/Frazier_Healthcare>,
        <https://1145.am/db/2334622/Frazier_Healthcare>,
        <https://1145.am/db/2334624/Frazier_Healthcare>,
        <https://1145.am/db/2335675/Frazier_Healthcare>,
        <https://1145.am/db/2335743/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2336032/Frazier_Healthcare>,
        <https://1145.am/db/2337166/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2338625/Frazier_Healthcare>,
        <https://1145.am/db/2338633/Frazier_Healthcare>,
        <https://1145.am/db/2339926/Frazier_Healthcare>,
        <https://1145.am/db/2340204/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2342352/Frazier_Healthcare>,
        <https://1145.am/db/2342629/Frazier_Healthcare>,
        <https://1145.am/db/2346532/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2346542/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2348754/Frazier_Healthcare>,
        <https://1145.am/db/2351519/Frazier_Healthcare>,
        <https://1145.am/db/2351520/Frazier_Healthcare>,
        <https://1145.am/db/2356269/Frazier_Healthcare>,
        <https://1145.am/db/2356306/Frazier_Healthcare>,
        <https://1145.am/db/2361549/Frazier_Healthcare>,
        <https://1145.am/db/2361551/Frazier_Healthcare>,
        <https://1145.am/db/2365700/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2366187/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2368333/Frazier_Healthcare>,
        <https://1145.am/db/2370761/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2537423/Frazier_Healthcare>,
        <https://1145.am/db/2553555/Frazier_Healthcare>,
        <https://1145.am/db/2584561/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2592685/Frazier_Healthcare>,
        <https://1145.am/db/490601/Frazier_Healthcare_Partners>,
        <https://1145.am/db/505366/Frazier_Healthcare_Partners>,
        <https://1145.am/db/578056/Frazier_Healthcare_Partners>,
        <https://1145.am/db/578059/Frazier_Healthcare_Partners>,
        <https://1145.am/db/699981/Frazier_Healthcare_Partners>,
        <https://1145.am/db/770024/Frazier_Healthcare_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340211/Series_A_Investment_Devon_Park_Bioventures_Vascular_Magnetics_Inc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-22T17:03:15+00:00"^^xsd:dateTime ;
    ns1:documentExtract "PHILADELPHIA- (BUSINESS WIRE) -Vascular Magnetics, Inc. announced today that it has raised $ 7 million in a Series A financing to advance the development of its proprietary, magnetically targeted drug delivery system for the treatment of peripheral artery disease (PAD) .",
        "Vascular Magnetics Raises $ 7 Million in Series A Financing to Advance Magnetically Targeted Drug Delivery System for Peripheral Artery Disease." ;
    ns1:documentTitle "Vascular Magnetics Raises $7 Million in Series A Financing to Advance Magnetically Targeted Drug Delivery System for Peripheral Artery Disease" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vascular-magnetics-raises-7-million-series-a-financing-to-advance-magnetically-targeted> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2340211/Vascular_Magnetics_Inc> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 7 Million",
        "$ 7 million" ;
    ns1:whereGeoName "Philadelphia" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4560349/about.rdf> ;
    ns1:whereRaw "PHILADELPHIA" .

<https://1145.am/db/2340284/Domain_Associates> a org:Organization ;
    ns1:basedInLowRaw "SALT LAKE CITY" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-11-21T12:07:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor; Appoints Gregory C. Critchfiel" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sera-prognostics-secures-19-3-million-series-a-funding-to-commercialize-preterm-birth> ;
    ns1:foundName "Domain Associates" ;
    ns1:investor <https://1145.am/db/2340284/Series_A_Investment_Catalyst_Health_Ventures_Domain_Associates_Interwest_Partners_Osage_University_Partners_Sera_Prognostics_Upstart_Life_Sciences_Capital_Completed> ;
    ns1:name "Domain Associates" ;
    ns1:sameAsHigh <https://1145.am/db/2294753/Domain_Associates>,
        <https://1145.am/db/2299776/Domain_Associates>,
        <https://1145.am/db/2300270/Domain_Associates>,
        <https://1145.am/db/2305524/Domain_Associates>,
        <https://1145.am/db/2305530/Domain_Associates>,
        <https://1145.am/db/2305706/Domain_Associates>,
        <https://1145.am/db/2306290/Domain_Associates_Llc>,
        <https://1145.am/db/2350044/Domain_Associates> ;
    ns1:sameAsMedium <https://1145.am/db/1859331/Domain_Associates>,
        <https://1145.am/db/2153759/Domain_Associates>,
        <https://1145.am/db/2155032/Domain_Associates>,
        <https://1145.am/db/2155189/Domain_Associates>,
        <https://1145.am/db/2289515/Domain_Associates>,
        <https://1145.am/db/2289819/Domain_Associates>,
        <https://1145.am/db/2290405/Domain_Associates>,
        <https://1145.am/db/2296841/Domain_Associates>,
        <https://1145.am/db/2297408/Domain_Associates>,
        <https://1145.am/db/2300293/Domain_Associates>,
        <https://1145.am/db/2300337/Domain_Associates>,
        <https://1145.am/db/2300455/Domain_Associates>,
        <https://1145.am/db/2302292/Domain_Associates_Llc>,
        <https://1145.am/db/2302508/Domain_Associates>,
        <https://1145.am/db/2303641/Domain_Associates>,
        <https://1145.am/db/2303642/Domain_Associates>,
        <https://1145.am/db/2303793/Domain_Associates>,
        <https://1145.am/db/2304578/Domain_Associates>,
        <https://1145.am/db/2304587/Domain_Associates>,
        <https://1145.am/db/2305713/Domain_Associates>,
        <https://1145.am/db/2305729/Domain_Associates>,
        <https://1145.am/db/2306873/Domain_Associates>,
        <https://1145.am/db/2307237/Domain_Associates>,
        <https://1145.am/db/2307644/Domain_Associates>,
        <https://1145.am/db/2309809/Domain_Associates>,
        <https://1145.am/db/2310073/Domain_Associates>,
        <https://1145.am/db/2311099/Domain_Associates>,
        <https://1145.am/db/2311221/Domain_Associates>,
        <https://1145.am/db/2312051/Domain_Associates>,
        <https://1145.am/db/2312120/Domain_Associates>,
        <https://1145.am/db/2312297/Domain_Associates>,
        <https://1145.am/db/2313171/Domain_Associates>,
        <https://1145.am/db/2316210/Domain_Associates>,
        <https://1145.am/db/2316214/Domain_Associates>,
        <https://1145.am/db/2317145/Domain_Associates>,
        <https://1145.am/db/2317951/Domain_Associates>,
        <https://1145.am/db/2318934/Domain_Associates>,
        <https://1145.am/db/2320925/Domain_Associates>,
        <https://1145.am/db/2322231/Domain_Associates>,
        <https://1145.am/db/2326423/Domain_Associates>,
        <https://1145.am/db/2326430/Domain_Associates_Llc>,
        <https://1145.am/db/2328030/Domain_Associates_Llc>,
        <https://1145.am/db/2328034/Domain_Associates_Llc>,
        <https://1145.am/db/2330075/Domain_Associates>,
        <https://1145.am/db/2330539/Domain_Associates>,
        <https://1145.am/db/2330549/Domain_Associates>,
        <https://1145.am/db/2331026/Domain_Associates>,
        <https://1145.am/db/2331047/Domain_Associates>,
        <https://1145.am/db/2331784/Domain_Associates>,
        <https://1145.am/db/2336221/Domain_Associates>,
        <https://1145.am/db/2340634/Domain_Associates>,
        <https://1145.am/db/2341764/Domain_Associates>,
        <https://1145.am/db/2343206/Domain_Associates>,
        <https://1145.am/db/2344090/Domain_Associates>,
        <https://1145.am/db/2344092/Domain_Associates>,
        <https://1145.am/db/2344100/Domain_Associates>,
        <https://1145.am/db/2344782/Domain_Associates>,
        <https://1145.am/db/2347984/Domain_Associates>,
        <https://1145.am/db/2349143/Domain_Associates>,
        <https://1145.am/db/2349753/Domain_Associates>,
        <https://1145.am/db/2352167/Domain_Associates>,
        <https://1145.am/db/2352170/Domain_Associates>,
        <https://1145.am/db/2352808/Domain_Associates>,
        <https://1145.am/db/2354899/Domain_Associates>,
        <https://1145.am/db/2354903/Domain_Associates>,
        <https://1145.am/db/2355936/Domain_Associates>,
        <https://1145.am/db/2355938/Domain_Associates>,
        <https://1145.am/db/2356301/Domain_Associates>,
        <https://1145.am/db/2357325/Domain_Associates>,
        <https://1145.am/db/2357981/Domain_Associates>,
        <https://1145.am/db/2358541/Domain_Associates>,
        <https://1145.am/db/2358883/Domain_Associates>,
        <https://1145.am/db/2361625/Domain_Associates>,
        <https://1145.am/db/2362278/Domain_Associates>,
        <https://1145.am/db/2365700/Domain_Associates>,
        <https://1145.am/db/2366128/Domain_Associates>,
        <https://1145.am/db/2366133/Domain_Associates>,
        <https://1145.am/db/2366187/Domain_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340284/Sera_Prognostics> a org:Organization ;
    ns1:description "women's health" ;
    ns1:documentDate "2011-11-21T12:07:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor; Appoints Gregory C. Critchfiel" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sera-prognostics-secures-19-3-million-series-a-funding-to-commercialize-preterm-birth> ;
    ns1:foundName "Sera Prognostics",
        "Sera Prognostics, Inc." ;
    ns1:industry "women's health" ;
    ns1:name "Sera Prognostics" ;
    ns1:sameAsMedium <https://1145.am/db/2155189/Sera_Prognostics>,
        <https://1145.am/db/2294753/Sera_Prognostics>,
        <https://1145.am/db/2296841/Sera_Prognostics>,
        <https://1145.am/db/607601/Sera_Prognostics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340305/Portola_Pharmaceuticals_Inc> a org:Organization ;
    ns1:basedInHighGeoName "South San Francisco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5397765/about.rdf> ;
    ns1:basedInHighRaw "SOUTH SAN FRANCISCO, CA" ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2011-11-21T16:01:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Portola Pharmaceuticals Announces Completion of $89 Million Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/portola-pharmaceuticals-announces-completion-of-89-million-financing> ;
    ns1:foundName "Portola Pharmaceuticals",
        "Portola Pharmaceuticals, Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Portola Pharmaceuticals",
        "Portola Pharmaceuticals, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2307845/Portola_Pharmaceuticals>,
        <https://1145.am/db/2316391/Portola_Pharmaceuticals>,
        <https://1145.am/db/2318281/Portola_Pharmaceuticals>,
        <https://1145.am/db/2322527/Portola_Pharmaceuticals>,
        <https://1145.am/db/2324613/Portola_Pharmaceuticals>,
        <https://1145.am/db/2335661/Portola_Pharmaceuticals>,
        <https://1145.am/db/2545937/Portola_Pharmaceuticals>,
        <https://1145.am/db/2551427/Porton_Pharma_Solutions>,
        <https://1145.am/db/2560655/Portola_Pharmaceuticals>,
        <https://1145.am/db/2569425/Portola_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2315602/Portola_Pharmaceuticals>,
        <https://1145.am/db/2569190/Portola_Pharmaceuticals_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340331/Excaliard_Pharmaceuticals> a org:Organization ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2011-11-22T14:17:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Isis to Receive Up to $14 Million from Pfizer for Its Acquisition of Excaliard Pharmaceuticals" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/isis-to-receive-up-to-14-million-from-pfizer-for-its-acquisition-of-excaliard> ;
    ns1:foundName "Excaliard",
        "Excaliard Pharmaceuticals",
        "Excaliard Pharmaceuticals, Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Excaliard Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/1263299/Exzell_Pharma>,
        <https://1145.am/db/2248538/Epix_Pharmaceuticals>,
        <https://1145.am/db/2281547/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2298768/Fosun>,
        <https://1145.am/db/2301913/Epix_Pharmaceuticals>,
        <https://1145.am/db/2302275/Epix_Pharmaceuticals>,
        <https://1145.am/db/2303843/Epix_Pharmaceuticals_Inc>,
        <https://1145.am/db/2304888/Eximias_Pharmaceutical>,
        <https://1145.am/db/2305797/Epix_Pharmaceuticals>,
        <https://1145.am/db/2312062/Epix_Pharmaceuticals>,
        <https://1145.am/db/2317779/Addex_Pharmaceuticals>,
        <https://1145.am/db/2318957/Epix_Pharmaceuticals>,
        <https://1145.am/db/2319956/Addex_Pharmaceuticals>,
        <https://1145.am/db/2323370/Exelixis>,
        <https://1145.am/db/2332912/Epix_Pharmaceuticals>,
        <https://1145.am/db/2340321/Excaliard_Pharmaceuticals>,
        <https://1145.am/db/2340324/Excaliard_Pharmaceuticals>,
        <https://1145.am/db/2340365/Addex_Pharmaceuticals>,
        <https://1145.am/db/2343273/Excaliard_Pharmaceuticals>,
        <https://1145.am/db/2355102/Addex_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2360771/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2560280/Exeltis>,
        <https://1145.am/db/2582158/Excaliard_Pharmaceuticals>,
        <https://1145.am/db/2584085/Excaliard_Pharmaceuticals>,
        <https://1145.am/db/416026/Claritas_Pharmaceuticals>,
        <https://1145.am/db/704156/Eximium>,
        <https://1145.am/db/788129/Claritas_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2340325/Excaliard_Pharmaceuticals>,
        <https://1145.am/db/2582160/Excaliard_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340331/Excaliard_Pharmaceuticals_Equity_Ownership_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-11-22T14:17:40+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CARLSBAD, Calif., Nov. 22, 2011 /PRNewswire/ - Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it will receive up to $ 14 million from Pfizer Inc. (NYSE: PFE) for its equity ownership of Excaliard Pharmaceuticals, Inc. from Pfizer's acquisition of Excaliard.",
        "Isis to Receive Up to $ 14 Million from Pfizer for Its Acquisition of Excaliard Pharmaceuticals." ;
    ns1:documentTitle "Isis to Receive Up to $14 Million from Pfizer for Its Acquisition of Excaliard Pharmaceuticals" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/isis-to-receive-up-to-14-million-from-pfizer-for-its-acquisition-of-excaliard> ;
    ns1:foundName "acquisition" ;
    ns1:name "acquisition" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2340331/Excaliard_Pharmaceuticals>,
        <https://1145.am/db/2340331/Isis_Pharmaceuticals_Inc> ;
    ns1:targetDetails "equity ownership" ;
    ns1:targetName "Excaliard Pharmaceuticals" ;
    ns1:valueRaw "Up to $ 14 Million",
        "up to $ 14 million" ;
    ns1:whenRaw "2011" ;
    ns1:whereGeoName "Carlsbad" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5334223/about.rdf> ;
    ns1:whereRaw "CARLSBAD" .

<https://1145.am/db/2340331/Isis_Pharmaceuticals_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Carlsbad" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5334223/about.rdf> ;
    ns1:basedInHighRaw "CARLSBAD, Calif." ;
    ns1:description "Pharmaceuticals",
        "pharmaceuticals" ;
    ns1:documentDate "2011-11-22T14:17:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Isis to Receive Up to $14 Million from Pfizer for Its Acquisition of Excaliard Pharmaceuticals" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/isis-to-receive-up-to-14-million-from-pfizer-for-its-acquisition-of-excaliard> ;
    ns1:foundName "Isis Pharmaceuticals, Inc",
        "Isis Pharmaceuticals, Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Isis Pharmaceuticals",
        "Isis Pharmaceuticals, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2303191/Isis_Pharmaceuticals_Inc>,
        <https://1145.am/db/2303199/Isis_Pharmaceuticals>,
        <https://1145.am/db/2305028/Isis_Pharmaceuticals>,
        <https://1145.am/db/2309171/Isis_Pharmaceuticals>,
        <https://1145.am/db/2309179/Isis_Pharmaceuticals>,
        <https://1145.am/db/2315697/Isis_Pharmaceuticals>,
        <https://1145.am/db/2321432/Isis_Pharmaceuticals>,
        <https://1145.am/db/2328030/Isis_Pharmaceuticals>,
        <https://1145.am/db/2328034/Isis_Pharmaceuticals>,
        <https://1145.am/db/2329864/Isis_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336932/Isis_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338296/Isis_Pharmaceuticals>,
        <https://1145.am/db/2343382/Isis_Pharmaceuticals>,
        <https://1145.am/db/2345011/Isis_Pharmaceuticals_Inc>,
        <https://1145.am/db/2345128/Isis_Pharmaceuticals_Inc>,
        <https://1145.am/db/2345690/Isis_Pharmaceuticals_Inc>,
        <https://1145.am/db/2351269/Isis_Pharmaceuticals>,
        <https://1145.am/db/2356079/Isis_Pharmaceuticals_Inc>,
        <https://1145.am/db/2371512/Isis_Pharmaceuticals>,
        <https://1145.am/db/2579951/Isis_Pharmaceuticals>,
        <https://1145.am/db/2582158/Isis_Pharmaceuticals_Inc>,
        <https://1145.am/db/2588813/Isis_Pharmaceuticals>,
        <https://1145.am/db/2595729/Isis_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341100/Investment_Opko_Health_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-27T21:38:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "OPKO Invests in BioZone Pharmaceuticals, Inc. Acquires Rights to Proprietary Technology to Enhance Solubility of Drugs." ;
    ns1:documentTitle "OPKO Invests in BioZone Pharmaceuticals, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/opko-invests-biozone-pharmaceuticals-inc> ;
    ns1:foundName "Invests" ;
    ns1:name "Invests" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2341100/Opko_Health> a org:Organization ;
    ns1:basedInHighGeoName "Miami" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4164138/about.rdf> ;
    ns1:basedInHighRaw "MIAMI" ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2341100/Biozone_Pharmaceuticals_Inc_Rights_Acquisition>,
        <https://1145.am/db/2341100/Qusome_Acquisition> ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2012-02-27T21:38:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "OPKO Invests in BioZone Pharmaceuticals, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/opko-invests-biozone-pharmaceuticals-inc> ;
    ns1:foundName "OPKO",
        "OPKO Health, Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2341100/Biozone_Pharmaceuticals_Inc_Rights_Acquisition>,
        <https://1145.am/db/2341100/Investment_Opko_Health_Completed> ;
    ns1:name "OPKO",
        "OPKO Health" ;
    ns1:sameAsHigh <https://1145.am/db/1042168/Opko_Health>,
        <https://1145.am/db/1520070/Opna_Bio>,
        <https://1145.am/db/2300237/Opko_Health>,
        <https://1145.am/db/2303326/Opko_Health>,
        <https://1145.am/db/2308778/Opko>,
        <https://1145.am/db/2312501/Opko_Health>,
        <https://1145.am/db/2318305/Opko_Health>,
        <https://1145.am/db/2319365/Opko_Health>,
        <https://1145.am/db/2319368/Opko_Health>,
        <https://1145.am/db/2328509/Opko_Health>,
        <https://1145.am/db/2342385/Opko_Health>,
        <https://1145.am/db/2350564/Opko_Health>,
        <https://1145.am/db/2351183/Opko_Health>,
        <https://1145.am/db/2351184/Opko_Health>,
        <https://1145.am/db/2538211/Opko_Health>,
        <https://1145.am/db/2543138/Opko_Health>,
        <https://1145.am/db/2564042/Opko_Health>,
        <https://1145.am/db/2587996/Opko_Health> ;
    ns1:sameAsMedium <https://1145.am/db/1283748/Opko_Health>,
        <https://1145.am/db/2294238/Opko_Health>,
        <https://1145.am/db/2321707/Opko_Health>,
        <https://1145.am/db/2340036/Opko_Health>,
        <https://1145.am/db/2342345/Opko_Health>,
        <https://1145.am/db/2361481/Opko_Health>,
        <https://1145.am/db/2592678/Opko_Health>,
        <https://1145.am/db/611905/Opko_Health>,
        <https://1145.am/db/613011/Opko_Health>,
        <https://1145.am/db/613838/Opko_Health> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341100/Qusome_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2012-02-27T21:38:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MIAMI, Feb 27, 2012 (BUSINESS WIRE) - OPKO Health, Inc. OPK +0.20 % announced today it made an investment in BioZone Pharmaceuticals, Inc., BZNE +47.60 % and acquired rights to BioZone's novel drug delivery platforms, including its QuSome (R) technology." ;
    ns1:documentTitle "OPKO Invests in BioZone Pharmaceuticals, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/opko-invests-biozone-pharmaceuticals-inc> ;
    ns1:foundName "acquired" ;
    ns1:name "acquired" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2341100/Qusome> ;
    ns1:targetName "QuSome" ;
    ns1:vendor <https://1145.am/db/2341100/Biozone_Pharmaceuticals_Inc> ;
    ns1:whenRaw "2012" ;
    ns1:whereGeoName "Miami" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4164138/about.rdf> ;
    ns1:whereRaw "MIAMI" .

<https://1145.am/db/2341136/Horizon_Pharma> a org:Organization ;
    ns1:documentDate "2012-02-29T16:48:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Horizon Pharma Announces $50.8 Million Private Placement" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/horizon-pharma-announces-50-8-million-private-placement> ;
    ns1:foundName "Horizon Pharma",
        "Horizon Pharma, Inc" ;
    ns1:industry "Pharma" ;
    ns1:name "Horizon Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/1573831/Horizon>,
        <https://1145.am/db/2337325/Horizon_Pharma_Plc>,
        <https://1145.am/db/2340250/Horizon_Pharma>,
        <https://1145.am/db/2345086/Horizon_Pharma_Plc>,
        <https://1145.am/db/2356175/Horizon_Pharma>,
        <https://1145.am/db/2365843/Horizon_Pharma>,
        <https://1145.am/db/2369244/Horizon_Pharma_Plc>,
        <https://1145.am/db/2569423/Horizon_Pharma_Plc>,
        <https://1145.am/db/2579775/Horizon_Pharma>,
        <https://1145.am/db/2581709/Horizon_Pharma>,
        <https://1145.am/db/2583646/Horizon_Pharma>,
        <https://1145.am/db/2584900/Horizon_Pharma>,
        <https://1145.am/db/2596292/Horizon_Pharma> ;
    ns1:sameAsMedium <https://1145.am/db/2342980/Horizon_Pharma>,
        <https://1145.am/db/2343023/Horizon_Pharma>,
        <https://1145.am/db/2344648/Horizon_Pharma_Plc>,
        <https://1145.am/db/2344675/Horizon_Pharma>,
        <https://1145.am/db/2362525/Horizon_Pharma>,
        <https://1145.am/db/2368098/Horizon_Pharma>,
        <https://1145.am/db/2368184/Horizon_Pharma_Plc>,
        <https://1145.am/db/2541469/Horizon_Pharma>,
        <https://1145.am/db/2568905/Horizon_Pharma_Plc>,
        <https://1145.am/db/2570088/Horizon_Pharma>,
        <https://1145.am/db/2570092/Horizon_Pharma>,
        <https://1145.am/db/2579783/Horizon_Pharma_Plc>,
        <https://1145.am/db/2580620/Horizon_Pharma>,
        <https://1145.am/db/2582703/Horizon_Pharma_Plc>,
        <https://1145.am/db/2582725/Horizon_Pharma>,
        <https://1145.am/db/2584647/Horizon_Pharma_Plc>,
        <https://1145.am/db/2584909/Horizon_Pharma> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343244/Argen-X> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:description "the discovery and development of human monoclonal antibodies" ;
    ns1:documentDate "2011-12-01T13:13:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argen-x-raises-eur-27-5-million-usd-37-million-oversubscribed-series-b-round> ;
    ns1:foundName "arGEN-X" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "arGEN-X" ;
    ns1:sameAsHigh <https://1145.am/db/1164950/Amryt>,
        <https://1145.am/db/1253383/Amneal_Pharmaceuticals>,
        <https://1145.am/db/2301966/Argen-X_Bv>,
        <https://1145.am/db/2313915/Argen-X_Bv>,
        <https://1145.am/db/355834/Ambrx>,
        <https://1145.am/db/365533/Ambrx> ;
    ns1:sameAsMedium <https://1145.am/db/2313911/Argen-X>,
        <https://1145.am/db/2343250/Argen-X>,
        <https://1145.am/db/2343598/Argen-X>,
        <https://1145.am/db/2369412/Argen-X> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343244/Forbion_Capital_Partners> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:description "fundraising" ;
    ns1:documentDate "2011-12-01T13:13:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argen-x-raises-eur-27-5-million-usd-37-million-oversubscribed-series-b-round> ;
    ns1:foundName "Forbion Capital Partners" ;
    ns1:investor <https://1145.am/db/2343244/Series_B_Investment_Biogeneration_Ventures_Credit_Agricole_Private_Equity_Erasmus_Biomedical_Fund_Forbion_Capital_Partners_Orbimed_Advisors_Seventure_Partners_Thuja_Capital_Vib_Argen-X_Completed> ;
    ns1:name "Forbion Capital Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2223193/Forbion_Capital_Partners>,
        <https://1145.am/db/2288529/Forbion_Capital_Partners>,
        <https://1145.am/db/2295207/Forbion_Capital_Partners>,
        <https://1145.am/db/2296065/Forbion_Capital_Partners>,
        <https://1145.am/db/2301966/Forbion_Capital_Partners>,
        <https://1145.am/db/2309865/Forbion_Capital_Partners>,
        <https://1145.am/db/2309872/Forbion_Capital_Partners>,
        <https://1145.am/db/2313401/Forbion_Capital_Partners>,
        <https://1145.am/db/2313410/Forbion_Capital_Partners>,
        <https://1145.am/db/2313915/Forbion_Capital_Partners>,
        <https://1145.am/db/2318829/Forbion_Capital_Partners>,
        <https://1145.am/db/2320503/Forbion_Capital_Partners>,
        <https://1145.am/db/2323586/Forbion_Capital_Partners>,
        <https://1145.am/db/2327009/Forbion_Capital_Partners>,
        <https://1145.am/db/2328040/Forbion_Capital_Partners>,
        <https://1145.am/db/2328763/Forbion_Capital_Partners>,
        <https://1145.am/db/2328769/Forbion_Capital_Partners>,
        <https://1145.am/db/2329919/Forbion_Capital_Partners>,
        <https://1145.am/db/2336126/Forbion_Capital_Partners>,
        <https://1145.am/db/2338373/Forbion_Capital_Partners>,
        <https://1145.am/db/2338987/Forbion_Capital_Partners>,
        <https://1145.am/db/2339427/Forbion_Capital_Partners>,
        <https://1145.am/db/2339428/Forbion_Capital_Partners>,
        <https://1145.am/db/2339932/Forbion_Capital_Partners>,
        <https://1145.am/db/2339933/Forbion_Capital_Partners>,
        <https://1145.am/db/2341942/Forbion_Capital_Partners>,
        <https://1145.am/db/2343202/Forbion_Capital_Partners>,
        <https://1145.am/db/2343210/Forbion_Capital_Partners>,
        <https://1145.am/db/2346397/Forbion_Capital_Partners>,
        <https://1145.am/db/2348506/Forbion_Capital_Partners>,
        <https://1145.am/db/2348523/Forbion_Capital_Partners>,
        <https://1145.am/db/2350101/Forbion_Capital_Partners>,
        <https://1145.am/db/2352566/Forbion_Capital_Partners>,
        <https://1145.am/db/2355511/Forbion_Capital_Partners>,
        <https://1145.am/db/2355512/Forbion_Capital_Partners>,
        <https://1145.am/db/2356989/Forbion_Capital_Partners>,
        <https://1145.am/db/2357941/Forbion_Capital_Partners>,
        <https://1145.am/db/2357956/Forbion_Capital_Partners>,
        <https://1145.am/db/2359960/Forbion_Capital_Partners>,
        <https://1145.am/db/2360313/Forbion_Capital_Partners>,
        <https://1145.am/db/2360317/Forbion_Capital_Partners>,
        <https://1145.am/db/2361390/Forbion_Capital_Partners>,
        <https://1145.am/db/2363593/Forbion_Capital_Partners>,
        <https://1145.am/db/2363597/Forbion_Capital_Partners>,
        <https://1145.am/db/2366539/Forbion_Capital_Partners>,
        <https://1145.am/db/2369872/Forbion_Capital_Partners>,
        <https://1145.am/db/2370054/Forbion_Capital_Partners>,
        <https://1145.am/db/2370056/Forbion_Capital_Partners>,
        <https://1145.am/db/2538923/Forbion_Capital_Partners>,
        <https://1145.am/db/2569491/Forbion_Capital_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343300/Mission_Therapeutics_Ltd> a org:Organization ;
    ns1:basedInHighGeoName "Cambridgeshire",
        "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2635167/about.rdf>,
        <https://sws.geonames.org/2653940/about.rdf> ;
    ns1:basedInHighRaw "Cambridge",
        "UK" ;
    ns1:description "cancer" ;
    ns1:documentDate "2011-08-25T13:28:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MISSION THERAPEUTICS, A NEW CAMBRIDGE-BASED SPIN-OUT COMPANY, SECURES £6M IN SERIES-A FUNDING LED BY SOFINNOVA PARTNERS" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mission-therapeutics-a-new-cambridge-based-spin-out-company-secures-%C2%A36m-series-a-funding> ;
    ns1:foundName "MISSION THERAPEUTICS",
        "MISSION Therapeutics Ltd" ;
    ns1:name "MISSION Therapeutics Ltd",
        "Mission Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1420108/Enliven_Therapeutics>,
        <https://1145.am/db/1468422/Compass_Therapeutics>,
        <https://1145.am/db/2280863/Gotham_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2336335/Mission_Therapeutics_Limited>,
        <https://1145.am/db/2367549/Mission_Therapeutics>,
        <https://1145.am/db/2367944/Mission_Therapeutics>,
        <https://1145.am/db/2369699/Mission_Therapeutics>,
        <https://1145.am/db/2370809/Mission_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344274/Assets_Acquisition_Momenta_Pharmaceuticals_Inc_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-12-05T17:22:34+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, Mass., Dec 5, 2011 (GlobeNewswire via COMTEX) - Momenta Pharmaceuticals, Inc. MNTA +0.12 %, a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it has signed an agreement to acquire the Sialic Switch assets of Virdante Pharmaceuticals, Inc., including intellectual property and cell lines, relating to the sialylation of intravenous immunoglobulin (IVIG) and other proteins." ;
    ns1:documentTitle "Momenta Pharmaceuticals Acquires Assets From Virdante Pharmaceuticals" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/momenta-pharmaceuticals-acquires-assets-from-virdante-pharmaceuticals> ;
    ns1:foundName "acquire" ;
    ns1:name "acquire" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:targetDetails "assets" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2344274/Assets_Acquisition_Momenta_Pharmaceuticals_Inc_Momenta_Pharmaceuticals_Inc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-12-05T17:22:34+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Momenta Pharmaceuticals Acquires Assets From Virdante Pharmaceuticals." ;
    ns1:documentTitle "Momenta Pharmaceuticals Acquires Assets From Virdante Pharmaceuticals" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/momenta-pharmaceuticals-acquires-assets-from-virdante-pharmaceuticals> ;
    ns1:foundName "Acquires" ;
    ns1:name "Acquires" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:targetDetails "Assets" ;
    ns1:vendor <https://1145.am/db/2344274/Momenta_Pharmaceuticals_Inc> ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2344274/Investment_Momenta_Pharmaceuticals_Inc_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-12-05T17:22:34+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Momenta made an upfront payment of $ 4.5 million and may make additional contingent milestone payments, which, if all development and regulatory milestones are achieved, will total $ 51.5 million." ;
    ns1:documentTitle "Momenta Pharmaceuticals Acquires Assets From Virdante Pharmaceuticals" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/momenta-pharmaceuticals-acquires-assets-from-virdante-pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:valueRaw "$ 4.5 million",
        "$ 51.5 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2344274/Momenta_Pharmaceuticals_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE, Mass." ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2344274/Assets_Acquisition_Momenta_Pharmaceuticals_Inc_Has_Not_Happened>,
        <https://1145.am/db/2344274/Assets_Acquisition_Momenta_Pharmaceuticals_Inc_Momenta_Pharmaceuticals_Inc_Completed> ;
    ns1:description "Pharmaceuticals",
        "a biotechnology company" ;
    ns1:documentDate "2011-12-05T17:22:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Momenta Pharmaceuticals Acquires Assets From Virdante Pharmaceuticals" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/momenta-pharmaceuticals-acquires-assets-from-virdante-pharmaceuticals> ;
    ns1:foundName "Momenta",
        "Momenta Pharmaceuticals",
        "Momenta Pharmaceuticals, Inc. MNTA",
        "Momenta Pharmaceuticals, Inc. MNTA +0.12 %",
        "Virdante Pharmaceuticals, Inc.",
        "Virdante Pharmaceuticals." ;
    ns1:industry "biotechnology",
        "pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2344274/Investment_Momenta_Pharmaceuticals_Inc_Has_Not_Happened> ;
    ns1:name "Momenta Pharmaceuticals",
        "Momenta Pharmaceuticals, Inc.",
        "Virdante Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/1081367/Casi_Pharmaceuticals_Inc>,
        <https://1145.am/db/1192310/Casi_Pharmaceuticals_Inc>,
        <https://1145.am/db/1366554/Casi_Pharmaceuticals_Inc>,
        <https://1145.am/db/1396752/Cevec_Pharmaceuticals>,
        <https://1145.am/db/2153295/Curzion_Pharmaceuticals>,
        <https://1145.am/db/2156297/Cerevel>,
        <https://1145.am/db/2285587/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2287377/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2301933/Ecr_Pharmaceuticals>,
        <https://1145.am/db/2301947/Ecr_Pharmaceuticals>,
        <https://1145.am/db/2302649/Ecr_Pharmaceuticals>,
        <https://1145.am/db/2309970/Eurand_Pharmaceuticals>,
        <https://1145.am/db/2311099/Celator_Pharmaceuticals>,
        <https://1145.am/db/2313397/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2313471/Celator_Pharmaceuticals>,
        <https://1145.am/db/2314551/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2314554/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2320852/Cempra_Pharmaceuticals>,
        <https://1145.am/db/2320853/Cempra_Pharmaceuticals>,
        <https://1145.am/db/2322242/Cerimon_Pharmaceuticals>,
        <https://1145.am/db/2326327/Provectus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2328825/Cempra_Pharmaceuticals>,
        <https://1145.am/db/2330539/Celator_Pharmaceuticals>,
        <https://1145.am/db/2338173/Celator_Pharmaceuticals>,
        <https://1145.am/db/2339182/Provectus_Pharmaceuticals>,
        <https://1145.am/db/2353209/Celator_Pharmaceuticals>,
        <https://1145.am/db/2355936/Celator_Pharmaceuticals>,
        <https://1145.am/db/2355938/Celator_Pharmaceuticals>,
        <https://1145.am/db/2361666/Celator®_Pharmaceuticals>,
        <https://1145.am/db/2363331/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2364675/Cevec_Pharmaceuticals>,
        <https://1145.am/db/2364774/Cevec_Pharmaceuticals>,
        <https://1145.am/db/2364776/Cevec_Pharmaceuticals>,
        <https://1145.am/db/2365376/Cevec_Pharmaceuticals>,
        <https://1145.am/db/2365795/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2366302/Cempra_Pharmaceuticals>,
        <https://1145.am/db/2367072/Provectus_Pharmaceuticals>,
        <https://1145.am/db/2367292/Cempra_Pharmaceuticals>,
        <https://1145.am/db/2368333/Celator_Pharmaceuticals>,
        <https://1145.am/db/2537737/Cevec_Pharmaceuticals>,
        <https://1145.am/db/2553248/Cenes_Pharmaceutical>,
        <https://1145.am/db/2574942/Celator_Pharmaceuticals>,
        <https://1145.am/db/2579346/Momenta_Pharmaceuticals>,
        <https://1145.am/db/958376/Cardior_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2312358/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2314347/Momenta_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344357/Metabolon> a org:Organization ;
    ns1:basedInHighGeoName "Park County",
        "Research",
        "Triangle" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2151718/about.rdf>,
        <https://sws.geonames.org/4790025/about.rdf>,
        <https://sws.geonames.org/5834587/about.rdf> ;
    ns1:basedInHighRaw "Research Triangle Park" ;
    ns1:description "Biochemical profiling" ;
    ns1:documentDate "2011-08-31T12:06:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Metabolon Secures $13 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/metabolon-secures-13-million-series-d-financing> ;
    ns1:foundName "Metabolon, Inc." ;
    ns1:industry "diagnostics and services" ;
    ns1:name "Metabolon" ;
    ns1:sameAsHigh <https://1145.am/db/2289020/Metabolon>,
        <https://1145.am/db/2295920/Metabolon>,
        <https://1145.am/db/2295941/Metabolon>,
        <https://1145.am/db/2300147/Metabolon>,
        <https://1145.am/db/2368199/Metabolon>,
        <https://1145.am/db/2368539/Metabolon>,
        <https://1145.am/db/548260/Metabolon> ;
    ns1:sameAsMedium <https://1145.am/db/1073716/Metabolon>,
        <https://1145.am/db/1229443/Metabolon>,
        <https://1145.am/db/2289056/Metabolon>,
        <https://1145.am/db/2293278/Metabolon>,
        <https://1145.am/db/2296512/Metabolon>,
        <https://1145.am/db/2303707/Metabolon>,
        <https://1145.am/db/2323317/Metabolon>,
        <https://1145.am/db/2324755/Metabolon>,
        <https://1145.am/db/2324756/Metabolon_Inc>,
        <https://1145.am/db/2333582/Metabolon>,
        <https://1145.am/db/2339592/Metabolon>,
        <https://1145.am/db/2344356/Metabolon>,
        <https://1145.am/db/830906/Metabolon> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2345318/Aratana_Therapeutics> a org:Organization ;
    ns1:description "developing innovative medicines for companion animals" ;
    ns1:documentDate "2011-12-07T15:38:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aratana Therapeutics Completes $15 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aratana-therapeutics-completes-15-million-series-b-financing> ;
    ns1:foundName "Aratana",
        "Aratana Therapeutics" ;
    ns1:industry "animal health" ;
    ns1:name "Aratana Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2337545/Aratana_Therapeutics>,
        <https://1145.am/db/2342737/Aratana_Therapeutics>,
        <https://1145.am/db/2345299/Aratana_Therapeutics>,
        <https://1145.am/db/2345317/Aratana_Therapeutics>,
        <https://1145.am/db/2359433/Aratana_Therapeutics_Inc>,
        <https://1145.am/db/2360046/Aratana_Therapeutics>,
        <https://1145.am/db/2363729/Aratana_Therapeutics>,
        <https://1145.am/db/2366744/Aratana_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2342733/Aratana_Therapeutics>,
        <https://1145.am/db/2359431/Aratana_Therapeutics>,
        <https://1145.am/db/2369239/Aratana_Therapeutics>,
        <https://1145.am/db/2369321/Aratana_Therapeutics>,
        <https://1145.am/db/2585632/Aratana_Therapeutics>,
        <https://1145.am/db/2587577/Aratana_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347389/Catabasis_Pharmaceuticals> a org:Organization ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2011-12-13T13:29:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/catabasis-pharmaceuticals-announces-8-million-series-a-extension-financing> ;
    ns1:foundName "Catabasis Pharmaceuticals" ;
    ns1:industry "pharmaceuticals" ;
    ns1:name "Catabasis Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/1069901/Catalent>,
        <https://1145.am/db/1264351/Catalent>,
        <https://1145.am/db/1270682/Catalent>,
        <https://1145.am/db/1351895/Catalent>,
        <https://1145.am/db/2084319/Catalent>,
        <https://1145.am/db/2100621/Catalent>,
        <https://1145.am/db/2294570/Catalent>,
        <https://1145.am/db/2317369/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2319326/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2322832/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2322846/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2329323/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2330434/Catalent>,
        <https://1145.am/db/2330437/Catalent>,
        <https://1145.am/db/2332572/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2334009/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2334028/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2334622/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2334624/Catalent>,
        <https://1145.am/db/2334628/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2334630/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2336296/Catabasis_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336303/Catabasis_Pharmaceuticals>,
        <https://1145.am/db/2336313/Catabasis_Pharmaceuticals>,
        <https://1145.am/db/2339783/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2340228/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2341652/Catabasis_Pharmaceuticals>,
        <https://1145.am/db/2342265/Catalent_Pharma>,
        <https://1145.am/db/2342267/Catalent_Pharma_Solutions_Inc>,
        <https://1145.am/db/2342506/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2343722/Catabasis_Pharmaceuticals>,
        <https://1145.am/db/2343725/Catabasis_Pharmaceuticals>,
        <https://1145.am/db/2343737/Catabasis_Pharmaceuticals>,
        <https://1145.am/db/2347391/Catabasis_Pharmaceuticals>,
        <https://1145.am/db/2347773/Catabasis_Pharmaceuticals>,
        <https://1145.am/db/2352114/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2353371/Catabasis_Pharmaceuticals>,
        <https://1145.am/db/2353463/Catabasis_Pharmaceuticals>,
        <https://1145.am/db/2354134/Catabasis_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358718/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2360756/Catabasis_Pharmaceuticals>,
        <https://1145.am/db/2360758/Catabasis_Pharmaceuticals>,
        <https://1145.am/db/2364972/Catabasis_Pharmaceuticals>,
        <https://1145.am/db/2367443/Catabasis_Pharmaceuticals>,
        <https://1145.am/db/2368835/Catalent>,
        <https://1145.am/db/2537127/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2537129/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2537640/Catalent_Inc>,
        <https://1145.am/db/2539210/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2539211/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2539575/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2540557/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2543491/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2544301/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2545252/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2545304/Catalent>,
        <https://1145.am/db/2547176/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2550077/Catalent>,
        <https://1145.am/db/2557238/Catalent>,
        <https://1145.am/db/2557482/Catalent>,
        <https://1145.am/db/2560766/Catalent>,
        <https://1145.am/db/2564490/Catalent>,
        <https://1145.am/db/2567731/Catalent>,
        <https://1145.am/db/2568494/Catalent>,
        <https://1145.am/db/2575565/Catalent_Pharma_Solutions>,
        <https://1145.am/db/2580881/Catabasis_Pharmaceuticals>,
        <https://1145.am/db/2594015/Catalent>,
        <https://1145.am/db/2594016/Catalent>,
        <https://1145.am/db/326452/Catalent>,
        <https://1145.am/db/360587/Catalent>,
        <https://1145.am/db/383164/Catalent>,
        <https://1145.am/db/435547/Catalent_Inc>,
        <https://1145.am/db/437463/Catalent_Inc>,
        <https://1145.am/db/496631/Catalent_Pharma_Solutions>,
        <https://1145.am/db/497145/Catalent_Pharma_Solutions>,
        <https://1145.am/db/734505/Catalent>,
        <https://1145.am/db/911386/Catalent>,
        <https://1145.am/db/995486/Catalent> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347397/Immusant> a org:Organization ;
    ns1:description "immunotherapeutic and diagnostic for Celiac Disease" ;
    ns1:documentDate "2011-12-13T14:26:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "ImmusanT Raises $20 Million in Series A Financing to Advance Immunotherapeutic and Diagnostic for Celiac Disease Read more: htt" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/immusant-raises-20-million-series-a-financing-to-advance-immunotherapeutic-and-diagnostic> ;
    ns1:foundName "ImmusanT",
        "ImmusanT, Inc." ;
    ns1:industry "biotechnology" ;
    ns1:name "ImmusanT" ;
    ns1:sameAsHigh <https://1145.am/db/2353234/Intrexon>,
        <https://1145.am/db/2358092/Inocard> ;
    ns1:sameAsMedium <https://1145.am/db/2290947/Immusant>,
        <https://1145.am/db/2296222/Immusant>,
        <https://1145.am/db/2352125/Immusant>,
        <https://1145.am/db/2354004/Immusant>,
        <https://1145.am/db/2354009/Immusant_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347397/Series_A_Investment_Immusant_Vatera_Healthcare_Partners_Llc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-12-13T14:26:01+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, Mass., Dec. 13, 2011 - /PRNewswire/ - ImmusanT, Inc. announced today it has raised $ 20 million in Series A financing from Vatera Healthcare Partners LLC to advance development of the biotechnology company's immunotherapeutic vaccine Nexvax2®, companion diagnostic and monitoring tool for celiac disease.",
        "ImmusanT Raises $ 20 Million in Series A Financing to Advance Immunotherapeutic and Diagnostic for Celiac Disease." ;
    ns1:documentTitle "ImmusanT Raises $20 Million in Series A Financing to Advance Immunotherapeutic and Diagnostic for Celiac Disease Read more: htt" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/immusant-raises-20-million-series-a-financing-to-advance-immunotherapeutic-and-diagnostic> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2347397/Immusant> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 20 Million",
        "$ 20 million" ;
    ns1:whenRaw "2011" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "CAMBRIDGE, Mass." .

<https://1145.am/db/2348448/Bessemer_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:documentDate "2011-12-15T14:20:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cerulean Pharma Closes $15 Million Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cerulean-pharma-closes-15-million-series-d-financing> ;
    ns1:foundName "Bessemer Venture Partners" ;
    ns1:investor <https://1145.am/db/2348448/Series_D_Investment_Bessemer_Venture_Partners_Cvf_Llc_Cerulean_Pharma_Inc_Henry_Crown_And_Company_Lilly_Ventures_Lux_Capital_Polaris_Venture_Partners_Venrock_Completed> ;
    ns1:name "Bessemer Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1060146/Bessemer_Venture_Partners>,
        <https://1145.am/db/1061468/Bessemer_Venture_Partners>,
        <https://1145.am/db/1061911/Bessemer_Venture_Partners>,
        <https://1145.am/db/1064710/Bessemer_Venture_Partners>,
        <https://1145.am/db/1090262/Bessemer_Venture_Partners>,
        <https://1145.am/db/1140521/Bessemer_Venture_Partners>,
        <https://1145.am/db/1150887/Bessemer_Venture_Partners>,
        <https://1145.am/db/1153184/Bessemer_Venture_Partners>,
        <https://1145.am/db/1168925/Bessemer_Venture_Partners>,
        <https://1145.am/db/1171251/Bessemer_Venture_Partners>,
        <https://1145.am/db/1287496/Bessemer_Venture_Partners>,
        <https://1145.am/db/1297270/Bessemer_Venture_Partners>,
        <https://1145.am/db/1298072/Bessemer_Venture_Partners>,
        <https://1145.am/db/1311917/Bessemer_Venture_Partners>,
        <https://1145.am/db/1412727/Bessemer_Venture_Partners>,
        <https://1145.am/db/1445566/Bessemer_Venture_Partners>,
        <https://1145.am/db/1449740/Bessemer_Venture_Partners>,
        <https://1145.am/db/1480187/Bessemer_Venture_Partners>,
        <https://1145.am/db/1490295/Bessemer_Venture_Partners>,
        <https://1145.am/db/1667738/Bessemer_Venture_Partners>,
        <https://1145.am/db/1669991/Bessemer_Venture_Partners>,
        <https://1145.am/db/1697155/Bessemer_Venture_Partners>,
        <https://1145.am/db/1698509/Bessemer_Venture_Partners>,
        <https://1145.am/db/1703633/Bessemer_Venture_Partners>,
        <https://1145.am/db/1706697/Bessemer_Venture_Partners>,
        <https://1145.am/db/1707187/Bessemer_Venture_Partners>,
        <https://1145.am/db/1712471/Bessemer_Venture_Partners>,
        <https://1145.am/db/1717313/Bessemer_Venture_Partners>,
        <https://1145.am/db/1718800/Bessemer_Venture_Partners>,
        <https://1145.am/db/1723948/Bessemer_Venture_Partners>,
        <https://1145.am/db/1725530/Bessemer_Venture_Partners>,
        <https://1145.am/db/1726088/Bessemer_Venture_Partners>,
        <https://1145.am/db/1731036/Bessemer_Venture_Partners>,
        <https://1145.am/db/1735755/Bessemer_Venture_Partners>,
        <https://1145.am/db/1736811/Bessemer_Venture_Partners>,
        <https://1145.am/db/1742802/Bessemer_Venture_Partners>,
        <https://1145.am/db/1744158/Bessemer_Venture_Partners>,
        <https://1145.am/db/1744201/Bessemer_Venture_Partners>,
        <https://1145.am/db/1744656/Bessemer_Venture_Partners>,
        <https://1145.am/db/1744676/Bessemer_Venture_Partners>,
        <https://1145.am/db/1748765/Bessemer_Venture_Partners>,
        <https://1145.am/db/1749643/Bessemer_Venture_Partners>,
        <https://1145.am/db/1750217/Bessemer_Venture_Partners>,
        <https://1145.am/db/1751506/Bessemer_Venture_Partners>,
        <https://1145.am/db/1751790/Bessemer_Venture_Partners>,
        <https://1145.am/db/1751800/Bessemer_Venture_Partners>,
        <https://1145.am/db/1752609/Bessemer_Venture_Partners>,
        <https://1145.am/db/1756092/Bessemer_Venture_Partners>,
        <https://1145.am/db/1756150/Bessemer_Venture_Partners>,
        <https://1145.am/db/1756999/Bessemer_Venture_Partners>,
        <https://1145.am/db/1757845/Bessemer_Venture_Partners>,
        <https://1145.am/db/1758776/Bessemer_Venture_Partners>,
        <https://1145.am/db/1759851/Bessemer_Venture_Partners>,
        <https://1145.am/db/1759923/Bessemer_Venture_Partners>,
        <https://1145.am/db/1760213/Bessemer_Venture_Partners>,
        <https://1145.am/db/1762343/Bessemer_Venture_Partners>,
        <https://1145.am/db/1763433/Bessemer_Venture_Partners>,
        <https://1145.am/db/1763774/Bessemer_Venture_Partners>,
        <https://1145.am/db/1765092/Bessemer_Venture_Partners>,
        <https://1145.am/db/1765646/Bessemer_Venture_Partners>,
        <https://1145.am/db/1767075/Bessemer_Venture_Partners>,
        <https://1145.am/db/1771769/Bessemer_Venture_Partners>,
        <https://1145.am/db/1772047/Bessemer_Venture_Partners>,
        <https://1145.am/db/1772381/Bessemer_Venture_Partners>,
        <https://1145.am/db/1774323/Bessemer_Venture_Partners>,
        <https://1145.am/db/1775794/Bessemer_Venture_Partners>,
        <https://1145.am/db/1776988/Bessemer_Venture_Partners>,
        <https://1145.am/db/1778844/Bessemer_Venture_Partners>,
        <https://1145.am/db/1779320/Bessemer_Venture_Partners>,
        <https://1145.am/db/1779634/Bessemer_Venture_Partners>,
        <https://1145.am/db/1780998/Bessemer_Venture_Partners>,
        <https://1145.am/db/1795531/Bessemer_Venture_Partners>,
        <https://1145.am/db/1797945/Bessemer_Venture_Partners>,
        <https://1145.am/db/1800364/Bessemer_Venture_Partners>,
        <https://1145.am/db/1801088/Bessemer_Venture_Partners>,
        <https://1145.am/db/1802034/Bessemer_Venture_Partners>,
        <https://1145.am/db/1802590/Bessemer_Venture_Partners>,
        <https://1145.am/db/1802834/Bessemer_Venture_Partners>,
        <https://1145.am/db/1806684/Bessemer_Venture_Partners>,
        <https://1145.am/db/1808735/Bessemer_Venture_Partners>,
        <https://1145.am/db/1813337/Bessemer_Venture_Partners>,
        <https://1145.am/db/1813349/Bessemer_Venture_Partners>,
        <https://1145.am/db/1814014/Bessemer_Venture_Partners>,
        <https://1145.am/db/1816701/Bessemer_Venture_Partners>,
        <https://1145.am/db/1818326/Bessemer_Venture_Partners>,
        <https://1145.am/db/1818535/Bessemer_Venture_Partners>,
        <https://1145.am/db/1819651/Bessemer_Venture_Partners>,
        <https://1145.am/db/1820660/Bessemer_Venture_Partners>,
        <https://1145.am/db/1821929/Bessemer_Venture_Partners>,
        <https://1145.am/db/1823001/Bessemer_Venture_Partners>,
        <https://1145.am/db/1823415/Bessemer_Venture_Partners>,
        <https://1145.am/db/1825267/Bessemer_Venture_Partners>,
        <https://1145.am/db/1826794/Bessemer_Ventures_Partners>,
        <https://1145.am/db/1828092/Bessemer_Venture_Partners>,
        <https://1145.am/db/1833296/Bessemer_Venture_Partners>,
        <https://1145.am/db/1836250/Bessemer_Venture_Partners>,
        <https://1145.am/db/1838678/Bessemer_Venture_Partners>,
        <https://1145.am/db/1839990/Bessemer_Venture_Partners>,
        <https://1145.am/db/1843244/Bessemer_Venture_Partners>,
        <https://1145.am/db/1846957/Bessemer_Venture_Partners>,
        <https://1145.am/db/1847160/Bessemer_Venture_Partners>,
        <https://1145.am/db/1849046/Bessemer_Venture_Partners>,
        <https://1145.am/db/1849606/Bessemer_Venture_Partners>,
        <https://1145.am/db/1849746/Bessemer_Venture_Partners>,
        <https://1145.am/db/1850076/Bessemer_Venture_Partners>,
        <https://1145.am/db/1850727/Bessemer_Venture_Partners>,
        <https://1145.am/db/1851792/Bessemer_Venture_Partners>,
        <https://1145.am/db/1853292/Bessemer_Venture_Partners>,
        <https://1145.am/db/1856085/Bessemer_Venture_Partners>,
        <https://1145.am/db/1857212/Bessemer_Venture_Partners>,
        <https://1145.am/db/1857278/Bessemer_Venture_Partners>,
        <https://1145.am/db/1859331/Bessemer_Venture_Partners>,
        <https://1145.am/db/1860367/Bessemer_Venture_Partners>,
        <https://1145.am/db/1860406/Bessemer_Venture_Partners>,
        <https://1145.am/db/1860637/Bessemer_Venture_Partners>,
        <https://1145.am/db/1861518/Bessemer_Venture_Partners>,
        <https://1145.am/db/1866032/Bessemer_Venture_Partners>,
        <https://1145.am/db/1876003/Bessemer_Venture_Partners>,
        <https://1145.am/db/1883858/Bessemer_Venture_Partners>,
        <https://1145.am/db/1885320/Bessemer_Venture_Partners>,
        <https://1145.am/db/1885998/Bessemer_Venture_Partners>,
        <https://1145.am/db/1889732/Bessemer_Venture_Partners>,
        <https://1145.am/db/1892105/Bessemer_Venture_Partners>,
        <https://1145.am/db/1893502/Bessemer_Venture_Partners>,
        <https://1145.am/db/1898837/Bessemer_Venture_Partners>,
        <https://1145.am/db/1904197/Bessemer_Venture_Partners>,
        <https://1145.am/db/1910644/Bessemer_Venture_Partners>,
        <https://1145.am/db/1914189/Bessemer_Venture_Partners>,
        <https://1145.am/db/1917346/Bessemer_Venture_Partners>,
        <https://1145.am/db/1921374/Bessemer_Venture_Partners>,
        <https://1145.am/db/1921599/Bessemer_Venture_Partners>,
        <https://1145.am/db/1947303/Bessemer_Venture_Partners>,
        <https://1145.am/db/1954147/Bessemer_Venture_Partners>,
        <https://1145.am/db/2011521/Bessemer_Venture_Partners>,
        <https://1145.am/db/2013193/Bessemer_Venture_Partners>,
        <https://1145.am/db/2031790/Bessemer_Venture_Partners>,
        <https://1145.am/db/2043214/Bessemer_Venture_Partners>,
        <https://1145.am/db/2051110/Bessemer_Venture_Partners>,
        <https://1145.am/db/2059038/Bessemer_Venture_Partners>,
        <https://1145.am/db/2070098/Bessemer_Venture_Partners>,
        <https://1145.am/db/207823/Bessemer_Venture_Partners>,
        <https://1145.am/db/2125259/Bessemer_Venture_Partners>,
        <https://1145.am/db/2127786/Bessemer_Venture_Partners>,
        <https://1145.am/db/2141061/Bessemer_Venture_Partners>,
        <https://1145.am/db/2142825/Bessemer_Venture_Partners>,
        <https://1145.am/db/2173983/Bessemer_Venture_Partners>,
        <https://1145.am/db/2181016/Bessemer_Venture_Partners>,
        <https://1145.am/db/2194210/Bessemer_Venture_Partners>,
        <https://1145.am/db/2197248/Bessemer_Venture_Partners>,
        <https://1145.am/db/221321/Bessemer_Venture_Partners>,
        <https://1145.am/db/2236188/Bessemer_Venture_Partners>,
        <https://1145.am/db/2303250/Bessemer_Venture_Partners>,
        <https://1145.am/db/2303251/Bessemer_Venture_Partners>,
        <https://1145.am/db/2303257/Bessemer_Venture_Partners>,
        <https://1145.am/db/2303675/Bessemer_Venture_Partners>,
        <https://1145.am/db/2311551/Bessemer_Venture_Partners>,
        <https://1145.am/db/2316356/Bessemer_Venture_Partners>,
        <https://1145.am/db/2317918/Bessemer_Venture_Partners>,
        <https://1145.am/db/2324076/Bessemer_Venture_Partners>,
        <https://1145.am/db/2325326/Bessemer_Venture_Partners>,
        <https://1145.am/db/2338625/Bessemer_Venture_Partners>,
        <https://1145.am/db/2338633/Bessemer_Venture_Partners>,
        <https://1145.am/db/2339925/Bessemer_Venture_Partners>,
        <https://1145.am/db/2339926/Bessemer_Venture_Partners>,
        <https://1145.am/db/2349437/Bessemer_Venture_Partners>,
        <https://1145.am/db/2351520/Bessemer_Venture_Partners>,
        <https://1145.am/db/2352414/Bessemer_Venture_Partners>,
        <https://1145.am/db/2353404/Bessemer_Venture_Partners>,
        <https://1145.am/db/2353415/Bessemer_Venture_Partners>,
        <https://1145.am/db/2362871/Bessemer_Venture_Partners>,
        <https://1145.am/db/2363330/Bessemer_Venture_Partners>,
        <https://1145.am/db/2621506/Bessemer_Venture_Partners>,
        <https://1145.am/db/2677219/Bessemer_Venture_Partners>,
        <https://1145.am/db/2766437/Bessemer_Venture_Partners>,
        <https://1145.am/db/293891/Bessemer_Venture_Partners>,
        <https://1145.am/db/325080/Bessemer_Venture_Partners>,
        <https://1145.am/db/341984/Bessemer_Venture_Partners>,
        <https://1145.am/db/341990/Bessemer_Venture_Partners>,
        <https://1145.am/db/425262/Bessemer_Venture_Partners>,
        <https://1145.am/db/472389/Bessemer_Venture_Partners>,
        <https://1145.am/db/473354/Bessemer_Venture_Partners>,
        <https://1145.am/db/478025/Bessemer_Venture_Partners>,
        <https://1145.am/db/506309/Bessemer_Venture_Partners>,
        <https://1145.am/db/507249/Bessemer_Venture_Partners>,
        <https://1145.am/db/508115/Bessemer_Venture_Partners>,
        <https://1145.am/db/511072/Bessemer_Venture_Partners>,
        <https://1145.am/db/513305/Bessemer_Venture_Partners>,
        <https://1145.am/db/559318/Bessemer_Venture_Partners>,
        <https://1145.am/db/575249/Bessemer_Venture_Partners>,
        <https://1145.am/db/606291/Bessemer_Venture_Partners>,
        <https://1145.am/db/668230/Bessemer_Venture_Partners>,
        <https://1145.am/db/668965/Bessemer_Venture_Partners>,
        <https://1145.am/db/676869/Bessemer_Venture_Partners>,
        <https://1145.am/db/678140/Bessemer_Venture_Partners>,
        <https://1145.am/db/694924/Bessemer_Venture_Partners>,
        <https://1145.am/db/699860/Bessemer_Venture_Partners>,
        <https://1145.am/db/700171/Bessemer_Venture_Partners>,
        <https://1145.am/db/803541/Bessemer_Venture_Partners>,
        <https://1145.am/db/829118/Bessemer_Venture_Partners>,
        <https://1145.am/db/8314/Bessemer_Venture_Partners>,
        <https://1145.am/db/832264/Bessemer_Venture_Partners>,
        <https://1145.am/db/847157/Bessemer_Venture_Partners>,
        <https://1145.am/db/862760/Bessemer_Venture_Partners>,
        <https://1145.am/db/862851/Bessemer_Venture_Partners>,
        <https://1145.am/db/877618/Bessemer_Venture_Partners>,
        <https://1145.am/db/884806/Bessemer_Venture_Partners>,
        <https://1145.am/db/902390/Bessemer_Venture_Partners>,
        <https://1145.am/db/907582/Bessemer_Venture_Partners>,
        <https://1145.am/db/907975/Bessemer_Venture_Partners>,
        <https://1145.am/db/924505/Bessemer_Venture_Partners>,
        <https://1145.am/db/955858/Bessemer_Venture_Partners>,
        <https://1145.am/db/960320/Bessemer_Venture_Partners>,
        <https://1145.am/db/971418/Bessemer_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348448/Cerulean_Pharma_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE, Mass." ;
    ns1:description "designing and developing nanopharmaceuticals" ;
    ns1:documentDate "2011-12-15T14:20:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cerulean Pharma Closes $15 Million Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cerulean-pharma-closes-15-million-series-d-financing> ;
    ns1:foundName "Cerulean Pharma",
        "Cerulean Pharma Inc." ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Cerulean Pharma",
        "Cerulean Pharma Inc." ;
    ns1:sameAsHigh <https://1145.am/db/1019870/Moderna>,
        <https://1145.am/db/1028098/A2pg>,
        <https://1145.am/db/1028744/Apnimed>,
        <https://1145.am/db/1029882/Apnimed>,
        <https://1145.am/db/1041428/Dr>,
        <https://1145.am/db/1042161/Wellgistics>,
        <https://1145.am/db/1042221/Wellgistics>,
        <https://1145.am/db/1096114/Astorg>,
        <https://1145.am/db/1096677/Astorg>,
        <https://1145.am/db/1138447/Apnimed>,
        <https://1145.am/db/1139445/Apnimed>,
        <https://1145.am/db/1152269/Alpha-5>,
        <https://1145.am/db/1163849/Productlife_Group>,
        <https://1145.am/db/1172760/Apexigen>,
        <https://1145.am/db/1215735/Astorg>,
        <https://1145.am/db/1219810/Prokidney_Corp>,
        <https://1145.am/db/1271008/Reviral_Ltd>,
        <https://1145.am/db/1272754/Prokidney_Corp>,
        <https://1145.am/db/1294637/LTS>,
        <https://1145.am/db/1307202/Leo_Pharma>,
        <https://1145.am/db/1309648/Achrom>,
        <https://1145.am/db/1323486/Glo_Pharma>,
        <https://1145.am/db/1374672/Sp_Industries>,
        <https://1145.am/db/1384852/Moderna_Inc>,
        <https://1145.am/db/1391799/Pharnext>,
        <https://1145.am/db/1454905/Aquestive>,
        <https://1145.am/db/1505021/Pharmaceutics_International_Inc>,
        <https://1145.am/db/1540522/Atec>,
        <https://1145.am/db/1541946/Abiomed>,
        <https://1145.am/db/1562763/Indivior>,
        <https://1145.am/db/1613904/Apnimed_Inc>,
        <https://1145.am/db/1615580/Apnimed>,
        <https://1145.am/db/1617770/Pharnext_Sa>,
        <https://1145.am/db/1648815/Indevr>,
        <https://1145.am/db/1681016/Enveric_Biosciences>,
        <https://1145.am/db/1745685/Drugstoc>,
        <https://1145.am/db/1838777/Medikly>,
        <https://1145.am/db/1936167/Reviral_Ltd>,
        <https://1145.am/db/1962783/Ora_Inc>,
        <https://1145.am/db/2039692/Rk_Pharma_Inc>,
        <https://1145.am/db/2051589/Ora_Inc>,
        <https://1145.am/db/2060641/Abionyx_Pharma>,
        <https://1145.am/db/2073336/Ose>,
        <https://1145.am/db/2132018/Solutions>,
        <https://1145.am/db/2139917/Leo_Pharma>,
        <https://1145.am/db/2151848/D___D_Pharmatech>,
        <https://1145.am/db/2152469/Sobi003>,
        <https://1145.am/db/2152499/Highchem>,
        <https://1145.am/db/2152633/Themis>,
        <https://1145.am/db/2152849/Therachon>,
        <https://1145.am/db/2152901/Abcellera>,
        <https://1145.am/db/2154166/Leo_Pharma>,
        <https://1145.am/db/2154252/Phoremost>,
        <https://1145.am/db/2155490/Enterome>,
        <https://1145.am/db/2155631/Achillion>,
        <https://1145.am/db/2155863/Therachon>,
        <https://1145.am/db/2212420/Cel-Sci_Corporation>,
        <https://1145.am/db/2235873/M3_Usa>,
        <https://1145.am/db/2244405/Seek>,
        <https://1145.am/db/2281535/Eqt_Life_Sciences>,
        <https://1145.am/db/2281676/Apnimed>,
        <https://1145.am/db/2283559/Oric>,
        <https://1145.am/db/2283918/Indivior>,
        <https://1145.am/db/2286215/Pandion>,
        <https://1145.am/db/2289550/Well>,
        <https://1145.am/db/2290753/Medivir>,
        <https://1145.am/db/2294621/Pharmaceutics_International>,
        <https://1145.am/db/2296235/Apexigen>,
        <https://1145.am/db/2297631/Clarient>,
        <https://1145.am/db/2298376/Caprion>,
        <https://1145.am/db/2301879/Magen_Biosciences>,
        <https://1145.am/db/2302863/Amri>,
        <https://1145.am/db/2303412/Hologic>,
        <https://1145.am/db/2303415/Amevive>,
        <https://1145.am/db/2303612/Intradigm_Corporation>,
        <https://1145.am/db/2303675/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2303720/Covance>,
        <https://1145.am/db/2305572/Covance_Inc>,
        <https://1145.am/db/2305703/Pinnacle_Bioventures>,
        <https://1145.am/db/2306640/Atryn>,
        <https://1145.am/db/2306640/Leo_Pharma>,
        <https://1145.am/db/2306724/Dermatech_Pty_Ltd>,
        <https://1145.am/db/2306725/Prevalere_Life_Sciences_Inc>,
        <https://1145.am/db/2306946/Amatsigroup>,
        <https://1145.am/db/2307526/Bioserv_Corporation>,
        <https://1145.am/db/2307529/Bioserv>,
        <https://1145.am/db/2307714/GTCR>,
        <https://1145.am/db/2308069/Bionomics>,
        <https://1145.am/db/2308807/Etrials_Worldwide>,
        <https://1145.am/db/2309352/Epicept_Corporation>,
        <https://1145.am/db/2309696/Encap>,
        <https://1145.am/db/2309697/Encap>,
        <https://1145.am/db/2310799/Inventiv_Health>,
        <https://1145.am/db/2312191/Medigene_Ag>,
        <https://1145.am/db/2312788/Leo_Pharma>,
        <https://1145.am/db/2312797/Leo_Pharma_A_S>,
        <https://1145.am/db/2312994/Upm>,
        <https://1145.am/db/2313383/Companyâ€™>,
        <https://1145.am/db/2314613/Advent_International>,
        <https://1145.am/db/2315373/Nitromed>,
        <https://1145.am/db/2315424/Covance_Inc>,
        <https://1145.am/db/2316707/Catalyst_Pharmaceutical>,
        <https://1145.am/db/2316856/Viranative_Ab>,
        <https://1145.am/db/2317006/Amri>,
        <https://1145.am/db/2317060/Ception>,
        <https://1145.am/db/2317144/Leo_Pharma>,
        <https://1145.am/db/2317334/Aesica>,
        <https://1145.am/db/2317369/Relthy>,
        <https://1145.am/db/2320351/Prochieve>,
        <https://1145.am/db/2320947/Nitromed>,
        <https://1145.am/db/2321635/Celator>,
        <https://1145.am/db/2322824/Amri>,
        <https://1145.am/db/2322826/Amri>,
        <https://1145.am/db/2323790/Amri>,
        <https://1145.am/db/2323861/Amri>,
        <https://1145.am/db/2324112/Nitromed>,
        <https://1145.am/db/2324118/Rem_Medical_Corporation>,
        <https://1145.am/db/2324350/Celmed_Biosciences_Inc>,
        <https://1145.am/db/2324394/Amdl>,
        <https://1145.am/db/2324985/Amri>,
        <https://1145.am/db/2325553/Fidelity_Biosciences>,
        <https://1145.am/db/2327076/Amri>,
        <https://1145.am/db/2327088/Covance>,
        <https://1145.am/db/2327241/Preotact_(r)>,
        <https://1145.am/db/2327258/Biocon_Limited>,
        <https://1145.am/db/2327374/Diamedica_Inc>,
        <https://1145.am/db/2327424/Innopharm>,
        <https://1145.am/db/2328008/Epicept_Corporation>,
        <https://1145.am/db/2328318/Medpointe>,
        <https://1145.am/db/2328713/Sepracor>,
        <https://1145.am/db/2329333/Biopharma_Services_Inc>,
        <https://1145.am/db/2330808/Sepracor>,
        <https://1145.am/db/2331911/Clarient>,
        <https://1145.am/db/2332005/R___d>,
        <https://1145.am/db/2332200/Compendia_Bioscience>,
        <https://1145.am/db/2332920/Nastech>,
        <https://1145.am/db/2333644/Targent>,
        <https://1145.am/db/2334020/Accovion>,
        <https://1145.am/db/2336287/Biomotiv>,
        <https://1145.am/db/2336355/Correvio>,
        <https://1145.am/db/2336625/Biota>,
        <https://1145.am/db/2336998/Medivation_Inc>,
        <https://1145.am/db/2337028/Medivation>,
        <https://1145.am/db/2337078/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2338888/Cerulean_Pharma>,
        <https://1145.am/db/2338939/Nuevolution_A_S>,
        <https://1145.am/db/2339816/Nuevolution_A_S>,
        <https://1145.am/db/2339997/(Appa)>,
        <https://1145.am/db/2340054/Amri>,
        <https://1145.am/db/2340115/Mission>,
        <https://1145.am/db/2340160/Intercell_Ag>,
        <https://1145.am/db/2340507/Rho>,
        <https://1145.am/db/2341572/Aesica>,
        <https://1145.am/db/2341869/Fidelity_Biosciences>,
        <https://1145.am/db/2341897/Fidelity_Biosciences>,
        <https://1145.am/db/2342581/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2342628/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2343325/Medivir>,
        <https://1145.am/db/2344595/Mabxience>,
        <https://1145.am/db/2347172/Medivir_Ab>,
        <https://1145.am/db/2347755/Leo_Pharma_Inc>,
        <https://1145.am/db/2348675/Signum_Biosciences>,
        <https://1145.am/db/2349050/Fidelity_Biosciences>,
        <https://1145.am/db/2349373/Asmacure>,
        <https://1145.am/db/2349740/Signum_Biosciences_Inc>,
        <https://1145.am/db/2349983/Leading_Biosciences_Inc>,
        <https://1145.am/db/2349990/Aesica>,
        <https://1145.am/db/2350847/Covance>,
        <https://1145.am/db/2351198/(Ptc)>,
        <https://1145.am/db/2351259/Biotime_Inc>,
        <https://1145.am/db/2352414/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2353223/Medivation_Inc>,
        <https://1145.am/db/2355036/Moderna>,
        <https://1145.am/db/2355194/Moderna>,
        <https://1145.am/db/2356488/Cerulean_Pharma>,
        <https://1145.am/db/2358197/Biopharma_Services_Inc>,
        <https://1145.am/db/2358403/Pht_Corporation>,
        <https://1145.am/db/2358637/Eurand>,
        <https://1145.am/db/2358638/Eurand_Nv>,
        <https://1145.am/db/2358734/Prosidion>,
        <https://1145.am/db/2358953/Abgent>,
        <https://1145.am/db/2359025/Nectid>,
        <https://1145.am/db/2359113/Eurand_Nv>,
        <https://1145.am/db/2359380/Amri>,
        <https://1145.am/db/2359577/Geno>,
        <https://1145.am/db/2359670/Biotie>,
        <https://1145.am/db/2359951/Entremed>,
        <https://1145.am/db/2360371/Preglem>,
        <https://1145.am/db/2360702/Cominnex>,
        <https://1145.am/db/2360922/Nuevolution_A_S>,
        <https://1145.am/db/2361675/Amri>,
        <https://1145.am/db/2361747/Servier>,
        <https://1145.am/db/2361926/Pharm-Olam_International_Ltd>,
        <https://1145.am/db/2362453/Pharnext>,
        <https://1145.am/db/2362607/Abide_Therapeutics>,
        <https://1145.am/db/2363722/Moderna>,
        <https://1145.am/db/2363725/Moderna>,
        <https://1145.am/db/2367022/Fidelity_Biosciences>,
        <https://1145.am/db/2367023/Fidelity_Biosciences>,
        <https://1145.am/db/2367298/Amri>,
        <https://1145.am/db/2368106/Obseva>,
        <https://1145.am/db/2368242/Symic>,
        <https://1145.am/db/2368257/Almirall>,
        <https://1145.am/db/2368329/Amri>,
        <https://1145.am/db/2368332/Amri>,
        <https://1145.am/db/2368333/R___d>,
        <https://1145.am/db/2368601/Promosome>,
        <https://1145.am/db/2368824/Almirall_Inc>,
        <https://1145.am/db/2369042/Abide_Therapeutics>,
        <https://1145.am/db/2369128/Aegerion>,
        <https://1145.am/db/2369269/R___d>,
        <https://1145.am/db/2369446/Presage_Biosciences>,
        <https://1145.am/db/2369490/Medivation>,
        <https://1145.am/db/2369708/Promedior>,
        <https://1145.am/db/2370156/Pharming_Group_Nv>,
        <https://1145.am/db/2370164/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2370265/Ose_Pharma>,
        <https://1145.am/db/2370267/Ose_Pharma>,
        <https://1145.am/db/2370437/MSD>,
        <https://1145.am/db/2370557/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2370579/Arvinas>,
        <https://1145.am/db/2370659/Nuevolution>,
        <https://1145.am/db/2370828/Nuevolution>,
        <https://1145.am/db/2371158/Moderna>,
        <https://1145.am/db/2371408/Business_Management>,
        <https://1145.am/db/2536140/Scinopharm>,
        <https://1145.am/db/2536209/TPG>,
        <https://1145.am/db/2536305/Radient>,
        <https://1145.am/db/2536469/Agila_Specialties>,
        <https://1145.am/db/2536473/Encap>,
        <https://1145.am/db/2536575/G___w>,
        <https://1145.am/db/2536576/G___w>,
        <https://1145.am/db/2536612/Pharmaceutics_International_Inc>,
        <https://1145.am/db/2536776/Oramed>,
        <https://1145.am/db/2538112/Pharmedium>,
        <https://1145.am/db/2539816/P___R_Group>,
        <https://1145.am/db/2539858/Aesica>,
        <https://1145.am/db/2539890/Scinopharm>,
        <https://1145.am/db/2540218/Amri>,
        <https://1145.am/db/2540222/Amri>,
        <https://1145.am/db/2540931/Accucaps>,
        <https://1145.am/db/2540931/Pharmtek>,
        <https://1145.am/db/2541419/Amri>,
        <https://1145.am/db/2541469/Agila_Specialties>,
        <https://1145.am/db/2542113/Profectus_Biosciences>,
        <https://1145.am/db/2542472/Aesica>,
        <https://1145.am/db/2543530/Covance>,
        <https://1145.am/db/2544087/Univercells>,
        <https://1145.am/db/2544258/C___O_Pharmaceutical_Technology>,
        <https://1145.am/db/2544596/Bioton>,
        <https://1145.am/db/2545125/Ascendis_Health>,
        <https://1145.am/db/2545545/Agila_Specialties>,
        <https://1145.am/db/2546430/Bal_Pharma>,
        <https://1145.am/db/2546892/Aphena>,
        <https://1145.am/db/2547568/Amec>,
        <https://1145.am/db/2548137/Innopharm>,
        <https://1145.am/db/2548674/Sepracor>,
        <https://1145.am/db/2548840/Btcp_Pharma_Llc>,
        <https://1145.am/db/2549082/British_Company>,
        <https://1145.am/db/2549201/Rexall_Health>,
        <https://1145.am/db/2550632/Amri>,
        <https://1145.am/db/2550638/Amri>,
        <https://1145.am/db/2553761/Mabxience>,
        <https://1145.am/db/2553978/Bioverativ>,
        <https://1145.am/db/2554838/Amri>,
        <https://1145.am/db/2555168/Prokidney>,
        <https://1145.am/db/2555326/Leo_Pharma>,
        <https://1145.am/db/2556356/Medivation>,
        <https://1145.am/db/2556744/Leo_Pharma>,
        <https://1145.am/db/2557034/West_Pharmaceutical>,
        <https://1145.am/db/2557482/Idifarma>,
        <https://1145.am/db/2558133/Lifehealth>,
        <https://1145.am/db/2559160/West_Pharmaceutical>,
        <https://1145.am/db/2560277/Aesica>,
        <https://1145.am/db/2560277/Consort>,
        <https://1145.am/db/2560766/Accucaps>,
        <https://1145.am/db/2560808/Novamedica>,
        <https://1145.am/db/2561121/Bioserv>,
        <https://1145.am/db/2562459/Eurand>,
        <https://1145.am/db/2563255/MSD>,
        <https://1145.am/db/2563772/Apiject>,
        <https://1145.am/db/2564003/Leo_Pharma>,
        <https://1145.am/db/2564490/Accucaps>,
        <https://1145.am/db/2564490/Pharmtek>,
        <https://1145.am/db/2565613/Servier>,
        <https://1145.am/db/2566037/Almirall>,
        <https://1145.am/db/2566348/Indivior>,
        <https://1145.am/db/2566348/Opiant>,
        <https://1145.am/db/2568711/West_Pharmaceutical>,
        <https://1145.am/db/2569107/Almirall_Sa>,
        <https://1145.am/db/2569356/Leo_Pharma_Inc>,
        <https://1145.am/db/2569393/R___d>,
        <https://1145.am/db/2570064/Aegerion>,
        <https://1145.am/db/2570177/Oramed>,
        <https://1145.am/db/2572329/Incivo®>,
        <https://1145.am/db/2572567/Northera>,
        <https://1145.am/db/2573050/Amatsigroup>,
        <https://1145.am/db/2573913/TPG>,
        <https://1145.am/db/2575143/Almirall>,
        <https://1145.am/db/2576254/Fougera>,
        <https://1145.am/db/2576550/TPG>,
        <https://1145.am/db/2576923/Pharmgate>,
        <https://1145.am/db/2576925/Pharmgate>,
        <https://1145.am/db/2577894/Advance_Properties_Ood>,
        <https://1145.am/db/2578052/Advent_International>,
        <https://1145.am/db/2578052/United_Medical>,
        <https://1145.am/db/2578645/Almirall>,
        <https://1145.am/db/2578667/Almirall>,
        <https://1145.am/db/2578667/Fycompa>,
        <https://1145.am/db/2579211/Proximagen>,
        <https://1145.am/db/2581197/Irom_Pharmaceutical>,
        <https://1145.am/db/2581832/West>,
        <https://1145.am/db/2586253/United_Biosource_Corporation>,
        <https://1145.am/db/2586420/Acuform>,
        <https://1145.am/db/2587709/Pharmstandard>,
        <https://1145.am/db/2589178/Oriel>,
        <https://1145.am/db/2590195/Nectid>,
        <https://1145.am/db/2590489/Amatsigroup>,
        <https://1145.am/db/2590528/C___O_Pharmaceutical>,
        <https://1145.am/db/2590556/Nycomed_Us>,
        <https://1145.am/db/2590827/Affairs>,
        <https://1145.am/db/2591609/Pharmstandard>,
        <https://1145.am/db/2591622/Pharmstandard>,
        <https://1145.am/db/2593060/Inventiv_Health>,
        <https://1145.am/db/2593265/Leo_Pharma>,
        <https://1145.am/db/2594186/Agila_Specialties>,
        <https://1145.am/db/2594699/Osi>,
        <https://1145.am/db/2595688/Fougera>,
        <https://1145.am/db/2598181/Amri>,
        <https://1145.am/db/2739044/Moderna>,
        <https://1145.am/db/2791590/Civica>,
        <https://1145.am/db/295168/Orifarm>,
        <https://1145.am/db/317543/Productlife_Group>,
        <https://1145.am/db/423883/Sohm_Inc>,
        <https://1145.am/db/449041/Advent_International>,
        <https://1145.am/db/515764/Sohm_Inc>,
        <https://1145.am/db/561196/Pharnext_Sa>,
        <https://1145.am/db/618115/Sohm>,
        <https://1145.am/db/654792/Innobic>,
        <https://1145.am/db/676564/Alvotech>,
        <https://1145.am/db/716162/Pharnext_Sa>,
        <https://1145.am/db/806327/Pharma_Nobis_Llc>,
        <https://1145.am/db/807295/Pharma_Nobis_Llc>,
        <https://1145.am/db/834480/Pharnext_Sa>,
        <https://1145.am/db/835269/Grand_Pharmaceutical_Group_Limited>,
        <https://1145.am/db/837157/Leo_Pharma_Inc>,
        <https://1145.am/db/848323/Pharmaceutics_International_Inc>,
        <https://1145.am/db/872336/Sohm_Inc>,
        <https://1145.am/db/882142/Aim>,
        <https://1145.am/db/886663/Théa>,
        <https://1145.am/db/888994/Théa>,
        <https://1145.am/db/943000/Pharnext>,
        <https://1145.am/db/965490/Reviral_Ltd> ;
    ns1:sameAsMedium <https://1145.am/db/2291713/Cerulean_Pharma>,
        <https://1145.am/db/2301089/Cerulean_Pharma>,
        <https://1145.am/db/2303674/Cerulean_Pharma>,
        <https://1145.am/db/2312088/Cerulean_Pharma>,
        <https://1145.am/db/2338883/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2342996/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2345089/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2348440/Cerulean_Pharma>,
        <https://1145.am/db/2357508/Cerulean_Pharma_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348453/Ariad_Pharmaceuticals> a org:Organization ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2011-12-15T14:52:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ariad plans $224M stock offering; Dicerna earns $5M milestone from KHK; Salk team touts potential of new Alzheimer's drug;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ariad-plans-224m-stock-offering-dicerna-earns-5m-milestone-from-khk-salk-team-touts> ;
    ns1:foundName "Ariad Pharmaceuticals ($ ARIA)" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Ariad Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/1000805/Aequus_Pharmaceuticals_Inc>,
        <https://1145.am/db/1232270/Oakrum_Pharma>,
        <https://1145.am/db/1306393/Aequus_Pharmaceuticals_Inc>,
        <https://1145.am/db/1334444/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/1334495/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/1360048/Alnylam_Pharmaceuticals_Inc>,
        <https://1145.am/db/1361196/Alnylam_Pharmaceuticals_Inc>,
        <https://1145.am/db/1622317/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/1622994/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2237604/Ariad_Pharmaceuticals_Inc>,
        <https://1145.am/db/2237612/Ariad_Pharmaceuticals_Inc>,
        <https://1145.am/db/2283918/Aelis>,
        <https://1145.am/db/2302275/Alexza_Pharmaceuticals>,
        <https://1145.am/db/2302625/Alseres_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302649/Ariad_Pharmaceuticals>,
        <https://1145.am/db/2303191/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2303199/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2303208/Alexza_Pharmaceuticals>,
        <https://1145.am/db/2303217/Avalon_Pharmaceuticals>,
        <https://1145.am/db/2304431/Ariad_Pharmaceuticals_Inc>,
        <https://1145.am/db/2309502/Alnylam_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310568/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2310582/Alnylam_Pharmaceuticals_Inc>,
        <https://1145.am/db/2312088/Ariad_Pharmaceuticals>,
        <https://1145.am/db/2315485/Alseres_Pharmaceuticals>,
        <https://1145.am/db/2315490/Alseres_Pharmaceuticals>,
        <https://1145.am/db/2317741/Alseres_Pharmaceuticals>,
        <https://1145.am/db/2318107/Alexza_Pharmaceuticals_Inc>,
        <https://1145.am/db/2318278/Alexza_Pharmaceuticals_Inc>,
        <https://1145.am/db/2318828/Alexza_Pharmaceuticals_Inc>,
        <https://1145.am/db/2320948/Alseres_Pharmaceuticals>,
        <https://1145.am/db/2322026/Ariad_Pharmaceuticals>,
        <https://1145.am/db/2322036/Ariad_Pharmaceuticals>,
        <https://1145.am/db/2324093/Avalon_Pharma>,
        <https://1145.am/db/2325198/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2325215/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2326541/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2327418/Aeolus_Pharmaceuticals>,
        <https://1145.am/db/2329655/Ariad_Pharmaceuticals>,
        <https://1145.am/db/2330949/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2334003/Adare_Pharmaceuticals>,
        <https://1145.am/db/2335728/Alexza_Pharmaceuticals_Inc>,
        <https://1145.am/db/2335806/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2336062/Ariad_Pharmaceuticals>,
        <https://1145.am/db/2337777/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2338107/Alexion_Pharmaceuticals>,
        <https://1145.am/db/2338548/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2339069/Ariad_Pharmaceuticals>,
        <https://1145.am/db/2339350/Alexza_Pharmaceuticals>,
        <https://1145.am/db/2339917/Ariad_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342632/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2342801/Alexza_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342843/Alexza_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342857/Affinium_Pharmaceuticals>,
        <https://1145.am/db/2344792/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2345725/Alexion_Pharmaceuticals>,
        <https://1145.am/db/2345772/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2345944/Affinium_Pharmaceuticals>,
        <https://1145.am/db/2346565/Aeolus_Pharmaceuticals>,
        <https://1145.am/db/2346580/Alexion_Pharmaceuticals>,
        <https://1145.am/db/2347717/Amphastar_Pharmaceuticals_Inc>,
        <https://1145.am/db/2348434/Ariad_Pharmaceuticals_Inc>,
        <https://1145.am/db/2348457/Ariad_Pharmaceuticals_Inc>,
        <https://1145.am/db/2348741/Amphastar_Pharmaceuticals>,
        <https://1145.am/db/2349493/Alexza_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349935/Alexza_Pharmaceuticals_Inc>,
        <https://1145.am/db/2351407/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2351432/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2351838/Alexza_Pharmaceuticals_Inc>,
        <https://1145.am/db/2351840/Alexza_Pharmaceuticals>,
        <https://1145.am/db/2353072/Ariad_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354144/Alexza_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357279/Avion_Pharmaceuticals>,
        <https://1145.am/db/2358229/Alnylam_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359297/Alexion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359330/Alnylam_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359332/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2359414/Alnylam_Pharmaceuticals_Inc>,
        <https://1145.am/db/2360584/Agere_Pharmaceuticals>,
        <https://1145.am/db/2360662/Alexza_Pharmaceuticals_Inc>,
        <https://1145.am/db/2360718/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2361757/Alnylam_Pharmaceuticals_Inc>,
        <https://1145.am/db/2362370/Alexion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363724/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2365739/Ariad_Pharmaceuticals_Inc>,
        <https://1145.am/db/2366477/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2368762/Ariad_Pharmaceuticals>,
        <https://1145.am/db/2368779/Ariad_Pharmaceuticals_Inc>,
        <https://1145.am/db/2368780/Ariad_Pharmaceuticals_Inc>,
        <https://1145.am/db/2369628/Adare_Pharmaceuticals>,
        <https://1145.am/db/2369746/Ariad_Pharmaceuticals>,
        <https://1145.am/db/2536601/Agere_Pharmaceuticals>,
        <https://1145.am/db/2536602/Agere_Pharmaceuticals>,
        <https://1145.am/db/2536762/Alexion_Pharmaceuticals>,
        <https://1145.am/db/2537618/Adare_Pharmaceuticals>,
        <https://1145.am/db/2537838/Aenova_Group>,
        <https://1145.am/db/2544525/Auctus_Pharma>,
        <https://1145.am/db/2545135/Agere_Pharmaceuticals>,
        <https://1145.am/db/2549890/Alexion_Pharmaceuticals>,
        <https://1145.am/db/2550884/Alexion_Pharmaceuticals>,
        <https://1145.am/db/2554959/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2558073/Aenova>,
        <https://1145.am/db/2559141/Aesica_Pharmaceuticals>,
        <https://1145.am/db/2559156/Aesica_Pharmaceuticals_Limited>,
        <https://1145.am/db/2566946/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2569509/Adare_Pharmaceuticals>,
        <https://1145.am/db/2571443/Alexza_Pharmaceuticals>,
        <https://1145.am/db/2571496/Ariad_Pharmaceuticals_Inc>,
        <https://1145.am/db/2580048/Alexion_Pharmaceuticals>,
        <https://1145.am/db/2586987/Ariad_Pharmaceuticals_Inc>,
        <https://1145.am/db/2586996/Ariad_Pharmaceuticals_Inc>,
        <https://1145.am/db/2588287/Alexza_Pharmaceuticals_Inc>,
        <https://1145.am/db/2590264/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2598400/Alexion_Pharmaceuticals>,
        <https://1145.am/db/381681/Alexion_Pharmaceuticals_Inc>,
        <https://1145.am/db/403466/Aerpio_Pharmaceuticals_Inc>,
        <https://1145.am/db/432278/Aerpio_Pharmaceuticals>,
        <https://1145.am/db/4491/Alexion_Pharmaceuticals_Inc>,
        <https://1145.am/db/4709/Alexion_Pharmaceuticals_Inc>,
        <https://1145.am/db/596781/Citius_Pharmaceuticals>,
        <https://1145.am/db/744958/Aesica_Pharmaceuticals_Limited>,
        <https://1145.am/db/746462/Aesica_Pharmaceuticals_Limited>,
        <https://1145.am/db/927404/Aerium_Therapeutics>,
        <https://1145.am/db/93590/Alexion_Pharmaceuticals_Inc>,
        <https://1145.am/db/94416/Alexion_Pharmaceuticals_Inc>,
        <https://1145.am/db/956778/Alnylam_Pharmaceuticals_Inc>,
        <https://1145.am/db/957088/Alnylam_Pharmaceuticals_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2361466/Ariad_Pharmaceuticals_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348453/Dicerna_Pharmaceuticals> a org:Organization ;
    ns1:basedInLowRaw "Japan" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2011-12-15T14:52:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ariad plans $224M stock offering; Dicerna earns $5M milestone from KHK; Salk team touts potential of new Alzheimer's drug;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ariad-plans-224m-stock-offering-dicerna-earns-5m-milestone-from-khk-salk-team-touts> ;
    ns1:foundName "Dicerna Pharmaceuticals" ;
    ns1:industry "pharmaceuticals" ;
    ns1:name "Dicerna Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/1408389/Dice_Therapeutics_Inc>,
        <https://1145.am/db/1414280/Dice_Therapeutics_Inc>,
        <https://1145.am/db/1430935/Dice_Therapeutics_Inc>,
        <https://1145.am/db/2279495/Dicerna_Pharmaceuticals>,
        <https://1145.am/db/2308925/Dicerna_Pharmaceuticals>,
        <https://1145.am/db/2308931/Dicerna_Pharmaceuticals>,
        <https://1145.am/db/2319004/Dicerna_Pharmaceuticals>,
        <https://1145.am/db/2336621/Dicerna_Pharmaceuticals>,
        <https://1145.am/db/2342804/Dicerna_Pharmaceuticals>,
        <https://1145.am/db/2343041/Dicerna_Pharmaceuticals>,
        <https://1145.am/db/2343058/Dicerna_Pharmaceuticals>,
        <https://1145.am/db/2349741/Dicerna_Pharmaceuticals>,
        <https://1145.am/db/2349753/Dicerna_Pharmaceuticals>,
        <https://1145.am/db/2350964/Dicerna_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353604/Dicerna_Pharmaceuticals_Inc>,
        <https://1145.am/db/2362491/Dicerna_Pharmaceuticals_Inc>,
        <https://1145.am/db/2566150/Dicerna_Pharma>,
        <https://1145.am/db/490489/Dicerna_Pharmaceuticals_Inc>,
        <https://1145.am/db/633908/Dicerna_Pharmaceuticals>,
        <https://1145.am/db/635744/Dicerna_Pharmaceuticals>,
        <https://1145.am/db/635895/Dicerna_Pharmaceuticals_Inc>,
        <https://1145.am/db/636407/Dicerna_Pharmaceuticals>,
        <https://1145.am/db/637582/Dicerna_Pharmaceuticals>,
        <https://1145.am/db/718330/Dicerna_Pharmaceuticals>,
        <https://1145.am/db/719216/Dicerna_Pharmaceuticals>,
        <https://1145.am/db/721891/Dicerna_Pharmaceuticals_Inc>,
        <https://1145.am/db/722559/Dicerna_Pharmaceuticals_Inc>,
        <https://1145.am/db/940792/Dice_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348453/Investment_Dicerna_Pharmaceuticals_Kyowa_Hakko_Kirin_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-12-15T14:52:57+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Dicerna Pharmaceuticals is pocketing a $ 5 million milestone payment from Kyowa Hakko Kirin as the pharma company takes the first oncology therapy into formal development." ;
    ns1:documentTitle "Ariad plans $224M stock offering; Dicerna earns $5M milestone from KHK; Salk team touts potential of new Alzheimer's drug;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ariad-plans-224m-stock-offering-dicerna-earns-5m-milestone-from-khk-salk-team-touts> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2348453/Dicerna_Pharmaceuticals> ;
    ns1:valueRaw "$ 5 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2349519/Aeris_Capital_Ag> a org:Organization ;
    ns1:basedInLowRaw "SOUTH SAN FRANCISCO" ;
    ns1:documentDate "2011-09-14T11:36:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Crescendo Bioscience Secures $56 Million in Funding to Expand Development and Commercialization of Personalized Diagnostics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crescendo-bioscience-secures-56-million-funding-to-expand-development-and-commercialization> ;
    ns1:foundName "aeris CAPITAL AG" ;
    ns1:investor <https://1145.am/db/2349519/Equity_Investment_Crescendo_Bioscience_Kleiner_Perkins_Caufield___Byers_Mohr_Davidow_Ventures_Myriad_Genetics_Aeris_Capital_Ag_Completed> ;
    ns1:name "aeris CAPITAL AG" ;
    ns1:sameAsMedium <https://1145.am/db/1697327/Aeris_Capital>,
        <https://1145.am/db/1730217/Aeris_Capital>,
        <https://1145.am/db/1856457/Aeris_Capital>,
        <https://1145.am/db/1860817/Aeris_Capital>,
        <https://1145.am/db/2293308/Aeris_Capital_Ag>,
        <https://1145.am/db/2308420/Aeris_Capital>,
        <https://1145.am/db/2308423/Aeris_Capital_Ag>,
        <https://1145.am/db/2308429/Aeris_Capital_Ag>,
        <https://1145.am/db/2326926/Aeris_Capital>,
        <https://1145.am/db/2326935/Aeris_Capital>,
        <https://1145.am/db/2337043/Aeris_Capital>,
        <https://1145.am/db/2360667/Aeris_Capital_Ag>,
        <https://1145.am/db/2575687/Aeris_Capital_Ag> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2349519/Crescendo_Bioscience> a org:Organization ;
    ns1:description "inflammatory diseases" ;
    ns1:documentDate "2011-09-14T11:36:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Crescendo Bioscience Secures $56 Million in Funding to Expand Development and Commercialization of Personalized Diagnostics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crescendo-bioscience-secures-56-million-funding-to-expand-development-and-commercialization> ;
    ns1:foundName "Crescendo Bioscience",
        "Crescendo Bioscience (R)" ;
    ns1:industry "Molecular diagnostics" ;
    ns1:name "Crescendo Bioscience" ;
    ns1:sameAsHigh <https://1145.am/db/1165239/Biocept_Inc>,
        <https://1145.am/db/1352490/Ventyx_Biosciences_Inc>,
        <https://1145.am/db/1594965/Htg_Molecular_Diagnostics_Inc>,
        <https://1145.am/db/1602121/Htg_Molecular_Diagnostics_Inc>,
        <https://1145.am/db/1638497/Ventyx_Biosciences>,
        <https://1145.am/db/2018611/Biocept>,
        <https://1145.am/db/2210280/Gen-Probe_Incorporated>,
        <https://1145.am/db/2287929/Genmark_Diagnostics>,
        <https://1145.am/db/2289026/Gen-Probe>,
        <https://1145.am/db/2289026/Hologic>,
        <https://1145.am/db/2289588/Clarient>,
        <https://1145.am/db/2290898/Gen-Probe>,
        <https://1145.am/db/2296394/Biodesix>,
        <https://1145.am/db/2296870/Biodesix>,
        <https://1145.am/db/2296872/Biodesix>,
        <https://1145.am/db/2298996/Gen-Probe>,
        <https://1145.am/db/2298996/Hologic>,
        <https://1145.am/db/2301901/Primera_Biosystems>,
        <https://1145.am/db/2302261/Gen-Probe>,
        <https://1145.am/db/2302265/Gen-Probe_Incorporated>,
        <https://1145.am/db/2305804/Gentra_Systems>,
        <https://1145.am/db/2306329/Biodesix>,
        <https://1145.am/db/2314062/Biodesix>,
        <https://1145.am/db/2315065/Biodesix>,
        <https://1145.am/db/2319505/Provista_Diagnostics>,
        <https://1145.am/db/2326257/Tepnel_Life_Sciences>,
        <https://1145.am/db/2327638/Eragen_Biosciences>,
        <https://1145.am/db/2329755/XDX>,
        <https://1145.am/db/2333633/Fisher_Scientific_International>,
        <https://1145.am/db/2340118/Gensignia_Life_Sciences>,
        <https://1145.am/db/2340467/Gen-Probe_Incorporated>,
        <https://1145.am/db/2355575/Eragen_Biosciences>,
        <https://1145.am/db/2355582/Eragen>,
        <https://1145.am/db/2362844/Akonni_Biosystems>,
        <https://1145.am/db/2364377/Roka_Bioscience>,
        <https://1145.am/db/2365186/Akonni_Biosystems>,
        <https://1145.am/db/2365188/Gen-Probe>,
        <https://1145.am/db/2367855/Roka_Bioscience>,
        <https://1145.am/db/2369197/Geneweave_Biosciences>,
        <https://1145.am/db/2369225/Roka_Bioscience>,
        <https://1145.am/db/703140/Htg_Molecular_Diagnostics>,
        <https://1145.am/db/835941/Biocept_Inc>,
        <https://1145.am/db/838575/Biocept_Inc>,
        <https://1145.am/db/913871/Htg_Molecular_Diagnostics_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2294544/Crescendo_Bioscience>,
        <https://1145.am/db/2294871/Crescendo_Bioscience>,
        <https://1145.am/db/2294902/Crescendo_Bioscience>,
        <https://1145.am/db/2296937/Crescendo_Bioscience>,
        <https://1145.am/db/2369844/Crescendo_Bioscience> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2349519/Mohr_Davidow_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SOUTH SAN FRANCISCO" ;
    ns1:description "What is the typical occupation of the person or organization that is typically involved in:" ;
    ns1:documentDate "2011-09-14T11:36:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Crescendo Bioscience Secures $56 Million in Funding to Expand Development and Commercialization of Personalized Diagnostics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crescendo-bioscience-secures-56-million-funding-to-expand-development-and-commercialization> ;
    ns1:foundName "Mohr Davidow Ventures" ;
    ns1:investor <https://1145.am/db/2349519/Equity_Investment_Crescendo_Bioscience_Kleiner_Perkins_Caufield___Byers_Mohr_Davidow_Ventures_Myriad_Genetics_Aeris_Capital_Ag_Completed> ;
    ns1:name "Mohr Davidow Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1704643/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1713745/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1825596/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1846737/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1861044/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1862878/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1866134/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1866492/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1867543/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1872463/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1873191/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1876054/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1880666/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1884011/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1890172/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1890619/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1891777/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1894610/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1906154/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1911282/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1911316/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1915393/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2206261/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2206263/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2292797/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2293308/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2312700/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2340423/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2340429/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2362862/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2635849/Mohr_Davidow_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2349519/Myriad_Genetics> a org:Organization ;
    ns1:description "inflammatory diseases" ;
    ns1:documentDate "2011-09-14T11:36:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Crescendo Bioscience Secures $56 Million in Funding to Expand Development and Commercialization of Personalized Diagnostics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crescendo-bioscience-secures-56-million-funding-to-expand-development-and-commercialization> ;
    ns1:foundName "Myriad Genetics" ;
    ns1:investor <https://1145.am/db/2349519/Equity_Investment_Crescendo_Bioscience_Kleiner_Perkins_Caufield___Byers_Mohr_Davidow_Ventures_Myriad_Genetics_Aeris_Capital_Ag_Completed> ;
    ns1:name "Myriad Genetics" ;
    ns1:sameAsMedium <https://1145.am/db/1461868/Myriad_Genetics>,
        <https://1145.am/db/1463558/Myriad_Genetics>,
        <https://1145.am/db/1591123/Myriad_Genetics>,
        <https://1145.am/db/2288035/Myriad_Genetics>,
        <https://1145.am/db/2293308/Myriad_Genetics>,
        <https://1145.am/db/2294544/Myriad_Genetics>,
        <https://1145.am/db/2296428/Myriad_Genetics>,
        <https://1145.am/db/2296937/Myriad_Genetics>,
        <https://1145.am/db/2296993/Myriad_Genetics>,
        <https://1145.am/db/2315046/Myriad_Genetics>,
        <https://1145.am/db/2320999/Myriad_Genetics>,
        <https://1145.am/db/2332792/Myriad_Genetics>,
        <https://1145.am/db/2332797/Myriad_Genetics>,
        <https://1145.am/db/2337718/Myriad_Genetics>,
        <https://1145.am/db/2340128/Myriad_Genetics>,
        <https://1145.am/db/2360291/Myriad_Genetics>,
        <https://1145.am/db/2361752/Myriad_Genetics>,
        <https://1145.am/db/2370810/Myriad_Genetics_Gmbh>,
        <https://1145.am/db/2538017/Myriad_Genetics>,
        <https://1145.am/db/317075/Myriad_Genetics>,
        <https://1145.am/db/469186/Myriad_Genetics>,
        <https://1145.am/db/470126/Myriad_Genetics>,
        <https://1145.am/db/470228/Myriad_Genetics>,
        <https://1145.am/db/500061/Myriad_Genetics>,
        <https://1145.am/db/697868/Myriad_Genetics>,
        <https://1145.am/db/737295/Myriad_Genetics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350491/Aviir_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Irvine" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5359777/about.rdf> ;
    ns1:basedInHighRaw "Irvine, California" ;
    ns1:description "cardiac disease assessment" ;
    ns1:documentDate "2011-12-20T01:20:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aviir Announces Agreement to Raise up to $30 Million in Latest Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aviir-announces-agreement-to-raise-up-to-30-million-latest-financing-round> ;
    ns1:foundName "Aviir, Inc." ;
    ns1:industry "biotechnology" ;
    ns1:name "Aviir, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/1013406/Moderna>,
        <https://1145.am/db/1042080/Section32>,
        <https://1145.am/db/1060047/Entera_Bio_Ltd>,
        <https://1145.am/db/1062535/20045078>,
        <https://1145.am/db/1086800/Senti_Biosciences>,
        <https://1145.am/db/1087133/Evelo_Biosciences>,
        <https://1145.am/db/1123329/Senti_Biosciences>,
        <https://1145.am/db/1201180/Agomab>,
        <https://1145.am/db/1201808/Agomab>,
        <https://1145.am/db/1202868/Brii_Biosciences_Limited>,
        <https://1145.am/db/1216158/Evelo_Biosciences>,
        <https://1145.am/db/1219346/Section_32>,
        <https://1145.am/db/1219817/Section_32>,
        <https://1145.am/db/1297445/Ansa_Biotechnologies>,
        <https://1145.am/db/1313715/Evelo_Biosciences>,
        <https://1145.am/db/1380232/Moderna>,
        <https://1145.am/db/1394919/Morningside>,
        <https://1145.am/db/1476593/Bioatla>,
        <https://1145.am/db/1514071/Moderna>,
        <https://1145.am/db/1556688/Ron_Alfa>,
        <https://1145.am/db/1563057/Moderna>,
        <https://1145.am/db/1576796/Gri_Bio>,
        <https://1145.am/db/1586050/Evelo_Biosciences>,
        <https://1145.am/db/1596811/Moderna>,
        <https://1145.am/db/159841/Moderna>,
        <https://1145.am/db/1617793/Moderna>,
        <https://1145.am/db/1689320/Innamed>,
        <https://1145.am/db/1690056/Zura>,
        <https://1145.am/db/1940289/Zura>,
        <https://1145.am/db/2302708/Promosome>,
        <https://1145.am/db/2303846/Cha_Biotech_Co>,
        <https://1145.am/db/2305822/Clal_Biotechnology_Industries>,
        <https://1145.am/db/2311730/Bionj>,
        <https://1145.am/db/2316631/Engene_Inc>,
        <https://1145.am/db/2320759/Ily101>,
        <https://1145.am/db/2323586/Promedior>,
        <https://1145.am/db/2324320/3i>,
        <https://1145.am/db/2330716/Gpc_Biotech>,
        <https://1145.am/db/2330797/Meridian_Bioscience>,
        <https://1145.am/db/2338371/Promedior>,
        <https://1145.am/db/2338373/Promedior>,
        <https://1145.am/db/2340408/Biovex_Group>,
        <https://1145.am/db/2340450/Promosome>,
        <https://1145.am/db/2341484/Armo_Biosciences_Inc>,
        <https://1145.am/db/2343210/Promedior>,
        <https://1145.am/db/2343742/Promedior>,
        <https://1145.am/db/2343749/Promedior>,
        <https://1145.am/db/2344691/GTX>,
        <https://1145.am/db/2348001/Ceregene>,
        <https://1145.am/db/2352800/Biovex_Group>,
        <https://1145.am/db/2353227/Moderna>,
        <https://1145.am/db/2354248/Moderna>,
        <https://1145.am/db/2355643/Promedior>,
        <https://1145.am/db/2357356/Life_Sciences_Fund>,
        <https://1145.am/db/2357505/Regenxbio>,
        <https://1145.am/db/2359227/Regenxbio_Inc>,
        <https://1145.am/db/2359685/Bioatla_Llc>,
        <https://1145.am/db/2360317/Engene_Inc>,
        <https://1145.am/db/2369154/Bioatla>,
        <https://1145.am/db/2543372/Ocata>,
        <https://1145.am/db/2543375/Ocata>,
        <https://1145.am/db/2548438/Bioatla>,
        <https://1145.am/db/2562317/Bioatla_Llc>,
        <https://1145.am/db/2581359/Biovex_Group>,
        <https://1145.am/db/2589106/Biovex_Group>,
        <https://1145.am/db/468723/Abcellera>,
        <https://1145.am/db/487431/Omniome>,
        <https://1145.am/db/506326/Acrigen>,
        <https://1145.am/db/527072/Amplo_Biotechnology>,
        <https://1145.am/db/548508/Gv20>,
        <https://1145.am/db/611340/Genenta_Science>,
        <https://1145.am/db/693678/Iveric_Bio>,
        <https://1145.am/db/697934/Iveric_Bio>,
        <https://1145.am/db/705474/Senti_Biosciences_Inc>,
        <https://1145.am/db/705671/Genenta_Science_Spa>,
        <https://1145.am/db/706523/Senti_Biosciences_Inc>,
        <https://1145.am/db/710299/Bioatla>,
        <https://1145.am/db/737781/Accro_Bioscience>,
        <https://1145.am/db/769568/Section_32>,
        <https://1145.am/db/780157/Explora_Biolabs>,
        <https://1145.am/db/887924/Avm0703>,
        <https://1145.am/db/906544/Precirix>,
        <https://1145.am/db/913978/Engene_Inc>,
        <https://1145.am/db/977143/Moderna> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350553/Nabsys_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Providence" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5224151/about.rdf> ;
    ns1:basedInHighRaw "PROVIDENCE, R.I." ;
    ns1:description "DNA sequencing and analysis" ;
    ns1:documentDate "2011-09-15T16:30:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NABsys Raises $10M for Continued Development and Commercialization of Solid-State Systems for Single-Molecule DNA Analysis" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nabsys-raises-10m-for-continued-development-and-commercialization-of-solid-state-systems> ;
    ns1:foundName "NABsys, Inc." ;
    ns1:name "NABsys, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2337580/Nabsys_Inc>,
        <https://1145.am/db/2354617/Nabsys_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/1217401/Nabsys>,
        <https://1145.am/db/1428338/Nabsys>,
        <https://1145.am/db/1493897/Nabsys>,
        <https://1145.am/db/2318634/Nabsys>,
        <https://1145.am/db/2342636/Nabsys_Inc>,
        <https://1145.am/db/2342864/Nabsys>,
        <https://1145.am/db/2564418/Nabsys>,
        <https://1145.am/db/976717/Nabsys> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352586/Amorcyte> a org:Organization ;
    ns1:description "a medical company" ;
    ns1:documentDate "2012-01-03T13:20:24+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NeoStem's CEO Letter to Shareholders" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/neostem-s-ceo-letter-to-shareholders> ;
    ns1:foundName "Amorcyte, LLC" ;
    ns1:name "Amorcyte" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352586/Progenitor_Cell_Therapy> a org:Organization ;
    ns1:description "a) None of the above choices. b) a company that makes" ;
    ns1:documentDate "2012-01-03T13:20:24+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NeoStem's CEO Letter to Shareholders" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/neostem-s-ceo-letter-to-shareholders> ;
    ns1:foundName "Progenitor Cell Therapy, LLC" ;
    ns1:name "Progenitor Cell Therapy" ;
    ns1:sameAsMedium <https://1145.am/db/2313373/Progenitor_Cell_Therapy>,
        <https://1145.am/db/2313392/Progenitor_Cell_Therapy>,
        <https://1145.am/db/2317923/Progenitor_Cell_Therapy>,
        <https://1145.am/db/2554680/Progenitor_Cell_Therapy> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352633/Zymeworks_Inc> a org:Organization ;
    ns1:basedInHighGeoName "British Columbia" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5909050/about.rdf> ;
    ns1:basedInHighRaw "British Columbia" ;
    ns1:description "Biotherapeutics" ;
    ns1:documentDate "2011-09-22T16:00:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zymeworks Completes $8.1 Million Round of Financing to Advance Platform Technology and Therapeutics Pipeline Programs" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zymeworks-completes-8-1-million-round-of-financing-to-advance-platform-technology-and> ;
    ns1:foundName "Zymeworks Inc." ;
    ns1:industry "Life Sciences" ;
    ns1:name "Zymeworks Inc." ;
    ns1:sameAsHigh <https://1145.am/db/1015645/Zymeworks_Inc>,
        <https://1145.am/db/1016632/Zymeworks_Inc>,
        <https://1145.am/db/1030113/Zymeworks_Inc>,
        <https://1145.am/db/1075621/Zymeworks>,
        <https://1145.am/db/1076106/Zymeworks>,
        <https://1145.am/db/1077389/Zymeworks_Inc>,
        <https://1145.am/db/1126412/Zymeworks>,
        <https://1145.am/db/1127032/Zymeworks>,
        <https://1145.am/db/1165468/Zymeworks_Inc>,
        <https://1145.am/db/1165674/Zymeworks_Inc>,
        <https://1145.am/db/1415410/Zymeworks_Inc>,
        <https://1145.am/db/1737730/Zymergen>,
        <https://1145.am/db/2225348/Zymenex_A_S>,
        <https://1145.am/db/2225352/Zymenex_A_S>,
        <https://1145.am/db/2290504/Zymeworks>,
        <https://1145.am/db/2326381/Zymenex_A_S>,
        <https://1145.am/db/2343759/Zymeworks_Inc>,
        <https://1145.am/db/2343771/Zymeworks>,
        <https://1145.am/db/2345918/Zymeworks_Inc>,
        <https://1145.am/db/2353635/Zymeworks>,
        <https://1145.am/db/2353983/Zymeworks_Inc>,
        <https://1145.am/db/2356853/Zymeworks_Inc>,
        <https://1145.am/db/607426/Zymeworks_Inc>,
        <https://1145.am/db/735769/Zymeworks_Inc>,
        <https://1145.am/db/736655/Zymeworks_Inc>,
        <https://1145.am/db/784103/Zymeworks_Inc>,
        <https://1145.am/db/786184/Zymeworks_Inc>,
        <https://1145.am/db/787862/Zymeworks_Inc>,
        <https://1145.am/db/788354/Zymeworks_Inc>,
        <https://1145.am/db/795471/Zymeworks_Inc>,
        <https://1145.am/db/796963/Zymeworks_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/1017937/Zymeworks_Inc>,
        <https://1145.am/db/1073750/Zymeworks>,
        <https://1145.am/db/1128241/Zymeworks_Inc>,
        <https://1145.am/db/2281273/Zymeworks>,
        <https://1145.am/db/2320465/Zymeworks_Inc>,
        <https://1145.am/db/2369027/Zymeworks> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353588/Care_Capital> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-01-04T13:03:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/elevation-pharmaceuticals-completes-30-million-series-b-financing-to-advance-aerosol-copd-1> ;
    ns1:foundName "Care Capital" ;
    ns1:investor <https://1145.am/db/2353588/Series_B_Investment_Canaan_Partners_Care_Capital_Elevation_Pharmaceuticals_Mesa_Verde_Venture_Partners_Novo_Ventures_Tpg_Biotech_Completed> ;
    ns1:name "Care Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2302351/Care_Capital_Llc>,
        <https://1145.am/db/2305706/Care_Capital>,
        <https://1145.am/db/2305713/Care_Capital>,
        <https://1145.am/db/2305822/Care_Capital>,
        <https://1145.am/db/2309376/Care_Capital>,
        <https://1145.am/db/2309387/Care_Capital>,
        <https://1145.am/db/2314850/Care_Capital_Llc>,
        <https://1145.am/db/2318708/Care_Capital>,
        <https://1145.am/db/2320353/Care_Capital>,
        <https://1145.am/db/2320354/Care_Capital>,
        <https://1145.am/db/2345213/Care_Capital>,
        <https://1145.am/db/2345214/Care_Capital>,
        <https://1145.am/db/2353608/Care_Capital>,
        <https://1145.am/db/2357169/Care_Capital>,
        <https://1145.am/db/2363459/Care_Capital>,
        <https://1145.am/db/2363460/Care_Capital>,
        <https://1145.am/db/2363475/Care_Capital>,
        <https://1145.am/db/2576944/Care_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353588/Mesa_Verde_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-01-04T13:03:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/elevation-pharmaceuticals-completes-30-million-series-b-financing-to-advance-aerosol-copd-1> ;
    ns1:foundName "Mesa Verde Venture Partners" ;
    ns1:investor <https://1145.am/db/2353588/Series_B_Investment_Canaan_Partners_Care_Capital_Elevation_Pharmaceuticals_Mesa_Verde_Venture_Partners_Novo_Ventures_Tpg_Biotech_Completed> ;
    ns1:name "Mesa Verde Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2309376/Mesa_Verde_Venture_Partners>,
        <https://1145.am/db/2309387/Mesa_Verde_Venture_Partners>,
        <https://1145.am/db/2331012/Mesa_Verde_Venture_Partners>,
        <https://1145.am/db/2353608/Mesa_Verde_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353588/Novo_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-01-04T13:03:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/elevation-pharmaceuticals-completes-30-million-series-b-financing-to-advance-aerosol-copd-1> ;
    ns1:foundName "Novo Ventures" ;
    ns1:investor <https://1145.am/db/2353588/Series_B_Investment_Canaan_Partners_Care_Capital_Elevation_Pharmaceuticals_Mesa_Verde_Venture_Partners_Novo_Ventures_Tpg_Biotech_Completed> ;
    ns1:name "Novo Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2251548/Novo_Ventures>,
        <https://1145.am/db/2284476/Novo_Ventures>,
        <https://1145.am/db/2313143/Novo_Ventures>,
        <https://1145.am/db/2326903/Novo_Ventures>,
        <https://1145.am/db/2330664/Novo_Ventures>,
        <https://1145.am/db/2330668/Novo_Ventures>,
        <https://1145.am/db/2336221/Novo_Ventures>,
        <https://1145.am/db/2339295/Novo_Ventures>,
        <https://1145.am/db/2343966/Novo_Ventures>,
        <https://1145.am/db/2350044/Novo_Ventures>,
        <https://1145.am/db/2352508/Novo_Ventures>,
        <https://1145.am/db/2353098/Novo_Ventures>,
        <https://1145.am/db/2353598/Novo_Ventures>,
        <https://1145.am/db/2353608/Novo_Ventures>,
        <https://1145.am/db/2354296/Novo_Ventures>,
        <https://1145.am/db/2354899/Novo_Ventures>,
        <https://1145.am/db/2354903/Novo_Ventures>,
        <https://1145.am/db/2356124/Novo_Ventures>,
        <https://1145.am/db/2358496/Novo_Ventures>,
        <https://1145.am/db/2358502/Novo_Ventures>,
        <https://1145.am/db/2361065/Novo_Ventures>,
        <https://1145.am/db/2362533/Novo_Ventures>,
        <https://1145.am/db/2363510/Novo_Ventures>,
        <https://1145.am/db/2365103/Novo_Ventures>,
        <https://1145.am/db/2370694/Novo_Ventures>,
        <https://1145.am/db/2371165/Novo_Ventures>,
        <https://1145.am/db/2371166/Novo_Ventures>,
        <https://1145.am/db/2570481/Novo_Ventures>,
        <https://1145.am/db/2570483/Novo_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353608/Care_Capital> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:description "financing" ;
    ns1:documentDate "2012-01-04T16:01:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/elevation-pharmaceuticals-completes-30-million-series-b-financing-to-advance-aerosol-copd> ;
    ns1:foundName "Care Capital" ;
    ns1:investor <https://1145.am/db/2353608/Series_B_Investment_Canaan_Partners_Care_Capital_Elevation_Pharmaceuticals_Mesa_Verde_Venture_Partners_Novo_Ventures_Tpg_Biotech_Completed> ;
    ns1:name "Care Capital" ;
    ns1:sameAsHigh <https://1145.am/db/2309376/Care_Capital>,
        <https://1145.am/db/2309387/Care_Capital>,
        <https://1145.am/db/2314850/Care_Capital_Llc>,
        <https://1145.am/db/2345213/Care_Capital>,
        <https://1145.am/db/2345214/Care_Capital>,
        <https://1145.am/db/2363475/Care_Capital>,
        <https://1145.am/db/2576944/Care_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/2302351/Care_Capital_Llc>,
        <https://1145.am/db/2305706/Care_Capital>,
        <https://1145.am/db/2305713/Care_Capital>,
        <https://1145.am/db/2305822/Care_Capital>,
        <https://1145.am/db/2318708/Care_Capital>,
        <https://1145.am/db/2320353/Care_Capital>,
        <https://1145.am/db/2320354/Care_Capital>,
        <https://1145.am/db/2353588/Care_Capital>,
        <https://1145.am/db/2357169/Care_Capital>,
        <https://1145.am/db/2363459/Care_Capital>,
        <https://1145.am/db/2363460/Care_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353608/Mesa_Verde_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-01-04T16:01:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/elevation-pharmaceuticals-completes-30-million-series-b-financing-to-advance-aerosol-copd> ;
    ns1:foundName "Mesa Verde Venture Partners" ;
    ns1:investor <https://1145.am/db/2353608/Series_B_Investment_Canaan_Partners_Care_Capital_Elevation_Pharmaceuticals_Mesa_Verde_Venture_Partners_Novo_Ventures_Tpg_Biotech_Completed> ;
    ns1:name "Mesa Verde Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2309376/Mesa_Verde_Venture_Partners>,
        <https://1145.am/db/2309387/Mesa_Verde_Venture_Partners>,
        <https://1145.am/db/2331012/Mesa_Verde_Venture_Partners>,
        <https://1145.am/db/2353588/Mesa_Verde_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353608/Novo_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-01-04T16:01:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/elevation-pharmaceuticals-completes-30-million-series-b-financing-to-advance-aerosol-copd> ;
    ns1:foundName "Novo Ventures" ;
    ns1:investor <https://1145.am/db/2353608/Series_B_Investment_Canaan_Partners_Care_Capital_Elevation_Pharmaceuticals_Mesa_Verde_Venture_Partners_Novo_Ventures_Tpg_Biotech_Completed> ;
    ns1:name "Novo Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2251548/Novo_Ventures>,
        <https://1145.am/db/2284476/Novo_Ventures>,
        <https://1145.am/db/2313143/Novo_Ventures>,
        <https://1145.am/db/2326903/Novo_Ventures>,
        <https://1145.am/db/2330664/Novo_Ventures>,
        <https://1145.am/db/2330668/Novo_Ventures>,
        <https://1145.am/db/2336221/Novo_Ventures>,
        <https://1145.am/db/2339295/Novo_Ventures>,
        <https://1145.am/db/2343966/Novo_Ventures>,
        <https://1145.am/db/2350044/Novo_Ventures>,
        <https://1145.am/db/2352508/Novo_Ventures>,
        <https://1145.am/db/2353098/Novo_Ventures>,
        <https://1145.am/db/2353588/Novo_Ventures>,
        <https://1145.am/db/2353598/Novo_Ventures>,
        <https://1145.am/db/2354296/Novo_Ventures>,
        <https://1145.am/db/2354899/Novo_Ventures>,
        <https://1145.am/db/2354903/Novo_Ventures>,
        <https://1145.am/db/2356124/Novo_Ventures>,
        <https://1145.am/db/2358496/Novo_Ventures>,
        <https://1145.am/db/2358502/Novo_Ventures>,
        <https://1145.am/db/2361065/Novo_Ventures>,
        <https://1145.am/db/2362533/Novo_Ventures>,
        <https://1145.am/db/2363510/Novo_Ventures>,
        <https://1145.am/db/2365103/Novo_Ventures>,
        <https://1145.am/db/2370694/Novo_Ventures>,
        <https://1145.am/db/2371165/Novo_Ventures>,
        <https://1145.am/db/2371166/Novo_Ventures>,
        <https://1145.am/db/2570481/Novo_Ventures>,
        <https://1145.am/db/2570483/Novo_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353610/Probiodrug_Ag> a org:Organization ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2012-01-04T16:04:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Probiodrug AG Raises Additional EUR 15 Million to Advance Its Clinical Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/probiodrug-ag-raises-additional-eur-15-million-to-advance-its-clinical-program> ;
    ns1:foundName "Probiodrug AG" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Probiodrug AG" ;
    ns1:sameAsHigh <https://1145.am/db/2325846/Probiodrug_Ag_(probiodrug)>,
        <https://1145.am/db/2336250/Probiodrug>,
        <https://1145.am/db/2342722/Probiodrug>,
        <https://1145.am/db/2353607/Probiodrug_Ag>,
        <https://1145.am/db/2361262/Probiodrug_Ag_(probiodrug)>,
        <https://1145.am/db/2367149/Probiodrug_Ag> ;
    ns1:sameAsMedium <https://1145.am/db/2325831/Probiodrug>,
        <https://1145.am/db/2364649/Probiodrug_Ag> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353646/Afexa> a org:Organization ;
    ns1:documentDate "2011-09-26T16:11:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Valeant hikes bid for Afexa; Cleveland BioLabs launches preclin cancer drug subsidiary; Mela diagnostic on path to an approval;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/valeant-hikes-bid-for-afexa-cleveland-biolabs-launches-preclin-cancer-drug-subsidiary-mela> ;
    ns1:foundName "Afexa" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Afexa" ;
    ns1:sameAsHigh <https://1145.am/db/2281080/Affinivax> ;
    ns1:sameAsMedium <https://1145.am/db/2339487/Afexa>,
        <https://1145.am/db/2571068/Afexa> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353646/Investment_Cleveland_Biolabs_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-09-26T16:11:31+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> With up to $ 26 million in support from a Russian venture fund, Cleveland BioLabs is setting up a new subsidiary to develop to develop a portfolio of preclinical cancer drugs." ;
    ns1:documentTitle "Valeant hikes bid for Afexa; Cleveland BioLabs launches preclin cancer drug subsidiary; Mela diagnostic on path to an approval;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/valeant-hikes-bid-for-afexa-cleveland-biolabs-launches-preclin-cancer-drug-subsidiary-mela> ;
    ns1:foundName "setting",
        "setting up" ;
    ns1:name "setting",
        "setting up" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "Russian Federation" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2017370/about.rdf> ;
    ns1:whereRaw "Russia" .

<https://1145.am/db/2353646/Valeant> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:buyer <https://1145.am/db/2353646/Afexa_Acquisition> ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2011-09-26T16:11:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Valeant hikes bid for Afexa; Cleveland BioLabs launches preclin cancer drug subsidiary; Mela diagnostic on path to an approval;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/valeant-hikes-bid-for-afexa-cleveland-biolabs-launches-preclin-cancer-drug-subsidiary-mela> ;
    ns1:foundName "Valeant" ;
    ns1:industry "pharmaceutical" ;
    ns1:investor <https://1145.am/db/2353646/Afexa_Acquisition> ;
    ns1:name "Valeant" ;
    ns1:sameAsHigh <https://1145.am/db/2288428/Valeant>,
        <https://1145.am/db/2294967/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2295456/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2302002/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2302007/Valeant_Canada_Limited>,
        <https://1145.am/db/2302007/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2302826/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2305757/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2305758/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2306724/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2306813/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2308734/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2312215/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2312221/Valeant>,
        <https://1145.am/db/2313272/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2313282/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2313320/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2313365/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2315100/Valeant>,
        <https://1145.am/db/2318350/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2318405/Valeant>,
        <https://1145.am/db/2319331/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2319722/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2322159/Valeant>,
        <https://1145.am/db/2322776/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2323106/Valeant>,
        <https://1145.am/db/2323111/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2324422/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2325692/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2325895/Valeant>,
        <https://1145.am/db/2330074/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2332074/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2335641/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2336083/Valeant>,
        <https://1145.am/db/2336258/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2336278/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2337634/Valeant>,
        <https://1145.am/db/2341518/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2346832/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2346833/Valeant_Canada_Limited>,
        <https://1145.am/db/2346833/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2348864/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2349239/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2349461/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2350907/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2354801/Valeant>,
        <https://1145.am/db/2354804/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2356945/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2357416/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2360703/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2361172/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2361190/Valeant>,
        <https://1145.am/db/2362893/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2362898/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2362898/Valeant_Pharmaceuticals_North_America_Llc>,
        <https://1145.am/db/2363430/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2365199/Valeant>,
        <https://1145.am/db/2365200/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2366467/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2366468/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2367825/Valeant>,
        <https://1145.am/db/2369037/Valeant>,
        <https://1145.am/db/2369371/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2369374/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2369618/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2538017/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2539802/Valeant>,
        <https://1145.am/db/2540219/Valeant>,
        <https://1145.am/db/2540467/Valeant>,
        <https://1145.am/db/2543893/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2543904/Valeant>,
        <https://1145.am/db/2544888/Valeant>,
        <https://1145.am/db/2545075/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2550867/Valeant>,
        <https://1145.am/db/2556458/Valeant>,
        <https://1145.am/db/2556718/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2556805/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2557472/Valeant>,
        <https://1145.am/db/2560716/Valeant>,
        <https://1145.am/db/2560770/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2566037/Valeant>,
        <https://1145.am/db/2568778/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2568799/Valeant_Canada>,
        <https://1145.am/db/2568808/Valeant_Canada>,
        <https://1145.am/db/2569148/Valeant>,
        <https://1145.am/db/2569149/Valeant>,
        <https://1145.am/db/2570033/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2570121/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2570390/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2571019/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2571068/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2572086/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2572449/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2572450/Valeant>,
        <https://1145.am/db/2572552/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2572553/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2572568/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2572605/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2572612/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2572932/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2573147/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2573199/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2573880/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2574433/Valeant>,
        <https://1145.am/db/2575134/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2575289/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2575552/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2575615/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2575800/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2576039/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2576047/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2576205/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2576478/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2576482/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2576956/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2576962/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2577145/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2577419/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2577770/Valeant>,
        <https://1145.am/db/2577771/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2577774/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2577775/Valeant>,
        <https://1145.am/db/2577846/Valeant>,
        <https://1145.am/db/2577958/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2578188/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2578333/Valeant_Canada>,
        <https://1145.am/db/2578700/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2579147/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2580042/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2580047/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2580122/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2580140/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2580774/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2580775/Valeant>,
        <https://1145.am/db/2580831/Valeant>,
        <https://1145.am/db/2581225/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2582260/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2582935/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2583270/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2583732/Valeant>,
        <https://1145.am/db/2583843/Valeant_Pharmaceuticals_North_America>,
        <https://1145.am/db/2584209/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2584216/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2584226/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2584644/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2584750/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2584818/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2585746/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2586657/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2586658/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2587640/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2588178/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2589040/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2589223/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2589781/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2590589/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2591690/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2592575/And_Valeant>,
        <https://1145.am/db/2593443/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2593831/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2594087/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2594236/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2594249/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2594252/Valeant>,
        <https://1145.am/db/2594253/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2594281/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2594413/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2594414/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2594557/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2594858/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2595025/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2595150/Valeant>,
        <https://1145.am/db/2595287/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2595706/Valeant>,
        <https://1145.am/db/2595853/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2595929/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2596290/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2596891/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2597119/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2597158/Valeant>,
        <https://1145.am/db/2597223/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2597433/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2597433/Valeant_Pharmaceuticals_North_America_Llc>,
        <https://1145.am/db/2597542/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2597746/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2597769/Valeant>,
        <https://1145.am/db/2598012/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2598032/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2598205/Valeant>,
        <https://1145.am/db/2598261/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2598266/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2598558/Valeant_Pharmaceuticals_International> ;
    ns1:sameAsMedium <https://1145.am/db/2288758/Valeant>,
        <https://1145.am/db/2328143/Valeant>,
        <https://1145.am/db/2547983/Valeant>,
        <https://1145.am/db/2571740/Valeant>,
        <https://1145.am/db/2572930/Valeant>,
        <https://1145.am/db/2573485/Valeant>,
        <https://1145.am/db/2575133/Valeant>,
        <https://1145.am/db/2576212/Valeant>,
        <https://1145.am/db/2579823/Valeant>,
        <https://1145.am/db/2582257/Valeant>,
        <https://1145.am/db/2582894/Valeant>,
        <https://1145.am/db/2583845/Valeant>,
        <https://1145.am/db/2584676/Valeant>,
        <https://1145.am/db/2589971/Valeant>,
        <https://1145.am/db/2590366/Valeant>,
        <https://1145.am/db/2593483/Valeant> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354625/Apogenix_Gmbh> a org:Organization ;
    ns1:basedInHighGeoName "Stadtkreis Heidelberg" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3220720/about.rdf> ;
    ns1:basedInHighRaw "Heidelberg" ;
    ns1:basedInLowRaw "EST" ;
    ns1:description "Biopharmaceutical",
        "Business" ;
    ns1:documentDate "2012-01-05T14:53:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Apogenix Raises EUR 7.5 Million to Further Advance APG101 to Treat Glioblastoma and other Tumors" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/apogenix-raises-eur-7-5-million-to-further-advance-apg101-to-treat-glioblastoma-and-other> ;
    ns1:foundName "Apogenix",
        "Apogenix / Apogenix",
        "Apogenix GmbH" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Apogenix",
        "Apogenix GmbH" ;
    ns1:sameAsHigh <https://1145.am/db/1202319/Apr>,
        <https://1145.am/db/2327489/Apogenix_Gmbh>,
        <https://1145.am/db/2359285/Affimed_Nv>,
        <https://1145.am/db/2369277/Affimed> ;
    ns1:sameAsMedium <https://1145.am/db/2327484/Apogenix>,
        <https://1145.am/db/2358599/Apogenix> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354706/Putney> a org:Organization ;
    ns1:basedInHighGeoName "Portland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4975802/about.rdf> ;
    ns1:basedInHighRaw "Portland, Maine" ;
    ns1:description "pharmaceutical company" ;
    ns1:documentDate "2011-09-29T16:18:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Safeguard Scientifics Leads $21M Round for Putney" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/safeguard-scientifics-leads-21m-round-for-putney> ;
    ns1:foundName "Putney" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Putney" ;
    ns1:sameAsHigh <https://1145.am/db/2573378/Putney_Inc>,
        <https://1145.am/db/2578849/Putney_Inc>,
        <https://1145.am/db/2578850/Putney_Inc>,
        <https://1145.am/db/2584695/Putney_Inc>,
        <https://1145.am/db/2591488/Putney>,
        <https://1145.am/db/2591491/Putney> ;
    ns1:sameAsMedium <https://1145.am/db/2580821/Putney_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355712/Cardio3biosciences> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Belgium" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2802361/about.rdf> ;
    ns1:basedInHighRaw "Belgium" ;
    ns1:description "the discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases" ;
    ns1:documentDate "2012-01-10T11:20:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cardio3 BioSciences Secures Additional €3.1 Million in Non-dilutive Funding From the Walloon Region and the European Commission" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cardio3-biosciences-secures-additional-%E2%82%AC3-1-million-non-dilutive-funding-from-walloon> ;
    ns1:foundName "Cardio3BioSciences" ;
    ns1:industry "biotechnology" ;
    ns1:name "Cardio3BioSciences" ;
    ns1:sameAsHigh <https://1145.am/db/2323050/Cardio3_Biosciences>,
        <https://1145.am/db/2323055/Cardio3_Biosciences>,
        <https://1145.am/db/2338195/Cardio3_Biosciences>,
        <https://1145.am/db/2341552/Warren_Sherman>,
        <https://1145.am/db/2346657/Cardio3_Biosciences>,
        <https://1145.am/db/2349766/Cardio3_Biosciences>,
        <https://1145.am/db/2355042/Cardio3_Biosciences>,
        <https://1145.am/db/2358402/Cardio3_Biosciences>,
        <https://1145.am/db/2364514/Heart_Metabolics_Limited>,
        <https://1145.am/db/2364518/Heart_Metabolics_Limited>,
        <https://1145.am/db/2586342/Cardio3> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355754/Biostar_Ventures> a org:Organization ;
    ns1:basedInLowRaw "MENLO PARK" ;
    ns1:documentDate "2011-10-04T15:38:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CV Ingenuity Announces Close of $16 Million Series B Financing Led by NEA" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cv-ingenuity-announces-close-of-16-million-series-b-financing-led-by-nea> ;
    ns1:foundName "BioStar Ventures" ;
    ns1:investor <https://1145.am/db/2355754/Series_B_Investment_Biostar_Ventures_Cv_Ingenuity_Cv_Ingenuity_New_Enterprise_Associates_Synergy_Ventures_Western_Technology_Completed> ;
    ns1:name "BioStar Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2154438/Biostar_Ventures>,
        <https://1145.am/db/2292772/Biostar_Ventures>,
        <https://1145.am/db/2293793/Biostar_Ventures>,
        <https://1145.am/db/2293913/Biostar_Ventures>,
        <https://1145.am/db/2297471/Biostar_Ventures>,
        <https://1145.am/db/2297644/Biostar_Ventures>,
        <https://1145.am/db/2299852/Biostar_Ventures>,
        <https://1145.am/db/2316203/Biostar_Ventures>,
        <https://1145.am/db/2334481/Biostar_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355754/Synergy_Ventures> a org:Organization ;
    ns1:basedInLowRaw "MENLO PARK" ;
    ns1:documentDate "2011-10-04T15:38:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CV Ingenuity Announces Close of $16 Million Series B Financing Led by NEA" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cv-ingenuity-announces-close-of-16-million-series-b-financing-led-by-nea> ;
    ns1:foundName "Synergy Ventures" ;
    ns1:investor <https://1145.am/db/2355754/Series_B_Investment_Biostar_Ventures_Cv_Ingenuity_Cv_Ingenuity_New_Enterprise_Associates_Synergy_Ventures_Western_Technology_Completed> ;
    ns1:name "Synergy Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2293793/Synergy_Ventures>,
        <https://1145.am/db/2295253/Synergy_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355754/Western_Technology> a org:Organization ;
    ns1:basedInLowRaw "MENLO PARK" ;
    ns1:documentDate "2011-10-04T15:38:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CV Ingenuity Announces Close of $16 Million Series B Financing Led by NEA" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cv-ingenuity-announces-close-of-16-million-series-b-financing-led-by-nea> ;
    ns1:foundName "Western Technology" ;
    ns1:investor <https://1145.am/db/2355754/Series_B_Investment_Biostar_Ventures_Cv_Ingenuity_Cv_Ingenuity_New_Enterprise_Associates_Synergy_Ventures_Western_Technology_Completed> ;
    ns1:name "Western Technology" ;
    ns1:sameAsMedium <https://1145.am/db/2293793/Western_Technology> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357799/Crystalgenomics_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Korea",
        "Seoul" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1835841/about.rdf>,
        <https://sws.geonames.org/1835848/about.rdf> ;
    ns1:basedInHighRaw "Korea",
        "Seoul" ;
    ns1:description "Biopharmaceutical",
        "Life Science" ;
    ns1:documentDate "2012-01-13T16:09:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CrystalGenomics Scores KRW 3 Billion in Strategic Equity Investment from KSLSF, a Life Science Fund Backed by the City of Seoul" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crystalgenomics-scores-krw-3-billion-strategic-equity-investment-from-kslsf-a-life-science> ;
    ns1:foundName "CrystalGenomics",
        "CrystalGenomics, Inc." ;
    ns1:industry "Life Science",
        "biopharmaceutical" ;
    ns1:name "CrystalGenomics",
        "CrystalGenomics, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2306123/Crystalgenomics_Inc>,
        <https://1145.am/db/2347963/Crystalgenomics>,
        <https://1145.am/db/2358279/Crystalgenomics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357799/KSLSF> a org:Organization ;
    ns1:basedInHighGeoName "Seoul" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1835848/about.rdf> ;
    ns1:basedInHighRaw "Seoul" ;
    ns1:description "Life Science" ;
    ns1:documentDate "2012-01-13T16:09:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CrystalGenomics Scores KRW 3 Billion in Strategic Equity Investment from KSLSF, a Life Science Fund Backed by the City of Seoul" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crystalgenomics-scores-krw-3-billion-strategic-equity-investment-from-kslsf-a-life-science> ;
    ns1:foundName "KSLSF" ;
    ns1:industry "Life Science" ;
    ns1:name "KSLSF" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357809/Clarimedix_Inc> a org:Organization ;
    ns1:description "the development of non-invasive therapeutics for the treatment of disorders associated with vascular dysfunction" ;
    ns1:documentDate "2012-01-15T18:53:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Clarimedix, Inc. Secures Investment for Proof-of-Concept Study in Cerebral Vasospasm" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/clarimedix-inc-secures-investment-for-proof-of-concept-study-cerebral-vasospasm> ;
    ns1:foundName "Clarimedix, Inc." ;
    ns1:name "Clarimedix, Inc." ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357809/Investment_Clarimedix_Inc_Johnson___Johnson_Corporate_Office_Of_Science_And_Technology_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-01-15T18:53:28+00:00"^^xsd:dateTime ;
    ns1:documentExtract "BOULDER, Colo., Jan. 11, 2012 /PRNewswire/ - Clarimedix, Inc., a privately held company focused on the development of non-invasive therapeutics for the treatment of disorders associated with vascular dysfunction, today announced that an investment has been secured from the Johnson & Johnson Corporate Office of Science and Technology (COSAT) .",
        "Clarimedix, Inc. Secures Investment for Proof-of-Concept Study in Cerebral Vasospasm." ;
    ns1:documentTitle "Clarimedix, Inc. Secures Investment for Proof-of-Concept Study in Cerebral Vasospasm" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/clarimedix-inc-secures-investment-for-proof-of-concept-study-cerebral-vasospasm> ;
    ns1:foundName "Investment",
        "investment" ;
    ns1:name "Investment",
        "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2357809/Clarimedix_Inc> ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2357829/San_Mateo_Calif-Entelos_Holding_Corporation> a org:Organization ;
    ns1:basedInHighGeoName "San Mateo County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5392427/about.rdf> ;
    ns1:basedInHighRaw "SAN MATEO, Calif." ;
    ns1:description "Business" ;
    ns1:documentDate "2012-01-17T14:04:24+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Entelos Announces Recapitalization and Significant Capital Infusion to Drive Future Growth" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/entelos-announces-recapitalization-and-significant-capital-infusion-to-drive-future-growth> ;
    ns1:foundName "SAN MATEO, Calif.-Entelos Holding Corporation" ;
    ns1:name "SAN MATEO, Calif.-Entelos Holding Corporation" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357858/Cleave_Biosciences> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "discovering and developing novel therapies for cancer" ;
    ns1:documentDate "2011-10-11T13:15:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cleave-biosciences-raises-42-million-series-a-financing-for-novel-cancer-therapies> ;
    ns1:foundName "Cleave Biosciences" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Cleave Biosciences" ;
    ns1:sameAsHigh <https://1145.am/db/2064599/Cleave_Therapeutics>,
        <https://1145.am/db/2348024/Cleave_Biosciences>,
        <https://1145.am/db/2348029/Cleave_Biosciences>,
        <https://1145.am/db/2348042/Cleave>,
        <https://1145.am/db/2349995/Cleave_Biosciences>,
        <https://1145.am/db/2367787/Cleave_Biosciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358883/Carticept_Medical> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "medical" ;
    ns1:documentDate "2012-01-19T16:26:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Carticept Medical Closes $10 Million Series C Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/carticept-medical-closes-10-million-series-c-financing-round> ;
    ns1:foundName "Carticept",
        "Carticept Medical, Inc.",
        "Carticept MedicalTM" ;
    ns1:industry "medical" ;
    ns1:name "Carticept",
        "Carticept Medical" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358883/Domain_Associates> a org:Organization ;
    ns1:basedInHighGeoName "Alpharetta" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4179574/about.rdf> ;
    ns1:basedInHighRaw "ALPHARETTA, Ga." ;
    ns1:documentDate "2012-01-19T16:26:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Carticept Medical Closes $10 Million Series C Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/carticept-medical-closes-10-million-series-c-financing-round> ;
    ns1:foundName "Domain Associates" ;
    ns1:investor <https://1145.am/db/2358883/Investment_Carticept_Medical_Domain_Associates_New_Enterprise_Associates_Sonosite_Inc_Completed> ;
    ns1:name "Domain Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1859331/Domain_Associates>,
        <https://1145.am/db/2153759/Domain_Associates>,
        <https://1145.am/db/2155032/Domain_Associates>,
        <https://1145.am/db/2155189/Domain_Associates>,
        <https://1145.am/db/2289515/Domain_Associates>,
        <https://1145.am/db/2289819/Domain_Associates>,
        <https://1145.am/db/2290405/Domain_Associates>,
        <https://1145.am/db/2294753/Domain_Associates>,
        <https://1145.am/db/2296841/Domain_Associates>,
        <https://1145.am/db/2297408/Domain_Associates>,
        <https://1145.am/db/2299776/Domain_Associates>,
        <https://1145.am/db/2300270/Domain_Associates>,
        <https://1145.am/db/2300293/Domain_Associates>,
        <https://1145.am/db/2300337/Domain_Associates>,
        <https://1145.am/db/2300455/Domain_Associates>,
        <https://1145.am/db/2302292/Domain_Associates_Llc>,
        <https://1145.am/db/2302508/Domain_Associates>,
        <https://1145.am/db/2303641/Domain_Associates>,
        <https://1145.am/db/2303642/Domain_Associates>,
        <https://1145.am/db/2303793/Domain_Associates>,
        <https://1145.am/db/2304578/Domain_Associates>,
        <https://1145.am/db/2304587/Domain_Associates>,
        <https://1145.am/db/2305524/Domain_Associates>,
        <https://1145.am/db/2305530/Domain_Associates>,
        <https://1145.am/db/2305706/Domain_Associates>,
        <https://1145.am/db/2305713/Domain_Associates>,
        <https://1145.am/db/2305729/Domain_Associates>,
        <https://1145.am/db/2306290/Domain_Associates_Llc>,
        <https://1145.am/db/2306873/Domain_Associates>,
        <https://1145.am/db/2307237/Domain_Associates>,
        <https://1145.am/db/2307644/Domain_Associates>,
        <https://1145.am/db/2309809/Domain_Associates>,
        <https://1145.am/db/2310073/Domain_Associates>,
        <https://1145.am/db/2311099/Domain_Associates>,
        <https://1145.am/db/2311221/Domain_Associates>,
        <https://1145.am/db/2312051/Domain_Associates>,
        <https://1145.am/db/2312120/Domain_Associates>,
        <https://1145.am/db/2312297/Domain_Associates>,
        <https://1145.am/db/2313171/Domain_Associates>,
        <https://1145.am/db/2316210/Domain_Associates>,
        <https://1145.am/db/2316214/Domain_Associates>,
        <https://1145.am/db/2317145/Domain_Associates>,
        <https://1145.am/db/2317951/Domain_Associates>,
        <https://1145.am/db/2318934/Domain_Associates>,
        <https://1145.am/db/2320925/Domain_Associates>,
        <https://1145.am/db/2322231/Domain_Associates>,
        <https://1145.am/db/2326423/Domain_Associates>,
        <https://1145.am/db/2326430/Domain_Associates_Llc>,
        <https://1145.am/db/2328030/Domain_Associates_Llc>,
        <https://1145.am/db/2328034/Domain_Associates_Llc>,
        <https://1145.am/db/2330075/Domain_Associates>,
        <https://1145.am/db/2330539/Domain_Associates>,
        <https://1145.am/db/2330549/Domain_Associates>,
        <https://1145.am/db/2331026/Domain_Associates>,
        <https://1145.am/db/2331047/Domain_Associates>,
        <https://1145.am/db/2331784/Domain_Associates>,
        <https://1145.am/db/2336221/Domain_Associates>,
        <https://1145.am/db/2340284/Domain_Associates>,
        <https://1145.am/db/2340634/Domain_Associates>,
        <https://1145.am/db/2341764/Domain_Associates>,
        <https://1145.am/db/2343206/Domain_Associates>,
        <https://1145.am/db/2344090/Domain_Associates>,
        <https://1145.am/db/2344092/Domain_Associates>,
        <https://1145.am/db/2344100/Domain_Associates>,
        <https://1145.am/db/2344782/Domain_Associates>,
        <https://1145.am/db/2347984/Domain_Associates>,
        <https://1145.am/db/2349143/Domain_Associates>,
        <https://1145.am/db/2349753/Domain_Associates>,
        <https://1145.am/db/2350044/Domain_Associates>,
        <https://1145.am/db/2352167/Domain_Associates>,
        <https://1145.am/db/2352170/Domain_Associates>,
        <https://1145.am/db/2352808/Domain_Associates>,
        <https://1145.am/db/2354899/Domain_Associates>,
        <https://1145.am/db/2354903/Domain_Associates>,
        <https://1145.am/db/2355936/Domain_Associates>,
        <https://1145.am/db/2355938/Domain_Associates>,
        <https://1145.am/db/2356301/Domain_Associates>,
        <https://1145.am/db/2357325/Domain_Associates>,
        <https://1145.am/db/2357981/Domain_Associates>,
        <https://1145.am/db/2358541/Domain_Associates>,
        <https://1145.am/db/2361625/Domain_Associates>,
        <https://1145.am/db/2362278/Domain_Associates>,
        <https://1145.am/db/2365700/Domain_Associates>,
        <https://1145.am/db/2366128/Domain_Associates>,
        <https://1145.am/db/2366133/Domain_Associates>,
        <https://1145.am/db/2366187/Domain_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358888/Dnanexus> a org:Organization ;
    ns1:description "DNA - based medicine and biotechnology" ;
    ns1:documentDate "2011-10-12T14:14:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DNAnexus Secures $15 Million Funding Led by Google Ventures and TPG Biotech" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dnanexus-secures-15-million-funding-led-by-google-ventures-and-tpg-biotech> ;
    ns1:foundName "DNAnexus" ;
    ns1:name "DNAnexus" ;
    ns1:sameAsMedium <https://1145.am/db/1354874/Dnanexus>,
        <https://1145.am/db/1436981/Dnanexus>,
        <https://1145.am/db/1438365/Dnanexus>,
        <https://1145.am/db/1636043/Dnanexus>,
        <https://1145.am/db/1639864/Dnanexus>,
        <https://1145.am/db/1747873/Dnanexus>,
        <https://1145.am/db/2208259/Dnanexus>,
        <https://1145.am/db/2308700/Dnanexus>,
        <https://1145.am/db/2322901/Dnanexus>,
        <https://1145.am/db/2323524/Dnanexus>,
        <https://1145.am/db/2327811/Dnanexus>,
        <https://1145.am/db/2328238/Dnanexus>,
        <https://1145.am/db/2342724/Dnanexus>,
        <https://1145.am/db/2357081/Dnanexus>,
        <https://1145.am/db/2357083/Dnanexus>,
        <https://1145.am/db/2370569/Dnanexus>,
        <https://1145.am/db/457671/Dnanexus>,
        <https://1145.am/db/884787/Dnanexus_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358888/Felicis_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:description "a DNA data management and analysis platform" ;
    ns1:documentDate "2011-10-12T14:14:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DNAnexus Secures $15 Million Funding Led by Google Ventures and TPG Biotech" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dnanexus-secures-15-million-funding-led-by-google-ventures-and-tpg-biotech> ;
    ns1:foundName "Felicis Ventures" ;
    ns1:investor <https://1145.am/db/2358888/Investment_Dnanexus_Felicis_Ventures_First_Round_Capital_Google_Ventures_K9_Ventures_Softtech_Vc_Tpg_Biotech_Completed> ;
    ns1:name "Felicis Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2358888/K9_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1066481/Felicis_Ventures>,
        <https://1145.am/db/1163072/Felicis_Ventures>,
        <https://1145.am/db/1165898/Felicis_Ventures>,
        <https://1145.am/db/1202633/Felicis_Ventures>,
        <https://1145.am/db/1203099/Felicis_Ventures>,
        <https://1145.am/db/1287476/Felicis_Ventures>,
        <https://1145.am/db/1311917/Felicis_Ventures>,
        <https://1145.am/db/1412353/Felicis_Ventures>,
        <https://1145.am/db/1412391/Felicis_Ventures>,
        <https://1145.am/db/1648491/Felicis_Ventures>,
        <https://1145.am/db/1723683/Felicis_Ventures>,
        <https://1145.am/db/1732969/Felicis_Ventures>,
        <https://1145.am/db/1737321/Felicis_Ventures>,
        <https://1145.am/db/1743310/Felicis_Ventures>,
        <https://1145.am/db/1743348/Felicis_Ventures>,
        <https://1145.am/db/1751544/Felicis_Ventures>,
        <https://1145.am/db/1753259/Felicis_Ventures>,
        <https://1145.am/db/1753588/Felicis_Ventures>,
        <https://1145.am/db/1756817/Felicis_Ventures>,
        <https://1145.am/db/1761713/Felicis_Ventures>,
        <https://1145.am/db/1763565/Felicis_Ventures>,
        <https://1145.am/db/1763895/Felicis_Ventures>,
        <https://1145.am/db/1769188/Felicis_Ventures>,
        <https://1145.am/db/1771642/Felicis_Ventures>,
        <https://1145.am/db/1773448/Felicis_Ventures>,
        <https://1145.am/db/1774323/Felicis_Ventures>,
        <https://1145.am/db/1774535/Felicis_Ventures>,
        <https://1145.am/db/1775965/Felicis_Ventures>,
        <https://1145.am/db/1776988/Felicis_Ventures>,
        <https://1145.am/db/1779906/Felicis_Ventures>,
        <https://1145.am/db/1783765/Felicis_Ventures>,
        <https://1145.am/db/1786203/Felicis_Ventures>,
        <https://1145.am/db/1788803/Felicis_Ventures>,
        <https://1145.am/db/1789735/Felicis_Ventures>,
        <https://1145.am/db/1794747/Felicis_Ventures>,
        <https://1145.am/db/1795027/Felicis_Ventures>,
        <https://1145.am/db/1804476/Felicis_Ventures>,
        <https://1145.am/db/1815044/Felicis_Ventures>,
        <https://1145.am/db/1817112/Felicis_Ventures>,
        <https://1145.am/db/1819125/Felicis_Ventures>,
        <https://1145.am/db/1823954/Felicis_Ventures>,
        <https://1145.am/db/1828072/Felicis_Ventures>,
        <https://1145.am/db/1829422/Felicis_Ventures>,
        <https://1145.am/db/1832906/Felicis_Ventures>,
        <https://1145.am/db/1833278/Felicis_Ventures>,
        <https://1145.am/db/1833935/Felicis_Ventures>,
        <https://1145.am/db/1834141/Felicis_Ventures>,
        <https://1145.am/db/1838117/Felicis_Ventures>,
        <https://1145.am/db/1838678/Felicis_Ventures>,
        <https://1145.am/db/1840881/Felicis_Ventures>,
        <https://1145.am/db/1844569/Felicis_Ventures>,
        <https://1145.am/db/1845164/Felicis_Ventures>,
        <https://1145.am/db/1845217/Felicis_Ventures>,
        <https://1145.am/db/1847890/Felicis_Ventures>,
        <https://1145.am/db/1850271/Felicis_Ventures>,
        <https://1145.am/db/1851633/Felicis_Ventures>,
        <https://1145.am/db/1853122/Felicis_Ventures>,
        <https://1145.am/db/1853693/Felicis_Ventures>,
        <https://1145.am/db/1856384/Felicis_Ventures>,
        <https://1145.am/db/1861054/Felicis_Ventures>,
        <https://1145.am/db/1861444/Felicis_Ventures>,
        <https://1145.am/db/1862590/Felicis_Ventures>,
        <https://1145.am/db/1865480/Felicis_Ventures>,
        <https://1145.am/db/1872651/Felicis_Ventures>,
        <https://1145.am/db/1877243/Felicis_Ventures>,
        <https://1145.am/db/1882598/Felicis_Ventures>,
        <https://1145.am/db/1890157/Felicis_Ventures>,
        <https://1145.am/db/1895138/Felicis_Ventures>,
        <https://1145.am/db/1896452/Felicis_Ventures>,
        <https://1145.am/db/1914622/Felicis_Ventures>,
        <https://1145.am/db/2134989/Felicis_Ventures>,
        <https://1145.am/db/2186101/Felicis_Ventures>,
        <https://1145.am/db/2186588/Felicis_Ventures>,
        <https://1145.am/db/2188510/Felicis_Ventures>,
        <https://1145.am/db/2188661/Felicis_Ventures>,
        <https://1145.am/db/2195219/Felicis_Ventures>,
        <https://1145.am/db/2210557/Felicis_Ventures>,
        <https://1145.am/db/2246579/Felicis_Ventures>,
        <https://1145.am/db/2251834/Felicis_Ventures>,
        <https://1145.am/db/2254568/Felicis_Ventures>,
        <https://1145.am/db/2326080/Felicis_Ventures>,
        <https://1145.am/db/247960/Felicis_Ventures>,
        <https://1145.am/db/293849/Felicis_Ventures>,
        <https://1145.am/db/313416/Felicis_Ventures>,
        <https://1145.am/db/342182/Felicis_Ventures>,
        <https://1145.am/db/354492/Felicis_Ventures>,
        <https://1145.am/db/395724/Felicis_Ventures>,
        <https://1145.am/db/401146/Felicis_Ventures>,
        <https://1145.am/db/435549/Felicis_Ventures>,
        <https://1145.am/db/437536/Felicis_Ventures>,
        <https://1145.am/db/513305/Felicis_Ventures>,
        <https://1145.am/db/658803/Felicis_Ventures>,
        <https://1145.am/db/704753/Felicis_Ventures>,
        <https://1145.am/db/767668/Felicis_Ventures>,
        <https://1145.am/db/768852/Felicis_Ventures>,
        <https://1145.am/db/769550/Felicis_Ventures>,
        <https://1145.am/db/778025/Felicis_Ventures>,
        <https://1145.am/db/779637/Felicis_Ventures>,
        <https://1145.am/db/781922/Felicis_Ventures>,
        <https://1145.am/db/782131/Felicis_Ventures>,
        <https://1145.am/db/783032/Felicis_Ventures>,
        <https://1145.am/db/797154/Felicis_Ventures>,
        <https://1145.am/db/800377/Felicis_Ventures>,
        <https://1145.am/db/877618/Felicis_Ventures>,
        <https://1145.am/db/993176/Felicis_Ventures>,
        <https://1145.am/db/993210/Felicis_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358888/Google_Ventures> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-10-12T14:14:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DNAnexus Secures $15 Million Funding Led by Google Ventures and TPG Biotech" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dnanexus-secures-15-million-funding-led-by-google-ventures-and-tpg-biotech> ;
    ns1:foundName "Google Ventures" ;
    ns1:investor <https://1145.am/db/2358888/Investment_Dnanexus_Felicis_Ventures_First_Round_Capital_Google_Ventures_K9_Ventures_Softtech_Vc_Tpg_Biotech_Completed> ;
    ns1:name "Google Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1150887/Google_Ventures>,
        <https://1145.am/db/1153184/Google_Ventures>,
        <https://1145.am/db/1296928/Andreessen_Horowitz>,
        <https://1145.am/db/1297051/Andreessen_Horowitz>,
        <https://1145.am/db/1323515/Andreessen_Horowitz>,
        <https://1145.am/db/1452107/Y_Combinator>,
        <https://1145.am/db/1455616/Y_Combinator>,
        <https://1145.am/db/1463603/Y_Combinator>,
        <https://1145.am/db/1712326/Y_Combinator>,
        <https://1145.am/db/1740000/Andreessen_Horowitz>,
        <https://1145.am/db/1740345/Andreessen_Horowitz>,
        <https://1145.am/db/1756840/Google_Ventures>,
        <https://1145.am/db/1757791/Andreessen_Horowitz>,
        <https://1145.am/db/1761905/500_Startups>,
        <https://1145.am/db/1783633/Andreessen_Horowitz>,
        <https://1145.am/db/1786818/Google_Ventures>,
        <https://1145.am/db/1788422/Andreessen_Horowitz>,
        <https://1145.am/db/1788647/Andreessen_Horowitz>,
        <https://1145.am/db/1813163/Andreessen_Horowitz>,
        <https://1145.am/db/1818174/Andreessen_Horowitz>,
        <https://1145.am/db/1821425/Google_Ventures>,
        <https://1145.am/db/1838531/Google_Capital>,
        <https://1145.am/db/1841307/Andreessen_Horowitz>,
        <https://1145.am/db/1849884/Google_Ventures>,
        <https://1145.am/db/1853496/Andreessen_Horowitz>,
        <https://1145.am/db/1854846/Andreessen_Horowitz>,
        <https://1145.am/db/1862168/Google_Ventures>,
        <https://1145.am/db/1862392/Andreessen_Horowitz>,
        <https://1145.am/db/1870015/Andreessen_Horowitz>,
        <https://1145.am/db/1896419/Google_Ventures>,
        <https://1145.am/db/1986122/Andreessen_Horowitz>,
        <https://1145.am/db/2097368/Google_Ventures>,
        <https://1145.am/db/2123953/Wonder_Ventures>,
        <https://1145.am/db/2181184/Google_Ventures>,
        <https://1145.am/db/2183352/Google_Ventures>,
        <https://1145.am/db/2311992/Google_Ventures>,
        <https://1145.am/db/238335/Andreessen_Horowitz>,
        <https://1145.am/db/494920/Google_Ventures>,
        <https://1145.am/db/522651/Andreessen_Horowitz>,
        <https://1145.am/db/526175/Andreessen_Horowitz>,
        <https://1145.am/db/744067/Andreessen_Horowitz>,
        <https://1145.am/db/751387/Andreessen_Horowitz>,
        <https://1145.am/db/817652/Andreessen_Horowitz>,
        <https://1145.am/db/831183/Andreessen_Horowitz>,
        <https://1145.am/db/874394/Andreessen_Horowitz>,
        <https://1145.am/db/893810/Y_Combinator>,
        <https://1145.am/db/923794/Andreessen_Horowitz>,
        <https://1145.am/db/938921/Y_Combinator> ;
    ns1:sameAsMedium <https://1145.am/db/1114979/Google_Ventures>,
        <https://1145.am/db/1156925/Google_Ventures>,
        <https://1145.am/db/1157294/Google_Ventures>,
        <https://1145.am/db/1187183/Google_Ventures>,
        <https://1145.am/db/1189383/Google_Ventures>,
        <https://1145.am/db/1202509/Google_Ventures>,
        <https://1145.am/db/1202633/Google_Ventures>,
        <https://1145.am/db/1203099/Google_Ventures>,
        <https://1145.am/db/1397630/Google_Ventures>,
        <https://1145.am/db/1425239/Google_Ventures>,
        <https://1145.am/db/1427745/Google_Ventures>,
        <https://1145.am/db/1557175/Google_Ventures>,
        <https://1145.am/db/1558567/Google_Ventures>,
        <https://1145.am/db/1632690/Google_Ventures>,
        <https://1145.am/db/1714555/Google_Ventures>,
        <https://1145.am/db/1739125/Google_Ventures>,
        <https://1145.am/db/1752659/Google_Ventures>,
        <https://1145.am/db/1758916/Google_Ventures>,
        <https://1145.am/db/1760954/Google_Ventures>,
        <https://1145.am/db/1760999/Google_Ventures>,
        <https://1145.am/db/1764012/Google_Ventures>,
        <https://1145.am/db/1768021/Google_Ventures>,
        <https://1145.am/db/1768511/Google_Ventures>,
        <https://1145.am/db/1769528/Google_Ventures>,
        <https://1145.am/db/1772778/Google_Ventures>,
        <https://1145.am/db/1773605/Google_Ventures>,
        <https://1145.am/db/1773703/Google_Ventures>,
        <https://1145.am/db/1776575/Google_Ventures>,
        <https://1145.am/db/1779277/Google_Ventures>,
        <https://1145.am/db/1780470/Google_Ventures>,
        <https://1145.am/db/1780582/Google_Ventures>,
        <https://1145.am/db/1786716/Google_Ventures>,
        <https://1145.am/db/1793129/Google_Ventures>,
        <https://1145.am/db/1794049/Google_Ventures>,
        <https://1145.am/db/1798836/Google_Ventures>,
        <https://1145.am/db/1799162/Google_Ventures>,
        <https://1145.am/db/1803296/Google_Ventures>,
        <https://1145.am/db/1804887/Google_Ventures>,
        <https://1145.am/db/1805764/Google_Ventures>,
        <https://1145.am/db/1807288/Google_Ventures>,
        <https://1145.am/db/1808484/Google_Ventures>,
        <https://1145.am/db/1811851/Google_Ventures>,
        <https://1145.am/db/1813266/Google_Ventures>,
        <https://1145.am/db/1814186/Google_Ventures>,
        <https://1145.am/db/1816707/Google_Ventures>,
        <https://1145.am/db/1817262/Google_Ventures>,
        <https://1145.am/db/1818901/Google_Ventures>,
        <https://1145.am/db/1820380/Google_Ventures>,
        <https://1145.am/db/1821752/Google_Ventures>,
        <https://1145.am/db/1824026/Google_Ventures>,
        <https://1145.am/db/1826007/Google_Ventures>,
        <https://1145.am/db/1827884/Google_Ventures>,
        <https://1145.am/db/1828072/Google_Ventures>,
        <https://1145.am/db/1830066/Google_Ventures>,
        <https://1145.am/db/1830101/Google_Ventures>,
        <https://1145.am/db/1830452/Google_Ventures>,
        <https://1145.am/db/1831764/Google_Ventures>,
        <https://1145.am/db/1832133/Google_Ventures>,
        <https://1145.am/db/1833010/Google_Ventures>,
        <https://1145.am/db/1833657/Google_Ventures>,
        <https://1145.am/db/1833931/Google_Ventures>,
        <https://1145.am/db/1834481/Google_Ventures>,
        <https://1145.am/db/1834503/Google_Ventures>,
        <https://1145.am/db/1837499/Google_Ventures>,
        <https://1145.am/db/1838965/Google_Ventures>,
        <https://1145.am/db/1840663/Google_Ventures>,
        <https://1145.am/db/1841061/Google_Ventures>,
        <https://1145.am/db/1842342/Google_Ventures>,
        <https://1145.am/db/1842817/Google_Ventures>,
        <https://1145.am/db/1843360/Google_Ventures>,
        <https://1145.am/db/1844180/Google_Ventures>,
        <https://1145.am/db/1844551/Google_Ventures>,
        <https://1145.am/db/1845023/Google_Ventures>,
        <https://1145.am/db/1848084/Google_Ventures>,
        <https://1145.am/db/1848585/Google_Ventures>,
        <https://1145.am/db/1849967/Google_Ventures>,
        <https://1145.am/db/1853335/Google_Ventures>,
        <https://1145.am/db/1854208/Google_Ventures>,
        <https://1145.am/db/1854279/Google_Ventures>,
        <https://1145.am/db/1854797/Google_Ventures>,
        <https://1145.am/db/1856811/Google_Ventures>,
        <https://1145.am/db/1857105/Google_Ventures>,
        <https://1145.am/db/1857240/Google_Ventures>,
        <https://1145.am/db/1858438/Google_Ventures>,
        <https://1145.am/db/1858646/Google_Ventures>,
        <https://1145.am/db/1860878/Google_Ventures>,
        <https://1145.am/db/1861342/Google_Ventures>,
        <https://1145.am/db/1864594/Google_Ventures>,
        <https://1145.am/db/1873505/Google_Ventures>,
        <https://1145.am/db/1876848/Google_Ventures>,
        <https://1145.am/db/1877178/Google_Ventures>,
        <https://1145.am/db/1877473/Google_Ventures>,
        <https://1145.am/db/1879716/Google_Ventures>,
        <https://1145.am/db/1882810/Google_Ventures>,
        <https://1145.am/db/1883008/Google_Ventures>,
        <https://1145.am/db/1885998/Google_Ventures>,
        <https://1145.am/db/1886357/Google_Ventures>,
        <https://1145.am/db/1886978/Google_Ventures>,
        <https://1145.am/db/1887982/Google_Ventures>,
        <https://1145.am/db/1896364/Google_Ventures>,
        <https://1145.am/db/1911314/Google_Ventures>,
        <https://1145.am/db/1947312/Google_Ventures>,
        <https://1145.am/db/2154341/Google_Ventures>,
        <https://1145.am/db/2180867/Google_Ventures>,
        <https://1145.am/db/2191183/Google_Ventures>,
        <https://1145.am/db/2194249/Google_Ventures>,
        <https://1145.am/db/2196786/Google_Ventures>,
        <https://1145.am/db/2198042/Google_Ventures>,
        <https://1145.am/db/2249658/Google_Ventures>,
        <https://1145.am/db/2269634/Google_Ventures>,
        <https://1145.am/db/2286291/Google_Ventures>,
        <https://1145.am/db/2292675/Google_Ventures>,
        <https://1145.am/db/2307494/Google_Ventures>,
        <https://1145.am/db/2308700/Google_Ventures>,
        <https://1145.am/db/2319338/Google_Ventures>,
        <https://1145.am/db/2323524/Google_Ventures>,
        <https://1145.am/db/2333119/Google_Ventures>,
        <https://1145.am/db/2342724/Google_Ventures>,
        <https://1145.am/db/2342725/Google_Ventures>,
        <https://1145.am/db/2349008/Google_Ventures>,
        <https://1145.am/db/2349426/Google_Ventures>,
        <https://1145.am/db/2350327/Google_Ventures>,
        <https://1145.am/db/2352489/Google_Ventures>,
        <https://1145.am/db/2356396/Google_Ventures>,
        <https://1145.am/db/2359987/Google_Ventures>,
        <https://1145.am/db/2367199/Google_Ventures>,
        <https://1145.am/db/2367201/Google_Ventures>,
        <https://1145.am/db/2367681/Google_Ventures>,
        <https://1145.am/db/2370208/Google_Ventures>,
        <https://1145.am/db/2370240/Google_Ventures>,
        <https://1145.am/db/2541350/Google_Ventures>,
        <https://1145.am/db/2583442/Google_Ventures>,
        <https://1145.am/db/490110/Google_Ventures>,
        <https://1145.am/db/658803/Google_Ventures>,
        <https://1145.am/db/773684/Google_Ventures>,
        <https://1145.am/db/8080/Google_Ventures>,
        <https://1145.am/db/823763/Google_Ventures>,
        <https://1145.am/db/923065/Google_Ventures>,
        <https://1145.am/db/962870/Google_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358888/K9_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:description "a DNA data management and analysis platform" ;
    ns1:documentDate "2011-10-12T14:14:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DNAnexus Secures $15 Million Funding Led by Google Ventures and TPG Biotech" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dnanexus-secures-15-million-funding-led-by-google-ventures-and-tpg-biotech> ;
    ns1:foundName "K9 Ventures" ;
    ns1:investor <https://1145.am/db/2358888/Investment_Dnanexus_Felicis_Ventures_First_Round_Capital_Google_Ventures_K9_Ventures_Softtech_Vc_Tpg_Biotech_Completed> ;
    ns1:name "K9 Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2358888/Felicis_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1376828/K9_Ventures>,
        <https://1145.am/db/1760197/K9_Ventures>,
        <https://1145.am/db/1815802/K9_Ventures>,
        <https://1145.am/db/1845114/K9_Ventures>,
        <https://1145.am/db/1850812/K9_Ventures>,
        <https://1145.am/db/1862824/K9_Ventures>,
        <https://1145.am/db/1890750/K9_Ventures>,
        <https://1145.am/db/797137/K9_Ventures>,
        <https://1145.am/db/800298/K9_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359960/Forbion_Capital_Partners> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Austria" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2782113/about.rdf> ;
    ns1:basedInHighRaw "Austria" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-10-17T11:54:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Hookipa Biotech Closes €7 million Series A Financing led by Sofinnova Partners" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/hookipa-biotech-closes-%E2%82%AC7-million-series-a-financing-led-by-sofinnova-partners> ;
    ns1:foundName "Forbion Capital Partners" ;
    ns1:investor <https://1145.am/db/2359960/Series_A_Investment_Forbion_Capital_Partners_Hookipa_Biotech_Sofinnova_Partners_Completed> ;
    ns1:name "Forbion Capital Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2288529/Forbion_Capital_Partners>,
        <https://1145.am/db/2313401/Forbion_Capital_Partners>,
        <https://1145.am/db/2338987/Forbion_Capital_Partners>,
        <https://1145.am/db/2339428/Forbion_Capital_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/2223193/Forbion_Capital_Partners>,
        <https://1145.am/db/2295207/Forbion_Capital_Partners>,
        <https://1145.am/db/2296065/Forbion_Capital_Partners>,
        <https://1145.am/db/2301966/Forbion_Capital_Partners>,
        <https://1145.am/db/2309865/Forbion_Capital_Partners>,
        <https://1145.am/db/2309872/Forbion_Capital_Partners>,
        <https://1145.am/db/2313410/Forbion_Capital_Partners>,
        <https://1145.am/db/2313915/Forbion_Capital_Partners>,
        <https://1145.am/db/2318829/Forbion_Capital_Partners>,
        <https://1145.am/db/2320503/Forbion_Capital_Partners>,
        <https://1145.am/db/2323586/Forbion_Capital_Partners>,
        <https://1145.am/db/2327009/Forbion_Capital_Partners>,
        <https://1145.am/db/2328040/Forbion_Capital_Partners>,
        <https://1145.am/db/2328763/Forbion_Capital_Partners>,
        <https://1145.am/db/2328769/Forbion_Capital_Partners>,
        <https://1145.am/db/2329919/Forbion_Capital_Partners>,
        <https://1145.am/db/2336126/Forbion_Capital_Partners>,
        <https://1145.am/db/2338373/Forbion_Capital_Partners>,
        <https://1145.am/db/2339427/Forbion_Capital_Partners>,
        <https://1145.am/db/2339932/Forbion_Capital_Partners>,
        <https://1145.am/db/2339933/Forbion_Capital_Partners>,
        <https://1145.am/db/2341942/Forbion_Capital_Partners>,
        <https://1145.am/db/2343202/Forbion_Capital_Partners>,
        <https://1145.am/db/2343210/Forbion_Capital_Partners>,
        <https://1145.am/db/2343244/Forbion_Capital_Partners>,
        <https://1145.am/db/2346397/Forbion_Capital_Partners>,
        <https://1145.am/db/2348506/Forbion_Capital_Partners>,
        <https://1145.am/db/2348523/Forbion_Capital_Partners>,
        <https://1145.am/db/2350101/Forbion_Capital_Partners>,
        <https://1145.am/db/2352566/Forbion_Capital_Partners>,
        <https://1145.am/db/2355511/Forbion_Capital_Partners>,
        <https://1145.am/db/2355512/Forbion_Capital_Partners>,
        <https://1145.am/db/2356989/Forbion_Capital_Partners>,
        <https://1145.am/db/2357941/Forbion_Capital_Partners>,
        <https://1145.am/db/2357956/Forbion_Capital_Partners>,
        <https://1145.am/db/2360313/Forbion_Capital_Partners>,
        <https://1145.am/db/2360317/Forbion_Capital_Partners>,
        <https://1145.am/db/2361390/Forbion_Capital_Partners>,
        <https://1145.am/db/2363593/Forbion_Capital_Partners>,
        <https://1145.am/db/2363597/Forbion_Capital_Partners>,
        <https://1145.am/db/2366539/Forbion_Capital_Partners>,
        <https://1145.am/db/2369872/Forbion_Capital_Partners>,
        <https://1145.am/db/2370054/Forbion_Capital_Partners>,
        <https://1145.am/db/2370056/Forbion_Capital_Partners>,
        <https://1145.am/db/2538923/Forbion_Capital_Partners>,
        <https://1145.am/db/2569491/Forbion_Capital_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359960/Hookipa_Biotech> a org:Organization ;
    ns1:description "developing new generation vaccines" ;
    ns1:documentDate "2011-10-17T11:54:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Hookipa Biotech Closes €7 million Series A Financing led by Sofinnova Partners" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/hookipa-biotech-closes-%E2%82%AC7-million-series-a-financing-led-by-sofinnova-partners> ;
    ns1:foundName "Hookipa Biotech" ;
    ns1:industry "biotech" ;
    ns1:name "Hookipa Biotech" ;
    ns1:sameAsHigh <https://1145.am/db/2361673/Hookipa_Biotech>,
        <https://1145.am/db/2363597/Hookipa_Biotech>,
        <https://1145.am/db/2555545/Hookipa_Biotech> ;
    ns1:sameAsMedium <https://1145.am/db/2363593/Hookipa_Biotech> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359987/Foundation_Medicine> a org:Organization ;
    ns1:description "cancer diagnostics" ;
    ns1:documentDate "2011-10-18T12:15:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Foundation Medicine Closes Expanded Series A Financing Totaling $33.5 Million; Kleiner Perkins Caufield & Byers and Google" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/foundation-medicine-closes-expanded-series-a-financing-totaling-33-5-million-kleiner> ;
    ns1:foundName "Foundation Medicine",
        "Foundation Medicine, Inc." ;
    ns1:industry "cancer diagnostics" ;
    ns1:name "Foundation Medicine" ;
    ns1:sameAsHigh <https://1145.am/db/1310760/Bioaffinity_Technologies>,
        <https://1145.am/db/1311923/Bioaffinity_Technologies>,
        <https://1145.am/db/1319633/Bioaffinity_Technologies>,
        <https://1145.am/db/1320425/Bioaffinity>,
        <https://1145.am/db/2067215/New_Day_Diagnostics>,
        <https://1145.am/db/2152366/Foundation_Medicine>,
        <https://1145.am/db/2234439/Foundation_Medicine>,
        <https://1145.am/db/2290247/Epic_Sciences>,
        <https://1145.am/db/2294252/Foundation_Medicine>,
        <https://1145.am/db/2333480/Diagnocure>,
        <https://1145.am/db/2358181/Foundation_Medicine> ;
    ns1:sameAsMedium <https://1145.am/db/2154351/Foundation_Medicine>,
        <https://1145.am/db/2154736/Foundation_Medicine>,
        <https://1145.am/db/2289430/Foundation_Medicine>,
        <https://1145.am/db/2290987/Foundation_Medicine>,
        <https://1145.am/db/2294783/Foundation_Medicine>,
        <https://1145.am/db/2296859/Foundation_Medicine>,
        <https://1145.am/db/2297300/Foundation_Medicine>,
        <https://1145.am/db/2298856/Foundation_Medicine>,
        <https://1145.am/db/2300201/Foundation_Medicine>,
        <https://1145.am/db/2300254/Foundation_Medicine>,
        <https://1145.am/db/2341645/Foundation_Medicine>,
        <https://1145.am/db/2341652/Foundation_Medicine>,
        <https://1145.am/db/2341662/Foundation_Medicine>,
        <https://1145.am/db/2341795/Foundation_Medicine>,
        <https://1145.am/db/2361646/Foundation_Medicine>,
        <https://1145.am/db/2362106/Foundation_Medicine>,
        <https://1145.am/db/2362134/Foundation_Medicine>,
        <https://1145.am/db/488608/Foundation_Medicine> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359987/Google_Ventures> a org:Organization ;
    ns1:description "Google Ventures Join as Investors" ;
    ns1:documentDate "2011-10-18T12:15:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Foundation Medicine Closes Expanded Series A Financing Totaling $33.5 Million; Kleiner Perkins Caufield & Byers and Google" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/foundation-medicine-closes-expanded-series-a-financing-totaling-33-5-million-kleiner> ;
    ns1:foundName "Google Ventures" ;
    ns1:investor <https://1145.am/db/2359987/Series_A_Investment_Foundation_Medicine_Google_Ventures_Kleiner_Perkins_Caufield___Byers_Third_Rock_Ventures_Completed> ;
    ns1:name "Google Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1114979/Google_Ventures>,
        <https://1145.am/db/1150887/Google_Ventures>,
        <https://1145.am/db/1153184/Google_Ventures>,
        <https://1145.am/db/1156925/Google_Ventures>,
        <https://1145.am/db/1157294/Google_Ventures>,
        <https://1145.am/db/1187183/Google_Ventures>,
        <https://1145.am/db/1189383/Google_Ventures>,
        <https://1145.am/db/1202509/Google_Ventures>,
        <https://1145.am/db/1202633/Google_Ventures>,
        <https://1145.am/db/1203099/Google_Ventures>,
        <https://1145.am/db/1397630/Google_Ventures>,
        <https://1145.am/db/1425239/Google_Ventures>,
        <https://1145.am/db/1427745/Google_Ventures>,
        <https://1145.am/db/1557175/Google_Ventures>,
        <https://1145.am/db/1558567/Google_Ventures>,
        <https://1145.am/db/1632690/Google_Ventures>,
        <https://1145.am/db/1714555/Google_Ventures>,
        <https://1145.am/db/1739125/Google_Ventures>,
        <https://1145.am/db/1752659/Google_Ventures>,
        <https://1145.am/db/1756840/Google_Ventures>,
        <https://1145.am/db/1758916/Google_Ventures>,
        <https://1145.am/db/1760954/Google_Ventures>,
        <https://1145.am/db/1760999/Google_Ventures>,
        <https://1145.am/db/1764012/Google_Ventures>,
        <https://1145.am/db/1768021/Google_Ventures>,
        <https://1145.am/db/1768511/Google_Ventures>,
        <https://1145.am/db/1769528/Google_Ventures>,
        <https://1145.am/db/1772778/Google_Ventures>,
        <https://1145.am/db/1773605/Google_Ventures>,
        <https://1145.am/db/1773703/Google_Ventures>,
        <https://1145.am/db/1776575/Google_Ventures>,
        <https://1145.am/db/1779277/Google_Ventures>,
        <https://1145.am/db/1780470/Google_Ventures>,
        <https://1145.am/db/1780582/Google_Ventures>,
        <https://1145.am/db/1786716/Google_Ventures>,
        <https://1145.am/db/1786818/Google_Ventures>,
        <https://1145.am/db/1793129/Google_Ventures>,
        <https://1145.am/db/1794049/Google_Ventures>,
        <https://1145.am/db/1798836/Google_Ventures>,
        <https://1145.am/db/1799162/Google_Ventures>,
        <https://1145.am/db/1803296/Google_Ventures>,
        <https://1145.am/db/1804887/Google_Ventures>,
        <https://1145.am/db/1805764/Google_Ventures>,
        <https://1145.am/db/1807288/Google_Ventures>,
        <https://1145.am/db/1808484/Google_Ventures>,
        <https://1145.am/db/1811851/Google_Ventures>,
        <https://1145.am/db/1813266/Google_Ventures>,
        <https://1145.am/db/1814186/Google_Ventures>,
        <https://1145.am/db/1816707/Google_Ventures>,
        <https://1145.am/db/1817262/Google_Ventures>,
        <https://1145.am/db/1818901/Google_Ventures>,
        <https://1145.am/db/1820380/Google_Ventures>,
        <https://1145.am/db/1821425/Google_Ventures>,
        <https://1145.am/db/1821752/Google_Ventures>,
        <https://1145.am/db/1824026/Google_Ventures>,
        <https://1145.am/db/1826007/Google_Ventures>,
        <https://1145.am/db/1827884/Google_Ventures>,
        <https://1145.am/db/1828072/Google_Ventures>,
        <https://1145.am/db/1830066/Google_Ventures>,
        <https://1145.am/db/1830101/Google_Ventures>,
        <https://1145.am/db/1830452/Google_Ventures>,
        <https://1145.am/db/1831764/Google_Ventures>,
        <https://1145.am/db/1832133/Google_Ventures>,
        <https://1145.am/db/1833010/Google_Ventures>,
        <https://1145.am/db/1833657/Google_Ventures>,
        <https://1145.am/db/1833931/Google_Ventures>,
        <https://1145.am/db/1834481/Google_Ventures>,
        <https://1145.am/db/1834503/Google_Ventures>,
        <https://1145.am/db/1837499/Google_Ventures>,
        <https://1145.am/db/1838965/Google_Ventures>,
        <https://1145.am/db/1840663/Google_Ventures>,
        <https://1145.am/db/1841061/Google_Ventures>,
        <https://1145.am/db/1842342/Google_Ventures>,
        <https://1145.am/db/1842817/Google_Ventures>,
        <https://1145.am/db/1843360/Google_Ventures>,
        <https://1145.am/db/1844180/Google_Ventures>,
        <https://1145.am/db/1844551/Google_Ventures>,
        <https://1145.am/db/1845023/Google_Ventures>,
        <https://1145.am/db/1848084/Google_Ventures>,
        <https://1145.am/db/1848585/Google_Ventures>,
        <https://1145.am/db/1849884/Google_Ventures>,
        <https://1145.am/db/1849967/Google_Ventures>,
        <https://1145.am/db/1853335/Google_Ventures>,
        <https://1145.am/db/1854208/Google_Ventures>,
        <https://1145.am/db/1854279/Google_Ventures>,
        <https://1145.am/db/1854797/Google_Ventures>,
        <https://1145.am/db/1856811/Google_Ventures>,
        <https://1145.am/db/1857105/Google_Ventures>,
        <https://1145.am/db/1857240/Google_Ventures>,
        <https://1145.am/db/1858438/Google_Ventures>,
        <https://1145.am/db/1858646/Google_Ventures>,
        <https://1145.am/db/1860878/Google_Ventures>,
        <https://1145.am/db/1861342/Google_Ventures>,
        <https://1145.am/db/1862168/Google_Ventures>,
        <https://1145.am/db/1864594/Google_Ventures>,
        <https://1145.am/db/1873505/Google_Ventures>,
        <https://1145.am/db/1876848/Google_Ventures>,
        <https://1145.am/db/1877178/Google_Ventures>,
        <https://1145.am/db/1877473/Google_Ventures>,
        <https://1145.am/db/1879716/Google_Ventures>,
        <https://1145.am/db/1882810/Google_Ventures>,
        <https://1145.am/db/1883008/Google_Ventures>,
        <https://1145.am/db/1885998/Google_Ventures>,
        <https://1145.am/db/1886357/Google_Ventures>,
        <https://1145.am/db/1886978/Google_Ventures>,
        <https://1145.am/db/1887982/Google_Ventures>,
        <https://1145.am/db/1896364/Google_Ventures>,
        <https://1145.am/db/1896419/Google_Ventures>,
        <https://1145.am/db/1911314/Google_Ventures>,
        <https://1145.am/db/1947312/Google_Ventures>,
        <https://1145.am/db/2097368/Google_Ventures>,
        <https://1145.am/db/2154341/Google_Ventures>,
        <https://1145.am/db/2180867/Google_Ventures>,
        <https://1145.am/db/2181184/Google_Ventures>,
        <https://1145.am/db/2183352/Google_Ventures>,
        <https://1145.am/db/2191183/Google_Ventures>,
        <https://1145.am/db/2194249/Google_Ventures>,
        <https://1145.am/db/2196786/Google_Ventures>,
        <https://1145.am/db/2198042/Google_Ventures>,
        <https://1145.am/db/2249658/Google_Ventures>,
        <https://1145.am/db/2269634/Google_Ventures>,
        <https://1145.am/db/2286291/Google_Ventures>,
        <https://1145.am/db/2292675/Google_Ventures>,
        <https://1145.am/db/2307494/Google_Ventures>,
        <https://1145.am/db/2308700/Google_Ventures>,
        <https://1145.am/db/2311992/Google_Ventures>,
        <https://1145.am/db/2319338/Google_Ventures>,
        <https://1145.am/db/2323524/Google_Ventures>,
        <https://1145.am/db/2333119/Google_Ventures>,
        <https://1145.am/db/2342724/Google_Ventures>,
        <https://1145.am/db/2342725/Google_Ventures>,
        <https://1145.am/db/2349008/Google_Ventures>,
        <https://1145.am/db/2349426/Google_Ventures>,
        <https://1145.am/db/2350327/Google_Ventures>,
        <https://1145.am/db/2352489/Google_Ventures>,
        <https://1145.am/db/2356396/Google_Ventures>,
        <https://1145.am/db/2358888/Google_Ventures>,
        <https://1145.am/db/2367199/Google_Ventures>,
        <https://1145.am/db/2367201/Google_Ventures>,
        <https://1145.am/db/2367681/Google_Ventures>,
        <https://1145.am/db/2370208/Google_Ventures>,
        <https://1145.am/db/2370240/Google_Ventures>,
        <https://1145.am/db/2541350/Google_Ventures>,
        <https://1145.am/db/2583442/Google_Ventures>,
        <https://1145.am/db/490110/Google_Ventures>,
        <https://1145.am/db/494920/Google_Ventures>,
        <https://1145.am/db/658803/Google_Ventures>,
        <https://1145.am/db/773684/Google_Ventures>,
        <https://1145.am/db/8080/Google_Ventures>,
        <https://1145.am/db/823763/Google_Ventures>,
        <https://1145.am/db/923065/Google_Ventures>,
        <https://1145.am/db/962870/Google_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360006/Topica_Pharmaceuticals> a org:Organization ;
    ns1:basedInHighGeoName "Palo Alto" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5380748/about.rdf> ;
    ns1:basedInHighRaw "PALO ALTO, CA" ;
    ns1:description "Biotechnology",
        "Pharmaceuticals" ;
    ns1:documentDate "2011-10-18T15:40:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TOPICA Announces Completion of $27 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/topica-announces-completion-of-27-million-series-b-financing> ;
    ns1:foundName "TOPICA",
        "TOPICA Pharmaceuticals, Inc." ;
    ns1:industry "biotechnology" ;
    ns1:name "TOPICA",
        "TOPICA Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/1103357/Esperion>,
        <https://1145.am/db/1183641/Tyme>,
        <https://1145.am/db/1184316/Tyme>,
        <https://1145.am/db/1198337/Recce_Pharmaceuticals_Ltd>,
        <https://1145.am/db/1213270/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/1216194/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/1224125/Ars_Pharmaceuticals>,
        <https://1145.am/db/1224418/Ars_Pharmaceuticals>,
        <https://1145.am/db/1225975/Ars_Pharmaceuticals_Inc>,
        <https://1145.am/db/1226849/Ars_Pharmaceuticals>,
        <https://1145.am/db/1252190/F2g_Ltd>,
        <https://1145.am/db/1265967/Tyme>,
        <https://1145.am/db/1266692/Tyme>,
        <https://1145.am/db/1322957/Biosion>,
        <https://1145.am/db/1334447/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/1360048/Alnylam_Pharmaceuticals_Inc>,
        <https://1145.am/db/1361196/Alnylam_Pharmaceuticals_Inc>,
        <https://1145.am/db/1366554/Casi_Pharmaceuticals_Inc>,
        <https://1145.am/db/1417340/Ars_Pharmaceuticals_Inc>,
        <https://1145.am/db/1417348/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1418572/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1430057/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497210/Indivior_Plc>,
        <https://1145.am/db/1497218/Indivior>,
        <https://1145.am/db/1505021/Pharmaceutics_International_Inc>,
        <https://1145.am/db/1538098/Biocon_Ltd>,
        <https://1145.am/db/1540449/Aerie_Pharmaceuticals>,
        <https://1145.am/db/160543/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/1606076/Gni_Group_Ltd>,
        <https://1145.am/db/1632868/Sovereign_Pharmaceuticals_Llc>,
        <https://1145.am/db/1661035/Biontech>,
        <https://1145.am/db/1685745/Dmk_Pharmaceuticals_Corp>,
        <https://1145.am/db/1957460/Pardes_Biosciences_Inc>,
        <https://1145.am/db/1979697/Amphastar_Pharmaceuticals>,
        <https://1145.am/db/2004101/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/2040011/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2054868/Pharmaceuticals_Inc>,
        <https://1145.am/db/2056005/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2056755/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2061803/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2152103/Am-Pharma>,
        <https://1145.am/db/2152849/Abide_Therapeutics>,
        <https://1145.am/db/2153295/Curzion_Pharmaceuticals>,
        <https://1145.am/db/2153719/Amag_Pharmaceuticals>,
        <https://1145.am/db/2154019/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154871/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2156002/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2212420/Cel-Sci_Corporation>,
        <https://1145.am/db/2218929/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2225379/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2234316/Intercell_Ag>,
        <https://1145.am/db/2250936/Fera_Pharmaceuticals>,
        <https://1145.am/db/2277669/Pharmerica_Corporation>,
        <https://1145.am/db/2285587/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2286671/Promedior>,
        <https://1145.am/db/2289865/Thar_Pharmaceuticals>,
        <https://1145.am/db/2289873/Thar_Pharmaceuticals>,
        <https://1145.am/db/2290753/Medivir>,
        <https://1145.am/db/2291914/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2297691/Ucb>,
        <https://1145.am/db/2298017/Kleo_Pharmaceuticals>,
        <https://1145.am/db/2298627/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2301798/Osi_Pharmaceuticals>,
        <https://1145.am/db/2301824/Presidio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302019/Oscient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2302552/Am-Pharma>,
        <https://1145.am/db/2303022/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303426/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2303552/Meda>,
        <https://1145.am/db/2303645/Akarx>,
        <https://1145.am/db/2303646/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2303647/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2303956/Prolexys_Pharmaceuticals>,
        <https://1145.am/db/2303974/Actimis_Pharmaceuticals>,
        <https://1145.am/db/2304342/PTC>,
        <https://1145.am/db/2305834/Nps_Pharmaceuticals>,
        <https://1145.am/db/2306115/Aesrx>,
        <https://1145.am/db/2306255/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2307834/Savient_Pharmaceuticals>,
        <https://1145.am/db/2307894/Lev_Pharmaceuticals>,
        <https://1145.am/db/2308423/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2308429/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310196/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2310568/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2310590/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2310989/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2311359/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2312088/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2312158/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2312257/The_Medicines_Company>,
        <https://1145.am/db/2313181/Pharmeng_International_Inc>,
        <https://1145.am/db/2313320/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313324/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313487/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2314317/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314474/Pharmion>,
        <https://1145.am/db/2314563/Inex_Pharmaceuticals>,
        <https://1145.am/db/2315170/Alan_Copa>,
        <https://1145.am/db/2315296/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315296/Pharmatec_Gmbh>,
        <https://1145.am/db/2315941/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2316481/Osi_Pharmaceuticals>,
        <https://1145.am/db/2316660/Pharmacopeia>,
        <https://1145.am/db/2316684/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2317949/Novalar_Pharmaceuticals>,
        <https://1145.am/db/2318104/Pharmaform>,
        <https://1145.am/db/2318711/Specialty_Pharmaceuticals>,
        <https://1145.am/db/2319846/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2319938/Del_Pharmaceuticals>,
        <https://1145.am/db/2319939/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2320768/Semafore_Pharmaceuticals>,
        <https://1145.am/db/2321150/Alinea_Pharmaceuticals>,
        <https://1145.am/db/2321256/Nps_Pharmaceuticals>,
        <https://1145.am/db/2321409/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321413/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321784/Acceliant>,
        <https://1145.am/db/2322159/Pharmaceutical>,
        <https://1145.am/db/2322850/Clinipace>,
        <https://1145.am/db/2323181/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2323273/Pharmion_Corporation>,
        <https://1145.am/db/2323278/Pharmion>,
        <https://1145.am/db/2323303/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2324141/Ucb>,
        <https://1145.am/db/2324372/Ucb>,
        <https://1145.am/db/2325215/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2325259/Pharmacopeia>,
        <https://1145.am/db/2325260/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2325269/Pharmacopeia>,
        <https://1145.am/db/2325394/Pharmion>,
        <https://1145.am/db/2326361/Apt_Pharmaceuticals>,
        <https://1145.am/db/2326397/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2326541/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2327241/Nps_Pharmaceuticals>,
        <https://1145.am/db/2327258/Biocon_Limited>,
        <https://1145.am/db/2328017/Calando_Pharmaceuticals>,
        <https://1145.am/db/2328330/Meda>,
        <https://1145.am/db/2328962/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2328996/Via_Pharmaceuticals>,
        <https://1145.am/db/2329696/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2329792/Semafore_Pharmaceuticals>,
        <https://1145.am/db/2329848/Idm_Pharma>,
        <https://1145.am/db/2330121/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2330576/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330734/Pharmaceuticals_Group>,
        <https://1145.am/db/2330858/Provid_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330882/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2330933/Biocon>,
        <https://1145.am/db/2330949/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2330951/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2330973/Bioxell>,
        <https://1145.am/db/2331692/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2331795/Ucb>,
        <https://1145.am/db/2332028/Donald_Leung>,
        <https://1145.am/db/2332912/Bioscrip>,
        <https://1145.am/db/2332920/Nastech>,
        <https://1145.am/db/2336040/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336041/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336175/Forum_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336225/Acorda>,
        <https://1145.am/db/2336629/Biota_Pharmaceuticals>,
        <https://1145.am/db/2336936/Amag_Pharmaceuticals>,
        <https://1145.am/db/2337053/N30_Pharmaceuticals>,
        <https://1145.am/db/2337481/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2337928/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338120/The_Medicines_Company>,
        <https://1145.am/db/2338123/The_Medicines_Company>,
        <https://1145.am/db/2339127/Kala_Pharmaceuticals>,
        <https://1145.am/db/2339830/Ocera>,
        <https://1145.am/db/2341743/Amag_Pharmaceuticals>,
        <https://1145.am/db/2342192/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2342224/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342225/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342687/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2343210/Promedior>,
        <https://1145.am/db/2343325/Medivir>,
        <https://1145.am/db/2343497/Fera_Pharmaceuticals>,
        <https://1145.am/db/2343966/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2344560/Dmi_Biosciences_Inc>,
        <https://1145.am/db/2344735/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344850/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346138/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2346775/N30_Pharmaceuticals>,
        <https://1145.am/db/2347123/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2347125/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2347169/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2348329/Esperance_Pharmaceuticals>,
        <https://1145.am/db/2348523/Am-Pharma_Bv>,
        <https://1145.am/db/2348620/Diartis_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349031/Meda>,
        <https://1145.am/db/2349111/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349461/Ista_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349573/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349581/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349608/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350147/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350975/Meda>,
        <https://1145.am/db/2351432/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2352516/S_*_Bio>,
        <https://1145.am/db/2353101/Index_Pharmaceuticals>,
        <https://1145.am/db/2353279/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Presidio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353326/Am-Pharma>,
        <https://1145.am/db/2354145/Amag_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354402/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354779/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354783/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2355102/Addex_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2355841/F2g_Ltd>,
        <https://1145.am/db/2355885/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2356391/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2356410/Ym_Biosciences_Inc>,
        <https://1145.am/db/2356434/The_Medicines_Company>,
        <https://1145.am/db/2356560/Theravance>,
        <https://1145.am/db/2357259/Galmed_Pharmaceuticals>,
        <https://1145.am/db/2357321/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2357423/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357456/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357905/The_Medicines_Company>,
        <https://1145.am/db/2358147/Omni_Bio_Pharmaceutical_Inc>,
        <https://1145.am/db/2358449/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358479/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359380/Amri>,
        <https://1145.am/db/2359517/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359539/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2359550/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2359681/Ucb>,
        <https://1145.am/db/2360258/Aldea_Pharmaceuticals>,
        <https://1145.am/db/2360371/Preglem>,
        <https://1145.am/db/2360596/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2361646/Biomarin>,
        <https://1145.am/db/2362378/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2362609/Amag_Pharmaceuticals>,
        <https://1145.am/db/2363154/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363248/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2363461/Ucb>,
        <https://1145.am/db/2363801/Preglem>,
        <https://1145.am/db/2364274/S_*_Bio_Pte_Ltd>,
        <https://1145.am/db/2364430/Cipla>,
        <https://1145.am/db/2365372/Bd>,
        <https://1145.am/db/2365450/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2366540/Prism_Pharmaceuticals>,
        <https://1145.am/db/2367182/Biotica>,
        <https://1145.am/db/2368165/Pieris_Pharmaceuticals>,
        <https://1145.am/db/2368189/Index_Pharmaceuticals>,
        <https://1145.am/db/2369126/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2369617/Amag_Pharmaceuticals_Inc>,
        <https://1145.am/db/2369825/Pieris_Pharmaceuticals>,
        <https://1145.am/db/2369883/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2369984/Biogaia>,
        <https://1145.am/db/2370399/Pharmamar>,
        <https://1145.am/db/2370437/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/2370437/MSD>,
        <https://1145.am/db/2371320/Pharco_Pharmaceuticals>,
        <https://1145.am/db/2371522/Dyax>,
        <https://1145.am/db/238320/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/2538019/Ucb>,
        <https://1145.am/db/2538392/Biocon>,
        <https://1145.am/db/2538422/Idt>,
        <https://1145.am/db/2538705/PTC>,
        <https://1145.am/db/2539759/Twi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2540249/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2541326/Advanced_Pharmaceutical>,
        <https://1145.am/db/2541419/Amri>,
        <https://1145.am/db/2542071/Ucb>,
        <https://1145.am/db/2544054/Cipla>,
        <https://1145.am/db/2544783/Citius_Pharmaceuticals>,
        <https://1145.am/db/2547068/Alapis>,
        <https://1145.am/db/2547319/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2547593/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2547596/Par_Pharmaceuticals>,
        <https://1145.am/db/2550232/Cipla>,
        <https://1145.am/db/2551601/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2552746/Supreme_Pharmaceuticals_Inc>,
        <https://1145.am/db/2554824/Cipla>,
        <https://1145.am/db/2555921/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2557028/DPX>,
        <https://1145.am/db/2558071/Cipla>,
        <https://1145.am/db/2561791/Cipla>,
        <https://1145.am/db/2562446/Specialty_Pharmaceutical>,
        <https://1145.am/db/2562552/Ucb>,
        <https://1145.am/db/2562723/Biontech>,
        <https://1145.am/db/2563255/MSD>,
        <https://1145.am/db/2563450/Kv_Pharmaceuticals>,
        <https://1145.am/db/2564030/Ucb>,
        <https://1145.am/db/2566424/Dbl_Pharmaceuticals>,
        <https://1145.am/db/2566946/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2567296/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2567319/PTC>,
        <https://1145.am/db/2569099/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2569102/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2569165/Pharmacyclics>,
        <https://1145.am/db/2569425/Ucb>,
        <https://1145.am/db/2569679/Pharmaceuticals_Inc>,
        <https://1145.am/db/2569952/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570122/Ucb>,
        <https://1145.am/db/2570419/Pharmacyclics>,
        <https://1145.am/db/2570733/Dyax_Corp>,
        <https://1145.am/db/2570807/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570834/Phrma>,
        <https://1145.am/db/2571136/Kala_Pharmaceuticals>,
        <https://1145.am/db/2571316/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2571723/Amag_Pharmaceuticals>,
        <https://1145.am/db/2572018/Meda>,
        <https://1145.am/db/2572393/Pharmacia_Corporation>,
        <https://1145.am/db/2573593/Biotica>,
        <https://1145.am/db/2574213/Pharmacia_Corporation>,
        <https://1145.am/db/2574421/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2575567/Fera_Pharmaceuticals>,
        <https://1145.am/db/2575850/Cipla>,
        <https://1145.am/db/2576967/Insight_Pharmaceuticals>,
        <https://1145.am/db/2578095/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2578177/Nexus_Pharmaceuticals>,
        <https://1145.am/db/2578209/Ucb>,
        <https://1145.am/db/2578420/Meda_Pharmaceuticals>,
        <https://1145.am/db/2578667/Almirall>,
        <https://1145.am/db/2579104/Ucb>,
        <https://1145.am/db/2581394/Biocon>,
        <https://1145.am/db/2581552/Imprimis_Pharmaceuticals>,
        <https://1145.am/db/2582283/Amag_Pharmaceuticals>,
        <https://1145.am/db/2582677/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2582681/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2583291/Savient_Pharmaceuticals>,
        <https://1145.am/db/2583352/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583352/Mikah>,
        <https://1145.am/db/2583430/Imprimis_Pharmaceuticals>,
        <https://1145.am/db/2583437/Meda>,
        <https://1145.am/db/2583783/Biomarin>,
        <https://1145.am/db/2584250/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2584617/Amag_Pharmaceuticals_Inc>,
        <https://1145.am/db/2584750/Meda>,
        <https://1145.am/db/2585327/Cipla_Limited>,
        <https://1145.am/db/2586547/Ucb>,
        <https://1145.am/db/2586968/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2587292/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2588049/Aegerion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2589317/Diartis_Pharmaceuticals>,
        <https://1145.am/db/2589414/Spepharm_Ag>,
        <https://1145.am/db/2590195/Nectid>,
        <https://1145.am/db/2592254/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/2592336/Dyax>,
        <https://1145.am/db/2592874/Ucb>,
        <https://1145.am/db/2593048/Meda>,
        <https://1145.am/db/2593573/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594106/Paras_Pharmaceuticals>,
        <https://1145.am/db/2594168/Meda>,
        <https://1145.am/db/2594183/Astex_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594257/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2594262/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2594414/Ista_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594798/Pharmerica>,
        <https://1145.am/db/2595202/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2595237/Emcure_Pharmaceuticals>,
        <https://1145.am/db/2595326/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2596054/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596356/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596636/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2597622/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2598012/Allos_Therapeutics>,
        <https://1145.am/db/2598137/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/299734/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/378431/Pharmathen>,
        <https://1145.am/db/378464/Pharmathen>,
        <https://1145.am/db/378839/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/381068/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/401218/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/402158/Puretech>,
        <https://1145.am/db/498367/Aspire_Pharma_Limited>,
        <https://1145.am/db/499171/Aspire_Pharma_Limited>,
        <https://1145.am/db/528878/Pieris_Pharmaceuticals>,
        <https://1145.am/db/538277/Adamas_Pharmaceuticals>,
        <https://1145.am/db/539267/Adamas_Pharmaceuticals>,
        <https://1145.am/db/540865/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541731/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541755/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/549059/Adamas_Pharmaceuticals>,
        <https://1145.am/db/587627/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/592025/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/612466/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/612973/Mingsight_Pharmaceuticals>,
        <https://1145.am/db/614114/Mingsight_Pharmaceuticals>,
        <https://1145.am/db/637582/The_Medicines_Co>,
        <https://1145.am/db/648300/Adamas_Pharmaceuticals>,
        <https://1145.am/db/712921/Mainpointe_Pharmaceuticals>,
        <https://1145.am/db/724999/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/731944/Aipharma>,
        <https://1145.am/db/739339/Iveric_Bio>,
        <https://1145.am/db/744958/Recipharm_Group>,
        <https://1145.am/db/746462/Recipharm_Group>,
        <https://1145.am/db/769779/Ucb_Sa>,
        <https://1145.am/db/769887/Ucb_Sa>,
        <https://1145.am/db/792894/Amt>,
        <https://1145.am/db/848323/Pharmaceutics_International_Inc>,
        <https://1145.am/db/854160/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/867644/Aipharma_Group_Ltd>,
        <https://1145.am/db/871621/Aipharma_Group_Ltd>,
        <https://1145.am/db/881631/Pharmcorx>,
        <https://1145.am/db/881719/Pharmcorx>,
        <https://1145.am/db/893741/Aipharma_Group_Ltd>,
        <https://1145.am/db/895336/Aipharma_Group_Ltd>,
        <https://1145.am/db/976867/Aprecia_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2318117/Topica_Pharmaceuticals>,
        <https://1145.am/db/2360004/Topica_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360945/Entremed> a org:Organization ;
    ns1:description "cancer" ;
    ns1:documentDate "2012-01-23T17:42:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "EntreMed Secures $10 Million Strategic Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/entremed-secures-10-million-strategic-financing> ;
    ns1:foundName "EntreMed",
        "EntreMed, Inc." ;
    ns1:industry "pharmaceutical" ;
    ns1:name "EntreMed" ;
    ns1:sameAsHigh <https://1145.am/db/101025/Scpharmaceuticals_Inc>,
        <https://1145.am/db/101329/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1031042/Intomics>,
        <https://1145.am/db/1033561/Hs_Pharmaceuticals>,
        <https://1145.am/db/1054457/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/1054503/Hs_Pharmaceuticals>,
        <https://1145.am/db/1061901/Pharmaessentia_Corporation>,
        <https://1145.am/db/1070158/Biognosys>,
        <https://1145.am/db/1079560/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1080385/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1092000/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/11010/Progenics_Pharmaceuticals>,
        <https://1145.am/db/1104169/20045078>,
        <https://1145.am/db/1118439/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1141704/Inmed_Pharmaceuticals>,
        <https://1145.am/db/1174705/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1176480/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1185008/TDV>,
        <https://1145.am/db/1186876/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/1198337/Recce_Pharmaceuticals_Ltd>,
        <https://1145.am/db/1216583/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1291286/Vital_Pharmaceuticals_Inc>,
        <https://1145.am/db/1294499/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1294506/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1295948/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1296487/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1307419/X4_Pharmaceuticals>,
        <https://1145.am/db/1322957/Biosion>,
        <https://1145.am/db/1329779/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1339033/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1343020/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/1370859/Bioivt>,
        <https://1145.am/db/1371279/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1387773/Aspire_Pharma>,
        <https://1145.am/db/1390741/Nexus_Pharmaceuticals_Inc>,
        <https://1145.am/db/1409143/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1417348/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1417723/Altasciences>,
        <https://1145.am/db/1418572/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1430057/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443334/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443968/Pharmajet®>,
        <https://1145.am/db/1445613/Pharmajet>,
        <https://1145.am/db/1487706/Phathom_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497210/Indivior_Plc>,
        <https://1145.am/db/1497210/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497218/Indivior>,
        <https://1145.am/db/1497218/Opiant_Pharmaceuticals>,
        <https://1145.am/db/1500616/Indivior_Plc>,
        <https://1145.am/db/1500616/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1502096/Indivior_Plc>,
        <https://1145.am/db/1502096/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1505968/Escient_Pharmaceuticals>,
        <https://1145.am/db/1508407/Escient_Pharmaceuticals>,
        <https://1145.am/db/1515279/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1520596/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1520597/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521624/Scpharmaceuticals>,
        <https://1145.am/db/1521695/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521941/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1523220/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1533327/Escient_Pharmaceuticals>,
        <https://1145.am/db/1533685/Escient_Pharmaceuticals>,
        <https://1145.am/db/1537336/Pharmajet®>,
        <https://1145.am/db/1538786/Pharmajet>,
        <https://1145.am/db/1540449/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1541946/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1548955/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1557072/Essential_Pharma>,
        <https://1145.am/db/1559882/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1571078/Organon>,
        <https://1145.am/db/1585097/Scpharmaceuticals_Inc>,
        <https://1145.am/db/158742/Biogen_Inc>,
        <https://1145.am/db/1595580/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/160543/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/1613688/Pharmalex>,
        <https://1145.am/db/1624479/Indivior_Plc>,
        <https://1145.am/db/1624479/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1625532/Indivior_Plc>,
        <https://1145.am/db/1625532/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1629605/Biogen>,
        <https://1145.am/db/1629663/Biogen>,
        <https://1145.am/db/1632411/Scipher_Medicine>,
        <https://1145.am/db/1632862/Scipher_Medicine>,
        <https://1145.am/db/1632868/Sovereign_Pharmaceuticals_Llc>,
        <https://1145.am/db/1661035/Biontech>,
        <https://1145.am/db/1680583/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/1687234/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/180589/Servier>,
        <https://1145.am/db/1955684/Eip_Pharma_Inc>,
        <https://1145.am/db/1979697/Amphastar_Pharmaceuticals>,
        <https://1145.am/db/2038168/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039291/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039678/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2040011/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2045820/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2049603/Inova_Pharmaceuticals>,
        <https://1145.am/db/2056005/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2056755/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2061803/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2062156/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2066480/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2071248/Biogen>,
        <https://1145.am/db/2074741/Biogen_Inc>,
        <https://1145.am/db/2092442/Leo_Pharma>,
        <https://1145.am/db/2093802/Meitheal_Pharmaceuticals>,
        <https://1145.am/db/2100253/Biogen_Inc>,
        <https://1145.am/db/2101006/Leo_Pharma_A_S>,
        <https://1145.am/db/2138834/Altasciences>,
        <https://1145.am/db/2151781/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2152103/Am-Pharma>,
        <https://1145.am/db/2152434/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2153727/Amunix_Pharmaceuticals>,
        <https://1145.am/db/2154019/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154118/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154527/The_Medicines_Company>,
        <https://1145.am/db/2154871/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155006/Medicines_Company>,
        <https://1145.am/db/2155312/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155622/Isa_Pharmaceuticals>,
        <https://1145.am/db/2155792/Ucb_Pharma>,
        <https://1145.am/db/2155798/Ucb_Pharma>,
        <https://1145.am/db/2155994/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2156002/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2198945/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2201094/Pharmadeals_Ltd>,
        <https://1145.am/db/2204969/Organon_Biosciences>,
        <https://1145.am/db/2207034/Cequent_Pharmaceuticals>,
        <https://1145.am/db/221697/Gw_Pharmaceuticals>,
        <https://1145.am/db/2217819/Pharmacopeia>,
        <https://1145.am/db/221787/Gw_Pharmaceuticals>,
        <https://1145.am/db/2218929/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2224859/Biologics>,
        <https://1145.am/db/2229191/Biologics>,
        <https://1145.am/db/2279276/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2279648/Organon>,
        <https://1145.am/db/2280123/Casi_Pharmaceuticals>,
        <https://1145.am/db/2280153/Pharming>,
        <https://1145.am/db/2281547/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2283570/Pherin_Pharmaceuticals>,
        <https://1145.am/db/2284358/Escient_Pharmaceuticals>,
        <https://1145.am/db/2285117/Immedica>,
        <https://1145.am/db/2285495/Bioivt>,
        <https://1145.am/db/2287224/Escient_Pharmaceuticals>,
        <https://1145.am/db/2287505/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2287572/T3_Pharmaceuticals>,
        <https://1145.am/db/2288192/Servier>,
        <https://1145.am/db/2290842/X4_Pharmaceuticals>,
        <https://1145.am/db/2291791/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2291914/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2294547/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2294570/Pharmatek>,
        <https://1145.am/db/2296094/Biogen>,
        <https://1145.am/db/2297534/Bio>,
        <https://1145.am/db/2298037/Ethicon>,
        <https://1145.am/db/2298627/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2299414/Biogen>,
        <https://1145.am/db/2301089/Cerulean_Pharma>,
        <https://1145.am/db/2301346/Pharmaron>,
        <https://1145.am/db/2301718/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2301735/Idera_Pharmaceuticals>,
        <https://1145.am/db/2301764/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2301798/Osi_Pharmaceuticals>,
        <https://1145.am/db/2302019/Oscient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2302275/Map_Pharmaceuticals>,
        <https://1145.am/db/2302426/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302431/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302552/Am-Pharma>,
        <https://1145.am/db/2302574/Via_Pharmaceuticals>,
        <https://1145.am/db/2302579/Via_Pharmaceuticals>,
        <https://1145.am/db/2302587/Access_Pharmaceuticals>,
        <https://1145.am/db/2302658/Biotie>,
        <https://1145.am/db/2302707/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2302774/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302779/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302890/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2302897/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2303022/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303121/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303131/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303182/Pharmexa>,
        <https://1145.am/db/2303208/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303426/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2303674/Cerulean_Pharma>,
        <https://1145.am/db/2303792/Access_Pharmaceuticals>,
        <https://1145.am/db/2303934/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2303956/Prolexys_Pharmaceuticals>,
        <https://1145.am/db/2304044/Novamed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2304097/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2304135/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2304610/Pharmos_Corp>,
        <https://1145.am/db/2304745/Critical_Pharmaceuticals>,
        <https://1145.am/db/2304831/Pharmion_Corporation>,
        <https://1145.am/db/2304934/Medicure>,
        <https://1145.am/db/2304985/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2305742/Mh_Pharma_Uk>,
        <https://1145.am/db/2305834/Nps_Pharmaceuticals>,
        <https://1145.am/db/2305927/Entremed>,
        <https://1145.am/db/2305956/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2306255/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2306299/Verily>,
        <https://1145.am/db/2306641/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2306962/Pharmaron>,
        <https://1145.am/db/2307239/Pharmaxis_Ltd>,
        <https://1145.am/db/2307246/Pharmaxis>,
        <https://1145.am/db/2307254/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2307651/Organon>,
        <https://1145.am/db/2307834/Savient_Pharmaceuticals>,
        <https://1145.am/db/2307871/Access_Pharmaceuticals>,
        <https://1145.am/db/2307894/Lev_Pharmaceuticals>,
        <https://1145.am/db/2307897/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2308423/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2308429/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2308446/Pharmathene>,
        <https://1145.am/db/2308922/Lev_Pharmaceuticals>,
        <https://1145.am/db/2308964/Slate_Pharmaceuticals>,
        <https://1145.am/db/2309001/Biocon>,
        <https://1145.am/db/2309301/Inc>,
        <https://1145.am/db/2309923/Diasome_Pharmaceuticals>,
        <https://1145.am/db/2310002/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2310002/Map_Pharmaceuticals>,
        <https://1145.am/db/2310045/Slate_Pharmaceuticals>,
        <https://1145.am/db/2310071/Encysive_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310196/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2310200/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2310219/Docpharma>,
        <https://1145.am/db/2310232/Genaissance_Pharmaceuticals>,
        <https://1145.am/db/2310471/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/2310473/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310476/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2310480/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310590/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2310790/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2310989/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310993/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2311166/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2311202/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2311217/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2311264/Medicure>,
        <https://1145.am/db/2311726/Inc>,
        <https://1145.am/db/2312088/Cerulean_Pharma>,
        <https://1145.am/db/2312088/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2312158/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2312193/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2312257/The_Medicines_Company>,
        <https://1145.am/db/2312344/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2312416/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2312476/Nps_Pharmaceuticals>,
        <https://1145.am/db/2312479/Nps_Pharmaceuticals>,
        <https://1145.am/db/2313305/Tetraphase_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313306/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2313320/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313320/Ore_Pharmaceuticals>,
        <https://1145.am/db/2313323/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313324/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313336/Sound_Pharmaceuticals>,
        <https://1145.am/db/2313487/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2313501/Bioalliance_Pharma>,
        <https://1145.am/db/2313527/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2313528/Us_Pharmaceutical_Company>,
        <https://1145.am/db/2314217/Sciele_Pharma>,
        <https://1145.am/db/2314271/Biomarck_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2314277/Biomarck_Pharmaceuticals>,
        <https://1145.am/db/2314317/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314375/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314474/Pharmion>,
        <https://1145.am/db/2314680/Pharming>,
        <https://1145.am/db/2314816/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314837/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2315159/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2315192/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2315296/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315485/Polpharma>,
        <https://1145.am/db/2315571/Sciele_Pharma>,
        <https://1145.am/db/2315624/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315624/Pharmos>,
        <https://1145.am/db/2315925/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2315941/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2316239/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2316418/Pharmaventures_Ltd>,
        <https://1145.am/db/2316435/Pharmaventures_Ltd>,
        <https://1145.am/db/2316481/Osi_Pharmaceuticals>,
        <https://1145.am/db/2316660/Pharmacopeia>,
        <https://1145.am/db/2316684/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2317337/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2317344/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2317635/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2317762/Pharmathene>,
        <https://1145.am/db/2317826/Anormed>,
        <https://1145.am/db/2317826/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2317842/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2317895/Esprit_Pharma>,
        <https://1145.am/db/2317929/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2318105/Pharma_Inc>,
        <https://1145.am/db/2318114/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2318248/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318285/Pht_Corporation>,
        <https://1145.am/db/2318469/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2318554/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318574/Idera_Pharmaceuticals>,
        <https://1145.am/db/2318711/Specialty_Pharmaceuticals>,
        <https://1145.am/db/2318743/Pharmos_Corporation>,
        <https://1145.am/db/2318808/Pharmathene>,
        <https://1145.am/db/2318986/Corgentech>,
        <https://1145.am/db/2318994/Cornerstone_Biopharma>,
        <https://1145.am/db/2319208/Osi_Pharmaceuticals>,
        <https://1145.am/db/2319687/Advisys>,
        <https://1145.am/db/2319790/Pharmacyclics>,
        <https://1145.am/db/2319806/Satori_Pharmaceuticals>,
        <https://1145.am/db/2319809/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2319938/Del_Pharmaceuticals>,
        <https://1145.am/db/2319939/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2320009/Map_Pharmaceuticals>,
        <https://1145.am/db/2320025/Am-Pharma>,
        <https://1145.am/db/2320025/Esprit_Pharma>,
        <https://1145.am/db/2320461/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2320767/Via_Pharmaceuticals>,
        <https://1145.am/db/2320903/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2320949/Medicines_Company>,
        <https://1145.am/db/2321148/Savient_Pharmaceuticals>,
        <https://1145.am/db/2321157/Access_Pharmaceuticals>,
        <https://1145.am/db/2321256/Nps_Pharmaceuticals>,
        <https://1145.am/db/2321409/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321413/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321565/2009-2010>,
        <https://1145.am/db/2321784/Acceliant>,
        <https://1145.am/db/2321860/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2321861/Astion_Pharma>,
        <https://1145.am/db/2321871/Astion_Pharma>,
        <https://1145.am/db/2321899/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2322135/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322235/Pharmacopeia>,
        <https://1145.am/db/2322291/Polpharma>,
        <https://1145.am/db/2322481/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322632/Savient_Pharmaceuticals>,
        <https://1145.am/db/2322942/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2322953/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2323173/Pharmacopeia>,
        <https://1145.am/db/2323181/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2323225/Arqule>,
        <https://1145.am/db/2323273/Pharmion_Corporation>,
        <https://1145.am/db/2323278/Pharmion>,
        <https://1145.am/db/2323358/Organon_Biosciences>,
        <https://1145.am/db/2324017/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2324024/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2324243/Arqule>,
        <https://1145.am/db/2324417/Biomimetic_Pharmaceuticals>,
        <https://1145.am/db/2324753/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2324838/Biogen>,
        <https://1145.am/db/2325070/The_Medicines_Company>,
        <https://1145.am/db/2325074/The_Medicines_Company>,
        <https://1145.am/db/2325259/Pharmacopeia>,
        <https://1145.am/db/2325269/Pharmacopeia>,
        <https://1145.am/db/2325394/Pharmion>,
        <https://1145.am/db/2325725/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2326025/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2326148/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2326286/Idera_Pharmaceuticals>,
        <https://1145.am/db/2326403/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2326466/Macromed>,
        <https://1145.am/db/2326474/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2327241/Nps_Pharmaceuticals>,
        <https://1145.am/db/2327450/York_Pharma>,
        <https://1145.am/db/2327480/Transdel_Pharmaceuticals>,
        <https://1145.am/db/2327649/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2327849/Pharmacia_Corporation>,
        <https://1145.am/db/2328043/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/2328220/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2328222/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2328616/Map_Pharmaceuticals>,
        <https://1145.am/db/2328650/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2328729/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2328988/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2328990/Mdrna>,
        <https://1145.am/db/2328996/Via_Pharmaceuticals>,
        <https://1145.am/db/2329309/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2329643/Pharmaceuticals_Inc>,
        <https://1145.am/db/2329756/Provid_Pharmaceuticals>,
        <https://1145.am/db/2329814/Map_Pharmaceuticals>,
        <https://1145.am/db/2329816/Map_Pharmaceuticals>,
        <https://1145.am/db/2330057/Pharmathene>,
        <https://1145.am/db/2330086/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330094/Idera_Pharmaceuticals>,
        <https://1145.am/db/2330207/Bioxell>,
        <https://1145.am/db/2330207/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2330534/Pharmion>,
        <https://1145.am/db/2330576/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330667/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330858/Provid_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330880/Access_Pharmaceuticals>,
        <https://1145.am/db/2330880/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330882/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2330951/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2330989/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2331692/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2331745/Elan_Pharmaceuticals>,
        <https://1145.am/db/2331756/Pro-Pharmaceuticals>,
        <https://1145.am/db/2331875/Bioalliance_Pharma>,
        <https://1145.am/db/2332473/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2332596/Esprit_Pharma>,
        <https://1145.am/db/2332777/S_*_Bio>,
        <https://1145.am/db/2332974/Osi_Pharmaceuticals>,
        <https://1145.am/db/2332980/Pharmos_Corporation>,
        <https://1145.am/db/2333492/Access_Pharmaceuticals>,
        <https://1145.am/db/2333569/Ception>,
        <https://1145.am/db/2333624/Pharmos>,
        <https://1145.am/db/2334034/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2334119/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334121/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334183/Idera_Pharmaceuticals>,
        <https://1145.am/db/2335077/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2336040/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336041/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336160/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2336293/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2336378/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336442/Bionor_Pharma_Asa>,
        <https://1145.am/db/2336452/Pharmaxis_Ltd>,
        <https://1145.am/db/2336503/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336505/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336506/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2336524/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336629/Biota_Pharmaceuticals>,
        <https://1145.am/db/2336934/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337053/N30_Pharmaceuticals>,
        <https://1145.am/db/2337345/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337348/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2337547/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337928/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337986/Pharmagen_Inc>,
        <https://1145.am/db/2338120/The_Medicines_Company>,
        <https://1145.am/db/2338123/The_Medicines_Company>,
        <https://1145.am/db/2338390/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338401/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2338430/Pharmacyclics>,
        <https://1145.am/db/2338551/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338735/Map_Pharmaceuticals>,
        <https://1145.am/db/2338877/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2338883/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2339019/Isa_Pharmaceuticals_Bv>,
        <https://1145.am/db/2339186/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2339570/Map_Pharmaceuticals>,
        <https://1145.am/db/2339718/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2339727/Pharmacyclics_Inc>,
        <https://1145.am/db/2339787/Pharmalink_Ab>,
        <https://1145.am/db/2339892/Pharmacyclics>,
        <https://1145.am/db/2339907/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2339910/Biomed_Pharmaceuticals>,
        <https://1145.am/db/2339922/Pharmaform>,
        <https://1145.am/db/2339979/Theravance>,
        <https://1145.am/db/2340000/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2340224/Satori_Pharmaceuticals>,
        <https://1145.am/db/2340291/Pharmasset>,
        <https://1145.am/db/2340373/Nps_Pharmaceuticals>,
        <https://1145.am/db/2340431/Savient_Pharmaceuticals>,
        <https://1145.am/db/2341523/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2341742/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2341752/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2341998/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2342192/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2342224/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342225/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342469/Pharmadel>,
        <https://1145.am/db/2342687/Bioalliance_Pharma>,
        <https://1145.am/db/2342800/Pharmathene>,
        <https://1145.am/db/2342805/Pharmathene>,
        <https://1145.am/db/2342918/Pharmalink_Ab>,
        <https://1145.am/db/2343264/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2343277/Pharmasset>,
        <https://1145.am/db/2343826/The_Medicines_Company>,
        <https://1145.am/db/2343837/Medicines_Co>,
        <https://1145.am/db/2343966/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2344011/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344076/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344079/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344131/Pharmascience_Inc>,
        <https://1145.am/db/2344207/Entremed>,
        <https://1145.am/db/2344624/Pharmagen_Inc>,
        <https://1145.am/db/2344735/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344739/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2344850/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344939/Theravance>,
        <https://1145.am/db/2344955/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2345106/Map_Pharmaceuticals>,
        <https://1145.am/db/2345474/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2345902/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346534/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346542/Conatus_Pharmaceuticals>,
        <https://1145.am/db/2346775/N30_Pharmaceuticals>,
        <https://1145.am/db/2346800/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346807/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346832/Vital_Science_Corp>,
        <https://1145.am/db/2346833/Vital_Science_Corp>,
        <https://1145.am/db/2346951/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346964/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2347127/Pharmacyte_Biotech>,
        <https://1145.am/db/2347169/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2347227/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2347272/Pharmascience>,
        <https://1145.am/db/2347519/Pharmadeals_Ltd>,
        <https://1145.am/db/2347644/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347648/Pharminox_Limited>,
        <https://1145.am/db/2347659/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347982/Epicept>,
        <https://1145.am/db/2348329/Esperance_Pharmaceuticals>,
        <https://1145.am/db/2348506/Am-Pharma_Bv>,
        <https://1145.am/db/2348523/Am-Pharma_Bv>,
        <https://1145.am/db/2348763/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2348864/Vital_Science_Corp>,
        <https://1145.am/db/2349103/Biota_Pharmaceuticals>,
        <https://1145.am/db/2349111/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349348/R-Pharm>,
        <https://1145.am/db/2349573/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349581/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349608/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349965/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350147/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350440/Ethicon>,
        <https://1145.am/db/2350852/Isa_Pharmaceuticals>,
        <https://1145.am/db/2351091/Biomotiv>,
        <https://1145.am/db/2351471/Mymetics_Corporation>,
        <https://1145.am/db/2351818/Biocon>,
        <https://1145.am/db/2352046/Costim_Pharmaceuticals>,
        <https://1145.am/db/2352165/Bio>,
        <https://1145.am/db/2352177/Theravance_Inc>,
        <https://1145.am/db/2352180/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2352333/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2352373/Adnagen>,
        <https://1145.am/db/2352538/Biota_Pharmaceuticals>,
        <https://1145.am/db/2352659/Nps_Pharmaceuticals>,
        <https://1145.am/db/2352784/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2352805/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2352808/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353006/Radient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2353093/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353098/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353101/Index_Pharmaceuticals>,
        <https://1145.am/db/2353254/Pharma_Inc>,
        <https://1145.am/db/2353262/Sound_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Presidio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353326/Am-Pharma>,
        <https://1145.am/db/2353364/Am-Pharma>,
        <https://1145.am/db/2353651/Pharmathene>,
        <https://1145.am/db/2353668/Biotie>,
        <https://1145.am/db/2354002/N30_Pharmaceuticals>,
        <https://1145.am/db/2354062/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354064/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354083/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354086/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354124/Uk>,
        <https://1145.am/db/2354146/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2354376/Aspireo_Pharmaceuticals>,
        <https://1145.am/db/2354380/Pharmaxis>,
        <https://1145.am/db/2354388/Pharmaxis>,
        <https://1145.am/db/2354402/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354406/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2354779/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354783/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354804/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2354836/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354913/Bionor_Pharma_Asa>,
        <https://1145.am/db/2355099/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355109/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355324/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2355678/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2355721/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2355884/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355885/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355941/Theratechnologies>,
        <https://1145.am/db/2355974/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2356294/Company>,
        <https://1145.am/db/2356294/Inc>,
        <https://1145.am/db/2356391/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2356434/The_Medicines_Company>,
        <https://1145.am/db/2357329/Pharmalink_Ab>,
        <https://1145.am/db/2357333/Pharmalink>,
        <https://1145.am/db/2357423/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357456/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357636/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2358047/Entremed>,
        <https://1145.am/db/2358405/Pharmagen_Inc>,
        <https://1145.am/db/2358449/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358479/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358732/Osi_Pharmaceuticals>,
        <https://1145.am/db/2358877/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359266/D-Pharm>,
        <https://1145.am/db/2359401/Scpharmaceuticals_Inc>,
        <https://1145.am/db/2359438/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2359474/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2359517/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359539/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2359550/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2359668/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2359882/Biotie>,
        <https://1145.am/db/2359926/Entremed>,
        <https://1145.am/db/2360155/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2360489/Medac_Pharma>,
        <https://1145.am/db/2360588/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2360596/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2360697/Medgenics>,
        <https://1145.am/db/2360739/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2361244/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2361516/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2362378/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2362456/Action_Pharma_A_S>,
        <https://1145.am/db/2362525/Horizon_Pharma>,
        <https://1145.am/db/2362593/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363186/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363285/Phenex_Pharmaceuticals_Ag>,
        <https://1145.am/db/2363340/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363387/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2363425/The_Medicines_Company>,
        <https://1145.am/db/2363433/The_Medicines_Company>,
        <https://1145.am/db/2363452/Pharmasum_Therapeutics_As>,
        <https://1145.am/db/2363530/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363801/Preglem>,
        <https://1145.am/db/2363955/Savient_Pharmaceuticals>,
        <https://1145.am/db/2364093/Biotie>,
        <https://1145.am/db/2364252/Nps_Pharmaceuticals>,
        <https://1145.am/db/2364274/S_*_Bio_Pte_Ltd>,
        <https://1145.am/db/2364276/S_*_Bio>,
        <https://1145.am/db/2364494/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2364495/Bioalliance_Pharma>,
        <https://1145.am/db/2364538/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2364541/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2364585/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2364593/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364601/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364774/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2364884/Entremed_Inc>,
        <https://1145.am/db/2365030/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2365098/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365224/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2365423/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365450/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2365724/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365763/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2366139/Prism_Pharmaceuticals>,
        <https://1145.am/db/2366388/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2366521/Novamed_Pharmaceuticals>,
        <https://1145.am/db/2366540/Prism_Pharmaceuticals>,
        <https://1145.am/db/2367021/Biotie>,
        <https://1145.am/db/2367070/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2367280/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2367438/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2367483/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367496/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367951/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2367962/Catalyst_Pharmaceuticals>,
        <https://1145.am/db/2368070/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2368339/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2368420/Intec_Pharma>,
        <https://1145.am/db/2368593/Bioquiddity_Incorporated>,
        <https://1145.am/db/2368632/Pharmacyclics>,
        <https://1145.am/db/2368739/Novartis_Pharmaceuticals>,
        <https://1145.am/db/2368788/Medigene>,
        <https://1145.am/db/2368826/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369004/Biogen>,
        <https://1145.am/db/2369037/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369126/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2369144/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369233/Biopharmx_Corporation>,
        <https://1145.am/db/2369402/Medicines_Company>,
        <https://1145.am/db/2369812/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2369931/Biogen>,
        <https://1145.am/db/2370022/Apellis_Pharmaceuticals>,
        <https://1145.am/db/2370078/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2370082/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2370089/Abide_Therapeutics>,
        <https://1145.am/db/2370399/Pharmamar>,
        <https://1145.am/db/2370637/Medgenics_Inc>,
        <https://1145.am/db/2370797/Pharmanest>,
        <https://1145.am/db/2370798/Pharmalink_Ab>,
        <https://1145.am/db/2370946/Biogen>,
        <https://1145.am/db/2371015/M_Pharma>,
        <https://1145.am/db/2371016/M_Pharma>,
        <https://1145.am/db/2371279/Biomunex_Pharmaceuticals>,
        <https://1145.am/db/2371491/Biopharmx_Corporation>,
        <https://1145.am/db/2536754/Oramed_Pharma>,
        <https://1145.am/db/2536756/Zao>,
        <https://1145.am/db/2537468/Pharmascience_Inc>,
        <https://1145.am/db/2538171/Biomeda_Group>,
        <https://1145.am/db/2538567/Upm_Pharmaceuticals>,
        <https://1145.am/db/2538861/Par_Pharmaceuticals>,
        <https://1145.am/db/2538901/The_Harvard_Drug_Group>,
        <https://1145.am/db/2539516/Par_Pharmaceuticals>,
        <https://1145.am/db/2539568/Zao>,
        <https://1145.am/db/2540193/Pharmanest>,
        <https://1145.am/db/2540449/Biocon>,
        <https://1145.am/db/2540951/Rytary>,
        <https://1145.am/db/2541039/Elan_Pharmaceuticals>,
        <https://1145.am/db/2541239/Pharmstar>,
        <https://1145.am/db/2541326/Advanced_Pharmaceutical>,
        <https://1145.am/db/2541717/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2541810/British_Pharma>,
        <https://1145.am/db/2542218/Pharmacyclics>,
        <https://1145.am/db/2543839/British_Pharma>,
        <https://1145.am/db/2544111/Unique_Pharmaceuticals>,
        <https://1145.am/db/2544358/Mundipharma>,
        <https://1145.am/db/2544596/Polpharma>,
        <https://1145.am/db/2544679/Neopharma>,
        <https://1145.am/db/2544783/Citius_Pharmaceuticals>,
        <https://1145.am/db/2545143/Mundipharma>,
        <https://1145.am/db/2545411/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2546441/Intas_Pharmaceuticals>,
        <https://1145.am/db/2546529/Pharma_Tech_Industries>,
        <https://1145.am/db/2546629/Par_Pharmaceutical>,
        <https://1145.am/db/2547189/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2547596/Par_Pharmaceuticals>,
        <https://1145.am/db/2548585/Par_Pharmaceuticals>,
        <https://1145.am/db/2548674/Sopharma>,
        <https://1145.am/db/2549477/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2549520/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2549919/Pharmathen>,
        <https://1145.am/db/2550212/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2550471/Pharmaform>,
        <https://1145.am/db/2550523/Pharmaron>,
        <https://1145.am/db/2550685/Upm_Pharmaceuticals>,
        <https://1145.am/db/2551427/Pharmablock_Sciences>,
        <https://1145.am/db/2551601/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2552169/Alembic_Pharmaceuticals>,
        <https://1145.am/db/2552465/Medis>,
        <https://1145.am/db/2552641/Plethico_Pharmaceuticals>,
        <https://1145.am/db/2552642/Mankind_Pharmaceuticals>,
        <https://1145.am/db/2552746/Supreme_Pharmaceuticals_Inc>,
        <https://1145.am/db/2552794/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553276/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553512/Pharmax_Pharmaceuticals>,
        <https://1145.am/db/2553708/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2554237/Intas_Pharmaceuticals>,
        <https://1145.am/db/2554810/Continuus_Pharmaceuticals>,
        <https://1145.am/db/2554814/Globalpharma>,
        <https://1145.am/db/2554858/Medicure_Usa_Inc>,
        <https://1145.am/db/2555338/Pharmacore>,
        <https://1145.am/db/2555890/Pharmalucence>,
        <https://1145.am/db/2555896/Pharmalucence>,
        <https://1145.am/db/2556805/Medicis_Pharmaceuticals>,
        <https://1145.am/db/2557303/Pharmaron>,
        <https://1145.am/db/2557538/Neopharma>,
        <https://1145.am/db/2558025/Pharmaxis>,
        <https://1145.am/db/2558026/Pharmaxis>,
        <https://1145.am/db/2558970/Biostar_Pharmaceuticals>,
        <https://1145.am/db/2559783/Polpharma>,
        <https://1145.am/db/2560083/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561100/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561312/Oxford_Pharmaceuticals>,
        <https://1145.am/db/2561438/Pharmacia___Upjohn>,
        <https://1145.am/db/2561978/Biomarin_Pharmaceuticals>,
        <https://1145.am/db/2562199/Novartis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2562446/Specialty_Pharmaceutical>,
        <https://1145.am/db/2562500/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2563255/Active_Pharmaceutical_Ingredients>,
        <https://1145.am/db/2563497/Creo_Pharmaceuticals>,
        <https://1145.am/db/2563497/Polpharma>,
        <https://1145.am/db/2564196/Pharmaron>,
        <https://1145.am/db/2564713/C2_Pharma>,
        <https://1145.am/db/2567007/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2567055/Sovereign_Pharmaceuticals>,
        <https://1145.am/db/2567283/The_Pharma_Giant>,
        <https://1145.am/db/2567438/Biogen>,
        <https://1145.am/db/2567651/Indivior>,
        <https://1145.am/db/2567651/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2568205/Biogen>,
        <https://1145.am/db/2568375/Biogen>,
        <https://1145.am/db/2569165/Pharmacyclics>,
        <https://1145.am/db/2569187/Pharmacyclics>,
        <https://1145.am/db/2569370/Co>,
        <https://1145.am/db/2569679/Pharmaceuticals_Inc>,
        <https://1145.am/db/2569729/The_Medicines_Company>,
        <https://1145.am/db/2569952/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570068/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2570289/Pharmacyclics>,
        <https://1145.am/db/2570419/Pharmacyclics>,
        <https://1145.am/db/2570449/Biocon>,
        <https://1145.am/db/2570741/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2570807/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570807/Pharmacyclics>,
        <https://1145.am/db/2570834/Phrma>,
        <https://1145.am/db/2572200/The_Medicines_Company>,
        <https://1145.am/db/2572870/Hi-Tech_Pharmaceuticals>,
        <https://1145.am/db/2573057/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2573058/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2573147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2573271/Physician_Therapeutics>,
        <https://1145.am/db/2573391/Url_Pharma>,
        <https://1145.am/db/2573392/Url_Pharma>,
        <https://1145.am/db/2573887/Biogen>,
        <https://1145.am/db/2574679/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2574891/Pharmacyclics>,
        <https://1145.am/db/2575222/Map_Pharmaceuticals>,
        <https://1145.am/db/2575242/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2575462/Paras_Pharmaceuticals>,
        <https://1145.am/db/2575623/Inova_Pharmaceuticals>,
        <https://1145.am/db/2576205/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2576967/Insight_Pharmaceuticals>,
        <https://1145.am/db/2577145/Medicis_Pharmaceutical>,
        <https://1145.am/db/2577259/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2577419/Osi_Pharmaceuticals>,
        <https://1145.am/db/2577675/Biogen>,
        <https://1145.am/db/2577684/Biogen>,
        <https://1145.am/db/2577894/Huvepharma_Ad>,
        <https://1145.am/db/2577934/Pharmascience>,
        <https://1145.am/db/2578177/Nexus_Pharmaceuticals>,
        <https://1145.am/db/2578319/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2578473/Aa_Pharma>,
        <https://1145.am/db/2578481/Aa_Pharma_Inc>,
        <https://1145.am/db/2579147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2579211/Eusa_Pharma>,
        <https://1145.am/db/2579538/Pharmaforce>,
        <https://1145.am/db/2580123/Savient_Pharmaceuticals>,
        <https://1145.am/db/2580479/Pharmaxis>,
        <https://1145.am/db/2581225/Inova_Pharmaceuticals>,
        <https://1145.am/db/2582110/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582153/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2582174/Pharmasset>,
        <https://1145.am/db/2582320/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582677/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2583013/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583022/Url_Pharma>,
        <https://1145.am/db/2583220/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2583270/Pharmaswiss>,
        <https://1145.am/db/2583291/Savient_Pharmaceuticals>,
        <https://1145.am/db/2583352/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583402/Osi_Pharmaceuticals>,
        <https://1145.am/db/2583414/Polpharma>,
        <https://1145.am/db/2583769/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2584209/Pharmaswiss_Sa>,
        <https://1145.am/db/2584226/Pharmaswiss_Sa>,
        <https://1145.am/db/2584250/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2585281/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2585887/Pharma_Inc>,
        <https://1145.am/db/2586968/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2587155/Millennium_Pharma>,
        <https://1145.am/db/2587616/Pharmaq>,
        <https://1145.am/db/2587696/R-Pharm>,
        <https://1145.am/db/2588049/Aegerion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2588718/Pharmacyclics>,
        <https://1145.am/db/2588884/Map_Pharmaceuticals>,
        <https://1145.am/db/2589884/Map_Pharmaceuticals>,
        <https://1145.am/db/2590159/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2590195/Pro-Tect_Pharmaceuticals>,
        <https://1145.am/db/2590409/Biogen>,
        <https://1145.am/db/2590910/Savient_Pharmaceuticals>,
        <https://1145.am/db/2591540/Polpharma>,
        <https://1145.am/db/2591690/Medicis_Pharmaceutical>,
        <https://1145.am/db/2591938/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2593142/Access_Pharmaceuticals>,
        <https://1145.am/db/2593573/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594042/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594106/Paras_Pharmaceuticals>,
        <https://1145.am/db/2594116/Pharmerica>,
        <https://1145.am/db/2594602/Osi_Pharma>,
        <https://1145.am/db/2594798/Pharmerica>,
        <https://1145.am/db/2595190/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595202/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2595210/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595237/Emcure_Pharmaceuticals>,
        <https://1145.am/db/2595413/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596054/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596307/Savient_Pharmaceuticals>,
        <https://1145.am/db/2596356/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596369/Pharmadeals_Ltd>,
        <https://1145.am/db/2596818/Pharmasset>,
        <https://1145.am/db/2597158/Nps_Pharmaceuticals>,
        <https://1145.am/db/2597180/Prism_Pharmaceuticals>,
        <https://1145.am/db/2597622/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2597935/Osi_Pharmaceuticals>,
        <https://1145.am/db/2598027/Nps_Pharmaceuticals>,
        <https://1145.am/db/2598099/Paras_Pharmaceuticals>,
        <https://1145.am/db/2598137/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2598195/Pharmatech>,
        <https://1145.am/db/2598605/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2765310/Biogen>,
        <https://1145.am/db/281576/Mymd_Pharmaceuticals>,
        <https://1145.am/db/307255/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/324642/Mundipharma>,
        <https://1145.am/db/367137/Biomat>,
        <https://1145.am/db/378431/Pharmathen>,
        <https://1145.am/db/378464/Pharmathen>,
        <https://1145.am/db/378839/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/380389/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/381068/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/401218/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/407888/Quoin_Pharmaceuticals>,
        <https://1145.am/db/410129/Catalyst_Pharmaceuticals_Inc>,
        <https://1145.am/db/427157/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/431169/Pharmablock>,
        <https://1145.am/db/4491/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/452957/Aerie_Pharmaceuticals>,
        <https://1145.am/db/468221/Aerie_Pharmaceuticals>,
        <https://1145.am/db/481129/Biocon_Ltd>,
        <https://1145.am/db/485351/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/486302/Phathom_Pharmaceuticals>,
        <https://1145.am/db/487010/Scipher_Medicine>,
        <https://1145.am/db/488564/Aerie_Pharmaceuticals>,
        <https://1145.am/db/498367/Aspire_Pharma_Limited>,
        <https://1145.am/db/499171/Aspire_Pharma_Limited>,
        <https://1145.am/db/538112/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/538277/Adamas_Pharmaceuticals>,
        <https://1145.am/db/539267/Adamas_Pharmaceuticals>,
        <https://1145.am/db/540865/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541731/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541755/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/545583/Citius_Pharmaceuticals>,
        <https://1145.am/db/546391/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/549059/Adamas_Pharmaceuticals>,
        <https://1145.am/db/567789/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/585607/Am-Pharma>,
        <https://1145.am/db/637582/The_Medicines_Co>,
        <https://1145.am/db/648300/Adamas_Pharmaceuticals>,
        <https://1145.am/db/662016/Prestige_Biopharma_Limited>,
        <https://1145.am/db/668495/Scipher_Medicine>,
        <https://1145.am/db/669775/Scipher_Medicine>,
        <https://1145.am/db/693128/Ascensus_Specialties>,
        <https://1145.am/db/700482/Novartis_Pharmaceuticals>,
        <https://1145.am/db/712037/Amunix_Pharmaceuticals>,
        <https://1145.am/db/712921/Mainpointe_Pharmaceuticals>,
        <https://1145.am/db/713105/Amunix_Pharmaceuticals_Inc>,
        <https://1145.am/db/713736/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/714923/Betterlife_Pharma_Inc>,
        <https://1145.am/db/715385/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/718008/Pharnext_Sa>,
        <https://1145.am/db/723883/Mymd_Pharmaceuticals>,
        <https://1145.am/db/724999/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/724999/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/734669/Escient_Pharmaceuticals>,
        <https://1145.am/db/742794/Hr®_Pharmaceuticals_Inc>,
        <https://1145.am/db/771062/Gw_Pharmaceuticals>,
        <https://1145.am/db/793071/Biogen_Inc>,
        <https://1145.am/db/835485/Pharmaessentia_Corporation>,
        <https://1145.am/db/854026/Aerie_Pharmaceuticals>,
        <https://1145.am/db/883896/Biontech>,
        <https://1145.am/db/884665/Pharmaceutical_Institute>,
        <https://1145.am/db/887575/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/889331/Théa_Pharma>,
        <https://1145.am/db/912469/Aerie_Pharmaceuticals>,
        <https://1145.am/db/913730/Aerie_Pharmaceuticals>,
        <https://1145.am/db/922740/Grand_Pharma>,
        <https://1145.am/db/976867/Aprecia_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2305070/Entremed>,
        <https://1145.am/db/2314637/Entremed>,
        <https://1145.am/db/2344202/Entremed>,
        <https://1145.am/db/2359951/Entremed> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2361004/Investment_New_Enterprise_Associates_Prosensa_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-01-25T15:00:07+00:00"^^xsd:dateTime ;
    ns1:documentExtract "LEIDEN, Netherlands- (BUSINESS WIRE) -Prosensa, the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet needs, announced today that it has raised €23 million in new equity financing.",
        "Prosensa Raises €23 Million in New Equity Financing Led by New Enterprise Associates." ;
    ns1:documentTitle "Prosensa Raises €23 Million in New Equity Financing Led by New Enterprise Associates" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/prosensa-raises-%E2%82%AC23-million-new-equity-financing-led-by-new-enterprise-associates> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2361004/Prosensa> ;
    ns1:targetDetails "equity" ;
    ns1:valueRaw "€23 Million",
        "€23 million" ;
    ns1:whereGeoName "Kingdom of Spain" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2510769/about.rdf> ;
    ns1:whereRaw "Spain" .

<https://1145.am/db/2361004/Prosensa> a org:Organization ;
    ns1:basedInLowRaw "Spain" ;
    ns1:description "a company" ;
    ns1:documentDate "2012-01-25T15:00:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Prosensa Raises €23 Million in New Equity Financing Led by New Enterprise Associates" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/prosensa-raises-%E2%82%AC23-million-new-equity-financing-led-by-new-enterprise-associates> ;
    ns1:foundName "Prosensa" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Prosensa" ;
    ns1:sameAsHigh <https://1145.am/db/2324624/Prosensa>,
        <https://1145.am/db/2336304/Phyxius_Pharma>,
        <https://1145.am/db/2356436/Prosensa>,
        <https://1145.am/db/2360979/Prosensa> ;
    ns1:sameAsMedium <https://1145.am/db/2336959/Prosensa>,
        <https://1145.am/db/2347792/Prosensa>,
        <https://1145.am/db/2357435/Prosensa>,
        <https://1145.am/db/2361005/Prosensa>,
        <https://1145.am/db/2368293/Prosensa> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2361022/Arteaus_Therapeutics> a org:Organization ;
    ns1:basedInHighGeoName "Cambridgeshire" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2653940/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE" ;
    ns1:description "a biotechnology development company",
        "creating new therapies for migraine prevention" ;
    ns1:documentDate "2011-10-19T13:49:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Arteaus Therapeutics, LLC Raises $18M to Prevent Migraines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/arteaus-therapeutics-llc-raises-18m-to-prevent-migraines> ;
    ns1:foundName "Arteaus",
        "Arteaus Therapeutics, LLC" ;
    ns1:industry "biotechnology" ;
    ns1:name "Arteaus",
        "Arteaus Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2322222/Artesian_Therapeutics>,
        <https://1145.am/db/2361018/Arteaus_Therapeutics>,
        <https://1145.am/db/2361027/Arteaus_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2361971/Micromet_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2012-01-26T13:53:34+00:00"^^xsd:dateTime ;
    ns1:documentExtract "THOUSAND OAKS, Calif., and ROCKVILLE, Md., Jan. 26, 2012 /PRNewswire/ - Amgen (NASDAQ: AMGN) and Micromet, Inc. (NASDAQ: MITI) today announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded in Germany with its research and development (R & D) center in Munich and headquarters in Rockville, Md., for $ 11 per share in cash." ;
    ns1:documentTitle "Amgen to Acquire Micromet" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/amgen-to-acquire-micromet-0> ;
    ns1:foundName "acquire",
        "merger" ;
    ns1:name "acquire",
        "merger" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2361971/Micromet> ;
    ns1:targetName "Micromet" ;
    ns1:valueRaw "approximately $ 1.16 billion" ;
    ns1:whereGeoName "Federal Republic of Germany" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:whereRaw "Germany" .

<https://1145.am/db/2361973/Micromet_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2012-01-26T14:20:53+00:00"^^xsd:dateTime ;
    ns1:documentExtract "THOUSAND OAKS, Calif., and ROCKVILLE, Md., Jan. 26, 2012 /PRNewswire/ - Amgen (NASDAQ: AMGN) and Micromet, Inc. (NASDAQ: MITI) today announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded in Germany with its research and development (R & D) center in Munich and headquarters in Rockville, Md., for $ 11 per share in cash." ;
    ns1:documentTitle "Amgen to Acquire Micromet" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/amgen-to-acquire-micromet> ;
    ns1:foundName "acquire",
        "merger" ;
    ns1:name "acquire",
        "merger" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2361973/Micromet> ;
    ns1:targetName "Micromet" ;
    ns1:valueRaw "approximately $ 1.16 billion" ;
    ns1:whereGeoName "Federal Republic of Germany" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:whereRaw "Germany" .

<https://1145.am/db/2362024/Acquisition_Dermira_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-10-21T12:34:34+00:00"^^xsd:dateTime ;
    ns1:documentExtract "In conjunction with the Series A closing, Dermira has acquired Valocor Therapeutics, which has a pipeline of innovative, development stage dermatology programs for the treatment of acne, inflammatory skin diseases, and other dermatologic conditions." ;
    ns1:documentTitle "Dermira Announces a $42m Series A Financing to Fund Therapeutic Advances in Dermatology" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dermira-announces-a-42m-series-a-financing-to-fund-therapeutic-advances-dermatology> ;
    ns1:foundName "acquired" ;
    ns1:name "acquired" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2362024/Valocor_Therapeutics> a org:Organization ;
    ns1:description "dermatology" ;
    ns1:documentDate "2011-10-21T12:34:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Dermira Announces a $42m Series A Financing to Fund Therapeutic Advances in Dermatology" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dermira-announces-a-42m-series-a-financing-to-fund-therapeutic-advances-dermatology> ;
    ns1:foundName "Valocor Therapeutics" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Valocor Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2357207/Valocor_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2362018/Valocor_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362024/Valocor_Therapeutics_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-10-21T12:34:34+00:00"^^xsd:dateTime ;
    ns1:documentExtract "In conjunction with the Series A closing, Dermira has acquired Valocor Therapeutics, which has a pipeline of innovative, development stage dermatology programs for the treatment of acne, inflammatory skin diseases, and other dermatologic conditions." ;
    ns1:documentTitle "Dermira Announces a $42m Series A Financing to Fund Therapeutic Advances in Dermatology" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dermira-announces-a-42m-series-a-financing-to-fund-therapeutic-advances-dermatology> ;
    ns1:foundName "acquired" ;
    ns1:name "acquired" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2362024/Valocor_Therapeutics> ;
    ns1:targetName "Valocor Therapeutics" .

<https://1145.am/db/2364014/Investment_Innovation_Norway_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-02T11:42:51+00:00"^^xsd:dateTime ;
    ns1:documentExtract "This funding follows the award of an Innovation Norway grant of NOK 9 million in early December 2011." ;
    ns1:documentTitle "Targovax Secures NOK 13 Million Series A Funding for TGO1 Pancreatic Cancer Vaccine Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/targovax-secures-nok-13-million-series-a-funding-for-tgo1-pancreatic-cancer-vaccine> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:valueRaw "NOK 9 million" ;
    ns1:whereGeoName "Kingdom of Norway" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3144096/about.rdf> ;
    ns1:whereRaw "Norway" .

<https://1145.am/db/2364014/Targovax> a org:Organization ;
    ns1:basedInLowRaw "Norway" ;
    ns1:description "Vaccine Development" ;
    ns1:documentDate "2012-02-02T11:42:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Targovax Secures NOK 13 Million Series A Funding for TGO1 Pancreatic Cancer Vaccine Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/targovax-secures-nok-13-million-series-a-funding-for-tgo1-pancreatic-cancer-vaccine> ;
    ns1:foundName "Targovax" ;
    ns1:industry "biopharma" ;
    ns1:name "Targovax" ;
    ns1:sameAsHigh <https://1145.am/db/2337114/Targovax>,
        <https://1145.am/db/2338378/Targacept>,
        <https://1145.am/db/2344673/Targovax>,
        <https://1145.am/db/2362635/Targovax>,
        <https://1145.am/db/2363043/Targovax>,
        <https://1145.am/db/2559702/Targovax>,
        <https://1145.am/db/2578736/Targovax>,
        <https://1145.am/db/2594440/Targovax> ;
    ns1:sameAsMedium <https://1145.am/db/2342565/Targovax> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364035/Auxogyn_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Menlo Park" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5372223/about.rdf> ;
    ns1:basedInHighRaw "MENLO PARK, Calif." ;
    ns1:description "advancing women's reproductive health" ;
    ns1:documentDate "2012-02-02T17:11:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Auxogyn Completes $20 Million In Series A Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/auxogyn-completes-20-million-series-a-funding> ;
    ns1:foundName "Auxogyn",
        "Auxogyn, Inc." ;
    ns1:industry "Biotech" ;
    ns1:name "Auxogyn",
        "Auxogyn, Inc." ;
    ns1:sameAsMedium <https://1145.am/db/2300433/Auxogyn> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365515/Karyopharm_Therapeutics_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Natick" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4944994/about.rdf> ;
    ns1:basedInHighRaw "NATICK, Mass." ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2011-11-02T15:27:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Karyopharm Therapeutics Closes $10 Million Series A2 Financing to Expand Planned Phase 1 Program of Oral Selective Inhibitors" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/karyopharm-therapeutics-closes-10-million-series-a2-financing-to-expand-planned-phase-1> ;
    ns1:foundName "Karyopharm Therapeutics",
        "Karyopharm Therapeutics Inc." ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Karyopharm Therapeutics",
        "Karyopharm Therapeutics Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2342798/Karyopharm_Therapeutics_Inc>,
        <https://1145.am/db/2343028/Karyopharm_Therapeutics_Inc>,
        <https://1145.am/db/2348220/Karyopharm_Therapeutics_Inc>,
        <https://1145.am/db/2348222/Karyopharm_Therapeutics>,
        <https://1145.am/db/2363625/Karyopharm_Therapeutics_Inc>,
        <https://1145.am/db/2365516/Karyopharm_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2358445/Karyopharm_Therapeutics_Inc>,
        <https://1145.am/db/2358448/Karyopharm_Therapeutics>,
        <https://1145.am/db/2366305/Karyopharm_Therapeutics_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365515/Series_A2_Investment_Chione_Ltd_Karyopharm_Therapeutics_Inc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-11-02T15:27:05+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Karyopharm Therapeutics Closes $ 10 Million Series A2 Financing to Expand Planned Phase 1 Program of Oral Selective Inhibitors of Nuclear Export (SINE) for Cancer.",
        "NATICK, Mass., Nov. 2, 2011 /PRNewswire via COMTEX/ - Karyopharm Therapeutics Inc., a leader in the new field of nuclear transport modulators, has completed a $ 10M Series A2 financing which complements the $ 20M Series A financing announced one year ago." ;
    ns1:documentTitle "Karyopharm Therapeutics Closes $10 Million Series A2 Financing to Expand Planned Phase 1 Program of Oral Selective Inhibitors" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/karyopharm-therapeutics-closes-10-million-series-a2-financing-to-expand-planned-phase-1> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2365515/Karyopharm_Therapeutics_Inc> ;
    ns1:targetDetails "Series A2" ;
    ns1:valueRaw "$ 10 Million",
        "$ 10M",
        "$ 20M" ;
    ns1:when "2011-11-02T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Nov. 2, 2011" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2365999/Altheos_Inc> a org:Organization ;
    ns1:basedInHighGeoName "South San Francisco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5397765/about.rdf> ;
    ns1:basedInHighRaw "SOUTH SAN FRANCISCO, Calif." ;
    ns1:documentDate "2012-02-09T15:43:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Altheos Announces Initiation of Phase 2a Clinical Trial for its Lead Glaucoma Drug Candidate, ATS907" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/altheos-announces-initiation-of-phase-2a-clinical-trial-for-its-lead-glaucoma-drug> ;
    ns1:foundName "Altheos",
        "Altheos, Inc." ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Altheos",
        "Altheos, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2324792/Activaero_Gmbh>,
        <https://1145.am/db/2329011/Altheos>,
        <https://1145.am/db/2357255/Activaero> ;
    ns1:sameAsMedium <https://1145.am/db/2329010/Altheos>,
        <https://1145.am/db/2365707/Altheos>,
        <https://1145.am/db/2366002/Altheos>,
        <https://1145.am/db/2366853/Altheos>,
        <https://1145.am/db/2590087/Altheos> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366003/Zealand_Pharma> a org:Organization ;
    ns1:basedInLowRaw "Zealand" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2012-02-09T16:50:11+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zealand Pharma to receive USD 20 million milestone payment following Sanofi's completion of the global GetGoal Phase III program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zealand-pharma-to-receive-usd-20-million-milestone-payment-following-sanofi-s-completion-of> ;
    ns1:foundName "Zealand Pharma",
        "Zealand Pharma A/S",
        "lixisenatide" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Zealand Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/1062539/Zealand_Pharma_A_S>,
        <https://1145.am/db/2151764/Zealand_Pharma>,
        <https://1145.am/db/2151962/Zealand_Pharma>,
        <https://1145.am/db/2154002/Zealand_Pharma>,
        <https://1145.am/db/2304370/Zealand_Pharma>,
        <https://1145.am/db/2340916/Zealand_Pharma_A_S>,
        <https://1145.am/db/2342034/Zealand_Pharma>,
        <https://1145.am/db/2350072/Zealand_Pharma>,
        <https://1145.am/db/2550783/Zealand_Pharma>,
        <https://1145.am/db/407866/Zealand_Pharma_A_S>,
        <https://1145.am/db/445124/Zealand_Pharma_A_S> ;
    ns1:sameAsMedium <https://1145.am/db/1062535/Zealand_Pharma_A_S> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366049/Draper_Fisher_Jurvetson> a org:Organization ;
    ns1:basedInLowRaw "SEATTLE" ;
    ns1:documentDate "2011-11-07T13:21:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Secures $20M in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-secures-20m-series-d-financing-0> ;
    ns1:foundName "Draper Fisher Jurvetson" ;
    ns1:investor <https://1145.am/db/2366049/Equity_Investment_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Henri_Termeer_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "Draper Fisher Jurvetson" ;
    ns1:sameAsMedium <https://1145.am/db/1700208/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1701580/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1715860/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1718217/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1720974/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1721069/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1725158/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1731011/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1731784/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1777036/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1802109/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1803082/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1808823/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1831887/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1832969/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1839922/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1842882/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1850727/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1854396/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1863426/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1867543/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1870436/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1871793/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1872742/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1875271/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1879085/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1885322/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1885417/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1892674/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1895406/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1896251/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1903583/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1904289/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1907762/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1907901/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1922530/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2325015/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2354295/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2366055/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2447981/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2621727/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2636386/Draper_Fisher_Jervetson>,
        <https://1145.am/db/2645160/Draper_Fisher_Jurvetson> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366049/Henri_Termeer> a org:Organization ;
    ns1:basedInLowRaw "SEATTLE" ;
    ns1:description "life science tools" ;
    ns1:documentDate "2011-11-07T13:21:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Secures $20M in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-secures-20m-series-d-financing-0> ;
    ns1:foundName "Henri Termeer" ;
    ns1:investor <https://1145.am/db/2366049/Equity_Investment_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Henri_Termeer_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "Henri Termeer" ;
    ns1:sameAsMedium <https://1145.am/db/2337664/Henri_Termeer>,
        <https://1145.am/db/2354295/Henri_Termeer>,
        <https://1145.am/db/2363396/Henri_Termeer>,
        <https://1145.am/db/2365079/Henri_Termeer>,
        <https://1145.am/db/2366055/Henri_Termeer> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366049/Ovp_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "SEATTLE" ;
    ns1:description "venture investors" ;
    ns1:documentDate "2011-11-07T13:21:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Secures $20M in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-secures-20m-series-d-financing-0> ;
    ns1:foundName "OVP Venture Partners" ;
    ns1:investor <https://1145.am/db/2366049/Equity_Investment_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Henri_Termeer_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "OVP Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1722057/Ventures_Platform>,
        <https://1145.am/db/1771229/Partners_Lp>,
        <https://1145.am/db/2354295/Ovp_Venture_Partners>,
        <https://1145.am/db/2366055/Ovp_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1907771/Ovp_Venture_Partners>,
        <https://1145.am/db/2302602/Ovp_Venture_Partners>,
        <https://1145.am/db/2302603/Ovp_Venture_Partners>,
        <https://1145.am/db/2326159/Ovp_Venture_Partners>,
        <https://1145.am/db/2329125/Ovp_Venture_Partners>,
        <https://1145.am/db/2329131/Ovp_Venture_Partners>,
        <https://1145.am/db/2345223/Ovp_Venture_Partners>,
        <https://1145.am/db/2345769/Ovp_Venture_Partners>,
        <https://1145.am/db/2347368/Ovp_Venture_Partners>,
        <https://1145.am/db/2352804/Ovp_Venture_Partners>,
        <https://1145.am/db/2352807/Ovp_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366055/Draper_Fisher_Jurvetson> a org:Organization ;
    ns1:basedInLowRaw "SEATTLE" ;
    ns1:documentDate "2011-11-07T13:25:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Secures $20M in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-secures-20m-series-d-financing> ;
    ns1:foundName "Draper Fisher Jurvetson" ;
    ns1:investor <https://1145.am/db/2366055/Equity_Investment_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Healthymagination_Fund_Henri_Termeer_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "Draper Fisher Jurvetson" ;
    ns1:sameAsMedium <https://1145.am/db/1700208/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1701580/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1715860/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1718217/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1720974/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1721069/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1725158/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1731011/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1731784/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1777036/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1802109/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1803082/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1808823/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1831887/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1832969/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1839922/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1842882/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1850727/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1854396/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1863426/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1867543/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1870436/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1871793/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1872742/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1875271/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1879085/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1885322/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1885417/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1892674/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1895406/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1896251/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1903583/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1904289/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1907762/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1907901/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1922530/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2325015/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2354295/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2366049/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2447981/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2621727/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2636386/Draper_Fisher_Jervetson>,
        <https://1145.am/db/2645160/Draper_Fisher_Jurvetson> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366055/Henri_Termeer> a org:Organization ;
    ns1:description "life science tools for translational research and developer of molecular diagnostics" ;
    ns1:documentDate "2011-11-07T13:25:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Secures $20M in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-secures-20m-series-d-financing> ;
    ns1:foundName "Henri Termeer" ;
    ns1:investor <https://1145.am/db/2366055/Equity_Investment_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Healthymagination_Fund_Henri_Termeer_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "Henri Termeer" ;
    ns1:sameAsMedium <https://1145.am/db/2337664/Henri_Termeer>,
        <https://1145.am/db/2354295/Henri_Termeer>,
        <https://1145.am/db/2363396/Henri_Termeer>,
        <https://1145.am/db/2365079/Henri_Termeer>,
        <https://1145.am/db/2366049/Henri_Termeer> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366055/Ovp_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "SEATTLE" ;
    ns1:description "venture investors" ;
    ns1:documentDate "2011-11-07T13:25:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Secures $20M in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-secures-20m-series-d-financing> ;
    ns1:foundName "OVP Venture Partners" ;
    ns1:investor <https://1145.am/db/2366055/Equity_Investment_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Healthymagination_Fund_Henri_Termeer_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "OVP Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1722057/Ventures_Platform>,
        <https://1145.am/db/1771229/Partners_Lp>,
        <https://1145.am/db/2354295/Ovp_Venture_Partners>,
        <https://1145.am/db/2366049/Ovp_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1907771/Ovp_Venture_Partners>,
        <https://1145.am/db/2302602/Ovp_Venture_Partners>,
        <https://1145.am/db/2302603/Ovp_Venture_Partners>,
        <https://1145.am/db/2326159/Ovp_Venture_Partners>,
        <https://1145.am/db/2329125/Ovp_Venture_Partners>,
        <https://1145.am/db/2329131/Ovp_Venture_Partners>,
        <https://1145.am/db/2345223/Ovp_Venture_Partners>,
        <https://1145.am/db/2345769/Ovp_Venture_Partners>,
        <https://1145.am/db/2347368/Ovp_Venture_Partners>,
        <https://1145.am/db/2352804/Ovp_Venture_Partners>,
        <https://1145.am/db/2352807/Ovp_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366079/Crosslink_Capital> a org:Organization ;
    ns1:basedInLowRaw "CALIF" ;
    ns1:documentDate "2011-11-08T12:17:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "COMPREHEND SYSTEMS SECURES $1.2MM IN SEED FUNDING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/comprehend-systems-secures-1-2mm-seed-funding> ;
    ns1:foundName "Crosslink Capital" ;
    ns1:investor <https://1145.am/db/2366079/Seed_Round_Investment_Comprehend_Systems_Crosslink_Capital_Garry_Tan_Quotidian_Ventures_Completed> ;
    ns1:name "Crosslink Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1066120/Crosslink_Capital>,
        <https://1145.am/db/1091554/Crosslink_Capital>,
        <https://1145.am/db/1091576/Crosslink_Capital>,
        <https://1145.am/db/1134229/Crosslink_Capital>,
        <https://1145.am/db/1390640/Crosslink_Capital>,
        <https://1145.am/db/1408186/Crosslink_Capital>,
        <https://1145.am/db/1433429/Crosslink_Capital>,
        <https://1145.am/db/1506306/Crosslink_Capital>,
        <https://1145.am/db/1508975/Crosslink_Capital>,
        <https://1145.am/db/1559082/Crosslink_Capital>,
        <https://1145.am/db/160809/Crosslink_Capital>,
        <https://1145.am/db/1697327/Crosslink_Capital>,
        <https://1145.am/db/1698138/Crosslink_Capital>,
        <https://1145.am/db/1716622/Crosslink_Capital>,
        <https://1145.am/db/1724789/Crosslink_Capital>,
        <https://1145.am/db/1737008/Crosslink_Capital>,
        <https://1145.am/db/1737278/Crosslink_Capital>,
        <https://1145.am/db/1740732/Crosslink_Capital>,
        <https://1145.am/db/1753148/Crosslink_Capital>,
        <https://1145.am/db/1755757/Crosslink_Capital>,
        <https://1145.am/db/1763964/Crosslink_Capital>,
        <https://1145.am/db/1770095/Crosslink_Capital>,
        <https://1145.am/db/1772041/Crosslink_Capital>,
        <https://1145.am/db/1773323/Crosslink_Capital>,
        <https://1145.am/db/1778522/Crosslink_Capital>,
        <https://1145.am/db/1780710/Crosslink_Capital>,
        <https://1145.am/db/1786705/Crosslink_Capital>,
        <https://1145.am/db/1790574/Crosslink_Capital>,
        <https://1145.am/db/1792682/Crosslink_Capital>,
        <https://1145.am/db/1805753/Crosslink_Capital>,
        <https://1145.am/db/1813326/Crosslink_Capital>,
        <https://1145.am/db/1828008/Crosslink_Capital>,
        <https://1145.am/db/1828036/Crosslink_Capital>,
        <https://1145.am/db/1842583/Crosslink_Capital>,
        <https://1145.am/db/1852928/Crosslink_Capital>,
        <https://1145.am/db/1854874/Crosslink_Capital>,
        <https://1145.am/db/1856736/Crosslink_Capital>,
        <https://1145.am/db/1863426/Crosslink_Capital>,
        <https://1145.am/db/1864601/Crosslink_Capital>,
        <https://1145.am/db/1870014/Crosslink_Capital>,
        <https://1145.am/db/1873031/Crosslink_Capital>,
        <https://1145.am/db/1873680/Crosslink_Capital>,
        <https://1145.am/db/1876103/Crosslink_Capital>,
        <https://1145.am/db/1877469/Crosslink_Capital>,
        <https://1145.am/db/1888815/Crosslink_Capital>,
        <https://1145.am/db/1890133/Crosslink_Capital>,
        <https://1145.am/db/1890136/Crosslink_Capital>,
        <https://1145.am/db/1892128/Crosslink_Capital>,
        <https://1145.am/db/1892902/Crosslink_Capital>,
        <https://1145.am/db/1893919/Crosslink_Capital>,
        <https://1145.am/db/1894610/Crosslink_Capital>,
        <https://1145.am/db/1895406/Crosslink_Capital>,
        <https://1145.am/db/1896735/Crosslink_Capital>,
        <https://1145.am/db/1911316/Crosslink_Capital>,
        <https://1145.am/db/1945479/Crosslink_Capital>,
        <https://1145.am/db/203518/Crosslink_Capital>,
        <https://1145.am/db/2095175/Crosslink_Capital>,
        <https://1145.am/db/209861/Crosslink_Capital>,
        <https://1145.am/db/2125508/Crosslink_Capital>,
        <https://1145.am/db/2321813/Crosslink_Capital>,
        <https://1145.am/db/2337826/Crosslink_Capital>,
        <https://1145.am/db/2606711/Crosslink_Capital>,
        <https://1145.am/db/285189/Crosslink_Capital>,
        <https://1145.am/db/342304/Crosslink_Capital>,
        <https://1145.am/db/490875/Crosslink_Capital>,
        <https://1145.am/db/593826/Crosslink_Capital>,
        <https://1145.am/db/657632/Crosslink_Capital>,
        <https://1145.am/db/751135/Crosslink_Capital>,
        <https://1145.am/db/838691/Crosslink_Capital>,
        <https://1145.am/db/879937/Crosslink_Capital>,
        <https://1145.am/db/880050/Crosslink_Capital>,
        <https://1145.am/db/880570/Crosslink_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366079/Garry_Tan> a org:Organization ;
    ns1:basedInLowRaw "CALIF" ;
    ns1:documentDate "2011-11-08T12:17:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "COMPREHEND SYSTEMS SECURES $1.2MM IN SEED FUNDING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/comprehend-systems-secures-1-2mm-seed-funding> ;
    ns1:foundName "Garry Tan" ;
    ns1:investor <https://1145.am/db/2366079/Seed_Round_Investment_Comprehend_Systems_Crosslink_Capital_Garry_Tan_Quotidian_Ventures_Completed> ;
    ns1:name "Garry Tan" ;
    ns1:sameAsMedium <https://1145.am/db/1740345/Garry_Tan>,
        <https://1145.am/db/1764067/Garry_Tan>,
        <https://1145.am/db/2337826/Garry_Tan> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366079/Quotidian_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CALIF" ;
    ns1:documentDate "2011-11-08T12:17:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "COMPREHEND SYSTEMS SECURES $1.2MM IN SEED FUNDING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/comprehend-systems-secures-1-2mm-seed-funding> ;
    ns1:foundName "Quotidian Ventures" ;
    ns1:investor <https://1145.am/db/2366079/Seed_Round_Investment_Comprehend_Systems_Crosslink_Capital_Garry_Tan_Quotidian_Ventures_Completed> ;
    ns1:name "Quotidian Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1838403/Quotidian_Ventures>,
        <https://1145.am/db/1847287/Quotidian_Ventures>,
        <https://1145.am/db/1850782/Quotidian_Ventures>,
        <https://1145.am/db/1852513/Quotidian_Ventures>,
        <https://1145.am/db/1874937/Quotidian_Ventures>,
        <https://1145.am/db/1887528/Quotidian_Ventures>,
        <https://1145.am/db/1892120/Quotidian_Ventures>,
        <https://1145.am/db/1892395/Quotidian_Ventures>,
        <https://1145.am/db/2337826/Quotidian_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2443170/Sensors_For_Medicine_And_Science_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Germantown" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4356050/about.rdf> ;
    ns1:basedInHighRaw "Germantown" ;
    ns1:description "Medical device" ;
    ns1:documentDate "2011-11-02T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "SMSI Raises $54.1 Million Series D Financing" ;
    ns1:documentURL <https://www.fierceelectronics.com/embedded/smsi-raises-54-1-million-series-d-financing> ;
    ns1:foundName "Sensors for Medicine and Science Inc" ;
    ns1:industry "medical device" ;
    ns1:name "Sensors for Medicine and Science Inc" ;
    ns1:sameAsHigh <https://1145.am/db/2288347/Medtronic> ;
    ns1:sameAsMedium <https://1145.am/db/2323303/Sensors_For_Medicine_And_Science> ;
    ns1:sourceName "Fierce Electronics" .

<https://1145.am/db/2525964/Northstar-at-Tahoe_Resort> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "professional snowboarder" ;
    ns1:documentDate "2011-10-20T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "North Lake Tahoe Rolls Out Improvements for 2011-2012 Ski Season" ;
    ns1:documentURL <https://www.travelagentcentral.com/destinations/north-lake-tahoe-rolls-out-improvements-for-2011-2012-ski-season> ;
    ns1:foundName "Northstar-at-Tahoe Resort" ;
    ns1:name "Northstar-at-Tahoe Resort" ;
    ns1:sourceName "Travel Agent Central" .

<https://1145.am/db/2546371/Ancor_Capital_Partners> a org:Organization ;
    ns1:basedInLowRaw "Canadian" ;
    ns1:buyer <https://1145.am/db/2546371/Acquisition_Ancor_Capital_Partners_Sentinel_Capital_Partners_Completed>,
        <https://1145.am/db/2546371/Wellspring_Pharmaceutical_Acquisition> ;
    ns1:documentDate "2011-11-08T12:41:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Endo wooed by $1.2M incentives from PA; Wellspring acquired by Sentinel, Ancor;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/endo-wooed-by-1-2m-incentives-from-pa-wellspring-acquired-by-sentinel-ancor> ;
    ns1:foundName "Ancor Capital Partners" ;
    ns1:name "Ancor Capital Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1003377/Ancor_Capital_Partners>,
        <https://1145.am/db/2578302/Ancor_Capital_Partners>,
        <https://1145.am/db/385804/Ancor_Capital_Partners> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546371/Hebei_Aoxing_Pharmaceutical_Group> a org:Organization ;
    ns1:basedInHighGeoName "People’s Republic of China" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:basedInHighRaw "China" ;
    ns1:documentDate "2011-11-08T12:41:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Endo wooed by $1.2M incentives from PA; Wellspring acquired by Sentinel, Ancor;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/endo-wooed-by-1-2m-incentives-from-pa-wellspring-acquired-by-sentinel-ancor> ;
    ns1:foundName "Hebei Aoxing Pharmaceutical Group" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Hebei Aoxing Pharmaceutical Group" ;
    ns1:sameAsHigh <https://1145.am/db/1243952/Nx_China>,
        <https://1145.am/db/1243957/Nx_China>,
        <https://1145.am/db/164375/Sino_Biopharmaceutical_Limited>,
        <https://1145.am/db/164709/Sino_Biopharmaceutical_Limited>,
        <https://1145.am/db/1931162/Sino_Biopharmaceutical_Limited>,
        <https://1145.am/db/2025005/Sino_Biopharmaceutical_Limited>,
        <https://1145.am/db/2283452/Huadong_Medicine>,
        <https://1145.am/db/2315545/Hebei_Aoxing_Pharmaceutical_Group_Company>,
        <https://1145.am/db/2360086/Hisun_Pharmaceutical_Of_China>,
        <https://1145.am/db/2545361/Eisai_China_Holdings_Ltd>,
        <https://1145.am/db/2550508/Sino>,
        <https://1145.am/db/2550510/Sino>,
        <https://1145.am/db/2569370/Eisai_China_Holdings_Ltd> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546371/Investment_Universal_Corp_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-11-08T12:41:08+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Kenya's Universal Corp. has been prequalified by the World Health Organization to manufacture the HIV drug, Lamozido." ;
    ns1:documentTitle "Endo wooed by $1.2M incentives from PA; Wellspring acquired by Sentinel, Ancor;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/endo-wooed-by-1-2m-incentives-from-pa-wellspring-acquired-by-sentinel-ancor> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "Canada" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:whereRaw "Canada" .

<https://1145.am/db/2546371/Sentinel_Capital_Partners> a org:Organization ;
    ns1:basedInLowRaw "Canadian" ;
    ns1:buyer <https://1145.am/db/2546371/Acquisition_Ancor_Capital_Partners_Sentinel_Capital_Partners_Completed>,
        <https://1145.am/db/2546371/Wellspring_Pharmaceutical_Acquisition> ;
    ns1:documentDate "2011-11-08T12:41:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Endo wooed by $1.2M incentives from PA; Wellspring acquired by Sentinel, Ancor;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/endo-wooed-by-1-2m-incentives-from-pa-wellspring-acquired-by-sentinel-ancor> ;
    ns1:foundName "Sentinel Capital Partners" ;
    ns1:name "Sentinel Capital Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1081072/Sentinel_Capital_Partners>,
        <https://1145.am/db/1163119/Sentinel_Capital_Partners>,
        <https://1145.am/db/1278249/Sentinel_Capital_Partners>,
        <https://1145.am/db/1509454/Sentinel_Capital_Partners>,
        <https://1145.am/db/1659810/Sentinel_Capital_Partners>,
        <https://1145.am/db/2578302/Sentinel_Capital_Partners>,
        <https://1145.am/db/417679/Sentinel_Capital_Partners>,
        <https://1145.am/db/631431/Sentinel_Capital_Partners>,
        <https://1145.am/db/719949/Sentinel_Capital_Partners>,
        <https://1145.am/db/720139/Sentinel_Capital_Partners>,
        <https://1145.am/db/720425/Sentinel_Capital_Partners>,
        <https://1145.am/db/756705/Sentinel_Capital_Partners>,
        <https://1145.am/db/901175/Sentinel_Capital_Partners>,
        <https://1145.am/db/965484/Sentinel_Capital_Partners> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2571679/Akorn_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Lake Forest",
        "Republic of India" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1269750/about.rdf>,
        <https://sws.geonames.org/4899012/about.rdf> ;
    ns1:basedInHighRaw "India",
        "LAKE FOREST, Ill." ;
    ns1:basedInLowRaw "India" ;
    ns1:buyer <https://1145.am/db/2571679/Assets_Acquisition_Akorn_Inc_Akorn_Inc_Has_Not_Happened>,
        <https://1145.am/db/2571679/Assets_Acquisition_Akorn_Inc_Nbz_Pharma_Limited_Has_Not_Happened> ;
    ns1:description "Pharmaceuticals",
        "contract manufacturer of sterile injectables",
        "generic pharmaceutical company" ;
    ns1:documentDate "2011-10-06T14:56:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Akorn Enters Into an Agreement to Acquire Certain Assets of Kilitch Drugs in India" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/akorn-enters-into-an-agreement-to-acquire-certain-assets-of-kilitch-drugs-india> ;
    ns1:foundName "Akorn",
        "Akorn, Inc.",
        "Kilitch Drugs",
        "Kilitch Drugs (India) Limited" ;
    ns1:industry "Pharmaceutical",
        "pharmaceutical" ;
    ns1:name "Akorn",
        "Akorn, Inc.",
        "Kilitch Drugs" ;
    ns1:sameAsHigh <https://1145.am/db/2246647/Kilitch_Drugs>,
        <https://1145.am/db/2249007/Kilitch_Drugs_India_Limited>,
        <https://1145.am/db/2546317/Kilitch_Drugs> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2571679/Assets_Acquisition_Akorn_Inc_Akorn_Inc_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-10-06T14:56:29+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Akorn Enters Into an Agreement to Acquire Certain Assets of Kilitch Drugs in India." ;
    ns1:documentTitle "Akorn Enters Into an Agreement to Acquire Certain Assets of Kilitch Drugs in India" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/akorn-enters-into-an-agreement-to-acquire-certain-assets-of-kilitch-drugs-india> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:targetDetails "Assets" ;
    ns1:vendor <https://1145.am/db/2571679/Akorn_Inc> ;
    ns1:whereGeoName "Republic of India" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:whereRaw "India" .

<https://1145.am/db/2571679/Assets_Acquisition_Akorn_Inc_Nbz_Pharma_Limited_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-10-06T14:56:29+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Akorn, Inc., a niche generic pharmaceutical company, announced today that it has entered into an agreement to acquire certain assets of Kilitch Drugs (India) Limited (\"KDIL\") , a leading contract manufacturer of sterile injectables in India, as well as certain assets of NBZ Pharma Limited, for approximately $ 52 million in cash and future contingent payments totaling up to approximately $ 6 million based on the achievement of certain milestones and financial targets." ;
    ns1:documentTitle "Akorn Enters Into an Agreement to Acquire Certain Assets of Kilitch Drugs in India" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/akorn-enters-into-an-agreement-to-acquire-certain-assets-of-kilitch-drugs-india> ;
    ns1:foundName "acquire" ;
    ns1:name "acquire" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:targetDetails "assets" ;
    ns1:valueRaw "approximately $ 52 million",
        "up to approximately $ 6 million" ;
    ns1:vendor <https://1145.am/db/2571679/Nbz_Pharma_Limited> ;
    ns1:whereGeoName "Republic of India" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:whereRaw "India" .

<https://1145.am/db/2571679/Nbz_Pharma_Limited> a org:Organization ;
    ns1:basedInLowRaw "India" ;
    ns1:description "pharmaceutical company" ;
    ns1:documentDate "2011-10-06T14:56:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Akorn Enters Into an Agreement to Acquire Certain Assets of Kilitch Drugs in India" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/akorn-enters-into-an-agreement-to-acquire-certain-assets-of-kilitch-drugs-india> ;
    ns1:foundName "NBZ Pharma Limited" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "NBZ Pharma Limited" ;
    ns1:sameAsHigh <https://1145.am/db/2246647/Nbz_Pharma_Limited>,
        <https://1145.am/db/2546317/Nbz_Pharma> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2574357/Investment_Nascsa_Purdue_Pharma_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-10-20T12:21:25+00:00"^^xsd:dateTime ;
    ns1:documentExtract "NASCSA Receives $ 200,000 Grant from Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs." ;
    ns1:documentTitle "NASCSA Receives $200,000 Grant from Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/nascsa-receives-200-000-grant-from-purdue-pharma-l-p-to-support-state-prescription-drug> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2574357/Nascsa> ;
    ns1:valueRaw "$ 200,000" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2574357/Investment_Purdue_Pharma_The_National_Association_Of_State_Controlled_Substances_Authorities_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-10-20T12:21:25+00:00"^^xsd:dateTime ;
    ns1:documentExtract "PORTLAND, Maine, Oct. 18, 2011 /PRNewswire via COMTEX/ - The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $ 200,000 grant from Purdue Pharma L.P. today at the organization's 27th annual conference in Portland, Maine." ;
    ns1:documentTitle "NASCSA Receives $200,000 Grant from Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/nascsa-receives-200-000-grant-from-purdue-pharma-l-p-to-support-state-prescription-drug> ;
    ns1:foundName "grant",
        "receipt" ;
    ns1:name "grant",
        "receipt" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2574357/The_National_Association_Of_State_Controlled_Substances_Authorities> ;
    ns1:valueRaw "$ 200,000" ;
    ns1:when "2011-10-18T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Oct. 18, 2011" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2574357/Nascsa> a org:Organization ;
    ns1:documentDate "2011-10-20T12:21:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NASCSA Receives $200,000 Grant from Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/nascsa-receives-200-000-grant-from-purdue-pharma-l-p-to-support-state-prescription-drug> ;
    ns1:foundName "NASCSA" ;
    ns1:name "NASCSA" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2574357/Purdue_Pharma> a org:Organization ;
    ns1:basedInLowRaw "Maine" ;
    ns1:description "Prescription Drug Monitoring Programs" ;
    ns1:documentDate "2011-10-20T12:21:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NASCSA Receives $200,000 Grant from Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/nascsa-receives-200-000-grant-from-purdue-pharma-l-p-to-support-state-prescription-drug> ;
    ns1:foundName "Pharma L.P.",
        "Purdue Pharma L.P." ;
    ns1:industry "Pharma",
        "Pharmaceutical" ;
    ns1:investor <https://1145.am/db/2574357/Investment_Nascsa_Purdue_Pharma_Completed>,
        <https://1145.am/db/2574357/Investment_Purdue_Pharma_The_National_Association_Of_State_Controlled_Substances_Authorities_Has_Not_Happened> ;
    ns1:name "Purdue",
        "Purdue Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/1086579/Small_Pharma>,
        <https://1145.am/db/1998924/Mankind_Pharma_Ltd>,
        <https://1145.am/db/2283171/Big_Pharma>,
        <https://1145.am/db/2288871/Big_Pharma_Novartis>,
        <https://1145.am/db/2301362/Pharma_Two_B>,
        <https://1145.am/db/2328969/Action_Pharma>,
        <https://1145.am/db/2347781/Purdue_Pharma_Lp>,
        <https://1145.am/db/2348198/Purdue_Pharma>,
        <https://1145.am/db/2354582/Action_Pharma>,
        <https://1145.am/db/2358619/Purdue_Pharma>,
        <https://1145.am/db/2362453/Action_Pharma>,
        <https://1145.am/db/2362893/Big_Pharma>,
        <https://1145.am/db/2367957/Pharma_Two_B>,
        <https://1145.am/db/2368026/Purdue_Pharma_Lp>,
        <https://1145.am/db/2369878/Purdue_Pharma_Lp>,
        <https://1145.am/db/2548034/Big_Pharma>,
        <https://1145.am/db/2548179/Universal_Corp>,
        <https://1145.am/db/2549597/Active_Pharmaceutical_Ingredient>,
        <https://1145.am/db/2550837/Big_Pharma>,
        <https://1145.am/db/2551401/Neopharma>,
        <https://1145.am/db/2551892/Neopharma>,
        <https://1145.am/db/2586804/Pharma_Healthcare>,
        <https://1145.am/db/2588468/Big_Pharma>,
        <https://1145.am/db/2593522/Purdue_Pharma_Lp>,
        <https://1145.am/db/422407/Pharma_Two_B_Ltd>,
        <https://1145.am/db/922961/Purdue_Pharma_Lp>,
        <https://1145.am/db/925028/Purdue_Pharma_Lp> ;
    ns1:sameAsMedium <https://1145.am/db/2152224/Purdue_Pharma>,
        <https://1145.am/db/2308422/Purdue_Pharma>,
        <https://1145.am/db/2309368/Purdue_Pharma>,
        <https://1145.am/db/2359404/Purdue_Pharma_Lp>,
        <https://1145.am/db/2560225/Purdue_Pharma>,
        <https://1145.am/db/2579074/Purdue_Pharma_Lp>,
        <https://1145.am/db/2587996/Purdue_Pharma> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2574357/The_National_Association_Of_State_Controlled_Substances_Authorities> a org:Organization ;
    ns1:basedInHighGeoName "Portland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4975802/about.rdf> ;
    ns1:basedInHighRaw "Portland, Maine" ;
    ns1:description "addressing prescription drug abuse and diversion" ;
    ns1:documentDate "2011-10-20T12:21:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NASCSA Receives $200,000 Grant from Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/nascsa-receives-200-000-grant-from-purdue-pharma-l-p-to-support-state-prescription-drug> ;
    ns1:foundName "The National Association of State Controlled Substances Authorities" ;
    ns1:name "The National Association of State Controlled Substances Authorities" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2578302/Ancor_Capital_Partners> a org:Organization ;
    ns1:basedInLowRaw "North American" ;
    ns1:description "healthcare" ;
    ns1:documentDate "2011-11-08T12:45:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sentinel Capital Partners Acquires WellSpring Pharmaceutical Corporation" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/sentinel-capital-partners-acquires-wellspring-pharmaceutical-corporation> ;
    ns1:foundName "Ancor Capital Partners" ;
    ns1:industry "private equity" ;
    ns1:investor <https://1145.am/db/2578302/Wellspring_Pharmaceutical_Corporation_Acquisition> ;
    ns1:name "Ancor Capital Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1008666/Abry_Partners>,
        <https://1145.am/db/1014464/Red_Door_Capital_Partners>,
        <https://1145.am/db/1016038/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1021/Sun_Capital_Partners>,
        <https://1145.am/db/1031030/Godspeed_Capital>,
        <https://1145.am/db/1042790/Atlantic_Street_Capital>,
        <https://1145.am/db/1051317/Ocean_Avenue_Capital_Partners>,
        <https://1145.am/db/1059981/Kline_Hill_Partners>,
        <https://1145.am/db/1060630/Kline_Hill_Partners>,
        <https://1145.am/db/1064824/Cvc_Capital_Partners>,
        <https://1145.am/db/1079016/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1079209/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1083961/Atlantic_Street_Capital>,
        <https://1145.am/db/1084696/Prospect_Hill_Growth_Partners>,
        <https://1145.am/db/1085856/Atlantic_Street_Capital>,
        <https://1145.am/db/1086147/Prospect_Hill_Growth_Partners>,
        <https://1145.am/db/1087313/Westview_Capital_Partners>,
        <https://1145.am/db/1101220/Aterian_Investment_Partners>,
        <https://1145.am/db/1103243/Aterian_Investment_Partners>,
        <https://1145.am/db/1112352/Victor_Capital_Partners>,
        <https://1145.am/db/1116308/Ampersand_Capital_Partners>,
        <https://1145.am/db/1128071/Cvc_Capital_Partners>,
        <https://1145.am/db/1149388/Great_Hill_Partners>,
        <https://1145.am/db/1151233/Great_Hill_Partners>,
        <https://1145.am/db/1152296/Triwest_Capital_Partners>,
        <https://1145.am/db/1196066/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1196661/Court_Square_Capital_Partners>,
        <https://1145.am/db/1197316/Court_Square_Capital_Partners>,
        <https://1145.am/db/1197858/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1203996/One_Rock_Capital_Partners>,
        <https://1145.am/db/1213136/Godspeed_Capital>,
        <https://1145.am/db/1223533/Granite_Creek_Capital_Partners>,
        <https://1145.am/db/1233600/South_Street_Partners>,
        <https://1145.am/db/1244678/Godspeed_Capital>,
        <https://1145.am/db/1244776/Arkview_Capital>,
        <https://1145.am/db/1245183/Great_Hill_Partners>,
        <https://1145.am/db/1245418/Godspeed_Capital>,
        <https://1145.am/db/1245688/Arkview_Capital>,
        <https://1145.am/db/1252784/Isleworth_Capital_Partners>,
        <https://1145.am/db/1253079/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1254864/Isleworth_Capital_Partners>,
        <https://1145.am/db/1264347/Sfw_Capital_Partners>,
        <https://1145.am/db/1265089/Sfw_Capital_Partners>,
        <https://1145.am/db/1265498/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1266311/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1272244/One_Rock_Capital_Partners>,
        <https://1145.am/db/1272478/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1273195/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1278671/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1278904/Godspeed_Capital>,
        <https://1145.am/db/1279638/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1281384/Thompson_Street_Capital_Partners_Vi_Lp>,
        <https://1145.am/db/1281913/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1282744/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1296402/Cvc_Capital_Partners>,
        <https://1145.am/db/1298503/Incline_Equity_Partners>,
        <https://1145.am/db/1318669/Eagletree_Capital>,
        <https://1145.am/db/1319084/Thayer_Street_Partners>,
        <https://1145.am/db/1322965/Blue_Wolf_Capital_Partners>,
        <https://1145.am/db/1323023/Blue_Wolf_Capital_Partners_Llc>,
        <https://1145.am/db/1335299/Sfw_Capital_Partners>,
        <https://1145.am/db/1335427/Sfw_Capital_Partners>,
        <https://1145.am/db/1345729/Cvc_Capital_Partners>,
        <https://1145.am/db/1347521/Oak_Street>,
        <https://1145.am/db/1351608/Nonantum_Capital_Partners>,
        <https://1145.am/db/1352481/Nonantum_Capital_Partners>,
        <https://1145.am/db/1358651/Cvc_Capital_Partners>,
        <https://1145.am/db/1369951/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1370181/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1375792/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1376070/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1386921/Sfw_Capital_Partners>,
        <https://1145.am/db/1387409/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1388089/Court_Square_Capital_Partners>,
        <https://1145.am/db/1388102/Sfw_Capital_Partners>,
        <https://1145.am/db/1388168/Oak_Hill_Capital_Partners>,
        <https://1145.am/db/1390496/Oak_Hill_Capital_Partners>,
        <https://1145.am/db/1408755/Advantary_Capital_Partners>,
        <https://1145.am/db/1422536/Godspeed_Capital>,
        <https://1145.am/db/1423290/Godspeed_Capital>,
        <https://1145.am/db/1432350/Oaktree_Capital_Management>,
        <https://1145.am/db/1440951/Aliph_Capital>,
        <https://1145.am/db/1451844/Grant_Avenue_Capital>,
        <https://1145.am/db/1454855/Grant_Avenue_Capital>,
        <https://1145.am/db/1459712/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1507816/Aliph_Capital>,
        <https://1145.am/db/1509925/Centerfield_Capital_Partners>,
        <https://1145.am/db/1553037/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1553107/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1554304/Ascend_Capital_Partners>,
        <https://1145.am/db/156114/Towerbrook_Capital_Partners>,
        <https://1145.am/db/1561967/Arlington_Capital_Partners>,
        <https://1145.am/db/1562363/Arlington_Capital_Partners>,
        <https://1145.am/db/157827/Towerbrook_Capital_Partners>,
        <https://1145.am/db/157887/Towerbrook_Capital_Partners>,
        <https://1145.am/db/1581979/Altamont_Capital_Partners>,
        <https://1145.am/db/1614023/Blue_Wolf_Capital_Partners>,
        <https://1145.am/db/1614865/Long_Ridge_Equity_Partners>,
        <https://1145.am/db/1615372/Blue_Wolf_Capital_Partners>,
        <https://1145.am/db/1616193/Long_Ridge_Equity_Partners>,
        <https://1145.am/db/1618787/Nonantum_Capital_Partners>,
        <https://1145.am/db/1618787/Ridgemont_Equity_Partners>,
        <https://1145.am/db/1619234/Arlington_Capital_Partners>,
        <https://1145.am/db/1619465/Nonantum_Capital_Partners>,
        <https://1145.am/db/1619465/Ridgemont_Equity_Partners>,
        <https://1145.am/db/1620909/Arlington_Capital_Partners>,
        <https://1145.am/db/1631042/Exeter_Street_Capital_Partners>,
        <https://1145.am/db/1651532/Cvc_Capital_Partners>,
        <https://1145.am/db/1656903/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1659093/Morgan_Stanley_Capital_Partners>,
        <https://1145.am/db/1659786/Ridgemont_Equity_Partners>,
        <https://1145.am/db/1659810/Morgan_Stanley_Capital_Partners>,
        <https://1145.am/db/1663459/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1667839/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1679207/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1711603/Oak_Hlll_Capital_Partners>,
        <https://1145.am/db/173152/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1735717/Hillhouse_Capital>,
        <https://1145.am/db/1740266/Great_Hill_Partners>,
        <https://1145.am/db/1746574/Hillhouse_Capital>,
        <https://1145.am/db/1749326/Sixth_Street_Partners>,
        <https://1145.am/db/179472/Hillhouse_Capital_Group>,
        <https://1145.am/db/1847894/Adams_Street_Partners>,
        <https://1145.am/db/1853872/Cvc_Capital_Partners>,
        <https://1145.am/db/1856857/Charterhouse_Capital_Partners>,
        <https://1145.am/db/1882372/Great_Hill_Partners>,
        <https://1145.am/db/1924169/Silver_Lake_Partners>,
        <https://1145.am/db/1926409/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/1929486/Cvc_Capital_Partners>,
        <https://1145.am/db/1939279/Court_Square_Capital_Partners>,
        <https://1145.am/db/1959321/Arkview_Capital>,
        <https://1145.am/db/1968065/Cvc_Capital_Partners>,
        <https://1145.am/db/1982583/Great_Hill_Partners>,
        <https://1145.am/db/1997896/Court_Square_Capital_Partners>,
        <https://1145.am/db/2003857/Alpinvest_Partners>,
        <https://1145.am/db/2019700/Godspeed_Capital>,
        <https://1145.am/db/2029386/Hillhouse_Capital_Group>,
        <https://1145.am/db/2033906/Grovecourt_Capital_Partners>,
        <https://1145.am/db/204108/Ridgemont_Equity_Partners>,
        <https://1145.am/db/204704/Cvc_Capital_Partners>,
        <https://1145.am/db/2050172/Great_Hill_Partners>,
        <https://1145.am/db/2051486/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/2067945/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/2071921/Bluestone_Equity_Partners>,
        <https://1145.am/db/2075548/Monroe_Street_Partners>,
        <https://1145.am/db/2075760/Arlington_Capital_Partners>,
        <https://1145.am/db/2083882/Grovecourt_Capital_Partners>,
        <https://1145.am/db/2099375/Grovecourt_Capital_Partners>,
        <https://1145.am/db/2109892/Ridgemont_Equity_Partners>,
        <https://1145.am/db/2110563/Grant_Avenue_Capital>,
        <https://1145.am/db/2126826/Cvc_Capital_Partners>,
        <https://1145.am/db/2130279/Great_Hill_Partners>,
        <https://1145.am/db/2132436/Arlington_Capital_Partners>,
        <https://1145.am/db/2133887/Arlington_Capital_Partners>,
        <https://1145.am/db/2138702/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/2146633/A___M_Capital_Partners>,
        <https://1145.am/db/2165613/Oak_Hill_Capital_Management_Llc>,
        <https://1145.am/db/2171577/Abry_Partners>,
        <https://1145.am/db/2177813/Hawk_Capital_Partners>,
        <https://1145.am/db/2230367/Blue_Wolf_Capital_Partners_Llc>,
        <https://1145.am/db/2240189/Blue_Wolf_Capital_Partners_Llc>,
        <https://1145.am/db/227023/Blue_Wolf_Capital_Partners_Llc>,
        <https://1145.am/db/2273269/Oak_Hill_Capital_Partners>,
        <https://1145.am/db/2279411/Sfw_Capital_Partners>,
        <https://1145.am/db/2309719/Ampersand_Capital_Partners>,
        <https://1145.am/db/2329/Sun_Capital_Partners>,
        <https://1145.am/db/2342842/Ampersand_Capital_Partners>,
        <https://1145.am/db/2344192/Ridgemont_Equity_Partners>,
        <https://1145.am/db/237583/One_Rock_Capital_Partners>,
        <https://1145.am/db/2527/Sun_Capital_Partners>,
        <https://1145.am/db/2546740/Ampersand_Capital_Partners>,
        <https://1145.am/db/2558911/Cvc_Capital_Partners>,
        <https://1145.am/db/2561042/Cvc_Capital_Partners>,
        <https://1145.am/db/2599816/Abry_Partners>,
        <https://1145.am/db/2601139/Canyon_Bridge_Capital_Partners>,
        <https://1145.am/db/2601907/Oak_Hill_Capital_Partners>,
        <https://1145.am/db/2605285/Abry_Partners>,
        <https://1145.am/db/2608284/Abry_Partners>,
        <https://1145.am/db/2612445/Silver_Lake_Partners>,
        <https://1145.am/db/2615297/Abry_Partners>,
        <https://1145.am/db/2615411/Oak_Hill_Capital_Partners>,
        <https://1145.am/db/2646338/Harbinger_Capital_Partners_Funds>,
        <https://1145.am/db/2662265/Silver_Lake_Partners>,
        <https://1145.am/db/2668916/Cvc_Capital_Partners>,
        <https://1145.am/db/2674903/Harbinger_Capital_Partners>,
        <https://1145.am/db/270061/Charterhouse_Capital_Partners>,
        <https://1145.am/db/2704736/Sixth_Street_Partners>,
        <https://1145.am/db/2731857/Hillhouse_Capital>,
        <https://1145.am/db/2754699/Hillhouse_Capital>,
        <https://1145.am/db/2766777/Ridgemont_Equity_Partners>,
        <https://1145.am/db/2798666/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/2820/Sun_Capital_Partners>,
        <https://1145.am/db/308877/Oaktree_Capital_Group>,
        <https://1145.am/db/309966/Oaktree_Capital_Group>,
        <https://1145.am/db/348360/Ace_Capital_Partners>,
        <https://1145.am/db/352877/Oaktree_Capital_Group>,
        <https://1145.am/db/360351/Blue_Wolf_Capital_Partners>,
        <https://1145.am/db/365378/Oak_Hill_Capital>,
        <https://1145.am/db/367654/Oak_Hill_Capital>,
        <https://1145.am/db/390812/Cvc_Capital_Partners>,
        <https://1145.am/db/413383/Charter_Oak_Equity>,
        <https://1145.am/db/413607/Nonantum_Capital_Partners>,
        <https://1145.am/db/421409/Blue_Wolf_Capital_Partners_Llc>,
        <https://1145.am/db/422483/Blue_Wolf_Capital_Partners_Llc>,
        <https://1145.am/db/428733/West_Lane_Capital_Partners_Llc>,
        <https://1145.am/db/430577/Arlington_Capital_Partners>,
        <https://1145.am/db/431676/Westview_Capital_Partners>,
        <https://1145.am/db/435888/Oaktree_Capital>,
        <https://1145.am/db/443026/Hillhouse_Capital>,
        <https://1145.am/db/446074/Towerbrook_Capital_Partners>,
        <https://1145.am/db/452368/Petershill_Partners>,
        <https://1145.am/db/452938/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/481161/Gatewood_Capital_Partners_Llc>,
        <https://1145.am/db/482784/Gatewood_Capital_Partners_Llc>,
        <https://1145.am/db/488637/Great_Hill_Partners>,
        <https://1145.am/db/490196/One_Rock_Capital_Partners>,
        <https://1145.am/db/526463/Ridgelake_Partners>,
        <https://1145.am/db/526978/Arlington_Capital_Partners>,
        <https://1145.am/db/527649/Arlington_Capital_Partners>,
        <https://1145.am/db/540664/Ridgemont_Equity_Partners>,
        <https://1145.am/db/555969/Ridgemont_Equity_Partners>,
        <https://1145.am/db/555987/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/556134/Aterian_Investment_Partners_Iv>,
        <https://1145.am/db/564781/Blue_Wolf_Capital_Partners_Llc>,
        <https://1145.am/db/567133/Blue_Wolf_Capital_Partners_Llc>,
        <https://1145.am/db/581473/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/582350/Eagletree_Capital>,
        <https://1145.am/db/583034/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/590254/Eagletree_Capital>,
        <https://1145.am/db/591820/Britehorn_Partners>,
        <https://1145.am/db/607097/Eagletree_Capital>,
        <https://1145.am/db/607534/Ridgemont_Equity_Partners>,
        <https://1145.am/db/607558/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/619175/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/619244/Great_Hill_Partners>,
        <https://1145.am/db/633069/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/638283/Cvc_Capital_Partners>,
        <https://1145.am/db/641201/Godspeed_Capital>,
        <https://1145.am/db/641409/Blue_Wolf_Capital_Partners_Llc>,
        <https://1145.am/db/641642/Godspeed_Capital>,
        <https://1145.am/db/642369/Oak_Hill_Capital>,
        <https://1145.am/db/643839/Cvc_Capital_Partners>,
        <https://1145.am/db/685346/Cvc_Capital_Partners>,
        <https://1145.am/db/688739/Cvc_Capital_Partners>,
        <https://1145.am/db/693284/Northleaf_Capital_Partners>,
        <https://1145.am/db/695148/Northleaf_Capital_Partners>,
        <https://1145.am/db/6994/Arlington_Capital_Partners>,
        <https://1145.am/db/701660/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/713274/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/714376/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/730791/Great_Hill_Partners>,
        <https://1145.am/db/739269/Great_Hill_Partners>,
        <https://1145.am/db/741241/Exeter_Street_Capital_Partners>,
        <https://1145.am/db/750874/Arlington_Capital_Partners>,
        <https://1145.am/db/755740/Godspeed_Capital>,
        <https://1145.am/db/790064/Godspeed_Capital>,
        <https://1145.am/db/790455/Godspeed_Capital>,
        <https://1145.am/db/800128/Great_Hill_Equity_Partners_Viii>,
        <https://1145.am/db/800128/Great_Hill_Partners>,
        <https://1145.am/db/830349/Hildred_Equity_Partners_Ii>,
        <https://1145.am/db/832/Abry_Partners>,
        <https://1145.am/db/846826/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/866641/Morgan_Stanley_Capital_Partners>,
        <https://1145.am/db/866641/Sheridan_Capital_Partners>,
        <https://1145.am/db/866708/Sfw_Capital_Partners>,
        <https://1145.am/db/867837/Sfw_Capital_Partners>,
        <https://1145.am/db/867942/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/890845/Dc_Capital_Partners_Llc>,
        <https://1145.am/db/894004/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/895233/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/901053/Blue_Wolf_Capital_Partners>,
        <https://1145.am/db/901700/Northleaf_Capital_Partners>,
        <https://1145.am/db/901836/Blue_Wolf_Capital_Partners>,
        <https://1145.am/db/902992/Northleaf_Capital_Partners>,
        <https://1145.am/db/907800/Court_Square_Capital_Partners>,
        <https://1145.am/db/935223/Red_Door_Capital_Partners_Llc>,
        <https://1145.am/db/946632/Graham_Allen_Partners>,
        <https://1145.am/db/952891/One_Rock_Capital_Partners>,
        <https://1145.am/db/955109/Thompson_Street_Capital_Partners>,
        <https://1145.am/db/963846/Seacrest_Capital>,
        <https://1145.am/db/973727/One_Rock_Capital_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1003377/Ancor_Capital_Partners>,
        <https://1145.am/db/2546371/Ancor_Capital_Partners>,
        <https://1145.am/db/385804/Ancor_Capital_Partners> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2578302/Sentinel_Capital_Partners> a org:Organization ;
    ns1:buyer <https://1145.am/db/2578302/Wellspring_Pharmaceutical_Corporation_Acquisition> ;
    ns1:description "private equity firm" ;
    ns1:documentDate "2011-11-08T12:45:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sentinel Capital Partners Acquires WellSpring Pharmaceutical Corporation" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/sentinel-capital-partners-acquires-wellspring-pharmaceutical-corporation> ;
    ns1:foundName "Sentinel",
        "Sentinel Capital Partners" ;
    ns1:industry "Healthcare" ;
    ns1:investor <https://1145.am/db/2578302/Wellspring_Pharmaceutical_Corporation_Acquisition> ;
    ns1:name "Sentinel Capital Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1081072/Sentinel_Capital_Partners>,
        <https://1145.am/db/1150358/Linden_Capital_Partners>,
        <https://1145.am/db/1163119/Sentinel_Capital_Partners>,
        <https://1145.am/db/1278249/Sentinel_Capital_Partners>,
        <https://1145.am/db/1415652/Vss_Capital_Partners>,
        <https://1145.am/db/1418645/Vss_Capital_Partners>,
        <https://1145.am/db/1509454/Sentinel_Capital_Partners>,
        <https://1145.am/db/1560866/Sentinel_Junior_Capital_Ii>,
        <https://1145.am/db/1584643/Avista_Capital_Partners>,
        <https://1145.am/db/2075627/Intandem_Capital_Partners>,
        <https://1145.am/db/2134320/Ascend_Capital_Partners>,
        <https://1145.am/db/2298631/Gt_Healthcare_Capital_Partners>,
        <https://1145.am/db/2334048/Ally_Bridge_Group_Capital_Partners>,
        <https://1145.am/db/2334957/Altaris_Capital_Partners>,
        <https://1145.am/db/2555844/Ally_Bridge_Group_Capital_Partners>,
        <https://1145.am/db/413034/Tt_Capital_Partners>,
        <https://1145.am/db/497819/Altaris_Capital_Partners>,
        <https://1145.am/db/562921/Tt_Capital_Partners>,
        <https://1145.am/db/563437/Consonance_Capital_Partners>,
        <https://1145.am/db/720139/Sentinel_Capital_Partners>,
        <https://1145.am/db/965484/Sentinel_Capital_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1659810/Sentinel_Capital_Partners>,
        <https://1145.am/db/2546371/Sentinel_Capital_Partners>,
        <https://1145.am/db/417679/Sentinel_Capital_Partners>,
        <https://1145.am/db/631431/Sentinel_Capital_Partners>,
        <https://1145.am/db/719949/Sentinel_Capital_Partners>,
        <https://1145.am/db/720425/Sentinel_Capital_Partners>,
        <https://1145.am/db/756705/Sentinel_Capital_Partners>,
        <https://1145.am/db/901175/Sentinel_Capital_Partners> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2587996/Businesses_Acquisition_Acino_Mepha_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-12-22T13:23:29+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Swiss drugmaker Acino plans to buy the Latin American and Asian businesses from Teva Pharmaceutical Industries' ($ TEVA) generics unit Mepha, as part of a deal worth €94 million ($ 122 million) ." ;
    ns1:documentTitle "Acino to buy Mepha businesses in Latin America, Asia; Ranbaxy's $500M reserve wipes out Lipitor gains;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/acino-to-buy-mepha-businesses-latin-america-asia-ranbaxy-s-500m-reserve-wipes-out-lipitor> ;
    ns1:foundName "buy" ;
    ns1:name "buy" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:targetDetails "businesses" ;
    ns1:valueRaw "$ 122 million",
        "€94 million" ;
    ns1:vendor <https://1145.am/db/2587996/Mepha> ;
    ns1:whereGeoName "Asia",
        "Latin America" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6255147/about.rdf> ;
    ns1:whereRaw "Latin American and Asian" .

<https://1145.am/db/2587996/Finetech_Pharmaceutical> a org:Organization ;
    ns1:basedInHighGeoName "State of Israel" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/294640/about.rdf> ;
    ns1:basedInHighRaw "Israel" ;
    ns1:documentDate "2011-12-22T13:23:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Acino to buy Mepha businesses in Latin America, Asia; Ranbaxy's $500M reserve wipes out Lipitor gains;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/acino-to-buy-mepha-businesses-latin-america-asia-ranbaxy-s-500m-reserve-wipes-out-lipitor> ;
    ns1:foundName "FineTech Pharmaceutical" ;
    ns1:industry "pharmaceutical ingredients" ;
    ns1:name "FineTech Pharmaceutical" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2587996/Finetech_Pharmaceutical_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-12-22T13:23:29+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Miami - based Opko Health is buying the Israeli active pharmaceutical ingredients manufacturer FineTech Pharmaceutical; terms were n't disclosed." ;
    ns1:documentTitle "Acino to buy Mepha businesses in Latin America, Asia; Ranbaxy's $500M reserve wipes out Lipitor gains;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/acino-to-buy-mepha-businesses-latin-america-asia-ranbaxy-s-500m-reserve-wipes-out-lipitor> ;
    ns1:foundName "buying" ;
    ns1:name "buying" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2587996/Finetech_Pharmaceutical> ;
    ns1:targetName "FineTech Pharmaceutical" ;
    ns1:whereGeoName "State of Israel" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/294640/about.rdf> ;
    ns1:whereRaw "Israel" .

<https://1145.am/db/2587996/Investment_Novocol_Pharmaceutical_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-12-22T13:23:29+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Dental anesthetic maker Novocol Pharmaceutical is spending about $ 54 million to upgrade a plant in Ontario, Canada." ;
    ns1:documentTitle "Acino to buy Mepha businesses in Latin America, Asia; Ranbaxy's $500M reserve wipes out Lipitor gains;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/acino-to-buy-mepha-businesses-latin-america-asia-ranbaxy-s-500m-reserve-wipes-out-lipitor> ;
    ns1:foundName "spending",
        "upgrade" ;
    ns1:name "spending",
        "upgrade" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:valueRaw "about $ 54 million" ;
    ns1:whereGeoName "Asia",
        "Latin America" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6255147/about.rdf> ;
    ns1:whereRaw "Latin American and Asian" .

<https://1145.am/db/2587996/Investment_Purdue_Pharma_Transcept_Pharmaceuticals_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-12-22T13:23:29+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Transcept Pharmaceuticals won a $ 10 million milestone payment from Purdue Pharma for the sleep drug Intermezzo's new listing in the FDA Orange Book." ;
    ns1:documentTitle "Acino to buy Mepha businesses in Latin America, Asia; Ranbaxy's $500M reserve wipes out Lipitor gains;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/acino-to-buy-mepha-businesses-latin-america-asia-ranbaxy-s-500m-reserve-wipes-out-lipitor> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2587996/Transcept_Pharmaceuticals> ;
    ns1:valueRaw "$ 10 million" ;
    ns1:whereGeoName "Asia",
        "Latin America" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6255147/about.rdf> ;
    ns1:whereRaw "Latin American and Asian" .

<https://1145.am/db/2587996/Mepha> a org:Organization ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:documentDate "2011-12-22T13:23:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Acino to buy Mepha businesses in Latin America, Asia; Ranbaxy's $500M reserve wipes out Lipitor gains;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/acino-to-buy-mepha-businesses-latin-america-asia-ranbaxy-s-500m-reserve-wipes-out-lipitor> ;
    ns1:foundName "Mepha" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Mepha" ;
    ns1:sameAsHigh <https://1145.am/db/2317060/Mepha_Ag>,
        <https://1145.am/db/2331204/Mepha>,
        <https://1145.am/db/2331205/Mepha>,
        <https://1145.am/db/2338110/Mezzion_Pharma_Co_Ltd>,
        <https://1145.am/db/2576594/Mepha>,
        <https://1145.am/db/2587261/Mepha>,
        <https://1145.am/db/2587948/Mepha> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2587996/Opko_Health> a org:Organization ;
    ns1:basedInHighGeoName "Miami" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4164138/about.rdf> ;
    ns1:basedInHighRaw "Miami" ;
    ns1:buyer <https://1145.am/db/2587996/Finetech_Pharmaceutical_Acquisition> ;
    ns1:documentDate "2011-12-22T13:23:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Acino to buy Mepha businesses in Latin America, Asia; Ranbaxy's $500M reserve wipes out Lipitor gains;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/acino-to-buy-mepha-businesses-latin-america-asia-ranbaxy-s-500m-reserve-wipes-out-lipitor> ;
    ns1:foundName "Opko Health" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Opko Health" ;
    ns1:sameAsHigh <https://1145.am/db/1042168/Opko_Health>,
        <https://1145.am/db/1520070/Opna_Bio>,
        <https://1145.am/db/2300237/Opko_Health>,
        <https://1145.am/db/2303326/Opko_Health>,
        <https://1145.am/db/2308778/Opko>,
        <https://1145.am/db/2312501/Opko_Health>,
        <https://1145.am/db/2319365/Opko_Health>,
        <https://1145.am/db/2319368/Opko_Health>,
        <https://1145.am/db/2328509/Opko_Health>,
        <https://1145.am/db/2341100/Opko_Health>,
        <https://1145.am/db/2342385/Opko_Health>,
        <https://1145.am/db/2350564/Opko_Health>,
        <https://1145.am/db/2351183/Opko_Health>,
        <https://1145.am/db/2351184/Opko_Health>,
        <https://1145.am/db/2538211/Opko_Health>,
        <https://1145.am/db/2543138/Opko_Health>,
        <https://1145.am/db/2564042/Opko_Health> ;
    ns1:sameAsMedium <https://1145.am/db/1283748/Opko_Health>,
        <https://1145.am/db/2294238/Opko_Health>,
        <https://1145.am/db/2318305/Opko_Health>,
        <https://1145.am/db/2321707/Opko_Health>,
        <https://1145.am/db/2340036/Opko_Health>,
        <https://1145.am/db/2342345/Opko_Health>,
        <https://1145.am/db/2361481/Opko_Health>,
        <https://1145.am/db/2592678/Opko_Health>,
        <https://1145.am/db/611905/Opko_Health>,
        <https://1145.am/db/613011/Opko_Health>,
        <https://1145.am/db/613838/Opko_Health> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2587996/Purdue_Pharma> a org:Organization ;
    ns1:documentDate "2011-12-22T13:23:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Acino to buy Mepha businesses in Latin America, Asia; Ranbaxy's $500M reserve wipes out Lipitor gains;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/acino-to-buy-mepha-businesses-latin-america-asia-ranbaxy-s-500m-reserve-wipes-out-lipitor> ;
    ns1:foundName "Purdue Pharma" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2587996/Investment_Purdue_Pharma_Transcept_Pharmaceuticals_Completed> ;
    ns1:name "Purdue Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/1218589/Pharmeasy>,
        <https://1145.am/db/1283229/Pharmasimple>,
        <https://1145.am/db/1297146/Grand_Pharma>,
        <https://1145.am/db/1348586/Mankind_Pharma_Ltd>,
        <https://1145.am/db/1969726/Pharma-Care>,
        <https://1145.am/db/1973625/Mankind_Pharma_Ltd>,
        <https://1145.am/db/2055701/Pharmeasy>,
        <https://1145.am/db/2153796/The_Big_Pharma>,
        <https://1145.am/db/2155713/Compugen>,
        <https://1145.am/db/2221113/Pharmmd>,
        <https://1145.am/db/2235891/Pharmerica_Corporation>,
        <https://1145.am/db/2239406/Pharmerica_Corporation>,
        <https://1145.am/db/2277669/Pharmerica_Corporation>,
        <https://1145.am/db/2280925/The_Big_Pharma>,
        <https://1145.am/db/2281130/The_Big_Pharma>,
        <https://1145.am/db/2283795/The_Big_Pharma>,
        <https://1145.am/db/2287111/Big_Pharma_Pfizer>,
        <https://1145.am/db/2299111/Compugen>,
        <https://1145.am/db/2299388/The_Us_Big_Pharma>,
        <https://1145.am/db/2306110/Pharming_Group>,
        <https://1145.am/db/2307844/Ap_Pharma>,
        <https://1145.am/db/2308422/Purdue_Pharma>,
        <https://1145.am/db/2309368/Purdue_Pharma>,
        <https://1145.am/db/2328026/Polymedix>,
        <https://1145.am/db/2340615/Forendo_Pharma>,
        <https://1145.am/db/2354567/Pharmasset>,
        <https://1145.am/db/2356559/Theravance>,
        <https://1145.am/db/2359404/Purdue_Pharma_Lp>,
        <https://1145.am/db/2364522/Pharmerica_Corporation>,
        <https://1145.am/db/2368951/Intec_Pharma>,
        <https://1145.am/db/2544065/Mankind_Pharma>,
        <https://1145.am/db/2558105/Life_Pharma>,
        <https://1145.am/db/2562258/Arch_Pharmalabs>,
        <https://1145.am/db/2563049/Pharmakon>,
        <https://1145.am/db/2584119/Pharmerica_Corporation>,
        <https://1145.am/db/2586160/Is_Pharma>,
        <https://1145.am/db/2593718/Pharmerica_Corporation>,
        <https://1145.am/db/2593719/Pharmerica_Corporation>,
        <https://1145.am/db/2595520/Pharmerica_Corporation>,
        <https://1145.am/db/2597972/Pharmerica_Corporation>,
        <https://1145.am/db/319633/Pharmathen>,
        <https://1145.am/db/608667/Pharmeasy>,
        <https://1145.am/db/612219/Drug_Development_And_Regulation>,
        <https://1145.am/db/771669/Polpharma>,
        <https://1145.am/db/771701/Polpharma>,
        <https://1145.am/db/940935/Mabxience>,
        <https://1145.am/db/972082/Design_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2152224/Purdue_Pharma>,
        <https://1145.am/db/2347781/Purdue_Pharma_Lp>,
        <https://1145.am/db/2348198/Purdue_Pharma>,
        <https://1145.am/db/2358619/Purdue_Pharma>,
        <https://1145.am/db/2368026/Purdue_Pharma_Lp>,
        <https://1145.am/db/2369878/Purdue_Pharma_Lp>,
        <https://1145.am/db/2560225/Purdue_Pharma>,
        <https://1145.am/db/2574357/Purdue_Pharma>,
        <https://1145.am/db/2579074/Purdue_Pharma_Lp>,
        <https://1145.am/db/2593522/Purdue_Pharma_Lp>,
        <https://1145.am/db/922961/Purdue_Pharma_Lp>,
        <https://1145.am/db/925028/Purdue_Pharma_Lp> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2587996/Transcept_Pharmaceuticals> a org:Organization ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2011-12-22T13:23:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Acino to buy Mepha businesses in Latin America, Asia; Ranbaxy's $500M reserve wipes out Lipitor gains;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/acino-to-buy-mepha-businesses-latin-america-asia-ranbaxy-s-500m-reserve-wipes-out-lipitor> ;
    ns1:foundName "Transcept Pharmaceuticals" ;
    ns1:industry "pharmaceuticals" ;
    ns1:name "Transcept Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2335868/Transcept_Pharmaceuticals>,
        <https://1145.am/db/2339857/Transcept_Pharmaceuticals_Inc>,
        <https://1145.am/db/2340655/Transcept_Pharmaceuticals>,
        <https://1145.am/db/2348770/Transcept_Pharmaceuticals>,
        <https://1145.am/db/2349056/Transcept_Pharmaceuticals>,
        <https://1145.am/db/2353164/Transcept_Pharmaceuticals>,
        <https://1145.am/db/2353169/Transcept>,
        <https://1145.am/db/2537482/Transcept_Pharmaceuticals> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2593681/Micromet_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2012-01-26T14:20:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "THOUSAND OAKS, Calif., and ROCKVILLE, Md., Jan. 26, 2012 /PRNewswire/ - Amgen (NASDAQ: AMGN) and Micromet, Inc. (NASDAQ: MITI) today announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded in Germany with its research and development (R & D) center in Munich and headquarters in Rockville, Md., for $ 11 per share in cash." ;
    ns1:documentTitle "Amgen to Acquire Micromet" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/amgen-to-acquire-micromet> ;
    ns1:foundName "acquire",
        "merger" ;
    ns1:name "acquire",
        "merger" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2593681/Micromet> ;
    ns1:targetName "Micromet" ;
    ns1:valueRaw "approximately $ 1.16 billion" ;
    ns1:whereGeoName "Federal Republic of Germany" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:whereRaw "Germany" .

<https://1145.am/db/2595150/Changzhou_Kony_Pharm> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:documentDate "2012-02-06T15:29:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DEA suspends Class 1 Cardinal Health facility; GSK earmarks $64M for Australian expansion;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dea-suspends-class-1-cardinal-health-facility-gsk-earmarks-64m-for-australian-expansion> ;
    ns1:foundName "Changzhou Kony Pharm" ;
    ns1:industry "pharmaceutical ingredients" ;
    ns1:name "Changzhou Kony Pharm" ;
    ns1:sameAsHigh <https://1145.am/db/1003417/Tiancheng_(germany)_Pharmaceutical_Holdings_Ag>,
        <https://1145.am/db/1441323/Changzhou_Biowin_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/1444206/Chongqing_Zhuoda_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/1616035/Jilin_Huisheng_Biopharmaceutical_Co_Ltd>,
        <https://1145.am/db/2359727/Nanjing_Meirui_Pharma_Co_Ltd> ;
    ns1:sameAsMedium <https://1145.am/db/2595154/Changzhou_Kony_Pharm_Co_Ltd> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2595150/Changzhou_Kony_Pharm_Stake_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-06T15:29:28+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Shanghai Pharmaceuticals said it would buy a 70 % stake in Changzhou Kony Pharm now, and the remaining 30 % over the next two years, to boost its presence in active pharmaceutical ingredients." ;
    ns1:documentTitle "DEA suspends Class 1 Cardinal Health facility; GSK earmarks $64M for Australian expansion;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dea-suspends-class-1-cardinal-health-facility-gsk-earmarks-64m-for-australian-expansion> ;
    ns1:foundName "buy" ;
    ns1:name "buy" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2595150/Changzhou_Kony_Pharm> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Changzhou Kony Pharm" ;
    ns1:whereGeoName "People’s Republic of China" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:whereRaw "China" .

<https://1145.am/db/2595150/Investment_Glaxosmithkline_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-06T15:29:28+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> GlaxoSmithKline ($ GSK) plans to invest A $ 60 million ($ 64 million) into an expansion of its manufacturing and R & D operations in Victoria, Australia, creating 58 new jobs by 2017." ;
    ns1:documentTitle "DEA suspends Class 1 Cardinal Health facility; GSK earmarks $64M for Australian expansion;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dea-suspends-class-1-cardinal-health-facility-gsk-earmarks-64m-for-australian-expansion> ;
    ns1:foundName "invest" ;
    ns1:name "invest" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:valueRaw "$ 64 million",
        "A $ 60 million" ;
    ns1:whereGeoName "Commonwealth of Australia" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2077456/about.rdf> ;
    ns1:whereRaw "Australia" .

<https://1145.am/db/2595150/Investment_Novartis_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-06T15:29:28+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Novartis ($ NVS) , which now owns the eye-care company Alcon, is sponsoring a program to improve ophthalmology in the U.K. via medical education, training and support." ;
    ns1:documentTitle "DEA suspends Class 1 Cardinal Health facility; GSK earmarks $64M for Australian expansion;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dea-suspends-class-1-cardinal-health-facility-gsk-earmarks-64m-for-australian-expansion> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "Commonwealth of Australia" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2077456/about.rdf> ;
    ns1:whereRaw "Australia" .

<https://1145.am/db/2595150/Questcor_Pharmaceuticals> a org:Organization ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2012-02-06T15:29:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DEA suspends Class 1 Cardinal Health facility; GSK earmarks $64M for Australian expansion;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dea-suspends-class-1-cardinal-health-facility-gsk-earmarks-64m-for-australian-expansion> ;
    ns1:foundName "Questcor Pharmaceuticals" ;
    ns1:industry "pharmaceuticals" ;
    ns1:name "Questcor Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2302151/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2303646/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2303647/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2307579/Questcor_Pharmaceuticals>,
        <https://1145.am/db/2309019/Penwest_Pharmaceuticals>,
        <https://1145.am/db/2309055/Penwest_Pharmaceuticals>,
        <https://1145.am/db/2310175/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2313303/Questcor_Pharmaceuticals>,
        <https://1145.am/db/2315296/Squire_Pharmaceuticals>,
        <https://1145.am/db/2318918/Faust_Pharmaceuticals>,
        <https://1145.am/db/2318994/Questcor_Pharmaceuticals>,
        <https://1145.am/db/2319656/Squire_Pharmaceuticals_Inc>,
        <https://1145.am/db/2319675/Indigo_Pharmaceuticals>,
        <https://1145.am/db/2320996/Questcor_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322672/Forum_Pharmaceuticals>,
        <https://1145.am/db/2323303/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2324401/Penwest_Pharmaceuticals>,
        <https://1145.am/db/2324777/Questcor_Pharmaceuticals>,
        <https://1145.am/db/2331222/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2336445/Questcor_Pharmaceuticals>,
        <https://1145.am/db/2342677/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2349710/Penwest_Pharmaceuticals>,
        <https://1145.am/db/2349713/Penwest_Pharmaceuticals>,
        <https://1145.am/db/2349732/Penwest_Pharmaceuticals_Co>,
        <https://1145.am/db/2349976/Questcor_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349977/Questcor_Pharmaceuticals>,
        <https://1145.am/db/2363259/Penwest_Pharmaceuticals_Co>,
        <https://1145.am/db/2363467/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2363705/Questcor_Pharmaceuticals_Inc>,
        <https://1145.am/db/2562216/Questcor_Pharmaceuticals>,
        <https://1145.am/db/2568751/Javelin_Pharmaceuticals_Inc>,
        <https://1145.am/db/2587292/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2587777/Questcor_Pharmaceuticals>,
        <https://1145.am/db/2589152/Penwest_Pharmaceuticals>,
        <https://1145.am/db/2589204/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2592590/Questcor_Pharmaceuticals>,
        <https://1145.am/db/2595382/Javelin_Pharmaceuticals_Inc>,
        <https://1145.am/db/2598340/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2598718/Javelin_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2307578/Questcor_Pharmaceuticals>,
        <https://1145.am/db/2336445/Questcor_Pharmaceutical_Inc>,
        <https://1145.am/db/2338549/Questcor_Pharmaceuticals>,
        <https://1145.am/db/2562217/Questcor_Pharmaceuticals>,
        <https://1145.am/db/2596480/Questcor_Pharmaceuticals> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2595150/Sanofi> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:description "pharmaceutical" ;
    ns1:documentDate "2012-02-06T15:29:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DEA suspends Class 1 Cardinal Health facility; GSK earmarks $64M for Australian expansion;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dea-suspends-class-1-cardinal-health-facility-gsk-earmarks-64m-for-australian-expansion> ;
    ns1:foundName "Sanofi" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Sanofi" ;
    ns1:sameAsHigh <https://1145.am/db/1110205/Sanofi_Sa>,
        <https://1145.am/db/1114745/Sanofi>,
        <https://1145.am/db/1116151/Sanofi>,
        <https://1145.am/db/1177954/Sanofi>,
        <https://1145.am/db/1252297/Sanofi>,
        <https://1145.am/db/1316541/Sanofi>,
        <https://1145.am/db/1317517/Sanofi>,
        <https://1145.am/db/137297/Sanofi>,
        <https://1145.am/db/138669/Sanofi>,
        <https://1145.am/db/1533327/Sanofi_Ventures>,
        <https://1145.am/db/1533685/Sanofi_Ventures>,
        <https://1145.am/db/1541946/Sanofi>,
        <https://1145.am/db/1548955/Sanofi>,
        <https://1145.am/db/1931929/Sanofi>,
        <https://1145.am/db/1935113/Sanofi>,
        <https://1145.am/db/194991/Sanofi>,
        <https://1145.am/db/195055/Sanofi>,
        <https://1145.am/db/1953742/Sanofi>,
        <https://1145.am/db/1985052/Sanofi>,
        <https://1145.am/db/2137147/Sanofi>,
        <https://1145.am/db/2152605/Sanofi>,
        <https://1145.am/db/2152611/Sanofi>,
        <https://1145.am/db/2154031/Sanofi>,
        <https://1145.am/db/2154432/Sanofi>,
        <https://1145.am/db/2154444/Sanofi>,
        <https://1145.am/db/2154660/Sanofi>,
        <https://1145.am/db/2154812/Sanofi>,
        <https://1145.am/db/2154850/Sanofi>,
        <https://1145.am/db/2155307/Sanofi>,
        <https://1145.am/db/2241046/Sanofi-Aventis>,
        <https://1145.am/db/2278957/Sanofi>,
        <https://1145.am/db/2279007/Sanofi>,
        <https://1145.am/db/2280255/Sanofi>,
        <https://1145.am/db/2282197/Sanofi>,
        <https://1145.am/db/2282344/Sanofi>,
        <https://1145.am/db/2285905/Sanofi>,
        <https://1145.am/db/2286521/Sanofi>,
        <https://1145.am/db/2286823/Sanofi>,
        <https://1145.am/db/2286894/Sanofi>,
        <https://1145.am/db/2287400/Sanofi>,
        <https://1145.am/db/2290842/Sanofi>,
        <https://1145.am/db/2293342/Sanofi>,
        <https://1145.am/db/2296552/Sanofi_Genzyme>,
        <https://1145.am/db/2297648/Sanofi>,
        <https://1145.am/db/2300140/Sanofi>,
        <https://1145.am/db/2301137/Sanofi>,
        <https://1145.am/db/2301170/Sanofi>,
        <https://1145.am/db/2303989/Sanofi-Aventis>,
        <https://1145.am/db/2303991/Sanofi-Aventis>,
        <https://1145.am/db/2303992/Sanofi-Aventis>,
        <https://1145.am/db/2304313/Sanofi-Aventis>,
        <https://1145.am/db/2304370/Sanofi>,
        <https://1145.am/db/2304646/Sanofi-Aventis>,
        <https://1145.am/db/2306290/Sanofi-Aventis>,
        <https://1145.am/db/2307903/Sanofi>,
        <https://1145.am/db/2308778/Sanofi-Aventis>,
        <https://1145.am/db/2308961/Sanofi-Aventis_Europe>,
        <https://1145.am/db/2309866/Sanofi>,
        <https://1145.am/db/2311677/Sanofi-Aventis_Us>,
        <https://1145.am/db/2312115/Sanofi-Aventis>,
        <https://1145.am/db/2313209/Sanofi-Aventis>,
        <https://1145.am/db/2313287/Sanofi-Aventis>,
        <https://1145.am/db/2315315/Sanofi-Aventis>,
        <https://1145.am/db/2319330/Sanofi-Aventis>,
        <https://1145.am/db/2319334/Sanofi>,
        <https://1145.am/db/2319764/Sanofi-Aventis_Us>,
        <https://1145.am/db/2319769/Sanofi>,
        <https://1145.am/db/2319773/Sanofi-Aventis_Us>,
        <https://1145.am/db/2319838/Sanofi-Aventis>,
        <https://1145.am/db/2320000/Sanofi-Aventis>,
        <https://1145.am/db/2321466/Sanofi-Aventis>,
        <https://1145.am/db/2321557/Sanofi-Aventis>,
        <https://1145.am/db/2322297/Sanofi-Aventis>,
        <https://1145.am/db/2322509/Sanofi-Aventis>,
        <https://1145.am/db/2324095/Sanofi-Aventis>,
        <https://1145.am/db/2325835/Sanofi-Aventis>,
        <https://1145.am/db/2326978/Sanofi>,
        <https://1145.am/db/2328712/Sanofi-Aventis>,
        <https://1145.am/db/2328729/Sanofi-Aventis>,
        <https://1145.am/db/2331206/Sanofi>,
        <https://1145.am/db/2333555/Sanofi>,
        <https://1145.am/db/2334183/Sanofi-Aventis>,
        <https://1145.am/db/2336075/Sanofi>,
        <https://1145.am/db/2336811/Sanofi>,
        <https://1145.am/db/2337279/Sanofi>,
        <https://1145.am/db/2337501/Sanofi>,
        <https://1145.am/db/2339639/Sanofi-Aventis>,
        <https://1145.am/db/2340923/Sanofi>,
        <https://1145.am/db/2341620/Sanofi>,
        <https://1145.am/db/2341792/Sanofi-Genzyme_Bioventures>,
        <https://1145.am/db/2341800/Sanofi-Genzyme_Bioventures>,
        <https://1145.am/db/2341959/Sanofi>,
        <https://1145.am/db/2342823/Sanofi>,
        <https://1145.am/db/2344788/Sanofi>,
        <https://1145.am/db/2344918/Sanofi>,
        <https://1145.am/db/2345128/Sanofi-Aventis>,
        <https://1145.am/db/2345144/Sanofi-Aventis>,
        <https://1145.am/db/2345275/Sanofi>,
        <https://1145.am/db/2345278/Sanofi>,
        <https://1145.am/db/2347557/Sanofi-Aventis>,
        <https://1145.am/db/2348041/Sanofi>,
        <https://1145.am/db/2350149/Sanofi>,
        <https://1145.am/db/2350156/Sanofi>,
        <https://1145.am/db/2350188/Sanofi>,
        <https://1145.am/db/2350290/Sanofi>,
        <https://1145.am/db/2353778/Sanofi-Aventis>,
        <https://1145.am/db/2354894/Sanofi>,
        <https://1145.am/db/2356384/Sanofi-Aventis>,
        <https://1145.am/db/2356453/Sanofi>,
        <https://1145.am/db/2358227/Sanofi>,
        <https://1145.am/db/2360382/Sanofi-Aventis>,
        <https://1145.am/db/2361756/Sanofi>,
        <https://1145.am/db/2361762/Sanofi-Aventis>,
        <https://1145.am/db/2362809/Sanofi-Aventis>,
        <https://1145.am/db/2362893/Sanofi>,
        <https://1145.am/db/2364295/Sanofi-Aventis>,
        <https://1145.am/db/2364717/Sanofi-Aventis>,
        <https://1145.am/db/2365152/Sanofi>,
        <https://1145.am/db/2366608/Sanofi-Aventis>,
        <https://1145.am/db/2366682/Sanofi>,
        <https://1145.am/db/2366691/Sanofi-Aventis>,
        <https://1145.am/db/2366935/Sanofi>,
        <https://1145.am/db/2367188/Sanofi>,
        <https://1145.am/db/2367537/Sanofi>,
        <https://1145.am/db/2368181/Sanofi_Group>,
        <https://1145.am/db/2369920/Sanofi>,
        <https://1145.am/db/2370852/Sanofi>,
        <https://1145.am/db/2370897/Sanofi>,
        <https://1145.am/db/2370991/Sanofi>,
        <https://1145.am/db/2536247/Sanofi>,
        <https://1145.am/db/2537459/Sanofi>,
        <https://1145.am/db/2537482/Sanofi-Aventis>,
        <https://1145.am/db/2538082/Sanofi>,
        <https://1145.am/db/2538595/Sanofi-Aventis>,
        <https://1145.am/db/2538666/Sanofi>,
        <https://1145.am/db/2538728/Sanofi>,
        <https://1145.am/db/2538761/Sanofi>,
        <https://1145.am/db/2539788/Sanofi>,
        <https://1145.am/db/2540527/Sanofi>,
        <https://1145.am/db/2541684/Sanofi>,
        <https://1145.am/db/2542471/Sanofi>,
        <https://1145.am/db/2542477/Sanofi>,
        <https://1145.am/db/2543989/Sanofi>,
        <https://1145.am/db/2544435/Sanofi>,
        <https://1145.am/db/2544525/Sanofi>,
        <https://1145.am/db/2544560/Sanofi>,
        <https://1145.am/db/2544596/Sanofi-Aventis>,
        <https://1145.am/db/2544788/Sanofi>,
        <https://1145.am/db/2546160/Sanofi>,
        <https://1145.am/db/2546321/Sanofi>,
        <https://1145.am/db/2546603/Sanofi-Aventis>,
        <https://1145.am/db/2546629/Sanofi-Aventis>,
        <https://1145.am/db/2547653/Sanofi-Aventis>,
        <https://1145.am/db/2548674/Sanofi-Aventis>,
        <https://1145.am/db/2548677/Sanofi-Aventis>,
        <https://1145.am/db/2549121/Sanofi-Aventis>,
        <https://1145.am/db/2549313/Sanofi_Pasteur>,
        <https://1145.am/db/2549862/Sanofi_India>,
        <https://1145.am/db/2549933/Sanofi>,
        <https://1145.am/db/2550420/Sanofi>,
        <https://1145.am/db/2550719/Sanofi>,
        <https://1145.am/db/2550743/Sanofi>,
        <https://1145.am/db/2550868/Sanofi>,
        <https://1145.am/db/2551966/Sanofi>,
        <https://1145.am/db/2552490/Sanofi>,
        <https://1145.am/db/2552794/Sanofi-Aventis>,
        <https://1145.am/db/2553131/Sanofi>,
        <https://1145.am/db/2553354/Sanofi-Aventis>,
        <https://1145.am/db/2553497/Sanofi>,
        <https://1145.am/db/2553799/Sanofi-Aventis>,
        <https://1145.am/db/2553978/Sanofi>,
        <https://1145.am/db/2554814/Sanofi>,
        <https://1145.am/db/2556017/Sanofi>,
        <https://1145.am/db/2557509/Sanofi>,
        <https://1145.am/db/2558115/Sanofi>,
        <https://1145.am/db/2558679/Sanofi>,
        <https://1145.am/db/2558927/Sanofi>,
        <https://1145.am/db/2559069/Sanofi-Aventis>,
        <https://1145.am/db/2559247/Sanofi>,
        <https://1145.am/db/2559471/Sanofi>,
        <https://1145.am/db/2560854/Sanofi>,
        <https://1145.am/db/2560886/Sanofi_Pasteur>,
        <https://1145.am/db/2561700/Sanofi>,
        <https://1145.am/db/2562230/Sanofi>,
        <https://1145.am/db/2562306/Sanofi>,
        <https://1145.am/db/2562482/Sanofi-Aventis>,
        <https://1145.am/db/2563447/Sanofi-Aventis>,
        <https://1145.am/db/2566057/Sanofi>,
        <https://1145.am/db/2566482/Sanofi>,
        <https://1145.am/db/2567475/Sanofi>,
        <https://1145.am/db/2567517/Sanofi>,
        <https://1145.am/db/2568031/Sanofi>,
        <https://1145.am/db/2568144/Sanofi>,
        <https://1145.am/db/2571093/Sanofi>,
        <https://1145.am/db/2571467/Sanofi>,
        <https://1145.am/db/2572739/Sanofi-Aventis>,
        <https://1145.am/db/2573878/Sanofi>,
        <https://1145.am/db/2574505/Sanofi-Aventis>,
        <https://1145.am/db/2575450/Sanofi-Aventis>,
        <https://1145.am/db/2575623/Sanofi-Aventis>,
        <https://1145.am/db/2576254/Sanofi>,
        <https://1145.am/db/2576512/Sanofi-Aventis>,
        <https://1145.am/db/2576516/Sanofi>,
        <https://1145.am/db/2577419/Sanofi-Aventis>,
        <https://1145.am/db/2578346/Sanofi>,
        <https://1145.am/db/2578503/Sanofi-Aventis>,
        <https://1145.am/db/2578550/Sanofi-Aventis>,
        <https://1145.am/db/2578745/Sanofi>,
        <https://1145.am/db/2581176/Sanofi>,
        <https://1145.am/db/2581325/Sanofi>,
        <https://1145.am/db/2581432/Sanofi>,
        <https://1145.am/db/2583301/Sanofi-Aventis>,
        <https://1145.am/db/2583302/Sanofi>,
        <https://1145.am/db/2585710/Sanofi>,
        <https://1145.am/db/2585746/Sanofi>,
        <https://1145.am/db/2586373/Sanofi>,
        <https://1145.am/db/2586657/Sanofi>,
        <https://1145.am/db/2586658/Sanofi>,
        <https://1145.am/db/2587087/Sanofi>,
        <https://1145.am/db/2588362/Sanofi>,
        <https://1145.am/db/2588622/Sanofi>,
        <https://1145.am/db/2589423/Sanofi>,
        <https://1145.am/db/2589657/Sanofi>,
        <https://1145.am/db/2590017/Sanofi-Aventis>,
        <https://1145.am/db/2590137/Sanofi-Aventis>,
        <https://1145.am/db/2591938/Sanofi>,
        <https://1145.am/db/2592083/Sanofi-Aventis>,
        <https://1145.am/db/2592093/Sanofi-Aventis>,
        <https://1145.am/db/2592987/Sanofi-Aventis>,
        <https://1145.am/db/2593103/Sanofi>,
        <https://1145.am/db/2593819/Sanofi-Aventis>,
        <https://1145.am/db/2594116/Sanofi>,
        <https://1145.am/db/2595039/Sanofi>,
        <https://1145.am/db/2595050/Sanofi>,
        <https://1145.am/db/2595051/Sanofi>,
        <https://1145.am/db/2595303/Sanofi-Aventis>,
        <https://1145.am/db/2595389/Sanofi-Aventis_Sp_Z_Oo>,
        <https://1145.am/db/2595483/Sanofi>,
        <https://1145.am/db/2595685/Sanofi>,
        <https://1145.am/db/2596034/Sanofi-Aventis>,
        <https://1145.am/db/2597433/Sanofi>,
        <https://1145.am/db/2597899/Sanofi-Aventis>,
        <https://1145.am/db/2598231/Sanofi>,
        <https://1145.am/db/2598237/Sanofi>,
        <https://1145.am/db/2598478/Sanofi-Aventis>,
        <https://1145.am/db/2767240/Sanofi>,
        <https://1145.am/db/2790381/Sanofi>,
        <https://1145.am/db/364048/Sanofi>,
        <https://1145.am/db/389077/Sanofi>,
        <https://1145.am/db/389114/Sanofi>,
        <https://1145.am/db/389294/Sanofi>,
        <https://1145.am/db/389303/Sanofi>,
        <https://1145.am/db/389554/Sanofi>,
        <https://1145.am/db/389590/Sanofi>,
        <https://1145.am/db/455480/Sanofi>,
        <https://1145.am/db/460895/Sanofi_Sa>,
        <https://1145.am/db/471607/Sanofi>,
        <https://1145.am/db/601458/Sanofi>,
        <https://1145.am/db/627105/Sanofi>,
        <https://1145.am/db/664174/Sanofi>,
        <https://1145.am/db/664442/Sanofi>,
        <https://1145.am/db/700482/Sanofi_Sa>,
        <https://1145.am/db/708041/Sanofi_Sa>,
        <https://1145.am/db/712037/Sanofi>,
        <https://1145.am/db/713105/Sanofi_Sa>,
        <https://1145.am/db/713127/Sanofi_Sa>,
        <https://1145.am/db/913775/Sanofi> ;
    ns1:sameAsMedium <https://1145.am/db/1936265/Sanofi>,
        <https://1145.am/db/2278955/Sanofi>,
        <https://1145.am/db/2335735/Sanofi>,
        <https://1145.am/db/2558779/Sanofi>,
        <https://1145.am/db/2562723/Sanofi>,
        <https://1145.am/db/2569421/Sanofi>,
        <https://1145.am/db/2581045/Sanofi>,
        <https://1145.am/db/2582063/Sanofi>,
        <https://1145.am/db/464512/Sanofi>,
        <https://1145.am/db/465648/Sanofi> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2595150/Valeant> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2595150/Dermik_Acquisition> ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2012-02-06T15:29:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DEA suspends Class 1 Cardinal Health facility; GSK earmarks $64M for Australian expansion;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dea-suspends-class-1-cardinal-health-facility-gsk-earmarks-64m-for-australian-expansion> ;
    ns1:foundName "Valeant" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Valeant" ;
    ns1:sameAsHigh <https://1145.am/db/2288428/Valeant>,
        <https://1145.am/db/2294967/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2295456/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2302002/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2302007/Valeant_Canada_Limited>,
        <https://1145.am/db/2302007/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2302826/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2305757/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2305758/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2306724/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2306813/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2308734/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2312215/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2312221/Valeant>,
        <https://1145.am/db/2313272/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2313282/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2313320/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2313365/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2315100/Valeant>,
        <https://1145.am/db/2318350/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2318405/Valeant>,
        <https://1145.am/db/2319331/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2319722/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2322159/Valeant>,
        <https://1145.am/db/2322776/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2323106/Valeant>,
        <https://1145.am/db/2323111/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2324422/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2325692/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2325895/Valeant>,
        <https://1145.am/db/2330074/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2332074/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2335641/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2336083/Valeant>,
        <https://1145.am/db/2336258/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2336278/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2337634/Valeant>,
        <https://1145.am/db/2341518/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2346832/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2346833/Valeant_Canada_Limited>,
        <https://1145.am/db/2346833/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2348864/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2349239/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2349461/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2350907/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2353646/Valeant>,
        <https://1145.am/db/2354801/Valeant>,
        <https://1145.am/db/2354804/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2356945/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2357416/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2360703/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2361172/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2361190/Valeant>,
        <https://1145.am/db/2362893/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2362898/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2362898/Valeant_Pharmaceuticals_North_America_Llc>,
        <https://1145.am/db/2363430/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2365199/Valeant>,
        <https://1145.am/db/2365200/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2366467/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2366468/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2367825/Valeant>,
        <https://1145.am/db/2369037/Valeant>,
        <https://1145.am/db/2369371/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2369374/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2369618/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2538017/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2539802/Valeant>,
        <https://1145.am/db/2540219/Valeant>,
        <https://1145.am/db/2540467/Valeant>,
        <https://1145.am/db/2543893/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2543904/Valeant>,
        <https://1145.am/db/2544888/Valeant>,
        <https://1145.am/db/2545075/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2550867/Valeant>,
        <https://1145.am/db/2556458/Valeant>,
        <https://1145.am/db/2556718/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2556805/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2557472/Valeant>,
        <https://1145.am/db/2560716/Valeant>,
        <https://1145.am/db/2560770/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2566037/Valeant>,
        <https://1145.am/db/2568778/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2568799/Valeant_Canada>,
        <https://1145.am/db/2568808/Valeant_Canada>,
        <https://1145.am/db/2569148/Valeant>,
        <https://1145.am/db/2569149/Valeant>,
        <https://1145.am/db/2570033/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2570121/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2570390/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2571019/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2571068/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2572086/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2572449/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2572450/Valeant>,
        <https://1145.am/db/2572552/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2572553/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2572568/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2572605/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2572612/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2572932/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2573147/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2573199/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2573880/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2574433/Valeant>,
        <https://1145.am/db/2575134/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2575289/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2575552/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2575615/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2575800/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2576039/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2576047/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2576205/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2576478/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2576482/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2576956/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2576962/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2577145/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2577419/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2577770/Valeant>,
        <https://1145.am/db/2577771/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2577774/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2577775/Valeant>,
        <https://1145.am/db/2577846/Valeant>,
        <https://1145.am/db/2577958/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2578188/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2578333/Valeant_Canada>,
        <https://1145.am/db/2578700/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2579147/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2580042/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2580047/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2580122/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2580140/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2580774/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2580775/Valeant>,
        <https://1145.am/db/2580831/Valeant>,
        <https://1145.am/db/2581225/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2582260/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2582935/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2583270/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2583732/Valeant>,
        <https://1145.am/db/2583843/Valeant_Pharmaceuticals_North_America>,
        <https://1145.am/db/2584209/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2584216/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2584226/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2584644/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2584750/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2584818/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2585746/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2586657/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2586658/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2587640/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2588178/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2589040/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2589223/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2589781/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2590589/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2591690/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2592575/And_Valeant>,
        <https://1145.am/db/2593443/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2593831/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2594087/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2594236/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2594249/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2594252/Valeant>,
        <https://1145.am/db/2594253/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2594281/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2594413/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2594414/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2594557/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2594858/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2595025/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2595287/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2595706/Valeant>,
        <https://1145.am/db/2595853/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2595929/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2596290/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2596891/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2597119/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2597158/Valeant>,
        <https://1145.am/db/2597223/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2597433/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2597433/Valeant_Pharmaceuticals_North_America_Llc>,
        <https://1145.am/db/2597542/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2597746/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2597769/Valeant>,
        <https://1145.am/db/2598012/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2598032/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2598205/Valeant>,
        <https://1145.am/db/2598261/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2598266/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2598558/Valeant_Pharmaceuticals_International> ;
    ns1:sameAsMedium <https://1145.am/db/2288758/Valeant>,
        <https://1145.am/db/2328143/Valeant>,
        <https://1145.am/db/2547983/Valeant>,
        <https://1145.am/db/2571740/Valeant>,
        <https://1145.am/db/2572930/Valeant>,
        <https://1145.am/db/2573485/Valeant>,
        <https://1145.am/db/2575133/Valeant>,
        <https://1145.am/db/2576212/Valeant>,
        <https://1145.am/db/2579823/Valeant>,
        <https://1145.am/db/2582257/Valeant>,
        <https://1145.am/db/2582894/Valeant>,
        <https://1145.am/db/2583845/Valeant>,
        <https://1145.am/db/2584676/Valeant>,
        <https://1145.am/db/2589971/Valeant>,
        <https://1145.am/db/2590366/Valeant>,
        <https://1145.am/db/2593483/Valeant> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2595511/Avonex> a org:Organization ;
    ns1:documentDate "2011-09-06T15:58:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biogen takes European MS marketing in-house with JV buyouts" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/biogen-takes-european-ms-marketing-house-jv-buyouts> ;
    ns1:foundName "Avonex" ;
    ns1:industry "multiple sclerosis" ;
    ns1:name "Avonex" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2595511/Avonex_Joint_Venture> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "joint venture" ;
    ns1:documentDate "2011-09-06T15:58:14+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Biogen Idec ($ BIIB) is taking its multiple sclerosis marketing in-house.",
        "The Massachusetts - based company has bought out the joint-venture partner that had been selling Avonex and Tysabri, forming wholly owned subsidiaries with commercial operations in 29 countries." ;
    ns1:documentTitle "Biogen takes European MS marketing in-house with JV buyouts" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/biogen-takes-european-ms-marketing-house-jv-buyouts> ;
    ns1:foundName "bought out",
        "selling" ;
    ns1:name "bought out",
        "selling" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2595511/Avonex> ;
    ns1:targetName "Avonex" .

<https://1145.am/db/2598439/McNeil-PPC> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2598439/Johnson___Johnson-Merck_Consumer_Pharmaceuticals_Co_Ownership_Merger> ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2011-09-29T12:19:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "McNEIL-PPC, Inc. Acquires Full Ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Joint Venture" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/mcneil-ppc-inc-acquires-full-ownership-of-johnson-johnson-merck-consumer-pharmaceuticals-co> ;
    ns1:foundName "McNEIL-PPC, Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "McNEIL-PPC" ;
    ns1:sameAsHigh <https://1145.am/db/2598439/McNeil_Consumer_Pharmaceuticals_Co>,
        <https://1145.am/db/2598455/McNeil-Ppc_Inc>,
        <https://1145.am/db/2598455/McNeil_Mmp_Llc>,
        <https://1145.am/db/2598458/McNeil-Ppc_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2583920/McNeil-PPC>,
        <https://1145.am/db/2598446/McNeil-Ppc_Inc> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2598439/Partnership_Interest_Acquisition_Johnson___Johnson_Inc_Merck_Sharp___Dohme_Corp_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-09-29T12:19:04+00:00"^^xsd:dateTime ;
    ns1:documentExtract "In addition, Johnson & Johnson Inc. through its McNeil Consumer Healthcare Division (McNeil Canada) has today acquired from Merck Canada Inc. its partnership interest in the Canadian joint venture." ;
    ns1:documentTitle "McNEIL-PPC, Inc. Acquires Full Ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Joint Venture" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/mcneil-ppc-inc-acquires-full-ownership-of-johnson-johnson-merck-consumer-pharmaceuticals-co> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:targetDetails "partnership interest" ;
    ns1:vendor <https://1145.am/db/2598439/Merck_Canada_Inc> ;
    ns1:whenRaw "\"" ;
    ns1:whereGeoName "Canada" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:whereRaw "Canada" .

<https://1145.am/db/2598439/Partnership_Interest_Investment_Johnson___Johnson_Inc_Merck_Canada_Inc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-09-29T12:19:04+00:00"^^xsd:dateTime ;
    ns1:documentExtract "FORT WASHINGTON, Pa., Sept. 28, 2011 /PRNewswire/ - McNEIL-PPC, Inc. and its affiliate McNeil MMP, LLC (McNEIL) announced today that they have completed the acquisition of full ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. joint venture in the United States from Merck Sharp & Dohme Corp. (Merck) .",
        "In addition, Johnson & Johnson Inc. through its McNeil Consumer Healthcare Division (McNeil Canada) has today acquired from Merck Canada Inc. its partnership interest in the Canadian joint venture." ;
    ns1:documentTitle "McNEIL-PPC, Inc. Acquires Full Ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Joint Venture" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/mcneil-ppc-inc-acquires-full-ownership-of-johnson-johnson-merck-consumer-pharmaceuticals-co> ;
    ns1:foundName "acquired" ;
    ns1:name "acquired" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2598439/McNeil_Consumer_Pharmaceuticals_Co>,
        <https://1145.am/db/2598439/Merck_Canada_Inc> ;
    ns1:targetDetails "partnership interest" ;
    ns1:targetName "McNeil Consumer Pharmaceuticals Co." ;
    ns1:whenRaw "2011" ;
    ns1:whereGeoName "Canada" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:whereRaw "Canada" .

<https://1145.am/db/2609817/Division_Acquisition_Alcatel-Lucent_Permira_Advisers_Stopped> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-09-06T13:54:19+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Alcatel-Lucent (NYSE: ALU) may be anxious to sell off its enterprise division to get some much needed cash to invest in its more profitable service provider business, but that dream is being deferred as Permira Advisers, a London - based buyout fund, decided not to purchase the whole unit." ;
    ns1:documentTitle "Alcatel-Lucent's enterprise sale to Permira Advisers falls through" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/alcatel-lucent-s-enterprise-sale-to-permira-advisers-falls-through> ;
    ns1:foundName "sell" ;
    ns1:name "sell" ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "stopped" ;
    ns1:targetDetails "division" ;
    ns1:vendor <https://1145.am/db/2609817/Alcatel-Lucent> ;
    ns1:whereGeoName "London" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2643743/about.rdf> ;
    ns1:whereRaw "London" .

<https://1145.am/db/2609817/Division_Investment_Alcatel-Lucent_Permira_Advisers_Stopped> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-09-06T13:54:19+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Alcatel-Lucent (NYSE: ALU) may be anxious to sell off its enterprise division to get some much needed cash to invest in its more profitable service provider business, but that dream is being deferred as Permira Advisers, a London - based buyout fund, decided not to purchase the whole unit.",
        "Permira is now in talks to purchase only Alcatel-Lucent's Genesys software division." ;
    ns1:documentTitle "Alcatel-Lucent's enterprise sale to Permira Advisers falls through" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/alcatel-lucent-s-enterprise-sale-to-permira-advisers-falls-through> ;
    ns1:foundName "purchase" ;
    ns1:name "purchase" ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "stopped" ;
    ns1:target <https://1145.am/db/2609817/Alcatel-Lucent>,
        <https://1145.am/db/2609817/Genesys> ;
    ns1:targetDetails "division" ;
    ns1:targetName "Genesys" ;
    ns1:valueRaw "$ 2.12 billion" ;
    ns1:whereGeoName "London" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2643743/about.rdf> ;
    ns1:whereRaw "London" .

<https://1145.am/db/2609817/Genesys> a org:Organization ;
    ns1:description "enterprise" ;
    ns1:documentDate "2011-09-06T13:54:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Alcatel-Lucent's enterprise sale to Permira Advisers falls through" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/alcatel-lucent-s-enterprise-sale-to-permira-advisers-falls-through> ;
    ns1:foundName "Genesys" ;
    ns1:name "Genesys" ;
    ns1:sameAsMedium <https://1145.am/db/1564520/Genesys>,
        <https://1145.am/db/2609645/Genesys>,
        <https://1145.am/db/2612072/Genesys>,
        <https://1145.am/db/2680847/Genesys>,
        <https://1145.am/db/676127/Genesys>,
        <https://1145.am/db/678154/Genesys>,
        <https://1145.am/db/760939/Genesys> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2609875/Current> a org:Organization ;
    ns1:basedInLowRaw "U.S." ;
    ns1:documentDate "2011-09-15T15:04:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CURRENT gets $13M to target international smart grid prospects" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/current-gets-13m-to-target-international-smart-grid-prospects> ;
    ns1:foundName "CURRENT" ;
    ns1:name "CURRENT" ;
    ns1:sameAsMedium <https://1145.am/db/1147258/Current>,
        <https://1145.am/db/1214407/Current>,
        <https://1145.am/db/1214411/Current>,
        <https://1145.am/db/1284993/Current>,
        <https://1145.am/db/1287702/Current>,
        <https://1145.am/db/1634220/Current>,
        <https://1145.am/db/1687168/Current>,
        <https://1145.am/db/1751566/Current>,
        <https://1145.am/db/1758975/Current>,
        <https://1145.am/db/1784198/Current>,
        <https://1145.am/db/1787980/Current>,
        <https://1145.am/db/317495/Current>,
        <https://1145.am/db/317529/Current>,
        <https://1145.am/db/318493/Current> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2618832/Surewest> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "CFO" ;
    ns1:documentDate "2012-02-27T13:11:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "SureWest, Consolidated name leaders of merger transition team" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/surewest-consolidated-name-leaders-merger-transition-team> ;
    ns1:foundName "SureWest" ;
    ns1:industry "telcos" ;
    ns1:name "SureWest" ;
    ns1:sameAsHigh <https://1145.am/db/2162077/Surewest_Communications>,
        <https://1145.am/db/2600980/Surewest_Communications>,
        <https://1145.am/db/2601467/Surewest>,
        <https://1145.am/db/2602107/Surewest>,
        <https://1145.am/db/2602900/Surewest>,
        <https://1145.am/db/2602911/Surewest>,
        <https://1145.am/db/2603175/Surewest_Communications>,
        <https://1145.am/db/2604322/Surewest_Communications>,
        <https://1145.am/db/2606792/Surewest>,
        <https://1145.am/db/2617406/Surewest_Communications> ;
    ns1:sameAsMedium <https://1145.am/db/2600722/Surewest> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2618832/Surewest_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2012-02-27T13:11:31+00:00"^^xsd:dateTime ;
    ns1:documentExtract "As Consolidated Communications (Nasdaq: CNSL) moves ahead with its acquisition of SureWest (Nasdaq: SURW) , the two service providers have appointed their CFOs-Dan Bessey, SureWest's chief financial officer, and Steve Childers, Consolidated's CFO-to lead the transition team.",
        "Consolidated Communications beefs up holdings by buying SureWest." ;
    ns1:documentTitle "SureWest, Consolidated name leaders of merger transition team" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/surewest-consolidated-name-leaders-merger-transition-team> ;
    ns1:foundName "acquisition",
        "buying" ;
    ns1:name "acquisition",
        "buying" ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2618832/Surewest> ;
    ns1:targetName "SureWest" ;
    ns1:whereGeoName "Kansas City" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4393217/about.rdf> ;
    ns1:whereRaw "Kansas City" .

<https://1145.am/db/2628938/Sprint_Nextel_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-09-25T22:54:41+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Dish Network is entertaining the idea of partnering or purchasing a wireless operator such as Sprint Nextel (NYSE: S) and Clearwire (NASDAQ: CLWR) , the company's chief executive Joseph Clayton told Bloomberg." ;
    ns1:documentTitle "Dish Network looking at partnering, acquiring wireless operator" ;
    ns1:documentURL <https://www.fiercewireless.com/tech/dish-network-looking-at-partnering-acquiring-wireless-operator> ;
    ns1:foundName "partnering",
        "purchasing" ;
    ns1:name "partnering",
        "purchasing" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2628938/Sprint_Nextel> ;
    ns1:targetName "Sprint Nextel" .

<https://1145.am/db/2651198/Mobile_Telesystems> a org:Organization ;
    ns1:basedInHighGeoName "Russian Federation" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2017370/about.rdf> ;
    ns1:basedInHighRaw "Russia" ;
    ns1:documentDate "2011-09-16T15:09:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: Russia's AFK Sistema in talks with FT for ownership swap" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/report-russia-s-afk-sistema-talks-ft-for-ownership-swap> ;
    ns1:foundName "Mobile TeleSystems" ;
    ns1:name "Mobile TeleSystems" ;
    ns1:sameAsMedium <https://1145.am/db/2636434/Mobile_Telesystems>,
        <https://1145.am/db/2653139/Mobile_Telesystems>,
        <https://1145.am/db/2662667/Mobile_Telesystems> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2652948/Telecable_De_Asturias> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Spain" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2510769/about.rdf> ;
    ns1:basedInHighRaw "Spain" ;
    ns1:description "Asset management",
        "TV, telephone and broadband services" ;
    ns1:documentDate "2011-10-19T10:53:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Carlyle Group takes control of Telecable" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/carlyle-group-takes-control-telecable> ;
    ns1:foundName "Telecable",
        "Telecable de Asturias" ;
    ns1:name "Telecable",
        "Telecable de Asturias" ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2654580/Metavante_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-10-31T15:08:03+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Monitise is also taking control of Monitise Americas by buying out joint venture partner Metavante, a subsidiary of banking and payments technology firm Fidelity National Information Services." ;
    ns1:documentTitle "Visa Europe buys m-pay expertise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/visa-europe-buys-m-pay-expertise> ;
    ns1:foundName "buying" ;
    ns1:name "buying" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2654580/Metavante> ;
    ns1:targetName "Metavante" ;
    ns1:vendor <https://1145.am/db/2654580/Fidelity_National_Information_Services> ;
    ns1:whereGeoName "North Salt Lake" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5779068/about.rdf> ;
    ns1:whereRaw "North American" .

<https://1145.am/db/2654580/Monitise> a org:Organization ;
    ns1:basedInLowRaw "Ireland" ;
    ns1:buyer <https://1145.am/db/2654580/Metavante_Acquisition> ;
    ns1:description "mobile money" ;
    ns1:documentDate "2011-10-31T15:08:03+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Visa Europe buys m-pay expertise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/visa-europe-buys-m-pay-expertise> ;
    ns1:foundName "Monitise" ;
    ns1:industry "mobile money" ;
    ns1:name "Monitise" ;
    ns1:sameAsMedium <https://1145.am/db/1855599/Monitise>,
        <https://1145.am/db/1885415/Monitise> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2654580/Stake_Investment_Monitise_Visa_Europe_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-10-31T15:08:03+00:00"^^xsd:dateTime ;
    ns1:documentExtract "A Visa Europe investment in mobile money firm Monitise will ensure the credit firm is at the forefront of mobile payments, chief Peter Ayliffe says.",
        "Visa Europe is pumping £24.7 million (€28.2 million) into Monitise for an 8.8 % stake, in a bid to cash in on the potential presented by a combination of growing smartphone and e-commerce usage, Ayliffe explains." ;
    ns1:documentTitle "Visa Europe buys m-pay expertise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/visa-europe-buys-m-pay-expertise> ;
    ns1:foundName "investment",
        "pumping" ;
    ns1:name "investment",
        "pumping" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2654580/Monitise> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Monitise" ;
    ns1:valueRaw "£24.7 million",
        "€28.2 million" ;
    ns1:whereGeoName "Europe" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6255148/about.rdf> ;
    ns1:whereRaw "Europe" .

<https://1145.am/db/2654580/Visa_Europe> a org:Organization ;
    ns1:description "CEO" ;
    ns1:documentDate "2011-10-31T15:08:03+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Visa Europe buys m-pay expertise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/visa-europe-buys-m-pay-expertise> ;
    ns1:foundName "Visa Europe" ;
    ns1:industry "credit firm" ;
    ns1:investor <https://1145.am/db/2654580/Stake_Investment_Monitise_Visa_Europe_Has_Not_Happened> ;
    ns1:name "Visa Europe" ;
    ns1:sameAsMedium <https://1145.am/db/2654597/Visa_Europe>,
        <https://1145.am/db/2668073/Visa_Europe> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2654597/Fidelity_National_Information_Services> a org:Organization ;
    ns1:basedInLowRaw "US" ;
    ns1:description "Business" ;
    ns1:documentDate "2011-11-02T18:06:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Visa Europe invests £24M in mobile banking firm Monitise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/visa-europe-invests-ps24m-mobile-banking-firm-monitise> ;
    ns1:foundName "Fidelity National Information Services" ;
    ns1:name "Fidelity National Information Services" ;
    ns1:participant <https://1145.am/db/2654597/Monitise_Americas_Shareholding_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/2057386/Fidelity_National_Information_Services>,
        <https://1145.am/db/2654580/Fidelity_National_Information_Services> ;
    ns1:sameAsMedium <https://1145.am/db/1295124/Fidelity_Information_Services>,
        <https://1145.am/db/1783216/Fidelity_National_Information_Services>,
        <https://1145.am/db/2201901/Fidelity_National_Information_Services> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2654597/Monitise_Americas> a org:Organization ;
    ns1:basedInHighGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:basedInHighRaw "UK" ;
    ns1:basedInLowRaw "US" ;
    ns1:buyer <https://1145.am/db/2654597/Monitise_Americas_Shareholding_Acquisition> ;
    ns1:description "financial transactions",
        "mobile banking and payment service provider" ;
    ns1:documentDate "2011-11-02T18:06:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Visa Europe invests £24M in mobile banking firm Monitise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/visa-europe-invests-ps24m-mobile-banking-firm-monitise> ;
    ns1:foundName "Monitise",
        "Monitise Americas" ;
    ns1:industry "banking and payment service provider" ;
    ns1:name "Monitise",
        "Monitise Americas" ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2654597/Visa_Europe> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "financial institutions" ;
    ns1:documentDate "2011-11-02T18:06:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Visa Europe invests £24M in mobile banking firm Monitise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/visa-europe-invests-ps24m-mobile-banking-firm-monitise> ;
    ns1:foundName "Visa Europe" ;
    ns1:investor <https://1145.am/db/2654597/Monitise_Americas_Shareholding_Acquisition> ;
    ns1:name "Visa Europe" ;
    ns1:sameAsMedium <https://1145.am/db/2654580/Visa_Europe>,
        <https://1145.am/db/2668073/Visa_Europe> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2659467/Acquisition_Walid_Bin_Tatal_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-12-20T04:28:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Saudi billionaire prince Walid bin Tatal and holding company KHC have bought into Twitter through a $ 300 million investment." ;
    ns1:documentTitle "Webwire: Sprint abandons Carrier IQ; Huawei, ZTE eye $200m India revenue" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-sprint-abandons-carrier-iq-huawei-zte-eye-200m-india-revenue> ;
    ns1:foundName "investment" ;
    ns1:name "investment" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "completed" ;
    ns1:valueRaw "$ 300 million" ;
    ns1:whereGeoName "Hellenic Republic" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/390903/about.rdf> ;
    ns1:whereRaw "Greece" .

<https://1145.am/db/2659467/Investment_Ote_Telekom_Srbija_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-12-20T04:28:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Telekom Srbija has arranged to buy back 20 % of its own shares from Greece's OTE for €380 million ($ 494.7 million) .",
        "Telekom Srbija has arranged to buy back 20 % of its own shares from Greece's OTE for €380 million ($ 494.7 million)." ;
    ns1:documentTitle "Webwire: Sprint abandons Carrier IQ; Huawei, ZTE eye $200m India revenue" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-sprint-abandons-carrier-iq-huawei-zte-eye-200m-india-revenue> ;
    ns1:foundName "buy" ;
    ns1:name "buy" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened",
        "stopped" ;
    ns1:target <https://1145.am/db/2659467/Ote> ;
    ns1:targetDetails "shares" ;
    ns1:valueRaw "$ 494.7 million",
        "€380 million" ;
    ns1:whereGeoName "Hellenic Republic" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/390903/about.rdf> ;
    ns1:whereRaw "Greece" .

<https://1145.am/db/2659467/Ote> a org:Organization ;
    ns1:basedInHighGeoName "Hellenic Republic" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/390903/about.rdf> ;
    ns1:basedInHighRaw "Greece" ;
    ns1:description "telecom" ;
    ns1:documentDate "2011-12-20T04:28:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: Sprint abandons Carrier IQ; Huawei, ZTE eye $200m India revenue" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-sprint-abandons-carrier-iq-huawei-zte-eye-200m-india-revenue> ;
    ns1:foundName "OTE" ;
    ns1:industry "Telecom" ;
    ns1:name "OTE" ;
    ns1:sameAsHigh <https://1145.am/db/1005341/Oi_Sa>,
        <https://1145.am/db/1042394/Whisl>,
        <https://1145.am/db/1043328/Congruex>,
        <https://1145.am/db/1045190/Congruex>,
        <https://1145.am/db/1102230/Uscellular>,
        <https://1145.am/db/1102231/Uscellular>,
        <https://1145.am/db/1218671/Ooredoo>,
        <https://1145.am/db/1235025/Commnet>,
        <https://1145.am/db/1235368/Commnet>,
        <https://1145.am/db/1291248/Oi_Sa>,
        <https://1145.am/db/1317948/Ooredoo>,
        <https://1145.am/db/1339791/Ooredoo>,
        <https://1145.am/db/1353275/Oi_Sa>,
        <https://1145.am/db/1446775/Ooredoo>,
        <https://1145.am/db/1481069/Commnet>,
        <https://1145.am/db/1482027/Commnet>,
        <https://1145.am/db/167781/Bt>,
        <https://1145.am/db/1791450/Bt>,
        <https://1145.am/db/1791450/Ee>,
        <https://1145.am/db/1813088/Bt>,
        <https://1145.am/db/1838339/Bt>,
        <https://1145.am/db/2028706/Total_Telecom_Solutions>,
        <https://1145.am/db/2058429/Bt>,
        <https://1145.am/db/2159158/General_Communications_Inc>,
        <https://1145.am/db/2165610/General_Communications_Inc>,
        <https://1145.am/db/2166298/General_Communications_Inc>,
        <https://1145.am/db/2600562/At>,
        <https://1145.am/db/2600786/Comptel>,
        <https://1145.am/db/2601974/Tw_Telecom>,
        <https://1145.am/db/2602941/Telco_Systems>,
        <https://1145.am/db/2603533/Telcocell>,
        <https://1145.am/db/2605265/Intracom_Telecom>,
        <https://1145.am/db/2608511/Bt>,
        <https://1145.am/db/2610118/Commscope>,
        <https://1145.am/db/2610311/Sercotel>,
        <https://1145.am/db/2612648/Commscope>,
        <https://1145.am/db/2612992/Bt>,
        <https://1145.am/db/2614504/Bt>,
        <https://1145.am/db/2615719/Abovenet>,
        <https://1145.am/db/2617064/Bt>,
        <https://1145.am/db/2617165/Oi>,
        <https://1145.am/db/2619726/Bt>,
        <https://1145.am/db/2620106/Bt>,
        <https://1145.am/db/2620140/Oi>,
        <https://1145.am/db/2620965/Bt>,
        <https://1145.am/db/2624908/O2>,
        <https://1145.am/db/2625247/Commscope>,
        <https://1145.am/db/2651003/Oi>,
        <https://1145.am/db/2651766/Oi>,
        <https://1145.am/db/2651770/O2_Uk>,
        <https://1145.am/db/2651808/Bt>,
        <https://1145.am/db/2652375/Bt>,
        <https://1145.am/db/2652384/Oi>,
        <https://1145.am/db/2653257/Ote>,
        <https://1145.am/db/2654001/Telecel>,
        <https://1145.am/db/2654997/Oi>,
        <https://1145.am/db/2656761/Ote>,
        <https://1145.am/db/2657419/Ote>,
        <https://1145.am/db/2661621/Ote>,
        <https://1145.am/db/2664097/Oi>,
        <https://1145.am/db/2665906/Oi>,
        <https://1145.am/db/2666063/Eaccess>,
        <https://1145.am/db/2666438/Oi>,
        <https://1145.am/db/2670786/Ote>,
        <https://1145.am/db/2671114/Bt>,
        <https://1145.am/db/2672150/Telco>,
        <https://1145.am/db/2675454/Oi>,
        <https://1145.am/db/2675558/Ote>,
        <https://1145.am/db/2676275/Kt>,
        <https://1145.am/db/2676659/Oi>,
        <https://1145.am/db/2676671/Oi>,
        <https://1145.am/db/2676871/Bt>,
        <https://1145.am/db/2679056/Oi>,
        <https://1145.am/db/2680115/Oi>,
        <https://1145.am/db/2682569/O2>,
        <https://1145.am/db/2682867/Bt>,
        <https://1145.am/db/358961/Netfortris>,
        <https://1145.am/db/373510/Oi_Sa>,
        <https://1145.am/db/383786/Bt>,
        <https://1145.am/db/384425/Bt>,
        <https://1145.am/db/463059/Kt_Corp>,
        <https://1145.am/db/582343/Comtech_Telecommunications_Corp>,
        <https://1145.am/db/735747/Telecom_Engineering_Group>,
        <https://1145.am/db/735880/Expereo>,
        <https://1145.am/db/836948/Netfortris>,
        <https://1145.am/db/90656/O2> ;
    ns1:sameAsMedium <https://1145.am/db/145211/Ote>,
        <https://1145.am/db/2615058/Ote>,
        <https://1145.am/db/2615826/Ote>,
        <https://1145.am/db/2659496/Ote>,
        <https://1145.am/db/2663196/Ote>,
        <https://1145.am/db/2669237/Ote>,
        <https://1145.am/db/2670667/Ote>,
        <https://1145.am/db/2673046/Ote>,
        <https://1145.am/db/2674215/Ote>,
        <https://1145.am/db/304860/Ote>,
        <https://1145.am/db/367624/Ote> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2659467/Twitter> a org:Organization ;
    ns1:documentDate "2011-12-20T04:28:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: Sprint abandons Carrier IQ; Huawei, ZTE eye $200m India revenue" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-sprint-abandons-carrier-iq-huawei-zte-eye-200m-india-revenue> ;
    ns1:foundName "Twitter" ;
    ns1:industry "social media" ;
    ns1:name "Twitter" ;
    ns1:sameAsHigh <https://1145.am/db/1004079/Twitter_Inc>,
        <https://1145.am/db/1008653/Twitter_Inc>,
        <https://1145.am/db/1015094/Twitter>,
        <https://1145.am/db/1035283/Twitter_Inc>,
        <https://1145.am/db/1035565/Twitter>,
        <https://1145.am/db/1038836/Twitter>,
        <https://1145.am/db/1039196/Twitter_Inc>,
        <https://1145.am/db/1058653/Twitter>,
        <https://1145.am/db/1069626/Twitter>,
        <https://1145.am/db/1107738/Twitter_Inc>,
        <https://1145.am/db/1115900/Twitter>,
        <https://1145.am/db/1197601/Twitter>,
        <https://1145.am/db/1258640/Twitter>,
        <https://1145.am/db/1339857/Twitter_Inc>,
        <https://1145.am/db/1391906/Twitter>,
        <https://1145.am/db/1393299/Twitter>,
        <https://1145.am/db/1396019/Twitter>,
        <https://1145.am/db/1400582/Twitter_Inc>,
        <https://1145.am/db/1437251/Twitter_Inc>,
        <https://1145.am/db/1446953/Twitter>,
        <https://1145.am/db/1451697/Twitter>,
        <https://1145.am/db/1452525/Twitter>,
        <https://1145.am/db/1454666/Twitter>,
        <https://1145.am/db/1454742/Twitter>,
        <https://1145.am/db/1462814/Twitter>,
        <https://1145.am/db/151438/Twitter>,
        <https://1145.am/db/1522460/Twitter_Inc>,
        <https://1145.am/db/1597139/Twitter>,
        <https://1145.am/db/1657876/Twitter_Inc>,
        <https://1145.am/db/1658356/Twitter_Inc>,
        <https://1145.am/db/1693718/Twitter>,
        <https://1145.am/db/1695821/Twitter>,
        <https://1145.am/db/1698554/Twitter>,
        <https://1145.am/db/1711822/Twitter>,
        <https://1145.am/db/1736219/Twitter>,
        <https://1145.am/db/1743491/Twitter>,
        <https://1145.am/db/1745890/Twitter>,
        <https://1145.am/db/1750594/Twitter>,
        <https://1145.am/db/1750608/Twitter>,
        <https://1145.am/db/1752496/Twitter>,
        <https://1145.am/db/1759256/Twitter>,
        <https://1145.am/db/1762828/Twitter>,
        <https://1145.am/db/1765375/Twitter>,
        <https://1145.am/db/1765863/Twitter>,
        <https://1145.am/db/1770557/Twitter>,
        <https://1145.am/db/1773816/Twitter>,
        <https://1145.am/db/1775650/Twitter>,
        <https://1145.am/db/1791409/Twitter>,
        <https://1145.am/db/1793842/Twitter>,
        <https://1145.am/db/1799834/Twitter>,
        <https://1145.am/db/1802095/Twitter>,
        <https://1145.am/db/1803989/Twitter>,
        <https://1145.am/db/1824101/Twitter>,
        <https://1145.am/db/1824493/Twitter>,
        <https://1145.am/db/1837367/Twitter>,
        <https://1145.am/db/1837726/Twitter>,
        <https://1145.am/db/1838848/Twitter>,
        <https://1145.am/db/1839892/Twitter>,
        <https://1145.am/db/1840554/Twitter>,
        <https://1145.am/db/1844699/Twitter>,
        <https://1145.am/db/1848814/Twitter>,
        <https://1145.am/db/1870501/Twitter>,
        <https://1145.am/db/1880563/Tweetup>,
        <https://1145.am/db/1887535/Twitter>,
        <https://1145.am/db/1895559/Twitter>,
        <https://1145.am/db/1906385/Cotweet>,
        <https://1145.am/db/2004116/Twitter>,
        <https://1145.am/db/2005427/Twitter>,
        <https://1145.am/db/2005501/Twitter>,
        <https://1145.am/db/2005571/Twitter>,
        <https://1145.am/db/2026523/Twitter>,
        <https://1145.am/db/2079109/Twitter>,
        <https://1145.am/db/2668154/Twitter>,
        <https://1145.am/db/2736764/Twitter>,
        <https://1145.am/db/2751607/Twitter>,
        <https://1145.am/db/2758157/Twitter>,
        <https://1145.am/db/297901/Twitter_Inc>,
        <https://1145.am/db/305035/Twitter_Inc>,
        <https://1145.am/db/323831/Twitter>,
        <https://1145.am/db/323850/Twitter_Inc>,
        <https://1145.am/db/349462/Twitter_Inc>,
        <https://1145.am/db/351127/Twitter_Inc>,
        <https://1145.am/db/366628/Twitter_Inc>,
        <https://1145.am/db/374582/Twitter_Inc>,
        <https://1145.am/db/529757/Twitter_Inc>,
        <https://1145.am/db/660318/Twitter_Inc>,
        <https://1145.am/db/661536/Twitter_Inc>,
        <https://1145.am/db/671722/Twitter_Inc>,
        <https://1145.am/db/677503/Twitter_Inc>,
        <https://1145.am/db/969376/Twitter>,
        <https://1145.am/db/979943/Twitter>,
        <https://1145.am/db/982288/Twitter>,
        <https://1145.am/db/984696/Twitter_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/1004605/Twitter>,
        <https://1145.am/db/1012027/Twitter>,
        <https://1145.am/db/1027380/Twitter_Inc>,
        <https://1145.am/db/1035482/Twitter_Inc>,
        <https://1145.am/db/1054270/Twitter>,
        <https://1145.am/db/1055004/Twitter>,
        <https://1145.am/db/1056096/Twitter>,
        <https://1145.am/db/1064881/Twitter>,
        <https://1145.am/db/1153338/Twitter>,
        <https://1145.am/db/1203313/Twitter_Inc>,
        <https://1145.am/db/1338998/Twitter>,
        <https://1145.am/db/1389061/Twitter>,
        <https://1145.am/db/1399323/Twitter>,
        <https://1145.am/db/1446769/Twitter_Inc>,
        <https://1145.am/db/1464977/Twitter>,
        <https://1145.am/db/1483770/Twitter>,
        <https://1145.am/db/1600329/Twitter>,
        <https://1145.am/db/1693639/Twitter>,
        <https://1145.am/db/1695846/Twitter>,
        <https://1145.am/db/1696405/Twitter>,
        <https://1145.am/db/1698604/Twitter>,
        <https://1145.am/db/1705739/Twitter>,
        <https://1145.am/db/1706572/Twitter>,
        <https://1145.am/db/1710303/Twitter>,
        <https://1145.am/db/1710533/Twitter>,
        <https://1145.am/db/1711161/Twitter>,
        <https://1145.am/db/1718058/Twitter>,
        <https://1145.am/db/1729828/Twitter>,
        <https://1145.am/db/1735605/Twitter>,
        <https://1145.am/db/1736463/Twitter>,
        <https://1145.am/db/1739031/Twitter>,
        <https://1145.am/db/1744703/Twitter>,
        <https://1145.am/db/1748419/Twitter>,
        <https://1145.am/db/1752495/Twitter>,
        <https://1145.am/db/1756686/Twitter>,
        <https://1145.am/db/1758303/Twitter>,
        <https://1145.am/db/1760617/Twitter>,
        <https://1145.am/db/1761874/Twitter>,
        <https://1145.am/db/1763369/Twitter>,
        <https://1145.am/db/1763372/Twitter>,
        <https://1145.am/db/1778404/Twitter>,
        <https://1145.am/db/1782831/Twitter>,
        <https://1145.am/db/1785935/Twitter>,
        <https://1145.am/db/1786646/Twitter>,
        <https://1145.am/db/1790271/Twitter>,
        <https://1145.am/db/1792149/Twitter>,
        <https://1145.am/db/1794889/Twitter>,
        <https://1145.am/db/1795360/Twitter>,
        <https://1145.am/db/1796344/Twitter>,
        <https://1145.am/db/1799097/Twitter>,
        <https://1145.am/db/1799343/Twitter>,
        <https://1145.am/db/1800114/Twitter>,
        <https://1145.am/db/1801529/Twitter>,
        <https://1145.am/db/1802868/Twitter>,
        <https://1145.am/db/1807746/Twitter>,
        <https://1145.am/db/1809750/Twitter>,
        <https://1145.am/db/1810190/Twitter>,
        <https://1145.am/db/1810726/Twitter>,
        <https://1145.am/db/1812542/Twitter>,
        <https://1145.am/db/1815857/Twitter>,
        <https://1145.am/db/1817206/Twitter>,
        <https://1145.am/db/1820535/Twitter>,
        <https://1145.am/db/1821127/Twitter>,
        <https://1145.am/db/1822061/Twitter>,
        <https://1145.am/db/1828998/Twitter>,
        <https://1145.am/db/1829570/Twitter>,
        <https://1145.am/db/1829822/Twitter>,
        <https://1145.am/db/1830191/Twitter>,
        <https://1145.am/db/1830473/Twitter>,
        <https://1145.am/db/1834062/Twitter>,
        <https://1145.am/db/1835057/Twitter>,
        <https://1145.am/db/1838276/Twitter>,
        <https://1145.am/db/1838829/Twitter>,
        <https://1145.am/db/1840613/Twitter>,
        <https://1145.am/db/1841450/Twitter>,
        <https://1145.am/db/1842844/Twitter>,
        <https://1145.am/db/1843567/Twitter>,
        <https://1145.am/db/1844221/Twitter>,
        <https://1145.am/db/1845756/Twitter>,
        <https://1145.am/db/1845929/Twitter>,
        <https://1145.am/db/1846900/Twitter>,
        <https://1145.am/db/1848176/Twitter>,
        <https://1145.am/db/1849642/Twitter>,
        <https://1145.am/db/1850236/Twitter>,
        <https://1145.am/db/1850294/Twitter>,
        <https://1145.am/db/1850436/Twitter>,
        <https://1145.am/db/1852301/Twitter>,
        <https://1145.am/db/1853816/Twitter>,
        <https://1145.am/db/1854196/Twitter>,
        <https://1145.am/db/1858530/Twitter>,
        <https://1145.am/db/1858844/Twitter>,
        <https://1145.am/db/1861058/Twitter>,
        <https://1145.am/db/1866158/Twitter>,
        <https://1145.am/db/1866514/Twitter>,
        <https://1145.am/db/1867185/Twitter>,
        <https://1145.am/db/1875343/Twitter>,
        <https://1145.am/db/1877638/Twitter>,
        <https://1145.am/db/1877762/Twitter>,
        <https://1145.am/db/1877796/Twitter>,
        <https://1145.am/db/1879350/Twitter>,
        <https://1145.am/db/1882363/Twitter>,
        <https://1145.am/db/1884027/Twitter>,
        <https://1145.am/db/1887350/Twitter>,
        <https://1145.am/db/1890402/Twitter>,
        <https://1145.am/db/1890876/Twitter>,
        <https://1145.am/db/1891493/Twitter>,
        <https://1145.am/db/1892969/Twitter>,
        <https://1145.am/db/1894147/Twitter>,
        <https://1145.am/db/1895529/Twitter>,
        <https://1145.am/db/1897969/Twitter>,
        <https://1145.am/db/1900439/Twitter>,
        <https://1145.am/db/1904404/Twitter>,
        <https://1145.am/db/1920621/Twitter>,
        <https://1145.am/db/2005125/Twitter>,
        <https://1145.am/db/2026215/Twitter>,
        <https://1145.am/db/209740/Twitter_Inc>,
        <https://1145.am/db/2107795/Twitter>,
        <https://1145.am/db/2134885/Twitter>,
        <https://1145.am/db/2158736/Twitter>,
        <https://1145.am/db/2167576/Twitter>,
        <https://1145.am/db/2623026/Twitter>,
        <https://1145.am/db/2632373/Twitter>,
        <https://1145.am/db/2635206/Twitter>,
        <https://1145.am/db/2651254/Twitter>,
        <https://1145.am/db/2657717/Twitter>,
        <https://1145.am/db/2658050/Twitter>,
        <https://1145.am/db/2663195/Twitter>,
        <https://1145.am/db/2668108/Twitter>,
        <https://1145.am/db/2669683/Twitter>,
        <https://1145.am/db/2674069/Twitter>,
        <https://1145.am/db/2686399/Twitter>,
        <https://1145.am/db/2755630/Twitter>,
        <https://1145.am/db/2758471/Twitter>,
        <https://1145.am/db/2762299/Twitter>,
        <https://1145.am/db/2772439/Twitter>,
        <https://1145.am/db/302186/Twitter_Inc>,
        <https://1145.am/db/302414/Twitter_Inc>,
        <https://1145.am/db/526966/Twitter>,
        <https://1145.am/db/527608/Twitter>,
        <https://1145.am/db/527674/Twitter>,
        <https://1145.am/db/659617/Twitter>,
        <https://1145.am/db/660688/Twitter>,
        <https://1145.am/db/731264/Twitter>,
        <https://1145.am/db/731841/Twitter>,
        <https://1145.am/db/752812/Twitter_Inc>,
        <https://1145.am/db/816929/Twitter>,
        <https://1145.am/db/852989/Twitter_Inc>,
        <https://1145.am/db/895957/Twitter>,
        <https://1145.am/db/981957/Twitter>,
        <https://1145.am/db/982329/Twitter>,
        <https://1145.am/db/983430/Twitter>,
        <https://1145.am/db/985715/Twitter>,
        <https://1145.am/db/998011/Twitter> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2659492/Joint_Venture_Acquisition_Corp_Softbank_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-12-23T02:40:30+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Japan's Softbank reportedly plans liquidate its 50/50 joint venture with News Corp which operates the Japanese-language version of MySpace, transferring management of the site to MySpace LLC." ;
    ns1:documentTitle "Webwire: KPN to sell French unit to Bouygues; TeliaSonera buys out Kcell" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-kpn-to-sell-french-unit-to-bouygues-teliasonera-buys-out-kcell> ;
    ns1:foundName "liquidate" ;
    ns1:name "liquidate" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:targetDetails "joint venture" ;
    ns1:vendor <https://1145.am/db/2659492/Softbank> ;
    ns1:whereGeoName "Japan" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1861060/about.rdf> ;
    ns1:whereRaw "Japan" .

<https://1145.am/db/2659492/Kcell> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Kazakhstan" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1522867/about.rdf> ;
    ns1:basedInHighRaw "Kazakhstan" ;
    ns1:documentDate "2011-12-23T02:40:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: KPN to sell French unit to Bouygues; TeliaSonera buys out Kcell" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-kpn-to-sell-french-unit-to-bouygues-teliasonera-buys-out-kcell> ;
    ns1:foundName "Kazakhstan's Kcell",
        "Kcell" ;
    ns1:name "Kcell" ;
    ns1:sameAsMedium <https://1145.am/db/2671975/Kcell> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2659492/Kcell_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "ipo" ;
    ns1:documentDate "2011-12-23T02:40:30+00:00"^^xsd:dateTime ;
    ns1:documentExtract "TeliaSonera has arranged to buy the 49 % of Kazakhstan's Kcell that it does not own for $ 1.5 billion, ahead of plans to float 25 % of the company in an IPO next year." ;
    ns1:documentTitle "Webwire: KPN to sell French unit to Bouygues; TeliaSonera buys out Kcell" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-kpn-to-sell-french-unit-to-bouygues-teliasonera-buys-out-kcell> ;
    ns1:foundName "buy",
        "float" ;
    ns1:name "buy",
        "float" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2659492/Kcell> ;
    ns1:targetName "Kcell" ;
    ns1:valueRaw "$ 1.5 billion" ;
    ns1:whereGeoName "Republic of Kazakhstan" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1522867/about.rdf> ;
    ns1:whereRaw "Kazakhstan" .

<https://1145.am/db/2659492/Kpn_France_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-12-23T02:40:30+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Dutch telco KPN will sell its KPN France unit, which operates MVNO Simyo on Bouygues Telecom's network, to Bouygues." ;
    ns1:documentTitle "Webwire: KPN to sell French unit to Bouygues; TeliaSonera buys out Kcell" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-kpn-to-sell-french-unit-to-bouygues-teliasonera-buys-out-kcell> ;
    ns1:foundName "sell" ;
    ns1:name "sell" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2659492/Kpn_France> ;
    ns1:targetName "KPN France" ;
    ns1:valueRaw "$ 26.2 million",
        "under €20 million" ;
    ns1:vendor <https://1145.am/db/2659492/Kpn_France> ;
    ns1:whereGeoName "Republic of France" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:whereRaw "France" .

<https://1145.am/db/2663406/T-Mobile_Usa_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-09-02T14:17:49+00:00"^^xsd:dateTime ;
    ns1:documentExtract "AT & T (NYSE: T) may have to divest up to 25 percent of T-Mobile USA's spectrum and customers to make AT & T's proposed $ 39 billion acquisition of T-Mobile palatable to the Department of Justice, which sued this week to block the deal, according to a Reuters report." ;
    ns1:documentTitle "Report: AT&T could divest up to 25% of T-Mobile to win approval for deal" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-at-t-could-divest-up-to-25-t-mobile-to-win-approval-for-deal> ;
    ns1:foundName "acquisition",
        "divest" ;
    ns1:name "acquisition",
        "divest" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened",
        "stopped" ;
    ns1:target <https://1145.am/db/2663406/T-Mobile_Usa> ;
    ns1:targetName "T-Mobile",
        "T-Mobile USA" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "USA" .

<https://1145.am/db/2664505/At___Ts> a org:Organization ;
    ns1:basedInLowRaw "USA" ;
    ns1:buyer <https://1145.am/db/2664505/T-Mobile_Usa_Acquisition> ;
    ns1:description "business" ;
    ns1:documentDate "2011-09-20T10:30:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "What are the most controversial (and brilliant) wireless business ideas of the past decade?" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/what-are-most-controversial-and-brilliant-wireless-business-ideas-past-decade> ;
    ns1:foundName "AT & T'",
        "AT & T's" ;
    ns1:industry "wireless" ;
    ns1:name "AT & T",
        "AT & T's" ;
    ns1:sameAsHigh <https://1145.am/db/1000082/At___T_Inc>,
        <https://1145.am/db/1756446/At___T>,
        <https://1145.am/db/1796420/At___T>,
        <https://1145.am/db/1822834/At___T>,
        <https://1145.am/db/1854000/At___T_*>,
        <https://1145.am/db/1862489/At___T>,
        <https://1145.am/db/1866809/At_T>,
        <https://1145.am/db/1899784/At___T_Inc>,
        <https://1145.am/db/211185/At___T_Inc>,
        <https://1145.am/db/2156880/At___T>,
        <https://1145.am/db/2157931/At_T>,
        <https://1145.am/db/2159365/At_T>,
        <https://1145.am/db/2161513/At___T>,
        <https://1145.am/db/2162741/At___T>,
        <https://1145.am/db/2163075/At_T>,
        <https://1145.am/db/2164453/At___T>,
        <https://1145.am/db/2165870/At___T>,
        <https://1145.am/db/2166622/At___T>,
        <https://1145.am/db/2167508/At___T>,
        <https://1145.am/db/2169997/At___T>,
        <https://1145.am/db/2171126/At___T>,
        <https://1145.am/db/2172351/At_T>,
        <https://1145.am/db/2172670/At_T>,
        <https://1145.am/db/2172901/At_T>,
        <https://1145.am/db/2172911/At_T>,
        <https://1145.am/db/2173415/At_T>,
        <https://1145.am/db/2173620/At_T>,
        <https://1145.am/db/2173675/At_T>,
        <https://1145.am/db/2175520/At_T>,
        <https://1145.am/db/2175716/At_T>,
        <https://1145.am/db/2176832/At_T>,
        <https://1145.am/db/2177450/At_T>,
        <https://1145.am/db/2177458/At_T>,
        <https://1145.am/db/2186280/At___T>,
        <https://1145.am/db/2452684/At___T_Inc>,
        <https://1145.am/db/249455/At___T_Inc>,
        <https://1145.am/db/2598875/At___T>,
        <https://1145.am/db/2598969/At___T>,
        <https://1145.am/db/2599373/At___T>,
        <https://1145.am/db/2599572/At_T>,
        <https://1145.am/db/2599648/At___T>,
        <https://1145.am/db/2600004/At___T>,
        <https://1145.am/db/2601425/At_T>,
        <https://1145.am/db/2602156/At___T>,
        <https://1145.am/db/2602281/At___T>,
        <https://1145.am/db/2603377/At___T>,
        <https://1145.am/db/2603439/At___T>,
        <https://1145.am/db/2603967/At___T_Communications>,
        <https://1145.am/db/2604247/At_T>,
        <https://1145.am/db/2604314/At___T>,
        <https://1145.am/db/2604539/At_T>,
        <https://1145.am/db/2604863/At___T>,
        <https://1145.am/db/2604967/At_T>,
        <https://1145.am/db/2604977/At___T>,
        <https://1145.am/db/2605006/At___T>,
        <https://1145.am/db/2605344/At_T>,
        <https://1145.am/db/2605760/At___T>,
        <https://1145.am/db/2606761/At___T>,
        <https://1145.am/db/2607386/At___T>,
        <https://1145.am/db/2608701/At___T>,
        <https://1145.am/db/2609030/At_T>,
        <https://1145.am/db/2610751/At___T>,
        <https://1145.am/db/2611854/At___T>,
        <https://1145.am/db/2613122/At_T>,
        <https://1145.am/db/2614719/At___T>,
        <https://1145.am/db/2614737/At___T>,
        <https://1145.am/db/2615500/At_T>,
        <https://1145.am/db/2617377/At___T>,
        <https://1145.am/db/2619593/At___T>,
        <https://1145.am/db/2619745/At___T>,
        <https://1145.am/db/2620484/At___T>,
        <https://1145.am/db/2624400/At_T>,
        <https://1145.am/db/2625764/At_T>,
        <https://1145.am/db/2627103/At_T>,
        <https://1145.am/db/2628029/At___T>,
        <https://1145.am/db/2628926/At_T>,
        <https://1145.am/db/2628936/At_T>,
        <https://1145.am/db/2628948/At_T>,
        <https://1145.am/db/2629447/At___T>,
        <https://1145.am/db/2629910/At_T>,
        <https://1145.am/db/2631175/At___T>,
        <https://1145.am/db/2632131/At___T>,
        <https://1145.am/db/2632273/At_T>,
        <https://1145.am/db/2633827/At___T>,
        <https://1145.am/db/2634130/At___T>,
        <https://1145.am/db/2635751/At___T>,
        <https://1145.am/db/2636649/At___T>,
        <https://1145.am/db/2636927/At___T>,
        <https://1145.am/db/2639568/At___T_Mobility>,
        <https://1145.am/db/2640140/At_T>,
        <https://1145.am/db/2641156/At_T>,
        <https://1145.am/db/2641303/At_T>,
        <https://1145.am/db/2641554/At_T>,
        <https://1145.am/db/2642638/At_T>,
        <https://1145.am/db/2643619/At_T>,
        <https://1145.am/db/2649776/At___T>,
        <https://1145.am/db/2650269/At_T>,
        <https://1145.am/db/2651977/At_T>,
        <https://1145.am/db/2652823/At_T>,
        <https://1145.am/db/2653492/At_T>,
        <https://1145.am/db/2657126/At___T>,
        <https://1145.am/db/2657127/At___T>,
        <https://1145.am/db/2658220/At_T>,
        <https://1145.am/db/2658524/At___T>,
        <https://1145.am/db/2659075/At___T>,
        <https://1145.am/db/2659265/At_T>,
        <https://1145.am/db/2660189/At_T>,
        <https://1145.am/db/2660328/At_T>,
        <https://1145.am/db/2660524/At___T>,
        <https://1145.am/db/2662193/At___T>,
        <https://1145.am/db/2663214/At___T>,
        <https://1145.am/db/2664500/At_T>,
        <https://1145.am/db/2664547/At_T>,
        <https://1145.am/db/2667130/At___T>,
        <https://1145.am/db/2667132/At___T>,
        <https://1145.am/db/2667338/At___T>,
        <https://1145.am/db/2668735/At___T>,
        <https://1145.am/db/2668814/At_T>,
        <https://1145.am/db/2669621/At___T>,
        <https://1145.am/db/2674316/At_T>,
        <https://1145.am/db/2676075/At_T>,
        <https://1145.am/db/2677102/At___T>,
        <https://1145.am/db/2677549/At_T>,
        <https://1145.am/db/2677987/At___T>,
        <https://1145.am/db/2678311/At_T>,
        <https://1145.am/db/2678753/At_T>,
        <https://1145.am/db/2679157/At___T>,
        <https://1145.am/db/2679240/At_T>,
        <https://1145.am/db/2680906/At___T>,
        <https://1145.am/db/2681046/At___T>,
        <https://1145.am/db/2681072/At___T>,
        <https://1145.am/db/2681074/At___T>,
        <https://1145.am/db/2681695/At___T_Mobility>,
        <https://1145.am/db/2681734/At_T>,
        <https://1145.am/db/2681829/At___T>,
        <https://1145.am/db/2682450/At___T>,
        <https://1145.am/db/2682574/At___T>,
        <https://1145.am/db/2683098/At___T>,
        <https://1145.am/db/2684028/At___T>,
        <https://1145.am/db/2684148/At_T>,
        <https://1145.am/db/2685112/At___T>,
        <https://1145.am/db/2685285/At___T>,
        <https://1145.am/db/2685526/At___T>,
        <https://1145.am/db/2685884/At___T_Mobility>,
        <https://1145.am/db/2685930/At_T>,
        <https://1145.am/db/2685941/At_T>,
        <https://1145.am/db/334907/At_T>,
        <https://1145.am/db/335104/At___T_Inc>,
        <https://1145.am/db/710798/At___T_Inc>,
        <https://1145.am/db/713292/At___T_Inc>,
        <https://1145.am/db/796295/At___T> ;
    ns1:sameAsMedium <https://1145.am/db/2647888/At___Ts> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2664505/Google> a org:Organization ;
    ns1:basedInLowRaw "USA" ;
    ns1:buyer <https://1145.am/db/2664505/Motorola_Mobility_Acquisition>,
        <https://1145.am/db/2664505/T-Mobile_Usa_Acquisition> ;
    ns1:description "search engine" ;
    ns1:documentDate "2011-09-20T10:30:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "What are the most controversial (and brilliant) wireless business ideas of the past decade?" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/what-are-most-controversial-and-brilliant-wireless-business-ideas-past-decade> ;
    ns1:foundName "Google'" ;
    ns1:name "Google" ;
    ns1:sameAsHigh <https://1145.am/db/1697208/Google>,
        <https://1145.am/db/1707415/Google_Inc>,
        <https://1145.am/db/1720864/Google>,
        <https://1145.am/db/1737526/Google>,
        <https://1145.am/db/1745775/Google>,
        <https://1145.am/db/1746459/Google>,
        <https://1145.am/db/1760788/Google>,
        <https://1145.am/db/1769482/Google>,
        <https://1145.am/db/1775616/Google>,
        <https://1145.am/db/1793825/Google>,
        <https://1145.am/db/1824018/Google>,
        <https://1145.am/db/1824305/Google>,
        <https://1145.am/db/1841458/Google_Inc>,
        <https://1145.am/db/1863462/Google>,
        <https://1145.am/db/1868489/Google>,
        <https://1145.am/db/1873704/Google>,
        <https://1145.am/db/1886541/Google>,
        <https://1145.am/db/1887780/Google>,
        <https://1145.am/db/1894569/Google>,
        <https://1145.am/db/2164099/Google>,
        <https://1145.am/db/2168618/Google>,
        <https://1145.am/db/2170088/Google>,
        <https://1145.am/db/2170124/Google>,
        <https://1145.am/db/2174085/Google>,
        <https://1145.am/db/2174887/Google>,
        <https://1145.am/db/2177262/Google>,
        <https://1145.am/db/2189110/Google>,
        <https://1145.am/db/222159/Google>,
        <https://1145.am/db/2524835/Google>,
        <https://1145.am/db/2524836/Google>,
        <https://1145.am/db/2527805/Google>,
        <https://1145.am/db/2527814/Google>,
        <https://1145.am/db/2611906/Google>,
        <https://1145.am/db/2612470/Google>,
        <https://1145.am/db/2614160/Google>,
        <https://1145.am/db/2623391/Google>,
        <https://1145.am/db/2623692/Google>,
        <https://1145.am/db/2654442/Google>,
        <https://1145.am/db/2664460/Google>,
        <https://1145.am/db/2665583/Google>,
        <https://1145.am/db/2666652/Google>,
        <https://1145.am/db/2667803/Google>,
        <https://1145.am/db/2669172/Google>,
        <https://1145.am/db/2669647/Google>,
        <https://1145.am/db/2670741/Google>,
        <https://1145.am/db/2670872/Google>,
        <https://1145.am/db/2674324/Google>,
        <https://1145.am/db/2677662/Google>,
        <https://1145.am/db/2681250/Google>,
        <https://1145.am/db/2686449/Google>,
        <https://1145.am/db/306767/Google>,
        <https://1145.am/db/489758/Google> ;
    ns1:sameAsMedium <https://1145.am/db/1106670/Google>,
        <https://1145.am/db/112896/Google>,
        <https://1145.am/db/1218545/Google>,
        <https://1145.am/db/1323515/Google>,
        <https://1145.am/db/1336111/Google_Llc>,
        <https://1145.am/db/1462007/Google>,
        <https://1145.am/db/1677491/Google>,
        <https://1145.am/db/1695636/Google>,
        <https://1145.am/db/1697158/Google>,
        <https://1145.am/db/1697634/Google>,
        <https://1145.am/db/1697695/Google>,
        <https://1145.am/db/1700956/Google>,
        <https://1145.am/db/1702905/Google>,
        <https://1145.am/db/1703059/Google>,
        <https://1145.am/db/1703789/Google>,
        <https://1145.am/db/1704398/Google>,
        <https://1145.am/db/1704767/Google>,
        <https://1145.am/db/1705792/Google>,
        <https://1145.am/db/1706457/Google>,
        <https://1145.am/db/1708232/Google>,
        <https://1145.am/db/1710376/Google>,
        <https://1145.am/db/1717957/Google>,
        <https://1145.am/db/1718244/Google>,
        <https://1145.am/db/1719418/Google>,
        <https://1145.am/db/1720718/Google>,
        <https://1145.am/db/1721364/Google>,
        <https://1145.am/db/1724856/Google>,
        <https://1145.am/db/1728038/Google>,
        <https://1145.am/db/1729557/Google>,
        <https://1145.am/db/1730099/Google>,
        <https://1145.am/db/1731064/Google>,
        <https://1145.am/db/1734054/Google>,
        <https://1145.am/db/1736673/Google>,
        <https://1145.am/db/1737025/Google>,
        <https://1145.am/db/1737156/Google>,
        <https://1145.am/db/1738139/Google>,
        <https://1145.am/db/1738867/Google>,
        <https://1145.am/db/1739221/Google>,
        <https://1145.am/db/1739522/Google>,
        <https://1145.am/db/1742225/Google>,
        <https://1145.am/db/1743102/Google>,
        <https://1145.am/db/1744789/Google>,
        <https://1145.am/db/1746725/Google>,
        <https://1145.am/db/1748902/Google>,
        <https://1145.am/db/1748912/Google>,
        <https://1145.am/db/1748945/Google>,
        <https://1145.am/db/1749554/Google>,
        <https://1145.am/db/1751204/Google>,
        <https://1145.am/db/1751390/Google>,
        <https://1145.am/db/1752062/Google>,
        <https://1145.am/db/1755918/Google>,
        <https://1145.am/db/1757953/Google>,
        <https://1145.am/db/1758152/Google>,
        <https://1145.am/db/1758222/Google>,
        <https://1145.am/db/1758466/Google>,
        <https://1145.am/db/1758482/Google>,
        <https://1145.am/db/1758684/Google>,
        <https://1145.am/db/1758703/Google>,
        <https://1145.am/db/1762615/Google>,
        <https://1145.am/db/1767376/Google>,
        <https://1145.am/db/1767407/Google>,
        <https://1145.am/db/1767820/Google>,
        <https://1145.am/db/1769091/Google>,
        <https://1145.am/db/1769940/Google>,
        <https://1145.am/db/1770726/Google>,
        <https://1145.am/db/1770813/Google>,
        <https://1145.am/db/1772295/Google>,
        <https://1145.am/db/1772305/Google>,
        <https://1145.am/db/1772373/Google>,
        <https://1145.am/db/1772719/Google>,
        <https://1145.am/db/1773437/Google>,
        <https://1145.am/db/1774154/Google>,
        <https://1145.am/db/1776165/Google>,
        <https://1145.am/db/1776355/Google>,
        <https://1145.am/db/1778164/Google>,
        <https://1145.am/db/1778465/Google>,
        <https://1145.am/db/1779223/Google>,
        <https://1145.am/db/1779285/Google>,
        <https://1145.am/db/1779669/Google>,
        <https://1145.am/db/1780554/Google>,
        <https://1145.am/db/1780932/Google>,
        <https://1145.am/db/1783458/Google>,
        <https://1145.am/db/1786028/Google>,
        <https://1145.am/db/1791967/Google>,
        <https://1145.am/db/1792698/Google>,
        <https://1145.am/db/1792910/Google>,
        <https://1145.am/db/1795057/Google>,
        <https://1145.am/db/1795099/Google>,
        <https://1145.am/db/1795360/Google>,
        <https://1145.am/db/1798124/Google>,
        <https://1145.am/db/1798130/Google>,
        <https://1145.am/db/1798739/Google>,
        <https://1145.am/db/1799129/Google>,
        <https://1145.am/db/1800114/Google>,
        <https://1145.am/db/1801884/Google>,
        <https://1145.am/db/1802109/Google>,
        <https://1145.am/db/1802418/Google>,
        <https://1145.am/db/1805871/Google>,
        <https://1145.am/db/1808224/Google>,
        <https://1145.am/db/1808959/Google>,
        <https://1145.am/db/1809694/Google>,
        <https://1145.am/db/1811332/Google>,
        <https://1145.am/db/1813540/Google>,
        <https://1145.am/db/1815058/Google>,
        <https://1145.am/db/1815094/Google>,
        <https://1145.am/db/1815217/Google>,
        <https://1145.am/db/181730/Google>,
        <https://1145.am/db/1817588/Google>,
        <https://1145.am/db/1817652/Google>,
        <https://1145.am/db/1818255/Google>,
        <https://1145.am/db/1819728/Google>,
        <https://1145.am/db/1820065/Google>,
        <https://1145.am/db/1821549/Google>,
        <https://1145.am/db/1822360/Google>,
        <https://1145.am/db/1823609/Google>,
        <https://1145.am/db/1826478/Google>,
        <https://1145.am/db/1826800/Google>,
        <https://1145.am/db/1827824/Google>,
        <https://1145.am/db/1828337/Google>,
        <https://1145.am/db/1829772/Google>,
        <https://1145.am/db/1830114/Google>,
        <https://1145.am/db/1830201/Google>,
        <https://1145.am/db/1831926/Google>,
        <https://1145.am/db/1833042/Google>,
        <https://1145.am/db/1833091/Google>,
        <https://1145.am/db/1834517/Google>,
        <https://1145.am/db/1834744/Google>,
        <https://1145.am/db/1837426/Google>,
        <https://1145.am/db/1837821/Google>,
        <https://1145.am/db/1838256/Google>,
        <https://1145.am/db/1838888/Google>,
        <https://1145.am/db/1839678/Google>,
        <https://1145.am/db/1839704/Google>,
        <https://1145.am/db/1840331/Google>,
        <https://1145.am/db/1840731/Google>,
        <https://1145.am/db/1843250/Google>,
        <https://1145.am/db/1844820/Google>,
        <https://1145.am/db/1846050/Google>,
        <https://1145.am/db/1846267/Google>,
        <https://1145.am/db/1847479/Google>,
        <https://1145.am/db/1847630/Google>,
        <https://1145.am/db/1847774/Google>,
        <https://1145.am/db/1849179/Google>,
        <https://1145.am/db/1849311/Google>,
        <https://1145.am/db/1850562/Google>,
        <https://1145.am/db/1851706/Google>,
        <https://1145.am/db/1852147/Google_Inc>,
        <https://1145.am/db/1853116/Google>,
        <https://1145.am/db/1853307/Google>,
        <https://1145.am/db/1853649/Google>,
        <https://1145.am/db/1857130/Google>,
        <https://1145.am/db/1857572/Google>,
        <https://1145.am/db/1858212/Google>,
        <https://1145.am/db/1858297/Google>,
        <https://1145.am/db/1858590/Google>,
        <https://1145.am/db/1858692/Google>,
        <https://1145.am/db/1858956/Google>,
        <https://1145.am/db/1859504/Google>,
        <https://1145.am/db/1859740/Google>,
        <https://1145.am/db/1859841/Google>,
        <https://1145.am/db/1862377/Google>,
        <https://1145.am/db/1865114/Google>,
        <https://1145.am/db/1865788/Google>,
        <https://1145.am/db/1867553/Google>,
        <https://1145.am/db/1869561/Google>,
        <https://1145.am/db/1869712/Google>,
        <https://1145.am/db/1871344/Google+>,
        <https://1145.am/db/1871611/Google>,
        <https://1145.am/db/1871915/Google>,
        <https://1145.am/db/1877246/Google>,
        <https://1145.am/db/1877348/Google>,
        <https://1145.am/db/1877354/Google>,
        <https://1145.am/db/1877356/Google>,
        <https://1145.am/db/1877357/Google>,
        <https://1145.am/db/1879028/Google>,
        <https://1145.am/db/1881522/Google>,
        <https://1145.am/db/1881903/Google>,
        <https://1145.am/db/1882463/Google>,
        <https://1145.am/db/1884438/Google>,
        <https://1145.am/db/1884486/Google>,
        <https://1145.am/db/1885182/Google>,
        <https://1145.am/db/1885243/Google>,
        <https://1145.am/db/1886030/Google>,
        <https://1145.am/db/1887769/Google>,
        <https://1145.am/db/1887823/Google>,
        <https://1145.am/db/1887836/Google>,
        <https://1145.am/db/1888219/Google>,
        <https://1145.am/db/1888284/Google>,
        <https://1145.am/db/1889055/Google>,
        <https://1145.am/db/1889259/Google>,
        <https://1145.am/db/1889867/Google>,
        <https://1145.am/db/1890160/Google>,
        <https://1145.am/db/1890192/Google>,
        <https://1145.am/db/1890424/Google>,
        <https://1145.am/db/1891853/Google>,
        <https://1145.am/db/1892482/Google>,
        <https://1145.am/db/1896336/Google>,
        <https://1145.am/db/1896565/Google>,
        <https://1145.am/db/1898576/Google>,
        <https://1145.am/db/1899822/Google>,
        <https://1145.am/db/1900317/Google_Inc>,
        <https://1145.am/db/1902108/Google>,
        <https://1145.am/db/1902687/Google>,
        <https://1145.am/db/1906416/Google>,
        <https://1145.am/db/1907859/Google>,
        <https://1145.am/db/1908799/Google>,
        <https://1145.am/db/1908800/Google>,
        <https://1145.am/db/1909430/Google>,
        <https://1145.am/db/1910432/Google>,
        <https://1145.am/db/1911348/Google>,
        <https://1145.am/db/1915046/Google>,
        <https://1145.am/db/1915624/Google>,
        <https://1145.am/db/1916204/Google>,
        <https://1145.am/db/1917060/Google>,
        <https://1145.am/db/1917642/Google>,
        <https://1145.am/db/1918520/Google>,
        <https://1145.am/db/1923676/Google>,
        <https://1145.am/db/1925079/Google>,
        <https://1145.am/db/1925850/Google>,
        <https://1145.am/db/1951121/Google>,
        <https://1145.am/db/1953004/Google>,
        <https://1145.am/db/197394/Google>,
        <https://1145.am/db/199411/Google>,
        <https://1145.am/db/2017044/Google>,
        <https://1145.am/db/2052555/Google>,
        <https://1145.am/db/2052989/Google>,
        <https://1145.am/db/2101918/Google>,
        <https://1145.am/db/2157766/Google>,
        <https://1145.am/db/2159950/Google>,
        <https://1145.am/db/2160798/Google>,
        <https://1145.am/db/2162077/Google>,
        <https://1145.am/db/2162792/Google>,
        <https://1145.am/db/2164941/Google>,
        <https://1145.am/db/2168612/Google>,
        <https://1145.am/db/2168633/Google>,
        <https://1145.am/db/2169255/Google>,
        <https://1145.am/db/2169256/Google>,
        <https://1145.am/db/2170078/Google>,
        <https://1145.am/db/2170852/Google>,
        <https://1145.am/db/2172445/Google>,
        <https://1145.am/db/2172598/Google>,
        <https://1145.am/db/2173392/Google>,
        <https://1145.am/db/2175293/Google>,
        <https://1145.am/db/2175679/Google>,
        <https://1145.am/db/2175876/Google>,
        <https://1145.am/db/2175906/Google>,
        <https://1145.am/db/2176439/Google>,
        <https://1145.am/db/2177610/Google>,
        <https://1145.am/db/2178519/Google>,
        <https://1145.am/db/2179004/Google>,
        <https://1145.am/db/2182718/Google>,
        <https://1145.am/db/2185365/Google>,
        <https://1145.am/db/2187497/Google>,
        <https://1145.am/db/2189690/Google>,
        <https://1145.am/db/2190148/Google>,
        <https://1145.am/db/2191086/Google>,
        <https://1145.am/db/2193606/Google>,
        <https://1145.am/db/2200229/Google>,
        <https://1145.am/db/2272691/Google>,
        <https://1145.am/db/2291187/Google>,
        <https://1145.am/db/2370295/Google>,
        <https://1145.am/db/2422695/Google>,
        <https://1145.am/db/2526804/Google>,
        <https://1145.am/db/2526840/Google>,
        <https://1145.am/db/2529473/Google>,
        <https://1145.am/db/2573984/Google>,
        <https://1145.am/db/2604772/Google>,
        <https://1145.am/db/2604783/Google>,
        <https://1145.am/db/2608334/Google>,
        <https://1145.am/db/2609095/Google>,
        <https://1145.am/db/2624673/Google>,
        <https://1145.am/db/2625283/Google>,
        <https://1145.am/db/2625598/Google>,
        <https://1145.am/db/2626062/Google>,
        <https://1145.am/db/2627016/Google>,
        <https://1145.am/db/2627999/Google>,
        <https://1145.am/db/2632002/Google>,
        <https://1145.am/db/2632674/Google>,
        <https://1145.am/db/2633301/Google>,
        <https://1145.am/db/2639636/Google>,
        <https://1145.am/db/2641504/Google>,
        <https://1145.am/db/2642235/Google>,
        <https://1145.am/db/2643391/Google>,
        <https://1145.am/db/2643797/Google>,
        <https://1145.am/db/2643947/Google>,
        <https://1145.am/db/2646085/Google>,
        <https://1145.am/db/2650594/Google>,
        <https://1145.am/db/2650814/Google>,
        <https://1145.am/db/2652107/Google>,
        <https://1145.am/db/2652313/Google>,
        <https://1145.am/db/2652344/Google>,
        <https://1145.am/db/2653149/Google>,
        <https://1145.am/db/2653764/Google>,
        <https://1145.am/db/2654863/Google>,
        <https://1145.am/db/2655692/Google>,
        <https://1145.am/db/2655699/Google>,
        <https://1145.am/db/2657713/Google>,
        <https://1145.am/db/2658031/Google>,
        <https://1145.am/db/2658037/Google>,
        <https://1145.am/db/2658152/Google>,
        <https://1145.am/db/2658673/Google_Inc>,
        <https://1145.am/db/2658696/Google>,
        <https://1145.am/db/2659042/Google>,
        <https://1145.am/db/2659387/Google>,
        <https://1145.am/db/2661233/Google>,
        <https://1145.am/db/2661238/Google>,
        <https://1145.am/db/2661287/Google>,
        <https://1145.am/db/2661289/Google>,
        <https://1145.am/db/2661290/Google>,
        <https://1145.am/db/2661298/Google>,
        <https://1145.am/db/2661302/Google>,
        <https://1145.am/db/2661307/Google>,
        <https://1145.am/db/2661315/Google>,
        <https://1145.am/db/2662204/Google>,
        <https://1145.am/db/2663334/Google>,
        <https://1145.am/db/2663792/Google>,
        <https://1145.am/db/2664557/Google>,
        <https://1145.am/db/2664675/Google>,
        <https://1145.am/db/2664847/Google>,
        <https://1145.am/db/2664986/Google>,
        <https://1145.am/db/2665530/Google>,
        <https://1145.am/db/2665685/Google>,
        <https://1145.am/db/2666538/Google>,
        <https://1145.am/db/2667309/Google>,
        <https://1145.am/db/2667642/Google>,
        <https://1145.am/db/2667768/Google>,
        <https://1145.am/db/2667823/Google>,
        <https://1145.am/db/2670335/Google>,
        <https://1145.am/db/2670351/Google>,
        <https://1145.am/db/2671693/Google>,
        <https://1145.am/db/2672934/Google>,
        <https://1145.am/db/2673032/Google>,
        <https://1145.am/db/2675505/Google>,
        <https://1145.am/db/2675758/Google>,
        <https://1145.am/db/2676995/Google>,
        <https://1145.am/db/2677426/Google>,
        <https://1145.am/db/2677514/Google>,
        <https://1145.am/db/2677517/Google>,
        <https://1145.am/db/2678139/Google>,
        <https://1145.am/db/2678181/Google>,
        <https://1145.am/db/2679166/Google>,
        <https://1145.am/db/2679193/Google>,
        <https://1145.am/db/2682016/Google>,
        <https://1145.am/db/2683123/Google>,
        <https://1145.am/db/2683129/Google>,
        <https://1145.am/db/2683133/Google>,
        <https://1145.am/db/2684336/Google>,
        <https://1145.am/db/2684516/Google>,
        <https://1145.am/db/2684668/Google>,
        <https://1145.am/db/2685515/Google>,
        <https://1145.am/db/2686013/Google>,
        <https://1145.am/db/2686075/Google>,
        <https://1145.am/db/2686285/Google>,
        <https://1145.am/db/2686301/Google>,
        <https://1145.am/db/2686399/Google>,
        <https://1145.am/db/2723493/Google>,
        <https://1145.am/db/2745983/Google>,
        <https://1145.am/db/2784669/Google>,
        <https://1145.am/db/301432/Google>,
        <https://1145.am/db/303111/Google>,
        <https://1145.am/db/494237/Google>,
        <https://1145.am/db/531962/Google>,
        <https://1145.am/db/587644/Google>,
        <https://1145.am/db/594884/Google_Llc>,
        <https://1145.am/db/608499/Google>,
        <https://1145.am/db/781794/Google>,
        <https://1145.am/db/884422/Google>,
        <https://1145.am/db/884534/Google_Llc>,
        <https://1145.am/db/886026/Google>,
        <https://1145.am/db/886172/Google>,
        <https://1145.am/db/890581/Google>,
        <https://1145.am/db/908751/Google_Llc>,
        <https://1145.am/db/909802/Google_Llc>,
        <https://1145.am/db/94376/Google> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2664505/Motorola_Mobility> a org:Organization ;
    ns1:basedInLowRaw "USA" ;
    ns1:description "the company that makes the products" ;
    ns1:documentDate "2011-09-20T10:30:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "What are the most controversial (and brilliant) wireless business ideas of the past decade?" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/what-are-most-controversial-and-brilliant-wireless-business-ideas-past-decade> ;
    ns1:foundName "Motorola Mobility" ;
    ns1:industry "wireless" ;
    ns1:name "Motorola Mobility" ;
    ns1:sameAsHigh <https://1145.am/db/1838866/Motorola_Solutions>,
        <https://1145.am/db/2158342/Motorola>,
        <https://1145.am/db/2168618/Motorola_Home>,
        <https://1145.am/db/2170043/Motorola>,
        <https://1145.am/db/2179004/Motorola_Home>,
        <https://1145.am/db/2608316/Motorola_Mobility>,
        <https://1145.am/db/2608496/Motorola>,
        <https://1145.am/db/2623537/Motorola>,
        <https://1145.am/db/2625888/Motorola>,
        <https://1145.am/db/2625961/Motorola>,
        <https://1145.am/db/2627016/Motorola_Mobility>,
        <https://1145.am/db/2629313/Motorola>,
        <https://1145.am/db/2633964/Motorola>,
        <https://1145.am/db/2648177/Motorola>,
        <https://1145.am/db/2648199/Motorola>,
        <https://1145.am/db/2659202/Motorola>,
        <https://1145.am/db/2659553/Motorola_Solutions>,
        <https://1145.am/db/2660264/Motorola>,
        <https://1145.am/db/2662347/Motorola_Solutions>,
        <https://1145.am/db/2662630/Motorola>,
        <https://1145.am/db/2665980/Motorola_Solutions>,
        <https://1145.am/db/2669172/Motorola>,
        <https://1145.am/db/2672497/Motorola>,
        <https://1145.am/db/2677517/Motorola_Mobility>,
        <https://1145.am/db/2684551/Motorola_Solutions> ;
    ns1:sameAsMedium <https://1145.am/db/1724826/Motorola_Mobility>,
        <https://1145.am/db/1834517/Motorola_Mobility>,
        <https://1145.am/db/1849962/Motorola_Mobility>,
        <https://1145.am/db/1861046/Motorola_Mobility>,
        <https://1145.am/db/1863515/Motorola_Mobility>,
        <https://1145.am/db/1872501/Motorola_Mobility>,
        <https://1145.am/db/1874674/Motorola_Mobility>,
        <https://1145.am/db/1877348/Motorola_Mobility>,
        <https://1145.am/db/1877354/Motorola_Mobility>,
        <https://1145.am/db/1877356/Motorola_Mobility>,
        <https://1145.am/db/1877357/Motorola_Mobility>,
        <https://1145.am/db/1887823/Motorola_Mobility>,
        <https://1145.am/db/1889055/Motorola_Mobility>,
        <https://1145.am/db/1890192/Motorola_Mobility>,
        <https://1145.am/db/1894742/Motorola_Mobility>,
        <https://1145.am/db/1896336/Motorola_Mobility>,
        <https://1145.am/db/2159950/Motorola_Mobility>,
        <https://1145.am/db/2162792/Motorola_Mobility>,
        <https://1145.am/db/2164941/Motorola_Mobility>,
        <https://1145.am/db/2173293/Motorola_Mobility>,
        <https://1145.am/db/2176148/Motorola_Mobility>,
        <https://1145.am/db/2176945/Motorola_Mobility>,
        <https://1145.am/db/2179102/Motorola_Mobility>,
        <https://1145.am/db/2650814/Motorola_Mobility>,
        <https://1145.am/db/2659145/Motorola_Mobility>,
        <https://1145.am/db/2660627/Motorola_Mobility>,
        <https://1145.am/db/2661287/Motorola_Mobility>,
        <https://1145.am/db/2661289/Motorola_Mobility>,
        <https://1145.am/db/2661298/Motorola_Mobility>,
        <https://1145.am/db/2661302/Motorola_Mobility>,
        <https://1145.am/db/2661315/Motorola_Mobility>,
        <https://1145.am/db/2661317/Motorola_Mobility>,
        <https://1145.am/db/2663792/Motorola_Mobility>,
        <https://1145.am/db/2665583/Motorola_Mobility>,
        <https://1145.am/db/2669647/Motorola_Mobile>,
        <https://1145.am/db/2671549/Motorola_Mobility>,
        <https://1145.am/db/2673710/Motorola_Mobility>,
        <https://1145.am/db/2675758/Motorola_Mobility>,
        <https://1145.am/db/2677426/Motorola_Mobility>,
        <https://1145.am/db/2678139/Motorola_Mobility>,
        <https://1145.am/db/2678181/Motorola_Mobility>,
        <https://1145.am/db/2683123/Motorola_Mobility>,
        <https://1145.am/db/2683129/Motorola_Mobility>,
        <https://1145.am/db/2684668/Motorola_Mobility> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2664505/Motorola_Mobility_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-09-20T10:30:17+00:00"^^xsd:dateTime ;
    ns1:documentExtract "It's too soon to say whether AT & T's (NYSE: T) proposed $ 39 billion acquisition of T-Mobile USA or Google's (NASDAQ: GOOG) planned $ 12.5 billion purchase of Motorola Mobility (NYSE: MMI) will turn out to be brilliant or bone-headed moves." ;
    ns1:documentTitle "What are the most controversial (and brilliant) wireless business ideas of the past decade?" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/what-are-most-controversial-and-brilliant-wireless-business-ideas-past-decade> ;
    ns1:foundName "purchase" ;
    ns1:name "purchase" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2664505/Motorola_Mobility> ;
    ns1:targetName "Motorola Mobility" ;
    ns1:valueRaw "$ 12.5 billion" .

<https://1145.am/db/2668825/Clearwire> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "network expansion and modernization" ;
    ns1:documentDate "2011-11-07T15:46:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sprint raises $4B in debt offering, hints at Clearwire funding" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/sprint-raises-4b-debt-offering-hints-at-clearwire-funding> ;
    ns1:foundName "Clearwire" ;
    ns1:name "Clearwire" ;
    ns1:sameAsMedium <https://1145.am/db/1867892/Clearwire>,
        <https://1145.am/db/2159451/Clearwire>,
        <https://1145.am/db/2168120/Clearwire>,
        <https://1145.am/db/2169703/Clearwire>,
        <https://1145.am/db/2171240/Clearwire>,
        <https://1145.am/db/2171262/Clearwire>,
        <https://1145.am/db/2621796/Clearwire>,
        <https://1145.am/db/2625093/Clearwire>,
        <https://1145.am/db/2625177/Clearwire>,
        <https://1145.am/db/2625440/Clearwire>,
        <https://1145.am/db/2627955/Clearwire>,
        <https://1145.am/db/2630836/Clearwire>,
        <https://1145.am/db/2630855/Clearwire>,
        <https://1145.am/db/2630872/Clearwire>,
        <https://1145.am/db/2636624/Clearwire>,
        <https://1145.am/db/2637003/Clearwire>,
        <https://1145.am/db/2640962/Clearwire>,
        <https://1145.am/db/2642478/Clearwire>,
        <https://1145.am/db/2643597/Clearwire>,
        <https://1145.am/db/2646795/Clearwire>,
        <https://1145.am/db/2649592/Clearwire>,
        <https://1145.am/db/2649957/Clearwire>,
        <https://1145.am/db/2650501/Clearwire>,
        <https://1145.am/db/2652311/Clearwire>,
        <https://1145.am/db/2653485/Clearwire>,
        <https://1145.am/db/2655150/Clearwire>,
        <https://1145.am/db/2657564/Clearwire>,
        <https://1145.am/db/2659616/Clearwire>,
        <https://1145.am/db/2659619/Clearwire>,
        <https://1145.am/db/2659620/Clearwire>,
        <https://1145.am/db/2659633/Clearwire>,
        <https://1145.am/db/2660278/Clearwire>,
        <https://1145.am/db/2661265/Clearwire>,
        <https://1145.am/db/2661271/Clearwire>,
        <https://1145.am/db/2661308/Clearwire>,
        <https://1145.am/db/2661312/Clearwire>,
        <https://1145.am/db/2663091/Clearwire>,
        <https://1145.am/db/2663923/Clearwire>,
        <https://1145.am/db/2663931/Clearwire>,
        <https://1145.am/db/2663933/Clearwire>,
        <https://1145.am/db/2663948/Clearwire>,
        <https://1145.am/db/2664520/Clearwire>,
        <https://1145.am/db/2665968/Clearwire>,
        <https://1145.am/db/2667137/Clearwire>,
        <https://1145.am/db/2668249/Clearwire>,
        <https://1145.am/db/2669292/Clearwire>,
        <https://1145.am/db/2669341/Clearwire>,
        <https://1145.am/db/2669741/Clearwire>,
        <https://1145.am/db/2670229/Clearwire>,
        <https://1145.am/db/2670429/Clearwire>,
        <https://1145.am/db/2671023/Clearwire>,
        <https://1145.am/db/2671053/Clearwire>,
        <https://1145.am/db/2671074/Clearwire>,
        <https://1145.am/db/2671624/Clearwire>,
        <https://1145.am/db/2672759/Clearwire>,
        <https://1145.am/db/2672778/Clearwire>,
        <https://1145.am/db/2672784/Clearwire>,
        <https://1145.am/db/2672787/Clearwire>,
        <https://1145.am/db/2673403/Clearwire>,
        <https://1145.am/db/2674457/Clearwire>,
        <https://1145.am/db/2674903/Clearwire>,
        <https://1145.am/db/2675127/Clearwire>,
        <https://1145.am/db/2676361/Clearwire>,
        <https://1145.am/db/2676378/Clearwire>,
        <https://1145.am/db/2677262/Clearwire>,
        <https://1145.am/db/2678748/Clearwire>,
        <https://1145.am/db/2678781/Clearwire>,
        <https://1145.am/db/2679627/Clearwire>,
        <https://1145.am/db/2679862/Clearwire>,
        <https://1145.am/db/2679897/Clearwire>,
        <https://1145.am/db/2680700/Clearwire>,
        <https://1145.am/db/2680710/Clearwire>,
        <https://1145.am/db/2680723/Clearwire>,
        <https://1145.am/db/2681306/Clearwire>,
        <https://1145.am/db/2682450/Clearwire>,
        <https://1145.am/db/2683321/Clearwire>,
        <https://1145.am/db/2683336/Clearwire>,
        <https://1145.am/db/2683681/Clearwire>,
        <https://1145.am/db/2683999/Clearwire>,
        <https://1145.am/db/2684106/Clearwire>,
        <https://1145.am/db/2684592/Clearwire>,
        <https://1145.am/db/2685131/Clearwire>,
        <https://1145.am/db/2686032/Clearwire> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2672172/T-Mobile_Usa_Assets_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-12-19T15:16:53+00:00"^^xsd:dateTime ;
    ns1:documentExtract "AT & T's (NYSE: T) plans to sell off assets in a bid to keep alive its proposed $ 39 billion acquisition of T-Mobile USA appear to be running out of steam, according to a report in the Wall Street Journal." ;
    ns1:documentTitle "Report: AT&T's attempts to sell off T-Mobile assets hit dead end" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-at-t-s-attempts-to-sell-off-t-mobile-assets-hit-dead-end> ;
    ns1:foundName "acquisition",
        "sell" ;
    ns1:name "acquisition",
        "sell" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "stopped" ;
    ns1:target <https://1145.am/db/2672172/T-Mobile_Usa> ;
    ns1:targetDetails "assets" ;
    ns1:targetName "T-Mobile USA" ;
    ns1:valueRaw "$ 39 billion" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "USA" .

<https://1145.am/db/2211610/Investment_Matt_Cutts_Yuri_Milner_Drchrono_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-01-26T14:30:02+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MOUNTAIN VIEW, Calif.- (BUSINESS WIRE) - drchrono, the company that is transforming the focus of healthcare from the enterprise to the provider, today announced it has closed a $ 2.8 million round of funding led by Yuri Milner and featuring new investors that share a legacy of innovation and business transformation." ;
    ns1:documentTitle "drchrono Closes New Funding Round Led by Yuri Milner; Google's Matt Cutts Joins as New Investor" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/drchrono-closes-new-funding-round-led-by-yuri-milner-google-s-matt-cutts-joins-as-new-investor-0> ;
    ns1:foundName "funding" ;
    ns1:name "funding" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2211610/Drchrono> ;
    ns1:valueRaw "$ 2.8 million" ;
    ns1:whereGeoName "Mountain View" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5375480/about.rdf> ;
    ns1:whereRaw "MOUNTAIN VIEW, Calif" .

<https://1145.am/db/2293793/Cv_Ingenuity> a org:Organization ;
    ns1:basedInHighGeoName "Palo Alto" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5380748/about.rdf> ;
    ns1:basedInHighRaw "Palo Alto, CA" ;
    ns1:description "life sciences start-ups" ;
    ns1:documentDate "2011-10-04T16:34:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NEA leads $16M round for drug-eluting balloon firm" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nea-leads-16m-round-for-drug-eluting-balloon-firm> ;
    ns1:foundName "CV Ingenuity",
        "medical devices firm" ;
    ns1:industry "medical devices" ;
    ns1:name "CV Ingenuity",
        "CVI" ;
    ns1:sameAsHigh <https://1145.am/db/2355754/Cv_Ingenuity> ;
    ns1:sameAsMedium <https://1145.am/db/2294842/Cv_Ingenuity>,
        <https://1145.am/db/2295328/Cv_Ingenuity> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2293793/Series_B_Investment_Cv_Ingenuity_New_Enterprise_Associates_Western_Technology_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-10-04T16:34:19+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CV Ingenuity has inflated its coffers with a fresh round of venture cash amid development of its drug-eluting balloon technology.",
        "The Palo Alto, CA - based medical devices firm has raised $ 16 million in a Series B round of financing to fuel work on its technology for treating peripheral artery disease and to grow its management ranks." ;
    ns1:documentTitle "NEA leads $16M round for drug-eluting balloon firm" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nea-leads-16m-round-for-drug-eluting-balloon-firm> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2293793/Cv_Ingenuity> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 16 million" ;
    ns1:whereGeoName "Palo Alto County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4870630/about.rdf> ;
    ns1:whereRaw "Palo Alto" .

<https://1145.am/db/2294263/Nobel_Biocare_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-10-24T14:06:06+00:00"^^xsd:dateTime ;
    ns1:documentExtract "EQT, a Swedish private equity company, has been looking at Nobel Biocare as a take over target \"for some time ,\" NZZ am Sonntag reported, citing two unnamed sources.",
        "Switzerland's Nobel Biocare rose the most in more than two years after reports emerged saying EQT Partners AB and Bain Capital are eyeing the dental-implant maker." ;
    ns1:documentTitle "Nobel Biocare rises on buyout talks" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nobel-biocare-rises-buyout-talks> ;
    ns1:foundName "acquisition",
        "take over" ;
    ns1:name "acquisition",
        "take over" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened",
        "stopped",
        "unknown" ;
    ns1:target <https://1145.am/db/2294263/Nobel_Biocare> ;
    ns1:targetName "Nobel Biocare" ;
    ns1:whereGeoName "Switzerland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:whereRaw "Switzerland" .

<https://1145.am/db/2337808/Series_A_Investment_Avaxia_Biologics_Boston_Harbor_Angels_Cherrystone_Angels_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-11-10T16:49:07+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Avaxia Biologics, Inc. Raises $ 2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease.",
        "LEXINGTON, Mass., Nov. 10, 2011 /PRNewswire/ - Avaxia Biologics, Inc., a privately-held biotech company developing oral antibody drugs that act locally within the gastrointestinal tract, announced today that the company completed its first close of $ 2.2 million of a Series A angel - led financing." ;
    ns1:documentTitle "Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bo" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/avaxia-biologics-inc-raises-2-2-million-first-closing-of-series-a-financing-to-advance-oral> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2337808/Avaxia_Biologics> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 2.2 Million",
        "$ 2.2 million" ;
    ns1:when "2011-11-10T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Nov. 10, 2011" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2337826/Comprehend_Systems> a org:Organization ;
    ns1:basedInHighGeoName "Palo Alto" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5380748/about.rdf> ;
    ns1:basedInHighRaw "PALO ALTO, Calif." ;
    ns1:description "Clinical Data Visualization and Analytics",
        "Clinical research and enterprise sales" ;
    ns1:documentDate "2011-11-12T10:30:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Comprehend Systems Secures $1.2MM in Seed Funding Leading VC and Angel Investors Back Growing Clinical Data Visualization" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/comprehend-systems-secures-1-2mm-seed-funding-leading-vc-and-angel-investors-back-growing> ;
    ns1:foundName "Comprehend (@ Comprehend)",
        "Comprehend Systems",
        "Comprehend Systems, Inc." ;
    ns1:name "Comprehend",
        "Comprehend Systems" ;
    ns1:sameAsHigh <https://1145.am/db/2332227/Comprehend_Systems> ;
    ns1:sameAsMedium <https://1145.am/db/2304511/Comprehend_Systems>,
        <https://1145.am/db/2366079/Comprehend_Systems> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338566/Series_A_Investment_Access_Bridgegap_Ventures_Mnemosyne_Pharmaceuticals_Slater_Technology_Fund_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-16T13:45:21+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Mnemosyne Pharmaceuticals, Inc. Completes $ 5.4 Million Series A Round to Support Drug Discovery Programs.",
        "PROVIDENCE, RI, Feb 16, 2012 (MARKETWIRE via COMTEX) - Mnemosyne Pharmaceuticals, Inc., an emerging biotechnology company focused on the discovery and development of small molecule drugs to treat neuropsychiatric disorders, has secured $ 5.4 million in a Series A financing." ;
    ns1:documentTitle "Mnemosyne Pharmaceuticals, Inc. Completes $5.4 Million Series A Round to Support Drug Discovery Programs" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mnemosyne-pharmaceuticals-inc-completes-5-4-million-series-a-round-to-support-drug> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2338566/Mnemosyne_Pharmaceuticals> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 5.4 Million",
        "$ 5.4 million" ;
    ns1:when "2012-02-16T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Feb 16, 2012" ;
    ns1:whereGeoName "Providence" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5224151/about.rdf> ;
    ns1:whereRaw "PROVIDENCE, RI" .

<https://1145.am/db/2338625/Third_Rock_Ventures> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-11-16T11:51:24+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Allena Pharmaceuticals Launches with $15 Million Series A Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/allena-pharmaceuticals-launches-15-million-series-a-round> ;
    ns1:foundName "Third Rock Ventures" ;
    ns1:investor <https://1145.am/db/2338625/Series_A_Investment_Allena_Pharmaceuticals_Bessemer_Venture_Partners_Frazier_Healthcare_Third_Rock_Ventures_Completed> ;
    ns1:name "Third Rock Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1042269/Third_Rock_Ventures>,
        <https://1145.am/db/1352190/Third_Prime_Ventures>,
        <https://1145.am/db/1412391/Third_Point_Ventures>,
        <https://1145.am/db/1739929/K3_Ventures>,
        <https://1145.am/db/1753054/Third_Point_Ventures>,
        <https://1145.am/db/1765385/K3_Ventures>,
        <https://1145.am/db/1928208/Third_Rock_Ventures>,
        <https://1145.am/db/2303251/Third_Rock_Ventures>,
        <https://1145.am/db/2303257/Third_Rock_Ventures>,
        <https://1145.am/db/2311551/Third_Rock_Ventures>,
        <https://1145.am/db/2335750/Third_Rock_Ventures>,
        <https://1145.am/db/2337555/Third_Rock_Ventures>,
        <https://1145.am/db/2337559/Third_Rock_Ventures>,
        <https://1145.am/db/2337974/Third_Rock_Ventures>,
        <https://1145.am/db/2341792/Third_Rock_Ventures>,
        <https://1145.am/db/2341800/Third_Rock_Ventures>,
        <https://1145.am/db/2355043/Third_Rock_Ventures>,
        <https://1145.am/db/2359334/Third_Rock_Ventures>,
        <https://1145.am/db/2362102/Third_Rock_Ventures>,
        <https://1145.am/db/2362128/Third_Rock_Ventures>,
        <https://1145.am/db/2580088/Third_Rock_Ventures>,
        <https://1145.am/db/441151/Third_Rock_Ventures>,
        <https://1145.am/db/620653/K3_Ventures>,
        <https://1145.am/db/633929/Trilogy_Equity_Partners>,
        <https://1145.am/db/773235/Third_Point_Ventures>,
        <https://1145.am/db/866101/Third_Point_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1086582/Third_Rock_Ventures>,
        <https://1145.am/db/1089269/Third_Rock_Ventures>,
        <https://1145.am/db/1325987/Third_Rock_Ventures>,
        <https://1145.am/db/1326547/Third_Rock_Ventures>,
        <https://1145.am/db/1503058/Third_Rock_Ventures>,
        <https://1145.am/db/159801/Third_Rock_Ventures>,
        <https://1145.am/db/2095032/Third_Rock_Ventures>,
        <https://1145.am/db/2152566/Third_Rock_Ventures>,
        <https://1145.am/db/2153763/Third_Rock_Ventures>,
        <https://1145.am/db/2281272/Third_Rock_Ventures>,
        <https://1145.am/db/2291199/Third_Rock_Ventures>,
        <https://1145.am/db/2291940/Third_Rock_Ventures>,
        <https://1145.am/db/2294789/Third_Rock_Ventures>,
        <https://1145.am/db/2298193/Third_Rock_Ventures>,
        <https://1145.am/db/2298844/Third_Rock_Ventures>,
        <https://1145.am/db/2300971/Third_Rock_Ventures>,
        <https://1145.am/db/2303250/Third_Rock_Ventures>,
        <https://1145.am/db/2303294/Third_Rock_Ventures>,
        <https://1145.am/db/2315931/Third_Rock_Ventures>,
        <https://1145.am/db/2315933/Third_Rock_Ventures>,
        <https://1145.am/db/2322522/Third_Rock_Ventures>,
        <https://1145.am/db/2322531/Third_Rock_Ventures>,
        <https://1145.am/db/2327474/Third_Rock_Ventures>,
        <https://1145.am/db/2335531/Third_Rock_Ventures>,
        <https://1145.am/db/2335755/Third_Rock_Ventures>,
        <https://1145.am/db/2336126/Third_Rock_Ventures>,
        <https://1145.am/db/2337889/Third_Rock_Ventures>,
        <https://1145.am/db/2337958/Third_Rock_Ventures>,
        <https://1145.am/db/2338633/Third_Rock_Ventures>,
        <https://1145.am/db/2339127/Third_Rock_Ventures>,
        <https://1145.am/db/2339128/Third_Rock_Ventures>,
        <https://1145.am/db/2339413/Third_Rock_Ventures>,
        <https://1145.am/db/2339704/Third_Rock_Ventures>,
        <https://1145.am/db/2339925/Third_Rock_Ventures>,
        <https://1145.am/db/2339926/Third_Rock_Ventures>,
        <https://1145.am/db/2341662/Third_Rock_Ventures>,
        <https://1145.am/db/2342754/Third_Rock_Ventures>,
        <https://1145.am/db/2342768/Third_Rock_Ventures>,
        <https://1145.am/db/2342771/Third_Rock_Ventures>,
        <https://1145.am/db/2344256/Third_Rock_Ventures>,
        <https://1145.am/db/2344912/Third_Rock_Ventures>,
        <https://1145.am/db/2344918/Third_Rock_Ventures>,
        <https://1145.am/db/2345224/Third_Rock_Ventures>,
        <https://1145.am/db/2346212/Third_Rock_Ventures>,
        <https://1145.am/db/2346216/Third_Rock_Ventures>,
        <https://1145.am/db/2346988/Third_Rock_Ventures>,
        <https://1145.am/db/2347885/Third_Rock_Ventures>,
        <https://1145.am/db/2350364/Third_Rock_Ventures>,
        <https://1145.am/db/2351009/Third_Rock_Ventures>,
        <https://1145.am/db/2351011/Third_Rock_Ventures>,
        <https://1145.am/db/2351348/Third_Rock_Ventures>,
        <https://1145.am/db/2351372/Third_Rock_Ventures>,
        <https://1145.am/db/2351520/Third_Rock_Ventures>,
        <https://1145.am/db/2351644/Third_Rock_Ventures>,
        <https://1145.am/db/2354307/Third_Rock_Ventures>,
        <https://1145.am/db/2354314/Third_Rock_Ventures>,
        <https://1145.am/db/2354608/Third_Rock_Ventures>,
        <https://1145.am/db/2354613/Third_Rock_Ventures>,
        <https://1145.am/db/2357253/Third_Rock_Ventures>,
        <https://1145.am/db/2357256/Third_Rock_Ventures>,
        <https://1145.am/db/2357722/Third_Rock_Ventures>,
        <https://1145.am/db/2358551/Third_Rock_Ventures>,
        <https://1145.am/db/2358737/Third_Rock_Ventures>,
        <https://1145.am/db/2359321/Third_Rock_Ventures>,
        <https://1145.am/db/2359447/Third_Rock_Ventures>,
        <https://1145.am/db/2359575/Third_Rock_Ventures>,
        <https://1145.am/db/2359818/Third_Rock_Ventures>,
        <https://1145.am/db/2359864/Third_Rock_Ventures>,
        <https://1145.am/db/2359873/Third_Rock_Ventures>,
        <https://1145.am/db/2359875/Third_Rock_Ventures>,
        <https://1145.am/db/2359887/Third_Rock_Ventures>,
        <https://1145.am/db/2359984/Third_Rock_Ventures>,
        <https://1145.am/db/2359987/Third_Rock_Ventures>,
        <https://1145.am/db/2360006/Third_Rock_Ventures>,
        <https://1145.am/db/2360169/Third_Rock_Ventures>,
        <https://1145.am/db/2360814/Third_Rock_Ventures>,
        <https://1145.am/db/2360877/Third_Rock_Ventures>,
        <https://1145.am/db/2362109/Third_Rock_Ventures>,
        <https://1145.am/db/2363422/Third_Rock_Ventures>,
        <https://1145.am/db/2364240/Third_Rock_Ventures>,
        <https://1145.am/db/2364249/Third_Rock_Ventures>,
        <https://1145.am/db/2364255/Third_Rock_Ventures>,
        <https://1145.am/db/2364283/Third_Rock_Ventures>,
        <https://1145.am/db/2364481/Third_Rock_Ventures>,
        <https://1145.am/db/2365109/Third_Rock_Ventures>,
        <https://1145.am/db/2365111/Third_Rock_Ventures>,
        <https://1145.am/db/2365315/Third_Rock_Ventures>,
        <https://1145.am/db/2366539/Third_Rock_Ventures>,
        <https://1145.am/db/2366641/Third_Rock_Ventures>,
        <https://1145.am/db/2367442/Third_Rock_Ventures>,
        <https://1145.am/db/2367448/Third_Rock_Ventures>,
        <https://1145.am/db/2368166/Third_Rock_Ventures>,
        <https://1145.am/db/2368501/Third_Rock_Ventures>,
        <https://1145.am/db/2369130/Third_Rock_Ventures>,
        <https://1145.am/db/2369202/Third_Rock_Ventures>,
        <https://1145.am/db/2370105/Third_Rock_Ventures_Llc>,
        <https://1145.am/db/2371191/Third_Rock_Ventures>,
        <https://1145.am/db/2584533/Third_Rock_Ventures>,
        <https://1145.am/db/572554/Third_Rock_Ventures>,
        <https://1145.am/db/768794/Third_Rock_Ventures>,
        <https://1145.am/db/769408/Third_Rock_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339384/Devon_Park_Bioventures> a org:Organization ;
    ns1:basedInLowRaw "PHILADELPHIA" ;
    ns1:documentDate "2012-02-22T13:14:12+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vascular Magnetics Raises $7 Million in Series A Financing to Advance Magnetically Targeted Drug Delivery System for Peripheral Artery Disease" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vascular-magnetics-raises-7-million-series-a-financing-to-advance-magnetically-targeted-1> ;
    ns1:foundName "Devon Park Bioventures" ;
    ns1:investor <https://1145.am/db/2339384/Series_A_Investment_Devon_Park_Bioventures_Vascular_Magnetics_Inc_Completed> ;
    ns1:name "Devon Park Bioventures" ;
    ns1:sameAsMedium <https://1145.am/db/2296656/Devon_Park_Bioventures>,
        <https://1145.am/db/2310020/Devon_Park_Bioventures>,
        <https://1145.am/db/2310031/Devon_Park_Bioventures>,
        <https://1145.am/db/2320852/Devon_Park_Bioventures>,
        <https://1145.am/db/2320853/Devon_Park_Bioventures>,
        <https://1145.am/db/2324076/Devon_Park_Bioventures>,
        <https://1145.am/db/2339395/Devon_Park_Bioventures>,
        <https://1145.am/db/2340208/Devon_Park_Bioventures>,
        <https://1145.am/db/2340211/Devon_Park_Bioventures>,
        <https://1145.am/db/2340887/Devon_Park_Bioventures>,
        <https://1145.am/db/2346972/Devon_Park_Bioventures>,
        <https://1145.am/db/2346973/Devon_Park_Bioventures>,
        <https://1145.am/db/2355183/Devon_Park_Bioventures>,
        <https://1145.am/db/2359510/Devon_Park_Bioventures>,
        <https://1145.am/db/2363460/Devon_Park_Bioventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339395/Devon_Park_Bioventures> a org:Organization ;
    ns1:basedInLowRaw "PHILADELPHIA" ;
    ns1:documentDate "2012-02-22T13:49:24+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vascular Magnetics Raises $7 Million in Series A Financing to Advance Magnetically Targeted Drug Delivery System for PAD" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vascular-magnetics-raises-7-million-series-a-financing-to-advance-magnetically-targeted-0> ;
    ns1:foundName "Devon Park Bioventures" ;
    ns1:investor <https://1145.am/db/2339395/Series_A_Investment_Devon_Park_Bioventures_Vascular_Magnetics_Inc_Completed> ;
    ns1:name "Devon Park Bioventures" ;
    ns1:sameAsMedium <https://1145.am/db/2296656/Devon_Park_Bioventures>,
        <https://1145.am/db/2310020/Devon_Park_Bioventures>,
        <https://1145.am/db/2310031/Devon_Park_Bioventures>,
        <https://1145.am/db/2320852/Devon_Park_Bioventures>,
        <https://1145.am/db/2320853/Devon_Park_Bioventures>,
        <https://1145.am/db/2324076/Devon_Park_Bioventures>,
        <https://1145.am/db/2339384/Devon_Park_Bioventures>,
        <https://1145.am/db/2340208/Devon_Park_Bioventures>,
        <https://1145.am/db/2340211/Devon_Park_Bioventures>,
        <https://1145.am/db/2340887/Devon_Park_Bioventures>,
        <https://1145.am/db/2346972/Devon_Park_Bioventures>,
        <https://1145.am/db/2346973/Devon_Park_Bioventures>,
        <https://1145.am/db/2355183/Devon_Park_Bioventures>,
        <https://1145.am/db/2359510/Devon_Park_Bioventures>,
        <https://1145.am/db/2363460/Devon_Park_Bioventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339419/Biocartis> a org:Organization ;
    ns1:basedInLowRaw "Benaruca" ;
    ns1:description "Molecular diagnostic" ;
    ns1:documentDate "2011-11-17T14:21:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising-0> ;
    ns1:foundName "Biocartis" ;
    ns1:industry "life science" ;
    ns1:name "Biocartis" ;
    ns1:sameAsHigh <https://1145.am/db/1199338/Discovery_Life_Sciences>,
        <https://1145.am/db/1298251/Discovery_Life_Sciences>,
        <https://1145.am/db/1553821/Cellesce>,
        <https://1145.am/db/2072483/Boundless_Bio>,
        <https://1145.am/db/2187099/Aetion>,
        <https://1145.am/db/2293814/Forbion>,
        <https://1145.am/db/2313533/Invitrogen>,
        <https://1145.am/db/2314407/Viagen>,
        <https://1145.am/db/2319965/Progentech>,
        <https://1145.am/db/2322622/Biocartis_Sa>,
        <https://1145.am/db/2328028/Life_Technologies_Corporation>,
        <https://1145.am/db/2332668/Life_Technologies_Corporation>,
        <https://1145.am/db/2339425/Biocartis>,
        <https://1145.am/db/2351845/Life_Technologies_Corporation>,
        <https://1145.am/db/2360368/Life_Technologies_Corporation>,
        <https://1145.am/db/2366638/Life_Technologies_Corporation>,
        <https://1145.am/db/2585456/Enavail>,
        <https://1145.am/db/404796/Discovery_Life_Sciences>,
        <https://1145.am/db/566298/Discovery>,
        <https://1145.am/db/786040/Generis>,
        <https://1145.am/db/953800/Standard_Biotools_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2290774/Biocartis>,
        <https://1145.am/db/2299864/Biocartis>,
        <https://1145.am/db/2322621/Biocartis_Sa>,
        <https://1145.am/db/2339424/Biocartis>,
        <https://1145.am/db/2356419/Biocartis> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339425/Biocartis> a org:Organization ;
    ns1:description "Molecular diagnostic" ;
    ns1:documentDate "2011-11-17T14:39:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising> ;
    ns1:foundName "Biocartis" ;
    ns1:industry "life science" ;
    ns1:name "Biocartis" ;
    ns1:sameAsHigh <https://1145.am/db/1199338/Discovery_Life_Sciences>,
        <https://1145.am/db/1298251/Discovery_Life_Sciences>,
        <https://1145.am/db/1553821/Cellesce>,
        <https://1145.am/db/2072483/Boundless_Bio>,
        <https://1145.am/db/2187099/Aetion>,
        <https://1145.am/db/2293814/Forbion>,
        <https://1145.am/db/2313533/Invitrogen>,
        <https://1145.am/db/2314407/Viagen>,
        <https://1145.am/db/2319965/Progentech>,
        <https://1145.am/db/2322622/Biocartis_Sa>,
        <https://1145.am/db/2328028/Life_Technologies_Corporation>,
        <https://1145.am/db/2332668/Life_Technologies_Corporation>,
        <https://1145.am/db/2339419/Biocartis>,
        <https://1145.am/db/2351845/Life_Technologies_Corporation>,
        <https://1145.am/db/2360368/Life_Technologies_Corporation>,
        <https://1145.am/db/2366638/Life_Technologies_Corporation>,
        <https://1145.am/db/2585456/Enavail>,
        <https://1145.am/db/404796/Discovery_Life_Sciences>,
        <https://1145.am/db/566298/Discovery>,
        <https://1145.am/db/786040/Generis>,
        <https://1145.am/db/953800/Standard_Biotools_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2290774/Biocartis>,
        <https://1145.am/db/2299864/Biocartis>,
        <https://1145.am/db/2322621/Biocartis_Sa>,
        <https://1145.am/db/2339424/Biocartis>,
        <https://1145.am/db/2356419/Biocartis> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340211/Devon_Park_Bioventures> a org:Organization ;
    ns1:basedInLowRaw "PHILADELPHIA" ;
    ns1:documentDate "2012-02-22T17:03:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vascular Magnetics Raises $7 Million in Series A Financing to Advance Magnetically Targeted Drug Delivery System for Peripheral Artery Disease" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vascular-magnetics-raises-7-million-series-a-financing-to-advance-magnetically-targeted> ;
    ns1:foundName "Devon Park Bioventures" ;
    ns1:investor <https://1145.am/db/2340211/Series_A_Investment_Devon_Park_Bioventures_Vascular_Magnetics_Inc_Completed> ;
    ns1:name "Devon Park Bioventures" ;
    ns1:sameAsMedium <https://1145.am/db/2296656/Devon_Park_Bioventures>,
        <https://1145.am/db/2310020/Devon_Park_Bioventures>,
        <https://1145.am/db/2310031/Devon_Park_Bioventures>,
        <https://1145.am/db/2320852/Devon_Park_Bioventures>,
        <https://1145.am/db/2320853/Devon_Park_Bioventures>,
        <https://1145.am/db/2324076/Devon_Park_Bioventures>,
        <https://1145.am/db/2339384/Devon_Park_Bioventures>,
        <https://1145.am/db/2339395/Devon_Park_Bioventures>,
        <https://1145.am/db/2340208/Devon_Park_Bioventures>,
        <https://1145.am/db/2340887/Devon_Park_Bioventures>,
        <https://1145.am/db/2346972/Devon_Park_Bioventures>,
        <https://1145.am/db/2346973/Devon_Park_Bioventures>,
        <https://1145.am/db/2355183/Devon_Park_Bioventures>,
        <https://1145.am/db/2359510/Devon_Park_Bioventures>,
        <https://1145.am/db/2363460/Devon_Park_Bioventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340305/Preferred_Stock_Investment_Eastern_Capital_Limited_Portola_Pharmaceuticals_Inc_Temasek_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-11-21T16:01:52+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Portola Pharmaceuticals Announces Completion of $ 89 Million Financing.",
        "SOUTH SAN FRANCISCO, CA, Nov 21, 2011 (MARKETWIRE via COMTEX) - Portola Pharmaceuticals, Inc. today announced that it has raised $ 89 million in a preferred stock financing." ;
    ns1:documentTitle "Portola Pharmaceuticals Announces Completion of $89 Million Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/portola-pharmaceuticals-announces-completion-of-89-million-financing> ;
    ns1:foundName "Financing",
        "financing",
        "raised" ;
    ns1:name "Financing",
        "financing",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2340305/Portola_Pharmaceuticals_Inc> ;
    ns1:targetDetails "preferred stock" ;
    ns1:valueRaw "$ 89 Million",
        "$ 89 million" ;
    ns1:whenRaw "2011" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2341100/Biozone_Pharmaceuticals_Inc_Rights_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2012-02-27T21:38:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MIAMI, Feb 27, 2012 (BUSINESS WIRE) - OPKO Health, Inc. OPK +0.20 % announced today it made an investment in BioZone Pharmaceuticals, Inc., BZNE +47.60 % and acquired rights to BioZone's novel drug delivery platforms, including its QuSome (R) technology." ;
    ns1:documentTitle "OPKO Invests in BioZone Pharmaceuticals, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/opko-invests-biozone-pharmaceuticals-inc> ;
    ns1:foundName "acquired",
        "investment" ;
    ns1:name "acquired",
        "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2341100/Biozone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2341100/Qusome> ;
    ns1:targetDetails "rights" ;
    ns1:targetName "BioZone Pharmaceuticals, Inc.",
        "QuSome" ;
    ns1:vendor <https://1145.am/db/2341100/Biozone_Pharmaceuticals_Inc> ;
    ns1:whenRaw "2012" ;
    ns1:whereGeoName "Miami" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4164138/about.rdf> ;
    ns1:whereRaw "MIAMI" .

<https://1145.am/db/2341100/Qusome> a org:Organization ;
    ns1:basedInLowRaw "MIAMI" ;
    ns1:description "drug delivery platforms" ;
    ns1:documentDate "2012-02-27T21:38:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "OPKO Invests in BioZone Pharmaceuticals, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/opko-invests-biozone-pharmaceuticals-inc> ;
    ns1:foundName "QuSome (R)" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "QuSome" ;
    ns1:sameAsHigh <https://1145.am/db/1374000/Qnovia_Inc>,
        <https://1145.am/db/1375285/Qnovia_Inc>,
        <https://1145.am/db/1959187/Qnovia>,
        <https://1145.am/db/2229864/Qpharma>,
        <https://1145.am/db/2292385/Quethera>,
        <https://1145.am/db/2302768/Qlt_Inc>,
        <https://1145.am/db/2305875/Qpharma>,
        <https://1145.am/db/2305876/Qpharma>,
        <https://1145.am/db/2319362/Qlt_Usa>,
        <https://1145.am/db/2325215/Qrxpharma>,
        <https://1145.am/db/2329140/Qrxpharma>,
        <https://1145.am/db/2336367/Qpharma>,
        <https://1145.am/db/2353721/Qps_Llc>,
        <https://1145.am/db/2359360/Qpharma>,
        <https://1145.am/db/2540931/Qs_Pharma>,
        <https://1145.am/db/2541138/Quva_Pharma>,
        <https://1145.am/db/2544111/Quva_Pharma>,
        <https://1145.am/db/2548185/Qualicaps>,
        <https://1145.am/db/2562208/Qualicaps>,
        <https://1145.am/db/2575198/Qps_Llc>,
        <https://1145.am/db/2595675/Qualicaps> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343244/Orbimed_Advisors> a org:Organization ;
    ns1:basedInHighGeoName "United States" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:basedInHighRaw "USA" ;
    ns1:description "fundraising" ;
    ns1:documentDate "2011-12-01T13:13:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argen-x-raises-eur-27-5-million-usd-37-million-oversubscribed-series-b-round> ;
    ns1:foundName "OrbiMed Advisors (USA)" ;
    ns1:investor <https://1145.am/db/2343244/Series_B_Investment_Biogeneration_Ventures_Credit_Agricole_Private_Equity_Erasmus_Biomedical_Fund_Forbion_Capital_Partners_Orbimed_Advisors_Seventure_Partners_Thuja_Capital_Vib_Argen-X_Completed> ;
    ns1:name "OrbiMed Advisors" ;
    ns1:sameAsMedium <https://1145.am/db/1665536/Orbimed_Advisors>,
        <https://1145.am/db/1809007/Orbimed_Advisors>,
        <https://1145.am/db/2198816/Orbimed_Advisors>,
        <https://1145.am/db/2245885/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2281230/Orbimed_Advisors>,
        <https://1145.am/db/2284506/Orbimed_Advisors>,
        <https://1145.am/db/2289056/Orbimed_Advisors>,
        <https://1145.am/db/2290078/Orbimed_Advisors>,
        <https://1145.am/db/2290200/Orbimed_Advisors>,
        <https://1145.am/db/2290444/Orbimed_Advisors>,
        <https://1145.am/db/2297604/Orbimed_Advisors>,
        <https://1145.am/db/2298956/Orbimed_Advisors>,
        <https://1145.am/db/2303098/Orbimed_Advisors>,
        <https://1145.am/db/2304242/Orbimed_Advisors>,
        <https://1145.am/db/2305656/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306251/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306705/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2309491/Orbimed_Advisors>,
        <https://1145.am/db/2310922/Orbimed_Advisors>,
        <https://1145.am/db/2312233/Orbimed_Advisors>,
        <https://1145.am/db/2317918/Orbimed_Advisors>,
        <https://1145.am/db/2318133/Orbimed_Advisors>,
        <https://1145.am/db/2318829/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2318832/Orbimed_Advisers>,
        <https://1145.am/db/2318851/Orbimed_Advisors>,
        <https://1145.am/db/2319338/Orbimed_Advisors>,
        <https://1145.am/db/2320914/Orbimed_Advisors>,
        <https://1145.am/db/2322345/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2324226/Orbimed_Advisors>,
        <https://1145.am/db/2325257/Orbimed_Advisors>,
        <https://1145.am/db/2325880/Orbimed_Advisors>,
        <https://1145.am/db/2328599/Orbimed_Advisors>,
        <https://1145.am/db/2328700/Orbimed_Advisors>,
        <https://1145.am/db/2329260/Orbimed_Advisors>,
        <https://1145.am/db/2330799/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2330920/Orbimed_Advisors>,
        <https://1145.am/db/2332120/Orbimed_Advisors>,
        <https://1145.am/db/2333495/Orbimed_Advisors>,
        <https://1145.am/db/2333504/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2333966/Orbimed_Advisors>,
        <https://1145.am/db/2335743/Orbimed_Advisors>,
        <https://1145.am/db/2336221/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2336503/Orbimed_Advisors>,
        <https://1145.am/db/2336505/Orbimed_Advisors>,
        <https://1145.am/db/2336524/Orbimed_Advisors>,
        <https://1145.am/db/2337166/Orbimed_Advisors>,
        <https://1145.am/db/2337250/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2337254/Orbimed_Advisors>,
        <https://1145.am/db/2339885/Orbimed_Advisors>,
        <https://1145.am/db/2339886/Orbimed_Advisors>,
        <https://1145.am/db/2342862/Orbimed_Advisors>,
        <https://1145.am/db/2342925/Orbimed_Advisors>,
        <https://1145.am/db/2342937/Orbimed_Advisors>,
        <https://1145.am/db/2344735/Orbimed_Advisors>,
        <https://1145.am/db/2344786/Orbimed_Advisors>,
        <https://1145.am/db/2345435/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345453/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345456/Orbimed_Advisors>,
        <https://1145.am/db/2346030/Orbimed_Advisors>,
        <https://1145.am/db/2350034/Orbimed_Advisors>,
        <https://1145.am/db/2350044/Orbimed_Advisors>,
        <https://1145.am/db/2352436/Orbimed_Advisors>,
        <https://1145.am/db/2352441/Orbimed_Advisors>,
        <https://1145.am/db/2352442/Orbimed_Advisors>,
        <https://1145.am/db/2352701/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2352804/Orbimed_Advisors>,
        <https://1145.am/db/2352807/Orbimed_Advisors>,
        <https://1145.am/db/2355034/Orbimed_Advisors>,
        <https://1145.am/db/2356297/Orbimed_Advisors>,
        <https://1145.am/db/2356420/Orbimed_Advisors>,
        <https://1145.am/db/2357253/Orbimed_Advisors>,
        <https://1145.am/db/2357256/Orbimed_Advisors>,
        <https://1145.am/db/2357858/Orbimed_Advisors>,
        <https://1145.am/db/2359125/Orbimed_Advisors>,
        <https://1145.am/db/2359468/Orbimed_Advisors>,
        <https://1145.am/db/2359864/Orbimed_Advisors>,
        <https://1145.am/db/2360174/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2361018/Orbimed_Advisors>,
        <https://1145.am/db/2361022/Orbimed_Advisors>,
        <https://1145.am/db/2361027/Orbimed_Advisors>,
        <https://1145.am/db/2362475/Orbimed_Advisors>,
        <https://1145.am/db/2362481/Orbimed_Advisors>,
        <https://1145.am/db/2363339/Orbimed_Advisors>,
        <https://1145.am/db/2365679/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2365868/Orbimed_Advisors>,
        <https://1145.am/db/2366519/Orbimed_Advisors>,
        <https://1145.am/db/2574232/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2583013/Orbimed_Advisors>,
        <https://1145.am/db/428737/Orbimed_Advisors>,
        <https://1145.am/db/456081/Orbimed_Advisors>,
        <https://1145.am/db/456089/Orbimed_Advisors>,
        <https://1145.am/db/458377/Orbimed_Advisors>,
        <https://1145.am/db/674484/Orbimed_Advisors> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348453/Investment_Glenmark_Napo_Pharmaceuticals_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-12-15T14:52:57+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Glenmark is seeking arbitration to settle a dispute over its collaboration with Napo Pharmaceuticals." ;
    ns1:documentTitle "Ariad plans $224M stock offering; Dicerna earns $5M milestone from KHK; Salk team touts potential of new Alzheimer's drug;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ariad-plans-224m-stock-offering-dicerna-earns-5m-milestone-from-khk-salk-team-touts> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2352633/Advanced_Biotechnologies_Venture_Fund> a org:Organization ;
    ns1:basedInLowRaw "British Columbia" ;
    ns1:description "Venture capital" ;
    ns1:documentDate "2011-09-22T16:00:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zymeworks Completes $8.1 Million Round of Financing to Advance Platform Technology and Therapeutics Pipeline Programs" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zymeworks-completes-8-1-million-round-of-financing-to-advance-platform-technology-and> ;
    ns1:foundName "Advanced Biotechnologies Venture Fund" ;
    ns1:investor <https://1145.am/db/2352633/Investment_Advanced_Biotechnologies_Venture_Fund_Zymeworks_Inc_Completed> ;
    ns1:name "Advanced Biotechnologies Venture Fund" ;
    ns1:sameAsHigh <https://1145.am/db/1223133/Bioadvance>,
        <https://1145.am/db/1223149/Bioadvance>,
        <https://1145.am/db/1422234/Forbion_Ventures>,
        <https://1145.am/db/1422725/Forbion_Ventures>,
        <https://1145.am/db/1867543/Tpg_Biotech>,
        <https://1145.am/db/1926411/Bioqube_Ventures>,
        <https://1145.am/db/1990861/Bioqube_Ventures>,
        <https://1145.am/db/2060484/Healthtech_Capital>,
        <https://1145.am/db/2155146/Biomatics_Capital_Partners>,
        <https://1145.am/db/2280492/Biovision_Ventures>,
        <https://1145.am/db/2285038/Time_Bioventures>,
        <https://1145.am/db/2286671/Forbion>,
        <https://1145.am/db/2298954/Biossom_Investment_Management>,
        <https://1145.am/db/2298978/Advent_Life_Sciences>,
        <https://1145.am/db/2301741/Bio_*_One_Capital>,
        <https://1145.am/db/2301792/Fonds_Bio-Innovation_Sec>,
        <https://1145.am/db/2302351/Medimmune_Ventures>,
        <https://1145.am/db/2305587/Medimmune_Ventures>,
        <https://1145.am/db/2309840/Bio_Fund>,
        <https://1145.am/db/2310285/Medventure_Associates>,
        <https://1145.am/db/2313322/Biomedinvest>,
        <https://1145.am/db/2313322/Hbm_Bioventures>,
        <https://1145.am/db/2313401/Biogen_Idec_New_Ventures>,
        <https://1145.am/db/2313438/Biomedinvest>,
        <https://1145.am/db/2313438/Hbm_Biocapital>,
        <https://1145.am/db/2313438/Hbm_Bioventures>,
        <https://1145.am/db/2313438/Sv_Life_Sciences>,
        <https://1145.am/db/2314400/Hbm_Biocapital>,
        <https://1145.am/db/2314515/Sv_Life_Sciences>,
        <https://1145.am/db/2314573/Avlar_Bioventures>,
        <https://1145.am/db/2316709/Bioadvance_Ventures>,
        <https://1145.am/db/2317737/Mc_Life_Sciences_Ventures>,
        <https://1145.am/db/2317779/Bio_*_One_Capital>,
        <https://1145.am/db/2319360/Medimmune_Ventures>,
        <https://1145.am/db/2321097/Healthcare_Ventures>,
        <https://1145.am/db/2323785/Medimmune_Ventures>,
        <https://1145.am/db/2324015/Medsciences_Capital>,
        <https://1145.am/db/2324195/Lotus_Bioscience_Ventures>,
        <https://1145.am/db/2325831/Bb_Biotech>,
        <https://1145.am/db/2325831/Hbm_Bioventures>,
        <https://1145.am/db/2336109/Biomed_Ventures>,
        <https://1145.am/db/2338673/Hopen_Life_Science_Ventures>,
        <https://1145.am/db/2339295/Biomedinvest>,
        <https://1145.am/db/2345037/Biomed_Ventures>,
        <https://1145.am/db/2347571/Advent_Life_Sciences>,
        <https://1145.am/db/2352382/Biomedinvest>,
        <https://1145.am/db/2354295/Biomed_Ventures>,
        <https://1145.am/db/2359240/Frontline_Bioventures>,
        <https://1145.am/db/2364853/Medimmune_Ventures>,
        <https://1145.am/db/2365171/Healthcare_Ventures>,
        <https://1145.am/db/2366049/Biomed_Ventures>,
        <https://1145.am/db/2366055/Biomed_Ventures>,
        <https://1145.am/db/2366133/Biopacificventures>,
        <https://1145.am/db/2368251/Sv_Life_Sciences>,
        <https://1145.am/db/2369916/Biomed_Ventures>,
        <https://1145.am/db/363714/Palliare>,
        <https://1145.am/db/564585/Bioqube_Ventures>,
        <https://1145.am/db/566971/Bioqube_Ventures>,
        <https://1145.am/db/684123/Biourja_Ventures>,
        <https://1145.am/db/938108/Bioeconomy_Capital>,
        <https://1145.am/db/971939/I___I_Biotech_Fund>,
        <https://1145.am/db/975114/I___I_Biotech_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/2356853/Advanced_Biotechnologies_Venture_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352633/Investment_Advanced_Biotechnologies_Venture_Fund_Zymeworks_Inc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-09-22T16:00:56+00:00"^^xsd:dateTime ;
    ns1:documentExtract "VANCOUVER, British Columbia, Sep 22, 2011 (BUSINESS WIRE) - Zymeworks Inc., a privately held biotherapeutics company focused on the development of best-in-class antibody and next generation protein - based therapeutics, today announced the completion of a financing totaling $ 8.1 million." ;
    ns1:documentTitle "Zymeworks Completes $8.1 Million Round of Financing to Advance Platform Technology and Therapeutics Pipeline Programs" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zymeworks-completes-8-1-million-round-of-financing-to-advance-platform-technology-and> ;
    ns1:foundName "financing",
        "investment" ;
    ns1:name "financing",
        "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2352633/Zymeworks_Inc> ;
    ns1:valueRaw "$ 8.1 million" ;
    ns1:whenRaw "2011" ;
    ns1:whereGeoName "British Columbia" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5909050/about.rdf> ;
    ns1:whereRaw "British Columbia" .

<https://1145.am/db/2353588/Canaan_Partners> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-01-04T13:03:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/elevation-pharmaceuticals-completes-30-million-series-b-financing-to-advance-aerosol-copd-1> ;
    ns1:foundName "Canaan Partners" ;
    ns1:investor <https://1145.am/db/2353588/Series_B_Investment_Canaan_Partners_Care_Capital_Elevation_Pharmaceuticals_Mesa_Verde_Venture_Partners_Novo_Ventures_Tpg_Biotech_Completed> ;
    ns1:name "Canaan Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1043342/Canaan_Partners>,
        <https://1145.am/db/146274/Canaan_Partners>,
        <https://1145.am/db/1695894/Canaan_Partners>,
        <https://1145.am/db/1696766/Canaan_Partners>,
        <https://1145.am/db/1697131/Canaan_Partners>,
        <https://1145.am/db/1702857/Canaan_Partners>,
        <https://1145.am/db/1711633/Canaan_Partners>,
        <https://1145.am/db/1724566/Canaan_Partners>,
        <https://1145.am/db/1734259/Canaan_Partners>,
        <https://1145.am/db/1741014/Canaan_Partners>,
        <https://1145.am/db/1741105/Canaan_Partners>,
        <https://1145.am/db/1741424/Canaan_Partners>,
        <https://1145.am/db/1749744/Canaan_Partners>,
        <https://1145.am/db/1754820/Canaan_Partners>,
        <https://1145.am/db/1768400/Canaan_Partners>,
        <https://1145.am/db/1770648/Canaan_Partners>,
        <https://1145.am/db/1791628/Canaan_Partners>,
        <https://1145.am/db/1792426/Canaan_Partners>,
        <https://1145.am/db/1793543/Canaan_Partners>,
        <https://1145.am/db/1796375/Canaan_Partners>,
        <https://1145.am/db/1814413/Canaan_Partners>,
        <https://1145.am/db/1819543/Canaan_Partners>,
        <https://1145.am/db/1827240/Canaan_Partners>,
        <https://1145.am/db/1829078/Canaan_Partners>,
        <https://1145.am/db/1829544/Canaan_Partners>,
        <https://1145.am/db/1836578/Canaan_Partners>,
        <https://1145.am/db/1842466/Canaan_Partners>,
        <https://1145.am/db/1845119/Canaan_Partners>,
        <https://1145.am/db/1852066/Canaan_Partners>,
        <https://1145.am/db/1858762/Canaan_Partners>,
        <https://1145.am/db/1863401/Canaan_Partners>,
        <https://1145.am/db/1866968/Canaan_Partners>,
        <https://1145.am/db/1894670/Canaan_Partners>,
        <https://1145.am/db/1897255/Canaan_Partners>,
        <https://1145.am/db/1900458/Canaan_Partners>,
        <https://1145.am/db/1906336/Canaan_Partners>,
        <https://1145.am/db/1907151/Canaan_Partners>,
        <https://1145.am/db/1907762/Canaan_Partners>,
        <https://1145.am/db/1910644/Canaan_Partners>,
        <https://1145.am/db/1919135/Canaan_Partners>,
        <https://1145.am/db/1920478/Canaan_Partners>,
        <https://1145.am/db/2164798/Canaan_Partners>,
        <https://1145.am/db/2164838/Canaan_Partners>,
        <https://1145.am/db/2210939/Canaan_Partners>,
        <https://1145.am/db/2238667/Canaan_Partners>,
        <https://1145.am/db/2287025/Canaan_Partners>,
        <https://1145.am/db/2287777/Canaan_Partners>,
        <https://1145.am/db/2297592/Canaan_Partners>,
        <https://1145.am/db/2298642/Canaan_Partners>,
        <https://1145.am/db/2301765/Canaan_Partners>,
        <https://1145.am/db/2304587/Canaan_Partners>,
        <https://1145.am/db/2304605/Canaan_Partners>,
        <https://1145.am/db/2306281/Canaan_Partners>,
        <https://1145.am/db/2308329/Canaan_Partners>,
        <https://1145.am/db/2309376/Canaan_Partners>,
        <https://1145.am/db/2309387/Canaan_Partners>,
        <https://1145.am/db/2313171/Canaan_Partners>,
        <https://1145.am/db/2320925/Canaan_Partners>,
        <https://1145.am/db/2322231/Canaan_Partners>,
        <https://1145.am/db/2329010/Canaan_Partners>,
        <https://1145.am/db/2329011/Canaan_Partners>,
        <https://1145.am/db/2329531/Canaan_Partners>,
        <https://1145.am/db/2332322/Canaan_Partners>,
        <https://1145.am/db/2337958/Canaan_Partners>,
        <https://1145.am/db/2337974/Canaan_Partners>,
        <https://1145.am/db/2346532/Canaan_Partners>,
        <https://1145.am/db/2347469/Canaan_Partners>,
        <https://1145.am/db/2351129/Canaan_Partners>,
        <https://1145.am/db/2351316/Canaan_Partners>,
        <https://1145.am/db/2351684/Canaan_Partners>,
        <https://1145.am/db/2353608/Canaan_Partners>,
        <https://1145.am/db/2355043/Canaan_Partners>,
        <https://1145.am/db/2355238/Canaan_Partners>,
        <https://1145.am/db/2355715/Canaan_Partners>,
        <https://1145.am/db/2358378/Canaan_Partners>,
        <https://1145.am/db/2359185/Canaan_Partners>,
        <https://1145.am/db/2360258/Canaan_Partners>,
        <https://1145.am/db/2360266/Canaan_Partners>,
        <https://1145.am/db/2360647/Canaan_Partners>,
        <https://1145.am/db/2363535/Canaan_Partners>,
        <https://1145.am/db/2365700/Canaan_Partners>,
        <https://1145.am/db/2366187/Canaan_Partners>,
        <https://1145.am/db/2366753/Canaan_Partners>,
        <https://1145.am/db/2368322/Canaan_Partners>,
        <https://1145.am/db/2368973/Canaan_Partners>,
        <https://1145.am/db/2368982/Canaan_Partners>,
        <https://1145.am/db/2370582/Canaan_Partners>,
        <https://1145.am/db/2370802/Canaan_Partners>,
        <https://1145.am/db/2370834/Canaan_Partners>,
        <https://1145.am/db/2572398/Canaan_Partners>,
        <https://1145.am/db/2583466/Canaan_Partners>,
        <https://1145.am/db/2635439/Canaan_Partners>,
        <https://1145.am/db/316299/Canaan_Partners>,
        <https://1145.am/db/319155/Canaan_Partners>,
        <https://1145.am/db/353476/Canaan_Partners>,
        <https://1145.am/db/411041/Canaan_Partners>,
        <https://1145.am/db/523179/Canaan_Partners>,
        <https://1145.am/db/564082/Canaan_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353588/Elevation_Pharmaceuticals> a org:Organization ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2012-01-04T13:03:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/elevation-pharmaceuticals-completes-30-million-series-b-financing-to-advance-aerosol-copd-1> ;
    ns1:foundName "Elevation",
        "Elevation Pharmaceuticals",
        "Elevation Pharmaceuticals, Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Elevation Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2309376/Elevation_Pharmaceuticals>,
        <https://1145.am/db/2309387/Elevation_Pharmaceuticals>,
        <https://1145.am/db/2352666/Elevation_Pharmaceuticals>,
        <https://1145.am/db/2352672/Elevation_Pharmaceuticals>,
        <https://1145.am/db/2352673/Elevation_Pharmaceuticals>,
        <https://1145.am/db/2353608/Elevation_Pharmaceuticals>,
        <https://1145.am/db/2354757/Elevation_Pharmaceuticals>,
        <https://1145.am/db/2354760/Elevation_Pharmaceuticals>,
        <https://1145.am/db/2354765/Elevation_Pharmaceuticals>,
        <https://1145.am/db/2569266/Elevation_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353608/Canaan_Partners> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-01-04T16:01:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/elevation-pharmaceuticals-completes-30-million-series-b-financing-to-advance-aerosol-copd> ;
    ns1:foundName "Canaan Partners" ;
    ns1:investor <https://1145.am/db/2353608/Series_B_Investment_Canaan_Partners_Care_Capital_Elevation_Pharmaceuticals_Mesa_Verde_Venture_Partners_Novo_Ventures_Tpg_Biotech_Completed> ;
    ns1:name "Canaan Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1043342/Canaan_Partners>,
        <https://1145.am/db/146274/Canaan_Partners>,
        <https://1145.am/db/1695894/Canaan_Partners>,
        <https://1145.am/db/1696766/Canaan_Partners>,
        <https://1145.am/db/1697131/Canaan_Partners>,
        <https://1145.am/db/1702857/Canaan_Partners>,
        <https://1145.am/db/1711633/Canaan_Partners>,
        <https://1145.am/db/1724566/Canaan_Partners>,
        <https://1145.am/db/1734259/Canaan_Partners>,
        <https://1145.am/db/1741014/Canaan_Partners>,
        <https://1145.am/db/1741105/Canaan_Partners>,
        <https://1145.am/db/1741424/Canaan_Partners>,
        <https://1145.am/db/1749744/Canaan_Partners>,
        <https://1145.am/db/1754820/Canaan_Partners>,
        <https://1145.am/db/1768400/Canaan_Partners>,
        <https://1145.am/db/1770648/Canaan_Partners>,
        <https://1145.am/db/1791628/Canaan_Partners>,
        <https://1145.am/db/1792426/Canaan_Partners>,
        <https://1145.am/db/1793543/Canaan_Partners>,
        <https://1145.am/db/1796375/Canaan_Partners>,
        <https://1145.am/db/1814413/Canaan_Partners>,
        <https://1145.am/db/1819543/Canaan_Partners>,
        <https://1145.am/db/1827240/Canaan_Partners>,
        <https://1145.am/db/1829078/Canaan_Partners>,
        <https://1145.am/db/1829544/Canaan_Partners>,
        <https://1145.am/db/1836578/Canaan_Partners>,
        <https://1145.am/db/1842466/Canaan_Partners>,
        <https://1145.am/db/1845119/Canaan_Partners>,
        <https://1145.am/db/1852066/Canaan_Partners>,
        <https://1145.am/db/1858762/Canaan_Partners>,
        <https://1145.am/db/1863401/Canaan_Partners>,
        <https://1145.am/db/1866968/Canaan_Partners>,
        <https://1145.am/db/1894670/Canaan_Partners>,
        <https://1145.am/db/1897255/Canaan_Partners>,
        <https://1145.am/db/1900458/Canaan_Partners>,
        <https://1145.am/db/1906336/Canaan_Partners>,
        <https://1145.am/db/1907151/Canaan_Partners>,
        <https://1145.am/db/1907762/Canaan_Partners>,
        <https://1145.am/db/1910644/Canaan_Partners>,
        <https://1145.am/db/1919135/Canaan_Partners>,
        <https://1145.am/db/1920478/Canaan_Partners>,
        <https://1145.am/db/2164798/Canaan_Partners>,
        <https://1145.am/db/2164838/Canaan_Partners>,
        <https://1145.am/db/2210939/Canaan_Partners>,
        <https://1145.am/db/2238667/Canaan_Partners>,
        <https://1145.am/db/2287025/Canaan_Partners>,
        <https://1145.am/db/2287777/Canaan_Partners>,
        <https://1145.am/db/2297592/Canaan_Partners>,
        <https://1145.am/db/2298642/Canaan_Partners>,
        <https://1145.am/db/2301765/Canaan_Partners>,
        <https://1145.am/db/2304587/Canaan_Partners>,
        <https://1145.am/db/2304605/Canaan_Partners>,
        <https://1145.am/db/2306281/Canaan_Partners>,
        <https://1145.am/db/2308329/Canaan_Partners>,
        <https://1145.am/db/2309376/Canaan_Partners>,
        <https://1145.am/db/2309387/Canaan_Partners>,
        <https://1145.am/db/2313171/Canaan_Partners>,
        <https://1145.am/db/2320925/Canaan_Partners>,
        <https://1145.am/db/2322231/Canaan_Partners>,
        <https://1145.am/db/2329010/Canaan_Partners>,
        <https://1145.am/db/2329011/Canaan_Partners>,
        <https://1145.am/db/2329531/Canaan_Partners>,
        <https://1145.am/db/2332322/Canaan_Partners>,
        <https://1145.am/db/2337958/Canaan_Partners>,
        <https://1145.am/db/2337974/Canaan_Partners>,
        <https://1145.am/db/2346532/Canaan_Partners>,
        <https://1145.am/db/2347469/Canaan_Partners>,
        <https://1145.am/db/2351129/Canaan_Partners>,
        <https://1145.am/db/2351316/Canaan_Partners>,
        <https://1145.am/db/2351684/Canaan_Partners>,
        <https://1145.am/db/2353588/Canaan_Partners>,
        <https://1145.am/db/2355043/Canaan_Partners>,
        <https://1145.am/db/2355238/Canaan_Partners>,
        <https://1145.am/db/2355715/Canaan_Partners>,
        <https://1145.am/db/2358378/Canaan_Partners>,
        <https://1145.am/db/2359185/Canaan_Partners>,
        <https://1145.am/db/2360258/Canaan_Partners>,
        <https://1145.am/db/2360266/Canaan_Partners>,
        <https://1145.am/db/2360647/Canaan_Partners>,
        <https://1145.am/db/2363535/Canaan_Partners>,
        <https://1145.am/db/2365700/Canaan_Partners>,
        <https://1145.am/db/2366187/Canaan_Partners>,
        <https://1145.am/db/2366753/Canaan_Partners>,
        <https://1145.am/db/2368322/Canaan_Partners>,
        <https://1145.am/db/2368973/Canaan_Partners>,
        <https://1145.am/db/2368982/Canaan_Partners>,
        <https://1145.am/db/2370582/Canaan_Partners>,
        <https://1145.am/db/2370802/Canaan_Partners>,
        <https://1145.am/db/2370834/Canaan_Partners>,
        <https://1145.am/db/2572398/Canaan_Partners>,
        <https://1145.am/db/2583466/Canaan_Partners>,
        <https://1145.am/db/2635439/Canaan_Partners>,
        <https://1145.am/db/316299/Canaan_Partners>,
        <https://1145.am/db/319155/Canaan_Partners>,
        <https://1145.am/db/353476/Canaan_Partners>,
        <https://1145.am/db/411041/Canaan_Partners>,
        <https://1145.am/db/523179/Canaan_Partners>,
        <https://1145.am/db/564082/Canaan_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353608/Elevation_Pharmaceuticals> a org:Organization ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2012-01-04T16:01:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/elevation-pharmaceuticals-completes-30-million-series-b-financing-to-advance-aerosol-copd> ;
    ns1:foundName "Elevation",
        "Elevation Pharmaceuticals",
        "Elevation Pharmaceuticals, Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Elevation Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2309376/Elevation_Pharmaceuticals>,
        <https://1145.am/db/2309387/Elevation_Pharmaceuticals>,
        <https://1145.am/db/2352666/Elevation_Pharmaceuticals>,
        <https://1145.am/db/2352672/Elevation_Pharmaceuticals>,
        <https://1145.am/db/2352673/Elevation_Pharmaceuticals>,
        <https://1145.am/db/2353588/Elevation_Pharmaceuticals>,
        <https://1145.am/db/2354757/Elevation_Pharmaceuticals>,
        <https://1145.am/db/2354760/Elevation_Pharmaceuticals>,
        <https://1145.am/db/2354765/Elevation_Pharmaceuticals>,
        <https://1145.am/db/2569266/Elevation_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354625/Investment_Apogenix_Gmbh_German_Cancer_Research_Center_Dievini_Hopp_Biotech_Holding_Gmbh___Co_Kg_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-01-05T14:53:53+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Apogenix / Apogenix Raises EUR 7.5 Million to Further Advance APG101 to Treat Glioblastoma and other Tumors.",
        "Apogenix Raises EUR 7.5 Million to Further Advance APG101 to Treat Glioblastoma and other Tumors.",
        "Heidelberg, January 5, 2012 - The biopharmaceutical company Apogenix GmbH today announced the successful completion of a EUR 7.5 million financing round led by dievini Hopp BioTech holding GmbH & Co. KG (dievini) .",
        "Heidelberg, January 5, 2012 - The biopharmaceutical company Apogenix GmbH today announced the successful completion of a EUR 7.5 million financing round led by dievini Hopp BioTech holding GmbH & Co. KG (dievini)." ;
    ns1:documentTitle "Apogenix Raises EUR 7.5 Million to Further Advance APG101 to Treat Glioblastoma and other Tumors" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/apogenix-raises-eur-7-5-million-to-further-advance-apg101-to-treat-glioblastoma-and-other> ;
    ns1:foundName "Raises",
        "financing" ;
    ns1:name "Raises",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2354625/Apogenix_Gmbh> ;
    ns1:valueRaw "EUR 7.5 Million",
        "EUR 7.5 million" ;
    ns1:when "2012-01-05T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Jan 5, 2012",
        "January 5, 2012" ;
    ns1:whereGeoName "Eastern Province" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6413337/about.rdf> ;
    ns1:whereRaw "EST" .

<https://1145.am/db/2354706/Investment_Putney_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-09-29T16:18:37+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Safeguard Scientifics, Inc. (NYSE: SFE) , a holding company that builds value in growth-stage life sciences and technology companies, today announced that it co - led a $ 21 million Series C financing for Putney, a Portland, ME - based specialty pharmaceutical company focused on providing high quality, cost-effective generic medicines for pets.",
        "Specialty pharmaceutical company Putney has raised $ 21 million in new financing co - led by listed Safeguard Scientifics Inc. NewSpring Health Capital and other, undisclosed investors also contributed." ;
    ns1:documentTitle "Safeguard Scientifics Leads $21M Round for Putney" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/safeguard-scientifics-leads-21m-round-for-putney> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2354706/Putney> ;
    ns1:targetDetails "Series C" ;
    ns1:targetName "Putney" ;
    ns1:valueRaw "$ 10 million",
        "$ 21 million" ;
    ns1:whereGeoName "Maine",
        "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4971068/about.rdf>,
        <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "Maine",
        "United States" .

<https://1145.am/db/2355715/Canaan_Ix> a org:Organization ;
    ns1:basedInLowRaw "global" ;
    ns1:description "visionary entrepreneurs" ;
    ns1:documentDate "2012-01-10T12:30:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Canaan Partners Closes $600 Million Fund, Canaan IX" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/canaan-partners-closes-600-million-fund-canaan-ix> ;
    ns1:foundName "Canaan IX" ;
    ns1:industry "venture capital" ;
    ns1:name "Canaan IX" ;
    ns1:sameAsHigh <https://1145.am/db/1845119/Canaan_Partners>,
        <https://1145.am/db/2301765/Canaan_Partners>,
        <https://1145.am/db/2355715/Canaan_Partners>,
        <https://1145.am/db/2370802/Canaan_Partners>,
        <https://1145.am/db/2370834/Canaan_Partners>,
        <https://1145.am/db/2635439/Canaan_Partners>,
        <https://1145.am/db/316299/Canaan_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355754/Cv_Ingenuity> a org:Organization ;
    ns1:basedInHighGeoName "Menlo Park" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5372223/about.rdf> ;
    ns1:basedInHighRaw "MENLO PARK" ;
    ns1:description "medical device" ;
    ns1:documentDate "2011-10-04T15:38:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CV Ingenuity Announces Close of $16 Million Series B Financing Led by NEA" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cv-ingenuity-announces-close-of-16-million-series-b-financing-led-by-nea> ;
    ns1:foundName "CV Ingenuity" ;
    ns1:industry "medical device" ;
    ns1:name "CV Ingenuity" ;
    ns1:sameAsHigh <https://1145.am/db/2293793/Cv_Ingenuity> ;
    ns1:sameAsMedium <https://1145.am/db/2294842/Cv_Ingenuity>,
        <https://1145.am/db/2295328/Cv_Ingenuity> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357829/Investment_Clearlake_Capital_Group_Imperium_Partners_Group_Llc_San_Mateo_Calif-Entelos_Holding_Corporation_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-01-17T14:04:24+00:00"^^xsd:dateTime ;
    ns1:documentExtract "SAN MATEO, Calif.-Entelos Holding Corporation (\"Entelos\" or the \"Company\") , a premier provider of in silico modeling and simulation products and services that help pharmaceutical and consumer product companies make informed decisions in their product development process, today announced that it has completed a recapitalization and has received a significant capital infusion led by Clearlake Capital Group, L.P. (\"Clearlake\") with participation by the Company's existing investor, Imperium Partners Group, LLC (\"Imperium\") ." ;
    ns1:documentTitle "Entelos Announces Recapitalization and Significant Capital Infusion to Drive Future Growth" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/entelos-announces-recapitalization-and-significant-capital-infusion-to-drive-future-growth> ;
    ns1:foundName "capital infusion",
        "recapitalization" ;
    ns1:name "capital infusion",
        "recapitalization" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2357829/San_Mateo_Calif-Entelos_Holding_Corporation> ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2357858/Orbimed_Advisors> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:documentDate "2011-10-11T13:15:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cleave-biosciences-raises-42-million-series-a-financing-for-novel-cancer-therapies> ;
    ns1:foundName "OrbiMed Advisors" ;
    ns1:investor <https://1145.am/db/2357858/Series_A_Investment_5am_Ventures_Astellas_Venture_Management_Clarus_Ventures_Cleave_Biosciences_Orbimed_Advisors_Us_Venture_Partners_Completed> ;
    ns1:name "OrbiMed Advisors" ;
    ns1:sameAsMedium <https://1145.am/db/1665536/Orbimed_Advisors>,
        <https://1145.am/db/1809007/Orbimed_Advisors>,
        <https://1145.am/db/2198816/Orbimed_Advisors>,
        <https://1145.am/db/2245885/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2281230/Orbimed_Advisors>,
        <https://1145.am/db/2284506/Orbimed_Advisors>,
        <https://1145.am/db/2289056/Orbimed_Advisors>,
        <https://1145.am/db/2290078/Orbimed_Advisors>,
        <https://1145.am/db/2290200/Orbimed_Advisors>,
        <https://1145.am/db/2290444/Orbimed_Advisors>,
        <https://1145.am/db/2297604/Orbimed_Advisors>,
        <https://1145.am/db/2298956/Orbimed_Advisors>,
        <https://1145.am/db/2303098/Orbimed_Advisors>,
        <https://1145.am/db/2304242/Orbimed_Advisors>,
        <https://1145.am/db/2305656/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306251/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306705/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2309491/Orbimed_Advisors>,
        <https://1145.am/db/2310922/Orbimed_Advisors>,
        <https://1145.am/db/2312233/Orbimed_Advisors>,
        <https://1145.am/db/2317918/Orbimed_Advisors>,
        <https://1145.am/db/2318133/Orbimed_Advisors>,
        <https://1145.am/db/2318829/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2318832/Orbimed_Advisers>,
        <https://1145.am/db/2318851/Orbimed_Advisors>,
        <https://1145.am/db/2319338/Orbimed_Advisors>,
        <https://1145.am/db/2320914/Orbimed_Advisors>,
        <https://1145.am/db/2322345/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2324226/Orbimed_Advisors>,
        <https://1145.am/db/2325257/Orbimed_Advisors>,
        <https://1145.am/db/2325880/Orbimed_Advisors>,
        <https://1145.am/db/2328599/Orbimed_Advisors>,
        <https://1145.am/db/2328700/Orbimed_Advisors>,
        <https://1145.am/db/2329260/Orbimed_Advisors>,
        <https://1145.am/db/2330799/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2330920/Orbimed_Advisors>,
        <https://1145.am/db/2332120/Orbimed_Advisors>,
        <https://1145.am/db/2333495/Orbimed_Advisors>,
        <https://1145.am/db/2333504/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2333966/Orbimed_Advisors>,
        <https://1145.am/db/2335743/Orbimed_Advisors>,
        <https://1145.am/db/2336221/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2336503/Orbimed_Advisors>,
        <https://1145.am/db/2336505/Orbimed_Advisors>,
        <https://1145.am/db/2336524/Orbimed_Advisors>,
        <https://1145.am/db/2337166/Orbimed_Advisors>,
        <https://1145.am/db/2337250/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2337254/Orbimed_Advisors>,
        <https://1145.am/db/2339885/Orbimed_Advisors>,
        <https://1145.am/db/2339886/Orbimed_Advisors>,
        <https://1145.am/db/2342862/Orbimed_Advisors>,
        <https://1145.am/db/2342925/Orbimed_Advisors>,
        <https://1145.am/db/2342937/Orbimed_Advisors>,
        <https://1145.am/db/2343244/Orbimed_Advisors>,
        <https://1145.am/db/2344735/Orbimed_Advisors>,
        <https://1145.am/db/2344786/Orbimed_Advisors>,
        <https://1145.am/db/2345435/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345453/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345456/Orbimed_Advisors>,
        <https://1145.am/db/2346030/Orbimed_Advisors>,
        <https://1145.am/db/2350034/Orbimed_Advisors>,
        <https://1145.am/db/2350044/Orbimed_Advisors>,
        <https://1145.am/db/2352436/Orbimed_Advisors>,
        <https://1145.am/db/2352441/Orbimed_Advisors>,
        <https://1145.am/db/2352442/Orbimed_Advisors>,
        <https://1145.am/db/2352701/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2352804/Orbimed_Advisors>,
        <https://1145.am/db/2352807/Orbimed_Advisors>,
        <https://1145.am/db/2355034/Orbimed_Advisors>,
        <https://1145.am/db/2356297/Orbimed_Advisors>,
        <https://1145.am/db/2356420/Orbimed_Advisors>,
        <https://1145.am/db/2357253/Orbimed_Advisors>,
        <https://1145.am/db/2357256/Orbimed_Advisors>,
        <https://1145.am/db/2359125/Orbimed_Advisors>,
        <https://1145.am/db/2359468/Orbimed_Advisors>,
        <https://1145.am/db/2359864/Orbimed_Advisors>,
        <https://1145.am/db/2360174/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2361018/Orbimed_Advisors>,
        <https://1145.am/db/2361022/Orbimed_Advisors>,
        <https://1145.am/db/2361027/Orbimed_Advisors>,
        <https://1145.am/db/2362475/Orbimed_Advisors>,
        <https://1145.am/db/2362481/Orbimed_Advisors>,
        <https://1145.am/db/2363339/Orbimed_Advisors>,
        <https://1145.am/db/2365679/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2365868/Orbimed_Advisors>,
        <https://1145.am/db/2366519/Orbimed_Advisors>,
        <https://1145.am/db/2574232/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2583013/Orbimed_Advisors>,
        <https://1145.am/db/428737/Orbimed_Advisors>,
        <https://1145.am/db/456081/Orbimed_Advisors>,
        <https://1145.am/db/456089/Orbimed_Advisors>,
        <https://1145.am/db/458377/Orbimed_Advisors>,
        <https://1145.am/db/674484/Orbimed_Advisors> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359960/Series_A_Investment_Forbion_Capital_Partners_Hookipa_Biotech_Sofinnova_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-10-17T11:54:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Hookipa Biotech Closes €7 million Series A Financing led by Sofinnova Partners.",
        "Vienna, Austria October 17, 2011 - Hookipa Biotech, a startup biotech company specialized in developing new generation vaccines, today announced that it has raised €7 million Series A financing led by Sofinnova Partners." ;
    ns1:documentTitle "Hookipa Biotech Closes €7 million Series A Financing led by Sofinnova Partners" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/hookipa-biotech-closes-%E2%82%AC7-million-series-a-financing-led-by-sofinnova-partners> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2359960/Hookipa_Biotech> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "€7 million" ;
    ns1:when "2011-10-17T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "October 17, 2011" ;
    ns1:whereGeoName "Republic of Austria" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2782113/about.rdf> ;
    ns1:whereRaw "Austria" .

<https://1145.am/db/2359987/Third_Rock_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:documentDate "2011-10-18T12:15:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Foundation Medicine Closes Expanded Series A Financing Totaling $33.5 Million; Kleiner Perkins Caufield & Byers and Google" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/foundation-medicine-closes-expanded-series-a-financing-totaling-33-5-million-kleiner> ;
    ns1:foundName "Third Rock Ventures" ;
    ns1:investor <https://1145.am/db/2359987/Series_A_Investment_Foundation_Medicine_Google_Ventures_Kleiner_Perkins_Caufield___Byers_Third_Rock_Ventures_Completed> ;
    ns1:name "Third Rock Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Third_Rock_Ventures>,
        <https://1145.am/db/1086582/Third_Rock_Ventures>,
        <https://1145.am/db/1089269/Third_Rock_Ventures>,
        <https://1145.am/db/1325987/Third_Rock_Ventures>,
        <https://1145.am/db/1326547/Third_Rock_Ventures>,
        <https://1145.am/db/1503058/Third_Rock_Ventures>,
        <https://1145.am/db/159801/Third_Rock_Ventures>,
        <https://1145.am/db/1928208/Third_Rock_Ventures>,
        <https://1145.am/db/2095032/Third_Rock_Ventures>,
        <https://1145.am/db/2152566/Third_Rock_Ventures>,
        <https://1145.am/db/2153763/Third_Rock_Ventures>,
        <https://1145.am/db/2281272/Third_Rock_Ventures>,
        <https://1145.am/db/2291199/Third_Rock_Ventures>,
        <https://1145.am/db/2291940/Third_Rock_Ventures>,
        <https://1145.am/db/2294789/Third_Rock_Ventures>,
        <https://1145.am/db/2298193/Third_Rock_Ventures>,
        <https://1145.am/db/2298844/Third_Rock_Ventures>,
        <https://1145.am/db/2300971/Third_Rock_Ventures>,
        <https://1145.am/db/2303250/Third_Rock_Ventures>,
        <https://1145.am/db/2303251/Third_Rock_Ventures>,
        <https://1145.am/db/2303257/Third_Rock_Ventures>,
        <https://1145.am/db/2303294/Third_Rock_Ventures>,
        <https://1145.am/db/2311551/Third_Rock_Ventures>,
        <https://1145.am/db/2315931/Third_Rock_Ventures>,
        <https://1145.am/db/2315933/Third_Rock_Ventures>,
        <https://1145.am/db/2322522/Third_Rock_Ventures>,
        <https://1145.am/db/2322531/Third_Rock_Ventures>,
        <https://1145.am/db/2327474/Third_Rock_Ventures>,
        <https://1145.am/db/2335531/Third_Rock_Ventures>,
        <https://1145.am/db/2335750/Third_Rock_Ventures>,
        <https://1145.am/db/2335755/Third_Rock_Ventures>,
        <https://1145.am/db/2336126/Third_Rock_Ventures>,
        <https://1145.am/db/2337555/Third_Rock_Ventures>,
        <https://1145.am/db/2337559/Third_Rock_Ventures>,
        <https://1145.am/db/2337889/Third_Rock_Ventures>,
        <https://1145.am/db/2337958/Third_Rock_Ventures>,
        <https://1145.am/db/2337974/Third_Rock_Ventures>,
        <https://1145.am/db/2338625/Third_Rock_Ventures>,
        <https://1145.am/db/2338633/Third_Rock_Ventures>,
        <https://1145.am/db/2339127/Third_Rock_Ventures>,
        <https://1145.am/db/2339128/Third_Rock_Ventures>,
        <https://1145.am/db/2339413/Third_Rock_Ventures>,
        <https://1145.am/db/2339704/Third_Rock_Ventures>,
        <https://1145.am/db/2339925/Third_Rock_Ventures>,
        <https://1145.am/db/2339926/Third_Rock_Ventures>,
        <https://1145.am/db/2341662/Third_Rock_Ventures>,
        <https://1145.am/db/2341792/Third_Rock_Ventures>,
        <https://1145.am/db/2341800/Third_Rock_Ventures>,
        <https://1145.am/db/2342754/Third_Rock_Ventures>,
        <https://1145.am/db/2342768/Third_Rock_Ventures>,
        <https://1145.am/db/2342771/Third_Rock_Ventures>,
        <https://1145.am/db/2344256/Third_Rock_Ventures>,
        <https://1145.am/db/2344912/Third_Rock_Ventures>,
        <https://1145.am/db/2344918/Third_Rock_Ventures>,
        <https://1145.am/db/2345224/Third_Rock_Ventures>,
        <https://1145.am/db/2346212/Third_Rock_Ventures>,
        <https://1145.am/db/2346216/Third_Rock_Ventures>,
        <https://1145.am/db/2346988/Third_Rock_Ventures>,
        <https://1145.am/db/2347885/Third_Rock_Ventures>,
        <https://1145.am/db/2350364/Third_Rock_Ventures>,
        <https://1145.am/db/2351009/Third_Rock_Ventures>,
        <https://1145.am/db/2351011/Third_Rock_Ventures>,
        <https://1145.am/db/2351348/Third_Rock_Ventures>,
        <https://1145.am/db/2351372/Third_Rock_Ventures>,
        <https://1145.am/db/2351520/Third_Rock_Ventures>,
        <https://1145.am/db/2351644/Third_Rock_Ventures>,
        <https://1145.am/db/2354307/Third_Rock_Ventures>,
        <https://1145.am/db/2354314/Third_Rock_Ventures>,
        <https://1145.am/db/2354608/Third_Rock_Ventures>,
        <https://1145.am/db/2354613/Third_Rock_Ventures>,
        <https://1145.am/db/2355043/Third_Rock_Ventures>,
        <https://1145.am/db/2357253/Third_Rock_Ventures>,
        <https://1145.am/db/2357256/Third_Rock_Ventures>,
        <https://1145.am/db/2357722/Third_Rock_Ventures>,
        <https://1145.am/db/2358551/Third_Rock_Ventures>,
        <https://1145.am/db/2358737/Third_Rock_Ventures>,
        <https://1145.am/db/2359321/Third_Rock_Ventures>,
        <https://1145.am/db/2359334/Third_Rock_Ventures>,
        <https://1145.am/db/2359447/Third_Rock_Ventures>,
        <https://1145.am/db/2359575/Third_Rock_Ventures>,
        <https://1145.am/db/2359818/Third_Rock_Ventures>,
        <https://1145.am/db/2359864/Third_Rock_Ventures>,
        <https://1145.am/db/2359873/Third_Rock_Ventures>,
        <https://1145.am/db/2359875/Third_Rock_Ventures>,
        <https://1145.am/db/2359887/Third_Rock_Ventures>,
        <https://1145.am/db/2359984/Third_Rock_Ventures>,
        <https://1145.am/db/2360006/Third_Rock_Ventures>,
        <https://1145.am/db/2360169/Third_Rock_Ventures>,
        <https://1145.am/db/2360814/Third_Rock_Ventures>,
        <https://1145.am/db/2360877/Third_Rock_Ventures>,
        <https://1145.am/db/2362102/Third_Rock_Ventures>,
        <https://1145.am/db/2362109/Third_Rock_Ventures>,
        <https://1145.am/db/2362128/Third_Rock_Ventures>,
        <https://1145.am/db/2363422/Third_Rock_Ventures>,
        <https://1145.am/db/2364240/Third_Rock_Ventures>,
        <https://1145.am/db/2364249/Third_Rock_Ventures>,
        <https://1145.am/db/2364255/Third_Rock_Ventures>,
        <https://1145.am/db/2364283/Third_Rock_Ventures>,
        <https://1145.am/db/2364481/Third_Rock_Ventures>,
        <https://1145.am/db/2365109/Third_Rock_Ventures>,
        <https://1145.am/db/2365111/Third_Rock_Ventures>,
        <https://1145.am/db/2365315/Third_Rock_Ventures>,
        <https://1145.am/db/2366539/Third_Rock_Ventures>,
        <https://1145.am/db/2366641/Third_Rock_Ventures>,
        <https://1145.am/db/2367442/Third_Rock_Ventures>,
        <https://1145.am/db/2367448/Third_Rock_Ventures>,
        <https://1145.am/db/2368166/Third_Rock_Ventures>,
        <https://1145.am/db/2368501/Third_Rock_Ventures>,
        <https://1145.am/db/2369130/Third_Rock_Ventures>,
        <https://1145.am/db/2369202/Third_Rock_Ventures>,
        <https://1145.am/db/2370105/Third_Rock_Ventures_Llc>,
        <https://1145.am/db/2371191/Third_Rock_Ventures>,
        <https://1145.am/db/2580088/Third_Rock_Ventures>,
        <https://1145.am/db/2584533/Third_Rock_Ventures>,
        <https://1145.am/db/441151/Third_Rock_Ventures>,
        <https://1145.am/db/572554/Third_Rock_Ventures>,
        <https://1145.am/db/768794/Third_Rock_Ventures>,
        <https://1145.am/db/769408/Third_Rock_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360006/Third_Rock_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CA" ;
    ns1:documentDate "2011-10-18T15:40:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TOPICA Announces Completion of $27 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/topica-announces-completion-of-27-million-series-b-financing> ;
    ns1:foundName "Third Rock Ventures" ;
    ns1:investor <https://1145.am/db/2360006/Series_B_Investment_Prospect_Venture_Partners_Topica_Pharmaceuticals_Third_Rock_Ventures_Yasuda_Enterprise_Development_Corporation_Completed> ;
    ns1:name "Third Rock Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Third_Rock_Ventures>,
        <https://1145.am/db/1086582/Third_Rock_Ventures>,
        <https://1145.am/db/1089269/Third_Rock_Ventures>,
        <https://1145.am/db/1325987/Third_Rock_Ventures>,
        <https://1145.am/db/1326547/Third_Rock_Ventures>,
        <https://1145.am/db/1503058/Third_Rock_Ventures>,
        <https://1145.am/db/159801/Third_Rock_Ventures>,
        <https://1145.am/db/1928208/Third_Rock_Ventures>,
        <https://1145.am/db/2095032/Third_Rock_Ventures>,
        <https://1145.am/db/2152566/Third_Rock_Ventures>,
        <https://1145.am/db/2153763/Third_Rock_Ventures>,
        <https://1145.am/db/2281272/Third_Rock_Ventures>,
        <https://1145.am/db/2291199/Third_Rock_Ventures>,
        <https://1145.am/db/2291940/Third_Rock_Ventures>,
        <https://1145.am/db/2294789/Third_Rock_Ventures>,
        <https://1145.am/db/2298193/Third_Rock_Ventures>,
        <https://1145.am/db/2298844/Third_Rock_Ventures>,
        <https://1145.am/db/2300971/Third_Rock_Ventures>,
        <https://1145.am/db/2303250/Third_Rock_Ventures>,
        <https://1145.am/db/2303251/Third_Rock_Ventures>,
        <https://1145.am/db/2303257/Third_Rock_Ventures>,
        <https://1145.am/db/2303294/Third_Rock_Ventures>,
        <https://1145.am/db/2311551/Third_Rock_Ventures>,
        <https://1145.am/db/2315931/Third_Rock_Ventures>,
        <https://1145.am/db/2315933/Third_Rock_Ventures>,
        <https://1145.am/db/2322522/Third_Rock_Ventures>,
        <https://1145.am/db/2322531/Third_Rock_Ventures>,
        <https://1145.am/db/2327474/Third_Rock_Ventures>,
        <https://1145.am/db/2335531/Third_Rock_Ventures>,
        <https://1145.am/db/2335750/Third_Rock_Ventures>,
        <https://1145.am/db/2335755/Third_Rock_Ventures>,
        <https://1145.am/db/2336126/Third_Rock_Ventures>,
        <https://1145.am/db/2337555/Third_Rock_Ventures>,
        <https://1145.am/db/2337559/Third_Rock_Ventures>,
        <https://1145.am/db/2337889/Third_Rock_Ventures>,
        <https://1145.am/db/2337958/Third_Rock_Ventures>,
        <https://1145.am/db/2337974/Third_Rock_Ventures>,
        <https://1145.am/db/2338625/Third_Rock_Ventures>,
        <https://1145.am/db/2338633/Third_Rock_Ventures>,
        <https://1145.am/db/2339127/Third_Rock_Ventures>,
        <https://1145.am/db/2339128/Third_Rock_Ventures>,
        <https://1145.am/db/2339413/Third_Rock_Ventures>,
        <https://1145.am/db/2339704/Third_Rock_Ventures>,
        <https://1145.am/db/2339925/Third_Rock_Ventures>,
        <https://1145.am/db/2339926/Third_Rock_Ventures>,
        <https://1145.am/db/2341662/Third_Rock_Ventures>,
        <https://1145.am/db/2341792/Third_Rock_Ventures>,
        <https://1145.am/db/2341800/Third_Rock_Ventures>,
        <https://1145.am/db/2342754/Third_Rock_Ventures>,
        <https://1145.am/db/2342768/Third_Rock_Ventures>,
        <https://1145.am/db/2342771/Third_Rock_Ventures>,
        <https://1145.am/db/2344256/Third_Rock_Ventures>,
        <https://1145.am/db/2344912/Third_Rock_Ventures>,
        <https://1145.am/db/2344918/Third_Rock_Ventures>,
        <https://1145.am/db/2345224/Third_Rock_Ventures>,
        <https://1145.am/db/2346212/Third_Rock_Ventures>,
        <https://1145.am/db/2346216/Third_Rock_Ventures>,
        <https://1145.am/db/2346988/Third_Rock_Ventures>,
        <https://1145.am/db/2347885/Third_Rock_Ventures>,
        <https://1145.am/db/2350364/Third_Rock_Ventures>,
        <https://1145.am/db/2351009/Third_Rock_Ventures>,
        <https://1145.am/db/2351011/Third_Rock_Ventures>,
        <https://1145.am/db/2351348/Third_Rock_Ventures>,
        <https://1145.am/db/2351372/Third_Rock_Ventures>,
        <https://1145.am/db/2351520/Third_Rock_Ventures>,
        <https://1145.am/db/2351644/Third_Rock_Ventures>,
        <https://1145.am/db/2354307/Third_Rock_Ventures>,
        <https://1145.am/db/2354314/Third_Rock_Ventures>,
        <https://1145.am/db/2354608/Third_Rock_Ventures>,
        <https://1145.am/db/2354613/Third_Rock_Ventures>,
        <https://1145.am/db/2355043/Third_Rock_Ventures>,
        <https://1145.am/db/2357253/Third_Rock_Ventures>,
        <https://1145.am/db/2357256/Third_Rock_Ventures>,
        <https://1145.am/db/2357722/Third_Rock_Ventures>,
        <https://1145.am/db/2358551/Third_Rock_Ventures>,
        <https://1145.am/db/2358737/Third_Rock_Ventures>,
        <https://1145.am/db/2359321/Third_Rock_Ventures>,
        <https://1145.am/db/2359334/Third_Rock_Ventures>,
        <https://1145.am/db/2359447/Third_Rock_Ventures>,
        <https://1145.am/db/2359575/Third_Rock_Ventures>,
        <https://1145.am/db/2359818/Third_Rock_Ventures>,
        <https://1145.am/db/2359864/Third_Rock_Ventures>,
        <https://1145.am/db/2359873/Third_Rock_Ventures>,
        <https://1145.am/db/2359875/Third_Rock_Ventures>,
        <https://1145.am/db/2359887/Third_Rock_Ventures>,
        <https://1145.am/db/2359984/Third_Rock_Ventures>,
        <https://1145.am/db/2359987/Third_Rock_Ventures>,
        <https://1145.am/db/2360169/Third_Rock_Ventures>,
        <https://1145.am/db/2360814/Third_Rock_Ventures>,
        <https://1145.am/db/2360877/Third_Rock_Ventures>,
        <https://1145.am/db/2362102/Third_Rock_Ventures>,
        <https://1145.am/db/2362109/Third_Rock_Ventures>,
        <https://1145.am/db/2362128/Third_Rock_Ventures>,
        <https://1145.am/db/2363422/Third_Rock_Ventures>,
        <https://1145.am/db/2364240/Third_Rock_Ventures>,
        <https://1145.am/db/2364249/Third_Rock_Ventures>,
        <https://1145.am/db/2364255/Third_Rock_Ventures>,
        <https://1145.am/db/2364283/Third_Rock_Ventures>,
        <https://1145.am/db/2364481/Third_Rock_Ventures>,
        <https://1145.am/db/2365109/Third_Rock_Ventures>,
        <https://1145.am/db/2365111/Third_Rock_Ventures>,
        <https://1145.am/db/2365315/Third_Rock_Ventures>,
        <https://1145.am/db/2366539/Third_Rock_Ventures>,
        <https://1145.am/db/2366641/Third_Rock_Ventures>,
        <https://1145.am/db/2367442/Third_Rock_Ventures>,
        <https://1145.am/db/2367448/Third_Rock_Ventures>,
        <https://1145.am/db/2368166/Third_Rock_Ventures>,
        <https://1145.am/db/2368501/Third_Rock_Ventures>,
        <https://1145.am/db/2369130/Third_Rock_Ventures>,
        <https://1145.am/db/2369202/Third_Rock_Ventures>,
        <https://1145.am/db/2370105/Third_Rock_Ventures_Llc>,
        <https://1145.am/db/2371191/Third_Rock_Ventures>,
        <https://1145.am/db/2580088/Third_Rock_Ventures>,
        <https://1145.am/db/2584533/Third_Rock_Ventures>,
        <https://1145.am/db/441151/Third_Rock_Ventures>,
        <https://1145.am/db/572554/Third_Rock_Ventures>,
        <https://1145.am/db/768794/Third_Rock_Ventures>,
        <https://1145.am/db/769408/Third_Rock_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2361022/Investment_Arteaus_Therapeutics_Atlas_Venture_Orbimed_Advisors_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-10-19T13:49:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Arteaus Therapeutics, LLC Raises $ 18M to Prevent Migraines.",
        "CAMBRIDGE, Mass., Oct 19, 2011 (BUSINESS WIRE) - Arteaus Therapeutics, LLC, a biotechnology development company focused on creating new therapies for migraine prevention, has raised $ 18M in financing from Atlas Venture and OrbiMed Advisors." ;
    ns1:documentTitle "Arteaus Therapeutics, LLC Raises $18M to Prevent Migraines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/arteaus-therapeutics-llc-raises-18m-to-prevent-migraines> ;
    ns1:foundName "Raises",
        "financing" ;
    ns1:name "Raises",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2361022/Arteaus_Therapeutics> ;
    ns1:valueRaw "$ 18M" ;
    ns1:whenRaw "2011" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2361022/Orbimed_Advisors> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2011-10-19T13:49:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Arteaus Therapeutics, LLC Raises $18M to Prevent Migraines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/arteaus-therapeutics-llc-raises-18m-to-prevent-migraines> ;
    ns1:foundName "OrbiMed Advisors" ;
    ns1:investor <https://1145.am/db/2361022/Investment_Arteaus_Therapeutics_Atlas_Venture_Orbimed_Advisors_Completed> ;
    ns1:name "OrbiMed Advisors" ;
    ns1:sameAsMedium <https://1145.am/db/1665536/Orbimed_Advisors>,
        <https://1145.am/db/1809007/Orbimed_Advisors>,
        <https://1145.am/db/2198816/Orbimed_Advisors>,
        <https://1145.am/db/2245885/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2281230/Orbimed_Advisors>,
        <https://1145.am/db/2284506/Orbimed_Advisors>,
        <https://1145.am/db/2289056/Orbimed_Advisors>,
        <https://1145.am/db/2290078/Orbimed_Advisors>,
        <https://1145.am/db/2290200/Orbimed_Advisors>,
        <https://1145.am/db/2290444/Orbimed_Advisors>,
        <https://1145.am/db/2297604/Orbimed_Advisors>,
        <https://1145.am/db/2298956/Orbimed_Advisors>,
        <https://1145.am/db/2303098/Orbimed_Advisors>,
        <https://1145.am/db/2304242/Orbimed_Advisors>,
        <https://1145.am/db/2305656/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306251/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306705/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2309491/Orbimed_Advisors>,
        <https://1145.am/db/2310922/Orbimed_Advisors>,
        <https://1145.am/db/2312233/Orbimed_Advisors>,
        <https://1145.am/db/2317918/Orbimed_Advisors>,
        <https://1145.am/db/2318133/Orbimed_Advisors>,
        <https://1145.am/db/2318829/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2318832/Orbimed_Advisers>,
        <https://1145.am/db/2318851/Orbimed_Advisors>,
        <https://1145.am/db/2319338/Orbimed_Advisors>,
        <https://1145.am/db/2320914/Orbimed_Advisors>,
        <https://1145.am/db/2322345/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2324226/Orbimed_Advisors>,
        <https://1145.am/db/2325257/Orbimed_Advisors>,
        <https://1145.am/db/2325880/Orbimed_Advisors>,
        <https://1145.am/db/2328599/Orbimed_Advisors>,
        <https://1145.am/db/2328700/Orbimed_Advisors>,
        <https://1145.am/db/2329260/Orbimed_Advisors>,
        <https://1145.am/db/2330799/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2330920/Orbimed_Advisors>,
        <https://1145.am/db/2332120/Orbimed_Advisors>,
        <https://1145.am/db/2333495/Orbimed_Advisors>,
        <https://1145.am/db/2333504/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2333966/Orbimed_Advisors>,
        <https://1145.am/db/2335743/Orbimed_Advisors>,
        <https://1145.am/db/2336221/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2336503/Orbimed_Advisors>,
        <https://1145.am/db/2336505/Orbimed_Advisors>,
        <https://1145.am/db/2336524/Orbimed_Advisors>,
        <https://1145.am/db/2337166/Orbimed_Advisors>,
        <https://1145.am/db/2337250/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2337254/Orbimed_Advisors>,
        <https://1145.am/db/2339885/Orbimed_Advisors>,
        <https://1145.am/db/2339886/Orbimed_Advisors>,
        <https://1145.am/db/2342862/Orbimed_Advisors>,
        <https://1145.am/db/2342925/Orbimed_Advisors>,
        <https://1145.am/db/2342937/Orbimed_Advisors>,
        <https://1145.am/db/2343244/Orbimed_Advisors>,
        <https://1145.am/db/2344735/Orbimed_Advisors>,
        <https://1145.am/db/2344786/Orbimed_Advisors>,
        <https://1145.am/db/2345435/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345453/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345456/Orbimed_Advisors>,
        <https://1145.am/db/2346030/Orbimed_Advisors>,
        <https://1145.am/db/2350034/Orbimed_Advisors>,
        <https://1145.am/db/2350044/Orbimed_Advisors>,
        <https://1145.am/db/2352436/Orbimed_Advisors>,
        <https://1145.am/db/2352441/Orbimed_Advisors>,
        <https://1145.am/db/2352442/Orbimed_Advisors>,
        <https://1145.am/db/2352701/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2352804/Orbimed_Advisors>,
        <https://1145.am/db/2352807/Orbimed_Advisors>,
        <https://1145.am/db/2355034/Orbimed_Advisors>,
        <https://1145.am/db/2356297/Orbimed_Advisors>,
        <https://1145.am/db/2356420/Orbimed_Advisors>,
        <https://1145.am/db/2357253/Orbimed_Advisors>,
        <https://1145.am/db/2357256/Orbimed_Advisors>,
        <https://1145.am/db/2357858/Orbimed_Advisors>,
        <https://1145.am/db/2359125/Orbimed_Advisors>,
        <https://1145.am/db/2359468/Orbimed_Advisors>,
        <https://1145.am/db/2359864/Orbimed_Advisors>,
        <https://1145.am/db/2360174/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2361018/Orbimed_Advisors>,
        <https://1145.am/db/2361027/Orbimed_Advisors>,
        <https://1145.am/db/2362475/Orbimed_Advisors>,
        <https://1145.am/db/2362481/Orbimed_Advisors>,
        <https://1145.am/db/2363339/Orbimed_Advisors>,
        <https://1145.am/db/2365679/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2365868/Orbimed_Advisors>,
        <https://1145.am/db/2366519/Orbimed_Advisors>,
        <https://1145.am/db/2574232/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2583013/Orbimed_Advisors>,
        <https://1145.am/db/428737/Orbimed_Advisors>,
        <https://1145.am/db/456081/Orbimed_Advisors>,
        <https://1145.am/db/456089/Orbimed_Advisors>,
        <https://1145.am/db/458377/Orbimed_Advisors>,
        <https://1145.am/db/674484/Orbimed_Advisors> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2361971/Amgen> a org:Organization ;
    ns1:basedInHighGeoName "Thousand Oaks" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5402405/about.rdf> ;
    ns1:basedInHighRaw "THOUSAND OAKS, Calif." ;
    ns1:buyer <https://1145.am/db/2361971/Micromet_Acquisition> ;
    ns1:description "biotechnology" ;
    ns1:documentDate "2012-01-26T13:53:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Amgen to Acquire Micromet" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/amgen-to-acquire-micromet-0> ;
    ns1:foundName "Amgen" ;
    ns1:industry "biotechnology" ;
    ns1:name "Amgen" ;
    ns1:sameAsHigh <https://1145.am/db/1079148/Bioage>,
        <https://1145.am/db/1083082/Bioage>,
        <https://1145.am/db/1322637/Sengenics>,
        <https://1145.am/db/1406211/Amgen>,
        <https://1145.am/db/1415508/Direct_Biologics_Inc>,
        <https://1145.am/db/1560943/Generate_Biomedicines>,
        <https://1145.am/db/1582218/Bioaffinity_Technologies>,
        <https://1145.am/db/1629918/Novotech>,
        <https://1145.am/db/1629919/Novotech>,
        <https://1145.am/db/1932925/Transgene>,
        <https://1145.am/db/1967508/Transgene>,
        <https://1145.am/db/1981398/Amgen>,
        <https://1145.am/db/1989264/Bioaffinity_Technologies>,
        <https://1145.am/db/2062962/Transgene>,
        <https://1145.am/db/2152253/Empirica>,
        <https://1145.am/db/2152634/Generation_Bio>,
        <https://1145.am/db/2153261/Genfit>,
        <https://1145.am/db/2153720/Macrogenics>,
        <https://1145.am/db/2154018/Forbion>,
        <https://1145.am/db/2281647/Abogen_Biosciences>,
        <https://1145.am/db/2300768/The_Big_Biotech>,
        <https://1145.am/db/2301977/Biogen_Idec_Inc>,
        <https://1145.am/db/2302669/Medigen_Biotechnology_Corporation>,
        <https://1145.am/db/2303130/Invitrogen_Corporation>,
        <https://1145.am/db/2305209/Biogen_Idec>,
        <https://1145.am/db/2305215/Biogen_Idec>,
        <https://1145.am/db/2305837/Macrogenics>,
        <https://1145.am/db/2306961/Transgene>,
        <https://1145.am/db/2307723/Maxim_Biotech>,
        <https://1145.am/db/2314822/Biogen_Idec>,
        <https://1145.am/db/2320759/Amgen>,
        <https://1145.am/db/2320765/Amgen>,
        <https://1145.am/db/2320775/Amgen>,
        <https://1145.am/db/2325681/Opgen>,
        <https://1145.am/db/2326996/Geneuro>,
        <https://1145.am/db/2336763/Ambit_Biosciences>,
        <https://1145.am/db/2337644/Genfit>,
        <https://1145.am/db/2337745/Biogen_Idec>,
        <https://1145.am/db/2340408/Amgen>,
        <https://1145.am/db/2343185/Opgen>,
        <https://1145.am/db/2346035/Ambit_Biosciences>,
        <https://1145.am/db/2347997/Ceregene>,
        <https://1145.am/db/2348620/Amunix_Inc>,
        <https://1145.am/db/2349307/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2350047/Macrogenics>,
        <https://1145.am/db/2350198/Applied_Genetic>,
        <https://1145.am/db/2351335/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2352800/Amgen>,
        <https://1145.am/db/2353256/The_Biotech>,
        <https://1145.am/db/2358383/Macrogenics>,
        <https://1145.am/db/2361405/Biogen_Idec>,
        <https://1145.am/db/2361973/Amgen>,
        <https://1145.am/db/2363538/Biogen_Idec>,
        <https://1145.am/db/2365300/Genocea>,
        <https://1145.am/db/2367817/Ambrx>,
        <https://1145.am/db/2369953/Forbion>,
        <https://1145.am/db/2370397/Genfit>,
        <https://1145.am/db/2371444/And_Versant>,
        <https://1145.am/db/2544774/Genome>,
        <https://1145.am/db/2556522/Biophausia>,
        <https://1145.am/db/2563336/Ambrx>,
        <https://1145.am/db/2581359/Amgen>,
        <https://1145.am/db/2589106/Amgen>,
        <https://1145.am/db/2593681/Amgen>,
        <https://1145.am/db/2718350/The_Big_Biotech>,
        <https://1145.am/db/2790676/Endeavor_Biomedicines>,
        <https://1145.am/db/365533/Ambrx>,
        <https://1145.am/db/435626/Boundless_Bio>,
        <https://1145.am/db/437762/Boundless_Bio>,
        <https://1145.am/db/559677/Genetether>,
        <https://1145.am/db/586002/Forbion>,
        <https://1145.am/db/734523/Boundless_Bio>,
        <https://1145.am/db/819348/Transgene>,
        <https://1145.am/db/944644/Transgene>,
        <https://1145.am/db/946928/Transgene> ;
    ns1:sameAsMedium <https://1145.am/db/1252426/Amgen_Inc>,
        <https://1145.am/db/1253935/Amgen>,
        <https://1145.am/db/1254815/Amgen>,
        <https://1145.am/db/1258904/Amgen_Inc>,
        <https://1145.am/db/1262006/Amgen>,
        <https://1145.am/db/1434130/Amgen>,
        <https://1145.am/db/1488570/Amgen>,
        <https://1145.am/db/1541946/Amgen>,
        <https://1145.am/db/1568872/Amgen_Inc>,
        <https://1145.am/db/1570839/Amgen_Inc>,
        <https://1145.am/db/1573831/Amgen>,
        <https://1145.am/db/1574155/Amgen>,
        <https://1145.am/db/1575688/Amgen_Inc>,
        <https://1145.am/db/1576668/Amgen_Inc>,
        <https://1145.am/db/1673901/Amgen>,
        <https://1145.am/db/1929668/Amgen>,
        <https://1145.am/db/198163/Amgen>,
        <https://1145.am/db/2008430/Amgen_Inc>,
        <https://1145.am/db/2008790/Amgen>,
        <https://1145.am/db/2009117/Amgen_Inc>,
        <https://1145.am/db/2011679/Amgen>,
        <https://1145.am/db/2012933/Amgen_Inc>,
        <https://1145.am/db/2013008/Amgen_Inc>,
        <https://1145.am/db/2016970/Amgen>,
        <https://1145.am/db/2043001/Amgen>,
        <https://1145.am/db/2046726/Amgen>,
        <https://1145.am/db/2098829/Amgen>,
        <https://1145.am/db/2105082/Amgen>,
        <https://1145.am/db/2106270/Amgen>,
        <https://1145.am/db/2107919/Amgen>,
        <https://1145.am/db/2117067/Amgen>,
        <https://1145.am/db/2117986/Amgen>,
        <https://1145.am/db/2138386/Amgen>,
        <https://1145.am/db/2152715/Amgen>,
        <https://1145.am/db/2153258/Amgen>,
        <https://1145.am/db/2154415/Amgen>,
        <https://1145.am/db/2155409/Amgen>,
        <https://1145.am/db/2155659/Amgen>,
        <https://1145.am/db/2249776/Amgen_Inc>,
        <https://1145.am/db/2282387/Amgen>,
        <https://1145.am/db/2282934/Amgen>,
        <https://1145.am/db/2283321/Amgen>,
        <https://1145.am/db/2285195/Amgen>,
        <https://1145.am/db/2285614/Amgen>,
        <https://1145.am/db/2285991/Amgen>,
        <https://1145.am/db/2286174/Amgen>,
        <https://1145.am/db/2291231/Amgen>,
        <https://1145.am/db/2292224/Amgen>,
        <https://1145.am/db/2292876/Amgen>,
        <https://1145.am/db/2299349/Amgen>,
        <https://1145.am/db/2302052/Amgen>,
        <https://1145.am/db/2303414/Amgen>,
        <https://1145.am/db/2312121/Amgen>,
        <https://1145.am/db/2313429/Amgen>,
        <https://1145.am/db/2317845/Amgen>,
        <https://1145.am/db/2318877/Amgen>,
        <https://1145.am/db/2320754/Amgen>,
        <https://1145.am/db/2320771/Amgen>,
        <https://1145.am/db/2321459/Amgen>,
        <https://1145.am/db/2321989/Amgen>,
        <https://1145.am/db/2322040/Amgen>,
        <https://1145.am/db/2322632/Amgen>,
        <https://1145.am/db/2326533/Amgen>,
        <https://1145.am/db/2326559/Amgen>,
        <https://1145.am/db/2327526/Amgen>,
        <https://1145.am/db/2327547/Amgen>,
        <https://1145.am/db/2328748/Amgen>,
        <https://1145.am/db/2329762/Amgen>,
        <https://1145.am/db/2333460/Amgen>,
        <https://1145.am/db/2334046/Amgen>,
        <https://1145.am/db/2337433/Amgen>,
        <https://1145.am/db/2337435/Amgen_Inc>,
        <https://1145.am/db/2337848/Amgen>,
        <https://1145.am/db/2338027/Amgen>,
        <https://1145.am/db/2338329/Amgen>,
        <https://1145.am/db/2338346/Amgen>,
        <https://1145.am/db/2338828/Amgen>,
        <https://1145.am/db/2340634/Amgen>,
        <https://1145.am/db/2340669/Amgen>,
        <https://1145.am/db/2343511/Amgen>,
        <https://1145.am/db/2343601/Amgen>,
        <https://1145.am/db/2343780/Amgen>,
        <https://1145.am/db/2343862/Amgen>,
        <https://1145.am/db/2344369/Amgen>,
        <https://1145.am/db/2344631/Amgen>,
        <https://1145.am/db/2344864/Amgen>,
        <https://1145.am/db/2345191/Amgen>,
        <https://1145.am/db/2345783/Amgen>,
        <https://1145.am/db/2345886/Amgen>,
        <https://1145.am/db/2346293/Amgen>,
        <https://1145.am/db/2347966/Amgen>,
        <https://1145.am/db/2347970/Amgen>,
        <https://1145.am/db/2347976/Amgen>,
        <https://1145.am/db/2349030/Amgen>,
        <https://1145.am/db/2349444/Amgen>,
        <https://1145.am/db/2350029/Amgen>,
        <https://1145.am/db/2350465/Amgen>,
        <https://1145.am/db/2350471/Amgen>,
        <https://1145.am/db/2353167/Amgen>,
        <https://1145.am/db/2354835/Amgen>,
        <https://1145.am/db/2355378/Amgen>,
        <https://1145.am/db/2355383/Amgen>,
        <https://1145.am/db/2355392/Amgen>,
        <https://1145.am/db/2355427/Amgen>,
        <https://1145.am/db/2357269/Amgen>,
        <https://1145.am/db/2357271/Amgen>,
        <https://1145.am/db/2357303/Amgen>,
        <https://1145.am/db/2357336/Amgen>,
        <https://1145.am/db/2357451/Amgen>,
        <https://1145.am/db/2357454/Amgen>,
        <https://1145.am/db/2357920/Amgen>,
        <https://1145.am/db/2358934/Amgen>,
        <https://1145.am/db/2359165/Amgen>,
        <https://1145.am/db/2359462/Amgen>,
        <https://1145.am/db/2359481/Amgen>,
        <https://1145.am/db/2359498/Amgen>,
        <https://1145.am/db/2360080/Amgen>,
        <https://1145.am/db/2360086/Amgen>,
        <https://1145.am/db/2361037/Amgen>,
        <https://1145.am/db/2361972/Amgen>,
        <https://1145.am/db/2362552/Amgen>,
        <https://1145.am/db/2363673/Amgen>,
        <https://1145.am/db/2364216/Amgen>,
        <https://1145.am/db/2367430/Amgen_Inc>,
        <https://1145.am/db/2368788/Amgen_Inc>,
        <https://1145.am/db/2370120/Amgen>,
        <https://1145.am/db/2370174/Amgen>,
        <https://1145.am/db/2370215/Amgen>,
        <https://1145.am/db/2370217/Amgen>,
        <https://1145.am/db/2371301/Amgen>,
        <https://1145.am/db/2538019/Amgen>,
        <https://1145.am/db/2539787/Amgen>,
        <https://1145.am/db/2540225/Amgen>,
        <https://1145.am/db/2543232/Amgen>,
        <https://1145.am/db/2543655/Amgen>,
        <https://1145.am/db/2544701/Amgen>,
        <https://1145.am/db/2545663/Amgen>,
        <https://1145.am/db/2545765/Amgen>,
        <https://1145.am/db/2548575/Amgen>,
        <https://1145.am/db/2550685/Amgen>,
        <https://1145.am/db/2550884/Amgen>,
        <https://1145.am/db/2551883/Amgen>,
        <https://1145.am/db/2551884/Amgen>,
        <https://1145.am/db/2553162/Amgen>,
        <https://1145.am/db/2553564/Amgen>,
        <https://1145.am/db/2554152/Amgen>,
        <https://1145.am/db/2555175/Amgen>,
        <https://1145.am/db/2556729/Amgen>,
        <https://1145.am/db/2557364/Amgen>,
        <https://1145.am/db/2558012/Amgen>,
        <https://1145.am/db/2558039/Amgen>,
        <https://1145.am/db/2558051/Amgen>,
        <https://1145.am/db/2558418/Amgen>,
        <https://1145.am/db/2559077/Amgen>,
        <https://1145.am/db/2561305/Amgen>,
        <https://1145.am/db/2561317/Amgen>,
        <https://1145.am/db/2561325/Amgen>,
        <https://1145.am/db/2561650/Amgen>,
        <https://1145.am/db/2566335/Amgen>,
        <https://1145.am/db/2566348/Amgen>,
        <https://1145.am/db/2567468/Amgen>,
        <https://1145.am/db/2567517/Amgen>,
        <https://1145.am/db/2567960/Amgen>,
        <https://1145.am/db/2567981/Amgen>,
        <https://1145.am/db/2568005/Amgen>,
        <https://1145.am/db/2568075/Amgen>,
        <https://1145.am/db/2568519/Amgen>,
        <https://1145.am/db/2572535/Amgen>,
        <https://1145.am/db/2572655/Amgen>,
        <https://1145.am/db/2573455/Amgen>,
        <https://1145.am/db/2573903/Amgen>,
        <https://1145.am/db/2573924/Amgen>,
        <https://1145.am/db/2573976/Amgen>,
        <https://1145.am/db/2574586/Amgen>,
        <https://1145.am/db/2575263/Amgen>,
        <https://1145.am/db/2575289/Amgen>,
        <https://1145.am/db/2576018/Amgen>,
        <https://1145.am/db/2576242/Amgen>,
        <https://1145.am/db/2576498/Amgen>,
        <https://1145.am/db/2577110/Amgen>,
        <https://1145.am/db/2577115/Amgen>,
        <https://1145.am/db/2577120/Amgen>,
        <https://1145.am/db/2578110/Amgen>,
        <https://1145.am/db/2578164/Amgen>,
        <https://1145.am/db/2578286/Amgen>,
        <https://1145.am/db/2579211/Amgen>,
        <https://1145.am/db/2579278/Amgen>,
        <https://1145.am/db/2580209/Amgen>,
        <https://1145.am/db/2580211/Amgen>,
        <https://1145.am/db/2580383/Amgen_Inc>,
        <https://1145.am/db/2581309/Amgen>,
        <https://1145.am/db/2581917/Amgen>,
        <https://1145.am/db/2583990/Amgen>,
        <https://1145.am/db/2584352/Amgen>,
        <https://1145.am/db/2585068/Amgen>,
        <https://1145.am/db/2586068/Amgen>,
        <https://1145.am/db/2586750/Amgen>,
        <https://1145.am/db/2587009/Amgen>,
        <https://1145.am/db/2587770/Amgen>,
        <https://1145.am/db/258901/Amgen_Inc>,
        <https://1145.am/db/2590194/Amgen>,
        <https://1145.am/db/2590988/Amgen_Inc>,
        <https://1145.am/db/2590989/Amgen>,
        <https://1145.am/db/2591587/Amgen>,
        <https://1145.am/db/2591594/Amgen>,
        <https://1145.am/db/2592573/Amgen>,
        <https://1145.am/db/2592618/Amgen>,
        <https://1145.am/db/2592924/Amgen>,
        <https://1145.am/db/2593423/Amgen>,
        <https://1145.am/db/2593426/Amgen>,
        <https://1145.am/db/2593433/Amgen_Inc>,
        <https://1145.am/db/2593434/Amgen>,
        <https://1145.am/db/2593465/Amgen>,
        <https://1145.am/db/2593973/Amgen>,
        <https://1145.am/db/2594099/Amgen>,
        <https://1145.am/db/2594285/Amgen>,
        <https://1145.am/db/2594292/Amgen>,
        <https://1145.am/db/2594298/Amgen>,
        <https://1145.am/db/2594347/Amgen>,
        <https://1145.am/db/2594990/Amgen>,
        <https://1145.am/db/2594993/Amgen>,
        <https://1145.am/db/2595020/Amgen>,
        <https://1145.am/db/2595549/Amgen>,
        <https://1145.am/db/2595564/Amgen>,
        <https://1145.am/db/2595587/Amgen>,
        <https://1145.am/db/2595605/Amgen>,
        <https://1145.am/db/2595608/Amgen>,
        <https://1145.am/db/2595930/Amgen>,
        <https://1145.am/db/2596467/Amgen>,
        <https://1145.am/db/2596819/Amgen>,
        <https://1145.am/db/2597499/Amgen>,
        <https://1145.am/db/2598066/Amgen>,
        <https://1145.am/db/2716207/Amgen>,
        <https://1145.am/db/2789236/Amgen>,
        <https://1145.am/db/2802001/Amgen>,
        <https://1145.am/db/531806/Amgen_Inc>,
        <https://1145.am/db/559746/Amgen> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2361973/Amgen> a org:Organization ;
    ns1:basedInHighGeoName "Thousand Oaks" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5402405/about.rdf> ;
    ns1:basedInHighRaw "THOUSAND OAKS, Calif." ;
    ns1:buyer <https://1145.am/db/2361973/Micromet_Acquisition> ;
    ns1:description "Biotechnology" ;
    ns1:documentDate "2012-01-26T14:20:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Amgen to Acquire Micromet" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/amgen-to-acquire-micromet> ;
    ns1:foundName "Amgen" ;
    ns1:industry "biotechnology" ;
    ns1:name "Amgen" ;
    ns1:sameAsHigh <https://1145.am/db/1079148/Bioage>,
        <https://1145.am/db/1083082/Bioage>,
        <https://1145.am/db/1322637/Sengenics>,
        <https://1145.am/db/1406211/Amgen>,
        <https://1145.am/db/1415508/Direct_Biologics_Inc>,
        <https://1145.am/db/1560943/Generate_Biomedicines>,
        <https://1145.am/db/1582218/Bioaffinity_Technologies>,
        <https://1145.am/db/1629918/Novotech>,
        <https://1145.am/db/1629919/Novotech>,
        <https://1145.am/db/1932925/Transgene>,
        <https://1145.am/db/1967508/Transgene>,
        <https://1145.am/db/1981398/Amgen>,
        <https://1145.am/db/1989264/Bioaffinity_Technologies>,
        <https://1145.am/db/2062962/Transgene>,
        <https://1145.am/db/2152253/Empirica>,
        <https://1145.am/db/2152634/Generation_Bio>,
        <https://1145.am/db/2153261/Genfit>,
        <https://1145.am/db/2153720/Macrogenics>,
        <https://1145.am/db/2154018/Forbion>,
        <https://1145.am/db/2281647/Abogen_Biosciences>,
        <https://1145.am/db/2300768/The_Big_Biotech>,
        <https://1145.am/db/2301977/Biogen_Idec_Inc>,
        <https://1145.am/db/2302669/Medigen_Biotechnology_Corporation>,
        <https://1145.am/db/2303130/Invitrogen_Corporation>,
        <https://1145.am/db/2305209/Biogen_Idec>,
        <https://1145.am/db/2305215/Biogen_Idec>,
        <https://1145.am/db/2305837/Macrogenics>,
        <https://1145.am/db/2306961/Transgene>,
        <https://1145.am/db/2307723/Maxim_Biotech>,
        <https://1145.am/db/2314822/Biogen_Idec>,
        <https://1145.am/db/2320759/Amgen>,
        <https://1145.am/db/2320765/Amgen>,
        <https://1145.am/db/2320775/Amgen>,
        <https://1145.am/db/2325681/Opgen>,
        <https://1145.am/db/2326996/Geneuro>,
        <https://1145.am/db/2336763/Ambit_Biosciences>,
        <https://1145.am/db/2337644/Genfit>,
        <https://1145.am/db/2337745/Biogen_Idec>,
        <https://1145.am/db/2340408/Amgen>,
        <https://1145.am/db/2343185/Opgen>,
        <https://1145.am/db/2346035/Ambit_Biosciences>,
        <https://1145.am/db/2347997/Ceregene>,
        <https://1145.am/db/2348620/Amunix_Inc>,
        <https://1145.am/db/2349307/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2350047/Macrogenics>,
        <https://1145.am/db/2350198/Applied_Genetic>,
        <https://1145.am/db/2351335/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2352800/Amgen>,
        <https://1145.am/db/2353256/The_Biotech>,
        <https://1145.am/db/2358383/Macrogenics>,
        <https://1145.am/db/2361405/Biogen_Idec>,
        <https://1145.am/db/2361971/Amgen>,
        <https://1145.am/db/2363538/Biogen_Idec>,
        <https://1145.am/db/2365300/Genocea>,
        <https://1145.am/db/2367817/Ambrx>,
        <https://1145.am/db/2369953/Forbion>,
        <https://1145.am/db/2370397/Genfit>,
        <https://1145.am/db/2371444/And_Versant>,
        <https://1145.am/db/2544774/Genome>,
        <https://1145.am/db/2556522/Biophausia>,
        <https://1145.am/db/2563336/Ambrx>,
        <https://1145.am/db/2581359/Amgen>,
        <https://1145.am/db/2589106/Amgen>,
        <https://1145.am/db/2593681/Amgen>,
        <https://1145.am/db/2718350/The_Big_Biotech>,
        <https://1145.am/db/2790676/Endeavor_Biomedicines>,
        <https://1145.am/db/365533/Ambrx>,
        <https://1145.am/db/435626/Boundless_Bio>,
        <https://1145.am/db/437762/Boundless_Bio>,
        <https://1145.am/db/559677/Genetether>,
        <https://1145.am/db/586002/Forbion>,
        <https://1145.am/db/734523/Boundless_Bio>,
        <https://1145.am/db/819348/Transgene>,
        <https://1145.am/db/944644/Transgene>,
        <https://1145.am/db/946928/Transgene> ;
    ns1:sameAsMedium <https://1145.am/db/1252426/Amgen_Inc>,
        <https://1145.am/db/1253935/Amgen>,
        <https://1145.am/db/1254815/Amgen>,
        <https://1145.am/db/1258904/Amgen_Inc>,
        <https://1145.am/db/1262006/Amgen>,
        <https://1145.am/db/1434130/Amgen>,
        <https://1145.am/db/1488570/Amgen>,
        <https://1145.am/db/1541946/Amgen>,
        <https://1145.am/db/1568872/Amgen_Inc>,
        <https://1145.am/db/1570839/Amgen_Inc>,
        <https://1145.am/db/1573831/Amgen>,
        <https://1145.am/db/1574155/Amgen>,
        <https://1145.am/db/1575688/Amgen_Inc>,
        <https://1145.am/db/1576668/Amgen_Inc>,
        <https://1145.am/db/1673901/Amgen>,
        <https://1145.am/db/1929668/Amgen>,
        <https://1145.am/db/198163/Amgen>,
        <https://1145.am/db/2008430/Amgen_Inc>,
        <https://1145.am/db/2008790/Amgen>,
        <https://1145.am/db/2009117/Amgen_Inc>,
        <https://1145.am/db/2011679/Amgen>,
        <https://1145.am/db/2012933/Amgen_Inc>,
        <https://1145.am/db/2013008/Amgen_Inc>,
        <https://1145.am/db/2016970/Amgen>,
        <https://1145.am/db/2043001/Amgen>,
        <https://1145.am/db/2046726/Amgen>,
        <https://1145.am/db/2098829/Amgen>,
        <https://1145.am/db/2105082/Amgen>,
        <https://1145.am/db/2106270/Amgen>,
        <https://1145.am/db/2107919/Amgen>,
        <https://1145.am/db/2117067/Amgen>,
        <https://1145.am/db/2117986/Amgen>,
        <https://1145.am/db/2138386/Amgen>,
        <https://1145.am/db/2152715/Amgen>,
        <https://1145.am/db/2153258/Amgen>,
        <https://1145.am/db/2154415/Amgen>,
        <https://1145.am/db/2155409/Amgen>,
        <https://1145.am/db/2155659/Amgen>,
        <https://1145.am/db/2249776/Amgen_Inc>,
        <https://1145.am/db/2282387/Amgen>,
        <https://1145.am/db/2282934/Amgen>,
        <https://1145.am/db/2283321/Amgen>,
        <https://1145.am/db/2285195/Amgen>,
        <https://1145.am/db/2285614/Amgen>,
        <https://1145.am/db/2285991/Amgen>,
        <https://1145.am/db/2286174/Amgen>,
        <https://1145.am/db/2291231/Amgen>,
        <https://1145.am/db/2292224/Amgen>,
        <https://1145.am/db/2292876/Amgen>,
        <https://1145.am/db/2299349/Amgen>,
        <https://1145.am/db/2302052/Amgen>,
        <https://1145.am/db/2303414/Amgen>,
        <https://1145.am/db/2312121/Amgen>,
        <https://1145.am/db/2313429/Amgen>,
        <https://1145.am/db/2317845/Amgen>,
        <https://1145.am/db/2318877/Amgen>,
        <https://1145.am/db/2320754/Amgen>,
        <https://1145.am/db/2320771/Amgen>,
        <https://1145.am/db/2321459/Amgen>,
        <https://1145.am/db/2321989/Amgen>,
        <https://1145.am/db/2322040/Amgen>,
        <https://1145.am/db/2322632/Amgen>,
        <https://1145.am/db/2326533/Amgen>,
        <https://1145.am/db/2326559/Amgen>,
        <https://1145.am/db/2327526/Amgen>,
        <https://1145.am/db/2327547/Amgen>,
        <https://1145.am/db/2328748/Amgen>,
        <https://1145.am/db/2329762/Amgen>,
        <https://1145.am/db/2333460/Amgen>,
        <https://1145.am/db/2334046/Amgen>,
        <https://1145.am/db/2337433/Amgen>,
        <https://1145.am/db/2337435/Amgen_Inc>,
        <https://1145.am/db/2337848/Amgen>,
        <https://1145.am/db/2338027/Amgen>,
        <https://1145.am/db/2338329/Amgen>,
        <https://1145.am/db/2338346/Amgen>,
        <https://1145.am/db/2338828/Amgen>,
        <https://1145.am/db/2340634/Amgen>,
        <https://1145.am/db/2340669/Amgen>,
        <https://1145.am/db/2343511/Amgen>,
        <https://1145.am/db/2343601/Amgen>,
        <https://1145.am/db/2343780/Amgen>,
        <https://1145.am/db/2343862/Amgen>,
        <https://1145.am/db/2344369/Amgen>,
        <https://1145.am/db/2344631/Amgen>,
        <https://1145.am/db/2344864/Amgen>,
        <https://1145.am/db/2345191/Amgen>,
        <https://1145.am/db/2345783/Amgen>,
        <https://1145.am/db/2345886/Amgen>,
        <https://1145.am/db/2346293/Amgen>,
        <https://1145.am/db/2347966/Amgen>,
        <https://1145.am/db/2347970/Amgen>,
        <https://1145.am/db/2347976/Amgen>,
        <https://1145.am/db/2349030/Amgen>,
        <https://1145.am/db/2349444/Amgen>,
        <https://1145.am/db/2350029/Amgen>,
        <https://1145.am/db/2350465/Amgen>,
        <https://1145.am/db/2350471/Amgen>,
        <https://1145.am/db/2353167/Amgen>,
        <https://1145.am/db/2354835/Amgen>,
        <https://1145.am/db/2355378/Amgen>,
        <https://1145.am/db/2355383/Amgen>,
        <https://1145.am/db/2355392/Amgen>,
        <https://1145.am/db/2355427/Amgen>,
        <https://1145.am/db/2357269/Amgen>,
        <https://1145.am/db/2357271/Amgen>,
        <https://1145.am/db/2357303/Amgen>,
        <https://1145.am/db/2357336/Amgen>,
        <https://1145.am/db/2357451/Amgen>,
        <https://1145.am/db/2357454/Amgen>,
        <https://1145.am/db/2357920/Amgen>,
        <https://1145.am/db/2358934/Amgen>,
        <https://1145.am/db/2359165/Amgen>,
        <https://1145.am/db/2359462/Amgen>,
        <https://1145.am/db/2359481/Amgen>,
        <https://1145.am/db/2359498/Amgen>,
        <https://1145.am/db/2360080/Amgen>,
        <https://1145.am/db/2360086/Amgen>,
        <https://1145.am/db/2361037/Amgen>,
        <https://1145.am/db/2361972/Amgen>,
        <https://1145.am/db/2362552/Amgen>,
        <https://1145.am/db/2363673/Amgen>,
        <https://1145.am/db/2364216/Amgen>,
        <https://1145.am/db/2367430/Amgen_Inc>,
        <https://1145.am/db/2368788/Amgen_Inc>,
        <https://1145.am/db/2370120/Amgen>,
        <https://1145.am/db/2370174/Amgen>,
        <https://1145.am/db/2370215/Amgen>,
        <https://1145.am/db/2370217/Amgen>,
        <https://1145.am/db/2371301/Amgen>,
        <https://1145.am/db/2538019/Amgen>,
        <https://1145.am/db/2539787/Amgen>,
        <https://1145.am/db/2540225/Amgen>,
        <https://1145.am/db/2543232/Amgen>,
        <https://1145.am/db/2543655/Amgen>,
        <https://1145.am/db/2544701/Amgen>,
        <https://1145.am/db/2545663/Amgen>,
        <https://1145.am/db/2545765/Amgen>,
        <https://1145.am/db/2548575/Amgen>,
        <https://1145.am/db/2550685/Amgen>,
        <https://1145.am/db/2550884/Amgen>,
        <https://1145.am/db/2551883/Amgen>,
        <https://1145.am/db/2551884/Amgen>,
        <https://1145.am/db/2553162/Amgen>,
        <https://1145.am/db/2553564/Amgen>,
        <https://1145.am/db/2554152/Amgen>,
        <https://1145.am/db/2555175/Amgen>,
        <https://1145.am/db/2556729/Amgen>,
        <https://1145.am/db/2557364/Amgen>,
        <https://1145.am/db/2558012/Amgen>,
        <https://1145.am/db/2558039/Amgen>,
        <https://1145.am/db/2558051/Amgen>,
        <https://1145.am/db/2558418/Amgen>,
        <https://1145.am/db/2559077/Amgen>,
        <https://1145.am/db/2561305/Amgen>,
        <https://1145.am/db/2561317/Amgen>,
        <https://1145.am/db/2561325/Amgen>,
        <https://1145.am/db/2561650/Amgen>,
        <https://1145.am/db/2566335/Amgen>,
        <https://1145.am/db/2566348/Amgen>,
        <https://1145.am/db/2567468/Amgen>,
        <https://1145.am/db/2567517/Amgen>,
        <https://1145.am/db/2567960/Amgen>,
        <https://1145.am/db/2567981/Amgen>,
        <https://1145.am/db/2568005/Amgen>,
        <https://1145.am/db/2568075/Amgen>,
        <https://1145.am/db/2568519/Amgen>,
        <https://1145.am/db/2572535/Amgen>,
        <https://1145.am/db/2572655/Amgen>,
        <https://1145.am/db/2573455/Amgen>,
        <https://1145.am/db/2573903/Amgen>,
        <https://1145.am/db/2573924/Amgen>,
        <https://1145.am/db/2573976/Amgen>,
        <https://1145.am/db/2574586/Amgen>,
        <https://1145.am/db/2575263/Amgen>,
        <https://1145.am/db/2575289/Amgen>,
        <https://1145.am/db/2576018/Amgen>,
        <https://1145.am/db/2576242/Amgen>,
        <https://1145.am/db/2576498/Amgen>,
        <https://1145.am/db/2577110/Amgen>,
        <https://1145.am/db/2577115/Amgen>,
        <https://1145.am/db/2577120/Amgen>,
        <https://1145.am/db/2578110/Amgen>,
        <https://1145.am/db/2578164/Amgen>,
        <https://1145.am/db/2578286/Amgen>,
        <https://1145.am/db/2579211/Amgen>,
        <https://1145.am/db/2579278/Amgen>,
        <https://1145.am/db/2580209/Amgen>,
        <https://1145.am/db/2580211/Amgen>,
        <https://1145.am/db/2580383/Amgen_Inc>,
        <https://1145.am/db/2581309/Amgen>,
        <https://1145.am/db/2581917/Amgen>,
        <https://1145.am/db/2583990/Amgen>,
        <https://1145.am/db/2584352/Amgen>,
        <https://1145.am/db/2585068/Amgen>,
        <https://1145.am/db/2586068/Amgen>,
        <https://1145.am/db/2586750/Amgen>,
        <https://1145.am/db/2587009/Amgen>,
        <https://1145.am/db/2587770/Amgen>,
        <https://1145.am/db/258901/Amgen_Inc>,
        <https://1145.am/db/2590194/Amgen>,
        <https://1145.am/db/2590988/Amgen_Inc>,
        <https://1145.am/db/2590989/Amgen>,
        <https://1145.am/db/2591587/Amgen>,
        <https://1145.am/db/2591594/Amgen>,
        <https://1145.am/db/2592573/Amgen>,
        <https://1145.am/db/2592618/Amgen>,
        <https://1145.am/db/2592924/Amgen>,
        <https://1145.am/db/2593423/Amgen>,
        <https://1145.am/db/2593426/Amgen>,
        <https://1145.am/db/2593433/Amgen_Inc>,
        <https://1145.am/db/2593434/Amgen>,
        <https://1145.am/db/2593465/Amgen>,
        <https://1145.am/db/2593973/Amgen>,
        <https://1145.am/db/2594099/Amgen>,
        <https://1145.am/db/2594285/Amgen>,
        <https://1145.am/db/2594292/Amgen>,
        <https://1145.am/db/2594298/Amgen>,
        <https://1145.am/db/2594347/Amgen>,
        <https://1145.am/db/2594990/Amgen>,
        <https://1145.am/db/2594993/Amgen>,
        <https://1145.am/db/2595020/Amgen>,
        <https://1145.am/db/2595549/Amgen>,
        <https://1145.am/db/2595564/Amgen>,
        <https://1145.am/db/2595587/Amgen>,
        <https://1145.am/db/2595605/Amgen>,
        <https://1145.am/db/2595608/Amgen>,
        <https://1145.am/db/2595930/Amgen>,
        <https://1145.am/db/2596467/Amgen>,
        <https://1145.am/db/2596819/Amgen>,
        <https://1145.am/db/2597499/Amgen>,
        <https://1145.am/db/2598066/Amgen>,
        <https://1145.am/db/2716207/Amgen>,
        <https://1145.am/db/2789236/Amgen>,
        <https://1145.am/db/2802001/Amgen>,
        <https://1145.am/db/531806/Amgen_Inc>,
        <https://1145.am/db/559746/Amgen> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362024/Dermira> a org:Organization ;
    ns1:buyer <https://1145.am/db/2362024/Acquisition_Dermira_Completed>,
        <https://1145.am/db/2362024/Valocor_Therapeutics_Acquisition> ;
    ns1:description "dermatology" ;
    ns1:documentDate "2011-10-21T12:34:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Dermira Announces a $42m Series A Financing to Fund Therapeutic Advances in Dermatology" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dermira-announces-a-42m-series-a-financing-to-fund-therapeutic-advances-dermatology> ;
    ns1:foundName "Dermira" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Dermira" ;
    ns1:sameAsHigh <https://1145.am/db/1005579/Novan>,
        <https://1145.am/db/1010678/Pinnacle_Dermatology>,
        <https://1145.am/db/1010779/American_Academy_Of_Dermatology>,
        <https://1145.am/db/1101009/Docs>,
        <https://1145.am/db/1151308/Westderm>,
        <https://1145.am/db/1153671/Westderm>,
        <https://1145.am/db/1166328/Advanced_Dermatology>,
        <https://1145.am/db/1166328/Esterson_Dermatology>,
        <https://1145.am/db/1183109/Innovaderm>,
        <https://1145.am/db/1183461/Innovaderm>,
        <https://1145.am/db/1215072/Dermtech>,
        <https://1145.am/db/1218063/Dermtech>,
        <https://1145.am/db/1234351/Dermtech>,
        <https://1145.am/db/1239346/Dermtech>,
        <https://1145.am/db/1404947/Integrated_Dermatology>,
        <https://1145.am/db/1408791/Integrated_Dermatology>,
        <https://1145.am/db/1460966/Dermatology_Partners>,
        <https://1145.am/db/1500910/SKNV>,
        <https://1145.am/db/195301/Dermtech>,
        <https://1145.am/db/1999693/Dermtech>,
        <https://1145.am/db/2012279/Dermtech>,
        <https://1145.am/db/2070188/Bliss_Dermatology>,
        <https://1145.am/db/2113090/Dermtech>,
        <https://1145.am/db/2236149/Direct_Dermatology>,
        <https://1145.am/db/2298653/Dermavant_Sciences>,
        <https://1145.am/db/2301879/Magen_Biosciences>,
        <https://1145.am/db/2306724/Dermatech_Pty_Ltd>,
        <https://1145.am/db/2337356/Dermira>,
        <https://1145.am/db/2346832/Vital_Science_Corp>,
        <https://1145.am/db/2346833/Vital_Science_Corp>,
        <https://1145.am/db/2347750/Mela_Sciences>,
        <https://1145.am/db/2359185/Dermira>,
        <https://1145.am/db/2359186/Dermira>,
        <https://1145.am/db/2363666/Dermira>,
        <https://1145.am/db/2363859/Vicept>,
        <https://1145.am/db/2368246/Almirall>,
        <https://1145.am/db/2566845/Dermira>,
        <https://1145.am/db/2586657/Dermik>,
        <https://1145.am/db/2586658/Dermik>,
        <https://1145.am/db/2595039/Skin_Medica>,
        <https://1145.am/db/2595150/Dermik>,
        <https://1145.am/db/2597433/Dermik>,
        <https://1145.am/db/354532/Dermtech>,
        <https://1145.am/db/412922/Pinnacle_Dermatology>,
        <https://1145.am/db/435599/Dermlab>,
        <https://1145.am/db/437716/Dermlab>,
        <https://1145.am/db/472836/Pinnacle_Dermatology>,
        <https://1145.am/db/475791/West_Dermatology>,
        <https://1145.am/db/521508/Dermtech>,
        <https://1145.am/db/524122/Dermtech>,
        <https://1145.am/db/526150/Pinnacle_Dermatology>,
        <https://1145.am/db/604489/West_Dermatology>,
        <https://1145.am/db/656689/Alastin>,
        <https://1145.am/db/659314/Alastin>,
        <https://1145.am/db/825630/Forefront_Dermatology>,
        <https://1145.am/db/834466/The_American_Board_Of_Dermatology>,
        <https://1145.am/db/849619/Dermtech>,
        <https://1145.am/db/850216/Dermtech>,
        <https://1145.am/db/898744/Novan>,
        <https://1145.am/db/975887/Pinnacle_Dermatology> ;
    ns1:sameAsMedium <https://1145.am/db/2154391/Dermira>,
        <https://1145.am/db/2362018/Dermira>,
        <https://1145.am/db/2560487/Dermira> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366049/Biomed_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SEATTLE" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-11-07T13:21:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Secures $20M in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-secures-20m-series-d-financing-0> ;
    ns1:foundName "BioMed Ventures" ;
    ns1:investor <https://1145.am/db/2366049/Equity_Investment_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Henri_Termeer_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "BioMed Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1223133/Bioadvance>,
        <https://1145.am/db/1223149/Bioadvance>,
        <https://1145.am/db/1422234/Forbion_Ventures>,
        <https://1145.am/db/1422725/Forbion_Ventures>,
        <https://1145.am/db/1867543/Tpg_Biotech>,
        <https://1145.am/db/1926411/Bioqube_Ventures>,
        <https://1145.am/db/1990861/Bioqube_Ventures>,
        <https://1145.am/db/2060484/Healthtech_Capital>,
        <https://1145.am/db/2155146/Biomatics_Capital_Partners>,
        <https://1145.am/db/2280492/Biovision_Ventures>,
        <https://1145.am/db/2285038/Time_Bioventures>,
        <https://1145.am/db/2286671/Forbion>,
        <https://1145.am/db/2298954/Biossom_Investment_Management>,
        <https://1145.am/db/2298978/Advent_Life_Sciences>,
        <https://1145.am/db/2301741/Bio_*_One_Capital>,
        <https://1145.am/db/2301792/Fonds_Bio-Innovation_Sec>,
        <https://1145.am/db/2302351/Medimmune_Ventures>,
        <https://1145.am/db/2305587/Medimmune_Ventures>,
        <https://1145.am/db/2309840/Bio_Fund>,
        <https://1145.am/db/2310285/Medventure_Associates>,
        <https://1145.am/db/2313322/Biomedinvest>,
        <https://1145.am/db/2313322/Hbm_Bioventures>,
        <https://1145.am/db/2313401/Biogen_Idec_New_Ventures>,
        <https://1145.am/db/2313438/Biomedinvest>,
        <https://1145.am/db/2313438/Hbm_Biocapital>,
        <https://1145.am/db/2313438/Hbm_Bioventures>,
        <https://1145.am/db/2313438/Sv_Life_Sciences>,
        <https://1145.am/db/2314400/Hbm_Biocapital>,
        <https://1145.am/db/2314515/Sv_Life_Sciences>,
        <https://1145.am/db/2314573/Avlar_Bioventures>,
        <https://1145.am/db/2316709/Bioadvance_Ventures>,
        <https://1145.am/db/2317737/Mc_Life_Sciences_Ventures>,
        <https://1145.am/db/2317779/Bio_*_One_Capital>,
        <https://1145.am/db/2319360/Medimmune_Ventures>,
        <https://1145.am/db/2321097/Healthcare_Ventures>,
        <https://1145.am/db/2323785/Medimmune_Ventures>,
        <https://1145.am/db/2324015/Medsciences_Capital>,
        <https://1145.am/db/2324195/Lotus_Bioscience_Ventures>,
        <https://1145.am/db/2325831/Bb_Biotech>,
        <https://1145.am/db/2325831/Hbm_Bioventures>,
        <https://1145.am/db/2336109/Biomed_Ventures>,
        <https://1145.am/db/2338673/Hopen_Life_Science_Ventures>,
        <https://1145.am/db/2339295/Biomedinvest>,
        <https://1145.am/db/2345037/Biomed_Ventures>,
        <https://1145.am/db/2347571/Advent_Life_Sciences>,
        <https://1145.am/db/2352382/Biomedinvest>,
        <https://1145.am/db/2352633/Advanced_Biotechnologies_Venture_Fund>,
        <https://1145.am/db/2354295/Biomed_Ventures>,
        <https://1145.am/db/2359240/Frontline_Bioventures>,
        <https://1145.am/db/2364853/Medimmune_Ventures>,
        <https://1145.am/db/2365171/Healthcare_Ventures>,
        <https://1145.am/db/2366055/Biomed_Ventures>,
        <https://1145.am/db/2366133/Biopacificventures>,
        <https://1145.am/db/2368251/Sv_Life_Sciences>,
        <https://1145.am/db/2369916/Biomed_Ventures>,
        <https://1145.am/db/363714/Palliare>,
        <https://1145.am/db/564585/Bioqube_Ventures>,
        <https://1145.am/db/566971/Bioqube_Ventures>,
        <https://1145.am/db/684123/Biourja_Ventures>,
        <https://1145.am/db/938108/Bioeconomy_Capital>,
        <https://1145.am/db/971939/I___I_Biotech_Fund>,
        <https://1145.am/db/975114/I___I_Biotech_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/2335675/Biomed_Ventures>,
        <https://1145.am/db/2336102/Biomed_Ventures>,
        <https://1145.am/db/2366046/Biomed_Ventures>,
        <https://1145.am/db/2368333/Biomed_Ventures>,
        <https://1145.am/db/2569522/Biomed_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366049/Nanostring_Technologies> a org:Organization ;
    ns1:basedInLowRaw "SEATTLE" ;
    ns1:description "life science tools" ;
    ns1:documentDate "2011-11-07T13:21:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Secures $20M in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-secures-20m-series-d-financing-0> ;
    ns1:foundName "NanoString Technologies, Inc." ;
    ns1:industry "life science tools" ;
    ns1:name "NanoString Technologies" ;
    ns1:sameAsHigh <https://1145.am/db/2099366/Nanostring_Technologies>,
        <https://1145.am/db/2203079/Nanostring_Technologies>,
        <https://1145.am/db/2294717/Nanostring_Technologies>,
        <https://1145.am/db/2327269/Nanostring_Technologies>,
        <https://1145.am/db/2327272/Nanostring_Technologies>,
        <https://1145.am/db/2336016/Nanostring_Technologies>,
        <https://1145.am/db/2336931/Nanostring_Technologies>,
        <https://1145.am/db/2343413/Nanostring_Technologiesnicole_Litchfield>,
        <https://1145.am/db/2346566/Nanostring_Technologies>,
        <https://1145.am/db/2354295/Nanostring_Technologies>,
        <https://1145.am/db/2365955/Nanostring_Technologies>,
        <https://1145.am/db/2366051/Nanostring_Technologies>,
        <https://1145.am/db/2366055/Nanostring_Technologies>,
        <https://1145.am/db/2366660/Nanostring_Technologies>,
        <https://1145.am/db/744099/Nanostring_Technologies>,
        <https://1145.am/db/746300/Nanostring_Technologies>,
        <https://1145.am/db/984298/Nanostring_Technologies>,
        <https://1145.am/db/985727/Nanostring_Technologies> ;
    ns1:sameAsMedium <https://1145.am/db/2368191/Nanostring_Technologies> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366055/Biomed_Ventures> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-11-07T13:25:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Secures $20M in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-secures-20m-series-d-financing> ;
    ns1:foundName "BioMed Ventures" ;
    ns1:investor <https://1145.am/db/2366055/Equity_Investment_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Healthymagination_Fund_Henri_Termeer_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "BioMed Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1223133/Bioadvance>,
        <https://1145.am/db/1223149/Bioadvance>,
        <https://1145.am/db/1422234/Forbion_Ventures>,
        <https://1145.am/db/1422725/Forbion_Ventures>,
        <https://1145.am/db/1867543/Tpg_Biotech>,
        <https://1145.am/db/1926411/Bioqube_Ventures>,
        <https://1145.am/db/1990861/Bioqube_Ventures>,
        <https://1145.am/db/2060484/Healthtech_Capital>,
        <https://1145.am/db/2155146/Biomatics_Capital_Partners>,
        <https://1145.am/db/2280492/Biovision_Ventures>,
        <https://1145.am/db/2285038/Time_Bioventures>,
        <https://1145.am/db/2286671/Forbion>,
        <https://1145.am/db/2298954/Biossom_Investment_Management>,
        <https://1145.am/db/2298978/Advent_Life_Sciences>,
        <https://1145.am/db/2301741/Bio_*_One_Capital>,
        <https://1145.am/db/2301792/Fonds_Bio-Innovation_Sec>,
        <https://1145.am/db/2302351/Medimmune_Ventures>,
        <https://1145.am/db/2305587/Medimmune_Ventures>,
        <https://1145.am/db/2309840/Bio_Fund>,
        <https://1145.am/db/2310285/Medventure_Associates>,
        <https://1145.am/db/2313322/Biomedinvest>,
        <https://1145.am/db/2313322/Hbm_Bioventures>,
        <https://1145.am/db/2313401/Biogen_Idec_New_Ventures>,
        <https://1145.am/db/2313438/Biomedinvest>,
        <https://1145.am/db/2313438/Hbm_Biocapital>,
        <https://1145.am/db/2313438/Hbm_Bioventures>,
        <https://1145.am/db/2313438/Sv_Life_Sciences>,
        <https://1145.am/db/2314400/Hbm_Biocapital>,
        <https://1145.am/db/2314515/Sv_Life_Sciences>,
        <https://1145.am/db/2314573/Avlar_Bioventures>,
        <https://1145.am/db/2316709/Bioadvance_Ventures>,
        <https://1145.am/db/2317737/Mc_Life_Sciences_Ventures>,
        <https://1145.am/db/2317779/Bio_*_One_Capital>,
        <https://1145.am/db/2319360/Medimmune_Ventures>,
        <https://1145.am/db/2321097/Healthcare_Ventures>,
        <https://1145.am/db/2323785/Medimmune_Ventures>,
        <https://1145.am/db/2324015/Medsciences_Capital>,
        <https://1145.am/db/2324195/Lotus_Bioscience_Ventures>,
        <https://1145.am/db/2325831/Bb_Biotech>,
        <https://1145.am/db/2325831/Hbm_Bioventures>,
        <https://1145.am/db/2336109/Biomed_Ventures>,
        <https://1145.am/db/2338673/Hopen_Life_Science_Ventures>,
        <https://1145.am/db/2339295/Biomedinvest>,
        <https://1145.am/db/2345037/Biomed_Ventures>,
        <https://1145.am/db/2347571/Advent_Life_Sciences>,
        <https://1145.am/db/2352382/Biomedinvest>,
        <https://1145.am/db/2352633/Advanced_Biotechnologies_Venture_Fund>,
        <https://1145.am/db/2354295/Biomed_Ventures>,
        <https://1145.am/db/2359240/Frontline_Bioventures>,
        <https://1145.am/db/2364853/Medimmune_Ventures>,
        <https://1145.am/db/2365171/Healthcare_Ventures>,
        <https://1145.am/db/2366049/Biomed_Ventures>,
        <https://1145.am/db/2366133/Biopacificventures>,
        <https://1145.am/db/2368251/Sv_Life_Sciences>,
        <https://1145.am/db/2369916/Biomed_Ventures>,
        <https://1145.am/db/363714/Palliare>,
        <https://1145.am/db/564585/Bioqube_Ventures>,
        <https://1145.am/db/566971/Bioqube_Ventures>,
        <https://1145.am/db/684123/Biourja_Ventures>,
        <https://1145.am/db/938108/Bioeconomy_Capital>,
        <https://1145.am/db/971939/I___I_Biotech_Fund>,
        <https://1145.am/db/975114/I___I_Biotech_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/2335675/Biomed_Ventures>,
        <https://1145.am/db/2336102/Biomed_Ventures>,
        <https://1145.am/db/2366046/Biomed_Ventures>,
        <https://1145.am/db/2368333/Biomed_Ventures>,
        <https://1145.am/db/2569522/Biomed_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366055/Nanostring_Technologies> a org:Organization ;
    ns1:basedInLowRaw "SEATTLE" ;
    ns1:description "life science tools for translational research and developer of molecular diagnostics" ;
    ns1:documentDate "2011-11-07T13:25:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Secures $20M in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-secures-20m-series-d-financing> ;
    ns1:foundName "NanoString",
        "NanoString Technologies, Inc." ;
    ns1:industry "life science tools" ;
    ns1:name "NanoString",
        "NanoString Technologies" ;
    ns1:sameAsHigh <https://1145.am/db/2099366/Nanostring_Technologies>,
        <https://1145.am/db/2203079/Nanostring_Technologies>,
        <https://1145.am/db/2327269/Nanostring_Technologies>,
        <https://1145.am/db/2327272/Nanostring_Technologies>,
        <https://1145.am/db/2336016/Nanostring_Technologies>,
        <https://1145.am/db/2336931/Nanostring_Technologies>,
        <https://1145.am/db/2343413/Nanostring_Technologiesnicole_Litchfield>,
        <https://1145.am/db/2346566/Nanostring_Technologies>,
        <https://1145.am/db/2354295/Nanostring_Technologies>,
        <https://1145.am/db/2365955/Nanostring_Technologies>,
        <https://1145.am/db/2366049/Nanostring_Technologies>,
        <https://1145.am/db/2366051/Nanostring_Technologies>,
        <https://1145.am/db/2366660/Nanostring_Technologies>,
        <https://1145.am/db/2368191/Nanostring_Technologies>,
        <https://1145.am/db/744099/Nanostring_Technologies>,
        <https://1145.am/db/746300/Nanostring_Technologies>,
        <https://1145.am/db/984298/Nanostring_Technologies>,
        <https://1145.am/db/985727/Nanostring_Technologies> ;
    ns1:sameAsMedium <https://1145.am/db/2294717/Nanostring_Technologies> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366079/Comprehend_Systems> a org:Organization ;
    ns1:basedInHighGeoName "Palo Alto" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5380748/about.rdf> ;
    ns1:basedInHighRaw "PALO ALTO, CALIF." ;
    ns1:documentDate "2011-11-08T12:17:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "COMPREHEND SYSTEMS SECURES $1.2MM IN SEED FUNDING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/comprehend-systems-secures-1-2mm-seed-funding> ;
    ns1:foundName "Comprehend",
        "Comprehend (@ Comprehend)",
        "Comprehend Systems, Inc." ;
    ns1:name "Comprehend",
        "Comprehend Systems" ;
    ns1:sameAsMedium <https://1145.am/db/2304511/Comprehend_Systems>,
        <https://1145.am/db/2332227/Comprehend_Systems>,
        <https://1145.am/db/2337826/Comprehend_Systems> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2525964/Northstar-at-Tahoe_Resort_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-10-20T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Vail Resorts has sunk $ 30 million in capital improvements into its newest acquisition, Northstar-at-Tahoe Resort, which opens for skiing and riding Nov. 18." ;
    ns1:documentTitle "North Lake Tahoe Rolls Out Improvements for 2011-2012 Ski Season" ;
    ns1:documentURL <https://www.travelagentcentral.com/destinations/north-lake-tahoe-rolls-out-improvements-for-2011-2012-ski-season> ;
    ns1:foundName "acquisition" ;
    ns1:name "acquisition" ;
    ns1:sourceName "Travel Agent Central" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2525964/Northstar-at-Tahoe_Resort> ;
    ns1:targetName "Northstar-at-Tahoe Resort" ;
    ns1:valueRaw "$ 30 million" ;
    ns1:when "2011-11-18T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Nov. 18" .

<https://1145.am/db/2546371/Acquisition_Ancor_Capital_Partners_Sentinel_Capital_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-11-08T12:41:08+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Wellspring Pharmaceutical, a Canadian manufacturer of specialty and OTC drugs, has been acquired by Sentinel Capital Partners and Ancor Capital Partners." ;
    ns1:documentTitle "Endo wooed by $1.2M incentives from PA; Wellspring acquired by Sentinel, Ancor;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/endo-wooed-by-1-2m-incentives-from-pa-wellspring-acquired-by-sentinel-ancor> ;
    ns1:foundName "acquired" ;
    ns1:name "acquired" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:whereGeoName "Canada" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:whereRaw "Canada" .

<https://1145.am/db/2546371/Investment_Genmab_Lonza_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-11-08T12:41:08+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Lonza has announced a development and manufacturing agreement with Genmab to produce HuMax-TF, a tumor-fighting antibody-drug conjugate." ;
    ns1:documentTitle "Endo wooed by $1.2M incentives from PA; Wellspring acquired by Sentinel, Ancor;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/endo-wooed-by-1-2m-incentives-from-pa-wellspring-acquired-by-sentinel-ancor> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "Canada" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:whereRaw "Canada" .

<https://1145.am/db/2546371/Wellspring_Pharmaceutical> a org:Organization ;
    ns1:basedInHighGeoName "Canada" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:basedInHighRaw "Canada" ;
    ns1:description "pharmaceutical" ;
    ns1:documentDate "2011-11-08T12:41:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Endo wooed by $1.2M incentives from PA; Wellspring acquired by Sentinel, Ancor;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/endo-wooed-by-1-2m-incentives-from-pa-wellspring-acquired-by-sentinel-ancor> ;
    ns1:foundName "Wellspring Pharmaceutical" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Wellspring Pharmaceutical" ;
    ns1:sameAsHigh <https://1145.am/db/2369402/Medicines_Company>,
        <https://1145.am/db/2578302/Wellspring_Pharmaceutical_Corporation>,
        <https://1145.am/db/2579538/Pharmaforce> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546371/Wellspring_Pharmaceutical_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-11-08T12:41:08+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Wellspring Pharmaceutical, a Canadian manufacturer of specialty and OTC drugs, has been acquired by Sentinel Capital Partners and Ancor Capital Partners." ;
    ns1:documentTitle "Endo wooed by $1.2M incentives from PA; Wellspring acquired by Sentinel, Ancor;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/endo-wooed-by-1-2m-incentives-from-pa-wellspring-acquired-by-sentinel-ancor> ;
    ns1:foundName "acquired" ;
    ns1:name "acquired" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2546371/Wellspring_Pharmaceutical> ;
    ns1:targetName "Wellspring Pharmaceutical" ;
    ns1:whereGeoName "Canada" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:whereRaw "Canada" .

<https://1145.am/db/2578302/Wellspring_Pharmaceutical_Corporation> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2011-11-08T12:45:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sentinel Capital Partners Acquires WellSpring Pharmaceutical Corporation" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/sentinel-capital-partners-acquires-wellspring-pharmaceutical-corporation> ;
    ns1:foundName "WellSpring Pharmaceutical Corporation" ;
    ns1:industry "Healthcare" ;
    ns1:name "WellSpring Pharmaceutical Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/2369402/Medicines_Company>,
        <https://1145.am/db/2370856/Atlantic_Healthcare>,
        <https://1145.am/db/2546371/Wellspring_Pharmaceutical>,
        <https://1145.am/db/2579538/Pharmaforce> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2593681/Amgen> a org:Organization ;
    ns1:basedInHighGeoName "Thousand Oaks" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5402405/about.rdf> ;
    ns1:basedInHighRaw "THOUSAND OAKS, Calif." ;
    ns1:buyer <https://1145.am/db/2593681/Micromet_Acquisition> ;
    ns1:description "Biotechnology" ;
    ns1:documentDate "2012-01-26T14:20:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Amgen to Acquire Micromet" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/amgen-to-acquire-micromet> ;
    ns1:foundName "Amgen" ;
    ns1:industry "biotechnology" ;
    ns1:name "Amgen" ;
    ns1:sameAsHigh <https://1145.am/db/1079148/Bioage>,
        <https://1145.am/db/1083082/Bioage>,
        <https://1145.am/db/1322637/Sengenics>,
        <https://1145.am/db/1406211/Amgen>,
        <https://1145.am/db/1415508/Direct_Biologics_Inc>,
        <https://1145.am/db/1560943/Generate_Biomedicines>,
        <https://1145.am/db/1582218/Bioaffinity_Technologies>,
        <https://1145.am/db/1629918/Novotech>,
        <https://1145.am/db/1629919/Novotech>,
        <https://1145.am/db/1932925/Transgene>,
        <https://1145.am/db/1967508/Transgene>,
        <https://1145.am/db/1981398/Amgen>,
        <https://1145.am/db/1989264/Bioaffinity_Technologies>,
        <https://1145.am/db/2062962/Transgene>,
        <https://1145.am/db/2152253/Empirica>,
        <https://1145.am/db/2152634/Generation_Bio>,
        <https://1145.am/db/2153261/Genfit>,
        <https://1145.am/db/2153720/Macrogenics>,
        <https://1145.am/db/2154018/Forbion>,
        <https://1145.am/db/2281647/Abogen_Biosciences>,
        <https://1145.am/db/2300768/The_Big_Biotech>,
        <https://1145.am/db/2301977/Biogen_Idec_Inc>,
        <https://1145.am/db/2302669/Medigen_Biotechnology_Corporation>,
        <https://1145.am/db/2303130/Invitrogen_Corporation>,
        <https://1145.am/db/2305209/Biogen_Idec>,
        <https://1145.am/db/2305215/Biogen_Idec>,
        <https://1145.am/db/2305837/Macrogenics>,
        <https://1145.am/db/2306961/Transgene>,
        <https://1145.am/db/2307723/Maxim_Biotech>,
        <https://1145.am/db/2314822/Biogen_Idec>,
        <https://1145.am/db/2320759/Amgen>,
        <https://1145.am/db/2320765/Amgen>,
        <https://1145.am/db/2320775/Amgen>,
        <https://1145.am/db/2325681/Opgen>,
        <https://1145.am/db/2326996/Geneuro>,
        <https://1145.am/db/2336763/Ambit_Biosciences>,
        <https://1145.am/db/2337644/Genfit>,
        <https://1145.am/db/2337745/Biogen_Idec>,
        <https://1145.am/db/2340408/Amgen>,
        <https://1145.am/db/2343185/Opgen>,
        <https://1145.am/db/2346035/Ambit_Biosciences>,
        <https://1145.am/db/2347997/Ceregene>,
        <https://1145.am/db/2348620/Amunix_Inc>,
        <https://1145.am/db/2349307/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2350047/Macrogenics>,
        <https://1145.am/db/2350198/Applied_Genetic>,
        <https://1145.am/db/2351335/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2352800/Amgen>,
        <https://1145.am/db/2353256/The_Biotech>,
        <https://1145.am/db/2358383/Macrogenics>,
        <https://1145.am/db/2361405/Biogen_Idec>,
        <https://1145.am/db/2361971/Amgen>,
        <https://1145.am/db/2361973/Amgen>,
        <https://1145.am/db/2363538/Biogen_Idec>,
        <https://1145.am/db/2365300/Genocea>,
        <https://1145.am/db/2367817/Ambrx>,
        <https://1145.am/db/2369953/Forbion>,
        <https://1145.am/db/2370397/Genfit>,
        <https://1145.am/db/2371444/And_Versant>,
        <https://1145.am/db/2544774/Genome>,
        <https://1145.am/db/2556522/Biophausia>,
        <https://1145.am/db/2563336/Ambrx>,
        <https://1145.am/db/2581359/Amgen>,
        <https://1145.am/db/2589106/Amgen>,
        <https://1145.am/db/2718350/The_Big_Biotech>,
        <https://1145.am/db/2790676/Endeavor_Biomedicines>,
        <https://1145.am/db/365533/Ambrx>,
        <https://1145.am/db/435626/Boundless_Bio>,
        <https://1145.am/db/437762/Boundless_Bio>,
        <https://1145.am/db/559677/Genetether>,
        <https://1145.am/db/586002/Forbion>,
        <https://1145.am/db/734523/Boundless_Bio>,
        <https://1145.am/db/819348/Transgene>,
        <https://1145.am/db/944644/Transgene>,
        <https://1145.am/db/946928/Transgene> ;
    ns1:sameAsMedium <https://1145.am/db/1252426/Amgen_Inc>,
        <https://1145.am/db/1253935/Amgen>,
        <https://1145.am/db/1254815/Amgen>,
        <https://1145.am/db/1258904/Amgen_Inc>,
        <https://1145.am/db/1262006/Amgen>,
        <https://1145.am/db/1434130/Amgen>,
        <https://1145.am/db/1488570/Amgen>,
        <https://1145.am/db/1541946/Amgen>,
        <https://1145.am/db/1568872/Amgen_Inc>,
        <https://1145.am/db/1570839/Amgen_Inc>,
        <https://1145.am/db/1573831/Amgen>,
        <https://1145.am/db/1574155/Amgen>,
        <https://1145.am/db/1575688/Amgen_Inc>,
        <https://1145.am/db/1576668/Amgen_Inc>,
        <https://1145.am/db/1673901/Amgen>,
        <https://1145.am/db/1929668/Amgen>,
        <https://1145.am/db/198163/Amgen>,
        <https://1145.am/db/2008430/Amgen_Inc>,
        <https://1145.am/db/2008790/Amgen>,
        <https://1145.am/db/2009117/Amgen_Inc>,
        <https://1145.am/db/2011679/Amgen>,
        <https://1145.am/db/2012933/Amgen_Inc>,
        <https://1145.am/db/2013008/Amgen_Inc>,
        <https://1145.am/db/2016970/Amgen>,
        <https://1145.am/db/2043001/Amgen>,
        <https://1145.am/db/2046726/Amgen>,
        <https://1145.am/db/2098829/Amgen>,
        <https://1145.am/db/2105082/Amgen>,
        <https://1145.am/db/2106270/Amgen>,
        <https://1145.am/db/2107919/Amgen>,
        <https://1145.am/db/2117067/Amgen>,
        <https://1145.am/db/2117986/Amgen>,
        <https://1145.am/db/2138386/Amgen>,
        <https://1145.am/db/2152715/Amgen>,
        <https://1145.am/db/2153258/Amgen>,
        <https://1145.am/db/2154415/Amgen>,
        <https://1145.am/db/2155409/Amgen>,
        <https://1145.am/db/2155659/Amgen>,
        <https://1145.am/db/2249776/Amgen_Inc>,
        <https://1145.am/db/2282387/Amgen>,
        <https://1145.am/db/2282934/Amgen>,
        <https://1145.am/db/2283321/Amgen>,
        <https://1145.am/db/2285195/Amgen>,
        <https://1145.am/db/2285614/Amgen>,
        <https://1145.am/db/2285991/Amgen>,
        <https://1145.am/db/2286174/Amgen>,
        <https://1145.am/db/2291231/Amgen>,
        <https://1145.am/db/2292224/Amgen>,
        <https://1145.am/db/2292876/Amgen>,
        <https://1145.am/db/2299349/Amgen>,
        <https://1145.am/db/2302052/Amgen>,
        <https://1145.am/db/2303414/Amgen>,
        <https://1145.am/db/2312121/Amgen>,
        <https://1145.am/db/2313429/Amgen>,
        <https://1145.am/db/2317845/Amgen>,
        <https://1145.am/db/2318877/Amgen>,
        <https://1145.am/db/2320754/Amgen>,
        <https://1145.am/db/2320771/Amgen>,
        <https://1145.am/db/2321459/Amgen>,
        <https://1145.am/db/2321989/Amgen>,
        <https://1145.am/db/2322040/Amgen>,
        <https://1145.am/db/2322632/Amgen>,
        <https://1145.am/db/2326533/Amgen>,
        <https://1145.am/db/2326559/Amgen>,
        <https://1145.am/db/2327526/Amgen>,
        <https://1145.am/db/2327547/Amgen>,
        <https://1145.am/db/2328748/Amgen>,
        <https://1145.am/db/2329762/Amgen>,
        <https://1145.am/db/2333460/Amgen>,
        <https://1145.am/db/2334046/Amgen>,
        <https://1145.am/db/2337433/Amgen>,
        <https://1145.am/db/2337435/Amgen_Inc>,
        <https://1145.am/db/2337848/Amgen>,
        <https://1145.am/db/2338027/Amgen>,
        <https://1145.am/db/2338329/Amgen>,
        <https://1145.am/db/2338346/Amgen>,
        <https://1145.am/db/2338828/Amgen>,
        <https://1145.am/db/2340634/Amgen>,
        <https://1145.am/db/2340669/Amgen>,
        <https://1145.am/db/2343511/Amgen>,
        <https://1145.am/db/2343601/Amgen>,
        <https://1145.am/db/2343780/Amgen>,
        <https://1145.am/db/2343862/Amgen>,
        <https://1145.am/db/2344369/Amgen>,
        <https://1145.am/db/2344631/Amgen>,
        <https://1145.am/db/2344864/Amgen>,
        <https://1145.am/db/2345191/Amgen>,
        <https://1145.am/db/2345783/Amgen>,
        <https://1145.am/db/2345886/Amgen>,
        <https://1145.am/db/2346293/Amgen>,
        <https://1145.am/db/2347966/Amgen>,
        <https://1145.am/db/2347970/Amgen>,
        <https://1145.am/db/2347976/Amgen>,
        <https://1145.am/db/2349030/Amgen>,
        <https://1145.am/db/2349444/Amgen>,
        <https://1145.am/db/2350029/Amgen>,
        <https://1145.am/db/2350465/Amgen>,
        <https://1145.am/db/2350471/Amgen>,
        <https://1145.am/db/2353167/Amgen>,
        <https://1145.am/db/2354835/Amgen>,
        <https://1145.am/db/2355378/Amgen>,
        <https://1145.am/db/2355383/Amgen>,
        <https://1145.am/db/2355392/Amgen>,
        <https://1145.am/db/2355427/Amgen>,
        <https://1145.am/db/2357269/Amgen>,
        <https://1145.am/db/2357271/Amgen>,
        <https://1145.am/db/2357303/Amgen>,
        <https://1145.am/db/2357336/Amgen>,
        <https://1145.am/db/2357451/Amgen>,
        <https://1145.am/db/2357454/Amgen>,
        <https://1145.am/db/2357920/Amgen>,
        <https://1145.am/db/2358934/Amgen>,
        <https://1145.am/db/2359165/Amgen>,
        <https://1145.am/db/2359462/Amgen>,
        <https://1145.am/db/2359481/Amgen>,
        <https://1145.am/db/2359498/Amgen>,
        <https://1145.am/db/2360080/Amgen>,
        <https://1145.am/db/2360086/Amgen>,
        <https://1145.am/db/2361037/Amgen>,
        <https://1145.am/db/2361972/Amgen>,
        <https://1145.am/db/2362552/Amgen>,
        <https://1145.am/db/2363673/Amgen>,
        <https://1145.am/db/2364216/Amgen>,
        <https://1145.am/db/2367430/Amgen_Inc>,
        <https://1145.am/db/2368788/Amgen_Inc>,
        <https://1145.am/db/2370120/Amgen>,
        <https://1145.am/db/2370174/Amgen>,
        <https://1145.am/db/2370215/Amgen>,
        <https://1145.am/db/2370217/Amgen>,
        <https://1145.am/db/2371301/Amgen>,
        <https://1145.am/db/2538019/Amgen>,
        <https://1145.am/db/2539787/Amgen>,
        <https://1145.am/db/2540225/Amgen>,
        <https://1145.am/db/2543232/Amgen>,
        <https://1145.am/db/2543655/Amgen>,
        <https://1145.am/db/2544701/Amgen>,
        <https://1145.am/db/2545663/Amgen>,
        <https://1145.am/db/2545765/Amgen>,
        <https://1145.am/db/2548575/Amgen>,
        <https://1145.am/db/2550685/Amgen>,
        <https://1145.am/db/2550884/Amgen>,
        <https://1145.am/db/2551883/Amgen>,
        <https://1145.am/db/2551884/Amgen>,
        <https://1145.am/db/2553162/Amgen>,
        <https://1145.am/db/2553564/Amgen>,
        <https://1145.am/db/2554152/Amgen>,
        <https://1145.am/db/2555175/Amgen>,
        <https://1145.am/db/2556729/Amgen>,
        <https://1145.am/db/2557364/Amgen>,
        <https://1145.am/db/2558012/Amgen>,
        <https://1145.am/db/2558039/Amgen>,
        <https://1145.am/db/2558051/Amgen>,
        <https://1145.am/db/2558418/Amgen>,
        <https://1145.am/db/2559077/Amgen>,
        <https://1145.am/db/2561305/Amgen>,
        <https://1145.am/db/2561317/Amgen>,
        <https://1145.am/db/2561325/Amgen>,
        <https://1145.am/db/2561650/Amgen>,
        <https://1145.am/db/2566335/Amgen>,
        <https://1145.am/db/2566348/Amgen>,
        <https://1145.am/db/2567468/Amgen>,
        <https://1145.am/db/2567517/Amgen>,
        <https://1145.am/db/2567960/Amgen>,
        <https://1145.am/db/2567981/Amgen>,
        <https://1145.am/db/2568005/Amgen>,
        <https://1145.am/db/2568075/Amgen>,
        <https://1145.am/db/2568519/Amgen>,
        <https://1145.am/db/2572535/Amgen>,
        <https://1145.am/db/2572655/Amgen>,
        <https://1145.am/db/2573455/Amgen>,
        <https://1145.am/db/2573903/Amgen>,
        <https://1145.am/db/2573924/Amgen>,
        <https://1145.am/db/2573976/Amgen>,
        <https://1145.am/db/2574586/Amgen>,
        <https://1145.am/db/2575263/Amgen>,
        <https://1145.am/db/2575289/Amgen>,
        <https://1145.am/db/2576018/Amgen>,
        <https://1145.am/db/2576242/Amgen>,
        <https://1145.am/db/2576498/Amgen>,
        <https://1145.am/db/2577110/Amgen>,
        <https://1145.am/db/2577115/Amgen>,
        <https://1145.am/db/2577120/Amgen>,
        <https://1145.am/db/2578110/Amgen>,
        <https://1145.am/db/2578164/Amgen>,
        <https://1145.am/db/2578286/Amgen>,
        <https://1145.am/db/2579211/Amgen>,
        <https://1145.am/db/2579278/Amgen>,
        <https://1145.am/db/2580209/Amgen>,
        <https://1145.am/db/2580211/Amgen>,
        <https://1145.am/db/2580383/Amgen_Inc>,
        <https://1145.am/db/2581309/Amgen>,
        <https://1145.am/db/2581917/Amgen>,
        <https://1145.am/db/2583990/Amgen>,
        <https://1145.am/db/2584352/Amgen>,
        <https://1145.am/db/2585068/Amgen>,
        <https://1145.am/db/2586068/Amgen>,
        <https://1145.am/db/2586750/Amgen>,
        <https://1145.am/db/2587009/Amgen>,
        <https://1145.am/db/2587770/Amgen>,
        <https://1145.am/db/258901/Amgen_Inc>,
        <https://1145.am/db/2590194/Amgen>,
        <https://1145.am/db/2590988/Amgen_Inc>,
        <https://1145.am/db/2590989/Amgen>,
        <https://1145.am/db/2591587/Amgen>,
        <https://1145.am/db/2591594/Amgen>,
        <https://1145.am/db/2592573/Amgen>,
        <https://1145.am/db/2592618/Amgen>,
        <https://1145.am/db/2592924/Amgen>,
        <https://1145.am/db/2593423/Amgen>,
        <https://1145.am/db/2593426/Amgen>,
        <https://1145.am/db/2593433/Amgen_Inc>,
        <https://1145.am/db/2593434/Amgen>,
        <https://1145.am/db/2593465/Amgen>,
        <https://1145.am/db/2593973/Amgen>,
        <https://1145.am/db/2594099/Amgen>,
        <https://1145.am/db/2594285/Amgen>,
        <https://1145.am/db/2594292/Amgen>,
        <https://1145.am/db/2594298/Amgen>,
        <https://1145.am/db/2594347/Amgen>,
        <https://1145.am/db/2594990/Amgen>,
        <https://1145.am/db/2594993/Amgen>,
        <https://1145.am/db/2595020/Amgen>,
        <https://1145.am/db/2595549/Amgen>,
        <https://1145.am/db/2595564/Amgen>,
        <https://1145.am/db/2595587/Amgen>,
        <https://1145.am/db/2595605/Amgen>,
        <https://1145.am/db/2595608/Amgen>,
        <https://1145.am/db/2595930/Amgen>,
        <https://1145.am/db/2596467/Amgen>,
        <https://1145.am/db/2596819/Amgen>,
        <https://1145.am/db/2597499/Amgen>,
        <https://1145.am/db/2598066/Amgen>,
        <https://1145.am/db/2716207/Amgen>,
        <https://1145.am/db/2789236/Amgen>,
        <https://1145.am/db/2802001/Amgen>,
        <https://1145.am/db/531806/Amgen_Inc>,
        <https://1145.am/db/559746/Amgen> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2595150/Dermik> a org:Organization ;
    ns1:description "dermatology" ;
    ns1:documentDate "2012-02-06T15:29:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DEA suspends Class 1 Cardinal Health facility; GSK earmarks $64M for Australian expansion;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dea-suspends-class-1-cardinal-health-facility-gsk-earmarks-64m-for-australian-expansion> ;
    ns1:foundName "Dermik" ;
    ns1:industry "dermatology" ;
    ns1:name "Dermik" ;
    ns1:sameAsHigh <https://1145.am/db/1005579/Novan>,
        <https://1145.am/db/1010678/Pinnacle_Dermatology>,
        <https://1145.am/db/1010779/American_Academy_Of_Dermatology>,
        <https://1145.am/db/1053658/Dermcare_Management>,
        <https://1145.am/db/1101009/Docs>,
        <https://1145.am/db/1102547/Docs>,
        <https://1145.am/db/1151308/Westderm>,
        <https://1145.am/db/1153671/Westderm>,
        <https://1145.am/db/1166328/Advanced_Dermatology>,
        <https://1145.am/db/1166328/Esterson_Dermatology>,
        <https://1145.am/db/1183109/Innovaderm>,
        <https://1145.am/db/1183461/Innovaderm>,
        <https://1145.am/db/1215072/Dermtech>,
        <https://1145.am/db/1218063/Dermtech>,
        <https://1145.am/db/1234351/Dermtech>,
        <https://1145.am/db/1239346/Dermtech>,
        <https://1145.am/db/1404947/Integrated_Dermatology>,
        <https://1145.am/db/1408791/Integrated_Dermatology>,
        <https://1145.am/db/1460966/Dermatology_Partners>,
        <https://1145.am/db/1500910/SKNV>,
        <https://1145.am/db/1651523/Onabet>,
        <https://1145.am/db/195301/Dermtech>,
        <https://1145.am/db/1999693/Dermtech>,
        <https://1145.am/db/2012279/Dermtech>,
        <https://1145.am/db/2070188/Bliss_Dermatology>,
        <https://1145.am/db/2113090/Dermtech>,
        <https://1145.am/db/2116825/Vanguard_Dermatology>,
        <https://1145.am/db/2236149/Direct_Dermatology>,
        <https://1145.am/db/2298653/Dermavant_Sciences>,
        <https://1145.am/db/2301879/Magen_Biosciences>,
        <https://1145.am/db/2306724/Dermatech_Pty_Ltd>,
        <https://1145.am/db/2346832/Vital_Science_Corp>,
        <https://1145.am/db/2346833/Vital_Science_Corp>,
        <https://1145.am/db/2347750/Mela_Sciences>,
        <https://1145.am/db/2356428/Spirig>,
        <https://1145.am/db/2359186/Dermira>,
        <https://1145.am/db/2362024/Dermira>,
        <https://1145.am/db/2363666/Dermira>,
        <https://1145.am/db/2363859/Vicept>,
        <https://1145.am/db/2368246/Almirall>,
        <https://1145.am/db/2560487/Dermira>,
        <https://1145.am/db/2586657/Dermik>,
        <https://1145.am/db/2586658/Dermik>,
        <https://1145.am/db/2595039/Skin_Medica>,
        <https://1145.am/db/2597433/Dermik>,
        <https://1145.am/db/354532/Dermtech>,
        <https://1145.am/db/412922/Pinnacle_Dermatology>,
        <https://1145.am/db/435599/Dermlab>,
        <https://1145.am/db/437716/Dermlab>,
        <https://1145.am/db/472836/Pinnacle_Dermatology>,
        <https://1145.am/db/475791/West_Dermatology>,
        <https://1145.am/db/521508/Dermtech>,
        <https://1145.am/db/524122/Dermtech>,
        <https://1145.am/db/526150/Pinnacle_Dermatology>,
        <https://1145.am/db/604489/West_Dermatology>,
        <https://1145.am/db/656689/Alastin>,
        <https://1145.am/db/659314/Alastin>,
        <https://1145.am/db/825630/Forefront_Dermatology>,
        <https://1145.am/db/834466/The_American_Board_Of_Dermatology>,
        <https://1145.am/db/849619/Dermtech>,
        <https://1145.am/db/850216/Dermtech>,
        <https://1145.am/db/898744/Novan>,
        <https://1145.am/db/975887/Dermatology_Physicians_Group>,
        <https://1145.am/db/975887/Pinnacle_Dermatology> ;
    ns1:sameAsMedium <https://1145.am/db/2362893/Dermik> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2595150/Dermik_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "divestment" ;
    ns1:documentDate "2012-02-06T15:29:28+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Valeant ($ VRX) wrapped up the divestiture of several generic skin products to Mylan ($ MYL) , as required by the Federal Trade Commission as a condition of its purchase of Sanofi's ($ SNY) dermatology business Dermik." ;
    ns1:documentTitle "DEA suspends Class 1 Cardinal Health facility; GSK earmarks $64M for Australian expansion;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dea-suspends-class-1-cardinal-health-facility-gsk-earmarks-64m-for-australian-expansion> ;
    ns1:foundName "divestiture",
        "purchase" ;
    ns1:name "divestiture",
        "purchase" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2595150/Dermik> ;
    ns1:targetName "Dermik" ;
    ns1:vendor <https://1145.am/db/2595150/Sanofi> ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2598439/Johnson___Johnson-Merck_Consumer_Pharmaceuticals_Co> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2011-09-29T12:19:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "McNEIL-PPC, Inc. Acquires Full Ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Joint Venture" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/mcneil-ppc-inc-acquires-full-ownership-of-johnson-johnson-merck-consumer-pharmaceuticals-co> ;
    ns1:foundName "Johnson & Johnson-Merck Consumer Pharmaceuticals Co." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Johnson & Johnson-Merck Consumer Pharmaceuticals Co." ;
    ns1:sameAsHigh <https://1145.am/db/1145060/Merck>,
        <https://1145.am/db/1186122/Merck___Co>,
        <https://1145.am/db/1217756/Merck_Kgaa>,
        <https://1145.am/db/141850/Merck>,
        <https://1145.am/db/1451511/Merck___Co>,
        <https://1145.am/db/1514452/Merck_Kgaa>,
        <https://1145.am/db/1519366/Merck>,
        <https://1145.am/db/1522616/Merck>,
        <https://1145.am/db/1541946/J___j>,
        <https://1145.am/db/154793/Merck>,
        <https://1145.am/db/1554738/Merck>,
        <https://1145.am/db/159841/Merck>,
        <https://1145.am/db/1966692/Merck_Kgaa>,
        <https://1145.am/db/1970288/Merck>,
        <https://1145.am/db/1970357/Merck>,
        <https://1145.am/db/1972206/Merck>,
        <https://1145.am/db/1998846/Germanys_Merck_Kgaa>,
        <https://1145.am/db/2010010/Merck___Co_Inc>,
        <https://1145.am/db/2040537/Merck>,
        <https://1145.am/db/2151833/Merck_Kgaa>,
        <https://1145.am/db/2151908/Merck_Kgaa>,
        <https://1145.am/db/2152045/Merck_Kgaa>,
        <https://1145.am/db/2152482/Merck>,
        <https://1145.am/db/2152633/Merck>,
        <https://1145.am/db/2152721/Merck>,
        <https://1145.am/db/2153637/Merck>,
        <https://1145.am/db/2153796/Merck>,
        <https://1145.am/db/2154708/Merck_Kgaa>,
        <https://1145.am/db/2154806/Merck>,
        <https://1145.am/db/2155194/Merck>,
        <https://1145.am/db/2155657/Merck>,
        <https://1145.am/db/2204455/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2217406/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/223588/Merck___Co_Inc>,
        <https://1145.am/db/223595/Merck___Co_Inc>,
        <https://1145.am/db/224121/Merck___Co_Inc>,
        <https://1145.am/db/2278879/Merck>,
        <https://1145.am/db/2279118/Merck>,
        <https://1145.am/db/2279238/Merck>,
        <https://1145.am/db/2280487/Merck___Co>,
        <https://1145.am/db/2281134/Merck>,
        <https://1145.am/db/2283230/Merck>,
        <https://1145.am/db/2284577/Merck>,
        <https://1145.am/db/2285024/Merck>,
        <https://1145.am/db/2285322/Merck>,
        <https://1145.am/db/2286215/Merck>,
        <https://1145.am/db/2286469/Merck>,
        <https://1145.am/db/2286759/Merck>,
        <https://1145.am/db/2287351/Merck>,
        <https://1145.am/db/2288192/Merck>,
        <https://1145.am/db/2288199/Merck>,
        <https://1145.am/db/2294623/Merck>,
        <https://1145.am/db/2298415/Merck_Kgaa>,
        <https://1145.am/db/2301300/J___j>,
        <https://1145.am/db/2302117/Merck___Co_Inc>,
        <https://1145.am/db/2302462/Merck_Kgaa>,
        <https://1145.am/db/2302856/Merck_Kgaa>,
        <https://1145.am/db/2303618/Merck_Sharp___Dohme>,
        <https://1145.am/db/2303818/Merck_Kgaa>,
        <https://1145.am/db/2304609/Merck_Kgaa>,
        <https://1145.am/db/2304616/Merck___Co_Inc>,
        <https://1145.am/db/2304619/Merck___Co_Inc>,
        <https://1145.am/db/2305804/Merck>,
        <https://1145.am/db/2306238/Merck>,
        <https://1145.am/db/2307377/Merck_Kgaa>,
        <https://1145.am/db/2307669/Merck>,
        <https://1145.am/db/2310391/Merck>,
        <https://1145.am/db/2312786/Merck>,
        <https://1145.am/db/2312813/Merck>,
        <https://1145.am/db/2313223/Merck>,
        <https://1145.am/db/2316418/Merck___Co>,
        <https://1145.am/db/2316435/Merck___Co>,
        <https://1145.am/db/2316525/Merck>,
        <https://1145.am/db/2317494/Merck>,
        <https://1145.am/db/2317795/Merck_Kgaa>,
        <https://1145.am/db/2317895/Merck_Kgaa>,
        <https://1145.am/db/2318264/J___j>,
        <https://1145.am/db/2318333/Merck_Kgaa>,
        <https://1145.am/db/2319111/Merck>,
        <https://1145.am/db/2319215/Merck_Kgaa>,
        <https://1145.am/db/2320352/Merck_Kgaa>,
        <https://1145.am/db/2320534/Merck_Kgaa>,
        <https://1145.am/db/2320820/Merck_Kgaa>,
        <https://1145.am/db/2321072/Merck___Co_Inc>,
        <https://1145.am/db/2323000/J___j>,
        <https://1145.am/db/2323722/Merck___Co>,
        <https://1145.am/db/2325084/Merck>,
        <https://1145.am/db/2325864/Merck>,
        <https://1145.am/db/2326224/Merck___Co_Inc>,
        <https://1145.am/db/2326286/Merck>,
        <https://1145.am/db/2328055/J___j>,
        <https://1145.am/db/2328359/Merck>,
        <https://1145.am/db/2328367/Merck>,
        <https://1145.am/db/2329586/Merck>,
        <https://1145.am/db/2329589/Merck___Co_Inc>,
        <https://1145.am/db/2329775/Merck_Kgaa>,
        <https://1145.am/db/2329787/Merck_Kgaa>,
        <https://1145.am/db/2330990/Merck_Kgaa>,
        <https://1145.am/db/2331199/Merck_Kgaa>,
        <https://1145.am/db/2331307/Merck_Kgaa>,
        <https://1145.am/db/2331745/J___j>,
        <https://1145.am/db/2332096/Merck___Co_Inc>,
        <https://1145.am/db/2335784/Merck_Kgaa>,
        <https://1145.am/db/2335812/Merck_Kgaa>,
        <https://1145.am/db/2335824/Merck_Kgaa>,
        <https://1145.am/db/2337047/Merck>,
        <https://1145.am/db/2337245/Boston-Merck>,
        <https://1145.am/db/2337246/Merck>,
        <https://1145.am/db/2337247/Merck___Co_Inc>,
        <https://1145.am/db/2337402/Merck_Sharp___Dohme_Bv>,
        <https://1145.am/db/2338348/Merck>,
        <https://1145.am/db/2339972/Merck_Serono>,
        <https://1145.am/db/2340479/Merck_Kgaa>,
        <https://1145.am/db/2341435/Merck>,
        <https://1145.am/db/2342387/Merck_Kgaa>,
        <https://1145.am/db/2342487/Merck>,
        <https://1145.am/db/2343123/Merck>,
        <https://1145.am/db/2343159/Merck>,
        <https://1145.am/db/2343161/Merck>,
        <https://1145.am/db/2343358/Merck_Kgaa>,
        <https://1145.am/db/2343584/Merck>,
        <https://1145.am/db/2343585/Merck>,
        <https://1145.am/db/2344286/Merck___Co_Inc>,
        <https://1145.am/db/2344290/Merck___Co_Inc>,
        <https://1145.am/db/2344563/Merck>,
        <https://1145.am/db/2344564/Merck>,
        <https://1145.am/db/2344792/Merck>,
        <https://1145.am/db/2346099/Merck_Kgaa>,
        <https://1145.am/db/2347933/Merck_Kgaa>,
        <https://1145.am/db/2348683/Merck>,
        <https://1145.am/db/2349084/Merck>,
        <https://1145.am/db/2350145/Merck>,
        <https://1145.am/db/2350594/Merck_Kgaa>,
        <https://1145.am/db/2350594/Merck_Serono>,
        <https://1145.am/db/2350645/Merck_Kgaa>,
        <https://1145.am/db/2350687/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2350706/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2350881/Merck>,
        <https://1145.am/db/2351858/Merck_Kgaa>,
        <https://1145.am/db/2352882/Merck_Kgaa>,
        <https://1145.am/db/2352961/Merck>,
        <https://1145.am/db/2355245/Merck_Kgaa>,
        <https://1145.am/db/2355800/Merck>,
        <https://1145.am/db/2357401/Merck_Kgaa>,
        <https://1145.am/db/2358644/Merck>,
        <https://1145.am/db/2359414/Merck>,
        <https://1145.am/db/2360369/Merck_Kgaa>,
        <https://1145.am/db/2360455/Merck>,
        <https://1145.am/db/2360816/Merck_Kgaa>,
        <https://1145.am/db/2360819/Merck_Kgaa>,
        <https://1145.am/db/2361274/Merck>,
        <https://1145.am/db/2361352/Merck_Kgaa>,
        <https://1145.am/db/2361913/Merck>,
        <https://1145.am/db/2362994/Merck>,
        <https://1145.am/db/2363210/And_Merck>,
        <https://1145.am/db/2363211/Merck>,
        <https://1145.am/db/2363215/Merck>,
        <https://1145.am/db/2365367/Merck>,
        <https://1145.am/db/2367207/Merck_Kgaa>,
        <https://1145.am/db/2367218/Merck_Kgaa>,
        <https://1145.am/db/2367613/Merck_Kgaa>,
        <https://1145.am/db/2367616/J___j>,
        <https://1145.am/db/2368041/Merck>,
        <https://1145.am/db/2368712/Merck>,
        <https://1145.am/db/2368719/Merck>,
        <https://1145.am/db/2368808/Merck>,
        <https://1145.am/db/2369162/Merck>,
        <https://1145.am/db/2369441/Merck_Kgaa>,
        <https://1145.am/db/2369641/Merck>,
        <https://1145.am/db/2370722/Merck>,
        <https://1145.am/db/2371269/Merck_Kgaa>,
        <https://1145.am/db/2536301/Merck>,
        <https://1145.am/db/2537455/Merck>,
        <https://1145.am/db/2538076/Merck___Co>,
        <https://1145.am/db/2539243/Merck>,
        <https://1145.am/db/2539257/Merck>,
        <https://1145.am/db/2539515/Merck_Kgaa>,
        <https://1145.am/db/2539561/Merck>,
        <https://1145.am/db/2540776/Merck>,
        <https://1145.am/db/2541112/Merck_Kgaa>,
        <https://1145.am/db/2541756/Merck>,
        <https://1145.am/db/2542057/Merck>,
        <https://1145.am/db/2542499/Merck>,
        <https://1145.am/db/2542731/Merck>,
        <https://1145.am/db/2542740/Merck>,
        <https://1145.am/db/2544107/Merck_Kgaa>,
        <https://1145.am/db/2544235/Merck>,
        <https://1145.am/db/2544391/Merck>,
        <https://1145.am/db/2545522/Merck_Kgaa>,
        <https://1145.am/db/2545618/Merck_Kgaa>,
        <https://1145.am/db/2546209/And_Merck_Kgaa>,
        <https://1145.am/db/2548696/Merck>,
        <https://1145.am/db/2549220/Merck_Manufacturing_Division>,
        <https://1145.am/db/2549220/Merck___Co>,
        <https://1145.am/db/2551075/Merck_Kgaa>,
        <https://1145.am/db/2551126/Merck>,
        <https://1145.am/db/2552135/Merck_Kgaa>,
        <https://1145.am/db/2552707/Merck___Co_Inc>,
        <https://1145.am/db/2553766/Merck_Kgaa>,
        <https://1145.am/db/2553841/Merck_Kgaas_Merck_Serono>,
        <https://1145.am/db/2556052/Merck>,
        <https://1145.am/db/2557023/Merck_Serono>,
        <https://1145.am/db/2557506/Merck___Co>,
        <https://1145.am/db/2557870/Merck_Millipore>,
        <https://1145.am/db/2558101/Merck_Kgaa>,
        <https://1145.am/db/2558555/Merck___Co>,
        <https://1145.am/db/2558691/Merck>,
        <https://1145.am/db/2558927/Merck>,
        <https://1145.am/db/2558947/Merck_Sharp_And_Dohme>,
        <https://1145.am/db/2559298/Merck>,
        <https://1145.am/db/2559346/Merck_Kgaa>,
        <https://1145.am/db/2559490/J___j>,
        <https://1145.am/db/2559511/Merck>,
        <https://1145.am/db/2559601/Merck>,
        <https://1145.am/db/2559783/Merck_Kgaa>,
        <https://1145.am/db/2559822/Merck>,
        <https://1145.am/db/2560113/Merck_Kgaa>,
        <https://1145.am/db/2560263/Merck_Kgaa>,
        <https://1145.am/db/2560758/Merck>,
        <https://1145.am/db/2561492/Merck_Kgaa>,
        <https://1145.am/db/2561650/Merck___Co>,
        <https://1145.am/db/2562041/Merck>,
        <https://1145.am/db/2563423/Merck>,
        <https://1145.am/db/2563450/Merck>,
        <https://1145.am/db/2564473/Merck_Kgaa>,
        <https://1145.am/db/2564583/Merck_Kgaa>,
        <https://1145.am/db/2565433/Merck>,
        <https://1145.am/db/2566424/Merck___Co>,
        <https://1145.am/db/2566606/Merck_Kgaa>,
        <https://1145.am/db/2566939/Merck>,
        <https://1145.am/db/2567245/Merck___Co>,
        <https://1145.am/db/2568284/Merck_Kgaa>,
        <https://1145.am/db/2568357/Merck>,
        <https://1145.am/db/2568495/Merck>,
        <https://1145.am/db/2568729/Merck___Co>,
        <https://1145.am/db/2568891/Merck_Kgaa>,
        <https://1145.am/db/2568903/Merck_Kgaa>,
        <https://1145.am/db/2569029/Merck_Serono>,
        <https://1145.am/db/2569515/J___j>,
        <https://1145.am/db/2570392/Merck_Kgaa>,
        <https://1145.am/db/2570807/Merck_Kgaa>,
        <https://1145.am/db/2571023/Merck_Kgaa>,
        <https://1145.am/db/2571569/Merck>,
        <https://1145.am/db/2572436/Merck_Canada>,
        <https://1145.am/db/2572620/Merck>,
        <https://1145.am/db/2572634/Merck>,
        <https://1145.am/db/2572675/Merck___Co_Inc>,
        <https://1145.am/db/2573613/Merck_Kgaa>,
        <https://1145.am/db/2574505/J___j>,
        <https://1145.am/db/2575021/Merck>,
        <https://1145.am/db/2575032/Merck>,
        <https://1145.am/db/2575427/Merck>,
        <https://1145.am/db/2575623/Merck_Kgaa>,
        <https://1145.am/db/2576127/Merck>,
        <https://1145.am/db/2576129/Merck_Sharp___Dohme_Bv>,
        <https://1145.am/db/2578485/Merck>,
        <https://1145.am/db/2579483/Merck>,
        <https://1145.am/db/2579763/Merck>,
        <https://1145.am/db/2580399/Merck>,
        <https://1145.am/db/2581295/Merck_Kgaa>,
        <https://1145.am/db/2581441/Merck_Kgaa>,
        <https://1145.am/db/2583045/Merck>,
        <https://1145.am/db/2583206/Merck_Consumer_Care>,
        <https://1145.am/db/2584116/Merck___Co_Inc>,
        <https://1145.am/db/2586198/Merck>,
        <https://1145.am/db/2586373/Merck>,
        <https://1145.am/db/2586732/Merck>,
        <https://1145.am/db/2586790/Merck>,
        <https://1145.am/db/2587758/Merck_Millipore>,
        <https://1145.am/db/2588111/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2588119/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2588121/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2590952/Merck_Kgaa>,
        <https://1145.am/db/2591137/Merck___Co_Inc>,
        <https://1145.am/db/2591395/Merck_Kgaa>,
        <https://1145.am/db/2591656/Merck___Co_Inc>,
        <https://1145.am/db/2592574/Merck>,
        <https://1145.am/db/2592875/Merck>,
        <https://1145.am/db/2592986/Merck>,
        <https://1145.am/db/2594591/Merck>,
        <https://1145.am/db/2594604/Merck>,
        <https://1145.am/db/2594687/Merck_Sharp_Dohme>,
        <https://1145.am/db/2595812/Merck>,
        <https://1145.am/db/2596015/Theramex>,
        <https://1145.am/db/2596156/Merck_Serono>,
        <https://1145.am/db/2596183/Merck_Kgaa>,
        <https://1145.am/db/2597131/Merck>,
        <https://1145.am/db/2597135/Merck_Serono>,
        <https://1145.am/db/2597451/Merck>,
        <https://1145.am/db/2598195/Merck_Kgaa>,
        <https://1145.am/db/2598430/Merck>,
        <https://1145.am/db/2598439/Merck_Sharp___Dohme_Corp>,
        <https://1145.am/db/2598446/Johnson___Johnson-Merck_Consumer_Pharmaceuticals_Co>,
        <https://1145.am/db/2598446/Merck>,
        <https://1145.am/db/2598455/Merck>,
        <https://1145.am/db/2598458/Merck>,
        <https://1145.am/db/2598523/Merck>,
        <https://1145.am/db/275241/Merck>,
        <https://1145.am/db/335436/Merck_Kgaa>,
        <https://1145.am/db/508163/Merck>,
        <https://1145.am/db/512986/Merck>,
        <https://1145.am/db/514478/Merck>,
        <https://1145.am/db/514938/Merck___Co>,
        <https://1145.am/db/515012/Merck>,
        <https://1145.am/db/515636/Merck>,
        <https://1145.am/db/516867/Merck>,
        <https://1145.am/db/517460/Merck___Co_Inc>,
        <https://1145.am/db/518115/Merck>,
        <https://1145.am/db/539381/Merck>,
        <https://1145.am/db/540665/Merck_Kgaa>,
        <https://1145.am/db/545265/Merck___Co>,
        <https://1145.am/db/546225/Merck___Co>,
        <https://1145.am/db/550927/Merck>,
        <https://1145.am/db/555027/Merck___Co_Inc>,
        <https://1145.am/db/557111/Merck___Co_Inc>,
        <https://1145.am/db/580628/Merck>,
        <https://1145.am/db/602160/Merck>,
        <https://1145.am/db/607613/Merck>,
        <https://1145.am/db/626833/Merck>,
        <https://1145.am/db/641350/Merck>,
        <https://1145.am/db/701833/Healthcare_Business_Sector_Of_Merck_Kgaa>,
        <https://1145.am/db/708442/Merck>,
        <https://1145.am/db/746997/Merck_Kgaa>,
        <https://1145.am/db/866117/Merck> ;
    ns1:sameAsMedium <https://1145.am/db/2598455/Johnson___Johnson_Merck_Consumer_Pharmaceuticals_Co>,
        <https://1145.am/db/2598458/Johnson___Johnson_Merck_Consumer_Pharmaceuticals_Co> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2598439/Johnson___Johnson-Merck_Consumer_Pharmaceuticals_Co_Ownership_Merger> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-09-29T12:19:04+00:00"^^xsd:dateTime ;
    ns1:documentExtract "FORT WASHINGTON, Pa., Sept. 28, 2011 /PRNewswire/ - McNEIL-PPC, Inc. and its affiliate McNeil MMP, LLC (McNEIL) announced today that they have completed the acquisition of full ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. joint venture in the United States from Merck Sharp & Dohme Corp. (Merck) .",
        "McNEIL-PPC, Inc. Acquires Full Ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Joint Venture." ;
    ns1:documentTitle "McNEIL-PPC, Inc. Acquires Full Ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Joint Venture" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/mcneil-ppc-inc-acquires-full-ownership-of-johnson-johnson-merck-consumer-pharmaceuticals-co> ;
    ns1:foundName "Acquires",
        "acquisition" ;
    ns1:name "Acquires",
        "acquisition" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2598439/Johnson___Johnson-Merck_Consumer_Pharmaceuticals_Co> ;
    ns1:targetDetails "ownership" ;
    ns1:targetName "Johnson & Johnson-Merck Consumer Pharmaceuticals Co." ;
    ns1:vendor <https://1145.am/db/2598439/Merck_Sharp___Dohme_Corp> ;
    ns1:when "2011-09-28T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "2011-September-28" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2598439/McNeil_Consumer_Pharmaceuticals_Co> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2598439/Johnson___Johnson-Merck_Consumer_Pharmaceuticals_Co_Ownership_Merger> ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2011-09-29T12:19:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "McNEIL-PPC, Inc. Acquires Full Ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Joint Venture" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/mcneil-ppc-inc-acquires-full-ownership-of-johnson-johnson-merck-consumer-pharmaceuticals-co> ;
    ns1:foundName "McNeil Consumer Pharmaceuticals Co.",
        "McNeil MMP, LLC" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "McNeil Consumer Pharmaceuticals Co." ;
    ns1:sameAsHigh <https://1145.am/db/2598439/McNeil-PPC>,
        <https://1145.am/db/2598455/McNeil-Ppc_Inc>,
        <https://1145.am/db/2598455/McNeil_Mmp_Llc>,
        <https://1145.am/db/2598458/McNeil-Ppc_Inc> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2598439/Merck_Canada_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Canada" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:basedInHighRaw "Canada" ;
    ns1:description "Healthcare" ;
    ns1:documentDate "2011-09-29T12:19:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "McNEIL-PPC, Inc. Acquires Full Ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Joint Venture" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/mcneil-ppc-inc-acquires-full-ownership-of-johnson-johnson-merck-consumer-pharmaceuticals-co> ;
    ns1:foundName "Merck Canada Inc." ;
    ns1:industry "Healthcare" ;
    ns1:name "Merck Canada Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2315919/Merck___Co_Inc>,
        <https://1145.am/db/2591060/Merck_Company_Foundation>,
        <https://1145.am/db/750997/Merck_Global_Health_Innovation_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/2572436/Merck_Canada> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2598439/Merck_Sharp___Dohme_Corp> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2011-09-29T12:19:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "McNEIL-PPC, Inc. Acquires Full Ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Joint Venture" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/mcneil-ppc-inc-acquires-full-ownership-of-johnson-johnson-merck-consumer-pharmaceuticals-co> ;
    ns1:foundName "Merck Canada Inc.",
        "Merck Sharp & Dohme Corp" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Merck Sharp & Dohme Corp",
        "Merck Sharp & Dohme Corp." ;
    ns1:sameAsHigh <https://1145.am/db/1145060/Merck>,
        <https://1145.am/db/1186122/Merck___Co>,
        <https://1145.am/db/1217756/Merck_Kgaa>,
        <https://1145.am/db/1362602/Merck___Co_Inc>,
        <https://1145.am/db/141850/Merck>,
        <https://1145.am/db/1451511/Merck___Co>,
        <https://1145.am/db/1514452/Merck_Kgaa>,
        <https://1145.am/db/1519366/Merck>,
        <https://1145.am/db/1522616/Merck>,
        <https://1145.am/db/154793/Merck>,
        <https://1145.am/db/1554738/Merck>,
        <https://1145.am/db/1570995/Merck>,
        <https://1145.am/db/1571146/Merck>,
        <https://1145.am/db/159841/Merck>,
        <https://1145.am/db/1635899/Merck>,
        <https://1145.am/db/1966692/Merck_Kgaa>,
        <https://1145.am/db/1970288/Merck>,
        <https://1145.am/db/1970357/Merck>,
        <https://1145.am/db/1972206/Merck>,
        <https://1145.am/db/1998846/Germanys_Merck_Kgaa>,
        <https://1145.am/db/2010010/Merck___Co_Inc>,
        <https://1145.am/db/2040537/Merck>,
        <https://1145.am/db/2151833/Merck_Kgaa>,
        <https://1145.am/db/2151908/Merck_Kgaa>,
        <https://1145.am/db/2152045/Merck_Kgaa>,
        <https://1145.am/db/2152482/Merck>,
        <https://1145.am/db/2152633/Merck>,
        <https://1145.am/db/2152721/Merck>,
        <https://1145.am/db/2153637/Merck>,
        <https://1145.am/db/2153796/Merck>,
        <https://1145.am/db/2154708/Merck_Kgaa>,
        <https://1145.am/db/2154806/Merck>,
        <https://1145.am/db/2155194/Merck>,
        <https://1145.am/db/2155657/Merck>,
        <https://1145.am/db/2204455/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2217406/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2220801/Merck_Kgaa>,
        <https://1145.am/db/223588/Merck___Co_Inc>,
        <https://1145.am/db/223595/Merck___Co_Inc>,
        <https://1145.am/db/224121/Merck___Co_Inc>,
        <https://1145.am/db/2278879/Merck>,
        <https://1145.am/db/2279118/Merck>,
        <https://1145.am/db/2279238/Merck>,
        <https://1145.am/db/2280487/Merck___Co>,
        <https://1145.am/db/2281134/Merck>,
        <https://1145.am/db/2283230/Merck>,
        <https://1145.am/db/2284577/Merck>,
        <https://1145.am/db/2285024/Merck>,
        <https://1145.am/db/2285322/Merck>,
        <https://1145.am/db/2286215/Merck>,
        <https://1145.am/db/2286469/Merck>,
        <https://1145.am/db/2286759/Merck>,
        <https://1145.am/db/2287351/Merck>,
        <https://1145.am/db/2288192/Merck>,
        <https://1145.am/db/2288199/Merck>,
        <https://1145.am/db/2294623/Merck>,
        <https://1145.am/db/2298415/Merck_Kgaa>,
        <https://1145.am/db/2302117/Merck___Co_Inc>,
        <https://1145.am/db/2302462/Merck_Kgaa>,
        <https://1145.am/db/2302856/Merck_Kgaa>,
        <https://1145.am/db/2303618/Merck_Sharp___Dohme>,
        <https://1145.am/db/2303818/Merck_Kgaa>,
        <https://1145.am/db/2304609/Merck_Kgaa>,
        <https://1145.am/db/2304616/Merck___Co_Inc>,
        <https://1145.am/db/2304619/Merck___Co_Inc>,
        <https://1145.am/db/2304635/Merck>,
        <https://1145.am/db/2305804/Merck>,
        <https://1145.am/db/2306238/Merck>,
        <https://1145.am/db/2307377/Merck_Kgaa>,
        <https://1145.am/db/2307669/Merck>,
        <https://1145.am/db/2309914/Merck>,
        <https://1145.am/db/2310391/Merck>,
        <https://1145.am/db/2312786/Merck>,
        <https://1145.am/db/2312813/Merck>,
        <https://1145.am/db/2313223/Merck>,
        <https://1145.am/db/2316418/Merck___Co>,
        <https://1145.am/db/2316435/Merck___Co>,
        <https://1145.am/db/2316525/Merck>,
        <https://1145.am/db/2317494/Merck>,
        <https://1145.am/db/2317795/Merck_Kgaa>,
        <https://1145.am/db/2317895/Merck_Kgaa>,
        <https://1145.am/db/2318333/Merck_Kgaa>,
        <https://1145.am/db/2319111/Merck>,
        <https://1145.am/db/2319215/Merck_Kgaa>,
        <https://1145.am/db/2320352/Merck_Kgaa>,
        <https://1145.am/db/2320534/Merck_Kgaa>,
        <https://1145.am/db/2320820/Merck_Kgaa>,
        <https://1145.am/db/2321072/Merck___Co_Inc>,
        <https://1145.am/db/2323722/Merck___Co>,
        <https://1145.am/db/2325084/Merck>,
        <https://1145.am/db/2325864/Merck>,
        <https://1145.am/db/2326224/Merck___Co_Inc>,
        <https://1145.am/db/2326286/Merck>,
        <https://1145.am/db/2328359/Merck>,
        <https://1145.am/db/2328367/Merck>,
        <https://1145.am/db/2329475/Merck>,
        <https://1145.am/db/2329586/Merck>,
        <https://1145.am/db/2329589/Merck___Co_Inc>,
        <https://1145.am/db/2329775/Merck_Kgaa>,
        <https://1145.am/db/2329787/Merck_Kgaa>,
        <https://1145.am/db/2329795/Merck_Kgaa>,
        <https://1145.am/db/2330990/Merck_Kgaa>,
        <https://1145.am/db/2331199/Merck_Kgaa>,
        <https://1145.am/db/2331307/Merck_Kgaa>,
        <https://1145.am/db/2331756/Merck>,
        <https://1145.am/db/2332096/Merck___Co_Inc>,
        <https://1145.am/db/2335784/Merck_Kgaa>,
        <https://1145.am/db/2335812/Merck_Kgaa>,
        <https://1145.am/db/2335824/Merck_Kgaa>,
        <https://1145.am/db/2337047/Merck>,
        <https://1145.am/db/2337072/Merck>,
        <https://1145.am/db/2337245/Boston-Merck>,
        <https://1145.am/db/2337246/Merck>,
        <https://1145.am/db/2337247/Merck___Co_Inc>,
        <https://1145.am/db/2337402/Merck_Sharp___Dohme_Bv>,
        <https://1145.am/db/2338348/Merck>,
        <https://1145.am/db/2339972/Merck_Serono>,
        <https://1145.am/db/2340479/Merck_Kgaa>,
        <https://1145.am/db/2341435/Merck>,
        <https://1145.am/db/2342387/Merck_Kgaa>,
        <https://1145.am/db/2342487/Merck>,
        <https://1145.am/db/2343123/Merck>,
        <https://1145.am/db/2343159/Merck>,
        <https://1145.am/db/2343161/Merck>,
        <https://1145.am/db/2343358/Merck_Kgaa>,
        <https://1145.am/db/2343584/Merck>,
        <https://1145.am/db/2343585/Merck>,
        <https://1145.am/db/2344286/Merck___Co_Inc>,
        <https://1145.am/db/2344290/Merck___Co_Inc>,
        <https://1145.am/db/2344563/Merck>,
        <https://1145.am/db/2344564/Merck>,
        <https://1145.am/db/2344792/Merck>,
        <https://1145.am/db/2346099/Merck_Kgaa>,
        <https://1145.am/db/2347933/Merck_Kgaa>,
        <https://1145.am/db/2348683/Merck>,
        <https://1145.am/db/2349084/Merck>,
        <https://1145.am/db/2350145/Merck>,
        <https://1145.am/db/2350594/Merck_Kgaa>,
        <https://1145.am/db/2350594/Merck_Serono>,
        <https://1145.am/db/2350645/Merck_Kgaa>,
        <https://1145.am/db/2350687/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2350706/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2350881/Merck>,
        <https://1145.am/db/2351858/Merck_Kgaa>,
        <https://1145.am/db/2352882/Merck_Kgaa>,
        <https://1145.am/db/2352961/Merck>,
        <https://1145.am/db/2355245/Merck_Kgaa>,
        <https://1145.am/db/2355800/Merck>,
        <https://1145.am/db/2356800/Merck>,
        <https://1145.am/db/2357401/Merck_Kgaa>,
        <https://1145.am/db/2358644/Merck>,
        <https://1145.am/db/2358663/Merck>,
        <https://1145.am/db/2359414/Merck>,
        <https://1145.am/db/2360369/Merck_Kgaa>,
        <https://1145.am/db/2360455/Merck>,
        <https://1145.am/db/2360816/Merck_Kgaa>,
        <https://1145.am/db/2360819/Merck_Kgaa>,
        <https://1145.am/db/2361274/Merck>,
        <https://1145.am/db/2361352/Merck_Kgaa>,
        <https://1145.am/db/2361913/Merck>,
        <https://1145.am/db/2362994/Merck>,
        <https://1145.am/db/2363210/And_Merck>,
        <https://1145.am/db/2363211/Merck>,
        <https://1145.am/db/2363215/Merck>,
        <https://1145.am/db/2365367/Merck>,
        <https://1145.am/db/2367207/Merck_Kgaa>,
        <https://1145.am/db/2367218/Merck_Kgaa>,
        <https://1145.am/db/2367613/Merck_Kgaa>,
        <https://1145.am/db/2368041/Merck>,
        <https://1145.am/db/2368712/Merck>,
        <https://1145.am/db/2368719/Merck>,
        <https://1145.am/db/2368808/Merck>,
        <https://1145.am/db/2369162/Merck>,
        <https://1145.am/db/2369441/Merck_Kgaa>,
        <https://1145.am/db/2369641/Merck>,
        <https://1145.am/db/2370722/Merck>,
        <https://1145.am/db/2371269/Merck_Kgaa>,
        <https://1145.am/db/2536301/Merck>,
        <https://1145.am/db/2537455/Merck>,
        <https://1145.am/db/2538076/Merck___Co>,
        <https://1145.am/db/2539243/Merck>,
        <https://1145.am/db/2539257/Merck>,
        <https://1145.am/db/2539515/Merck_Kgaa>,
        <https://1145.am/db/2539561/Merck>,
        <https://1145.am/db/2540776/Merck>,
        <https://1145.am/db/2541112/Merck_Kgaa>,
        <https://1145.am/db/2541756/Merck>,
        <https://1145.am/db/2542057/Merck>,
        <https://1145.am/db/2542499/Merck>,
        <https://1145.am/db/2542731/Merck>,
        <https://1145.am/db/2542740/Merck>,
        <https://1145.am/db/2544107/Merck_Kgaa>,
        <https://1145.am/db/2544235/Merck>,
        <https://1145.am/db/2544391/Merck>,
        <https://1145.am/db/2545522/Merck_Kgaa>,
        <https://1145.am/db/2545618/Merck_Kgaa>,
        <https://1145.am/db/2546209/And_Merck_Kgaa>,
        <https://1145.am/db/2546686/Merck>,
        <https://1145.am/db/2548696/Merck>,
        <https://1145.am/db/2549220/Merck_Manufacturing_Division>,
        <https://1145.am/db/2549220/Merck___Co>,
        <https://1145.am/db/2551075/Merck_Kgaa>,
        <https://1145.am/db/2551126/Merck>,
        <https://1145.am/db/2552135/Merck_Kgaa>,
        <https://1145.am/db/2552707/Merck___Co_Inc>,
        <https://1145.am/db/2553766/Merck_Kgaa>,
        <https://1145.am/db/2553841/Merck_Kgaas_Merck_Serono>,
        <https://1145.am/db/2556052/Merck>,
        <https://1145.am/db/2557023/Merck_Serono>,
        <https://1145.am/db/2557506/Merck___Co>,
        <https://1145.am/db/2557870/Merck_Millipore>,
        <https://1145.am/db/2558101/Merck_Kgaa>,
        <https://1145.am/db/2558555/Merck___Co>,
        <https://1145.am/db/2558691/Merck>,
        <https://1145.am/db/2558927/Merck>,
        <https://1145.am/db/2558947/Merck_Sharp_And_Dohme>,
        <https://1145.am/db/2559298/Merck>,
        <https://1145.am/db/2559346/Merck_Kgaa>,
        <https://1145.am/db/2559511/Merck>,
        <https://1145.am/db/2559601/Merck>,
        <https://1145.am/db/2559783/Merck_Kgaa>,
        <https://1145.am/db/2559822/Merck>,
        <https://1145.am/db/2560113/Merck_Kgaa>,
        <https://1145.am/db/2560263/Merck_Kgaa>,
        <https://1145.am/db/2560758/Merck>,
        <https://1145.am/db/2561492/Merck_Kgaa>,
        <https://1145.am/db/2561650/Merck___Co>,
        <https://1145.am/db/2562041/Merck>,
        <https://1145.am/db/2563423/Merck>,
        <https://1145.am/db/2563450/Merck>,
        <https://1145.am/db/2564473/Merck_Kgaa>,
        <https://1145.am/db/2564583/Merck_Kgaa>,
        <https://1145.am/db/2565433/Merck>,
        <https://1145.am/db/2566424/Merck___Co>,
        <https://1145.am/db/2566606/Merck_Kgaa>,
        <https://1145.am/db/2566939/Merck>,
        <https://1145.am/db/2567245/Merck___Co>,
        <https://1145.am/db/2568284/Merck_Kgaa>,
        <https://1145.am/db/2568357/Merck>,
        <https://1145.am/db/2568495/Merck>,
        <https://1145.am/db/2568729/Merck___Co>,
        <https://1145.am/db/2568891/Merck_Kgaa>,
        <https://1145.am/db/2568903/Merck_Kgaa>,
        <https://1145.am/db/2569029/Merck_Serono>,
        <https://1145.am/db/2570392/Merck_Kgaa>,
        <https://1145.am/db/2570807/Merck_Kgaa>,
        <https://1145.am/db/2571023/Merck_Kgaa>,
        <https://1145.am/db/2571569/Merck>,
        <https://1145.am/db/2571683/Merck>,
        <https://1145.am/db/2572436/Merck_Canada>,
        <https://1145.am/db/2572620/Merck>,
        <https://1145.am/db/2572634/Merck>,
        <https://1145.am/db/2572675/Merck___Co_Inc>,
        <https://1145.am/db/2573613/Merck_Kgaa>,
        <https://1145.am/db/2574609/Merck_Specialities_Private_Ltd>,
        <https://1145.am/db/2575021/Merck>,
        <https://1145.am/db/2575032/Merck>,
        <https://1145.am/db/2575427/Merck>,
        <https://1145.am/db/2575623/Merck_Kgaa>,
        <https://1145.am/db/2576127/Merck>,
        <https://1145.am/db/2576129/Merck_Sharp___Dohme_Bv>,
        <https://1145.am/db/2577464/Sanofi-Aventis_And_Merck>,
        <https://1145.am/db/2577485/Sanofi-Aventis_And_Merck___Co_Inc>,
        <https://1145.am/db/2578485/Merck>,
        <https://1145.am/db/2579483/Merck>,
        <https://1145.am/db/2579763/Merck>,
        <https://1145.am/db/2580399/Merck>,
        <https://1145.am/db/2581295/Merck_Kgaa>,
        <https://1145.am/db/2581441/Merck_Kgaa>,
        <https://1145.am/db/2583045/Merck>,
        <https://1145.am/db/2583206/Merck_Consumer_Care>,
        <https://1145.am/db/2584116/Merck___Co_Inc>,
        <https://1145.am/db/2584136/Merck___Co_Inc>,
        <https://1145.am/db/2586198/Merck>,
        <https://1145.am/db/2586373/Merck>,
        <https://1145.am/db/2586732/Merck>,
        <https://1145.am/db/2586790/Merck>,
        <https://1145.am/db/2587758/Merck_Millipore>,
        <https://1145.am/db/2587981/Merck>,
        <https://1145.am/db/2588111/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2588119/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2588121/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2590952/Merck_Kgaa>,
        <https://1145.am/db/2591137/Merck___Co_Inc>,
        <https://1145.am/db/2591395/Merck_Kgaa>,
        <https://1145.am/db/2591656/Merck___Co_Inc>,
        <https://1145.am/db/2592574/Merck>,
        <https://1145.am/db/2592875/Merck>,
        <https://1145.am/db/2592986/Merck>,
        <https://1145.am/db/2594591/Merck>,
        <https://1145.am/db/2594604/Merck>,
        <https://1145.am/db/2594687/Merck_Sharp_Dohme>,
        <https://1145.am/db/2595812/Merck>,
        <https://1145.am/db/2596015/Theramex>,
        <https://1145.am/db/2596156/Merck_Serono>,
        <https://1145.am/db/2596183/Merck_Kgaa>,
        <https://1145.am/db/2596909/Merck>,
        <https://1145.am/db/2597131/Merck>,
        <https://1145.am/db/2597135/Merck_Serono>,
        <https://1145.am/db/2597451/Merck>,
        <https://1145.am/db/2598195/Merck_Kgaa>,
        <https://1145.am/db/2598430/Merck>,
        <https://1145.am/db/2598439/Johnson___Johnson-Merck_Consumer_Pharmaceuticals_Co>,
        <https://1145.am/db/2598446/Johnson___Johnson-Merck_Consumer_Pharmaceuticals_Co>,
        <https://1145.am/db/2598446/Merck>,
        <https://1145.am/db/2598455/Merck>,
        <https://1145.am/db/2598458/Merck>,
        <https://1145.am/db/2598523/Merck>,
        <https://1145.am/db/275241/Merck>,
        <https://1145.am/db/335436/Merck_Kgaa>,
        <https://1145.am/db/420173/Merck>,
        <https://1145.am/db/508163/Merck>,
        <https://1145.am/db/510419/Merck>,
        <https://1145.am/db/511540/Merck>,
        <https://1145.am/db/512986/Merck>,
        <https://1145.am/db/514478/Merck>,
        <https://1145.am/db/514938/Merck___Co>,
        <https://1145.am/db/515012/Merck>,
        <https://1145.am/db/515636/Merck>,
        <https://1145.am/db/516867/Merck>,
        <https://1145.am/db/517460/Merck___Co_Inc>,
        <https://1145.am/db/518115/Merck>,
        <https://1145.am/db/539381/Merck>,
        <https://1145.am/db/540665/Merck_Kgaa>,
        <https://1145.am/db/545265/Merck___Co>,
        <https://1145.am/db/546225/Merck___Co>,
        <https://1145.am/db/550927/Merck>,
        <https://1145.am/db/555027/Merck___Co_Inc>,
        <https://1145.am/db/557111/Merck___Co_Inc>,
        <https://1145.am/db/580628/Merck>,
        <https://1145.am/db/602160/Merck>,
        <https://1145.am/db/607613/Merck>,
        <https://1145.am/db/626833/Merck>,
        <https://1145.am/db/641350/Merck>,
        <https://1145.am/db/678858/Merck>,
        <https://1145.am/db/680862/Merck>,
        <https://1145.am/db/701833/Healthcare_Business_Sector_Of_Merck_Kgaa>,
        <https://1145.am/db/708442/Merck>,
        <https://1145.am/db/746997/Merck_Kgaa>,
        <https://1145.am/db/866117/Merck>,
        <https://1145.am/db/868747/Merck>,
        <https://1145.am/db/884408/Merck_Kgaa> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2609817/Alcatel-Lucent> a org:Organization ;
    ns1:basedInLowRaw "London" ;
    ns1:description "service provider business" ;
    ns1:documentDate "2011-09-06T13:54:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Alcatel-Lucent's enterprise sale to Permira Advisers falls through" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/alcatel-lucent-s-enterprise-sale-to-permira-advisers-falls-through> ;
    ns1:foundName "Alcatel-Lucent" ;
    ns1:name "Alcatel-Lucent" ;
    ns1:sameAsMedium <https://1145.am/db/1790667/Alcatel-Lucent>,
        <https://1145.am/db/1790669/Alcatel-Lucent>,
        <https://1145.am/db/1790693/Alcatel-Lucent>,
        <https://1145.am/db/1795878/Alcatel-Lucent>,
        <https://1145.am/db/1819651/Alcatel-Lucent>,
        <https://1145.am/db/1855135/Alcatel-Lucent>,
        <https://1145.am/db/1875987/Alcatel-Lucent>,
        <https://1145.am/db/1885641/Alcatel-Lucent>,
        <https://1145.am/db/2174456/Alcatel-Lucent>,
        <https://1145.am/db/2449514/Alcatel-Lucent>,
        <https://1145.am/db/2599088/Alcatel-Lucent>,
        <https://1145.am/db/2599392/Alcatel-Lucent>,
        <https://1145.am/db/2599632/Alcatel-Lucent>,
        <https://1145.am/db/2599798/Alcatel-Lucent>,
        <https://1145.am/db/2600870/Alcatel-Lucent>,
        <https://1145.am/db/2601072/Alcatel-Lucent>,
        <https://1145.am/db/2601349/Alcatel-Lucent>,
        <https://1145.am/db/2601506/Alcatel-Lucent>,
        <https://1145.am/db/2601537/Alcatel-Lucent>,
        <https://1145.am/db/2601910/Alcatel-Lucent>,
        <https://1145.am/db/2602219/Alcatel-Lucent>,
        <https://1145.am/db/2602933/Alcatel-Lucent>,
        <https://1145.am/db/2604986/Alcatel-Lucent>,
        <https://1145.am/db/2604991/Alcatel-Lucent>,
        <https://1145.am/db/2606223/Alcatel-Lucent>,
        <https://1145.am/db/2606495/Alcatel-Lucent>,
        <https://1145.am/db/2606731/Alcatel-Lucent>,
        <https://1145.am/db/2607244/Alcatel-Lucent>,
        <https://1145.am/db/2607408/Alcatel-Lucent>,
        <https://1145.am/db/2607614/Alcatel-Lucent>,
        <https://1145.am/db/2609611/Alcatel-Lucent>,
        <https://1145.am/db/2609629/Alcatel-Lucent>,
        <https://1145.am/db/2609645/Alcatel-Lucent>,
        <https://1145.am/db/2610550/Alcatel-Lucent>,
        <https://1145.am/db/2610915/Alcatel-Lucent>,
        <https://1145.am/db/2611850/Alcatel-Lucent>,
        <https://1145.am/db/2611855/Alcatel-Lucent>,
        <https://1145.am/db/2612045/Alcatel-Lucent>,
        <https://1145.am/db/2612072/Alcatel-Lucent>,
        <https://1145.am/db/2612273/Alcatel-Lucent>,
        <https://1145.am/db/2612583/Alcatel-Lucent>,
        <https://1145.am/db/2612780/Alcatel-Lucent>,
        <https://1145.am/db/2613443/Alcatel-Lucent>,
        <https://1145.am/db/2614261/Alcatel-Lucent>,
        <https://1145.am/db/2614782/Alcatel-Lucent>,
        <https://1145.am/db/2614789/Alcatel-Lucent>,
        <https://1145.am/db/2614792/Alcatel-Lucent>,
        <https://1145.am/db/2614999/Alcatel-Lucent>,
        <https://1145.am/db/2615500/Alcatel-Lucent>,
        <https://1145.am/db/2617770/Alcatel-Lucent>,
        <https://1145.am/db/2620115/Alcatel-Lucent>,
        <https://1145.am/db/2624637/Alcatel-Lucent>,
        <https://1145.am/db/2625358/Alcatel-Lucent>,
        <https://1145.am/db/2633937/Alcatel-Lucent>,
        <https://1145.am/db/2635749/Alcatel-Lucent>,
        <https://1145.am/db/2636765/Alcatel-Lucent>,
        <https://1145.am/db/2636778/Alcatel-Lucent>,
        <https://1145.am/db/2638547/Alcatel-Lucent>,
        <https://1145.am/db/2639975/Alcatel-Lucent>,
        <https://1145.am/db/2641663/Alcatel-Lucent>,
        <https://1145.am/db/2642991/Alcatel-Lucent>,
        <https://1145.am/db/2651008/Alcatel-Lucent>,
        <https://1145.am/db/2651521/Alcatel-Lucent>,
        <https://1145.am/db/2651685/Alcatel-Lucent>,
        <https://1145.am/db/2652551/Alcatel-Lucent>,
        <https://1145.am/db/2653427/Alcatel-Lucent>,
        <https://1145.am/db/2654012/Alcatel-Lucent>,
        <https://1145.am/db/2654017/Alcatel-Lucent>,
        <https://1145.am/db/2654155/Alcatel-Lucent>,
        <https://1145.am/db/2654238/Alcatel-Lucent>,
        <https://1145.am/db/2654528/Alcatel_Lucent>,
        <https://1145.am/db/2655001/Alcatel-Lucent>,
        <https://1145.am/db/2655372/Alcatel-Lucent>,
        <https://1145.am/db/2655622/Alcatel-Lucent>,
        <https://1145.am/db/2655768/Alcatel-Lucent>,
        <https://1145.am/db/2655792/Alcatel-Lucent>,
        <https://1145.am/db/2656166/Alcatel-Lucent>,
        <https://1145.am/db/2656737/Alcatel-Lucent>,
        <https://1145.am/db/2656749/Alcatel-Lucent>,
        <https://1145.am/db/2656808/Alcatel-Lucent>,
        <https://1145.am/db/2656920/Alcatel-Lucent>,
        <https://1145.am/db/2657196/Alcatel-Lucent>,
        <https://1145.am/db/2657268/Alcatel-Lucent>,
        <https://1145.am/db/2657902/Alcatel-Lucent>,
        <https://1145.am/db/2658200/Alcatel-Lucent>,
        <https://1145.am/db/2658774/Alcatel-Lucent>,
        <https://1145.am/db/2659374/Alcatel-Lucent>,
        <https://1145.am/db/2660932/Alcatel-Lucent>,
        <https://1145.am/db/2661927/Alcatel-Lucent>,
        <https://1145.am/db/2663033/Alcatel-Lucent>,
        <https://1145.am/db/2663052/Alcatel-Lucent>,
        <https://1145.am/db/2663073/Alcatel-Lucent>,
        <https://1145.am/db/2663106/Alcatel-Lucent>,
        <https://1145.am/db/2663114/Alcatel-Lucent>,
        <https://1145.am/db/2663834/Alcatel-Lucent>,
        <https://1145.am/db/2663941/Alcatel-Lucent>,
        <https://1145.am/db/2664215/Alcatel-Lucent>,
        <https://1145.am/db/2664225/Alcatel-Lucent>,
        <https://1145.am/db/2664922/Alcatel-Lucent>,
        <https://1145.am/db/2665201/Alcatel-Lucent>,
        <https://1145.am/db/2665703/Alcatel-Lucent>,
        <https://1145.am/db/2665720/Alcatel-Lucent>,
        <https://1145.am/db/2665866/Alcatel-Lucent>,
        <https://1145.am/db/2666163/Alcatel-Lucent>,
        <https://1145.am/db/2666280/Alcatel-Lucent>,
        <https://1145.am/db/2666307/Alcatel-Lucent>,
        <https://1145.am/db/2666346/Alcatel-Lucent>,
        <https://1145.am/db/2666366/Alcatel-Lucent>,
        <https://1145.am/db/2666375/Alcatel-Lucent>,
        <https://1145.am/db/2666563/Alcatel-Lucent>,
        <https://1145.am/db/2666729/Alcatel_Lucent>,
        <https://1145.am/db/2666818/Alcatel-Lucent>,
        <https://1145.am/db/2667186/Alcatel-Lucent>,
        <https://1145.am/db/2667192/Alcatel-Lucent>,
        <https://1145.am/db/2667452/Alcatel-Lucent>,
        <https://1145.am/db/2668257/Alcatel-Lucent>,
        <https://1145.am/db/2668422/Alcatel-Lucent>,
        <https://1145.am/db/2668973/Alcatel-Lucent>,
        <https://1145.am/db/2668986/Alcatel-Lucent>,
        <https://1145.am/db/2670204/Alcatel-Lucent>,
        <https://1145.am/db/2670501/Alcatel-Lucent>,
        <https://1145.am/db/2670547/Alcatel-Lucent>,
        <https://1145.am/db/2670735/Alcatel-Lucent>,
        <https://1145.am/db/2670748/Alcatel-Lucent>,
        <https://1145.am/db/2671140/Alcatel-Lucent>,
        <https://1145.am/db/2671336/Alcatel-Lucent>,
        <https://1145.am/db/2671922/Alcatel-Lucent>,
        <https://1145.am/db/2672328/Alcatel-Lucent>,
        <https://1145.am/db/2672337/Alcatel-Lucent>,
        <https://1145.am/db/2672864/Alcatel-Lucent>,
        <https://1145.am/db/2672932/Alcatel-Lucent>,
        <https://1145.am/db/2674110/Alcatel_Lucent>,
        <https://1145.am/db/2675256/Alcatel-Lucent>,
        <https://1145.am/db/2676711/Alcatel-Lucent>,
        <https://1145.am/db/2676997/Alcatel-Lucent>,
        <https://1145.am/db/2678826/Alcatel-Lucent>,
        <https://1145.am/db/2678859/Alcatel-Lucent>,
        <https://1145.am/db/2679013/Alcatel-Lucent>,
        <https://1145.am/db/2679049/Alcatel-Lucent>,
        <https://1145.am/db/2679386/Alcatel-Lucent>,
        <https://1145.am/db/2679680/Alcatel-Lucent>,
        <https://1145.am/db/2680847/Alcatel-Lucent>,
        <https://1145.am/db/2681373/Alcatel-Lucent>,
        <https://1145.am/db/2681782/Alcatel-Lucent>,
        <https://1145.am/db/2682873/Alcatel-Lucent>,
        <https://1145.am/db/2683040/Alcatel-Lucent>,
        <https://1145.am/db/2683818/Alcatel-Lucent>,
        <https://1145.am/db/2684278/Alcatel-Lucent> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2651198/Mobile_Telesystems_Stake_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-09-16T15:09:31+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Russian financial holding company AFK Sistema is reportedly in significant negotiations with France Telecom (FT) aimed at exchanging a controlling stake in Russian operator Mobile TeleSystems (MTS) for a smaller interest in FT." ;
    ns1:documentTitle "Report: Russia's AFK Sistema in talks with FT for ownership swap" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/report-russia-s-afk-sistema-talks-ft-for-ownership-swap> ;
    ns1:foundName "buying",
        "exchanging" ;
    ns1:name "buying",
        "exchanging" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2651198/Mobile_Telesystems> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Mobile TeleSystems" ;
    ns1:whereGeoName "Russian Federation" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2017370/about.rdf> ;
    ns1:whereRaw "Russia" .

<https://1145.am/db/2652948/Telecable_De_Asturias_Stake_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-10-19T10:53:58+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Asset management firm The Carlyle Group is taking control of Spanish operator Telecable de Asturias in a deal that values the firm at €400 million.",
        "Carlyle is acquiring an 85 % stake in Telecable, which offers TV, telephone and broadband services to 156,000 subscribers in Spain's Asturias region." ;
    ns1:documentTitle "Carlyle Group takes control of Telecable" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/carlyle-group-takes-control-telecable> ;
    ns1:foundName "acquiring",
        "taking control" ;
    ns1:name "acquiring",
        "taking control" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2652948/Telecable_De_Asturias> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Telecable",
        "Telecable de Asturias" ;
    ns1:valueRaw "€400 million" ;
    ns1:whereGeoName "Kingdom of Spain" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2510769/about.rdf> ;
    ns1:whereRaw "Spain" .

<https://1145.am/db/2654580/Fidelity_National_Information_Services> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "banking and payments technology" ;
    ns1:documentDate "2011-10-31T15:08:03+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Visa Europe buys m-pay expertise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/visa-europe-buys-m-pay-expertise> ;
    ns1:foundName "Fidelity National Information Services" ;
    ns1:industry "banking and payments technology" ;
    ns1:name "Fidelity National Information Services" ;
    ns1:sameAsHigh <https://1145.am/db/2057386/Fidelity_National_Information_Services>,
        <https://1145.am/db/2654597/Fidelity_National_Information_Services> ;
    ns1:sameAsMedium <https://1145.am/db/1295124/Fidelity_Information_Services>,
        <https://1145.am/db/1783216/Fidelity_National_Information_Services>,
        <https://1145.am/db/2201901/Fidelity_National_Information_Services> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2654580/Metavante> a org:Organization ;
    ns1:basedInLowRaw "North American" ;
    ns1:description "banking and payments technology" ;
    ns1:documentDate "2011-10-31T15:08:03+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Visa Europe buys m-pay expertise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/visa-europe-buys-m-pay-expertise> ;
    ns1:foundName "Metavante" ;
    ns1:industry "banking and payments technology" ;
    ns1:name "Metavante" ;
    ns1:sameAsMedium <https://1145.am/db/2654597/Metavante> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2654597/Metavante> a org:Organization ;
    ns1:basedInLowRaw "US" ;
    ns1:description "Banking Business Review article" ;
    ns1:documentDate "2011-11-02T18:06:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Visa Europe invests £24M in mobile banking firm Monitise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/visa-europe-invests-ps24m-mobile-banking-firm-monitise> ;
    ns1:foundName "Metavante" ;
    ns1:name "Metavante" ;
    ns1:sameAsMedium <https://1145.am/db/2654580/Metavante> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2659467/Investment_Khc_Walid_Bin_Tatal_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-12-20T04:28:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Saudi billionaire prince Walid bin Tatal and holding company KHC have bought into Twitter through a $ 300 million investment." ;
    ns1:documentTitle "Webwire: Sprint abandons Carrier IQ; Huawei, ZTE eye $200m India revenue" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-sprint-abandons-carrier-iq-huawei-zte-eye-200m-india-revenue> ;
    ns1:foundName "bought" ;
    ns1:name "bought" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "completed" ;
    ns1:valueRaw "$ 300 million" ;
    ns1:whereGeoName "Hellenic Republic" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/390903/about.rdf> ;
    ns1:whereRaw "Greece" .

<https://1145.am/db/2659492/Kpn_France> a org:Organization ;
    ns1:basedInHighGeoName "Dutch" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4804628/about.rdf> ;
    ns1:basedInHighRaw "Dutch" ;
    ns1:basedInLowRaw "France" ;
    ns1:documentDate "2011-12-23T02:40:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: KPN to sell French unit to Bouygues; TeliaSonera buys out Kcell" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-kpn-to-sell-french-unit-to-bouygues-teliasonera-buys-out-kcell> ;
    ns1:foundName "KPN",
        "KPN France" ;
    ns1:industry "telco" ;
    ns1:name "KPN",
        "KPN France" ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2659492/Softbank> a org:Organization ;
    ns1:basedInHighGeoName "Japan" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1861060/about.rdf> ;
    ns1:basedInHighRaw "Japan" ;
    ns1:documentDate "2011-12-23T02:40:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: KPN to sell French unit to Bouygues; TeliaSonera buys out Kcell" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-kpn-to-sell-french-unit-to-bouygues-teliasonera-buys-out-kcell> ;
    ns1:foundName "Softbank" ;
    ns1:name "Softbank" ;
    ns1:sameAsMedium <https://1145.am/db/103808/Softbank_Corp>,
        <https://1145.am/db/1129671/Softbank>,
        <https://1145.am/db/1130952/Softbank>,
        <https://1145.am/db/1140286/Softbank>,
        <https://1145.am/db/116996/Softbank>,
        <https://1145.am/db/1179523/Softbank>,
        <https://1145.am/db/1193504/Softbank>,
        <https://1145.am/db/1215073/Softbank>,
        <https://1145.am/db/1255221/Softbank>,
        <https://1145.am/db/1347499/Softbank>,
        <https://1145.am/db/1492141/Softbank>,
        <https://1145.am/db/1558864/Softbank>,
        <https://1145.am/db/1566837/Softbank>,
        <https://1145.am/db/1684127/Softbank>,
        <https://1145.am/db/1694388/Softbank>,
        <https://1145.am/db/1734925/Softbank>,
        <https://1145.am/db/1735554/Softbank>,
        <https://1145.am/db/1735679/Softbank>,
        <https://1145.am/db/1739469/Softbank>,
        <https://1145.am/db/1740946/Softbank>,
        <https://1145.am/db/1742129/Softbank>,
        <https://1145.am/db/1742163/Softbank>,
        <https://1145.am/db/1742280/Softbank>,
        <https://1145.am/db/1748253/Softbank_Corp>,
        <https://1145.am/db/1748731/Softbank>,
        <https://1145.am/db/1750206/Softbank>,
        <https://1145.am/db/1750248/Softbank>,
        <https://1145.am/db/1753451/Softbank>,
        <https://1145.am/db/1754897/Softbank>,
        <https://1145.am/db/1755776/Softbank>,
        <https://1145.am/db/1756852/Softbank>,
        <https://1145.am/db/1758188/Softbank>,
        <https://1145.am/db/1758916/Softbank>,
        <https://1145.am/db/1759748/Softbank>,
        <https://1145.am/db/1759802/Softbank>,
        <https://1145.am/db/1760606/Softbank>,
        <https://1145.am/db/1763417/Softbank>,
        <https://1145.am/db/1766871/Softbank>,
        <https://1145.am/db/1766892/Softbank>,
        <https://1145.am/db/1767668/Softbank>,
        <https://1145.am/db/1768278/Softbank>,
        <https://1145.am/db/1769212/Softbank>,
        <https://1145.am/db/1769550/Softbank>,
        <https://1145.am/db/1770897/Softbank>,
        <https://1145.am/db/1772843/Softbank>,
        <https://1145.am/db/1775977/Softbank>,
        <https://1145.am/db/1776410/Softbank>,
        <https://1145.am/db/1779650/Softbank>,
        <https://1145.am/db/1782128/Softbank>,
        <https://1145.am/db/1786903/Softbank>,
        <https://1145.am/db/1787663/Softbank>,
        <https://1145.am/db/1787801/Softbank>,
        <https://1145.am/db/1788297/Softbank>,
        <https://1145.am/db/1788831/Softbank>,
        <https://1145.am/db/1789602/Softbank>,
        <https://1145.am/db/1790374/Softbank>,
        <https://1145.am/db/1792881/Softbank>,
        <https://1145.am/db/1795875/Softbank>,
        <https://1145.am/db/1797477/Softbank>,
        <https://1145.am/db/1798154/Softbank>,
        <https://1145.am/db/1803340/Softbank>,
        <https://1145.am/db/1804251/Softbank>,
        <https://1145.am/db/1804413/Softbank>,
        <https://1145.am/db/1805577/Softbank>,
        <https://1145.am/db/1806191/Softbank>,
        <https://1145.am/db/1807737/Softbank>,
        <https://1145.am/db/1808504/Softbank>,
        <https://1145.am/db/1808604/Softbank>,
        <https://1145.am/db/1809360/Softbank>,
        <https://1145.am/db/1811437/Softbank>,
        <https://1145.am/db/1811458/Softbank>,
        <https://1145.am/db/1815886/Softbank>,
        <https://1145.am/db/1816406/Softbank>,
        <https://1145.am/db/1816990/Softbank>,
        <https://1145.am/db/1818582/Softbank>,
        <https://1145.am/db/1818992/Softbank>,
        <https://1145.am/db/1819190/Softbank>,
        <https://1145.am/db/1821102/Softbank>,
        <https://1145.am/db/1822498/Softbank>,
        <https://1145.am/db/1822884/Softbank>,
        <https://1145.am/db/1823172/Softbank>,
        <https://1145.am/db/1827733/Softbank>,
        <https://1145.am/db/1835740/Softbank>,
        <https://1145.am/db/1835811/Softbank_Corp>,
        <https://1145.am/db/1837864/Softbank>,
        <https://1145.am/db/1839534/Softbank_Corp>,
        <https://1145.am/db/1846380/Softbank>,
        <https://1145.am/db/1852090/Softbank>,
        <https://1145.am/db/1853730/Softbank>,
        <https://1145.am/db/1858650/Softbank>,
        <https://1145.am/db/1860196/Softbank>,
        <https://1145.am/db/1860815/Softbank>,
        <https://1145.am/db/1868572/Softbank>,
        <https://1145.am/db/1870857/Softbank>,
        <https://1145.am/db/1875218/Softbank>,
        <https://1145.am/db/1879401/Softbank>,
        <https://1145.am/db/1893839/Softbank>,
        <https://1145.am/db/1921528/Softbank>,
        <https://1145.am/db/1950339/Softbank>,
        <https://1145.am/db/1956539/Softbank_Corp>,
        <https://1145.am/db/2056248/Softbank>,
        <https://1145.am/db/2059616/Softbank>,
        <https://1145.am/db/2084597/Softbank>,
        <https://1145.am/db/2107274/Softbank>,
        <https://1145.am/db/210986/Softbank_Corp>,
        <https://1145.am/db/2119946/Softbank>,
        <https://1145.am/db/2159062/Softbank_Corp>,
        <https://1145.am/db/2164394/Softbank>,
        <https://1145.am/db/2164415/Softbank_Corp>,
        <https://1145.am/db/2185522/Softbank>,
        <https://1145.am/db/2287135/Softbank>,
        <https://1145.am/db/2295289/Softbank>,
        <https://1145.am/db/2407089/Softbank>,
        <https://1145.am/db/2410135/Softbank>,
        <https://1145.am/db/2410849/Softbank>,
        <https://1145.am/db/2412438/Softbank>,
        <https://1145.am/db/2412439/Softbank>,
        <https://1145.am/db/2425544/Softbank_Corp>,
        <https://1145.am/db/2430024/Softbank>,
        <https://1145.am/db/244985/Softbank>,
        <https://1145.am/db/2616385/Softbank_Corp>,
        <https://1145.am/db/2616774/Softbank>,
        <https://1145.am/db/2618577/Softbank_Corp>,
        <https://1145.am/db/2629357/Softbank>,
        <https://1145.am/db/2630698/Softbank>,
        <https://1145.am/db/2633199/Softbank>,
        <https://1145.am/db/2643948/Softbank>,
        <https://1145.am/db/2648388/Softbank>,
        <https://1145.am/db/2648461/Softbank>,
        <https://1145.am/db/2653485/Softbank>,
        <https://1145.am/db/2654774/Softbank>,
        <https://1145.am/db/2655150/Softbank>,
        <https://1145.am/db/2655930/Softbank>,
        <https://1145.am/db/2655974/Softbank>,
        <https://1145.am/db/2656904/Softbank>,
        <https://1145.am/db/2656997/Softbank>,
        <https://1145.am/db/2658979/Softbank>,
        <https://1145.am/db/2658990/Softbank>,
        <https://1145.am/db/2659014/Softbank>,
        <https://1145.am/db/2659276/Softbank>,
        <https://1145.am/db/2659586/Softbank>,
        <https://1145.am/db/2659587/Softbank>,
        <https://1145.am/db/2659591/Softbank>,
        <https://1145.am/db/2659594/Softbank>,
        <https://1145.am/db/2659601/Softbank>,
        <https://1145.am/db/2659612/Softbank>,
        <https://1145.am/db/2659619/Softbank>,
        <https://1145.am/db/2659620/Softbank>,
        <https://1145.am/db/2659633/Softbank>,
        <https://1145.am/db/2661725/Softbank>,
        <https://1145.am/db/2663254/Softbank>,
        <https://1145.am/db/2664293/Softbank>,
        <https://1145.am/db/2664422/Softbank>,
        <https://1145.am/db/2665296/Softbank>,
        <https://1145.am/db/2666063/Softbank>,
        <https://1145.am/db/2666088/Softbank>,
        <https://1145.am/db/2666839/Softbank>,
        <https://1145.am/db/2667152/Softbank>,
        <https://1145.am/db/2669621/Softbank>,
        <https://1145.am/db/2670440/Softbank>,
        <https://1145.am/db/2670872/Softbank>,
        <https://1145.am/db/2671590/Softbank>,
        <https://1145.am/db/2675650/Softbank>,
        <https://1145.am/db/2675856/Softbank>,
        <https://1145.am/db/2676358/Softbank>,
        <https://1145.am/db/2676370/Softbank>,
        <https://1145.am/db/2676565/Softbank>,
        <https://1145.am/db/2677542/Softbank>,
        <https://1145.am/db/2678734/Softbank>,
        <https://1145.am/db/2678752/Softbank>,
        <https://1145.am/db/2678777/Softbank>,
        <https://1145.am/db/2679862/Softbank>,
        <https://1145.am/db/2679897/Softbank>,
        <https://1145.am/db/2680061/Softbank>,
        <https://1145.am/db/2684180/Softbank>,
        <https://1145.am/db/2684436/Softbank>,
        <https://1145.am/db/2749329/Softbank>,
        <https://1145.am/db/277038/Softbank>,
        <https://1145.am/db/283626/Softbank>,
        <https://1145.am/db/302450/Softbank>,
        <https://1145.am/db/328776/Softbank_Corp>,
        <https://1145.am/db/328788/Softbank_Corp>,
        <https://1145.am/db/329019/Softbank>,
        <https://1145.am/db/329219/Softbank>,
        <https://1145.am/db/329220/Softbank>,
        <https://1145.am/db/331680/Softbank>,
        <https://1145.am/db/343587/Softbank>,
        <https://1145.am/db/344177/Softbank>,
        <https://1145.am/db/357570/Softbank>,
        <https://1145.am/db/359190/Softbank>,
        <https://1145.am/db/368673/Softbank>,
        <https://1145.am/db/368676/Softbank>,
        <https://1145.am/db/369042/Softbank>,
        <https://1145.am/db/370085/Softbank>,
        <https://1145.am/db/377807/Softbank>,
        <https://1145.am/db/387932/Softbank>,
        <https://1145.am/db/394986/Softbank>,
        <https://1145.am/db/395563/Softbank>,
        <https://1145.am/db/437556/Softbank>,
        <https://1145.am/db/438632/Softbank>,
        <https://1145.am/db/439819/Softbank>,
        <https://1145.am/db/477269/Softbank>,
        <https://1145.am/db/488382/Softbank>,
        <https://1145.am/db/531806/Softbank>,
        <https://1145.am/db/559220/Softbank>,
        <https://1145.am/db/592879/Softbank_Corp>,
        <https://1145.am/db/638401/Softbank>,
        <https://1145.am/db/653010/Softbank>,
        <https://1145.am/db/667957/Softbank>,
        <https://1145.am/db/668011/Softbank>,
        <https://1145.am/db/670806/Softbank>,
        <https://1145.am/db/685688/Softbank>,
        <https://1145.am/db/745714/Softbank>,
        <https://1145.am/db/747644/Softbank>,
        <https://1145.am/db/752217/Softbank>,
        <https://1145.am/db/753020/Softbank>,
        <https://1145.am/db/778652/Softbank>,
        <https://1145.am/db/799047/Softbank>,
        <https://1145.am/db/799292/Softbank>,
        <https://1145.am/db/8080/Softbank>,
        <https://1145.am/db/813667/Softbank>,
        <https://1145.am/db/857493/Softbank>,
        <https://1145.am/db/886532/Softbank>,
        <https://1145.am/db/915106/Softbank>,
        <https://1145.am/db/930512/Softbank>,
        <https://1145.am/db/976375/Softbank>,
        <https://1145.am/db/999577/Softbank> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2663406/At_T> a org:Organization ;
    ns1:basedInLowRaw "USA" ;
    ns1:buyer <https://1145.am/db/2663406/T-Mobile_Usa_Acquisition> ;
    ns1:description "mergers" ;
    ns1:documentDate "2011-09-02T14:17:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: AT&T could divest up to 25% of T-Mobile to win approval for deal" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-at-t-could-divest-up-to-25-t-mobile-to-win-approval-for-deal> ;
    ns1:foundName "AT & T" ;
    ns1:name "AT&T" ;
    ns1:sameAsHigh <https://1145.am/db/2157633/At_T>,
        <https://1145.am/db/2175146/At___T>,
        <https://1145.am/db/2661274/At_T>,
        <https://1145.am/db/2674918/At___T> ;
    ns1:sameAsMedium <https://1145.am/db/1000082/At___T_Inc>,
        <https://1145.am/db/1308612/At___T>,
        <https://1145.am/db/144483/At___T_Inc>,
        <https://1145.am/db/167287/At___T_Inc>,
        <https://1145.am/db/1677823/At___T_Inc>,
        <https://1145.am/db/1694065/At_T>,
        <https://1145.am/db/1707104/At___T>,
        <https://1145.am/db/1717987/At_T>,
        <https://1145.am/db/1751612/At___T>,
        <https://1145.am/db/1756446/At___T>,
        <https://1145.am/db/1760205/At_T>,
        <https://1145.am/db/1778517/At___T>,
        <https://1145.am/db/1778753/At___T>,
        <https://1145.am/db/1779566/At___T>,
        <https://1145.am/db/1785893/At_T>,
        <https://1145.am/db/1788936/At___T>,
        <https://1145.am/db/1789394/At___T>,
        <https://1145.am/db/1796420/At___T>,
        <https://1145.am/db/1799816/At_T>,
        <https://1145.am/db/1810646/At_T>,
        <https://1145.am/db/1812513/At___T>,
        <https://1145.am/db/1822834/At___T>,
        <https://1145.am/db/1824992/At___T>,
        <https://1145.am/db/1826385/At_T>,
        <https://1145.am/db/1836084/At___T>,
        <https://1145.am/db/1850952/At___T>,
        <https://1145.am/db/1853716/At___T>,
        <https://1145.am/db/1854000/At___T_*>,
        <https://1145.am/db/1859847/At___T>,
        <https://1145.am/db/1862489/At___T>,
        <https://1145.am/db/1866809/At_T>,
        <https://1145.am/db/1888480/At___T>,
        <https://1145.am/db/1899784/At___T_Inc>,
        <https://1145.am/db/1901295/At___T>,
        <https://1145.am/db/1901770/At___T>,
        <https://1145.am/db/206449/At___T_Inc>,
        <https://1145.am/db/211185/At___T_Inc>,
        <https://1145.am/db/2156880/At___T>,
        <https://1145.am/db/2157127/At___T>,
        <https://1145.am/db/2157161/At_T>,
        <https://1145.am/db/2157500/At___T>,
        <https://1145.am/db/2157791/At___T>,
        <https://1145.am/db/2157795/At_T>,
        <https://1145.am/db/2157931/At_T>,
        <https://1145.am/db/2157947/At___T>,
        <https://1145.am/db/2157965/At___T>,
        <https://1145.am/db/2158219/At_T>,
        <https://1145.am/db/2158287/At___T>,
        <https://1145.am/db/2158505/At_T>,
        <https://1145.am/db/2158868/At_T>,
        <https://1145.am/db/2159143/At___T>,
        <https://1145.am/db/2159365/At_T>,
        <https://1145.am/db/2159599/At___T>,
        <https://1145.am/db/2160074/At___T>,
        <https://1145.am/db/2161513/At___T>,
        <https://1145.am/db/2162041/At_T>,
        <https://1145.am/db/2162163/At___T>,
        <https://1145.am/db/2162249/At___T>,
        <https://1145.am/db/2162280/At_T>,
        <https://1145.am/db/2162386/At_T>,
        <https://1145.am/db/2162741/At___T>,
        <https://1145.am/db/2162994/At___T>,
        <https://1145.am/db/2163075/At_T>,
        <https://1145.am/db/2163699/At___T>,
        <https://1145.am/db/2163719/At_T>,
        <https://1145.am/db/2163888/At___T>,
        <https://1145.am/db/2163936/At___T>,
        <https://1145.am/db/2164453/At___T>,
        <https://1145.am/db/2164870/At___T>,
        <https://1145.am/db/2165758/At___T>,
        <https://1145.am/db/2165870/At___T>,
        <https://1145.am/db/2165984/At___T>,
        <https://1145.am/db/2166027/At_T>,
        <https://1145.am/db/2166622/At___T>,
        <https://1145.am/db/2167508/At___T>,
        <https://1145.am/db/2167511/At___T>,
        <https://1145.am/db/2169802/At_T>,
        <https://1145.am/db/2169997/At___T>,
        <https://1145.am/db/2170598/At___T>,
        <https://1145.am/db/2170599/At___T>,
        <https://1145.am/db/2170755/At___T>,
        <https://1145.am/db/2171126/At___T>,
        <https://1145.am/db/2171416/At_T>,
        <https://1145.am/db/2171918/At___T>,
        <https://1145.am/db/2172351/At_T>,
        <https://1145.am/db/2172670/At_T>,
        <https://1145.am/db/2172745/At___T>,
        <https://1145.am/db/2172901/At_T>,
        <https://1145.am/db/2172911/At_T>,
        <https://1145.am/db/2172998/At___T>,
        <https://1145.am/db/2173075/At___T>,
        <https://1145.am/db/2173138/At___T>,
        <https://1145.am/db/2173404/At___T>,
        <https://1145.am/db/2173415/At_T>,
        <https://1145.am/db/2173582/At___T>,
        <https://1145.am/db/2173586/At___T>,
        <https://1145.am/db/2173620/At_T>,
        <https://1145.am/db/2173675/At_T>,
        <https://1145.am/db/2173980/At___T>,
        <https://1145.am/db/2174357/At_T>,
        <https://1145.am/db/2174408/At___T>,
        <https://1145.am/db/2174633/At_T>,
        <https://1145.am/db/2174986/At_T>,
        <https://1145.am/db/2175475/At_T>,
        <https://1145.am/db/2175520/At_T>,
        <https://1145.am/db/2175716/At_T>,
        <https://1145.am/db/2176832/At_T>,
        <https://1145.am/db/2177450/At_T>,
        <https://1145.am/db/2177451/At_T>,
        <https://1145.am/db/2177458/At_T>,
        <https://1145.am/db/2177576/At___T>,
        <https://1145.am/db/2177636/At___T>,
        <https://1145.am/db/2179905/At_T>,
        <https://1145.am/db/2186280/At___T>,
        <https://1145.am/db/2229162/At___T>,
        <https://1145.am/db/2262401/At___T>,
        <https://1145.am/db/2266575/At_T>,
        <https://1145.am/db/2452684/At___T_Inc>,
        <https://1145.am/db/249455/At___T_Inc>,
        <https://1145.am/db/2598875/At___T>,
        <https://1145.am/db/2598969/At___T>,
        <https://1145.am/db/2598996/At_T>,
        <https://1145.am/db/2599069/At___T>,
        <https://1145.am/db/2599373/At___T>,
        <https://1145.am/db/2599572/At_T>,
        <https://1145.am/db/2599648/At___T>,
        <https://1145.am/db/2600001/At___T>,
        <https://1145.am/db/2600004/At___T>,
        <https://1145.am/db/2600202/At___T>,
        <https://1145.am/db/2600515/At___T>,
        <https://1145.am/db/2600548/At_T>,
        <https://1145.am/db/2600561/At_T>,
        <https://1145.am/db/2601297/At_T>,
        <https://1145.am/db/2601425/At_T>,
        <https://1145.am/db/2601887/At___T>,
        <https://1145.am/db/2602156/At___T>,
        <https://1145.am/db/2602281/At___T>,
        <https://1145.am/db/2602579/At_T>,
        <https://1145.am/db/2603377/At___T>,
        <https://1145.am/db/2603439/At___T>,
        <https://1145.am/db/2603531/At_T>,
        <https://1145.am/db/2603590/At___T>,
        <https://1145.am/db/2604223/At___T>,
        <https://1145.am/db/2604247/At_T>,
        <https://1145.am/db/2604314/At___T>,
        <https://1145.am/db/2604539/At_T>,
        <https://1145.am/db/2604863/At___T>,
        <https://1145.am/db/2604967/At_T>,
        <https://1145.am/db/2604977/At___T>,
        <https://1145.am/db/2605006/At___T>,
        <https://1145.am/db/2605344/At_T>,
        <https://1145.am/db/2605760/At___T>,
        <https://1145.am/db/2606502/At___T>,
        <https://1145.am/db/2606612/At___T>,
        <https://1145.am/db/2606761/At___T>,
        <https://1145.am/db/2607386/At___T>,
        <https://1145.am/db/2607794/At_T>,
        <https://1145.am/db/2607834/At_T>,
        <https://1145.am/db/2608701/At___T>,
        <https://1145.am/db/2608961/At_T>,
        <https://1145.am/db/2609030/At_T>,
        <https://1145.am/db/2609668/At_T>,
        <https://1145.am/db/2610620/At_T>,
        <https://1145.am/db/2610751/At___T>,
        <https://1145.am/db/2611067/At_T>,
        <https://1145.am/db/2611202/At___T>,
        <https://1145.am/db/2611854/At___T>,
        <https://1145.am/db/2613066/At_T>,
        <https://1145.am/db/2613122/At_T>,
        <https://1145.am/db/2614651/At___T>,
        <https://1145.am/db/2614719/At___T>,
        <https://1145.am/db/2614737/At___T>,
        <https://1145.am/db/2614886/At_T>,
        <https://1145.am/db/2615213/At_T>,
        <https://1145.am/db/2615500/At_T>,
        <https://1145.am/db/2615516/At_T>,
        <https://1145.am/db/2616317/At_T>,
        <https://1145.am/db/2616340/At___T>,
        <https://1145.am/db/2617072/At___T>,
        <https://1145.am/db/2617377/At___T>,
        <https://1145.am/db/2617606/At_T>,
        <https://1145.am/db/2617838/At___T>,
        <https://1145.am/db/2619115/At_T>,
        <https://1145.am/db/2619421/At_T>,
        <https://1145.am/db/2619593/At___T>,
        <https://1145.am/db/2619596/At___T>,
        <https://1145.am/db/2619745/At___T>,
        <https://1145.am/db/2620484/At___T>,
        <https://1145.am/db/2620838/At_T>,
        <https://1145.am/db/2622833/At___T>,
        <https://1145.am/db/2623193/At___T>,
        <https://1145.am/db/2623936/At___T>,
        <https://1145.am/db/2624400/At_T>,
        <https://1145.am/db/2624431/At_T>,
        <https://1145.am/db/2625058/At_T>,
        <https://1145.am/db/2625764/At_T>,
        <https://1145.am/db/2625808/At_T>,
        <https://1145.am/db/2626750/At___T>,
        <https://1145.am/db/2627018/At___T>,
        <https://1145.am/db/2627103/At_T>,
        <https://1145.am/db/2627470/At___T>,
        <https://1145.am/db/2627982/At_T>,
        <https://1145.am/db/2628029/At___T>,
        <https://1145.am/db/2628482/At_T>,
        <https://1145.am/db/2628926/At_T>,
        <https://1145.am/db/2628936/At_T>,
        <https://1145.am/db/2628948/At_T>,
        <https://1145.am/db/2629447/At___T>,
        <https://1145.am/db/2629910/At_T>,
        <https://1145.am/db/2630839/At_T>,
        <https://1145.am/db/2631175/At___T>,
        <https://1145.am/db/2631207/At___T>,
        <https://1145.am/db/2632121/At___T>,
        <https://1145.am/db/2632131/At___T>,
        <https://1145.am/db/2632273/At_T>,
        <https://1145.am/db/2633416/At___T>,
        <https://1145.am/db/2633504/At_T>,
        <https://1145.am/db/2633827/At___T>,
        <https://1145.am/db/2634130/At___T>,
        <https://1145.am/db/2634349/At_T>,
        <https://1145.am/db/2635751/At___T>,
        <https://1145.am/db/2636028/At___T>,
        <https://1145.am/db/2636629/At___T>,
        <https://1145.am/db/2636649/At___T>,
        <https://1145.am/db/2636927/At___T>,
        <https://1145.am/db/2637568/At___T>,
        <https://1145.am/db/2637597/At_T>,
        <https://1145.am/db/2637732/At___T>,
        <https://1145.am/db/2638620/At___T>,
        <https://1145.am/db/2639462/At_T>,
        <https://1145.am/db/2639641/At_T>,
        <https://1145.am/db/2640140/At_T>,
        <https://1145.am/db/2640631/At___T>,
        <https://1145.am/db/2640947/At_T>,
        <https://1145.am/db/2640950/At_T>,
        <https://1145.am/db/2641156/At_T>,
        <https://1145.am/db/2641303/At_T>,
        <https://1145.am/db/2641554/At_T>,
        <https://1145.am/db/2642326/At___T>,
        <https://1145.am/db/2642638/At_T>,
        <https://1145.am/db/2643619/At_T>,
        <https://1145.am/db/2644481/At___T>,
        <https://1145.am/db/2646315/At___T>,
        <https://1145.am/db/2648327/At___T>,
        <https://1145.am/db/2648632/At_T>,
        <https://1145.am/db/2649776/At___T>,
        <https://1145.am/db/2649914/At_T>,
        <https://1145.am/db/2650269/At_T>,
        <https://1145.am/db/2651977/At_T>,
        <https://1145.am/db/2652105/At___T>,
        <https://1145.am/db/2652671/At___T>,
        <https://1145.am/db/2652765/At___T>,
        <https://1145.am/db/2652823/At_T>,
        <https://1145.am/db/2652834/At_T>,
        <https://1145.am/db/2652840/At_T>,
        <https://1145.am/db/2653426/At_T>,
        <https://1145.am/db/2653492/At_T>,
        <https://1145.am/db/2653594/At___T>,
        <https://1145.am/db/2653676/At___T>,
        <https://1145.am/db/2654379/At___T>,
        <https://1145.am/db/2654386/At_T>,
        <https://1145.am/db/2655150/At___T>,
        <https://1145.am/db/2655429/At___T>,
        <https://1145.am/db/2655954/At___T>,
        <https://1145.am/db/2656604/At___T>,
        <https://1145.am/db/2657126/At___T>,
        <https://1145.am/db/2657127/At___T>,
        <https://1145.am/db/2657140/At___T>,
        <https://1145.am/db/2657220/At___T>,
        <https://1145.am/db/2658006/At___T>,
        <https://1145.am/db/2658220/At_T>,
        <https://1145.am/db/2658238/At___T>,
        <https://1145.am/db/2658524/At___T>,
        <https://1145.am/db/2658539/At___T>,
        <https://1145.am/db/2659075/At___T>,
        <https://1145.am/db/2659265/At_T>,
        <https://1145.am/db/2659619/At_T>,
        <https://1145.am/db/2660189/At_T>,
        <https://1145.am/db/2660328/At_T>,
        <https://1145.am/db/2660524/At___T>,
        <https://1145.am/db/2660785/At___T>,
        <https://1145.am/db/2661120/At___T>,
        <https://1145.am/db/2661159/At_T>,
        <https://1145.am/db/2661168/At___T>,
        <https://1145.am/db/2661290/At_T>,
        <https://1145.am/db/2661418/At___T>,
        <https://1145.am/db/2661680/At_T>,
        <https://1145.am/db/2662193/At___T>,
        <https://1145.am/db/2662354/At_T>,
        <https://1145.am/db/2662383/At___T>,
        <https://1145.am/db/2663214/At___T>,
        <https://1145.am/db/2663421/At___T>,
        <https://1145.am/db/2664378/At_T>,
        <https://1145.am/db/2664500/At_T>,
        <https://1145.am/db/2664517/At_T>,
        <https://1145.am/db/2664547/At_T>,
        <https://1145.am/db/2664691/At___T>,
        <https://1145.am/db/2664887/At___T>,
        <https://1145.am/db/2665469/At___T>,
        <https://1145.am/db/2665579/At_T>,
        <https://1145.am/db/2665710/At___T>,
        <https://1145.am/db/2665731/At_T>,
        <https://1145.am/db/2666095/At_T>,
        <https://1145.am/db/2666575/At___T>,
        <https://1145.am/db/2666714/At_T>,
        <https://1145.am/db/2667130/At___T>,
        <https://1145.am/db/2667132/At___T>,
        <https://1145.am/db/2667338/At___T>,
        <https://1145.am/db/2668714/At_T>,
        <https://1145.am/db/2668735/At___T>,
        <https://1145.am/db/2668814/At_T>,
        <https://1145.am/db/2669621/At___T>,
        <https://1145.am/db/2669628/At_T>,
        <https://1145.am/db/2669920/At_T>,
        <https://1145.am/db/2669926/At_T>,
        <https://1145.am/db/2671029/At_T>,
        <https://1145.am/db/2671484/At_T>,
        <https://1145.am/db/2671605/At_T>,
        <https://1145.am/db/2671920/At_T>,
        <https://1145.am/db/2672079/At_T>,
        <https://1145.am/db/2672172/At___T>,
        <https://1145.am/db/2672184/At_T>,
        <https://1145.am/db/2673753/At___T>,
        <https://1145.am/db/2673923/At___T>,
        <https://1145.am/db/2674316/At_T>,
        <https://1145.am/db/2676075/At_T>,
        <https://1145.am/db/2677102/At___T>,
        <https://1145.am/db/2677549/At_T>,
        <https://1145.am/db/2677987/At___T>,
        <https://1145.am/db/2678311/At_T>,
        <https://1145.am/db/2678753/At_T>,
        <https://1145.am/db/2679157/At___T>,
        <https://1145.am/db/2679240/At_T>,
        <https://1145.am/db/2679476/At_T>,
        <https://1145.am/db/2679803/At___T>,
        <https://1145.am/db/2680232/At___T>,
        <https://1145.am/db/2680246/At_T>,
        <https://1145.am/db/2680251/At_T>,
        <https://1145.am/db/2680761/At___T>,
        <https://1145.am/db/2680894/At_T>,
        <https://1145.am/db/2680897/At___T>,
        <https://1145.am/db/2680905/At___T>,
        <https://1145.am/db/2680906/At___T>,
        <https://1145.am/db/2681046/At___T>,
        <https://1145.am/db/2681072/At___T>,
        <https://1145.am/db/2681074/At___T>,
        <https://1145.am/db/2681734/At_T>,
        <https://1145.am/db/2681829/At___T>,
        <https://1145.am/db/2682409/At_T>,
        <https://1145.am/db/2682447/At___T>,
        <https://1145.am/db/2682450/At___T>,
        <https://1145.am/db/2682574/At___T>,
        <https://1145.am/db/2682630/At___T>,
        <https://1145.am/db/2682698/At___T>,
        <https://1145.am/db/2682715/At_T>,
        <https://1145.am/db/2683008/At___T>,
        <https://1145.am/db/2683098/At___T>,
        <https://1145.am/db/2683420/At___T>,
        <https://1145.am/db/2683473/At_T>,
        <https://1145.am/db/2683713/At___T>,
        <https://1145.am/db/2683735/At___T>,
        <https://1145.am/db/2684028/At___T>,
        <https://1145.am/db/2684148/At_T>,
        <https://1145.am/db/2684435/At_T>,
        <https://1145.am/db/2684439/At___T>,
        <https://1145.am/db/2684475/At___T>,
        <https://1145.am/db/2684713/At___T>,
        <https://1145.am/db/2684726/At___T>,
        <https://1145.am/db/2685112/At___T>,
        <https://1145.am/db/2685243/At___T>,
        <https://1145.am/db/2685245/At___T>,
        <https://1145.am/db/2685254/At___T>,
        <https://1145.am/db/2685271/At___T>,
        <https://1145.am/db/2685285/At___T>,
        <https://1145.am/db/2685505/At_T>,
        <https://1145.am/db/2685526/At___T>,
        <https://1145.am/db/2685618/At_T>,
        <https://1145.am/db/2685640/At_T>,
        <https://1145.am/db/2685654/At___T>,
        <https://1145.am/db/2685762/At_T>,
        <https://1145.am/db/2685811/At_T>,
        <https://1145.am/db/2685903/At___T>,
        <https://1145.am/db/2685930/At_T>,
        <https://1145.am/db/2685940/At_T>,
        <https://1145.am/db/2685941/At_T>,
        <https://1145.am/db/2686475/At_T>,
        <https://1145.am/db/2686540/At___T>,
        <https://1145.am/db/334907/At_T>,
        <https://1145.am/db/335104/At___T_Inc>,
        <https://1145.am/db/401388/At___T>,
        <https://1145.am/db/470135/At___T_Inc>,
        <https://1145.am/db/485256/At_T>,
        <https://1145.am/db/513323/At___T>,
        <https://1145.am/db/6235/At___T>,
        <https://1145.am/db/710355/At___T_Inc>,
        <https://1145.am/db/710798/At___T_Inc>,
        <https://1145.am/db/713292/At___T_Inc>,
        <https://1145.am/db/715099/At___T_Inc>,
        <https://1145.am/db/715441/At___T_Inc>,
        <https://1145.am/db/724048/At___T>,
        <https://1145.am/db/725944/At___T>,
        <https://1145.am/db/737813/At___T_Inc>,
        <https://1145.am/db/796295/At___T>,
        <https://1145.am/db/897774/At___T>,
        <https://1145.am/db/966560/At___T_Inc> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2664505/T-Mobile_Usa_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-09-20T10:30:17+00:00"^^xsd:dateTime ;
    ns1:documentExtract "It's too soon to say whether AT & T's (NYSE: T) proposed $ 39 billion acquisition of T-Mobile USA or Google's (NASDAQ: GOOG) planned $ 12.5 billion purchase of Motorola Mobility (NYSE: MMI) will turn out to be brilliant or bone-headed moves." ;
    ns1:documentTitle "What are the most controversial (and brilliant) wireless business ideas of the past decade?" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/what-are-most-controversial-and-brilliant-wireless-business-ideas-past-decade> ;
    ns1:foundName "acquisition",
        "purchase" ;
    ns1:name "acquisition",
        "purchase" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2664505/T-Mobile_Usa> ;
    ns1:targetName "T-Mobile USA" ;
    ns1:valueRaw "$ 12.5 billion",
        "$ 39 billion" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "USA" .

<https://1145.am/db/2669942/Dish_Network_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:basedInLowRaw "America" ;
    ns1:description "video delivery service" ;
    ns1:documentDate "2011-11-30T16:59:41+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Dish paid $ 2.775 billion to purchase DBSD North America and TerreStar Networks, and intends to use the companies' spectrum to push a mobile video strategy to complement its wired video delivery service.",
        "Sprint Nextel (NYSE: S) has given its assent to Dish Network's plans to acquire 40 MHz of S-band satellite spectrum in the 2 GHz band, and said that Dish's proposed LTE-Advanced network for that spectrum will not interfere with Sprint's operations on its adjacent 1900 MHz PCS spectrum, according to FCC filings." ;
    ns1:documentTitle "Sprint signs off on Dish's proposed wireless venture" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/sprint-signs-off-dish-s-proposed-wireless-venture> ;
    ns1:foundName "DBSD North America",
        "acquire",
        "purchase" ;
    ns1:name "Dish Network",
        "acquire",
        "purchase" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2669942/Dish_Network_Acquisition> ;
    ns1:targetName "Dish Network" ;
    ns1:valueRaw "$ 2.775 billion" ;
    ns1:whereGeoName "North Salt Lake" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5779068/about.rdf> ;
    ns1:whereRaw "North America" .

<https://1145.am/db/2672172/At___T> a org:Organization ;
    ns1:basedInLowRaw "USA" ;
    ns1:buyer <https://1145.am/db/2672172/T-Mobile_Usa_Assets_Acquisition> ;
    ns1:documentDate "2011-12-19T15:16:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: AT&T's attempts to sell off T-Mobile assets hit dead end" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-at-t-s-attempts-to-sell-off-t-mobile-assets-hit-dead-end> ;
    ns1:foundName "AT & T'" ;
    ns1:name "AT & T" ;
    ns1:sameAsMedium <https://1145.am/db/1000082/At___T_Inc>,
        <https://1145.am/db/1308612/At___T>,
        <https://1145.am/db/144483/At___T_Inc>,
        <https://1145.am/db/167287/At___T_Inc>,
        <https://1145.am/db/1677823/At___T_Inc>,
        <https://1145.am/db/1694065/At_T>,
        <https://1145.am/db/1707104/At___T>,
        <https://1145.am/db/1717987/At_T>,
        <https://1145.am/db/1751612/At___T>,
        <https://1145.am/db/1756446/At___T>,
        <https://1145.am/db/1760205/At_T>,
        <https://1145.am/db/1778517/At___T>,
        <https://1145.am/db/1778753/At___T>,
        <https://1145.am/db/1779566/At___T>,
        <https://1145.am/db/1785893/At_T>,
        <https://1145.am/db/1788936/At___T>,
        <https://1145.am/db/1789394/At___T>,
        <https://1145.am/db/1796420/At___T>,
        <https://1145.am/db/1799816/At_T>,
        <https://1145.am/db/1810646/At_T>,
        <https://1145.am/db/1812513/At___T>,
        <https://1145.am/db/1822834/At___T>,
        <https://1145.am/db/1824992/At___T>,
        <https://1145.am/db/1826385/At_T>,
        <https://1145.am/db/1836084/At___T>,
        <https://1145.am/db/1850952/At___T>,
        <https://1145.am/db/1853716/At___T>,
        <https://1145.am/db/1854000/At___T_*>,
        <https://1145.am/db/1859847/At___T>,
        <https://1145.am/db/1862489/At___T>,
        <https://1145.am/db/1866809/At_T>,
        <https://1145.am/db/1888480/At___T>,
        <https://1145.am/db/1899784/At___T_Inc>,
        <https://1145.am/db/1901295/At___T>,
        <https://1145.am/db/1901770/At___T>,
        <https://1145.am/db/206449/At___T_Inc>,
        <https://1145.am/db/211185/At___T_Inc>,
        <https://1145.am/db/2156880/At___T>,
        <https://1145.am/db/2157127/At___T>,
        <https://1145.am/db/2157161/At_T>,
        <https://1145.am/db/2157500/At___T>,
        <https://1145.am/db/2157633/At_T>,
        <https://1145.am/db/2157791/At___T>,
        <https://1145.am/db/2157795/At_T>,
        <https://1145.am/db/2157931/At_T>,
        <https://1145.am/db/2157947/At___T>,
        <https://1145.am/db/2157965/At___T>,
        <https://1145.am/db/2158219/At_T>,
        <https://1145.am/db/2158287/At___T>,
        <https://1145.am/db/2158505/At_T>,
        <https://1145.am/db/2158868/At_T>,
        <https://1145.am/db/2159143/At___T>,
        <https://1145.am/db/2159365/At_T>,
        <https://1145.am/db/2159599/At___T>,
        <https://1145.am/db/2160074/At___T>,
        <https://1145.am/db/2161513/At___T>,
        <https://1145.am/db/2162041/At_T>,
        <https://1145.am/db/2162163/At___T>,
        <https://1145.am/db/2162249/At___T>,
        <https://1145.am/db/2162280/At_T>,
        <https://1145.am/db/2162386/At_T>,
        <https://1145.am/db/2162741/At___T>,
        <https://1145.am/db/2162994/At___T>,
        <https://1145.am/db/2163075/At_T>,
        <https://1145.am/db/2163699/At___T>,
        <https://1145.am/db/2163719/At_T>,
        <https://1145.am/db/2163888/At___T>,
        <https://1145.am/db/2163936/At___T>,
        <https://1145.am/db/2164453/At___T>,
        <https://1145.am/db/2164870/At___T>,
        <https://1145.am/db/2165758/At___T>,
        <https://1145.am/db/2165870/At___T>,
        <https://1145.am/db/2165984/At___T>,
        <https://1145.am/db/2166027/At_T>,
        <https://1145.am/db/2166622/At___T>,
        <https://1145.am/db/2167508/At___T>,
        <https://1145.am/db/2167511/At___T>,
        <https://1145.am/db/2169802/At_T>,
        <https://1145.am/db/2169997/At___T>,
        <https://1145.am/db/2170598/At___T>,
        <https://1145.am/db/2170599/At___T>,
        <https://1145.am/db/2170755/At___T>,
        <https://1145.am/db/2171126/At___T>,
        <https://1145.am/db/2171416/At_T>,
        <https://1145.am/db/2171918/At___T>,
        <https://1145.am/db/2172351/At_T>,
        <https://1145.am/db/2172670/At_T>,
        <https://1145.am/db/2172745/At___T>,
        <https://1145.am/db/2172901/At_T>,
        <https://1145.am/db/2172911/At_T>,
        <https://1145.am/db/2172998/At___T>,
        <https://1145.am/db/2173075/At___T>,
        <https://1145.am/db/2173138/At___T>,
        <https://1145.am/db/2173404/At___T>,
        <https://1145.am/db/2173415/At_T>,
        <https://1145.am/db/2173582/At___T>,
        <https://1145.am/db/2173586/At___T>,
        <https://1145.am/db/2173620/At_T>,
        <https://1145.am/db/2173675/At_T>,
        <https://1145.am/db/2173980/At___T>,
        <https://1145.am/db/2174357/At_T>,
        <https://1145.am/db/2174408/At___T>,
        <https://1145.am/db/2174633/At_T>,
        <https://1145.am/db/2174986/At_T>,
        <https://1145.am/db/2175146/At___T>,
        <https://1145.am/db/2175475/At_T>,
        <https://1145.am/db/2175520/At_T>,
        <https://1145.am/db/2175716/At_T>,
        <https://1145.am/db/2176832/At_T>,
        <https://1145.am/db/2177450/At_T>,
        <https://1145.am/db/2177451/At_T>,
        <https://1145.am/db/2177458/At_T>,
        <https://1145.am/db/2177576/At___T>,
        <https://1145.am/db/2177636/At___T>,
        <https://1145.am/db/2179905/At_T>,
        <https://1145.am/db/2186280/At___T>,
        <https://1145.am/db/2229162/At___T>,
        <https://1145.am/db/2262401/At___T>,
        <https://1145.am/db/2266575/At_T>,
        <https://1145.am/db/2452684/At___T_Inc>,
        <https://1145.am/db/249455/At___T_Inc>,
        <https://1145.am/db/2598875/At___T>,
        <https://1145.am/db/2598969/At___T>,
        <https://1145.am/db/2598996/At_T>,
        <https://1145.am/db/2599069/At___T>,
        <https://1145.am/db/2599373/At___T>,
        <https://1145.am/db/2599572/At_T>,
        <https://1145.am/db/2599648/At___T>,
        <https://1145.am/db/2600001/At___T>,
        <https://1145.am/db/2600004/At___T>,
        <https://1145.am/db/2600202/At___T>,
        <https://1145.am/db/2600515/At___T>,
        <https://1145.am/db/2600548/At_T>,
        <https://1145.am/db/2600561/At_T>,
        <https://1145.am/db/2601297/At_T>,
        <https://1145.am/db/2601425/At_T>,
        <https://1145.am/db/2601887/At___T>,
        <https://1145.am/db/2602156/At___T>,
        <https://1145.am/db/2602281/At___T>,
        <https://1145.am/db/2602579/At_T>,
        <https://1145.am/db/2603377/At___T>,
        <https://1145.am/db/2603439/At___T>,
        <https://1145.am/db/2603531/At_T>,
        <https://1145.am/db/2603590/At___T>,
        <https://1145.am/db/2604223/At___T>,
        <https://1145.am/db/2604247/At_T>,
        <https://1145.am/db/2604314/At___T>,
        <https://1145.am/db/2604539/At_T>,
        <https://1145.am/db/2604863/At___T>,
        <https://1145.am/db/2604967/At_T>,
        <https://1145.am/db/2604977/At___T>,
        <https://1145.am/db/2605006/At___T>,
        <https://1145.am/db/2605344/At_T>,
        <https://1145.am/db/2605760/At___T>,
        <https://1145.am/db/2606502/At___T>,
        <https://1145.am/db/2606612/At___T>,
        <https://1145.am/db/2606761/At___T>,
        <https://1145.am/db/2607386/At___T>,
        <https://1145.am/db/2607794/At_T>,
        <https://1145.am/db/2607834/At_T>,
        <https://1145.am/db/2608701/At___T>,
        <https://1145.am/db/2608961/At_T>,
        <https://1145.am/db/2609030/At_T>,
        <https://1145.am/db/2609668/At_T>,
        <https://1145.am/db/2610620/At_T>,
        <https://1145.am/db/2610751/At___T>,
        <https://1145.am/db/2611067/At_T>,
        <https://1145.am/db/2611202/At___T>,
        <https://1145.am/db/2611854/At___T>,
        <https://1145.am/db/2613066/At_T>,
        <https://1145.am/db/2613122/At_T>,
        <https://1145.am/db/2614651/At___T>,
        <https://1145.am/db/2614719/At___T>,
        <https://1145.am/db/2614737/At___T>,
        <https://1145.am/db/2614886/At_T>,
        <https://1145.am/db/2615213/At_T>,
        <https://1145.am/db/2615500/At_T>,
        <https://1145.am/db/2615516/At_T>,
        <https://1145.am/db/2616317/At_T>,
        <https://1145.am/db/2616340/At___T>,
        <https://1145.am/db/2617072/At___T>,
        <https://1145.am/db/2617377/At___T>,
        <https://1145.am/db/2617606/At_T>,
        <https://1145.am/db/2617838/At___T>,
        <https://1145.am/db/2619115/At_T>,
        <https://1145.am/db/2619421/At_T>,
        <https://1145.am/db/2619593/At___T>,
        <https://1145.am/db/2619596/At___T>,
        <https://1145.am/db/2619745/At___T>,
        <https://1145.am/db/2620484/At___T>,
        <https://1145.am/db/2620838/At_T>,
        <https://1145.am/db/2622833/At___T>,
        <https://1145.am/db/2623193/At___T>,
        <https://1145.am/db/2623936/At___T>,
        <https://1145.am/db/2624400/At_T>,
        <https://1145.am/db/2624431/At_T>,
        <https://1145.am/db/2625058/At_T>,
        <https://1145.am/db/2625764/At_T>,
        <https://1145.am/db/2625808/At_T>,
        <https://1145.am/db/2626750/At___T>,
        <https://1145.am/db/2627018/At___T>,
        <https://1145.am/db/2627103/At_T>,
        <https://1145.am/db/2627470/At___T>,
        <https://1145.am/db/2627982/At_T>,
        <https://1145.am/db/2628029/At___T>,
        <https://1145.am/db/2628482/At_T>,
        <https://1145.am/db/2628926/At_T>,
        <https://1145.am/db/2628936/At_T>,
        <https://1145.am/db/2628948/At_T>,
        <https://1145.am/db/2629447/At___T>,
        <https://1145.am/db/2629910/At_T>,
        <https://1145.am/db/2630839/At_T>,
        <https://1145.am/db/2631175/At___T>,
        <https://1145.am/db/2631207/At___T>,
        <https://1145.am/db/2632121/At___T>,
        <https://1145.am/db/2632131/At___T>,
        <https://1145.am/db/2632273/At_T>,
        <https://1145.am/db/2633416/At___T>,
        <https://1145.am/db/2633504/At_T>,
        <https://1145.am/db/2633827/At___T>,
        <https://1145.am/db/2634130/At___T>,
        <https://1145.am/db/2634349/At_T>,
        <https://1145.am/db/2635751/At___T>,
        <https://1145.am/db/2636028/At___T>,
        <https://1145.am/db/2636629/At___T>,
        <https://1145.am/db/2636649/At___T>,
        <https://1145.am/db/2636927/At___T>,
        <https://1145.am/db/2637568/At___T>,
        <https://1145.am/db/2637597/At_T>,
        <https://1145.am/db/2637732/At___T>,
        <https://1145.am/db/2638620/At___T>,
        <https://1145.am/db/2639462/At_T>,
        <https://1145.am/db/2639641/At_T>,
        <https://1145.am/db/2640140/At_T>,
        <https://1145.am/db/2640631/At___T>,
        <https://1145.am/db/2640947/At_T>,
        <https://1145.am/db/2640950/At_T>,
        <https://1145.am/db/2641156/At_T>,
        <https://1145.am/db/2641303/At_T>,
        <https://1145.am/db/2641554/At_T>,
        <https://1145.am/db/2642326/At___T>,
        <https://1145.am/db/2642638/At_T>,
        <https://1145.am/db/2643619/At_T>,
        <https://1145.am/db/2644481/At___T>,
        <https://1145.am/db/2646315/At___T>,
        <https://1145.am/db/2648327/At___T>,
        <https://1145.am/db/2648632/At_T>,
        <https://1145.am/db/2649776/At___T>,
        <https://1145.am/db/2649914/At_T>,
        <https://1145.am/db/2650269/At_T>,
        <https://1145.am/db/2651977/At_T>,
        <https://1145.am/db/2652105/At___T>,
        <https://1145.am/db/2652671/At___T>,
        <https://1145.am/db/2652765/At___T>,
        <https://1145.am/db/2652823/At_T>,
        <https://1145.am/db/2652834/At_T>,
        <https://1145.am/db/2652840/At_T>,
        <https://1145.am/db/2653426/At_T>,
        <https://1145.am/db/2653492/At_T>,
        <https://1145.am/db/2653594/At___T>,
        <https://1145.am/db/2653676/At___T>,
        <https://1145.am/db/2654379/At___T>,
        <https://1145.am/db/2654386/At_T>,
        <https://1145.am/db/2655150/At___T>,
        <https://1145.am/db/2655429/At___T>,
        <https://1145.am/db/2655954/At___T>,
        <https://1145.am/db/2656604/At___T>,
        <https://1145.am/db/2657126/At___T>,
        <https://1145.am/db/2657127/At___T>,
        <https://1145.am/db/2657140/At___T>,
        <https://1145.am/db/2657220/At___T>,
        <https://1145.am/db/2658006/At___T>,
        <https://1145.am/db/2658220/At_T>,
        <https://1145.am/db/2658238/At___T>,
        <https://1145.am/db/2658524/At___T>,
        <https://1145.am/db/2658539/At___T>,
        <https://1145.am/db/2659075/At___T>,
        <https://1145.am/db/2659265/At_T>,
        <https://1145.am/db/2659619/At_T>,
        <https://1145.am/db/2660189/At_T>,
        <https://1145.am/db/2660328/At_T>,
        <https://1145.am/db/2660524/At___T>,
        <https://1145.am/db/2660785/At___T>,
        <https://1145.am/db/2661120/At___T>,
        <https://1145.am/db/2661159/At_T>,
        <https://1145.am/db/2661168/At___T>,
        <https://1145.am/db/2661274/At_T>,
        <https://1145.am/db/2661290/At_T>,
        <https://1145.am/db/2661418/At___T>,
        <https://1145.am/db/2661680/At_T>,
        <https://1145.am/db/2662193/At___T>,
        <https://1145.am/db/2662354/At_T>,
        <https://1145.am/db/2662383/At___T>,
        <https://1145.am/db/2663214/At___T>,
        <https://1145.am/db/2663406/At_T>,
        <https://1145.am/db/2663421/At___T>,
        <https://1145.am/db/2664378/At_T>,
        <https://1145.am/db/2664500/At_T>,
        <https://1145.am/db/2664517/At_T>,
        <https://1145.am/db/2664547/At_T>,
        <https://1145.am/db/2664691/At___T>,
        <https://1145.am/db/2664887/At___T>,
        <https://1145.am/db/2665469/At___T>,
        <https://1145.am/db/2665579/At_T>,
        <https://1145.am/db/2665710/At___T>,
        <https://1145.am/db/2665731/At_T>,
        <https://1145.am/db/2666095/At_T>,
        <https://1145.am/db/2666575/At___T>,
        <https://1145.am/db/2666714/At_T>,
        <https://1145.am/db/2667130/At___T>,
        <https://1145.am/db/2667132/At___T>,
        <https://1145.am/db/2667338/At___T>,
        <https://1145.am/db/2668714/At_T>,
        <https://1145.am/db/2668735/At___T>,
        <https://1145.am/db/2668814/At_T>,
        <https://1145.am/db/2669621/At___T>,
        <https://1145.am/db/2669628/At_T>,
        <https://1145.am/db/2669920/At_T>,
        <https://1145.am/db/2669926/At_T>,
        <https://1145.am/db/2671029/At_T>,
        <https://1145.am/db/2671484/At_T>,
        <https://1145.am/db/2671605/At_T>,
        <https://1145.am/db/2671920/At_T>,
        <https://1145.am/db/2672079/At_T>,
        <https://1145.am/db/2672184/At_T>,
        <https://1145.am/db/2673753/At___T>,
        <https://1145.am/db/2673923/At___T>,
        <https://1145.am/db/2674316/At_T>,
        <https://1145.am/db/2674918/At___T>,
        <https://1145.am/db/2676075/At_T>,
        <https://1145.am/db/2677102/At___T>,
        <https://1145.am/db/2677549/At_T>,
        <https://1145.am/db/2677987/At___T>,
        <https://1145.am/db/2678311/At_T>,
        <https://1145.am/db/2678753/At_T>,
        <https://1145.am/db/2679157/At___T>,
        <https://1145.am/db/2679240/At_T>,
        <https://1145.am/db/2679476/At_T>,
        <https://1145.am/db/2679803/At___T>,
        <https://1145.am/db/2680232/At___T>,
        <https://1145.am/db/2680246/At_T>,
        <https://1145.am/db/2680251/At_T>,
        <https://1145.am/db/2680761/At___T>,
        <https://1145.am/db/2680894/At_T>,
        <https://1145.am/db/2680897/At___T>,
        <https://1145.am/db/2680905/At___T>,
        <https://1145.am/db/2680906/At___T>,
        <https://1145.am/db/2681046/At___T>,
        <https://1145.am/db/2681072/At___T>,
        <https://1145.am/db/2681074/At___T>,
        <https://1145.am/db/2681734/At_T>,
        <https://1145.am/db/2681829/At___T>,
        <https://1145.am/db/2682409/At_T>,
        <https://1145.am/db/2682447/At___T>,
        <https://1145.am/db/2682450/At___T>,
        <https://1145.am/db/2682574/At___T>,
        <https://1145.am/db/2682630/At___T>,
        <https://1145.am/db/2682698/At___T>,
        <https://1145.am/db/2682715/At_T>,
        <https://1145.am/db/2683008/At___T>,
        <https://1145.am/db/2683098/At___T>,
        <https://1145.am/db/2683420/At___T>,
        <https://1145.am/db/2683473/At_T>,
        <https://1145.am/db/2683713/At___T>,
        <https://1145.am/db/2683735/At___T>,
        <https://1145.am/db/2684028/At___T>,
        <https://1145.am/db/2684148/At_T>,
        <https://1145.am/db/2684435/At_T>,
        <https://1145.am/db/2684439/At___T>,
        <https://1145.am/db/2684475/At___T>,
        <https://1145.am/db/2684713/At___T>,
        <https://1145.am/db/2684726/At___T>,
        <https://1145.am/db/2685112/At___T>,
        <https://1145.am/db/2685243/At___T>,
        <https://1145.am/db/2685245/At___T>,
        <https://1145.am/db/2685254/At___T>,
        <https://1145.am/db/2685271/At___T>,
        <https://1145.am/db/2685285/At___T>,
        <https://1145.am/db/2685505/At_T>,
        <https://1145.am/db/2685526/At___T>,
        <https://1145.am/db/2685618/At_T>,
        <https://1145.am/db/2685640/At_T>,
        <https://1145.am/db/2685654/At___T>,
        <https://1145.am/db/2685762/At_T>,
        <https://1145.am/db/2685811/At_T>,
        <https://1145.am/db/2685903/At___T>,
        <https://1145.am/db/2685930/At_T>,
        <https://1145.am/db/2685940/At_T>,
        <https://1145.am/db/2685941/At_T>,
        <https://1145.am/db/2686475/At_T>,
        <https://1145.am/db/2686540/At___T>,
        <https://1145.am/db/334907/At_T>,
        <https://1145.am/db/335104/At___T_Inc>,
        <https://1145.am/db/401388/At___T>,
        <https://1145.am/db/470135/At___T_Inc>,
        <https://1145.am/db/485256/At_T>,
        <https://1145.am/db/513323/At___T>,
        <https://1145.am/db/6235/At___T>,
        <https://1145.am/db/710355/At___T_Inc>,
        <https://1145.am/db/710798/At___T_Inc>,
        <https://1145.am/db/713292/At___T_Inc>,
        <https://1145.am/db/715099/At___T_Inc>,
        <https://1145.am/db/715441/At___T_Inc>,
        <https://1145.am/db/724048/At___T>,
        <https://1145.am/db/725944/At___T>,
        <https://1145.am/db/737813/At___T_Inc>,
        <https://1145.am/db/796295/At___T>,
        <https://1145.am/db/897774/At___T>,
        <https://1145.am/db/966560/At___T_Inc> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2293308/Kleiner_Perkins_Caufield___Byers> a org:Organization ;
    ns1:basedInLowRaw "Americans" ;
    ns1:documentDate "2011-09-12T13:49:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Crescendo raises $56M, enters pact with Myriad" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/crescendo-raises-56m-enters-pact-myriad> ;
    ns1:foundName "Kleiner Perkins Caufield & Byers" ;
    ns1:investor <https://1145.am/db/2293308/Crescendo_Series_C_Investment> ;
    ns1:name "Kleiner Perkins Caufield & Byers" ;
    ns1:sameAsMedium <https://1145.am/db/1697155/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1709036/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1714786/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1719362/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1792401/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1794049/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1794342/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1795003/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1796259/Kleiner_Perkins_Caufield_Byers>,
        <https://1145.am/db/1798154/Kleiner_Perkins_Caufield_Byers>,
        <https://1145.am/db/1802208/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1802525/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1805986/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1806158/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1808735/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1814186/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1816928/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1821378/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1824878/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1825866/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1826126/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1827381/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1830311/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1835647/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1838965/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1839326/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1840650/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1844931/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1845205/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1847021/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1849969/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1850246/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1850293/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1850642/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1852048/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1852697/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1853217/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1853292/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/1854098/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1856424/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1858545/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1858646/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1859219/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1860406/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1860644/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1861870/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1864650/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1865436/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1868593/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1868958/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1870791/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1871768/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1872947/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/1872971/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1874419/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1876759/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1881582/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1883859/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1890121/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1891856/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1892105/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1892746/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1895292/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1906922/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1907771/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1915400/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2227037/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2230414/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2288899/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2289585/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2291836/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2300306/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2300337/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2305254/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/2305256/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2310485/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2311540/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2312700/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2313567/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2316038/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2317750/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2317753/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2321949/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2325726/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/2326444/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2326926/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/2331026/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2331047/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2332010/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2336391/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2338251/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2338254/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2341484/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2341487/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2344782/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2349519/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2355531/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2355543/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2359987/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2362457/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2364035/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2367199/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2629526/Kleiner_Perkins_Caufield___Byers> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2295691/Investment_Aphelion_Capital_California_Technology_Ventures_Clear_Catheter_Systems_Research_Corporation_Technologies_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-01-04T12:39:29+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Clear Catheter Systems has closed its first institutional round of financing." ;
    ns1:documentTitle "Clear Catheter nabs $4M in first round of financing; Uptake raises $35M to develop emphysema tech;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/clear-catheter-nabs-4m-first-round-financing-uptake-raises-35m-to-develop-emphysema> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2295691/Clear_Catheter_Systems> ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "U.S." .

<https://1145.am/db/2337826/Seed_Investment_Comprehend_Systems_Crosslink_Capital_Garry_Tan_Palo_Alto_Calif_Quotidian_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-11-12T10:30:47+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Comprehend Systems Secures $ 1.2MM in Seed Funding.",
        "PALO ALTO, Calif.- (EON: Enhanced Online News) -Driven by increasing demand from drug and medical device developers for cost-effective and user-friendly data analytics tools, Comprehend Systems, Inc. closed $ 1.2 million in seed round funding to support further development of Comprehend ClinicalTM, its clinical data visualization and analytics software." ;
    ns1:documentTitle "Comprehend Systems Secures $1.2MM in Seed Funding Leading VC and Angel Investors Back Growing Clinical Data Visualization" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/comprehend-systems-secures-1-2mm-seed-funding-leading-vc-and-angel-investors-back-growing> ;
    ns1:foundName "Funding",
        "funding" ;
    ns1:name "Funding",
        "funding" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2337826/Comprehend_Systems>,
        <https://1145.am/db/2337826/Palo_Alto_Calif> ;
    ns1:targetDetails "Seed",
        "seed",
        "seed round" ;
    ns1:valueRaw "$ 1.2 million",
        "$ 1.2MM" ;
    ns1:whereGeoName "Time" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3134627/about.rdf> ;
    ns1:whereRaw "Eastern Time" .

<https://1145.am/db/2338625/Series_A_Investment_Allena_Pharmaceuticals_Bessemer_Venture_Partners_Frazier_Healthcare_Third_Rock_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-11-16T11:51:24+00:00"^^xsd:dateTime ;
    ns1:documentExtract "- November 16, 2011 - Allena Pharmaceuticals, Inc., a company developing and commercializing innovative non-systemic oral protein therapeutics, today announced that it has secured $ 15 million in Series A venture capital financing.",
        "Allena Pharmaceuticals Launches with $ 15 Million Series A Round." ;
    ns1:documentTitle "Allena Pharmaceuticals Launches with $15 Million Series A Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/allena-pharmaceuticals-launches-15-million-series-a-round> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2338625/Allena_Pharmaceuticals> ;
    ns1:targetDetails "Series A",
        "venture capital" ;
    ns1:valueRaw "$ 15 Million",
        "$ 15 million" ;
    ns1:when "2011-11-16T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "November 16, 2011" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2339384/Vascular_Magnetics_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Philadelphia" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4560349/about.rdf> ;
    ns1:basedInHighRaw "PHILADELPHIA" ;
    ns1:description "disease" ;
    ns1:documentDate "2012-02-22T13:14:12+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vascular Magnetics Raises $7 Million in Series A Financing to Advance Magnetically Targeted Drug Delivery System for Peripheral Artery Disease" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vascular-magnetics-raises-7-million-series-a-financing-to-advance-magnetically-targeted-1> ;
    ns1:foundName "Vascular Magnetics",
        "Vascular Magnetics, Inc." ;
    ns1:name "Vascular Magnetics",
        "Vascular Magnetics, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2340211/Vascular_Magnetics_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2296656/Vascular_Magnetics>,
        <https://1145.am/db/2339395/Vascular_Magnetics_Inc>,
        <https://1145.am/db/2340208/Vascular_Magnetics>,
        <https://1145.am/db/2569578/Vascular_Magnetics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339395/Vascular_Magnetics_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Philadelphia" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4560349/about.rdf> ;
    ns1:basedInHighRaw "PHILADELPHIA" ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2012-02-22T13:49:24+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vascular Magnetics Raises $7 Million in Series A Financing to Advance Magnetically Targeted Drug Delivery System for PAD" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vascular-magnetics-raises-7-million-series-a-financing-to-advance-magnetically-targeted-0> ;
    ns1:foundName "-Vascular Magnetics, Inc.",
        "Vascular Magnetics",
        "Vascular Magnetics, Inc." ;
    ns1:name "Vascular Magnetics",
        "Vascular Magnetics, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2569578/Vascular_Magnetics> ;
    ns1:sameAsMedium <https://1145.am/db/2296656/Vascular_Magnetics>,
        <https://1145.am/db/2339384/Vascular_Magnetics_Inc>,
        <https://1145.am/db/2340208/Vascular_Magnetics>,
        <https://1145.am/db/2340211/Vascular_Magnetics_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340211/Vascular_Magnetics_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Philadelphia" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4560349/about.rdf> ;
    ns1:basedInHighRaw "PHILADELPHIA" ;
    ns1:description "disease" ;
    ns1:documentDate "2012-02-22T17:03:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vascular Magnetics Raises $7 Million in Series A Financing to Advance Magnetically Targeted Drug Delivery System for Peripheral Artery Disease" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vascular-magnetics-raises-7-million-series-a-financing-to-advance-magnetically-targeted> ;
    ns1:foundName "Vascular Magnetics",
        "Vascular Magnetics, Inc." ;
    ns1:name "Vascular Magnetics",
        "Vascular Magnetics, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2339384/Vascular_Magnetics_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2296656/Vascular_Magnetics>,
        <https://1145.am/db/2339395/Vascular_Magnetics_Inc>,
        <https://1145.am/db/2340208/Vascular_Magnetics>,
        <https://1145.am/db/2569578/Vascular_Magnetics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341100/Biozone_Pharmaceuticals_Inc> a org:Organization ;
    ns1:basedInLowRaw "MIAMI" ;
    ns1:description "Pharmaceuticals",
        "pharmaceuticals" ;
    ns1:documentDate "2012-02-27T21:38:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "OPKO Invests in BioZone Pharmaceuticals, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/opko-invests-biozone-pharmaceuticals-inc> ;
    ns1:foundName ", BZNE",
        "BZNE",
        "BioZone",
        "BioZone Pharmaceuticals, Inc",
        "BioZone Pharmaceuticals, Inc.",
        "BioZone Pharmaceuticals, Inc.," ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "BioZone Pharmaceuticals",
        "BioZone Pharmaceuticals, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/1143136/Innovation_Pharmaceuticals>,
        <https://1145.am/db/1155387/Applied_Therapeutics>,
        <https://1145.am/db/1155566/Applied_Therapeutics>,
        <https://1145.am/db/1156304/Dem_Biopharma_Inc>,
        <https://1145.am/db/128975/Md_Biosciences>,
        <https://1145.am/db/1339426/Innovation_Pharmaceuticals>,
        <https://1145.am/db/1340493/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/1341223/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/1533327/Pfm_Health_Sciences>,
        <https://1145.am/db/1533685/Pfm_Health_Sciences>,
        <https://1145.am/db/1586737/Biondvax_Pharmaceuticals_Ltd>,
        <https://1145.am/db/1595800/Biondvax_Pharmaceuticals_Ltd>,
        <https://1145.am/db/1649045/Sfj_Pharmaceuticals>,
        <https://1145.am/db/1926551/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/2045154/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/2049027/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/2113074/Lib_Therapeutics_Inc>,
        <https://1145.am/db/2114624/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/2302655/Biotie_Therapies_Inc>,
        <https://1145.am/db/2303707/Laureate_Pharma>,
        <https://1145.am/db/2304092/Ym_Biosciences>,
        <https://1145.am/db/2304888/Ym_Biosciences>,
        <https://1145.am/db/2306597/Oxford_Biomedica>,
        <https://1145.am/db/2307766/Actient_Pharmaceuticals>,
        <https://1145.am/db/2313272/Dow_Pharmaceutical_Sciences>,
        <https://1145.am/db/2315609/Dor_Biopharma>,
        <https://1145.am/db/2319004/Oxford_Biosciences>,
        <https://1145.am/db/2319239/Osi_Pharmaceuticals>,
        <https://1145.am/db/2327418/Arca_Biopharma>,
        <https://1145.am/db/2330973/Ym_Biosciences>,
        <https://1145.am/db/2336730/Omni_Bio_Pharmaceutical>,
        <https://1145.am/db/2343019/Galmed_Pharma>,
        <https://1145.am/db/2344632/Arca_Biopharma>,
        <https://1145.am/db/2347051/Apricus_Biosciences_Inc>,
        <https://1145.am/db/2349888/Apricus_Biosciences>,
        <https://1145.am/db/2351386/Biondvax_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2353371/Biotie_Therapies>,
        <https://1145.am/db/2355416/Biondvax_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2355692/Sfj_Pharmaceuticals>,
        <https://1145.am/db/2356410/Ym_Biosciences_Inc>,
        <https://1145.am/db/2358147/Omni_Bio_Pharmaceutical_Inc>,
        <https://1145.am/db/2358157/Omni_Bio_Pharmaceutical_Inc>,
        <https://1145.am/db/2359367/Apricus_Biosciences>,
        <https://1145.am/db/2361597/Biotie_Therapies_Corp>,
        <https://1145.am/db/2362959/Oxford_Biomedica>,
        <https://1145.am/db/2365677/Laureate_Pharma>,
        <https://1145.am/db/2365685/Laureate_Pharma>,
        <https://1145.am/db/2368379/Forum_Pharmaceuticals_Inc>,
        <https://1145.am/db/2369308/Biotie_Therapies_Corp>,
        <https://1145.am/db/2371216/Biothera_Pharmaceuticals>,
        <https://1145.am/db/2371281/Regen_Biopharma_Inc>,
        <https://1145.am/db/2537228/Laureate_Pharma>,
        <https://1145.am/db/2543721/Oxford_Biomedica>,
        <https://1145.am/db/2558456/Cti_Biopharma>,
        <https://1145.am/db/2583439/Biozone_Pharmaceuticals>,
        <https://1145.am/db/502710/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/504033/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/505547/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/507962/Brii_Biosciences_Limited>,
        <https://1145.am/db/668452/Fore_Biotherapeutics>,
        <https://1145.am/db/669678/Fore_Biotherapeutics>,
        <https://1145.am/db/734706/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/800276/Diamedica_Therapeutics_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347389/Clarus_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:documentDate "2011-12-13T13:29:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/catabasis-pharmaceuticals-announces-8-million-series-a-extension-financing> ;
    ns1:foundName "Clarus Ventures" ;
    ns1:investor <https://1145.am/db/2347389/Series_A_Investment_Advanced_Technology_Ventures_Catabasis_Pharmaceuticals_Clarus_Ventures_Medimmune_Ventures_Sv_Life_Sciences_Completed> ;
    ns1:name "Clarus Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2289229/Clarus_Ventures>,
        <https://1145.am/db/2302292/Clarus_Ventures>,
        <https://1145.am/db/2302994/Clarus_Ventures>,
        <https://1145.am/db/2303563/Clarus_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304261/Clarus_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2306754/Clarus_Ventures>,
        <https://1145.am/db/2311011/Clarus_Ventures>,
        <https://1145.am/db/2311595/Clarus_Ventures>,
        <https://1145.am/db/2312277/Clarus_Ventures>,
        <https://1145.am/db/2312288/Clarus_Ventures>,
        <https://1145.am/db/2312945/Clarus_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2315059/Clarus_Ventures>,
        <https://1145.am/db/2317145/Clarus_Ventures>,
        <https://1145.am/db/2318851/Clarus_Ventures>,
        <https://1145.am/db/2321137/Clarus_Ventures>,
        <https://1145.am/db/2324936/Clarus_Ventures>,
        <https://1145.am/db/2325880/Clarus_Ventures>,
        <https://1145.am/db/2327405/Clarus_Ventures>,
        <https://1145.am/db/2329773/Clarus_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335928/Clarus_Ventures>,
        <https://1145.am/db/2336313/Clarus_Ventures>,
        <https://1145.am/db/2336944/Clarus_Ventures>,
        <https://1145.am/db/2341003/Clarus_Ventures>,
        <https://1145.am/db/2341600/Clarus_Ventures>,
        <https://1145.am/db/2342624/Clarus_Ventures>,
        <https://1145.am/db/2342629/Clarus_Ventures_Llc>,
        <https://1145.am/db/2343722/Clarus_Ventures>,
        <https://1145.am/db/2343725/Clarus_Ventures>,
        <https://1145.am/db/2343737/Clarus_Ventures>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2349120/Clarus_Ventures>,
        <https://1145.am/db/2349717/Clarus_Ventures>,
        <https://1145.am/db/2349722/Clarus_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2351958/Clarus_Ventures>,
        <https://1145.am/db/2352808/Clarus_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2353771/Clarus_Ventures>,
        <https://1145.am/db/2353789/Clarus_Ventures>,
        <https://1145.am/db/2354295/Clarus_Ventures>,
        <https://1145.am/db/2355435/Clarus_Ventures>,
        <https://1145.am/db/2356084/Clarus_Ventures>,
        <https://1145.am/db/2357858/Clarus_Ventures>,
        <https://1145.am/db/2359654/Clarus_Ventures>,
        <https://1145.am/db/2360756/Clarus_Ventures>,
        <https://1145.am/db/2360758/Clarus_Ventures>,
        <https://1145.am/db/2364468/Clarus_Ventures>,
        <https://1145.am/db/2364471/Clarus_Ventures>,
        <https://1145.am/db/2365171/Clarus_Ventures>,
        <https://1145.am/db/2365184/Clarus_Ventures>,
        <https://1145.am/db/2366049/Clarus_Ventures>,
        <https://1145.am/db/2366055/Clarus_Ventures>,
        <https://1145.am/db/2368297/Clarus_Ventures>,
        <https://1145.am/db/2370240/Clarus_Ventures>,
        <https://1145.am/db/2584561/Clarus_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2349519/Kleiner_Perkins_Caufield___Byers> a org:Organization ;
    ns1:basedInHighGeoName "South San Francisco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5397765/about.rdf> ;
    ns1:basedInHighRaw "SOUTH SAN FRANCISCO" ;
    ns1:description "The Series C investment round was led by aeris CAPITAL AG and was joined" ;
    ns1:documentDate "2011-09-14T11:36:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Crescendo Bioscience Secures $56 Million in Funding to Expand Development and Commercialization of Personalized Diagnostics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crescendo-bioscience-secures-56-million-funding-to-expand-development-and-commercialization> ;
    ns1:foundName "Kleiner Perkins Caufield & Byers" ;
    ns1:investor <https://1145.am/db/2349519/Equity_Investment_Crescendo_Bioscience_Kleiner_Perkins_Caufield___Byers_Mohr_Davidow_Ventures_Myriad_Genetics_Aeris_Capital_Ag_Completed> ;
    ns1:name "Kleiner Perkins Caufield & Byers" ;
    ns1:sameAsMedium <https://1145.am/db/1697155/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1709036/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1714786/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1719362/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1792401/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1794049/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1794342/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1795003/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1796259/Kleiner_Perkins_Caufield_Byers>,
        <https://1145.am/db/1798154/Kleiner_Perkins_Caufield_Byers>,
        <https://1145.am/db/1802208/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1802525/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1805986/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1806158/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1808735/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1814186/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1816928/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1821378/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1824878/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1825866/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1826126/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1827381/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1830311/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1835647/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1838965/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1839326/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1840650/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1844931/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1845205/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1847021/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1849969/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1850246/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1850293/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1850642/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1852048/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1852697/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1853217/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1853292/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/1854098/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1856424/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1858545/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1858646/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1859219/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1860406/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1860644/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1861870/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1864650/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1865436/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1868593/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1868958/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1870791/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1871768/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1872947/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/1872971/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1874419/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1876759/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1881582/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1883859/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1890121/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1891856/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1892105/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1892746/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1895292/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1906922/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1907771/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1915400/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2227037/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2230414/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2288899/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2289585/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2291836/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2293308/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2300306/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2300337/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2305254/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/2305256/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2310485/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2311540/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2312700/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2313567/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2316038/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2317750/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2317753/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2321949/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2325726/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/2326444/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2326926/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/2331026/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2331047/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2332010/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2336391/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2338251/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2338254/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2341484/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2341487/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2344782/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2355531/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2355543/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2359987/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2362457/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2364035/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2367199/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2629526/Kleiner_Perkins_Caufield___Byers> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350491/Investment_Aberdare_Ventures_Aviir_Inc_Bay_City_Capital_New_Leaf_Venture_Partners_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-12-20T01:20:37+00:00"^^xsd:dateTime ;
    ns1:documentExtract "IRVINE, Calif.- (BUSINESS WIRE) - Aviir, Inc., a biotechnology company specializing in cardiac disease assessment, announced that it entered into an agreement with multiple investors to raise up to $ 30 million in the company's latest financing round." ;
    ns1:documentTitle "Aviir Announces Agreement to Raise up to $30 Million in Latest Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aviir-announces-agreement-to-raise-up-to-30-million-latest-financing-round> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2350491/Aviir_Inc> ;
    ns1:valueRaw "up to $ 30 million" ;
    ns1:whereGeoName "California" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5332921/about.rdf> ;
    ns1:whereRaw "California" .

<https://1145.am/db/2353588/Tpg_Biotech> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-01-04T13:03:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/elevation-pharmaceuticals-completes-30-million-series-b-financing-to-advance-aerosol-copd-1> ;
    ns1:foundName "TPG Biotech" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2353588/Series_B_Investment_Canaan_Partners_Care_Capital_Elevation_Pharmaceuticals_Mesa_Verde_Venture_Partners_Novo_Ventures_Tpg_Biotech_Completed> ;
    ns1:name "TPG Biotech" ;
    ns1:sameAsHigh <https://1145.am/db/1156401/Artios_Pharma_Limited>,
        <https://1145.am/db/1604485/Aeon_Biopharma>,
        <https://1145.am/db/1606180/Aeon_Biopharma>,
        <https://1145.am/db/2065968/Aeon_Biopharma>,
        <https://1145.am/db/2153279/Artios_Pharma>,
        <https://1145.am/db/2254330/Avecia_Biologics>,
        <https://1145.am/db/2281204/Adarx_Pharmaceuticals>,
        <https://1145.am/db/2290753/Karo_Pharma>,
        <https://1145.am/db/2293662/Artios_Pharma>,
        <https://1145.am/db/2299423/Tpg_Biotech>,
        <https://1145.am/db/2319111/Aeras>,
        <https://1145.am/db/2322526/Genetix_Pharmaceuticals>,
        <https://1145.am/db/2323608/Genetix_Pharmaceuticals>,
        <https://1145.am/db/2339922/Biotech_Investment_Group>,
        <https://1145.am/db/2341380/Alexion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342894/Savara_Pharmaceuticals>,
        <https://1145.am/db/2345996/Alphacore_Pharma>,
        <https://1145.am/db/2347301/Aeras>,
        <https://1145.am/db/2349489/Alexza_Pharma>,
        <https://1145.am/db/2349856/Allena_Pharmaceuticals>,
        <https://1145.am/db/2351519/Allena_Pharmaceuticals>,
        <https://1145.am/db/2353608/Tpg_Biotech>,
        <https://1145.am/db/2355318/Aeras>,
        <https://1145.am/db/2356408/Acadia_Pharmaceuticals>,
        <https://1145.am/db/2360526/Sideris_Pharmaceuticals>,
        <https://1145.am/db/2366977/Inspire_Pharmaceuticals>,
        <https://1145.am/db/2368346/Aeras>,
        <https://1145.am/db/2369363/Akari_Therapeutics>,
        <https://1145.am/db/2541473/Elona_Biotechnologies>,
        <https://1145.am/db/2545610/Altus_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/1863540/Tpg_Biotech>,
        <https://1145.am/db/1867543/Tpg_Biotech>,
        <https://1145.am/db/2300337/Tpg_Biotech>,
        <https://1145.am/db/2302333/Tpg_Biotech>,
        <https://1145.am/db/2308700/Tpg_Biotech>,
        <https://1145.am/db/2336221/Tpg_Biotech>,
        <https://1145.am/db/2342557/Tpg_Biotech>,
        <https://1145.am/db/2342558/Tpg_Biotech>,
        <https://1145.am/db/2342724/Tpg_Biotech>,
        <https://1145.am/db/2344678/Tpg_Biotech>,
        <https://1145.am/db/2350044/Tpg_Biotech>,
        <https://1145.am/db/2351897/Tpg_Biotech>,
        <https://1145.am/db/2352508/Tpg_Biotech>,
        <https://1145.am/db/2353771/Tpg_Biotech>,
        <https://1145.am/db/2353789/Tpg_Biotech>,
        <https://1145.am/db/2354537/Tpg_Biotech>,
        <https://1145.am/db/2354899/Tpg_Biotech>,
        <https://1145.am/db/2354903/Tpg_Biotech>,
        <https://1145.am/db/2358515/Tpg_Biotech>,
        <https://1145.am/db/2358888/Tpg_Biotech>,
        <https://1145.am/db/2359562/Tpg_Biotech>,
        <https://1145.am/db/2362457/Tpg_Biotech>,
        <https://1145.am/db/2364035/Tpg_Biotech>,
        <https://1145.am/db/2365868/Tpg_Biotech>,
        <https://1145.am/db/2368351/Tpg_Biotech>,
        <https://1145.am/db/316299/Tpg_Biotech> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353608/Tpg_Biotech> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-01-04T16:01:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/elevation-pharmaceuticals-completes-30-million-series-b-financing-to-advance-aerosol-copd> ;
    ns1:foundName "TPG Biotech" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2353608/Series_B_Investment_Canaan_Partners_Care_Capital_Elevation_Pharmaceuticals_Mesa_Verde_Venture_Partners_Novo_Ventures_Tpg_Biotech_Completed> ;
    ns1:name "TPG Biotech" ;
    ns1:sameAsHigh <https://1145.am/db/1156401/Artios_Pharma_Limited>,
        <https://1145.am/db/1604485/Aeon_Biopharma>,
        <https://1145.am/db/1606180/Aeon_Biopharma>,
        <https://1145.am/db/2065968/Aeon_Biopharma>,
        <https://1145.am/db/2153279/Artios_Pharma>,
        <https://1145.am/db/2254330/Avecia_Biologics>,
        <https://1145.am/db/2281204/Adarx_Pharmaceuticals>,
        <https://1145.am/db/2290753/Karo_Pharma>,
        <https://1145.am/db/2293662/Artios_Pharma>,
        <https://1145.am/db/2299423/Tpg_Biotech>,
        <https://1145.am/db/2319111/Aeras>,
        <https://1145.am/db/2322526/Genetix_Pharmaceuticals>,
        <https://1145.am/db/2323608/Genetix_Pharmaceuticals>,
        <https://1145.am/db/2339922/Biotech_Investment_Group>,
        <https://1145.am/db/2341380/Alexion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342894/Savara_Pharmaceuticals>,
        <https://1145.am/db/2345996/Alphacore_Pharma>,
        <https://1145.am/db/2347301/Aeras>,
        <https://1145.am/db/2349489/Alexza_Pharma>,
        <https://1145.am/db/2349856/Allena_Pharmaceuticals>,
        <https://1145.am/db/2351519/Allena_Pharmaceuticals>,
        <https://1145.am/db/2353588/Tpg_Biotech>,
        <https://1145.am/db/2355318/Aeras>,
        <https://1145.am/db/2356408/Acadia_Pharmaceuticals>,
        <https://1145.am/db/2360526/Sideris_Pharmaceuticals>,
        <https://1145.am/db/2366977/Inspire_Pharmaceuticals>,
        <https://1145.am/db/2368346/Aeras>,
        <https://1145.am/db/2369363/Akari_Therapeutics>,
        <https://1145.am/db/2541473/Elona_Biotechnologies>,
        <https://1145.am/db/2545610/Altus_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/1863540/Tpg_Biotech>,
        <https://1145.am/db/1867543/Tpg_Biotech>,
        <https://1145.am/db/2300337/Tpg_Biotech>,
        <https://1145.am/db/2302333/Tpg_Biotech>,
        <https://1145.am/db/2308700/Tpg_Biotech>,
        <https://1145.am/db/2336221/Tpg_Biotech>,
        <https://1145.am/db/2342557/Tpg_Biotech>,
        <https://1145.am/db/2342558/Tpg_Biotech>,
        <https://1145.am/db/2342724/Tpg_Biotech>,
        <https://1145.am/db/2344678/Tpg_Biotech>,
        <https://1145.am/db/2350044/Tpg_Biotech>,
        <https://1145.am/db/2351897/Tpg_Biotech>,
        <https://1145.am/db/2352508/Tpg_Biotech>,
        <https://1145.am/db/2353771/Tpg_Biotech>,
        <https://1145.am/db/2353789/Tpg_Biotech>,
        <https://1145.am/db/2354537/Tpg_Biotech>,
        <https://1145.am/db/2354899/Tpg_Biotech>,
        <https://1145.am/db/2354903/Tpg_Biotech>,
        <https://1145.am/db/2358515/Tpg_Biotech>,
        <https://1145.am/db/2358888/Tpg_Biotech>,
        <https://1145.am/db/2359562/Tpg_Biotech>,
        <https://1145.am/db/2362457/Tpg_Biotech>,
        <https://1145.am/db/2364035/Tpg_Biotech>,
        <https://1145.am/db/2365868/Tpg_Biotech>,
        <https://1145.am/db/2368351/Tpg_Biotech>,
        <https://1145.am/db/316299/Tpg_Biotech> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353646/Afexa_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-09-26T16:11:31+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Valeant has bumped its bid for Afexa after a hostile suitor, Paladin Labs, offered to sweeten its own offer.",
        "Valeant says it will pay $ 85.4 million for Afexa in an effort aimed at adding Cold-FX to its list of marketed drugs." ;
    ns1:documentTitle "Valeant hikes bid for Afexa; Cleveland BioLabs launches preclin cancer drug subsidiary; Mela diagnostic on path to an approval;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/valeant-hikes-bid-for-afexa-cleveland-biolabs-launches-preclin-cancer-drug-subsidiary-mela> ;
    ns1:foundName "pay",
        "setting" ;
    ns1:name "pay",
        "setting" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened",
        "stopped" ;
    ns1:target <https://1145.am/db/2353646/Afexa> ;
    ns1:targetName "Afexa" ;
    ns1:valueRaw "$ 85.4 million" .

<https://1145.am/db/2355712/Investment_Cardio3biosciences_European_Commission_Seventh_Framework_Programme_Walloon_Region_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-01-10T11:20:38+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The Belgian biotechnology company, Cardio3BioSciences, a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases, today announces it has secured a total of €3.1 million in non-dilutive funding from the Walloon Region and the European Commission's Seventh Framework Programme (FP7) ." ;
    ns1:documentTitle "Cardio3 BioSciences Secures Additional €3.1 Million in Non-dilutive Funding From the Walloon Region and the European Commission" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cardio3-biosciences-secures-additional-%E2%82%AC3-1-million-non-dilutive-funding-from-walloon> ;
    ns1:foundName "funding" ;
    ns1:name "funding" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2355712/Cardio3biosciences> ;
    ns1:valueRaw "€3.1 million" ;
    ns1:whereGeoName "Kingdom of Belgium" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2802361/about.rdf> ;
    ns1:whereRaw "Belgium" .

<https://1145.am/db/2357799/Investment_Crystalgenomics_Inc_Korea_Seoul_Life_Science_Fund_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-01-13T16:09:51+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CrystalGenomics Scores KRW 3 Billion in Strategic Equity Investment from KSLSF, a Life Science Fund Backed by the City of Seoul and the Ministry of Knowledge Economy.",
        "PANGYO, South Korea, Jan. 13, 2012 /PRNewswire/ - CrystalGenomics, Inc., a clinical stage biopharmaceutical company headquartered in Korea, has just announced that it has successfully raised KRW 3 Billion (USD 2.6 Million) in a private placement to the Korea Seoul Life Science Fund (KSLSF).",
        "This is the third time within the past month that CrystalGenomics has raised capital following a KRW 10 Billion bond issuance to KDB Capital, a major financial institution in Korea on December 6th and another KRW 10 Billion in bonds issued to Tube Investment, a local investment firm on December 22nd." ;
    ns1:documentTitle "CrystalGenomics Scores KRW 3 Billion in Strategic Equity Investment from KSLSF, a Life Science Fund Backed by the City of Seoul" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crystalgenomics-scores-krw-3-billion-strategic-equity-investment-from-kslsf-a-life-science> ;
    ns1:foundName "Investment",
        "issuance",
        "private placement",
        "raised" ;
    ns1:name "Investment",
        "issuance",
        "private placement",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2357799/Crystalgenomics_Inc>,
        <https://1145.am/db/2357799/KSLSF> ;
    ns1:targetDetails "Strategic Equity" ;
    ns1:valueRaw "KRW 10 Billion",
        "KRW 3 Billion",
        "USD 2.6 Million" ;
    ns1:when "2012-01-13T00:00:00"^^xsd:dateTime,
        "2012-12-06T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "December 6th",
        "Jan. 13, 2012" ;
    ns1:whereGeoName "Seoul" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1835848/about.rdf> ;
    ns1:whereRaw "Seoul" .

<https://1145.am/db/2357858/Clarus_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:documentDate "2011-10-11T13:15:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cleave-biosciences-raises-42-million-series-a-financing-for-novel-cancer-therapies> ;
    ns1:foundName "Clarus Ventures" ;
    ns1:investor <https://1145.am/db/2357858/Series_A_Investment_5am_Ventures_Astellas_Venture_Management_Clarus_Ventures_Cleave_Biosciences_Orbimed_Advisors_Us_Venture_Partners_Completed> ;
    ns1:name "Clarus Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2289229/Clarus_Ventures>,
        <https://1145.am/db/2302292/Clarus_Ventures>,
        <https://1145.am/db/2302994/Clarus_Ventures>,
        <https://1145.am/db/2303563/Clarus_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304261/Clarus_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2306754/Clarus_Ventures>,
        <https://1145.am/db/2311011/Clarus_Ventures>,
        <https://1145.am/db/2311595/Clarus_Ventures>,
        <https://1145.am/db/2312277/Clarus_Ventures>,
        <https://1145.am/db/2312288/Clarus_Ventures>,
        <https://1145.am/db/2312945/Clarus_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2315059/Clarus_Ventures>,
        <https://1145.am/db/2317145/Clarus_Ventures>,
        <https://1145.am/db/2318851/Clarus_Ventures>,
        <https://1145.am/db/2321137/Clarus_Ventures>,
        <https://1145.am/db/2324936/Clarus_Ventures>,
        <https://1145.am/db/2325880/Clarus_Ventures>,
        <https://1145.am/db/2327405/Clarus_Ventures>,
        <https://1145.am/db/2329773/Clarus_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335928/Clarus_Ventures>,
        <https://1145.am/db/2336313/Clarus_Ventures>,
        <https://1145.am/db/2336944/Clarus_Ventures>,
        <https://1145.am/db/2341003/Clarus_Ventures>,
        <https://1145.am/db/2341600/Clarus_Ventures>,
        <https://1145.am/db/2342624/Clarus_Ventures>,
        <https://1145.am/db/2342629/Clarus_Ventures_Llc>,
        <https://1145.am/db/2343722/Clarus_Ventures>,
        <https://1145.am/db/2343725/Clarus_Ventures>,
        <https://1145.am/db/2343737/Clarus_Ventures>,
        <https://1145.am/db/2347389/Clarus_Ventures>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2349120/Clarus_Ventures>,
        <https://1145.am/db/2349717/Clarus_Ventures>,
        <https://1145.am/db/2349722/Clarus_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2351958/Clarus_Ventures>,
        <https://1145.am/db/2352808/Clarus_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2353771/Clarus_Ventures>,
        <https://1145.am/db/2353789/Clarus_Ventures>,
        <https://1145.am/db/2354295/Clarus_Ventures>,
        <https://1145.am/db/2355435/Clarus_Ventures>,
        <https://1145.am/db/2356084/Clarus_Ventures>,
        <https://1145.am/db/2359654/Clarus_Ventures>,
        <https://1145.am/db/2360756/Clarus_Ventures>,
        <https://1145.am/db/2360758/Clarus_Ventures>,
        <https://1145.am/db/2364468/Clarus_Ventures>,
        <https://1145.am/db/2364471/Clarus_Ventures>,
        <https://1145.am/db/2365171/Clarus_Ventures>,
        <https://1145.am/db/2365184/Clarus_Ventures>,
        <https://1145.am/db/2366049/Clarus_Ventures>,
        <https://1145.am/db/2366055/Clarus_Ventures>,
        <https://1145.am/db/2368297/Clarus_Ventures>,
        <https://1145.am/db/2370240/Clarus_Ventures>,
        <https://1145.am/db/2584561/Clarus_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358883/Investment_Carticept_Medical_Domain_Associates_New_Enterprise_Associates_Sonosite_Inc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-01-19T16:26:58+00:00"^^xsd:dateTime ;
    ns1:documentExtract "ALPHARETTA, Ga.- (BUSINESS WIRE) -Carticept Medical, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced that it has completed a $ 10 million round of financing, led by existing investors Domain Associates, New Enterprise Associates and SonoSite, Inc.",
        "Carticept MedicalTM Closes $ 10 Million Series C Financing Round.",
        "This latest round of financing increases the venture capital investment in Carticept to a combined total of $ 53 million." ;
    ns1:documentTitle "Carticept Medical Closes $10 Million Series C Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/carticept-medical-closes-10-million-series-c-financing-round> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2358883/Carticept_Medical> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 10 Million",
        "$ 10 million",
        "$ 53 million" ;
    ns1:whereGeoName "Alpharetta" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4179574/about.rdf> ;
    ns1:whereRaw "ALPHARETTA" .

<https://1145.am/db/2358888/Tpg_Biotech> a org:Organization ;
    ns1:description "biotechnology" ;
    ns1:documentDate "2011-10-12T14:14:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DNAnexus Secures $15 Million Funding Led by Google Ventures and TPG Biotech" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dnanexus-secures-15-million-funding-led-by-google-ventures-and-tpg-biotech> ;
    ns1:foundName "TPG Biotech" ;
    ns1:investor <https://1145.am/db/2358888/Investment_Dnanexus_Felicis_Ventures_First_Round_Capital_Google_Ventures_K9_Ventures_Softtech_Vc_Tpg_Biotech_Completed> ;
    ns1:name "TPG Biotech" ;
    ns1:sameAsHigh <https://1145.am/db/2359562/Tpg_Biotech> ;
    ns1:sameAsMedium <https://1145.am/db/1863540/Tpg_Biotech>,
        <https://1145.am/db/1867543/Tpg_Biotech>,
        <https://1145.am/db/2299423/Tpg_Biotech>,
        <https://1145.am/db/2300337/Tpg_Biotech>,
        <https://1145.am/db/2302333/Tpg_Biotech>,
        <https://1145.am/db/2308700/Tpg_Biotech>,
        <https://1145.am/db/2336221/Tpg_Biotech>,
        <https://1145.am/db/2342557/Tpg_Biotech>,
        <https://1145.am/db/2342558/Tpg_Biotech>,
        <https://1145.am/db/2342724/Tpg_Biotech>,
        <https://1145.am/db/2344678/Tpg_Biotech>,
        <https://1145.am/db/2350044/Tpg_Biotech>,
        <https://1145.am/db/2351897/Tpg_Biotech>,
        <https://1145.am/db/2352508/Tpg_Biotech>,
        <https://1145.am/db/2353588/Tpg_Biotech>,
        <https://1145.am/db/2353608/Tpg_Biotech>,
        <https://1145.am/db/2353771/Tpg_Biotech>,
        <https://1145.am/db/2353789/Tpg_Biotech>,
        <https://1145.am/db/2354537/Tpg_Biotech>,
        <https://1145.am/db/2354899/Tpg_Biotech>,
        <https://1145.am/db/2354903/Tpg_Biotech>,
        <https://1145.am/db/2358515/Tpg_Biotech>,
        <https://1145.am/db/2362457/Tpg_Biotech>,
        <https://1145.am/db/2364035/Tpg_Biotech>,
        <https://1145.am/db/2365868/Tpg_Biotech>,
        <https://1145.am/db/2368351/Tpg_Biotech>,
        <https://1145.am/db/316299/Tpg_Biotech> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359987/Kleiner_Perkins_Caufield___Byers> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-10-18T12:15:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Foundation Medicine Closes Expanded Series A Financing Totaling $33.5 Million; Kleiner Perkins Caufield & Byers and Google" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/foundation-medicine-closes-expanded-series-a-financing-totaling-33-5-million-kleiner> ;
    ns1:foundName "Kleiner Perkins Caufield & Byers" ;
    ns1:investor <https://1145.am/db/2359987/Series_A_Investment_Foundation_Medicine_Google_Ventures_Kleiner_Perkins_Caufield___Byers_Third_Rock_Ventures_Completed> ;
    ns1:name "Kleiner Perkins Caufield & Byers" ;
    ns1:sameAsHigh <https://1145.am/db/1006794/Elevate_Ventures>,
        <https://1145.am/db/1117048/Studio_Vc>,
        <https://1145.am/db/1140521/Elevation_Capital>,
        <https://1145.am/db/1213119/Fin_Capital>,
        <https://1145.am/db/1215930/Enavate_Sciences>,
        <https://1145.am/db/1219982/Thirty_Five_Ventures>,
        <https://1145.am/db/1230379/Advantage_Capital>,
        <https://1145.am/db/1307987/Venture_Highway>,
        <https://1145.am/db/1352420/Necessary_Ventures>,
        <https://1145.am/db/1504977/Advantage_Capital>,
        <https://1145.am/db/1668144/Applied_Ventures>,
        <https://1145.am/db/1688359/Necessary_Ventures>,
        <https://1145.am/db/1698464/Cathay_Innovation>,
        <https://1145.am/db/1702554/Main_Sequence_Ventures>,
        <https://1145.am/db/1719362/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1724979/Institutional_Venture_Partners>,
        <https://1145.am/db/1730174/Incubic_Venture_Capital>,
        <https://1145.am/db/1741725/Discovery_Ventures>,
        <https://1145.am/db/1746456/Active_Capital>,
        <https://1145.am/db/1747943/Firstround_Capital>,
        <https://1145.am/db/1749347/Main_Sequence_Ventures>,
        <https://1145.am/db/1752158/Hbcuvc>,
        <https://1145.am/db/1753744/Elevate_Ventures>,
        <https://1145.am/db/1754080/Cathay_Innovation>,
        <https://1145.am/db/1754580/Elevation_Capital>,
        <https://1145.am/db/1754765/Inventure>,
        <https://1145.am/db/1755479/Seed_Capital>,
        <https://1145.am/db/1760794/Appworks>,
        <https://1145.am/db/1761999/Access_Technology_Ventures>,
        <https://1145.am/db/1764278/Okta_Ventures>,
        <https://1145.am/db/1768909/Venture_Highway>,
        <https://1145.am/db/1769525/Seed_Capital>,
        <https://1145.am/db/1800466/Inventure>,
        <https://1145.am/db/1806610/Institutional_Venture_Partners>,
        <https://1145.am/db/1806644/Institutional_Venture_Partners>,
        <https://1145.am/db/1808735/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1809854/Institutional_Venture_Partners>,
        <https://1145.am/db/1810769/Institutional_Venture_Partners>,
        <https://1145.am/db/1811872/Seedcamp>,
        <https://1145.am/db/1821378/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1823230/Innovative_Venture_Fund_Investment>,
        <https://1145.am/db/1825866/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1826126/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1828008/Institutional_Venture_Partners>,
        <https://1145.am/db/1830014/Institutional_Venture_Partners>,
        <https://1145.am/db/1831764/Institutional_Venture_Partners>,
        <https://1145.am/db/1836984/Launch_Capital>,
        <https://1145.am/db/1844931/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1845205/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1849969/Institutional_Venture_Partners>,
        <https://1145.am/db/1849969/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1854098/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1860406/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1860644/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1868593/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1870791/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1872971/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1891856/Institutional_Venture_Partners>,
        <https://1145.am/db/1892105/Institutional_Venture_Partners>,
        <https://1145.am/db/1892105/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1896364/Launch_Capital>,
        <https://1145.am/db/1907771/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1911076/Ata_Ventures>,
        <https://1145.am/db/1932453/Framework_Ventures>,
        <https://1145.am/db/2144387/New_Age_Ventures>,
        <https://1145.am/db/2230414/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/229368/Essence_Ventures>,
        <https://1145.am/db/2305256/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2310485/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2312700/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2313567/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2326444/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2332010/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2339214/Adage_Capital>,
        <https://1145.am/db/2341487/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2347571/Amunix>,
        <https://1145.am/db/2348618/Amunix>,
        <https://1145.am/db/2355531/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2364492/Bioventures>,
        <https://1145.am/db/2369359/Bioventures>,
        <https://1145.am/db/244100/Creative_Ventures>,
        <https://1145.am/db/2629526/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2656715/Institutional_Venture_Partners>,
        <https://1145.am/db/319155/Emergent_Ventures>,
        <https://1145.am/db/430525/Acapital>,
        <https://1145.am/db/449505/Elevate_Ventures>,
        <https://1145.am/db/491609/Emergent_Ventures>,
        <https://1145.am/db/517818/Cathay_Innovation>,
        <https://1145.am/db/626399/Embedded_Ventures>,
        <https://1145.am/db/674609/Main_Sequence_Ventures>,
        <https://1145.am/db/678162/Main_Sequence_Ventures>,
        <https://1145.am/db/696051/Framework_Ventures>,
        <https://1145.am/db/697473/Framework_Ventures>,
        <https://1145.am/db/718563/Creative_Ventures>,
        <https://1145.am/db/724376/Ten_Innovate>,
        <https://1145.am/db/730448/Seed_Capital>,
        <https://1145.am/db/734449/Evolve_Ventures>,
        <https://1145.am/db/751176/Core_Innovationcapital>,
        <https://1145.am/db/768154/Compound_Ventures>,
        <https://1145.am/db/830571/Okta_Ventures>,
        <https://1145.am/db/889658/Propel_Venture>,
        <https://1145.am/db/890529/Embedded_Ventures>,
        <https://1145.am/db/891145/Advantage_Capital>,
        <https://1145.am/db/937210/Cathay_Innovation>,
        <https://1145.am/db/971415/Firstround_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1697155/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1709036/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1714786/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1792401/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1794049/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1794342/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1795003/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1796259/Kleiner_Perkins_Caufield_Byers>,
        <https://1145.am/db/1798154/Kleiner_Perkins_Caufield_Byers>,
        <https://1145.am/db/1802208/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1802525/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1805986/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1806158/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1814186/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1816928/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1824878/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1827381/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1830311/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1835647/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1838965/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1839326/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1840650/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1847021/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1850246/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1850293/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1850642/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1852048/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1852697/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1853217/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1853292/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/1856424/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1858545/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1858646/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1859219/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1861870/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1864650/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1865436/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1868958/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1871768/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1872947/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/1874419/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1876759/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1881582/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1883859/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1890121/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1891856/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1892746/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1895292/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1906922/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1915400/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2227037/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2288899/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2289585/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2291836/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2293308/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2300306/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2300337/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2305254/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/2311540/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2316038/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2317750/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2317753/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2321949/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2325726/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/2326926/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/2331026/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2331047/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2336391/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2338251/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2338254/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2341484/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2344782/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2349519/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2355543/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2362457/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2364035/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2367199/Kleiner_Perkins_Caufield___Byers> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359987/Series_A_Investment_Foundation_Medicine_Google_Ventures_Kleiner_Perkins_Caufield___Byers_Third_Rock_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-10-18T12:15:01+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, Mass., Oct 18, 2011 (BUSINESS WIRE) - Foundation Medicine, Inc., a cancer diagnostics company that aims to bring comprehensive cancer genome analysis to routine care, today announced that the company has closed an expanded Series A financing, bringing the total raised in the round to $ 33.5 million.",
        "Foundation Medicine Closes Expanded Series A Financing Totaling $ 33.5 Million; Kleiner Perkins Caufield & Byers and Google Ventures Join as Investors." ;
    ns1:documentTitle "Foundation Medicine Closes Expanded Series A Financing Totaling $33.5 Million; Kleiner Perkins Caufield & Byers and Google" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/foundation-medicine-closes-expanded-series-a-financing-totaling-33-5-million-kleiner> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2359987/Foundation_Medicine> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 33.5 Million",
        "$ 33.5 million" ;
    ns1:when "2011-10-18T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Oct 18, 2011" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "CAMBRIDGE, Mass" .

<https://1145.am/db/2360006/Series_B_Investment_Prospect_Venture_Partners_Topica_Pharmaceuticals_Third_Rock_Ventures_Yasuda_Enterprise_Development_Corporation_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-10-18T15:40:22+00:00"^^xsd:dateTime ;
    ns1:documentExtract "PALO ALTO, CA, Oct 18, 2011 (MARKETWIRE via COMTEX) - TOPICA Pharmaceuticals, Inc., a privately held biotechnology company, today announced that it has raised $ 27 million in a Series B financing, led by Third Rock Ventures and existing investors Prospect Venture Partners and Yasuda Enterprise Development Corporation, Ltd.",
        "TOPICA Announces Completion of $ 27 Million Series B Financing." ;
    ns1:documentTitle "TOPICA Announces Completion of $27 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/topica-announces-completion-of-27-million-series-b-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2360006/Topica_Pharmaceuticals> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 27 Million",
        "$ 27 million" ;
    ns1:when "2011-10-18T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Oct 18, 2011" ;
    ns1:whereGeoName "Palo Alto" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5380748/about.rdf> ;
    ns1:whereRaw "PALO ALTO, CA" .

<https://1145.am/db/2360945/Investment_Emerging_Technology_Partners_Llc_Entremed_Idg-Accel_China_Growth_Fund_Ii_Lp_Tak_W_Mak_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-01-23T17:42:34+00:00"^^xsd:dateTime ;
    ns1:documentExtract "EntreMed Secures $ 10 Million Strategic Financing.",
        "ROCKVILLE, Md., Jan. 23, 2012 /PRNewswire via COMTEX/ - EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has secured $ 10 million in financing with strategic accredited investors, including IDG-Accel China Growth Fund II L.P. (\"IDG\") , Emerging Technology Partners, LLC (\"ETP\") , and Dr. Tak W. Mak, Director of The Campbell Family Institute for Cancer Research." ;
    ns1:documentTitle "EntreMed Secures $10 Million Strategic Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/entremed-secures-10-million-strategic-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2360945/Entremed> ;
    ns1:valueRaw "$ 10 Million",
        "$ 10 million" ;
    ns1:when "2012-01-23T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Jan. 23, 2012" ;
    ns1:whereRaw "EntreMed Secures $ 10 Million Strategic Financing" .

<https://1145.am/db/2361971/Micromet> a org:Organization ;
    ns1:basedInHighGeoName "City of Rockville" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/7316547/about.rdf> ;
    ns1:basedInHighRaw "Rockville, Md." ;
    ns1:description "research and development" ;
    ns1:documentDate "2012-01-26T13:53:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Amgen to Acquire Micromet" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/amgen-to-acquire-micromet-0> ;
    ns1:foundName "Micromet" ;
    ns1:industry "biotechnology" ;
    ns1:name "Micromet" ;
    ns1:sameAsHigh <https://1145.am/db/1084063/Micronoma>,
        <https://1145.am/db/1536932/Microba>,
        <https://1145.am/db/1536933/Microba>,
        <https://1145.am/db/1536935/Microba>,
        <https://1145.am/db/1537197/Microba>,
        <https://1145.am/db/1537314/Microba>,
        <https://1145.am/db/1540915/Microba>,
        <https://1145.am/db/1540922/Microba>,
        <https://1145.am/db/1540927/Microba>,
        <https://1145.am/db/2351252/Microbix_Biosystems_Inc>,
        <https://1145.am/db/2361973/Micromet>,
        <https://1145.am/db/2434368/Microcal>,
        <https://1145.am/db/2590252/Microlin_Bio>,
        <https://1145.am/db/2593681/Micromet> ;
    ns1:sameAsMedium <https://1145.am/db/2249776/Micromet>,
        <https://1145.am/db/2302112/Micromet>,
        <https://1145.am/db/2304395/Micromet>,
        <https://1145.am/db/2322945/Micromet>,
        <https://1145.am/db/2324417/Micromet>,
        <https://1145.am/db/2326910/Micromet>,
        <https://1145.am/db/2326912/Micromet>,
        <https://1145.am/db/2326913/Micromet>,
        <https://1145.am/db/2328502/Micromet>,
        <https://1145.am/db/2328514/Micromet>,
        <https://1145.am/db/2329862/Micromet>,
        <https://1145.am/db/2332739/Micromet>,
        <https://1145.am/db/2342663/Micromet_Inc>,
        <https://1145.am/db/2343292/Micromet>,
        <https://1145.am/db/2350471/Micromet>,
        <https://1145.am/db/2353461/Micromet>,
        <https://1145.am/db/2361972/Micromet>,
        <https://1145.am/db/2538653/Micromet>,
        <https://1145.am/db/2596467/Micromet> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2361973/Micromet> a org:Organization ;
    ns1:basedInHighGeoName "City of Rockville" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/7316547/about.rdf> ;
    ns1:basedInHighRaw "Rockville, Md." ;
    ns1:description "research and development" ;
    ns1:documentDate "2012-01-26T14:20:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Amgen to Acquire Micromet" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/amgen-to-acquire-micromet> ;
    ns1:foundName "Micromet" ;
    ns1:industry "biotechnology" ;
    ns1:name "Micromet" ;
    ns1:sameAsHigh <https://1145.am/db/1084063/Micronoma>,
        <https://1145.am/db/1536932/Microba>,
        <https://1145.am/db/1536933/Microba>,
        <https://1145.am/db/1536935/Microba>,
        <https://1145.am/db/1537197/Microba>,
        <https://1145.am/db/1537314/Microba>,
        <https://1145.am/db/1540915/Microba>,
        <https://1145.am/db/1540922/Microba>,
        <https://1145.am/db/1540927/Microba>,
        <https://1145.am/db/2351252/Microbix_Biosystems_Inc>,
        <https://1145.am/db/2361971/Micromet>,
        <https://1145.am/db/2434368/Microcal>,
        <https://1145.am/db/2590252/Microlin_Bio>,
        <https://1145.am/db/2593681/Micromet> ;
    ns1:sameAsMedium <https://1145.am/db/2249776/Micromet>,
        <https://1145.am/db/2302112/Micromet>,
        <https://1145.am/db/2304395/Micromet>,
        <https://1145.am/db/2322945/Micromet>,
        <https://1145.am/db/2324417/Micromet>,
        <https://1145.am/db/2326910/Micromet>,
        <https://1145.am/db/2326912/Micromet>,
        <https://1145.am/db/2326913/Micromet>,
        <https://1145.am/db/2328502/Micromet>,
        <https://1145.am/db/2328514/Micromet>,
        <https://1145.am/db/2329862/Micromet>,
        <https://1145.am/db/2332739/Micromet>,
        <https://1145.am/db/2342663/Micromet_Inc>,
        <https://1145.am/db/2343292/Micromet>,
        <https://1145.am/db/2350471/Micromet>,
        <https://1145.am/db/2353461/Micromet>,
        <https://1145.am/db/2361972/Micromet>,
        <https://1145.am/db/2538653/Micromet>,
        <https://1145.am/db/2596467/Micromet> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364014/Investment_Birk_Venture_Ro_Invest_Radium_Hospital_Research_Foundation_Targovax_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-02T11:42:51+00:00"^^xsd:dateTime ;
    ns1:documentExtract "OSLO, Norway, Feb 01, 2012 (BUSINESS WIRE) - Targovax, an oncology biopharma company, today announced that it has secured NOK 13 million (USD 2.2 million) from a consortium comprising the Radium Hospital Research Foundation, Birk Venture, RO Invest and existing owners for further development of its lead candidate, TG01, a therapeutic vaccine for pancreatic cancer.",
        "Targovax Secures NOK 13 Million Series A Funding for TGO1 Pancreatic Cancer Vaccine Development." ;
    ns1:documentTitle "Targovax Secures NOK 13 Million Series A Funding for TGO1 Pancreatic Cancer Vaccine Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/targovax-secures-nok-13-million-series-a-funding-for-tgo1-pancreatic-cancer-vaccine> ;
    ns1:foundName "Funding" ;
    ns1:name "Funding" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2364014/Targovax> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "NOK 13 Million",
        "NOK 13 million",
        "USD 2.2 million" ;
    ns1:whereGeoName "Kingdom of Norway" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3144096/about.rdf> ;
    ns1:whereRaw "Norway" .

<https://1145.am/db/2364035/Kleiner_Perkins_Caufield_And_Byers> a org:Organization ;
    ns1:basedInHighGeoName "Menlo Park" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5372223/about.rdf> ;
    ns1:basedInHighRaw "MENLO PARK" ;
    ns1:documentDate "2012-02-02T17:11:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Auxogyn Completes $20 Million In Series A Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/auxogyn-completes-20-million-series-a-funding> ;
    ns1:foundName "Kleiner Perkins Caufield and Byers" ;
    ns1:investor <https://1145.am/db/2364035/Series_A_Investment_Auxogyn_Inc_Kleiner_Perkins_Caufield_And_Byers_Merck_Serono_Ventures_Tpg_Biotech_Completed> ;
    ns1:name "Kleiner Perkins Caufield and Byers" ;
    ns1:sameAsMedium <https://1145.am/db/1697155/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1709036/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1714786/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1719362/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1792401/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1794049/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1794342/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1795003/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1796259/Kleiner_Perkins_Caufield_Byers>,
        <https://1145.am/db/1798154/Kleiner_Perkins_Caufield_Byers>,
        <https://1145.am/db/1802208/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1802525/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1805986/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1806158/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1808735/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1814186/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1816928/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1821378/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1824878/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1825866/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1826126/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1827381/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1830311/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1835647/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1838965/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1839326/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1840650/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1844931/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1845205/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1847021/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1849969/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1850246/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1850293/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1850642/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1852048/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1852697/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1853217/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1853292/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/1854098/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1856424/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1858545/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1858646/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1859219/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1860406/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1860644/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1861870/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1864650/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1865436/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1868593/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1868958/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1870791/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1871768/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1872947/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/1872971/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1874419/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1876759/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1881582/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1883859/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1890121/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1891856/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1892105/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1892746/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1895292/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1906922/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1907771/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1915400/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2227037/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2230414/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2288899/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2289585/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2291836/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2293308/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2300306/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2300337/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2305254/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/2305256/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2310485/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2311540/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2312700/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2313567/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2316038/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2317750/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2317753/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2321949/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2325726/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/2326444/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2326926/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/2331026/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2331047/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2332010/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2336391/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2338251/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2338254/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2341484/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2341487/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2344782/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2349519/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2355531/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2355543/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2359987/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2362457/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2367199/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2629526/Kleiner_Perkins_Caufield___Byers> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364035/Series_A_Investment_Auxogyn_Inc_Kleiner_Perkins_Caufield_And_Byers_Merck_Serono_Ventures_Tpg_Biotech_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-02T17:11:49+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Auxogyn Completes $ 20 Million In Series A Funding.",
        "MENLO PARK, Calif., Feb. 2, 2012 /PRNewswire via COMTEX/ - Auxogyn, Inc., a privately-held company focused on advancing women's reproductive health, today announced the close of the final tranche of its Series A financing, bringing the total funding to $ 20 million." ;
    ns1:documentTitle "Auxogyn Completes $20 Million In Series A Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/auxogyn-completes-20-million-series-a-funding> ;
    ns1:foundName "Funding",
        "financing" ;
    ns1:name "Funding",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2364035/Auxogyn_Inc> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 20 Million",
        "$ 20 million" ;
    ns1:whenRaw "May 2010" ;
    ns1:whereGeoName "Menlo Park" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5372223/about.rdf> ;
    ns1:whereRaw "MENLO PARK, Calif" .

<https://1145.am/db/2364035/Tpg_Biotech> a org:Organization ;
    ns1:basedInHighGeoName "Menlo Park" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5372223/about.rdf> ;
    ns1:basedInHighRaw "MENLO PARK" ;
    ns1:documentDate "2012-02-02T17:11:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Auxogyn Completes $20 Million In Series A Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/auxogyn-completes-20-million-series-a-funding> ;
    ns1:foundName "TPG Biotech" ;
    ns1:industry "medical technology" ;
    ns1:investor <https://1145.am/db/2364035/Series_A_Investment_Auxogyn_Inc_Kleiner_Perkins_Caufield_And_Byers_Merck_Serono_Ventures_Tpg_Biotech_Completed> ;
    ns1:name "TPG Biotech" ;
    ns1:sameAsHigh <https://1145.am/db/2325726/Tpg_Biotechnology> ;
    ns1:sameAsMedium <https://1145.am/db/1863540/Tpg_Biotech>,
        <https://1145.am/db/1867543/Tpg_Biotech>,
        <https://1145.am/db/2299423/Tpg_Biotech>,
        <https://1145.am/db/2300337/Tpg_Biotech>,
        <https://1145.am/db/2302333/Tpg_Biotech>,
        <https://1145.am/db/2308700/Tpg_Biotech>,
        <https://1145.am/db/2336221/Tpg_Biotech>,
        <https://1145.am/db/2342557/Tpg_Biotech>,
        <https://1145.am/db/2342558/Tpg_Biotech>,
        <https://1145.am/db/2342724/Tpg_Biotech>,
        <https://1145.am/db/2344678/Tpg_Biotech>,
        <https://1145.am/db/2350044/Tpg_Biotech>,
        <https://1145.am/db/2351897/Tpg_Biotech>,
        <https://1145.am/db/2352508/Tpg_Biotech>,
        <https://1145.am/db/2353588/Tpg_Biotech>,
        <https://1145.am/db/2353608/Tpg_Biotech>,
        <https://1145.am/db/2353771/Tpg_Biotech>,
        <https://1145.am/db/2353789/Tpg_Biotech>,
        <https://1145.am/db/2354537/Tpg_Biotech>,
        <https://1145.am/db/2354899/Tpg_Biotech>,
        <https://1145.am/db/2354903/Tpg_Biotech>,
        <https://1145.am/db/2358515/Tpg_Biotech>,
        <https://1145.am/db/2358888/Tpg_Biotech>,
        <https://1145.am/db/2359562/Tpg_Biotech>,
        <https://1145.am/db/2362457/Tpg_Biotech>,
        <https://1145.am/db/2365868/Tpg_Biotech>,
        <https://1145.am/db/2368351/Tpg_Biotech>,
        <https://1145.am/db/316299/Tpg_Biotech> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366049/Clarus_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SEATTLE" ;
    ns1:description "venture investors" ;
    ns1:documentDate "2011-11-07T13:21:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Secures $20M in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-secures-20m-series-d-financing-0> ;
    ns1:foundName "Clarus Ventures" ;
    ns1:investor <https://1145.am/db/2366049/Equity_Investment_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Henri_Termeer_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "Clarus Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1696744/Cloquet_Capital_Partners>,
        <https://1145.am/db/2294202/Clarus_Funds>,
        <https://1145.am/db/2336944/Clarus_Ventures>,
        <https://1145.am/db/2354295/Clarus_Ventures>,
        <https://1145.am/db/2366055/Clarus_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2289229/Clarus_Ventures>,
        <https://1145.am/db/2302292/Clarus_Ventures>,
        <https://1145.am/db/2302994/Clarus_Ventures>,
        <https://1145.am/db/2303563/Clarus_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304261/Clarus_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2306754/Clarus_Ventures>,
        <https://1145.am/db/2311011/Clarus_Ventures>,
        <https://1145.am/db/2311595/Clarus_Ventures>,
        <https://1145.am/db/2312277/Clarus_Ventures>,
        <https://1145.am/db/2312288/Clarus_Ventures>,
        <https://1145.am/db/2312945/Clarus_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2315059/Clarus_Ventures>,
        <https://1145.am/db/2317145/Clarus_Ventures>,
        <https://1145.am/db/2318851/Clarus_Ventures>,
        <https://1145.am/db/2321137/Clarus_Ventures>,
        <https://1145.am/db/2324936/Clarus_Ventures>,
        <https://1145.am/db/2325880/Clarus_Ventures>,
        <https://1145.am/db/2327405/Clarus_Ventures>,
        <https://1145.am/db/2329773/Clarus_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335928/Clarus_Ventures>,
        <https://1145.am/db/2336313/Clarus_Ventures>,
        <https://1145.am/db/2341003/Clarus_Ventures>,
        <https://1145.am/db/2341600/Clarus_Ventures>,
        <https://1145.am/db/2342624/Clarus_Ventures>,
        <https://1145.am/db/2342629/Clarus_Ventures_Llc>,
        <https://1145.am/db/2343722/Clarus_Ventures>,
        <https://1145.am/db/2343725/Clarus_Ventures>,
        <https://1145.am/db/2343737/Clarus_Ventures>,
        <https://1145.am/db/2347389/Clarus_Ventures>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2349120/Clarus_Ventures>,
        <https://1145.am/db/2349717/Clarus_Ventures>,
        <https://1145.am/db/2349722/Clarus_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2351958/Clarus_Ventures>,
        <https://1145.am/db/2352808/Clarus_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2353771/Clarus_Ventures>,
        <https://1145.am/db/2353789/Clarus_Ventures>,
        <https://1145.am/db/2355435/Clarus_Ventures>,
        <https://1145.am/db/2356084/Clarus_Ventures>,
        <https://1145.am/db/2357858/Clarus_Ventures>,
        <https://1145.am/db/2359654/Clarus_Ventures>,
        <https://1145.am/db/2360756/Clarus_Ventures>,
        <https://1145.am/db/2360758/Clarus_Ventures>,
        <https://1145.am/db/2364468/Clarus_Ventures>,
        <https://1145.am/db/2364471/Clarus_Ventures>,
        <https://1145.am/db/2365171/Clarus_Ventures>,
        <https://1145.am/db/2365184/Clarus_Ventures>,
        <https://1145.am/db/2368297/Clarus_Ventures>,
        <https://1145.am/db/2370240/Clarus_Ventures>,
        <https://1145.am/db/2584561/Clarus_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366055/Clarus_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SEATTLE" ;
    ns1:description "venture investors" ;
    ns1:documentDate "2011-11-07T13:25:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Secures $20M in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-secures-20m-series-d-financing> ;
    ns1:foundName "Clarus Ventures" ;
    ns1:investor <https://1145.am/db/2366055/Equity_Investment_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Healthymagination_Fund_Henri_Termeer_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "Clarus Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1696744/Cloquet_Capital_Partners>,
        <https://1145.am/db/2294202/Clarus_Funds>,
        <https://1145.am/db/2336944/Clarus_Ventures>,
        <https://1145.am/db/2354295/Clarus_Ventures>,
        <https://1145.am/db/2366049/Clarus_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2289229/Clarus_Ventures>,
        <https://1145.am/db/2302292/Clarus_Ventures>,
        <https://1145.am/db/2302994/Clarus_Ventures>,
        <https://1145.am/db/2303563/Clarus_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304261/Clarus_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2306754/Clarus_Ventures>,
        <https://1145.am/db/2311011/Clarus_Ventures>,
        <https://1145.am/db/2311595/Clarus_Ventures>,
        <https://1145.am/db/2312277/Clarus_Ventures>,
        <https://1145.am/db/2312288/Clarus_Ventures>,
        <https://1145.am/db/2312945/Clarus_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2315059/Clarus_Ventures>,
        <https://1145.am/db/2317145/Clarus_Ventures>,
        <https://1145.am/db/2318851/Clarus_Ventures>,
        <https://1145.am/db/2321137/Clarus_Ventures>,
        <https://1145.am/db/2324936/Clarus_Ventures>,
        <https://1145.am/db/2325880/Clarus_Ventures>,
        <https://1145.am/db/2327405/Clarus_Ventures>,
        <https://1145.am/db/2329773/Clarus_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335928/Clarus_Ventures>,
        <https://1145.am/db/2336313/Clarus_Ventures>,
        <https://1145.am/db/2341003/Clarus_Ventures>,
        <https://1145.am/db/2341600/Clarus_Ventures>,
        <https://1145.am/db/2342624/Clarus_Ventures>,
        <https://1145.am/db/2342629/Clarus_Ventures_Llc>,
        <https://1145.am/db/2343722/Clarus_Ventures>,
        <https://1145.am/db/2343725/Clarus_Ventures>,
        <https://1145.am/db/2343737/Clarus_Ventures>,
        <https://1145.am/db/2347389/Clarus_Ventures>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2349120/Clarus_Ventures>,
        <https://1145.am/db/2349717/Clarus_Ventures>,
        <https://1145.am/db/2349722/Clarus_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2351958/Clarus_Ventures>,
        <https://1145.am/db/2352808/Clarus_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2353771/Clarus_Ventures>,
        <https://1145.am/db/2353789/Clarus_Ventures>,
        <https://1145.am/db/2355435/Clarus_Ventures>,
        <https://1145.am/db/2356084/Clarus_Ventures>,
        <https://1145.am/db/2357858/Clarus_Ventures>,
        <https://1145.am/db/2359654/Clarus_Ventures>,
        <https://1145.am/db/2360756/Clarus_Ventures>,
        <https://1145.am/db/2360758/Clarus_Ventures>,
        <https://1145.am/db/2364468/Clarus_Ventures>,
        <https://1145.am/db/2364471/Clarus_Ventures>,
        <https://1145.am/db/2365171/Clarus_Ventures>,
        <https://1145.am/db/2365184/Clarus_Ventures>,
        <https://1145.am/db/2368297/Clarus_Ventures>,
        <https://1145.am/db/2370240/Clarus_Ventures>,
        <https://1145.am/db/2584561/Clarus_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2546371/Investment_Genmab_Lonza_Universal_Corp_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-11-08T12:41:08+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Lonza has announced a development and manufacturing agreement with Genmab to produce HuMax-TF, a tumor-fighting antibody-drug conjugate." ;
    ns1:documentTitle "Endo wooed by $1.2M incentives from PA; Wellspring acquired by Sentinel, Ancor;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/endo-wooed-by-1-2m-incentives-from-pa-wellspring-acquired-by-sentinel-ancor> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "Canada" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:whereRaw "Canada" .

<https://1145.am/db/2578302/Wellspring_Pharmaceutical_Corporation_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-11-08T12:45:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "NEW YORK, November 7, 2011 - Sentinel Capital Partners, a private equity firm that invests in promising lower middle market companies, today announced its acquisition of WellSpring Pharmaceutical Corporation, a North American manufacturer and marketer of specialty prescription and over-the-counter pharmaceuticals.",
        "Sentinel Capital Partners Acquires WellSpring Pharmaceutical Corporation." ;
    ns1:documentTitle "Sentinel Capital Partners Acquires WellSpring Pharmaceutical Corporation" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/sentinel-capital-partners-acquires-wellspring-pharmaceutical-corporation> ;
    ns1:foundName "Acquires",
        "acquisition" ;
    ns1:name "Acquires",
        "acquisition" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2578302/Wellspring_Pharmaceutical_Corporation> ;
    ns1:targetName "WellSpring Pharmaceutical Corporation" ;
    ns1:when "2011-11-07T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "November 7, 2011" ;
    ns1:whereGeoName "North Salt Lake" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5779068/about.rdf> ;
    ns1:whereRaw "North American" .

<https://1145.am/db/2593681/Micromet> a org:Organization ;
    ns1:basedInHighGeoName "City of Rockville" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/7316547/about.rdf> ;
    ns1:basedInHighRaw "Rockville, Md." ;
    ns1:description "research and development" ;
    ns1:documentDate "2012-01-26T14:20:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Amgen to Acquire Micromet" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/amgen-to-acquire-micromet> ;
    ns1:foundName "Micromet" ;
    ns1:industry "biotechnology" ;
    ns1:name "Micromet" ;
    ns1:sameAsHigh <https://1145.am/db/1084063/Micronoma>,
        <https://1145.am/db/1536932/Microba>,
        <https://1145.am/db/1536933/Microba>,
        <https://1145.am/db/1536935/Microba>,
        <https://1145.am/db/1537197/Microba>,
        <https://1145.am/db/1537314/Microba>,
        <https://1145.am/db/1540915/Microba>,
        <https://1145.am/db/1540922/Microba>,
        <https://1145.am/db/1540927/Microba>,
        <https://1145.am/db/2351252/Microbix_Biosystems_Inc>,
        <https://1145.am/db/2361971/Micromet>,
        <https://1145.am/db/2361973/Micromet>,
        <https://1145.am/db/2434368/Microcal>,
        <https://1145.am/db/2590252/Microlin_Bio> ;
    ns1:sameAsMedium <https://1145.am/db/2249776/Micromet>,
        <https://1145.am/db/2302112/Micromet>,
        <https://1145.am/db/2304395/Micromet>,
        <https://1145.am/db/2322945/Micromet>,
        <https://1145.am/db/2324417/Micromet>,
        <https://1145.am/db/2326910/Micromet>,
        <https://1145.am/db/2326912/Micromet>,
        <https://1145.am/db/2326913/Micromet>,
        <https://1145.am/db/2328502/Micromet>,
        <https://1145.am/db/2328514/Micromet>,
        <https://1145.am/db/2329862/Micromet>,
        <https://1145.am/db/2332739/Micromet>,
        <https://1145.am/db/2342663/Micromet_Inc>,
        <https://1145.am/db/2343292/Micromet>,
        <https://1145.am/db/2350471/Micromet>,
        <https://1145.am/db/2353461/Micromet>,
        <https://1145.am/db/2361972/Micromet>,
        <https://1145.am/db/2538653/Micromet>,
        <https://1145.am/db/2596467/Micromet> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2654597/Monitise_Americas_Shareholding_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-11-02T18:06:37+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Separately, Monitise has agreed to acquire the 51 per cent shareholding in its US joint venture, Monitise Americas, that is owned by Metavante, a subsidiary of Fidelity National Information Services.",
        "Visa Europe has taken an 8.8 per cent holding in Monitise, a UK - based mobile banking and payment service provider, with a £24.7 million investment." ;
    ns1:documentTitle "Visa Europe invests £24M in mobile banking firm Monitise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/visa-europe-invests-ps24m-mobile-banking-firm-monitise> ;
    ns1:foundName "acquire",
        "investment" ;
    ns1:name "acquire",
        "investment" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2654597/Monitise_Americas> ;
    ns1:targetDetails "holding",
        "shareholding" ;
    ns1:targetName "Monitise",
        "Monitise Americas" ;
    ns1:valueRaw "£24.7 million" ;
    ns1:vendor <https://1145.am/db/2654597/Metavante> ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland",
        "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf>,
        <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "UK",
        "US" .

<https://1145.am/db/2659467/Twitter_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-12-20T04:28:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Saudi billionaire prince Walid bin Tatal and holding company KHC have bought into Twitter through a $ 300 million investment." ;
    ns1:documentTitle "Webwire: Sprint abandons Carrier IQ; Huawei, ZTE eye $200m India revenue" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-sprint-abandons-carrier-iq-huawei-zte-eye-200m-india-revenue> ;
    ns1:foundName "bought",
        "investment" ;
    ns1:name "bought",
        "investment" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2659467/Twitter> ;
    ns1:targetName "Twitter" ;
    ns1:valueRaw "$ 300 million" .

<https://1145.am/db/2664500/At_T> a org:Organization ;
    ns1:basedInLowRaw "USA" ;
    ns1:buyer <https://1145.am/db/2664500/T-Mobile_Usa_Acquisition> ;
    ns1:description "Business" ;
    ns1:documentDate "2011-09-19T14:18:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: AT&T reaches out to Sprint, MetroPCS, Leap on T-Mobile asset sales" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-at-t-reaches-out-to-sprint-metropcs-leap-t-mobile-asset-sales> ;
    ns1:foundName "AT & T" ;
    ns1:name "AT&T" ;
    ns1:sameAsHigh <https://1145.am/db/1000082/At___T_Inc>,
        <https://1145.am/db/1822834/At___T>,
        <https://1145.am/db/1854000/At___T_*>,
        <https://1145.am/db/1862489/At___T>,
        <https://1145.am/db/1866809/At_T>,
        <https://1145.am/db/1899784/At___T_Inc>,
        <https://1145.am/db/211185/At___T_Inc>,
        <https://1145.am/db/2156880/At___T>,
        <https://1145.am/db/2159365/At_T>,
        <https://1145.am/db/2161513/At___T>,
        <https://1145.am/db/2163075/At_T>,
        <https://1145.am/db/2164453/At___T>,
        <https://1145.am/db/2165870/At___T>,
        <https://1145.am/db/2167508/At___T>,
        <https://1145.am/db/2171126/At___T>,
        <https://1145.am/db/2172351/At_T>,
        <https://1145.am/db/2172670/At_T>,
        <https://1145.am/db/2172901/At_T>,
        <https://1145.am/db/2172911/At_T>,
        <https://1145.am/db/2173620/At_T>,
        <https://1145.am/db/2175520/At_T>,
        <https://1145.am/db/2176832/At_T>,
        <https://1145.am/db/2598875/At___T>,
        <https://1145.am/db/2598969/At___T>,
        <https://1145.am/db/2604247/At_T>,
        <https://1145.am/db/2604314/At___T>,
        <https://1145.am/db/2604539/At_T>,
        <https://1145.am/db/2607386/At___T>,
        <https://1145.am/db/2610751/At___T>,
        <https://1145.am/db/2613122/At_T>,
        <https://1145.am/db/2615500/At_T>,
        <https://1145.am/db/2619593/At___T>,
        <https://1145.am/db/2627103/At_T>,
        <https://1145.am/db/2628029/At___T>,
        <https://1145.am/db/2628926/At_T>,
        <https://1145.am/db/2628936/At_T>,
        <https://1145.am/db/2628948/At_T>,
        <https://1145.am/db/2629910/At_T>,
        <https://1145.am/db/2632273/At_T>,
        <https://1145.am/db/2633827/At___T>,
        <https://1145.am/db/2636649/At___T>,
        <https://1145.am/db/2640140/At_T>,
        <https://1145.am/db/2641554/At_T>,
        <https://1145.am/db/2650269/At_T>,
        <https://1145.am/db/2652823/At_T>,
        <https://1145.am/db/2658220/At_T>,
        <https://1145.am/db/2658524/At___T>,
        <https://1145.am/db/2659075/At___T>,
        <https://1145.am/db/2659265/At_T>,
        <https://1145.am/db/2660524/At___T>,
        <https://1145.am/db/2664505/At___Ts>,
        <https://1145.am/db/2664547/At_T>,
        <https://1145.am/db/2667130/At___T>,
        <https://1145.am/db/2667338/At___T>,
        <https://1145.am/db/2668814/At_T>,
        <https://1145.am/db/2676075/At_T>,
        <https://1145.am/db/2678753/At_T>,
        <https://1145.am/db/2680906/At___T>,
        <https://1145.am/db/2681695/At___T_Mobility>,
        <https://1145.am/db/2681734/At_T>,
        <https://1145.am/db/2682450/At___T>,
        <https://1145.am/db/2684148/At_T>,
        <https://1145.am/db/2685930/At_T>,
        <https://1145.am/db/2685941/At_T>,
        <https://1145.am/db/335104/At___T_Inc>,
        <https://1145.am/db/713292/At___T_Inc>,
        <https://1145.am/db/796295/At___T> ;
    ns1:sameAsMedium <https://1145.am/db/1308612/At___T>,
        <https://1145.am/db/144483/At___T_Inc>,
        <https://1145.am/db/167287/At___T_Inc>,
        <https://1145.am/db/1677823/At___T_Inc>,
        <https://1145.am/db/1694065/At_T>,
        <https://1145.am/db/1707104/At___T>,
        <https://1145.am/db/1717987/At_T>,
        <https://1145.am/db/1751612/At___T>,
        <https://1145.am/db/1756446/At___T>,
        <https://1145.am/db/1760205/At_T>,
        <https://1145.am/db/1778517/At___T>,
        <https://1145.am/db/1778753/At___T>,
        <https://1145.am/db/1779566/At___T>,
        <https://1145.am/db/1785893/At_T>,
        <https://1145.am/db/1788936/At___T>,
        <https://1145.am/db/1789394/At___T>,
        <https://1145.am/db/1796420/At___T>,
        <https://1145.am/db/1799816/At_T>,
        <https://1145.am/db/1810646/At_T>,
        <https://1145.am/db/1812513/At___T>,
        <https://1145.am/db/1824992/At___T>,
        <https://1145.am/db/1826385/At_T>,
        <https://1145.am/db/1836084/At___T>,
        <https://1145.am/db/1850952/At___T>,
        <https://1145.am/db/1853716/At___T>,
        <https://1145.am/db/1859847/At___T>,
        <https://1145.am/db/1888480/At___T>,
        <https://1145.am/db/1901295/At___T>,
        <https://1145.am/db/1901770/At___T>,
        <https://1145.am/db/206449/At___T_Inc>,
        <https://1145.am/db/2157127/At___T>,
        <https://1145.am/db/2157161/At_T>,
        <https://1145.am/db/2157500/At___T>,
        <https://1145.am/db/2157633/At_T>,
        <https://1145.am/db/2157791/At___T>,
        <https://1145.am/db/2157795/At_T>,
        <https://1145.am/db/2157931/At_T>,
        <https://1145.am/db/2157947/At___T>,
        <https://1145.am/db/2157965/At___T>,
        <https://1145.am/db/2158219/At_T>,
        <https://1145.am/db/2158287/At___T>,
        <https://1145.am/db/2158505/At_T>,
        <https://1145.am/db/2158868/At_T>,
        <https://1145.am/db/2159143/At___T>,
        <https://1145.am/db/2159599/At___T>,
        <https://1145.am/db/2160074/At___T>,
        <https://1145.am/db/2162041/At_T>,
        <https://1145.am/db/2162163/At___T>,
        <https://1145.am/db/2162249/At___T>,
        <https://1145.am/db/2162280/At_T>,
        <https://1145.am/db/2162386/At_T>,
        <https://1145.am/db/2162741/At___T>,
        <https://1145.am/db/2162994/At___T>,
        <https://1145.am/db/2163699/At___T>,
        <https://1145.am/db/2163719/At_T>,
        <https://1145.am/db/2163888/At___T>,
        <https://1145.am/db/2163936/At___T>,
        <https://1145.am/db/2164870/At___T>,
        <https://1145.am/db/2165758/At___T>,
        <https://1145.am/db/2165984/At___T>,
        <https://1145.am/db/2166027/At_T>,
        <https://1145.am/db/2166622/At___T>,
        <https://1145.am/db/2167511/At___T>,
        <https://1145.am/db/2169802/At_T>,
        <https://1145.am/db/2169997/At___T>,
        <https://1145.am/db/2170598/At___T>,
        <https://1145.am/db/2170599/At___T>,
        <https://1145.am/db/2170755/At___T>,
        <https://1145.am/db/2171416/At_T>,
        <https://1145.am/db/2171918/At___T>,
        <https://1145.am/db/2172745/At___T>,
        <https://1145.am/db/2172998/At___T>,
        <https://1145.am/db/2173075/At___T>,
        <https://1145.am/db/2173138/At___T>,
        <https://1145.am/db/2173404/At___T>,
        <https://1145.am/db/2173415/At_T>,
        <https://1145.am/db/2173582/At___T>,
        <https://1145.am/db/2173586/At___T>,
        <https://1145.am/db/2173675/At_T>,
        <https://1145.am/db/2173980/At___T>,
        <https://1145.am/db/2174357/At_T>,
        <https://1145.am/db/2174408/At___T>,
        <https://1145.am/db/2174633/At_T>,
        <https://1145.am/db/2174986/At_T>,
        <https://1145.am/db/2175146/At___T>,
        <https://1145.am/db/2175475/At_T>,
        <https://1145.am/db/2175716/At_T>,
        <https://1145.am/db/2177450/At_T>,
        <https://1145.am/db/2177451/At_T>,
        <https://1145.am/db/2177458/At_T>,
        <https://1145.am/db/2177576/At___T>,
        <https://1145.am/db/2177636/At___T>,
        <https://1145.am/db/2179905/At_T>,
        <https://1145.am/db/2186280/At___T>,
        <https://1145.am/db/2229162/At___T>,
        <https://1145.am/db/2262401/At___T>,
        <https://1145.am/db/2266575/At_T>,
        <https://1145.am/db/2452684/At___T_Inc>,
        <https://1145.am/db/249455/At___T_Inc>,
        <https://1145.am/db/2598996/At_T>,
        <https://1145.am/db/2599069/At___T>,
        <https://1145.am/db/2599373/At___T>,
        <https://1145.am/db/2599572/At_T>,
        <https://1145.am/db/2599648/At___T>,
        <https://1145.am/db/2600001/At___T>,
        <https://1145.am/db/2600004/At___T>,
        <https://1145.am/db/2600202/At___T>,
        <https://1145.am/db/2600515/At___T>,
        <https://1145.am/db/2600548/At_T>,
        <https://1145.am/db/2600561/At_T>,
        <https://1145.am/db/2601297/At_T>,
        <https://1145.am/db/2601425/At_T>,
        <https://1145.am/db/2601887/At___T>,
        <https://1145.am/db/2602156/At___T>,
        <https://1145.am/db/2602281/At___T>,
        <https://1145.am/db/2602579/At_T>,
        <https://1145.am/db/2603377/At___T>,
        <https://1145.am/db/2603439/At___T>,
        <https://1145.am/db/2603531/At_T>,
        <https://1145.am/db/2603590/At___T>,
        <https://1145.am/db/2604223/At___T>,
        <https://1145.am/db/2604863/At___T>,
        <https://1145.am/db/2604967/At_T>,
        <https://1145.am/db/2604977/At___T>,
        <https://1145.am/db/2605006/At___T>,
        <https://1145.am/db/2605344/At_T>,
        <https://1145.am/db/2605760/At___T>,
        <https://1145.am/db/2606502/At___T>,
        <https://1145.am/db/2606612/At___T>,
        <https://1145.am/db/2606761/At___T>,
        <https://1145.am/db/2607794/At_T>,
        <https://1145.am/db/2607834/At_T>,
        <https://1145.am/db/2608701/At___T>,
        <https://1145.am/db/2608961/At_T>,
        <https://1145.am/db/2609030/At_T>,
        <https://1145.am/db/2609668/At_T>,
        <https://1145.am/db/2610620/At_T>,
        <https://1145.am/db/2611067/At_T>,
        <https://1145.am/db/2611202/At___T>,
        <https://1145.am/db/2611854/At___T>,
        <https://1145.am/db/2613066/At_T>,
        <https://1145.am/db/2614651/At___T>,
        <https://1145.am/db/2614719/At___T>,
        <https://1145.am/db/2614737/At___T>,
        <https://1145.am/db/2614886/At_T>,
        <https://1145.am/db/2615213/At_T>,
        <https://1145.am/db/2615516/At_T>,
        <https://1145.am/db/2616317/At_T>,
        <https://1145.am/db/2616340/At___T>,
        <https://1145.am/db/2617072/At___T>,
        <https://1145.am/db/2617377/At___T>,
        <https://1145.am/db/2617606/At_T>,
        <https://1145.am/db/2617838/At___T>,
        <https://1145.am/db/2619115/At_T>,
        <https://1145.am/db/2619421/At_T>,
        <https://1145.am/db/2619596/At___T>,
        <https://1145.am/db/2619745/At___T>,
        <https://1145.am/db/2620484/At___T>,
        <https://1145.am/db/2620838/At_T>,
        <https://1145.am/db/2622833/At___T>,
        <https://1145.am/db/2623193/At___T>,
        <https://1145.am/db/2623936/At___T>,
        <https://1145.am/db/2624400/At_T>,
        <https://1145.am/db/2624431/At_T>,
        <https://1145.am/db/2625058/At_T>,
        <https://1145.am/db/2625764/At_T>,
        <https://1145.am/db/2625808/At_T>,
        <https://1145.am/db/2626750/At___T>,
        <https://1145.am/db/2627018/At___T>,
        <https://1145.am/db/2627470/At___T>,
        <https://1145.am/db/2627982/At_T>,
        <https://1145.am/db/2628482/At_T>,
        <https://1145.am/db/2629447/At___T>,
        <https://1145.am/db/2630839/At_T>,
        <https://1145.am/db/2631175/At___T>,
        <https://1145.am/db/2631207/At___T>,
        <https://1145.am/db/2632121/At___T>,
        <https://1145.am/db/2632131/At___T>,
        <https://1145.am/db/2633416/At___T>,
        <https://1145.am/db/2633504/At_T>,
        <https://1145.am/db/2634130/At___T>,
        <https://1145.am/db/2634349/At_T>,
        <https://1145.am/db/2635751/At___T>,
        <https://1145.am/db/2636028/At___T>,
        <https://1145.am/db/2636629/At___T>,
        <https://1145.am/db/2636927/At___T>,
        <https://1145.am/db/2637568/At___T>,
        <https://1145.am/db/2637597/At_T>,
        <https://1145.am/db/2637732/At___T>,
        <https://1145.am/db/2638620/At___T>,
        <https://1145.am/db/2639462/At_T>,
        <https://1145.am/db/2639641/At_T>,
        <https://1145.am/db/2640631/At___T>,
        <https://1145.am/db/2640947/At_T>,
        <https://1145.am/db/2640950/At_T>,
        <https://1145.am/db/2641156/At_T>,
        <https://1145.am/db/2641303/At_T>,
        <https://1145.am/db/2642326/At___T>,
        <https://1145.am/db/2642638/At_T>,
        <https://1145.am/db/2643619/At_T>,
        <https://1145.am/db/2644481/At___T>,
        <https://1145.am/db/2646315/At___T>,
        <https://1145.am/db/2648327/At___T>,
        <https://1145.am/db/2648632/At_T>,
        <https://1145.am/db/2649776/At___T>,
        <https://1145.am/db/2649914/At_T>,
        <https://1145.am/db/2651977/At_T>,
        <https://1145.am/db/2652105/At___T>,
        <https://1145.am/db/2652671/At___T>,
        <https://1145.am/db/2652765/At___T>,
        <https://1145.am/db/2652834/At_T>,
        <https://1145.am/db/2652840/At_T>,
        <https://1145.am/db/2653426/At_T>,
        <https://1145.am/db/2653492/At_T>,
        <https://1145.am/db/2653594/At___T>,
        <https://1145.am/db/2653676/At___T>,
        <https://1145.am/db/2654379/At___T>,
        <https://1145.am/db/2654386/At_T>,
        <https://1145.am/db/2655150/At___T>,
        <https://1145.am/db/2655429/At___T>,
        <https://1145.am/db/2655954/At___T>,
        <https://1145.am/db/2656604/At___T>,
        <https://1145.am/db/2657126/At___T>,
        <https://1145.am/db/2657127/At___T>,
        <https://1145.am/db/2657140/At___T>,
        <https://1145.am/db/2657220/At___T>,
        <https://1145.am/db/2658006/At___T>,
        <https://1145.am/db/2658238/At___T>,
        <https://1145.am/db/2658539/At___T>,
        <https://1145.am/db/2659619/At_T>,
        <https://1145.am/db/2660189/At_T>,
        <https://1145.am/db/2660328/At_T>,
        <https://1145.am/db/2660785/At___T>,
        <https://1145.am/db/2661120/At___T>,
        <https://1145.am/db/2661159/At_T>,
        <https://1145.am/db/2661168/At___T>,
        <https://1145.am/db/2661274/At_T>,
        <https://1145.am/db/2661290/At_T>,
        <https://1145.am/db/2661418/At___T>,
        <https://1145.am/db/2661680/At_T>,
        <https://1145.am/db/2662193/At___T>,
        <https://1145.am/db/2662354/At_T>,
        <https://1145.am/db/2662383/At___T>,
        <https://1145.am/db/2663214/At___T>,
        <https://1145.am/db/2663406/At_T>,
        <https://1145.am/db/2663421/At___T>,
        <https://1145.am/db/2664378/At_T>,
        <https://1145.am/db/2664517/At_T>,
        <https://1145.am/db/2664691/At___T>,
        <https://1145.am/db/2664887/At___T>,
        <https://1145.am/db/2665469/At___T>,
        <https://1145.am/db/2665579/At_T>,
        <https://1145.am/db/2665710/At___T>,
        <https://1145.am/db/2665731/At_T>,
        <https://1145.am/db/2666095/At_T>,
        <https://1145.am/db/2666575/At___T>,
        <https://1145.am/db/2666714/At_T>,
        <https://1145.am/db/2667132/At___T>,
        <https://1145.am/db/2668714/At_T>,
        <https://1145.am/db/2668735/At___T>,
        <https://1145.am/db/2669621/At___T>,
        <https://1145.am/db/2669628/At_T>,
        <https://1145.am/db/2669920/At_T>,
        <https://1145.am/db/2669926/At_T>,
        <https://1145.am/db/2671029/At_T>,
        <https://1145.am/db/2671484/At_T>,
        <https://1145.am/db/2671605/At_T>,
        <https://1145.am/db/2671920/At_T>,
        <https://1145.am/db/2672079/At_T>,
        <https://1145.am/db/2672172/At___T>,
        <https://1145.am/db/2672184/At_T>,
        <https://1145.am/db/2673753/At___T>,
        <https://1145.am/db/2673923/At___T>,
        <https://1145.am/db/2674316/At_T>,
        <https://1145.am/db/2674918/At___T>,
        <https://1145.am/db/2677102/At___T>,
        <https://1145.am/db/2677549/At_T>,
        <https://1145.am/db/2677987/At___T>,
        <https://1145.am/db/2678311/At_T>,
        <https://1145.am/db/2679157/At___T>,
        <https://1145.am/db/2679240/At_T>,
        <https://1145.am/db/2679476/At_T>,
        <https://1145.am/db/2679803/At___T>,
        <https://1145.am/db/2680232/At___T>,
        <https://1145.am/db/2680246/At_T>,
        <https://1145.am/db/2680251/At_T>,
        <https://1145.am/db/2680761/At___T>,
        <https://1145.am/db/2680894/At_T>,
        <https://1145.am/db/2680897/At___T>,
        <https://1145.am/db/2680905/At___T>,
        <https://1145.am/db/2681046/At___T>,
        <https://1145.am/db/2681072/At___T>,
        <https://1145.am/db/2681074/At___T>,
        <https://1145.am/db/2681829/At___T>,
        <https://1145.am/db/2682409/At_T>,
        <https://1145.am/db/2682447/At___T>,
        <https://1145.am/db/2682574/At___T>,
        <https://1145.am/db/2682630/At___T>,
        <https://1145.am/db/2682698/At___T>,
        <https://1145.am/db/2682715/At_T>,
        <https://1145.am/db/2683008/At___T>,
        <https://1145.am/db/2683098/At___T>,
        <https://1145.am/db/2683420/At___T>,
        <https://1145.am/db/2683473/At_T>,
        <https://1145.am/db/2683713/At___T>,
        <https://1145.am/db/2683735/At___T>,
        <https://1145.am/db/2684028/At___T>,
        <https://1145.am/db/2684435/At_T>,
        <https://1145.am/db/2684439/At___T>,
        <https://1145.am/db/2684475/At___T>,
        <https://1145.am/db/2684713/At___T>,
        <https://1145.am/db/2684726/At___T>,
        <https://1145.am/db/2685112/At___T>,
        <https://1145.am/db/2685243/At___T>,
        <https://1145.am/db/2685245/At___T>,
        <https://1145.am/db/2685254/At___T>,
        <https://1145.am/db/2685271/At___T>,
        <https://1145.am/db/2685285/At___T>,
        <https://1145.am/db/2685505/At_T>,
        <https://1145.am/db/2685526/At___T>,
        <https://1145.am/db/2685618/At_T>,
        <https://1145.am/db/2685640/At_T>,
        <https://1145.am/db/2685654/At___T>,
        <https://1145.am/db/2685762/At_T>,
        <https://1145.am/db/2685811/At_T>,
        <https://1145.am/db/2685903/At___T>,
        <https://1145.am/db/2685940/At_T>,
        <https://1145.am/db/2686475/At_T>,
        <https://1145.am/db/2686540/At___T>,
        <https://1145.am/db/334907/At_T>,
        <https://1145.am/db/401388/At___T>,
        <https://1145.am/db/470135/At___T_Inc>,
        <https://1145.am/db/485256/At_T>,
        <https://1145.am/db/513323/At___T>,
        <https://1145.am/db/6235/At___T>,
        <https://1145.am/db/710355/At___T_Inc>,
        <https://1145.am/db/710798/At___T_Inc>,
        <https://1145.am/db/715099/At___T_Inc>,
        <https://1145.am/db/715441/At___T_Inc>,
        <https://1145.am/db/724048/At___T>,
        <https://1145.am/db/725944/At___T>,
        <https://1145.am/db/737813/At___T_Inc>,
        <https://1145.am/db/897774/At___T>,
        <https://1145.am/db/966560/At___T_Inc> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2664500/Sprint_Nextel> a org:Organization ;
    ns1:basedInLowRaw "USA" ;
    ns1:description "selling spectrum and customers" ;
    ns1:documentDate "2011-09-19T14:18:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: AT&T reaches out to Sprint, MetroPCS, Leap on T-Mobile asset sales" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-at-t-reaches-out-to-sprint-metropcs-leap-t-mobile-asset-sales> ;
    ns1:foundName "Sprint Nextel" ;
    ns1:name "Sprint Nextel" ;
    ns1:participant <https://1145.am/db/2664500/T-Mobile_Usa_Acquisition> ;
    ns1:sameAsMedium <https://1145.am/db/1700728/Sprint_Nextel>,
        <https://1145.am/db/1922758/Sprint_Nextel>,
        <https://1145.am/db/2601654/Sprint_Nextel>,
        <https://1145.am/db/2603188/Sprint_Nextel>,
        <https://1145.am/db/2613768/Sprint_Nextel>,
        <https://1145.am/db/2618452/Sprint_Nextel>,
        <https://1145.am/db/2621979/Sprint_Nextel>,
        <https://1145.am/db/2623369/Sprint_Nextel>,
        <https://1145.am/db/2624044/Sprint_Nextel>,
        <https://1145.am/db/2624525/Sprint_Nextel>,
        <https://1145.am/db/2627059/Sprint_Nextel>,
        <https://1145.am/db/2628938/Sprint_Nextel>,
        <https://1145.am/db/2629073/Sprint_Nextel>,
        <https://1145.am/db/2630836/Sprint_Nextel>,
        <https://1145.am/db/2633820/Sprint_Nextel>,
        <https://1145.am/db/2635673/Sprint_Nextel>,
        <https://1145.am/db/2635753/Sprint_Nextel>,
        <https://1145.am/db/2636424/Sprint_Nextel>,
        <https://1145.am/db/2637760/Sprint_Nextel>,
        <https://1145.am/db/2638532/Sprint_Nextel>,
        <https://1145.am/db/2639658/Sprint_Nextel>,
        <https://1145.am/db/2640151/Sprint_Nextel>,
        <https://1145.am/db/2641693/Sprint_Nextel>,
        <https://1145.am/db/2642428/Sprint_Nextel>,
        <https://1145.am/db/2642478/Sprint_Nextel>,
        <https://1145.am/db/2643537/Sprint_Nextel>,
        <https://1145.am/db/2645284/Sprint_Nextel>,
        <https://1145.am/db/2645977/Sprint_Nextel>,
        <https://1145.am/db/2646748/Sprint_Nextel>,
        <https://1145.am/db/2650873/Sprint_Nextel>,
        <https://1145.am/db/2652311/Sprint_Nextel>,
        <https://1145.am/db/2655732/Sprint_Nextel>,
        <https://1145.am/db/2658291/Sprint_Nextel>,
        <https://1145.am/db/2658589/Sprint_Nextel>,
        <https://1145.am/db/2659586/Sprint_Nextel>,
        <https://1145.am/db/2659587/Sprint_Nextel>,
        <https://1145.am/db/2659594/Sprint_Nextel>,
        <https://1145.am/db/2659601/Sprint_Nextel>,
        <https://1145.am/db/2659616/Sprint_Nextel>,
        <https://1145.am/db/2659619/Sprint_Nextel>,
        <https://1145.am/db/2659620/Sprint_Nextel>,
        <https://1145.am/db/2661271/Sprint_Nextel>,
        <https://1145.am/db/2661312/Sprint_Nextel>,
        <https://1145.am/db/2661735/Sprint_Nextel>,
        <https://1145.am/db/2662872/Sprint_Nextel>,
        <https://1145.am/db/2663091/Sprint_Nextel>,
        <https://1145.am/db/2663421/Sprint_Nextel>,
        <https://1145.am/db/2663923/Sprint_Nextel>,
        <https://1145.am/db/2663931/Sprint_Nextel>,
        <https://1145.am/db/2663933/Sprint_Nextel>,
        <https://1145.am/db/2663948/Sprint_Nextel>,
        <https://1145.am/db/2665296/Sprint_Nextel>,
        <https://1145.am/db/2665579/Sprint_Nextel>,
        <https://1145.am/db/2666088/Sprint_Nextel>,
        <https://1145.am/db/2666977/Sprint_Nextel>,
        <https://1145.am/db/2667152/Sprint_Nextel>,
        <https://1145.am/db/2668031/Sprint_Nextel>,
        <https://1145.am/db/2668249/Sprint_Nextel>,
        <https://1145.am/db/2668825/Sprint_Nextel>,
        <https://1145.am/db/2669292/Sprint_Nextel>,
        <https://1145.am/db/2669341/Sprint_Nextel>,
        <https://1145.am/db/2669942/Sprint_Nextel>,
        <https://1145.am/db/2670436/Sprint_Nextel>,
        <https://1145.am/db/2670440/Sprint_Nextel>,
        <https://1145.am/db/2670504/Sprint_Nextel>,
        <https://1145.am/db/2671333/Sprint_Nextel>,
        <https://1145.am/db/2671590/Sprint_Nextel>,
        <https://1145.am/db/2671649/Sprint_Nextel>,
        <https://1145.am/db/2672759/Sprint_Nextel>,
        <https://1145.am/db/2672784/Sprint_Nextel>,
        <https://1145.am/db/2672793/Sprint_Nextel>,
        <https://1145.am/db/2673337/Sprint_Nextel>,
        <https://1145.am/db/2674457/Sprint_Nextel>,
        <https://1145.am/db/2674875/Sprint_Nextel>,
        <https://1145.am/db/2675179/Sprint_Nextel>,
        <https://1145.am/db/2675183/Sprint_Nextel>,
        <https://1145.am/db/2675704/Sprint_Nextel>,
        <https://1145.am/db/2676326/Sprint_Nextel>,
        <https://1145.am/db/2676361/Sprint_Nextel>,
        <https://1145.am/db/2676370/Sprint_Nextel>,
        <https://1145.am/db/2676975/Sprint_Nextel>,
        <https://1145.am/db/2676993/Sprint_Nextel>,
        <https://1145.am/db/2677327/Sprint_Nextel>,
        <https://1145.am/db/2678562/Sprint_Nextel>,
        <https://1145.am/db/2678731/Sprint_Nextel>,
        <https://1145.am/db/2678748/Sprint_Nextel>,
        <https://1145.am/db/2678777/Sprint_Nextel>,
        <https://1145.am/db/2678781/Sprint_Nextel>,
        <https://1145.am/db/2679694/Sprint_Nextel>,
        <https://1145.am/db/2680061/Sprint_Nextel>,
        <https://1145.am/db/2681522/Sprint_Nextel>,
        <https://1145.am/db/2682580/Sprint_Nextel>,
        <https://1145.am/db/2682983/Sprint_Nextel>,
        <https://1145.am/db/2683612/Sprint_Nextel>,
        <https://1145.am/db/2683681/Sprint_Nextel>,
        <https://1145.am/db/2683726/Sprint_Nextel>,
        <https://1145.am/db/2684103/Sprint_Nextel>,
        <https://1145.am/db/2684413/Sprint_Nextel>,
        <https://1145.am/db/2684884/Sprint_Nextel>,
        <https://1145.am/db/2685112/Sprint_Nextel>,
        <https://1145.am/db/2685113/Sprint_Nextel>,
        <https://1145.am/db/2685267/Sprint_Nextel>,
        <https://1145.am/db/2686032/Sprint_Nextel>,
        <https://1145.am/db/2686200/Sprint_Nextel> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2669942/Sprint_Nextel> a org:Organization ;
    ns1:basedInLowRaw "America" ;
    ns1:buyer <https://1145.am/db/2669942/Dish_Network_Acquisition> ;
    ns1:description "Dish Network" ;
    ns1:documentDate "2011-11-30T16:59:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sprint signs off on Dish's proposed wireless venture" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/sprint-signs-off-dish-s-proposed-wireless-venture> ;
    ns1:foundName "Sprint Nextel" ;
    ns1:name "Sprint Nextel" ;
    ns1:sameAsHigh <https://1145.am/db/2158731/Verizon>,
        <https://1145.am/db/2678734/Sprint> ;
    ns1:sameAsMedium <https://1145.am/db/1700728/Sprint_Nextel>,
        <https://1145.am/db/1922758/Sprint_Nextel>,
        <https://1145.am/db/2601654/Sprint_Nextel>,
        <https://1145.am/db/2603188/Sprint_Nextel>,
        <https://1145.am/db/2613768/Sprint_Nextel>,
        <https://1145.am/db/2618452/Sprint_Nextel>,
        <https://1145.am/db/2621979/Sprint_Nextel>,
        <https://1145.am/db/2623369/Sprint_Nextel>,
        <https://1145.am/db/2624044/Sprint_Nextel>,
        <https://1145.am/db/2624525/Sprint_Nextel>,
        <https://1145.am/db/2627059/Sprint_Nextel>,
        <https://1145.am/db/2628938/Sprint_Nextel>,
        <https://1145.am/db/2629073/Sprint_Nextel>,
        <https://1145.am/db/2630836/Sprint_Nextel>,
        <https://1145.am/db/2633820/Sprint_Nextel>,
        <https://1145.am/db/2635673/Sprint_Nextel>,
        <https://1145.am/db/2635753/Sprint_Nextel>,
        <https://1145.am/db/2636424/Sprint_Nextel>,
        <https://1145.am/db/2637760/Sprint_Nextel>,
        <https://1145.am/db/2638532/Sprint_Nextel>,
        <https://1145.am/db/2639658/Sprint_Nextel>,
        <https://1145.am/db/2640151/Sprint_Nextel>,
        <https://1145.am/db/2641693/Sprint_Nextel>,
        <https://1145.am/db/2642428/Sprint_Nextel>,
        <https://1145.am/db/2642478/Sprint_Nextel>,
        <https://1145.am/db/2643537/Sprint_Nextel>,
        <https://1145.am/db/2645284/Sprint_Nextel>,
        <https://1145.am/db/2645977/Sprint_Nextel>,
        <https://1145.am/db/2646748/Sprint_Nextel>,
        <https://1145.am/db/2650873/Sprint_Nextel>,
        <https://1145.am/db/2652311/Sprint_Nextel>,
        <https://1145.am/db/2655732/Sprint_Nextel>,
        <https://1145.am/db/2658291/Sprint_Nextel>,
        <https://1145.am/db/2658589/Sprint_Nextel>,
        <https://1145.am/db/2659586/Sprint_Nextel>,
        <https://1145.am/db/2659587/Sprint_Nextel>,
        <https://1145.am/db/2659594/Sprint_Nextel>,
        <https://1145.am/db/2659601/Sprint_Nextel>,
        <https://1145.am/db/2659616/Sprint_Nextel>,
        <https://1145.am/db/2659619/Sprint_Nextel>,
        <https://1145.am/db/2659620/Sprint_Nextel>,
        <https://1145.am/db/2661271/Sprint_Nextel>,
        <https://1145.am/db/2661312/Sprint_Nextel>,
        <https://1145.am/db/2661735/Sprint_Nextel>,
        <https://1145.am/db/2662872/Sprint_Nextel>,
        <https://1145.am/db/2663091/Sprint_Nextel>,
        <https://1145.am/db/2663421/Sprint_Nextel>,
        <https://1145.am/db/2663923/Sprint_Nextel>,
        <https://1145.am/db/2663931/Sprint_Nextel>,
        <https://1145.am/db/2663933/Sprint_Nextel>,
        <https://1145.am/db/2663948/Sprint_Nextel>,
        <https://1145.am/db/2664500/Sprint_Nextel>,
        <https://1145.am/db/2665296/Sprint_Nextel>,
        <https://1145.am/db/2665579/Sprint_Nextel>,
        <https://1145.am/db/2666088/Sprint_Nextel>,
        <https://1145.am/db/2666977/Sprint_Nextel>,
        <https://1145.am/db/2667152/Sprint_Nextel>,
        <https://1145.am/db/2668031/Sprint_Nextel>,
        <https://1145.am/db/2668249/Sprint_Nextel>,
        <https://1145.am/db/2668825/Sprint_Nextel>,
        <https://1145.am/db/2669292/Sprint_Nextel>,
        <https://1145.am/db/2669341/Sprint_Nextel>,
        <https://1145.am/db/2670436/Sprint_Nextel>,
        <https://1145.am/db/2670440/Sprint_Nextel>,
        <https://1145.am/db/2670504/Sprint_Nextel>,
        <https://1145.am/db/2671333/Sprint_Nextel>,
        <https://1145.am/db/2671590/Sprint_Nextel>,
        <https://1145.am/db/2671649/Sprint_Nextel>,
        <https://1145.am/db/2672759/Sprint_Nextel>,
        <https://1145.am/db/2672784/Sprint_Nextel>,
        <https://1145.am/db/2672793/Sprint_Nextel>,
        <https://1145.am/db/2673337/Sprint_Nextel>,
        <https://1145.am/db/2674457/Sprint_Nextel>,
        <https://1145.am/db/2674875/Sprint_Nextel>,
        <https://1145.am/db/2675179/Sprint_Nextel>,
        <https://1145.am/db/2675183/Sprint_Nextel>,
        <https://1145.am/db/2675704/Sprint_Nextel>,
        <https://1145.am/db/2676326/Sprint_Nextel>,
        <https://1145.am/db/2676361/Sprint_Nextel>,
        <https://1145.am/db/2676370/Sprint_Nextel>,
        <https://1145.am/db/2676975/Sprint_Nextel>,
        <https://1145.am/db/2676993/Sprint_Nextel>,
        <https://1145.am/db/2677327/Sprint_Nextel>,
        <https://1145.am/db/2678562/Sprint_Nextel>,
        <https://1145.am/db/2678731/Sprint_Nextel>,
        <https://1145.am/db/2678748/Sprint_Nextel>,
        <https://1145.am/db/2678777/Sprint_Nextel>,
        <https://1145.am/db/2678781/Sprint_Nextel>,
        <https://1145.am/db/2679694/Sprint_Nextel>,
        <https://1145.am/db/2680061/Sprint_Nextel>,
        <https://1145.am/db/2681522/Sprint_Nextel>,
        <https://1145.am/db/2682580/Sprint_Nextel>,
        <https://1145.am/db/2682983/Sprint_Nextel>,
        <https://1145.am/db/2683612/Sprint_Nextel>,
        <https://1145.am/db/2683681/Sprint_Nextel>,
        <https://1145.am/db/2683726/Sprint_Nextel>,
        <https://1145.am/db/2684103/Sprint_Nextel>,
        <https://1145.am/db/2684413/Sprint_Nextel>,
        <https://1145.am/db/2684884/Sprint_Nextel>,
        <https://1145.am/db/2685112/Sprint_Nextel>,
        <https://1145.am/db/2685113/Sprint_Nextel>,
        <https://1145.am/db/2685267/Sprint_Nextel>,
        <https://1145.am/db/2686032/Sprint_Nextel>,
        <https://1145.am/db/2686200/Sprint_Nextel> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2293793/New_Enterprise_Associates> a org:Organization ;
    ns1:basedInHighGeoName "Palo Alto County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4870630/about.rdf> ;
    ns1:basedInHighRaw "Palo Alto" ;
    ns1:description "life sciences start-ups" ;
    ns1:documentDate "2011-10-04T16:34:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NEA leads $16M round for drug-eluting balloon firm" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nea-leads-16m-round-for-drug-eluting-balloon-firm> ;
    ns1:foundName "New",
        "New Enterprise Associates" ;
    ns1:industry "medical devices" ;
    ns1:investor <https://1145.am/db/2293793/Series_B_Investment_Biostar_Ventures_New_Enterprise_Associates_Synergy_Ventures_Western_Technology_Completed>,
        <https://1145.am/db/2293793/Series_B_Investment_Cv_Ingenuity_New_Enterprise_Associates_Western_Technology_Completed> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsHigh <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates> ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2293793/Series_B_Investment_Biostar_Ventures_New_Enterprise_Associates_Synergy_Ventures_Western_Technology_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-10-04T16:34:19+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The Palo Alto, CA - based medical devices firm has raised $ 16 million in a Series B round of financing to fuel work on its technology for treating peripheral artery disease and to grow its management ranks." ;
    ns1:documentTitle "NEA leads $16M round for drug-eluting balloon firm" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nea-leads-16m-round-for-drug-eluting-balloon-firm> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 16 million" ;
    ns1:whereGeoName "Palo Alto County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4870630/about.rdf> ;
    ns1:whereRaw "Palo Alto" .

<https://1145.am/db/2340207/Series_B_Investment_Boston_Millennia_Partners_Collegium_Pharmaceutical_Frazier_Healthcare_Ventures_Longitude_Capital_Skyline_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-22T16:24:21+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CUMBERLAND, R.I.- (BUSINESS WIRE) -Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, announced today that it has raised $ 22.5 million in a Series B financing round led by Longitude Capital and Skyline Ventures.",
        "Collegium Pharmaceutical Announces Series B Financing and Advancement of Development Program for its DETERx® Tamper-Resistant, Extended-Release Opioid." ;
    ns1:documentTitle "Collegium Pharmaceutical Announces Series B Financing and Advancement of Development Program for its DETERx® Tamper-Resistant, Extended-Release Opioid" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/collegium-pharmaceutical-announces-series-b-financing-and-advancement-of-development> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2340207/Collegium_Pharmaceutical> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 22.5 million" ;
    ns1:whereGeoName "Cumberland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5221703/about.rdf> ;
    ns1:whereRaw "CUMBERLAND, R.I." .

<https://1145.am/db/2345318/Series_B_Investment_Aratana_Therapeutics_Avalon_Ventures_Cultivian_Ventures_Ewing_Marion_Kauffman_Foundation_Mpm_Capital_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-12-07T15:38:02+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Aratana Therapeutics Completes $ 15 Million Series B Financing.",
        "KANSAS CITY, Kan., Dec. 7, 2011 /PRNewswire/ - Aratana Therapeutics, an animal health company developing innovative medicines for companion animals, announced today the closing of a $ 15 million Series B financing, bringing the total capital raised since Aratana was launched earlier this year to $ 31 million." ;
    ns1:documentTitle "Aratana Therapeutics Completes $15 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aratana-therapeutics-completes-15-million-series-b-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2345318/Aratana_Therapeutics> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 15 Million",
        "$ 15 million",
        "$ 31 million" ;
    ns1:when "2011-12-07T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Dec. 7, 2011" ;
    ns1:whereGeoName "Kansas" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4273857/about.rdf> ;
    ns1:whereRaw "Kansas" .

<https://1145.am/db/2347389/Series_A_Investment_Advanced_Technology_Ventures_Catabasis_Pharmaceuticals_Clarus_Ventures_Medimmune_Ventures_Sv_Life_Sciences_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-12-13T13:29:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, Mass., Dec 13, 2011 (BUSINESS WIRE) - Catabasis Pharmaceuticals, a biopharmaceutical company leveraging the therapeutic potential of omega-3 fatty acids for the treatment of inflammatory and metabolic diseases, today announced it has received an additional $ 8 million in Series A financing, bringing the total amount raised to $ 47.6 million.",
        "Catabasis Pharmaceuticals Announces $ 8 Million Series A Extension Financing." ;
    ns1:documentTitle "Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/catabasis-pharmaceuticals-announces-8-million-series-a-extension-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2347389/Catabasis_Pharmaceuticals> ;
    ns1:targetDetails "Extension",
        "Series A" ;
    ns1:valueRaw "$ 47.6 million",
        "$ 8 Million",
        "$ 8 million" ;
    ns1:whenRaw "2011" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "CAMBRIDGE, Mass." .

<https://1145.am/db/2349519/Equity_Investment_Crescendo_Bioscience_Kleiner_Perkins_Caufield___Byers_Mohr_Davidow_Ventures_Myriad_Genetics_Aeris_Capital_Ag_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-09-14T11:36:57+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Crescendo Bioscience (R) Secures $ 56 Million in Funding to Expand Development and Commercialization of Personalized Diagnostics for Inflammatory Diseases.",
        "SOUTH SAN FRANCISCO, Calif., Sep 8, 2011 (GlobeNewswire via COMTEX) - Crescendo Bioscience, a molecular diagnostics company developing quantitative biomarker tests for rheumatoid arthritis (RA) and other inflammatory diseases, announced today that it has completed a $ 31 million Series C equity financing and entered into a strategic investment agreement with Myriad Genetics for $ 25 million, raising a total of $ 56 million." ;
    ns1:documentTitle "Crescendo Bioscience Secures $56 Million in Funding to Expand Development and Commercialization of Personalized Diagnostics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crescendo-bioscience-secures-56-million-funding-to-expand-development-and-commercialization> ;
    ns1:foundName "Funding",
        "financing",
        "investment" ;
    ns1:name "Funding",
        "financing",
        "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2349519/Crescendo_Bioscience> ;
    ns1:targetDetails "Series C",
        "equity" ;
    ns1:valueRaw "$ 25 Million",
        "$ 25 million",
        "$ 31 Million",
        "$ 31 million",
        "$ 56 Million",
        "$ 56 million" ;
    ns1:whenRaw "2011" ;
    ns1:whereGeoName "South San Francisco" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5397765/about.rdf> ;
    ns1:whereRaw "SOUTH SAN FRANCISCO, Calif" .

<https://1145.am/db/2355715/Canaan_Partners> a org:Organization ;
    ns1:basedInLowRaw "global" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-01-10T12:30:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Canaan Partners Closes $600 Million Fund, Canaan IX" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/canaan-partners-closes-600-million-fund-canaan-ix> ;
    ns1:foundName "Canaan Partners" ;
    ns1:industry "venture capital" ;
    ns1:name "Canaan Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1043342/Canaan_Partners>,
        <https://1145.am/db/1427471/Potentum_Partners>,
        <https://1145.am/db/1695894/Canaan_Partners>,
        <https://1145.am/db/1697131/Canaan_Partners>,
        <https://1145.am/db/1724566/Canaan_Partners>,
        <https://1145.am/db/1735660/Forward_Partners>,
        <https://1145.am/db/1747333/Framework_Venture_Partners>,
        <https://1145.am/db/1770648/Canaan_Partners>,
        <https://1145.am/db/1776537/Partech_Partners>,
        <https://1145.am/db/1791628/Canaan_Partners>,
        <https://1145.am/db/1819543/Canaan_Partners>,
        <https://1145.am/db/1842466/Canaan_Partners>,
        <https://1145.am/db/1845119/Canaan_Partners>,
        <https://1145.am/db/1863401/Canaan_Partners>,
        <https://1145.am/db/1910644/Canaan_Partners>,
        <https://1145.am/db/2141055/Excell_Partners>,
        <https://1145.am/db/2297592/Canaan_Partners>,
        <https://1145.am/db/2301765/Canaan_Partners>,
        <https://1145.am/db/2309376/Canaan_Partners>,
        <https://1145.am/db/2309387/Canaan_Partners>,
        <https://1145.am/db/2351129/Canaan_Partners>,
        <https://1145.am/db/2355043/Canaan_Partners>,
        <https://1145.am/db/2355715/Canaan_Ix>,
        <https://1145.am/db/2363535/Canaan_Partners>,
        <https://1145.am/db/2366187/Canaan_Partners>,
        <https://1145.am/db/2370802/Canaan_Partners>,
        <https://1145.am/db/2370834/Canaan_Partners>,
        <https://1145.am/db/2583466/Canaan_Partners>,
        <https://1145.am/db/2635439/Canaan_Partners>,
        <https://1145.am/db/3043/Elsewhere_Partners>,
        <https://1145.am/db/316299/Canaan_Partners>,
        <https://1145.am/db/645540/Envisioning_Partners>,
        <https://1145.am/db/935302/Framework_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/146274/Canaan_Partners>,
        <https://1145.am/db/1696766/Canaan_Partners>,
        <https://1145.am/db/1702857/Canaan_Partners>,
        <https://1145.am/db/1711633/Canaan_Partners>,
        <https://1145.am/db/1734259/Canaan_Partners>,
        <https://1145.am/db/1741014/Canaan_Partners>,
        <https://1145.am/db/1741105/Canaan_Partners>,
        <https://1145.am/db/1741424/Canaan_Partners>,
        <https://1145.am/db/1749744/Canaan_Partners>,
        <https://1145.am/db/1754820/Canaan_Partners>,
        <https://1145.am/db/1768400/Canaan_Partners>,
        <https://1145.am/db/1792426/Canaan_Partners>,
        <https://1145.am/db/1793543/Canaan_Partners>,
        <https://1145.am/db/1796375/Canaan_Partners>,
        <https://1145.am/db/1814413/Canaan_Partners>,
        <https://1145.am/db/1827240/Canaan_Partners>,
        <https://1145.am/db/1829078/Canaan_Partners>,
        <https://1145.am/db/1829544/Canaan_Partners>,
        <https://1145.am/db/1836578/Canaan_Partners>,
        <https://1145.am/db/1852066/Canaan_Partners>,
        <https://1145.am/db/1858762/Canaan_Partners>,
        <https://1145.am/db/1866968/Canaan_Partners>,
        <https://1145.am/db/1894670/Canaan_Partners>,
        <https://1145.am/db/1897255/Canaan_Partners>,
        <https://1145.am/db/1900458/Canaan_Partners>,
        <https://1145.am/db/1906336/Canaan_Partners>,
        <https://1145.am/db/1907151/Canaan_Partners>,
        <https://1145.am/db/1907762/Canaan_Partners>,
        <https://1145.am/db/1919135/Canaan_Partners>,
        <https://1145.am/db/1920478/Canaan_Partners>,
        <https://1145.am/db/2164798/Canaan_Partners>,
        <https://1145.am/db/2164838/Canaan_Partners>,
        <https://1145.am/db/2210939/Canaan_Partners>,
        <https://1145.am/db/2238667/Canaan_Partners>,
        <https://1145.am/db/2287025/Canaan_Partners>,
        <https://1145.am/db/2287777/Canaan_Partners>,
        <https://1145.am/db/2298642/Canaan_Partners>,
        <https://1145.am/db/2304587/Canaan_Partners>,
        <https://1145.am/db/2304605/Canaan_Partners>,
        <https://1145.am/db/2306281/Canaan_Partners>,
        <https://1145.am/db/2308329/Canaan_Partners>,
        <https://1145.am/db/2313171/Canaan_Partners>,
        <https://1145.am/db/2320925/Canaan_Partners>,
        <https://1145.am/db/2322231/Canaan_Partners>,
        <https://1145.am/db/2329010/Canaan_Partners>,
        <https://1145.am/db/2329011/Canaan_Partners>,
        <https://1145.am/db/2329531/Canaan_Partners>,
        <https://1145.am/db/2332322/Canaan_Partners>,
        <https://1145.am/db/2337958/Canaan_Partners>,
        <https://1145.am/db/2337974/Canaan_Partners>,
        <https://1145.am/db/2346532/Canaan_Partners>,
        <https://1145.am/db/2347469/Canaan_Partners>,
        <https://1145.am/db/2351316/Canaan_Partners>,
        <https://1145.am/db/2351684/Canaan_Partners>,
        <https://1145.am/db/2353588/Canaan_Partners>,
        <https://1145.am/db/2353608/Canaan_Partners>,
        <https://1145.am/db/2355238/Canaan_Partners>,
        <https://1145.am/db/2358378/Canaan_Partners>,
        <https://1145.am/db/2359185/Canaan_Partners>,
        <https://1145.am/db/2360258/Canaan_Partners>,
        <https://1145.am/db/2360266/Canaan_Partners>,
        <https://1145.am/db/2360647/Canaan_Partners>,
        <https://1145.am/db/2365700/Canaan_Partners>,
        <https://1145.am/db/2366753/Canaan_Partners>,
        <https://1145.am/db/2368322/Canaan_Partners>,
        <https://1145.am/db/2368973/Canaan_Partners>,
        <https://1145.am/db/2368982/Canaan_Partners>,
        <https://1145.am/db/2370582/Canaan_Partners>,
        <https://1145.am/db/2572398/Canaan_Partners>,
        <https://1145.am/db/319155/Canaan_Partners>,
        <https://1145.am/db/353476/Canaan_Partners>,
        <https://1145.am/db/411041/Canaan_Partners>,
        <https://1145.am/db/523179/Canaan_Partners>,
        <https://1145.am/db/564082/Canaan_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355754/New_Enterprise_Associates> a org:Organization ;
    ns1:basedInHighGeoName "Menlo Park" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5372223/about.rdf> ;
    ns1:basedInHighRaw "MENLO PARK, Calif." ;
    ns1:description "Venture capital" ;
    ns1:documentDate "2011-10-04T15:38:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CV Ingenuity Announces Close of $16 Million Series B Financing Led by NEA" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cv-ingenuity-announces-close-of-16-million-series-b-financing-led-by-nea> ;
    ns1:foundName "New Enterprise Associates" ;
    ns1:industry "venture capital" ;
    ns1:investor <https://1145.am/db/2355754/Series_B_Investment_Biostar_Ventures_Cv_Ingenuity_Cv_Ingenuity_New_Enterprise_Associates_Synergy_Ventures_Western_Technology_Completed> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsHigh <https://1145.am/db/1061564/Evonik_Venture_Capital>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1768899/Eventures>,
        <https://1145.am/db/1786672/Eventures>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1806644/Eventures>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2170734/Eventures>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/330761/Emv_Capital>,
        <https://1145.am/db/490907/Echelon_Capital>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/936724/Efung_Capital>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355754/Series_B_Investment_Biostar_Ventures_Cv_Ingenuity_Cv_Ingenuity_New_Enterprise_Associates_Synergy_Ventures_Western_Technology_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-10-04T15:38:41+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CV Ingenuity (CVI) , which is focused on the development of a drug-eluting balloon platform technology that aims to treat peripheral artery disease while also working to prevent restenosis, will use this latest round of funding to accelerate product development and expand the leadership team.",
        "MENLO PARK, Calif., Oct. 4, 2011 /PRNewswire/ - CV Ingenuity, a privately-held medical device company, today announced the close of a $ 16 million Series B round of financing led by New Enterprise Associates (NEA) , a leading global venture capital firm." ;
    ns1:documentTitle "CV Ingenuity Announces Close of $16 Million Series B Financing Led by NEA" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cv-ingenuity-announces-close-of-16-million-series-b-financing-led-by-nea> ;
    ns1:foundName "financing",
        "funding" ;
    ns1:name "financing",
        "funding" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2355754/Cv_Ingenuity> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 16 million" ;
    ns1:when "2011-10-04T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Oct. 4, 2011" ;
    ns1:whereGeoName "Menlo Park" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5372223/about.rdf> ;
    ns1:whereRaw "MENLO PARK" .

<https://1145.am/db/2358883/New_Enterprise_Associates> a org:Organization ;
    ns1:basedInLowRaw "Ga" ;
    ns1:documentDate "2012-01-19T16:26:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Carticept Medical Closes $10 Million Series C Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/carticept-medical-closes-10-million-series-c-financing-round> ;
    ns1:foundName "New Enterprise Associates" ;
    ns1:investor <https://1145.am/db/2358883/Investment_Carticept_Medical_Domain_Associates_New_Enterprise_Associates_Sonosite_Inc_Completed> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2361004/New_Enterprise_Associates> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-01-25T15:00:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Prosensa Raises €23 Million in New Equity Financing Led by New Enterprise Associates" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/prosensa-raises-%E2%82%AC23-million-new-equity-financing-led-by-new-enterprise-associates> ;
    ns1:foundName "New Enterprise Associates" ;
    ns1:investor <https://1145.am/db/2361004/Investment_New_Enterprise_Associates_Prosensa_Completed> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsHigh <https://1145.am/db/1061564/Evonik_Venture_Capital>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1768899/Eventures>,
        <https://1145.am/db/1786672/Eventures>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1806644/Eventures>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2170734/Eventures>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/330761/Emv_Capital>,
        <https://1145.am/db/490907/Echelon_Capital>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/936724/Efung_Capital>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2443170/New_Enterprise_Associates> a org:Organization ;
    ns1:basedInLowRaw "GERMANTOWN" ;
    ns1:description "Investing" ;
    ns1:documentDate "2011-11-02T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "SMSI Raises $54.1 Million Series D Financing" ;
    ns1:documentURL <https://www.fierceelectronics.com/embedded/smsi-raises-54-1-million-series-d-financing> ;
    ns1:foundName "New Enterprise Associates" ;
    ns1:investor <https://1145.am/db/2443170/Equity_Investment_Anthem_Capital_Delphi_Ventures_Greenspring_Associates_Healthcare_Ventures_New_Enterprise_Associates_Sensors_For_Medicine_And_Science_Inc_Completed> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsHigh <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates> ;
    ns1:sameAsMedium <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Electronics" .

<https://1145.am/db/2628938/Sprint_Nextel> a org:Organization ;
    ns1:basedInLowRaw "America" ;
    ns1:description "partnering or purchasing a wireless operator" ;
    ns1:documentDate "2011-09-25T22:54:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Dish Network looking at partnering, acquiring wireless operator" ;
    ns1:documentURL <https://www.fiercewireless.com/tech/dish-network-looking-at-partnering-acquiring-wireless-operator> ;
    ns1:foundName "Sprint Nextel" ;
    ns1:name "Sprint Nextel" ;
    ns1:sameAsMedium <https://1145.am/db/1700728/Sprint_Nextel>,
        <https://1145.am/db/1922758/Sprint_Nextel>,
        <https://1145.am/db/2601654/Sprint_Nextel>,
        <https://1145.am/db/2603188/Sprint_Nextel>,
        <https://1145.am/db/2613768/Sprint_Nextel>,
        <https://1145.am/db/2618452/Sprint_Nextel>,
        <https://1145.am/db/2621979/Sprint_Nextel>,
        <https://1145.am/db/2623369/Sprint_Nextel>,
        <https://1145.am/db/2624044/Sprint_Nextel>,
        <https://1145.am/db/2624525/Sprint_Nextel>,
        <https://1145.am/db/2627059/Sprint_Nextel>,
        <https://1145.am/db/2629073/Sprint_Nextel>,
        <https://1145.am/db/2630836/Sprint_Nextel>,
        <https://1145.am/db/2633820/Sprint_Nextel>,
        <https://1145.am/db/2635673/Sprint_Nextel>,
        <https://1145.am/db/2635753/Sprint_Nextel>,
        <https://1145.am/db/2636424/Sprint_Nextel>,
        <https://1145.am/db/2637760/Sprint_Nextel>,
        <https://1145.am/db/2638532/Sprint_Nextel>,
        <https://1145.am/db/2639658/Sprint_Nextel>,
        <https://1145.am/db/2640151/Sprint_Nextel>,
        <https://1145.am/db/2641693/Sprint_Nextel>,
        <https://1145.am/db/2642428/Sprint_Nextel>,
        <https://1145.am/db/2642478/Sprint_Nextel>,
        <https://1145.am/db/2643537/Sprint_Nextel>,
        <https://1145.am/db/2645284/Sprint_Nextel>,
        <https://1145.am/db/2645977/Sprint_Nextel>,
        <https://1145.am/db/2646748/Sprint_Nextel>,
        <https://1145.am/db/2650873/Sprint_Nextel>,
        <https://1145.am/db/2652311/Sprint_Nextel>,
        <https://1145.am/db/2655732/Sprint_Nextel>,
        <https://1145.am/db/2658291/Sprint_Nextel>,
        <https://1145.am/db/2658589/Sprint_Nextel>,
        <https://1145.am/db/2659586/Sprint_Nextel>,
        <https://1145.am/db/2659587/Sprint_Nextel>,
        <https://1145.am/db/2659594/Sprint_Nextel>,
        <https://1145.am/db/2659601/Sprint_Nextel>,
        <https://1145.am/db/2659616/Sprint_Nextel>,
        <https://1145.am/db/2659619/Sprint_Nextel>,
        <https://1145.am/db/2659620/Sprint_Nextel>,
        <https://1145.am/db/2661271/Sprint_Nextel>,
        <https://1145.am/db/2661312/Sprint_Nextel>,
        <https://1145.am/db/2661735/Sprint_Nextel>,
        <https://1145.am/db/2662872/Sprint_Nextel>,
        <https://1145.am/db/2663091/Sprint_Nextel>,
        <https://1145.am/db/2663421/Sprint_Nextel>,
        <https://1145.am/db/2663923/Sprint_Nextel>,
        <https://1145.am/db/2663931/Sprint_Nextel>,
        <https://1145.am/db/2663933/Sprint_Nextel>,
        <https://1145.am/db/2663948/Sprint_Nextel>,
        <https://1145.am/db/2664500/Sprint_Nextel>,
        <https://1145.am/db/2665296/Sprint_Nextel>,
        <https://1145.am/db/2665579/Sprint_Nextel>,
        <https://1145.am/db/2666088/Sprint_Nextel>,
        <https://1145.am/db/2666977/Sprint_Nextel>,
        <https://1145.am/db/2667152/Sprint_Nextel>,
        <https://1145.am/db/2668031/Sprint_Nextel>,
        <https://1145.am/db/2668249/Sprint_Nextel>,
        <https://1145.am/db/2668825/Sprint_Nextel>,
        <https://1145.am/db/2669292/Sprint_Nextel>,
        <https://1145.am/db/2669341/Sprint_Nextel>,
        <https://1145.am/db/2669942/Sprint_Nextel>,
        <https://1145.am/db/2670436/Sprint_Nextel>,
        <https://1145.am/db/2670440/Sprint_Nextel>,
        <https://1145.am/db/2670504/Sprint_Nextel>,
        <https://1145.am/db/2671333/Sprint_Nextel>,
        <https://1145.am/db/2671590/Sprint_Nextel>,
        <https://1145.am/db/2671649/Sprint_Nextel>,
        <https://1145.am/db/2672759/Sprint_Nextel>,
        <https://1145.am/db/2672784/Sprint_Nextel>,
        <https://1145.am/db/2672793/Sprint_Nextel>,
        <https://1145.am/db/2673337/Sprint_Nextel>,
        <https://1145.am/db/2674457/Sprint_Nextel>,
        <https://1145.am/db/2674875/Sprint_Nextel>,
        <https://1145.am/db/2675179/Sprint_Nextel>,
        <https://1145.am/db/2675183/Sprint_Nextel>,
        <https://1145.am/db/2675704/Sprint_Nextel>,
        <https://1145.am/db/2676326/Sprint_Nextel>,
        <https://1145.am/db/2676361/Sprint_Nextel>,
        <https://1145.am/db/2676370/Sprint_Nextel>,
        <https://1145.am/db/2676975/Sprint_Nextel>,
        <https://1145.am/db/2676993/Sprint_Nextel>,
        <https://1145.am/db/2677327/Sprint_Nextel>,
        <https://1145.am/db/2678562/Sprint_Nextel>,
        <https://1145.am/db/2678731/Sprint_Nextel>,
        <https://1145.am/db/2678748/Sprint_Nextel>,
        <https://1145.am/db/2678777/Sprint_Nextel>,
        <https://1145.am/db/2678781/Sprint_Nextel>,
        <https://1145.am/db/2679694/Sprint_Nextel>,
        <https://1145.am/db/2680061/Sprint_Nextel>,
        <https://1145.am/db/2681522/Sprint_Nextel>,
        <https://1145.am/db/2682580/Sprint_Nextel>,
        <https://1145.am/db/2682983/Sprint_Nextel>,
        <https://1145.am/db/2683612/Sprint_Nextel>,
        <https://1145.am/db/2683681/Sprint_Nextel>,
        <https://1145.am/db/2683726/Sprint_Nextel>,
        <https://1145.am/db/2684103/Sprint_Nextel>,
        <https://1145.am/db/2684413/Sprint_Nextel>,
        <https://1145.am/db/2684884/Sprint_Nextel>,
        <https://1145.am/db/2685112/Sprint_Nextel>,
        <https://1145.am/db/2685113/Sprint_Nextel>,
        <https://1145.am/db/2685267/Sprint_Nextel>,
        <https://1145.am/db/2686032/Sprint_Nextel>,
        <https://1145.am/db/2686200/Sprint_Nextel> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2663406/T-Mobile_Usa> a org:Organization ;
    ns1:basedInHighGeoName "United States" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:basedInHighRaw "USA" ;
    ns1:basedInLowRaw "USA" ;
    ns1:description "consumers" ;
    ns1:documentDate "2011-09-02T14:17:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: AT&T could divest up to 25% of T-Mobile to win approval for deal" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-at-t-could-divest-up-to-25-t-mobile-to-win-approval-for-deal> ;
    ns1:foundName "T-Mobile",
        "T-Mobile USA" ;
    ns1:name "T-Mobile",
        "T-Mobile USA" ;
    ns1:sameAsHigh <https://1145.am/db/2658539/T-Mobile>,
        <https://1145.am/db/2658575/T-Mobile_Usa>,
        <https://1145.am/db/2671029/T-Mobile_Usa> ;
    ns1:sameAsMedium <https://1145.am/db/1325578/T-Mobile_Us_Inc>,
        <https://1145.am/db/1333909/T-Mobile_Us>,
        <https://1145.am/db/1335192/T-Mobile_Usa>,
        <https://1145.am/db/1335249/T-Mobile_Usa>,
        <https://1145.am/db/1338725/T-Mobile_Us>,
        <https://1145.am/db/1673449/T-Mobile_Us>,
        <https://1145.am/db/1682956/T-Mobile_Us>,
        <https://1145.am/db/1845755/T-Mobile_Us>,
        <https://1145.am/db/1849778/T-Mobile_Usa>,
        <https://1145.am/db/1938719/T-Mobile_Us_Inc>,
        <https://1145.am/db/2050728/T-Mobile_Us>,
        <https://1145.am/db/2113124/T-Mobile_Usa>,
        <https://1145.am/db/2113624/T-Mobile_Us>,
        <https://1145.am/db/2156872/T-Mobile_Us>,
        <https://1145.am/db/2160856/T-Mobile_Us>,
        <https://1145.am/db/2624400/T-Mobile_Usa>,
        <https://1145.am/db/2625058/T-Mobile_Usa>,
        <https://1145.am/db/2625764/T-Mobile_Usa>,
        <https://1145.am/db/2625808/T-Mobile_Usa>,
        <https://1145.am/db/2627253/T-Mobile_Usa>,
        <https://1145.am/db/2627982/T-Mobile_Usa>,
        <https://1145.am/db/2628029/T-Mobile_Usa>,
        <https://1145.am/db/2628936/T-Mobile_Usa>,
        <https://1145.am/db/2628948/T-Mobile_Usa>,
        <https://1145.am/db/2629910/T-Mobile_Usa>,
        <https://1145.am/db/2630839/T-Mobile_Usa>,
        <https://1145.am/db/2639641/T-Mobile_Usa>,
        <https://1145.am/db/2640440/T-Mobile_Usa>,
        <https://1145.am/db/2640631/T-Mobile_Usa>,
        <https://1145.am/db/2643007/T-Mobile_Usa>,
        <https://1145.am/db/2644928/T-Mobile_Us>,
        <https://1145.am/db/2645879/T-Mobile_Us>,
        <https://1145.am/db/2650593/T-Mobile_Us>,
        <https://1145.am/db/2651447/T-Mobile_Usa>,
        <https://1145.am/db/2653683/T-Mobile_Us>,
        <https://1145.am/db/2653777/T-Mobile_Usa>,
        <https://1145.am/db/2654246/T-Mobile_Us>,
        <https://1145.am/db/2654263/T-Mobile_Us>,
        <https://1145.am/db/2655150/T-Mobile_Us>,
        <https://1145.am/db/2655154/T-Mobile_Us>,
        <https://1145.am/db/2656030/T-Mobile_Us>,
        <https://1145.am/db/2656226/T-Mobile_Us>,
        <https://1145.am/db/2656851/T-Mobile_Usa>,
        <https://1145.am/db/2657573/T-Mobile_Usa>,
        <https://1145.am/db/2658024/T-Mobile_Us>,
        <https://1145.am/db/2658043/T-Mobile_Us>,
        <https://1145.am/db/2658068/T-Mobile_Us>,
        <https://1145.am/db/2658213/T-Mobile_Us>,
        <https://1145.am/db/2658466/T-Mobile_Usa>,
        <https://1145.am/db/2658550/T-Mobile_Usa>,
        <https://1145.am/db/2658574/T-Mobile_Usa>,
        <https://1145.am/db/2659586/T-Mobile_Usa>,
        <https://1145.am/db/2659597/T-Mobile_Usa>,
        <https://1145.am/db/2661143/T-Mobile_Us>,
        <https://1145.am/db/2661274/T-Mobile_Usa>,
        <https://1145.am/db/2661290/T-Mobile_Usa>,
        <https://1145.am/db/2661405/T-Mobile_Us>,
        <https://1145.am/db/2661443/T-Mobile_Us>,
        <https://1145.am/db/2661680/T-Mobile_Usa>,
        <https://1145.am/db/2662808/T-Mobile_Usa>,
        <https://1145.am/db/2662860/T-Mobile_Usa>,
        <https://1145.am/db/2663146/T-Mobile_Us>,
        <https://1145.am/db/2663421/T-Mobile_Usa>,
        <https://1145.am/db/2663473/T-Mobile_Usa>,
        <https://1145.am/db/2663892/T-Mobile_Usa>,
        <https://1145.am/db/2664422/T-Mobile_Us>,
        <https://1145.am/db/2664500/T-Mobile_Usa>,
        <https://1145.am/db/2664505/T-Mobile_Usa>,
        <https://1145.am/db/2664517/T-Mobile_Usa>,
        <https://1145.am/db/2664547/T-Mobile_Usa>,
        <https://1145.am/db/2664692/T-Mobile_Us>,
        <https://1145.am/db/2665477/T-Mobile_Us>,
        <https://1145.am/db/2665579/T-Mobile_Usa>,
        <https://1145.am/db/2666714/T-Mobile_Usa>,
        <https://1145.am/db/2667620/T-Mobile_Us>,
        <https://1145.am/db/2668208/T-Mobile_Usa>,
        <https://1145.am/db/2668212/T-Mobile_Usa>,
        <https://1145.am/db/2668226/T-Mobile_Usa>,
        <https://1145.am/db/2668687/T-Mobile_Us>,
        <https://1145.am/db/2668814/T-Mobile_Usa>,
        <https://1145.am/db/2669319/T-Mobile_Usa>,
        <https://1145.am/db/2669321/T-Mobile_Usa>,
        <https://1145.am/db/2669338/T-Mobile_Usa>,
        <https://1145.am/db/2669512/T-Mobile_Us>,
        <https://1145.am/db/2669881/T-Mobile_Usa>,
        <https://1145.am/db/2669920/T-Mobile_Usa>,
        <https://1145.am/db/2669926/T-Mobile_Usa>,
        <https://1145.am/db/2670397/T-Mobile_Usa>,
        <https://1145.am/db/2671585/T-Mobile_Usa>,
        <https://1145.am/db/2671623/T-Mobile_Usa>,
        <https://1145.am/db/2671629/T-Mobile_Usa>,
        <https://1145.am/db/2672172/T-Mobile_Usa>,
        <https://1145.am/db/2672184/T-Mobile_Usa>,
        <https://1145.am/db/2673934/T-Mobile_Usa>,
        <https://1145.am/db/2674405/T-Mobile_Us>,
        <https://1145.am/db/2675647/T-Mobile_Us>,
        <https://1145.am/db/2676846/T-Mobile_Us>,
        <https://1145.am/db/2677262/T-Mobile_Usa>,
        <https://1145.am/db/2677564/T-Mobile_Us>,
        <https://1145.am/db/2677884/T-Mobile_Us>,
        <https://1145.am/db/2678023/T-Mobile_Us>,
        <https://1145.am/db/2679803/T-Mobile_Usa>,
        <https://1145.am/db/2679871/T-Mobile_Us>,
        <https://1145.am/db/2680365/T-Mobile_Usa>,
        <https://1145.am/db/2681282/T-Mobile_Usa>,
        <https://1145.am/db/2681407/T-Mobile_Us>,
        <https://1145.am/db/2681734/T-Mobile_Us>,
        <https://1145.am/db/2681889/T-Mobile_Us>,
        <https://1145.am/db/2682066/T-Mobile_Usa>,
        <https://1145.am/db/2682450/T-Mobile_Us>,
        <https://1145.am/db/2682698/T-Mobile_Usa>,
        <https://1145.am/db/2683912/T-Mobile_Usa>,
        <https://1145.am/db/2684079/T-Mobile_Usa>,
        <https://1145.am/db/2684148/T-Mobile_Us>,
        <https://1145.am/db/2684705/T-Mobile_Usa>,
        <https://1145.am/db/2685202/T-Mobile_Usa>,
        <https://1145.am/db/2685245/T-Mobile_Usa>,
        <https://1145.am/db/2685254/T-Mobile_Usa>,
        <https://1145.am/db/2685267/T-Mobile_Usa>,
        <https://1145.am/db/2685271/T-Mobile_Usa>,
        <https://1145.am/db/2685285/T-Mobile_Usa>,
        <https://1145.am/db/2685505/T-Mobile_Usa>,
        <https://1145.am/db/2685618/T-Mobile_Usa>,
        <https://1145.am/db/2685624/T-Mobile_Usa>,
        <https://1145.am/db/2685654/T-Mobile_Usa>,
        <https://1145.am/db/2685762/T-Mobile_Usa>,
        <https://1145.am/db/2685783/T-Mobile_Usa>,
        <https://1145.am/db/2685799/T-Mobile_Usa>,
        <https://1145.am/db/2685811/T-Mobile_Usa>,
        <https://1145.am/db/2685884/T-Mobile_Usa>,
        <https://1145.am/db/2685930/T-Mobile_Usa>,
        <https://1145.am/db/2685940/T-Mobile_Usa>,
        <https://1145.am/db/2686023/T-Mobile_Usa>,
        <https://1145.am/db/2686200/T-Mobile_Usa>,
        <https://1145.am/db/398217/T-Mobile_Us>,
        <https://1145.am/db/461272/T-Mobile_Us_Inc>,
        <https://1145.am/db/479322/T-Mobile_Us>,
        <https://1145.am/db/480217/T-Mobile_Us>,
        <https://1145.am/db/662586/T-Mobile_Usa>,
        <https://1145.am/db/665472/T-Mobile_Usa>,
        <https://1145.am/db/667175/T-Mobile_Usa>,
        <https://1145.am/db/97818/T-Mobile_Us> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2664500/T-Mobile_Usa> a org:Organization ;
    ns1:basedInLowRaw "USA" ;
    ns1:description "Business" ;
    ns1:documentDate "2011-09-19T14:18:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: AT&T reaches out to Sprint, MetroPCS, Leap on T-Mobile asset sales" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-at-t-reaches-out-to-sprint-metropcs-leap-t-mobile-asset-sales> ;
    ns1:foundName "T-Mobile USA" ;
    ns1:name "T-Mobile USA" ;
    ns1:sameAsHigh <https://1145.am/db/1682956/T-Mobile_Us>,
        <https://1145.am/db/1938719/T-Mobile_Us_Inc>,
        <https://1145.am/db/2050728/T-Mobile_Us>,
        <https://1145.am/db/2163191/T-Mobile>,
        <https://1145.am/db/2165344/T-Mobile>,
        <https://1145.am/db/2624400/T-Mobile_Usa>,
        <https://1145.am/db/2625058/T-Mobile_Usa>,
        <https://1145.am/db/2628029/T-Mobile_Usa>,
        <https://1145.am/db/2628936/T-Mobile_Usa>,
        <https://1145.am/db/2629910/T-Mobile_Usa>,
        <https://1145.am/db/2645770/T-Mobile>,
        <https://1145.am/db/2652628/Deutsche_Telekom>,
        <https://1145.am/db/2653683/T-Mobile_Us>,
        <https://1145.am/db/2653777/T-Mobile_Usa>,
        <https://1145.am/db/2655430/T-Mobile>,
        <https://1145.am/db/2656851/T-Mobile_Usa>,
        <https://1145.am/db/2658466/T-Mobile_Usa>,
        <https://1145.am/db/2659586/T-Mobile_Usa>,
        <https://1145.am/db/2659631/T-Mobile>,
        <https://1145.am/db/2661443/T-Mobile_Us>,
        <https://1145.am/db/2662383/T-Mobile>,
        <https://1145.am/db/2662808/T-Mobile_Usa>,
        <https://1145.am/db/2662969/T-Mobile_Uk>,
        <https://1145.am/db/2663146/T-Mobile_Us>,
        <https://1145.am/db/2664505/T-Mobile_Usa>,
        <https://1145.am/db/2664692/T-Mobile_Us>,
        <https://1145.am/db/2665579/T-Mobile_Usa>,
        <https://1145.am/db/2667620/T-Mobile_Us>,
        <https://1145.am/db/2668208/T-Mobile_Usa>,
        <https://1145.am/db/2668814/T-Mobile_Usa>,
        <https://1145.am/db/2670397/T-Mobile_Usa>,
        <https://1145.am/db/2674405/T-Mobile_Us>,
        <https://1145.am/db/2674444/Deutsche_Telekom>,
        <https://1145.am/db/2675647/T-Mobile_Us>,
        <https://1145.am/db/2676846/T-Mobile_Us>,
        <https://1145.am/db/2678023/T-Mobile_Us>,
        <https://1145.am/db/2679871/T-Mobile_Us>,
        <https://1145.am/db/2680365/T-Mobile_Usa>,
        <https://1145.am/db/2681407/T-Mobile_Us>,
        <https://1145.am/db/2685243/T-Mobile>,
        <https://1145.am/db/2686023/T-Mobile_Usa>,
        <https://1145.am/db/338081/T-Mobile>,
        <https://1145.am/db/398217/T-Mobile_Us>,
        <https://1145.am/db/453209/T-Mobile> ;
    ns1:sameAsMedium <https://1145.am/db/1325578/T-Mobile_Us_Inc>,
        <https://1145.am/db/1333909/T-Mobile_Us>,
        <https://1145.am/db/1335192/T-Mobile_Usa>,
        <https://1145.am/db/1335249/T-Mobile_Usa>,
        <https://1145.am/db/1338725/T-Mobile_Us>,
        <https://1145.am/db/1673449/T-Mobile_Us>,
        <https://1145.am/db/1845755/T-Mobile_Us>,
        <https://1145.am/db/1849778/T-Mobile_Usa>,
        <https://1145.am/db/2113124/T-Mobile_Usa>,
        <https://1145.am/db/2113624/T-Mobile_Us>,
        <https://1145.am/db/2156872/T-Mobile_Us>,
        <https://1145.am/db/2160856/T-Mobile_Us>,
        <https://1145.am/db/2625764/T-Mobile_Usa>,
        <https://1145.am/db/2625808/T-Mobile_Usa>,
        <https://1145.am/db/2627253/T-Mobile_Usa>,
        <https://1145.am/db/2627982/T-Mobile_Usa>,
        <https://1145.am/db/2628948/T-Mobile_Usa>,
        <https://1145.am/db/2630839/T-Mobile_Usa>,
        <https://1145.am/db/2639641/T-Mobile_Usa>,
        <https://1145.am/db/2640440/T-Mobile_Usa>,
        <https://1145.am/db/2640631/T-Mobile_Usa>,
        <https://1145.am/db/2643007/T-Mobile_Usa>,
        <https://1145.am/db/2644928/T-Mobile_Us>,
        <https://1145.am/db/2645879/T-Mobile_Us>,
        <https://1145.am/db/2650593/T-Mobile_Us>,
        <https://1145.am/db/2651447/T-Mobile_Usa>,
        <https://1145.am/db/2654246/T-Mobile_Us>,
        <https://1145.am/db/2654263/T-Mobile_Us>,
        <https://1145.am/db/2655150/T-Mobile_Us>,
        <https://1145.am/db/2655154/T-Mobile_Us>,
        <https://1145.am/db/2656030/T-Mobile_Us>,
        <https://1145.am/db/2656226/T-Mobile_Us>,
        <https://1145.am/db/2657573/T-Mobile_Usa>,
        <https://1145.am/db/2658024/T-Mobile_Us>,
        <https://1145.am/db/2658043/T-Mobile_Us>,
        <https://1145.am/db/2658068/T-Mobile_Us>,
        <https://1145.am/db/2658213/T-Mobile_Us>,
        <https://1145.am/db/2658550/T-Mobile_Usa>,
        <https://1145.am/db/2658574/T-Mobile_Usa>,
        <https://1145.am/db/2658575/T-Mobile_Usa>,
        <https://1145.am/db/2659597/T-Mobile_Usa>,
        <https://1145.am/db/2661143/T-Mobile_Us>,
        <https://1145.am/db/2661274/T-Mobile_Usa>,
        <https://1145.am/db/2661290/T-Mobile_Usa>,
        <https://1145.am/db/2661405/T-Mobile_Us>,
        <https://1145.am/db/2661680/T-Mobile_Usa>,
        <https://1145.am/db/2662860/T-Mobile_Usa>,
        <https://1145.am/db/2663406/T-Mobile_Usa>,
        <https://1145.am/db/2663421/T-Mobile_Usa>,
        <https://1145.am/db/2663473/T-Mobile_Usa>,
        <https://1145.am/db/2663892/T-Mobile_Usa>,
        <https://1145.am/db/2664422/T-Mobile_Us>,
        <https://1145.am/db/2664517/T-Mobile_Usa>,
        <https://1145.am/db/2664547/T-Mobile_Usa>,
        <https://1145.am/db/2665477/T-Mobile_Us>,
        <https://1145.am/db/2666714/T-Mobile_Usa>,
        <https://1145.am/db/2668212/T-Mobile_Usa>,
        <https://1145.am/db/2668226/T-Mobile_Usa>,
        <https://1145.am/db/2668687/T-Mobile_Us>,
        <https://1145.am/db/2669319/T-Mobile_Usa>,
        <https://1145.am/db/2669321/T-Mobile_Usa>,
        <https://1145.am/db/2669338/T-Mobile_Usa>,
        <https://1145.am/db/2669512/T-Mobile_Us>,
        <https://1145.am/db/2669881/T-Mobile_Usa>,
        <https://1145.am/db/2669920/T-Mobile_Usa>,
        <https://1145.am/db/2669926/T-Mobile_Usa>,
        <https://1145.am/db/2671029/T-Mobile_Usa>,
        <https://1145.am/db/2671585/T-Mobile_Usa>,
        <https://1145.am/db/2671623/T-Mobile_Usa>,
        <https://1145.am/db/2671629/T-Mobile_Usa>,
        <https://1145.am/db/2672172/T-Mobile_Usa>,
        <https://1145.am/db/2672184/T-Mobile_Usa>,
        <https://1145.am/db/2673934/T-Mobile_Usa>,
        <https://1145.am/db/2677262/T-Mobile_Usa>,
        <https://1145.am/db/2677564/T-Mobile_Us>,
        <https://1145.am/db/2677884/T-Mobile_Us>,
        <https://1145.am/db/2679803/T-Mobile_Usa>,
        <https://1145.am/db/2681282/T-Mobile_Usa>,
        <https://1145.am/db/2681734/T-Mobile_Us>,
        <https://1145.am/db/2681889/T-Mobile_Us>,
        <https://1145.am/db/2682066/T-Mobile_Usa>,
        <https://1145.am/db/2682450/T-Mobile_Us>,
        <https://1145.am/db/2682698/T-Mobile_Usa>,
        <https://1145.am/db/2683912/T-Mobile_Usa>,
        <https://1145.am/db/2684079/T-Mobile_Usa>,
        <https://1145.am/db/2684148/T-Mobile_Us>,
        <https://1145.am/db/2684705/T-Mobile_Usa>,
        <https://1145.am/db/2685202/T-Mobile_Usa>,
        <https://1145.am/db/2685245/T-Mobile_Usa>,
        <https://1145.am/db/2685254/T-Mobile_Usa>,
        <https://1145.am/db/2685267/T-Mobile_Usa>,
        <https://1145.am/db/2685271/T-Mobile_Usa>,
        <https://1145.am/db/2685285/T-Mobile_Usa>,
        <https://1145.am/db/2685505/T-Mobile_Usa>,
        <https://1145.am/db/2685618/T-Mobile_Usa>,
        <https://1145.am/db/2685624/T-Mobile_Usa>,
        <https://1145.am/db/2685654/T-Mobile_Usa>,
        <https://1145.am/db/2685762/T-Mobile_Usa>,
        <https://1145.am/db/2685783/T-Mobile_Usa>,
        <https://1145.am/db/2685799/T-Mobile_Usa>,
        <https://1145.am/db/2685811/T-Mobile_Usa>,
        <https://1145.am/db/2685884/T-Mobile_Usa>,
        <https://1145.am/db/2685930/T-Mobile_Usa>,
        <https://1145.am/db/2685940/T-Mobile_Usa>,
        <https://1145.am/db/2686200/T-Mobile_Usa>,
        <https://1145.am/db/461272/T-Mobile_Us_Inc>,
        <https://1145.am/db/479322/T-Mobile_Us>,
        <https://1145.am/db/480217/T-Mobile_Us>,
        <https://1145.am/db/662586/T-Mobile_Usa>,
        <https://1145.am/db/665472/T-Mobile_Usa>,
        <https://1145.am/db/667175/T-Mobile_Usa>,
        <https://1145.am/db/97818/T-Mobile_Us> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2664500/T-Mobile_Usa_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-09-19T14:18:39+00:00"^^xsd:dateTime ;
    ns1:documentExtract "AT & T (NYSE: T) has been in touch with rivals including Sprint Nextel (NYSE: S) , MetroPCS (NASDAQ: PCS) and Leap Wireless (NASDAQ: LEAP) to discuss selling spectrum and customers in a bid to save its proposed $ 39 billion acquisition of T-Mobile USA, according to a Bloomberg report." ;
    ns1:documentTitle "Report: AT&T reaches out to Sprint, MetroPCS, Leap on T-Mobile asset sales" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-at-t-reaches-out-to-sprint-metropcs-leap-t-mobile-asset-sales> ;
    ns1:foundName "acquisition",
        "selling" ;
    ns1:name "acquisition",
        "selling" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "stopped" ;
    ns1:target <https://1145.am/db/2664500/T-Mobile_Usa> ;
    ns1:targetName "T-Mobile USA" ;
    ns1:valueRaw "$ 39 billion" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "USA" .

<https://1145.am/db/2664505/T-Mobile_Usa> a org:Organization ;
    ns1:basedInLowRaw "USA" ;
    ns1:description "business" ;
    ns1:documentDate "2011-09-20T10:30:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "What are the most controversial (and brilliant) wireless business ideas of the past decade?" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/what-are-most-controversial-and-brilliant-wireless-business-ideas-past-decade> ;
    ns1:foundName "T-Mobile USA" ;
    ns1:industry "wireless" ;
    ns1:name "T-Mobile USA" ;
    ns1:sameAsHigh <https://1145.am/db/1682956/T-Mobile_Us>,
        <https://1145.am/db/1706069/T-Mobile>,
        <https://1145.am/db/1729077/T-Mobile_Uk>,
        <https://1145.am/db/1786440/T-Mobile>,
        <https://1145.am/db/1845755/T-Mobile_Us>,
        <https://1145.am/db/1849778/T-Mobile_Usa>,
        <https://1145.am/db/1938719/T-Mobile_Us_Inc>,
        <https://1145.am/db/2050728/T-Mobile_Us>,
        <https://1145.am/db/2160856/T-Mobile_Us>,
        <https://1145.am/db/2162996/T-Mobile>,
        <https://1145.am/db/2163191/T-Mobile>,
        <https://1145.am/db/2165344/T-Mobile>,
        <https://1145.am/db/2624400/T-Mobile_Usa>,
        <https://1145.am/db/2625058/T-Mobile_Usa>,
        <https://1145.am/db/2625764/T-Mobile_Usa>,
        <https://1145.am/db/2626176/T-Mobile>,
        <https://1145.am/db/2628029/T-Mobile_Usa>,
        <https://1145.am/db/2628936/T-Mobile_Usa>,
        <https://1145.am/db/2629910/T-Mobile_Usa>,
        <https://1145.am/db/2633551/T-Mobile>,
        <https://1145.am/db/2636340/T-Mobile>,
        <https://1145.am/db/2640339/T-Mobile>,
        <https://1145.am/db/2645770/T-Mobile>,
        <https://1145.am/db/2646883/T-Mobile>,
        <https://1145.am/db/2648336/T-Mobile>,
        <https://1145.am/db/2650593/T-Mobile_Us>,
        <https://1145.am/db/2652628/Deutsche_Telekom>,
        <https://1145.am/db/2653683/T-Mobile_Us>,
        <https://1145.am/db/2653777/T-Mobile_Usa>,
        <https://1145.am/db/2655150/T-Mobile_Us>,
        <https://1145.am/db/2655430/T-Mobile>,
        <https://1145.am/db/2656030/T-Mobile_Us>,
        <https://1145.am/db/2656851/T-Mobile_Usa>,
        <https://1145.am/db/2657573/T-Mobile_Usa>,
        <https://1145.am/db/2658466/T-Mobile_Usa>,
        <https://1145.am/db/2659586/T-Mobile_Usa>,
        <https://1145.am/db/2659631/T-Mobile>,
        <https://1145.am/db/2661443/T-Mobile_Us>,
        <https://1145.am/db/2662383/T-Mobile>,
        <https://1145.am/db/2662808/T-Mobile_Usa>,
        <https://1145.am/db/2662969/T-Mobile_Uk>,
        <https://1145.am/db/2663146/T-Mobile_Us>,
        <https://1145.am/db/2663473/T-Mobile_Usa>,
        <https://1145.am/db/2664500/T-Mobile_Usa>,
        <https://1145.am/db/2664692/T-Mobile_Us>,
        <https://1145.am/db/2665579/T-Mobile_Usa>,
        <https://1145.am/db/2667222/T-Mobile>,
        <https://1145.am/db/2667612/T-Mobile>,
        <https://1145.am/db/2667620/T-Mobile_Us>,
        <https://1145.am/db/2668208/T-Mobile_Usa>,
        <https://1145.am/db/2668814/T-Mobile_Usa>,
        <https://1145.am/db/2669926/T-Mobile_Usa>,
        <https://1145.am/db/2670397/T-Mobile_Usa>,
        <https://1145.am/db/2672184/T-Mobile_Usa>,
        <https://1145.am/db/2674405/T-Mobile_Us>,
        <https://1145.am/db/2674444/Deutsche_Telekom>,
        <https://1145.am/db/2675647/T-Mobile_Us>,
        <https://1145.am/db/2676846/T-Mobile_Us>,
        <https://1145.am/db/2678023/T-Mobile_Us>,
        <https://1145.am/db/2679871/T-Mobile_Us>,
        <https://1145.am/db/2680365/T-Mobile_Usa>,
        <https://1145.am/db/2681407/T-Mobile_Us>,
        <https://1145.am/db/2682450/T-Mobile_Us>,
        <https://1145.am/db/2685243/T-Mobile>,
        <https://1145.am/db/2685271/T-Mobile_Usa>,
        <https://1145.am/db/2685285/T-Mobile_Usa>,
        <https://1145.am/db/2685526/T-Mobile>,
        <https://1145.am/db/2686023/T-Mobile_Usa>,
        <https://1145.am/db/338081/T-Mobile>,
        <https://1145.am/db/398217/T-Mobile_Us>,
        <https://1145.am/db/453209/T-Mobile> ;
    ns1:sameAsMedium <https://1145.am/db/1325578/T-Mobile_Us_Inc>,
        <https://1145.am/db/1333909/T-Mobile_Us>,
        <https://1145.am/db/1335192/T-Mobile_Usa>,
        <https://1145.am/db/1335249/T-Mobile_Usa>,
        <https://1145.am/db/1338725/T-Mobile_Us>,
        <https://1145.am/db/1673449/T-Mobile_Us>,
        <https://1145.am/db/2113124/T-Mobile_Usa>,
        <https://1145.am/db/2113624/T-Mobile_Us>,
        <https://1145.am/db/2156872/T-Mobile_Us>,
        <https://1145.am/db/2625808/T-Mobile_Usa>,
        <https://1145.am/db/2627253/T-Mobile_Usa>,
        <https://1145.am/db/2627982/T-Mobile_Usa>,
        <https://1145.am/db/2628948/T-Mobile_Usa>,
        <https://1145.am/db/2630839/T-Mobile_Usa>,
        <https://1145.am/db/2639641/T-Mobile_Usa>,
        <https://1145.am/db/2640440/T-Mobile_Usa>,
        <https://1145.am/db/2640631/T-Mobile_Usa>,
        <https://1145.am/db/2643007/T-Mobile_Usa>,
        <https://1145.am/db/2644928/T-Mobile_Us>,
        <https://1145.am/db/2645879/T-Mobile_Us>,
        <https://1145.am/db/2651447/T-Mobile_Usa>,
        <https://1145.am/db/2654246/T-Mobile_Us>,
        <https://1145.am/db/2654263/T-Mobile_Us>,
        <https://1145.am/db/2655154/T-Mobile_Us>,
        <https://1145.am/db/2656226/T-Mobile_Us>,
        <https://1145.am/db/2658024/T-Mobile_Us>,
        <https://1145.am/db/2658043/T-Mobile_Us>,
        <https://1145.am/db/2658068/T-Mobile_Us>,
        <https://1145.am/db/2658213/T-Mobile_Us>,
        <https://1145.am/db/2658550/T-Mobile_Usa>,
        <https://1145.am/db/2658574/T-Mobile_Usa>,
        <https://1145.am/db/2658575/T-Mobile_Usa>,
        <https://1145.am/db/2659597/T-Mobile_Usa>,
        <https://1145.am/db/2661143/T-Mobile_Us>,
        <https://1145.am/db/2661274/T-Mobile_Usa>,
        <https://1145.am/db/2661290/T-Mobile_Usa>,
        <https://1145.am/db/2661405/T-Mobile_Us>,
        <https://1145.am/db/2661680/T-Mobile_Usa>,
        <https://1145.am/db/2662860/T-Mobile_Usa>,
        <https://1145.am/db/2663406/T-Mobile_Usa>,
        <https://1145.am/db/2663421/T-Mobile_Usa>,
        <https://1145.am/db/2663892/T-Mobile_Usa>,
        <https://1145.am/db/2664422/T-Mobile_Us>,
        <https://1145.am/db/2664517/T-Mobile_Usa>,
        <https://1145.am/db/2664547/T-Mobile_Usa>,
        <https://1145.am/db/2665477/T-Mobile_Us>,
        <https://1145.am/db/2666714/T-Mobile_Usa>,
        <https://1145.am/db/2668212/T-Mobile_Usa>,
        <https://1145.am/db/2668226/T-Mobile_Usa>,
        <https://1145.am/db/2668687/T-Mobile_Us>,
        <https://1145.am/db/2669319/T-Mobile_Usa>,
        <https://1145.am/db/2669321/T-Mobile_Usa>,
        <https://1145.am/db/2669338/T-Mobile_Usa>,
        <https://1145.am/db/2669512/T-Mobile_Us>,
        <https://1145.am/db/2669881/T-Mobile_Usa>,
        <https://1145.am/db/2669920/T-Mobile_Usa>,
        <https://1145.am/db/2671029/T-Mobile_Usa>,
        <https://1145.am/db/2671585/T-Mobile_Usa>,
        <https://1145.am/db/2671623/T-Mobile_Usa>,
        <https://1145.am/db/2671629/T-Mobile_Usa>,
        <https://1145.am/db/2672172/T-Mobile_Usa>,
        <https://1145.am/db/2673934/T-Mobile_Usa>,
        <https://1145.am/db/2677262/T-Mobile_Usa>,
        <https://1145.am/db/2677564/T-Mobile_Us>,
        <https://1145.am/db/2677884/T-Mobile_Us>,
        <https://1145.am/db/2679803/T-Mobile_Usa>,
        <https://1145.am/db/2681282/T-Mobile_Usa>,
        <https://1145.am/db/2681734/T-Mobile_Us>,
        <https://1145.am/db/2681889/T-Mobile_Us>,
        <https://1145.am/db/2682066/T-Mobile_Usa>,
        <https://1145.am/db/2682698/T-Mobile_Usa>,
        <https://1145.am/db/2683912/T-Mobile_Usa>,
        <https://1145.am/db/2684079/T-Mobile_Usa>,
        <https://1145.am/db/2684148/T-Mobile_Us>,
        <https://1145.am/db/2684705/T-Mobile_Usa>,
        <https://1145.am/db/2685202/T-Mobile_Usa>,
        <https://1145.am/db/2685245/T-Mobile_Usa>,
        <https://1145.am/db/2685254/T-Mobile_Usa>,
        <https://1145.am/db/2685267/T-Mobile_Usa>,
        <https://1145.am/db/2685505/T-Mobile_Usa>,
        <https://1145.am/db/2685618/T-Mobile_Usa>,
        <https://1145.am/db/2685624/T-Mobile_Usa>,
        <https://1145.am/db/2685654/T-Mobile_Usa>,
        <https://1145.am/db/2685762/T-Mobile_Usa>,
        <https://1145.am/db/2685783/T-Mobile_Usa>,
        <https://1145.am/db/2685799/T-Mobile_Usa>,
        <https://1145.am/db/2685811/T-Mobile_Usa>,
        <https://1145.am/db/2685884/T-Mobile_Usa>,
        <https://1145.am/db/2685930/T-Mobile_Usa>,
        <https://1145.am/db/2685940/T-Mobile_Usa>,
        <https://1145.am/db/2686200/T-Mobile_Usa>,
        <https://1145.am/db/461272/T-Mobile_Us_Inc>,
        <https://1145.am/db/479322/T-Mobile_Us>,
        <https://1145.am/db/480217/T-Mobile_Us>,
        <https://1145.am/db/662586/T-Mobile_Usa>,
        <https://1145.am/db/665472/T-Mobile_Usa>,
        <https://1145.am/db/667175/T-Mobile_Usa>,
        <https://1145.am/db/97818/T-Mobile_Us> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2672172/T-Mobile_Usa> a org:Organization ;
    ns1:basedInLowRaw "USA" ;
    ns1:documentDate "2011-12-19T15:16:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: AT&T's attempts to sell off T-Mobile assets hit dead end" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-at-t-s-attempts-to-sell-off-t-mobile-assets-hit-dead-end> ;
    ns1:foundName "T-Mobile USA" ;
    ns1:name "T-Mobile USA" ;
    ns1:sameAsMedium <https://1145.am/db/1325578/T-Mobile_Us_Inc>,
        <https://1145.am/db/1333909/T-Mobile_Us>,
        <https://1145.am/db/1335192/T-Mobile_Usa>,
        <https://1145.am/db/1335249/T-Mobile_Usa>,
        <https://1145.am/db/1338725/T-Mobile_Us>,
        <https://1145.am/db/1673449/T-Mobile_Us>,
        <https://1145.am/db/1682956/T-Mobile_Us>,
        <https://1145.am/db/1845755/T-Mobile_Us>,
        <https://1145.am/db/1849778/T-Mobile_Usa>,
        <https://1145.am/db/1938719/T-Mobile_Us_Inc>,
        <https://1145.am/db/2050728/T-Mobile_Us>,
        <https://1145.am/db/2113124/T-Mobile_Usa>,
        <https://1145.am/db/2113624/T-Mobile_Us>,
        <https://1145.am/db/2156872/T-Mobile_Us>,
        <https://1145.am/db/2160856/T-Mobile_Us>,
        <https://1145.am/db/2624400/T-Mobile_Usa>,
        <https://1145.am/db/2625058/T-Mobile_Usa>,
        <https://1145.am/db/2625764/T-Mobile_Usa>,
        <https://1145.am/db/2625808/T-Mobile_Usa>,
        <https://1145.am/db/2627253/T-Mobile_Usa>,
        <https://1145.am/db/2627982/T-Mobile_Usa>,
        <https://1145.am/db/2628029/T-Mobile_Usa>,
        <https://1145.am/db/2628936/T-Mobile_Usa>,
        <https://1145.am/db/2628948/T-Mobile_Usa>,
        <https://1145.am/db/2629910/T-Mobile_Usa>,
        <https://1145.am/db/2630839/T-Mobile_Usa>,
        <https://1145.am/db/2639641/T-Mobile_Usa>,
        <https://1145.am/db/2640440/T-Mobile_Usa>,
        <https://1145.am/db/2640631/T-Mobile_Usa>,
        <https://1145.am/db/2643007/T-Mobile_Usa>,
        <https://1145.am/db/2644928/T-Mobile_Us>,
        <https://1145.am/db/2645879/T-Mobile_Us>,
        <https://1145.am/db/2650593/T-Mobile_Us>,
        <https://1145.am/db/2651447/T-Mobile_Usa>,
        <https://1145.am/db/2653683/T-Mobile_Us>,
        <https://1145.am/db/2653777/T-Mobile_Usa>,
        <https://1145.am/db/2654246/T-Mobile_Us>,
        <https://1145.am/db/2654263/T-Mobile_Us>,
        <https://1145.am/db/2655150/T-Mobile_Us>,
        <https://1145.am/db/2655154/T-Mobile_Us>,
        <https://1145.am/db/2656030/T-Mobile_Us>,
        <https://1145.am/db/2656226/T-Mobile_Us>,
        <https://1145.am/db/2656851/T-Mobile_Usa>,
        <https://1145.am/db/2657573/T-Mobile_Usa>,
        <https://1145.am/db/2658024/T-Mobile_Us>,
        <https://1145.am/db/2658043/T-Mobile_Us>,
        <https://1145.am/db/2658068/T-Mobile_Us>,
        <https://1145.am/db/2658213/T-Mobile_Us>,
        <https://1145.am/db/2658466/T-Mobile_Usa>,
        <https://1145.am/db/2658550/T-Mobile_Usa>,
        <https://1145.am/db/2658574/T-Mobile_Usa>,
        <https://1145.am/db/2658575/T-Mobile_Usa>,
        <https://1145.am/db/2659586/T-Mobile_Usa>,
        <https://1145.am/db/2659597/T-Mobile_Usa>,
        <https://1145.am/db/2661143/T-Mobile_Us>,
        <https://1145.am/db/2661274/T-Mobile_Usa>,
        <https://1145.am/db/2661290/T-Mobile_Usa>,
        <https://1145.am/db/2661405/T-Mobile_Us>,
        <https://1145.am/db/2661443/T-Mobile_Us>,
        <https://1145.am/db/2661680/T-Mobile_Usa>,
        <https://1145.am/db/2662808/T-Mobile_Usa>,
        <https://1145.am/db/2662860/T-Mobile_Usa>,
        <https://1145.am/db/2663146/T-Mobile_Us>,
        <https://1145.am/db/2663406/T-Mobile_Usa>,
        <https://1145.am/db/2663421/T-Mobile_Usa>,
        <https://1145.am/db/2663473/T-Mobile_Usa>,
        <https://1145.am/db/2663892/T-Mobile_Usa>,
        <https://1145.am/db/2664422/T-Mobile_Us>,
        <https://1145.am/db/2664500/T-Mobile_Usa>,
        <https://1145.am/db/2664505/T-Mobile_Usa>,
        <https://1145.am/db/2664517/T-Mobile_Usa>,
        <https://1145.am/db/2664547/T-Mobile_Usa>,
        <https://1145.am/db/2664692/T-Mobile_Us>,
        <https://1145.am/db/2665477/T-Mobile_Us>,
        <https://1145.am/db/2665579/T-Mobile_Usa>,
        <https://1145.am/db/2666714/T-Mobile_Usa>,
        <https://1145.am/db/2667620/T-Mobile_Us>,
        <https://1145.am/db/2668208/T-Mobile_Usa>,
        <https://1145.am/db/2668212/T-Mobile_Usa>,
        <https://1145.am/db/2668226/T-Mobile_Usa>,
        <https://1145.am/db/2668687/T-Mobile_Us>,
        <https://1145.am/db/2668814/T-Mobile_Usa>,
        <https://1145.am/db/2669319/T-Mobile_Usa>,
        <https://1145.am/db/2669321/T-Mobile_Usa>,
        <https://1145.am/db/2669338/T-Mobile_Usa>,
        <https://1145.am/db/2669512/T-Mobile_Us>,
        <https://1145.am/db/2669881/T-Mobile_Usa>,
        <https://1145.am/db/2669920/T-Mobile_Usa>,
        <https://1145.am/db/2669926/T-Mobile_Usa>,
        <https://1145.am/db/2670397/T-Mobile_Usa>,
        <https://1145.am/db/2671029/T-Mobile_Usa>,
        <https://1145.am/db/2671585/T-Mobile_Usa>,
        <https://1145.am/db/2671623/T-Mobile_Usa>,
        <https://1145.am/db/2671629/T-Mobile_Usa>,
        <https://1145.am/db/2672184/T-Mobile_Usa>,
        <https://1145.am/db/2673934/T-Mobile_Usa>,
        <https://1145.am/db/2674405/T-Mobile_Us>,
        <https://1145.am/db/2675647/T-Mobile_Us>,
        <https://1145.am/db/2676846/T-Mobile_Us>,
        <https://1145.am/db/2677262/T-Mobile_Usa>,
        <https://1145.am/db/2677564/T-Mobile_Us>,
        <https://1145.am/db/2677884/T-Mobile_Us>,
        <https://1145.am/db/2678023/T-Mobile_Us>,
        <https://1145.am/db/2679803/T-Mobile_Usa>,
        <https://1145.am/db/2679871/T-Mobile_Us>,
        <https://1145.am/db/2680365/T-Mobile_Usa>,
        <https://1145.am/db/2681282/T-Mobile_Usa>,
        <https://1145.am/db/2681407/T-Mobile_Us>,
        <https://1145.am/db/2681734/T-Mobile_Us>,
        <https://1145.am/db/2681889/T-Mobile_Us>,
        <https://1145.am/db/2682066/T-Mobile_Usa>,
        <https://1145.am/db/2682450/T-Mobile_Us>,
        <https://1145.am/db/2682698/T-Mobile_Usa>,
        <https://1145.am/db/2683912/T-Mobile_Usa>,
        <https://1145.am/db/2684079/T-Mobile_Usa>,
        <https://1145.am/db/2684148/T-Mobile_Us>,
        <https://1145.am/db/2684705/T-Mobile_Usa>,
        <https://1145.am/db/2685202/T-Mobile_Usa>,
        <https://1145.am/db/2685245/T-Mobile_Usa>,
        <https://1145.am/db/2685254/T-Mobile_Usa>,
        <https://1145.am/db/2685267/T-Mobile_Usa>,
        <https://1145.am/db/2685271/T-Mobile_Usa>,
        <https://1145.am/db/2685285/T-Mobile_Usa>,
        <https://1145.am/db/2685505/T-Mobile_Usa>,
        <https://1145.am/db/2685618/T-Mobile_Usa>,
        <https://1145.am/db/2685624/T-Mobile_Usa>,
        <https://1145.am/db/2685654/T-Mobile_Usa>,
        <https://1145.am/db/2685762/T-Mobile_Usa>,
        <https://1145.am/db/2685783/T-Mobile_Usa>,
        <https://1145.am/db/2685799/T-Mobile_Usa>,
        <https://1145.am/db/2685811/T-Mobile_Usa>,
        <https://1145.am/db/2685884/T-Mobile_Usa>,
        <https://1145.am/db/2685930/T-Mobile_Usa>,
        <https://1145.am/db/2685940/T-Mobile_Usa>,
        <https://1145.am/db/2686023/T-Mobile_Usa>,
        <https://1145.am/db/2686200/T-Mobile_Usa>,
        <https://1145.am/db/398217/T-Mobile_Us>,
        <https://1145.am/db/461272/T-Mobile_Us_Inc>,
        <https://1145.am/db/479322/T-Mobile_Us>,
        <https://1145.am/db/480217/T-Mobile_Us>,
        <https://1145.am/db/662586/T-Mobile_Usa>,
        <https://1145.am/db/665472/T-Mobile_Usa>,
        <https://1145.am/db/667175/T-Mobile_Usa>,
        <https://1145.am/db/97818/T-Mobile_Us> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2293308/Crescendo_Series_C_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-09-12T13:49:20+00:00"^^xsd:dateTime ;
    ns1:documentExtract "If Myriad does ends up buying Crescendo, it would add a sixth disease specialty-rheumatology-to its portfolio.",
        "South San Francisco - based Crescendo Bioscience has raised $ 56 million as a result of completing a $ 31 million Series C equity financing round and entering an investment agreement with Myriad Genetics ($ MYGN) for $ 25 million that is accompanied by a three-year option to buy Crescendo." ;
    ns1:documentTitle "Crescendo raises $56M, enters pact with Myriad" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/crescendo-raises-56m-enters-pact-myriad> ;
    ns1:foundName "buy",
        "buying",
        "financing",
        "investment" ;
    ns1:name "buy",
        "buying",
        "financing",
        "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2293308/Crescendo> ;
    ns1:targetDetails "Series C" ;
    ns1:targetName "Crescendo" ;
    ns1:valueRaw "$ 25 million",
        "$ 31 million",
        "$ 56 million" ;
    ns1:whereGeoName "South San Francisco" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5397765/about.rdf> ;
    ns1:whereRaw "South San Francisco" .

<https://1145.am/db/2337767/Series_B_Investment_Capdecisif_2_Frci_(fonds_Régional_De_Co-Investissement_Dile-De-France)_Fa_Dièse_G1j_Ile-De-France_Innavirvax_Pradeyrol_Développement_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-14T16:47:59+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Evry (France) , February 12, 2012 - InnaVirVax, a biopharmaceutical company dedicated to the development of therapeutic and diagnostic solutions in pathologies associated with immune dysregulation, announced today the closing of a $ 4.9 million (€3.7 million) Series B round of funding.",
        "InnaVirVax lands $ 4.9 Million in Series B funding Round." ;
    ns1:documentTitle "InnaVirVax lands $4.9 Million in Series B funding Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/innavirvax-lands-4-9-million-series-b-funding-round> ;
    ns1:foundName "funding" ;
    ns1:name "funding" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2337767/Innavirvax> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 4.9 Million",
        "$ 4.9 million",
        "€3.7 million" ;
    ns1:whereGeoName "Republic of France" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:whereRaw "France" .

<https://1145.am/db/2340284/Series_A_Investment_Catalyst_Health_Ventures_Domain_Associates_Interwest_Partners_Osage_University_Partners_Sera_Prognostics_Upstart_Life_Sciences_Capital_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-11-21T12:07:55+00:00"^^xsd:dateTime ;
    ns1:documentExtract "SALT LAKE CITY, Nov. 15, 2011 (GLOBE NEWSWIRE) - Sera Prognostics, Inc., a women's health company developing diagnostic tests for early prediction of preterm birth and other pregnancy complications, today announced the closing of a $ 19.3 million Series A financing led by venture capital firms InterWest Partners, Domain Associates and Catalyst Health Ventures.",
        "Sera Prognostics Secures $ 19.3 Million Series A Funding to Commercialize Preterm Birth Predictor; Appoints Gregory C. Critchfield, MD as Chief Executive Officer." ;
    ns1:documentTitle "Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor; Appoints Gregory C. Critchfiel" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sera-prognostics-secures-19-3-million-series-a-funding-to-commercialize-preterm-birth> ;
    ns1:foundName "Funding",
        "financing" ;
    ns1:name "Funding",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2340284/Sera_Prognostics> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 19.3 Million",
        "$ 19.3 million" ;
    ns1:when "2011-11-15T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Nov. 15, 2011" ;
    ns1:whereGeoName "Salt Lake City" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5780993/about.rdf> ;
    ns1:whereRaw "SALT LAKE CITY" .

<https://1145.am/db/2353588/Series_B_Investment_Canaan_Partners_Care_Capital_Elevation_Pharmaceuticals_Mesa_Verde_Venture_Partners_Novo_Ventures_Tpg_Biotech_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-01-04T13:03:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Elevation Pharmaceuticals Completes $ 30 Million Series B Financing to Advance Aerosol COPD Therapy.",
        "Novo Ventures is very pleased to be able to support Elevation's efforts to improve the lives of COPD patients with our investment in the company's Series B financing ,\" said Dr. Lukatch.",
        "SAN DIEGO, Jan. 4, 2012 /PRNewswire/ - Elevation Pharmaceuticals, Inc. announced today the closing of a $ 30 million Series B financing, led by new investor Novo Ventures, to fund development of Elevation's new aerosol therapy for patients living with chronic obstructive pulmonary disease (COPD) ." ;
    ns1:documentTitle "Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/elevation-pharmaceuticals-completes-30-million-series-b-financing-to-advance-aerosol-copd-1> ;
    ns1:foundName "financing",
        "investment" ;
    ns1:name "financing",
        "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2353588/Elevation_Pharmaceuticals> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 30 Million",
        "$ 30 million" ;
    ns1:when "2012-01-04T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Jan. 4, 2012" ;
    ns1:whereGeoName "San Diego County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:whereRaw "SAN DIEGO" .

<https://1145.am/db/2353608/Series_B_Investment_Canaan_Partners_Care_Capital_Elevation_Pharmaceuticals_Mesa_Verde_Venture_Partners_Novo_Ventures_Tpg_Biotech_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-01-04T16:01:51+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Elevation Pharmaceuticals Completes $ 30 Million Series B Financing to Advance Aerosol COPD Therapy.",
        "Novo Ventures is very pleased to be able to support Elevation's efforts to improve the lives of COPD patients with our investment in the company's Series B financing ,\" said Dr. Lukatch.",
        "SAN DIEGO - Elevation Pharmaceuticals, Inc. announced today the closing of a $ 30 million Series B financing, led by new investor Novo Ventures, to fund development of Elevation's new aerosol therapy for patients living with chronic obstructive pulmonary disease (COPD) ." ;
    ns1:documentTitle "Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/elevation-pharmaceuticals-completes-30-million-series-b-financing-to-advance-aerosol-copd> ;
    ns1:foundName "financing",
        "investment" ;
    ns1:name "financing",
        "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2353608/Elevation_Pharmaceuticals> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 30 Million",
        "$ 30 million" ;
    ns1:whereGeoName "San Diego County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:whereRaw "SAN DIEGO" .

<https://1145.am/db/2357858/Series_A_Investment_5am_Ventures_Astellas_Venture_Management_Clarus_Ventures_Cleave_Biosciences_Orbimed_Advisors_Us_Venture_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-10-11T13:15:33+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Cleave Biosciences Raises $ 42 Million in Series A Financing for Novel Cancer Therapies.",
        "SAN FRANCISCO, Oct. 11, 2011 /PRNewswire via COMTEX/ - Cleave Biosciences, a newly established biopharmaceutical company discovering and developing novel therapies for cancer, announced today it has raised $ 42 million in Series A financing." ;
    ns1:documentTitle "Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cleave-biosciences-raises-42-million-series-a-financing-for-novel-cancer-therapies> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2357858/Cleave_Biosciences> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 42 Million",
        "$ 42 million" ;
    ns1:when "2011-10-11T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Oct. 11, 2011" ;
    ns1:whereGeoName "San Francisco" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391959/about.rdf> ;
    ns1:whereRaw "SAN FRANCISCO" .

<https://1145.am/db/2366079/Seed_Round_Investment_Comprehend_Systems_Crosslink_Capital_Garry_Tan_Quotidian_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-11-08T12:17:40+00:00"^^xsd:dateTime ;
    ns1:documentExtract "PALO ALTO, CALIF. - November 8, 2011 - Driven by increasing demand from drug and medical device developers for cost-effective and user-friendly data analytics tools, Comprehend Systems, Inc. closed $ 1.2 million in seed round funding to support further development of Comprehend ClinicalTM, its clinical data visualization and analytics software." ;
    ns1:documentTitle "COMPREHEND SYSTEMS SECURES $1.2MM IN SEED FUNDING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/comprehend-systems-secures-1-2mm-seed-funding> ;
    ns1:foundName "funding",
        "raises" ;
    ns1:name "funding",
        "raises" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2366079/Comprehend_Systems> ;
    ns1:targetDetails "seed",
        "seed round" ;
    ns1:valueRaw "$ 1.2 million",
        "$ 1.2MM" ;
    ns1:when "2011-11-08T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "November 8, 2011" ;
    ns1:whereGeoName "California" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5332921/about.rdf> ;
    ns1:whereRaw "CALIF" .

<https://1145.am/db/2443170/Equity_Investment_Anthem_Capital_Delphi_Ventures_Greenspring_Associates_Healthcare_Ventures_New_Enterprise_Associates_Sensors_For_Medicine_And_Science_Inc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-11-02T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "GERMANTOWN, MD /Marketwire/ - Sensors for Medicine and Science Inc. (SMSI) , a privately held medical device company, focused on the development and commercialization of the first fully implantable, long-term continuous glucose monitoring (CGM) system for people with diabetes, announced a $ 54.1 million Series D equity financing." ;
    ns1:documentTitle "SMSI Raises $54.1 Million Series D Financing" ;
    ns1:documentURL <https://www.fierceelectronics.com/embedded/smsi-raises-54-1-million-series-d-financing> ;
    ns1:foundName "financing",
        "funding" ;
    ns1:name "financing",
        "funding" ;
    ns1:sourceName "Fierce Electronics" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2443170/Sensors_For_Medicine_And_Science_Inc> ;
    ns1:targetDetails "equity" ;
    ns1:valueRaw "$ 54.1 million" ;
    ns1:whereGeoName "Germantown" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4356050/about.rdf> ;
    ns1:whereRaw "Germantown" .

<https://1145.am/db/2609875/Investment_Associated_Partners_Business_Media_China_Current_Enertech_Capital_Goldman_Sachs_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-09-15T15:04:16+00:00"^^xsd:dateTime ;
    ns1:documentExtract "With an emphasis on Europe and Asia, CURRENT has just received $ 13 million in new funding to develop new powerline - based products for metering, grid reliability, and transformer station communications." ;
    ns1:documentTitle "CURRENT gets $13M to target international smart grid prospects" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/current-gets-13m-to-target-international-smart-grid-prospects> ;
    ns1:foundName "funding" ;
    ns1:name "funding" ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2609875/Current> ;
    ns1:valueRaw "$ 13 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "U.S." .

<https://1145.am/db/2668825/Sprint_Nextel> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "debt" ;
    ns1:documentDate "2011-11-07T15:46:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sprint raises $4B in debt offering, hints at Clearwire funding" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/sprint-raises-4b-debt-offering-hints-at-clearwire-funding> ;
    ns1:foundName "Sprint Nextel" ;
    ns1:name "Sprint Nextel" ;
    ns1:sameAsHigh <https://1145.am/db/1700728/Sprint_Nextel>,
        <https://1145.am/db/2657041/T-Mobile>,
        <https://1145.am/db/2676993/Sprint_Nextel> ;
    ns1:sameAsMedium <https://1145.am/db/1922758/Sprint_Nextel>,
        <https://1145.am/db/2601654/Sprint_Nextel>,
        <https://1145.am/db/2603188/Sprint_Nextel>,
        <https://1145.am/db/2613768/Sprint_Nextel>,
        <https://1145.am/db/2618452/Sprint_Nextel>,
        <https://1145.am/db/2621979/Sprint_Nextel>,
        <https://1145.am/db/2623369/Sprint_Nextel>,
        <https://1145.am/db/2624044/Sprint_Nextel>,
        <https://1145.am/db/2624525/Sprint_Nextel>,
        <https://1145.am/db/2627059/Sprint_Nextel>,
        <https://1145.am/db/2628938/Sprint_Nextel>,
        <https://1145.am/db/2629073/Sprint_Nextel>,
        <https://1145.am/db/2630836/Sprint_Nextel>,
        <https://1145.am/db/2633820/Sprint_Nextel>,
        <https://1145.am/db/2635673/Sprint_Nextel>,
        <https://1145.am/db/2635753/Sprint_Nextel>,
        <https://1145.am/db/2636424/Sprint_Nextel>,
        <https://1145.am/db/2637760/Sprint_Nextel>,
        <https://1145.am/db/2638532/Sprint_Nextel>,
        <https://1145.am/db/2639658/Sprint_Nextel>,
        <https://1145.am/db/2640151/Sprint_Nextel>,
        <https://1145.am/db/2641693/Sprint_Nextel>,
        <https://1145.am/db/2642428/Sprint_Nextel>,
        <https://1145.am/db/2642478/Sprint_Nextel>,
        <https://1145.am/db/2643537/Sprint_Nextel>,
        <https://1145.am/db/2645284/Sprint_Nextel>,
        <https://1145.am/db/2645977/Sprint_Nextel>,
        <https://1145.am/db/2646748/Sprint_Nextel>,
        <https://1145.am/db/2650873/Sprint_Nextel>,
        <https://1145.am/db/2652311/Sprint_Nextel>,
        <https://1145.am/db/2655732/Sprint_Nextel>,
        <https://1145.am/db/2658291/Sprint_Nextel>,
        <https://1145.am/db/2658589/Sprint_Nextel>,
        <https://1145.am/db/2659586/Sprint_Nextel>,
        <https://1145.am/db/2659587/Sprint_Nextel>,
        <https://1145.am/db/2659594/Sprint_Nextel>,
        <https://1145.am/db/2659601/Sprint_Nextel>,
        <https://1145.am/db/2659616/Sprint_Nextel>,
        <https://1145.am/db/2659619/Sprint_Nextel>,
        <https://1145.am/db/2659620/Sprint_Nextel>,
        <https://1145.am/db/2661271/Sprint_Nextel>,
        <https://1145.am/db/2661312/Sprint_Nextel>,
        <https://1145.am/db/2661735/Sprint_Nextel>,
        <https://1145.am/db/2662872/Sprint_Nextel>,
        <https://1145.am/db/2663091/Sprint_Nextel>,
        <https://1145.am/db/2663421/Sprint_Nextel>,
        <https://1145.am/db/2663923/Sprint_Nextel>,
        <https://1145.am/db/2663931/Sprint_Nextel>,
        <https://1145.am/db/2663933/Sprint_Nextel>,
        <https://1145.am/db/2663948/Sprint_Nextel>,
        <https://1145.am/db/2664500/Sprint_Nextel>,
        <https://1145.am/db/2665296/Sprint_Nextel>,
        <https://1145.am/db/2665579/Sprint_Nextel>,
        <https://1145.am/db/2666088/Sprint_Nextel>,
        <https://1145.am/db/2666977/Sprint_Nextel>,
        <https://1145.am/db/2667152/Sprint_Nextel>,
        <https://1145.am/db/2668031/Sprint_Nextel>,
        <https://1145.am/db/2668249/Sprint_Nextel>,
        <https://1145.am/db/2669292/Sprint_Nextel>,
        <https://1145.am/db/2669341/Sprint_Nextel>,
        <https://1145.am/db/2669942/Sprint_Nextel>,
        <https://1145.am/db/2670436/Sprint_Nextel>,
        <https://1145.am/db/2670440/Sprint_Nextel>,
        <https://1145.am/db/2670504/Sprint_Nextel>,
        <https://1145.am/db/2671333/Sprint_Nextel>,
        <https://1145.am/db/2671590/Sprint_Nextel>,
        <https://1145.am/db/2671649/Sprint_Nextel>,
        <https://1145.am/db/2672759/Sprint_Nextel>,
        <https://1145.am/db/2672784/Sprint_Nextel>,
        <https://1145.am/db/2672793/Sprint_Nextel>,
        <https://1145.am/db/2673337/Sprint_Nextel>,
        <https://1145.am/db/2674457/Sprint_Nextel>,
        <https://1145.am/db/2674875/Sprint_Nextel>,
        <https://1145.am/db/2675179/Sprint_Nextel>,
        <https://1145.am/db/2675183/Sprint_Nextel>,
        <https://1145.am/db/2675704/Sprint_Nextel>,
        <https://1145.am/db/2676326/Sprint_Nextel>,
        <https://1145.am/db/2676361/Sprint_Nextel>,
        <https://1145.am/db/2676370/Sprint_Nextel>,
        <https://1145.am/db/2676975/Sprint_Nextel>,
        <https://1145.am/db/2677327/Sprint_Nextel>,
        <https://1145.am/db/2678562/Sprint_Nextel>,
        <https://1145.am/db/2678731/Sprint_Nextel>,
        <https://1145.am/db/2678748/Sprint_Nextel>,
        <https://1145.am/db/2678777/Sprint_Nextel>,
        <https://1145.am/db/2678781/Sprint_Nextel>,
        <https://1145.am/db/2679694/Sprint_Nextel>,
        <https://1145.am/db/2680061/Sprint_Nextel>,
        <https://1145.am/db/2681522/Sprint_Nextel>,
        <https://1145.am/db/2682580/Sprint_Nextel>,
        <https://1145.am/db/2682983/Sprint_Nextel>,
        <https://1145.am/db/2683612/Sprint_Nextel>,
        <https://1145.am/db/2683681/Sprint_Nextel>,
        <https://1145.am/db/2683726/Sprint_Nextel>,
        <https://1145.am/db/2684103/Sprint_Nextel>,
        <https://1145.am/db/2684413/Sprint_Nextel>,
        <https://1145.am/db/2684884/Sprint_Nextel>,
        <https://1145.am/db/2685112/Sprint_Nextel>,
        <https://1145.am/db/2685113/Sprint_Nextel>,
        <https://1145.am/db/2685267/Sprint_Nextel>,
        <https://1145.am/db/2686032/Sprint_Nextel>,
        <https://1145.am/db/2686200/Sprint_Nextel> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2344357/Series_D_Investment_Aurora_Funds_Harris___Harris_Group_Fletcher_Spaght_Fulcrum_Financial_Partners_Keating_Capital_Metabolon_Sevin_Rosen_Funds_Syngenta_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-08-31T12:06:31+00:00"^^xsd:dateTime ;
    ns1:documentExtract "RESEARCH TRIANGLE PARK, N.C.- (EON: Enhanced Online News) -Metabolon, Inc., a diagnostics and services company offering the industry's leading biochemical profiling technology, announced today that it has secured $ 13.1 million in a Series D financing." ;
    ns1:documentTitle "Metabolon Secures $13 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/metabolon-secures-13-million-series-d-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2344357/Metabolon> ;
    ns1:targetDetails "Series D" ;
    ns1:valueRaw "$ 13.1 million" ;
    ns1:whereGeoName "Park County",
        "Research",
        "Triangle" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2151718/about.rdf>,
        <https://sws.geonames.org/4790025/about.rdf>,
        <https://sws.geonames.org/5834587/about.rdf> ;
    ns1:whereRaw "RESEARCH TRIANGLE PARK" .

<https://1145.am/db/2358888/Investment_Dnanexus_Felicis_Ventures_First_Round_Capital_Google_Ventures_K9_Ventures_Softtech_Vc_Tpg_Biotech_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-10-12T14:14:42+00:00"^^xsd:dateTime ;
    ns1:documentExtract "DNAnexus Secures $ 15 Million Funding Led by Google Ventures and TPG Biotech.",
        "MOUNTAIN VIEW, Calif., Oct 12, 2011 (BUSINESS WIRE) - DNAnexus, a DNA data management and analysis platform, today announced that it has secured $ 15 million in second-round funding, led by Google Ventures and TPG Biotech." ;
    ns1:documentTitle "DNAnexus Secures $15 Million Funding Led by Google Ventures and TPG Biotech" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dnanexus-secures-15-million-funding-led-by-google-ventures-and-tpg-biotech> ;
    ns1:foundName "Funding",
        "funding" ;
    ns1:name "Funding",
        "funding" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2358888/Dnanexus> ;
    ns1:targetDetails "second" ;
    ns1:valueRaw "$ 15 Million",
        "$ 15 million" ;
    ns1:when "2011-10-12T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Oct 12, 2011" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2366049/Equity_Investment_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Henri_Termeer_Nanostring_Technologies_Ovp_Venture_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-11-07T13:21:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "SEATTLE- (BUSINESS WIRE) - NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it has closed $ 20 million in a Series D round of equity financing." ;
    ns1:documentTitle "NanoString Secures $20M in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-secures-20m-series-d-financing-0> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2366049/Nanostring_Technologies> ;
    ns1:targetDetails "equity" ;
    ns1:valueRaw "$ 20 million" ;
    ns1:whereGeoName "Seattle" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5809844/about.rdf> ;
    ns1:whereRaw "Seattle" .

<https://1145.am/db/2366055/Equity_Investment_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Healthymagination_Fund_Henri_Termeer_Nanostring_Technologies_Ovp_Venture_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-11-07T13:25:27+00:00"^^xsd:dateTime ;
    ns1:documentExtract "NanoString Secures $ 20M in Series D Financing.",
        "SEATTLE, Nov 07, 2011 (BUSINESS WIRE) - NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it has closed $ 20 million in a Series D round of equity financing." ;
    ns1:documentTitle "NanoString Secures $20M in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-secures-20m-series-d-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2366055/Nanostring_Technologies> ;
    ns1:targetDetails "Series D",
        "equity" ;
    ns1:valueRaw "$ 20 million",
        "$ 20M" ;
    ns1:when "2011-11-07T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Nov 07, 2011" ;
    ns1:whereGeoName "Seattle" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5809844/about.rdf> ;
    ns1:whereRaw "Seattle" .

<https://1145.am/db/2353610/Investment_Bb_Biotech_Biogen_Idec_New_Ventures_Edmond_De_Rothschild_Investment_Partners_Goodvent__Ibg_Hbm_Bioventures_Life_Sciences_Partners_Probiodrug_Ag_Tvm_Capital_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-01-04T16:04:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "HALLE/SAALE, Germany - Probiodrug AG today announced it has secured EUR 15 million additional financing for the ongoing development of its glutaminyl cyclase (QC) inhibitor program.",
        "Probiodrug AG Raises Additional EUR 15 Million to Advance Its Clinical Program." ;
    ns1:documentTitle "Probiodrug AG Raises Additional EUR 15 Million to Advance Its Clinical Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/probiodrug-ag-raises-additional-eur-15-million-to-advance-its-clinical-program> ;
    ns1:foundName "Raises",
        "financing" ;
    ns1:name "Raises",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2353610/Probiodrug_Ag> ;
    ns1:valueRaw "EUR 15 million" ;
    ns1:whereGeoName "Switzerland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:whereRaw "Switzerland" .

<https://1145.am/db/2338527/Investment_Celladon_Corporation_Enterprise_Partners_Venture_Capital_Gbs_Venture_Partners_H___Q_Healthcare_Life_Sciences_Investors_Johnson___Johnson_Development_Corporation_Lundbeckfond_Ventures_Novartis_Venture_Funds_Pfizer_Venture_Investments_Venrock_Associates_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-02-15T15:32:21+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Celladon Corporation Completes $ 43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure.",
        "LA JOLLA, Calif., Feb. 15, 2012 /PRNewswire via COMTEX/ - Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced today that it has completed a $ 43 million equity financing to advance its lead investigational product candidate MYDICAR® for the treatment of heart failure." ;
    ns1:documentTitle "Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/celladon-corporation-completes-43-million-financing-to-advance-mydicar%C2%AE-for-treatment-of> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2338527/Celladon_Corporation>,
        <https://1145.am/db/2338527/Mydicar> ;
    ns1:targetDetails "equity" ;
    ns1:targetName "MYDICAR" ;
    ns1:valueRaw "$ 43 Million",
        "$ 43 million" ;
    ns1:when "2012-02-15T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Feb. 15, 2012" ;
    ns1:whereGeoName "Berne",
        "La Jolla" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5108881/about.rdf>,
        <https://sws.geonames.org/5363943/about.rdf> ;
    ns1:whereRaw "Celladon Corporation",
        "LA JOLLA, Calif" .

<https://1145.am/db/2343244/Series_B_Investment_Biogeneration_Ventures_Credit_Agricole_Private_Equity_Erasmus_Biomedical_Fund_Forbion_Capital_Partners_Orbimed_Advisors_Seventure_Partners_Thuja_Capital_Vib_Argen-X_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-12-01T13:13:51+00:00"^^xsd:dateTime ;
    ns1:documentExtract "arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE AntibodyTM platform, announced today the closing of a EUR 27.5 million (USD 37 million) Series B fundraising round, which was oversubscribed." ;
    ns1:documentTitle "arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argen-x-raises-eur-27-5-million-usd-37-million-oversubscribed-series-b-round> ;
    ns1:foundName "fundraising" ;
    ns1:name "fundraising" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2343244/Argen-X> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "EUR 27.5 million",
        "USD 37 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "USA" .

<https://1145.am/db/2348448/Series_D_Investment_Bessemer_Venture_Partners_Cvf_Llc_Cerulean_Pharma_Inc_Henry_Crown_And_Company_Lilly_Ventures_Lux_Capital_Polaris_Venture_Partners_Venrock_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-12-15T14:20:23+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, Mass., Dec 15, 2011 (BUSINESS WIRE) - Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that it has closed a $ 15 million Series D financing with participation from new investor, CVF, LLC, an affiliate of Henry Crown and Company of Chicago, Illinois, as well as full participation from all other existing investors, including Polaris Venture Partners, Venrock, Lilly Ventures, Lux Capital, and Bessemer Venture Partners.",
        "Cerulean Pharma Closes $ 15 Million Series D Financing." ;
    ns1:documentTitle "Cerulean Pharma Closes $15 Million Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cerulean-pharma-closes-15-million-series-d-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2348448/Cerulean_Pharma_Inc> ;
    ns1:targetDetails "Series D" ;
    ns1:valueRaw "$ 15 Million",
        "$ 15 million" ;
    ns1:whenRaw "2011" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "CAMBRIDGE, Mass." .

<https://1145.am/db/2339419/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-11-17T14:21:08+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Biocartis, a company developing and commercializing compact molecular diagnostic (MDx) systems designed to drive the widespread adoption of personalized medicine and other applications including the improved diagnosis of infectious disease, announced today the completion of EUR 71 million (USD 100 million) Series C equity fund raising backed by existing investors, new investors and industrial collaborators and partners." ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising-0> ;
    ns1:foundName "fund raising" ;
    ns1:name "fund raising" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2339419/Biocartis> ;
    ns1:targetDetails "Series C",
        "equity" ;
    ns1:valueRaw "EUR 71 million",
        "USD 100 million" .

<https://1145.am/db/2339425/Series_C_Investment_Biocartis_Biovest_Debiopharm_Group_Ihl_Sa_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Valiance_Wellcome_Trust_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-11-17T14:39:45+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising.",
        "Biocartis, a company developing and commercializing compact molecular diagnostic (MDx) systems designed to drive the widespread adoption of personalized medicine and other applications including the improved diagnosis of infectious disease, announced today the completion of EUR 71 million (USD 100 million) Series C equity fund raising backed by existing investors, new investors and industrial collaborators and partners." ;
    ns1:documentTitle "Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-eur-71-million-usd-100-million-series-c-fund-raising> ;
    ns1:foundName "Raising",
        "fund raising" ;
    ns1:name "Raising",
        "fund raising" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2339425/Biocartis> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "EUR 71 Million",
        "EUR 71 million",
        "USD 100 Million",
        "USD 100 million" .

